Psyllid ID: psy17952

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800----
Protein Sequence
MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAAEEGEEPRTTLPLFGRHQLSPNNRRNICR
Secondary Structure (PSIPRED)
cHHHHHHHHHccccccccEEEEEEEccEEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEcccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccHHHHHHHcccccccccEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHccccccccEEEEEEEccEEEEEEEcccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccEEEEcccccccccccccccccccccHHHHHHccccccccccccHHcccHHHHHHHccccccccccHHHHHHHHHccccccccccccHHHHHHHccccccccccccHHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHcccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccHHHHHHHHHHHHHHHcccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHcccccEEEEEEEEcccccEEEEEEHcccccHHHHHHcHccccHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEcccccEEEccHHHcccccccccEEEEEEEccHHHHHccccccccHHHHHHHHHHHHHHHHcccccccccccccEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEccccccccccHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEHccccccHHHcccccccccccccHHHHHHHHHHHcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccccccccccEEEEEEEcccHHHcccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccHHHcccccccccccccccccccccccccccHHHHHHHHHHHcccccccHHHHHcccccccccHHEHHccccccHHHHHHHHHccccccHHHHHHHHHHHccccccEEEEEEccccccccccccccEEEEHHHccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEEEEcccHccccccccccccccEEEccEEEEcccccccccccccccccccccccEEEEEEcHHHHHHHHHHHcHHHcccccccEEEEEHHHHHHHHHHccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mpagssllrqlkhpntieyrgcylrdHTAWLVMEYCLGSASDIIevhkrplkeEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNilltetgtvkladfgsasikcpansfvgtpywmapEVILamdegqydgkvdvwslgitpgslkdpeiaelfdkedpeKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQlkhpntieyrgcylrdHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFnfevhkrplkeEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNilltetgtvkladfgsasikcpansfvgtpywmapEVILamdegqydgkvDVWSLGITCIElaerkppyfnmnAMSALYHIaqndtpclqssdwsVIKTISstaerkppyfnmnAMSALYHIaqndtpclqssdwsdTFAHFVSSClaknpadrpssgrllthdlvtrprspsVLVDLIRRTKAAVRDLDNLNYRKMKKILMadgadtestidpddtpdeqagndssksnsitsehsvqsvgvgvnphdptpnsssqahnrhhhhhpvthlsqhsynnnnsnysslfspQLVMEYCLGSASDIIevhkrplkeEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIlltetgtvkldtpdeqagndssksnsitsehsvqsvgvgvnphdptpnsssqahnrhhhhhpvTHLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAAeegeeprttlplfgrhqlspnnrrnicr
Flexible Loop (DISEMBL)
MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRqlkhpntieYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISStaerkppyFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAknpadrpssgrllthdlvtrprspsvlvdlirrtkaavrdldnlnyrKMKKILMADGADTESTIDPDDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTetgtvkldtpdeqagndssksnsitSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAAEEGeeprttlplfgrhqlspnnrrnicr
Low Complexity Region (SEG)
MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNsssqahnrhhhhhpvthlsqhsynnnnsnyssLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAhnrhhhhhpvthLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAAEEGEEPRTTLPLFGRHQLSPNNRRNICR
Disordered region (IsUnstruct)
************HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA***************DLV*****PSVLVDLIRRTKAAVRDLDNLNYRKMKKIL************************************************************************************LFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV*******************************************************THLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAA****************************
Disordered Region (DISOPRED)
MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAE****ED*EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRR************************ADTESTIDPDDTPDEQAGNDSSKSNSITSEHSVQS***********PNSSSQAHNRHHHHHP**********NNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEE***********************************
Disordered Region (DISEMBL)
MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDD**************************VGVNPHD**********************SQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTP************************VGVNPHD*****************PVTHLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAAEEGEEPRTTLPLFGRHQLSPNNRRNICR
Disordered Region (DISPRO)
MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNS*********HHHPVTHLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAAEEGEEPRTTLPLFGRHQLSP******C*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLIAVGAGEMWARAVWTGIETAVDTRGHIIVVQEEEVIMWAAEEGEEPRTTLPLFGRHQLSPNNRRNICR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	804	2.2.26 [Sep-21-2011]
O88664	1001	Serine/threonine-protein	yes	N/A	0.389	0.312	0.612	1e-135
Q5F2E8	1001	Serine/threonine-protein	yes	N/A	0.389	0.312	0.612	1e-135
Q7L7X3	1001	Serine/threonine-protein	yes	N/A	0.389	0.312	0.612	1e-134
Q53UA7	898	Serine/threonine-protein	no	N/A	0.391	0.350	0.601	1e-134
Q9I9E0	898	Serine/threonine-protein	no	N/A	0.437	0.391	0.576	1e-133
Q8BYC6	898	Serine/threonine-protein	no	N/A	0.391	0.350	0.591	1e-132
Q6DD27	896	Serine/threonine-protein	N/A	N/A	0.427	0.383	0.569	1e-132
Q9H2K8	898	Serine/threonine-protein	no	N/A	0.391	0.350	0.598	1e-132
Q5R4F3	898	Serine/threonine-protein	no	N/A	0.391	0.350	0.598	1e-132
Q7ZYJ0	1001	Serine/threonine-protein	N/A	N/A	0.389	0.312	0.596	1e-131

>sp|O88664|TAOK1_RAT Serine/threonine-protein kinase TAO1 OS=Rattus norvegicus GN=Taok1 PE=1 SV=1

 Score =  482 bits (1240), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 237/387 (61%), Positives = 270/387 (69%), Gaps = 74/387 (19%)

Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           GSLKDPEIAELF KEDPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  
Sbjct: 8   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQST 67

Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
           EKW DI+KE++FL+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVH        
Sbjct: 68  EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-------- 119

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                                    K+PL+E EIAAI  G L+GL YLHS   IHRD+KA
Sbjct: 120 -------------------------KKPLQEVEIAAITHGALQGLAYLHSHTMIHRDIKA 154

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           GNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT
Sbjct: 155 GNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           CIELAERKPP FNMNAMSALYHIAQN++P LQS++W                        
Sbjct: 215 CIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW------------------------ 250

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                            SD F +FV SCL K P DRP+S  LL H  V R R  +VL+DL
Sbjct: 251 -----------------SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDL 293

Query: 504 IRRTKAAVRDLDNLNYRKMKKILMADG 530
           I+RTK AVR+LDNL YRKMKK+L  + 
Sbjct: 294 IQRTKDAVRELDNLQYRKMKKLLFQEA 320

Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade.
Rattus norvegicus (taxid: 10116)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q5F2E8|TAOK1_MOUSE Serine/threonine-protein kinase TAO1 OS=Mus musculus GN=Taok1 PE=1 SV=1

 Score =  481 bits (1238), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 237/387 (61%), Positives = 270/387 (69%), Gaps = 74/387 (19%)

Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           GSLKDPEIAELF KEDPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  
Sbjct: 8   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQST 67

Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
           EKW DI+KE++FL+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVH        
Sbjct: 68  EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-------- 119

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                                    K+PL+E EIAAI  G L+GL YLHS   IHRD+KA
Sbjct: 120 -------------------------KKPLQEVEIAAITHGALQGLAYLHSHTMIHRDIKA 154

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           GNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT
Sbjct: 155 GNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           CIELAERKPP FNMNAMSALYHIAQN++P LQS++W                        
Sbjct: 215 CIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW------------------------ 250

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                            SD F +FV SCL K P DRP+S  LL H  V R R  +VL+DL
Sbjct: 251 -----------------SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDL 293

Query: 504 IRRTKAAVRDLDNLNYRKMKKILMADG 530
           I+RTK AVR+LDNL YRKMKK+L  + 
Sbjct: 294 IQRTKDAVRELDNLQYRKMKKLLFQEA 320

Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7L7X3|TAOK1_HUMAN Serine/threonine-protein kinase TAO1 OS=Homo sapiens GN=TAOK1 PE=1 SV=1

 Score =  481 bits (1237), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 237/387 (61%), Positives = 270/387 (69%), Gaps = 74/387 (19%)

Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           GSLKDPEIAELF KEDPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  
Sbjct: 8   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQST 67

Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
           EKW DI+KE++FL+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVH        
Sbjct: 68  EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-------- 119

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                                    K+PL+E EIAAI  G L+GL YLHS   IHRD+KA
Sbjct: 120 -------------------------KKPLQEVEIAAITHGALQGLAYLHSHTMIHRDIKA 154

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           GNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT
Sbjct: 155 GNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           CIELAERKPP FNMNAMSALYHIAQN++P LQS++W                        
Sbjct: 215 CIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW------------------------ 250

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                            SD F +FV SCL K P DRP+S  LL H  V R R  +VL+DL
Sbjct: 251 -----------------SDYFRNFVDSCLQKIPQDRPTSEELLKHIFVLRERPETVLIDL 293

Query: 504 IRRTKAAVRDLDNLNYRKMKKILMADG 530
           I+RTK AVR+LDNL YRKMKK+L  + 
Sbjct: 294 IQRTKDAVRELDNLQYRKMKKLLFQEA 320

Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q53UA7|TAOK3_RAT Serine/threonine-protein kinase TAO3 OS=Rattus norvegicus GN=Taok3 PE=2 SV=1

 Score =  478 bits (1230), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 234/389 (60%), Positives = 265/389 (68%), Gaps = 74/389 (19%)

Query: 141 ITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           +  G LKDPEIAELF KEDPE++F DL EIGHGSFGAVY+A    + E+VAIKKMSY GK
Sbjct: 1   MRKGVLKDPEIAELFFKEDPEELFIDLHEIGHGSFGAVYFATNAHTNEVVAIKKMSYSGK 60

Query: 201 QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIERE 260
           Q  EKW DILKE+RFL+QLKHPNTIEY+GCYL++HTAWLVMEYCLGSASD++EVH     
Sbjct: 61  QTHEKWQDILKEVRFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH----- 115

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
                                       K+PL+E EIAAI  G L+GL YLH    IHRD
Sbjct: 116 ----------------------------KKPLQEVEIAAITHGALQGLAYLHFHSLIHRD 147

Query: 321 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           +KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVD+WSL
Sbjct: 148 IKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDEGQYDGKVDIWSL 207

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GITCIELAERKPP FNMNAMSALYHIAQND+P LQS +W                     
Sbjct: 208 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSREW--------------------- 246

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                               +D+F  FV  CL K P +RP++  LL HD + R R P VL
Sbjct: 247 --------------------TDSFRRFVDYCLHKIPQERPAAAELLRHDFIRRERPPRVL 286

Query: 501 VDLIRRTKAAVRDLDNLNYRKMKKILMAD 529
           +DLI+RTK AVR+LDNL YRKMKKIL  +
Sbjct: 287 IDLIQRTKDAVRELDNLQYRKMKKILFQE 315

Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of MAPK8/JNK cascade and diminishes its activation in response epidermal growth factor (EGF).

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus GN=TAOK3 PE=2 SV=2

 Score =  477 bits (1227), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 246/427 (57%), Positives = 285/427 (66%), Gaps = 75/427 (17%)

Query: 141 ITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           +  G  KDPEIA+LF K+DPE+IF  L EIGHGSFGAVY+A    + E+VA+KKMSY GK
Sbjct: 1   MRKGVPKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK 60

Query: 201 QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIERE 260
           Q  EKW DI+KE++FL+QLKHPNTIEY+GCYL++HTAWLVMEYCLGSASD++EVH     
Sbjct: 61  QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDMLEVH----- 115

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
                                       K+PL+E EIAAI  G L+GL YLHS  +IHRD
Sbjct: 116 ----------------------------KKPLQEVEIAAITHGALQGLAYLHSHCKIHRD 147

Query: 321 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           +KAGNILLTE G VKLADFGSASI  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL
Sbjct: 148 IKAGNILLTEPGQVKLADFGSASIVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 207

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GITCIELAERKPP FNMNAMSALYHIAQND+P LQS++W                     
Sbjct: 208 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW--------------------- 246

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                               SD+F  FV  CL K P +RPSS  LL HD V R R P VL
Sbjct: 247 --------------------SDSFRGFVDYCLQKIPQERPSSADLLRHDFVRRDRPPRVL 286

Query: 501 VDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAG-NDSSKSNSITS 559
           +DLI+RTK AVR+LDNL YRKMKKIL  +  +   T   ++  D + G N S K +S+ S
Sbjct: 287 IDLIQRTKDAVRELDNLQYRKMKKILFQETRNGPLTESQEEEEDSEHGSNLSRKMDSLGS 346

Query: 560 EHSVQSV 566
            HS+ S+
Sbjct: 347 NHSIPSM 353

Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP kinase kinases. Inhibits basal activity of MAPK8/JNK cascade.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BYC6|TAOK3_MOUSE Serine/threonine-protein kinase TAO3 OS=Mus musculus GN=Taok3 PE=1 SV=2

 Score =  473 bits (1218), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 230/389 (59%), Positives = 266/389 (68%), Gaps = 74/389 (19%)

Query: 141 ITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           +  G+LKDPEIA+LF K+DPE++F DL EIGHGSFGAVY+A    + E+VA+KKMSY GK
Sbjct: 1   MRKGALKDPEIADLFFKDDPEELFIDLHEIGHGSFGAVYFATNAHTNEVVAVKKMSYSGK 60

Query: 201 QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIERE 260
           Q  EKW DILKE++FL+QLKHPNTIEY+GCYL++HTAWLVMEYCLGSASD++EVH     
Sbjct: 61  QTHEKWQDILKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH----- 115

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
                                       K+PL+E EIAAI  G L+GL YLH    IHRD
Sbjct: 116 ----------------------------KKPLQEVEIAAITHGALQGLAYLHFHSLIHRD 147

Query: 321 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           +KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVD+WSL
Sbjct: 148 IKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDEGQYDGKVDIWSL 207

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GITCIELAERKPP FNMNAMSALYHIAQND+P LQS +W                     
Sbjct: 208 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSREW--------------------- 246

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                               +D+F  FV  CL K P +RP++  LL HD + R R P VL
Sbjct: 247 --------------------TDSFRRFVDYCLHKIPQERPAAVELLRHDFIRRERPPKVL 286

Query: 501 VDLIRRTKAAVRDLDNLNYRKMKKILMAD 529
           +DLI+RTK AVR+LDNL YRKMKKIL  +
Sbjct: 287 IDLIQRTKDAVRELDNLQYRKMKKILFQE 315

Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of MAPK8/JNK cascade and diminishes its activation in response epidermal growth factor (EGF).

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6DD27|TAOK3_XENLA Serine/threonine-protein kinase TAO3 OS=Xenopus laevis GN=taok3 PE=2 SV=1

 Score =  473 bits (1216), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 241/423 (56%), Positives = 281/423 (66%), Gaps = 79/423 (18%)

Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           G +KDP+ A+LF KEDPE+IF DL EIGHGSFGAVY+A    + EIVA+KKMSY GKQ  
Sbjct: 4   GLVKDPDNADLFCKEDPERIFVDLHEIGHGSFGAVYFATNSTTNEIVAVKKMSYSGKQMN 63

Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
           EKW DI+KE++FL+QLKHPNTIEY+GCYL+DHTAWLVMEYCLGSASD++EVH        
Sbjct: 64  EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKDHTAWLVMEYCLGSASDLLEVH-------- 115

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                                    K+PL+E EIAAI  G L+GL YLHS   IHRD+KA
Sbjct: 116 -------------------------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 150

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           GNILLTE G VKLADFGSAS   PANSFVGTPYWMAPEVILAMDEGQYDGK+D+WSLGIT
Sbjct: 151 GNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKIDIWSLGIT 210

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           CIELAERKPP FNMNAMSALYHIAQN++P LQS++W                        
Sbjct: 211 CIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW------------------------ 246

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                            +D+F  FV  CL K P +RP+S  LL HD V R R   VL+DL
Sbjct: 247 -----------------TDSFKGFVDYCLQKLPQERPASLELLRHDFVWRERPARVLIDL 289

Query: 504 IRRTKAAVRDLDNLNYRKMKKILMAD---GADTESTIDPDDTPDEQAGNDSSKSNSITSE 560
           I+RTK AVR+LDNL YRKMKKIL  +   G   ES  D +D+  E   + + K +S+ S 
Sbjct: 290 IQRTKDAVRELDNLQYRKMKKILFQESRNGPLNESQEDDEDS--EHGTSLTRKMDSLGSN 347

Query: 561 HSV 563
           HS+
Sbjct: 348 HSI 350

Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP kinase kinases. Inhibits basal activity of MAPK8/JNK cascade.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9H2K8|TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens GN=TAOK3 PE=1 SV=2

 Score =  473 bits (1216), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 233/389 (59%), Positives = 264/389 (67%), Gaps = 74/389 (19%)

Query: 141 ITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           +  G LKDPEIA+LF K+DPE++F  L EIGHGSFGAVY+A    + E+VAIKKMSY GK
Sbjct: 1   MRKGVLKDPEIADLFYKDDPEELFIGLHEIGHGSFGAVYFATNAHTSEVVAIKKMSYSGK 60

Query: 201 QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIERE 260
           Q  EKW DILKE++FLRQLKHPNTIEY+GCYL++HTAWLVMEYCLGSASD++EVH     
Sbjct: 61  QTHEKWQDILKEVKFLRQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH----- 115

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
                                       K+PL+E EIAAI  G L GL YLHS   IHRD
Sbjct: 116 ----------------------------KKPLQEVEIAAITHGALHGLAYLHSHALIHRD 147

Query: 321 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           +KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVD+WSL
Sbjct: 148 IKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDEGQYDGKVDIWSL 207

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GITCIELAERKPP FNMNAMSALYHIAQND+P LQS++W                     
Sbjct: 208 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW--------------------- 246

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                               +D+F  FV  CL K P +RP+S  LL HD V R R   VL
Sbjct: 247 --------------------TDSFRRFVDYCLQKIPQERPTSAELLRHDFVRRDRPLRVL 286

Query: 501 VDLIRRTKAAVRDLDNLNYRKMKKILMAD 529
           +DLI+RTK AVR+LDNL YRKMKKIL  +
Sbjct: 287 IDLIQRTKDAVRELDNLQYRKMKKILFQE 315

Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of MAPK8/JNK cascade and diminishes its activation in response epidermal growth factor (EGF).

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5R4F3|TAOK3_PONAB Serine/threonine-protein kinase TAO3 OS=Pongo abelii GN=TAOK3 PE=2 SV=1

 Score =  471 bits (1213), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 233/389 (59%), Positives = 263/389 (67%), Gaps = 74/389 (19%)

Query: 141 ITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           +  G LKDPEIA+LF K+DPE++F  L EIGHGSFGAVY+A    + E+VAIKKMSY GK
Sbjct: 1   MRKGVLKDPEIADLFYKDDPEELFIGLHEIGHGSFGAVYFATNAHTNEVVAIKKMSYSGK 60

Query: 201 QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIERE 260
           Q  EKW DILKE++FLRQLKHPNTIEY+GCYL++HTAWLVMEYCLGSASD++EVH     
Sbjct: 61  QTHEKWQDILKEVKFLRQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH----- 115

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
                                       K+PL+E EIAAI  G L GL YLHS   IHRD
Sbjct: 116 ----------------------------KKPLQEVEIAAITHGALHGLAYLHSHALIHRD 147

Query: 321 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           +KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL
Sbjct: 148 IKAGNILLTEPGQVKLADFGSASVASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 207

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GITCIELAERKP  FNMNAMSALYHIAQND+P LQS++W                     
Sbjct: 208 GITCIELAERKPALFNMNAMSALYHIAQNDSPTLQSNEW--------------------- 246

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                               +D+F  FV  CL K P +RP+S  LL HD V R R   VL
Sbjct: 247 --------------------TDSFRRFVDYCLQKIPQERPTSAELLRHDFVRRDRPLRVL 286

Query: 501 VDLIRRTKAAVRDLDNLNYRKMKKILMAD 529
           +DLI+RTK AVR+LDNL YRKMKKIL  +
Sbjct: 287 IDLIQRTKDAVRELDNLQYRKMKKILFQE 315

Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of MAPK8/JNK cascade and diminishes its activation in response epidermal growth factor (EGF).

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7ZYJ0|TAO1B_XENLA Serine/threonine-protein kinase TAO1-B OS=Xenopus laevis GN=taok1-b PE=2 SV=1

 Score =  471 bits (1211), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 231/387 (59%), Positives = 268/387 (69%), Gaps = 74/387 (19%)

Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           GSLKDP++AELF ++DPEK+F DLREIGHGSFGAVY+A    + E+VAIKKMSY GKQ  
Sbjct: 8   GSLKDPDVAELFFRDDPEKLFSDLREIGHGSFGAVYFAHDARTSEVVAIKKMSYSGKQSN 67

Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
           EKW DI+KE++FL++++HPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVH        
Sbjct: 68  EKWQDIIKEVKFLQRIQHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-------- 119

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                                    K+PL+E EIAAI  G L+GL YLHS   IHRD+KA
Sbjct: 120 -------------------------KKPLQEIEIAAITHGALQGLAYLHSHNLIHRDIKA 154

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           GNILLTE G VKLADFGSASI  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT
Sbjct: 155 GNILLTEPGQVKLADFGSASIVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           C+ELAERKPP FNMNAMSALYHIAQN++P LQS++W                        
Sbjct: 215 CVELAERKPPLFNMNAMSALYHIAQNESPTLQSTEW------------------------ 250

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                            SD F +FV SCL K P DRP+S  LL H  V R R  +VL+DL
Sbjct: 251 -----------------SDYFRNFVDSCLHKIPQDRPTSDELLKHMFVLRERPETVLIDL 293

Query: 504 IRRTKAAVRDLDNLNYRKMKKILMADG 530
           I+RTK AVR+LDNL YRKMKK+L  + 
Sbjct: 294 IQRTKDAVRELDNLQYRKMKKLLFQEA 320

Serine/threonine-protein kinase involved in various processes such as p38/mapk14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of upstream MAP kinase kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	804
242010515	903	predicted protein [Pediculus humanus cor	0.437	0.389	0.728	0.0
332023435	897	Serine/threonine-protein kinase TAO1 [Ac	0.461	0.413	0.689	1e-179
380016628	897	PREDICTED: serine/threonine-protein kina	0.461	0.413	0.685	1e-178
307207950	896	Serine/threonine-protein kinase TAO1 [Ha	0.461	0.414	0.681	1e-178
307174672	897	Serine/threonine-protein kinase TAO1 [Ca	0.461	0.413	0.685	1e-177
322790303	902	hypothetical protein SINV_80069 [Solenop	0.461	0.411	0.682	1e-177
328793690	1079	PREDICTED: serine/threonine-protein kina	0.461	0.343	0.685	1e-176
345493111	973	PREDICTED: serine/threonine-protein kina	0.481	0.397	0.658	1e-175
383852655	897	PREDICTED: serine/threonine-protein kina	0.461	0.413	0.676	1e-175
345493113	895	PREDICTED: serine/threonine-protein kina	0.481	0.432	0.658	1e-175

>gi|242010515|ref|XP_002426013.1| predicted protein [Pediculus humanus corporis] gi|212510004|gb|EEB13275.1| predicted protein [Pediculus humanus corporis]

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/427 (72%), Positives = 331/427 (77%), Gaps = 75/427 (17%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCL++REIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLLTREIVAIKKMSYLGKQS 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQLKHPNTIEY+GC+LRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  LEKWQDILKEIRFLRQLKHPNTIEYKGCFLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKEEEIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 120 --------------------------KRPLKEEEIAAICEGVLRGLSYLHSLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TC+ELAERKPPYFNMNAMSALYHIAQNDTP LQSS+W                       
Sbjct: 214 TCVELAERKPPYFNMNAMSALYHIAQNDTPQLQSSEW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             S+ F HFV SCL KNP +RP+SG+LL+H LVTR RS  VL+D
Sbjct: 251 ------------------SEVFRHFVDSCLKKNPNERPTSGKLLSHQLVTRQRSSHVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI+RTKAAVR+LDNLNYRKMKKILM D ++ EST+ D DDTPDEQAG DSSKSNSITSEH
Sbjct: 293 LIQRTKAAVRELDNLNYRKMKKILMVDSSENESTVGDADDTPDEQAGGDSSKSNSITSEH 352

Query: 562 SVQSVGV 568
           S+ S+GV
Sbjct: 353 SIHSMGV 359

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332023435|gb|EGI63678.1| Serine/threonine-protein kinase TAO1 [Acromyrmex echinatior]

 Score =  636 bits (1640), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 316/458 (68%), Positives = 335/458 (73%), Gaps = 87/458 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELF+K DPEKIFEDLREIGHGSFGAVYYARCLV++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFEKNDPEKIFEDLREIGHGSFGAVYYARCLVTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQL HPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  VEKWQDILKEIRFLRQLNHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKEEEIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 120 --------------------------KRPLKEEEIAAICEGVLRGLHYLHSLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQNDTP L S DW                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNDTPTLNSPDW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             +D F HFV  CL K+P +RP+SG+LL+H  VTRPRSP VL+D
Sbjct: 251 ------------------TDIFRHFVEVCLTKSPIERPTSGKLLSHQFVTRPRSPQVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI+RTKAAVR+LDNLNYRKMKKILM D  +TEST+ D DDTPDEQ G DSSKSNSITSEH
Sbjct: 293 LIQRTKAAVRELDNLNYRKMKKILMIDACETESTVGDADDTPDEQTGGDSSKSNSITSEH 352

Query: 562 SVQSVGVGVNPHD------PTPN------SSSQAHNRH 587
           S+ S+GV  +         P PN      SS    NRH
Sbjct: 353 SIHSMGVSASSQSSSTNSLPLPNADGNDYSSGSVRNRH 390

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380016628|ref|XP_003692280.1| PREDICTED: serine/threonine-protein kinase TAO1-like [Apis florea]

 Score =  632 bits (1631), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 314/458 (68%), Positives = 334/458 (72%), Gaps = 87/458 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELF+K DPEKIFEDLREIGHGSFGAVYYARCLV++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFEKNDPEKIFEDLREIGHGSFGAVYYARCLVTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQL HPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  VEKWQDILKEIRFLRQLNHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKE+EIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 120 --------------------------KRPLKEDEIAAICEGVLRGLHYLHSLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQNDTP L S DW                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNDTPTLNSPDW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             SD F HFV  CL K+P +RP+SG+LL+H  VTR RSP VL+D
Sbjct: 251 ------------------SDVFRHFVEVCLTKSPTERPASGKLLSHQFVTRTRSPQVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI+RTKAAVR+LDNLNYRKMKKILM D  +TEST+ D DDTPDEQ G DSSKSNSITSEH
Sbjct: 293 LIQRTKAAVRELDNLNYRKMKKILMIDACETESTVGDADDTPDEQTGGDSSKSNSITSEH 352

Query: 562 SVQSVGVGVNPHD------PTPN------SSSQAHNRH 587
           S+ S+GV  +         P PN      S+    NRH
Sbjct: 353 SIHSMGVSASSQSSSTNSLPLPNADANDYSTGSVRNRH 390

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307207950|gb|EFN85509.1| Serine/threonine-protein kinase TAO1 [Harpegnathos saltator]

 Score =  632 bits (1630), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 312/458 (68%), Positives = 335/458 (73%), Gaps = 87/458 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELF+K DPEKIFEDLREIGHGSFGAVYYARCLV++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFEKNDPEKIFEDLREIGHGSFGAVYYARCLVTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQL HPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  VEKWQDILKEIRFLRQLNHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKE+EIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 120 --------------------------KRPLKEDEIAAICEGVLRGLHYLHSLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSAS+KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASVKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQNDTP L S DW                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNDTPTLNSPDW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             +D F HFV  CL K+P +RP+SG+LL+H  VTR RSP VL+D
Sbjct: 251 ------------------TDVFRHFVEVCLTKSPIERPTSGKLLSHQFVTRTRSPQVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI+RTKAAVR+LDNLNYRKMKKILM D  +TEST+ D DDTPDEQ G DSSKSNSITSEH
Sbjct: 293 LIQRTKAAVRELDNLNYRKMKKILMIDACETESTVGDTDDTPDEQTGGDSSKSNSITSEH 352

Query: 562 SVQSVGVGVNPHD------PTPNSSSQAH------NRH 587
           S+ S+GV  +         P PN+ S  +      NRH
Sbjct: 353 SIHSIGVSASSQSSSTNSLPLPNADSNDYSTGSVRNRH 390

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307174672|gb|EFN65055.1| Serine/threonine-protein kinase TAO1 [Camponotus floridanus]

 Score =  630 bits (1624), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 314/458 (68%), Positives = 333/458 (72%), Gaps = 87/458 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELF+K DPEKIFEDLREIGHGSFGAVYYARCLV++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFEKNDPEKIFEDLREIGHGSFGAVYYARCLVTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQL HPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  VEKWQDILKEIRFLRQLNHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKEEEIAAIC GVLRGLNYLH+LGRIHRDVK
Sbjct: 120 --------------------------KRPLKEEEIAAICDGVLRGLNYLHNLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQNDTP L S DW                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNDTPTLNSPDW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             +D F HFV  CL K+P +R +SG+LL+H  VTR RSP VL+D
Sbjct: 251 ------------------TDVFRHFVEVCLTKSPIERLTSGKLLSHPFVTRSRSPQVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI+RTKAAVR+LDNLNYRKMKKILM D  +TEST+ D DDTPDEQ G DSSKSNSITSEH
Sbjct: 293 LIQRTKAAVRELDNLNYRKMKKILMIDACETESTVGDADDTPDEQTGGDSSKSNSITSEH 352

Query: 562 SVQSVGVGVNPHD------PTPN------SSSQAHNRH 587
           S+ S+GV  +         P PN      SS    NRH
Sbjct: 353 SIHSMGVSASSQSSSTNSLPLPNADGNDYSSGSVRNRH 390

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322790303|gb|EFZ15302.1| hypothetical protein SINV_80069 [Solenopsis invicta]

 Score =  627 bits (1618), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 316/463 (68%), Positives = 335/463 (72%), Gaps = 92/463 (19%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELF+K DPEKIFEDLREIGHGSFGAVYYARCLV++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFEKNDPEKIFEDLREIGHGSFGAVYYARCLVTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQL HPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  VEKWQDILKEIRFLRQLNHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKEEEIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 120 --------------------------KRPLKEEEIAAICEGVLRGLHYLHSLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQNDTP L S DW                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNDTPTLNSPDW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT-----HDLVTRPRSP 497
                             +D F HFV  CL K+P +RP+SG+LL+     H LVTR RSP
Sbjct: 251 ------------------TDVFRHFVEVCLTKSPIERPTSGKLLSVSCPYHQLVTRLRSP 292

Query: 498 SVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNS 556
            VL+DLI+RTKAAVR+LDNLNYRKMKKILM D  +TEST+ D DDTPDEQ G DSSKSNS
Sbjct: 293 QVLIDLIQRTKAAVRELDNLNYRKMKKILMIDSCETESTVGDADDTPDEQTGGDSSKSNS 352

Query: 557 ITSEHSVQSVGVGVNPHD------PTPN------SSSQAHNRH 587
           ITSEHS+ S+GV  +         P PN      SS    NRH
Sbjct: 353 ITSEHSIHSMGVSASSQSSSTNSLPLPNADGNDFSSGSVRNRH 395

Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328793690|ref|XP_396577.3| PREDICTED: serine/threonine-protein kinase TAO1 [Apis mellifera]

 Score =  625 bits (1613), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 314/458 (68%), Positives = 334/458 (72%), Gaps = 87/458 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELF+K DPEKIFEDLREIGHGSFGAVYYARCLV++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFEKNDPEKIFEDLREIGHGSFGAVYYARCLVTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQL HPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  VEKWQDILKEIRFLRQLNHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKE+EIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 120 --------------------------KRPLKEDEIAAICEGVLRGLHYLHSLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQNDTP L S DW                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNDTPTLNSPDW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             SD F HFV  CL K+P +RP+SG+LL+H  VTR RSP VL+D
Sbjct: 251 ------------------SDVFRHFVEVCLTKSPTERPASGKLLSHQFVTRTRSPQVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI+RTKAAVR+LDNLNYRKMKKILM D  +TEST+ D DDTPDEQ G DSSKSNSITSEH
Sbjct: 293 LIQRTKAAVRELDNLNYRKMKKILMIDACETESTVGDADDTPDEQTGGDSSKSNSITSEH 352

Query: 562 SVQSVGVGVNPHD------PTPN------SSSQAHNRH 587
           S+ S+GV  +         P PN      S+    NRH
Sbjct: 353 SIHSMGVSASSQSSSTNSLPLPNADANDYSTGSVRNRH 390

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345493111|ref|XP_003427006.1| PREDICTED: serine/threonine-protein kinase TAO1-like isoform 2 [Nasonia vitripennis]

 Score =  623 bits (1607), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 312/474 (65%), Positives = 341/474 (71%), Gaps = 87/474 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEI+ELF+K DPEKIFEDLREIGHGSFGAVYYARCL+++EIVAIKKMSYLGKQ 
Sbjct: 85  PGSLKDPEISELFEKNDPEKIFEDLREIGHGSFGAVYYARCLLTKEIVAIKKMSYLGKQT 144

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQLKHPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 145 MEKWQDILKEIRFLRQLKHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 197

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKE+EIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 198 --------------------------KRPLKEDEIAAICEGVLRGLHYLHSLGRIHRDVK 231

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSAS+KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 232 AGNILLTENGTVKLADFGSASVKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 291

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQN+ P L S++W                       
Sbjct: 292 TCIELAERKPPYFNMNAMSALYHIAQNERPTLNSAEW----------------------- 328

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             +D F HFV  CL K+P++RP+SG+LL+H  VTR RSP VL+D
Sbjct: 329 ------------------TDVFRHFVEVCLTKSPSERPTSGKLLSHQFVTRTRSPQVLID 370

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI RTKAAVR+LDNLNYRKMKKILM D  +TES + D DDTPDEQ G DSSKSNSITSEH
Sbjct: 371 LIGRTKAAVRELDNLNYRKMKKILMIDTCETESQVGDADDTPDEQTGGDSSKSNSITSEH 430

Query: 562 SVQSVGVGVNPHD------PTPNS-----SSQAHNRHHHHHPVT-HLSQHSYNN 603
           S+ S+GV  +         P  N+     S    NRH     VT +L +H  NN
Sbjct: 431 SIHSMGVSASSQSSSTNSLPMQNADANDYSGSVRNRHKMSAGVTANLLEHGANN 484

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383852655|ref|XP_003701842.1| PREDICTED: serine/threonine-protein kinase TAO1-like [Megachile rotundata]

 Score =  623 bits (1606), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 310/458 (67%), Positives = 330/458 (72%), Gaps = 87/458 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEIAELF+K DPEKIFEDLREIGHGSFGAVYYARCLV++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEIAELFEKNDPEKIFEDLREIGHGSFGAVYYARCLVTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQL HPNTI+Y+GCYL+DHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  VEKWQDILKEIRFLRQLNHPNTIKYKGCYLKDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKE+EIAAIC GVLRGL YLHS GRIHRDVK
Sbjct: 120 --------------------------KRPLKEDEIAAICDGVLRGLYYLHSFGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQNDTP   S DW                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNDTPTFNSPDW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             SD F HFV  CL K+P +RPSSG+LL+H  VTR  SP VL+D
Sbjct: 251 ------------------SDVFRHFVEVCLTKSPTERPSSGKLLSHQFVTRTCSPQVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI+RTKAAVR+LDNLNYRKMKKILM D  +TEST+ D DDTPDEQ G DSSKSNSITSEH
Sbjct: 293 LIQRTKAAVRELDNLNYRKMKKILMIDACETESTVGDADDTPDEQTGGDSSKSNSITSEH 352

Query: 562 SVQSVGVGVNPHD------PTPN------SSSQAHNRH 587
           S+ S+GV  +         P PN      S+    NRH
Sbjct: 353 SIHSMGVSASSQSSSTNSLPLPNADANDYSTGSVRNRH 390

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345493113|ref|XP_001599444.2| PREDICTED: serine/threonine-protein kinase TAO1-like isoform 1 [Nasonia vitripennis]

 Score =  622 bits (1605), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 312/474 (65%), Positives = 341/474 (71%), Gaps = 87/474 (18%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PGSLKDPEI+ELF+K DPEKIFEDLREIGHGSFGAVYYARCL+++EIVAIKKMSYLGKQ 
Sbjct: 7   PGSLKDPEISELFEKNDPEKIFEDLREIGHGSFGAVYYARCLLTKEIVAIKKMSYLGKQT 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DILKEIRFLRQLKHPNTIEY+GCYLRDHTAWLVMEYCLGSASDIIEVH       
Sbjct: 67  MEKWQDILKEIRFLRQLKHPNTIEYKGCYLRDHTAWLVMEYCLGSASDIIEVH------- 119

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     KRPLKE+EIAAIC GVLRGL+YLHSLGRIHRDVK
Sbjct: 120 --------------------------KRPLKEDEIAAICEGVLRGLHYLHSLGRIHRDVK 153

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILLTE GTVKLADFGSAS+KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 154 AGNILLTENGTVKLADFGSASVKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIELAERKPPYFNMNAMSALYHIAQN+ P L S++W                       
Sbjct: 214 TCIELAERKPPYFNMNAMSALYHIAQNERPTLNSAEW----------------------- 250

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                             +D F HFV  CL K+P++RP+SG+LL+H  VTR RSP VL+D
Sbjct: 251 ------------------TDVFRHFVEVCLTKSPSERPTSGKLLSHQFVTRTRSPQVLID 292

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMADGADTESTI-DPDDTPDEQAGNDSSKSNSITSEH 561
           LI RTKAAVR+LDNLNYRKMKKILM D  +TES + D DDTPDEQ G DSSKSNSITSEH
Sbjct: 293 LIGRTKAAVRELDNLNYRKMKKILMIDTCETESQVGDADDTPDEQTGGDSSKSNSITSEH 352

Query: 562 SVQSVGVGVNPHD------PTPNS-----SSQAHNRHHHHHPVT-HLSQHSYNN 603
           S+ S+GV  +         P  N+     S    NRH     VT +L +H  NN
Sbjct: 353 SIHSMGVSASSQSSSTNSLPMQNADANDYSGSVRNRHKMSAGVTANLLEHGANN 406

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	804
FB|FBgn0031030	1039	Tao "Tao" [Drosophila melanoga	0.167	0.129	0.881	5.3e-118
UNIPROTKB|E1BYH0	733	TAOK1 "Uncharacterized protein	0.167	0.184	0.822	2.3e-97
UNIPROTKB|F1RN84	848	LOC100622172 "Uncharacterized	0.167	0.159	0.814	2.3e-96
UNIPROTKB|E1BYH2	1001	TAOK1 "Uncharacterized protein	0.167	0.134	0.822	7e-96
RGD|708455	1001	Taok1 "TAO kinase 1" [Rattus n	0.167	0.134	0.814	5.9e-96
ZFIN|ZDB-GENE-100921-50	903	taok3a "TAO kinase 3a" [Danio	0.167	0.149	0.822	2.7e-97
UNIPROTKB|Q7L7X3	1001	TAOK1 "Serine/threonine-protei	0.167	0.134	0.814	5.3e-95
UNIPROTKB|E1BJ19	1001	TAOK1 "Uncharacterized protein	0.167	0.134	0.814	5.3e-95
UNIPROTKB|E2QRV2	1001	TAOK1 "Uncharacterized protein	0.167	0.134	0.814	5.3e-95
MGI|MGI:1914490	1001	Taok1 "TAO kinase 1" [Mus musc	0.167	0.134	0.814	5.3e-95

FB|FBgn0031030 Tao "Tao" [Drosophila melanogaster (taxid:7227)]

 Score = 649 (233.5 bits), Expect = 5.3e-118, Sum P(3) = 5.3e-118
 Identities = 119/135 (88%), Positives = 128/135 (94%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             LRQL HPNTIEY+GCYLR+ TAWLVMEYC+GSASDIIEVHK+PL E+EIAAIC GVL GL
Sbjct:    79 LRQLNHPNTIEYKGCYLRESTAWLVMEYCVGSASDIIEVHKKPLHEDEIAAICLGVLSGL 138

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
             +YLHSLGRIHRD+KAGNILLT+ G VKLADFGSA+IKCPANSFVGTPYWMAPEVILAMDE
Sbjct:   139 SYLHSLGRIHRDIKAGNILLTDNGVVKLADFGSAAIKCPANSFVGTPYWMAPEVILAMDE 198

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   199 GQYDGKVDVWSLGIT 213

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0005524 "ATP binding" evidence=IEA

GO:0006915 "apoptotic process" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0045471 "response to ethanol" evidence=IMP

GO:0048036 "central complex development" evidence=IMP

GO:0042220 "response to cocaine" evidence=IMP

GO:0035094 "response to nicotine" evidence=IMP

GO:0016319 "mushroom body development" evidence=IMP

GO:0046621 "negative regulation of organ growth" evidence=IMP

GO:0035329 "hippo signaling cascade" evidence=IGI

GO:0035332 "positive regulation of hippo signaling cascade" evidence=IGI

GO:0030707 "ovarian follicle cell development" evidence=IMP

GO:0045807 "positive regulation of endocytosis" evidence=IMP

GO:0045178 "basal part of cell" evidence=IDA

UNIPROTKB|E1BYH0 TAOK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 601 (216.6 bits), Expect = 2.3e-97, Sum P(2) = 2.3e-97
 Identities = 111/135 (82%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSASI  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1RN84 LOC100622172 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 596 (214.9 bits), Expect = 2.3e-96, Sum P(2) = 2.3e-96
 Identities = 110/135 (81%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHTMIHRDIKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0046330 "positive regulation of JNK cascade" evidence=IEA

GO:0031572 "G2 DNA damage checkpoint" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E1BYH2 TAOK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 601 (216.6 bits), Expect = 7.0e-96, Sum P(2) = 7.0e-96
 Identities = 111/135 (82%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSASI  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0031572 "G2 DNA damage checkpoint" evidence=IEA

GO:0046330 "positive regulation of JNK cascade" evidence=IEA

RGD|708455 Taok1 "TAO kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 596 (214.9 bits), Expect = 5.9e-96, Sum P(2) = 5.9e-96
 Identities = 110/135 (81%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHTMIHRDIKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IMP;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IMP

GO:0006915 "apoptotic process" evidence=ISO;ISS

GO:0006974 "response to DNA damage stimulus" evidence=ISO;ISS

GO:0019901 "protein kinase binding" evidence=IDA

GO:0030295 "protein kinase activator activity" evidence=IMP

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO;ISS

GO:0032874 "positive regulation of stress-activated MAPK cascade" evidence=ISO;ISS

GO:0045860 "positive regulation of protein kinase activity" evidence=IMP

GO:0046330 "positive regulation of JNK cascade" evidence=ISO;ISS

GO:0051493 "regulation of cytoskeleton organization" evidence=IDA

GO:0031577 "spindle checkpoint" evidence=ISO

ZFIN|ZDB-GENE-100921-50 taok3a "TAO kinase 3a" [Danio rerio (taxid:7955)]

 Score = 594 (214.2 bits), Expect = 2.7e-97, Sum P(2) = 2.7e-97
 Identities = 111/135 (82%), Positives = 121/135 (89%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L QL+HPNTIEY+GCYL+D+TAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L GL
Sbjct:    81 LEQLRHPNTIEYKGCYLKDNTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALLGL 140

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRDVKAGNILLTE G VKLADFGSASI  PANSFVGTPYWMAPEVILAMDE
Sbjct:   141 AYLHSHNMIHRDVKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDE 200

Query:   128 GQYDGKVDVWSLGIT 142
             GQY+GKVD+WSLGIT
Sbjct:   201 GQYEGKVDIWSLGIT 215

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|Q7L7X3 TAOK1 "Serine/threonine-protein kinase TAO1" [Homo sapiens (taxid:9606)]

 Score = 596 (214.9 bits), Expect = 5.3e-95, Sum P(2) = 5.3e-95
 Identities = 110/135 (81%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHTMIHRDIKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0006281 "DNA repair" evidence=IEA

GO:0031577 "spindle checkpoint" evidence=IDA

GO:0031572 "G2 DNA damage checkpoint" evidence=IMP

GO:0032874 "positive regulation of stress-activated MAPK cascade" evidence=IMP

GO:0006974 "response to DNA damage stimulus" evidence=IDA

GO:0046330 "positive regulation of JNK cascade" evidence=IDA

GO:0006915 "apoptotic process" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS

GO:0051493 "regulation of cytoskeleton organization" evidence=ISS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0005524 "ATP binding" evidence=NAS

GO:0016301 "kinase activity" evidence=NAS

GO:0016740 "transferase activity" evidence=NAS

GO:0000087 "M phase of mitotic cell cycle" evidence=TAS

GO:0000236 "mitotic prometaphase" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

UNIPROTKB|E1BJ19 TAOK1 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 596 (214.9 bits), Expect = 5.3e-95, Sum P(2) = 5.3e-95
 Identities = 110/135 (81%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHTMIHRDIKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0046330 "positive regulation of JNK cascade" evidence=IEA

GO:0031572 "G2 DNA damage checkpoint" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2QRV2 TAOK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 596 (214.9 bits), Expect = 5.3e-95, Sum P(2) = 5.3e-95
 Identities = 110/135 (81%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHTMIHRDIKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0046330 "positive regulation of JNK cascade" evidence=IEA

GO:0031572 "G2 DNA damage checkpoint" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1914490 Taok1 "TAO kinase 1" [Mus musculus (taxid:10090)]

 Score = 596 (214.9 bits), Expect = 5.3e-95, Sum P(2) = 5.3e-95
 Identities = 110/135 (81%), Positives = 123/135 (91%)

Query:     8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
             L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL
Sbjct:    80 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 139

Query:    68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE 127
              YLHS   IHRD+KAGNILLTE G VKLADFGSAS+  PANSFVGTPYWMAPEVILAMDE
Sbjct:   140 AYLHSHTMIHRDIKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDE 199

Query:   128 GQYDGKVDVWSLGIT 142
             GQYDGKVDVWSLGIT
Sbjct:   200 GQYDGKVDVWSLGIT 214

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006915 "apoptotic process" evidence=ISO

GO:0006974 "response to DNA damage stimulus" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030295 "protein kinase activator activity" evidence=ISO

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO

GO:0032874 "positive regulation of stress-activated MAPK cascade" evidence=ISO

GO:0045860 "positive regulation of protein kinase activity" evidence=ISO

GO:0046330 "positive regulation of JNK cascade" evidence=ISO

GO:0051493 "regulation of cytoskeleton organization" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	804
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	0.0
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-165
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-162
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-160
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-101
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-93
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-91
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-89
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-88
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-85
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-78
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-76
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-75
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-74
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-73
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-65
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-65
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-64
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-63
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-63
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-61
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-59
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-59
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-59
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-57
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-57
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-56
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-56
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-56
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-56
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-54
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-53
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-52
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-52
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-51
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-51
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-50
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-50
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-48
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-47
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-46
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-46
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-45
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-44
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-44
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-43
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-43
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-42
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-41
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-41
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-41
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-41
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-40
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-39
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-39
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-38
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-38
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-38
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-38
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-38
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-38
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-38
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-37
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-37
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-36
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-36
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-36
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-36
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-36
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-35
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-35
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-35
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-35
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-34
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-34
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-33
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-33
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-33
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-33
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-33
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-33
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-33
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-32
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-32
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-32
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-31
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-31
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-31
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-31
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-31
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-31
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-31
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-30
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-30
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-30
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-30
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-30
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-29
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-29
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-29
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-29
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-29
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-28
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-28
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-28
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-28
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-28
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-27
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-27
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-27
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-27
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-27
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-27
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-26
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-26
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-26
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-26
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-26
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	9e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-25
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-25
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-25
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-25
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-25
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-25
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-25
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-24
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-24
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-23
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-23
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-23
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-23
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-22
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-22
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-22
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-21
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-21
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-21
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-21
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-20
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-20
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-19
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-19
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-19
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-19
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-18
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-18
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-18
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-17
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-17
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-17
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-17
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-16
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-16
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-16
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-15
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-14
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-13
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-13
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-11
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-11
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-11
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-10
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-08
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-08
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-08
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-08
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-07
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-07
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-07
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-06
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-06
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-05
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-05
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-04
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-04
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-04
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	0.001
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	0.001
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	0.001
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	0.002
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	0.002
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.002
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	0.002
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.002
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.002
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.002
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.003
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	0.004
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	0.004
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	0.004
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	0.004
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.004
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.004
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.004

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  572 bits (1477), Expect = 0.0
 Identities = 242/380 (63%), Positives = 268/380 (70%), Gaps = 74/380 (19%)

Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA 207
           DPEIAELF K+DPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  EKW 
Sbjct: 1   DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ 60

Query: 208 DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
           DI+KE+RFL+QL+HPNTIEY+GCYLR+HTAWLVMEYCLGSASDI+EVH            
Sbjct: 61  DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVH------------ 108

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
                                K+PL+E EIAAIC G L+GL YLHS  RIHRD+KAGNIL
Sbjct: 109 ---------------------KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL 147

Query: 328 LTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           LTE GTVKLADFGSAS+  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL
Sbjct: 148 LTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                                                    AERKPP FNMNAMSALYHI
Sbjct: 208 -----------------------------------------AERKPPLFNMNAMSALYHI 226

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRT 507
           AQND+P L S+DWSD F +FV SCL K P DRPSS  LL H  V R R P+V++DLI+RT
Sbjct: 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRT 286

Query: 508 KAAVRDLDNLNYRKMKKILM 527
           K AVR+LDNL YRKMKKIL 
Sbjct: 287 KDAVRELDNLQYRKMKKILF 306

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  480 bits (1237), Expect = e-165
 Identities = 231/383 (60%), Positives = 262/383 (68%), Gaps = 74/383 (19%)

Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           G +KDPEIA+LF K+DPE+IF  L EIGHGSFGAVY+A    + E+VA+KKMSY GKQ  
Sbjct: 3   GVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN 62

Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
           EKW DI+KE++FL+QLKHPNTIEY+GCYL++HTAWLVMEYCLGSASD++EVH        
Sbjct: 63  EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH-------- 114

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                                    K+PL+E EIAAI  G L+GL YLHS   IHRD+KA
Sbjct: 115 -------------------------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           GNILLTE G VKLADFGSAS   PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT
Sbjct: 150 GNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 209

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           CIEL                                         AERKPP FNMNAMSA
Sbjct: 210 CIEL-----------------------------------------AERKPPLFNMNAMSA 228

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
           LYHIAQND+P LQS++W+D+F  FV  CL K P +RP+S  LL HD V R R   VL+DL
Sbjct: 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDL 288

Query: 504 IRRTKAAVRDLDNLNYRKMKKIL 526
           I+RTK AVR+LDNL YRKMKKIL
Sbjct: 289 IQRTKDAVRELDNLQYRKMKKIL 311

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  473 bits (1219), Expect = e-162
 Identities = 238/383 (62%), Positives = 269/383 (70%), Gaps = 74/383 (19%)

Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           GSLKDPEIAELF KEDPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  
Sbjct: 7   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66

Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
           EKW DI+KE++FL+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVH        
Sbjct: 67  EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-------- 118

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                                    K+PL+E EIAAI  G L+GL YLHS   IHRD+KA
Sbjct: 119 -------------------------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 153

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           GNILLTE G VKLADFGSASI  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT
Sbjct: 154 GNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 213

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           CIEL                                         AERKPP FNMNAMSA
Sbjct: 214 CIEL-----------------------------------------AERKPPLFNMNAMSA 232

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
           LYHIAQN++P LQS++WSD F +FV SCL K P DRP+S  LL H  V R R  +VL+DL
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDL 292

Query: 504 IRRTKAAVRDLDNLNYRKMKKIL 526
           I+RTK AVR+LDNL YRKMKK+L
Sbjct: 293 IQRTKDAVRELDNLQYRKMKKLL 315

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  468 bits (1205), Expect = e-160
 Identities = 230/382 (60%), Positives = 263/382 (68%), Gaps = 74/382 (19%)

Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA 207
           DP++AELF K+DPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  EKW 
Sbjct: 1   DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60

Query: 208 DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
           DI+KE+RFL++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSASD++EVH            
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH------------ 108

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
                                K+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNIL
Sbjct: 109 ---------------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147

Query: 328 LTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           L+E G VKL DFGSASI  PAN FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                                                    AERKPP FNMNAMSALYHI
Sbjct: 208 -----------------------------------------AERKPPLFNMNAMSALYHI 226

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRT 507
           AQN++P LQS  WS+ F +FV SCL K P DRP+S  LL H  V R R P+V++DLI+RT
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286

Query: 508 KAAVRDLDNLNYRKMKKILMAD 529
           K AVR+LDNL YRKMKKIL  +
Sbjct: 287 KDAVRELDNLQYRKMKKILFQE 308

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  312 bits (803), Expect = e-101
 Identities = 125/330 (37%), Positives = 162/330 (49%), Gaps = 83/330 (25%)

Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           +FE L +IG G FG VY AR   + + VAIK +    K   EK   I+ EI+ L++ KHP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHP 57

Query: 223 NTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           N ++Y G YL+    W+VME+C  GS  D+++                            
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN------------------------- 92

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                   + L E +IA +C  +L+GL YLHS G IHRD+KA NILLT  G VKL DFG 
Sbjct: 93  --------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGL 144

Query: 342 ASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           ++        N+ VGTPYWMAPEVI   +   YD K D+WSLGIT IELAE KPPY  + 
Sbjct: 145 SAQLSDTKARNTMVGTPYWMAPEVI---NGKPYDYKADIWSLGITAIELAEGKPPYSELP 201

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
            M AL+ IA N  P L++ +                                        
Sbjct: 202 PMKALFKIATNGPPGLRNPEK--------------------------------------- 222

Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
            WSD F  F+  CL KNP  RP++ +LL H
Sbjct: 223 -WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  295 bits (756), Expect = 1e-93
 Identities = 116/137 (84%), Positives = 126/137 (91%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
             L+QL+HPNTIEY+GCYLR+HTAWLVMEYCLGSASDI+EVHK+PL+E EIAAIC G L+
Sbjct: 67  RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQ 126

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAM 125
           GL YLHS  RIHRD+KAGNILLTE GTVKLADFGSAS+  PANSFVGTPYWMAPEVILAM
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAM 186

Query: 126 DEGQYDGKVDVWSLGIT 142
           DEGQYDGKVDVWSLGIT
Sbjct: 187 DEGQYDGKVDVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  286 bits (733), Expect = 6e-91
 Identities = 123/334 (36%), Positives = 170/334 (50%), Gaps = 79/334 (23%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           P++ +E ++ IG G++G VY AR + + E+VAIK +     +  + +  I +EI  L++ 
Sbjct: 1   PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL---EPGDDFEIIQQEISMLKEC 57

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           +HPN + Y G YLR    W+VMEYC G S  DI                           
Sbjct: 58  RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI--------------------------- 90

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                 ++V + PL E +IA +C   L+GL YLH  G+IHRD+K  NILLTE G VKLAD
Sbjct: 91  ------YQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLAD 144

Query: 339 FG-SASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG SA +        SF+GTPYWMAPEV     +G YDGK D+W+LGIT IELAE +PP 
Sbjct: 145 FGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
           F+++ M AL+ I++++ P                    PP                    
Sbjct: 205 FDLHPMRALFLISKSNFP--------------------PPKLK----------------- 227

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                WS  F  F+  CL K+P  RP++ +LL H
Sbjct: 228 -DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  280 bits (719), Expect = 6e-89
 Identities = 121/337 (35%), Positives = 164/337 (48%), Gaps = 86/337 (25%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           PE++F+ L ++G GS+G+VY A    + ++VAIK +        E   +I+KEI  L+Q 
Sbjct: 1   PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQC 55

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             P  ++Y G Y ++   W+VMEYC  GS SDI+++                        
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT----------------------- 92

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                      + L EEEIAAI    L+GL YLHS  +IHRD+KAGNILL E G  KLAD
Sbjct: 93  ----------NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLAD 142

Query: 339 FGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG +          N+ +GTP+WMAPEVI    E  Y+ K D+WSLGIT IE+AE KPPY
Sbjct: 143 FGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGYNNKADIWSLGITAIEMAEGKPPY 199

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
            +++ M A++ I     P L                  P                     
Sbjct: 200 SDIHPMRAIFMIPNKPPPTL----------------SDP--------------------- 222

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                WS  F  FV  CL K+P +RPS+ +LL H  +
Sbjct: 223 ---EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  280 bits (719), Expect = 1e-88
 Identities = 127/352 (36%), Positives = 170/352 (48%), Gaps = 86/352 (24%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           ++F  L  IG GSFG VY A    + ++VAIK +    ++  ++  DI +EI+FL Q + 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRS 58

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           P   +Y G +L+    W++MEYC  GS  D+                     LK      
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDL---------------------LKP----- 92

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                      L E  IA I   VL GL YLH  G+IHRD+KA NILL+E G VKLADFG
Sbjct: 93  ---------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG 143

Query: 341 -SASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
            S  +       N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IELA+ +PP   
Sbjct: 144 VSGQLTSTMSKRNTFVGTPFWMAPEVI---KQSGYDEKADIWSLGITAIELAKGEPPL-- 198

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
                               SD                   ++ M  L+ I +N+ P L+
Sbjct: 199 --------------------SD-------------------LHPMRVLFLIPKNNPPSLE 219

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
            + +S  F  FVS CL K+P +RPS+  LL H  + + +  S L  LI R K
Sbjct: 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIK 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  272 bits (699), Expect = 2e-85
 Identities = 123/357 (34%), Positives = 167/357 (46%), Gaps = 85/357 (23%)

Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
           ++  + DP +++++L +IG G+ G VY A    + + VAIKKM  L KQ  E    I+ E
Sbjct: 10  DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKEL---IINE 65

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQ 271
           I  ++  KHPN ++Y   YL     W+VMEY   GS +DII  +                
Sbjct: 66  ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN---------------- 109

Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
                               + E +IA +C  VL+GL YLHS   IHRD+K+ NILL++ 
Sbjct: 110 -----------------FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD 152

Query: 332 GTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G+VKLADFG A+         NS VGTPYWMAPEVI   D   Y  KVD+WSLGI CIE+
Sbjct: 153 GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD---YGPKVDIWSLGIMCIEM 209

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
           AE +PPY     + AL+ I     P L++ +                             
Sbjct: 210 AEGEPPYLREPPLRALFLITTKGIPPLKNPE----------------------------- 240

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI 504
                       WS  F  F++ CL K+P  RPS+  LL H  + +         LI
Sbjct: 241 -----------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  254 bits (650), Expect = 3e-78
 Identities = 112/136 (82%), Positives = 122/136 (89%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
            L+QLKHPNTIEY+GCYL++HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+G
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMD 126
           L YLHS   IHRD+KAGNILLTE G VKLADFGSAS   PANSFVGTPYWMAPEVILAMD
Sbjct: 134 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMD 193

Query: 127 EGQYDGKVDVWSLGIT 142
           EGQYDGKVDVWSLGIT
Sbjct: 194 EGQYDGKVDVWSLGIT 209

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  248 bits (633), Expect = 8e-76
 Identities = 109/136 (80%), Positives = 121/136 (88%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
            L++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAA+  G L+G
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMD 126
           L YLHS   IHRDVKAGNILL+E G VKL DFGSASI  PAN FVGTPYWMAPEVILAMD
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMD 187

Query: 127 EGQYDGKVDVWSLGIT 142
           EGQYDGKVDVWSLGIT
Sbjct: 188 EGQYDGKVDVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  244 bits (626), Expect = 2e-75
 Identities = 97/328 (29%), Positives = 135/328 (41%), Gaps = 80/328 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L ++G GSFG VY AR   + ++VAIK +    K+  +    IL+EI+ L++LKHPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK--KKIKKDRERILREIKILKKLKHPN 58

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +     +  +   +LVMEYC                      G+             LF
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYC--------------------EGGD-------------LF 85

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           +    +  L E+E       +L  L YLHS G +HRD+K  NILL E G VKLADFG A 
Sbjct: 86  DLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR 145

Query: 344 I---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
                    +FVGTP +MAPEV+L      Y   VD+WSLG+   EL   KPP+   + +
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLL---GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQL 202

Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
             L+       P     +W                                       D 
Sbjct: 203 LELFKKIGKPKPPFPPPEW---------------------------------------DI 223

Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           S      +   L K+P  R ++   L H
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  244 bits (624), Expect = 2e-74
 Identities = 111/136 (81%), Positives = 123/136 (90%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
            L+++KHPN+IEY+GCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAAI  G L+G
Sbjct: 78  FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMD 126
           L YLHS   IHRD+KAGNILLTE G VKLADFGSASI  PANSFVGTPYWMAPEVILAMD
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMD 197

Query: 127 EGQYDGKVDVWSLGIT 142
           EGQYDGKVDVWSLGIT
Sbjct: 198 EGQYDGKVDVWSLGIT 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  241 bits (616), Expect = 1e-73
 Identities = 121/347 (34%), Positives = 157/347 (45%), Gaps = 88/347 (25%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP  IFE +  IG G++G VY AR   + ++VAIK M  +     ++  +I +E   LR+
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRK 58

Query: 219 L-KHPNTIEYRGCYL------RDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRL 270
              HPN   + G ++       D   WLVME C  GS +D+++                 
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK----------------- 101

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                              + LKEE IA I    LRGL YLH    IHRD+K  NILLT+
Sbjct: 102 -------------GLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK 148

Query: 331 TGTVKLADFG-SASIKCPA---NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITC 384
              VKL DFG SA +       N+F+GTPYWMAPEVI      +  YD + DVWSLGIT 
Sbjct: 149 NAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208

Query: 385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
           IELA+ KPP  +M+ M AL+ I +N  P L+S                            
Sbjct: 209 IELADGKPPLCDMHPMRALFKIPRNPPPTLKS---------------------------- 240

Query: 445 YHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                         +WS  F  F+S CL KN   RP    LL H  +
Sbjct: 241 ------------PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  218 bits (557), Expect = 2e-65
 Identities = 107/328 (32%), Positives = 142/328 (43%), Gaps = 91/328 (27%)

Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
            IG G+FG VY    L + + VAIK++S    +  E    I++EI  L+ LKHPN ++Y 
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 229 GCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
           G      + ++++EY   GS   II+                          F  F    
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIK-------------------------KFGPFP--- 97

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--- 344
                 E  +A     VL+GL YLH  G IHRD+KA NIL T+ G VKLADFG A+    
Sbjct: 98  ------ESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND 151

Query: 345 -KCPANSFVGTPYWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAERKPPYFNMNAM 400
                 S VGTPYWMAPEVI      +  G     D+WSLG T IEL    PPY+++N M
Sbjct: 152 VSKDDASVVGTPYWMAPEVI------EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205

Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
           +AL+ I Q+D P L                                              
Sbjct: 206 AALFRIVQDDHPPLPEGI------------------------------------------ 223

Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           S     F+  C  K+P  RP++ +LL H
Sbjct: 224 SPELKDFLMQCFQKDPNLRPTAKQLLKH 251

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  218 bits (557), Expect = 2e-65
 Identities = 114/335 (34%), Positives = 155/335 (46%), Gaps = 83/335 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +  IG G+   VY A CL + E VAIK++    ++C     ++ KE++ + Q  HPN
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            ++Y   ++     WLVM Y   GS  DI++                             
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMK----------------------------- 91

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-S 341
                 +  L E  IA +   VL+GL YLHS G+IHRD+KAGNILL E G+VK+ADFG S
Sbjct: 92  --SSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149

Query: 342 ASIKCPA-------NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPP 393
           AS+            +FVGTP WMAPEV   M++   YD K D+WS GIT IELA    P
Sbjct: 150 ASLADGGDRTRKVRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGITAIELATGAAP 206

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y     M  L    QND P L+           + A+ K                     
Sbjct: 207 YSKYPPMKVLMLTLQNDPPSLE-----------TGADYKK-------------------- 235

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                 +S +F   +S CL K+P+ RP++  LL H
Sbjct: 236 ------YSKSFRKMISLCLQKDPSKRPTAEELLKH 264

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  216 bits (553), Expect = 1e-64
 Identities = 120/355 (33%), Positives = 168/355 (47%), Gaps = 85/355 (23%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSRE--IVAIKKMSYLGKQCAEKWADILKEIRF 215
            +P  I+E + E+G G+FG VY A+    +E  + A  K+  +  +  E+  D + EI  
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQ---HKETGLFAAAKIIQIESE--EELEDFMVEIDI 55

Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           L + KHPN +     Y  ++  W+++E+C G A D I +   E E               
Sbjct: 56  LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIML---ELE--------------- 97

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                         R L E +I  +C  +L  LN+LHS   IHRD+KAGNILLT  G VK
Sbjct: 98  --------------RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVK 143

Query: 336 LADFG-SASIKCPA---NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAE 389
           LADFG SA  K      ++F+GTPYWMAPEV+      +  YD K D+WSLGIT IELA+
Sbjct: 144 LADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ 203

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
            +PP+  +N M  L  I +++ P L                                   
Sbjct: 204 MEPPHHELNPMRVLLKILKSEPPTL----------------------------------- 228

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI 504
                 Q S WS +F  F+ SCL K+P DRP++  LL H  V+       + DL+
Sbjct: 229 -----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  213 bits (544), Expect = 1e-63
 Identities = 106/332 (31%), Positives = 145/332 (43%), Gaps = 76/332 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E LR++G GSFG VY A+   + +IVA+K +    ++  +K     +EIR LR+L HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKS-KKDQTARREIRILRRLSHPN 59

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +     +      +LVMEYC                                 E   LF
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYC---------------------------------EGGDLF 86

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           ++     PL E+E   I   +LRGL YLHS G IHRD+K  NILL E G VK+ADFG A 
Sbjct: 87  DYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAK 146

Query: 344 IKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                     +FVGTP++MAPEV+L      Y  KVDVWSLG+   EL   KPP+   N 
Sbjct: 147 KLLKSSSSLTTFVGTPWYMAPEVLL--GGNGYGPKVDVWSLGVILYELLTGKPPFSGENI 204

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           +  L  I +                        PP                +    + S 
Sbjct: 205 LDQLQLIRRI---------------------LGPPL---------------EFDEPKWSS 228

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
            S+     +  CL K+P+ RP++  +L H   
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  211 bits (539), Expect = 9e-63
 Identities = 101/331 (30%), Positives = 137/331 (41%), Gaps = 89/331 (26%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
             +G GSFG+VY A    + E++A+K +  L     E+   + +EIR L  L+HPN + Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 228 RGCYL-RDHTAW-LVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
            G     +     + +EY   GS S +++                               
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLK------------------------------K 94

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           F      L E  I      +L GL YLHS G +HRD+K  NIL+   G VKLADFG A  
Sbjct: 95  F----GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150

Query: 345 K------CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM- 397
                      S  GTPYWMAPEVI      +Y    D+WSLG T IE+A  KPP+  + 
Sbjct: 151 LGDIETGEGTGSVRGTPYWMAPEVI---RGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207

Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQS 457
           N M+ALY I  +                      +PP                  P   S
Sbjct: 208 NPMAALYKIGSSG---------------------EPPEI----------------PEHLS 230

Query: 458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
            +  D    F+  CL ++P  RP++  LL H
Sbjct: 231 EEAKD----FLRKCLRRDPKKRPTADELLQH 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  205 bits (525), Expect = 7e-61
 Identities = 74/158 (46%), Positives = 98/158 (62%), Gaps = 15/158 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           +L++ KHPN ++Y G YL+    W+VME+C  GS  D+++   + L E +IA +C  +L+
Sbjct: 50  ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK 109

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK---CPANSFVGTPYWMAPEVI 122
           GL YLHS G IHRD+KA NILLT  G VKL DFG ++        N+ VGTPYWMAPEVI
Sbjct: 110 GLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVI 169

Query: 123 LAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP 160
              +   YD K D+WSLGIT          EL + + P
Sbjct: 170 ---NGKPYDYKADIWSLGIT--------AIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  202 bits (516), Expect = 2e-59
 Identities = 126/355 (35%), Positives = 170/355 (47%), Gaps = 86/355 (24%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DPE++F  L  IG GSFG VY      ++E+VAIK +    ++  ++  DI +EI  L Q
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL--EEAEDEIEDIQQEITVLSQ 58

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
              P    Y G YL+    W++MEY                     G G+ L  LK    
Sbjct: 59  CDSPYITRYYGSYLKGTKLWIIMEYL--------------------GGGSALDLLK---- 94

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                       PL+E  IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G VKLAD
Sbjct: 95  ----------PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLAD 144

Query: 339 FGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG A      +   N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IELA+ +PP 
Sbjct: 145 FGVAGQLTDTQIKRNTFVGTPFWMAPEVI---KQSAYDFKADIWSLGITAIELAKGEPPN 201

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
            +++ M  L+ I +N  P L+                                       
Sbjct: 202 SDLHPMRVLFLIPKNSPPTLEGQ------------------------------------- 224

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
                +S  F  FV +CL K+P  RP++  LL H  +TR  +  S L +LI R K
Sbjct: 225 -----YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYK 274

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  201 bits (513), Expect = 3e-59
 Identities = 118/339 (34%), Positives = 167/339 (49%), Gaps = 80/339 (23%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR 214
             + +P++ FE ++ IG G++G VY AR + + E+ AIK +     +  E +A + +EI 
Sbjct: 2   LSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEII 58

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQL 273
            ++  KH N + Y G YLR    W+ ME+C G S  DI         +HV G        
Sbjct: 59  MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI---------YHVTG-------- 101

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                            PL E +IA +    L+GL YLHS G++HRD+K  NILLT+ G 
Sbjct: 102 -----------------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH 144

Query: 334 VKLADFG-SASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           VKLADFG SA I        SF+GTPYWMAPEV     +G Y+   D+W++GIT IELAE
Sbjct: 145 VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE 204

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
            +PP F+++ M AL+                    + + +  +PP               
Sbjct: 205 LQPPMFDLHPMRALF--------------------LMTKSNFQPPKLK------------ 232

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                     WS++F HFV   L KNP  RP++ +LL H
Sbjct: 233 ------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  200 bits (511), Expect = 7e-59
 Identities = 82/154 (53%), Positives = 101/154 (65%), Gaps = 10/154 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVL 64
           S+L++ +HPN + Y G YLR    W+VMEYC G S  DI +V + PL E +IA +C   L
Sbjct: 52  SMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL 111

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIK---CPANSFVGTPYWMAPE 120
           +GL YLH  G+IHRD+K  NILLTE G VKLADFG SA +        SF+GTPYWMAPE
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL 154
           V     +G YDGK D+W+LGIT       E+AEL
Sbjct: 172 VAAVERKGGYDGKCDIWALGITA-----IELAEL 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  196 bits (498), Expect = 4e-57
 Identities = 119/338 (35%), Positives = 168/338 (49%), Gaps = 82/338 (24%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + +P+  +E ++ +G G++G VY AR L + E+ A+K +     +  + ++ I +EI  +
Sbjct: 4   RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL---EPGDDFSLIQQEIFMV 60

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           ++ KH N + Y G YL     W+ MEYC G S  DI         +HV G          
Sbjct: 61  KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI---------YHVTG---------- 101

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                          PL E +IA +C   L+GL YLHS G++HRD+K  NILLT+ G VK
Sbjct: 102 ---------------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVK 146

Query: 336 LADFGSASIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           LADFG A+ K  A      SF+GTPYWMAPEV      G Y+   D+W++GIT IELAE 
Sbjct: 147 LADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
           +PP F+++ M AL+                    + S +  +PP                
Sbjct: 206 QPPMFDLHPMRALF--------------------LMSKSNFQPPKLK------------- 232

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                  + WS TF +FV   L KNP  RP++ RLLTH
Sbjct: 233 -----DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  195 bits (497), Expect = 9e-57
 Identities = 119/355 (33%), Positives = 172/355 (48%), Gaps = 86/355 (24%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DPE++F  L  IG GSFG V+      ++++VAIK +    ++  ++  DI +EI  L Q
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEITVLSQ 58

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
              P   +Y G YL+    W++MEY                     G G+ L  L+    
Sbjct: 59  CDSPYVTKYYGSYLKGTKLWIIMEYL--------------------GGGSALDLLRA--- 95

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                       P  E +IA +   +L+GL+YLHS  +IHRD+KA N+LL+E G VKLAD
Sbjct: 96  -----------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLAD 144

Query: 339 FGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG A      +   N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IELA+ +PP 
Sbjct: 145 FGVAGQLTDTQIKRNTFVGTPFWMAPEVI---QQSAYDSKADIWSLGITAIELAKGEPPN 201

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
            +M+ M  L+ I +N+ P L                                        
Sbjct: 202 SDMHPMRVLFLIPKNNPPTL---------------------------------------- 221

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
             + ++S  F  F+ +CL K+P+ RP++  LL H  + +  +  S L +LI R K
Sbjct: 222 --TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  194 bits (495), Expect = 1e-56
 Identities = 73/142 (51%), Positives = 93/142 (65%), Gaps = 8/142 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S+L+Q   P  ++Y G Y ++   W+VMEYC  GS SDI+++  + L EEEIAAI    L
Sbjct: 50  SILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL 109

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPE 120
           +GL YLHS  +IHRD+KAGNILL E G  KLADFG +          N+ +GTP+WMAPE
Sbjct: 110 KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           VI    E  Y+ K D+WSLGIT
Sbjct: 170 VIQ---EIGYNNKADIWSLGIT 188

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  194 bits (496), Expect = 2e-56
 Identities = 112/356 (31%), Positives = 167/356 (46%), Gaps = 90/356 (25%)

Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH- 221
           +++ L  IG G++GAVY  + + +  +VA+K ++       +  +DI +E+  L QL+  
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQS 59

Query: 222 --PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
             PN  +Y G YL+    W++MEY  G                    G+    +K     
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEG--------------------GSVRTLMKA---- 95

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                      P+ E+ I+ I   VL  L Y+H +G IHRD+KA NIL+T TG VKL DF
Sbjct: 96  ----------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDF 145

Query: 340 GSA----SIKCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
           G A          ++FVGTPYWMAPEVI    EG+ YD K D+WSLGIT  E+A   PPY
Sbjct: 146 GVAALLNQNSSKRSTFVGTPYWMAPEVIT---EGKYYDTKADIWSLGITIYEMATGNPPY 202

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
            +++A  A+  I ++                      KPP                    
Sbjct: 203 SDVDAFRAMMLIPKS----------------------KPPR------------------- 221

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV-TRPRSP-SVLVDLIRRTK 508
           L+ + +S     FV++CL + P +R S+  LL    +    ++P S+L +LI R +
Sbjct: 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELISRYQ 277

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  194 bits (494), Expect = 2e-56
 Identities = 123/356 (34%), Positives = 174/356 (48%), Gaps = 88/356 (24%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DPE++F  L +IG GSFG V+      ++++VAIK +    ++  ++  DI +EI  L Q
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--EEAEDEIEDIQQEITVLSQ 58

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
              P   +Y G YL+D   W++MEY  G SA D++E                        
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------------------------ 94

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                        PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G VKLA
Sbjct: 95  -----------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 143

Query: 338 DFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG A      +   N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IELA+ +PP
Sbjct: 144 DFGVAGQLTDTQIKRNTFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIELAKGEPP 200

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           +  ++ M  L+ I +N+ P L+                                      
Sbjct: 201 HSELHPMKVLFLIPKNNPPTLE-------------------------------------- 222

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
                ++S     FV +CL K P+ RP++  LL H  + R  +  S L +LI R K
Sbjct: 223 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  194 bits (495), Expect = 2e-56
 Identities = 116/359 (32%), Positives = 168/359 (46%), Gaps = 81/359 (22%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP +++E + E+G G+FG VY A+   ++E  A+     +  +  E+  D + EI  L  
Sbjct: 9   DPNEVWEIIGELGDGAFGKVYKAK---NKETGALAAAKVIETKSEEELEDYMVEIEILAT 65

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HP  ++  G +  D   W+++E+C G A D I +                        
Sbjct: 66  CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL---------------------- 103

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                      R L E +I  IC  +L  L YLHS+  IHRD+KAGN+LLT  G +KLAD
Sbjct: 104 ----------DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLAD 153

Query: 339 FGSASIKCPA----NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         +SF+GTPYWMAPEV++   M +  YD K D+WSLGIT IE+A+ +P
Sbjct: 154 FGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA+++ P L                                      
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTL-------------------------------------- 235

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAV 511
              Q S WS  F  F+ + L K+P  RPS+ +LL H  V+   S   L +L+   KA V
Sbjct: 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAKAEV 292

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  188 bits (479), Expect = 5e-54
 Identities = 112/354 (31%), Positives = 158/354 (44%), Gaps = 86/354 (24%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D  DP    ++  +IG GS G V  A    +   VA+KKM    +Q  E    +  E+  
Sbjct: 13  DPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL---LFNEVVI 69

Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLK 274
           +R  +HPN +E    YL     W+VME+  G A +DI+                      
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV---------------------- 107

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                        H R + EE+IA +C  VL+ L++LH+ G IHRD+K+ +ILLT  G V
Sbjct: 108 ------------THTR-MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRV 154

Query: 335 KLADFG---SASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           KL+DFG     S + P   S VGTPYWMAPEVI  +    Y  +VD+WSLGI  IE+ + 
Sbjct: 155 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL---PYGTEVDIWSLGIMVIEMVDG 211

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
           +PPYFN   + A+  I  N                       PP                
Sbjct: 212 EPPYFNEPPLQAMKRIRDN----------------------LPPKLKN---------LHK 240

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI 504
            +P L+S         F+   L ++PA R ++  LL H  + +   PS +V L+
Sbjct: 241 VSPRLRS---------FLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPLM 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  185 bits (473), Expect = 2e-53
 Identities = 70/140 (50%), Positives = 87/140 (62%), Gaps = 10/140 (7%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           L Q + P   +Y G +L+    W++MEYC  GS  D+++     L E  IA I   VL G
Sbjct: 53  LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLG 110

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIK---CPANSFVGTPYWMAPEVI 122
           L YLH  G+IHRD+KA NILL+E G VKLADFG S  +       N+FVGTP+WMAPEVI
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 123 LAMDEGQYDGKVDVWSLGIT 142
               +  YD K D+WSLGIT
Sbjct: 171 ---KQSGYDEKADIWSLGIT 187

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  184 bits (469), Expect = 1e-52
 Identities = 71/141 (50%), Positives = 90/141 (63%), Gaps = 8/141 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            +++  KHPN ++Y   YL     W+VMEY   GS +DII  +   + E +IA +C  VL
Sbjct: 67  LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL 126

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPE 120
           +GL YLHS   IHRD+K+ NILL++ G+VKLADFG A+         NS VGTPYWMAPE
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           VI   D   Y  KVD+WSLGI
Sbjct: 187 VIKRKD---YGPKVDIWSLGI 204

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  184 bits (469), Expect = 1e-52
 Identities = 121/359 (33%), Positives = 164/359 (45%), Gaps = 86/359 (23%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAIK+M+ L +Q   K   I+ EI  +R+
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQ--PKKELIINEILVMRE 72

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            KHPN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 106

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL   G+VKL 
Sbjct: 107 ---------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 157

Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ+ +                      +SA+         
Sbjct: 215 YLNENPLRALYLIATNGTPELQNPE---------------------KLSAI--------- 244

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVR 512
                     F  F++ CL  +   R S+  LL H  +   +  S L  LI   K A +
Sbjct: 245 ----------FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAAKEATK 293

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  180 bits (459), Expect = 2e-51
 Identities = 126/362 (34%), Positives = 172/362 (47%), Gaps = 96/362 (26%)

Query: 145 SLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE 204
           SL D +++ L    DP  IFE +  +G+G++G VY  R + + ++ AIK M        +
Sbjct: 2   SLDDIDLSAL---RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TED 54

Query: 205 KWADILKEIRFLRQLKHPNTIE-YRGCYLR------DHTAWLVMEYC-LGSASDIIEVHW 256
           +  +I  EI  L++  H   I  Y G +++      D   WLVME+C  GS +D+++   
Sbjct: 55  EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK--- 111

Query: 257 IEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
                     GN                       LKE+ IA IC  +LRGL +LH+   
Sbjct: 112 -------NTKGN----------------------ALKEDWIAYICREILRGLAHLHAHKV 142

Query: 317 IHRDVKAGNILLTETGTVKLADFG-SASIKCPA---NSFVGTPYWMAPEVILAMDE---G 369
           IHRD+K  N+LLTE   VKL DFG SA +       N+F+GTPYWMAPEVI A DE    
Sbjct: 143 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI-ACDENPDA 201

Query: 370 QYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA 429
            YD + D+WSLGIT IE+AE  PP  +M+ M AL+ I +N                    
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-------------------- 241

Query: 430 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
              PP                  P L+S  WS  F  F+  CL KN   RPS+ +LL H 
Sbjct: 242 ---PP------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280

Query: 490 LV 491
            +
Sbjct: 281 FI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  179 bits (454), Expect = 6e-51
 Identities = 125/348 (35%), Positives = 167/348 (47%), Gaps = 93/348 (26%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP  IFE +  +G+G++G VY  R + + ++ AIK M   G +  E    I +EI  L++
Sbjct: 3   DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE----IKQEINMLKK 58

Query: 219 LKH-PNTIEYRGCYLR------DHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRL 270
             H  N   Y G +++      D   WLVME+C  GS +D+I+             GN  
Sbjct: 59  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK----------NTKGN-- 106

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                                LKEE IA IC  +LRGL++LH    IHRD+K  N+LLTE
Sbjct: 107 --------------------TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 146

Query: 331 TGTVKLADFG-SASIKCPA---NSFVGTPYWMAPEVILAMDE---GQYDGKVDVWSLGIT 383
              VKL DFG SA +       N+F+GTPYWMAPEVI A DE     YD K D+WSLGIT
Sbjct: 147 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI-ACDENPDATYDFKSDLWSLGIT 205

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
            IE+AE  PP                   C                       +M+ M A
Sbjct: 206 AIEMAEGAPPL------------------C-----------------------DMHPMRA 224

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
           L+ I +N  P L+S  WS  F  F+ SCL KN + RP++ +L+ H  +
Sbjct: 225 LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (450), Expect = 8e-51
 Identities = 81/226 (35%), Positives = 115/226 (50%), Gaps = 43/226 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G FG VY AR   + + VAIK +    +  +    ++L+EI  L++L HPN ++  G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK--EDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 230 CYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
            +  ++  +LVMEYC  GS  D++                                 + +
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLL---------------------------------KEN 85

Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE-TGTVKLADFGSASI--- 344
           +  L E+EI  I   +L GL YLHS G IHRD+K  NILL    G VKLADFG + +   
Sbjct: 86  EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145

Query: 345 -KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            K    + VGTP +MAPEV+  + +G Y  K D+WSLG+   EL E
Sbjct: 146 DKSLLKTIVGTPAYMAPEVL--LGKGYYSEKSDIWSLGVILYELPE 189

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  177 bits (449), Expect = 5e-50
 Identities = 114/357 (31%), Positives = 164/357 (45%), Gaps = 82/357 (22%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           +PE+ +E + E+G G+FG VY A+   ++E   +     +  +  E+  D + EI  L  
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQ---NKETGVLAAAKVIDTKSEEELEDYMVEIDILAS 58

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HPN ++    +  ++  W+++E+C G A D +    +E E                  
Sbjct: 59  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV---MLELE------------------ 97

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                      RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T  G +KLAD
Sbjct: 98  -----------RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLAD 146

Query: 339 FGSASIKCPA----NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         +SF+GTPYWMAPEV++     +  YD K DVWSLGIT IE+A+ +P
Sbjct: 147 FGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA+++ P L                                      
Sbjct: 207 PHHELNPMRVLLKIAKSEPPTLA------------------------------------- 229

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKA 509
              Q S WS  F  F+  CL KN   R ++ +LL H  VT   S   + +LI   KA
Sbjct: 230 ---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT-VNSNKPIRELIAEAKA 282

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  176 bits (448), Expect = 6e-50
 Identities = 90/330 (27%), Positives = 136/330 (41%), Gaps = 85/330 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +++IG GSFG VY  R     ++  +K++        E+  D L E++ L++L HPN
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLNHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+Y   +       +VMEY                    +G G+  Q++K         
Sbjct: 61  IIKYYESFEEKGKLCIVMEYA-------------------DG-GDLSQKIK--------- 91

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
             +   +P  EE+I      +   L YLHS   +HRD+K  NI LT  G VKL DFG + 
Sbjct: 92  KQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK 151

Query: 343 ---SIKCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCI--ELAERKPPYFN 396
              S    A + VGTPY+++PE+     + + Y+ K D+WSLG  C+  EL   K P F 
Sbjct: 152 VLSSTVDLAKTVVGTPYYLSPELC----QNKPYNYKSDIWSLG--CVLYELCTLKHP-FE 204

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
              +  L                   K +       P  +                    
Sbjct: 205 GENLLELAL-----------------KILKGQYPPIPSQY-------------------- 227

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
               S    + VSS L K+P +RPS  ++L
Sbjct: 228 ----SSELRNLVSSLLQKDPEERPSIAQIL 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  173 bits (440), Expect = 7e-49
 Identities = 89/336 (26%), Positives = 145/336 (43%), Gaps = 85/336 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
            E ++ +G GS G VY  R   + +I A+KK+   G +   K   +L+E++ LR  + P 
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK--QLLRELKTLRSCESPY 60

Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            ++  G + ++    +V+EY   GS +D+++                             
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--------------------------- 93

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFG- 340
                    + E  +A I   +L+GL+YLH+    IHRD+K  N+L+   G VK+ADFG 
Sbjct: 94  -------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI 146

Query: 341 SASIKC---PANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFN 396
           S  ++      N+FVGT  +M+PE I    +G+      D+WSLG+T +E A  K P+  
Sbjct: 147 SKVLENTLDQCNTFVGTVTYMSPERI----QGESYSYAADIWSLGLTLLECALGKFPFLP 202

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
               S                                 +F +     +  I     P L 
Sbjct: 203 PGQPS---------------------------------FFEL-----MQAICDGPPPSLP 224

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
           + ++S  F  F+S+CL K+P  RPS+  LL H  + 
Sbjct: 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  172 bits (438), Expect = 1e-48
 Identities = 63/175 (36%), Positives = 90/175 (51%), Gaps = 23/175 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            +L++LKHPN +     +  +   +LVMEYC  G   D+++  +  L E+E       +L
Sbjct: 49  KILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQIL 107

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KCPANSFVGTPYWMAPEV 121
             L YLHS G +HRD+K  NILL E G VKLADFG A          +FVGTP +MAPEV
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELF-------DKEDPEKIFEDLRE 169
           +L      Y   VD+WSLG+         + EL          +   ++F+ + +
Sbjct: 168 LL---GKGYGKAVDIWSLGVI--------LYELLTGKPPFPGDDQLLELFKKIGK 211

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  169 bits (431), Expect = 1e-47
 Identities = 93/338 (27%), Positives = 133/338 (39%), Gaps = 86/338 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM-----SYLGKQCAEKWADILKEIRFLRQ 218
            E L E+G G+ G V       + +I+A+K +       + KQ       IL+E+  L +
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-------ILRELDILHK 55

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
              P  + + G +  +    + MEY  G + D I                          
Sbjct: 56  CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKI-------------------------- 89

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLA 337
                  +  +  + E  +  I   VL+GL YLH     IHRDVK  NIL+   G +KL 
Sbjct: 90  ------LKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLC 143

Query: 338 DFGSAS--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           DFG +   +   A +FVGT  +MAPE I       Y  K D+WSLG++ IELA  + PY 
Sbjct: 144 DFGVSGQLVNSLAKTFVGTSSYMAPERI---QGNDYSVKSDIWSLGLSLIELATGRFPYP 200

Query: 396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL 455
                       +ND P                               L +I     P L
Sbjct: 201 P-----------ENDPP-------------------------DGIFELLQYIVNEPPPRL 224

Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
            S  +S  F  FV+ CL K+P +RPS   LL H  + +
Sbjct: 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  166 bits (423), Expect = 1e-46
 Identities = 94/327 (28%), Positives = 135/327 (41%), Gaps = 81/327 (24%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYL--GKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           +G GSFG+VY    L   +  A+K++S    G+   E    + +EI  L +L+HPN ++Y
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
            G    +   ++ +E   G                    G+  + LK +           
Sbjct: 68  LGTEREEDNLYIFLELVPG--------------------GSLAKLLKKYG---------- 97

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SI 344
                 E  I      +L GL YLH    +HRD+K  NIL+   G VKLADFG A     
Sbjct: 98  ---SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154

Query: 345 KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALY 404
              A SF G+PYWMAPEVI    +G Y    D+WSLG T +E+A  KPP+      S L 
Sbjct: 155 FSFAKSFKGSPYWMAPEVI--AQQGGYGLAADIWSLGCTVLEMATGKPPW------SQLE 206

Query: 405 HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF 464
            +A                                   A++ I ++          SD  
Sbjct: 207 GVA-----------------------------------AVFKIGRSKELPPIPDHLSDEA 231

Query: 465 AHFVSSCLAKNPADRPSSGRLLTHDLV 491
             F+  CL ++P+ RP++  LL H  V
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  166 bits (422), Expect = 3e-46
 Identities = 120/360 (33%), Positives = 164/360 (45%), Gaps = 86/360 (23%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAIK+M+    Q   K   I+ EI  +R+
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL---QQQPKKELIINEILVMRE 72

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            K+PN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 106

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L++LHS   IHRD+K+ NILL   G+VKL 
Sbjct: 107 ---------VTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLT 157

Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ                     N   +SA+         
Sbjct: 215 YLNENPLRALYLIATNGTPELQ---------------------NPERLSAV--------- 244

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
                     F  F++ CL  +   R S+  LL H  +   +  S L  LI   K A+++
Sbjct: 245 ----------FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAIKN 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  165 bits (418), Expect = 1e-45
 Identities = 119/360 (33%), Positives = 162/360 (45%), Gaps = 86/360 (23%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   I+ EI  +R+
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRE 73

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            K+PN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 107

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL   G+VKL 
Sbjct: 108 ---------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158

Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ                     N   +SA+         
Sbjct: 216 YLNENPLRALYLIATNGTPELQ---------------------NPEKLSAI--------- 245

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
                     F  F++ CL  +   R S+  LL H  +   +  S L  LI   K A ++
Sbjct: 246 ----------FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKN 295

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  161 bits (408), Expect = 2e-44
 Identities = 112/358 (31%), Positives = 163/358 (45%), Gaps = 86/358 (24%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D  DP    ++  +IG GS G V  A    S ++VA+KKM    +Q  E    +  E+  
Sbjct: 14  DPGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVI 70

Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLK 274
           +R  +H N +E    YL     W+VME+  G A +DI+                      
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---------------------- 108

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                        H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  G V
Sbjct: 109 ------------THTR-MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155

Query: 335 KLADFG---SASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           KL+DFG     S + P   S VGTPYWMAPE+I  +    Y  +VD+WSLGI  IE+ + 
Sbjct: 156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIMVIEMVDG 212

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
           +PPYFN   + A+  I  N  P L++                                  
Sbjct: 213 EPPYFNEPPLKAMKMIRDNLPPKLKN-------------------------------LHK 241

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
            +P L+          F+   L ++PA R ++  LL H  + +   PS +V L+R+ +
Sbjct: 242 VSPSLKG---------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLMRQNR 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 5e-44
 Identities = 71/153 (46%), Positives = 88/153 (57%), Gaps = 17/153 (11%)

Query: 7   LLRQL-KHPNTIEYRGCYL------RDHTAWLVMEYCL-GSASDIIE---VHKRPLKEEE 55
           +LR+   HPN   + G ++       D   WLVME C  GS +D+++      + LKEE 
Sbjct: 55  ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA---NSFV 111
           IA I    LRGL YLH    IHRD+K  NILLT+   VKL DFG SA +       N+F+
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 112 GTPYWMAPEVILAM--DEGQYDGKVDVWSLGIT 142
           GTPYWMAPEVI      +  YD + DVWSLGIT
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  159 bits (405), Expect = 1e-43
 Identities = 95/354 (26%), Positives = 144/354 (40%), Gaps = 58/354 (16%)

Query: 167 LREIGHGSFGA--VYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L  IG        V+ A+   +  +VA+KK++ L     E    + +EI   RQL+HPN 
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 225 IEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
           + Y   ++ D   ++V      GS  D+++ H+       EG+                 
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF------PEGL----------------- 98

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS-- 341
                     E  IA I   VL  L+Y+HS G IHR VKA +ILL+  G V L+      
Sbjct: 99  ---------PELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSV 149

Query: 342 ---------ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
                      +     S V    W++PEV L  +   Y+ K D++S+GIT  ELA    
Sbjct: 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEV-LQQNLQGYNEKSDIYSVGITACELANGHV 208

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+ +M A   L    +   PCL   D S       +  +                    T
Sbjct: 209 PFKDMPATQMLLEKVRGTVPCLL--DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRT 266

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIR 505
                  +S+ F  FV  CL ++P  RPS+ +LL H    +  R  + L+DL++
Sbjct: 267 -------FSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLDLLK 313

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  157 bits (398), Expect = 7e-43
 Identities = 111/358 (31%), Positives = 159/358 (44%), Gaps = 86/358 (24%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D+ DP  + E+  +IG GS G V  AR   S   VA+K M    +Q  E    +  E+  
Sbjct: 15  DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVI 71

Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLK 274
           +R  +H N +E    YL     W++ME+  G A +DI                       
Sbjct: 72  MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI----------------------- 108

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                       V +  L EE+IA +C  VL+ L YLHS G IHRD+K+ +ILLT  G V
Sbjct: 109 ------------VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRV 156

Query: 335 KLADFG---SASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           KL+DFG     S   P   S VGTPYWMAPEVI       Y  +VD+WSLGI  IE+ + 
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI---SRTPYGTEVDIWSLGIMVIEMVDG 213

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
           +PPYF+ + + A+  +  +  P L++                               A  
Sbjct: 214 EPPYFSDSPVQAMKRLRDSPPPKLKN-------------------------------AHK 242

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
            +P L+          F+   L + P +R ++  LL H  + +   P  LV LI++ +
Sbjct: 243 ISPVLRD---------FLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYR 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  156 bits (396), Expect = 1e-42
 Identities = 112/359 (31%), Positives = 164/359 (45%), Gaps = 86/359 (23%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G V+ A  + + + VAIK+++ L KQ  ++   I+ EI  +++
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKEL--IINEILVMKE 72

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           LK+PN + +   +L     ++VMEY  G S +D+                          
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV-------------------------- 106

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LH+   IHRD+K+ N+LL   G+VKL 
Sbjct: 107 ---------VTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLT 157

Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ+ +                                   
Sbjct: 215 YLNENPLRALYLIATNGTPELQNPE----------------------------------- 239

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVR 512
                  S  F  F++ CL  +   R S+  LL H  +   +  S L  LI   K A++
Sbjct: 240 -----KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMK 293

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (393), Expect = 2e-42
 Identities = 81/228 (35%), Positives = 104/228 (45%), Gaps = 30/228 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            +LR+L HPN +     +      +LVMEYC  G   D +     PL E+E   I   +L
Sbjct: 50  RILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQIL 108

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPE 120
           RGL YLHS G IHRD+K  NILL E G VK+ADFG A           +FVGTP++MAPE
Sbjct: 109 RGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE 168

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP--EKIFED----LREIGHGS 174
           V+L      Y  KVDVWSLG+         + EL   + P   +   D    +R I    
Sbjct: 169 VLL--GGNGYGPKVDVWSLGVI--------LYELLTGKPPFSGENILDQLQLIRRILGPP 218

Query: 175 FGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
                      S E  A   +     +   K     +EI     L+HP
Sbjct: 219 LEFDEPKWSSGSEE--AKDLIKKCLNKDPSKRPTA-EEI-----LQHP 258

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  153 bits (388), Expect = 2e-42
 Identities = 63/142 (44%), Positives = 89/142 (62%), Gaps = 8/142 (5%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           +L++L HPN ++  G +  ++  +LVMEYC  GS  D+++ ++  L E+EI  I   +L 
Sbjct: 44  ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILE 103

Query: 66  GLNYLHSLGRIHRDVKAGNILLTE-TGTVKLADFGSASI----KCPANSFVGTPYWMAPE 120
           GL YLHS G IHRD+K  NILL    G VKLADFG + +    K    + VGTP +MAPE
Sbjct: 104 GLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPE 163

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           V+  + +G Y  K D+WSLG+ 
Sbjct: 164 VL--LGKGYYSEKSDIWSLGVI 183

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  154 bits (391), Expect = 3e-42
 Identities = 71/146 (48%), Positives = 88/146 (60%), Gaps = 17/146 (11%)

Query: 10  QLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRP---LKEEEIAAICSGVLR 65
           Q  HPN ++Y   ++     WLVM Y   GS  DI++    P   L E  IA +   VL+
Sbjct: 55  QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLK 113

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA-------NSFVGTPYWM 117
           GL YLHS G+IHRD+KAGNILL E G+VK+ADFG SAS+            +FVGTP WM
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 118 APEVILAMDEGQ-YDGKVDVWSLGIT 142
           APEV   M++   YD K D+WS GIT
Sbjct: 174 APEV---MEQVHGYDFKADIWSFGIT 196

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  155 bits (391), Expect = 3e-41
 Identities = 108/434 (24%), Positives = 158/434 (36%), Gaps = 83/434 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  LR++G GSFG VY AR    R++VA+K ++   +  +++    L+EI+ L  L HP 
Sbjct: 2   YRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 224 TI-EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            I +    +  + + +LVMEY  G                                   L
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDG------------------------------GSLEDL 88

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT-VKLADFGS 341
                 K PL E E   I + +L  L YLHS G IHRD+K  NILL   G  VKL DFG 
Sbjct: 89  LKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL 148

Query: 342 AS----------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           A           I    ++ VGTP +MAPEV+L +         D+WSLGIT  EL    
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Query: 392 PPYFNMNAMS----ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
           PP+      S     L  I +  TP L S                               
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNP------------------------ 244

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRT 507
                        S   +  +   LAK+P +R SS   L+HDL+   +     +  + + 
Sbjct: 245 ----------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294

Query: 508 KAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSSKSNSITSEHSVQSVG 567
             +     +L       I   +      +    D  +       +  +S     S   + 
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLS 354

Query: 568 VGVNPHDPTPNSSS 581
              +     P  S+
Sbjct: 355 TASSKRSSLPKISA 368

Length = 384

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  152 bits (385), Expect = 4e-41
 Identities = 110/345 (31%), Positives = 150/345 (43%), Gaps = 85/345 (24%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP   +E +  IG G++G VY         + A+K +  +     E    I  E   L+ 
Sbjct: 19  DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQS 74

Query: 219 L-KHPNTIEYRGCYLR-DHTA----WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           L  HPN +++ G + + D       WLV+E C G +  + E+        V+G+      
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGS--VTEL--------VKGL------ 118

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L C              + L E  I+ I  G L GL +LH+   IHRDVK  NILLT  G
Sbjct: 119 LIC-------------GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG 165

Query: 333 TVKLADFGSA----SIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIE 386
            VKL DFG +    S +   N+ VGTP+WMAPEVI    +    YD + DVWSLGIT IE
Sbjct: 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Query: 387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH 446
           L +  PP F+M+ +  L+ I +N  P L                                
Sbjct: 226 LGDGDPPLFDMHPVKTLFKIPRNPPPTL-------------------------------- 253

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                   L    W  +F HF+S CL K+   RPS   LL H  +
Sbjct: 254 --------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 5e-41
 Identities = 68/143 (47%), Positives = 90/143 (62%), Gaps = 7/143 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD-IIEVHKRPLKEEEIAAICSGVLR 65
           +L + KHPN +     Y  ++  W+++E+C G A D I+   +R L E +I  +C  +L 
Sbjct: 55  ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA---NSFVGTPYWMAPEV 121
            LN+LHS   IHRD+KAGNILLT  G VKLADFG SA  K      ++F+GTPYWMAPEV
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174

Query: 122 IL--AMDEGQYDGKVDVWSLGIT 142
           +      +  YD K D+WSLGIT
Sbjct: 175 VACETFKDNPYDYKADIWSLGIT 197

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  151 bits (382), Expect = 6e-41
 Identities = 70/146 (47%), Positives = 90/146 (61%), Gaps = 14/146 (9%)

Query: 6   SLLRQLKH---PNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICS 61
           +LL QL+    PN  +Y G YL+    W++MEY  G S   +++    P+ E+ I+ I  
Sbjct: 51  ALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIR 108

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWM 117
            VL  L Y+H +G IHRD+KA NIL+T TG VKL DFG A          ++FVGTPYWM
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWM 168

Query: 118 APEVILAMDEGQ-YDGKVDVWSLGIT 142
           APEVI    EG+ YD K D+WSLGIT
Sbjct: 169 APEVIT---EGKYYDTKADIWSLGIT 191

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  150 bits (380), Expect = 1e-40
 Identities = 99/344 (28%), Positives = 135/344 (39%), Gaps = 96/344 (27%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L  IG GSFG V   R     +I+  K++ Y      EK   ++ E+  LR+LKHPN
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ-LVSEVNILRELKHPN 60

Query: 224 TIEYRGCYLRDH-----TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL--KCF 276
            + Y   Y R       T ++VMEYC     D                   L QL  KC 
Sbjct: 61  IVRY---YDRIIDRSNQTLYIVMEYC--EGGD-------------------LAQLIQKCK 96

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-----IHRDVKAGNILLTET 331
            E          ++ ++EE I  I + +L  L   H+        +HRD+K  NI L   
Sbjct: 97  KE----------RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146

Query: 332 GTVKLADFGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
             VKL DFG A I       A ++VGTPY+M+PE +  M    YD K D+WSLG    EL
Sbjct: 147 NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM---SYDEKSDIWSLGCLIYEL 203

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
               PP+    A + L                 +   I     R+ PY            
Sbjct: 204 CALSPPF---TARNQL----------------QLASKIKEGKFRRIPYR----------- 233

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                       +S      + S L  +P  RPS+  LL   L+
Sbjct: 234 ------------YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 3e-40
 Identities = 68/163 (41%), Positives = 85/163 (52%), Gaps = 23/163 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            LL+ LKHPN ++Y G      + ++++EY   GS   II+    P  E  +A     VL
Sbjct: 51  DLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVL 109

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPE 120
           +GL YLH  G IHRD+KA NIL T+ G VKLADFG A+          S VGTPYWMAPE
Sbjct: 110 QGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169

Query: 121 VILAMDEGQYDG---KVDVWSLGITPGSLKDPEIAELFDKEDP 160
           VI      +  G     D+WSLG T        + EL     P
Sbjct: 170 VI------EMSGASTASDIWSLGCT--------VIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  146 bits (372), Expect = 1e-39
 Identities = 77/329 (23%), Positives = 122/329 (37%), Gaps = 96/329 (29%)

Query: 167 LREIGHGSFGAVYYARCL----VSREIVAIKKMSYLGKQCA--EKWADILKEIRFLRQLK 220
            +++G G+FG VY              VA+K +    K+ A  ++  + L+E R +R+L 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKLD 59

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HPN ++  G    +    +VMEY  G                    G+ L  L+      
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPG--------------------GDLLDYLR------ 93

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                +   + L   ++ +    + RG+ YL S   IHRD+ A N L+ E   VK++DFG
Sbjct: 94  -----KNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 148

Query: 341 ------SASIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KP 392
                            +  P  WMAPE +    EG++  K DVWS G+   E+    + 
Sbjct: 149 LSRDLYDDDYYKVKGGKL--PIRWMAPESL---KEGKFTSKSDVWSFGVLLWEIFTLGEE 203

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           PY  M+    L ++ +                      R P   N      LY +     
Sbjct: 204 PYPGMSNAEVLEYLKKG--------------------YRLPKPPNCP--PELYKLML--- 238

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
                             C A++P DRP+
Sbjct: 239 -----------------QCWAEDPEDRPT 250

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  147 bits (373), Expect = 2e-39
 Identities = 108/355 (30%), Positives = 155/355 (43%), Gaps = 86/355 (24%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP +  +   +IG GS G V  A    + + VA+KKM    +Q  E    +  E+  +R 
Sbjct: 19  DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRD 75

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             H N ++    YL     W+VME+  G A +DI+                         
Sbjct: 76  YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV------------------------- 110

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                     H R + EE+IA +C  VLR L+YLH+ G IHRD+K+ +ILLT  G +KL+
Sbjct: 111 ---------THTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLS 160

Query: 338 DFG---SASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG     S + P   S VGTPYWMAPEVI  +    Y  +VD+WSLGI  IE+ + +PP
Sbjct: 161 DFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL---PYGTEVDIWSLGIMVIEMIDGEPP 217

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           YFN   + A+  I  N  P ++                                      
Sbjct: 218 YFNEPPLQAMRRIRDNLPPRVK-------------------------------------- 239

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
              S   S     F+   L + P+ R ++  LL H  +     PS +V L+R+ +
Sbjct: 240 --DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMRQYR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  146 bits (371), Expect = 2e-39
 Identities = 73/329 (22%), Positives = 121/329 (36%), Gaps = 96/329 (29%)

Query: 167 LREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCA--EKWADILKEIRFLRQLK 220
            +++G G+FG VY        E     VA+K +    K+ A  E+  + L+E   +++L 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL----KEGASEEEREEFLEEASIMKKLS 59

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           HPN +   G   +    ++V EY   G                   + + L++       
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGD------------------LLDFLRK------- 94

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   H   L  +++  +   + +G+ YL S   +HRD+ A N L+TE   VK++DF
Sbjct: 95  --------HGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDF 146

Query: 340 GSASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KP 392
           G +      + +        P  WMAPE +    +G++  K DVWS G+   E+    + 
Sbjct: 147 GLSRDIYEDDYYRKRGGGKLPIKWMAPESL---KDGKFTSKSDVWSFGVLLWEIFTLGEQ 203

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           PY  M+    L  +                        R P     N    LY +     
Sbjct: 204 PYPGMSNEEVLELLEDG--------------------YRLPR--PENCPDELYELML--- 238

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
                             C A +P DRP+
Sbjct: 239 -----------------QCWAYDPEDRPT 250

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  146 bits (370), Expect = 3e-39
 Identities = 77/329 (23%), Positives = 126/329 (38%), Gaps = 97/329 (29%)

Query: 167 LREIGHGSFGAVYYAR---CLVSREI-VAIKKMSYLGKQCA--EKWADILKEIRFLRQLK 220
            +++G G+FG VY  +       +++ VA+K +    K+ A  ++  + L+E R +R+L 
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL----KEDASEQQIEEFLREARIMRKLD 59

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HPN ++  G    +   ++VMEY  G                    G+ L  L+      
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEG--------------------GDLLSYLR------ 93

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                  ++  L   ++ +    + RG+ YL S   IHRD+ A N L+ E   VK++DFG
Sbjct: 94  ------KNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 147

Query: 341 ------SASIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KP 392
                            +  P  WMAPE +    EG++  K DVWS G+   E+    + 
Sbjct: 148 LSRDLYDDDYYRKRGGKL--PIRWMAPESL---KEGKFTSKSDVWSFGVLLWEIFTLGEQ 202

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           PY  M+    L ++                        R P   N      LY +     
Sbjct: 203 PYPGMSNEEVLEYLKNG--------------------YRLPQPPNCP--PELYDLML--- 237

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
                             C A++P DRP+
Sbjct: 238 -----------------QCWAEDPEDRPT 249

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  145 bits (367), Expect = 6e-39
 Identities = 88/333 (26%), Positives = 132/333 (39%), Gaps = 87/333 (26%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYL-GKQCAEKWADILKEIRFLRQLKHPNTI 225
             +IG G+FG VY A  L + E++A+K++          K  +I  E++ L  LKHPN +
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK--EIADEMKVLELLKHPNLV 62

Query: 226 EYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +Y G  +     ++ MEYC  G+  +++E                               
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELLE------------------------------- 91

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
              H R L E  I      +L GL YLHS G +HRD+K  NI L   G +KL DFG A  
Sbjct: 92  ---HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148

Query: 345 KCPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
                        S  GTP +MAPEVI       +    D+WSLG   +E+A  K P+  
Sbjct: 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL- 455
           ++                  +++ +                      ++H+     P + 
Sbjct: 209 LD------------------NEFQI----------------------MFHVGAGHKPPIP 228

Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
            S   S     F+  CL  +P  RP++  LL H
Sbjct: 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  144 bits (365), Expect = 1e-38
 Identities = 58/146 (39%), Positives = 73/146 (50%), Gaps = 13/146 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYL-RDHTAW-LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSG 62
            +L  L+HPN + Y G     +     + +EY   GS S +++     L E  I      
Sbjct: 51  RILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQ 109

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK------CPANSFVGTPYW 116
           +L GL YLHS G +HRD+K  NIL+   G VKLADFG A             S  GTPYW
Sbjct: 110 ILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
           MAPEVI      +Y    D+WSLG T
Sbjct: 170 MAPEVI---RGEEYGRAADIWSLGCT 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  144 bits (366), Expect = 1e-38
 Identities = 71/160 (44%), Positives = 96/160 (60%), Gaps = 18/160 (11%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVL 64
            ++R  +HPN +E    YL     W+VME+  G A +DI+  H R + EE+IA +C  VL
Sbjct: 68  VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLAVL 125

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG---SASIKCPA-NSFVGTPYWMAPE 120
           + L++LH+ G IHRD+K+ +ILLT  G VKL+DFG     S + P   S VGTPYWMAPE
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 185

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP 160
           VI  +    Y  +VD+WSLGI         + E+ D E P
Sbjct: 186 VISRL---PYGTEVDIWSLGIM--------VIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  145 bits (367), Expect = 1e-38
 Identities = 96/339 (28%), Positives = 140/339 (41%), Gaps = 83/339 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS-----YLGKQCAEKWADILKEIRFLRQ 218
             +L  +G G+ G+V   R   +  I A+K ++      L KQ       IL+E+   + 
Sbjct: 3   IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ-------ILRELEINKS 55

Query: 219 LKHPNTIEYRGCYLRDHTAWL--VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            K P  ++Y G +L + ++ +   MEYC G + D I     +R       G R+      
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR-------GGRI------ 102

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                            E+ +  I   VL+GL+YLHS   IHRD+K  NILLT  G VKL
Sbjct: 103 ----------------GEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKL 146

Query: 337 ADFGSAS--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
            DFG +   +   A +F GT ++MAPE I       Y    DVWSLG+T +E        
Sbjct: 147 CDFGVSGELVNSLAGTFTGTSFYMAPERIQG---KPYSITSDVWSLGLTLLE-------- 195

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSV--IKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
                      +AQN  P     +  +  I+ +S       P                D 
Sbjct: 196 -----------VAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL-------------KDE 231

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
           P      WS+ F  F+  CL K+P  RP+   +L H  +
Sbjct: 232 PGNGIK-WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 1e-38
 Identities = 91/335 (27%), Positives = 143/335 (42%), Gaps = 60/335 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKH 221
           +E L  +G G++G V   R   + EIVAIKK   S   +   +     L+E++ LRQL+H
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT---ALREVKVLRQLRH 59

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N +  +  + R    +LV EY              ER          L+ L        
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYV-------------ER--------TLLELL-------- 90

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
               E     L  + + +    +L+ + Y HS   IHRD+K  NIL++E+G +KL DFG 
Sbjct: 91  ----EASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGF 146

Query: 342 A-SIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           A +++         +V T ++ APE+++   +  Y   VDVW++G    EL + +P +  
Sbjct: 147 ARALRARPASPLTDYVATRWYRAPELLVG--DTNYGKPVDVWAIGCIMAELLDGEPLFPG 204

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA--QNDTPC 454
            + +  LY I +    CL     S  +  SS      P F   A          +   P 
Sbjct: 205 DSDIDQLYLIQK----CLGPLPPSHQELFSSN-----PRFAGVAFPEPSQPESLERRYPG 255

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
             SS   D    F+ +CL  +P +R +   LL H 
Sbjct: 256 KVSSPALD----FLKACLRMDPKERLTCDELLQHP 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  145 bits (366), Expect = 1e-38
 Identities = 108/352 (30%), Positives = 149/352 (42%), Gaps = 88/352 (25%)

Query: 154 LFDK-EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
           +FD   DP   +E +  IG G++G V+      +    A+K +  +     E    I  E
Sbjct: 9   IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAE 64

Query: 213 IRFLRQLK-HPNTIEYRGCYLRDHTA-----WLVMEYCLG-SASDIIEVHWIEREFHVEG 265
              L+ L  HPN +++ G Y +         WLV+E C G S +D+           V+G
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL-----------VKG 113

Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
              R ++++                   E  IA I    L GL +LH    IHRDVK  N
Sbjct: 114 FLKRGERME-------------------EPIIAYILHEALMGLQHLHVNKTIHRDVKGNN 154

Query: 326 ILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWS 379
           ILLT  G VKL DFG +    S +   N+ VGTP+WMAPEVI    +    YD + DVWS
Sbjct: 155 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214

Query: 380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMN 439
           LGIT IEL +  PP  +++ M AL+ I +N  P L                         
Sbjct: 215 LGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH------------------------ 250

Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                           Q   WS+ F  F+  CL K+   RP+   LL H  +
Sbjct: 251 ----------------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score =  140 bits (355), Expect = 2e-38
 Identities = 62/213 (29%), Positives = 83/213 (38%), Gaps = 45/213 (21%)

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
           EV  RPL EEEI A+C   L  L  LH         K+GNILLT  G +KL   GS + K
Sbjct: 8   EVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL--DGSVAFK 59

Query: 346 CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYH 405
            P  S    PY+MAPEVI      +   K D++SLGIT  E  + + PY     +SA+  
Sbjct: 60  TPEQSRP-DPYFMAPEVIQGQSYTE---KADIYSLGITLYEALDYELPYNEERELSAILE 115

Query: 406 IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA 465
           I  N  P                                      D   L+    + +F 
Sbjct: 116 ILLNGMPADD---------------------------------PRDRSNLEGVSAARSFE 142

Query: 466 HFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
            F+  C ++ P  R ++   L H       +  
Sbjct: 143 DFMRLCASRLPQRREAANHYLAHCRALFAETLE 175

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 3e-38
 Identities = 93/335 (27%), Positives = 152/335 (45%), Gaps = 63/335 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLK- 220
           ++ ++++G G+FG+VY AR   + E+VAIKKM    K+    W +   L+E++ LR+L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNE 56

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HPN ++ +  +  +   + V EY                       GN  Q +K      
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYM---------------------EGNLYQLMKDRK--- 92

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                    +P  E  I +I   +L+GL ++H  G  HRD+K  N+L++    VK+ADFG
Sbjct: 93  --------GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG 144

Query: 341 SA-SIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKPPYF 395
            A  I+   P   +V T ++ APE++L      Y   VD+W+LG  CI  EL   +P + 
Sbjct: 145 LAREIRSRPPYTDYVSTRWYRAPEILLR--STSYSSPVDIWALG--CIMAELYTLRPLFP 200

Query: 396 NMNAMSALYHIAQ-NDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
             + +  LY I     TP     DW     ++S    + P F   A ++L+ +  N +P 
Sbjct: 201 GSSEIDQLYKICSVLGTP--TKQDWPEGYKLASKLGFRFPQF---APTSLHQLIPNASP- 254

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
                        +   L  +P  RP++ + L H 
Sbjct: 255 --------EAIDLIKDMLRWDPKKRPTASQALQHP 281

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 6e-38
 Identities = 87/334 (26%), Positives = 141/334 (42%), Gaps = 63/334 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ L +IG G++G VY AR  ++ EIVAIKK+    +         L+EI+ L++L HPN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP-KTALREIKLLKELNHPN 59

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+    +      +LV E+     +D+ ++                             
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFMD---TDLYKL----------------------------- 87

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
             +  +R L E  I +    +L+GL + HS G +HRD+K  N+L+   G +KLADFG A 
Sbjct: 88  -IKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLAR 146

Query: 344 IKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKPPYFNM 397
                       V T ++ APE++L      Y   VD+WS+G  CI  EL  R+P +   
Sbjct: 147 SFGSPVRPYTHYVVTRWYRAPELLLGD--KGYSTPVDIWSVG--CIFAELLSRRPLFPGK 202

Query: 398 NAMSALYHIAQN-DTPCLQSSDWSVIKTIS-STAERKPPYFNMNAMSALYHIAQN-DTPC 454
           + +  L+ I +   TP      W    +++ +     P    M     L  +  N     
Sbjct: 203 SEIDQLFKIFRTLGTPD--PEVWPKFTSLARNYKFSFPKKAGMP----LPKLFPNASPQA 256

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           L            +S  L  +P  R ++ + L H
Sbjct: 257 LD----------LLSQMLHYDPHKRITAEQALAH 280

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  141 bits (356), Expect = 1e-37
 Identities = 91/332 (27%), Positives = 139/332 (41%), Gaps = 81/332 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ L+++G GS+G+VY  + L   +  A+K++  LG    ++  D + EIR L  + HPN
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            I Y+  +L  +   +VMEY   G  S  I                R ++          
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAIS--------------KRKKK---------- 96

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                 ++ + E+EI  I   +LRGL  LH    +HRD+K+ NILL     VK+ D G +
Sbjct: 97  ------RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150

Query: 343 SI--KCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMNA 399
            +  K  A + +GTP++MAPEV     +G+ Y  K D+WSLG    E+A   PP F   +
Sbjct: 151 KVLKKNMAKTQIGTPHYMAPEVW----KGRPYSYKSDIWSLGCLLYEMATFAPP-FEARS 205

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           M  L +                 K         PP +                       
Sbjct: 206 MQDLRY-----------------KVQRGKYPPIPPIY----------------------- 225

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
            S    +F+ S L   P  RP+  ++L    V
Sbjct: 226 -SQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  140 bits (354), Expect = 2e-37
 Identities = 72/155 (46%), Positives = 94/155 (60%), Gaps = 7/155 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLR 65
           +++  KH N + Y G YLR    W+ ME+C G S  DI  V   PL E +IA +    L+
Sbjct: 59  MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQ 117

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIK---CPANSFVGTPYWMAPEV 121
           GL YLHS G++HRD+K  NILLT+ G VKLADFG SA I        SF+GTPYWMAPEV
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFD 156
                +G Y+   D+W++GIT   L + +   +FD
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQ-PPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  138 bits (348), Expect = 2e-36
 Identities = 76/156 (48%), Positives = 99/156 (63%), Gaps = 12/156 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVL 64
           ++L Q   P   +Y G YL+D   W++MEY  G SA D++E    PL E +IA I   +L
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREIL 111

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPE 120
           +GL+YLHS  +IHRD+KA N+LL+E G VKLADFG A      +   N+FVGTP+WMAPE
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLK--DPEIAEL 154
           VI    +  YD K D+WSLGIT   L   +P  +EL
Sbjct: 172 VI---KQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  138 bits (351), Expect = 2e-36
 Identities = 76/241 (31%), Positives = 112/241 (46%), Gaps = 56/241 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLRQ 218
           +E L ++G G++G VY AR   + EIVA+KK+    +   E+  +      L+EI  L++
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI----RLDNEE--EGIPSTALREISLLKE 54

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           LKHPN ++       +   +LV EYC     D                            
Sbjct: 55  LKHPNIVKLLDVIHTERKLYLVFEYC---DMD---------------------------- 83

Query: 279 HFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              L  + +    PL    I +I   +LRGL Y HS   +HRD+K  NIL+   G +KLA
Sbjct: 84  ---LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLA 140

Query: 338 DFGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
           DFG A +   P  ++   V T ++ APE++L      Y   VD+WS+G  CI  E+   K
Sbjct: 141 DFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK--HYSTAVDIWSVG--CIFAEMITGK 196

Query: 392 P 392
           P
Sbjct: 197 P 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  137 bits (348), Expect = 2e-36
 Identities = 98/323 (30%), Positives = 139/323 (43%), Gaps = 79/323 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+  ++IG G F  VY A CL+   +VA+KK+       A+   D LKEI  L+QL HPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+Y   ++ ++   +V+E  L  A D                      L    +HF   
Sbjct: 64  VIKYLASFIENNELNIVLE--LADAGD----------------------LSRMIKHFK-- 97

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
                KR + E  I      +   L ++HS   +HRD+K  N+ +T TG VKL D G   
Sbjct: 98  ---KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR 154

Query: 341 -SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
             +S    A+S VGTPY+M+PE I    E  Y+ K D+WSLG  C+              
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERI---HENGYNFKSDIWSLG--CL-------------- 195

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF--NMNAMSALYHIAQNDTPCLQS 457
              LY +A      LQS                 P++   MN  S    I + D P L +
Sbjct: 196 ---LYEMA-----ALQS-----------------PFYGDKMNLYSLCKKIEKCDYPPLPA 230

Query: 458 SDWSDTFAHFVSSCLAKNPADRP 480
             +S+     VS C+  +P  RP
Sbjct: 231 DHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  137 bits (346), Expect = 3e-36
 Identities = 93/331 (28%), Positives = 133/331 (40%), Gaps = 86/331 (25%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY--LGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           +G G+FG VY    + +   +A+K++ +     +  ++   +  EI+ L+ L+H   ++Y
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
            GC   D T  + MEY  G                    G+   QLK +           
Sbjct: 70  YGCLRDDETLSIFMEYMPG--------------------GSVKDQLKAYG---------- 99

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----S 343
               L E         +L G+ YLHS   +HRD+K  NIL    G VKL DFG++    +
Sbjct: 100 ---ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156

Query: 344 IKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
           I        S  GTPYWM+PEVI    EG Y  K DVWS+G T +E+   KPP+    AM
Sbjct: 157 ICSSGTGMKSVTGTPYWMSPEVISG--EG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213

Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
           +A++ IA                                         Q   P L  S  
Sbjct: 214 AAIFKIAT----------------------------------------QPTNPQL-PSHV 232

Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
           S    +F+     +N   RPS+  LL H  V
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  137 bits (345), Expect = 5e-36
 Identities = 74/154 (48%), Positives = 94/154 (61%), Gaps = 13/154 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++++ KH N + Y G YL     W+ MEYC G S  DI  V   PL E +IA +C   L+
Sbjct: 59  MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQ 117

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMAPE 120
           GL YLHS G++HRD+K  NILLT+ G VKLADFG A+ K  A      SF+GTPYWMAPE
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPE 176

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL 154
           V      G Y+   D+W++GIT       E+AEL
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITA-----IELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  135 bits (341), Expect = 2e-35
 Identities = 71/149 (47%), Positives = 91/149 (61%), Gaps = 8/149 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++L Q   P    Y G YL+    W++MEY LG  S +  +   PL+E  IA I   +L+
Sbjct: 54  TVLSQCDSPYITRYYGSYLKGTKLWIIMEY-LGGGSALDLLKPGPLEETYIATILREILK 112

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEV 121
           GL+YLHS  +IHRD+KA N+LL+E G VKLADFG A      +   N+FVGTP+WMAPEV
Sbjct: 113 GLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPE 150
           I    +  YD K D+WSLGIT   L   E
Sbjct: 173 I---KQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (340), Expect = 2e-35
 Identities = 55/143 (38%), Positives = 77/143 (53%), Gaps = 13/143 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHK---RPLKEEEIAAICSG 62
           +L++L HPN I+Y   +       +VMEY   G  S  I+  K   +P  EE+I      
Sbjct: 52  ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMA 118
           +   L YLHS   +HRD+K  NI LT  G VKL DFG +    S    A + VGTPY+++
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171

Query: 119 PEVILAMDEGQ-YDGKVDVWSLG 140
           PE+     + + Y+ K D+WSLG
Sbjct: 172 PELC----QNKPYNYKSDIWSLG 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  134 bits (340), Expect = 3e-35
 Identities = 65/256 (25%), Positives = 110/256 (42%), Gaps = 53/256 (20%)

Query: 168 REIGHGSFGAVY--YARCLVSREI-VAIKKMSYLGKQCA--EKWADILKEIRFLRQLKHP 222
           +++G G+FG VY    +    +   VA+K +    K+ A  E+  D LKE R +++L HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDASEEERKDFLKEARVMKKLGHP 56

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +   G    +   +LV+EY  G                    G+ L  L+   +   +
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEG--------------------GDLLDYLR---KSRPV 93

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
           F        L  +++ +    + +G+ YL S   +HRD+ A N L+ E   VK++DFG +
Sbjct: 94  FPSPEKST-LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152

Query: 343 SIKCPANSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER- 390
                 + +    Y           WMAPE +    +G +  K DVWS G+   E+    
Sbjct: 153 R-----DVYDDDYYRKKTGGKLPIRWMAPESL---KDGIFTSKSDVWSFGVLLWEIFTLG 204

Query: 391 KPPYFNMNAMSALYHI 406
             PY  ++    L ++
Sbjct: 205 ATPYPGLSNEEVLEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  134 bits (339), Expect = 4e-35
 Identities = 69/149 (46%), Positives = 91/149 (61%), Gaps = 8/149 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++L Q   P   +Y G YL+    W++MEY LG  S +  +   P  E +IA +   +L+
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKGTKLWIIMEY-LGGGSALDLLRAGPFDEFQIATMLKEILK 112

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEV 121
           GL+YLHS  +IHRD+KA N+LL+E G VKLADFG A      +   N+FVGTP+WMAPEV
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPE 150
           I    +  YD K D+WSLGIT   L   E
Sbjct: 173 I---QQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  134 bits (338), Expect = 4e-35
 Identities = 95/337 (28%), Positives = 145/337 (43%), Gaps = 94/337 (27%)

Query: 170 IGHGSFGAVYYARCLVSR-EIVAIKKMSY--LGKQCAEK-WADILKEIRFLRQLKHPNTI 225
           +G G++G VY    L ++ +++A+K++         AEK +  + +E+  L+ LKH N +
Sbjct: 8   LGKGAYGTVYCG--LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 226 EYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +Y G  L D+T  + ME+  G S S I+               NR               
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL---------------NRFG------------- 97

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                 PL E         +L G+ YLH+   +HRD+K  N++L   G +KL DFG A  
Sbjct: 98  ------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151

Query: 345 KCPAN----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
                          S  GTPYWMAPEVI   +E  Y  K D+WS+G T  E+A  KPP 
Sbjct: 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVI---NESGYGRKSDIWSIGCTVFEMATGKPPL 208

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
            +M+ ++A+++I  +                     R P  F+  A              
Sbjct: 209 ASMDRLAAMFYIGAHRGL----------------MPRLPDSFSAAA-------------- 238

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                       FV+SCL ++  +RPS+ +LL HD +
Sbjct: 239 ----------IDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  134 bits (338), Expect = 7e-35
 Identities = 65/143 (45%), Positives = 88/143 (61%), Gaps = 7/143 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLR 65
           +L    HP  ++  G +  D   W+++E+C G A D I +   R L E +I  IC  +L 
Sbjct: 62  ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE 121

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEV 121
            L YLHS+  IHRD+KAGN+LLT  G +KLADFG ++         +SF+GTPYWMAPEV
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEV 181

Query: 122 IL--AMDEGQYDGKVDVWSLGIT 142
           ++   M +  YD K D+WSLGIT
Sbjct: 182 VMCETMKDTPYDYKADIWSLGIT 204

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  132 bits (334), Expect = 1e-34
 Identities = 93/324 (28%), Positives = 139/324 (42%), Gaps = 75/324 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+  ++IG G F  VY A CL+ R+ VA+KK+       A+   D +KEI  L+QL HPN
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+Y   ++ D+   +V+E  L  A D+ ++                           + 
Sbjct: 64  VIKYLDSFIEDNELNIVLE--LADAGDLSQM---------------------------IK 94

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
            F+  KR + E  +      +   + ++HS   +HRD+K  N+ +T TG VKL D G   
Sbjct: 95  YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154

Query: 341 -SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
             +S    A+S VGTPY+M+PE I    E  Y+ K D+WSLG    E+A  + P++    
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERI---HENGYNFKSDIWSLGCLLYEMAALQSPFY---- 207

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                             D                   MN  S    I Q D P L +  
Sbjct: 208 -----------------GD------------------KMNLFSLCQKIEQCDYPPLPTEH 232

Query: 460 WSDTFAHFVSSCLAKNPADRPSSG 483
           +S+     VS C+  +P  RP  G
Sbjct: 233 YSEKLRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  131 bits (331), Expect = 4e-34
 Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 44/278 (15%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           ++IG G F  VY A CL+    VA+KK+       A+  AD +KEI  L+QL HPN I+Y
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
              ++ D+   +V+E  L  A D+  +                           + +F+ 
Sbjct: 68  YASFIEDNELNIVLE--LADAGDLSRM---------------------------IKHFKK 98

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SAS 343
            KR + E+ +      +   L ++HS   +HRD+K  N+ +T TG VKL D G     +S
Sbjct: 99  QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158

Query: 344 IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF--NMNAMS 401
               A+S VGTPY+M+PE I    E  Y+ K D+WSLG    E+A  + P++   MN  S
Sbjct: 159 KTTAAHSLVGTPYYMSPERI---HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215

Query: 402 ALYHIAQNDTPCLQSSDWS------VIKTISSTAERKP 433
               I Q D P L S  +S      V   I+   E++P
Sbjct: 216 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  131 bits (330), Expect = 1e-33
 Identities = 65/140 (46%), Positives = 84/140 (60%), Gaps = 10/140 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++R+ KHPN + Y   YL     W+VMEY  G S +D+  V +  + E +IAA+C   L+
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQ 126

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEV 121
            L +LHS   IHRD+K+ NILL   G+VKL DFG  +   P  S     VGTPYWMAPEV
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           +       Y  KVD+WSLGI
Sbjct: 187 V---TRKAYGPKVDIWSLGI 203

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  130 bits (329), Expect = 2e-33
 Identities = 53/65 (81%), Positives = 58/65 (89%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASDI+EVHK+PL+E EIAAIC G L+GL YLHS  RIHRD+KAGNILLTE 
Sbjct: 92  LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP 151

Query: 676 GTVKL 680
           GTVKL
Sbjct: 152 GTVKL 156

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  129 bits (325), Expect = 3e-33
 Identities = 84/333 (25%), Positives = 138/333 (41%), Gaps = 86/333 (25%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKM---SYLGKQCAEKWADILK----EIRFLRQLKHP 222
           IG G++G VY A  + + E++A+K++   + +  +   +  D++K    EI  L+ L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           N ++Y G    +    + +EY  G S    +  +                          
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-------------------------- 102

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG- 340
                      +E+ +      VL GL YLHS G +HRD+KA N+L+   G  K++DFG 
Sbjct: 103 --------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGI 154

Query: 341 ---SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
              S  I       S  G+ +WMAPEVI +  +G Y  KVD+WSLG   +E+   + P+ 
Sbjct: 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG-YSAKVDIWSLGCVVLEMFAGRRPWS 213

Query: 396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL 455
           +  A++A++ +                          PP                  P  
Sbjct: 214 DEEAIAAMFKLG--------------------NKRSAPP-----------------IPPD 236

Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
            S + S     F+++C   NP +RP++  LL H
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  128 bits (323), Expect = 4e-33
 Identities = 56/141 (39%), Positives = 77/141 (54%), Gaps = 7/141 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           +LL +L+HPN ++Y G    +   ++ +E    GS + +++ +     E  I      +L
Sbjct: 54  ALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQIL 112

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGTPYWMAPEV 121
            GL YLH    +HRD+K  NIL+   G VKLADFG A        A SF G+PYWMAPEV
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172

Query: 122 ILAMDEGQYDGKVDVWSLGIT 142
           I    +G Y    D+WSLG T
Sbjct: 173 I--AQQGGYGLAADIWSLGCT 191

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  129 bits (325), Expect = 4e-33
 Identities = 97/337 (28%), Positives = 141/337 (41%), Gaps = 68/337 (20%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM-----SYLGKQCAEKWADILKEIRFLRQ 218
           +E L +IG GS+G V+  R   + +IVAIKK        + K+ A      L+EIR L+Q
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA------LREIRMLKQ 56

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           LKHPN +     + R     LV EYC                                 +
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYC---------------------------------D 83

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
           H  L   E + R + E  I  I    L+ +N+ H    IHRDVK  NIL+T+ G +KL D
Sbjct: 84  HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCD 143

Query: 339 FGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG A I          +V T ++ APE+++   + QY   VDVW++G    EL   +P +
Sbjct: 144 FGFARILTGPGDDYTDYVATRWYRAPELLVG--DTQYGPPVDVWAIGCVFAELLTGQPLW 201

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
              + +  LY I                KT+     R    F+ N       I + +T  
Sbjct: 202 PGKSDVDQLYLI---------------RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246

Query: 455 LQSSDWSDTFAH---FVSSCLAKNPADRPSSGRLLTH 488
              S + +  +    F+  CL  +P +R S   LL H
Sbjct: 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  128 bits (322), Expect = 4e-33
 Identities = 86/327 (26%), Positives = 131/327 (40%), Gaps = 81/327 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE L +IG GSFG V+       + + A+K++        E+  + + E R L +L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER-EEAIDEARVLAKLDSSY 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I Y   +L      +VMEY                       G+  + LK         
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAEN--------------------GDLHKLLKMQ------- 93

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 RPL E+++      +L GL +LHS   +HRD+K+ N+ L     VK+ D G A 
Sbjct: 94  ----RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149

Query: 344 IKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +       AN+ VGTPY+++PE+    ++  Y+ K DVW+LG+   E    K P F+ N 
Sbjct: 150 LLSDNTNFANTIVGTPYYLSPELC---EDKPYNEKSDVWALGVVLYECCTGKHP-FDANN 205

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
             AL                 ++K I       PP      +S +Y              
Sbjct: 206 QGAL-----------------ILKIIRG---VFPP------VSQMY-------------- 225

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
            S   A  +  CL K+   RP + +LL
Sbjct: 226 -SQQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  129 bits (326), Expect = 6e-33
 Identities = 80/247 (32%), Positives = 114/247 (46%), Gaps = 56/247 (22%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEI 213
                FE L  IG G++G VY AR   S EIVA+KK+        +   D      L+EI
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM------DNERDGIPISSLREI 57

Query: 214 RFLRQLKHPNTIEYRGCYLRDH--TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
             L  L+HPN +E +   +  H  + +LVMEYC             E++     + + L 
Sbjct: 58  TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC-------------EQD-----LASLLD 99

Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
            +                 P  E ++  +   +LRGL YLH    IHRD+K  N+LLT+ 
Sbjct: 100 NMPT---------------PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK 144

Query: 332 GTVKLADFGSAS-IKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI-- 385
           G +K+ADFG A     PA      V T ++ APE++L      Y   +D+W++G  CI  
Sbjct: 145 GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT--YTTAIDMWAVG--CILA 200

Query: 386 ELAERKP 392
           EL   KP
Sbjct: 201 ELLAHKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  128 bits (322), Expect = 7e-33
 Identities = 81/260 (31%), Positives = 119/260 (45%), Gaps = 54/260 (20%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKM---SYLGKQCAEKWA--DILK-EIRFLRQLKHPN 223
           IG GSFG+VY      S E++A+K++   S        K +  D L  EI  L++L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++Y G  L      + +EY  G +              V  +   L     F E     
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGS--------------VAAL---LNNYGAFEE----- 105

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                   L    +  I    L+GLNYLH+ G IHRD+K  NIL+   G +K++DFG  S
Sbjct: 106 -------TLVRNFVRQI----LKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFG-IS 153

Query: 344 IKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
            K  AN           S  G+ +WMAPEV+    +  Y  K D+WSLG   +E+   K 
Sbjct: 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVV---KQTSYTRKADIWSLGCLVVEMLTGKH 210

Query: 393 PYFNMNAMSALYHIAQNDTP 412
           P+ +   + A++ I +N +P
Sbjct: 211 PFPDCTQLQAIFKIGENASP 230

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  128 bits (322), Expect = 9e-33
 Identities = 63/143 (44%), Positives = 87/143 (60%), Gaps = 7/143 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLR 65
           +L    HPN ++    +  ++  W+++E+C G A D + +  +RPL E +I  +C   L 
Sbjct: 55  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE 114

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEV 121
            LNYLH    IHRD+KAGNIL T  G +KLADFG ++         +SF+GTPYWMAPEV
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174

Query: 122 IL--AMDEGQYDGKVDVWSLGIT 142
           ++     +  YD K DVWSLGIT
Sbjct: 175 VMCETSKDRPYDYKADVWSLGIT 197

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 2e-32
 Identities = 84/322 (26%), Positives = 120/322 (37%), Gaps = 91/322 (28%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLKHPNTIE 226
           +G GSFG V   R   + ++ A+K +    K+   K  ++   L E   L ++ HP  ++
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 227 YRGCYLRDHTA-WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                 +     +LV+EY  G             E       + L +   F+E  A F  
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGG------------ELF-----SHLSKEGRFSEERARF-- 97

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
                       A I       L YLHSLG I+RD+K  NILL   G +KL DFG A   
Sbjct: 98  ----------YAAEIVLA----LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143

Query: 346 CP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                  N+F GTP ++APEV+L      Y   VD WSLG+   E+   KPP++  +   
Sbjct: 144 SSEGSRTNTFCGTPEYLAPEVLL---GKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-RK 199

Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 461
            +Y                  K +     + P  F                        S
Sbjct: 200 EIYE-----------------KIL-----KDPLRF--------------------PEFLS 217

Query: 462 DTFAHFVSSCLAKNPADRPSSG 483
                 +S  L K+P  R  SG
Sbjct: 218 PEARDLISGLLQKDPTKRLGSG 239

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  126 bits (320), Expect = 2e-32
 Identities = 78/350 (22%), Positives = 120/350 (34%), Gaps = 114/350 (32%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLK- 220
           F+  + IG GSF  V  A+   + +  AIK +    L K+   K+  I KE+  L +L  
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV--LTRLNG 60

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK---CFT 277
           HP  I+    +  +   + V+EY                       G  LQ ++      
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPN--------------------GELLQYIRKYGSLD 100

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
           E    F                  + +L  L YLHS G IHRD+K  NILL +   +K+ 
Sbjct: 101 EKCTRF----------------YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKIT 144

Query: 338 DFGSASIKCP------------------------ANSFVGTPYWMAPEVILAMDEGQYDG 373
           DFG+A +  P                          SFVGT  +++PE++   +E     
Sbjct: 145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL---NEKPAGK 201

Query: 374 KVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKP 433
             D+W+LG    ++   KPP F                    S+++   + I       P
Sbjct: 202 SSDLWALGCIIYQMLTGKPP-FR------------------GSNEYLTFQKILKLEYSFP 242

Query: 434 PYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSG 483
           P F  +A                           +   L  +P DR    
Sbjct: 243 PNFPPDAKD------------------------LIEKLLVLDPQDRLGVN 268

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  126 bits (320), Expect = 6e-32
 Identities = 91/363 (25%), Positives = 136/363 (37%), Gaps = 113/363 (31%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS------YLGKQCAEKWADILKEIRFLR 217
           +E L+ IG G++G V  A    +   VAIKK+S         K+       IL+EI+ LR
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-------ILREIKLLR 54

Query: 218 QLKHPNTIEYRGCYLRD----------HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
            L+H N I      L D          +  ++V E                       M 
Sbjct: 55  HLRHENIIG-----LLDILRPPSPEDFNDVYIVTEL----------------------ME 87

Query: 268 NRLQQ-LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 326
             L + +K               +PL ++ I      +LRGL YLHS   IHRD+K  NI
Sbjct: 88  TDLHKVIK-------------SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNI 134

Query: 327 LLTETGTVKLADFGSASIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWS 379
           L+     +K+ DFG A    P          +V T ++ APE++L+     Y   +D+WS
Sbjct: 135 LVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR--YTKAIDIWS 192

Query: 380 LGITCI--ELAERKP--P---YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERK 432
           +G  CI  EL  RKP  P   Y +      L  I +     L +     +K I+      
Sbjct: 193 VG--CIFAELLTRKPLFPGRDYIDQ-----LNLIVE----VLGTPSEEDLKFIT------ 235

Query: 433 PPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA-------HFVSSCLAKNPADRPSSGRL 485
               +  A + L  + +           S  F          +   L  +P  R ++   
Sbjct: 236 ----SEKARNYLKSLPKKPKK-----PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286

Query: 486 LTH 488
           L H
Sbjct: 287 LAH 289

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  124 bits (313), Expect = 1e-31
 Identities = 52/146 (35%), Positives = 74/146 (50%), Gaps = 13/146 (8%)

Query: 7   LLRQLK------HPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAI 59
           +LR+L        P  + + G +  +    + MEY   GS   I++  +  + E  +  I
Sbjct: 46  ILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKI 105

Query: 60  CSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPYW 116
              VL+GL YLH     IHRDVK  NIL+   G +KL DFG +   +   A +FVGT  +
Sbjct: 106 AVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSY 165

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
           MAPE I       Y  K D+WSLG++
Sbjct: 166 MAPERI---QGNDYSVKSDIWSLGLS 188

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  123 bits (311), Expect = 2e-31
 Identities = 91/292 (31%), Positives = 126/292 (43%), Gaps = 52/292 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-CAEKWA--DILKEIRFLRQLK 220
           FE LR IG G+FG V   +   ++++ A+K M+   KQ C EK +  ++L E R L++L 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN---KQKCVEKGSVRNVLNERRILQELN 58

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HP  +     +  +   +LV++  LG   D+         +H       L Q   F+E  
Sbjct: 59  HPFLVNLWYSFQDEENMYLVVDLLLGG--DL--------RYH-------LSQKVKFSEEQ 101

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
             F             I  I       L YLHS G IHRD+K  NILL E G V + DF 
Sbjct: 102 VKF------------WICEIVLA----LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFN 145

Query: 341 SASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN- 396
            A+   P     S  GTP +MAPEV+       Y   VD WSLG+T  E    K PY   
Sbjct: 146 IATKVTPDTLTTSTSGTPGYMAPEVLCRQG---YSVAVDWWSLGVTAYECLRGKRPYRGH 202

Query: 397 ----MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
                + + A    A    P   S++   I  I+   ER P     + +  L
Sbjct: 203 SRTIRDQIRAKQETADVLYPATWSTE--AIDAINKLLERDPQKRLGDNLKDL 252

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  123 bits (310), Expect = 3e-31
 Identities = 71/145 (48%), Positives = 90/145 (62%), Gaps = 16/145 (11%)

Query: 13  HPNTIEYRGCYLR------DHTAWLVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVL 64
           H N   Y G +++      D   WLVME+C  GS +D+++  K   LKE+ IA IC  +L
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA---NSFVGTPYWMAPE 120
           RGL +LH+   IHRD+K  N+LLTE   VKL DFG SA +       N+F+GTPYWMAPE
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191

Query: 121 VILAMDE---GQYDGKVDVWSLGIT 142
           VI A DE     YD + D+WSLGIT
Sbjct: 192 VI-ACDENPDATYDYRSDIWSLGIT 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  123 bits (309), Expect = 3e-31
 Identities = 74/145 (51%), Positives = 90/145 (62%), Gaps = 16/145 (11%)

Query: 13  HPNTIEYRGCYLR------DHTAWLVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVL 64
           H N   Y G +++      D   WLVME+C  GS +D+I+  K   LKEE IA IC  +L
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA---NSFVGTPYWMAPE 120
           RGL++LH    IHRD+K  N+LLTE   VKL DFG SA +       N+F+GTPYWMAPE
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181

Query: 121 VILAMDE---GQYDGKVDVWSLGIT 142
           VI A DE     YD K D+WSLGIT
Sbjct: 182 VI-ACDENPDATYDFKSDLWSLGIT 205

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  123 bits (311), Expect = 3e-31
 Identities = 95/357 (26%), Positives = 143/357 (40%), Gaps = 92/357 (25%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR 214
            D  D     E+L EIG G+ G VY  R   +  ++A+K+M   G    E+   IL ++ 
Sbjct: 12  ADLND----LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLD 65

Query: 215 FLRQLKH--PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
            +    H  P  ++  G ++ D   ++ ME                       M   L +
Sbjct: 66  VV-LKSHDCPYIVKCYGYFITDSDVFICMEL----------------------MSTCLDK 102

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL---HSLGRIHRDVKAGNILLT 329
           L    +            P+ E+ +  +   +++ L+YL   H +  IHRDVK  NILL 
Sbjct: 103 LLKRIQG-----------PIPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLD 149

Query: 330 ETGTVKLADFGSAS--IKCPANS-FVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCI 385
            +G VKL DFG +   +   A +   G   +MAPE I   D   +YD + DVWSLGI+ +
Sbjct: 150 ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209

Query: 386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
           ELA  + PY N                    +++ V                      L 
Sbjct: 210 ELATGQFPYKNCK------------------TEFEV----------------------LT 229

Query: 446 HIAQNDTPCLQSSD-WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLV 501
            I Q + P L  ++ +S  F  FV  CL K+   RP    LL H  + R  +  V V
Sbjct: 230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  123 bits (310), Expect = 4e-31
 Identities = 71/159 (44%), Positives = 91/159 (57%), Gaps = 18/159 (11%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLR 65
           ++R  +H N +E    YL     W++ME+  G A +DI  V +  L EE+IA +C  VL+
Sbjct: 71  IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI--VSQTRLNEEQIATVCESVLQ 128

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG---SASIKCPA-NSFVGTPYWMAPEV 121
            L YLHS G IHRD+K+ +ILLT  G VKL+DFG     S   P   S VGTPYWMAPEV
Sbjct: 129 ALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 188

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP 160
           I       Y  +VD+WSLGI         + E+ D E P
Sbjct: 189 I---SRTPYGTEVDIWSLGIM--------VIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  123 bits (311), Expect = 4e-31
 Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 52/239 (21%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-ILKEIRFLRQLKHPNTI 225
           L  IG G+ G V+ A+   + E VA+KK+    ++      +  L+EI+ L+  +HP  +
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +    +       LVMEY     S+++     + E                         
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPSDLSEVLR----DEE------------------------- 93

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----- 340
               RPL E ++ +    +L+G+ Y+H+ G +HRD+K  N+L++  G +K+ADFG     
Sbjct: 94  ----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF 149

Query: 341 SASIKCPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAE--RKPPYF 395
           S       +  V T ++ APE++     G   YD  VD+W++G  CI  AE     P F
Sbjct: 150 SEEEPRLYSHQVATRWYRAPELLY----GARKYDPGVDLWAVG--CI-FAELLNGSPLF 201

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  123 bits (309), Expect = 6e-31
 Identities = 72/171 (42%), Positives = 96/171 (56%), Gaps = 19/171 (11%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           ++R   H N ++    YL     W+VME+  G A   I  H R + EE+IA +C  VLR 
Sbjct: 72  IMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRA 130

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFG---SASIKCPA-NSFVGTPYWMAPEVI 122
           L+YLH+ G IHRD+K+ +ILLT  G +KL+DFG     S + P   S VGTPYWMAPEVI
Sbjct: 131 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI 190

Query: 123 LAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP---EKIFEDLREI 170
             +    Y  +VD+WSLGI         + E+ D E P   E   + +R I
Sbjct: 191 SRL---PYGTEVDIWSLGIM--------VIEMIDGEPPYFNEPPLQAMRRI 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  121 bits (304), Expect = 2e-30
 Identities = 90/328 (27%), Positives = 146/328 (44%), Gaps = 71/328 (21%)

Query: 165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           E + ++G G+ G+V   + + +  ++A K +    K    K   IL+E++ + + + P  
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRSPYI 65

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           + + G +L ++   + ME+        ++   ++R +   G                   
Sbjct: 66  VSFYGAFLNENNICMCMEF--------MDCGSLDRIYKKGG------------------- 98

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSAS 343
                 P+  E +  I   V+ GL YL+++ RI HRD+K  NIL+   G +KL DFG + 
Sbjct: 99  ------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152

Query: 344 --IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
             I   A++FVGT  +M+PE I     G+Y  K DVWSLGI+ IELA  K P+    A S
Sbjct: 153 ELINSIADTFVGTSTYMSPERIQG---GKYTVKSDVWSLGISIIELALGKFPF----AFS 205

Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 461
            +    Q+D                           M  +  L  I Q   P L SSD+ 
Sbjct: 206 NIDDDGQDDP--------------------------MGILDLLQQIVQEPPPRLPSSDFP 239

Query: 462 DTFAHFVSSCLAKNPADRPSSGRLLTHD 489
           +    FV +CL K+P +RP+  +L    
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMP 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  120 bits (303), Expect = 3e-30
 Identities = 69/158 (43%), Positives = 92/158 (58%), Gaps = 16/158 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           ++R  +H N +E    YL     W+VME+  G A   I  H R + EE+IAA+C  VL+ 
Sbjct: 70  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKA 128

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFG---SASIKCP-ANSFVGTPYWMAPEVI 122
           L+ LH+ G IHRD+K+ +ILLT  G VKL+DFG     S + P   S VGTPYWMAPE+I
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188

Query: 123 LAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP 160
             +    Y  +VD+WSLGI         + E+ D E P
Sbjct: 189 SRL---PYGPEVDIWSLGIM--------VIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  120 bits (304), Expect = 3e-30
 Identities = 94/341 (27%), Positives = 139/341 (40%), Gaps = 90/341 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF-LRQLKHP 222
            E + E+G G++G V   R + +  I+A+K++        +K   +L ++   +R +  P
Sbjct: 3   LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK--RLLMDLDISMRSVDCP 60

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            T+ + G   R+   W+ ME                       M   L +          
Sbjct: 61  YTVTFYGALFREGDVWICMEV----------------------MDTSLDK---------- 88

Query: 283 FNFEVHKRPL--KEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADF 339
           F  +V+ + L   E+ +  I   +++ L YLHS L  IHRDVK  N+L+   G VKL DF
Sbjct: 89  FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDF 148

Query: 340 G-SASIKCPANSFVGT------PYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERK 391
           G S  +    +S   T      PY MAPE I   +++  YD K DVWSLGIT IELA  +
Sbjct: 149 GISGYL---VDSVAKTIDAGCKPY-MAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
            PY                TP  Q                            L  + +  
Sbjct: 205 FPY------------DSWKTPFQQ----------------------------LKQVVEEP 224

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
           +P L +  +S  F  FV+ CL KN  +RP+   LL H    
Sbjct: 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  118 bits (299), Expect = 7e-30
 Identities = 56/145 (38%), Positives = 73/145 (50%), Gaps = 10/145 (6%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
             +L  LKHPN ++Y G  +     ++ MEYC  G+  +++E H R L E  I      +
Sbjct: 50  MKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQL 108

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA--------NSFVGTPY 115
           L GL YLHS G +HRD+K  NI L   G +KL DFG A               S  GTP 
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLG 140
           +MAPEVI       +    D+WSLG
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLG 193

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  119 bits (301), Expect = 7e-30
 Identities = 62/150 (41%), Positives = 85/150 (56%), Gaps = 17/150 (11%)

Query: 7   LLRQL------KHPNTIEYRGCYLRDHTAWL--VMEYCLGSASDII--EVHKRPLK--EE 54
           +LR+L      K P  ++Y G +L + ++ +   MEYC G + D I  +V KR  +  E+
Sbjct: 46  ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK 105

Query: 55  EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVG 112
            +  I   VL+GL+YLHS   IHRD+K  NILLT  G VKL DFG +   +   A +F G
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG 165

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           T ++MAPE I       Y    DVWSLG+T
Sbjct: 166 TSFYMAPERIQG---KPYSITSDVWSLGLT 192

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 8e-30
 Identities = 65/177 (36%), Positives = 90/177 (50%), Gaps = 26/177 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           SLL++LKHPN ++       +   +LV EYC       ++    PL    I +I   +LR
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEV 121
           GL Y HS   +HRD+K  NIL+   G +KLADFG A +   P  ++   V T ++ APE+
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 122 ILAMDEGQYDGKVDVWSLG------IT-----PGSLKDPEIAELFDKEDPEKIFEDL 167
           +L      Y   VD+WS+G      IT     PG   D EI +LF      KIF+ L
Sbjct: 170 LLGSK--HYSTAVDIWSVGCIFAEMITGKPLFPG---DSEIDQLF------KIFQIL 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  118 bits (298), Expect = 9e-30
 Identities = 50/142 (35%), Positives = 81/142 (57%), Gaps = 12/142 (8%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LR  + P  ++  G + ++    +V+EY   GS +D+++     + E  +A I   +L+G
Sbjct: 53  LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKG 111

Query: 67  LNYLHS-LGRIHRDVKAGNILLTETGTVKLADFG-SASIKC---PANSFVGTPYWMAPEV 121
           L+YLH+    IHRD+K  N+L+   G VK+ADFG S  ++      N+FVGT  +M+PE 
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER 171

Query: 122 ILAMDEGQYDG-KVDVWSLGIT 142
           I    +G+      D+WSLG+T
Sbjct: 172 I----QGESYSYAADIWSLGLT 189

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  118 bits (298), Expect = 9e-30
 Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 10/144 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S++++L HPN +   G   +    ++V EY   G   D +  H   L  +++  +   + 
Sbjct: 53  SIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIA 112

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT-----PY-WMA 118
           +G+ YL S   +HRD+ A N L+TE   VK++DFG +      + +        P  WMA
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PE +    +G++  K DVWS G+ 
Sbjct: 173 PESL---KDGKFTSKSDVWSFGVL 193

Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 1e-29
 Identities = 73/243 (30%), Positives = 113/243 (46%), Gaps = 53/243 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA-DI--LKEIRFLRQLK 220
           +E + +IG G++G VY AR   + E+VA+KK+    +   EK    I  ++EI+ L++L+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKLR 56

Query: 221 HPNTIEYRGCYLRDH--TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           HPN +  +         + ++V EY     + +++      E           Q+KC   
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP----EVKFT-----ESQIKC--- 104

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                                    +L GL YLHS G +HRD+K  NIL+   G +KLAD
Sbjct: 105 ---------------------YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLAD 143

Query: 339 FGSASIKCPANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
           FG A      NS      V T ++  PE++L     +Y  +VD+WS+G  CI  EL   K
Sbjct: 144 FGLARPYTKRNSADYTNRVITLWYRPPELLLG--ATRYGPEVDMWSVG--CILAELFLGK 199

Query: 392 PPY 394
           P +
Sbjct: 200 PIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  118 bits (298), Expect = 2e-29
 Identities = 96/343 (27%), Positives = 134/343 (39%), Gaps = 99/343 (28%)

Query: 165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL----- 219
           +DL EIG G+FG V       S  I+A+K++            D  ++ R L  L     
Sbjct: 7   KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--------VDEKEQKRLLMDLDVVMR 58

Query: 220 --KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
               P  +++ G   R+   W+ ME  L   S                            
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICME--LMDIS---------------------------L 89

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL-HSLGRIHRDVKAGNILLTETGTVKL 336
           + F  + +EV K  + EE +  I    ++ LNYL   L  IHRDVK  NILL   G +KL
Sbjct: 90  DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL 149

Query: 337 ADFG-SASIKCPANSFVGT------PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            DFG S  +    +S   T      PY MAPE I       YD + DVWSLGIT  E+A 
Sbjct: 150 CDFGISGQL---VDSIAKTRDAGCRPY-MAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
            K PY                                       P +N +    L  + +
Sbjct: 206 GKFPY---------------------------------------PKWN-SVFDQLTQVVK 225

Query: 450 NDTPCLQSSD---WSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
            D P L +S+   +S +F +F++ CL K+ + RP    LL H 
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  117 bits (296), Expect = 2e-29
 Identities = 67/242 (27%), Positives = 96/242 (39%), Gaps = 51/242 (21%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           I  G++G V+ A+   + +I AIK +         +   +L E   L Q + P  ++   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +      +LVMEY  G                    G+    L    E+          
Sbjct: 61  SFQGKKNLYLVMEYLPG--------------------GD----LASLLENVGSL------ 90

Query: 290 RPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------S 341
               +E++A I    ++  L YLHS G IHRD+K  NIL+   G +KL DFG        
Sbjct: 91  ----DEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146

Query: 342 ASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
             I    +       VGTP ++APEVIL      +   VD WSLG    E     PP F+
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQG---HSKTVDWWSLGCILYEFLVGIPP-FH 202

Query: 397 MN 398
             
Sbjct: 203 GE 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  118 bits (297), Expect = 4e-29
 Identities = 74/241 (30%), Positives = 103/241 (42%), Gaps = 53/241 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD------ILKEIRFLR 217
           +E  +++G G++  VY AR   +  IVAIKK+    K    K A        L+EI+ L+
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI----KLGERKEAKDGINFTALREIKLLQ 57

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +LKHPN I     +       LV E+       +I+              ++        
Sbjct: 58  ELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIK--------------DK-------- 95

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                         L   +I +     LRGL YLHS   +HRD+K  N+L+   G +KLA
Sbjct: 96  -----------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLA 144

Query: 338 DFGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
           DFG A S   P       V T ++ APE  L      Y   VD+WS+G  CI  EL  R 
Sbjct: 145 DFGLARSFGSPNRKMTHQVVTRWYRAPE--LLFGARHYGVGVDMWSVG--CIFAELLLRV 200

Query: 392 P 392
           P
Sbjct: 201 P 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  116 bits (293), Expect = 5e-29
 Identities = 59/153 (38%), Positives = 82/153 (53%), Gaps = 24/153 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDH-----TAWLVMEYCL-GSASDIIEVHKR---PLKEEEI 56
           ++LR+LKHPN + Y   Y R       T ++VMEYC  G  + +I+  K+    ++EE I
Sbjct: 51  NILRELKHPNIVRY---YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107

Query: 57  AAICSGVLRGLNYLHSLGR-----IHRDVKAGNILLTETGTVKLADFGSASI----KCPA 107
             I + +L  L   H+        +HRD+K  NI L     VKL DFG A I       A
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167

Query: 108 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
            ++VGTPY+M+PE +  M    YD K D+WSLG
Sbjct: 168 KTYVGTPYYMSPEQLNHM---SYDEKSDIWSLG 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  116 bits (293), Expect = 5e-29
 Identities = 90/329 (27%), Positives = 138/329 (41%), Gaps = 88/329 (26%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY-----LGKQCAEKWADILKEIRFLRQLKHPNT 224
           +GHG+ G VY A  L++R I+A+K +       L KQ       I+ E+  L +   P  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ-------IMSELEILYKCDSPYI 61

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I + G +  ++   +  E+  G + D+                                 
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLDVY-------------------------------- 89

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS- 343
                R + E  +  I   V++GL YL SL  +HRDVK  N+L+   G VKL DFG ++ 
Sbjct: 90  -----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144

Query: 344 -IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA 402
            +   A ++VGT  +MAPE I      QY    DVWSLGI+ +ELA  + PY        
Sbjct: 145 LVNSIAKTYVGTNAYMAPERISG---EQYGIHSDVWSLGISFMELALGRFPY-------- 193

Query: 403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD 462
                    P +Q +  S++                  +  L  I   D P L    +S+
Sbjct: 194 ---------PQIQKNQGSLM-----------------PLQLLQCIVDEDPPVLPVGQFSE 227

Query: 463 TFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
            F HF++ C+ K P +RP+   L+ H  +
Sbjct: 228 KFVHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  115 bits (288), Expect = 3e-28
 Identities = 64/140 (45%), Positives = 85/140 (60%), Gaps = 10/140 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++R+ K+PN + Y   YL     W+VMEY  G S +D+  V +  + E +IAA+C   L+
Sbjct: 69  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQ 126

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEV 121
            L++LHS   IHRD+K+ NILL   G+VKL DFG  +   P  S     VGTPYWMAPEV
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           +       Y  KVD+WSLGI
Sbjct: 187 V---TRKAYGPKVDIWSLGI 203

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  114 bits (286), Expect = 3e-28
 Identities = 83/254 (32%), Positives = 120/254 (47%), Gaps = 49/254 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY--LGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           +G G+FG VY    + +   +A K++ +     + +++ + +  EI+ L+ L+H   ++Y
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 228 RGCYLRDH---TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
            GC LRD    T  + MEY  G                    G+   QLK +        
Sbjct: 70  YGC-LRDRAEKTLTIFMEYMPG--------------------GSVKDQLKAYG------- 101

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 342
                  L E         +L G++YLHS   +HRD+K  NIL    G VKL DFG++  
Sbjct: 102 ------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155

Query: 343 -SIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
               C +     S  GTPYWM+PEVI    EG Y  K DVWSLG T +E+   KPP+   
Sbjct: 156 LQTICMSGTGIRSVTGTPYWMSPEVISG--EG-YGRKADVWSLGCTVVEMLTEKPPWAEY 212

Query: 398 NAMSALYHIAQNDT 411
            AM+A++ IA   T
Sbjct: 213 EAMAAIFKIATQPT 226

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  114 bits (287), Expect = 5e-28
 Identities = 87/336 (25%), Positives = 142/336 (42%), Gaps = 62/336 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E+L  +G GS+G V   +   + +IVAIKK     +         ++EIR L+QL+H N
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +     + R    +LV E                                 F +H  L 
Sbjct: 62  LVNLIEVFRRKKRLYLVFE---------------------------------FVDHTVLD 88

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
           + E +   L E  +      +LRG+ + HS   IHRD+K  NIL++++G VKL DFG A 
Sbjct: 89  DLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148

Query: 343 SIKCPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           ++  P      +V T ++ APE+++   + +Y   VD+W++G    E+   +P +   + 
Sbjct: 149 TLAAPGEVYTDYVATRWYRAPELLVG--DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           +  LYHI               IK + +   R    F  N + A   + +      +  +
Sbjct: 207 IDQLYHI---------------IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI--EPLE 249

Query: 460 -----WSDTFAHFVSSCLAKNPADRPSSGRLLTHDL 490
                 S         CL  +P DRPSS +LL H+ 
Sbjct: 250 KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  114 bits (286), Expect = 6e-28
 Identities = 64/140 (45%), Positives = 84/140 (60%), Gaps = 10/140 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++R+ K+PN + Y   YL     W+VMEY  G S +D+  V +  + E +IAA+C   L+
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQ 127

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEV 121
            L +LHS   IHRD+K+ NILL   G+VKL DFG  +   P  S     VGTPYWMAPEV
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           +       Y  KVD+WSLGI
Sbjct: 188 V---TRKAYGPKVDIWSLGI 204

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  113 bits (284), Expect = 6e-28
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 13/145 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++R+L HPN ++  G    +   ++VMEY   G     +  ++  L   ++ +    + 
Sbjct: 53  RIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIA 112

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------SASIKCPANSFVGTPY-WM 117
           RG+ YL S   IHRD+ A N L+ E   VK++DFG                 +  P  WM
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWM 170

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           APE +    EG++  K DVWS G+ 
Sbjct: 171 APESL---KEGKFTSKSDVWSFGVL 192

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (283), Expect = 6e-28
 Identities = 87/331 (26%), Positives = 138/331 (41%), Gaps = 89/331 (26%)

Query: 164 FEDLREIGHGSFG-AVYYARCLVSREIVAIKKMSYLGKQCAEKWA-DILKEIRFLRQLKH 221
           +  +R +G G+FG A  Y R      +V  K+++    + +EK   D L EI  L  L+H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVV-WKEVNL--TRLSEKERRDALNEIVILSLLQH 58

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           PN I Y   ++ D+T  + MEY  G +  D I V                Q+ + F E  
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VR---------------QKGQLFEEEM 102

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
            L+                I S V    +Y+H  G +HRD+K  NI LT+ G +KL DFG
Sbjct: 103 VLWYLF------------QIVSAV----SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFG 146

Query: 341 SASI----KCPANSFVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPYF 395
            + I       A + VGTPY+M+PE    + +G +Y+ K D+W+LG    EL   K  + 
Sbjct: 147 ISKILGSEYSMAETVVGTPYYMSPE----LCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202

Query: 396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL 455
             N ++ +  I Q         +++ + ++ S+                           
Sbjct: 203 ATNPLNLVVKIVQ--------GNYTPVVSVYSSELIS----------------------- 231

Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
                       V S L ++P  RP++  +L
Sbjct: 232 -----------LVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  113 bits (284), Expect = 7e-28
 Identities = 75/248 (30%), Positives = 115/248 (46%), Gaps = 50/248 (20%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G++G VY AR L ++  +AIK++     +  +    + +EI     LKH N ++Y G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP---LHEEIALHSYLKHRNIVQYLG 72

Query: 230 CYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
               +    + ME   G S S ++   W                                
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKW-------------------------------- 100

Query: 289 KRPLKEEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGS---- 341
             PLK+ E  I      +L GL YLH    +HRD+K  N+L+ T +G VK++DFG+    
Sbjct: 101 -GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159

Query: 342 ASIKCPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAERKPPYFNM-N 398
           A I     +F GT  +MAPEVI   D+G   Y    D+WSLG T +E+A  KPP+  +  
Sbjct: 160 AGINPCTETFTGTLQYMAPEVI---DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216

Query: 399 AMSALYHI 406
             +A++ +
Sbjct: 217 PQAAMFKV 224

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  113 bits (286), Expect = 9e-28
 Identities = 79/252 (31%), Positives = 114/252 (45%), Gaps = 56/252 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---------EIR 214
           FE ++ +G GSFG V   R   S +  A+K +S        K   I+K         E R
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS--------KA-KIVKLKQVEHVLNEKR 53

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            L+ ++HP  +   G +  D   +LVMEY  G      E+      F        L++  
Sbjct: 54  ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG-----EL------FS------HLRKSG 96

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            F E  A F              AA    V+  L YLHSL  ++RD+K  N+LL   G +
Sbjct: 97  RFPEPVARF-------------YAA---QVVLALEYLHSLDIVYRDLKPENLLLDSDGYI 140

Query: 335 KLADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           K+ DFG A  +K    +  GTP ++APE+IL+     Y   VD W+LGI   E+    PP
Sbjct: 141 KITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKG---YGKAVDWWALGILIYEMLAGYPP 197

Query: 394 YFNMNAMSALYH 405
           +F+ N +  +Y 
Sbjct: 198 FFDDNPI-QIYE 208

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  113 bits (283), Expect = 1e-27
 Identities = 72/179 (40%), Positives = 101/179 (56%), Gaps = 17/179 (9%)

Query: 3   AGSSLLRQL-KHPNTIEYRGCYLR-DHTA----WLVMEYCLG-SASDIIE---VHKRPLK 52
           A  ++L+ L  HPN +++ G + + D       WLV+E C G S +++++   +  + L 
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 53  EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPAN 108
           E  I+ I  G L GL +LH+   IHRDVK  NILLT  G VKL DFG +    S +   N
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186

Query: 109 SFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFE 165
           + VGTP+WMAPEVI    +    YD + DVWSLGIT   L D +   LFD    + +F+
Sbjct: 187 TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD-PPLFDMHPVKTLFK 244

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  112 bits (281), Expect = 2e-27
 Identities = 71/159 (44%), Positives = 90/159 (56%), Gaps = 17/159 (10%)

Query: 13  HPNTIEYRGCYLRDHTA-----WLVMEYCLG-SASDIIE-VHKRPLKEEE--IAAICSGV 63
           HPN +++ G Y +         WLV+E C G S +D+++   KR  + EE  IA I    
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAP 119
           L GL +LH    IHRDVK  NILLT  G VKL DFG +    S +   N+ VGTP+WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 120 EVILAMDE--GQYDGKVDVWSLGITPGSL--KDPEIAEL 154
           EVI    +    YD + DVWSLGIT   L   DP +A+L
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  112 bits (280), Expect = 2e-27
 Identities = 81/254 (31%), Positives = 124/254 (48%), Gaps = 49/254 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILK-EIRFLRQLKHPNTIEY 227
           +G G+FG VY      +   +A+K++ +    Q   K  + L+ EI+ L+ L+H   ++Y
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 228 RGCYLRDHTA---WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
            GC LRD       + +EY  G +                 + ++L+     TE+     
Sbjct: 70  YGC-LRDPEEKKLSIFVEYMPGGS-----------------IKDQLKAYGALTEN----- 106

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 342
             V +R  ++         +L+G++YLHS   +HRD+K  NIL    G VKL DFG++  
Sbjct: 107 --VTRRYTRQ---------ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155

Query: 343 -SIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
               C +     S  GTPYWM+PEVI    EG Y  K DVWS+  T +E+   KPP+   
Sbjct: 156 IQTICMSGTGIKSVTGTPYWMSPEVISG--EG-YGRKADVWSVACTVVEMLTEKPPWAEY 212

Query: 398 NAMSALYHIAQNDT 411
            AM+A++ IA   T
Sbjct: 213 EAMAAIFKIATQPT 226

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  112 bits (282), Expect = 2e-27
 Identities = 84/341 (24%), Positives = 135/341 (39%), Gaps = 77/341 (22%)

Query: 165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           E L E+G G++G+VY      +   +A+K++     +   K+  I+ E+  L +   P  
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYI 61

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +++ G +  +   ++ MEY    + D                               L+ 
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLD------------------------------KLYA 91

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYL-HSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
             V    + E+ +  I   V++GL +L      IHRDVK  N+L+   G VKL DFG + 
Sbjct: 92  GGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG 151

Query: 344 --IKCPANSFVGTPYWMAPEVIL---AMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
             +   A + +G   +MAPE I          Y  + DVWSLG++ +E+A  + PY    
Sbjct: 152 NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY---- 207

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
                                             PP    N  + L  I   D P L  S
Sbjct: 208 ----------------------------------PPETYANIFAQLSAIVDGDPPTL-PS 232

Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
            +SD    FV+ CL K P  RP+  +LL H  + + ++  V
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  112 bits (282), Expect = 3e-27
 Identities = 96/343 (27%), Positives = 148/343 (43%), Gaps = 54/343 (15%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE L E+G G+ G V       S  I+A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIR-NQIIRELKVLHECNSPY 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D +                    LK         
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQV--------------------LK--------- 91

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYL---HSLGRIHRDVKAGNILLTETGTVKLADFG 340
             +  + P  E  +  I   VLRGL YL   H +  +HRDVK  NIL+   G +KL DFG
Sbjct: 92  --KAGRIP--ENILGKISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFG 145

Query: 341 SAS--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP-PYFN 396
            +   I   ANSFVGT  +M+PE    +    Y  + D+WSLG++ +E+A  R P P  +
Sbjct: 146 VSGQLIDSMANSFVGTRSYMSPE---RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
              + A++    ++    ++ +     +       +P    M     L +I     P L 
Sbjct: 203 AKELEAMFGRPVSE---GEAKESHRPVSGHPPDSPRP----MAIFELLDYIVNEPPPKLP 255

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
           S  +SD F  FV  CL KNP +R     L  H  + R     V
Sbjct: 256 SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (278), Expect = 4e-27
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 44/219 (20%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRP-LKEEEIAAICSGV 63
            ++R+L HPN ++  G    +    +VMEY   G   D +  ++   L   ++ +    +
Sbjct: 53  RIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------SASIKCPANSFVGTPY-W 116
            RG+ YL S   IHRD+ A N L+ E   VK++DFG                 +  P  W
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRW 170

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFG 176
           MAPE +    EG++  K DVWS G+         + E+F                  + G
Sbjct: 171 MAPESL---KEGKFTSKSDVWSFGVL--------LWEIF------------------TLG 201

Query: 177 AVYYARCLVSREIVA-IKKMSYLGK--QCAEKWADILKE 212
              Y   + + E++  +KK   L K   C  +   ++ +
Sbjct: 202 EEPYPG-MSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQ 239

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 5e-27
 Identities = 47/139 (33%), Positives = 71/139 (51%), Gaps = 6/139 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            LL++L HPN I+    +      +LV E+       +I+  +R L E  I +    +L+
Sbjct: 50  KLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF----VGTPYWMAPEV 121
           GL + HS G +HRD+K  N+L+   G +KLADFG A             V T ++ APE+
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169

Query: 122 ILAMDEGQYDGKVDVWSLG 140
           +L      Y   VD+WS+G
Sbjct: 170 LLGD--KGYSTPVDIWSVG 186

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  111 bits (280), Expect = 6e-27
 Identities = 79/265 (29%), Positives = 114/265 (43%), Gaps = 74/265 (27%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA---DILK 211
           F   D    +E L +IG G+FG V+ AR   +++IVA+KK+        EK       L+
Sbjct: 5   FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN----EKEGFPITALR 60

Query: 212 EIRFLRQLKHPNTIE--------------YRGCYLRDHTAWLVMEYCLGSASDIIEVHWI 257
           EI+ L+ LKH N +               Y+G      + +LV E+C             
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKG------SFYLVFEFC------------- 101

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
             E  + G+               L N  V        EI  +   +L GL Y+H    +
Sbjct: 102 --EHDLAGL---------------LSNKNVK---FTLSEIKKVMKMLLNGLYYIHRNKIL 141

Query: 318 HRDVKAGNILLTETGTVKLADFG-----SASIKCPANSF---VGTPYWMAPEVILAMDEG 369
           HRD+KA NIL+T+ G +KLADFG     S S     N +   V T ++  PE++L   E 
Sbjct: 142 HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG--ER 199

Query: 370 QYDGKVDVWSLGITCI--ELAERKP 392
            Y   +D+W  G  CI  E+  R P
Sbjct: 200 DYGPPIDMWGAG--CIMAEMWTRSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  112 bits (281), Expect = 6e-27
 Identities = 84/272 (30%), Positives = 126/272 (46%), Gaps = 54/272 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM------SYLGKQCAEKWADILKEIRFLR 217
           + DL+ +G G+FG V  AR  ++ + VAIKK+        L K+         +E++ L+
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-------TYRELKLLK 64

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            L+H N I                     S SDI      +  F  E +G  L +L    
Sbjct: 65  HLRHENII---------------------SLSDIFISPLEDIYFVTELLGTDLHRL---- 99

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    +  RPL+++ I      +LRGL Y+HS G +HRD+K  NIL+ E   +K+ 
Sbjct: 100 ---------LTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150

Query: 338 DFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           DFG A I+ P    +V T Y+ APE++L     +YD +VD+WS G    E+ E KP +  
Sbjct: 151 DFGLARIQDPQMTGYVSTRYYRAPEIMLTWQ--KYDVEVDIWSAGCIFAEMLEGKPLFPG 208

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISST 428
            + ++    I    T  L +    VI TI S 
Sbjct: 209 KDHVNQFSII----TDLLGTPPDDVINTICSE 236

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  110 bits (275), Expect = 2e-26
 Identities = 59/140 (42%), Positives = 85/140 (60%), Gaps = 10/140 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++++LK+PN + +   +L     ++VMEY  G S +D+  V +  + E +IAA+C   L+
Sbjct: 69  VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV--VTETCMDEAQIAAVCRECLQ 126

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEV 121
            L +LH+   IHRD+K+ N+LL   G+VKL DFG  +   P  S     VGTPYWMAPEV
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           +       Y  KVD+WSLGI
Sbjct: 187 V---TRKAYGPKVDIWSLGI 203

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score =  106 bits (266), Expect = 2e-26
 Identities = 48/105 (45%), Positives = 58/105 (55%), Gaps = 12/105 (11%)

Query: 38  GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 97
            S +DI+EV  RPL EEEI A+C   L  L  LH         K+GNILLT  G +KL  
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52

Query: 98  FGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
            GS + K P  S    PY+MAPEVI      +   K D++SLGIT
Sbjct: 53  DGSVAFKTPEQSRP-DPYFMAPEVIQGQSYTE---KADIYSLGIT 93

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 2e-26
 Identities = 59/144 (40%), Positives = 76/144 (52%), Gaps = 12/144 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLR 65
           LL+ L+H   ++Y GC   D T  + MEY  G S  D ++ +   L E         +L 
Sbjct: 57  LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILE 115

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCP---ANSFVGTPYWMA 118
           G+ YLHS   +HRD+K  NIL    G VKL DFG++    +I        S  GTPYWM+
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PEVI    EG Y  K DVWS+G T
Sbjct: 176 PEVISG--EG-YGRKADVWSVGCT 196

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 3e-26
 Identities = 82/243 (33%), Positives = 113/243 (46%), Gaps = 53/243 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK-- 220
           +E+L EIG G++G VY AR L +   VA+KK+   L ++        L+EI  L+QL+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESF 58

Query: 221 -HPNTIEYR----GCYL-RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            HPN +       G    R+    LV E                   HV+      Q L 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFE-------------------HVD------QDLA 93

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            +            K  L  E I  +   +LRG+++LHS   +HRD+K  NIL+T  G V
Sbjct: 94  TYLSK-------CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV 146

Query: 335 KLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAE 389
           K+ADFG A I        S V T ++ APEV+L      Y   VD+WS+G  CI  EL  
Sbjct: 147 KIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS---SYATPVDMWSVG--CIFAELFR 201

Query: 390 RKP 392
           R+P
Sbjct: 202 RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  110 bits (276), Expect = 4e-26
 Identities = 96/371 (25%), Positives = 152/371 (40%), Gaps = 96/371 (25%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY------LGKQCAEKWAD 208
           FD     K    +  IG G++G V  A    S + VAIKK+ +      L K+       
Sbjct: 1   FDVGSRYKP---IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKR------- 50

Query: 209 ILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGN 268
            L+E++ LR  KH N I  R             +      +D  +V+ +     ++ M +
Sbjct: 51  TLRELKILRHFKHDNIIAIR-------------DILRPPGADFKDVYVV-----MDLMES 92

Query: 269 RLQQLKCFTEHFALFNFEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
            L  +             +H  +PL EE I      +LRGL Y+HS   IHRD+K  N+L
Sbjct: 93  DLHHI-------------IHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLL 139

Query: 328 LTETGTVKLADFGSASIKCPANS----------FVGTPYWMAPEVILAMDEGQYDGKVDV 377
           + E   +++ DFG A  +  ++S          +V T ++ APE++L++ E  Y   +D+
Sbjct: 140 VNEDCELRIGDFGMA--RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE--YTTAIDM 195

Query: 378 WSLGITCIELAE---RKPPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKP 433
           WS+G  CI  AE   R+  +   N +  L  I     +P  +     V+  I S   RK 
Sbjct: 196 WSVG--CI-FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE-----VLNRIGSDRVRK- 246

Query: 434 PYFNMNAMSALYHIAQNDTPCLQSSDWSDTF--AH-----FVSSCLAKNPADRPSSGRLL 486
            Y               + P  Q   WS  F  A       +S  L  +P +R +  + L
Sbjct: 247 -YI-------------QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292

Query: 487 THDLVTRPRSP 497
            H  + +   P
Sbjct: 293 QHPFLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  108 bits (270), Expect = 4e-26
 Identities = 80/254 (31%), Positives = 118/254 (46%), Gaps = 49/254 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY--LGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           +G G+FG VY      +   +A+K++ +     + +++   +  EI+ L+ L H   ++Y
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 228 RGCYLRD---HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
            GC LRD    T  + ME+  G                    G+   QLK +        
Sbjct: 70  YGC-LRDPMERTLSIFMEHMPG--------------------GSIKDQLKSYG------- 101

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 342
                  L E         +L G++YLHS   +HRD+K  NIL    G VKL DFG++  
Sbjct: 102 ------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155

Query: 343 -SIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
               C +     S  GTPYWM+PEVI    EG Y  K D+WS+G T +E+   KPP+   
Sbjct: 156 LQTICLSGTGMKSVTGTPYWMSPEVISG--EG-YGRKADIWSVGCTVVEMLTEKPPWAEF 212

Query: 398 NAMSALYHIAQNDT 411
            AM+A++ IA   T
Sbjct: 213 EAMAAIFKIATQPT 226

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  107 bits (269), Expect = 7e-26
 Identities = 87/336 (25%), Positives = 129/336 (38%), Gaps = 88/336 (26%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK---WADILKEIRFLRQLKHPNTIE 226
           +G G+F + Y AR + +  ++A+K+++Y+    +E+      + KEIR + +L HP+ I 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G    D    L +E+  G +        +       G                     
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGS--------VSHLLSKYG--------------------- 98

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT-VKLADFGSASIK 345
                 KE  I      +LRGL+YLH    IHRDVK  N+L+  TG  +++ADFG+A  +
Sbjct: 99  ----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA-AR 153

Query: 346 CPAN---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
             A            +GT  +MAPEV+      QY    DVWS+G   IE+A  KPP+ N
Sbjct: 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGE---QYGRSCDVWSVGCVIIEMATAKPPW-N 209

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
               S                                     N ++ ++ IA   T    
Sbjct: 210 AEKHS-------------------------------------NHLALIFKIASATTAPSI 232

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
               S         CL   P DRP S  LL H +  
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  107 bits (268), Expect = 8e-26
 Identities = 53/146 (36%), Positives = 79/146 (54%), Gaps = 19/146 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAA----I 59
            +L  L+HPN I Y   ++ D+T  + MEY  G      I+    +  +EE +      I
Sbjct: 51  VILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY 115
            S V    +Y+H  G +HRD+K  NI LT+ G +KL DFG + I       A + VGTPY
Sbjct: 111 VSAV----SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166

Query: 116 WMAPEVILAMDEG-QYDGKVDVWSLG 140
           +M+PE    + +G +Y+ K D+W+LG
Sbjct: 167 YMSPE----LCQGVKYNFKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 9e-26
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +LRQL+H N +  +  + R    +LV EY   +  +++E     L  + + +    +L+
Sbjct: 52  KVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ 111

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPAN----SFVGTPYWMAPE 120
            + Y HS   IHRD+K  NIL++E+G +KL DFG A +++         +V T ++ APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKE 158
           +++   +  Y   VDVW++G          +AEL D E
Sbjct: 172 LLVG--DTNYGKPVDVWAIGCI--------MAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score =  108 bits (272), Expect = 9e-26
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 77/354 (21%)

Query: 165 EDLREIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK-EIRFLRQLKH 221
           E L  IG G      V  AR   + E V +++++   + C  +    L+ E+   +   H
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINL--EACTNEMVTFLQGELHVSKLFNH 58

Query: 222 PNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           PN + YR  ++ D+  W+V  +   GSA D+I  H+++      GM              
Sbjct: 59  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD------GM-------------- 98

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA--- 337
                        E  IA I  GVL+ L+Y+H +G +HR VKA +IL++  G V L+   
Sbjct: 99  ------------SELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 146

Query: 338 ----------------DFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
                           DF   S+K           W++PEV+    +G YD K D++S+G
Sbjct: 147 SNLSMINHGQRLRVVHDFPKYSVKVLP--------WLSPEVLQQNLQG-YDAKSDIYSVG 197

Query: 382 ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSS-----DWSVIKTISSTAERKPPYF 436
           IT  ELA    P+ +M A   L        PCL  +     +   +K   S A       
Sbjct: 198 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGAN----SG 253

Query: 437 NMNAMSALYHIAQNDTPCLQ--SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
              + +       N        +  +S  F HFV  CL +NP  RPS+  LL H
Sbjct: 254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  106 bits (267), Expect = 1e-25
 Identities = 43/77 (55%), Positives = 51/77 (66%), Gaps = 4/77 (5%)

Query: 608 YSSLFSPQ---LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR 663
           Y S F      +VMEYC  GS SDI+++  + L EEEIAAI    L+GL YLHS  +IHR
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR 123

Query: 664 DVKAGNILLTETGTVKL 680
           D+KAGNILL E G  KL
Sbjct: 124 DIKAGNILLNEEGQAKL 140

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  108 bits (271), Expect = 1e-25
 Identities = 51/147 (34%), Positives = 73/147 (49%), Gaps = 14/147 (9%)

Query: 9   RQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVH-KRPLKEEEIAAICSGVLRG 66
           RQL+HPN + Y   ++ D   ++V      GS  D+++ H    L E  IA I   VL  
Sbjct: 54  RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS-----------ASIKCPANSFVGTPY 115
           L+Y+HS G IHR VKA +ILL+  G V L+                 +     S V    
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W++PEV L  +   Y+ K D++S+GIT
Sbjct: 174 WLSPEV-LQQNLQGYNEKSDIYSVGIT 199

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (268), Expect = 1e-25
 Identities = 53/142 (37%), Positives = 75/142 (52%), Gaps = 9/142 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVL 64
             L+ L H N ++Y G    +    + +EY  G S    +  + R  +E+ +      VL
Sbjct: 60  ETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVL 118

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASI--KCPANSFVGTPYWMA 118
            GL YLHS G +HRD+KA N+L+   G  K++DFG    S  I       S  G+ +WMA
Sbjct: 119 EGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEVI +  +G Y  KVD+WSLG
Sbjct: 179 PEVIHSYSQG-YSAKVDIWSLG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  106 bits (265), Expect = 1e-25
 Identities = 72/250 (28%), Positives = 116/250 (46%), Gaps = 40/250 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +++IG GSFG +Y A+     E   IK++        EK A   KE+  L ++KHPN
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + +   +  +   ++VMEYC G                    G+ ++++    +   LF
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDG--------------------GDLMKRIN--RQRGVLF 98

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV-KLADFGSA 342
           +         E++I +    +  GL ++H    +HRD+K+ NI L++ G V KL DFG A
Sbjct: 99  S---------EDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149

Query: 343 SIKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                +       VGTPY+++PE+        Y+ K D+WSLG    EL   K P+   N
Sbjct: 150 RQLNDSMELAYTCVGTPYYLSPEIC---QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Query: 399 AMSALYHIAQ 408
               +  I Q
Sbjct: 207 LHQLVLKICQ 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  105 bits (264), Expect = 2e-25
 Identities = 47/143 (32%), Positives = 77/143 (53%), Gaps = 9/143 (6%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH-KRPLKEEEIAAICSG 62
           + +L +L     I Y   +L      +VMEY   G    ++++   RPL E+++      
Sbjct: 50  ARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQ 109

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMA 118
           +L GL +LHS   +HRD+K+ N+ L     VK+ D G A +       AN+ VGTPY+++
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE+    ++  Y+ K DVW+LG+
Sbjct: 170 PELC---EDKPYNEKSDVWALGV 189

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  106 bits (267), Expect = 2e-25
 Identities = 43/140 (30%), Positives = 75/140 (53%), Gaps = 11/140 (7%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
           L+  +HP  ++    +       LVMEY     S+++   +RPL E ++ +    +L+G+
Sbjct: 53  LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGV 112

Query: 68  NYLHSLGRIHRDVKAGNILLTETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVI 122
            Y+H+ G +HRD+K  N+L++  G +K+ADFG     S       +  V T ++ APE++
Sbjct: 113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 123 LAMDEGQ--YDGKVDVWSLG 140
                G   YD  VD+W++G
Sbjct: 173 Y----GARKYDPGVDLWAVG 188

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  105 bits (264), Expect = 2e-25
 Identities = 74/235 (31%), Positives = 113/235 (48%), Gaps = 40/235 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  LR +G GSFG     + + S +  A+K++     + +    D  KE   L ++KHPN
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL--PKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++  +  D   ++VMEYC G   D+++               +LQ+ K F E   L 
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGG--DLMQ-------------KIKLQRGKLFPEDTILQ 104

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
            F              +C GV     ++H    +HRD+K+ NI LT+ G VKL DFGSA 
Sbjct: 105 WF------------VQMCLGV----QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148

Query: 344 IKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +       A ++VGTPY++ PE+   M    Y+ K D+WSLG    EL   K P+
Sbjct: 149 LLTSPGAYACTYVGTPYYVPPEIWENM---PYNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  106 bits (266), Expect = 3e-25
 Identities = 54/81 (66%), Positives = 63/81 (77%), Gaps = 2/81 (2%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL YLHS   IHRD+KAGNILLTE 
Sbjct: 98  LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 157

Query: 676 GTVKLDTPDEQAGNDSSKSNS 696
           G VKL   D  + + SS +NS
Sbjct: 158 GQVKL--ADFGSASKSSPANS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  106 bits (267), Expect = 3e-25
 Identities = 72/242 (29%), Positives = 110/242 (45%), Gaps = 56/242 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLRQ 218
           +E L  I  G++G VY AR   + EIVA+KK+        EK  +      L+EI  L +
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM------EKEKEGFPITSLREINILLK 60

Query: 219 LKHPNTIEYRGCYL--RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           L+HPN +  +   +       ++VMEY             +E +            LK  
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEY-------------VEHD------------LKSL 95

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            E          K+P  + E+  +   +L G+ +LH    +HRD+K  N+LL   G +K+
Sbjct: 96  MET--------MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKI 147

Query: 337 ADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAER 390
            DFG A    S   P    V T ++ APE++L     +Y   +D+WS+G  CI  EL  +
Sbjct: 148 CDFGLAREYGSPLKPYTQLVVTLWYRAPELLL--GAKEYSTAIDMWSVG--CIFAELLTK 203

Query: 391 KP 392
           KP
Sbjct: 204 KP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 5e-25
 Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 25/172 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
           ++L ++ HP  ++      +     +LV+EY   G     +    R   EE      + +
Sbjct: 45  NILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAAEI 102

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAP 119
           +  L YLHSLG I+RD+K  NILL   G +KL DFG A          N+F GTP ++AP
Sbjct: 103 VLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAP 162

Query: 120 EVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFE 165
           EV+L      Y   VD WSLG+         + E+      F  ED ++I+E
Sbjct: 163 EVLL---GKGYGKAVDWWSLGVL--------LYEMLTGKPPFYAEDRKEIYE 203

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 8e-25
 Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 28/157 (17%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG---------SASDIIEVHKRPLKEEEI 56
            ++++L HPN +   G    +   +LV+EY  G         S        K  L  +++
Sbjct: 48  RVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY- 115
            +    + +G+ YL S   +HRD+ A N L+ E   VK++DFG +      + +    Y 
Sbjct: 108 LSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYR 162

Query: 116 ----------WMAPEVILAMDEGQYDGKVDVWSLGIT 142
                     WMAPE +    +G +  K DVWS G+ 
Sbjct: 163 KKTGGKLPIRWMAPESL---KDGIFTSKSDVWSFGVL 196

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (260), Expect = 9e-25
 Identities = 57/148 (38%), Positives = 76/148 (51%), Gaps = 17/148 (11%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGVL 64
           LL+ LKH N ++Y G  L D+T  + ME+  G +  I  +  R  PL E         +L
Sbjct: 55  LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGS--ISSILNRFGPLPEPVFCKYTKQIL 112

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN----------SFVGTP 114
            G+ YLH+   +HRD+K  N++L   G +KL DFG A                 S  GTP
Sbjct: 113 DGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           YWMAPEVI   +E  Y  K D+WS+G T
Sbjct: 173 YWMAPEVI---NESGYGRKSDIWSIGCT 197

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  103 bits (259), Expect = 2e-24
 Identities = 48/65 (73%), Positives = 55/65 (84%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASD++EVHK+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNILL+E 
Sbjct: 92  LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151

Query: 676 GTVKL 680
           G VKL
Sbjct: 152 GLVKL 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (262), Expect = 3e-24
 Identities = 61/152 (40%), Positives = 79/152 (51%), Gaps = 15/152 (9%)

Query: 6   SLLRQLKHPNTI-EYRGCYLRDHTAWLVMEYCLG-SASDIIEVH--KRPLKEEEIAAICS 61
            +L  L HP  I +    +  + + +LVMEY  G S  D+++    K PL E E   I +
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGT-VKLADFGSAS----------IKCPANSF 110
            +L  L YLHS G IHRD+K  NILL   G  VKL DFG A           I    ++ 
Sbjct: 109 QILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168

Query: 111 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           VGTP +MAPEV+L +         D+WSLGIT
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200

Length = 384

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  103 bits (258), Expect = 4e-24
 Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 16/158 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDH--TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           LL  L+HPN +E +   +  H  + +LVMEYC    + +++    P  E ++  +   +L
Sbjct: 59  LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPANSF---VGTPYWMAPE 120
           RGL YLH    IHRD+K  N+LLT+ G +K+ADFG A     PA      V T ++ APE
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKE 158
           ++L      Y   +D+W++G          +AEL   +
Sbjct: 179 LLLGCTT--YTTAIDMWAVGCI--------LAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  102 bits (256), Expect = 4e-24
 Identities = 56/180 (31%), Positives = 77/180 (42%), Gaps = 37/180 (20%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC----LGSASDIIEVHKRPLKEEEIAAICSGV 63
           L Q + P  ++    +      +LVMEY     L S  + +      L E+      + +
Sbjct: 47  LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEI 102

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------SASIKCPANS-----FV 111
           +  L YLHS G IHRD+K  NIL+   G +KL DFG          I    +       V
Sbjct: 103 VLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFE 165
           GTP ++APEVIL      +   VD WSLG          + E       F  E PE+IF+
Sbjct: 163 GTPDYIAPEVILGQG---HSKTVDWWSLGCI--------LYEFLVGIPPFHGETPEEIFQ 211

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  103 bits (260), Expect = 5e-24
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 56/239 (23%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
             +++L  +G G++G V  A    +   VAIKK+S    Q A       +E+R L+ + H
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDH 73

Query: 222 PNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ-LK 274
            N I     +    +       +LV                         MG  L   +K
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHL----------------------MGADLNNIVK 111

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C              + L ++ I  +   +LRGL Y+HS G IHRD+K  NI + E   +
Sbjct: 112 C--------------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 157

Query: 335 KLADFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A      +     +V T ++ APE++L  +   Y+  VD+WS+G  CI +AE
Sbjct: 158 KILDFGLAR---HTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVG--CI-MAE 208

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  103 bits (258), Expect = 5e-24
 Identities = 97/346 (28%), Positives = 153/346 (44%), Gaps = 62/346 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V   +   S  I+A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 64

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 95

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                 + + EE +  +   VLRGL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 96  ----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151

Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP-PYFNMN 398
              I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +ELA  R P P  +  
Sbjct: 152 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPP-----YFNMNAMSA------LYHI 447
            + A++       P +   D    +  S +   +PP        M++  A      L +I
Sbjct: 209 ELEAIF-----GRPVV---DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI 260

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
                P L +  ++  F  FV+ CL KNPA+R     L+ H  + R
Sbjct: 261 VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  101 bits (254), Expect = 6e-24
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 10/94 (10%)

Query: 588 HHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICS 646
            H + V +   +   +            +VME+C  GS  D+++   + L E +IA +C 
Sbjct: 55  KHPNIVKYYGSYLKKDE---------LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCK 105

Query: 647 GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            +L+GL YLHS G IHRD+KA NILLT  G VKL
Sbjct: 106 ELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKL 139

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  101 bits (253), Expect = 6e-24
 Identities = 72/233 (30%), Positives = 108/233 (46%), Gaps = 41/233 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +R +G G+FG V+  R    +++V IK++        E+ A    E + L+ L HPN
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            IEY   +L D    +VMEY  G                  G      Q +C        
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPG------------------GTLAEYIQKRC-------- 94

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV-KLADFGSA 342
                   L E+ I      +L  L+++H+   +HRD+K  NILL +   V K+ DFG +
Sbjct: 95  -----NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149

Query: 343 SI---KCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERK 391
            I   K  A + VGTP +++PE+     EG+ Y+ K D+W+LG    ELA  K
Sbjct: 150 KILSSKSKAYTVVGTPCYISPELC----EGKPYNQKSDIWALGCVLYELASLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  102 bits (256), Expect = 7e-24
 Identities = 53/81 (65%), Positives = 63/81 (77%), Gaps = 2/81 (2%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASD++EVHK+PL+E EIAAI  G L+GL YLHS   IHRD+KAGNILLTE 
Sbjct: 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161

Query: 676 GTVKLDTPDEQAGNDSSKSNS 696
           G VKL   D  + + +S +NS
Sbjct: 162 GQVKL--ADFGSASIASPANS 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  102 bits (255), Expect = 7e-24
 Identities = 51/138 (36%), Positives = 75/138 (54%), Gaps = 6/138 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L+QLKHPN +     + R     LV EYC  +  + +E + R + E  I  I    L+ 
Sbjct: 53  MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEVI 122
           +N+ H    IHRDVK  NIL+T+ G +KL DFG A I          +V T ++ APE++
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172

Query: 123 LAMDEGQYDGKVDVWSLG 140
           +   + QY   VDVW++G
Sbjct: 173 VG--DTQYGPPVDVWAIG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (251), Expect = 1e-23
 Identities = 54/141 (38%), Positives = 79/141 (56%), Gaps = 11/141 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDII---EVHKRPLKEEEIAAICSG 62
           +L  + HPN I Y+  +L  +   +VMEY   G  S  I   +  ++ + E+EI  I   
Sbjct: 52  ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTPYWMAPE 120
           +LRGL  LH    +HRD+K+ NILL     VK+ D G + +  K  A + +GTP++MAPE
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPE 171

Query: 121 VILAMDEGQ-YDGKVDVWSLG 140
           V     +G+ Y  K D+WSLG
Sbjct: 172 VW----KGRPYSYKSDIWSLG 188

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 2e-23
 Identities = 73/277 (26%), Positives = 111/277 (40%), Gaps = 91/277 (32%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQC------AEKWADILKEI-- 213
           FE ++ IG G+FG V+  R   + ++ A+K +  S + K+       AE+  DIL +   
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAER--DILADADS 60

Query: 214 RFLRQLKHPNTIEYRGCYLRD-HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
            ++ +L             +D    +LVMEY  G   D++               N L +
Sbjct: 61  PWIVKLY---------YSFQDEEHLYLVMEYMPGG--DLM---------------NLLIR 94

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
              F E  A F           E + A+        + +H LG IHRD+K  NIL+   G
Sbjct: 95  KDVFPEETARFYIA--------ELVLAL--------DSVHKLGFIHRDIKPDNILIDADG 138

Query: 333 TVKLADFGSAS---------------------------------IKCPANSFVGTPYWMA 359
            +KLADFG                                     +  ANS VGTP ++A
Sbjct: 139 HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIA 198

Query: 360 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           PEV+       Y  + D WSLG+   E+    PP+++
Sbjct: 199 PEVLRGT---PYGLECDWWSLGVILYEMLYGFPPFYS 232

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  100 bits (251), Expect = 2e-23
 Identities = 84/330 (25%), Positives = 131/330 (39%), Gaps = 86/330 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSY----LGKQCAEK---WADILKEIRF 215
           +  L  +G G+FG VY  R     + ++A+K+++      GK   E+     DI+ E+  
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 216 LR-QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           ++ QL+HPN + Y   +L +   ++VM+   G+                  +G     LK
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP-----------------LGEHFNSLK 104

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGT 333
              + F             EE I  I   ++  L YLH   RI HRD+   NI+L E   
Sbjct: 105 EKKQRFT------------EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK 152

Query: 334 VKLADFGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           V + DFG A  K P +   S VGT  +  PE++     G+   K DVW+ G  CI     
Sbjct: 153 VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGE---KADVWAFG--CI----- 202

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
                       LY +       LQ                 PP+++ N +S    I + 
Sbjct: 203 ------------LYQMCT-----LQ-----------------PPFYSTNMLSLATKIVEA 228

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRP 480
               L    +S+     ++SCL  +   RP
Sbjct: 229 VYEPLPEGMYSEDVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 2e-23
 Identities = 84/299 (28%), Positives = 116/299 (38%), Gaps = 65/299 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD----ILKEIRFLRQL 219
           F+ L ++G G +G V+ A+   + EIVA+K+M    K       +    +L E   L   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMK---KSLLF-KLNEVRHVLTERDILTTT 58

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           K    ++    +  D   +L MEY  G   D        R          L  L   +E 
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGG--DF-------RTL--------LNNLGVLSED 101

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A F           E   A+        + LH LG IHRD+K  N L+  +G +KL DF
Sbjct: 102 HARFYMA--------EMFEAV--------DALHELGYIHRDLKPENFLIDASGHIKLTDF 145

Query: 340 G-SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           G S  I   ANS VG+P +MAPEV+       YD  VD WSLG    E     PP+    
Sbjct: 146 GLSKGIVTYANSVVGSPDYMAPEVLRGK---GYDFTVDYWSLGCMLYEFLCGFPPFSGST 202

Query: 399 A---MSALYHIAQ------NDTPCLQSSD--WSVIKTISSTAER---------KPPYFN 437
                  L +  +       D P    SD  W +I  + +   R           P+F 
Sbjct: 203 PNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  102 bits (255), Expect = 2e-23
 Identities = 85/336 (25%), Positives = 135/336 (40%), Gaps = 84/336 (25%)

Query: 165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           E +  IG G+ G VY      +  + A+K +   G         I +EI  LR + HPN 
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVI--YGNHEDTVRRQICREIEILRDVNHPNV 134

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++    +  +    +++E+  G +              +EG             H A   
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGS--------------LEG------------THIA--- 165

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                    E+ +A +   +L G+ YLH    +HRD+K  N+L+     VK+ADFG + I
Sbjct: 166 --------DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Query: 345 KC----PANSFVGTPYWMAPEVI-LAMDEGQYDGKV-DVWSLGITCIELAERKPPYFNMN 398
                 P NS VGT  +M+PE I   ++ G YDG   D+WSLG++ +E    + P+    
Sbjct: 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF---- 273

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
                           +  DW+ +                  M A+      + P   S 
Sbjct: 274 -------------GVGRQGDWASL------------------MCAICMSQPPEAPATASR 302

Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
           +    F HF+S CL + PA R S+ +LL H  + R 
Sbjct: 303 E----FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334

Length = 353

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 38/66 (57%), Positives = 46/66 (69%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEYC G S  DI +V + PL E +IA +C   L+GL YLH  G+IHRD+K  NILLTE
Sbjct: 77  IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136

Query: 675 TGTVKL 680
            G VKL
Sbjct: 137 DGDVKL 142

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 52/146 (35%), Positives = 78/146 (53%), Gaps = 15/146 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           +LL++L+H N ++Y G  L      + +EY  G +   +  +    +E  +      +L+
Sbjct: 58  ALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK 117

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----------SFVGTP 114
           GLNYLH+ G IHRD+K  NIL+   G +K++DFG  S K  AN           S  G+ 
Sbjct: 118 GLNYLHNRGIIHRDIKGANILVDNKGGIKISDFG-ISKKLEANSLSTKTNGARPSLQGSV 176

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLG 140
           +WMAPEV+    +  Y  K D+WSLG
Sbjct: 177 FWMAPEVV---KQTSYTRKADIWSLG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 99.3 bits (247), Expect = 1e-22
 Identities = 94/345 (27%), Positives = 151/345 (43%), Gaps = 50/345 (14%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  I+A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 64

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 95

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
             +  + P  E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 96  --KAGRIP--EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151

Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
              I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +E+A  + P    +A 
Sbjct: 152 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208

Query: 401 SALYHIAQNDTPCLQSSDWSVI-----KTISSTA-ERKPPYFNMNAMSALYHIAQNDTPC 454
                           S+ S       + +SS   + +PP   M     L +I     P 
Sbjct: 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPP---MAIFELLDYIVNEPPPK 265

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
           L S  +   F  FV+ CL KNPA+R    +L+ H  + R  +  V
Sbjct: 266 LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEV 310

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 98.0 bits (245), Expect = 2e-22
 Identities = 47/138 (34%), Positives = 77/138 (55%), Gaps = 7/138 (5%)

Query: 8   LRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLR 65
           LR+L  HPN ++ +  +  +   + V EY  G+   +++  K +P  E  I +I   +L+
Sbjct: 51  LRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKC--PANSFVGTPYWMAPEVI 122
           GL ++H  G  HRD+K  N+L++    VK+ADFG A  I+   P   +V T ++ APE++
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170

Query: 123 LAMDEGQYDGKVDVWSLG 140
           L      Y   VD+W+LG
Sbjct: 171 LR--STSYSSPVDIWALG 186

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 64/181 (35%), Positives = 90/181 (49%), Gaps = 27/181 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAA-ICSGV 63
            +L +  HP  ++    +      +++MEYCLG     I+    R L +E  A    + V
Sbjct: 45  EILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACV 102

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKC--PANSFVGTPYWMAPE 120
           +    YLH+ G I+RD+K  N+LL   G VKL DFG A  +K      +F GTP ++APE
Sbjct: 103 VLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELF--------DKEDPEKIFED-LREIG 171
           +IL   +G YD  VD WSLGI         + EL         D EDP +I+ D L+  G
Sbjct: 163 IILN--KG-YDFSVDYWSLGIL--------LYELLTGRPPFGEDDEDPMEIYNDILKGNG 211

Query: 172 H 172
            
Sbjct: 212 K 212

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 68/231 (29%), Positives = 101/231 (43%), Gaps = 45/231 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           +G G FG V   +        A+K +   ++ +   ++   I  E   L +  HP  ++ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE--HIFSEKEILEECNHPFIVKL 58

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
              +      +++MEYCLG                    G              L+   +
Sbjct: 59  YRTFKDKKYIYMLMEYCLG--------------------GE-------------LWTI-L 84

Query: 288 HKRPLKEEEIAA-ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIK 345
             R L +E  A    + V+    YLH+ G I+RD+K  N+LL   G VKL DFG A  +K
Sbjct: 85  RDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK 144

Query: 346 C--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
                 +F GTP ++APE+IL   +G YD  VD WSLGI   EL   +PP+
Sbjct: 145 SGQKTWTFCGTPEYVAPEIILN--KG-YDFSVDYWSLGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 54/144 (37%), Positives = 78/144 (54%), Gaps = 15/144 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV------HKRPLKEEEIAAIC 60
           LL+QL HPN I+Y   ++ ++   +V+E  L  A D+  +       KR + E  I    
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLE--LADAGDLSRMIKHFKKQKRLIPERTIWKYF 112

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYW 116
             +   L ++HS   +HRD+K  N+ +T TG VKL D G     +S    A+S VGTPY+
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           M+PE I    E  Y+ K D+WSLG
Sbjct: 173 MSPERI---HENGYNFKSDIWSLG 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 96.2 bits (239), Expect = 5e-22
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 45/275 (16%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +R +G GS+G V   R     +   IKK++       E+ A   +E + L QLKHPN + 
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA-AEQEAQLLSQLKHPNIVA 63

Query: 227 YRGCYL-RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           YR  +   D   ++VM +C G                    G+   +LK           
Sbjct: 64  YRESWEGEDGLLYIVMGFCEG--------------------GDLYHKLK----------- 92

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI- 344
           E   + L E ++      +   L YLH    +HRD+K  N+ LT T  +K+ D G A + 
Sbjct: 93  EQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152

Query: 345 --KCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
             +C  A++ +GTPY+M+PE+        Y+ K DVW+LG    E+A  K   FN   M+
Sbjct: 153 ENQCDMASTLIGTPYYMSPEL---FSNKPYNYKSDVWALGCCVYEMATLKHA-FNAKDMN 208

Query: 402 AL-YHIAQNDTPCLQSSDWS--VIKTISSTAERKP 433
           +L Y I +   P +   D+S  + + I++   ++P
Sbjct: 209 SLVYRIIEGKLPPM-PKDYSPELGELIATMLSKRP 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.8 bits (238), Expect = 6e-22
 Identities = 52/142 (36%), Positives = 81/142 (57%), Gaps = 13/142 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK----RPLKEEEIAAICSG 62
           LL ++KHPN + ++  +  D   ++VMEYC G   D+++  K    +   E+ I      
Sbjct: 51  LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG--DLMQKIKLQRGKLFPEDTILQWFVQ 108

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMA 118
           +  G+ ++H    +HRD+K+ NI LT+ G VKL DFGSA +       A ++VGTPY++ 
Sbjct: 109 MCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168

Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PE+   M    Y+ K D+WSLG
Sbjct: 169 PEIWENM---PYNNKSDIWSLG 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 50/138 (36%), Positives = 67/138 (48%), Gaps = 6/138 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LL++LKHPN I     +       LV E+       +I+     L   +I +     LRG
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEVI 122
           L YLHS   +HRD+K  N+L+   G +KLADFG A S   P       V T ++ APE  
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE-- 172

Query: 123 LAMDEGQYDGKVDVWSLG 140
           L      Y   VD+WS+G
Sbjct: 173 LLFGARHYGVGVDMWSVG 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 94.8 bits (235), Expect = 1e-21
 Identities = 66/175 (37%), Positives = 89/175 (50%), Gaps = 24/175 (13%)

Query: 7   LLRQLKHPNTIEYRGCYLRDH---TAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSG 62
           LL+ L+H   ++Y GC LRD    T  + MEY  G S  D ++ +   L E         
Sbjct: 57  LLKNLQHERIVQYYGC-LRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQ 114

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPAN----SFVGTPY 115
           +L G++YLHS   +HRD+K  NIL    G VKL DFG++      C +     S  GTPY
Sbjct: 115 ILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREI 170
           WM+PEVI    EG Y  K DVWSLG T        + E+  ++ P   +E +  I
Sbjct: 175 WMSPEVISG--EG-YGRKADVWSLGCT--------VVEMLTEKPPWAEYEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 56/147 (38%), Positives = 77/147 (52%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEE--IAAICSG 62
           +L   LKH N ++Y G    +    + ME   G S S ++     PLK+ E  I      
Sbjct: 57  ALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGS----ASIKCPANSFVGTPYWM 117
           +L GL YLH    +HRD+K  N+L+ T +G VK++DFG+    A I     +F GT  +M
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYM 176

Query: 118 APEVILAMDEGQ--YDGKVDVWSLGIT 142
           APEVI   D+G   Y    D+WSLG T
Sbjct: 177 APEVI---DKGPRGYGAPADIWSLGCT 200

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 76/254 (29%), Positives = 114/254 (44%), Gaps = 58/254 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA---DILKEIRFLRQLK 220
           F+ + +IG G++G VY AR   + E+VA+KK+    +   EK       ++EI+ LRQL 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKV----RLDNEKEGFPITAIREIKILRQLN 64

Query: 221 HPNTIEYRGC---------YLRDHTA-WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           H N +  +           + +D  A +LV EY       ++E           G+ +  
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE----------SGLVH-- 112

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                       F+         E+ I +    +L GLNY H    +HRD+K  NILL  
Sbjct: 113 ------------FS---------EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN 151

Query: 331 TGTVKLADFGSASI-----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            G +KLADFG A +       P  + V T ++  PE++L   E +Y   +DVWS G    
Sbjct: 152 KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILG 209

Query: 386 ELAERKPPYFNMNA 399
           EL  +K P F  N 
Sbjct: 210 ELFTKK-PIFQANQ 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 96.5 bits (241), Expect = 1e-21
 Identities = 100/390 (25%), Positives = 162/390 (41%), Gaps = 95/390 (24%)

Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQ 218
            + +E L+++G G++G V+ A    ++E+VA+KK+  ++     A++     +EI FL++
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR---TFREIMFLQE 62

Query: 219 LK-HPNTIE----YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           L  HPN ++     +    +D   +LV EY             +E + H     N L+  
Sbjct: 63  LGDHPNIVKLLNVIKAENDKD--IYLVFEY-------------METDLHAVIRANILE-- 105

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                       +VHKR         I   +L+ L Y+HS   IHRD+K  NILL     
Sbjct: 106 ------------DVHKR--------YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR 145

Query: 334 VKLADFGSA-SIKCPANS--------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           VKLADFG A S+     +        +V T ++ APE++L     +Y   VD+WS+G  C
Sbjct: 146 VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG--STRYTKGVDMWSVG--C 201

Query: 385 IELAE--RKPPYF----NMNA----MSALYHIAQNDTPCLQSS-DWSVIKTISSTAERKP 433
           I L E     P F     +N     +  +   +  D   ++S    +++ ++ S   RKP
Sbjct: 202 I-LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPS-RPRKP 259

Query: 434 PYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
                  +  L   A +D                +   L  NP  R ++   L H  V +
Sbjct: 260 -------LDELLPKASDDA------------LDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Query: 494 PRSPSVLVDLIRRTKAAVRD---LDNLNYR 520
             +PS    L       + D   L    YR
Sbjct: 301 FHNPSDEPVLPYPITIPLDDNVKLSVAEYR 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 43/235 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ + +IG G++G VY AR  ++ EIVA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKELNHPN 59

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        ++  +LV E+      D                      LK + +     
Sbjct: 60  IVRLLDVVHSENKLYLVFEFL-----D--------------------LDLKKYMDS---- 90

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                   L    I +    +L+G+ Y HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 91  ---SPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
           +   P  ++   V T ++ APE++L     QY   VD+WS+G  CI  E+  R+P
Sbjct: 148 AFGVPVRTYTHEVVTLWYRAPEILLG--SRQYSTPVDIWSIG--CIFAEMVNRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 67/249 (26%), Positives = 105/249 (42%), Gaps = 48/249 (19%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V+  +     + VAIK +    ++ A    D ++E + + +L HPN ++
Sbjct: 9   LKELGSGQFGVVHLGKWRGKID-VAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF- 285
             G   +    ++V EY                                   +  L N+ 
Sbjct: 64  LYGVCTKQRPIFIVTEY---------------------------------MANGCLLNYL 90

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
              K  L  E +  +CS V   + YL S G IHRD+ A N L+ E   VK++DFG A   
Sbjct: 91  RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150

Query: 344 IKCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYFNMNA 399
           +     S  GT +   W  PEV    D  ++  K DVWS G+   E+ +E K PY   + 
Sbjct: 151 LDDQYTSSQGTKFPVKWAPPEVF---DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207

Query: 400 MSALYHIAQ 408
              +  ++ 
Sbjct: 208 SEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 78/332 (23%), Positives = 132/332 (39%), Gaps = 81/332 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  +++IG GSFG     +     +   IK+++       E+  +  KE+  L  +KHPN
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++Y+  +  +   ++VM+YC G                               + +   
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGG------------------------------DLYKKI 90

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           N +       E++I      +   L ++H    +HRD+K+ NI LT+ GT+KL DFG A 
Sbjct: 91  NAQ-RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149

Query: 344 IKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +       A + +GTPY+++PE+    +   Y+ K D+W+LG    E+   K   F    
Sbjct: 150 VLNSTVELARTCIGTPYYLSPEIC---ENRPYNNKSDIWALGCVLYEMCTLKHA-FEAGN 205

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           M  L                 V+K I  +    PP                      SS 
Sbjct: 206 MKNL-----------------VLKIIRGSY---PPV---------------------SSH 224

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
           +S    + VS    +NP DRPS   +L  + +
Sbjct: 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 94.1 bits (234), Expect = 4e-21
 Identities = 67/233 (28%), Positives = 111/233 (47%), Gaps = 39/233 (16%)

Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
            F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HP
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 59

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N ++       ++  +LV E+          +H               Q LK F +   L
Sbjct: 60  NIVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASPL 94

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
               +         I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A
Sbjct: 95  SGIPLP-------LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147

Query: 343 -SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
            +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+
Sbjct: 148 RAFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 93.6 bits (233), Expect = 5e-21
 Identities = 55/147 (37%), Positives = 76/147 (51%), Gaps = 16/147 (10%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII-EVHKRPL--KEEEIAAICSGVL 64
           +R +  P T+ + G   R+   W+ ME    S      +V+ + L   E+ +  I   ++
Sbjct: 54  MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113

Query: 65  RGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT------PYW 116
           + L YLHS L  IHRDVK  N+L+   G VKL DFG S  +    +S   T      PY 
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL---VDSVAKTIDAGCKPY- 169

Query: 117 MAPEVI-LAMDEGQYDGKVDVWSLGIT 142
           MAPE I   +++  YD K DVWSLGIT
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGIT 196

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 94.7 bits (236), Expect = 5e-21
 Identities = 70/232 (30%), Positives = 105/232 (45%), Gaps = 46/232 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLKHPNTIE 226
           IG G++G V  A+   + E VAIKK++       +   D    L+EI+ LR L H N I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA----NAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                ++D    ++      + +D+  V+        E M   L Q+   ++        
Sbjct: 69  -----IKD----IMPPPHREAFNDVYIVY--------ELMDTDLHQIIRSSQ-------- 103

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC 346
                L ++        +LRGL Y+HS   +HRD+K  N+LL     +K+ DFG A    
Sbjct: 104 ----TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159

Query: 347 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
               F    V T ++ APE++L   E  Y   +DVWS+G  CI  EL  RKP
Sbjct: 160 EKGDFMTEYVVTRWYRAPELLLNCSE--YTTAIDVWSVG--CIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 93.9 bits (233), Expect = 5e-21
 Identities = 74/236 (31%), Positives = 113/236 (47%), Gaps = 39/236 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--- 220
           +E + EIG G++G VY AR   S   VA+K +     +     + + +E+  L++L+   
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV-REVALLKRLEAFD 60

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ-LKCFTEH 279
           HPN +              +M+ C  S +D        RE  V  +   + Q L+ + + 
Sbjct: 61  HPNIVR-------------LMDVCATSRTD--------RETKVTLVFEHVDQDLRTYLD- 98

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                 +V    L  E I  +    LRGL++LH+   +HRD+K  NIL+T  G VKLADF
Sbjct: 99  ------KVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADF 152

Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           G A I   +      V T ++ APEV+L   +  Y   VD+WS+G    E+  RKP
Sbjct: 153 GLARIYSCQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 93.1 bits (231), Expect = 5e-21
 Identities = 71/284 (25%), Positives = 124/284 (43%), Gaps = 41/284 (14%)

Query: 168 REIGHGSFGAVYYA---RCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           + +G GSFG VY     + +    +  +K++  +G+    +     +E + L +L HP  
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIP-VGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +++   +L      ++ EYC G   D                  +L++LK   +  +   
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLD-----------------CKLEELKHTGKTLS--- 104

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                    E ++      +L G++Y+H    +HRD+KA NI L +   +K+ DFG + +
Sbjct: 105 ---------ENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRL 154

Query: 345 ---KCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               C  A +F GTPY+M+PE   A+    YD K D+WSLG    E+      +   N +
Sbjct: 155 LMGSCDLATTFTGTPYYMSPE---ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL 211

Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
           S +  I +  TP L  +    + +I  +   K P    +A   L
Sbjct: 212 SVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 93.3 bits (232), Expect = 7e-21
 Identities = 90/331 (27%), Positives = 138/331 (41%), Gaps = 57/331 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L +IG G++G V+ A+   + EIVA+K++  L        +  L+EI  L++LKH N
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        D    LV EYC     D                    Q LK +       
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYC-----D--------------------QDLKKY------- 88

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
            F+     +  E + +    +L+GL + HS   +HRD+K  N+L+ + G +KLADFG A 
Sbjct: 89  -FDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P   +   V T ++  P+V+       Y   +D+WS G    ELA    P F  N 
Sbjct: 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAGRPLFPGND 205

Query: 400 MS-ALYHI-AQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQS 457
           +   L  I     TP  +S  W  +  +        PY    A ++L ++     P L +
Sbjct: 206 VDDQLKRIFRLLGTPTEES--WPGVSKLPDY----KPYPMYPATTSLVNV----VPKL-N 254

Query: 458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           S   D   +     L  NP  R S+   L H
Sbjct: 255 STGRDLLQNL----LVCNPVQRISAEEALQH 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 92.4 bits (229), Expect = 9e-21
 Identities = 53/144 (36%), Positives = 79/144 (54%), Gaps = 15/144 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV------HKRPLKEEEIAAIC 60
           LL+QL HPN I+Y   ++ D+   +V+E  L  A D+ ++       KR + E  +    
Sbjct: 55  LLKQLNHPNVIKYLDSFIEDNELNIVLE--LADAGDLSQMIKYFKKQKRLIPERTVWKYF 112

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYW 116
             +   + ++HS   +HRD+K  N+ +T TG VKL D G     +S    A+S VGTPY+
Sbjct: 113 VQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           M+PE I    E  Y+ K D+WSLG
Sbjct: 173 MSPERI---HENGYNFKSDIWSLG 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 92.2 bits (229), Expect = 9e-21
 Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 38/239 (15%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR-QLKHPNTI 225
           L+ I  G+FG+VY A+   + +  AIK +         +  ++  E   +  Q + P   
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +    +      +LVMEY  G     +          ++ +G                  
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASL----------IKTLG------------------ 92

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
                 L E+      + V+ G+  LH  G IHRD+K  N+L+ +TG +KL DFG +   
Sbjct: 93  -----GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147

Query: 346 CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALY 404
                FVGTP ++APE IL + +   D   D WSLG    E     PP F+     A++
Sbjct: 148 LENKKFVGTPDYLAPETILGVGD---DKMSDWWSLGCVIFEFLFGYPP-FHAETPDAVF 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 10/98 (10%)

Query: 584 HNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKRPLKEEEIA 642
                H + V +   +   +       L+   +VMEY   GS +DII  +   + E +IA
Sbjct: 69  MKDCKHPNIVDYYDSYLVGD------ELW---VVMEYMDGGSLTDIITQNFVRMNEPQIA 119

Query: 643 AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            +C  VL+GL YLHS   IHRD+K+ NILL++ G+VKL
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKL 157

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 54/144 (37%), Positives = 79/144 (54%), Gaps = 15/144 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV------HKRPLKEEEIAAIC 60
           LL+QL HPN I+Y   ++ D+   +V+E  L  A D+  +       KR + E+ +    
Sbjct: 55  LLKQLNHPNVIKYYASFIEDNELNIVLE--LADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYW 116
             +   L ++HS   +HRD+K  N+ +T TG VKL D G     +S    A+S VGTPY+
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           M+PE I    E  Y+ K D+WSLG
Sbjct: 173 MSPERI---HENGYNFKSDIWSLG 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 77/255 (30%), Positives = 114/255 (44%), Gaps = 65/255 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKK-MSYLGKQCAEKWADILKEIRFLRQLKHP 222
           +E L ++G G+FG VY AR + +  +VA+KK + +  K      A  L+EI+ L++LKHP
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKKLKHP 67

Query: 223 N-------TIEYRGCYLRDH-TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           N        +E      R   + ++V  Y                      M + L  L 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPY----------------------MDHDLSGL- 104

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                  L N  V    L E +I      +L G+NYLH    +HRD+KA NIL+   G +
Sbjct: 105 -------LENPSVK---LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGIL 154

Query: 335 KLADFGSASI--KCPAN-------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWS 379
           K+ADFG A      P N             + V T ++  PE++L   E +Y   VD+W 
Sbjct: 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG--ERRYTTAVDIW- 211

Query: 380 LGITCI--ELAERKP 392
            GI C+  E+  R+P
Sbjct: 212 -GIGCVFAEMFTRRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 83/366 (22%), Positives = 140/366 (38%), Gaps = 93/366 (25%)

Query: 163 IFEDLREIGHGSFGAVYYARCLVSR--EIVAIKKMSYLGKQCAEKWADI----LKEIRFL 216
            +E    IG G++G VY A+    +  +  AIKK     K   E++  I     +EI  L
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALL 56

Query: 217 RQLKHPNTIEYRGCYLRDHT--AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           R+LKH N +     +L       +L+ +Y                               
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYA------------------------------ 86

Query: 275 CFTEH--FALFNFEVHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 329
              EH  + +  F    +   +    + ++   +L G++YLHS   +HRD+K  NIL+  
Sbjct: 87  ---EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG 143

Query: 330 ---ETGTVKLADFGSASI-----KCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 379
              E G VK+ D G A +     K  A  +  V T ++ APE++L      Y   +D+W+
Sbjct: 144 EGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR--HYTKAIDIWA 201

Query: 380 LGITCI--ELAERKPPYFNMNA---MSALYHIAQND-------TPCLQSSDWSVIKTI-- 425
           +G  CI  EL   +P +    A    S  +   Q +       TP  +  DW  IK +  
Sbjct: 202 IG--CIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEK--DWPDIKKMPE 257

Query: 426 --SSTAERKPPYFNMNAMSALYHIAQN-DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS 482
             +   + K   +  N+++      +  D+               +   L  +P  R ++
Sbjct: 258 YDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF----------DLLRKLLEYDPTKRITA 307

Query: 483 GRLLTH 488
              L H
Sbjct: 308 EEALEH 313

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 31/163 (19%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE-VHKRP-LKEEEIAAICSGV 63
            L R   HP  I+    +  +   + V+EY      ++++ + K   L E+      + +
Sbjct: 54  VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG--ELLQYIRKYGSLDEKCTRFYAAEI 111

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----------------- 106
           L  L YLHS G IHRD+K  NILL +   +K+ DFG+A +  P                 
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 107 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                    SFVGT  +++PE++   +E       D+W+LG  
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL---NEKPAGKSSDLWALGCI 211

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 92.6 bits (231), Expect = 3e-20
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 31/154 (20%)

Query: 7   LLRQLKHPNTIEYRGCYLRD----------HTAWLVMEYCLGSASD---IIEVHKRPLKE 53
           LLR L+H N I      L D          +  ++V E      +D   +I+   +PL +
Sbjct: 52  LLRHLRHENIIG-----LLDILRPPSPEDFNDVYIVTEL---METDLHKVIK-SPQPLTD 102

Query: 54  EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS---- 109
           + I      +LRGL YLHS   IHRD+K  NIL+     +K+ DFG A    P       
Sbjct: 103 DHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 110 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
              +V T ++ APE++L+     Y   +D+WS+G
Sbjct: 163 LTEYVVTRWYRAPELLLSSSR--YTKAIDIWSVG 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 51/142 (35%), Positives = 72/142 (50%), Gaps = 12/142 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDI---IEVHKRPLKEEEIAAICSGV 63
           +L++L HP  +     +  +   +LV++  LG   D+   +   K    EE++      +
Sbjct: 53  ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLS-QKVKFSEEQVKFWICEI 109

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPE 120
           +  L YLHS G IHRD+K  NILL E G V + DF  A+   P     S  GTP +MAPE
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           V+       Y   VD WSLG+T
Sbjct: 170 VLCRQG---YSVAVDWWSLGVT 188

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 57/177 (32%), Positives = 86/177 (48%), Gaps = 29/177 (16%)

Query: 7   LLRQLKHPNTIEYRGCYLRDH--TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           LL++L+HPN +  +         + ++V EY     + +++  +    E +I      +L
Sbjct: 51  LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL 110

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF-----VGTPYWMAP 119
            GL YLHS G +HRD+K  NIL+   G +KLADFG A      NS      V T ++  P
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Query: 120 EVILAMDEGQYDGKVDVWSLG-ITPGSLKDPEIAELFDKEDP----------EKIFE 165
           E++L     +Y  +VD+WS+G I         +AELF  +            EKIFE
Sbjct: 171 ELLLG--ATRYGPEVDMWSVGCI---------LAELFLGKPIFQGSTELEQLEKIFE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 35/65 (53%), Positives = 42/65 (64%), Gaps = 3/65 (4%)

Query: 617 VMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +MEYC  GS  D+++     L E  IA I   VL GL YLH  G+IHRD+KA NILL+E 
Sbjct: 77  IMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE 134

Query: 676 GTVKL 680
           G VKL
Sbjct: 135 GDVKL 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 6e-20
 Identities = 50/132 (37%), Positives = 74/132 (56%), Gaps = 6/132 (4%)

Query: 14  PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL 73
           P  + + G +L ++   + ME+    + D I     P+  E +  I   V+ GL YL+++
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 74  GRI-HRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPYWMAPEVILAMDEGQY 130
            RI HRD+K  NIL+   G +KL DFG +   I   A++FVGT  +M+PE I     G+Y
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG---GKY 179

Query: 131 DGKVDVWSLGIT 142
             K DVWSLGI+
Sbjct: 180 TVKSDVWSLGIS 191

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 90.7 bits (226), Expect = 6e-20
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 22/176 (12%)

Query: 6   SLLRQLKHPNTIEYRGCYL--RDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           ++L +L+HPN +  +   +       ++VMEY       ++E  K+P  + E+  +   +
Sbjct: 56  NILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL 115

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAP 119
           L G+ +LH    +HRD+K  N+LL   G +K+ DFG A    S   P    V T ++ AP
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAP 175

Query: 120 EVILAMDEGQYDGKVDVWSLGITPGSL--KDP------EIAELFDKEDPEKIFEDL 167
           E++L     +Y   +D+WS+G     L  K P      EI +L       KIF+ L
Sbjct: 176 ELLL--GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL------NKIFKLL 223

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 7e-20
 Identities = 74/263 (28%), Positives = 102/263 (38%), Gaps = 79/263 (30%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE---KWADILKEIRFLRQLK 220
           F+ ++ +G G  G V+  R   + ++ A+K +    K+      K   +L E   L  L 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLD---KKEMIKRNKVKRVLTEQEILATLD 59

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL---QQLKCFT 277
           HP        +  +    LVM+YC G             E        RL   Q  KC +
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGG------------ELF------RLLQRQPGKCLS 101

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
           E  A F              AA    VL  L YLH LG ++RD+K  NILL E+G + L+
Sbjct: 102 EEVARF-------------YAA---EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLS 145

Query: 338 DF-------------------GSAS----------IKCPA----NSFVGTPYWMAPEVIL 364
           DF                   GS                     NSFVGT  ++APEVI 
Sbjct: 146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS 205

Query: 365 AMDEGQYDGKVDVWSLGITCIEL 387
              +G +   VD W+LGI   E+
Sbjct: 206 G--DG-HGSAVDWWTLGILLYEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 91.7 bits (228), Expect = 7e-20
 Identities = 72/236 (30%), Positives = 105/236 (44%), Gaps = 57/236 (24%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V+ + VAIKK+S         K A   +E+  ++ + 
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA--YRELVLMKLVN 73

Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       +LVME  L  A+ + +V  I+ +   E M   L Q+ 
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVME--LMDAN-LCQV--IQMDLDHERMSYLLYQML 128

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 129 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 157

Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           K+ DFG A       SF+ TP     Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 158 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVG--CI 206

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 62/175 (35%), Positives = 88/175 (50%), Gaps = 24/175 (13%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA---WLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSG 62
           LL+ L+H   ++Y GC LRD       + +EY  G S  D ++ +   L E         
Sbjct: 57  LLKNLRHDRIVQYYGC-LRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQ 114

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA----NSFVGTPY 115
           +L+G++YLHS   +HRD+K  NIL    G VKL DFG++      C +     S  GTPY
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREI 170
           WM+PEVI    EG Y  K DVWS+  T        + E+  ++ P   +E +  I
Sbjct: 175 WMSPEVISG--EG-YGRKADVWSVACT--------VVEMLTEKPPWAEYEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 61/183 (33%), Positives = 88/183 (48%), Gaps = 35/183 (19%)

Query: 6   SLLRQLK---HPNTIEYR----GCYL-RDHTAWLVMEYCLGSASDIIEVHKRP-LKEEEI 56
           +LL+QL+   HPN +       G    R+    LV E+     +  +    +P L  E I
Sbjct: 50  ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI 109

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC---PANSFVGT 113
             +   +LRG+++LHS   +HRD+K  NIL+T  G VK+ADFG A I        S V T
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLG-ITPGSLKDPEIAELF----------DKEDPEK 162
            ++ APEV+L      Y   VD+WS+G I          AELF          + +  +K
Sbjct: 170 LWYRAPEVLLQS---SYATPVDMWSVGCI---------FAELFRRRPLFRGTSEADQLDK 217

Query: 163 IFE 165
           IF+
Sbjct: 218 IFD 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 64/175 (36%), Positives = 88/175 (50%), Gaps = 24/175 (13%)

Query: 7   LLRQLKHPNTIEYRGCYLRD---HTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSG 62
           LL+ L H   ++Y GC LRD    T  + ME+   GS  D ++ +   L E         
Sbjct: 57  LLKNLLHERIVQYYGC-LRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQ 114

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPAN----SFVGTPY 115
           +L G++YLHS   +HRD+K  NIL    G VKL DFG++      C +     S  GTPY
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREI 170
           WM+PEVI    EG Y  K D+WS+G T        + E+  ++ P   FE +  I
Sbjct: 175 WMSPEVISG--EG-YGRKADIWSVGCT--------VVEMLTEKPPWAEFEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 45/146 (30%), Positives = 81/146 (55%), Gaps = 19/146 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR-------PLKEEEIAA 58
           ++L  +KHPN ++Y+  +  +   ++VM+YC G      +++K+          E++I  
Sbjct: 51  AVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILD 105

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTP 114
               +   L ++H    +HRD+K+ NI LT+ GT+KL DFG A +       A + +GTP
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP 165

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLG 140
           Y+++PE+    +   Y+ K D+W+LG
Sbjct: 166 YYLSPEIC---ENRPYNNKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 46/233 (19%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLK-HPN 223
           L +IG G+F  V  A+   + +  AIK M    K+  +    +  L+EI+ LR+L  HPN
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPN 59

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
                                      I+ +     E   +    RL  L        L+
Sbjct: 60  ---------------------------ILRLI----EVLFDRKTGRLA-LVFELMDMNLY 87

Query: 284 NF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
              +  KRPL E+ + +    +L+ L+++H  G  HRD+K  NIL+ +   +KLADFGS 
Sbjct: 88  ELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSC 146

Query: 343 -SI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
             I  K P   ++ T ++ APE +L    G Y  K+D+W++G    E+    P
Sbjct: 147 RGIYSKPPYTEYISTRWYRAPECLLTD--GYYGPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 68/239 (28%), Positives = 101/239 (42%), Gaps = 55/239 (23%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQL-KHPN 223
           + +G GSFG V  A    + E+ A+K    L K    +  D+   + E R L    KHP 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVK---VLKKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
             +   C+      + VMEY  G   D++        FH+       Q+   F E  A F
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGG--DLM--------FHI-------QRSGRFDEPRARF 100

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                          A    ++ GL +LH  G I+RD+K  N+LL   G +K+ADFG   
Sbjct: 101 --------------YAAE--IVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG--- 141

Query: 344 IKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
             C           +F GTP ++APE++       Y   VD W+LG+   E+   + P+
Sbjct: 142 -MCKEGILGGVTTSTFCGTPDYIAPEILSYQP---YGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 49/136 (36%), Positives = 74/136 (54%), Gaps = 6/136 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHT-AWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           LL+ L+H N I     ++      + V E        ++    RPL+++ I      +LR
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILR 119

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILA 124
           GL Y+HS G +HRD+K  NIL+ E   +K+ DFG A I+ P    +V T Y+ APE++L 
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLT 179

Query: 125 MDEGQYDGKVDVWSLG 140
               +YD +VD+WS G
Sbjct: 180 WQ--KYDVEVDIWSAG 193

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 37/236 (15%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
            E ++ +G G+FG V+  R  +S    A+K M+       ++   +  E R L+++ HP 
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I            +++MEY  G                   + + L+    F+    LF
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGE-----------------LFSYLRNSGRFSNSTGLF 105

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                       EI  +C+     L YLHS   ++RD+K  NILL + G +KL DFG A 
Sbjct: 106 ---------YASEI--VCA-----LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Query: 343 SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
            ++    +  GTP ++APEVI +    +    VD W+LGI   E+    PP+F+ N
Sbjct: 150 KLRDRTWTLCGTPEYLAPEVIQSKGHNK---AVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 89.4 bits (222), Expect = 4e-19
 Identities = 67/258 (25%), Positives = 101/258 (39%), Gaps = 77/258 (29%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKM-------------SYLGKQCAEKWADILKEIRFL 216
           +G G++G V  A   ++ +IVAIKK+               +G  C   +   L+E++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVG-MCGIHFT-TLRELKIM 74

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL--QQLK 274
            ++KH N +     Y+      LVM+     ASD+ +V  ++R+        RL   Q+K
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM---ASDLKKV--VDRKI-------RLTESQVK 122

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                        I   +L GLN LH    +HRD+   NI +   G  
Sbjct: 123 C------------------------ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158

Query: 335 KLADFGSASIKCPANSFVGTPYW----------MAPEVI--------LAMDEGQYDGKVD 376
           K+ADFG A                         M  +V+        L M   +Y   VD
Sbjct: 159 KIADFGLAR--RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVD 216

Query: 377 VWSLGITCI--ELAERKP 392
           +WS+G  CI  EL   KP
Sbjct: 217 MWSVG--CIFAELLTGKP 232

Length = 335

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 70/239 (29%), Positives = 105/239 (43%), Gaps = 56/239 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLKH 221
           +++L  IG G++G V  A    +   VAIKK+S    Q  C       L+EI+ LR+ KH
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIKILRRFKH 62

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N                           II +  I R    E   N +  ++   E   
Sbjct: 63  EN---------------------------IIGILDIIRPPSFESF-NDVYIVQELMET-- 92

Query: 282 LFNFEVHK----RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
               +++K    + L  + I      +LRGL Y+HS   +HRD+K  N+LL     +K+ 
Sbjct: 93  ----DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKIC 148

Query: 338 DFGSASIKCPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           DFG A I  P +        +V T ++ APE++L      Y   +D+WS+G  CI LAE
Sbjct: 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG--YTKAIDIWSVG--CI-LAE 202

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 88/337 (26%), Positives = 143/337 (42%), Gaps = 64/337 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLK 220
           +E + EIG G++G V+ AR L +    VA+K++     Q  E+   +  ++E+  LR L+
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLE 59

Query: 221 ---HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
              HPN +              + + C  S +D  E        HV+      Q L  + 
Sbjct: 60  TFEHPNVVR-------------LFDVCTVSRTDR-ETKLTLVFEHVD------QDLTTYL 99

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
           +       +V +  +  E I  +   +LRGL++LHS   +HRD+K  NIL+T +G +KLA
Sbjct: 100 D-------KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 152

Query: 338 DFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           DFG A   S +    S V T ++ APEV+L   +  Y   VD+WS+G    E+  RKP +
Sbjct: 153 DFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLF 209

Query: 395 ---FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
               +++ +  +  +           DW     +   A                   +  
Sbjct: 210 RGSSDVDQLGKILDVIGLPGE----EDWPRDVALPRQAFHSKS----------AQPIEKF 255

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                  D  +     +  CL  NPA R S+   L+H
Sbjct: 256 VT-----DIDELGKDLLLKCLTFNPAKRISAYSALSH 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 88.9 bits (220), Expect = 5e-19
 Identities = 91/353 (25%), Positives = 141/353 (39%), Gaps = 82/353 (23%)

Query: 169 EIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL-KEIRFLRQLKHPNTI 225
           EIG G  +  +VY AR   +  +V ++      + C E+    L  E+      +HPN +
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDL--ENCTEEHLKALQNEVVLSHFFRHPNIM 62

Query: 226 EYRGCYLRDHTAWLV---MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                +      W++   M Y  GSA+ ++      + +  EGM   L            
Sbjct: 63  TSWTVFTTGSWLWVISPFMAY--GSANSLL------KTYFPEGMSEAL------------ 102

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                         I  I  G LRGLNYLH  G IHR++KA +IL++  G V L+  G +
Sbjct: 103 --------------IGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLS 146

Query: 343 SIKC--------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            +                P  S    P W++PE +L  D   Y+ K D++S+GIT  ELA
Sbjct: 147 HLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPE-LLRQDLYGYNVKSDIYSVGITACELA 204

Query: 389 ERKPPYFNMNAMSAL---------YHIAQNDTPC----LQSSDWSVIKTISSTAERKPPY 435
             + P+ +M     L           +     PC    +++S   V   I  +       
Sbjct: 205 TGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMT 264

Query: 436 FNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
             M +        +  TP   S  +S  F + V  CL ++P  RPS+  LL+H
Sbjct: 265 QTMTS-------ERLRTP--SSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 25/151 (16%)

Query: 7   LLRQLKHPNTIEYR------GCYLRDHTAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAI 59
           +LR  KH N I  R      G   +D   ++VM+        II  H  +PL EE I   
Sbjct: 57  ILRHFKHDNIIAIRDILRPPGADFKD--VYVVMDLMESDLHHII--HSDQPLTEEHIRYF 112

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS---------- 109
              +LRGL Y+HS   IHRD+K  N+L+ E   +++ DFG A  +  ++S          
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA--RGLSSSPTEHKYFMTE 170

Query: 110 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           +V T ++ APE++L++ E  Y   +D+WS+G
Sbjct: 171 YVATRWYRAPELLLSLPE--YTTAIDMWSVG 199

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 52/141 (36%), Positives = 80/141 (56%), Gaps = 11/141 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRP-LKEEEIAAICSGVL 64
           +L+ L HPN IEY   +L D    +VMEY   G+ ++ I+      L E+ I      +L
Sbjct: 52  VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTV-KLADFGSASI---KCPANSFVGTPYWMAPE 120
             L+++H+   +HRD+K  NILL +   V K+ DFG + I   K  A + VGTP +++PE
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171

Query: 121 VILAMDEGQ-YDGKVDVWSLG 140
           +     EG+ Y+ K D+W+LG
Sbjct: 172 LC----EGKPYNQKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 42/234 (17%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G FG V   R   + +I A+K M        E  +   +E   L     P   + + 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +      +LVMEY  G                    G+ L  L              ++
Sbjct: 69  AFQDKDNLYLVMEYQPG--------------------GDLLSLLN------------RYE 96

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
               E+      + ++  ++ +H +G +HRD+K  N+L+  TG +KLADFGSA+ +  AN
Sbjct: 97  DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTAN 155

Query: 350 SFV------GTPYWMAPEVILAMD---EGQYDGKVDVWSLGITCIELAERKPPY 394
             V      GTP ++APEV+  M+   +G Y  + D WSLG+   E+   + P+
Sbjct: 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 88.1 bits (218), Expect = 1e-18
 Identities = 78/269 (28%), Positives = 117/269 (43%), Gaps = 52/269 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + DL+++G G++G V  A    +   VAIKK+ Y   Q         +E+R L+ +KH N
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHEN 75

Query: 224 TIEYRGCYLRD------HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            I     +  D      H  +LVM +                      MG  L +L    
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPF----------------------MGTDLGKLM--- 110

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                     H++ L E+ I  +   +L+GL Y+H+ G IHRD+K GN+ + E   +K+ 
Sbjct: 111 ---------KHEK-LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160

Query: 338 DFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           DFG A         +V T ++ APEVIL      Y   VD+WS+G    E+   KP +  
Sbjct: 161 DFGLARQTDSEMTGYVVTRWYRAPEVILNW--MHYTQTVDIWSVGCIMAEMLTGKPLFKG 218

Query: 397 MNAMSALYHIAQ-NDTPC------LQSSD 418
            + +  L  I +   TP       LQS D
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSED 247

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 87.6 bits (217), Expect = 1e-18
 Identities = 68/246 (27%), Positives = 105/246 (42%), Gaps = 61/246 (24%)

Query: 164 FEDLREIGHGSFGAV----------YYA-RCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
           FE    +G GSFG V          YYA +CL  REI+ +K++ +           + +E
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-----------VAQE 68

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
              L +L HP  +     +  ++  + ++E+ +G           E   H+   G     
Sbjct: 69  KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG----------ELFTHLRKAGR---- 114

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
              F    A F                  + ++    YLHS   I+RD+K  N+LL   G
Sbjct: 115 ---FPNDVAKF----------------YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG 155

Query: 333 TVKLADFGSASIKCPANSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            VK+ DFG A  K P  +F   GTP ++APEVI +   G+    VD W++G+   E    
Sbjct: 156 HVKVTDFGFAK-KVPDRTFTLCGTPEYLAPEVIQSKGHGK---AVDWWTMGVLLYEFIAG 211

Query: 391 KPPYFN 396
            PP+F+
Sbjct: 212 YPPFFD 217

Length = 329

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 90/344 (26%), Positives = 137/344 (39%), Gaps = 74/344 (21%)

Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
             E  R IG+G+FG V+        + VA+KKM  + +        + +E++ L   KH 
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC-KRVFRELKMLCFFKHD 59

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA- 281
           N +                     SA DI++                   +  F E +  
Sbjct: 60  NVL---------------------SALDILQP----------------PHIDPFEEIYVV 82

Query: 282 --LFNFEVHK-----RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
             L   ++HK     +PL  + +      +LRGL YLHS G +HRD+K GN+L+     +
Sbjct: 83  TELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVL 142

Query: 335 KLADFGSASIKCPANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--EL 387
           K+ DFG A ++ P  S      V T Y+ APE++  M    Y   VD+WS+G  CI  EL
Sbjct: 143 KICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL--MGSRHYTSAVDIWSVG--CIFAEL 198

Query: 388 AERKPPYFNMNAMSALYHIAQN-DTPCL--QSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
             R+  +   + +  L  I     TP L    S     +        KPP     ++  L
Sbjct: 199 LGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPP-----SLPVL 253

Query: 445 YHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           Y +         SS  +    H +   L  +P  R S+   L H
Sbjct: 254 YTL---------SSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 62/251 (24%), Positives = 86/251 (34%), Gaps = 57/251 (22%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYA-----RCLVSREIVAIKKMSYLGKQCAEKWADILK 211
            E P      LR +GHG+FG VY               VA+K +     +  E  +D L 
Sbjct: 1   PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE--SDFLM 58

Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E   + +  H N +   G        ++++E   G                    G+   
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAG--------------------GD--- 95

Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
            LK F               L  +++      V +G  YL     IHRD+ A N LLT  
Sbjct: 96  -LKSFLRENR--PRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCK 152

Query: 332 G---TVKLADFGSASIKCPANSFVGTPY------------WMAPEVILAMDEGQYDGKVD 376
           G     K+ADFG       A       Y            WM PE  L   +G +  K D
Sbjct: 153 GPGRVAKIADFGM------ARDIYRASYYRKGGRAMLPIKWMPPEAFL---DGIFTSKTD 203

Query: 377 VWSLGITCIEL 387
           VWS G+   E+
Sbjct: 204 VWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.4 bits (215), Expect = 2e-18
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 35/198 (17%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLK-EEEIAAI-CSGV 63
            +L+ ++HP  +   G +  D   +LVMEY  G   ++    ++  +  E +A    + V
Sbjct: 53  RILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQV 110

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPANSFVGTPYWMAPEVI 122
           +  L YLHSL  ++RD+K  N+LL   G +K+ DFG A  +K    +  GTP ++APE+I
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEII 170

Query: 123 LAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFEDLREIGHGSFG 176
           L+     Y   VD W+LGI         I E+      F  ++P +I+E + E      G
Sbjct: 171 LSKG---YGKAVDWWALGIL--------IYEMLAGYPPFFDDNPIQIYEKILE------G 213

Query: 177 AVYY-------ARCLVSR 187
            V +       A+ L+  
Sbjct: 214 KVRFPSFFSPDAKDLIRN 231

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 2e-18
 Identities = 47/151 (31%), Positives = 64/151 (42%), Gaps = 48/151 (31%)

Query: 30  WLVMEYCLGSASDIIE--VHKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAG 83
           +LVMEY  G   D++   + K    EE     IA +   +    + +H LG IHRD+K  
Sbjct: 77  YLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLAL----DSVHKLGFIHRDIKPD 130

Query: 84  NILLTETGTVKLADFGSAS---------------------------------IKCPANSF 110
           NIL+   G +KLADFG                                     +  ANS 
Sbjct: 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANST 190

Query: 111 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           VGTP ++APEV+       Y  + D WSLG+
Sbjct: 191 VGTPDYIAPEVLRGT---PYGLECDWWSLGV 218

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 45/112 (40%), Positives = 60/112 (53%), Gaps = 4/112 (3%)

Query: 30  WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           +L MEY  G     +  +   L E+      + +   ++ LH LG IHRD+K  N L+  
Sbjct: 77  YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136

Query: 90  TGTVKLADFG-SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           +G +KL DFG S  I   ANS VG+P +MAPEV+       YD  VD WSLG
Sbjct: 137 SGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGK---GYDFTVDYWSLG 185

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 19/150 (12%)

Query: 30  WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           +LVMEY  G     +      L E+      + V+ G+  LH  G IHRD+K  N+L+ +
Sbjct: 73  YLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ 132

Query: 90  TGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDP 149
           TG +KL DFG +        FVGTP ++APE IL + +   D   D WSLG         
Sbjct: 133 TGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGD---DKMSDWWSLGCV------- 182

Query: 150 EIAEL------FDKEDPEKIFEDL--REIG 171
            I E       F  E P+ +F+++  R I 
Sbjct: 183 -IFEFLFGYPPFHAETPDAVFDNILSRRIN 211

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 87.3 bits (216), Expect = 2e-18
 Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 52/240 (21%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFL 216
           E PE+ +  L+++G G++G+V  A    + E VAIKK+S     +   K A   +E+  L
Sbjct: 12  ELPER-YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA--YRELTLL 68

Query: 217 RQLKHPNTIEYRGCY-----LRD-HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           + ++H N I     +       +    +LVM Y                      M   L
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY----------------------MQTDL 106

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
           Q+              +   PL E+++  +   +L GL Y+HS G IHRD+K GN+ + E
Sbjct: 107 QK--------------IMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152

Query: 331 TGTVKLADFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
              +K+ DFG A         +V T ++ APEVIL  +   Y+  VD+WS+G  CI +AE
Sbjct: 153 DCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL--NWMHYNQTVDIWSVG--CI-MAE 207

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 39/233 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ L ++G G++  VY  R   + EIVA+K++    ++     A  ++EI  +++LKH N
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--IREISLMKELKHEN 59

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        ++   LV EY        ++ H           G R              
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTH-----------GVR-------------- 94

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                   L    + +    +L+G+ + H    +HRD+K  N+L+ + G +KLADFG A 
Sbjct: 95  ------GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148

Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           +   P N+F   V T ++ AP+V+L      Y   +D+WS+G    E+   +P
Sbjct: 149 AFGIPVNTFSNEVVTLWYRAPDVLLG--SRTYSTSIDIWSVGCIMAEMITGRP 199

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 72/237 (30%), Positives = 101/237 (42%), Gaps = 47/237 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEKWADILKEIR-FLRQLKHPNTI 225
           IG GSFG V  A+     +  A+K   K + L K+  +    I+ E    L+ +KHP  +
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKH---IMAERNVLLKNVKHPFLV 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                +      + V++Y  G           E  FH       LQ+ + F E  A F  
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGG----------ELFFH-------LQRERSFPEPRARF-- 100

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----S 341
                     EIA+        L YLHSL  I+RD+K  NILL   G V L DFG     
Sbjct: 101 -------YAAEIAS-------ALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 342 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                  ++F GTP ++APEV+       YD  VD W LG    E+    PP+++ +
Sbjct: 147 IEHSKTTSTFCGTPEYLAPEVLRKQP---YDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 55/143 (38%), Positives = 69/143 (48%), Gaps = 20/143 (13%)

Query: 14  PNTIEYRGCYLRDHTAWLVMEYCLGSAS------DIIEVHKRPLKEEEIAAICSGVLRGL 67
           P  +++ G   R+   W+ ME  L   S       + EV K  + EE +  I    ++ L
Sbjct: 63  PYIVKFYGALFREGDCWICME--LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 68  NYL-HSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT------PYWMAP 119
           NYL   L  IHRDVK  NILL   G +KL DFG S  +    +S   T      PY MAP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPY-MAP 176

Query: 120 EVILAMDEGQYDGKVDVWSLGIT 142
           E I       YD + DVWSLGIT
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGIT 199

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 73/269 (27%), Positives = 109/269 (40%), Gaps = 70/269 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSR--EIVAIKKMS-YLGKQCAEKWADILKEIRFLRQLK 220
           +E ++E+G G++G V  AR   +   E VAIKK++    K+   K A  L+E++ LR  +
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA--LRELKLLRHFR 59

Query: 221 -HPNTI-----------EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGN 268
            H N              +   YL +     +ME  L     II                
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEE----LMEADL---HQIIRSG------------- 99

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
             Q L     HF  F +++                 L GL Y+HS   +HRD+K GN+L+
Sbjct: 100 --QPLTDA--HFQSFIYQI-----------------LCGLKYIHSANVLHRDLKPGNLLV 138

Query: 329 TETGTVKLADFGSASIKCPANSFVGTPY--------WM-APEVILAMDEGQYDGKVDVWS 379
                +K+ DFG A      N      +        W  APE++L+     Y   +DVWS
Sbjct: 139 NADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRAPEIMLSFQS--YTKAIDVWS 195

Query: 380 LGITCIELAERKPPYFNMNAMSALYHIAQ 408
           +G    EL  RKP +   + +  L  I Q
Sbjct: 196 VGCILAELLGRKPVFKGKDYVDQLNQILQ 224

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 80/345 (23%), Positives = 122/345 (35%), Gaps = 100/345 (28%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVS---REIVAIK--KMSYLGKQCAEKWADILKEI 213
           DP  +  + + IG G FG V   R  +       VAIK  K     KQ      D L E 
Sbjct: 2   DPSYVTIE-KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ----RLDFLTEA 56

Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             + Q  HPN I   G   +     ++ EY                      M       
Sbjct: 57  SIMGQFDHPNIIRLEGVVTKSRPVMIITEY----------------------M------- 87

Query: 274 KCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
               E+ +L  F   +       ++  +  G+  G+ YL  +  +HRD+ A NIL+    
Sbjct: 88  ----ENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL 143

Query: 333 TVKLADFGSASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
             K++DFG +     + +   T     P  W APE   A+   ++    DVWS GI   E
Sbjct: 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE---AIAYRKFTSASDVWSFGIVMWE 200

Query: 387 L---AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
           +    ER  PY++M                   S+  VIK +       PP   M+  SA
Sbjct: 201 VMSYGER--PYWDM-------------------SNQDVIKAVEDGYRLPPP---MDCPSA 236

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           LY +                       C  K+  +RP+  ++++ 
Sbjct: 237 LYQLML--------------------DCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 47/141 (33%), Positives = 69/141 (48%), Gaps = 9/141 (6%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++ +L HPN ++  G   +    ++V EY   G   + +   K  L  E +  +CS V  
Sbjct: 52  VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCE 111

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPY---WMAPE 120
            + YL S G IHRD+ A N L+ E   VK++DFG A   +     S  GT +   W  PE
Sbjct: 112 AMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPE 171

Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V    D  ++  K DVWS G+
Sbjct: 172 VF---DYSRFSSKSDVWSFGV 189

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 85.3 bits (211), Expect = 5e-18
 Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 40/250 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E + +IG G++G VY AR  V+ E +A+KK+  L ++     +  ++EI  L++++H N
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +  +     +   +LV EY      D+                     LK   +    F
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYL-----DL--------------------DLKKHMDSSPDF 97

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE-TGTVKLADFGSA 342
                        I      +LRG+ Y HS   +HRD+K  N+L+   T  +KLADFG A
Sbjct: 98  AKNPRL-------IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150

Query: 343 -SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
            +   P  +F   V T ++ APE++L      Y   VD+WS+G    E+  +KP +   +
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLG--SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208

Query: 399 AMSALYHIAQ 408
            +  L+ I +
Sbjct: 209 EIDELFKIFR 218

Length = 294

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.8 bits (207), Expect = 8e-18
 Identities = 84/325 (25%), Positives = 123/325 (37%), Gaps = 90/325 (27%)

Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           EIG G FG V+    L  R+ VAIK +    ++ A    D ++E + + +L HP  ++  
Sbjct: 11  EIGSGQFGLVWLGYWLEKRK-VAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G         LV E                                 F EH  L ++   
Sbjct: 66  GVCTERSPICLVFE---------------------------------FMEHGCLSDYLRA 92

Query: 289 KR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC- 346
           +R    +E +  +C  V  G+ YL S   IHRD+ A N L+ E   VK++DFG       
Sbjct: 93  QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152

Query: 347 -PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYFNMNAMS 401
               S  GT +   W +PEV       +Y  K DVWS G+   E+ +E K PY N     
Sbjct: 153 DQYTSSTGTKFPVKWSSPEVF---SFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN----- 204

Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 461
                          S+  V++TI++      P     A  ++Y + Q+           
Sbjct: 205 --------------RSNSEVVETINAGFRLYKPRL---ASQSVYELMQH----------- 236

Query: 462 DTFAHFVSSCLAKNPADRPSSGRLL 486
                    C  + P DRPS   LL
Sbjct: 237 ---------CWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 83.8 bits (207), Expect = 9e-18
 Identities = 49/144 (34%), Positives = 78/144 (54%), Gaps = 12/144 (8%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD--IIEVHK--RPLKEEEIAAIC 60
           + LL +L HP  +++   +L      ++ EYC G   D  + E+    + L E ++    
Sbjct: 53  AQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF 112

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KCP-ANSFVGTPYW 116
             +L G++Y+H    +HRD+KA NI L +   +K+ DFG + +    C  A +F GTPY+
Sbjct: 113 IQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYY 171

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           M+PE   A+    YD K D+WSLG
Sbjct: 172 MSPE---ALKHQGYDSKSDIWSLG 192

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 11/93 (11%)

Query: 590 HHP-VTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSG 647
            HP +  L    + + +  Y       LVMEYC  G   D+++  +  L E+E       
Sbjct: 55  KHPNIVRL-YDVFEDEDKLY-------LVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQ 105

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L  L YLHS G +HRD+K  NILL E G VKL
Sbjct: 106 ILSALEYLHSKGIVHRDLKPENILLDEDGHVKL 138

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 58/178 (32%), Positives = 83/178 (46%), Gaps = 30/178 (16%)

Query: 7   LLRQLK--H----PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           ++R+LK  H    P  + + G +  D    + ME+  G + D +      + E  +  I 
Sbjct: 46  IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS 105

Query: 61  SGVLRGLNYL---HSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPY 115
             VLRGL YL   H +  +HRDVK  NIL+   G +KL DFG +   I   ANSFVGT  
Sbjct: 106 IAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 163

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLG------------ITPGSLKDPEIAELFDKEDPE 161
           +M+PE    +    Y  + D+WSLG            I P   K  E+  +F +   E
Sbjct: 164 YMSPE---RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSE 216

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 48/143 (33%), Positives = 77/143 (53%), Gaps = 14/143 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAAICSG 62
           LL ++KHPN + +   +  +   ++VMEYC G   D+++   R       E++I +    
Sbjct: 52  LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQ 109

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTV-KLADFGSASIKCPANSF----VGTPYWM 117
           +  GL ++H    +HRD+K+ NI L++ G V KL DFG A     +       VGTPY++
Sbjct: 110 ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYL 169

Query: 118 APEVILAMDEGQYDGKVDVWSLG 140
           +PE+        Y+ K D+WSLG
Sbjct: 170 SPEIC---QNRPYNNKTDIWSLG 189

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 50/143 (34%), Positives = 76/143 (53%), Gaps = 10/143 (6%)

Query: 5   SSLLRQLKHPNTIEYRGCYL-RDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICS 61
           + LL QLKHPN + YR  +   D   ++VM +C G      + E   + L E ++     
Sbjct: 50  AQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV 109

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KCP-ANSFVGTPYWM 117
            +   L YLH    +HRD+K  N+ LT T  +K+ D G A +   +C  A++ +GTPY+M
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169

Query: 118 APEVILAMDEGQYDGKVDVWSLG 140
           +PE+        Y+ K DVW+LG
Sbjct: 170 SPEL---FSNKPYNYKSDVWALG 189

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 69/257 (26%), Positives = 97/257 (37%), Gaps = 43/257 (16%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P + F   R++G G FG V+          VAIK +         K  D  KE++ L+
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILK---SDDLLKQQDFQKEVQALK 57

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +L+H + I            +++ E              +E+       G+ L  L+   
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITEL-------------MEK-------GSLLAFLR--- 94

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                       + L    +  +   V  G+ YL     IHRD+ A NIL+ E    K+A
Sbjct: 95  --------SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVA 146

Query: 338 DFGSAS-IKCPANSFVGT--PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KP 392
           DFG A  IK           PY W APE   A   G +  K DVWS GI   E+    + 
Sbjct: 147 DFGLARLIKEDVYLSSDKKIPYKWTAPE---AASHGTFSTKSDVWSFGILLYEMFTYGQV 203

Query: 393 PYFNMNAMSALYHIAQN 409
           PY  MN       I   
Sbjct: 204 PYPGMNNHEVYDQITAG 220

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 52/188 (27%), Positives = 88/188 (46%), Gaps = 30/188 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHT--AWLVMEYCLGSASDIIEVHKRP----LKEEEIAAI 59
           +LLR+LKH N +     +L       +L+ +Y       II+ H++     +    + ++
Sbjct: 54  ALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL 113

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASI-----KCPA--N 108
              +L G++YLHS   +HRD+K  NIL+     E G VK+ D G A +     K  A  +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 109 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDK 157
             V T ++ APE++L      Y   +D+W++G           I  G     + +  F +
Sbjct: 174 PVVVTIWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231

Query: 158 EDPEKIFE 165
           +  E+IFE
Sbjct: 232 DQLERIFE 239

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 63/228 (27%), Positives = 95/228 (41%), Gaps = 47/228 (20%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNY 69
           KHP   +   C+      + VMEY  G      I    +         A    ++ GL +
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--IVLGLQF 111

Query: 70  LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPYWMAPEV 121
           LH  G I+RD+K  N+LL   G +K+ADFG     C           +F GTP ++APE+
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKIADFG----MCKEGILGGVTTSTFCGTPDYIAPEI 167

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFEDLREIGHGSF 175
           +       Y   VD W+LG+         + E+      F+ +D +++F+ + E      
Sbjct: 168 LSYQP---YGPAVDWWALGVL--------LYEMLAGQSPFEGDDEDELFQSILE------ 210

Query: 176 GAVYYARCLVSREIVAIKKMSYLGKQ------CAEKWADILKEIRFLR 217
             V Y R L S+E  +I K S+L K       C       +K   F R
Sbjct: 211 DEVRYPRWL-SKEAKSILK-SFLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 44/127 (34%), Positives = 72/127 (56%), Gaps = 15/127 (11%)

Query: 27  HTAWLVMEYCLGSASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 83
              +LVMEY  G   D++ +   ++    E+      + ++  ++ +H +G +HRD+K  
Sbjct: 74  DNLYLVMEYQPGG--DLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE 131

Query: 84  NILLTETGTVKLADFGSASIKCPANSFV------GTPYWMAPEVILAMD---EGQYDGKV 134
           N+L+  TG +KLADFGSA+ +  AN  V      GTP ++APEV+  M+   +G Y  + 
Sbjct: 132 NVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190

Query: 135 DVWSLGI 141
           D WSLG+
Sbjct: 191 DWWSLGV 197

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 68/245 (27%), Positives = 110/245 (44%), Gaps = 58/245 (23%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRF 215
            ++  + ++++G G FG V   R       + E VA+K +++ G++     +D  +EI  
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR--SDFEREIEI 59

Query: 216 LRQLKHPNTIEYRGCYLRDHTA--WLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           LR L H N ++Y+G   +       L+MEY   GS  D ++        H + + N  + 
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-------RHRDQI-NLKRL 111

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L        LF+ +             IC    +G++YL S   IHRD+ A NIL+    
Sbjct: 112 L--------LFSSQ-------------IC----KGMDYLGSQRYIHRDLAARNILVESED 146

Query: 333 TVKLADFGSASI----------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
            VK++DFG A +          K P  S +   +W APE    +   ++    DVWS G+
Sbjct: 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWYAPE---CLRTSKFSSASDVWSFGV 200

Query: 383 TCIEL 387
           T  EL
Sbjct: 201 TLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 38/227 (16%)

Query: 170 IGHGSFGAVYYAR-----CLVSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-KHP 222
           +G G+FG V  A             VA+K    L     EK  +D++ E+  ++ + KH 
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N I   G   ++   ++V+EY           H   R+F        L+  +   E+ + 
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYA---------AHGNLRDF--------LRARRPPGEYASP 119

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
            +    +  L ++++ +    V RG+ +L S   IHRD+ A N+L+TE   +K+ADFG A
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 343 -SIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGI 382
             I    + +  T     P  WMAPE   A+ +  Y  + DVWS G+
Sbjct: 180 RDIHH-IDYYRKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGV 222

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 9/138 (6%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L +   P  I + G +  ++   +  E+  G + D+     R + E  +  I   V++G
Sbjct: 52  ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKG 107

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPYWMAPEVILA 124
           L YL SL  +HRDVK  N+L+   G VKL DFG ++  +   A ++VGT  +MAPE I  
Sbjct: 108 LTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISG 167

Query: 125 MDEGQYDGKVDVWSLGIT 142
               QY    DVWSLGI+
Sbjct: 168 ---EQYGIHSDVWSLGIS 182

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 30/156 (19%)

Query: 7   LLRQLKHPNTIE--------------YRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLK 52
           +L+ LKH N +               Y+G      + +LV E+C    + ++        
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKG------SFYLVFEFCEHDLAGLLSNKNVKFT 117

Query: 53  EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-----SASIKCPA 107
             EI  +   +L GL Y+H    +HRD+KA NIL+T+ G +KLADFG     S S     
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 108 NSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           N +   V T ++  PE++L   E  Y   +D+W  G
Sbjct: 178 NRYTNRVVTLWYRPPELLLG--ERDYGPPIDMWGAG 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 50/145 (34%), Positives = 75/145 (51%), Gaps = 19/145 (13%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           L++ + H N I     +    +       +LVME  L  A+ + +V +  L  E ++ + 
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME--LMDAN-LCQVIQMDLDHERMSYLL 124

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----Y 115
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A       SF+ TP     Y
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 182

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLG 140
           + APEVIL M    Y   VD+WS+G
Sbjct: 183 YRAPEVILGMG---YKENVDIWSVG 204

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 45/118 (38%), Positives = 59/118 (50%), Gaps = 6/118 (5%)

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           LF     +    E E+    + ++  L++LH LG I+RD+K  NILL   G V L DFG 
Sbjct: 92  LFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGL 151

Query: 342 ASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +          A SF GT  +MAPEVI     G +D  VD WSLG+   EL     P+
Sbjct: 152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG-HDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 74/243 (30%), Positives = 105/243 (43%), Gaps = 55/243 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLR-QL 219
           F  L  +G GSFG V  A    + E+ AIK    L K    +  D+   + E R L    
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIK---ILKKDVIIQDDDVECTMVEKRVLALPG 58

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           K P   +   C+      + VMEY  G   D++        +H+       QQ+  F E 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGG--DLM--------YHI-------QQVGKFKEP 101

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A+F            EIA        GL +LHS G I+RD+K  N++L   G +K+ADF
Sbjct: 102 HAVF---------YAAEIAI-------GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADF 145

Query: 340 GSASIKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           G     C  N        +F GTP ++APE+I       Y   VD W+ G+   E+   +
Sbjct: 146 G----MCKENIFGGKTTRTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQ 198

Query: 392 PPY 394
           PP+
Sbjct: 199 PPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 83.8 bits (207), Expect = 3e-17
 Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 10/140 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LL+ + HP+ I  +   +      +V+ +        +    RPL  ++   I   +L G
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEG 169

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-----FVGTPYWMAPEV 121
           L YLH+   IHRDVK  NI + +   V + D G+A  + P  +       GT    APEV
Sbjct: 170 LRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA--QFPVVAPAFLGLAGTVETNAPEV 227

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
            LA D  +Y+ K D+WS GI
Sbjct: 228 -LARD--KYNSKADIWSAGI 244

Length = 357

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 83.3 bits (206), Expect = 4e-17
 Identities = 87/342 (25%), Positives = 135/342 (39%), Gaps = 82/342 (23%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GS+G V  A    + E VAIKK++ + +  ++    IL+EI+ LR L+HP       
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA-TRILREIKLLRLLRHP------- 59

Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFH-----VEGMGNRLQQL-----K 274
                               DI+E+  I      REF       E M + L Q+      
Sbjct: 60  --------------------DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD 99

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
              EH   F +++                 LR L Y+H+    HRD+K  NIL      +
Sbjct: 100 LTPEHHQFFLYQL-----------------LRALKYIHTANVFHRDLKPKNILANADCKL 142

Query: 335 KLADFGSASI---KCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           K+ DFG A +     P   F    V T ++ APE+  +    +Y   +D+WS+G    E+
Sbjct: 143 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEV 201

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
              KP +   N +  L  I    T  L +     I  + +   R+     +++M      
Sbjct: 202 LTGKPLFPGKNVVHQLDLI----TDLLGTPSPETISRVRNEKARR----YLSSMR----- 248

Query: 448 AQNDTPCLQSSDWSDTFA-HFVSSCLAKNPADRPSSGRLLTH 488
            +   P  Q    +D  A   +   LA +P DRP++   L  
Sbjct: 249 KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 83.6 bits (206), Expect = 4e-17
 Identities = 84/297 (28%), Positives = 135/297 (45%), Gaps = 49/297 (16%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A     R+ VA+KK+S   +          +E+R L+
Sbjct: 12  EVPER-YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA-RRTYRELRLLK 69

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I             L +     S  +  EV+ +        MG  L  + KC 
Sbjct: 70  HMKHENVI-----------GLLDVFTPATSIENFNEVYLV-----TNLMGADLNNIVKC- 112

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L +E +  +   +LRGL Y+HS G IHRD+K  N+ + E   +++
Sbjct: 113 -------------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159

Query: 337 ADFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL + K  + 
Sbjct: 160 LDFGLARQADDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLKGKALFP 217

Query: 396 NMNAMSALYHIAQ-NDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
             + +  L  I +   TP   S +  V+K ISS   RK  Y       +L H+ Q D
Sbjct: 218 GNDYIDQLKRIMEVVGTP---SPE--VLKKISSEHARK--YI-----QSLPHMPQQD 262

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.3 bits (203), Expect = 4e-17
 Identities = 72/246 (29%), Positives = 99/246 (40%), Gaps = 62/246 (25%)

Query: 167 LREIGHGSFGAV----YYARCLVSREIVAIKKM-SYLGKQCAEKWADILKEIRFLRQLKH 221
           +R +G G FG V    Y      + E+VA+K +    G+Q    W    KEI  L+ L H
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW---KKEINILKTLYH 65

Query: 222 PNTIEYRGCYLR--DHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            N ++Y+GC          L+MEY  LGS  D +  H +            L QL  F +
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN-----------LAQLLLFAQ 114

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                                IC     G+ YLHS   IHRD+ A N+LL     VK+ D
Sbjct: 115 Q--------------------IC----EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150

Query: 339 FGSAS----------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           FG A           ++   +S V   +W A E    + E ++    DVWS G+T  EL 
Sbjct: 151 FGLAKAVPEGHEYYRVREDGDSPV---FWYAVE---CLKENKFSYASDVWSFGVTLYELL 204

Query: 389 ERKPPY 394
                 
Sbjct: 205 THCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 39/208 (18%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH 71
           +HP  +    C+  +     VMEY  G    ++ +H     E       + V+ GL YLH
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDL-MMHIHTDVFSEPRAVFYAACVVLGLQYLH 118

Query: 72  SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPYWMAPEVIL 123
               ++RD+K  N+LL   G VK+ADFG     C           +F GTP ++APEV+ 
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFG----LCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 124 AMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFEDLREIGHGSFGA 177
              E  Y   VD W LG+         I E+      F  +D E++F+ +          
Sbjct: 175 ---ETSYTRAVDWWGLGVL--------IYEMLVGESPFPGDDEEEVFDSIVN------DE 217

Query: 178 VYYARCLVSREIVAIKKMSYLGKQCAEK 205
           V Y R L SRE ++I  M  L ++  E+
Sbjct: 218 VRYPRFL-SREAISI--MRRLLRRNPER 242

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 85.9 bits (212), Expect = 4e-17
 Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 62/278 (22%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E     +E +++IG+G FG V+  +   ++E    K +SY G +  EK + ++ E+  
Sbjct: 7   DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNV 65

Query: 216 LRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           +R+LKH N + Y   +L   +   +++ME+C   A D               +   +Q  
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQKLYILMEFC--DAGD---------------LSRNIQ-- 106

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-------IHRDVKAGNI 326
           KC+     +F        ++E  I  I   +L  L Y H+L         +HRD+K  NI
Sbjct: 107 KCYK----MFG------KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI 156

Query: 327 LLTETGT------------------VKLADFG---SASIKCPANSFVGTPYWMAPEVILA 365
            L+ TG                    K+ DFG   +  I+  A+S VGTPY+ +PE++L 
Sbjct: 157 FLS-TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL- 214

Query: 366 MDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
            +   YD K D+W+LG    EL   K P+   N  S L
Sbjct: 215 HETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 14/145 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            L+ +L HP+ I   G    D    L +E+  G +   +       KE  I      +LR
Sbjct: 55  RLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR 114

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGT-VKLADFGSASIKCPAN---------SFVGTPY 115
           GL+YLH    IHRDVK  N+L+  TG  +++ADFG+A  +  A            +GT  
Sbjct: 115 GLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA-ARLAAKGTGAGEFQGQLLGTIA 173

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLG 140
           +MAPEV+      QY    DVWS+G
Sbjct: 174 FMAPEVLRGE---QYGRSCDVWSVG 195

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 82.7 bits (204), Expect = 5e-17
 Identities = 53/155 (34%), Positives = 78/155 (50%), Gaps = 30/155 (19%)

Query: 13  HPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYL 70
           HPN + YR  ++ D+  W+V  +   GSA D+I  H    + E  IA I  GVL+ L+Y+
Sbjct: 58  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117

Query: 71  HSLGRIHRDVKAGNILLTETGTVKLA-------------------DFGSASIKCPANSFV 111
           H +G +HR VKA +IL++  G V L+                   DF   S+K       
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP---- 173

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL 146
               W++PEV+    +G YD K D++S+GIT   L
Sbjct: 174 ----WLSPEVLQQNLQG-YDAKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 59/216 (27%), Positives = 84/216 (38%), Gaps = 45/216 (20%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-ILKEIRFLRQLKHPNTIEYR 228
           IG G FG V         + VA+K +     +     A   L E   +  L+HPN ++  
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCL-----KDDSTAAQAFLAEASVMTTLRHPNLVQLL 66

Query: 229 GCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
           G  L+ +  ++V EY   GS  D +      R   V      L Q   F           
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAV----ITLAQQLGFALD-------- 110

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP 347
                       +C G    + YL     +HRD+ A N+L++E    K++DFG A     
Sbjct: 111 ------------VCEG----MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154

Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGI 382
                  P  W APE   A+ E ++  K DVWS GI
Sbjct: 155 GQDSGKLPVKWTAPE---ALREKKFSTKSDVWSFGI 187

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 82.7 bits (205), Expect = 6e-17
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 17/144 (11%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ + H N I     +    +       +LV        ++I++  K  L ++ I  + 
Sbjct: 67  LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLV 124

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYW 116
             +LRGL Y+HS G IHRD+K  NI + E   +K+ DFG A      +     +V T ++
Sbjct: 125 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVATRWY 181

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
            APE++L  +   Y+  VD+WS+G
Sbjct: 182 RAPEIML--NWMHYNQTVDIWSVG 203

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 38/233 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  + +IG G++G VY  R   + +IVA+KK+  L  +     +  ++EI  L++L+HPN
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR-LESEEEGVPSTAIREISLLKELQHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +  +   +++   +L+                   EF    +   L  L          
Sbjct: 61  IVCLQDVLMQESRLYLIF------------------EFLSMDLKKYLDSLP--------- 93

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                 + +  E + +    +L+G+ + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 94  ----KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           +   P   +   V T ++ APEV+L     +Y   VD+WS+G    E+A +KP
Sbjct: 150 AFGIPVRVYTHEVVTLWYRAPEVLLG--SPRYSTPVDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 67/250 (26%), Positives = 116/250 (46%), Gaps = 42/250 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE L  +G G++G V   R   ++EIVAIKK     ++  E     L+E++ LR LK  N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD-SEENEEVKETTLRELKMLRTLKQEN 61

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +E +  + R    +LV EY             +E+        N L+ L          
Sbjct: 62  IVELKEAFRRRGKLYLVFEY-------------VEK--------NMLELL---------- 90

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
             E     +  E++ +    +++ +++ H    +HRD+K  N+L++    +KL DFG A 
Sbjct: 91  --EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148

Query: 343 --SIKCPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
             S    AN   +V T ++ +PE++L      Y   VD+WS+G    EL++ +P +   +
Sbjct: 149 NLSEGSNANYTEYVATRWYRSPELLLG---APYGKAVDMWSVGCILGELSDGQPLFPGES 205

Query: 399 AMSALYHIAQ 408
            +  L+ I +
Sbjct: 206 EIDQLFTIQK 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 45/138 (32%), Positives = 77/138 (55%), Gaps = 6/138 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L+QL+H N +     + R    +LV E+   +  D +E +   L E  +      +LRG
Sbjct: 53  MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRG 112

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANS---FVGTPYWMAPEVI 122
           + + HS   IHRD+K  NIL++++G VKL DFG A ++  P      +V T ++ APE++
Sbjct: 113 IEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172

Query: 123 LAMDEGQYDGKVDVWSLG 140
           +   + +Y   VD+W++G
Sbjct: 173 VG--DTKYGRAVDIWAVG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 48/139 (34%), Positives = 73/139 (52%), Gaps = 6/139 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L +   P  + + G +  D    + ME+  G + D +    + + EE +  +   VLRG
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115

Query: 67  LNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPYWMAPEVIL 123
           L YL    +I HRDVK  NIL+   G +KL DFG +   I   ANSFVGT  +M+PE   
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--- 172

Query: 124 AMDEGQYDGKVDVWSLGIT 142
            +    Y  + D+WS+G++
Sbjct: 173 RLQGTHYSVQSDIWSMGLS 191

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 81.9 bits (202), Expect = 1e-16
 Identities = 47/141 (33%), Positives = 75/141 (53%), Gaps = 12/141 (8%)

Query: 7   LLRQLKHPNTIEYRGCY-----LRD-HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ ++H N I     +       +    +LVM Y     +D+ ++   PL E+++  + 
Sbjct: 67  LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ---TDLQKIMGHPLSEDKVQYLV 123

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAP 119
             +L GL Y+HS G IHRD+K GN+ + E   +K+ DFG A         +V T ++ AP
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAP 183

Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           EVIL  +   Y+  VD+WS+G
Sbjct: 184 EVIL--NWMHYNQTVDIWSVG 202

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 72/251 (28%), Positives = 99/251 (39%), Gaps = 70/251 (27%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK--EIRFLRQLK- 220
           F  L  +G G FG V  A    + E+ AIK         A K  DI+   E+  L   K 
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIK---------ALKKGDIIARDEVESLMCEKR 51

Query: 221 ---------HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
                    HP  +    C+  +     VMEY  G   D++         H+        
Sbjct: 52  IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG--DLM--------MHI-------- 93

Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
               F+E  A+F               A C  V+ GL YLH    ++RD+K  N+LL   
Sbjct: 94  HTDVFSEPRAVF--------------YAAC--VVLGLQYLHENKIVYRDLKLDNLLLDTE 137

Query: 332 GTVKLADFGSASIKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           G VK+ADFG     C           +F GTP ++APEV+    E  Y   VD W LG+ 
Sbjct: 138 GFVKIADFG----LCKEGMGFGDRTSTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVL 190

Query: 384 CIELAERKPPY 394
             E+   + P+
Sbjct: 191 IYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 82.0 bits (202), Expect = 1e-16
 Identities = 75/237 (31%), Positives = 103/237 (43%), Gaps = 47/237 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEKWADILKEIR-FLRQLKHPNTI 225
           IG GSFG V  AR     +  A+K   K + L K+  EK   I+ E    L+ +KHP  +
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEK--HIMSERNVLLKNVKHPFLV 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                +      + V++Y  G           E  +H       LQ+ +CF E  A F  
Sbjct: 60  GLHFSFQTADKLYFVLDYINGG----------ELFYH-------LQRERCFLEPRARF-- 100

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
                     EIA+        L YLHSL  ++RD+K  NILL   G + L DFG     
Sbjct: 101 -------YAAEIAS-------ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146

Query: 346 CPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
              N     F GTP ++APEV   + +  YD  VD W LG    E+    PP+++ N
Sbjct: 147 IEHNGTTSTFCGTPEYLAPEV---LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 62/242 (25%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++E+G G FG V+  +   ++  VAIK ++  G    E   D ++E + + +L HP  ++
Sbjct: 9   MKELGSGQFGVVHLGK-WRAQIKVAIKAINE-GAMSEE---DFIEEAKVMMKLSHPKLVQ 63

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    ++V E                                 F E+  L N+ 
Sbjct: 64  LYGVCTQQKPLYIVTE---------------------------------FMENGCLLNYL 90

Query: 287 VHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----- 340
             ++  L ++ + ++C  V  G+ YL     IHRD+ A N L++ TG VK++DFG     
Sbjct: 91  RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150

Query: 341 -------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 392
                  S+  K P         W  PEV       +Y  K DVWS G+   E+  E K 
Sbjct: 151 LDDEYTSSSGAKFPVK-------WSPPEVFNF---SKYSSKSDVWSFGVLMWEVFTEGKM 200

Query: 393 PY 394
           P+
Sbjct: 201 PF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 46/137 (33%), Positives = 75/137 (54%), Gaps = 11/137 (8%)

Query: 14  PNTIEYRGCYLRDHTAWLVMEYCLGSASD-IIEVHKRPLKEEEIAAICSGVLRGLNYL-- 70
           P  ++  G ++ D   ++ ME  + +  D +++  + P+ E+ +  +   +++ L+YL  
Sbjct: 74  PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132

Query: 71  -HSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANS-FVGTPYWMAPEVILAMD 126
            H +  IHRDVK  NILL  +G VKL DFG +   +   A +   G   +MAPE I   D
Sbjct: 133 KHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190

Query: 127 E-GQYDGKVDVWSLGIT 142
              +YD + DVWSLGI+
Sbjct: 191 PNPKYDIRADVWSLGIS 207

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 46/142 (32%), Positives = 76/142 (53%), Gaps = 10/142 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +LR + HPN ++    +  +    +++E+  G + +          E+ +A +   +L G
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQILSG 180

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVI 122
           + YLH    +HRD+K  N+L+     VK+ADFG + I      P NS VGT  +M+PE I
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERI 240

Query: 123 -LAMDEGQYDGKV-DVWSLGIT 142
              ++ G YDG   D+WSLG++
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVS 262

Length = 353

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 52/155 (33%), Positives = 74/155 (47%), Gaps = 17/155 (10%)

Query: 7   LLRQLKHPNTIEYRGC---------YLRDHTA-WLVMEYCLGSASDIIEVHKRPLKEEEI 56
           +LRQL H N +  +           + +D  A +LV EY       ++E       E+ I
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-----KCPANSFV 111
            +    +L GLNY H    +HRD+K  NILL   G +KLADFG A +       P  + V
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL 146
            T ++  PE++L   E +Y   +DVWS G   G L
Sbjct: 179 ITLWYRPPELLLG--EERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 41/190 (21%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKRPLKEEE 55
           KH N I   G   ++   ++V+EY                   ++ D     +  L +++
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT- 113
           + +    V RG+ +L S   IHRD+ A N+L+TE   +K+ADFG A  I    + +  T 
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH-IDYYRKTT 192

Query: 114 ----PY-WMAPEVILAMDEGQYDGKVDVWSLGI------TPGSLKDPEIAELFDKEDPEK 162
               P  WMAPE   A+ +  Y  + DVWS G+      T G    P I         E+
Sbjct: 193 NGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------EE 242

Query: 163 IFEDLREIGH 172
           +F+ L+E G+
Sbjct: 243 LFKLLKE-GY 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 43/116 (37%), Positives = 59/116 (50%), Gaps = 6/116 (5%)

Query: 31  LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 90
           L+++Y  G         +    E E+    + ++  L++LH LG I+RD+K  NILL   
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE 141

Query: 91  GTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           G V L DFG +          A SF GT  +MAPEVI     G +D  VD WSLG+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG-HDKAVDWWSLGV 196

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 59/221 (26%), Positives = 84/221 (38%), Gaps = 35/221 (15%)

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
           RPL  ++   I   +L GL YLH+   IHRDVK  NI + +   V + D G+A  + P  
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA--QFPVV 209

Query: 350 S-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-------LAERKPPYFNM 397
           +       GT    APEV LA D  +Y+ K D+WS GI   E       + E  P     
Sbjct: 210 APAFLGLAGTVETNAPEV-LARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266

Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ------ND 451
              S   H+ +            +I T+    E  P       +      A         
Sbjct: 267 YVKSCHSHLLK------------IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTR 314

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
            PC Q  +        V   L  + A RPS+  +L + +  
Sbjct: 315 YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355

Length = 357

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 81.3 bits (200), Expect = 2e-16
 Identities = 77/309 (24%), Positives = 123/309 (39%), Gaps = 57/309 (18%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           R IG GS+  V   R   +  I A+K  K   +       W    K + F +   HP  +
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLV 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
               C+  +   + V+EY  G   D++        FH++                     
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGG--DLM--------FHMQ--------------------- 88

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
              +R L EE      + +   LNYLH  G I+RD+K  N+LL   G +KL D+G     
Sbjct: 89  --RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146

Query: 346 C-PANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
             P ++   F GTP ++APE++   D   Y   VD W+LG+   E+   + P F++    
Sbjct: 147 LRPGDTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSP-FDI---- 198

Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP----CLQS 457
               +  +D P   + D+ + + I     R P   ++ A S L      D      C   
Sbjct: 199 ----VGSSDNPDQNTEDY-LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQ 253

Query: 458 SDWSDTFAH 466
           + ++D   H
Sbjct: 254 TGFADIQGH 262

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 73/276 (26%), Positives = 114/276 (41%), Gaps = 81/276 (29%)

Query: 167 LREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           ++++G G+FG+V   R       + E+VA+KK+ +     AE   D  +EI  L+ L+H 
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHD 65

Query: 223 NTIEYRG-CY------LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           N ++Y+G CY      LR     LVMEY   GS  D ++ H                + +
Sbjct: 66  NIVKYKGVCYSAGRRNLR-----LVMEYLPYGSLRDYLQKH----------------RER 104

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                  L+  +             IC    +G+ YL S   +HRD+   NIL+     V
Sbjct: 105 LDHRKLLLYASQ-------------IC----KGMEYLGSKRYVHRDLATRNILVESENRV 147

Query: 335 KLADFGSASI----------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           K+ DFG   +          + P  S +   +W APE   ++ E ++    DVWS G+  
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPI---FWYAPE---SLTESKFSVASDVWSFGVVL 201

Query: 385 IEL-----AERKPPYFNMNAM-------SALYHIAQ 408
            EL         PP   M  M         +YH+ +
Sbjct: 202 YELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 40/231 (17%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G+FG V   R   + +  A+K +        ++ A  L E R L+  +HP     + 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +        VMEY  G           E  FH       L + + F+E  A F      
Sbjct: 63  SFQTHDRLCFVMEYANGG----------ELFFH-------LSRERVFSEDRARF------ 99

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIK 345
                E ++A        L YLHS   ++RD+K  N++L + G +K+ DFG      S  
Sbjct: 100 --YGAEIVSA--------LGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149

Query: 346 CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
               +F GTP ++APEV   +++  Y   VD W LG+   E+   + P++N
Sbjct: 150 ATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 65/267 (24%), Positives = 99/267 (37%), Gaps = 63/267 (23%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKW------- 206
           E P +    + ++G G FG V+          S +  A    +      A K        
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 207 ---ADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFH 262
               D LKE++ L +L  PN     G    D    ++MEY   G                
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD--------------- 105

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
                  L Q     +H A  +      + L    +  + + +  G+ YL SL  +HRD+
Sbjct: 106 -------LNQF--LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL 156

Query: 322 KAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-----------WMAPEVILAMDEGQ 370
              N L+ +  T+K+ADFG +      N +    Y           WMA E +L    G+
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSR-----NLYSSDYYRVQGRAPLPIRWMAWESVLL---GK 208

Query: 371 YDGKVDVWSLGITCIE---LAERKPPY 394
           +  K DVW+ G+T  E   L  R+ PY
Sbjct: 209 FTTKSDVWAFGVTLWEILTLC-REQPY 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 67/242 (27%), Positives = 96/242 (39%), Gaps = 54/242 (22%)

Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKW-----ADILKEIRFLRQLKHPN 223
            IG G+FG V+  R       VA+K        C E       A  L+E R L+Q  HPN
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVK-------SCRETLPPDLKAKFLQEARILKQYSHPN 54

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G   +    ++VME   G                    G+ L  L+         
Sbjct: 55  IVRLIGVCTQKQPIYIVMELVQG--------------------GDFLTFLRTEGPR---- 90

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                   LK +E+  +      G+ YL S   IHRD+ A N L+TE   +K++DFG + 
Sbjct: 91  --------LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR 142

Query: 343 ----SIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFN 396
                +          P  W APE   A++ G+Y  + DVWS GI   E  +    PY N
Sbjct: 143 EEEDGVYASTGGMKQIPVKWTAPE---ALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199

Query: 397 MN 398
           ++
Sbjct: 200 LS 201

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 74/243 (30%), Positives = 107/243 (44%), Gaps = 48/243 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEKWADILKEIR-FLRQLKHPNTI 225
           IG GSFG V  A+        A+K   K + L K+   +   I+ E    L+ LKHP  +
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK---EQNHIMAERNVLLKNLKHPFLV 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                +      + V++Y  G           E  FH       LQ+ +CF E  A F  
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGG----------ELFFH-------LQRERCFLEPRARF-- 100

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----S 341
                     E+A+        + YLHSL  I+RD+K  NILL   G V L DFG     
Sbjct: 101 -------YAAEVAS-------AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 342 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
              +   ++F GTP ++APEV   + +  YD  VD W LG    E+    PP+++ + +S
Sbjct: 147 VEPEETTSTFCGTPEYLAPEV---LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VS 202

Query: 402 ALY 404
            +Y
Sbjct: 203 QMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 71/264 (26%), Positives = 108/264 (40%), Gaps = 44/264 (16%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYR 228
           IG GSFG V  A+  +  +  A+K +        ++   I+ E    L+ +KHP  +   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
             +      + V+++  G           E  FH       LQ+ + F E  A F     
Sbjct: 63  YSFQTTEKLYFVLDFVNGG----------ELFFH-------LQRERSFPEPRARF----- 100

Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASI 344
                    A I S     L YLHS+  ++RD+K  NILL   G V L DFG      + 
Sbjct: 101 -------YAAEIASA----LGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ 149

Query: 345 KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA-- 402
                +F GTP ++APEVI    +  YD  VD W LG    E+    PP++  +      
Sbjct: 150 SDTTTTFCGTPEYLAPEVI---RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206

Query: 403 -LYHIAQNDTPCLQSSDWSVIKTI 425
            + H      P    + WS+++ +
Sbjct: 207 NILHKPLVLRPGASLTAWSILEEL 230

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 35/69 (50%), Positives = 42/69 (60%), Gaps = 4/69 (5%)

Query: 616 LVMEYCL-GSASDIIE---VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           LVME C  GS +D+++      + LKEE IA I    LRGL YLH    IHRD+K  NIL
Sbjct: 86  LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNIL 145

Query: 672 LTETGTVKL 680
           LT+   VKL
Sbjct: 146 LTKNAEVKL 154

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 57/180 (31%), Positives = 85/180 (47%), Gaps = 31/180 (17%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC---LGSASDIIEVHKRPLKEEEIAAICSG 62
           SLL++L HPN +        ++  +LV E+    L    D        L    I +    
Sbjct: 50  SLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMD--SSPLTGLDPPLIKSYLYQ 107

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMA 118
           +L+G+ Y HS   +HRD+K  N+L+   G +KLADFG A +   P  ++   V T ++ A
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 119 PEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           PE++L     QY   VD+WS+G           + PG   D EI +LF      +IF  L
Sbjct: 168 PEILLG--SRQYSTPVDIWSIGCIFAEMVNRRPLFPG---DSEIDQLF------RIFRTL 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 62/248 (25%), Positives = 95/248 (38%), Gaps = 64/248 (25%)

Query: 168 REIGHGSFGAV---YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +E+GHG+FG+V    Y         VA+K +        +K  + L+E   + QL HP  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58

Query: 225 IEYRGCYLRDHTAW-LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
           +   G    +     LVME                    +  +G              L 
Sbjct: 59  VRLIGVCKGE--PLMLVME--------------------LAPLG-------------PLL 83

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SA 342
            +   +R +   ++  +   V  G+ YL S   +HRD+ A N+LL      K++DFG S 
Sbjct: 84  KYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSR 143

Query: 343 SIKCPANSFVGTPY------------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           ++        G+ Y            W APE I   + G++  K DVWS G+T  E    
Sbjct: 144 ALG------AGSDYYRATTAGRWPLKWYAPECI---NYGKFSSKSDVWSYGVTLWEAFSY 194

Query: 391 -KPPYFNM 397
              PY  M
Sbjct: 195 GAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 35/67 (52%), Positives = 43/67 (64%), Gaps = 2/67 (2%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LVMEYC  GS  D+++ ++  L E+EI  I   +L GL YLHS G IHRD+K  NILL  
Sbjct: 68  LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS 127

Query: 675 -TGTVKL 680
             G VKL
Sbjct: 128 DNGKVKL 134

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 45/232 (19%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L ++G G++  V+  R  ++  +VA+K++    ++ A   A  ++E+  L+ LKH N + 
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVT 68

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREF--HVEGMGNRLQQLKCFTEHFALFN 284
                  D +  LV EY             ++++   +++  GN +        +  +F 
Sbjct: 69  LHDIVHTDKSLTLVFEY-------------LDKDLKQYMDDCGNIMS-----MHNVKIFL 110

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +++                 LRGL Y H    +HRD+K  N+L+ E G +KLADFG A  
Sbjct: 111 YQI-----------------LRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153

Query: 345 K-CPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           K  P  ++   V T ++  P+V+L   E  Y  ++D+W +G    E+A  +P
Sbjct: 154 KSVPTKTYSNEVVTLWYRPPDVLLGSSE--YSTQIDMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 79.6 bits (196), Expect = 6e-16
 Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 48/257 (18%)

Query: 147 KDPEIAELFDKEDPEKIFED---LREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQC 202
           KD +  +   +++  K +ED   +R +G GSFG V  A         VAIK+     K  
Sbjct: 13  KDSDSTKEPKRKNKMK-YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK-SKII 70

Query: 203 AEKWAD-ILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREF 261
            +K  D +  E + L  + HP  +   G +  +   +LV+E+ +G             EF
Sbjct: 71  KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG------------EF 118

Query: 262 HVEGMGNRL--QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR 319
                 N+     + CF     +  FE                       YL SL  ++R
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFE-----------------------YLQSLNIVYR 155

Query: 320 DVKAGNILLTETGTVKLADFGSASI-KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 378
           D+K  N+LL + G +K+ DFG A +      +  GTP ++APE++L +  G+     D W
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGK---AADWW 212

Query: 379 SLGITCIELAERKPPYF 395
           +LGI   E+    PP++
Sbjct: 213 TLGIFIYEILVGCPPFY 229

Length = 340

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 80.8 bits (199), Expect = 6e-16
 Identities = 47/124 (37%), Positives = 71/124 (57%), Gaps = 19/124 (15%)

Query: 31  LVMEYCLGSASDIIEVHKR------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 84
           L+MEY  GS  D+ +  K+      P +E E+  +   ++  L+ +HS   +HRD+K+ N
Sbjct: 142 LIMEY--GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199

Query: 85  ILLTETGTVKLADFG-------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 137
           I L  TG +KL DFG       S S+   A+SF GTPY++APE+    +  +Y  K D+W
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDV-ASSFCGTPYYLAPEL---WERKRYSKKADMW 255

Query: 138 SLGI 141
           SLG+
Sbjct: 256 SLGV 259

Length = 478

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 41/233 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ L ++G GS+  VY  R  ++ ++VA+K++    ++ A   A  ++E   L+ LKH N
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA--IREASLLKDLKHAN 64

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +          T  LV EY        ++           G G  +  ++ F   F L 
Sbjct: 65  IVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC---------GGGLSMHNVRLFL--FQL- 112

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                                LRGL Y H    +HRD+K  N+L++E G +KLADFG A 
Sbjct: 113 ---------------------LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Query: 344 IKC-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
            K  P+ ++   V T ++  P+V+L   E  Y   +D+W +G    E+A  +P
Sbjct: 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTE--YSTSLDMWGVGCIFYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 61/250 (24%), Positives = 96/250 (38%), Gaps = 58/250 (23%)

Query: 159 DPEKIFEDLREIGHGSFGAVY--YARCLVSREI---VAIKKMSYLGKQCA--EKWADILK 211
             EKI   +RE+G GSFG VY   A+ +V  E    VAIK ++    + A   +  + L 
Sbjct: 4   PREKI-TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLN 58

Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRL 270
           E   +++    + +   G         +VME    G     +     E E +        
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG---- 114

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                               P   ++   + + +  G+ YL +   +HRD+ A N ++ E
Sbjct: 115 --------------------PPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154

Query: 331 TGTVKLADFGSASIKCPANSFVGTPY------------WMAPEVILAMDEGQYDGKVDVW 378
             TVK+ DFG             T Y            WMAPE   ++ +G +  K DVW
Sbjct: 155 DLTVKIGDFGM------TRDIYETDYYRKGGKGLLPVRWMAPE---SLKDGVFTTKSDVW 205

Query: 379 SLGITCIELA 388
           S G+   E+A
Sbjct: 206 SFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 48/140 (34%), Positives = 75/140 (53%), Gaps = 9/140 (6%)

Query: 7   LLRQLK-HPNTIEYRGCYLRDHTA--WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
            LR+L  HPN +          T    LV E    +  ++I+  KRPL E+ + +    +
Sbjct: 50  ALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL 109

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SI--KCPANSFVGTPYWMAPE 120
           L+ L+++H  G  HRD+K  NIL+ +   +KLADFGS   I  K P   ++ T ++ APE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168

Query: 121 VILAMDEGQYDGKVDVWSLG 140
            +L    G Y  K+D+W++G
Sbjct: 169 CLLTD--GYYGPKMDIWAVG 186

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 64/247 (25%), Positives = 97/247 (39%), Gaps = 63/247 (25%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
            R++G G FG V+      + + VA+K +    K         L+E + +++L+H     
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK-VAVKTL----KPGTMSPEAFLQEAQIMKKLRHDK--- 62

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM--GNRLQQLKCFTEHFALFN 284
                       LV  Y + S  + I   +I  E+    M  G+ L  LK          
Sbjct: 63  ------------LVQLYAVCSEEEPI---YIVTEY----MSKGSLLDFLK---------- 93

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 342
                + L+  ++  + + +  G+ YL S   IHRD+ A NIL+ E    K+ADFG A  
Sbjct: 94  -SGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL 152

Query: 343 ----------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-K 391
                       K P         W APE       G++  K DVWS GI   E+    +
Sbjct: 153 IEDDEYTAREGAKFPIK-------WTAPEAANY---GRFTIKSDVWSFGILLTEIVTYGR 202

Query: 392 PPYFNMN 398
            PY  M 
Sbjct: 203 VPYPGMT 209

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 77.7 bits (192), Expect = 9e-16
 Identities = 35/66 (53%), Positives = 40/66 (60%), Gaps = 2/66 (3%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LVMEYC  G   D +     PL E+E   I   +LRGL YLHS G IHRD+K  NILL E
Sbjct: 75  LVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDE 133

Query: 675 TGTVKL 680
            G VK+
Sbjct: 134 NGVVKI 139

Length = 260

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.3 bits (193), Expect = 9e-16
 Identities = 58/177 (32%), Positives = 88/177 (49%), Gaps = 25/177 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC---LGSASDIIEVHKRPLKEEEIAAICSG 62
           SLL++L HPN ++       ++  +LV E+    L    D   +   PL    I +    
Sbjct: 51  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPL--PLIKSYLFQ 108

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMA 118
           +L+GL + HS   +HRD+K  N+L+   G +KLADFG A +   P  ++   V T ++ A
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 119 PEVILAMDEGQYDGKVDVWSLG------ITPGSL--KDPEIAELFDKEDPEKIFEDL 167
           PE++L      Y   VD+WSLG      +T  +L   D EI +LF      +IF  L
Sbjct: 169 PEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF------RIFRTL 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 80.4 bits (198), Expect = 9e-16
 Identities = 87/354 (24%), Positives = 140/354 (39%), Gaps = 91/354 (25%)

Query: 149 PEIAELFDKEDPEKIFEDLREI-GHGSFGAVYYA-RCLVSREIVAIKKMSYLGKQCAEKW 206
           PE  E+ +  +P +    L  + G     A + A R    +E V + K   L  +    +
Sbjct: 53  PEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKV-VAKFVMLNDERQAAY 111

Query: 207 ADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM 266
           A    E+  L    H   +++   +  D    L+MEY  GS  D+               
Sbjct: 112 AR--SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY--GSGGDL--------------- 152

Query: 267 GNRL--QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 324
            N+   Q+LK   EH           P +E E+  +   ++  L+ +HS   +HRD+K+ 
Sbjct: 153 -NKQIKQRLK---EHL----------PFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSA 198

Query: 325 NILLTETGTVKLADFG-------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 377
           NI L  TG +KL DFG       S S+   A+SF GTPY++APE+    +  +Y  K D+
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDV-ASSFCGTPYYLAPEL---WERKRYSKKADM 254

Query: 378 WSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFN 437
           WSLG+   EL     P+                                  ++R+     
Sbjct: 255 WSLGVILYELLTLHRPF-------------------------------KGPSQRE----- 278

Query: 438 MNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
              M  + +   +  PC      S      +   L+KNPA RP++ +LL  + +
Sbjct: 279 --IMQQVLYGKYDPFPC----PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 37/69 (53%), Positives = 45/69 (65%), Gaps = 5/69 (7%)

Query: 616 LVMEYCL-GSASDIIEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           LVM Y   GS  DI++    P   L E  IA +   VL+GL YLHS G+IHRD+KAGNIL
Sbjct: 76  LVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNIL 134

Query: 672 LTETGTVKL 680
           L E G+VK+
Sbjct: 135 LGEDGSVKI 143

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 13/141 (9%)

Query: 9   RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-----SDIIEVHKRPLKEEEIAAICSGV 63
            QL+HPN + Y   +L +   ++VM+   G+      + + E  +R   EE I  I   +
Sbjct: 64  EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR-FTEERIWNIFVQM 122

Query: 64  LRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAP 119
           +  L YLH   RI HRD+   NI+L E   V + DFG A  K P +   S VGT  +  P
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182

Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           E++     G+   K DVW+ G
Sbjct: 183 EIVKNEPYGE---KADVWAFG 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 43/141 (30%), Positives = 73/141 (51%), Gaps = 8/141 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH--KRPLKEEEIAAICSGV 63
           SL+++LKH N +        ++   LV EY        ++ H  +  L    + +    +
Sbjct: 50  SLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAP 119
           L+G+ + H    +HRD+K  N+L+ + G +KLADFG A +   P N+F   V T ++ AP
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169

Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           +V+L      Y   +D+WS+G
Sbjct: 170 DVLLG--SRTYSTSIDIWSVG 188

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 61/192 (31%), Positives = 90/192 (46%), Gaps = 41/192 (21%)

Query: 30  WLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 87
           + VMEY  G      I +V K   KE       + +  GL +LHS G I+RD+K  N++L
Sbjct: 77  YFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 88  TETGTVKLADFGSASIKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 139
              G +K+ADFG     C  N        +F GTP ++APE+I       Y   VD W+ 
Sbjct: 135 DAEGHIKIADFG----MCKENIFGGKTTRTFCGTPDYIAPEIIAYQ---PYGKSVDWWAF 187

Query: 140 GITPGSLKDPEIAEL------FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK 193
           G+         + E+      FD ED +++F+ + E        V Y + L S+E V+I 
Sbjct: 188 GVL--------LYEMLAGQPPFDGEDEDELFQSIME------HNVSYPKSL-SKEAVSIC 232

Query: 194 KMSYLGKQCAEK 205
           K   L K  A++
Sbjct: 233 K-GLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 1e-15
 Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 51/203 (25%)

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
           R  +E E   +   VL  ++++HS   IHRD+K+ NILL   G VKL DFG + +     
Sbjct: 138 RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV 197

Query: 350 S------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
           S      F GTPY++APE+        Y  K D++SLG+   EL   K P F+   M  +
Sbjct: 198 SDDVGRTFCGTPYYVAPEI---WRRKPYSKKADMFSLGVLLYELLTLKRP-FDGENMEEV 253

Query: 404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT 463
            H                 KT++   +  PP               + +P +Q       
Sbjct: 254 MH-----------------KTLAGRYDPLPP---------------SISPEMQE------ 275

Query: 464 FAHFVSSCLAKNPADRPSSGRLL 486
               V++ L+ +P  RPSS +LL
Sbjct: 276 ---IVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 75/251 (29%), Positives = 106/251 (42%), Gaps = 48/251 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLR-QLKHPNTI 225
           +G GSFG V  A    + E  AIK    L K    +  D+   + E R L    +HP   
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKA---LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                +      + VMEY  G   D++        FH+       Q    F E  A F  
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGG--DLM--------FHI-------QSSGRFDEARARF-- 100

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
                     EI  IC     GL +LH  G I+RD+K  N+LL + G +K+ADFG     
Sbjct: 101 -------YAAEI--IC-----GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146

Query: 346 C----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 A++F GTP ++APE++      +Y+  VD WS G+   E+   + P F+     
Sbjct: 147 MNGEGKASTFCGTPDYIAPEILKGQ---KYNESVDWWSFGVLLYEMLIGQSP-FHGEDED 202

Query: 402 ALYHIAQNDTP 412
            L+    ND P
Sbjct: 203 ELFDSILNDRP 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 61/250 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK--EIRFLRQ--- 218
           FE L+ IG G+FG V   +   + ++ A+K ++        KW ++LK  E    R+   
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN--------KW-EMLKRAETACFREERD 53

Query: 219 -LKHPN-----TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
            L + +      + Y   +  ++  +LVM+Y +G                    G+ L  
Sbjct: 54  VLVNGDRRWITNLHY--AFQDENNLYLVMDYYVG--------------------GDLLTL 91

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L  F +       E   R    E + AI S        +H LG +HRD+K  N+LL + G
Sbjct: 92  LSKFEDRLP----EDMARFYLAEMVLAIDS--------VHQLGYVHRDIKPDNVLLDKNG 139

Query: 333 TVKLADFGS-----ASIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCI 385
            ++LADFGS     A     +N  VGTP +++PE++ AM++  G+Y  + D WSLG+   
Sbjct: 140 HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199

Query: 386 ELAERKPPYF 395
           E+   + P++
Sbjct: 200 EMLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 41/232 (17%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L ++G G++  V+  R  ++  +VA+K++    ++ A   A  ++E+  L+ LKH N + 
Sbjct: 10  LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKNLKHANIVT 67

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                  +    LV EY     SD+ +        +++  GN +        +  +F F+
Sbjct: 68  LHDIIHTERCLTLVFEYL---DSDLKQ--------YLDNCGNLMS-----MHNVKIFMFQ 111

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK- 345
           +                 LRGL+Y H    +HRD+K  N+L+ E G +KLADFG A  K 
Sbjct: 112 L-----------------LRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154

Query: 346 CPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
            P  ++   V T ++  P+V+L   E  Y   +D+W +G    E+A  +P +
Sbjct: 155 VPTKTYSNEVVTLWYRPPDVLLGSTE--YSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 51/280 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + DLR +G GS G V+ A      + VA+KK+     Q        L+EI+ +R+L H N
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDN 63

Query: 224 TI---EYRGCYLRDHTAWLVMEYCLGSASDIIEVH--WIEREFHVEGMGNRLQQLKCFTE 278
            +   E  G    D T              + E++  +I +E+    + N L+Q     E
Sbjct: 64  IVKVYEVLGPSGSDLTE---------DVGSLTELNSVYIVQEYMETDLANVLEQGPLSEE 114

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLA 337
           H  LF ++                 +LRGL Y+HS   +HRD+K  N+ + TE   +K+ 
Sbjct: 115 HARLFMYQ-----------------LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157

Query: 338 DFGSASIKCPANSFVG-------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           DFG A I  P  S  G       T ++ +P ++L+ +   Y   +D+W+ G    E+   
Sbjct: 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLTG 215

Query: 391 KPPYFNMNAMSALYHIA-------QNDTPCLQSSDWSVIK 423
           KP +   + +  +  I        + D   L +   S ++
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVR 255

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 70/252 (27%), Positives = 108/252 (42%), Gaps = 48/252 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLR-QLKHPNTI 225
           +G GSFG V+ A    + +  AIK    L K       D+   + E R L    +HP   
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKA---LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                +      + VMEY  G   D++        FH++                +   F
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGG--DLM--------FHIQ----------------SCHKF 93

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----S 341
           ++ +      EI  IC     GL +LHS G ++RD+K  NILL   G +K+ADFG    +
Sbjct: 94  DLPRATFYAAEI--IC-----GLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146

Query: 342 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                   +F GTP ++APE++L     +Y+  VD WS G+   E+   + P+   +   
Sbjct: 147 MLGDAKTCTFCGTPDYIAPEILLGQ---KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-E 202

Query: 402 ALYHIAQNDTPC 413
            L+   + D PC
Sbjct: 203 ELFQSIRMDNPC 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 55/237 (23%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L ++G G++  VY  R  ++  +VA+K++    ++ A   A  ++E+  L+ LKH N + 
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVT 68

Query: 227 YRGCYLRDHTAWLVMEYC-------LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
                  + +  LV EY        L    + I +H ++                     
Sbjct: 69  LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK--------------------- 107

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
             LF F++                 LRGLNY H    +HRD+K  N+L+ E G +KLADF
Sbjct: 108 --LFLFQL-----------------LRGLNYCHRRKVLHRDLKPQNLLINERGELKLADF 148

Query: 340 GSASIKC-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           G A  K  P  ++   V T ++  P+++L   +  Y  ++D+W +G    E++  +P
Sbjct: 149 GLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD--YSTQIDMWGVGCIFYEMSTGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 34/73 (46%), Positives = 45/73 (61%), Gaps = 3/73 (4%)

Query: 611 LFSPQLVM--EYCLGSASD-IIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 667
            +  +L +  E+C G A D I+   +R L E +I  +C  +L  LN+LHS   IHRD+KA
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131

Query: 668 GNILLTETGTVKL 680
           GNILLT  G VKL
Sbjct: 132 GNILLTLDGDVKL 144

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 55/174 (31%), Positives = 73/174 (41%), Gaps = 48/174 (27%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH----KRP---LKEEEIAAIC 60
           L  L HP        +  +    LVM+YC G      E+     ++P   L EE      
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGG-----ELFRLLQRQPGKCLSEEVARFYA 109

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF-------------------GSA 101
           + VL  L YLH LG ++RD+K  NILL E+G + L+DF                   GS 
Sbjct: 110 AEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 102 S----------IKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
                               NSFVGT  ++APEVI    +G +   VD W+LGI
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DG-HGSAVDWWTLGI 220

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 77.7 bits (191), Expect = 3e-15
 Identities = 49/141 (34%), Positives = 75/141 (53%), Gaps = 11/141 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRD------HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ +KH N I     +  D      H  +LVM + +G+    +  H++ L E+ I  + 
Sbjct: 67  LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MGTDLGKLMKHEK-LSEDRIQFLV 124

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAP 119
             +L+GL Y+H+ G IHRD+K GN+ + E   +K+ DFG A         +V T ++ AP
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAP 184

Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           EVIL      Y   VD+WS+G
Sbjct: 185 EVILNW--MHYTQTVDIWSVG 203

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 55/251 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ I +G++GAVY  R   +R+  A+KK++        +   +  E   L   ++P 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +     +       +VMEY                   VEG G+    LK         
Sbjct: 63  VVSMFCSFETKRHLCMVMEY-------------------VEG-GDCATLLK--------- 93

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
               +   L  +      +  +  L YLH+ G +HRD+K  N+L+T  G +KL DFG   
Sbjct: 94  ----NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149

Query: 341 -----------SASIKCPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
                         I+     F+     GTP ++APEVIL    G+    VD W++GI  
Sbjct: 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIIL 206

Query: 385 IELAERKPPYF 395
            E      P+F
Sbjct: 207 YEFLVGCVPFF 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 77.8 bits (191), Expect = 3e-15
 Identities = 94/354 (26%), Positives = 144/354 (40%), Gaps = 66/354 (18%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 74

Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 129

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 130 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 158

Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 159 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 213

Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY--- 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +     L+   
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGL-TFPKLFPDS 271

Query: 446 -HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
              A ++   L++S   D     +S  L  +PA R S    L H  +     P+
Sbjct: 272 LFPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDEALQHPYINVWYDPA 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.8 bits (189), Expect = 4e-15
 Identities = 68/238 (28%), Positives = 96/238 (40%), Gaps = 57/238 (23%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLR-QLKHPNTI 225
           +G GSFG V  A    + E+ AIK    L K    +  D+   + E R L    KHP   
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIK---VLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
               C+      + VMEY  G   D++                                F
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGG--DLM--------------------------------F 85

Query: 286 EVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           ++ + R   E       + V   L +LH  G I+RD+K  NILL   G  KLADFG    
Sbjct: 86  QIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFG---- 141

Query: 345 KCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
            C           +F GTP ++APE+   + E +Y   VD W+LG+   E+   +PP+
Sbjct: 142 MCKEGILNGVTTTTFCGTPDYIAPEI---LQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 77.0 bits (189), Expect = 4e-15
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 60/243 (24%)

Query: 170 IGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           +G G+FG V          YYA  ++ +E++  K          ++ A  + E R L+  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNT 52

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           +HP     +  +        VMEY  G           E  FH       L + + FTE 
Sbjct: 53  RHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRERVFTEE 95

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A F                  + ++  L YLHS   ++RD+K  N++L + G +K+ DF
Sbjct: 96  RARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 139

Query: 340 G----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           G      S      +F GTP ++APEV   +++  Y   VD W LG+   E+   + P++
Sbjct: 140 GLCKEGISDGATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196

Query: 396 NMN 398
           N +
Sbjct: 197 NQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 67/256 (26%), Positives = 112/256 (43%), Gaps = 47/256 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L +IG G++G VY AR   + ++VA+KK + L           L+EI  L+ L    
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 224 TIEYRGCYLRDHTA--------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
            I        +H          +LV EY                      + + L++   
Sbjct: 62  YIVRLLDV--EHVEEKNGKPSLYLVFEY----------------------LDSDLKK--- 94

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTV 334
               F   N     RPL  + I +    +L+G+ + H  G +HRD+K  N+L+  + G +
Sbjct: 95  ----FMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL 150

Query: 335 KLADFG-SASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           K+AD G   +   P  S+   + T ++ APEV+L      Y   VD+WS+G    E++ +
Sbjct: 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG--STHYSTPVDIWSVGCIFAEMSRK 208

Query: 391 KPPYFNMNAMSALYHI 406
           +P +   + +  L HI
Sbjct: 209 QPLFPGDSELQQLLHI 224

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 45/238 (18%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
            +IG G+FG VY    L     VA+K  +       +     L+E   L+Q  HPN ++ 
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVK--TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
            G  ++    ++VME   G                    G+ L  L+             
Sbjct: 58  IGVCVQKQPIYIVMELVPG--------------------GSLLTFLR------------K 85

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-----SA 342
            K  L  +++  +      G+ YL S   IHRD+ A N L+ E   +K++DFG       
Sbjct: 86  KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEG 145

Query: 343 SIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYFNMN 398
            I   ++     P  W APE   A++ G+Y  + DVWS GI   E  +    PY  M+
Sbjct: 146 GIYTVSDGLKQIPIKWTAPE---ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 49/257 (19%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+ +   L+E+G G FG V Y +    +  VAIK +    K+ +    + ++E + + +
Sbjct: 2   DPKDL-TFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMK 55

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           L H   ++  G   +    ++V EY                      M N      C   
Sbjct: 56  LSHEKLVQLYGVCTKQRPIYIVTEY----------------------MSN-----GC--- 85

Query: 279 HFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              L N+   H +  +  ++  +C  V  G+ YL S   IHRD+ A N L+ + G VK++
Sbjct: 86  ---LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVS 142

Query: 338 DFGSAS--IKCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERK 391
           DFG +   +     S VG+ +   W  PEV+L     ++  K DVW+ G+   E+ +  K
Sbjct: 143 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS---KFSSKSDVWAFGVLMWEVYSLGK 199

Query: 392 PPYFNMNAMSALYHIAQ 408
            PY   N    +  ++Q
Sbjct: 200 MPYERFNNSETVEKVSQ 216

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 53/236 (22%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEI------RFLRQLKH 221
           +G G FG V   +   + ++ A KK+    L K+  E+ A   K+I      RF+  L +
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
               +   C        LVM   L +  D+        ++H+  +G        F E  A
Sbjct: 61  AFETKDDLC--------LVMT--LMNGGDL--------KYHIYNVGEPG-----FPEARA 97

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           +F              A I  G    L +LH    ++RD+K  N+LL + G V+++D G 
Sbjct: 98  IF------------YAAQIICG----LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141

Query: 342 A---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           A             GTP +MAPEV+       YD  VD ++LG T  E+   + P+
Sbjct: 142 AVELKGGKKIKGRAGTPGYMAPEVLQ---GEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 61/255 (23%), Positives = 102/255 (40%), Gaps = 38/255 (14%)

Query: 167 LREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
            RE+G G+FG V+   C        +E+VA+K +       A K  D  +E   L   +H
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK--DFEREAELLTNFQH 67

Query: 222 PNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            N +++ G         +V EY   G  +  +  H  +  F ++   + + +L       
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAF-LKSPDSPMGELT------ 120

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                          ++  I   +  G+ YL S   +HRD+   N L+     VK+ DFG
Sbjct: 121 -------------LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFG 167

Query: 341 -SASIKCPANSFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPP 393
            S  +       VG     P  WM PE I+     ++  + DVWS G+   E+    K P
Sbjct: 168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVVLWEIFTYGKQP 224

Query: 394 YFNMNAMSALYHIAQ 408
           ++ ++    +  I Q
Sbjct: 225 WYGLSNEEVIECITQ 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 55/177 (31%), Positives = 79/177 (44%), Gaps = 25/177 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           SLL+ LKH N +          T  LV EY        ++     L    +      +LR
Sbjct: 55  SLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-PANSF---VGTPYWMAPEV 121
           GL Y H    +HRD+K  N+L++E G +KLADFG A  K  P+ ++   V T ++  P+V
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174

Query: 122 ILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           +L   E  Y   +D+W +G           + PGS  D E       +   KIF  L
Sbjct: 175 LLGSTE--YSTSLDMWGVGCIFYEMATGRPLFPGS-TDVE-------DQLHKIFRVL 221

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 67/239 (28%), Positives = 117/239 (48%), Gaps = 44/239 (18%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR 214
           F K D    +E L ++G GS+  VY  +  V+ ++VA+K +    ++     A  ++E  
Sbjct: 1   FGKADS---YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA--IREAS 55

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            L+ LKH N +          T  LV EY     +D+ +  ++++  H  G+        
Sbjct: 56  LLKGLKHANIVLLHDIIHTKETLTLVFEYV---HTDLCQ--YMDK--HPGGL-------- 100

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
              E+  LF F++                 LRGL+Y+H    +HRD+K  N+L+++TG +
Sbjct: 101 -HPENVKLFLFQL-----------------LRGLSYIHQRYILHRDLKPQNLLISDTGEL 142

Query: 335 KLADFGSASIK-CPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           KLADFG A  K  P++++   V T ++  P+V+L   E  Y   +D+W +G   +E+ +
Sbjct: 143 KLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE--YSTCLDMWGVGCIFVEMIQ 199

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 48/237 (20%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G+FG V   R   S +  A+K +        ++ A  L E R L+  +HP     + 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +        VMEY  G           E  FH+                         +
Sbjct: 63  SFQTKDRLCFVMEYVNGG----------ELFFHLS-----------------------RE 89

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--------S 341
           R   E+      + ++  L+YLHS   ++RD+K  N++L + G +K+ DFG        +
Sbjct: 90  RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149

Query: 342 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           A++K    +F GTP ++APEV   +++  Y   VD W LG+   E+   + P++N +
Sbjct: 150 ATMK----TFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 42/239 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ ++ IG G+FG V   R   S+++ A+K +S          A   +E   +       
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  D   ++VMEY  G   D++ +                           + 
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGG--DLVNL---------------------------MS 135

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           N+++      E+      + V+  L+ +HS+G IHRDVK  N+LL ++G +KLADFG+  
Sbjct: 136 NYDI-----PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC- 189

Query: 344 IKCPANSF------VGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF 395
           +K  AN        VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P++
Sbjct: 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 64/237 (27%), Positives = 94/237 (39%), Gaps = 42/237 (17%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GSFG V   R   ++ I A+K +         +    L E   L Q+  P  +  + 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +      +LV+ +  G              FH       LQ+   F    A F      
Sbjct: 61  SFQSPEKLYLVLAFINGG-----------ELFH------HLQREGRFDLSRARF------ 97

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + +L  L  LH    I+RD+K  NILL   G + L DFG   +     
Sbjct: 98  ----------YTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147

Query: 348 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF--NMNAM 400
              N+F GTP ++APE++L      Y   VD W+LG+   E+    PP++  N+N M
Sbjct: 148 DKTNTFCGTPEYLAPELLLGHG---YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 33/66 (50%), Positives = 47/66 (71%), Gaps = 3/66 (4%)

Query: 616 LVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VME+  G A +DI+  H R + EE+IA +C  VL+ L++LH+ G IHRD+K+ +ILLT 
Sbjct: 93  VVMEFLEGGALTDIV-THTR-MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS 150

Query: 675 TGTVKL 680
            G VKL
Sbjct: 151 DGRVKL 156

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 45/139 (32%), Positives = 72/139 (51%), Gaps = 6/139 (4%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L +   P  + + G +  D    + ME+  G + D +      + E+ +  +   V++G
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 115

Query: 67  LNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPYWMAPEVIL 123
           L YL    +I HRDVK  NIL+   G +KL DFG +   I   ANSFVGT  +M+PE   
Sbjct: 116 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--- 172

Query: 124 AMDEGQYDGKVDVWSLGIT 142
            +    Y  + D+WS+G++
Sbjct: 173 RLQGTHYSVQSDIWSMGLS 191

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 39/152 (25%), Positives = 61/152 (40%), Gaps = 21/152 (13%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           ++ ++KH N +     Y+      LVM+        +++   R L E ++  I   +L G
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-LTESQVKCILLQILNG 131

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYW---------- 116
           LN LH    +HRD+   NI +   G  K+ADFG A                         
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR--RYGYPPYSDTLSKDETMQRREE 189

Query: 117 MAPEVI--------LAMDEGQYDGKVDVWSLG 140
           M  +V+        L M   +Y   VD+WS+G
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221

Length = 335

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 52/147 (35%), Positives = 80/147 (54%), Gaps = 15/147 (10%)

Query: 6   SLLRQLK---HPNTIE-YRGCYL----RDHTAWLVMEYCLGSASDIIEVHKRP-LKEEEI 56
           ++LR L+   HPN +  +  C +    R+    LV E+     +  ++    P +  E I
Sbjct: 53  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 112

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGT 113
             +   +LRGL++LHS   +HRD+K  NIL+T +G +KLADFG A   S +    S V T
Sbjct: 113 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 172

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLG 140
            ++ APEV+L   +  Y   VD+WS+G
Sbjct: 173 LWYRAPEVLL---QSSYATPVDLWSVG 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 43/144 (29%), Positives = 75/144 (52%), Gaps = 12/144 (8%)

Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAI- 59
              S+L +L HP  +     +  ++  + ++E+ +G    + + +  + P    ++A   
Sbjct: 67  QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFP---NDVAKFY 123

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV--GTPYWM 117
            + ++    YLHS   I+RD+K  N+LL   G VK+ DFG A  K P  +F   GTP ++
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLCGTPEYL 182

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APEVI +   G+    VD W++G+
Sbjct: 183 APEVIQSKGHGK---AVDWWTMGV 203

Length = 329

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 19/148 (12%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTA--WLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           LR L H N ++Y+G   +       L+MEY   GS  D ++ H+  +  + +    S + 
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----------KCPANSFVGTP 114
           +G++YL S   IHRD+ A NIL+     VK++DFG A +          K P  S +   
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--- 176

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           +W APE    +   ++    DVWS G+T
Sbjct: 177 FWYAPE---CLRTSKFSSASDVWSFGVT 201

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 60/187 (32%), Positives = 85/187 (45%), Gaps = 29/187 (15%)

Query: 7   LLRQLKHPNTIEYRGCYLR--DHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAA--ICS 61
           +L+ L H N ++Y+GC          L+MEY  LGS  D +  HK  L +  + A  IC 
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC- 117

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS----------IKCPANSFV 111
               G+ YLHS   IHRD+ A N+LL     VK+ DFG A           ++   +S V
Sbjct: 118 ---EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIG 171
              +W A E    + E ++    DVWS G+T   L    +     K+ P K FE++    
Sbjct: 175 ---FWYAVE---CLKENKFSYASDVWSFGVTLYEL----LTHCDSKQSPPKKFEEMIGPK 224

Query: 172 HGSFGAV 178
            G    V
Sbjct: 225 QGQMTVV 231

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 6/142 (4%)

Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKE-EEIAAIC 60
           A +S++  L+HPN ++  G  L+ +  ++V EY   GS  D +    R +    +     
Sbjct: 49  AEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFA 108

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMAP 119
             V  G+ YL     +HRD+ A N+L++E    K++DFG A            P  W AP
Sbjct: 109 LDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAP 168

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E   A+ E ++  K DVWS GI
Sbjct: 169 E---ALREKKFSTKSDVWSFGI 187

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 24/177 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC---LGSASDIIEVHKRPLKEEEIAAICSG 62
           SLL++L+HPN +  +   +++   +L+ E+    L    D +   +  +  E + +    
Sbjct: 51  SLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY-MDAELVKSYLYQ 109

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMA 118
           +L+G+ + HS   +HRD+K  N+L+   G +KLADFG A +   P   +   V T ++ A
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169

Query: 119 PEVILAMDEGQYDGKVDVWSLG------ITPGSL--KDPEIAELFDKEDPEKIFEDL 167
           PEV+L     +Y   VD+WS+G       T   L   D EI +LF      +IF  L
Sbjct: 170 PEVLLG--SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF------RIFRIL 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 43/188 (22%)

Query: 7   LLRQLKHPNTIEYRG-CY------LRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAA 58
           +L+ L+H N ++Y+G CY      LR     LVMEY   GS  D ++ H+  L   ++  
Sbjct: 58  ILKSLQHDNIVKYKGVCYSAGRRNLR-----LVMEYLPYGSLRDYLQKHRERLDHRKLLL 112

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----------KCPAN 108
             S + +G+ YL S   +HRD+   NIL+     VK+ DFG   +          + P  
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172

Query: 109 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKED----PEKIF 164
           S +   +W APE   ++ E ++    DVWS G+         + ELF   D    P   F
Sbjct: 173 SPI---FWYAPE---SLTESKFSVASDVWSFGVV--------LYELFTYSDKSCSPPAEF 218

Query: 165 EDLREIGH 172
             +R +G+
Sbjct: 219 --MRMMGN 224

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 15/146 (10%)

Query: 30  WLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 87
           + VMEY  G      I    +         A  + ++ GL +LH  G I+RD+K  N+LL
Sbjct: 72  FFVMEYLNGGDLMFHIQSSGRFDEARARFYA--AEIICGLQFLHKKGIIYRDLKLDNVLL 129

Query: 88  TETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP 143
            + G +K+ADFG           A++F GTP ++APE++      +Y+  VD WS G+  
Sbjct: 130 DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ---KYNESVDWWSFGVL- 185

Query: 144 GSLKDPEIAEL-FDKEDPEKIFEDLR 168
             L +  I +  F  ED +++F+ + 
Sbjct: 186 --LYEMLIGQSPFHGEDEDELFDSIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 65/241 (26%), Positives = 97/241 (40%), Gaps = 44/241 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ-LKH- 221
           FE L+ +G G++G V+  R +   +   +  M  L K    + A   +  R  RQ L+H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 222 ---PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
              P  +     +  D    L+++Y  G                                
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGG------------------------------- 90

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
              LF     +   KE+E+      ++  L +LH LG I+RD+K  NILL   G V L D
Sbjct: 91  --ELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 148

Query: 339 FG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           FG            A SF GT  +MAP+++   D G +D  VD WS+G+   EL     P
Sbjct: 149 FGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG-HDKAVDWWSMGVLMYELLTGASP 207

Query: 394 Y 394
           +
Sbjct: 208 F 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 75.4 bits (185), Expect = 2e-14
 Identities = 63/240 (26%), Positives = 111/240 (46%), Gaps = 44/240 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E ++ IG G+FG V   R   +R++ A+K +S          A   +E   +     P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  D   ++VMEY  G   D++ +                           + 
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNL---------------------------MS 135

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS-- 341
           N++V   P K        + V+  L+ +HS+G IHRDVK  N+LL ++G +KLADFG+  
Sbjct: 136 NYDV---PEKWARFYT--AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190

Query: 342 -----ASIKCPANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF 395
                  ++C  ++ VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P++
Sbjct: 191 KMNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 73/309 (23%), Positives = 122/309 (39%), Gaps = 59/309 (19%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           R IG GS+  V   R   + +I A+K  K   +       W    K + F +   +P  +
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHV-FEQASSNPFLV 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
               C+      +LV+EY  G   D++        FH++                     
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNG--GDLM--------FHMQ--------------------- 88

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
              +R L EE      + +   LN+LH  G I+RD+K  N+LL   G +KL D+G     
Sbjct: 89  --RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146

Query: 346 C----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                  ++F GTP ++APE++   +   Y   VD W+LG+   E+   + P+  +    
Sbjct: 147 LGPGDTTSTFCGTPNYIAPEILRGEE---YGFSVDWWALGVLMFEMMAGRSPFDII---- 199

Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP----CLQS 457
                   D P + + D+ + + I     R P + ++ A   L      D      C   
Sbjct: 200 -------TDNPDMNTEDY-LFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQ 251

Query: 458 SDWSDTFAH 466
           + +SD  +H
Sbjct: 252 TGFSDIKSH 260

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 12/143 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHT-----AWLVMEYCLGSASDIIEVHKRPLKEEEIAAICS 61
           LLR L H N I  +      H       ++V E        II    + L ++       
Sbjct: 57  LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR-SSQTLSDDHCQYFLY 115

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF----VGTPYWM 117
            +LRGL Y+HS   +HRD+K  N+LL     +K+ DFG A        F    V T ++ 
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175

Query: 118 APEVILAMDEGQYDGKVDVWSLG 140
           APE++L   E  Y   +DVWS+G
Sbjct: 176 APELLLNCSE--YTTAIDVWSVG 196

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 40/102 (39%), Positives = 57/102 (55%), Gaps = 7/102 (6%)

Query: 44  IEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 103
           I V  +PL  + +      +LRGL YLHS G +HRD+K GN+L+     +K+ DFG A +
Sbjct: 93  IIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Query: 104 KCPANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           + P  S      V T Y+ APE++  M    Y   VD+WS+G
Sbjct: 153 EEPDESKHMTQEVVTQYYRAPEIL--MGSRHYTSAVDIWSVG 192

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 9/143 (6%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
           + ++ +L HP  ++  G         LV E+   G  SD +   +    +E +  +C  V
Sbjct: 50  AQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV 109

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--PANSFVGTPY---WMA 118
             G+ YL S   IHRD+ A N L+ E   VK++DFG           S  GT +   W +
Sbjct: 110 CEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS 169

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV       +Y  K DVWS G+
Sbjct: 170 PEVF---SFSKYSSKSDVWSFGV 189

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 48/140 (34%), Positives = 75/140 (53%), Gaps = 6/140 (4%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           +SLL+ LKH N +          T  LV EY        ++ H   L  E +      +L
Sbjct: 54  ASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL 113

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK-CPANSF---VGTPYWMAPE 120
           RGL+Y+H    +HRD+K  N+L+++TG +KLADFG A  K  P++++   V T ++  P+
Sbjct: 114 RGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173

Query: 121 VILAMDEGQYDGKVDVWSLG 140
           V+L   E  Y   +D+W +G
Sbjct: 174 VLLGSTE--YSTCLDMWGVG 191

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 51/241 (21%)

Query: 161 EKIF-EDLREIGHGSFGAV----YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           EK F + +R++G G FG V    Y      + E VA+K +    +      AD+ KEI  
Sbjct: 2   EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEI 59

Query: 216 LRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           LR L H N ++Y+G    D  +   L+ME+ L S S  ++ +    +  +    N  QQL
Sbjct: 60  LRNLYHENIVKYKGICTEDGGNGIKLIMEF-LPSGS--LKEYLPRNKNKI----NLKQQL 112

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +                     IC    +G++YL S   +HRD+ A N+L+     
Sbjct: 113 KYAVQ---------------------IC----KGMDYLGSRQYVHRDLAARNVLVESEHQ 147

Query: 334 VKLADFG-SASIKCPANSF-----VGTP-YWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           VK+ DFG + +I+     +     + +P +W APE ++   + ++    DVWS G+T  E
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI---QSKFYIASDVWSFGVTLYE 204

Query: 387 L 387
           L
Sbjct: 205 L 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 61/259 (23%)

Query: 169 EIGHGSFGAVYYARCLVSREI--VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++G G++G VY A+    ++    A+K++   G   +       +EI  LR+LKHPN I 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-----CREIALLRELKHPNVIA 62

Query: 227 YRGCYLR--DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
            +  +L   D   WL+ +Y       II+ H   +                         
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASK------------------------- 97

Query: 285 FEVHKRPLK--EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLAD 338
              +K+P++     + ++   +L G++YLH+   +HRD+K  NIL+     E G VK+AD
Sbjct: 98  --ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155

Query: 339 FGSASI-KCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
            G A +   P       +  V T ++ APE++L      Y   +D+W++G    EL   +
Sbjct: 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSE 213

Query: 392 PPYFNMNAMSALYHIAQND 410
           P          ++H  Q D
Sbjct: 214 P----------IFHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 24/150 (16%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGV 63
           + ++RQ  HP+ ++  G  + ++  W+VME   LG     ++V+K  L    +      +
Sbjct: 58  AYIMRQFDHPHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SASIKCPANSFV 111
              L YL S   +HRD+ A N+L++    VKL DFG            ++  K P     
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK--- 173

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
               WMAPE I   +  ++    DVW  G+
Sbjct: 174 ----WMAPESI---NFRRFTSASDVWMFGV 196

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 27/230 (11%)

Query: 170 IGHGSFGAVYYA-----RCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +G G FG V  A     +       VA+K +         +  D+L E   L+Q+ HP+ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS--ELRDLLSEFNLLKQVNHPHV 65

Query: 225 IEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
           I+  G   +D    L++EY   GS    +         ++   GNR            L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS--------YLD 117

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           N +   R L   ++ +    + RG+ YL  +  +HRD+ A N+L+ E   +K++DFG + 
Sbjct: 118 NPDE--RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 344 IKCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                +S+V          WMA E   ++ +  Y  + DVWS G+   E+
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIE---SLFDHIYTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 66/245 (26%), Positives = 100/245 (40%), Gaps = 54/245 (22%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           R IG GS+  V       +R I A+K  K   +       W    K + F     HP  +
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLV 59

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
               C+  +   + V+E+  G   D++        FH++                     
Sbjct: 60  GLHSCFQTESRLFFVIEFVSG--GDLM--------FHMQ--------------------- 88

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
              +R L EE      + +   LN+LH  G I+RD+K  N+LL   G +KL D+G     
Sbjct: 89  --RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG----M 142

Query: 346 CPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFN 396
           C           +F GTP ++APE++   D   Y   VD W+LG+   E +A R P  F+
Sbjct: 143 CKEGIRPGDTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSP--FD 197

Query: 397 MNAMS 401
           +  MS
Sbjct: 198 IVGMS 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 74.7 bits (183), Expect = 3e-14
 Identities = 61/240 (25%), Positives = 111/240 (46%), Gaps = 44/240 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++ IG G+FG V   R   S+++ A+K +S          A   +E   +     P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  D   ++VMEY  G   D++ +                           + 
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGG--DLVNL---------------------------MS 135

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
           N++V ++  K        + V+  L+ +HS+G IHRDVK  N+LL + G +KLADFG   
Sbjct: 136 NYDVPEKWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190

Query: 341 ----SASIKCPANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF 395
               +  ++C  ++ VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P++
Sbjct: 191 KMDETGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 70/243 (28%), Positives = 105/243 (43%), Gaps = 55/243 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQL- 219
           F  L  +G GSFG V  A    + E+ AIK    L K    +  D+   + E R L    
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIK---ILKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           K P   +   C+      + VMEY  G   D++        +H++ +G        F E 
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGG--DLM--------YHIQQVGK-------FKEP 101

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A+F            EI+        GL +LH  G I+RD+K  N++L   G +K+ADF
Sbjct: 102 QAVF---------YAAEISV-------GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADF 145

Query: 340 GSASIKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           G     C  +        +F GTP ++APE+I     G+    VD W+ G+   E+   +
Sbjct: 146 G----MCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK---SVDWWAYGVLLYEMLAGQ 198

Query: 392 PPY 394
           PP+
Sbjct: 199 PPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 6/139 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            LL++LKH N +        D    LV EYC        +     +  E + +    +L+
Sbjct: 51  CLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEV 121
           GL + HS   +HRD+K  N+L+ + G +KLADFG A +   P   +   V T ++  P+V
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170

Query: 122 ILAMDEGQYDGKVDVWSLG 140
           +       Y   +D+WS G
Sbjct: 171 LFGAK--LYSTSIDMWSAG 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (182), Expect = 4e-14
 Identities = 72/243 (29%), Positives = 104/243 (42%), Gaps = 62/243 (25%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G+FG VY  R   +R I A+K +S              KEI   +++ H  TI  R 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK-------------KEIVAKKEVAH--TIGERN 45

Query: 230 ---CYLRDHTAWLV-MEYCLGSASDII---------EVHWIEREFHVEGMGNRLQQLKCF 276
                L D + ++V +++   + SD+          E+ W             LQ+   F
Sbjct: 46  ILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFW------------HLQKEGRF 93

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
           +E  A F                I   VL  L +LH    ++RD+K  NILL  TG + L
Sbjct: 94  SEDRAKF---------------YIAELVL-ALEHLHKYDIVYRDLKPENILLDATGHIAL 137

Query: 337 ADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
            DFG +          N+F GT  ++APEV+L  DE  Y   VD WSLG+   E+     
Sbjct: 138 CDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL--DEKGYTKHVDFWSLGVLVFEMCCGWS 195

Query: 393 PYF 395
           P++
Sbjct: 196 PFY 198

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 67/266 (25%), Positives = 106/266 (39%), Gaps = 52/266 (19%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E      + LR++G G FG V+      +   VA+K +    K       D L E + ++
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTL----KPGTMDPKDFLAEAQIMK 56

Query: 218 QLKHPNTIE-YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           +L+HP  I+ Y  C L +   ++V E                                  
Sbjct: 57  KLRHPKLIQLYAVCTLEE-PIYIVTE---------------------------------L 82

Query: 277 TEHFALFNFEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            ++ +L  +      R LK  ++  + + V  G+ YL +   IHRD+ A N+L+ E    
Sbjct: 83  MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNIC 142

Query: 335 KLADFGSASI--KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ADFG A +  +    +  G  +   W APE  L     ++  K DVWS GI   E+  
Sbjct: 143 KVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY---NRFSIKSDVWSFGILLTEIVT 199

Query: 390 R-KPPYFNMNAMSALYHIAQN-DTPC 413
             + PY  M     L  + Q    PC
Sbjct: 200 YGRMPYPGMTNAEVLQQVDQGYRMPC 225

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 74.3 bits (182), Expect = 4e-14
 Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 15/149 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ + H N I     +    +       +LVME    +   +I +    L  E ++ + 
Sbjct: 73  LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLL 129

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWM 117
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A   C       +V T Y+ 
Sbjct: 130 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYR 189

Query: 118 APEVILAMDEGQYDGKVDVWSLGITPGSL 146
           APEVIL M    Y   VD+WS+G   G L
Sbjct: 190 APEVILGM---GYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 31/65 (47%), Positives = 38/65 (58%), Gaps = 2/65 (3%)

Query: 617 VMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           ++EY   GS   II+    P  E  +A     VL+GL YLH  G IHRD+KA NIL T+ 
Sbjct: 77  ILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135

Query: 676 GTVKL 680
           G VKL
Sbjct: 136 GVVKL 140

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 23/182 (12%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII---EVHKRPLKEEEIAAICSGV 63
           +L +   P  +++ G +  +   ++ MEY    + D +    V    + E+ +  I   V
Sbjct: 52  ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111

Query: 64  LRGLNYL-HSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPYWMAPE 120
           ++GL +L      IHRDVK  N+L+   G VKL DFG +   +   A + +G   +MAPE
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPE 171

Query: 121 VIL---AMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFEDLREIG 171
            I          Y  + DVWSLG++        I E+      +  E    IF  L  I 
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLS--------ILEMALGRYPYPPETYANIFAQLSAIV 223

Query: 172 HG 173
            G
Sbjct: 224 DG 225

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.4 bits (180), Expect = 5e-14
 Identities = 66/235 (28%), Positives = 98/235 (41%), Gaps = 47/235 (20%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLR-QLKHPN 223
           R +G GSFG V  AR   S  + A+K    L K    +  D+   + E R L     HP 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVK---VLKKDVILQDDDVECTMTEKRILSLARNHPF 57

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
             +   C+      + VME+  G   D++        FH+       Q+ + F E  A F
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGG--DLM--------FHI-------QKSRRFDEARARF 100

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                             + +   L +LH  G I+RD+K  N+LL   G  KLADFG   
Sbjct: 101 ----------------YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Query: 344 IK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
                    ++F GTP ++APE+   + E  Y   VD W++G+   E+     P+
Sbjct: 145 EGIFNGKTTSTFCGTPDYIAPEI---LQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 63/236 (26%), Positives = 95/236 (40%), Gaps = 44/236 (18%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK----QCAEKWADILKEIRFLRQLKHP 222
           L+ +G G +G V+  R +   +   I  M  L K    +  +  A    E   L  +KHP
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             ++    +      +L++EY  G           E   H+E  G  ++   CF      
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGG----------ELFMHLEREGIFMEDTACF------ 104

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-- 340
                              S +   L +LH  G I+RD+K  NILL   G VKL DFG  
Sbjct: 105 -----------------YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC 147

Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
             S       ++F GT  +MAPE+++    G+    VD WSLG    ++    PP+
Sbjct: 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGK---AVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 16/162 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +LR LK  N +E +  + R    +LV EY   +  +++E     +  E++ +    +++ 
Sbjct: 53  MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA 112

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPAN--SFVGTPYWMAPEV 121
           +++ H    +HRD+K  N+L++    +KL DFG A   S    AN   +V T ++ +PE+
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKD--------PEIAELF 155
           +L      Y   VD+WS+G   G L D         EI +LF
Sbjct: 173 LLG---APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 75/261 (28%), Positives = 109/261 (41%), Gaps = 61/261 (23%)

Query: 170 IGHGSFGAVYYARCLV-----SREI-VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +G G+FG VY           S  I VA+K +   G    EK  + LKE   +    HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEK-KEFLKEAHLMSNFNHPN 60

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++  G  L +   +++ME  L    D++   ++ R+  VE  G  L  LK         
Sbjct: 61  IVKLLGVCLLNEPQYIIME--LMEGGDLL--SYL-RDARVERFGPPLLTLK--------- 106

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG-----TVKLAD 338
                       E+  IC  V +G  YL  +  IHRD+ A N L++E G      VK+ D
Sbjct: 107 ------------ELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154

Query: 339 FGSASIKCPANSFVGTPY------------WMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           FG       A     + Y            WMAPE +L   +G++  + DVWS G+   E
Sbjct: 155 FGL------ARDIYKSDYYRKEGEGLLPVRWMAPESLL---DGKFTTQSDVWSFGVLMWE 205

Query: 387 -LAERKPPYFNMNAMSALYHI 406
            L   + PY  +N    L H+
Sbjct: 206 ILTLGQQPYPALNNQEVLQHV 226

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.1 bits (180), Expect = 7e-14
 Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 25/158 (15%)

Query: 6   SLLRQLKHPN-------TIEYRGCYLRDH-TAWLVMEYCLGSASDIIEVHKRPLKEEEIA 57
            +L++LKHPN        +E      R   + ++V  Y     S ++E     L E +I 
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPAN------- 108
                +L G+NYLH    +HRD+KA NIL+   G +K+ADFG A      P N       
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 109 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
                 + V T ++  PE++L   E +Y   VD+W +G
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLG--ERRYTTAVDIWGIG 214

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.7 bits (178), Expect = 9e-14
 Identities = 50/146 (34%), Positives = 75/146 (51%), Gaps = 15/146 (10%)

Query: 30  WLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 87
           + VMEY  G      I   HK  L      A  + ++ GL +LHS G ++RD+K  NILL
Sbjct: 72  FFVMEYLNGGDLMFHIQSCHKFDLPRATFYA--AEIICGLQFLHSKGIVYRDLKLDNILL 129

Query: 88  TETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP 143
              G +K+ADFG    +        +F GTP ++APE++L     +Y+  VD WS G+  
Sbjct: 130 DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ---KYNTSVDWWSFGVL- 185

Query: 144 GSLKDPEIAEL-FDKEDPEKIFEDLR 168
             L +  I +  F   D E++F+ +R
Sbjct: 186 --LYEMLIGQSPFHGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 19/170 (11%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S +L+  +HP     +  +        VMEY  G         +R   E+      + ++
Sbjct: 46  SRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 105

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPE 120
             L YLHS   ++RD+K  N++L + G +K+ DFG      S      +F GTP ++APE
Sbjct: 106 SALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 121 VILAMDEGQYDGKVDVWSLGITP-----GSLKDPEIAELFDKEDPEKIFE 165
           V   +++  Y   VD W LG+       G L        F  +D EK+FE
Sbjct: 166 V---LEDNDYGRAVDWWGLGVVMYEMMCGRLP-------FYNQDHEKLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 10/142 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP-LKEEEIAAICSGVLR 65
           +L+Q  HPN +   G   +    ++VME   G         + P LK +E+  +      
Sbjct: 46  ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAA 105

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-----SIKCPANSFVGTPY-WMAP 119
           G+ YL S   IHRD+ A N L+TE   +K++DFG +      +          P  W AP
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP 165

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E   A++ G+Y  + DVWS GI
Sbjct: 166 E---ALNYGRYSSESDVWSFGI 184

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 19/151 (12%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           L++ + H N I     +    +       +LVME    +   +I++    L  E ++ + 
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLL 125

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----Y 115
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A  +    SF+ TP     Y
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVVTRY 183

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGITPGSL 146
           + APEVIL M    Y   VD+WS+G   G +
Sbjct: 184 YRAPEVILGMG---YKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 23/156 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVH------KRPLK--EEE 55
           +LLR+LKHPN I  +  +L   D   WL+ +Y       II+ H      K+P++     
Sbjct: 50  ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASI-KCP---- 106
           + ++   +L G++YLH+   +HRD+K  NIL+     E G VK+AD G A +   P    
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 107 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
              +  V T ++ APE++L      Y   +D+W++G
Sbjct: 170 ADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 78/285 (27%), Positives = 116/285 (40%), Gaps = 53/285 (18%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K ++ L+ IG G+ G V  A   V    VA+KK+S     Q   K A   +E+  L+ + 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA--YRELVLLKCVN 78

Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       +LVME    +   +I +     E   E M   L Q+ 
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-----ELDHERMSYLLYQML 133

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 134 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 162

Query: 335 KLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           K+ DFG A   C       +V T Y+ APEVIL M    Y   VD+WS+G    EL +  
Sbjct: 163 KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGELVKGS 219

Query: 392 PPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
             +   + +      I Q  TP  +  +  +  T+ +  E +P Y
Sbjct: 220 VIFQGTDHIDQWNKVIEQLGTPSAEFMN-RLQPTVRNYVENRPQY 263

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 73.2 bits (179), Expect = 1e-13
 Identities = 77/287 (26%), Positives = 120/287 (41%), Gaps = 57/287 (19%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81

Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165

Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+ +
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIK 220

Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
               +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 221 GGVLFPGTDHIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 266

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 69/265 (26%), Positives = 106/265 (40%), Gaps = 36/265 (13%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARC--LVSRE---IVAIKKMSYLGKQCAEKWADILKE 212
           E P    E +R+IG G+FG V+ AR   L+  E   +VA+K +    +  A+  AD  +E
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQRE 58

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIE---VHWIEREFHVEGMGN 268
              + +  HPN ++  G         L+ EY   G  ++ +            H      
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
           +                     PL   E   I   V  G+ YL     +HRD+   N L+
Sbjct: 119 KCGLNPL---------------PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163

Query: 329 TETGTVKLADFG-SASI----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGI 382
            E   VK+ADFG S +I       A+     P  WM PE I      +Y  + DVW+ G+
Sbjct: 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY---NRYTTESDVWAYGV 220

Query: 383 TCIEL-AERKPPYFNMNAMSALYHI 406
              E+ +    PY+ M     +Y++
Sbjct: 221 VLWEIFSYGMQPYYGMAHEEVIYYV 245

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 61/244 (25%)

Query: 170 IGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           +G G+FG V          YYA  ++ +E++  K          ++ A  L E R L+  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTENRVLQNS 52

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           +HP     +  +        VMEY  G           E  FH       L + + F+E 
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGG----------ELFFH-------LSRERVFSED 95

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLAD 338
            A F                  + ++  L+YLHS   + +RD+K  N++L + G +K+ D
Sbjct: 96  RARF----------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITD 139

Query: 339 FG--SASIKCPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG     IK  A   +F GTP ++APEV   +++  Y   VD W LG+   E+   + P+
Sbjct: 140 FGLCKEGIKDGATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Query: 395 FNMN 398
           +N +
Sbjct: 197 YNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 7/133 (5%)

Query: 13  HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS 72
           HP  +    C+  +   + V+EY  G         +R L EE      + +   LNYLH 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 73  LGRIHRDVKAGNILLTETGTVKLADFGSASIKC-PANS---FVGTPYWMAPEVILAMDEG 128
            G I+RD+K  N+LL   G +KL D+G       P ++   F GTP ++APE++   D  
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-- 172

Query: 129 QYDGKVDVWSLGI 141
            Y   VD W+LG+
Sbjct: 173 -YGFSVDWWALGV 184

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.4 bits (180), Expect = 2e-13
 Identities = 45/124 (36%), Positives = 65/124 (52%), Gaps = 17/124 (13%)

Query: 49  RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 108
           R  +E E   +   VL  ++++HS   IHRD+K+ NILL   G VKL DFG + +     
Sbjct: 138 RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV 197

Query: 109 S------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPG---SLKDPEIAELFDKED 159
           S      F GTPY++APE+        Y  K D++SLG+      +LK P     FD E+
Sbjct: 198 SDDVGRTFCGTPYYVAPEI---WRRKPYSKKADMFSLGVLLYELLTLKRP-----FDGEN 249

Query: 160 PEKI 163
            E++
Sbjct: 250 MEEV 253

Length = 496

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 42/122 (34%), Positives = 73/122 (59%), Gaps = 12/122 (9%)

Query: 30  WLVMEYCLGSASDIIEVHKR---PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 86
           +LVM+Y +G   D++ +  +    L E+      + ++  ++ +H LG +HRD+K  N+L
Sbjct: 77  YLVMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVL 134

Query: 87  LTETGTVKLADFGS-----ASIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSL 139
           L + G ++LADFGS     A     +N  VGTP +++PE++ AM++  G+Y  + D WSL
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194

Query: 140 GI 141
           G+
Sbjct: 195 GV 196

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 15/132 (11%)

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           F++++      EI  +C     GL +LHS G I+RD+K  N++L   G +K+ADFG    
Sbjct: 93  FDLYRATFYAAEI--VC-----GLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145

Query: 345 KC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
                  A++F GTP ++APE++  +   +Y   VD WS G+   E+   + P F+ +  
Sbjct: 146 NVFGDNRASTFCGTPDYIAPEILQGL---KYTFSVDWWSFGVLLYEMLIGQSP-FHGDDE 201

Query: 401 SALYHIAQNDTP 412
             L+   + DTP
Sbjct: 202 DELFESIRVDTP 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 68/246 (27%), Positives = 96/246 (39%), Gaps = 56/246 (22%)

Query: 168 REIGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + IG G FG V   R  +   REI VAIK  K  Y  KQ      D L E   + Q  HP
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ----RRDFLSEASIMGQFDHP 65

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N I   G   +     +V EY    + D                      L+     F +
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAF--------------------LRKHDGQFTV 105

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                        ++  +  G+  G+ YL  +G +HRD+ A NIL+      K++DFG +
Sbjct: 106 I------------QLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153

Query: 343 SI--KCPANSFVGT----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKP 392
            +    P  ++       P  W APE I      ++    DVWS GI   E+    ER  
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR---KFTSASDVWSYGIVMWEVMSYGER-- 208

Query: 393 PYFNMN 398
           PY+ M+
Sbjct: 209 PYWEMS 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 72/243 (29%), Positives = 104/243 (42%), Gaps = 55/243 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLR-QL 219
           F  L  +G GSFG V  A    + E+ AIK    L K    +  D+   + E R L    
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIK---ILKKDVVIQDDDVECTMVEKRVLALSG 58

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           K P   +   C+      + VMEY  G   D++        + +       QQ+  F E 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGG--DLM--------YQI-------QQVGRFKEP 101

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A+F            EIA        GL +LHS G I+RD+K  N++L   G +K+ADF
Sbjct: 102 HAVF---------YAAEIAI-------GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADF 145

Query: 340 GSASIKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           G     C  N        +F GTP ++APE+I     G+    VD W+ G+   E+   +
Sbjct: 146 G----MCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK---SVDWWAFGVLLYEMLAGQ 198

Query: 392 PPY 394
            P+
Sbjct: 199 APF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 67/259 (25%), Positives = 112/259 (43%), Gaps = 61/259 (23%)

Query: 169 EIGHGSFGAVYYARCLVSREI--VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++G G++G VY A+    ++    A+K++   G   +       +EI  LR+LKHPN I 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLRELKHPNVIS 62

Query: 227 YRGCYLR--DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
            +  +L   D   WL+ +Y       II+ H   +                         
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK------------------------- 97

Query: 285 FEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLAD 338
              +K+P  L    + ++   +L G++YLH+   +HRD+K  NIL+     E G VK+AD
Sbjct: 98  --ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155

Query: 339 FGSASI-KCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
            G A +   P       +  V T ++ APE++L      Y   +D+W++G    EL   +
Sbjct: 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSE 213

Query: 392 PPYFNMNAMSALYHIAQND 410
           P          ++H  Q D
Sbjct: 214 P----------IFHCRQED 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 23/156 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVH------KRP--LKEEE 55
           +LLR+LKHPN I  +  +L   D   WL+ +Y       II+ H      K+P  L    
Sbjct: 50  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASI-KCP---- 106
           + ++   +L G++YLH+   +HRD+K  NIL+     E G VK+AD G A +   P    
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 107 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
              +  V T ++ APE++L      Y   +D+W++G
Sbjct: 170 ADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 72.7 bits (178), Expect = 2e-13
 Identities = 52/148 (35%), Positives = 73/148 (49%), Gaps = 21/148 (14%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVME------YCLGSASDIIEVHKRPLKEEEIAA 58
           + +LR + HP+ I+ +G +  +    L++       YC  +A       KR +   +I A
Sbjct: 134 AHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA-------KRNIAICDILA 186

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-----FVGT 113
           I   VLR + YLH    IHRD+KA NI +   G V L DFG+A      N+     + GT
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLGI 141
               APE +LA D   Y   VD+WS GI
Sbjct: 247 IATNAPE-LLARDP--YGPAVDIWSAGI 271

Length = 391

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 44/228 (19%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---EIRFLRQLKHPN 223
           L+ +G GSFG V+  R +   +   +  M  L K+   K  D ++   E   L ++ HP 
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPF 59

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  +   +L++++  G   D+                 RL +   FTE    F
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGG--DLF---------------TRLSKEVMFTEEDVKF 102

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
                       E+A         L++LHSLG I+RD+K  NILL E G +KL DFG   
Sbjct: 103 YLA---------ELAL-------ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Query: 341 -SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            S   +  A SF GT  +MAPEV+   +   +    D WS G+   E+
Sbjct: 147 ESIDHEKKAYSFCGTVEYMAPEVV---NRRGHTQSADWWSFGVLMFEM 191

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 31/172 (18%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-------LGSASDIIEVHKRPLKEEEIAA 58
           SLL+ LKH N +        D +  LV EY        +    +I+ +H        +  
Sbjct: 56  SLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN-------VKI 108

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK-CPANSF---VGTP 114
               +LRGL Y H    +HRD+K  N+L+ E G +KLADFG A  K  P  ++   V T 
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELF 155
           ++  P+V+L   E  Y  ++D+W +G           + PGS  + E+  +F
Sbjct: 169 WYRPPDVLLGSSE--YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 47/140 (33%), Positives = 66/140 (47%), Gaps = 19/140 (13%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII-EVHK-RPLKEEEIAAICSGVLRGLNY 69
           KHP       C+      + VMEY  G   D++ ++ + R   E       + V   L +
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGG--DLMFQIQRSRKFDEPRSRFYAAEVTLALMF 111

Query: 70  LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPYWMAPEV 121
           LH  G I+RD+K  NILL   G  KLADFG     C           +F GTP ++APE+
Sbjct: 112 LHRHGVIYRDLKLDNILLDAEGHCKLADFG----MCKEGILNGVTTTTFCGTPDYIAPEI 167

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
              + E +Y   VD W+LG+
Sbjct: 168 ---LQELEYGPSVDWWALGV 184

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 10/145 (6%)

Query: 4   GSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSG 62
            + +L+Q  HPN ++  G  ++    ++VME   G S    +   K  L  +++  +   
Sbjct: 42  EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-----SASIKCPANSFVGTPY-W 116
              G+ YL S   IHRD+ A N L+ E   +K++DFG        I   ++     P  W
Sbjct: 102 AAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE   A++ G+Y  + DVWS GI
Sbjct: 162 TAPE---ALNYGRYTSESDVWSYGI 183

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 45/120 (37%), Positives = 71/120 (59%), Gaps = 11/120 (9%)

Query: 30  WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNILLT 88
           ++VMEY  G   D++ +       E+ A   +  V+  L+ +HS+G IHRDVK  N+LL 
Sbjct: 119 YMVMEYMPGG--DLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 89  ETGTVKLADFGSASIKCPANSF------VGTPYWMAPEVILAM-DEGQYDGKVDVWSLGI 141
           ++G +KLADFG+  +K  AN        VGTP +++PEV+ +   +G Y  + D WS+G+
Sbjct: 177 KSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 62/264 (23%), Positives = 95/264 (35%), Gaps = 67/264 (25%)

Query: 168 REIGHGSFGAVY---YARCLVSREIVAIKKMSYLGKQCAE--KWADILKEIRFLRQLKHP 222
           R IG G FG VY   Y      +  VA+K      K C         L+E   +RQ  HP
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTC----KNCTSPSVREKFLQEAYIMRQFDHP 67

Query: 223 NTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           + ++  G  + ++  W+VME   LG                   + + LQ  K   +  +
Sbjct: 68  HIVKLIGV-ITENPVWIVMELAPLGE------------------LRSYLQVNKYSLDLAS 108

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG- 340
           L  +                  +   L YL S   +HRD+ A N+L++    VKL DFG 
Sbjct: 109 LILY---------------SYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL 153

Query: 341 -----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
                      ++  K P         WMAPE I   +  ++    DVW  G+   E+  
Sbjct: 154 SRYLEDESYYKASKGKLPIK-------WMAPESI---NFRRFTSASDVWMFGVCMWEILM 203

Query: 390 R-KPPYFNMNAMSALYHIAQNDTP 412
               P+  +     +  I   +  
Sbjct: 204 LGVKPFQGVKNNDVIGRIENGERL 227

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 71.8 bits (176), Expect = 4e-13
 Identities = 43/120 (35%), Positives = 56/120 (46%), Gaps = 9/120 (7%)

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           LF +     PL  E+   I   +L  L YLH  G IHRDVK  NI L E     L DFG+
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGA 231

Query: 342 A-----SIKCPAN-SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           A         P    + GT    +PE +LA+D   Y  K D+WS G+   E++ +    F
Sbjct: 232 ACKLDAHPDTPQCYGWSGTLETNSPE-LLALDP--YCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 4e-13
 Identities = 75/281 (26%), Positives = 108/281 (38%), Gaps = 80/281 (28%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ IG G+FG V   +   +  I A+KK+         + +++L++     Q+ H  
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---------RKSEMLEK----EQVAHVR 49

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFAL 282
               R         W+V  Y   S  D   ++ I  E+   G M   L +   FTE    
Sbjct: 50  A--ERDILAEADNPWVVKLYY--SFQDENYLYLI-MEYLPGGDMMTLLMKKDTFTEEETR 104

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-- 340
           F           E I AI S        +H LG IHRD+K  N+LL   G +KL+DFG  
Sbjct: 105 FYIA--------ETILAIDS--------IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148

Query: 341 -----------------------SASIKCP-----------------ANSFVGTPYWMAP 360
                                     I  P                 A S VGTP ++AP
Sbjct: 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAP 208

Query: 361 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
           EV L   +  Y+ + D WSLG+   E+    PP+ + N   
Sbjct: 209 EVFL---QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 36/66 (54%), Positives = 44/66 (66%), Gaps = 2/66 (3%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + MEYC G S  DI  V   PL E +IA +C   L+GL YLHS G++HRD+K  NILLT+
Sbjct: 83  ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD 141

Query: 675 TGTVKL 680
            G VKL
Sbjct: 142 NGDVKL 147

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 69.5 bits (170), Expect = 7e-13
 Identities = 32/89 (35%), Positives = 45/89 (50%), Gaps = 10/89 (11%)

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGT 113
           A I  G    L +LH    ++RD+K  N+LL + G V+++D G A             GT
Sbjct: 102 AQIICG----LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           P +MAPEV+       YD  VD ++LG T
Sbjct: 158 PGYMAPEVLQ---GEVYDFSVDWFALGCT 183

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.1 bits (171), Expect = 7e-13
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 17/169 (10%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S +L+  +HP     +  +        VMEY  G         +R   E+      + ++
Sbjct: 46  SRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV 105

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--------SASIKCPANSFVGTPYW 116
             L+YLHS   ++RD+K  N++L + G +K+ DFG        +A++K    +F GTP +
Sbjct: 106 SALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK----TFCGTPEY 161

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFE 165
           +APEV   +++  Y   VD W LG+    +    +   F  +D EK+FE
Sbjct: 162 LAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 70.8 bits (173), Expect = 7e-13
 Identities = 44/125 (35%), Positives = 73/125 (58%), Gaps = 13/125 (10%)

Query: 26  DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGN 84
           D   ++VMEY  G   D++ +       E+ A   +  V+  L+ +HS+G IHRDVK  N
Sbjct: 115 DRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 172

Query: 85  ILLTETGTVKLADFGS-------ASIKCPANSFVGTPYWMAPEVILAM-DEGQYDGKVDV 136
           +LL ++G +KLADFG+         ++C  ++ VGTP +++PEV+ +   +G Y  + D 
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 137 WSLGI 141
           WS+G+
Sbjct: 231 WSVGV 235

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.0 bits (171), Expect = 7e-13
 Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 11/111 (9%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMA 118
           ++ GL +LHS G I+RD+K  N++L   G +K+ADFG           A++F GTP ++A
Sbjct: 105 IVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIA 164

Query: 119 PEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL-FDKEDPEKIFEDLR 168
           PE++  +   +Y   VD WS G+    L +  I +  F  +D +++FE +R
Sbjct: 165 PEILQGL---KYTFSVDWWSFGVL---LYEMLIGQSPFHGDDEDELFESIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 76/288 (26%), Positives = 114/288 (39%), Gaps = 56/288 (19%)

Query: 168 REIGHGSFGAVYYARCL-VSREIVAIK---KMSYLGKQCAEKWADILKEIRFLRQL-KHP 222
           + +G G+FG V  A    +S+    +K   KM       +E+ A ++ E++ +  L  H 
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA-LMSELKIMSHLGNHE 99

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +   G         ++ EYC                              C+ +   L
Sbjct: 100 NIVNLLGACTIGGPILVITEYC------------------------------CYGD---L 126

Query: 283 FNFEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
            NF   KR   L  E++ +    V +G+ +L S   IHRD+ A N+LLT    VK+ DFG
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186

Query: 341 SA-SIKCPANSFV-GTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPP 393
            A  I   +N  V G       WMAPE I       Y  + DVWS GI   E+ +    P
Sbjct: 187 LARDIMNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGILLWEIFSLGSNP 243

Query: 394 YFNMNAMSALYHIAQN----DTPCLQSSD-WSVIKTISSTAERKPPYF 436
           Y  M   S  Y + +       P    ++ + ++KT       K P F
Sbjct: 244 YPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTF 291

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.6 bits (170), Expect = 9e-13
 Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 20/146 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-------LGSASDIIEVHKRPLKEEEIAA 58
           SLL+ LKH N +        + +  LV EY        L    + I +H   L       
Sbjct: 56  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL------- 108

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-PANSF---VGTP 114
               +LRGLNY H    +HRD+K  N+L+ E G +KLADFG A  K  P  ++   V T 
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL 168

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLG 140
           ++  P+++L   +  Y  ++D+W +G
Sbjct: 169 WYRPPDILLGSTD--YSTQIDMWGVG 192

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 27/66 (40%), Positives = 36/66 (54%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + +EY   GS S +++     L E  I      +L GL YLHS G +HRD+K  NIL+  
Sbjct: 78  IFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS 136

Query: 675 TGTVKL 680
            G VKL
Sbjct: 137 DGVVKL 142

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 42/100 (42%), Positives = 59/100 (59%), Gaps = 12/100 (12%)

Query: 593 VTHLSQHSYNNNNSNYSSLF---SPQ-------LVMEYC-LGSASDIIEVHK-RPLKEEE 640
           +  L ++S++ N + Y   F   SP        LVME+C  GS +D+++  K   LKE+ 
Sbjct: 63  INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           IA IC  +LRGL +LH+   IHRD+K  N+LLTE   VKL
Sbjct: 123 IAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKL 162

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 50/142 (35%), Positives = 69/142 (48%), Gaps = 12/142 (8%)

Query: 8   LRQLKHPNTIEYRG-CYL----RDHTAWLVMEYCLGSASDIIEVHKRP-LKEEEIAAICS 61
           L    HPN +     C      R+    LV E+        ++    P L  E I  +  
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KCPANSFVGTPYWMA 118
             LRGL++LH+   +HRD+K  NIL+T  G VKLADFG A I   +      V T ++ A
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEV+L   +  Y   VD+WS+G
Sbjct: 176 PEVLL---QSTYATPVDMWSVG 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 58/185 (31%), Positives = 86/185 (46%), Gaps = 40/185 (21%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-------LGSASDIIEVHKRPLKEEEIAA 58
           SLL++++H N +  +     +   +LV EY        + S+ D  +  +       I  
Sbjct: 53  SLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------IKT 106

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTE-TGTVKLADFGSA-SIKCPANSF---VGT 113
               +LRG+ Y HS   +HRD+K  N+L+   T  +KLADFG A +   P  +F   V T
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT 166

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEK 162
            ++ APE++L      Y   VD+WS+G           + PG   D EI ELF      K
Sbjct: 167 LWYRAPEILLG--SRHYSTPVDIWSVGCIFAEMVNQKPLFPG---DSEIDELF------K 215

Query: 163 IFEDL 167
           IF  L
Sbjct: 216 IFRIL 220

Length = 294

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 7/144 (4%)

Query: 1   MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           M   + LL+ LKHP  +     +      + V++Y  G         +R   E       
Sbjct: 43  MAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYA 102

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYW 116
           + V   + YLHSL  I+RD+K  NILL   G V L DFG        +   ++F GTP +
Sbjct: 103 AEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEY 162

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           +APEV   + +  YD  VD W LG
Sbjct: 163 LAPEV---LRKEPYDRTVDWWCLG 183

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 41/130 (31%), Positives = 60/130 (46%), Gaps = 22/130 (16%)

Query: 31  LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 90
           +VMEY  G     +  +   L  +      +  +  L YLH+ G +HRD+K  N+L+T  
Sbjct: 78  MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM 137

Query: 91  GTVKLADFG--------------SASIKCPANSFV-----GTPYWMAPEVILAMDEGQYD 131
           G +KL DFG                 I+     F+     GTP ++APEVIL    G+  
Sbjct: 138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK-- 195

Query: 132 GKVDVWSLGI 141
             VD W++GI
Sbjct: 196 -PVDWWAMGI 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 42/137 (30%), Positives = 64/137 (46%), Gaps = 15/137 (10%)

Query: 13  HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS 72
           HP  +    C+  +   + V+E+  G         +R L EE      + +   LN+LH 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114

Query: 73  LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPYWMAPEVILA 124
            G I+RD+K  N+LL   G +KL D+G     C           +F GTP ++APE++  
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYG----MCKEGIRPGDTTSTFCGTPNYIAPEILRG 170

Query: 125 MDEGQYDGKVDVWSLGI 141
            D   Y   VD W+LG+
Sbjct: 171 ED---YGFSVDWWALGV 184

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 45/137 (32%), Positives = 76/137 (55%), Gaps = 13/137 (9%)

Query: 14  PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG-VLRGLNYLHS 72
           P  ++    +  D   ++VMEY  G   D++ +       E+ A   +  V+  L+ +HS
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGG--DLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS 160

Query: 73  LGRIHRDVKAGNILLTETGTVKLADFG-------SASIKCPANSFVGTPYWMAPEVILAM 125
           +G IHRDVK  N+LL + G +KLADFG       +  ++C  ++ VGTP +++PEV+ + 
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC--DTAVGTPDYISPEVLKSQ 218

Query: 126 -DEGQYDGKVDVWSLGI 141
             +G Y  + D WS+G+
Sbjct: 219 GGDGYYGRECDWWSVGV 235

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 44/122 (36%), Positives = 67/122 (54%), Gaps = 13/122 (10%)

Query: 30  WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           ++VME    +   +I++    L  E ++ +   +L G+ +LHS G IHRD+K  NI++  
Sbjct: 105 YIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161

Query: 90  TGTVKLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITPG 144
             T+K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G   G
Sbjct: 162 DCTLKILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMG 216

Query: 145 SL 146
            +
Sbjct: 217 EM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 33/221 (14%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNY 69
           K P   +   C+      + VMEY  G      I +V +   KE       + +  GL +
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFF 116

Query: 70  LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPYWMAPEV 121
           LHS G I+RD+K  N++L   G +K+ADFG     C  N        +F GTP ++APE+
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENMWDGVTTKTFCGTPDYIAPEI 172

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYA 181
           I     G+    VD W+ G+    +   +    F+ ED +++F+ + E  H     V Y 
Sbjct: 173 IAYQPYGK---SVDWWAFGVLLYEMLAGQAP--FEGEDEDELFQSIME--HN----VAYP 221

Query: 182 RCLVSREIVAIKK---MSYLGKQ--CAEKWADILKEIRFLR 217
           + + S+E VAI K     + GK+  C  +    +KE  F R
Sbjct: 222 KSM-SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 40/236 (16%)

Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G FG V  A  L       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 119

Query: 281 ALFNFEVHK---RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++ +     +  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179

Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 79/337 (23%), Positives = 134/337 (39%), Gaps = 69/337 (20%)

Query: 166 DLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           +L ++G GS+  VY     ++ ++VA+K +S   ++     A  ++E   L+ LKH N +
Sbjct: 9   NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLLKGLKHANIV 66

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                     T   V EY          +H    ++ ++  G           +  LF F
Sbjct: 67  LLHDIIHTKETLTFVFEY----------MHTDLAQYMIQHPGG------LHPYNVRLFMF 110

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA--- 342
           ++                 LRGL Y+H    +HRD+K  N+L++  G +KLADFG A   
Sbjct: 111 QL-----------------LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAK 153

Query: 343 SIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM-NAM 400
           SI     +S V T ++  P+V+L   +  Y   +D+W  G   IE+ + +P +  + +  
Sbjct: 154 SIPSQTYSSEVVTLWYRPPDVLLGATD--YSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211

Query: 401 SALYHIAQNDTPCLQSSDWSVIKT--------ISSTAERKPPYFNMNAMSALYHIAQNDT 452
             L  I            W+V+          +S     KP +F       L  + +  +
Sbjct: 212 EQLEKI------------WTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLS 259

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
              ++ D         S  L   P DR S+   L H 
Sbjct: 260 RPPKAED-------LASQMLMMFPKDRISAQDALLHP 289

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 53/172 (30%), Positives = 81/172 (47%), Gaps = 13/172 (7%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           +SLL+ LKH N +          T   V EY     +  +  H   L    +      +L
Sbjct: 54  ASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL 113

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA-NSFVGTPYWMAPE 120
           RGL Y+H    +HRD+K  N+L++  G +KLADFG A   SI     +S V T ++  P+
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPD 173

Query: 121 VILAMDEGQYDGKVDVWSLG-----ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           V+L   +  Y   +D+W  G     +  G    P ++++F  E  EKI+  L
Sbjct: 174 VLLGATD--YSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVL 221

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S    Q         +E+R L+
Sbjct: 14  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLK 71

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 72  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 114

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 115 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161

Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 162 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 211

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 51/245 (20%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQ---CAEKWADILKEIRFLR 217
           FE L+ IG G+FG V   +   + ++ A+K   K   L +    C  +  D+L       
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----G 58

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             +   T+ Y   +  ++  +LVM+Y +G                    G+ L  L  F 
Sbjct: 59  DNQWITTLHY--AFQDENNLYLVMDYYVG--------------------GDLLTLLSKFE 96

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
           +       E   R    E + AI S        +H L  +HRD+K  NIL+   G ++LA
Sbjct: 97  DRLP----EDMARFYLAEMVIAIDS--------VHQLHYVHRDIKPDNILMDMNGHIRLA 144

Query: 338 DFGSA-----SIKCPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAER 390
           DFGS           ++  VGTP +++PE++ AM++G+  Y  + D WSLG+   E+   
Sbjct: 145 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Query: 391 KPPYF 395
           + P++
Sbjct: 205 ETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 34/66 (51%), Positives = 43/66 (65%), Gaps = 2/66 (3%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + ME+C G S  DI  V   PL E +IA +    L+GL YLHS G++HRD+K  NILLT+
Sbjct: 83  ICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141

Query: 675 TGTVKL 680
            G VKL
Sbjct: 142 NGHVKL 147

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 42/100 (42%), Positives = 58/100 (58%), Gaps = 12/100 (12%)

Query: 593 VTHLSQHSYNNNNSNYSSLFSPQ----------LVMEYC-LGSASDIIEVHK-RPLKEEE 640
           +  L ++S++ N + Y   F  +          LVME+C  GS +D+I+  K   LKEE 
Sbjct: 53  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 112

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           IA IC  +LRGL++LH    IHRD+K  N+LLTE   VKL
Sbjct: 113 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 152

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 51/154 (33%), Positives = 74/154 (48%), Gaps = 32/154 (20%)

Query: 7   LLRQLK-HPNTIE----YRGCYLRDHTAWLVMEYCLGSASDII------EVHKRPLKEEE 55
            L++L  HPN ++     +    +D   +LV EY       +I      +VHKR      
Sbjct: 59  FLQELGDHPNIVKLLNVIKAENDKD--IYLVFEYMETDLHAVIRANILEDVHKR------ 110

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANS----- 109
              I   +L+ L Y+HS   IHRD+K  NILL     VKLADFG A S+     +     
Sbjct: 111 --YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 110 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
              +V T ++ APE++L     +Y   VD+WS+G
Sbjct: 169 LTDYVATRWYRAPEILLG--STRYTKGVDMWSVG 200

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 32/85 (37%), Positives = 48/85 (56%), Gaps = 9/85 (10%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-------SFVGTPY 115
           +LRGL Y+HS   +HRD+K  N+LL     +K+ DFG A I  P +        +V T +
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLG 140
           + APE++L      Y   +D+WS+G
Sbjct: 175 YRAPEIMLNSKG--YTKAIDIWSVG 197

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 9/165 (5%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S +L+  +HP     +  +        VMEY  G         +R   EE      + ++
Sbjct: 46  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 105

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPE 120
             L YLHS   ++RD+K  N++L + G +K+ DFG      S      +F GTP ++APE
Sbjct: 106 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 121 VILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFE 165
           V   +++  Y   VD W LG+    +    +   F  +D E++FE
Sbjct: 166 V---LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 9/143 (6%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
           + ++ +L H   ++  G   +    ++V EY   G   + +  H +  +  ++  +C  V
Sbjct: 50  AKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV 109

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPY---WMA 118
             G+ YL S   IHRD+ A N L+ + G VK++DFG +   +     S VG+ +   W  
Sbjct: 110 CEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV+L     ++  K DVW+ G+
Sbjct: 170 PEVLLYS---KFSSKSDVWAFGV 189

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 7/133 (5%)

Query: 13  HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS 72
           +P  +    C+      +LV+EY  G         +R L EE      + +   LN+LH 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 73  LGRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEG 128
            G I+RD+K  N+LL   G +KL D+G            ++F GTP ++APE++   +  
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-- 172

Query: 129 QYDGKVDVWSLGI 141
            Y   VD W+LG+
Sbjct: 173 -YGFSVDWWALGV 184

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 34/201 (16%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVL 64
           L  Q K P   +   C+      + VMEY  G      I +V K   KE +     + + 
Sbjct: 54  LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEIS 111

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPYW 116
            GL +LH  G I+RD+K  N++L   G +K+ADFG     C  +        +F GTP +
Sbjct: 112 VGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFG----MCKEHMVDGVTTRTFCGTPDY 167

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGITPGSL---KDPEIAELFDKEDPEKIFEDLREIGHG 173
           +APE+I     G+    VD W+ G+    +   + P     FD ED +++F+ + E  H 
Sbjct: 168 IAPEIIAYQPYGK---SVDWWAYGVLLYEMLAGQPP-----FDGEDEDELFQSIME--HN 217

Query: 174 SFGAVYYARCLVSREIVAIKK 194
               V Y + L S+E V+I K
Sbjct: 218 ----VSYPKSL-SKEAVSICK 233

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 36/80 (45%), Positives = 47/80 (58%), Gaps = 7/80 (8%)

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEV 121
            L++LHSLG I+RD+K  NILL E G +KL DFG    S   +  A SF GT  +MAPEV
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           +   +   +    D WS G+
Sbjct: 170 V---NRRGHTQSADWWSFGV 186

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 67/250 (26%), Positives = 112/250 (44%), Gaps = 61/250 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK--EIRFLRQLKH 221
           FE ++ IG G+FG V   +   +  I A+K ++        KW ++LK  E    R+ ++
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN--------KW-EMLKRAETACFREERN 53

Query: 222 P---------NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
                      T+ Y   +  ++  +LVM+Y +G                    G+ L  
Sbjct: 54  VLVNGDCQWITTLHY--AFQDENYLYLVMDYYVG--------------------GDLLTL 91

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L  F +       E   R    E + AI S        +H L  +HRD+K  N+LL   G
Sbjct: 92  LSKFEDRLP----EDMARFYIAEMVLAIHS--------IHQLHYVHRDIKPDNVLLDMNG 139

Query: 333 TVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCI 385
            ++LADFGS           ++  VGTP +++PE++ AM++  G+Y  + D WSLG+   
Sbjct: 140 HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199

Query: 386 ELAERKPPYF 395
           E+   + P++
Sbjct: 200 EMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 69.7 bits (170), Expect = 2e-12
 Identities = 102/427 (23%), Positives = 167/427 (39%), Gaps = 100/427 (23%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKM----SYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           IG+GSFG VY A C+ + E VAIKK+     Y  +           E+  ++ L H N I
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----------ELLIMKNLNHINII 122

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDI---IEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                +L+D   +   E    +  +I   + + +I +  H             + +H+A 
Sbjct: 123 -----FLKD---YYYTECFKKNEKNIFLNVVMEFIPQTVHK------------YMKHYAR 162

Query: 283 FNFEVHKRPLKEEEIAA--ICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADF 339
            N   H  PL   ++ +  +C    R L Y+HS    HRD+K  N+L+   T T+KL DF
Sbjct: 163 NN---HALPLFLVKLYSYQLC----RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215

Query: 340 GSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           GSA          S++ + ++ APE++L      Y   +D+WSLG    E+    P +  
Sbjct: 216 GSAKNLLAGQRSVSYICSRFYRAPELMLG--ATNYTTHIDLWSLGCIIAEMILGYPIFSG 273

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +++  L  I Q            V+ T        P    +  M+  Y  A    P ++
Sbjct: 274 QSSVDQLVRIIQ------------VLGT--------PTEDQLKEMNPNY--ADIKFPDVK 311

Query: 457 SSDWSDTFA--------HFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV--------L 500
             D    F         +F+S  L   P  R +    L        R P +        L
Sbjct: 312 PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKL 371

Query: 501 VDLIRRTKAAVRDLDNLNYRKM---------KKILMADGADTESTIDPDDTPDEQAGNDS 551
            DL     A ++++ +   RK+         K+ LM+D  D     D       ++  D+
Sbjct: 372 PDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEFLMSDENDANIIADKISKDFGESNIDA 431

Query: 552 SKSNSIT 558
             +N+  
Sbjct: 432 KNNNAKN 438

Length = 440

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 7/93 (7%)

Query: 593 VTHLSQHSYNNNNSNYSSLFSPQ---LVMEY-CLGSASDIIEVH-KRPLKEEEIAAICSG 647
            +   QH   N     +S        +V      GS  D+++ H    L E  IA I   
Sbjct: 52  TSRQLQH--PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKD 109

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           VL  L+Y+HS G IHR VKA +ILL+  G V L
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSGDGKVVL 142

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 34/69 (49%), Positives = 43/69 (62%), Gaps = 4/69 (5%)

Query: 616 LVMEYCLGSASDII--EVHKRPLK--EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           + MEYC G + D I  +V KR  +  E+ +  I   VL+GL+YLHS   IHRD+K  NIL
Sbjct: 78  IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL 137

Query: 672 LTETGTVKL 680
           LT  G VKL
Sbjct: 138 LTRKGQVKL 146

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 46/144 (31%), Positives = 64/144 (44%), Gaps = 7/144 (4%)

Query: 1   MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           M   + LL+ +KHP  +     +      + V++Y  G         +R   E       
Sbjct: 43  MAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYA 102

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYW 116
           + +   L YLHSL  I+RD+K  NILL   G V L DFG            ++F GTP +
Sbjct: 103 AEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEY 162

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           +APEV+       YD  VD W LG
Sbjct: 163 LAPEVLRKQP---YDRTVDWWCLG 183

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 38/174 (21%)

Query: 10  QLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGL 67
           QL HP  +   G    +     LVME   LG     +   +R +   ++  +   V  G+
Sbjct: 52  QLDHPCIVRLIGVCKGE--PLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGM 108

Query: 68  NYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY----------- 115
            YL S   +HRD+ A N+LL      K++DFG S ++        G+ Y           
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG------AGSDYYRATTAGRWPL 162

Query: 116 -WMAPEVILAMDEGQYDGKVDVWSLGIT----------P-GSLKDPEIAELFDK 157
            W APE I   + G++  K DVWS G+T          P G +K  E+  + + 
Sbjct: 163 KWYAPECI---NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 44/139 (31%), Positives = 67/139 (48%), Gaps = 6/139 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           SLL+ LKH N +        +    LV EY        ++     +    +      +LR
Sbjct: 55  SLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK-CPANSF---VGTPYWMAPEV 121
           GL+Y H    +HRD+K  N+L+ E G +KLADFG A  K  P  ++   V T ++  P+V
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174

Query: 122 ILAMDEGQYDGKVDVWSLG 140
           +L   E  Y   +D+W +G
Sbjct: 175 LLGSTE--YSTPIDMWGVG 191

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 9/143 (6%)

Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAI-CS 61
           A  ++L  +KHP  ++    +      +L++EY L      + + +  +  E+ A    S
Sbjct: 49  AERNILEAVKHPFIVDLIYAFQTGGKLYLILEY-LSGGELFMHLEREGIFMEDTACFYLS 107

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWM 117
            +   L +LH  G I+RD+K  NILL   G VKL DFG    S       ++F GT  +M
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYM 167

Query: 118 APEVILAMDEGQYDGKVDVWSLG 140
           APE+++    G+    VD WSLG
Sbjct: 168 APEILMRSGHGK---AVDWWSLG 187

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 32/66 (48%), Positives = 43/66 (65%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C G A D I +   R L E +I  IC  +L  L YLHS+  IHRD+KAGN+LLT 
Sbjct: 86  IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145

Query: 675 TGTVKL 680
            G +KL
Sbjct: 146 DGDIKL 151

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 23/65 (35%), Positives = 42/65 (64%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEY     S+++   +RPL E ++ +    +L+G+ Y+H+ G +HRD+K  N+L++  
Sbjct: 76  LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135

Query: 676 GTVKL 680
           G +K+
Sbjct: 136 GVLKI 140

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 11/147 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ +KH N I     +    +       +LV        ++I++  K  L +E +  + 
Sbjct: 67  LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHVQFLI 124

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAP 119
             +LRGL Y+HS G IHRD+K  N+ + E   +++ DFG A         +V T ++ AP
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAP 184

Query: 120 EVILAMDEGQYDGKVDVWSLGITPGSL 146
           E++L  +   Y+  VD+WS+G     L
Sbjct: 185 EIML--NWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 44/144 (30%), Positives = 65/144 (45%), Gaps = 7/144 (4%)

Query: 1   MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           M   + LL+ +KHP  +     +      + V+++  G         +R   E       
Sbjct: 43  MAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYA 102

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYW 116
           + +   L YLHS+  ++RD+K  NILL   G V L DFG      +      +F GTP +
Sbjct: 103 AEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEY 162

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           +APEVI    +  YD  VD W LG
Sbjct: 163 LAPEVI---RKQPYDNTVDWWCLG 183

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 4/136 (2%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L  + HP  +   G +  +   +LV+E+ +G          +    +      + ++  
Sbjct: 84  ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-KCPANSFVGTPYWMAPEVILAM 125
             YL SL  ++RD+K  N+LL + G +K+ DFG A +      +  GTP ++APE++L +
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNV 203

Query: 126 DEGQYDGKVDVWSLGI 141
             G+     D W+LGI
Sbjct: 204 GHGK---AADWWTLGI 216

Length = 340

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 11/141 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVL 64
           SL R   HP   +   C+      + VME+  G    +  + K R   E       + + 
Sbjct: 50  SLARN--HPFLTQLYCCFQTPDRLFFVMEFVNG-GDLMFHIQKSRRFDEARARFYAAEIT 106

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPE 120
             L +LH  G I+RD+K  N+LL   G  KLADFG            ++F GTP ++APE
Sbjct: 107 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166

Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           +   + E  Y   VD W++G+
Sbjct: 167 I---LQEMLYGPSVDWWAMGV 184

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 68/263 (25%), Positives = 103/263 (39%), Gaps = 68/263 (25%)

Query: 168 REIGHGSFGAVYYARCLVSREI---VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           R IG G FG VY+   + S       A+K ++ +     E+    LKE   ++   HPN 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNV 58

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +   G  L    + LV                                +  + +H  L N
Sbjct: 59  LSLLGICLPSEGSPLV--------------------------------VLPYMKHGDLRN 86

Query: 285 F---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           F   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E+ TVK+ADFG 
Sbjct: 87  FIRSETHNPTVKD--LIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGL 144

Query: 342 A---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           A                 K P         WMA E   ++   ++  K DVWS G+   E
Sbjct: 145 ARDIYDKEYYSVHNHTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLWE 194

Query: 387 LAER-KPPYFNMNAMSALYHIAQ 408
           L  R  PPY ++++     ++ Q
Sbjct: 195 LMTRGAPPYPDVDSFDITVYLLQ 217

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 25/67 (37%), Positives = 41/67 (61%), Gaps = 3/67 (4%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLT 673
           +V+EY   GS +D+++     + E  +A I   +L+GL+YLH+    IHRD+K  N+L+ 
Sbjct: 76  IVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134

Query: 674 ETGTVKL 680
             G VK+
Sbjct: 135 SKGEVKI 141

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
           S++ Q  HPN I   G   +     ++ EY   GS    +  +       ++  +  G+ 
Sbjct: 57  SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIA 116

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT-----PY-WMA 118
            G+ YL  +  +HRD+ A NIL+      K++DFG +     + +   T     P  W A
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A+   ++    DVWS GI
Sbjct: 177 PE---AIAYRKFTSASDVWSFGI 196

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 14/146 (9%)

Query: 5   SSLLRQLKHPNTIE-YRGCYLRD--HTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAIC 60
           + ++++L+HP  I+ Y  C L +  +    +M+Y  GS  + ++    R LK  ++  + 
Sbjct: 52  AQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDMA 109

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTPY--- 115
           + V  G+ YL +   IHRD+ A N+L+ E    K+ADFG A +  +    +  G  +   
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGI 141
           W APE  L     ++  K DVWS GI
Sbjct: 170 WTAPEAALY---NRFSIKSDVWSFGI 192

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.1 bits (166), Expect = 5e-12
 Identities = 68/225 (30%), Positives = 95/225 (42%), Gaps = 35/225 (15%)

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           L+ +   KR +   +I AI   VLR + YLH    IHRD+KA NI +   G V L DFG+
Sbjct: 169 LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA 228

Query: 342 ASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           A      N+     + GT    APE +LA D   Y   VD+WS GI   E+A      F 
Sbjct: 229 ACFPVDINANKYYGWAGTIATNAPE-LLARDP--YGPAVDIWSAGIVLFEMATCHDSLFE 285

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            + +         D  C   SD   IK I   +   P  F ++A + L  I        +
Sbjct: 286 KDGL---------DGDC--DSDRQ-IKLIIRRSGTHPNEFPIDAQANLDEIYIG--LAKK 331

Query: 457 SSD-------WSDTF------AHFVSSCLAKNPADRPSSGRLLTH 488
           SS        W++ +       + +   LA +   RPS+  LL  
Sbjct: 332 SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376

Length = 391

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 45/241 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ-LKH- 221
           FE L+ +G G++G V+  R +   +   +  M  L K    + A  ++  R  R  L+H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 222 ---PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
              P  +     +  +    L+++Y  G                           + FT 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGG--------------------------EMFTH 95

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
            +   NF        E+E+      ++  L +LH LG ++RD+K  NILL   G V L D
Sbjct: 96  LYQRDNF-------SEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTD 148

Query: 339 FGSA-----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           FG +       K    SF GT  +MAPE+I    +G +   VD WSLGI   EL     P
Sbjct: 149 FGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG--KGGHGKAVDWWSLGILIFELLTGASP 206

Query: 394 Y 394
           +
Sbjct: 207 F 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 65/264 (24%), Positives = 110/264 (41%), Gaps = 56/264 (21%)

Query: 168 REIGHGSFGAVYY--ARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
            EIG+G FG V    A   +S+  V +K++        ++    L+E++  R+L HPN +
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELR--ASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 226 EYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNR--LQQLKCFTEHFAL 282
           +  G  +      LV+E+C LG   + +      R   V  M  +  LQ++ C       
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRS---NRG-MVAQMAQKDVLQRMAC------- 107

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                        E+A+       GL +LH    IH D+   N  LT   +VK+ D+G A
Sbjct: 108 -------------EVAS-------GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Query: 343 SIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKV-------DVWSLGITCIELAE 389
             + P + ++          W+APE+   ++    D          ++WSLG+T  EL  
Sbjct: 148 LEQYPEDYYITKDCHAVPLRWLAPEL---VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Query: 390 RKP-PYFNMNAMSAL-YHIAQNDT 411
               PY +++    L   + + D 
Sbjct: 205 AADQPYPDLSDEQVLKQVVREQDI 228

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 51/285 (17%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +  + ++++G+G FG V+      + + VA+K +   G    E +   L+E + ++
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLK-PGTMSPESF---LEEAQIMK 56

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +L+H                 LV  Y + S   I    +I  E+  +G            
Sbjct: 57  KLRHDK---------------LVQLYAVVSEEPI----YIVTEYMSKG------------ 85

Query: 278 EHFALFNF--EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
              +L +F  +   R LK   +  + + V  G+ Y+  +  IHRD+++ NIL+ +    K
Sbjct: 86  ---SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK 142

Query: 336 LADFGSASI----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           +ADFG A +    +  A      P  W APE  L    G++  K DVWS GI   EL  +
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTK 199

Query: 391 -KPPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKP 433
            + PY  MN    L  + +    PC Q    S+ + +    ++ P
Sbjct: 200 GRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDP 244

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 23/150 (15%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
           + ++ +L HP  ++  G   +    ++V E+   G   + +   +  L ++ + ++C  V
Sbjct: 50  AKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDV 109

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SASIKCPANSFV 111
             G+ YL     IHRD+ A N L++ TG VK++DFG            S+  K P     
Sbjct: 110 CEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK--- 166

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
               W  PEV       +Y  K DVWS G+
Sbjct: 167 ----WSPPEVFNF---SKYSSKSDVWSFGV 189

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 41/116 (35%), Positives = 59/116 (50%), Gaps = 6/116 (5%)

Query: 31  LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 90
           L+++Y  G         +   KE+E+      ++  L +LH LG I+RD+K  NILL   
Sbjct: 82  LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN 141

Query: 91  GTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           G V L DFG            A SF GT  +MAP+++   D G +D  VD WS+G+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG-HDKAVDWWSMGV 196

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 64/230 (27%), Positives = 91/230 (39%), Gaps = 49/230 (21%)

Query: 169 EIGHGSFGAVYYARCLVS--REI-VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           ++G GSFG V       S  + I VA+K +     + ++   D LKE   +  L H N I
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK--SDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 226 EYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
              G  L  H   +V E   LGS  D +                R   L  F     L +
Sbjct: 60  RLYGVVL-THPLMMVTELAPLGSLLDRL----------------RKDALGHFLIS-TLCD 101

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SAS 343
           + V        +IA        G+ YL S   IHRD+ A NILL     VK+ DFG   +
Sbjct: 102 YAV--------QIAN-------GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRA 146

Query: 344 IKCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +    + +V   +      W APE   ++    +    DVW  G+T  E+
Sbjct: 147 LPQNEDHYVMEEHLKVPFAWCAPE---SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 37/93 (39%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 589 HHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSG 647
           H + V  L    Y NN           +++E+C G A D + +  +RPL E +I  +C  
Sbjct: 61  HPNIVKLLDAFYYENN---------LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            L  LNYLH    IHRD+KAGNIL T  G +KL
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKL 144

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 33/65 (50%), Positives = 45/65 (69%), Gaps = 1/65 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           ++MEY LG  S +  +   PL+E  IA I   +L+GL+YLHS  +IHRD+KA N+LL+E 
Sbjct: 79  IIMEY-LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137

Query: 676 GTVKL 680
           G VKL
Sbjct: 138 GDVKL 142

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 35/66 (53%), Positives = 47/66 (71%), Gaps = 3/66 (4%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++MEY  G SA D++E    PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E
Sbjct: 79  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 136

Query: 675 TGTVKL 680
            G VKL
Sbjct: 137 HGEVKL 142

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 30/82 (36%), Positives = 41/82 (50%), Gaps = 10/82 (12%)

Query: 601 YNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-L 658
           YNN + +        + MEY   GS   I++  +  + E  +  I   VL+GL YLH   
Sbjct: 69  YNNGDIS--------ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 659 GRIHRDVKAGNILLTETGTVKL 680
             IHRDVK  NIL+   G +KL
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKL 142

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 42/97 (43%), Positives = 55/97 (56%), Gaps = 13/97 (13%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQL--VMEYCLGSASDIIEVHKRPLKEEEIAA 643
           R +HH  V  +    YN      S L   +L  VME+  G A   I  H R + EE+IA 
Sbjct: 74  RDYHHENVVDM----YN------SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAT 122

Query: 644 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +C  VLR L+YLH+ G IHRD+K+ +ILLT  G +KL
Sbjct: 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKL 159

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 4/137 (2%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +L+++ HP  I            +++MEY  G        +             S ++ 
Sbjct: 53  RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC 112

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAPEVILA 124
            L YLHS   ++RD+K  NILL + G +KL DFG A  ++    +  GTP ++APEVI +
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQS 172

Query: 125 MDEGQYDGKVDVWSLGI 141
               +    VD W+LGI
Sbjct: 173 KGHNK---AVDWWALGI 186

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 24/154 (15%)

Query: 11  LKHPNTIEYRGCYLRDHTAWLV---MEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRG 66
            +HPN +     +      W++   M Y  GSA+ +++ +    + E  I  I  G LRG
Sbjct: 56  FRHPNIMTSWTVFTTGSWLWVISPFMAY--GSANSLLKTYFPEGMSEALIGNILFGALRG 113

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--------------PANSFVG 112
           LNYLH  G IHR++KA +IL++  G V L+  G + +                P  S   
Sbjct: 114 LNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV 171

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL 146
            P W++PE +L  D   Y+ K D++S+GIT   L
Sbjct: 172 LP-WLSPE-LLRQDLYGYNVKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 64/237 (27%), Positives = 97/237 (40%), Gaps = 43/237 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLKH 221
           F   R +G G FG V   +   + ++ A K++    + K+  E  A  L E + L ++  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
              +     Y       LV+    G           + +FH+  MGN       F E  A
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGG----------DLKFHIYNMGN-----PGFEEERA 104

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           LF              A I  G    L  LH    ++RD+K  NILL + G ++++D G 
Sbjct: 105 LF------------YAAEILCG----LEDLHRENTVYRDLKPENILLDDYGHIRISDLGL 148

Query: 342 ASIKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           A +K P        VGT  +MAPEV+   +  +Y    D W LG    E+ E + P+
Sbjct: 149 A-VKIPEGESIRGRVGTVGYMAPEVL---NNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 39/235 (16%)

Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQL 219
           L E+G G+FG VY          +S   VAIK  K +   K       +  +E   +  L
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKV----QQEFRQEAELMSDL 65

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           +HPN +   G   ++    ++ EY   +  D+ E  ++ R      +G            
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYL--AHGDLHE--FLVRNSPHSDVG------------ 109

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A    E  K  L   +   I   +  G+ YL S   +HRD+ A N L+ E  TVK++DF
Sbjct: 110 -AESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDF 168

Query: 340 G-------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G       +   +  + S +    WM PE IL    G++  + D+WS G+   E+
Sbjct: 169 GLSRDIYSADYYRVQSKSLLPV-RWMPPEAILY---GKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 64.8 bits (159), Expect = 2e-11
 Identities = 21/68 (30%), Positives = 34/68 (50%), Gaps = 1/68 (1%)

Query: 614 PQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
             +V EY   G   D +  H   L  +++  +   + +G+ YL S   +HRD+ A N L+
Sbjct: 76  LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV 135

Query: 673 TETGTVKL 680
           TE   VK+
Sbjct: 136 TENLVVKI 143

Length = 258

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 32/155 (20%)

Query: 7   LLRQLK-HPNTI-----------EYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEE 54
           LLR  + H N              +   YL +     +ME  L     II    +PL + 
Sbjct: 54  LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE----LMEADL---HQIIR-SGQPLTDA 105

Query: 55  EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP 114
              +    +L GL Y+HS   +HRD+K GN+L+     +K+ DFG A      N      
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAG 164

Query: 115 Y--------WM-APEVILAMDEGQYDGKVDVWSLG 140
           +        W  APE++L+     Y   +DVWS+G
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQS--YTKAIDVWSVG 197

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 25/152 (16%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKRPLKEEE 55
           KH N I   G   +D   ++++EY                 +  + DI  V    +  ++
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP- 114
           + +    V RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A      + +  T  
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 115 -----YWMAPEVILAMDEGQYDGKVDVWSLGI 141
                 WMAPE   A+ +  Y  + DVWS G+
Sbjct: 199 GRLPVKWMAPE---ALFDRVYTHQSDVWSFGV 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 64/251 (25%), Positives = 96/251 (38%), Gaps = 49/251 (19%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRF 215
            E   E ++ +G G+FG VY    +   E     VAIK +    +   +   +IL E   
Sbjct: 5   KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYV 62

Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           +  + HP+ +   G              CL S   +I                +L  L C
Sbjct: 63  MASVDHPHVVRLLGI-------------CLSSQVQLI---------------TQLMPLGC 94

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             ++        HK  +  + +   C  + +G++YL     +HRD+ A N+L+     VK
Sbjct: 95  LLDYV-----RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVK 149

Query: 336 LADFGSASIKCPANSFV-----GTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A +               P  WMA E IL      Y  K DVWS G+T  EL  
Sbjct: 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVTVWELMT 206

Query: 390 -RKPPYFNMNA 399
               PY  + A
Sbjct: 207 FGAKPYEGIPA 217

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMA 359
           ++ GL +LH    I+RD+K  N+LL   G V+++D G A      +     + GTP +MA
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165

Query: 360 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           PE++    E +YD  VD ++LG+T  E+   + P+
Sbjct: 166 PELLQ--GE-EYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 53/223 (23%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK-----EIRFLRQLKHPNT 224
           +G G+FG V+    L  +  VA+K        C E     LK     E R L+Q  HPN 
Sbjct: 3   LGKGNFGEVFKG-TLKDKTPVAVKT-------CKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++  G   +    ++VME   G                    G+ L  L+          
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPG--------------------GDFLSFLR---------- 84

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
               K  LK +++         G+ YL S   IHRD+ A N L+ E   +K++DFG +  
Sbjct: 85  --KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142

Query: 345 K----CPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGI 382
           +      ++     P  W APE   A++ G+Y  + DVWS GI
Sbjct: 143 EDDGIYSSSGLKQIPIKWTAPE---ALNYGRYSSESDVWSYGI 182

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 41/190 (21%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKRPLKEEE 55
           KH N I   G   ++   ++++EY                      DI +V +  L  ++
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-------IKCPAN 108
           + +    V RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A         K  +N
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 109 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI------TPGSLKDPEIAELFDKEDPEK 162
             +    WMAPE   A+ +  Y  + DVWS GI      T G    P I         E+
Sbjct: 196 GRLPVK-WMAPE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-------EE 244

Query: 163 IFEDLREIGH 172
           +F+ LRE GH
Sbjct: 245 LFKLLRE-GH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 64.4 bits (158), Expect = 3e-11
 Identities = 26/65 (40%), Positives = 34/65 (52%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EYC       ++    PL    I +I   +LRGL Y HS   +HRD+K  NIL+   
Sbjct: 75  LVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD 134

Query: 676 GTVKL 680
           G +KL
Sbjct: 135 GVLKL 139

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 28/71 (39%), Positives = 42/71 (59%), Gaps = 3/71 (4%)

Query: 610 SLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 669
           S+F   LVMEYC    + +++    P  E ++  +   +LRGL YLH    IHRD+K  N
Sbjct: 82  SIF---LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSN 138

Query: 670 ILLTETGTVKL 680
           +LLT+ G +K+
Sbjct: 139 LLLTDKGCLKI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 41/151 (27%), Positives = 55/151 (36%), Gaps = 31/151 (20%)

Query: 13  HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP-------LKEEEIAAICSGVLR 65
           H N +   G        ++++E   G          RP       L  +++      V +
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETG---TVKLADFGSASIKCPANSFVGTPY------- 115
           G  YL     IHRD+ A N LLT  G     K+ADFG       A       Y       
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM------ARDIYRASYYRKGGRA 181

Query: 116 -----WMAPEVILAMDEGQYDGKVDVWSLGI 141
                WM PE  L   +G +  K DVWS G+
Sbjct: 182 MLPIKWMPPEAFL---DGIFTSKTDVWSFGV 209

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 45/144 (31%), Positives = 64/144 (44%), Gaps = 7/144 (4%)

Query: 1   MPAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           M   + LL+ +KHP  +     +      + V++Y  G         +R   E       
Sbjct: 43  MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 102

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYW 116
           + +   L YLHSL  ++RD+K  NILL   G + L DFG        N     F GTP +
Sbjct: 103 AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEY 162

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG 140
           +APEV   + +  YD  VD W LG
Sbjct: 163 LAPEV---LHKQPYDRTVDWWCLG 183

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 11/120 (9%)

Query: 30  WLVMEYCLGSASDIIEVHKR----PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 85
           +LV EY        ++ + R    PL  + I +    +L+G+ + H  G +HRD+K  N+
Sbjct: 82  YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141

Query: 86  LL-TETGTVKLADFG-SASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           L+  + G +K+AD G   +   P  S+   + T ++ APEV+L      Y   VD+WS+G
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG--STHYSTPVDIWSVG 199

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 48/151 (31%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 6   SLLRQLK-------HPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRP-LKEEEI 56
           +L+ +LK       H N +   G         ++ EYC  G   + +   +   L  E++
Sbjct: 84  ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL 143

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFV-GTP 114
            +    V +G+ +L S   IHRD+ A N+LLT    VK+ DFG A  I   +N  V G  
Sbjct: 144 LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203

Query: 115 Y----WMAPEVILAMDEGQYDGKVDVWSLGI 141
                WMAPE I       Y  + DVWS GI
Sbjct: 204 RLPVKWMAPESIF---NCVYTFESDVWSYGI 231

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 39/126 (30%), Positives = 72/126 (57%), Gaps = 12/126 (9%)

Query: 26  DHTAWLVMEYCLGSASDIIEVHKR---PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 82
           ++  +LVM+Y +G   D++ +  +    L E+      + ++  ++ +H L  +HRD+K 
Sbjct: 73  ENNLYLVMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP 130

Query: 83  GNILLTETGTVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAMDEGQ--YDGKVD 135
            NIL+   G ++LADFGS           ++  VGTP +++PE++ AM++G+  Y  + D
Sbjct: 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190

Query: 136 VWSLGI 141
            WSLG+
Sbjct: 191 WWSLGV 196

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 17/148 (11%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICS--- 61
           +++  L H N I   G  L  H   +V E   LGS  D   + K  L    I+ +C    
Sbjct: 48  AIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLD--RLRKDALGHFLISTLCDYAV 104

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY----- 115
            +  G+ YL S   IHRD+ A NILL     VK+ DFG   ++    + +V   +     
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 116 -WMAPEVILAMDEGQYDGKVDVWSLGIT 142
            W APE   ++    +    DVW  G+T
Sbjct: 165 AWCAPE---SLRTRTFSHASDVWMFGVT 189

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 13/145 (8%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP---LKEEEIAAICS 61
           + +L+Q  HPN ++  G   +    ++VME  L    D +   ++    LK +++     
Sbjct: 43  ARILKQYDHPNIVKLIGVCTQRQPIYIVME--LVPGGDFLSFLRKKKDELKTKQLVKFAL 100

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK----CPANSFVGTPY-W 116
               G+ YL S   IHRD+ A N L+ E   +K++DFG +  +      ++     P  W
Sbjct: 101 DAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE   A++ G+Y  + DVWS GI
Sbjct: 161 TAPE---ALNYGRYSSESDVWSYGI 182

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 11/146 (7%)

Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHK-RPLKEEEIAAIC 60
           A ++L++QL+HP  +       ++   +++ EY   GS  D ++  +   L   ++  + 
Sbjct: 50  AEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA 108

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY- 115
           + +  G+ ++     IHRD++A NIL++ET   K+ADFG A +    +  A      P  
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK 168

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGI 141
           W APE   A++ G +  K DVWS GI
Sbjct: 169 WTAPE---AINYGTFTIKSDVWSFGI 191

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 31/65 (47%), Positives = 44/65 (67%), Gaps = 1/65 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           ++MEY LG  S +  +   P  E +IA +   +L+GL+YLHS  +IHRD+KA N+LL+E 
Sbjct: 79  IIMEY-LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ 137

Query: 676 GTVKL 680
           G VKL
Sbjct: 138 GDVKL 142

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 41/146 (28%), Positives = 76/146 (52%), Gaps = 13/146 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRD--HTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGV 63
           +LR L H N ++Y+G    D  +   L+ME+   GS  + +  +K  +  ++       +
Sbjct: 59  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSF-----VGTP-YW 116
            +G++YL S   +HRD+ A N+L+     VK+ DFG + +I+     +     + +P +W
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
            APE ++   + ++    DVWS G+T
Sbjct: 179 YAPECLI---QSKFYIASDVWSFGVT 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 6/79 (7%)

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVI 122
           L +LH    ++RD+K  NILL  TG + L DFG +          N+F GT  ++APEV+
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 123 LAMDEGQYDGKVDVWSLGI 141
           L  DE  Y   VD WSLG+
Sbjct: 169 L--DEKGYTKHVDFWSLGV 185

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 4e-11
 Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 27/149 (18%)

Query: 7   LLRQLKHPNTI-------------EYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLK 52
           LL+ +KH N I             E+   YL  H         +G+  ++I++  K  L 
Sbjct: 69  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL--------MGADLNNIVKCQK--LT 118

Query: 53  EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPANSFV 111
           ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+ DFG A         +V
Sbjct: 119 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 178

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
            T ++ APE++L  +   Y+  VD+WS+G
Sbjct: 179 ATRWYRAPEIML--NWMHYNQTVDIWSVG 205

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 38/235 (16%)

Query: 168 REIGHGSFGAVYYARCL-VSRE------IVAIKKMSYLGKQCAEKWADILKEIRFLRQL- 219
           + +G G FG V  A    + +        VA+K +        +  AD++ E+  ++ + 
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIG 75

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           KH N I   G   ++   ++++EY   +  ++       REF        L+  +     
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEY--AAKGNL-------REF--------LRARRPPGPD 118

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
           +     +V +  L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+ADF
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADF 178

Query: 340 GSAS-------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G A         K  +N  +    WMAPE   A+ +  Y  + DVWS GI   E+
Sbjct: 179 GLARGVHDIDYYKKTSNGRLPVK-WMAPE---ALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 74/262 (28%), Positives = 110/262 (41%), Gaps = 52/262 (19%)

Query: 170 IGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPN 223
           +G G+FG V  A         S   VA+K M   G   +E  A ++ E++ L  +  H N
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVK-MLKEGATASEYKA-LMTELKILIHIGHHLN 72

Query: 224 TIEYRG-CYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGN--RLQQLKC---- 275
            +   G C        +++EYC  G+ S+ +     +RE          R +++K     
Sbjct: 73  VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRS---KRECFSPYRNKSTRKREMKQKEGK 129

Query: 276 -----------------FTEHFALFNFE-------VHKRPLKEEEIAAICSGVLRGLNYL 311
                            F E  +L + E       ++K PL  E++ +    V RG+ +L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189

Query: 312 HSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPY----WMAPEVILA 365
            S   IHRD+ A NILL+E   VK+ DFG A    K P     G       WMAPE I  
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF- 248

Query: 366 MDEGQYDGKVDVWSLGITCIEL 387
             +  Y  + DVWS G+   E+
Sbjct: 249 --DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 44/231 (19%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G FGAV        +  VA+K +     +C       L+E   + +L H N +   G
Sbjct: 14  IGEGEFGAVLQGEYTGQK--VAVKNI-----KCDVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
             L +   ++VME    S  +++          V      + QL  F+            
Sbjct: 67  VILHN-GLYIVMELM--SKGNLVNFLRTRGRALVS-----VIQLLQFSLD---------- 108

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
                         V  G+ YL S   +HRD+ A NIL++E G  K++DFG A +     
Sbjct: 109 --------------VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154

Query: 350 SFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYFNMN 398
                P  W APE   A+   ++  K DVWS G+   E+ +  + PY  M+
Sbjct: 155 DNSKLPVKWTAPE---ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 38/253 (15%)

Query: 169 EIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           E+G G+FG V+ A C        + +VA+K +    +   +   D  +E   L  L+H +
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTVLQHQH 68

Query: 224 TIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            + + G         +V EY   G  +  +  H  + +    G      QL         
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL------- 121

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-S 341
                        ++ AI S +  G+ YL SL  +HRD+   N L+ +   VK+ DFG S
Sbjct: 122 ------------GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169

Query: 342 ASIKCPANSFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYF 395
             I       VG     P  WM PE IL     ++  + D+WS G+   E+    K P++
Sbjct: 170 RDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDIWSFGVVLWEIFTYGKQPWY 226

Query: 396 NMNAMSALYHIAQ 408
            ++   A+  I Q
Sbjct: 227 QLSNTEAIECITQ 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 63.7 bits (156), Expect = 5e-11
 Identities = 29/68 (42%), Positives = 35/68 (51%), Gaps = 4/68 (5%)

Query: 617 VMEYC-LGSASDIIEVHK---RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           VMEY   G  S  I+  K   +P  EE+I      +   L YLHS   +HRD+K  NI L
Sbjct: 77  VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL 136

Query: 673 TETGTVKL 680
           T  G VKL
Sbjct: 137 TSNGLVKL 144

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 41/97 (42%), Positives = 54/97 (55%), Gaps = 13/97 (13%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQL--VMEYCLGSASDIIEVHKRPLKEEEIAA 643
           R + H  V  +    YN      S L   +L  VME+  G A   I  H R + EE+IAA
Sbjct: 72  RDYQHENVVEM----YN------SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAA 120

Query: 644 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +C  VL+ L+ LH+ G IHRD+K+ +ILLT  G VKL
Sbjct: 121 VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKL 157

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 34/66 (51%), Positives = 45/66 (68%), Gaps = 3/66 (4%)

Query: 616 LVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ME+  G A +DI  V +  L EE+IA +C  VL+ L YLHS G IHRD+K+ +ILLT 
Sbjct: 95  VLMEFLQGGALTDI--VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152

Query: 675 TGTVKL 680
            G VKL
Sbjct: 153 DGRVKL 158

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 63.3 bits (155), Expect = 5e-11
 Identities = 21/67 (31%), Positives = 32/67 (47%), Gaps = 1/67 (1%)

Query: 614 PQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
             +VMEY   G     +  ++  L   ++ +    + RG+ YL S   IHRD+ A N L+
Sbjct: 76  LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 135

Query: 673 TETGTVK 679
            E   VK
Sbjct: 136 GENLVVK 142

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 44/142 (30%), Positives = 61/142 (42%), Gaps = 13/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAAICSGV 63
           L++L+H + I            +++ E  L     ++   + P    L    +  +   V
Sbjct: 56  LKRLRHKHLISLFAVCSVGEPVYIITE--LMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPANSFVGT--PY-WMAP 119
             G+ YL     IHRD+ A NIL+ E    K+ADFG A  IK           PY W AP
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E   A   G +  K DVWS GI
Sbjct: 174 E---AASHGTFSTKSDVWSFGI 192

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 26/150 (17%)

Query: 7   LLRQLKHPNTIE-YRGCYLRDHTAWLVMEY-CLGSASDII-EVHKRPLKEEEIAAICSGV 63
           ++++L+H   ++ Y  C   +   ++V EY   GS  D +     + L+  ++  + + +
Sbjct: 54  IMKKLRHDKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA------------SIKCPANSFV 111
             G+ YL S   IHRD+ A NIL+ E    K+ADFG A              K P     
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK--- 169

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
               W APE       G++  K DVWS GI
Sbjct: 170 ----WTAPEAANY---GRFTIKSDVWSFGI 192

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 10/164 (6%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L+  +HP     +  +        VMEY  G         +R   E+      + ++  
Sbjct: 48  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 107

Query: 67  LNYLHSLGRI-HRDVKAGNILLTETGTVKLADFG--SASIKCPAN--SFVGTPYWMAPEV 121
           L+YLHS   + +RD+K  N++L + G +K+ DFG     IK  A   +F GTP ++APEV
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFE 165
              +++  Y   VD W LG+    +    +   F  +D EK+FE
Sbjct: 168 ---LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFE 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 39/126 (30%), Positives = 72/126 (57%), Gaps = 12/126 (9%)

Query: 26  DHTAWLVMEYCLGSASDIIEVHKR---PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 82
           ++  +LVM+Y +G   D++ +  +    L E+      + ++  ++ +H L  +HRD+K 
Sbjct: 73  ENYLYLVMDYYVGG--DLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130

Query: 83  GNILLTETGTVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVD 135
            N+LL   G ++LADFGS           ++  VGTP +++PE++ AM++  G+Y  + D
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190

Query: 136 VWSLGI 141
            WSLG+
Sbjct: 191 WWSLGV 196

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 64/248 (25%), Positives = 97/248 (39%), Gaps = 59/248 (23%)

Query: 167 LRE-IGHGSFGAVYYARCLVSRE--------------IVAIKKMSYLGKQCAEKWADILK 211
           L+E +G G FG V+        E              +VA+K +     + A    D LK
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN--DFLK 66

Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGN-RL 270
           EI+ + +LK+PN I   G  + D    ++ EY                      M N  L
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEY----------------------MENGDL 104

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
            Q     E  + F    +   +    +  +   +  G+ YL SL  +HRD+   N L+  
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164

Query: 331 TGTVKLADFGSASIKCPANSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWS 379
             T+K+ADFG +      N + G  Y           WMA E IL    G++    DVW+
Sbjct: 165 HYTIKIADFGMSR-----NLYSGDYYRIQGRAVLPIRWMAWESILL---GKFTTASDVWA 216

Query: 380 LGITCIEL 387
            G+T  E+
Sbjct: 217 FGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 7/143 (4%)

Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTA-WLVMEY-CLGSASDIIEVHKRP-LKEEEIAAI 59
           A +S++ QL+H N ++  G  + +    ++V EY   GS  D +    R  L  + +   
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMA 118
              V   + YL +   +HRD+ A N+L++E    K++DFG              P  W A
Sbjct: 108 SLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 167

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A+ E ++  K DVWS GI
Sbjct: 168 PE---ALREKKFSTKSDVWSFGI 187

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 36/97 (37%), Positives = 46/97 (47%), Gaps = 18/97 (18%)

Query: 623 GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLD- 681
            S +DI+EV  RPL EEEI A+C   L  L  LH         K+GNILLT  G +KLD 
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKLDG 54

Query: 682 ----TPDEQAGNDS-------SKSNSITSEHSVQSVG 707
                  EQ+  D         +  S T +  + S+G
Sbjct: 55  SVAFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLG 91

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 69/253 (27%), Positives = 106/253 (41%), Gaps = 60/253 (23%)

Query: 158 EDPEKIFEDLREIGHGSFGAV---YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR 214
           E P +  + ++++G G FG V   YY         VAIK +    KQ +      L E  
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSL----KQGSMSPEAFLAEAN 53

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            ++QL+HP                LV  Y + +   I    +I  E+   G         
Sbjct: 54  LMKQLQHPR---------------LVRLYAVVTQEPI----YIITEYMENG--------- 85

Query: 275 CFTEHFALFNF----EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                 +L +F    E  K  L   ++  + + +  G+ ++     IHRD++A NIL++E
Sbjct: 86  ------SLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE 137

Query: 331 TGTVKLADFGSASI----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           T   K+ADFG A +    +  A      P  W APE   A++ G +  K DVWS GI   
Sbjct: 138 TLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE---AINYGTFTIKSDVWSFGILLT 194

Query: 386 ELAER-KPPYFNM 397
           E+    + PY  M
Sbjct: 195 EIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 31/231 (13%)

Query: 167 LREIGHGSFGAVY----YARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + E+G  +FG +Y    Y   +   ++VAIK +  +     ++W +  +E   + +L HP
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHP 67

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +   G   ++    ++ EY   +  D+ E   I R  H +        + C ++    
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYL--NQGDLHEF-LIMRSPHSD--------VGCSSDEDGT 116

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                 K  L   +   I   +  G+ YL S   +H+D+ A NIL+ E   VK++D G +
Sbjct: 117 V-----KSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171

Query: 343 SIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                A+ +   P       WM PE I+    G++    D+WS G+   E+
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMY---GKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 55/233 (23%), Positives = 103/233 (44%), Gaps = 43/233 (18%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           +G G FG V   +   + ++ A KK+    L K+  EK A + KEI  L ++  P  +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
              Y  +    L +   L +  D+        ++H+                     + V
Sbjct: 59  --AYAFESKTHLCLVMSLMNGGDL--------KYHI---------------------YNV 87

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP 347
            +R L+ E +    + +  G+ +LHS+  ++RD+K  N+LL + G  +L+D G A ++  
Sbjct: 88  GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELK 146

Query: 348 ANSFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
               +    GT  +MAPE++    E  Y   VD +++G +  E+   + P+ +
Sbjct: 147 DGKTITQRAGTNGYMAPEILK---EEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 7e-11
 Identities = 48/144 (33%), Positives = 63/144 (43%), Gaps = 16/144 (11%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVM---EYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           +L+ + H   I     Y    T  +VM   +  L +  D       PL  E+   I   +
Sbjct: 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG----PLPLEQAITIQRRL 194

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-----SIKCPAN-SFVGTPYWM 117
           L  L YLH  G IHRDVK  NI L E     L DFG+A         P    + GT    
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           +PE +LA+D   Y  K D+WS G+
Sbjct: 255 SPE-LLALDP--YCAKTDIWSAGL 275

Length = 392

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 30/157 (19%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVH----------KRPLKEEEI 56
           L +L  PN     G    D    ++MEY   G  +  ++ H           + L    +
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY- 115
             + + +  G+ YL SL  +HRD+   N L+ +  T+K+ADFG +      N +    Y 
Sbjct: 133 LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYSSDYYR 187

Query: 116 ----------WMAPEVILAMDEGQYDGKVDVWSLGIT 142
                     WMA E +L    G++  K DVW+ G+T
Sbjct: 188 VQGRAPLPIRWMAWESVLL---GKFTTKSDVWAFGVT 221

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 76/280 (27%), Positives = 120/280 (42%), Gaps = 52/280 (18%)

Query: 165 EDLR---EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           E LR   ++G G FG V+      + + VAIK +   G    E +   L+E + +++L+H
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLK-PGTMMPEAF---LQEAQIMKKLRH 60

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
                            LV  Y + S   I    +I  EF   G G+ L  LK       
Sbjct: 61  DK---------------LVPLYAVVSEEPI----YIVTEFM--GKGSLLDFLK------- 92

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
               E   + LK  ++  + + +  G+ Y+  +  IHRD++A NIL+ +    K+ADFG 
Sbjct: 93  ----EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGL 148

Query: 342 ASIKCPANSFV---GTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
           A +    N +    G  +   W APE  L    G++  K DVWS GI   EL  + + PY
Sbjct: 149 ARL-IEDNEYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPY 204

Query: 395 FNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKP 433
             M     L  + +    PC Q    S+ + +    ++ P
Sbjct: 205 PGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 65/237 (27%), Positives = 98/237 (41%), Gaps = 43/237 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLKH 221
           F   R +G G FG V   +   + ++ A KK+    + K+  E  A  L E + L ++  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
              +     Y       LV+   L +  D+        +FH+  MGN       F E  A
Sbjct: 60  RFVVSLAYAYETKDALCLVLT--LMNGGDL--------KFHIYNMGN-----PGFDEERA 104

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           +F              A I  G    L  LH    ++RD+K  NILL + G ++++D G 
Sbjct: 105 VF------------YAAEITCG----LEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148

Query: 342 ASIKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           A ++ P        VGT  +MAPEV+      +Y    D W LG    E+ E K P+
Sbjct: 149 A-VEIPEGETIRGRVGTVGYMAPEVV---KNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.4 bits (154), Expect = 9e-11
 Identities = 45/113 (39%), Positives = 59/113 (52%), Gaps = 15/113 (13%)

Query: 602 NNNNSNY--SSLFSPQL--VMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH 656
           + N  NY  S L   +L  VMEY  G S +D+  V +  + E +IAA+C   L+ L +LH
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLH 132

Query: 657 SLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
           S   IHRD+K+ NILL   G+VKL         D      IT E S +S  VG
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKL--------TDFGFCAQITPEQSKRSTMVG 177

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 30/66 (45%), Positives = 42/66 (63%), Gaps = 3/66 (4%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++MEY  G S   +++    P+ E+ I+ I   VL  L Y+H +G IHRD+KA NIL+T 
Sbjct: 79  IIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN 136

Query: 675 TGTVKL 680
           TG VKL
Sbjct: 137 TGNVKL 142

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 47/203 (23%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-----------------CLGSASDIIEVHK 48
           +LL+Q+ HP+ I+  G   +D    L++EY                      SD      
Sbjct: 55  NLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS 114

Query: 49  -------RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 101
                  R L   ++ +    + RG+ YL  +  +HRD+ A N+L+ E   +K++DFG +
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 102 SIKCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLG------ITPGSLKDP 149
                 +S+V          WMA E   ++ +  Y  + DVWS G      +T G    P
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231

Query: 150 EIAELFDKEDPEKIFEDLREIGH 172
            IA       PE++F +L + G+
Sbjct: 232 GIA-------PERLF-NLLKTGY 246

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 11/145 (7%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
           +S++ Q  HPN I   G   +     +V EY   GS    +  H       ++  +  G+
Sbjct: 56  ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI 115

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGT----PY-W 116
             G+ YL  +G +HRD+ A NIL+      K++DFG + +    P  ++       P  W
Sbjct: 116 ASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE I      ++    DVWS GI
Sbjct: 176 TAPEAIAYR---KFTSASDVWSYGI 197

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 41/116 (35%), Positives = 58/116 (50%), Gaps = 7/116 (6%)

Query: 31  LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 90
           L+++Y  G         +    E+E+      ++  L +LH LG ++RD+K  NILL   
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE 141

Query: 91  GTVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           G V L DFG +       K    SF GT  +MAPE+I    +G +   VD WSLGI
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG--KGGHGKAVDWWSLGI 195

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 63/327 (19%), Positives = 112/327 (34%), Gaps = 79/327 (24%)

Query: 170 IGHGSFGAVYYAR-----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +G G FG V+ A+           +V +K +     +  +  ++  +E+   R+L H N 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKLSHKNV 70

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +   G        ++++EY                          L  LK F       +
Sbjct: 71  VRLLGLCREAEPHYMILEYT------------------------DLGDLKQFLRATKSKD 106

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
            ++   PL  ++  A+C+ +  G+++L +   +HRD+ A N L++    VK++    +  
Sbjct: 107 EKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166

Query: 345 K-----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                     + +    W+APE +    E  +  K DVWS G+   E+       F    
Sbjct: 167 VYNSEYYKLRNALIPLRWLAPEAVQ---EDDFSTKSDVWSFGVLMWEV-------FTQGE 216

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           +        +D   L           +   E   P       S LY +            
Sbjct: 217 LP---FYGLSDEEVLNRLQ-------AGKLELPVP---EGCPSRLYKLMT---------- 253

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
                      C A NP DRPS   L+
Sbjct: 254 ----------RCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 46/145 (31%), Positives = 69/145 (47%), Gaps = 21/145 (14%)

Query: 31  LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           LV +   LGS  D +  H+  L  + +   C  + +G+ YL     +HR++ A NILL  
Sbjct: 85  LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144

Query: 90  TGTVKLADFGSASIKCPAN-----SFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITP 143
              V++ADFG A +  P +     S   TP  WMA E IL    G+Y  + DVWS G+T 
Sbjct: 145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF---GRYTHQSDVWSYGVTV 201

Query: 144 -----------GSLKDPEIAELFDK 157
                        ++  E+ +L +K
Sbjct: 202 WEMMSYGAEPYAGMRPHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 39/202 (19%)

Query: 208 DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGM 266
           D LKE++ L +LK PN I   G  + +    ++ EY   G  +  +  H ++ +      
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK------ 118

Query: 267 GNRLQQLKCFTEHFALFNFEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
                      E+        H  P +    +  +   +  G+ YL SL  +HRD+   N
Sbjct: 119 ----------EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168

Query: 326 ILLTETGTVKLADFGSASIKCPANSFVGTPY-----------WMAPEVILAMDEGQYDGK 374
            L+ E  T+K+ADFG +      N + G  Y           WMA E IL    G++   
Sbjct: 169 CLVGENLTIKIADFGMSR-----NLYAGDYYRIQGRAVLPIRWMAWECILM---GKFTTA 220

Query: 375 VDVWSLGITCIELAE--RKPPY 394
            DVW+ G+T  E+    ++ PY
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPY 242

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 83/345 (24%), Positives = 136/345 (39%), Gaps = 75/345 (21%)

Query: 168 REIGHGSFGAVYYARCL-VSRE------IVAIKKMSYLGKQCAEKWADILKEIRFLRQL- 219
           + +G G FG V  A  + + ++       VA+K +        +  +D++ E+  ++ + 
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIG 75

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           KH N I   G   +D   ++++EY                       GN  + L+     
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYA--------------------SKGNLREYLRARRPP 115

Query: 280 FALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
              ++F+  K P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKI 175

Query: 337 ADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+   
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLLWEIFTL 232

Query: 391 KP-PY--------FNM-----------NAMSALY-------HIAQNDTPCLQS--SDWSV 421
              PY        F +           N    LY       H   +  P  +    D   
Sbjct: 233 GGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292

Query: 422 IKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH 466
           + T++ST E    Y +++     Y     D+P   SS     FAH
Sbjct: 293 VLTVTSTDE----YLDLSVPFEQYSPGCPDSPSSCSSGDDSVFAH 333

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 23/65 (35%), Positives = 36/65 (55%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+       +I+  +R L E  I +    +L+GL + HS G +HRD+K  N+L+   
Sbjct: 75  LVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE 134

Query: 676 GTVKL 680
           G +KL
Sbjct: 135 GVLKL 139

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 33/160 (20%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKE----------E 54
           S++++    + +   G         +VME    G     +    RP  E          +
Sbjct: 61  SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQ 119

Query: 55  EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP 114
           +   + + +  G+ YL +   +HRD+ A N ++ E  TVK+ DFG             T 
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM------TRDIYETD 173

Query: 115 Y------------WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           Y            WMAPE   ++ +G +  K DVWS G+ 
Sbjct: 174 YYRKGGKGLLPVRWMAPE---SLKDGVFTTKSDVWSFGVV 210

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 41/107 (38%), Positives = 55/107 (51%), Gaps = 9/107 (8%)

Query: 41  SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 100
            +  E++K PL  E++ +    V RG+ +L S   IHRD+ A NILL+E   VK+ DFG 
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL 219

Query: 101 AS--IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGI 141
           A    K P     G       WMAPE I    +  Y  + DVWS G+
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIF---DKVYTTQSDVWSFGV 263

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 69/262 (26%), Positives = 105/262 (40%), Gaps = 47/262 (17%)

Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KH 221
           + +GHG+FG V  A         S   VA+K M   G   +E  A ++ E++ L  +  H
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVK-MLKEGATASEHKA-LMSELKILIHIGNH 70

Query: 222 PNTIEYRG-CYLRDHTAWLVMEYC-LGSASDI-------------------IEVHWIERE 260
            N +   G C   +    +++E+C  G+ S+                         +  +
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVH---------KRPLKEEEIAAICSGVLRGLNYL 311
             V+      Q    F+      +   +         K PL  E++      V RG+ +L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 312 HSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPY----WMAPEVILA 365
            S   IHRD+ A NILL+E   VK+ DFG A    K P     G+      WMAPE I  
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF- 249

Query: 366 MDEGQYDGKVDVWSLGITCIEL 387
             +  Y  + DVWS G+   E+
Sbjct: 250 --DKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 55/253 (21%)

Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++  
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   R+   +++ E+                       GN L  L               
Sbjct: 69  GVCTREPPFYIITEFM--------------------TYGNLLDYL--------------- 93

Query: 289 KRPLKEEEIAAI-----CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
            R    +E+ A+      + +   + YL     IHRD+ A N L+ E   VK+ADFG + 
Sbjct: 94  -RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152

Query: 344 I----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PPYFNM 397
           +       A++    P  W APE   ++   ++  K DVW+ G+   E+A     PY  +
Sbjct: 153 LMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209

Query: 398 NAMSALYHIAQND 410
           + +S +Y + +  
Sbjct: 210 D-LSQVYELLEKG 221

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 38/235 (16%)

Query: 168 REIGHGSFGAVYYARCL-VSREI------VAIKKMSYLGKQCAEK-WADILKEIRFLRQL 219
           + +G G FG V  A  + + +E       VA+K    L     EK  +D++ E+  ++ +
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMI 80

Query: 220 -KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            KH N I   G   +D   ++++EY   S  ++ E     R   +E   N  Q       
Sbjct: 81  GKHKNIINLLGACTQDGPLYVIVEY--ASKGNLREYLRARRPPGMEYCYNPTQ------- 131

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                   V +  L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+AD
Sbjct: 132 --------VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 183

Query: 339 FGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           FG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 45/122 (36%), Positives = 61/122 (50%), Gaps = 10/122 (8%)

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPA 348
            PL  +++    S V +G+++L S   IHRDV A N+LLT+    K+ DFG A  I   +
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 349 NSFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYFNMNAMSA 402
           N  V      P  WMAPE I    +  Y  + DVWS GI   E+ +  K PY  +   S 
Sbjct: 267 NYVVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323

Query: 403 LY 404
            Y
Sbjct: 324 FY 325

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 26/65 (40%), Positives = 37/65 (56%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EYC  +  + +E + R + E  I  I    L+ +N+ H    IHRDVK  NIL+T+ 
Sbjct: 77  LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ 136

Query: 676 GTVKL 680
           G +KL
Sbjct: 137 GQIKL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 32/83 (38%), Positives = 44/83 (53%), Gaps = 7/83 (8%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMA 118
           +L  L  LH    I+RD+K  NILL   G + L DFG   +        N+F GTP ++A
Sbjct: 102 LLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE++L      Y   VD W+LG+
Sbjct: 162 PELLLGHG---YTKAVDWWTLGV 181

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPL-KEEEIAAICSG 62
           ++++ +L H N +   G  L +   ++VME    G+  + +    R L    ++      
Sbjct: 50  TAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD 108

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMAPEV 121
           V  G+ YL S   +HRD+ A NIL++E G  K++DFG A +          P  W APE 
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPE- 167

Query: 122 ILAMDEGQYDGKVDVWSLGI 141
             A+   ++  K DVWS G+
Sbjct: 168 --ALKHKKFSSKSDVWSYGV 185

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 62.9 bits (153), Expect = 3e-10
 Identities = 63/278 (22%), Positives = 99/278 (35%), Gaps = 83/278 (29%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F  ++ IG G+FG V   R + +  + A+K +         + A +  E   L +  +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +      + VM+Y  G                   M + L +L  F E  A F
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGG-----------------DMMSLLIRLGIFEEDLARF 105

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
                        IA +   +      +H +G IHRD+K  NIL+   G +KL DFG   
Sbjct: 106 ------------YIAELTCAI----ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149

Query: 341 --------------------------------SASIK------------CPANSFVGTPY 356
                                              +K            C A+S VGTP 
Sbjct: 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209

Query: 357 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           ++APEV+L      Y    D WS+G+   E+   +PP+
Sbjct: 210 YIAPEVLLRTG---YTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 71/258 (27%), Positives = 100/258 (38%), Gaps = 60/258 (23%)

Query: 170 IGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           IG G FG V   R  +   REI VAIK  K  Y  KQ      D L E   + Q  HPN 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ----RRDFLSEASIMGQFDHPNI 67

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   +     ++ E                                 F E+ AL +
Sbjct: 68  IHLEGVVTKSRPVMIITE---------------------------------FMENGALDS 94

Query: 285 F-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
           F   +       ++  +  G+  G+ YL  +  +HRD+ A NIL+      K++DFG   
Sbjct: 95  FLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Query: 341 ----SASIKCPANSFVGT-PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERK 391
                 S     +S  G  P  W APE   A+   ++    DVWS GI   E+    ER 
Sbjct: 155 FLEDDTSDPTYTSSLGGKIPIRWTAPE---AIAYRKFTSASDVWSYGIVMWEVMSYGER- 210

Query: 392 PPYFNMNAMSALYHIAQN 409
            PY++M+    +  I Q+
Sbjct: 211 -PYWDMSNQDVINAIEQD 227

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.4 bits (150), Expect = 4e-10
 Identities = 22/66 (33%), Positives = 37/66 (56%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
            V EY  G+   +++  K +P  E  I +I   +L+GL ++H  G  HRD+K  N+L++ 
Sbjct: 75  FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG 134

Query: 675 TGTVKL 680
              VK+
Sbjct: 135 PEVVKI 140

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 38/121 (31%), Positives = 64/121 (52%), Gaps = 12/121 (9%)

Query: 28  TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 87
           + ++V EY     ++++E  + PL EE        +LRGL Y+HS   +HRD+K  N+ +
Sbjct: 90  SVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147

Query: 88  -TETGTVKLADFGSASIKCPANSFVG-------TPYWMAPEVILAMDEGQYDGKVDVWSL 139
            TE   +K+ DFG A I  P  S  G       T ++ +P ++L+ +   Y   +D+W+ 
Sbjct: 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAA 205

Query: 140 G 140
           G
Sbjct: 206 G 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 33/150 (22%), Positives = 65/150 (43%), Gaps = 17/150 (11%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC---------LGSASDIIEVHKRPLKEEEIA 57
           + R+L H N +   G        ++++EY            + S   ++   PL  ++  
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK-----CPANSFVG 112
           A+C+ +  G+++L +   +HRD+ A N L++    VK++    +            + + 
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              W+APE +    E  +  K DVWS G+ 
Sbjct: 181 PLRWLAPEAVQ---EDDFSTKSDVWSFGVL 207

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 40/100 (40%), Positives = 51/100 (51%), Gaps = 9/100 (9%)

Query: 48  KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKC 105
           K PL  E++      V RG+ +L S   IHRD+ A NILL+E   VK+ DFG A    K 
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227

Query: 106 PANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGI 141
           P     G+      WMAPE I    +  Y  + DVWS G+
Sbjct: 228 PDYVRKGSARLPLKWMAPESIF---DKVYTTQSDVWSFGV 264

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 56/244 (22%)

Query: 170 IGHGSFGAVYYARCLVS--REI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           IG G FG V+     +   +E+ VAIK  K  Y  KQ      D L E   + Q  H N 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ----RQDFLSEASIMGQFSHHNI 68

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   +   A ++ EY    A D                    + L+     F+ + 
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALD--------------------KYLRDHDGEFSSY- 107

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                      ++  +  G+  G+ YL  +  +HRD+ A NIL+      K++DFG + +
Sbjct: 108 -----------QLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156

Query: 345 --KCPANSFVGT----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPPY 394
               P  ++  +    P  W APE   A+   ++    DVWS GI   E+    ER  PY
Sbjct: 157 LEDDPEGTYTTSGGKIPIRWTAPE---AIAYRKFTSASDVWSFGIVMWEVMSFGER--PY 211

Query: 395 FNMN 398
           ++M+
Sbjct: 212 WDMS 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 29/160 (18%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-----------------LGSASDIIEVHK 48
            L+  L+HPN +   G   ++    ++ EY                  +G+ S    V K
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV-K 118

Query: 49  RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------SA 101
             L   +   I   +  G+ YL S   +HRD+ A N L+ E  TVK++DFG       + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Query: 102 SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
             +  + S +    WM PE IL    G++  + D+WS G+
Sbjct: 179 YYRVQSKSLLPV-RWMPPEAILY---GKFTTESDIWSFGV 214

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 29/64 (45%), Positives = 37/64 (57%), Gaps = 2/64 (3%)

Query: 618 MEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           MEYC  G+  +++E H R L E  I      +L GL YLHS G +HRD+K  NI L   G
Sbjct: 78  MEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG 136

Query: 677 TVKL 680
            +KL
Sbjct: 137 VIKL 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 62.4 bits (151), Expect = 6e-10
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 36/169 (21%)

Query: 6   SLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGS--ASDIIEVHKR--PLKEEEIAAI 59
           +++R+LKH N + Y   +L   +   +++ME+C     + +I + +K    ++E  I  I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 60  CSGVLRGLNYLHSLGR-------IHRDVKAGNILLTETGT------------------VK 94
              +L  L Y H+L         +HRD+K  NI L+ TG                    K
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS-TGIRHIGKITAQANNLNGRPIAK 182

Query: 95  LADFG---SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           + DFG   +  I+  A+S VGTPY+ +PE++L  +   YD K D+W+LG
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELLL-HETKSYDDKSDMWALG 230

Length = 1021

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 50/256 (19%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +  + ++++G G FG V+      S + VA+K +   G    + +   L+E   ++
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLK-PGTMSVQAF---LEEANLMK 56

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            L+H   +       ++   +++ EY   GS  D ++          EG    L +L  F
Sbjct: 57  TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDF 108

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
           +   A                         G+ Y+     IHRD++A N+L++E+   K+
Sbjct: 109 SAQIA------------------------EGMAYIERKNYIHRDLRAANVLVSESLMCKI 144

Query: 337 ADFGSASI----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER- 390
           ADFG A +    +  A      P  W APE   A++ G +  K DVWS GI   E+    
Sbjct: 145 ADFGLARVIEDNEYTAREGAKFPIKWTAPE---AINFGSFTIKSDVWSFGILLYEIVTYG 201

Query: 391 KPPY---FNMNAMSAL 403
           K PY    N + MSAL
Sbjct: 202 KIPYPGMSNSDVMSAL 217

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 31/84 (36%), Positives = 49/84 (58%), Gaps = 7/84 (8%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMA 118
           ++ GL +LH    I+RD+K  N+LL   G V+++D G A      +     + GTP +MA
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PE++    E +YD  VD ++LG+T
Sbjct: 166 PELLQ--GE-EYDFSVDYFALGVT 186

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 10/128 (7%)

Query: 267 GNRLQQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
           G  LQ +   +   +L +    H+  L  + +   C  + +G+ YL     +HR++ A N
Sbjct: 80  GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARN 139

Query: 326 ILLTETGTVKLADFGSASIKCPAN-----SFVGTPY-WMAPEVILAMDEGQYDGKVDVWS 379
           ILL     V++ADFG A +  P +     S   TP  WMA E IL    G+Y  + DVWS
Sbjct: 140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF---GRYTHQSDVWS 196

Query: 380 LGITCIEL 387
            G+T  E+
Sbjct: 197 YGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRP---------------LKEEE 55
           KH N I   G   +D   ++++EY   G+  + +   + P               L  ++
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP- 114
           + +    V RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A      + +  T  
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 115 -----YWMAPEVILAMDEGQYDGKVDVWSLGI 141
                 WMAPE   A+ +  Y  + DVWS G+
Sbjct: 202 GRLPVKWMAPE---ALFDRIYTHQSDVWSFGV 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 65/260 (25%), Positives = 106/260 (40%), Gaps = 60/260 (23%)

Query: 168 REIGHGSFGAVY----YARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +EIG+G FG V     Y    V+R +V   K +   K+      + L++    R L+HPN
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE----QNEFLQQGDPYRILQHPN 56

Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVH-WIEREFHVEGMGNRLQQLKCFTEHFA 281
            ++  G  +      LV EYC LG     +    W  R          LQ++ C      
Sbjct: 57  ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMAC------ 106

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                         EIAA       G+ ++H    +H D+   N  LT   TVK+ D+G 
Sbjct: 107 --------------EIAA-------GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Query: 342 ASIKCPANSFVGTP-------YWMAPEVI-------LAMDEGQYDGKVDVWSLGITCIEL 387
              +   + ++ T         W+APE++       +  ++ +     +VW+LG+T  EL
Sbjct: 146 GPSRYKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPS---NVWALGVTLWEL 201

Query: 388 AER-KPPYFNMNAMSALYHI 406
            E    PY +++    L H+
Sbjct: 202 FENAAQPYSHLSDREVLNHV 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 60.1 bits (145), Expect = 7e-10
 Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 51/243 (20%)

Query: 165 EDLR---EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           E LR   ++G G FG V+      +   VAIK +   G    E +   L+E + +++L+H
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK-PGTMSPEAF---LQEAQVMKKLRH 60

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
                            LV  Y + S   I    +I  E+  +G  + L  LK     + 
Sbjct: 61  EK---------------LVQLYAVVSEEPI----YIVTEYMSKG--SLLDFLKGEMGKY- 98

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                     L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG 
Sbjct: 99  ----------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 148

Query: 342 ASIKCPANSFV---GTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
           A +    N +    G  +   W APE  L    G++  K DVWS GI   EL  + + PY
Sbjct: 149 ARL-IEDNEYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPY 204

Query: 395 FNM 397
             M
Sbjct: 205 PGM 207

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 59.9 bits (146), Expect = 8e-10
 Identities = 22/68 (32%), Positives = 33/68 (48%), Gaps = 2/68 (2%)

Query: 614 PQLVMEYC-LGSASDIIEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
             +VMEY   G   D +  ++   L   ++ +    + RG+ YL S   IHRD+ A N L
Sbjct: 76  LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135

Query: 672 LTETGTVK 679
           + E   VK
Sbjct: 136 VGENLVVK 143

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 61.2 bits (148), Expect = 8e-10
 Identities = 69/271 (25%), Positives = 104/271 (38%), Gaps = 77/271 (28%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE L+ IG G+FG V   R +  ++   I  M  L K      AD+L++     Q+ H  
Sbjct: 3   FESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRK------ADMLEK----EQVAHIR 49

Query: 224 TIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
               R   +    AW+V M Y      ++    ++  EF   G                +
Sbjct: 50  A--ERDILVEADGAWVVKMFYSFQDKRNL----YLIMEFLPGG---------------DM 88

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
               + K  L EE      +  +  ++ +H LG IHRD+K  N+LL   G VKL+DFG  
Sbjct: 89  MTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148

Query: 343 S--------------IKCPANSF-------------------------VGTPYWMAPEVI 363
           +                 P + F                         VGTP ++APEV 
Sbjct: 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF 208

Query: 364 LAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +   +  Y+   D WSLG+   E+    PP+
Sbjct: 209 M---QTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 37/163 (22%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEE---------E 55
           + L+    HPN ++  G  L +   +++ME  L    D++   +    E          E
Sbjct: 50  AHLMSNFNHPNIVKLLGVCLLNEPQYIIME--LMEGGDLLSYLRDARVERFGPPLLTLKE 107

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG-----TVKLADFGSASIKCPANSF 110
           +  IC  V +G  YL  +  IHRD+ A N L++E G      VK+ DFG       A   
Sbjct: 108 LLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL------ARDI 161

Query: 111 VGTPY------------WMAPEVILAMDEGQYDGKVDVWSLGI 141
             + Y            WMAPE +L   +G++  + DVWS G+
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLL---DGKFTTQSDVWSFGV 201

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 36/112 (32%), Positives = 51/112 (45%), Gaps = 9/112 (8%)

Query: 37  LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 96
           LG   D +  HK  +  + +   C  + +G++YL     +HRD+ A N+L+     VK+ 
Sbjct: 92  LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKIT 151

Query: 97  DFGSASIKCPANSFV-----GTPY-WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           DFG A +               P  WMA E IL      Y  K DVWS G+T
Sbjct: 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVT 200

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 57/189 (30%), Positives = 85/189 (44%), Gaps = 39/189 (20%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRP----------LKEE-----E 55
           KH N I   G   +D   ++++EY   G+  + +   + P          L EE     +
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP- 114
           + +    V RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A      + +  T  
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 115 -----YWMAPEVILAMDEGQYDGKVDVWSLGI------TPGSLKDPEIAELFDKEDPEKI 163
                 WMAPE   A+ +  Y  + DVWS G+      T G    P I         E++
Sbjct: 196 GRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------VEEL 245

Query: 164 FEDLREIGH 172
           F+ L+E GH
Sbjct: 246 FKLLKE-GH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 76/303 (25%), Positives = 122/303 (40%), Gaps = 53/303 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVS--REIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-K 220
           F+D+  IG G+FG V  AR      R   AIK+M     +  +   D   E+  L +L  
Sbjct: 11  FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGH 66

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HPN I   G    +H  +L +        ++++     R    +               F
Sbjct: 67  HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD-------------PAF 111

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A+ N       L  +++    + V RG++YL     IHRD+ A NIL+ E    K+ADFG
Sbjct: 112 AIANSTAST--LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 169

Query: 341 -SASIKCPANSFVGT-PY-WMAPEVILAMDEGQYDGKVDVWSLGI--------------- 382
            S   +      +G  P  WMA E   +++   Y    DVWS G+               
Sbjct: 170 LSRGQEVYVKKTMGRLPVRWMAIE---SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226

Query: 383 -TCIELAERKPPYFN----MNAMSALYHIAQN---DTPCLQSSDWSVIKTISSTAERKPP 434
            TC EL E+ P  +     +N    +Y + +    + P  + S   ++ +++   E +  
Sbjct: 227 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286

Query: 435 YFN 437
           Y N
Sbjct: 287 YVN 289

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 8/105 (7%)

Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANS 350
           E E+    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P  S
Sbjct: 96  EAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155

Query: 351 FVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPY 394
            VGT  +MAPEV   + +G  YD   D +SLG    +L     P+
Sbjct: 156 -VGTHGYMAPEV---LQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 1e-09
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 42/219 (19%)

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
           RPL   ++ A+   +L  ++Y+H  G IHRD+K  N+L+     + L DFG+A   C A 
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA---CFAR 311

Query: 350 SFVGTPYWM---------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               TP+           APEV LA D   Y   VD+WS G+   E A            
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEV-LAGDP--YTPSVDIWSAGLVIFEAAVHT--------- 359

Query: 401 SALYHIAQNDT--PCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL-----YHIAQNDTP 453
           ++L+  ++ D   P     D  +++ I   A+     F  +A S L     +  A+N  P
Sbjct: 360 ASLFSASRGDERRPY----DAQILRIIRQ-AQVHVDEFPQHAGSRLVSQYRHRAARNRRP 414

Query: 454 CLQSSDWSDTFA------HFVSSCLAKNPADRPSSGRLL 486
                 W+  +       + V   L  + A RPS+  LL
Sbjct: 415 AYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL 453

Length = 461

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 39/108 (36%), Positives = 55/108 (50%), Gaps = 9/108 (8%)

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K+ L  E++      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 45/154 (29%), Positives = 64/154 (41%), Gaps = 45/154 (29%)

Query: 30  WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           +L+MEY  G     + + K    EEE     +  +  ++ +H LG IHRD+K  N+LL  
Sbjct: 77  YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136

Query: 90  TGTVKLADFG-------------------------SASIKCP-----------------A 107
            G +KL+DFG                            I  P                 A
Sbjct: 137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA 196

Query: 108 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
            S VGTP ++APEV L   +  Y+ + D WSLG+
Sbjct: 197 YSTVGTPDYIAPEVFL---QTGYNKECDWWSLGV 227

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 18/148 (12%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAI---- 59
           +++++++KHPN ++  G   R+   +++ E+   G+  D +    R    +E+ A+    
Sbjct: 53  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLY 108

Query: 60  -CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
             + +   + YL     IHRD+ A N L+ E   VK+ADFG + +       A++    P
Sbjct: 109 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168

Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   ++   ++  K DVW+ G+
Sbjct: 169 IKWTAPE---SLAYNKFSIKSDVWAFGV 193

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 39/99 (39%), Positives = 52/99 (52%), Gaps = 9/99 (9%)

Query: 49  RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPA 107
            PL  +++    S V +G+++L S   IHRDV A N+LLT+    K+ DFG A  I   +
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 108 NSFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
           N  V      P  WMAPE I    +  Y  + DVWS GI
Sbjct: 267 NYVVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGI 302

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 8/92 (8%)

Query: 53  EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANS 109
           E E+    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P  S
Sbjct: 96  EAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155

Query: 110 FVGTPYWMAPEVILAMDEG-QYDGKVDVWSLG 140
            VGT  +MAPEV   + +G  YD   D +SLG
Sbjct: 156 -VGTHGYMAPEV---LQKGVAYDSSADWFSLG 183

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 9/103 (8%)

Query: 45  EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 102
           +++K+ L  E++      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 103 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGI 141
            K P     G       WMAPE I    +  Y  + DVWS G+
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGV 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 40/254 (15%)

Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           RE+G G+FG V+ A C        + +VA+K +        +   D  +E   L  L+H 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK---DFHREAELLTNLQHE 67

Query: 223 NTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           + +++ G  +      +V EY   G  +  +  H  +     EG            E   
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP--------AE--- 116

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                     L + ++  I   +  G+ YL S   +HRD+   N L+ E   VK+ DFG 
Sbjct: 117 ----------LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM 166

Query: 342 ASIKCPANSF-VGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPY 394
           +      + + VG        WM PE I+     ++  + DVWSLG+   E+    K P+
Sbjct: 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSLGVVLWEIFTYGKQPW 223

Query: 395 FNMNAMSALYHIAQ 408
           + ++    +  I Q
Sbjct: 224 YQLSNNEVIECITQ 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 44/120 (36%), Positives = 58/120 (48%), Gaps = 10/120 (8%)

Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANS 350
           L  E++ +    V +G+++L S   IHRD+ A NILLT     K+ DFG A  I+  +N 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 351 FVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYFNMNAMSALY 404
            V      P  WMAPE I       Y  + DVWS GI   E+ +    PY  M   S  Y
Sbjct: 271 VVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 17/134 (12%)

Query: 276 FTEHFALFNF----EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
           F    +L +F    E  K+PL +  +    + +  G+ ++     IHRD++A NIL++ +
Sbjct: 81  FMAKGSLLDFLKSDEGSKQPLPK--LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 138

Query: 332 GTVKLADFGSASIKCPANSFV---GTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
              K+ADFG A +    N +    G  +   W APE   A++ G +  K DVWS GI  +
Sbjct: 139 LVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE---AINFGSFTIKSDVWSFGILLM 194

Query: 386 ELAER-KPPYFNMN 398
           E+    + PY  M+
Sbjct: 195 EIVTYGRIPYPGMS 208

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 24/151 (15%)

Query: 7   LLRQLKHPNTIEYRGCYL-------RD-HTAWLVMEYCLGSASDIIEVHKR--PLKEEEI 56
           LLR L+HP+ +E +   L       +D +  + +ME      SD+ +V K    L  E  
Sbjct: 52  LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHH 105

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KCPANSF--- 110
                 +LR L Y+H+    HRD+K  NIL      +K+ DFG A +     P   F   
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 111 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
            V T ++ APE+  +    +Y   +D+WS+G
Sbjct: 166 YVATRWYRAPELCGSF-FSKYTPAIDIWSIG 195

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 42/151 (27%)

Query: 30  WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           +L+ME+  G     + + K  L EE      +  +  ++ +H LG IHRD+K  N+LL  
Sbjct: 77  YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136

Query: 90  TGTVKLADFGSAS--------------IKCPANSF------------------------- 110
            G VKL+DFG  +                 P + F                         
Sbjct: 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYST 196

Query: 111 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           VGTP ++APEV +   +  Y+   D WSLG+
Sbjct: 197 VGTPDYIAPEVFM---QTGYNKLCDWWSLGV 224

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 41/109 (37%), Positives = 56/109 (51%), Gaps = 9/109 (8%)

Query: 39  SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 98
             S+I+E  +  L  E++ +    V +G+++L S   IHRD+ A NILLT     K+ DF
Sbjct: 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDF 258

Query: 99  GSA-SIKCPANSFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
           G A  I+  +N  V      P  WMAPE I       Y  + DVWS GI
Sbjct: 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGI 304

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 65/254 (25%), Positives = 102/254 (40%), Gaps = 37/254 (14%)

Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           RE+G G+FG V+ A C        + +VA+K    L         D  +E   L  L+H 
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKA---LKDPTLAARKDFQREAELLTNLQHE 67

Query: 223 NTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           + +++ G         +V EY   G  +  +  H  +    V+G     Q  +   E   
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG-----QPRQAKGE--- 119

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG- 340
                     L   ++  I S +  G+ YL S   +HRD+   N L+     VK+ DFG 
Sbjct: 120 ----------LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 169

Query: 341 SASIKCPANSFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPY 394
           S  +       VG     P  WM PE I+     ++  + DVWS G+   E+    K P+
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPW 226

Query: 395 FNMNAMSALYHIAQ 408
           F ++    +  I Q
Sbjct: 227 FQLSNTEVIECITQ 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 49/185 (26%), Positives = 75/185 (40%), Gaps = 41/185 (22%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC----LGSASDIIEVHKRPLKEEEIAAI--- 59
           ++ +LK+PN I   G  + D    ++ EY     L       E+         I ++   
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 60  -----CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP 114
                   +  G+ YL SL  +HRD+   N L+    T+K+ADFG +      N + G  
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-----NLYSGDY 184

Query: 115 Y-----------WMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFD--KEDPE 161
           Y           WMA E IL    G++    DVW+ G+T        + E+F   KE P 
Sbjct: 185 YRIQGRAVLPIRWMAWESILL---GKFTTASDVWAFGVT--------LWEMFTLCKEQPY 233

Query: 162 KIFED 166
            +  D
Sbjct: 234 SLLSD 238

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 71/271 (26%), Positives = 109/271 (40%), Gaps = 77/271 (28%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE L+ IG G+FG V   R +  ++   +  M  L K      AD+L++     Q+ H  
Sbjct: 3   FESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRK------ADMLEK----EQVGHIR 49

Query: 224 TIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
               R   +   + W+V M Y   S  D + ++ I  EF   G                +
Sbjct: 50  A--ERDILVEADSLWVVKMFY---SFQDKLNLYLI-MEFLPGG---------------DM 88

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-- 340
               + K  L EEE     +  +  ++ +H LG IHRD+K  N+LL   G VKL+DFG  
Sbjct: 89  MTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLC 148

Query: 341 -------------SASIKCPAN------------------------SFVGTPYWMAPEVI 363
                        + +   P++                        S VGTP ++APEV 
Sbjct: 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF 208

Query: 364 LAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +   +  Y+   D WSLG+   E+    PP+
Sbjct: 209 M---QTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 81/336 (24%), Positives = 121/336 (36%), Gaps = 102/336 (30%)

Query: 168 REIGHGSFGAVYYARCLVSREI--VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           + +G G FG+V   +      I  VA+K M  +      +  D L E   +++  HPN +
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMK-IAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
              G              CL +                EG  + +  L  F +H  L +F
Sbjct: 64  RLIGV-------------CLQTVES-------------EGYPSPVVILP-FMKHGDLHSF 96

Query: 286 EVHKR----P--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            ++ R    P  L  + +    + +  G+ YL S   IHRD+ A N +L E   V +ADF
Sbjct: 97  LLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156

Query: 340 G-SASI------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G S  I            K P         W+A E   ++ +  Y  K DVWS G+T  E
Sbjct: 157 GLSKKIYNGDYYRQGRIAKMPVK-------WIAIE---SLADRVYTTKSDVWSFGVTMWE 206

Query: 387 LAER-KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
           +A R + PY                 P +++S+                         +Y
Sbjct: 207 IATRGQTPY-----------------PGVENSE-------------------------IY 224

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
              +      Q  D  D     +SSC   NP DRPS
Sbjct: 225 DYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPS 260

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 66/277 (23%), Positives = 102/277 (36%), Gaps = 83/277 (29%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARC----------------LVSREIVAIKKMSYLGKQ 201
           E P K      ++G G FG V+                         +VA+K +    ++
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML----RE 56

Query: 202 CAEKWA--DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIER 259
            A K A  D LKEI+ + +LK PN I      +      ++ EY                
Sbjct: 57  DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEY---------------- 100

Query: 260 EFHVEGMGN-RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLR--------GLNY 310
                 M N  L Q     E          +   ++ ++  I    L         G+ Y
Sbjct: 101 ------MENGDLNQFLSRHEP---------QEAAEKADVVTISYSTLIFMATQIASGMKY 145

Query: 311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-----------WMA 359
           L SL  +HRD+   N L+ +  T+K+ADFG +      N + G  Y           WM+
Sbjct: 146 LSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYSGDYYRIQGRAVLPIRWMS 200

Query: 360 PEVILAMDEGQYDGKVDVWSLGITCIELAE--RKPPY 394
            E IL    G++    DVW+ G+T  E+    ++ PY
Sbjct: 201 WESILL---GKFTTASDVWAFGVTLWEILTLCKEQPY 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 7e-09
 Identities = 22/65 (33%), Positives = 37/65 (56%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EY   +  +++E     L  + + +    +L+ + Y HS   IHRD+K  NIL++E+
Sbjct: 77  LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES 136

Query: 676 GTVKL 680
           G +KL
Sbjct: 137 GVLKL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 11/144 (7%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDII-EVHKRPLKEEEIAAICSG 62
           + ++++L+H   ++     + +   ++V EY   GS  D + +   R LK   +  + + 
Sbjct: 52  AQIMKKLRHDKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY-WM 117
           V  G+ Y+  +  IHRD+++ NIL+ +    K+ADFG A +    +  A      P  W 
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APE  L    G++  K DVWS GI
Sbjct: 171 APEAALY---GRFTIKSDVWSFGI 191

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.4 bits (138), Expect = 7e-09
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 13/145 (8%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDII-EVHKRPLKEEEIAAICSG 62
           + ++++L+H   +      + +   ++V E+   GS  D + E   + LK  ++  + + 
Sbjct: 52  AQIMKKLRHDKLVPLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV---GTPY---W 116
           +  G+ Y+  +  IHRD++A NIL+ +    K+ADFG A +    N +    G  +   W
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW 169

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE  L    G++  K DVWS GI
Sbjct: 170 TAPEAALY---GRFTIKSDVWSFGI 191

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD-IIEVHKRPLKEEEIAAICSGV 63
           +S++ Q  H N I   G   +   A ++ EY    A D  +  H       ++  +  G+
Sbjct: 57  ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGT----PY-W 116
             G+ YL  +  +HRD+ A NIL+      K++DFG + +    P  ++  +    P  W
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE   A+   ++    DVWS GI
Sbjct: 177 TAPE---AIAYRKFTSASDVWSFGI 198

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 46/113 (40%), Positives = 60/113 (53%), Gaps = 15/113 (13%)

Query: 602 NNNNSNY--SSLFSPQL--VMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH 656
           N N  NY  S L   +L  VMEY  G S +D+  V +  + E +IAA+C   L+ L++LH
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALDFLH 132

Query: 657 SLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
           S   IHRD+K+ NILL   G+VKL         D      IT E S +S  VG
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKL--------TDFGFCAQITPEQSKRSTMVG 177

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 4/69 (5%)

Query: 616 LVMEYC-LGSASDII---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           +VMEY   G  S  I   +  ++ + E+EI  I   +LRGL  LH    +HRD+K+ NIL
Sbjct: 76  IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANIL 135

Query: 672 LTETGTVKL 680
           L     VK+
Sbjct: 136 LVANDLVKI 144

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 63/244 (25%), Positives = 95/244 (38%), Gaps = 62/244 (25%)

Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E     VAIK++       A K  +IL E   +
Sbjct: 6   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 63

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+      C L        +  CL S   +I                +L    C 
Sbjct: 64  ASVDNPHV-----CRL--------LGICLTSTVQLI---------------TQLMPFGCL 95

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 96  LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKI 150

Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 151 TDFGLAKLLGADEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 200

Query: 384 CIEL 387
             EL
Sbjct: 201 VWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 29/169 (17%)

Query: 9   RQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDII---EVHKRPLKEEEIAA-ICSGV 63
           R+L HPN ++  G  +      LV+E+C LG   + +         + ++++   +   V
Sbjct: 50  RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP------YWM 117
             GL +LH    IH D+   N  LT   +VK+ D+G A  + P + ++          W+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 118 APEVILAMDEGQYDGKV-------DVWSLGITPGSLKDPEIAELFDKED 159
           APE+   ++    D          ++WSLG+T        + ELF   D
Sbjct: 170 APEL---VEIRGQDLLPKDQTKKSNIWSLGVT--------MWELFTAAD 207

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 38/166 (22%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEE---------- 55
           +L +LK PN I   G  + +    ++ EY   G  +  +  H    KEE           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 56  --------IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA 107
                   +  +   +  G+ YL SL  +HRD+   N L+ E  T+K+ADFG +      
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR----- 186

Query: 108 NSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           N + G  Y           WMA E IL    G++    DVW+ G+T
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILM---GKFTTASDVWAFGVT 229

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 10/144 (6%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHK-RPLKEEEIAAICSG 62
           ++L++ L+H   +       ++   +++ EY   GS  D ++  +   +   ++    + 
Sbjct: 52  ANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY-WM 117
           +  G+ Y+     IHRD++A N+L++E+   K+ADFG A +    +  A      P  W 
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APE   A++ G +  K DVWS GI
Sbjct: 172 APE---AINFGSFTIKSDVWSFGI 192

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 1e-08
 Identities = 45/144 (31%), Positives = 65/144 (45%), Gaps = 15/144 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LLR+L HP  +      +      LV+          +    RPL   ++ A+   +L  
Sbjct: 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSA 272

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWM--------- 117
           ++Y+H  G IHRD+K  N+L+     + L DFG+A   C A     TP+           
Sbjct: 273 IDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA---CFARGSWSTPFHYGIAGTVDTN 329

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APEV LA D   Y   VD+WS G+
Sbjct: 330 APEV-LAGDP--YTPSVDIWSAGL 350

Length = 461

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 17/147 (11%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDII---EVHKRPLKEEEIAAIC 60
           +++++ L+H   ++      ++   +++ E+   GS  D +   E  K+PL +  +    
Sbjct: 52  ANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPK--LIDFS 108

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV---GTPY-- 115
           + +  G+ ++     IHRD++A NIL++ +   K+ADFG A +    N +    G  +  
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPI 167

Query: 116 -WMAPEVILAMDEGQYDGKVDVWSLGI 141
            W APE   A++ G +  K DVWS GI
Sbjct: 168 KWTAPE---AINFGSFTIKSDVWSFGI 191

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.8 bits (139), Expect = 1e-08
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 42/151 (27%)

Query: 30  WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           +L+ME+  G     + + K  L EEE     +  +  ++ +H LG IHRD+K  N+LL  
Sbjct: 77  YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136

Query: 90  TGTVKLADFG---------------SASIKCPAN------------------------SF 110
            G VKL+DFG               + +   P++                        S 
Sbjct: 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFST 196

Query: 111 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           VGTP ++APEV +   +  Y+   D WSLG+
Sbjct: 197 VGTPDYIAPEVFM---QTGYNKLCDWWSLGV 224

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 43/237 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLKH 221
           F   R +G G FG V   +   + ++ A KK+    + K+  E  A  L E R L ++  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
              +     Y       LV+    G           + +FH+  MGN       F E  A
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGG----------DLKFHIYNMGN-----PGFDEQRA 104

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           +F              A +C G    L  L     ++RD+K  NILL + G ++++D G 
Sbjct: 105 IF------------YAAELCCG----LEDLQRERIVYRDLKPENILLDDRGHIRISDLGL 148

Query: 342 ASIKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           A ++ P        VGT  +MAPEVI   +  +Y    D W LG    E+ + + P+
Sbjct: 149 A-VQIPEGETVRGRVGTVGYMAPEVI---NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 18/150 (12%)

Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV--GTPY----W 357
           V RG+ +L S   +HRD+ A N+LL +   VK+ DFG A      +++V  G+ +    W
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305

Query: 358 MAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYFNM-------NAMSALYHIAQN 409
           MAPE I    +  Y    DVWS GI   E+ +    PY  M       N + + Y +A+ 
Sbjct: 306 MAPESIF---DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP 362

Query: 410 DTPCLQSSDWSVIKTISSTAERKPPYFNMN 439
           D    +  D  ++K  +S  E++P + +++
Sbjct: 363 DHATQEVYD-IMVKCWNSEPEKRPSFLHLS 391

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)

Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA 348
             E+E+    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P 
Sbjct: 94  FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153

Query: 349 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
            S VGT  +MAPEV+       YD   D +SLG    +L     P+
Sbjct: 154 AS-VGTHGYMAPEVL--QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 26/69 (37%), Positives = 35/69 (50%), Gaps = 8/69 (11%)

Query: 616 LVMEYC----LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           LVMEY     L S  + +      L E+      + ++  L YLHS G IHRD+K  NIL
Sbjct: 70  LVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 672 LTETGTVKL 680
           +   G +KL
Sbjct: 126 IDSNGHLKL 134

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 23/65 (35%), Positives = 33/65 (50%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+       +I+     L   +I +     LRGL YLHS   +HRD+K  N+L+   
Sbjct: 79  LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138

Query: 676 GTVKL 680
           G +KL
Sbjct: 139 GVLKL 143

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 8/94 (8%)

Query: 51  LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF 110
            +EE      + +L GL  LH    ++RD+K  NILL + G ++++D G A +K P    
Sbjct: 99  FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGES 157

Query: 111 ----VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
               VGT  +MAPEV+   +  +Y    D W LG
Sbjct: 158 IRGRVGTVGYMAPEVL---NNQRYTLSPDYWGLG 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 13/145 (8%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIE-VHKRPLKEEEIAAICSG 62
           + ++++L+H   ++     + +   ++V EY   GS  D ++    + L+  ++  + + 
Sbjct: 52  AQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV---GTPY---W 116
           +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    N +    G  +   W
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 169

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE  L    G++  K DVWS GI
Sbjct: 170 TAPEAALY---GRFTIKSDVWSFGI 191

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 50/240 (20%)

Query: 169 EIGHGSFGAVY--YARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           E+G G+FG V     +   S + VA+K +       A K  ++L+E   ++QL +P  + 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQLDNPYIVR 60

Query: 227 YRGCYLRDHTAW-LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
             G  + +  +W LVME                    +  +G              L  F
Sbjct: 61  MIG--ICEAESWMLVME--------------------LAELG-------------PLNKF 85

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASI 344
               + + E+ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S ++
Sbjct: 86  LQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145

Query: 345 KCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNM 397
               N +    +      W APE    M+  ++  K DVWS G+   E  +  + PY  M
Sbjct: 146 GADENYYKAKTHGKWPVKWYAPE---CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 66/257 (25%), Positives = 96/257 (37%), Gaps = 60/257 (23%)

Query: 169 EIGHGSFG----AVYYARCLVSREI-VAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKH 221
           E+G G+FG     VY  R    ++I VAIK +    K   EK    ++++E   + QL +
Sbjct: 2   ELGSGNFGCVKKGVYKMR---KKQIDVAIKVL----KNENEKSVRDEMMREAEIMHQLDN 54

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P  +   G         LVME   G                                   
Sbjct: 55  PYIVRMIGV-CEAEALMLVMEMASGGP--------------------------------- 80

Query: 282 LFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           L  F   K+  +    +  +   V  G+ YL     +HRD+ A N+LL      K++DFG
Sbjct: 81  LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140

Query: 341 -SASIKC-----PANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 392
            S ++        A S    P  W APE I      ++  + DVWS GIT  E  +  + 
Sbjct: 141 LSKALGADDSYYKARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGITMWEAFSYGQK 197

Query: 393 PYFNMNAMSALYHIAQN 409
           PY  M     +  I Q 
Sbjct: 198 PYKKMKGPEVMSFIEQG 214

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 46/113 (40%), Positives = 59/113 (52%), Gaps = 15/113 (13%)

Query: 602 NNNNSNY--SSLFSPQL--VMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH 656
           N N  NY  S L   +L  VMEY  G S +D+  V +  + E +IAA+C   L+ L +LH
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLH 133

Query: 657 SLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
           S   IHRD+K+ NILL   G+VKL         D      IT E S +S  VG
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKL--------TDFGFCAQITPEQSKRSTMVG 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 79/307 (25%), Positives = 121/307 (39%), Gaps = 59/307 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           FED+  IG G+FG V   R ++ ++      AIK +     +   +  D   E+  L +L
Sbjct: 6   FEDV--IGEGNFGQV--IRAMIKKDGLKMNAAIKMLKEFASENDHR--DFAGELEVLCKL 59

Query: 220 -KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             HPN I   G        ++ +EY   G+  D +      R+  V      L+    F 
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL------RKSRV------LETDPAFA 107

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
           +             L  +++    S V  G+ YL     IHRD+ A N+L+ E    K+A
Sbjct: 108 KEHGT------ASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161

Query: 338 DFG-SASIKCPANSFVGT-PY-WMAPEVILAMDEGQYDGKVDVWSLGI------------ 382
           DFG S   +      +G  P  WMA E   +++   Y  K DVWS G+            
Sbjct: 162 DFGLSRGEEVYVKKTMGRLPVRWMAIE---SLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Query: 383 ----TCIELAERKPPYFNM----NAMSALYHIAQN---DTPCLQSSDWSVIKTISSTAER 431
               TC EL E+ P  + M    N    +Y + +    D P  +     +   +S   E 
Sbjct: 219 YCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278

Query: 432 KPPYFNM 438
           +  Y NM
Sbjct: 279 RKAYVNM 285

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.5 bits (133), Expect = 4e-08
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G S +D+  V +  + E +IAA+C   L+ L +LH+   IHRD+K+ N+LL  
Sbjct: 93  VVMEYLAGGSLTDV--VTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM 150

Query: 675 TGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
            G+VKL         D      IT E S +S  VG
Sbjct: 151 DGSVKL--------TDFGFCAQITPEQSKRSTMVG 177

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 42/152 (27%), Positives = 64/152 (42%), Gaps = 27/152 (17%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLV-MEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           +++   HPN +   G  L    + LV + Y   G   + I         +++      V 
Sbjct: 49  IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA 108

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---------------SIKCPANS 109
           +G+ YL S   +HRD+ A N +L E+ TVK+ADFG A                 K P   
Sbjct: 109 KGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK- 167

Query: 110 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
                 WMA E   ++   ++  K DVWS G+
Sbjct: 168 ------WMALE---SLQTQKFTTKSDVWSFGV 190

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 43  IIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 102
           I  V +R L+ E +    + +  G+ +LHS+  ++RD+K  N+LL + G  +L+D G A 
Sbjct: 84  IYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA- 142

Query: 103 IKCPANSFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLG-----ITPGSLKDPEIAE 153
           ++      +    GT  +MAPE++    E  Y   VD +++G     +  G     +  E
Sbjct: 143 VELKDGKTITQRAGTNGYMAPEILK---EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199

Query: 154 LFDKED-PEKIFEDLREIGHGSFGA 177
              KE+   +  ED  +  H +F  
Sbjct: 200 KVAKEELKRRTLEDEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 15/150 (10%)

Query: 1   MPAGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAA 58
           +   +++++QL +P  +   G  + +  +W LVME   LG  +  ++ +K  + E+ I  
Sbjct: 43  LLREANVMQQLDNPYIVRMIG--ICEAESWMLVMELAELGPLNKFLQKNKH-VTEKNITE 99

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY-- 115
           +   V  G+ YL     +HRD+ A N+LL      K++DFG S ++    N +    +  
Sbjct: 100 LVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159

Query: 116 ----WMAPEVILAMDEGQYDGKVDVWSLGI 141
               W APE    M+  ++  K DVWS G+
Sbjct: 160 WPVKWYAPE---CMNYYKFSSKSDVWSFGV 186

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 54.4 bits (132), Expect = 5e-08
 Identities = 27/75 (36%), Positives = 36/75 (48%), Gaps = 5/75 (6%)

Query: 607 NYSSLFSPQLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 665
               L+   LV+EY   G     +    R   EE      + ++  L YLHSLG I+RD+
Sbjct: 64  TEEKLY---LVLEYAPGGELFSHLSKEGR-FSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 666 KAGNILLTETGTVKL 680
           K  NILL   G +KL
Sbjct: 120 KPENILLDADGHIKL 134

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 43/237 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLKH 221
           F   R +G G FG V   +   + ++ A KK+    + K+  E  A  L E + L ++  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
              +     Y       LV+   L +  D+        +FH+  MG        F E  A
Sbjct: 60  RFVVSLAYAYETKDALCLVLT--LMNGGDL--------KFHIYHMGE-----AGFEEGRA 104

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           +F              A IC G    L  LH    ++RD+K  NILL + G ++++D G 
Sbjct: 105 VF------------YAAEICCG----LEDLHQERIVYRDLKPENILLDDHGHIRISDLGL 148

Query: 342 ASIKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           A +  P        VGT  +MAPEV+      +Y    D W+LG    E+   + P+
Sbjct: 149 A-VHVPEGQTIKGRVGTVGYMAPEVV---KNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 63/284 (22%), Positives = 102/284 (35%), Gaps = 87/284 (30%)

Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           +F  ++ +G G+FG V  AR + ++ + A+K +         + A +  E   L +  + 
Sbjct: 2   MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE 61

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             +     +      + VM+Y  G                   M + L ++  F E  A 
Sbjct: 62  WVVRLYYSFQDKDNLYFVMDYIPGG-----------------DMMSLLIRMGIFPEDLAR 104

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-- 340
           F           E   A+ S        +H +G IHRD+K  NIL+   G +KL DFG  
Sbjct: 105 FYIA--------ELTCAVES--------VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148

Query: 341 -------------------------------SASIKCP------------------ANSF 351
                                           A+ +C                   A+S 
Sbjct: 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSL 208

Query: 352 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           VGTP ++APEV+L      Y    D WS+G+   E+   +PP+ 
Sbjct: 209 VGTPNYIAPEVLLRTG---YTQLCDWWSVGVILYEMLVGQPPFL 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 55.5 bits (132), Expect = 6e-08
 Identities = 37/103 (35%), Positives = 47/103 (45%), Gaps = 12/103 (11%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLG-SASDIIEVH--KRPLKE 638
           Q     +H   +  L     +  +          LVMEY  G S  D+++    K PL E
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLY--------LVMEYVDGGSLEDLLKKIGRKGPLSE 100

Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT-VKL 680
            E   I + +L  L YLHS G IHRD+K  NILL   G  VKL
Sbjct: 101 SEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKL 143

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 54.5 bits (132), Expect = 7e-08
 Identities = 25/106 (23%), Positives = 45/106 (42%), Gaps = 17/106 (16%)

Query: 609 SSLFSPQLVMEYCLGSASDIIE-VHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 666
            +L+    V+EY      ++++ + K   L E+      + +L  L YLHS G IHRD+K
Sbjct: 75  ENLY---FVLEYAPNG--ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK 129

Query: 667 AGNILLTETGTVKL----------DTPDEQAGNDSSKSNSITSEHS 702
             NILL +   +K+               ++    + +     E +
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 26/160 (16%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-----------------LGSASDIIEVH 47
           +SL+ +L HPN +   G   ++    ++ EY                  +G +SD     
Sbjct: 58  ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117

Query: 48  KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA 107
           K  L   +   I   +  G+ YL S   +H+D+ A NIL+ E   VK++D G +     A
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177

Query: 108 NSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGI 141
           + +   P       WM PE I+    G++    D+WS G+
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMY---GKFSSDSDIWSFGV 214

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 54.1 bits (131), Expect = 8e-08
 Identities = 23/65 (35%), Positives = 35/65 (53%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +V EY     + +++  +    E +I      +L GL YLHS G +HRD+K  NIL+   
Sbjct: 77  MVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND 136

Query: 676 GTVKL 680
           G +KL
Sbjct: 137 GVLKL 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 54.3 bits (131), Expect = 8e-08
 Identities = 28/93 (30%), Positives = 44/93 (47%), Gaps = 4/93 (4%)

Query: 590 HHPVTHLSQ--HSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG 647
           H  V +L +   +     + Y   F   LV E+C    + ++          EI  +   
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSF--YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L GL Y+H    +HRD+KA NIL+T+ G +KL
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKL 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 53.7 bits (130), Expect = 9e-08
 Identities = 21/74 (28%), Positives = 33/74 (44%), Gaps = 9/74 (12%)

Query: 616 LVMEYCLG---------SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 666
           LV+EY  G         S        K  L  +++ +    + +G+ YL S   +HRD+ 
Sbjct: 73  LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132

Query: 667 AGNILLTETGTVKL 680
           A N L+ E   VK+
Sbjct: 133 ARNCLVGEDLVVKI 146

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 51  LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA 107
             E+E+    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P 
Sbjct: 94  FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153

Query: 108 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
            S VGT  +MAPEV+       YD   D +SLG
Sbjct: 154 AS-VGTHGYMAPEVL--QKGTAYDSSADWFSLG 183

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 23/65 (35%), Positives = 33/65 (50%), Gaps = 1/65 (1%)

Query: 617 VMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTET 675
           VM+  L      +      + E+ +  I   +++ L YLHS L  IHRDVK  N+L+   
Sbjct: 81  VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN 140

Query: 676 GTVKL 680
           G VKL
Sbjct: 141 GQVKL 145

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 4/85 (4%)

Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMAPEV 362
           V   + YL +   +HRD+ A N+L++E    K++DFG              P  W APE 
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE- 169

Query: 363 ILAMDEGQYDGKVDVWSLGITCIEL 387
             A+ E ++  K DVWS GI   E+
Sbjct: 170 --ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 13/147 (8%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD-IIEVHKRPLKEEEIAAICSGV 63
           +S++ Q  HPN I   G   +     ++ E+    A D  +  +       ++  +  G+
Sbjct: 56  ASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI 115

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------SASIKCPANSFVGT-PY 115
             G+ YL  +  +HRD+ A NIL+      K++DFG         S     +S  G  P 
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 116 -WMAPEVILAMDEGQYDGKVDVWSLGI 141
            W APE   A+   ++    DVWS GI
Sbjct: 176 RWTAPE---AIAYRKFTSASDVWSYGI 199

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 9/145 (6%)

Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD-IIEVHKRPLKEEEIAAICS 61
           A +  L Q  H N +   G   R +T  +V EY    A D  +  H+  L   ++  +  
Sbjct: 55  AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS---IKCPANSFVGTP--YW 116
           G+  G+ YL  +G +H+ + A  +L+      K++ F        +    +  G     W
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE   A+    +    DVWS GI
Sbjct: 175 AAPE---AIQYHHFSSASDVWSFGI 196

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 62/246 (25%), Positives = 100/246 (40%), Gaps = 53/246 (21%)

Query: 168 REIGHGSFGAVYYARCLVSREI-----VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G FG+V   +  +S++      VA+K M       +E   + L E   ++   HP
Sbjct: 5   KILGEGEFGSVMEGQ--LSQDDGSQLKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHP 61

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIER-EFHVEGMGNRLQQLKCFTEHFA 281
           N ++  G                     ++ + +++  + H   + +RL  L        
Sbjct: 62  NVMKLIGVCFE-------ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG- 340
           L  F V        +IA        G+ YL +   IHRD+ A N +L E  TV +ADFG 
Sbjct: 115 LLKFMV--------DIA-------LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159

Query: 341 SASIKCPANSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           S  I      + G  Y           W+A E   ++ +  Y  K DVW+ G+T  E+A 
Sbjct: 160 SKKI------YSGDYYRQGRIAKMPVKWIAIE---SLADRVYTSKSDVWAFGVTMWEIAT 210

Query: 390 R-KPPY 394
           R + PY
Sbjct: 211 RGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 53.7 bits (130), Expect = 2e-07
 Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 10/98 (10%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASD---IIEVHKRPLKEEEIA 642
           RH  H  +  L       +  +++ ++   +V E      +D   +I+   +PL ++ I 
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVY---IVTEL---METDLHKVIK-SPQPLTDDHIQ 106

Query: 643 AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
                +LRGL YLHS   IHRD+K  NIL+     +K+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKI 144

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 30/158 (18%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH--KRPLKEEEIAAICSGV 63
           ++ +LK PN I      +      ++ EY   G  +  +  H  +   ++ ++  I    
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 64  LR--------GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY 115
           L         G+ YL SL  +HRD+   N L+ +  T+K+ADFG +      N + G  Y
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYSGDYY 186

Query: 116 -----------WMAPEVILAMDEGQYDGKVDVWSLGIT 142
                      WM+ E IL    G++    DVW+ G+T
Sbjct: 187 RIQGRAVLPIRWMSWESILL---GKFTTASDVWAFGVT 221

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 9/85 (10%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV--GTPY----W 116
           V RG+ +L S   +HRD+ A N+LL +   VK+ DFG A      +++V  G+ +    W
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           MAPE I    +  Y    DVWS GI
Sbjct: 306 MAPESIF---DNLYTTLSDVWSYGI 327

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 65/240 (27%), Positives = 97/240 (40%), Gaps = 54/240 (22%)

Query: 168 REIGHGSFGAVYYARC---LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +EIG+G FG V            ++V  +       Q   K+   L+E +  R L+H N 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKF---LEEAQPYRSLQHSNL 57

Query: 225 IEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
           ++  G         LVME+C LG     +           +     LQ++ C        
Sbjct: 58  LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT--TLQRMAC-------- 107

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                       EIA        GL +LH    IH D+   N LLT   TVK+ D+G + 
Sbjct: 108 ------------EIAL-------GLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148

Query: 344 IKCPANSFVGTP-------YWMAPEVI-------LAMDEGQYDGKVDVWSLGITCIELAE 389
            K   + +V TP        W+APE++       L +D+ +   + +VWSLG+T  EL E
Sbjct: 149 NKYKEDYYV-TPDQLWVPLRWIAPELVDEVHGNLLVVDQTK---ESNVWSLGVTIWELFE 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 52.6 bits (127), Expect = 3e-07
 Identities = 21/65 (32%), Positives = 36/65 (55%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VMEY       ++E  K+P  + E+  +   +L G+ +LH    +HRD+K  N+LL   
Sbjct: 83  MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR 142

Query: 676 GTVKL 680
           G +K+
Sbjct: 143 GILKI 147

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 34/122 (27%), Positives = 47/122 (38%), Gaps = 50/122 (40%)

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--------------------------- 99
           +  +H +G IHRD+K  NIL+   G +KL DFG                           
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173

Query: 100 --------SASIK------------CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 139
                      +K            C A+S VGTP ++APEV+L      Y    D WS+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG---YTQLCDWWSV 230

Query: 140 GI 141
           G+
Sbjct: 231 GV 232

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.0 bits (130), Expect = 3e-07
 Identities = 70/272 (25%), Positives = 109/272 (40%), Gaps = 85/272 (31%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD--ILKEIRFLR---- 217
           ++ +R IG G  G VY A   V    VA+KK+        E  ++  +LK+ RFLR    
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-------EDLSENPLLKK-RFLREAKI 55

Query: 218 --QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII--EVHWIEREFHVEGMGNRLQQ- 272
              L HP                +V  Y + S  D +   + +IE        G  L+  
Sbjct: 56  AADLIHPG---------------IVPVYSICSDGDPVYYTMPYIE--------GYTLKSL 92

Query: 273 LKCFTEHFALFNFEVHKRPLKEEE-IAA-------ICSGVLRGLNYLHSLGRIHRDVKAG 324
           LK   +       E   + L E+  + A       IC+ +     Y+HS G +HRD+K  
Sbjct: 93  LKSVWQK------ESLSKELAEKTSVGAFLSIFHKICATI----EYVHSKGVLHRDLKPD 142

Query: 325 NILLTETGTVKLADFGSA-------------SIKCPANSF---------VGTPYWMAPEV 362
           NILL   G V + D+G+A              +      +         VGTP +MAPE 
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202

Query: 363 ILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +L +   +     D+++LG+   ++     PY
Sbjct: 203 LLGVPASE---STDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 23/113 (20%)

Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--- 344
           +K  +  +++   C  + +G++YL  +  +HRD+ A N+L+     VK+ DFG A +   
Sbjct: 102 NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161

Query: 345 ----------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                     K P         WMA E IL     ++  + DVWS G+T  EL
Sbjct: 162 DETEYHADGGKVPIK-------WMALESIL---HRRFTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 58/249 (23%), Positives = 109/249 (43%), Gaps = 32/249 (12%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           RE+G GSFG VY     +++ +V  +  + +  +   + A + + I FL +    + ++ 
Sbjct: 12  RELGQGSFGMVYEG---IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE---ASVMKE 65

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFALFNFE 286
             C+   H   L+     G  + +I       E    G + + L+ L+   E+    N  
Sbjct: 66  FNCH---HVVRLLGVVSQGQPTLVI------MELMTRGDLKSYLRSLRPEMEN----NPV 112

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC 346
                LK+  +  +   +  G+ YL++   +HRD+ A N ++ E  TVK+ DFG      
Sbjct: 113 QAPPSLKK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 170

Query: 347 PANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNA 399
             + +      +    WM+PE   ++ +G +    DVWS G+   E+A   + PY  M+ 
Sbjct: 171 ETDYYRKGGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227

Query: 400 MSALYHIAQ 408
              L  + +
Sbjct: 228 EQVLRFVME 236

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 19/46 (41%), Positives = 23/46 (50%)

Query: 635 PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
              E  I      +L GL YLH    +HRD+K  NIL+   G VKL
Sbjct: 98  SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKL 143

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 25/91 (27%), Positives = 49/91 (53%), Gaps = 7/91 (7%)

Query: 590 HHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 649
            H   ++ Q+  ++ ++++ ++F     +EY  G +   +  +    +E  +      +L
Sbjct: 64  QHE--NIVQYLGSSLDADHLNIF-----LEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116

Query: 650 RGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +GLNYLH+ G IHRD+K  NIL+   G +K+
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGIKI 147

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 29/64 (45%), Positives = 39/64 (60%), Gaps = 3/64 (4%)

Query: 618 MEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           M Y  GSA D+I  H    + E  IA I  GVL+ L+Y+H +G +HR VKA +IL++  G
Sbjct: 81  MAY--GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138

Query: 677 TVKL 680
            V L
Sbjct: 139 KVYL 142

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 23/156 (14%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR-------------PLK 52
           LL   +H N +++ G         +V EY   G  +  +  H                L 
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120

Query: 53  EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFV 111
             ++  I   +  G+ YL S   +HRD+   N L+     VK+ DFG S  +       V
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180

Query: 112 G----TPY-WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           G     P  WM PE I+     ++  + DVWS G+ 
Sbjct: 181 GGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVV 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.1 bits (127), Expect = 4e-07
 Identities = 31/80 (38%), Positives = 45/80 (56%), Gaps = 6/80 (7%)

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCPAN---SFVGTPYWMAPE 120
           R L Y+HS    HRD+K  N+L+   T T+KL DFGSA          S++ + ++ APE
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240

Query: 121 VILAMDEGQYDGKVDVWSLG 140
           ++L      Y   +D+WSLG
Sbjct: 241 LMLG--ATNYTTHIDLWSLG 258

Length = 440

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 39/149 (26%), Positives = 60/149 (40%), Gaps = 23/149 (15%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           ++  + +P+     G  L      +      G   D +  HK  +  + +   C  + +G
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-------------KCPANSFVGT 113
           +NYL     +HRD+ A N+L+     VK+ DFG A +             K P       
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK----- 176

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
             WMA E IL      Y  + DVWS G+T
Sbjct: 177 --WMALESIL---HRIYTHQSDVWSYGVT 200

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 39/140 (27%), Positives = 52/140 (37%), Gaps = 54/140 (38%)

Query: 311 LHSLGRIHRDVKAGNILLTETGTVKLADFG-------------------SASIKCPAN-- 349
           +H LG IHRD+K  NIL+   G +KL+DFG                     S K   +  
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 350 ------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWS 379
                                         S VGTP ++APE+ L    GQ   + D WS
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ---ECDWWS 233

Query: 380 LGITCIELAERKPPYFNMNA 399
           LG    E     PP+ + N+
Sbjct: 234 LGAIMFECLIGWPPFCSENS 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 9/98 (9%)

Query: 50  PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASI----K 104
           PL   E   I   V  G+ YL     +HRD+   N L+ E   VK+ADFG S +I     
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 105 CPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             A+     P  WM PE I      +Y  + DVW+ G+
Sbjct: 186 YKASENDAIPIRWMPPESIFY---NRYTTESDVWAYGV 220

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 35/124 (28%), Positives = 57/124 (45%), Gaps = 25/124 (20%)

Query: 32  VMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 91
           +M Y  G   D +  +K  +  +++   C  + +G++YL  +  +HRD+ A N+L+    
Sbjct: 89  LMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN 146

Query: 92  TVKLADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 138
            VK+ DFG A +             K P         WMA E IL     ++  + DVWS
Sbjct: 147 HVKITDFGLARLLDIDETEYHADGGKVPIK-------WMALESIL---HRRFTHQSDVWS 196

Query: 139 LGIT 142
            G+T
Sbjct: 197 YGVT 200

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 5e-07
 Identities = 24/55 (43%), Positives = 33/55 (60%)

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF 110
           I  +   VL GL  LH +G +HRD+K  N+L+T  G VK+ DFG+A   C   +F
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF 365

Length = 507

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 5e-07
 Identities = 24/55 (43%), Positives = 33/55 (60%)

Query: 297 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF 351
           I  +   VL GL  LH +G +HRD+K  N+L+T  G VK+ DFG+A   C   +F
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF 365

Length = 507

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 6e-07
 Identities = 26/71 (36%), Positives = 36/71 (50%), Gaps = 12/71 (16%)

Query: 616 LVMEYCLGSASDIIE--VHKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAGN 669
           LVMEY  G   D++   + K    EE     IA +   +    + +H LG IHRD+K  N
Sbjct: 78  LVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLAL----DSVHKLGFIHRDIKPDN 131

Query: 670 ILLTETGTVKL 680
           IL+   G +KL
Sbjct: 132 ILIDADGHIKL 142

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 64/252 (25%), Positives = 95/252 (37%), Gaps = 65/252 (25%)

Query: 168 REIGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           R +G G FG+V  A+      S + VA+K M       +    + L+E   +++  HPN 
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFDHPNV 63

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL---QQLKCFTEHFA 281
           I+  G  LR                                   RL     +  F +H  
Sbjct: 64  IKLIGVSLRSRAK------------------------------GRLPIPMVILPFMKHGD 93

Query: 282 LFNFEVHKR------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
           L  F +  R       L  + +      +  G+ YL S   IHRD+ A N +L E  TV 
Sbjct: 94  LHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC 153

Query: 336 LADFG-SASIKCPANSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWSLGIT 383
           +ADFG S  I      + G  Y           W+A E   ++ +  Y    DVW+ G+T
Sbjct: 154 VADFGLSKKI------YSGDYYRQGCASKLPVKWLALE---SLADNVYTTHSDVWAFGVT 204

Query: 384 CIELAER-KPPY 394
             E+  R + PY
Sbjct: 205 MWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 8/92 (8%)

Query: 53  EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF-- 110
           EE      + +  GL  LH    ++RD+K  NILL + G ++++D G A ++ P      
Sbjct: 101 EERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIR 159

Query: 111 --VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
             VGT  +MAPEV+      +Y    D W LG
Sbjct: 160 GRVGTVGYMAPEVV---KNERYTFSPDWWGLG 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 23/67 (34%), Positives = 38/67 (56%), Gaps = 2/67 (2%)

Query: 616 LVMEYCL-GSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +VMEY   G    ++++   RPL E+++      +L GL +LHS   +HRD+K+ N+ L 
Sbjct: 76  IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135

Query: 674 ETGTVKL 680
               VK+
Sbjct: 136 AYDNVKI 142

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 31/69 (44%), Positives = 42/69 (60%), Gaps = 4/69 (5%)

Query: 616 LVMEYCLG-SASDIIE---VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           LV+E C G S +++++   +  + L E  I+ I  G L GL +LH+   IHRDVK  NIL
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160

Query: 672 LTETGTVKL 680
           LT  G VKL
Sbjct: 161 LTTEGGVKL 169

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 29/72 (40%), Positives = 39/72 (54%), Gaps = 12/72 (16%)

Query: 616 LVMEYCLGSASDIIEVH----KRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 668
           LVM+YC G      E+     ++P   L EE      + VL  L YLH LG ++RD+K  
Sbjct: 78  LVMDYCPGG-----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPE 132

Query: 669 NILLTETGTVKL 680
           NILL E+G + L
Sbjct: 133 NILLHESGHIML 144

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 28/64 (43%), Positives = 39/64 (60%), Gaps = 3/64 (4%)

Query: 618 MEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           M Y  GSA+ +++ +    + E  I  I  G LRGLNYLH  G IHR++KA +IL++  G
Sbjct: 81  MAY--GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG 138

Query: 677 TVKL 680
            V L
Sbjct: 139 LVSL 142

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 11/120 (9%)

Query: 31  LVMEYCLGSASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           LVME   G   +     K+  +    +  +   V  G+ YL     +HRD+ A N+LL  
Sbjct: 71  LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130

Query: 90  TGTVKLADFG-SASIKC-----PANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGIT 142
               K++DFG S ++        A S    P  W APE I      ++  + DVWS GIT
Sbjct: 131 QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGIT 187

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 60/253 (23%), Positives = 107/253 (42%), Gaps = 48/253 (18%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E   +    LRE+G GSFG VY      +R+I+  +  + +  +   + A + + I FL 
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEG---NARDIIKGEAETRVAVKTVNESASLRERIEFLN 58

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCF 276
           +    + ++   C+   H   L+     G  + ++       E    G + + L+ L+  
Sbjct: 59  E---ASVMKGFTCH---HVVRLLGVVSKGQPTLVV------MELMAHGDLKSYLRSLRPE 106

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            E+         + P   +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+
Sbjct: 107 AEN------NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160

Query: 337 ADFGSASIKCPANSFVGTPY------------WMAPEVILAMDEGQYDGKVDVWSLGITC 384
            DFG             T Y            WMAPE   ++ +G +    D+WS G+  
Sbjct: 161 GDFGM------TRDIYETDYYRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGVVL 211

Query: 385 IE---LAERKPPY 394
            E   LAE+  PY
Sbjct: 212 WEITSLAEQ--PY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.8 bits (124), Expect = 1e-06
 Identities = 31/77 (40%), Positives = 45/77 (58%), Gaps = 4/77 (5%)

Query: 30  WLVMEYCLGSASDIIEV-HKRPLKEEEIAA-ICSGVLRGLNYLHSLGRIHRDVKAGNILL 87
           +LVMEY +G   D+  + H     +EE+A    S V   L+YLH  G IHRD+K  N+L+
Sbjct: 80  YLVMEYLIGG--DVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137

Query: 88  TETGTVKLADFGSASIK 104
           +  G +KL DFG + + 
Sbjct: 138 SNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 34/69 (49%), Positives = 41/69 (59%), Gaps = 4/69 (5%)

Query: 616 LVMEYCLG-SASDIIE-VHKRPLKEEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           LV+E C G S +D+++   KR  + EE  IA I    L GL +LH    IHRDVK  NIL
Sbjct: 97  LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNIL 156

Query: 672 LTETGTVKL 680
           LT  G VKL
Sbjct: 157 LTTEGGVKL 165

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 13/87 (14%)

Query: 600 SYNNNNSNYSSLFSPQLVMEYCLGS--ASDIIEVHKRPLKEEEIAA----ICSGVLRGLN 653
           +Y N+  + ++L    + MEY  G      I+    +  +EE +      I S V    +
Sbjct: 63  AYYNHFMDDNTLL---IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV----S 115

Query: 654 YLHSLGRIHRDVKAGNILLTETGTVKL 680
           Y+H  G +HRD+K  NI LT+ G +KL
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKL 142

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 62/244 (25%), Positives = 92/244 (37%), Gaps = 56/244 (22%)

Query: 168 REIGHGSFGAVYYARCL---VSREI-VAIKKMSYLGKQCAEKWA-DILKEIRFLRQLKHP 222
           R +G G FG +    CL     RE+ VAI     L   C++K     L E   L Q  H 
Sbjct: 11  RILGTGRFGELCRG-CLKLPSKRELPVAIHT---LRAGCSDKQRRGFLAEALTLGQFDHS 66

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +   G   R +T  +V EY                      M N            AL
Sbjct: 67  NIVRLEGVITRGNTMMIVTEY----------------------MSNG-----------AL 93

Query: 283 FNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
            +F   H+  L   ++  +  G+  G+ YL  +G +H+ + A  +L+      K++ F  
Sbjct: 94  DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR 153

Query: 342 AS---IKCPANSFVGTP--YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPP 393
                 +    +  G     W APE   A+    +    DVWS GI   E+    ER  P
Sbjct: 154 LQEDKSEAIYTTMSGKSPVLWAAPE---AIQYHHFSSASDVWSFGIVMWEVMSYGER--P 208

Query: 394 YFNM 397
           Y++M
Sbjct: 209 YWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 35/122 (28%), Positives = 45/122 (36%), Gaps = 54/122 (44%)

Query: 70  LHSLGRIHRDVKAGNILLTETGTVKLADFG-------------------SASIKCPAN-- 108
           +H LG IHRD+K  NIL+   G +KL+DFG                     S K   +  
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 109 ------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWS 138
                                         S VGTP ++APE+ L    GQ   + D WS
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ---ECDWWS 233

Query: 139 LG 140
           LG
Sbjct: 234 LG 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 7/78 (8%)

Query: 604 NNSNYSSLFSPQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 662
               Y S+F     +EY  G S    +  + R  +E+ +      VL GL YLHS G +H
Sbjct: 78  TTEEYLSIF-----LEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGLAYLHSKGILH 131

Query: 663 RDVKAGNILLTETGTVKL 680
           RD+KA N+L+   G  K+
Sbjct: 132 RDLKADNLLVDADGICKI 149

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 5/95 (5%)

Query: 588 HHHHP-VTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRP-LKEEEIAAIC 645
              HP +  L    +         L    LV E+     +  +    +P L  E I  + 
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLT---LVFEHVDQDLATYLSKCPKPGLPPETIKDLM 113

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
             +LRG+++LHS   +HRD+K  NIL+T  G VK+
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKI 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 15/100 (15%)

Query: 586 RHHHHHPVTHL-----SQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEE 640
           +H  H  V  L     S  S +     Y       LVM Y     +D+ ++   PL E++
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFY-------LVMPYMQ---TDLQKIMGHPLSEDK 118

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +  +   +L GL Y+HS G IHRD+K GN+ + E   +K+
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKI 158

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 51  LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANS 109
           L  +++    + V RG++YL     IHRD+ A NIL+ E    K+ADFG S   +     
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180

Query: 110 FVGT-PY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
            +G  P  WMA E   +++   Y    DVWS G+
Sbjct: 181 TMGRLPVRWMAIE---SLNYSVYTTNSDVWSYGV 211

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 39/171 (22%)

Query: 9   RQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR-------PLKEEEIAA-I 59
           R L+H N ++  G         LVME+C LG     +   ++       P   + +A  I
Sbjct: 50  RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP----- 114
             G+L    +LH    IH D+   N LLT   TVK+ D+G +  K   + +V TP     
Sbjct: 110 ALGLL----HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV-TPDQLWV 164

Query: 115 --YWMAPEVI-------LAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFD 156
              W+APE++       L +D+ +   + +VWSLG+T        I ELF+
Sbjct: 165 PLRWIAPELVDEVHGNLLVVDQTK---ESNVWSLGVT--------IWELFE 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 64/251 (25%), Positives = 98/251 (39%), Gaps = 46/251 (18%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK--WADILKEIRFLRQL-KHPNTIE 226
           IG G+FG V   +  + ++ + +       K+ A K    D   E+  L +L  HPN I 
Sbjct: 3   IGEGNFGQV--LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 227 YRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
             G        +L +EY   G+  D                   L++ +      A    
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDF------------------LRKSRVLETDPAFAIA 102

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASI 344
                 L  +++    + V RG++YL     IHRD+ A NIL+ E    K+ADFG S   
Sbjct: 103 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 162

Query: 345 KCPANSFVGT-PY-WMAPEVILAMDEGQYDGKVDVWSLGI----------------TCIE 386
           +      +G  P  WMA E   +++   Y    DVWS G+                TC E
Sbjct: 163 EVYVKKTMGRLPVRWMAIE---SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219

Query: 387 LAERKPPYFNM 397
           L E+ P  + +
Sbjct: 220 LYEKLPQGYRL 230

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 9/90 (10%)

Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV--GTPY----W 357
           V  G+ +L S   +HRD+ A N+L+ E   VK+ DFG A      ++++  G+ +    W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307

Query: 358 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           MAPE I       Y    DVWS GI   E+
Sbjct: 308 MAPESIF---NNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 35/115 (30%), Positives = 52/115 (45%), Gaps = 6/115 (5%)

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET-GTVKLADFG 340
           LF+    +  L E E+  I   ++  LN LH    IH D+K  N+L       + L D+G
Sbjct: 96  LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYG 155

Query: 341 SASIKCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
              I    + + GT  + +PE I     G  YD   D W++G+   EL   K P+
Sbjct: 156 LCKIIGTPSCYDGTLDYFSPEKIK----GHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.2 bits (120), Expect = 4e-06
 Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 37/127 (29%)

Query: 45  EVHKRPLKEEE-IAA-------ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 96
           E   + L E+  + A       IC+ +     Y+HS G +HRD+K  NILL   G V + 
Sbjct: 100 ESLSKELAEKTSVGAFLSIFHKICATI----EYVHSKGVLHRDLKPDNILLGLFGEVVIL 155

Query: 97  DFGSA-------------SIKCPANSF---------VGTPYWMAPEVILAMDEGQYDGKV 134
           D+G+A              +      +         VGTP +MAPE +L +   +     
Sbjct: 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE---ST 212

Query: 135 DVWSLGI 141
           D+++LG+
Sbjct: 213 DIYALGV 219

Length = 932

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 9/85 (10%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV--GTPY----W 116
           V  G+ +L S   +HRD+ A N+L+ E   VK+ DFG A      ++++  G+ +    W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           MAPE I       Y    DVWS GI
Sbjct: 308 MAPESIF---NNLYTTLSDVWSFGI 329

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 30/161 (18%)

Query: 6   SLLR-QLKHPNTIEYRGCYLRDHTAWLVMEYC-----------------LGSASDIIEVH 47
           +++R +L+HPN +   G   ++    ++  YC                 +GS  D   V 
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV- 117

Query: 48  KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------S 100
           K  L+  +   I + +  G+ +L S   +H+D+   N+L+ +   VK++D G       +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 101 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
              K   NS +    WM+PE I+    G++    D+WS G+
Sbjct: 178 DYYKLMGNSLLPI-RWMSPEAIMY---GKFSIDSDIWSYGV 214

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 48.0 bits (115), Expect = 7e-06
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)

Query: 616 LVMEYCL-GSASDIIEVHKR---PLKEEEIAAICSGVLRGLNYLHSLGR-----IHRDVK 666
           +VMEYC  G  + +I+  K+    ++EE I  I + +L  L   H+        +HRD+K
Sbjct: 78  IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137

Query: 667 AGNILLTETGTVKL 680
             NI L     VKL
Sbjct: 138 PANIFLDANNNVKL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 48.5 bits (116), Expect = 7e-06
 Identities = 20/48 (41%), Positives = 29/48 (60%)

Query: 633 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            +PL EE I      +LRGL Y+HS   IHRD+K  N+L+ E   +++
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRI 148

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 31/183 (16%)

Query: 9   RQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDII---EVHKRPLKEEEIAAICSGVL 64
           R L+HPN ++  G  +      LV EYC LG     +   + H+R  +   +  +   + 
Sbjct: 50  RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-------YWM 117
            G+ ++H    +H D+   N  LT   TVK+ D+G    +   + ++ T         W+
Sbjct: 110 AGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWL 168

Query: 118 APEVI-------LAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDK-EDPEKIFEDLRE 169
           APE++       +  ++ +     +VW+LG+T        + ELF+    P     D   
Sbjct: 169 APELVGEFHGGLITAEQTKPS---NVWALGVT--------LWELFENAAQPYSHLSDREV 217

Query: 170 IGH 172
           + H
Sbjct: 218 LNH 220

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 21/49 (42%), Positives = 27/49 (55%)

Query: 632 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            K    EE++      ++  L YLHS G IHRD+K  NILL E G V +
Sbjct: 93  QKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHI 141

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 24/65 (36%), Positives = 32/65 (49%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EY       ++E       E+ I +    +L GLNY H    +HRD+K  NILL   
Sbjct: 93  LVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK 152

Query: 676 GTVKL 680
           G +KL
Sbjct: 153 GQIKL 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 36/124 (29%), Positives = 52/124 (41%), Gaps = 28/124 (22%)

Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY------- 356
           +  G++YLH  G IH+D+ A N ++ E   VK+ D   +    P +      Y       
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD------YHCLGDNE 179

Query: 357 -----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPY-----FNMNAM-SALY 404
                WMA E   ++   +Y    DVWS G+   EL    + PY     F M A     Y
Sbjct: 180 NRPVKWMALE---SLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236

Query: 405 HIAQ 408
            +AQ
Sbjct: 237 RLAQ 240

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 48.3 bits (115), Expect = 9e-06
 Identities = 21/47 (44%), Positives = 31/47 (65%)

Query: 634 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           RPL+++ I      +LRGL Y+HS G +HRD+K  NIL+ E   +K+
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 47.6 bits (114), Expect = 9e-06
 Identities = 27/67 (40%), Positives = 37/67 (55%), Gaps = 4/67 (5%)

Query: 616 LVMEYCLGSA-SDIIEVHKRPLKEEEIAA-ICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++MEYCLG     I+    R L +E  A    + V+    YLH+ G I+RD+K  N+LL 
Sbjct: 70  MLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD 127

Query: 674 ETGTVKL 680
             G VKL
Sbjct: 128 SNGYVKL 134

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 24/52 (46%), Positives = 29/52 (55%), Gaps = 1/52 (1%)

Query: 630 EVHKRPLKEEEIAAICSGVLRGLNYL-HSLGRIHRDVKAGNILLTETGTVKL 680
           EV K  + EE +  I    ++ LNYL   L  IHRDVK  NILL   G +KL
Sbjct: 98  EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL 149

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 51/193 (26%), Positives = 77/193 (39%), Gaps = 55/193 (28%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQC-----AEKWADILKEIRF 215
           F  ++ I  G+FG VY  R   + ++ A+K   K   + K       AE+ A  L +  F
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 216 LRQLKHPNTIEYRGCYLRDHTA---WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           +  L           Y    +A   +LVMEY +G          ++   H+ G       
Sbjct: 66  IVHL-----------YYSLQSANNVYLVMEYLIGGD--------VKSLLHIYGY------ 100

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
              F E  A+                   S V   L+YLH  G IHRD+K  N+L++  G
Sbjct: 101 ---FDEEMAVKYI----------------SEVALALDYLHRHGIIHRDLKPDNMLISNEG 141

Query: 333 TVKLADFGSASIK 345
            +KL DFG + + 
Sbjct: 142 HIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 38/161 (23%), Positives = 61/161 (37%), Gaps = 34/161 (21%)

Query: 5   SSLLRQLKHPN-------TIEYRG----CYLRDHTAWLVMEYCLGSASDIIEVHKRPLKE 53
           S LL  L H N        IE        Y   +  W  ++  L         + + L  
Sbjct: 59  SCLLYGLSHQNILPILHVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 54  EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT 113
           +++  +   +  G++YLH  G IH+D+ A N ++ E   VK+ D   +    P +     
Sbjct: 117 QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD----- 171

Query: 114 PY------------WMAPEVILAMDEGQYDGKVDVWSLGIT 142
            Y            WMA E   ++   +Y    DVWS G+ 
Sbjct: 172 -YHCLGDNENRPVKWMALE---SLVNKEYSSASDVWSFGVL 208

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 38/108 (35%), Positives = 55/108 (50%), Gaps = 9/108 (8%)

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-S 343
           F+   RPL ++   AI   +L  + Y+H    IHRD+K  NI L   G + L DFG+A  
Sbjct: 258 FDWKDRPLLKQ-TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 344 IKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            +    +F    VGT    +PE ILA D   Y    D+WS G+  +++
Sbjct: 317 FEKEREAFDYGWVGTVATNSPE-ILAGD--GYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 36/142 (25%), Positives = 61/142 (42%), Gaps = 9/142 (6%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           ++  + HP+ +   G  L      +      G   D +  HK  +  + +   C  + +G
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI------KCPANSFVGTPYWMAPE 120
           + YL     +HRD+ A N+L+     VK+ DFG A +      +  A+       WMA E
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
            I      ++  + DVWS G+T
Sbjct: 182 CI---HYRKFTHQSDVWSYGVT 200

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 24/65 (36%), Positives = 37/65 (56%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+   +  D +E +   L E  +      +LRG+ + HS   IHRD+K  NIL++++
Sbjct: 77  LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS 136

Query: 676 GTVKL 680
           G VKL
Sbjct: 137 GVVKL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 5/66 (7%)

Query: 618 MEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYL---HSLGRIHRDVKAGNILLTE 674
           ME+  G + D +      + E  +  I   VLRGL YL   H +  +HRDVK  NIL+  
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI--MHRDVKPSNILVNS 135

Query: 675 TGTVKL 680
            G +KL
Sbjct: 136 RGEIKL 141

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 18/41 (43%), Positives = 26/41 (63%)

Query: 634 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + L ++ I  +   +LRGL Y+HS G IHRD+K  NI + E
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 153

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 24/66 (36%), Positives = 33/66 (50%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V EY   G   + +   K  L  E +  +CS V   + YL S G IHRD+ A N L+ E
Sbjct: 76  IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135

Query: 675 TGTVKL 680
              VK+
Sbjct: 136 DNVVKV 141

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 24/65 (36%), Positives = 34/65 (52%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEY  G     +      L E+      + V+ G+  LH  G IHRD+K  N+L+ +T
Sbjct: 74  LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT 133

Query: 676 GTVKL 680
           G +KL
Sbjct: 134 GHLKL 138

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 25/91 (27%), Positives = 44/91 (48%), Gaps = 6/91 (6%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
           QA  R   H  +  L +  ++      +      LV E    +  ++I+  KRPL E+ +
Sbjct: 49  QALRRLSPHPNILRLIEVLFDRKTGRLA------LVFELMDMNLYELIKGRKRPLPEKRV 102

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
            +    +L+ L+++H  G  HRD+K  NIL+
Sbjct: 103 KSYMYQLLKSLDHMHRNGIFHRDIKPENILI 133

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 9/98 (9%)

Query: 50  PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPAN 108
            L   ++ AI S +  G+ YL SL  +HRD+   N L+ +   VK+ DFG S  I     
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177

Query: 109 SFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             VG     P  WM PE IL     ++  + D+WS G+
Sbjct: 178 YRVGGRTMLPIRWMPPESILYR---KFTTESDIWSFGV 212

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 22/156 (14%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH------------KRPL 51
           + LL  L+H + +++ G  +      +V EY   G  +  +  H               L
Sbjct: 58  AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAEL 117

Query: 52  KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF- 110
            + ++  I   +  G+ YL S   +HRD+   N L+ E   VK+ DFG +      + + 
Sbjct: 118 TQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177

Query: 111 VGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGI 141
           VG        WM PE I+     ++  + DVWSLG+
Sbjct: 178 VGGHTMLPIRWMPPESIMYR---KFTTESDVWSLGV 210

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 12/88 (13%)

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF----VG 112
           A IC G    L  LH    ++RD+K  NILL + G ++++D G A +  P        VG
Sbjct: 109 AEICCG----LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVG 163

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           T  +MAPEV+      +Y    D W+LG
Sbjct: 164 TVGYMAPEVV---KNERYTFSPDWWALG 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 39/235 (16%)

Query: 167 LREIGHGSFGAVYYARCLVS-----REIVAIKKMSYLGKQCAE-KWADILKEIRFLR-QL 219
           + E+G   FG VY      +      + VAIK +    K  AE    +  K    +R +L
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL----KDKAEGPLREEFKHEAMMRSRL 65

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           +HPN +   G   ++    ++  YC  S SD+ E   + R  H + +G+           
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYC--SHSDLHEF-LVMRSPHSD-VGSTDDD------- 114

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                 +  K  L+  +   I + +  G+ +L S   +H+D+   N+L+ +   VK++D 
Sbjct: 115 ------KTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDL 168

Query: 340 G-------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G       +   K   NS +    WM+PE I+    G++    D+WS G+   E+
Sbjct: 169 GLFREVYAADYYKLMGNSLLPI-RWMSPEAIMY---GKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 52/235 (22%), Positives = 89/235 (37%), Gaps = 44/235 (18%)

Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIK-KMSYLGKQCAEKW-ADILKEIRFLRQ 218
           E   + ++ +G G+FG VY    +   E V I   +  L +    K   + + E   +  
Sbjct: 6   ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           + HP+ +   G              CL     ++                +L    C  +
Sbjct: 66  MDHPHLVRLLGV-------------CLSPTIQLV---------------TQLMPHGCLLD 97

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
           +        HK  +  + +   C  + +G+ YL     +HRD+ A N+L+     VK+ D
Sbjct: 98  YV-----HEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITD 152

Query: 339 FGSASI------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           FG A +      +  A+       WMA E I      ++  + DVWS G+T  EL
Sbjct: 153 FGLARLLEGDEKEYNADGGKMPIKWMALECI---HYRKFTHQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 33/105 (31%), Positives = 46/105 (43%), Gaps = 23/105 (21%)

Query: 51  LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASI------ 103
           L  + +    + +  G+ YL S   IHRD+ A N +L E   V +ADFG S  I      
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168

Query: 104 ------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                 K P         W+A E   ++ +  Y  K DVWS G+T
Sbjct: 169 RQGRIAKMPVK-------WIAIE---SLADRVYTTKSDVWSFGVT 203

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 21/92 (22%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY------ 115
           +  G+ YL +   IHRD+ A N +L E  TV +ADFG S  I      + G  Y      
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI------YSGDYYRQGRIA 175

Query: 116 -----WMAPEVILAMDEGQYDGKVDVWSLGIT 142
                W+A E   ++ +  Y  K DVW+ G+T
Sbjct: 176 KMPVKWIAIE---SLADRVYTSKSDVWAFGVT 204

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 34/89 (38%), Positives = 45/89 (50%), Gaps = 8/89 (8%)

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF----VG 112
           AI   +L  + Y+H    IHRD+K  NI L   G + L DFG+A   +    +F    VG
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           T    +PE ILA D   Y    D+WS G+
Sbjct: 331 TVATNSPE-ILAGD--GYCEITDIWSCGL 356

Length = 501

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 4e-05
 Identities = 69/268 (25%), Positives = 104/268 (38%), Gaps = 53/268 (19%)

Query: 118 APEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIF------EDL---R 168
           AP   LA+    Y        L  TPG    P   ++F     E +F      +D    +
Sbjct: 89  APGAALALLAATY--------LWATPGVA--PGFVDMFVLAPLEGLFRPSFKKDDFVLGK 138

Query: 169 EIGHGSFGAVYYA----RCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           ++G G+FG VY A    +         +KK +  G    E W                N 
Sbjct: 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWM---------------NE 181

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF---TEHFA 281
              R C   +  A  V  +    +S   + +W+   +  E     L Q K F    E + 
Sbjct: 182 RVRRAC--PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYL 239

Query: 282 LFNFEVHKRPLKEEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE-TGTVKLAD 338
           L   +   + L+ E   I  I   +L  L+ LHS G +HRDVK  NI+ +E +G+ K+ D
Sbjct: 240 LGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIID 299

Query: 339 FGSAS-----IKCPANSFVGTPYWMAPE 361
            G+A+     I      F+  P + APE
Sbjct: 300 LGAAADLRVGINYIPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 23/65 (35%), Positives = 40/65 (61%), Gaps = 2/65 (3%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVM + +G+    +  H++ L E+ I  +   +L+GL Y+H+ G IHRD+K GN+ + E 
Sbjct: 97  LVMPF-MGTDLGKLMKHEK-LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154

Query: 676 GTVKL 680
             +K+
Sbjct: 155 CELKI 159

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 24/65 (36%), Positives = 35/65 (53%), Gaps = 8/65 (12%)

Query: 629 IEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET--------GTVKL 680
           I V  +PL  + +      +LRGL YLHS G +HRD+K GN+L+           G  ++
Sbjct: 93  IIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Query: 681 DTPDE 685
           + PDE
Sbjct: 153 EEPDE 157

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 25/143 (17%)

Query: 2   PAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICS 61
           P G+ LL  L+    +E    + ++H          G+AS         L  +++    S
Sbjct: 86  PYGN-LLDFLRKSRVLETDPAFAKEH----------GTAST--------LTSQQLLQFAS 126

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-PY-WMA 118
            V  G+ YL     IHRD+ A N+L+ E    K+ADFG S   +      +G  P  WMA
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
            E   +++   Y  K DVWS G+
Sbjct: 187 IE---SLNYSVYTTKSDVWSFGV 206

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.3 bits (110), Expect = 5e-05
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 8/95 (8%)

Query: 32  VMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE-T 90
           V  Y LG   D+ +  +R  + + I  I   +L  L+ LHS G +HRDVK  NI+ +E +
Sbjct: 235 VEPYLLGKVQDLPKGLER--ENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS 292

Query: 91  GTVKLADFGSAS-----IKCPANSFVGTPYWMAPE 120
           G+ K+ D G+A+     I      F+  P + APE
Sbjct: 293 GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTE 674
           + ME+    + D I     P+  E +  I   V+ GL YL+++ RI HRD+K  NIL+  
Sbjct: 80  MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS 139

Query: 675 TGTVKL 680
            G +KL
Sbjct: 140 RGQIKL 145

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 44.8 bits (106), Expect = 7e-05
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 11/100 (11%)

Query: 584 HNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEE--I 641
           H+   H + V +L   S N     +  +F  Q+      GS S ++     PLK+ E  I
Sbjct: 59  HSYLKHRNIVQYLGSDSENG----FFKIFMEQVPG----GSLSALLRSKWGPLKDNEQTI 110

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKL 680
                 +L GL YLH    +HRD+K  N+L+ T +G VK+
Sbjct: 111 IFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKI 150

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 22/86 (25%), Positives = 46/86 (53%), Gaps = 12/86 (13%)

Query: 598 QHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEV---HKRPLKEEEIAAICSGVLRGLNY 654
           Q+++ + ++ Y       LVMEY  G   D++ +   ++    E+      + ++  ++ 
Sbjct: 67  QYAFQDKDNLY-------LVMEYQPGG--DLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 655 LHSLGRIHRDVKAGNILLTETGTVKL 680
           +H +G +HRD+K  N+L+  TG +KL
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKL 143

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 24/69 (34%), Positives = 39/69 (56%), Gaps = 1/69 (1%)

Query: 613 SPQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           S +L+MEY   GS  D ++ H+  +  + +    S + +G++YL S   IHRD+ A NIL
Sbjct: 82  SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNIL 141

Query: 672 LTETGTVKL 680
           +     VK+
Sbjct: 142 VESEDLVKI 150

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 19/45 (42%), Positives = 25/45 (55%)

Query: 634 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 678
           RPL  ++   I   +L GL YLH+   IHRDVK  NI + +   V
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQV 196

Length = 357

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 3/85 (3%)

Query: 597 SQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH 656
           S      +  + + L S  +V EY     ++++E  + PL EE        +LRGL Y+H
Sbjct: 74  SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIH 131

Query: 657 SLGRIHRDVKAGNILL-TETGTVKL 680
           S   +HRD+K  N+ + TE   +K+
Sbjct: 132 SANVLHRDLKPANVFINTEDLVLKI 156

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 34/123 (27%), Positives = 47/123 (38%), Gaps = 54/123 (43%)

Query: 70  LHSLGRIHRDVKAGNILLTETGTVKLADFG------------------------------ 99
           +H +G IHRD+K  NIL+   G +KL DFG                              
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 100 ---SASIKCP------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 138
               A+ +C                   A+S VGTP ++APEV+L      Y    D WS
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG---YTQLCDWWS 233

Query: 139 LGI 141
           +G+
Sbjct: 234 VGV 236

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 44.9 bits (106), Expect = 8e-05
 Identities = 20/42 (47%), Positives = 24/42 (57%)

Query: 635 PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
             KE  I      +LRGL+YLH    IHRDVK  N+L+  TG
Sbjct: 99  AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 8e-05
 Identities = 20/47 (42%), Positives = 28/47 (59%)

Query: 634 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           R  +E E   +   VL  ++++HS   IHRD+K+ NILL   G VKL
Sbjct: 138 RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Length = 496

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 23/65 (35%), Positives = 34/65 (52%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L+ME+  G     + + K  L EE      +  +  ++ +H LG IHRD+K  N+LL   
Sbjct: 78  LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK 137

Query: 676 GTVKL 680
           G VKL
Sbjct: 138 GHVKL 142

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.1 bits (106), Expect = 8e-05
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 25/143 (17%)

Query: 2   PAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICS 61
           P G+ LL  L+    +E    +   +           +AS         L  +++    +
Sbjct: 79  PHGN-LLDFLRKSRVLETDPAFAIAN----------STAST--------LSSQQLLHFAA 119

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-PY-WMA 118
            V RG++YL     IHRD+ A NIL+ E    K+ADFG S   +      +G  P  WMA
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
            E   +++   Y    DVWS G+
Sbjct: 180 IE---SLNYSVYTTNSDVWSYGV 199

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.1 bits (107), Expect = 9e-05
 Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 1/65 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVM+        +++   R L E ++  I   +L GLN LH    +HRD+   NI +   
Sbjct: 97  LVMDIMASDLKKVVDRKIR-LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155

Query: 676 GTVKL 680
           G  K+
Sbjct: 156 GICKI 160

Length = 335

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 19/45 (42%), Positives = 27/45 (60%)

Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           L E +I      +L G+NYLH    +HRD+KA NIL+   G +K+
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKI 156

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 21/66 (31%), Positives = 30/66 (45%), Gaps = 4/66 (6%)

Query: 617 VMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           VMEY  G      I    +         A    ++ GL +LH  G I+RD+K  N+LL  
Sbjct: 74  VMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--IVLGLQFLHERGIIYRDLKLDNVLLDS 131

Query: 675 TGTVKL 680
            G +K+
Sbjct: 132 EGHIKI 137

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 30/69 (43%), Positives = 38/69 (55%), Gaps = 7/69 (10%)

Query: 615 QLVMEYC-LGSASDIIEVHKRPLKEEEIAA--ICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           QL+MEY  LGS  D +  HK  L +  + A  IC     G+ YLHS   IHRD+ A N+L
Sbjct: 84  QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC----EGMAYLHSQHYIHRDLAARNVL 139

Query: 672 LTETGTVKL 680
           L     VK+
Sbjct: 140 LDNDRLVKI 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 31/92 (33%), Positives = 43/92 (46%), Gaps = 21/92 (22%)

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY------ 115
           +  G+ YL S   IHRD+ A N +L E  TV +ADFG S  I      + G  Y      
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI------YSGDYYRQGCAS 175

Query: 116 -----WMAPEVILAMDEGQYDGKVDVWSLGIT 142
                W+A E   ++ +  Y    DVW+ G+T
Sbjct: 176 KLPVKWLALE---SLADNVYTTHSDVWAFGVT 204

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 21/100 (21%)

Query: 54  EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT 113
           +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+ DFG             T
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM------TRDIYET 172

Query: 114 PY------------WMAPEVILAMDEGQYDGKVDVWSLGI 141
            Y            WMAPE   ++ +G +    D+WS G+
Sbjct: 173 DYYRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGV 209

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 25/64 (39%), Positives = 32/64 (50%), Gaps = 2/64 (3%)

Query: 618 MEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           MEY  G S  D ++ +   L E         +L G+ YLHS   +HRD+K  NIL    G
Sbjct: 83  MEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG 141

Query: 677 TVKL 680
            VKL
Sbjct: 142 NVKL 145

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 22/67 (32%), Positives = 34/67 (50%), Gaps = 4/67 (5%)

Query: 616 LVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           + ME+  G +  I  +  R  PL E         +L G+ YLH+   +HRD+K  N++L 
Sbjct: 79  IFMEFVPGGS--ISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM 136

Query: 674 ETGTVKL 680
             G +KL
Sbjct: 137 PNGIIKL 143

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 24/62 (38%), Positives = 34/62 (54%), Gaps = 4/62 (6%)

Query: 619 EYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 678
           E+  G + D+     R + E  +  I   V++GL YL SL  +HRDVK  N+L+   G V
Sbjct: 79  EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQV 134

Query: 679 KL 680
           KL
Sbjct: 135 KL 136

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTE 674
           + ME+  G + D +    + + EE +  +   VLRGL YL    +I HRDVK  NIL+  
Sbjct: 80  ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS 139

Query: 675 TGTVKL 680
            G +KL
Sbjct: 140 RGEIKL 145

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 4/77 (5%)

Query: 604 NNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR 663
              N++ L+  + +ME  L     II    +PL +    +    +L GL Y+HS   +HR
Sbjct: 74  FPGNFNELYLYEELMEADL---HQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHR 129

Query: 664 DVKAGNILLTETGTVKL 680
           D+K GN+L+     +K+
Sbjct: 130 DLKPGNLLVNADCELKI 146

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 25/71 (35%), Positives = 40/71 (56%), Gaps = 8/71 (11%)

Query: 616 LVMEYCLGSASDIIEVHKR------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 669
           L+MEY  GS  D+ +  K+      P +E E+  +   ++  L+ +HS   +HRD+K+ N
Sbjct: 142 LIMEY--GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199

Query: 670 ILLTETGTVKL 680
           I L  TG +KL
Sbjct: 200 IFLMPTGIIKL 210

Length = 478

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 21/65 (32%), Positives = 31/65 (47%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EY        ++     L    +      +LRGL Y H    +HRD+K  N+L++E 
Sbjct: 80  LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER 139

Query: 676 GTVKL 680
           G +KL
Sbjct: 140 GELKL 144

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 21/65 (32%), Positives = 33/65 (50%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VMEY  G     +  +   L  +      +  +  L YLH+ G +HRD+K  N+L+T  
Sbjct: 78  MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM 137

Query: 676 GTVKL 680
           G +KL
Sbjct: 138 GHIKL 142

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 24/65 (36%), Positives = 35/65 (53%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L+ME+  G     + + K  L EEE     +  +  ++ +H LG IHRD+K  N+LL   
Sbjct: 78  LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK 137

Query: 676 GTVKL 680
           G VKL
Sbjct: 138 GHVKL 142

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 8/79 (10%)

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF----VGTPYWMAPEV 121
           GL  L     ++RD+K  NILL + G ++++D G A ++ P        VGT  +MAPEV
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEV 172

Query: 122 ILAMDEGQYDGKVDVWSLG 140
           I   +  +Y    D W LG
Sbjct: 173 I---NNEKYTFSPDWWGLG 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 9/82 (10%)

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF------VGTPYWMAP 119
           G+ YL++   +HRD+ A N ++ E  TVK+ DFG        + +      +    WM+P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E   ++ +G +    DVWS G+
Sbjct: 191 E---SLKDGVFTTYSDVWSFGV 209

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 37/145 (25%), Positives = 55/145 (37%), Gaps = 10/145 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           SL+ QL H + ++  G  +RD    +V EY   G     +   K  +       +   + 
Sbjct: 53  SLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLA 111

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGT-------VKLADFGSASIKCPANSFVGTPYWM 117
             L+YL     +H +V   NIL+   G        +KL+D G           V    W+
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI 171

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           APE I    +       D WS G T
Sbjct: 172 APECI-RNGQASLTIAADKWSFGTT 195

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 23/65 (35%), Positives = 36/65 (55%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EY        ++ H   L  E +      +LRGL+Y+H    +HRD+K  N+L+++T
Sbjct: 80  LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT 139

Query: 676 GTVKL 680
           G +KL
Sbjct: 140 GELKL 144

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 18/30 (60%), Positives = 23/30 (76%)

Query: 651 GLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            L++LHSLG I+RD+K  NILL E G +KL
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKL 139

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 1/64 (1%)

Query: 617 VMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           VMEY  G    ++ +H     E       + V+ GL YLH    ++RD+K  N+LL   G
Sbjct: 80  VMEYAAGGDL-MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG 138

Query: 677 TVKL 680
            VK+
Sbjct: 139 FVKI 142

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VME   LG     ++V+K  L    +      +   L YL S   +HRD+ A N+L++ 
Sbjct: 83  IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS 142

Query: 675 TGTVKL 680
              VKL
Sbjct: 143 PDCVKL 148

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 21/48 (43%), Positives = 23/48 (47%)

Query: 633 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
             PL  E+   I   +L  L YLH  G IHRDVK  NI L E     L
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL 226

Length = 392

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 23/65 (35%), Positives = 34/65 (52%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L+MEY  G     + + K    EEE     +  +  ++ +H LG IHRD+K  N+LL   
Sbjct: 78  LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK 137

Query: 676 GTVKL 680
           G +KL
Sbjct: 138 GHIKL 142

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.5 bits (101), Expect = 4e-04
 Identities = 38/136 (27%), Positives = 61/136 (44%), Gaps = 14/136 (10%)

Query: 12  KHPNTIEYRGCY--LRDHTAWLVMEYCLGSASDIIEV--HKRPLKEEEIAAICSGVLRGL 67
            +PN I+       L+ H   L+M+Y      D+ ++   +  L E E+  I   ++  L
Sbjct: 67  DNPNFIKLYYSVTTLKGHV--LIMDYIKDG--DLFDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 68  NYLHSLGRIHRDVKAGNILLTET-GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMD 126
           N LH    IH D+K  N+L       + L D+G   I    + + GT  + +PE I    
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIK--- 179

Query: 127 EGQ-YDGKVDVWSLGI 141
            G  YD   D W++G+
Sbjct: 180 -GHNYDVSFDWWAVGV 194

Length = 267

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 22/90 (24%), Positives = 40/90 (44%), Gaps = 4/90 (4%)

Query: 18  EYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 77
           +       D  ++L+ME+  G   D +   ++    E++A +    L  L+ L  L   H
Sbjct: 57  KVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAEL----LAKLHQLPLLVLCH 112

Query: 78  RDVKAGNILLTETGTVKLADFGSASIKCPA 107
            D+  GNIL+ +   + + D+  A    PA
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 19/97 (19%)

Query: 591 HPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKR-------PLKEEEIAA 643
           HP     Q S+  N + Y       +VM+YC G      +++K+          E++I  
Sbjct: 58  HPNIVQYQESFEENGNLY-------IVMDYCEGG-----DLYKKINAQRGVLFPEDQILD 105

Query: 644 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
               +   L ++H    +HRD+K+ NI LT+ GT+KL
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKL 142

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 5e-04
 Identities = 17/36 (47%), Positives = 23/36 (63%), Gaps = 4/36 (11%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVK 679
           +L G++YLHS   +HRD+K  NIL+     E G VK
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVK 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 3/64 (4%)

Query: 617 VMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
             EY    + D     +  L ++++ +    V RG+ +L S   IHRD+ A N+L+TE  
Sbjct: 113 PGEYA---SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169

Query: 677 TVKL 680
            +K+
Sbjct: 170 VMKI 173

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 20/54 (37%), Positives = 32/54 (59%)

Query: 627 DIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           DI +V +  L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKI 175

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 20/42 (47%), Positives = 29/42 (69%)

Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           E I  +   +LRGL++LHS   +HRD+K  NIL+T +G +KL
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 21/65 (32%), Positives = 33/65 (50%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L+++Y  G         +    E E+    + ++  L++LH LG I+RD+K  NILL   
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE 141

Query: 676 GTVKL 680
           G V L
Sbjct: 142 GHVVL 146

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 25/159 (15%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHK---------RPLKEE 54
           + LL  L+H + +++ G         +V EY   G  +  +  H          +P + +
Sbjct: 58  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 117

Query: 55  ------EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA 107
                 ++  I S +  G+ YL S   +HRD+   N L+     VK+ DFG S  +    
Sbjct: 118 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177

Query: 108 NSFVG----TPY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
              VG     P  WM PE I+     ++  + DVWS G+
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGV 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 6e-04
 Identities = 35/131 (26%), Positives = 52/131 (39%), Gaps = 17/131 (12%)

Query: 6   SLLRQLKHPNTIEY--RGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           +L  +L HPN +     G        + V EY  G     +      L   E   +   V
Sbjct: 30  ALCARLYHPNIVALLDSG-EAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQV 88

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGT---VKLADFG-----------SASIKCPANS 109
           L  L   H+ G +HRD+K  NI++++TG     K+ DFG             +       
Sbjct: 89  LDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148

Query: 110 FVGTPYWMAPE 120
            +GTP + APE
Sbjct: 149 VLGTPTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 20/51 (39%), Positives = 30/51 (58%), Gaps = 3/51 (5%)

Query: 345 KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           +C A+S VGTP ++APEV+L      Y    D WS+G+   E+   +PP+ 
Sbjct: 202 RCLAHSLVGTPNYIAPEVLL---RKGYTQLCDWWSVGVILFEMLVGQPPFL 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 42.0 bits (99), Expect = 7e-04
 Identities = 20/51 (39%), Positives = 31/51 (60%), Gaps = 5/51 (9%)

Query: 633 KRPLKEEEIAAICSGVLRGLNYL---HSLGRIHRDVKAGNILLTETGTVKL 680
           + P+ E+ +  +   +++ L+YL   H +  IHRDVK  NILL  +G VKL
Sbjct: 108 QGPIPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKL 156

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 24/69 (34%), Positives = 38/69 (55%), Gaps = 6/69 (8%)

Query: 616 LVMEYCLGSASDIIEVHK----RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           +VMEYC G   D+++  K    +   E+ I      +  G+ ++H    +HRD+K+ NI 
Sbjct: 75  IVMEYCDGG--DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132

Query: 672 LTETGTVKL 680
           LT+ G VKL
Sbjct: 133 LTQNGKVKL 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 21/45 (46%), Positives = 28/45 (62%)

Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           L  E I  +    LRGL++LH+   +HRD+K  NIL+T  G VKL
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKL 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 15/33 (45%), Positives = 22/33 (66%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +LRGL Y+HS   +HRD+K  N+LL     +K+
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKI 147

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 10/101 (9%)

Query: 579 SSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVME-YCLGSASDIIEVHKRPLK 637
           ++++AH     +HP     + ++  N   ++ L  P+   + YC  +A       KR + 
Sbjct: 130 TATEAHILRAINHPSIIQLKGTFTYNK--FTCLILPRYKTDLYCYLAA-------KRNIA 180

Query: 638 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 678
             +I AI   VLR + YLH    IHRD+KA NI +   G V
Sbjct: 181 ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221

Length = 391

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.6 bits (100), Expect = 8e-04
 Identities = 28/67 (41%), Positives = 39/67 (58%), Gaps = 4/67 (5%)

Query: 616 LVMEYCLGSASDIIEV-HKRPLKEEEIAA-ICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LVMEY +G   D+  + H     +EE+A    S V   L+YLH  G IHRD+K  N+L++
Sbjct: 81  LVMEYLIGG--DVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138

Query: 674 ETGTVKL 680
             G +KL
Sbjct: 139 NEGHIKL 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 0.001
 Identities = 21/65 (32%), Positives = 32/65 (49%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L MEY  G     +  +   L E+      + +   ++ LH LG IHRD+K  N L+  +
Sbjct: 78  LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS 137

Query: 676 GTVKL 680
           G +KL
Sbjct: 138 GHIKL 142

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 41.8 bits (99), Expect = 0.001
 Identities = 22/51 (43%), Positives = 27/51 (52%), Gaps = 8/51 (15%)

Query: 630 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +VHKR         I   +L+ L Y+HS   IHRD+K  NILL     VKL
Sbjct: 106 DVHKR--------YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL 148

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 17/39 (43%), Positives = 25/39 (64%)

Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           L +E +  +   +LRGL Y+HS G IHRD+K  N+ + E
Sbjct: 115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE 153

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 23/67 (34%), Positives = 36/67 (53%), Gaps = 1/67 (1%)

Query: 615 QLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +LVMEY   GS  D ++ H+  L   ++    S + +G+ YL S   +HRD+   NIL+ 
Sbjct: 83  RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE 142

Query: 674 ETGTVKL 680
               VK+
Sbjct: 143 SENRVKI 149

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 27/72 (37%), Positives = 36/72 (50%), Gaps = 3/72 (4%)

Query: 609 SSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 668
           S LF   LV+EY  G         +R L EE      + +   LN+LH  G I+RD+K  
Sbjct: 69  SRLF---LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 669 NILLTETGTVKL 680
           N+LL   G +KL
Sbjct: 126 NVLLDADGHIKL 137

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 22/55 (40%), Positives = 33/55 (60%)

Query: 626 SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            +  E++K PL  E++ +    V RG+ +L S   IHRD+ A NILL+E   VK+
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI 214

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 18/40 (45%), Positives = 25/40 (62%)

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           I  +   VL GL  LH +G +HRD+K  N+L+T  G VK+
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKI 350

Length = 507

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 25/85 (29%), Positives = 37/85 (43%), Gaps = 14/85 (16%)

Query: 291 PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT---VKLADFG------- 340
            L   E   +   VL  L   H+ G +HRD+K  NI++++TG     K+ DFG       
Sbjct: 75  ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134

Query: 341 ----SASIKCPANSFVGTPYWMAPE 361
                 +        +GTP + APE
Sbjct: 135 VRDADVATLTRTTEVLGTPTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 18/48 (37%), Positives = 26/48 (54%)

Query: 633 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           KR + E  I      +   L ++HS   +HRD+K  N+ +T TG VKL
Sbjct: 100 KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKL 147

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 40.2 bits (95), Expect = 0.002
 Identities = 15/33 (45%), Positives = 22/33 (66%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           V+  L YLHSL  ++RD+K  N+LL   G +K+
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKI 142

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 40.8 bits (96), Expect = 0.002
 Identities = 15/33 (45%), Positives = 22/33 (66%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +LRGL Y+HS   +HRD+K  N+LL     +K+
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 149

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 14/82 (17%)

Query: 611 LFSPQ----------LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 660
           +F+PQ          LVME  L  A+ + +V +  L  E ++ +   +L G+ +LHS G 
Sbjct: 83  VFTPQKSLEEFQDVYLVME--LMDAN-LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 139

Query: 661 IHRDVKAGNILLTETGTVK-LD 681
           IHRD+K  NI++    T+K LD
Sbjct: 140 IHRDLKPSNIVVKSDCTLKILD 161

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 17/45 (37%), Positives = 27/45 (60%)

Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           L ++ + ++C  V  G+ YL     IHRD+ A N L++ TG VK+
Sbjct: 97  LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKV 141

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 27/72 (37%), Positives = 35/72 (48%), Gaps = 3/72 (4%)

Query: 609 SSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 668
           S LF    V+EY  G         +R L EE      + +   LNYLH  G I+RD+K  
Sbjct: 69  SRLF---FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125

Query: 669 NILLTETGTVKL 680
           N+LL   G +KL
Sbjct: 126 NVLLDSEGHIKL 137

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 25/66 (37%), Positives = 39/66 (59%), Gaps = 3/66 (4%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G   D++ +       E+ A   +  V+  L+ +HS+G IHRDVK  N+LL +
Sbjct: 120 MVMEYMPGG--DLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 177

Query: 675 TGTVKL 680
           +G +KL
Sbjct: 178 SGHLKL 183

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 3/72 (4%)

Query: 609 SSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 668
           S LF    V+E+  G         +R L EE      + +   LN+LH  G I+RD+K  
Sbjct: 69  SRLF---FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLD 125

Query: 669 NILLTETGTVKL 680
           N+LL   G +KL
Sbjct: 126 NVLLDAEGHIKL 137

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 25/66 (37%), Positives = 38/66 (57%), Gaps = 3/66 (4%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G   D++ +       E+ A   +  V+  L+ +HS+G IHRDVK  N+LL +
Sbjct: 120 MVMEYMPGG--DLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 177

Query: 675 TGTVKL 680
            G +KL
Sbjct: 178 HGHLKL 183

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 4/63 (6%)

Query: 618 MEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 677
           MEY    + DI  V    +  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 120 MEY----SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV 175

Query: 678 VKL 680
           +K+
Sbjct: 176 MKI 178

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 21/48 (43%), Positives = 28/48 (58%)

Query: 633 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           K PL  E++      V RG+ +L S   IHRD+ A NILL+E   VK+
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI 215

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 40.8 bits (96), Expect = 0.002
 Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 5/68 (7%)

Query: 31  LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 90
           +VMEY  G     +E+++  L  E    I   +L  +   +  G +H D+   NIL+TE 
Sbjct: 184 VVMEYIEG-----VELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238

Query: 91  GTVKLADF 98
           G + + D+
Sbjct: 239 GDIVVIDW 246

Length = 304

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 25/66 (37%), Positives = 39/66 (59%), Gaps = 3/66 (4%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G   D++ +       E+ A   +  V+  L+ +HS+G IHRDVK  N+LL +
Sbjct: 120 MVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 177

Query: 675 TGTVKL 680
           +G +KL
Sbjct: 178 SGHLKL 183

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 15/65 (23%), Positives = 34/65 (52%)

Query: 619 EYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 678
           ++   + S   ++   PL  ++  A+C+ +  G+++L +   +HRD+ A N L++    V
Sbjct: 97  QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV 156

Query: 679 KLDTP 683
           K+   
Sbjct: 157 KVSLL 161

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 31/147 (21%), Positives = 52/147 (35%), Gaps = 39/147 (26%)

Query: 204 EKWADILKEIRFLRQLKHPNTI--EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREF 261
           EK AD  +E+  L+ L        +       D  ++L+ME+        IE   ++   
Sbjct: 33  EKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW--------IEGETLDEVS 84

Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
             E    +    +   E  A    ++H+ PL           VL            H D+
Sbjct: 85  EEE----KEDIAEQLAELLA----KLHQLPLL----------VL-----------CHGDL 115

Query: 322 KAGNILLTETGTVKLADFGSASIKCPA 348
             GNIL+ +   + + D+  A    PA
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 42/178 (23%), Positives = 70/178 (39%), Gaps = 33/178 (18%)

Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           +F  ++ +G G+FG V  A  + +  + A+K +         + A +  E   L +  + 
Sbjct: 2   MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             ++    +      + VM+Y  G                   M + L +++ F E  A 
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGG-----------------DMMSLLIRMEVFPEVLAR 104

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           F           E   AI S        +H +G IHRD+K  NIL+   G +KL DFG
Sbjct: 105 FYIA--------ELTLAIES--------VHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 39.7 bits (92), Expect = 0.004
 Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 2/66 (3%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + MEY  G S  D ++ +   L E         +L G++YLHS   +HRD+K  NIL   
Sbjct: 83  IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS 141

Query: 675 TGTVKL 680
            G VKL
Sbjct: 142 AGNVKL 147

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 17/33 (51%), Positives = 23/33 (69%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L+G++YLHS   +HRD+K  NIL    G VKL
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKL 147

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 17/33 (51%), Positives = 22/33 (66%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L G++YLHS   +HRD+K  NIL    G VKL
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKL 147

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 18/67 (26%), Positives = 33/67 (49%), Gaps = 2/67 (2%)

Query: 616 LVMEYCLGSASDIIEVH--KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LV EY        ++ H  +  L    + +    +L+G+ + H    +HRD+K  N+L+ 
Sbjct: 75  LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN 134

Query: 674 ETGTVKL 680
           + G +KL
Sbjct: 135 KRGELKL 141

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.1 bits (93), Expect = 0.004
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 16/90 (17%)

Query: 604 NNSNYSSL---FSPQ----------LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 650
           N+ N  SL   F+PQ          LVME    +   +I++    L  E ++ +   +L 
Sbjct: 74  NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLC 130

Query: 651 GLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           G+ +LHS G IHRD+K  NI++    T+K+
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 20/79 (25%), Positives = 37/79 (46%), Gaps = 7/79 (8%)

Query: 604 NNSNYSSLFSPQLVMEYCLGSASDIIEVHKR----PLKEEEIAAICSGVLRGLNYLHSLG 659
             +   SL+   LV EY        ++ + R    PL  + I +    +L+G+ + H  G
Sbjct: 74  EKNGKPSLY---LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG 130

Query: 660 RIHRDVKAGNILLTETGTV 678
            +HRD+K  N+L+ +   +
Sbjct: 131 VMHRDLKPQNLLVDKQKGL 149

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 19/51 (37%), Positives = 31/51 (60%)

Query: 630 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +++K+ L  E++      V +G+ +L S   IHRD+ A NILL+E   VK+
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKI 220

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	804
KOG0577|consensus	948		100.0
KOG0615|consensus	475		100.0
KOG0603|consensus	612		100.0
KOG0581|consensus	364		100.0
KOG0593|consensus	396		100.0
KOG0575|consensus	592		100.0
KOG0598|consensus	357		100.0
KOG0578|consensus	550		100.0
KOG0661|consensus	538		100.0
KOG0600|consensus	560		100.0
KOG0595|consensus	429		100.0
KOG0591|consensus	375		100.0
KOG0616|consensus	355		100.0
KOG0659|consensus	318		100.0
KOG0201|consensus	467		100.0
KOG0582|consensus	516		100.0
KOG0592|consensus	604		100.0
KOG0033|consensus	355		100.0
KOG0579|consensus	1187		100.0
KOG0605|consensus	550		100.0
KOG0663|consensus	419		100.0
KOG0574|consensus	502		100.0
KOG0583|consensus	370		100.0
KOG0588|consensus	786		100.0
KOG0597|consensus	808		100.0
KOG0660|consensus	359		100.0
KOG0198|consensus	313		100.0
KOG0594|consensus	323		100.0
KOG0599|consensus	411		100.0
KOG0585|consensus	576		100.0
KOG0032|consensus	382		100.0
KOG0658|consensus	364		100.0
KOG0694|consensus	694		100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0611|consensus	668		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0667|consensus	586		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0580|consensus	281		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0192|consensus	362		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0603|consensus	612		100.0
KOG0610|consensus	459		100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG1035|consensus	1351		100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0589|consensus	426		100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG4717|consensus	864		100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0662|consensus	292		100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0690|consensus	516		100.0
KOG4721|consensus	904		100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0983|consensus	391		100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0197|consensus	468		100.0
KOG0666|consensus	438		100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0607|consensus	463		100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0604|consensus	400		100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0576|consensus	829		100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG4279|consensus	1226		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0669|consensus	376		100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0986|consensus	591		100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0587|consensus	953		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0612|consensus	1317		100.0
KOG0596|consensus	677		100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4645|consensus	1509		100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0586|consensus	596		100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0193|consensus	678		100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG4236|consensus	888		100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG1989|consensus	738		100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0696|consensus	683		100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG1006|consensus	361		100.0
KOG2345|consensus	302		100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0584|consensus	632		100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0590|consensus	601		100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0614|consensus	732		100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0194|consensus	474		100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0608|consensus	1034		100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0671|consensus	415		100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1026|consensus	774		100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0665|consensus	369		100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1187|consensus	361		100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0668|consensus	338		100.0
KOG1095|consensus	1025		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0695|consensus	593		100.0
KOG4250|consensus	732		100.0
KOG0664|consensus	449		100.0
KOG0576|consensus	829		100.0
KOG1151|consensus	775		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984|consensus	282		100.0
KOG0196|consensus	996		100.0
KOG1094|consensus	807		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4257|consensus	974		100.0
KOG4278|consensus	1157		100.0
KOG1290|consensus	590		100.0
KOG0670|consensus	752		100.0
KOG0199|consensus	1039		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152|consensus	772		99.97
KOG0595|consensus	429		99.97
KOG0615|consensus	475		99.97
KOG1027|consensus	903		99.97
KOG1167|consensus	418		99.97
KOG0200|consensus	609		99.97
KOG0598|consensus	357		99.97
KOG0591|consensus	375		99.97
KOG0593|consensus	396		99.97
KOG0577|consensus	948		99.97
KOG0581|consensus	364		99.97
KOG1025|consensus	1177		99.97
KOG2052|consensus	513		99.97
KOG3653|consensus	534		99.97
KOG0616|consensus	355		99.96
KOG0600|consensus	560		99.96
KOG0661|consensus	538		99.96
KOG0590|consensus	601		99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0575|consensus	592		99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0659|consensus	318		99.96
KOG0663|consensus	419		99.95
KOG0658|consensus	364		99.95
KOG1345|consensus	378		99.95
KOG0578|consensus	550		99.95
KOG0192|consensus	362		99.95
KOG0583|consensus	370		99.95
KOG0592|consensus	604		99.95
KOG0588|consensus	786		99.94
KOG0594|consensus	323		99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG0198|consensus	313		99.94
KOG0582|consensus	516		99.94
KOG0605|consensus	550		99.94
KOG1024|consensus	563		99.94
KOG0597|consensus	808		99.94
KOG0197|consensus	468		99.94
KOG0660|consensus	359		99.93
KOG0694|consensus	694		99.93
KOG0579|consensus	1187		99.93
KOG0585|consensus	576		99.93
KOG0599|consensus	411		99.93
KOG0033|consensus	355		99.93
KOG0611|consensus	668		99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG4721|consensus	904		99.92
KOG0574|consensus	502		99.92
KOG0589|consensus	426		99.92
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
KOG0662|consensus	292		99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.91
KOG0984|consensus	282		99.91
KOG1187|consensus	361		99.91
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.91
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.91
KOG0610|consensus	459		99.91
KOG0666|consensus	438		99.91
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.91
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
KOG0690|consensus	516		99.91
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.91
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.9
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.9
KOG0986|consensus	591		99.9
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.9
KOG0194|consensus	474		99.9
KOG0614|consensus	732		99.9
KOG0580|consensus	281		99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.9
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.9
PHA03212	391	serine/threonine kinase US3; Provisional	99.9
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.9
KOG0201|consensus	467		99.9
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.9
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
KOG0665|consensus	369		99.9
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.9
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.9
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.9
KOG0032|consensus	382		99.89
KOG0667|consensus	586		99.89
PTZ00267	478	NIMA-related protein kinase; Provisional	99.89
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.89
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.89

>KOG0577|consensus

Probab=100.00  E-value=9.5e-70  Score=591.33  Aligned_cols=367  Identities=69%  Similarity=1.133  Sum_probs=332.8

Q ss_pred             ccCCCCCCCcchhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc
Q psy17952        140 GITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL  219 (804)
Q Consensus       140 G~~~g~l~~~~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L  219 (804)
                      |..+|++++|+|+++|.++||++.|..++.||.|+||.||.|++..+.+.||||+|+..+++..++|+++++|+++|++|
T Consensus         4 ~~r~GslKDPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l   83 (948)
T KOG0577|consen    4 GGRPGSLKDPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL   83 (948)
T ss_pred             CCCCCCCCCchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc
Confidence            45688999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCceeEeeeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHH
Q psy17952        220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAA  299 (804)
Q Consensus       220 ~HpNIV~l~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~  299 (804)
                      +|||+|.|.+||..+...|||||||-|+..|++++                                 +++++.|.++..
T Consensus        84 ~HPntieYkgCyLre~TaWLVMEYClGSAsDlleV---------------------------------hkKplqEvEIAA  130 (948)
T KOG0577|consen   84 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEV---------------------------------HKKPLQEVEIAA  130 (948)
T ss_pred             cCCCcccccceeeccchHHHHHHHHhccHHHHHHH---------------------------------HhccchHHHHHH
Confidence            99999999999999999999999999999998874                                 367899999999


Q ss_pred             HHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHH
Q psy17952        300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  379 (804)
Q Consensus       300 i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWS  379 (804)
                      |+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|.+.+|+++|+|||+|||||+|+.++.|.|+.|+||||
T Consensus       131 i~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWS  210 (948)
T KOG0577|consen  131 ITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  210 (948)
T ss_pred             HHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCC
Q psy17952        380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD  459 (804)
Q Consensus       380 lGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~  459 (804)
                      |||++.||+.++||++++|.+.++|+|.++                                         ++|.++...
T Consensus       211 LGITCIELAERkPPlFnMNAMSALYHIAQN-----------------------------------------esPtLqs~e  249 (948)
T KOG0577|consen  211 LGITCIELAERKPPLFNMNAMSALYHIAQN-----------------------------------------ESPTLQSNE  249 (948)
T ss_pred             ccchhhhhhhcCCCccCchHHHHHHHHHhc-----------------------------------------CCCCCCCch
Confidence            999999999988888777666666666554                                         445556678


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhhHHHHHHHHHhcCCCCCCCCCC
Q psy17952        460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDP  539 (804)
Q Consensus       460 ~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~  539 (804)
                      ||+.|++|+..||++-|.+|||++++|+|+|+.+.+++.++.+++++++.+++++++++|+++|++++.+..+......+
T Consensus       250 WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKdaVrELDNlqYrKMkKilf~e~~ng~~ae~~  329 (948)
T KOG0577|consen  250 WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEAPNGPGAEGP  329 (948)
T ss_pred             hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHHHHHHhhhhhHHHHHHHHhhccCCCCCCCCC
Confidence            89999999999999999999999999999999999999999999999999999999999999999999888777655444


Q ss_pred             CCC-cccccCCCCCCCCccccccccccccccCCCCCCCCCCc
Q psy17952        540 DDT-PDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSS  580 (804)
Q Consensus       540 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (804)
                      .+. ..+...+.....++..+.+++.++++.....+...++.
T Consensus       330 e~ee~~d~~~~~a~~~~s~~sshSi~Smsisa~sQSSs~nsl  371 (948)
T KOG0577|consen  330 EEEEEADHYGGRAGTLNSLGSSHSIPSMSISASSQSSSVNSL  371 (948)
T ss_pred             chhhhcccccccccccccccccccCcccceecccccccccch
Confidence            443 34555667777888999999998888776544444433

>KOG0615|consensus

Probab=100.00  E-value=6.4e-56  Score=470.13  Aligned_cols=264  Identities=30%  Similarity=0.454  Sum_probs=222.0

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccc----hhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC----AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~----~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      ..+.|.+.+.||+|+||.|-+|..+.||+.||||+++......    ......+.+|++||++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3456889999999999999999999999999999997543222    123344679999999999999999999999999


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..||||||++||                                 +||+++...+.+.|+..+.+++|++.|+.|||++|
T Consensus       250 s~YmVlE~v~GG---------------------------------eLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G  296 (475)
T KOG0615|consen  250 SSYMVLEYVEGG---------------------------------ELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG  296 (475)
T ss_pred             ceEEEEEEecCc---------------------------------cHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC
Confidence            999999999987                                 68888888999999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCC---CcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTET---GTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~---g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||++.+   -.+||+|||+|+....   ..++||||.|.|||++.......|..++||||+||+||-+|+
T Consensus       297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs  376 (475)
T KOG0615|consen  297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS  376 (475)
T ss_pred             cccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence            9999999999999876   6799999999987643   357899999999999976433344458999999999999999


Q ss_pred             CCCCCCCCCh-HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 RKPPYFNMNA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 G~~PF~~~~~-~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      |.+||.+... .....+|.++..++.                  |                     +.....|++..+||
T Consensus       377 G~pPFS~~~~~~sl~eQI~~G~y~f~------------------p---------------------~~w~~Iseea~dlI  417 (475)
T KOG0615|consen  377 GYPPFSEEYTDPSLKEQILKGRYAFG------------------P---------------------LQWDRISEEALDLI  417 (475)
T ss_pred             cCCCcccccCCccHHHHHhcCccccc------------------C---------------------hhhhhhhHHHHHHH
Confidence            9999987543 224445554433211                  1                     12234689999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||+.||++|||++|+|+||||....
T Consensus       418 ~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  418 NWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             HHhhEeCcccCcCHHHHhcChhhhccc
Confidence            999999999999999999999998654

>KOG0603|consensus

Probab=100.00  E-value=3.9e-55  Score=488.03  Aligned_cols=397  Identities=27%  Similarity=0.361  Sum_probs=313.4

Q ss_pred             HHHHHhcC-CCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~-HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      +.++..++ ||++|+++..|+++..+|++++|..|+.+.........+++...+.+...++.|++++|+.+|||||+|++
T Consensus        47 r~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~e  126 (612)
T KOG0603|consen   47 RIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLE  126 (612)
T ss_pred             HHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccccc
Confidence            45777886 99999999999999999999999987654433334567899999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCC----------------
Q psy17952         84 NILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLK----------------  147 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~----------------  147 (804)
                      ||+++.+|.+|+.|||+++........|||..|||||+++     .+...+|+|++|.+..++.                
T Consensus       127 nilld~~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~  201 (612)
T KOG0603|consen  127 NVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILK  201 (612)
T ss_pred             ceeecccCccccCCchhhhHhHhhhhcccchhhhhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhh
Confidence            9999999999999999998654444449999999999983     3677899999886521110                


Q ss_pred             ----Ccc-------------------------------h-------------------h-------------cc----cc
Q psy17952        148 ----DPE-------------------------------I-------------------A-------------EL----FD  156 (804)
Q Consensus       148 ----~~~-------------------------------i-------------------~-------------el----f~  156 (804)
                          .|.                               +                   .             ..    |.
T Consensus       202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft  281 (612)
T KOG0603|consen  202 AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFT  281 (612)
T ss_pred             hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhc
Confidence                000                               0                   0             00    00


Q ss_pred             C------------------------------C-----CcccccccccccccccccceEEEEeeeceeEEEEEeccccccc
Q psy17952        157 K------------------------------E-----DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ  201 (804)
Q Consensus       157 ~------------------------------~-----dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~  201 (804)
                      .                              .     ...+.|+....+|.|+||.|-+|.+..+++..|+|.+....  
T Consensus       282 ~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--  359 (612)
T KOG0603|consen  282 SQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--  359 (612)
T ss_pred             cCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc--
Confidence            0                              0     01234777788999999999999999999999999987531  


Q ss_pred             chhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhccc
Q psy17952        202 CAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF  280 (804)
Q Consensus       202 ~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~  280 (804)
                           .+..+|+.++... +||||+++++++.+....|+|||++.|+.                                
T Consensus       360 -----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e--------------------------------  402 (612)
T KOG0603|consen  360 -----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE--------------------------------  402 (612)
T ss_pred             -----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH--------------------------------
Confidence                 2234577665554 79999999999999999999999999862                                


Q ss_pred             ccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee-cCCCcEEEEecccccccCCC-CccccCcccc
Q psy17952        281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPA-NSFVGTPYWM  358 (804)
Q Consensus       281 ~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl-~~~g~vKL~DFGla~~~~~~-~~~~GT~~Y~  358 (804)
                       +.+.+.....+. .++..|+.||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++..... .+.+-|..|.
T Consensus       403 -ll~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~  480 (612)
T KOG0603|consen  403 -LLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALTLQYV  480 (612)
T ss_pred             -HHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccchhhccc
Confidence             222222333333 6788899999999999999999999999999999 68999999999999876543 2446788899


Q ss_pred             cchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccc
Q psy17952        359 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM-SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFN  437 (804)
Q Consensus       359 APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~-~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~  437 (804)
                      |||++.   ...|+.++||||||++||+||+|+.||...... +...+|..                        +    
T Consensus       481 APEvl~---~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~------------------------~----  529 (612)
T KOG0603|consen  481 APEVLA---IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM------------------------P----  529 (612)
T ss_pred             Chhhhc---cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC------------------------C----
Confidence            999984   467999999999999999999999999654332 22222210                        0    


Q ss_pred             hhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccc-cCCC
Q psy17952        438 MNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV-TRPR  495 (804)
Q Consensus       438 ~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~-~~~~  495 (804)
                                       ..+...|+.+++||++||+.||.+||++++++.|||+ .++.
T Consensus       530 -----------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t  571 (612)
T KOG0603|consen  530 -----------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT  571 (612)
T ss_pred             -----------------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence                             0114569999999999999999999999999999999 4444

>KOG0581|consensus

Probab=100.00  E-value=7.3e-54  Score=452.35  Aligned_cols=262  Identities=35%  Similarity=0.579  Sum_probs=218.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc-eEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT-AWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~-~~lVm  241 (804)
                      ..+.++.||+|..|+||+|+++.|++.+|+|.+...  ......+++.+|++++++++||+||++|++|..++. .+|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            367889999999999999999999999999998432  334556889999999999999999999999999995 99999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRD  320 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRD  320 (804)
                      |||+||..|-+                                 ....+.++|.....|+.+|++||.|||. ++|||||
T Consensus       158 EYMDgGSLd~~---------------------------------~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRD  204 (364)
T KOG0581|consen  158 EYMDGGSLDDI---------------------------------LKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRD  204 (364)
T ss_pred             hhcCCCCHHHH---------------------------------HhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeecc
Confidence            99996543322                                 1123679999999999999999999995 9999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC--CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~--~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |||+|||++..|.|||||||.|+...  ..++++||..|||||.+.   +..|+.++||||||++++||++|+.||...+
T Consensus       205 IKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~---g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~  281 (364)
T KOG0581|consen  205 IKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERIS---GESYSVKSDIWSLGLSLLELAIGRFPYPPPN  281 (364)
T ss_pred             CCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhc---CCcCCcccceecccHHHHHHhhCCCCCCCcC
Confidence            99999999999999999999997643  467899999999999995   4689999999999999999999999996430


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      +                                  +  .+.....+..|...++|.++...||++|++||.+||++||.+
T Consensus       282 ~----------------------------------~--~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~  325 (364)
T KOG0581|consen  282 P----------------------------------P--YLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSE  325 (364)
T ss_pred             C----------------------------------C--CCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCccc
Confidence            0                                  0  001122233344445556666679999999999999999999


Q ss_pred             CCCHHHHHcCccccCCCCCc
Q psy17952        479 RPSSGRLLTHDLVTRPRSPS  498 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~~~~~~  498 (804)
                      |||+.|+|+|||+++...+.
T Consensus       326 R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  326 RPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             CCCHHHHhcCHHHhhccccc
Confidence            99999999999998765543

>KOG0593|consensus

Probab=100.00  E-value=3.9e-54  Score=440.40  Aligned_cols=279  Identities=30%  Similarity=0.498  Sum_probs=224.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|+.+.++|+|+||+||+|+++.||+.||||++... ..+....+-.+|||++|++|+|||+|.++++|.....++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            4699999999999999999999999999999987532 233344456789999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||+-...+.++                                 .....++++.++.|+.|++.|+.|||+++||||||
T Consensus        81 E~~dhTvL~eLe---------------------------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDI  127 (396)
T KOG0593|consen   81 EYCDHTVLHELE---------------------------------RYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDI  127 (396)
T ss_pred             eecchHHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccC
Confidence            999876444332                                 23457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC-CC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC-PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~-~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||||+.+|.+||||||+|+... +.   +.++.|++|+|||++.+  ..+|+..+||||+||++.||++|.+.|.+.
T Consensus       128 KPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG--DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~  205 (396)
T KOG0593|consen  128 KPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG--DTQYGKPVDIWAIGCVFAELLTGEPLWPGR  205 (396)
T ss_pred             ChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc--cCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence            9999999999999999999998765 32   35799999999999976  468999999999999999999999999999


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC---CCCCCccHHHHHHHHHhccc
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC---LQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~---~~~~~~s~~l~dli~~cL~~  474 (804)
                      ++.+++|.|.+.-++..+. ....+        ...|+|..-      .++....+.   ..-+..+..+.||+.+||++
T Consensus       206 SDiDQLy~I~ktLG~L~pr-hq~iF--------~~N~~F~Gv------~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~  270 (396)
T KOG0593|consen  206 SDIDQLYLIRKTLGNLIPR-HQSIF--------SSNPFFHGV------RLPEPEHPEPLERKYPKISNVLLDLLKKCLKM  270 (396)
T ss_pred             chHHHHHHHHHHHcccCHH-HHHHh--------ccCCceeee------ecCCCCCccchhhhcccchHHHHHHHHHHhcC
Confidence            9999999997643322110 00111        011222110      011111111   11234577899999999999


Q ss_pred             CCCCCCCHHHHHcCccc
Q psy17952        475 NPADRPSSGRLLTHDLV  491 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~  491 (804)
                      ||.+|+|++|+|.|+||
T Consensus       271 dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  271 DPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             CccccccHHHHhcChHH
Confidence            99999999999999999

>KOG0575|consensus

Probab=100.00  E-value=1.2e-52  Score=465.45  Aligned_cols=257  Identities=32%  Similarity=0.544  Sum_probs=225.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|+..+.||+|||+.||.+++..+|+.||+|++.+.........+.+.+||+|.++|+|||||+++++|++..++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999998755555666788999999999999999999999999999999999


Q ss_pred             eecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |+|. |++..++                                  ..+++++|.+++.+++||+.||.|||+++|||||
T Consensus        98 ELC~~~sL~el~----------------------------------Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRD  143 (592)
T KOG0575|consen   98 ELCHRGSLMELL----------------------------------KRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRD  143 (592)
T ss_pred             EecCCccHHHHH----------------------------------HhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecc
Confidence            9997 5543333                                  2457899999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      ||..|+||+++.+|||+|||+|.....    ..+.||||.|.|||++.   ...++..+||||+||+||-||.|+|||..
T Consensus       144 LKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~---k~gHsfEvDiWSlGcvmYtLL~G~PPFet  220 (592)
T KOG0575|consen  144 LKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLN---KSGHSFEVDIWSLGCVMYTLLVGRPPFET  220 (592)
T ss_pred             cchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhc---cCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence            999999999999999999999986543    35789999999999995   45688899999999999999999999988


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+.+.+|..++..                                           .+...|.++++||.++|+.||
T Consensus       221 k~vkety~~Ik~~~Y~-------------------------------------------~P~~ls~~A~dLI~~lL~~~P  257 (592)
T KOG0575|consen  221 KTVKETYNKIKLNEYS-------------------------------------------MPSHLSAEAKDLIRKLLRPNP  257 (592)
T ss_pred             chHHHHHHHHHhcCcc-------------------------------------------cccccCHHHHHHHHHHhcCCc
Confidence            7777777666543321                                           113578999999999999999


Q ss_pred             CCCCCHHHHHcCccccCCCCCc
Q psy17952        477 ADRPSSGRLLTHDLVTRPRSPS  498 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~~~~  498 (804)
                      .+|||++++|.|+||++...+.
T Consensus       258 ~~Rpsl~~vL~h~Ff~~g~~p~  279 (592)
T KOG0575|consen  258 SERPSLDEVLDHPFFKSGFTPA  279 (592)
T ss_pred             ccCCCHHHHhcCHhhhCCCcCC
Confidence            9999999999999997765544

>KOG0598|consensus

Probab=100.00  E-value=3.1e-52  Score=439.93  Aligned_cols=253  Identities=30%  Similarity=0.490  Sum_probs=222.8

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||.++.+.|++.+|+|++++..-...+..+....|..||.+++||+||+++..|++.+.+|||+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            48999999999999999999999999999999986544444456788999999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.||                                 +||.-+.+.+.|+|+.++.++.+|+.||.|||++||||||||
T Consensus       106 ~~~GG---------------------------------eLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlK  152 (357)
T KOG0598|consen  106 YLNGG---------------------------------ELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLK  152 (357)
T ss_pred             ccCCc---------------------------------cHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            99987                                 455555667889999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||||.+|+++|+|||+|+...    ...++|||+.|||||++++   ..|+..+|+|||||++|||++|.+||.+.+
T Consensus       153 PENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~---~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  153 PENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG---KGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             HHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhc---CCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            999999999999999999998643    3456899999999999964   579999999999999999999999999998


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......|.++..+                                          ..+.-++.++++|++++|++||++
T Consensus       230 ~~~~~~~I~~~k~~------------------------------------------~~p~~ls~~ardll~~LL~rdp~~  267 (357)
T KOG0598|consen  230 VKKMYDKILKGKLP------------------------------------------LPPGYLSEEARDLLKKLLKRDPRQ  267 (357)
T ss_pred             HHHHHHHHhcCcCC------------------------------------------CCCccCCHHHHHHHHHHhccCHHH
Confidence            88777777654311                                          111236889999999999999999


Q ss_pred             CC----CHHHHHcCccccC
Q psy17952        479 RP----SSGRLLTHDLVTR  493 (804)
Q Consensus       479 Rp----sa~elL~Hp~~~~  493 (804)
                      |.    .+.++-+||||..
T Consensus       268 RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  268 RLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             hcCCCCChHHhhcCccccc
Confidence            95    7889999999975

>KOG0578|consensus

Probab=100.00  E-value=5.8e-52  Score=456.83  Aligned_cols=274  Identities=42%  Similarity=0.742  Sum_probs=240.9

Q ss_pred             cCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       156 ~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      ...||...|....+||+|+-|.||.|+...+++.||||++.....   ...+-+++|+.+|+..+|+|||++++.|.-.+
T Consensus       267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  267 SQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             cCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            457888999999999999999999999999999999999975432   23456889999999999999999999999999


Q ss_pred             ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      .+|+||||++|| |.|++.                                   .-.++|.+++.|+++++.||+|||++
T Consensus       344 eLWVVMEym~ggsLTDvVt-----------------------------------~~~~~E~qIA~Icre~l~aL~fLH~~  388 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVT-----------------------------------KTRMTEGQIAAICREILQGLKFLHAR  388 (550)
T ss_pred             eeEEEEeecCCCchhhhhh-----------------------------------cccccHHHHHHHHHHHHHHHHHHHhc
Confidence            999999999865 444442                                   23489999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||||.+|||++.+|.+||+|||++.....    ..+.+|||+|||||++.   ...|++|+||||||++++||+.|
T Consensus       389 gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvt---rk~YG~KVDIWSLGIMaIEMveG  465 (550)
T KOG0578|consen  389 GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVT---RKPYGPKVDIWSLGIMAIEMVEG  465 (550)
T ss_pred             ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhh---hcccCccccchhhhhHHHHHhcC
Confidence            999999999999999999999999999876433    35789999999999984   56899999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .|||.+.++..++|.|..+.+|.++.                                        ....|.+|+||+.+
T Consensus       466 EPPYlnE~PlrAlyLIa~ng~P~lk~----------------------------------------~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  466 EPPYLNENPLRALYLIATNGTPKLKN----------------------------------------PEKLSPELKDFLDR  505 (550)
T ss_pred             CCCccCCChHHHHHHHhhcCCCCcCC----------------------------------------ccccCHHHHHHHHH
Confidence            99999999999999998877664321                                        13468999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHH
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAA  510 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~  510 (804)
                      ||+.||.+|++|.++|.||||.....++.+..++...+.+
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~~~~~~  545 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKMAKPESSLNPLILAARKA  545 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHHHHHHHh
Confidence            9999999999999999999999888888888887765543

>KOG0661|consensus

Probab=100.00  E-value=7.7e-52  Score=445.76  Aligned_cols=284  Identities=30%  Similarity=0.507  Sum_probs=231.2

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhh--HHHHHHHHhhcC-CCceeEeeeEEeecC
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD--ILKEIRFLRQLK-HPNTIEYRGCYLRDH  235 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~--~~~Ei~iL~~L~-HpNIV~l~~~~~~~~  235 (804)
                      ..+++|.++++||.|+||.||+|+.+.+++.||||+|+.....    +++  -+||+..|++|+ |||||++.+++.+.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s----~ee~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc----HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            3567899999999999999999999999999999998743222    333  368999999999 999999999998887


Q ss_pred             -ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 -TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 -~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                       .+|+|||||+.+|.++++.                                 +.+.|+|.+++.|+.||++||+|+|.+
T Consensus        83 ~~L~fVfE~Md~NLYqLmK~---------------------------------R~r~fse~~irnim~QilqGL~hiHk~  129 (538)
T KOG0661|consen   83 RILYFVFEFMDCNLYQLMKD---------------------------------RNRLFSESDIRNIMYQILQGLAHIHKH  129 (538)
T ss_pred             ceEeeeHHhhhhhHHHHHhh---------------------------------cCCcCCHHHHHHHHHHHHHHHHHHHhc
Confidence             9999999999887776641                                 256899999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEeccccccc---CCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~---~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |+.|||+||||||+.....+||+|||+|+..   .+.+.++.|++|+|||+|+.  .+.|+.++||||+|||++|+++-+
T Consensus       130 GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLr--s~~Ys~pvD~wA~GcI~aEl~sLr  207 (538)
T KOG0661|consen  130 GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLR--SGYYSSPVDMWAVGCIMAELYSLR  207 (538)
T ss_pred             CcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhh--ccccCCchHHHHHHHHHHHHHHhc
Confidence            9999999999999998889999999999864   34567899999999999984  578999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.|.|.++.+++++|+.- ++|..  ..|..-..+.......-|.+......           .+. +.++.++.++|.+
T Consensus       208 PLFPG~sE~Dqi~KIc~VLGtP~~--~~~~eg~~La~~mnf~~P~~~~~~l~-----------~L~-p~~s~~~~~li~~  273 (538)
T KOG0661|consen  208 PLFPGASEIDQIYKICEVLGTPDK--DSWPEGYNLASAMNFRFPQVKPSPLK-----------DLL-PNASSEAASLIER  273 (538)
T ss_pred             ccCCCCcHHHHHHHHHHHhCCCcc--ccchhHHHHHHHhccCCCcCCCCChH-----------HhC-cccCHHHHHHHHH
Confidence            999999999999999874 33321  22332222222111111111111111           111 3489999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||.+||.+||||.|+|+||||....
T Consensus       274 ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  274 LLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HhcCCCccCccHHHHhcCccccccc
Confidence            9999999999999999999997643

>KOG0600|consensus

Probab=100.00  E-value=8.5e-51  Score=440.55  Aligned_cols=280  Identities=29%  Similarity=0.472  Sum_probs=227.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLV  240 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~lV  240 (804)
                      .|+.+++||+|+||.||+|++..+|+.||+|+++... ..........|||.||++|+|||||+|.+.....  ..+|||
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4999999999999999999999999999999997543 2334445678999999999999999999988776  689999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      +|||+.+|..++.                                 ...-.|++.+++.|++|+++||+|||++||+|||
T Consensus       197 FeYMdhDL~GLl~---------------------------------~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRD  243 (560)
T KOG0600|consen  197 FEYMDHDLSGLLS---------------------------------SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRD  243 (560)
T ss_pred             Eecccchhhhhhc---------------------------------CCCcccChHHHHHHHHHHHHHHHHHhhcCeeecc
Confidence            9999887655442                                 1133689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||.+|||||.+|.+||+|||+|++...     .++.+-|.+|+|||+|+|.  ..|+.++|+||.||||.||++|++.|.
T Consensus       244 IK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~--t~Yg~aVDlWS~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  244 IKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGA--TSYGTAVDLWSVGCILAELFLGKPILQ  321 (560)
T ss_pred             ccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCC--cccccceeehhhhHHHHHHHcCCCCcC
Confidence            999999999999999999999986543     3456889999999999874  579999999999999999999999999


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccc--cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA--ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~--~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      +.++++++..|.+..+... ...|++. .+....  ....+|..  ....            .-..++....+|+..+|.
T Consensus       322 G~tEveQl~kIfklcGSP~-e~~W~~~-kLP~~~~~kp~~~y~r--~l~E------------~~~~~~~~~l~Ll~~lL~  385 (560)
T KOG0600|consen  322 GRTEVEQLHKIFKLCGSPT-EDYWPVS-KLPHATIFKPQQPYKR--RLRE------------TFKDFPASALDLLEKLLS  385 (560)
T ss_pred             CccHHHHHHHHHHHhCCCC-hhccccc-cCCcccccCCCCcccc--hHHH------------HhccCCHHHHHHHHHHhc
Confidence            9999999999987543322 2335522 222111  11111111  0000            123568889999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .||.+|.||.++|+++||+..
T Consensus       386 ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  386 LDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cCccccccHHHHhcCcccccC
Confidence            999999999999999999543

>KOG0595|consensus

Probab=100.00  E-value=1.5e-50  Score=430.33  Aligned_cols=255  Identities=35%  Similarity=0.542  Sum_probs=216.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+..++||+|+||+||+|+++.++..||||.+.+... ..+..+.+..|+.+|+.++|||||.+++++.+++.+|||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            48889999999999999999999999999999875422 34455678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.||                                 +|-+|+..++.++|+.++.++.||+.||++||+++|||||||
T Consensus        90 yC~gG---------------------------------DLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLK  136 (429)
T KOG0595|consen   90 YCNGG---------------------------------DLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLK  136 (429)
T ss_pred             eCCCC---------------------------------CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence            99965                                 344455667799999999999999999999999999999999


Q ss_pred             CCCeeecCC------CcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        323 AGNILLTET------GTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       323 P~NILl~~~------g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |+||||+..      -.+||+|||+|+...+.   .+.||||.|||||++.   .++|+.|+|+||+|+|+|+|++|++|
T Consensus       137 PQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~---~~~YdAKADLWSiG~Ilyq~l~g~~P  213 (429)
T KOG0595|consen  137 PQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIM---SQQYDAKADLWSIGTILYQCLTGKPP  213 (429)
T ss_pred             cceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHH---hccccchhhHHHHHHHHHHHHhCCCC
Confidence            999999875      35899999999987653   4789999999999995   46899999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+..+.+..+.++..-                    .|                    ......+....+++...|+
T Consensus       214 f~a~t~~eL~~~~~k~~~~--------------------~~--------------------~~~~~~s~~~~~Ll~~ll~  253 (429)
T KOG0595|consen  214 FDAETPKELLLYIKKGNEI--------------------VP--------------------VLPAELSNPLRELLISLLQ  253 (429)
T ss_pred             ccccCHHHHHHHHhccccc--------------------cC--------------------chhhhccCchhhhhhHHHh
Confidence            9988888777666543210                    00                    0112234556689999999


Q ss_pred             cCCCCCCCHHHHHcCccccCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .||.+|.+..+-+.|+++...
T Consensus       254 ~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  254 RNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             cCccccCchHHhhhhhhcccC
Confidence            999999999999999988654

>KOG0591|consensus

Probab=100.00  E-value=8.9e-52  Score=419.37  Aligned_cols=246  Identities=37%  Similarity=0.668  Sum_probs=211.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeee-EEeecCc-eEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG-CYLRDHT-AWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~-~~~~~~~-~~l  239 (804)
                      ..|+++++||+|+||+||++++..+|..||.|.+. .+..+...++.+..|+.+|++|+|||||++++ .|.++.. ++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            45999999999999999999999999999999998 34455667788999999999999999999988 5555555 899


Q ss_pred             EEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CC-
Q psy17952        240 VMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS--LG-  315 (804)
Q Consensus       240 VmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~--~g-  315 (804)
                      |||||. |+|..+++                              .+...++.++|..+++++.|++.||..||+  .. 
T Consensus        98 vmE~c~~GDLsqmIk------------------------------~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~  147 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIK------------------------------HFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRG  147 (375)
T ss_pred             HHHhhcccCHHHHHH------------------------------HHHhccccCchHHHHHHHHHHHHHHHHHhcccccc
Confidence            999998 55655554                              123456779999999999999999999999  44 


Q ss_pred             -CeecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        316 -RIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       316 -IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                       |+||||||.||+|+.+|.+||+|||+++.....    .+++|||+||+||++.   ..+|+.||||||+||++|||++-
T Consensus       148 ~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~---~~~Y~~kSDiWslGCllyEMcaL  224 (375)
T KOG0591|consen  148 TVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIH---ESGYNFKSDIWSLGCLLYEMCAL  224 (375)
T ss_pred             ceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHh---cCCCCcchhHHHHHHHHHHHHhc
Confidence             999999999999999999999999999876543    4689999999999995   46899999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.+-.+.-.+|.+++.|                                         ..+...+|.++..+|..
T Consensus       225 ~~PF~g~n~~~L~~KI~qgd~~-----------------------------------------~~p~~~YS~~l~~li~~  263 (375)
T KOG0591|consen  225 QSPFYGDNLLSLCKKIEQGDYP-----------------------------------------PLPDEHYSTDLRELINM  263 (375)
T ss_pred             CCCcccccHHHHHHHHHcCCCC-----------------------------------------CCcHHHhhhHHHHHHHH
Confidence            9999999877777777666543                                         22234578999999999


Q ss_pred             hcccCCCCCCCH
Q psy17952        471 CLAKNPADRPSS  482 (804)
Q Consensus       471 cL~~dP~~Rpsa  482 (804)
                      |+..||+.||+.
T Consensus       264 ci~vd~~~RP~t  275 (375)
T KOG0591|consen  264 CIAVDPEQRPDT  275 (375)
T ss_pred             HccCCcccCCCc
Confidence            999999999985

>KOG0616|consensus

Probab=100.00  E-value=2.7e-50  Score=411.83  Aligned_cols=252  Identities=27%  Similarity=0.459  Sum_probs=226.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+.++.||.|+||+|.+++++.+|..+|+|.+++...-..+..+...+|..+|+.+.||++|++++.|.+.+.+|||||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            48999999999999999999999999999999986555555667788899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |++||                                 +||.+.++.++|+|..++.++.||+.||+|||+++|++||||
T Consensus       125 yv~GG---------------------------------ElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLK  171 (355)
T KOG0616|consen  125 YVPGG---------------------------------ELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLK  171 (355)
T ss_pred             ccCCc---------------------------------cHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCC
Confidence            99987                                 577777788999999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS  401 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~  401 (804)
                      |+|||||.+|.+||+|||+|+.... ..+.||||.|+|||++.   ...|+.++|+|||||++|||++|.+||.+.+++.
T Consensus       172 PENiLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~---sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~  248 (355)
T KOG0616|consen  172 PENLLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQ---SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ  248 (355)
T ss_pred             hHHeeeccCCcEEEEeccceEEecCcEEEecCCccccChHHhh---cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence            9999999999999999999976543 45789999999999995   4679999999999999999999999999999988


Q ss_pred             HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC--
Q psy17952        402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR--  479 (804)
Q Consensus       402 ~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R--  479 (804)
                      ...+|+.++.                   ..|+                        .++.+++||++++|++|-.+|  
T Consensus       249 iY~KI~~~~v-------------------~fP~------------------------~fs~~~kdLl~~LL~vD~t~R~g  285 (355)
T KOG0616|consen  249 IYEKILEGKV-------------------KFPS------------------------YFSSDAKDLLKKLLQVDLTKRFG  285 (355)
T ss_pred             HHHHHHhCcc-------------------cCCc------------------------ccCHHHHHHHHHHHhhhhHhhhc
Confidence            8888876542                   2233                        357889999999999999999  


Q ss_pred             ---CCHHHHHcCccccC
Q psy17952        480 ---PSSGRLLTHDLVTR  493 (804)
Q Consensus       480 ---psa~elL~Hp~~~~  493 (804)
                         ....++..||||..
T Consensus       286 nlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  286 NLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             CcCCCccccccCccccc
Confidence               46678999999974

>KOG0659|consensus

Probab=100.00  E-value=1e-49  Score=402.33  Aligned_cols=285  Identities=28%  Similarity=0.433  Sum_probs=229.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .+|..+++||+|.||.||+|++..||+.||||+++.... ....-...+|||+.|+.++|||||.++++|...+.+-||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            368999999999999999999999999999999976432 2233356789999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||++.+|..+++                                 .+...++..+++.++.|+++||+|||++.|+||||
T Consensus        81 Efm~tdLe~vIk---------------------------------d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDl  127 (318)
T KOG0659|consen   81 EFMPTDLEVVIK---------------------------------DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDL  127 (318)
T ss_pred             EeccccHHHHhc---------------------------------ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccC
Confidence            999987766553                                 12456899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCCC----ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~~----~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||.|+||+++|.+||+|||+|+...+..    ..+-|.+|+|||++.|.  ..|+..+||||.|||+.||+-|.|-|.|.
T Consensus       128 KPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGs--r~Yg~~VDmWavGCI~AELllr~P~fpG~  205 (318)
T KOG0659|consen  128 KPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGS--RQYGTGVDMWAVGCIFAELLLRVPFFPGD  205 (318)
T ss_pred             CccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccc--hhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence            9999999999999999999998765322    23789999999999764  57999999999999999999999999999


Q ss_pred             ChHHHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      ++.+++..|... ++|.  ...|+-+..+.       .|..      +...+... ....-+..++++.||+.++|..||
T Consensus       206 sDidQL~~If~~LGTP~--~~~WP~~~~lp-------dY~~------~~~~P~~~-~~~lf~aas~d~ldLl~~m~~ynP  269 (318)
T KOG0659|consen  206 SDIDQLSKIFRALGTPT--PDQWPEMTSLP-------DYVK------IQQFPKPP-LNNLFPAASSDALDLLSKMLTYNP  269 (318)
T ss_pred             chHHHHHHHHHHcCCCC--cccCccccccc-------cHHH------HhcCCCCc-cccccccccHHHHHHHHhhhccCc
Confidence            999999998874 3332  22343332221       1111      00000000 000123457888999999999999


Q ss_pred             CCCCCHHHHHcCccccCCCCCc
Q psy17952        477 ADRPSSGRLLTHDLVTRPRSPS  498 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~~~~  498 (804)
                      .+|+||.|+|+|+||+....+.
T Consensus       270 ~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  270 KKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             hhcccHHHHhcchhhhcCCCCC
Confidence            9999999999999998755443

>KOG0201|consensus

Probab=100.00  E-value=7.6e-51  Score=435.30  Aligned_cols=270  Identities=47%  Similarity=0.794  Sum_probs=230.9

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .++...|..++.||+|+||.||+|.+..+++.||||.+...  ......+++.+|+.+|.++++|||.++|++|..+..+
T Consensus         9 ~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen    9 IDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             CCcccccccchhccccccceeeeeeeccccceEEEEEechh--hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            45666789999999999999999999999999999998753  2344567889999999999999999999999999999


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |++||||.|| +.++++                                  ....++|..+..|+++++.||.|||+++.
T Consensus        87 wiiMey~~gGsv~~lL~----------------------------------~~~~~~E~~i~~ilre~l~~l~ylH~~~k  132 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLK----------------------------------SGNILDEFEIAVILREVLKGLDYLHSEKK  132 (467)
T ss_pred             HHHHHHhcCcchhhhhc----------------------------------cCCCCccceeeeehHHHHHHhhhhhhcce
Confidence            9999999865 444332                                  23345888999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +|||||+.|||+..+|.+||+|||+|.....    ..+++|||+|||||++.   ...|+.|+||||||++++||++|.|
T Consensus       133 iHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~---~~~Y~~KADIWSLGITaiEla~GeP  209 (467)
T KOG0201|consen  133 IHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIK---QSGYDTKADIWSLGITAIELAKGEP  209 (467)
T ss_pred             ecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhc---cccccchhhhhhhhHHHHHHhcCCC
Confidence            9999999999999999999999999965432    36899999999999995   3579999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+..++..++.|.+                                         ..+|.+.. .||+.|++||..||
T Consensus       210 P~s~~hPmrvlflIpk-----------------------------------------~~PP~L~~-~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  210 PHSKLHPMRVLFLIPK-----------------------------------------SAPPRLDG-DFSPPFKEFVEACL  247 (467)
T ss_pred             CCcccCcceEEEeccC-----------------------------------------CCCCcccc-ccCHHHHHHHHHHh
Confidence            9988776655554433                                         33344443 78999999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHH
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK  508 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~  508 (804)
                      .+||+.||||.++|+|+|+++..+...+.+++.+.+
T Consensus       248 ~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~  283 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYK  283 (467)
T ss_pred             hcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHH
Confidence            999999999999999999999777777777776554

>KOG0582|consensus

Probab=100.00  E-value=2.6e-49  Score=423.29  Aligned_cols=268  Identities=40%  Similarity=0.686  Sum_probs=227.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++..+||.|.-++||+|+++.+++.||||++....  +......+.+|++.|+.++|||||+++.+|..+..+|+||.
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk--c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK--CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh--hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4999999999999999999999999999999997643  33447889999999999999999999999999999999999


Q ss_pred             ecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||. |++.+++...                                -...++|..++.|++++++||.|||.+|-|||||
T Consensus       105 fMa~GS~ldIik~~--------------------------------~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdv  152 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTY--------------------------------YPDGLEEASIATILREVLKALDYLHQNGHIHRDV  152 (516)
T ss_pred             hhcCCcHHHHHHHH--------------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCceeccc
Confidence            997 6677776522                                1235899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC--------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |+.||||+.+|.|||+|||++....        ..++++|||+|||||++.. ....|+.|+||||||++..||++|..|
T Consensus       153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q-~~~GYdfKaDIwSfGITA~ELA~G~aP  231 (516)
T KOG0582|consen  153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ-QLHGYDFKADIWSFGITACELAHGHAP  231 (516)
T ss_pred             ccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh-cccCccchhhhhhhhHHHHHHhcCCCC
Confidence            9999999999999999999874321        1156799999999999754 345699999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |....+++.+.+-.++.+|.+...                                 ..+......++..|+.++..||+
T Consensus       232 f~k~pPmkvLl~tLqn~pp~~~t~---------------------------------~~~~d~~k~~~ksf~e~i~~CL~  278 (516)
T KOG0582|consen  232 FSKYPPMKVLLLTLQNDPPTLLTS---------------------------------GLDKDEDKKFSKSFREMIALCLV  278 (516)
T ss_pred             cccCChHHHHHHHhcCCCCCcccc---------------------------------cCChHHhhhhcHHHHHHHHHHhh
Confidence            999999999888888776643210                                 00111223467799999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCCCCc
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPRSPS  498 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~~~~  498 (804)
                      +||.+||||+++|+|+||++.....
T Consensus       279 kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  279 KDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             cCcccCCCHHHHhccHHHhhccchh
Confidence            9999999999999999999876544

>KOG0592|consensus

Probab=100.00  E-value=3.3e-49  Score=431.24  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=219.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|...+.||+|+|++|++|+++.+++.+|||++.+.--....+..-+.+|-.+|.+| .||.||+|+..|.++..+|+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            389999999999999999999999999999998754433344455677899999999 7999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+++|                                 +|++++.+.+.|+|..++.++.||+.||+|||++|||||||
T Consensus       154 e~A~nG---------------------------------dll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDl  200 (604)
T KOG0592|consen  154 EYAPNG---------------------------------DLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDL  200 (604)
T ss_pred             EecCCC---------------------------------cHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccC
Confidence            999865                                 34455567789999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-----------------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-----------------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ||+|||||.||++||+|||.|+...+                 ..+++||..|.+||+|.   .+..+..+|||+||||+
T Consensus       201 KPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~---~~~~~~~sDiWAlGCil  277 (604)
T KOG0592|consen  201 KPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN---DSPAGPSSDLWALGCIL  277 (604)
T ss_pred             ChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc---CCCCCcccchHHHHHHH
Confidence            99999999999999999999975321                 13589999999999994   45678899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      |.|++|+|||.+.++-..+.+|..-+.+                                           .+..+++.+
T Consensus       278 yQmlaG~PPFra~NeyliFqkI~~l~y~-------------------------------------------fp~~fp~~a  314 (604)
T KOG0592|consen  278 YQMLAGQPPFRAANEYLIFQKIQALDYE-------------------------------------------FPEGFPEDA  314 (604)
T ss_pred             HHHhcCCCCCccccHHHHHHHHHHhccc-------------------------------------------CCCCCCHHH
Confidence            9999999999999988777777543211                                           123467889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +|||+++|..||.+|+|++|+.+||||...
T Consensus       315 ~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  315 RDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             HHHHHHHHccCccccccHHHHhhCcccccC
Confidence            999999999999999999999999999753

>KOG0033|consensus

Probab=100.00  E-value=6.9e-50  Score=398.29  Aligned_cols=258  Identities=26%  Similarity=0.421  Sum_probs=219.5

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ++.|++.+.||+|.|+.||+|.+..||+.+|+|.+... +......+.+.+|++|.+.|+|||||++++.+...+..|||
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~-k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhh-hhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            45689999999999999999999999999999988643 33344678899999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      +|+|.|+                                 +|+.-++.+-.++|..+..+++||++||.|||.+||||||
T Consensus        89 Fe~m~G~---------------------------------dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRD  135 (355)
T KOG0033|consen   89 FDLVTGG---------------------------------ELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRD  135 (355)
T ss_pred             Eecccch---------------------------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceecc
Confidence            9999987                                 2222233344578999999999999999999999999999


Q ss_pred             CCCCCeeecCC---CcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        321 VKAGNILLTET---GTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       321 LKP~NILl~~~---g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      +||+|+|+.+.   .-+||+|||+|......   ..++|||.|||||++.   ..+|+..+||||.|||||-||.|.+||
T Consensus       136 vkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr---kdpy~kpvDiW~cGViLfiLL~G~~PF  212 (355)
T KOG0033|consen  136 LKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYILLVGYPPF  212 (355)
T ss_pred             CChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh---cCCCCCcchhhhhhHHHHHHHhCCCCC
Confidence            99999999643   36999999999765532   3578999999999984   568999999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      ++.+.......|.++...                                       .+....+..++++++|+++||..
T Consensus       213 ~~~~~~rlye~I~~g~yd---------------------------------------~~~~~w~~is~~Ak~LvrrML~~  253 (355)
T KOG0033|consen  213 WDEDQHRLYEQIKAGAYD---------------------------------------YPSPEWDTVTPEAKSLIRRMLTV  253 (355)
T ss_pred             CCccHHHHHHHHhccccC---------------------------------------CCCcccCcCCHHHHHHHHHHhcc
Confidence            998887777777665431                                       11122345789999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ||++|.|+.|+|+|||+.+.
T Consensus       254 dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  254 NPKKRITADEALKHPWICNR  273 (355)
T ss_pred             ChhhhccHHHHhCCchhcch
Confidence            99999999999999999763

>KOG0579|consensus

Probab=100.00  E-value=9.9e-50  Score=436.54  Aligned_cols=277  Identities=41%  Similarity=0.749  Sum_probs=241.2

Q ss_pred             CCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       157 ~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      ..+|.+.++++..||.|+||.||+|..+.++-..|-|.|..   ...+..++++-||+||..++||+||+|++.|..++.
T Consensus        27 dlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   27 DLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             cCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence            44688889999999999999999999998888888888753   345667889999999999999999999999999999


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +|+..|||.||..|.+-.                                .-.+.|+|.++..+++|++.||.|||+++|
T Consensus       104 LwiliEFC~GGAVDaiml--------------------------------EL~r~LtE~QIqvvc~q~ldALn~LHs~~i  151 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIML--------------------------------ELGRVLTEDQIQVVCYQVLDALNWLHSQNI  151 (1187)
T ss_pred             eEEEEeecCCchHhHHHH--------------------------------HhccccchHHHHHHHHHHHHHHHHHhhcch
Confidence            999999999997765521                                124579999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEeccccccc----CCCCccccCcccccchhhcc--cCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILA--MDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~----~~~~~~~GT~~Y~APEvl~~--~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||..|||++.+|.++|+|||++...    ....+|+|||+|||||+...  +...+|+.++||||||++|.||+.+
T Consensus       152 IHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi  231 (1187)
T KOG0579|consen  152 IHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI  231 (1187)
T ss_pred             hhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence            99999999999999999999999998543    23568999999999999854  3456899999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .||....+++..+..|.+.++|.+                                        +.++.|+..|.||+.+
T Consensus       232 EPPHhelnpMRVllKiaKSePPTL----------------------------------------lqPS~Ws~~F~DfLk~  271 (1187)
T KOG0579|consen  232 EPPHHELNPMRVLLKIAKSEPPTL----------------------------------------LQPSHWSRSFSDFLKR  271 (1187)
T ss_pred             CCCccccchHHHHHHHhhcCCCcc----------------------------------------cCcchhhhHHHHHHHH
Confidence            999999999999998877655422                                        2346799999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHH
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK  508 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~  508 (804)
                      ||.+||..||+++++|+|||+....+.+.+.+++...+
T Consensus       272 cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLlAEak  309 (1187)
T KOG0579|consen  272 CLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELLAEAK  309 (1187)
T ss_pred             HHhcCCccCCCHHHHhhCcccccCCcchHHHHHHHHHH
Confidence            99999999999999999999998877776666665444

>KOG0605|consensus

Probab=100.00  E-value=9.3e-49  Score=428.38  Aligned_cols=256  Identities=28%  Similarity=0.429  Sum_probs=220.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+.++.||+|+||.||+|+.+.||+.+|+|++++.........+.++.|-.+|...++|+||+|+.+|++...+|||||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            49999999999999999999999999999999987665566677889999999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |++||                                 ++...+.+.+.|+|+.++.++.+++.|++-||..|+||||||
T Consensus       222 ylPGG---------------------------------D~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIK  268 (550)
T KOG0605|consen  222 YLPGG---------------------------------DMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIK  268 (550)
T ss_pred             ecCCc---------------------------------cHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCC
Confidence            99987                                 222334467889999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEeccccccc--------------------------CC-------------------------CCcc
Q psy17952        323 AGNILLTETGTVKLADFGSASIK--------------------------CP-------------------------ANSF  351 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~--------------------------~~-------------------------~~~~  351 (804)
                      |+|+|||..|++||+|||||.-.                          .+                         ..+.
T Consensus       269 PdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~St  348 (550)
T KOG0605|consen  269 PDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYST  348 (550)
T ss_pred             hhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcc
Confidence            99999999999999999998310                          00                         0145


Q ss_pred             ccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccC
Q psy17952        352 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER  431 (804)
Q Consensus       352 ~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~  431 (804)
                      +|||-|||||++++   ..|+..+|+||||||+||||.|.|||.+.++.+...+|..+..-                 ..
T Consensus       349 VGTPDYiAPEVll~---kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-----------------l~  408 (550)
T KOG0605|consen  349 VGTPDYIAPEVLLG---KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-----------------LK  408 (550)
T ss_pred             cCCccccchHHHhc---CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-----------------cc
Confidence            89999999999974   45999999999999999999999999999999988888654210                 00


Q ss_pred             CCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC---HHHHHcCccccCC
Q psy17952        432 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS---SGRLLTHDLVTRP  494 (804)
Q Consensus       432 ~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps---a~elL~Hp~~~~~  494 (804)
                      .                      +.....+++++|||.+||. ||++|..   ++|+-+||||+..
T Consensus       409 f----------------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  409 F----------------------PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             C----------------------CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            1                      1123457999999999999 9999975   8999999999763

>KOG0663|consensus

Probab=100.00  E-value=9.9e-49  Score=405.55  Aligned_cols=290  Identities=27%  Similarity=0.406  Sum_probs=230.1

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--C
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--H  235 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~  235 (804)
                      -..-+.|+.+.+|++|+||.||+|+++.|++.||+|+++... .....--..+|||.+|.+++|||||.+.++....  +
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            334456999999999999999999999999999999997543 2223333468999999999999999998887653  5


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+|+|||||+.++..+++.                                 .+.+|.+.+++.++.|+++|++|||.+.
T Consensus       151 ~iy~VMe~~EhDLksl~d~---------------------------------m~q~F~~~evK~L~~QlL~glk~lH~~w  197 (419)
T KOG0663|consen  151 KIYIVMEYVEHDLKSLMET---------------------------------MKQPFLPGEVKTLMLQLLRGLKHLHDNW  197 (419)
T ss_pred             eeeeeHHHHHhhHHHHHHh---------------------------------ccCCCchHHHHHHHHHHHHHHHHHhhce
Confidence            7999999999877666541                                 2357899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |+||||||+|+|++..|.+||+|||+|+....    .+..+-|.+|+|||++++.  ..|++++|+||+|||+.||++++
T Consensus       198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~--~tyst~iDMWSvGCI~aE~l~~k  275 (419)
T KOG0663|consen  198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGA--KTYSTAVDMWSVGCIFAELLTQK  275 (419)
T ss_pred             eEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCC--cccCcchhhhhHHHHHHHHHhcC
Confidence            99999999999999999999999999987643    3456889999999999874  57999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccc-cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~-~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.|.|.++.+++.+|.+. ++|.  ...|+.+..+.... ...++.+    ...+.    ..++   ....|+...+|+.
T Consensus       276 Plf~G~sE~dQl~~If~llGtPt--e~iwpg~~~lp~~k~~~f~~~p----yn~lr----~kF~---~~~lse~g~~Lln  342 (419)
T KOG0663|consen  276 PLFPGKSEIDQLDKIFKLLGTPS--EAIWPGYSELPAVKKMTFSEHP----YNNLR----KKFG---ALSLSEQGFDLLN  342 (419)
T ss_pred             CCCCCCchHHHHHHHHHHhCCCc--cccCCCccccchhhccccCCCC----chhhh----hhcc---ccccchhHHHHHH
Confidence            999999999999999874 3332  23344333222110 1111110    01111    1111   1226799999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .+|..||.+|.||.|+|+|+||.....
T Consensus       343 ~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  343 KLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             HHhccCccccccHHHhhcccccccCCC
Confidence            999999999999999999999987543

>KOG0574|consensus

Probab=100.00  E-value=2.5e-50  Score=410.59  Aligned_cols=268  Identities=43%  Similarity=0.807  Sum_probs=233.8

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ..|+..|.++.+||+|+||.||+|.++.+|+.+|||++..     ....+.+.+||.||++++.|++|+|||.|.....+
T Consensus        29 K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   29 KPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             CChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            4578889999999999999999999999999999998853     23467899999999999999999999999999999


Q ss_pred             EEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||. |+..|++.                                 .++++|+|+++..+++..++||+|||...-
T Consensus       104 WIVMEYCGAGSiSDI~R---------------------------------~R~K~L~E~EIs~iL~~TLKGL~YLH~~~K  150 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMR---------------------------------ARRKPLSEQEISAVLRDTLKGLQYLHDLKK  150 (502)
T ss_pred             EeehhhcCCCcHHHHHH---------------------------------HhcCCccHHHHHHHHHHHHhHHHHHHHHHH
Confidence            99999997 77777664                                 135689999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      ||||||..|||++.+|.+||+|||+|.....    .++.+|||.|||||++.   .-.|+.++||||||++..||+.|+|
T Consensus       151 IHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~---EIGY~~~ADIWSLGITaIEMAEG~P  227 (502)
T KOG0574|consen  151 IHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIE---EIGYDTKADIWSLGITAIEMAEGRP  227 (502)
T ss_pred             HHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHH---HhccchhhhHhhhcchhhhhhcCCC
Confidence            9999999999999999999999999976543    46789999999999995   3469999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+..++.++++|....                      ||.|.                  .+..||++|-||+++||
T Consensus       228 PYsDIHPMRAIFMIPT~P----------------------PPTF~------------------KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  228 PYSDIHPMRAIFMIPTKP----------------------PPTFK------------------KPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             CcccccccceeEeccCCC----------------------CCCCC------------------ChHhhhhHHHHHHHHHh
Confidence            999988888777764322                      22221                  12458999999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCCchhHHHHHH
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRR  506 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~  506 (804)
                      .++|++|-||.++++|||++....-..+..++..
T Consensus       268 iK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~  301 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQD  301 (502)
T ss_pred             cCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHH
Confidence            9999999999999999999988776666665544

>KOG0583|consensus

Probab=100.00  E-value=4.7e-48  Score=428.80  Aligned_cols=254  Identities=33%  Similarity=0.519  Sum_probs=217.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEeccccccc-c-hhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-C-AEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-~-~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~  238 (804)
                      ..|++.+.||+|+||+|++|++..+++.||+|.+...... . ....+.+.+|+.++++++ ||||+++++++.....+|
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            4599999999999999999999999999999976643111 1 123345668999999999 999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.||                                 +||+++...++++|.+++.+|+|+++|++|||++||+|
T Consensus        97 ivmEy~~gG---------------------------------dL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~H  143 (370)
T KOG0583|consen   97 IVMEYCSGG---------------------------------DLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVH  143 (370)
T ss_pred             EEEEecCCc---------------------------------cHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEee
Confidence            999999885                                 56677777889999999999999999999999999999


Q ss_pred             cCCCCCCeeecCC-CcEEEEeccccccc----CCCCccccCcccccchhhcccCCCCCC-CcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTET-GTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~-g~vKL~DFGla~~~----~~~~~~~GT~~Y~APEvl~~~~~~~y~-~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+|||++.+ +.+||+|||+|...    ....+.||||.|+|||++.+  ...|+ .++||||+||+||.|++|..
T Consensus       144 RDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~  221 (370)
T KOG0583|consen  144 RDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRL  221 (370)
T ss_pred             CCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCC
Confidence            9999999999999 99999999999866    23457899999999999964  22276 57999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCc-cHHHHHHHHHh
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW-SDTFAHFVSSC  471 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~-s~~l~dli~~c  471 (804)
                      ||.+.+.......|.++...                   .|                        ..+ |+++++|+.+|
T Consensus       222 PF~d~~~~~l~~ki~~~~~~-------------------~p------------------------~~~~S~~~~~Li~~m  258 (370)
T KOG0583|consen  222 PFDDSNVPNLYRKIRKGEFK-------------------IP------------------------SYLLSPEARSLIEKM  258 (370)
T ss_pred             CCCCccHHHHHHHHhcCCcc-------------------CC------------------------CCcCCHHHHHHHHHH
Confidence            99987777666665443211                   01                        123 88999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      |..||.+|+|+.+++.||||+.
T Consensus       259 L~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  259 LVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             cCCCcccCCCHHHHhhChhhcc
Confidence            9999999999999999999986

>KOG0588|consensus

Probab=100.00  E-value=1.7e-48  Score=433.00  Aligned_cols=252  Identities=29%  Similarity=0.510  Sum_probs=225.3

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||.|+-|.|.+|++..||+.+|||.+.............+.+||-||+.+.||||+.++++|++...+|+|+||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            77888899999999999999999999999999765444444556789999999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      ++||                                 +||++...+++++|.+++++++||+.|+.|||..+|+||||||
T Consensus        94 v~gG---------------------------------ELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKp  140 (786)
T KOG0588|consen   94 VPGG---------------------------------ELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKP  140 (786)
T ss_pred             cCCc---------------------------------hhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCc
Confidence            9987                                 6888999999999999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~-ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +|+|||..+.+||+|||+|....+.   .+.||+|.|.|||++.|   .+|+. ++||||+|||||.||+|+.||.+.|-
T Consensus       141 ENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G---~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi  217 (786)
T KOG0588|consen  141 ENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSG---RPYDGRPSDVWSCGVILFALLTGKLPFDDDNI  217 (786)
T ss_pred             hhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcC---CCCCCCccccchhHHHHHHHHhCCCCCCCccH
Confidence            9999999999999999999876554   47899999999999964   56764 79999999999999999999998887


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ...+.++.+|...                                           .+..+|.++++||.+||..||++|
T Consensus       218 r~LLlKV~~G~f~-------------------------------------------MPs~Is~eaQdLLr~ml~VDp~~R  254 (786)
T KOG0588|consen  218 RVLLLKVQRGVFE-------------------------------------------MPSNISSEAQDLLRRMLDVDPSTR  254 (786)
T ss_pred             HHHHHHHHcCccc-------------------------------------------CCCcCCHHHHHHHHHHhccCcccc
Confidence            7777777655321                                           114568999999999999999999


Q ss_pred             CCHHHHHcCccccCC
Q psy17952        480 PSSGRLLTHDLVTRP  494 (804)
Q Consensus       480 psa~elL~Hp~~~~~  494 (804)
                      .|.+|+++|||+...
T Consensus       255 iT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  255 ITTEEILKHPFLSGY  269 (786)
T ss_pred             ccHHHHhhCchhhcC
Confidence            999999999999753

>KOG0597|consensus

Probab=100.00  E-value=7.9e-49  Score=427.35  Aligned_cols=252  Identities=36%  Similarity=0.583  Sum_probs=218.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|-+.+.||+|+||+||+|+.+.+.+.||||.+.+.++. .+....+.+|++|+++|+|||||.++++|++...+|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            3588899999999999999999999999999999876554 345677899999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+|..+++                                  ..+.++|+.++.|+.|+++||.|||+.+|+|||+
T Consensus        81 e~a~g~L~~il~----------------------------------~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~  126 (808)
T KOG0597|consen   81 EYAVGDLFTILE----------------------------------QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDM  126 (808)
T ss_pred             hhhhhhHHHHHH----------------------------------hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccC
Confidence            999997554443                                  4578999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||.|||++..|.+|+||||+|+.....    .+..|||.|||||++.   ++.|+..+|+||+|||+|||++|+|||...
T Consensus       127 kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~---e~pyd~~sDlWslGcilYE~~~G~PPF~a~  203 (808)
T KOG0597|consen  127 KPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE---EQPYDHTSDLWSLGCILYELYVGQPPFYAR  203 (808)
T ss_pred             CcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHc---CCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence            999999999999999999999876543    3457999999999984   578999999999999999999999999876


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +-......|...+.                                           ..+...|..|.+|+..+|.+||.
T Consensus       204 si~~Lv~~I~~d~v-------------------------------------------~~p~~~S~~f~nfl~gLL~kdP~  240 (808)
T KOG0597|consen  204 SITQLVKSILKDPV-------------------------------------------KPPSTASSSFVNFLQGLLIKDPA  240 (808)
T ss_pred             HHHHHHHHHhcCCC-------------------------------------------CCcccccHHHHHHHHHHhhcChh
Confidence            55555554443221                                           11235688999999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy17952        478 DRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~  494 (804)
                      +|.|..+++.|||++..
T Consensus       241 ~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  241 QRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             hcccHHHHhcChHHhhh
Confidence            99999999999998753

>KOG0660|consensus

Probab=100.00  E-value=7.6e-48  Score=405.19  Aligned_cols=282  Identities=26%  Similarity=0.391  Sum_probs=222.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-----cCce
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-----DHTA  237 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-----~~~~  237 (804)
                      .|..++.||+|+||.|+.|.++.+|+.||||++.... ...-..++.+||+.+|+.++|+|||.+.+.+..     -+.+
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4666899999999999999999999999999987322 223345678999999999999999999998876     3568


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+|+|+|+.+|..+++                                  ....|+++.++.++.|++.||.|+|+.+|+
T Consensus       102 YiV~elMetDL~~iik----------------------------------~~~~L~d~H~q~f~YQiLrgLKyiHSAnVi  147 (359)
T KOG0660|consen  102 YLVFELMETDLHQIIK----------------------------------SQQDLTDDHAQYFLYQILRGLKYIHSANVI  147 (359)
T ss_pred             EEehhHHhhHHHHHHH----------------------------------cCccccHHHHHHHHHHHHHhcchhhccccc
Confidence            9999999766554443                                  334599999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||||||+|+|++.+..+||||||+|+...+      .+.++-|.+|+|||+++.  ...|+.++||||.|||+.||++|+
T Consensus       148 HRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~--~~~Yt~aiDiWSvGCI~AEmL~gk  225 (359)
T KOG0660|consen  148 HRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN--SSEYTKAIDIWSVGCILAEMLTGK  225 (359)
T ss_pred             ccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc--cccccchhhhhhhhHHHHHHHcCC
Confidence            999999999999999999999999987642      245789999999999964  567999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC-C-CCCCCCccHHHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT-P-CLQSSDWSDTFAHFV  468 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~-p-~~~~~~~s~~l~dli  468 (804)
                      +-|.|.+..+++..|..- ++|     ....+..+.+...          ..-+...++.+. | ...-+..++.+.||+
T Consensus       226 plFpG~d~v~Ql~lI~~~lGtP-----~~e~l~~i~s~~a----------r~yi~slp~~p~~~f~~~fp~a~p~AidLl  290 (359)
T KOG0660|consen  226 PLFPGKDYVHQLQLILELLGTP-----SEEDLQKIRSEKA----------RPYIKSLPQIPKQPFSSIFPNANPLAIDLL  290 (359)
T ss_pred             CCCCCCchHHHHHHHHHhcCCC-----CHHHHHHhccHHH----------HHHHHhCCCCCCCCHHHHcCCCCHHHHHHH
Confidence            999999999999988764 222     1122333321110          000000000000 0 001235689999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .+||+.||.+|+|++|+|+|||+..-..
T Consensus       291 ekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  291 EKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             HHHhccCccccCCHHHHhcChhhhhhcC
Confidence            9999999999999999999999976433

>KOG0198|consensus

Probab=100.00  E-value=2.3e-47  Score=409.06  Aligned_cols=253  Identities=36%  Similarity=0.578  Sum_probs=205.0

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC--ceEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH--TAWLV  240 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~--~~~lV  240 (804)
                      .+...+.||+|+||.||++.+..+|+..|||.+....   ....+.+.+|+++|++|+|||||+++|......  .+++.
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            3778889999999999999999999999999887542   122567899999999999999999999855544  68999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~-~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||+.| ++.+++.                                  ..+ .|+|..++.+++||++||+|||++||||
T Consensus        95 mEy~~~GsL~~~~~----------------------------------~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH  140 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIK----------------------------------RYGGKLPEPLVRRYTRQILEGLAYLHSKGIVH  140 (313)
T ss_pred             eeccCCCcHHHHHH----------------------------------HcCCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            999985 4444432                                  223 7999999999999999999999999999


Q ss_pred             cCCCCCCeeecC-CCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        319 RDVKAGNILLTE-TGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       319 RDLKP~NILl~~-~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      |||||+|||++. ++.+||+|||+|+....       ...+.|||.|||||++..  +...+.++|||||||++.||+||
T Consensus       141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~--g~~~~~~sDiWSlGCtVvEM~Tg  218 (313)
T KOG0198|consen  141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN--GEVARRESDIWSLGCTVVEMLTG  218 (313)
T ss_pred             cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC--CCcCCccchhhhcCCEEEeccCC
Confidence            999999999999 79999999999875442       235789999999999952  11123489999999999999999


Q ss_pred             CCCCCC-CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        391 KPPYFN-MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       391 ~~PF~~-~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      ++||.+ ......+..+....                                        ..| ..+...|+++++|+.
T Consensus       219 ~~PW~~~~~~~~~~~~ig~~~----------------------------------------~~P-~ip~~ls~~a~~Fl~  257 (313)
T KOG0198|consen  219 KPPWSEFFEEAEALLLIGRED----------------------------------------SLP-EIPDSLSDEAKDFLR  257 (313)
T ss_pred             CCcchhhcchHHHHHHHhccC----------------------------------------CCC-CCCcccCHHHHHHHH
Confidence            999977 34444444443221                                        011 112347899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +||++||++||||.++|.|||.....
T Consensus       258 ~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  258 KCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHhhcCcccCcCHHHHhhChhhhccc
Confidence            99999999999999999999987643

>KOG0594|consensus

Probab=100.00  E-value=1.5e-46  Score=396.65  Aligned_cols=289  Identities=28%  Similarity=0.444  Sum_probs=227.6

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCc-eeEeeeEEeecC----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN-TIEYRGCYLRDH----  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IV~l~~~~~~~~----  235 (804)
                      ...|+.+++||+|+||+||+|+.+.+|+.||+|+++..... ........||+.+|+.|+|+| ||.+++++.+.+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            34589999999999999999999999999999999764332 223455789999999999999 999999998877    


Q ss_pred             --ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        236 --TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       236 --~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                        .+|+|+||+.-++.+.++..                              ......++...++.+++||+.||+|||+
T Consensus        89 ~~~l~lvfe~~d~DL~~ymd~~------------------------------~~~~~g~~~~~ik~~m~Qll~gl~~~H~  138 (323)
T KOG0594|consen   89 IGKLYLVFEFLDRDLKKYMDSL------------------------------PKKPQGLPPRLIKSFMRQLLRGLAFLHS  138 (323)
T ss_pred             cceEEEEEEeecccHHHHHHhc------------------------------cccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence              89999999987766555311                              0001357778999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccC-CC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKC-PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~-~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ++|+||||||+||||+++|.+||+|||+|+... +.   ...++|.+|+|||++++.  ..|++.+||||+|||++||++
T Consensus       139 ~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs--~~Ys~~vDiWs~GcIfaEm~~  216 (323)
T KOG0594|consen  139 HGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGS--TSYSTSVDIWSLGCIFAEMFT  216 (323)
T ss_pred             CCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCC--CcCCCCcchHhHHHHHHHHHh
Confidence            999999999999999999999999999998654 32   346899999999999874  469999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +++.|.+.++.+++..|.+- ++|.  ...|+.+..........+.+.......            ...+..+.+..+++
T Consensus       217 ~~~LFpG~se~~ql~~If~~lGtP~--e~~Wp~v~~~~~~k~~f~~~~~~~~l~------------~~~~~~~~~~~dll  282 (323)
T KOG0594|consen  217 RRPLFPGDSEIDQLFRIFRLLGTPN--EKDWPGVSSLPDYKAPFPKWPGPKDLS------------SILPKLDPDGIELL  282 (323)
T ss_pred             CCCCCCCCcHHHHHHHHHHHcCCCC--ccCCCCccccccccccCcCCCCccchH------------HhccccCccHHHHH
Confidence            99999999999999998763 3443  234554433332221111111111100            01122346889999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .+||+.+|.+|.||..+|.||||.....
T Consensus       283 ~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  283 SKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             HHHhccCcccCcCHHHHhcChhhccccc
Confidence            9999999999999999999999987544

>KOG0599|consensus

Probab=100.00  E-value=2.7e-47  Score=384.68  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=221.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccc-----cchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecC
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK-----QCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~-----~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~  235 (804)
                      ..|+-.+.||+|..++|.+|.++.+++.+|+|++.....     ...+..+...+|+.||+++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            346777889999999999999999999999999864321     1223345667899999998 5999999999999999


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+++|+|+|+.|                                 +|||+...+..++|++.++|++|+++|+.|||.++
T Consensus        97 F~FlVFdl~prG---------------------------------ELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~  143 (411)
T KOG0599|consen   97 FVFLVFDLMPRG---------------------------------ELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN  143 (411)
T ss_pred             hhhhhhhhcccc---------------------------------hHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh
Confidence            999999999744                                 57777777888999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCCC---ccccCcccccchhhccc---CCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~---~~~GT~~Y~APEvl~~~---~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||||||||+|||++++..+||+|||+|+...+..   ..||||+|.|||.+...   ....|+..+|+||+|||||.||.
T Consensus       144 IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa  223 (411)
T KOG0599|consen  144 IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA  223 (411)
T ss_pred             hhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc
Confidence            9999999999999999999999999998876653   57999999999998531   34468889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||+....+-.+.+|.+|...+.                                       .....++|.+.+|||+
T Consensus       224 GcpPFwHRkQmlMLR~ImeGkyqF~---------------------------------------speWadis~~~KdLIs  264 (411)
T KOG0599|consen  224 GCPPFWHRKQMLMLRMIMEGKYQFR---------------------------------------SPEWADISATVKDLIS  264 (411)
T ss_pred             CCCchhHHHHHHHHHHHHhcccccC---------------------------------------CcchhhccccHHHHHH
Confidence            9999998888878888877654321                                       1122456888999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccc
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +||+.||.+|.|+.|+|+||||
T Consensus       265 rlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  265 RLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             HHHeeCchhcccHHHHhcChHH
Confidence            9999999999999999999999

>KOG0585|consensus

Probab=100.00  E-value=2.7e-46  Score=402.21  Aligned_cols=259  Identities=30%  Similarity=0.494  Sum_probs=211.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEeccccccc-----------chhhhhhHHHHHHHHhhcCCCceeEeee
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-----------CAEKWADILKEIRFLRQLKHPNTIEYRG  229 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-----------~~~~~~~~~~Ei~iL~~L~HpNIV~l~~  229 (804)
                      -+.|++++.||+|+||.|-+|++..+++.||||++.+....           .....+.+.+||.||++|.|||||+|++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            34699999999999999999999999999999998643211           0112357889999999999999999999


Q ss_pred             EEeec--CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCC-CCHHHHHHHHHHHHH
Q psy17952        230 CYLRD--HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRP-LKEEEIAAICSGVLR  306 (804)
Q Consensus       230 ~~~~~--~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~-l~e~~i~~i~~qil~  306 (804)
                      +..+.  +.+|||+|||..|...     |.                             ....+ +++.+++.|+++++.
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~-----w~-----------------------------p~d~~els~~~Ar~ylrDvv~  221 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVK-----WC-----------------------------PPDKPELSEQQARKYLRDVVL  221 (576)
T ss_pred             eecCcccCceEEEEEeccCCccc-----cC-----------------------------CCCcccccHHHHHHHHHHHHH
Confidence            98764  6899999999865211     10                             11233 899999999999999


Q ss_pred             HHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC---------CccccCcccccchhhcccCCCCC-CCccc
Q psy17952        307 GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---------NSFVGTPYWMAPEVILAMDEGQY-DGKVD  376 (804)
Q Consensus       307 gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---------~~~~GT~~Y~APEvl~~~~~~~y-~~ksD  376 (804)
                      ||+|||.+|||||||||+|+||+++|++||+|||.+......         ...+|||.|||||.+.+.....| +.+.|
T Consensus       222 GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~D  301 (576)
T KOG0585|consen  222 GLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALD  301 (576)
T ss_pred             HHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhh
Confidence            999999999999999999999999999999999998643111         23689999999999875332334 34799


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCC
Q psy17952        377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ  456 (804)
Q Consensus       377 IWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~  456 (804)
                      |||+||+||.|+.|+.||.+....+...+|......                   .|                      .
T Consensus       302 iWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~-------------------fP----------------------~  340 (576)
T KOG0585|consen  302 IWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLE-------------------FP----------------------E  340 (576)
T ss_pred             hhhhhhhHHHhhhccCCcccchHHHHHHHHhcCccc-------------------CC----------------------C
Confidence            999999999999999999998888877777543211                   01                      1


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       457 ~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .++..+.++|||.++|++||++|.+..++..|||.++.
T Consensus       341 ~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  341 NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            12457889999999999999999999999999999876

>KOG0032|consensus

Probab=100.00  E-value=7e-46  Score=411.58  Aligned_cols=260  Identities=33%  Similarity=0.559  Sum_probs=223.6

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCce
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~  237 (804)
                      +....|++.+.||+|.||.||+|+++.+|+.+|+|.+.+...........+.+|+.+|++++ |||||.++++|++...+
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34556999999999999999999999999999999997644433334567899999999999 99999999999999999


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+|||+|.||                                 +||+.+... .++|.++..+++|+++|+.|||+.||+
T Consensus       112 ~lvmEL~~GG---------------------------------eLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvv  157 (382)
T KOG0032|consen  112 YLVMELCEGG---------------------------------ELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVV  157 (382)
T ss_pred             EEEEEecCCc---------------------------------hHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence            9999999986                                 455555544 499999999999999999999999999


Q ss_pred             ecCCCCCCeeecCC----CcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTET----GTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~----g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+|+|+...    +.+|++|||+|....+.   ...+|||.|+|||++.   ...|+..+||||+||++|.|++|
T Consensus       158 HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~---~~~y~~~~DiWS~Gvi~yiLL~G  234 (382)
T KOG0032|consen  158 HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLG---GRPYGDEVDVWSIGVILYILLSG  234 (382)
T ss_pred             eccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhc---CCCCCcccchhHHHHHHHHHhhC
Confidence            99999999999643    47999999999876552   4579999999999984   36799999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .+||.+.+.......|..+...+                                       +......+|+.+++||.+
T Consensus       235 ~~PF~~~~~~~~~~~i~~~~~~f---------------------------------------~~~~w~~is~~akd~i~~  275 (382)
T KOG0032|consen  235 VPPFWGETEFEIFLAILRGDFDF---------------------------------------TSEPWDDISESAKDFIRK  275 (382)
T ss_pred             CCCCcCCChhHHHHHHHcCCCCC---------------------------------------CCCCccccCHHHHHHHHH
Confidence            99999998888777776654311                                       112234568999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ||..||.+|+|+.++|+|||+...
T Consensus       276 ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  276 LLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             hcccCcccCCCHHHHhcCccccCC
Confidence            999999999999999999999875

>KOG0658|consensus

Probab=100.00  E-value=6.9e-47  Score=398.62  Aligned_cols=281  Identities=30%  Similarity=0.457  Sum_probs=220.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----c
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----T  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----~  236 (804)
                      -.|+..+.+|.|+||.||+|....+++.||||++-...+.       --+|+++|+.++|||||++..+|....     .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            3488999999999999999999999999999987543221       247999999999999999988876432     3


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ..+||||++-++.+.++.                              +...+..++.-+++-++.||++||.|||+.||
T Consensus        97 lnlVleymP~tL~~~~r~------------------------------~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~I  146 (364)
T KOG0658|consen   97 LNLVLEYMPETLYRVIRH------------------------------YTRANQRMPLLEIKLYTYQLFRGLAYLHSHGI  146 (364)
T ss_pred             HHHHHHhchHHHHHHHHH------------------------------HhhcCCCCceeeeHHHHHHHHHHHHHHHhcCc
Confidence            458999998877665531                              22345678888999999999999999999999


Q ss_pred             eecCCCCCCeeecCC-CcEEEEecccccccC---CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTET-GTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~-g~vKL~DFGla~~~~---~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+|+|+|.+ |.+||||||.|+...   +..++..|++|+|||++.+.  ..|+.++||||.||++.||+-|++
T Consensus       147 cHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga--~~Yt~~IDiWSaGCV~aELl~g~p  224 (364)
T KOG0658|consen  147 CHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVMAELLKGQP  224 (364)
T ss_pred             ccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCc--cccCceeEEhhhhHHHHHHhcCCc
Confidence            999999999999976 899999999998754   44578899999999999874  579999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccc-cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~-~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      -|.|.+..+++..|.+- ++|.     .+.++.+.... ...-|           .+.....-.......++++.+|+.+
T Consensus       225 lFpG~s~~dQL~eIik~lG~Pt-----~e~I~~mn~~y~~~~~p-----------~ik~~~~~~~~~~~~~~d~~dll~~  288 (364)
T KOG0658|consen  225 LFPGDSSVDQLVEIIKVLGTPT-----REDIKSMNPNYTEFKFP-----------QIKAHPWHKVFFKRLPPDALDLLSK  288 (364)
T ss_pred             ccCCCCHHHHHHHHHHHhCCCC-----HHHHhhcCcccccccCc-----------ccccccceeecccCCCHHHHHHHHH
Confidence            99999999999988874 2332     12222222110 00000           0001111112345668999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRSP  497 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~~  497 (804)
                      +|+.+|.+|.++.|+|.||||...+.+
T Consensus       289 ~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  289 LLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HhccChhhcCCHHHHhcchhhHHhhCc
Confidence            999999999999999999999765544

>KOG0694|consensus

Probab=100.00  E-value=3.2e-46  Score=418.46  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=221.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|..+++||+|+||+|+++..+.+++.+|||.+++......+..+..+.|.+|+...+ ||.+++++.+|++.+++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            35899999999999999999999999999999998766555666788899999988775 99999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||+.||.  +                                -.+.+.+.|+|..++.|+..|+.||+|||++|||+||
T Consensus       448 mey~~Ggd--m--------------------------------~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRD  493 (694)
T KOG0694|consen  448 MEYVAGGD--L--------------------------------MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRD  493 (694)
T ss_pred             EEecCCCc--E--------------------------------EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeee
Confidence            99999872  1                                1234567899999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      ||.+|||||.+|.+||+|||+++...    ..+++||||.|||||++.   +..|+.++|+|||||+|||||.|++||.+
T Consensus       494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~---e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g  570 (694)
T KOG0694|consen  494 LKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLT---EQSYTRAVDWWGLGVLLYEMLVGESPFPG  570 (694)
T ss_pred             cchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhc---cCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999999998543    356899999999999995   56899999999999999999999999999


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .++.+....|...+..                                           .+...|.++.++++++|.+||
T Consensus       571 ddEee~FdsI~~d~~~-------------------------------------------yP~~ls~ea~~il~~ll~k~p  607 (694)
T KOG0694|consen  571 DDEEEVFDSIVNDEVR-------------------------------------------YPRFLSKEAIAIMRRLLRKNP  607 (694)
T ss_pred             CCHHHHHHHHhcCCCC-------------------------------------------CCCcccHHHHHHHHHHhccCc
Confidence            9998888877653321                                           112358899999999999999


Q ss_pred             CCCCCH-----HHHHcCccccCC
Q psy17952        477 ADRPSS-----GRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa-----~elL~Hp~~~~~  494 (804)
                      ++|..+     +++.+||||+..
T Consensus       608 ~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  608 EKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             ccccCCCCCCchhhhhCCccccC
Confidence            999865     789999999763

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-45  Score=397.19  Aligned_cols=305  Identities=79%  Similarity=1.295  Sum_probs=255.6

Q ss_pred             CcchhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEe
Q psy17952        148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY  227 (804)
Q Consensus       148 ~~~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l  227 (804)
                      ++.+++++...+|++.|+..+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++
T Consensus         1 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~   80 (307)
T cd06607           1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY   80 (307)
T ss_pred             ChhHHHhhcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            35677888899999999999999999999999999999999999998865444444455678899999999999999999


Q ss_pred             eeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHH
Q psy17952        228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRG  307 (804)
Q Consensus       228 ~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~g  307 (804)
                      ++++...+..|+||||+.|++.+++.                                 .....+++..+..++.|++.|
T Consensus        81 ~~~~~~~~~~~lv~e~~~g~l~~~~~---------------------------------~~~~~l~~~~~~~~~~ql~~~  127 (307)
T cd06607          81 KGCYLREHTAWLVMEYCLGSASDILE---------------------------------VHKKPLQEVEIAAICHGALQG  127 (307)
T ss_pred             EEEEEeCCeEEEEHHhhCCCHHHHHH---------------------------------HcccCCCHHHHHHHHHHHHHH
Confidence            99999999999999999987655432                                 123468899999999999999


Q ss_pred             HHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        308 LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       308 L~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |.|||++||+||||||+||+++.++.+||+|||++..........|++.|+|||++.+...+.++.++|||||||++|||
T Consensus       128 L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el  207 (307)
T cd06607         128 LAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  207 (307)
T ss_pred             HHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence            99999999999999999999999999999999999876666677899999999998644456688899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|++||.+.+.....+.+.....                                         +......++..+.+|
T Consensus       208 ~tg~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~l  246 (307)
T cd06607         208 AERKPPLFNMNAMSALYHIAQNDS-----------------------------------------PTLSSNDWSDYFRNF  246 (307)
T ss_pred             HcCCCCCCCccHHHHHHHHhcCCC-----------------------------------------CCCCchhhCHHHHHH
Confidence            999999988776665554432211                                         111223467889999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhhHHHHHHHH
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKIL  526 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~  526 (804)
                      +.+||..||++|||+.+++.||||.....+....++..+.+.......+..+.++++.+
T Consensus       247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (307)
T cd06607         247 VDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDNLQYRKMKKIL  305 (307)
T ss_pred             HHHHhcCChhhCcCHHHHhcChhhcccCCcHHHHHHHHHHHHHhhhccccchhHHHHHh
Confidence            99999999999999999999999999888887888888777777777666676666543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0611|consensus

Probab=100.00  E-value=4.8e-46  Score=391.65  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=223.3

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .....+|++.+.||+|.||+|-+|+....|+.||||.|++....+......+.+||+||+.|+||||+.+|++|++.+.+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            34556799999999999999999999999999999999876666666677889999999999999999999999999999


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      .|||||..||                                 +|++|+..++.|+|.+++.+++||.+|+.|||.++++
T Consensus       129 vivMEYaS~G---------------------------------eLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVv  175 (668)
T KOG0611|consen  129 VIVMEYASGG---------------------------------ELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVV  175 (668)
T ss_pred             EEEEEecCCc---------------------------------cHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccce
Confidence            9999999876                                 5778888889999999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCC-CcccHHHHHHHHHHHHhCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~-~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||.+|||+|.++++||+|||++-.....   .+|||+|.|.+||++.+   .+|. +.+|-|||||+||.|..|..|
T Consensus       176 HRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG---~PY~GPEVDsWsLGvLLYtLVyGtMP  252 (668)
T KOG0611|consen  176 HRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNG---TPYKGPEVDSWSLGVLLYTLVYGTMP  252 (668)
T ss_pred             ecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCC---CCCCCCccchhhHHHHHHHHhhcccc
Confidence            9999999999999999999999999765543   57999999999999954   5664 579999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+-.....+|..+..                   +.|                         .-+.++.-||+.||.
T Consensus       253 FDG~Dhk~lvrQIs~GaY-------------------rEP-------------------------~~PSdA~gLIRwmLm  288 (668)
T KOG0611|consen  253 FDGRDHKRLVRQISRGAY-------------------REP-------------------------ETPSDASGLIRWMLM  288 (668)
T ss_pred             cCCchHHHHHHHhhcccc-------------------cCC-------------------------CCCchHHHHHHHHHh
Confidence            998876666555544321                   111                         123456779999999


Q ss_pred             cCCCCCCCHHHHHcCccccC
Q psy17952        474 KNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .||++|.|..++..|-|+.-
T Consensus       289 VNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  289 VNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             cCcccchhHHHHhhhheeec
Confidence            99999999999999988864

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.7e-45  Score=393.57  Aligned_cols=278  Identities=23%  Similarity=0.378  Sum_probs=212.7

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||+|.++....  ......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            48999999999999999999999999999998864321  1223457799999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|++.+.+.                                 .....+++..+..++.||+.||+|||++||+|||||
T Consensus        84 ~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk  130 (288)
T cd07871          84 YLDSDLKQYLD---------------------------------NCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK  130 (288)
T ss_pred             CCCcCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            99987544332                                 112357889999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||+++....    .....||+.|+|||++.+  ...++.++||||+||++|||++|++||.+.+
T Consensus       131 p~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             HHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcC--CcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999865321    234578999999999853  3468889999999999999999999999888


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhccccc-CCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~-~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      ..+.+..+.+....... ..|+.+........ ..|.+             ............++++.+||.+||++||.
T Consensus       209 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~dll~~mL~~dp~  274 (288)
T cd07871         209 VKEELHLIFRLLGTPTE-ETWPGITSNEEFRSYLFPQY-------------RAQPLINHAPRLDTDGIDLLSSLLLYETK  274 (288)
T ss_pred             HHHHHHHHHHHhCCCCh-HHhhccccchhhhccccCcc-------------CCCchHHhCCCCCHHHHHHHHHhcCcCcc
Confidence            77777666543221111 11111100000000 00000             00000011234688999999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.|+|+||||
T Consensus       275 ~R~t~~~~l~hp~f  288 (288)
T cd07871         275 SRISAEAALRHSYF  288 (288)
T ss_pred             cCCCHHHHhcCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.8e-45  Score=394.73  Aligned_cols=284  Identities=26%  Similarity=0.442  Sum_probs=210.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++..+++.||||++.....  ......+.+|+.+++.++||||+++++++.++...|+||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            359999999999999999999999999999998864322  122245678999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.|++.+.+.                                 ...+.++++.++.++.|++.||+|||++||+||||
T Consensus        83 e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl  129 (303)
T cd07869          83 EYVHTDLCQYMD---------------------------------KHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL  129 (303)
T ss_pred             ECCCcCHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            999887544332                                 12346889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||++....    .....+||+.|+|||++.+  ...++.++|||||||++|||++|.+||.+.
T Consensus       130 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         130 KPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999986432    1234678999999999853  245788999999999999999999999876


Q ss_pred             ChH-HHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        398 NAM-SALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       398 ~~~-~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      .+. +.+..+... ..|.  ...|........   ..+..+.......+..       ......+++.+.+|+.+||+.|
T Consensus       208 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~dli~~mL~~d  275 (303)
T cd07869         208 KDIQDQLERIFLVLGTPN--EDTWPGVHSLPH---FKPERFTLYSPKNLRQ-------AWNKLSYVNHAEDLASKLLQCF  275 (303)
T ss_pred             ccHHHHHHHHHHHhCCCC--hhhccchhhccc---cccccccccCCccHHH-------HhhccCCChHHHHHHHHHhccC
Confidence            443 333333221 1111  111111111000   0000000000000000       0111235688999999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy17952        476 PADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~~~  494 (804)
                      |++|||+.|+|+||||...
T Consensus       276 p~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         276 PKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             chhccCHHHHhcCcccccC
Confidence            9999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0667|consensus

Probab=100.00  E-value=3.5e-45  Score=410.47  Aligned_cols=289  Identities=28%  Similarity=0.403  Sum_probs=221.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-C-----CceeEeeeEEeecCc
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-H-----PNTIEYRGCYLRDHT  236 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pNIV~l~~~~~~~~~  236 (804)
                      +|++++.||+|+||.|.+|.+..|++.||||+++..    .....+...|+.+|..|+ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            689999999999999999999999999999998642    344566788999999997 4     389999999999999


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +|||+|+++-+|.++++.+                                +..+|+...++.|+.||+.||.+||+.||
T Consensus       263 lciVfELL~~NLYellK~n--------------------------------~f~Glsl~~ir~~~~Qil~~L~~L~~l~I  310 (586)
T KOG0667|consen  263 LCIVFELLSTNLYELLKNN--------------------------------KFRGLSLPLVRKFAQQILTALLFLHELGI  310 (586)
T ss_pred             eeeeehhhhhhHHHHHHhc--------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            9999999988888877521                                34568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCC--cEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        317 IHRDVKAGNILLTETG--TVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       317 iHRDLKP~NILl~~~g--~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||+|||||||||.+.+  .|||+|||+|+.... ..+++.+++|+|||+|+|   .+|+.+.||||||||++||++|.|.
T Consensus       311 IHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILG---lpY~~~IDmWSLGCIlAEL~tG~PL  387 (586)
T KOG0667|consen  311 IHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILG---LPYDTAIDMWSLGCILAELFTGEPL  387 (586)
T ss_pred             eeccCChhheeeccCCcCceeEEecccccccCCcceeeeeccccccchhhcc---CCCCCccceeehhhhHHhHhcCccc
Confidence            9999999999997644  799999999987544 347899999999999985   5899999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccC------CCCccchhh---------hHHHHhhccC--CCC---
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER------KPPYFNMNA---------MSALYHIAQN--DTP---  453 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~------~pp~~~~~~---------~~~l~~i~~~--~~p---  453 (804)
                      |.|.++.+++..|..--+....    ..+..-......      .+.......         ....+.....  ..|   
T Consensus       388 fpG~ne~DQl~~I~e~lG~Pp~----~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~  463 (586)
T KOG0667|consen  388 FPGDNEYDQLARIIEVLGLPPP----KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGS  463 (586)
T ss_pred             cCCCCHHHHHHHHHHHhCCCCH----HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCC
Confidence            9999999999998763211100    111111100000      000000000         0011111000  111   


Q ss_pred             -CCC---CCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        454 -CLQ---SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       454 -~~~---~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                       ...   ...-...|.|||.+||.+||.+|+|+.++|+|||++..
T Consensus       464 ~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  464 RSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             cccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence             000   01124578999999999999999999999999999853

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=394.96  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=209.5

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|++..+++.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            48899999999999999999999999999998864322223344667899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|+.                                 |++++...+.+++..+..++.|++.||+|||++||+|||||
T Consensus        82 ~~~~~~---------------------------------L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  128 (291)
T cd05612          82 YVPGGE---------------------------------LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK  128 (291)
T ss_pred             CCCCCC---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            998651                                 22223345678999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS  401 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~  401 (804)
                      |+|||++.+|.+||+|||+++.... ....+||+.|+|||++.   ...++.++|||||||++|||++|+.||.+.+...
T Consensus       129 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  205 (291)
T cd05612         129 PENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQ---SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG  205 (291)
T ss_pred             HHHeEECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999999875433 23568999999999985   3467889999999999999999999998876655


Q ss_pred             HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC
Q psy17952        402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS  481 (804)
Q Consensus       402 ~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps  481 (804)
                      ....+..+..+                                           .....+..+++||.+||+.||.+||+
T Consensus       206 ~~~~i~~~~~~-------------------------------------------~~~~~~~~~~~li~~~l~~dp~~R~~  242 (291)
T cd05612         206 IYEKILAGKLE-------------------------------------------FPRHLDLYAKDLIKKLLVVDRTRRLG  242 (291)
T ss_pred             HHHHHHhCCcC-------------------------------------------CCccCCHHHHHHHHHHcCCCHHHccC
Confidence            54444322100                                           01234788999999999999999995


Q ss_pred             -----HHHHHcCccccC
Q psy17952        482 -----SGRLLTHDLVTR  493 (804)
Q Consensus       482 -----a~elL~Hp~~~~  493 (804)
                           +++++.||||..
T Consensus       243 ~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         243 NMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CccCCHHHHhcCccccC
Confidence                 999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.8e-45  Score=389.15  Aligned_cols=280  Identities=25%  Similarity=0.408  Sum_probs=213.0

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            48999999999999999999999999999998864322 22334567899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|++.+.+.                                 .....+++..++.++.|++.||.|||+.||+|||||
T Consensus        81 ~~~~~~l~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk  127 (287)
T cd07848          81 YVEKNMLELLE---------------------------------EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK  127 (287)
T ss_pred             cCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99987543221                                 123468899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |+|||++.++.+||+|||++.....     .....||+.|+|||++.   +..++.++|||||||++|||++|++||.+.
T Consensus       128 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL---GAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             HHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHc---CCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999875422     12457999999999985   356889999999999999999999999988


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhccc-ccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISST-AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~-~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      +..+.+..+.....+... ..+.....-... ....|........           ........|.++.+|+.+||++||
T Consensus       205 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~s~~~~dll~~~L~~~P  272 (287)
T cd07848         205 SEIDQLFTIQKVLGPLPA-EQMKLFYSNPRFHGLRFPAVNHPQSL-----------ERRYLGILSGVLLDLMKNLLKLNP  272 (287)
T ss_pred             CHHHHHHHHHHhhCCCCH-HHHHhhhccchhcccccCcccCcccH-----------HHhhhcccCHHHHHHHHHHccCCc
Confidence            777766665543222111 011100000000 0000000000000           000112368899999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy17952        477 ADRPSSGRLLTHDLV  491 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~  491 (804)
                      ++|||++++|+||||
T Consensus       273 ~~R~s~~~~l~hp~f  287 (287)
T cd07848         273 TDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCCCHHHHhcCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4e-45  Score=400.32  Aligned_cols=248  Identities=25%  Similarity=0.433  Sum_probs=204.8

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS  247 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~  247 (804)
                      +.||+|+||.||+|++..+++.||||++.............+++|+.+|++++||||+++++++...+..|+||||+.|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999886432222334456789999999999999999999999999999999999875


Q ss_pred             chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCee
Q psy17952        248 ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL  327 (804)
Q Consensus       248 l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NIL  327 (804)
                      .                                 |++++...+.+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        81 ~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIl  127 (323)
T cd05571          81 E---------------------------------LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLM  127 (323)
T ss_pred             c---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEE
Confidence            2                                 2222234567899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy17952        328 LTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL  403 (804)
Q Consensus       328 l~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l  403 (804)
                      ++.++.+||+|||+|+....    ....+||+.|+|||++.   ...|+.++|||||||++|||++|+.||.+.+.....
T Consensus       128 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~  204 (323)
T cd05571         128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF  204 (323)
T ss_pred             ECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhc---CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH
Confidence            99999999999999875321    23468999999999984   356889999999999999999999999876654444


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---  480 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---  480 (804)
                      ..+.....                                           .....+++++.+||.+||++||++||   
T Consensus       205 ~~~~~~~~-------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  241 (323)
T cd05571         205 ELILMEEI-------------------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGG  241 (323)
T ss_pred             HHHHcCCC-------------------------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCC
Confidence            33322110                                           01134688999999999999999999   


Q ss_pred             --CHHHHHcCccccCC
Q psy17952        481 --SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 --sa~elL~Hp~~~~~  494 (804)
                        ++.++++||||...
T Consensus       242 ~~~~~~ll~h~~f~~~  257 (323)
T cd05571         242 PEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCCHHHHHcCCCcCCC
Confidence              89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-45  Score=401.02  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=210.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+...........+.+.+|+.+|++++||||+++++++..++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            34899999999999999999999999999999886432222334567889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+.                                 |.+++...+.+++..+..++.||+.||+|||++||+||||
T Consensus        98 e~~~~~~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dl  144 (329)
T PTZ00263         98 EFVVGGE---------------------------------LFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDL  144 (329)
T ss_pred             cCCCCCh---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence            9998751                                 1222233457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      ||+|||++.++.+||+|||+++.... ....+||+.|+|||++.   ...++.++|||||||++|||++|..||.+.+..
T Consensus       145 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  221 (329)
T PTZ00263        145 KPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQ---SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF  221 (329)
T ss_pred             CHHHEEECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHc---CCCCCCcceeechHHHHHHHHcCCCCCCCCCHH
Confidence            99999999999999999999975433 33568999999999985   356788999999999999999999999887665


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      .....+..+..+                                           .+..++..+++||.+||+.||.+||
T Consensus       222 ~~~~~i~~~~~~-------------------------------------------~p~~~~~~~~~li~~~L~~dP~~R~  258 (329)
T PTZ00263        222 RIYEKILAGRLK-------------------------------------------FPNWFDGRARDLVKGLLQTDHTKRL  258 (329)
T ss_pred             HHHHHHhcCCcC-------------------------------------------CCCCCCHHHHHHHHHHhhcCHHHcC
Confidence            554444322100                                           0123577899999999999999999


Q ss_pred             C-----HHHHHcCccccC
Q psy17952        481 S-----SGRLLTHDLVTR  493 (804)
Q Consensus       481 s-----a~elL~Hp~~~~  493 (804)
                      +     ++++++||||..
T Consensus       259 ~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        259 GTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             CCCCCCHHHHhcCCccCC
Confidence            7     799999999975

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.1e-44  Score=388.15  Aligned_cols=307  Identities=75%  Similarity=1.228  Sum_probs=259.5

Q ss_pred             CCCcchhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCcee
Q psy17952        146 LKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI  225 (804)
Q Consensus       146 l~~~~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV  225 (804)
                      .+++++..++.+.++++.|..+++||+|+||.||+|++..+++.||+|.+.............+.+|+++++.++|||++
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   84 (313)
T cd06633           5 VKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI   84 (313)
T ss_pred             cCCHHHHHHhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCc
Confidence            45677788888889999999999999999999999999999999999998754443344456788999999999999999


Q ss_pred             EeeeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHH
Q psy17952        226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVL  305 (804)
Q Consensus       226 ~l~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil  305 (804)
                      ++++++.+....|+||||+.|++.+++.                                 ....++++.++..++.|++
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~---------------------------------~~~~~l~~~~~~~~~~qi~  131 (313)
T cd06633          85 EYKGCYLKEHTAWLVMEYCLGSASDLLE---------------------------------VHKKPLQEVEIAAITHGAL  131 (313)
T ss_pred             cEEEEEEeCCEEEEEEecCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHH
Confidence            9999999999999999999887654432                                 1234688999999999999


Q ss_pred             HHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        306 RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       306 ~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      .||.|||++||+||||||+||+++.++.+||+|||++..........|+..|+|||++.....+.++.++|||||||++|
T Consensus       132 ~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~  211 (313)
T cd06633         132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  211 (313)
T ss_pred             HHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHH
Confidence            99999999999999999999999999999999999987665556678999999999985434456888999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      ||++|.+||.+.+....+..+.....                                         +......++..++
T Consensus       212 el~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~  250 (313)
T cd06633         212 ELAERKPPLFNMNAMSALYHIAQNDS-----------------------------------------PTLQSNEWTDSFR  250 (313)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCC-----------------------------------------CCCCccccCHHHH
Confidence            99999999988776665555433211                                         1122234678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhhHHHHHHHH
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKIL  526 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~  526 (804)
                      +|+.+||+.+|.+||++.++++||||......+.+.+.+.......+.+.+..++++++.+
T Consensus       251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (313)
T cd06633         251 GFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNLQYRKMKKIL  311 (313)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCchhHHHHHHHHHHHHHHhhhhHHHHHHHHHHh
Confidence            9999999999999999999999999999888888888888888888888888888888765

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.7e-44  Score=388.05  Aligned_cols=310  Identities=77%  Similarity=1.248  Sum_probs=260.5

Q ss_pred             CCCCCCcchhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCC
Q psy17952        143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP  222 (804)
Q Consensus       143 ~g~l~~~~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~Hp  222 (804)
                      .++..++++...+.+.+++..|+..+.||+|+||.||++++..+++.||+|.+........+....+.+|++++++++||
T Consensus         6 ~~~~~~~~~~~~~~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~   85 (317)
T cd06635           6 AGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP   85 (317)
T ss_pred             ccCCCCHHHHHHhcCCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCC
Confidence            35567777888888999999999999999999999999999999999999988654333444556788999999999999


Q ss_pred             ceeEeeeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHH
Q psy17952        223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICS  302 (804)
Q Consensus       223 NIV~l~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~  302 (804)
                      |++++++++..++..|+||||+.|++.+++.                                 ....++++.++..++.
T Consensus        86 ~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~---------------------------------~~~~~l~~~~~~~i~~  132 (317)
T cd06635          86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLE---------------------------------VHKKPLQEVEIAAITH  132 (317)
T ss_pred             CEEEEEEEEeeCCeEEEEEeCCCCCHHHHHH---------------------------------HhcCCCCHHHHHHHHH
Confidence            9999999999999999999999987655432                                 1234688999999999


Q ss_pred             HHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        303 GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       303 qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      |++.||.|||++||+||||||+||+++.++.+||+|||++..........|++.|+|||++.....+.++.++|||||||
T Consensus       133 ~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGv  212 (317)
T cd06635         133 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  212 (317)
T ss_pred             HHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHH
Confidence            99999999999999999999999999999999999999987666556678999999999985444456888999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       383 il~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ++|||++|++||.+.+....+..+.....                                         +......+++
T Consensus       213 il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~  251 (317)
T cd06635         213 TCIELAERKPPLFNMNAMSALYHIAQNES-----------------------------------------PTLQSNEWSD  251 (317)
T ss_pred             HHHHHHhCCCCCCCccHHHHHHHHHhccC-----------------------------------------CCCCCccccH
Confidence            99999999999987766555555433211                                         1112234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhhHHHHHHHH
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKIL  526 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~  526 (804)
                      .+++|+.+||+.+|.+|||+.++++|+|+........+.+...+.....+++.+..++++++.+
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDNLQYRKMKKLL  315 (317)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccchhhHHHHHHHHHHHHhhhHHHHHHHHh
Confidence            8999999999999999999999999999988887777777788888888888888888877654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-44  Score=400.87  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=206.7

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||+|++..+++.||||+++............+.+|+.++++++||||+++++++.+...+|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            48899999999999999999999999999999864332223344567889999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+.                                 |.+++...+.+++.+++.++.|++.||+|||++||+|||||
T Consensus        82 ~~~gg~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlK  128 (363)
T cd05628          82 FLPGGD---------------------------------MMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK  128 (363)
T ss_pred             CCCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC
Confidence            998751                                 22223345679999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---------------------------------------CCccccCcccccchhh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---------------------------------------ANSFVGTPYWMAPEVI  363 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---------------------------------------~~~~~GT~~Y~APEvl  363 (804)
                      |+|||++.++.+||+|||+|+....                                       ..+.+||+.|+|||++
T Consensus       129 p~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~  208 (363)
T cd05628         129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF  208 (363)
T ss_pred             HHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH
Confidence            9999999999999999999863211                                       1235899999999998


Q ss_pred             cccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHH
Q psy17952        364 LAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA  443 (804)
Q Consensus       364 ~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~  443 (804)
                      .   +..|+.++|||||||++|||++|++||.+.+..+....+......                 ...|          
T Consensus       209 ~---~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~p----------  258 (363)
T cd05628         209 M---QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKET-----------------LIFP----------  258 (363)
T ss_pred             c---CCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCc-----------------ccCC----------
Confidence            5   356889999999999999999999999887766665555432110                 0000          


Q ss_pred             HHhhccCCCCCCCCCCccHHHHHHHHHhcc--cCCCCCCCHHHHHcCccccCC
Q psy17952        444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLA--KNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       444 l~~i~~~~~p~~~~~~~s~~l~dli~~cL~--~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                                  .....++++++||.+++.  .++..||+++|+++||||...
T Consensus       259 ------------~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         259 ------------PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             ------------CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence                        112367899999998765  233356899999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=401.66  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=209.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||||.+.............+.+|+.+|+.++||||++++++|.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            48899999999999999999999999999999864322223344567889999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+.                                 |.+++...+.+++..++.++.||+.||+|||++||+|||||
T Consensus        82 ~~~~g~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk  128 (364)
T cd05599          82 YLPGGD---------------------------------MMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK  128 (364)
T ss_pred             CCCCcH---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence            998751                                 22223344578999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC------------------------------------------CCccccCcccccc
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP------------------------------------------ANSFVGTPYWMAP  360 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~------------------------------------------~~~~~GT~~Y~AP  360 (804)
                      |+|||++.++.+||+|||++.....                                          ..+.+||+.|+||
T Consensus       129 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  208 (364)
T cd05599         129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAP  208 (364)
T ss_pred             HHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCH
Confidence            9999999999999999999853211                                          0124799999999


Q ss_pred             hhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhh
Q psy17952        361 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA  440 (804)
Q Consensus       361 Evl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~  440 (804)
                      |++.   ...|+.++|||||||++|||++|.+||.+.+..+....+......                            
T Consensus       209 E~~~---~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~----------------------------  257 (364)
T cd05599         209 EVFL---QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET----------------------------  257 (364)
T ss_pred             HHHc---CCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc----------------------------
Confidence            9984   456899999999999999999999999887766655544322100                            


Q ss_pred             hHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC---HHHHHcCccccCC
Q psy17952        441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS---SGRLLTHDLVTRP  494 (804)
Q Consensus       441 ~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps---a~elL~Hp~~~~~  494 (804)
                                 .+......+++++.+||.+||. +|.+|++   +.++|+||||...
T Consensus       258 -----------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         258 -----------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             -----------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence                       0001112468899999999996 9999998   9999999999764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580|consensus

Probab=100.00  E-value=2.3e-45  Score=366.23  Aligned_cols=253  Identities=29%  Similarity=0.421  Sum_probs=213.5

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|-||.||+|+.+.++..||+|++.+..-.......++.||++|-+.|+||||+++|++|.+....||++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            38999999999999999999999999999999865443333344678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |..+| +...+                  +              ......++|..+..++.|++.||.|||.++||||||
T Consensus       103 ya~~gel~k~L------------------~--------------~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdi  150 (281)
T KOG0580|consen  103 YAPRGELYKDL------------------Q--------------EGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDI  150 (281)
T ss_pred             ecCCchHHHHH------------------H--------------hcccccccccchhHHHHHHHHHHHHhccCCcccCCC
Confidence            99754 22111                  1              013456899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC--CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~--~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      ||+|+|++.+|.+||+|||.+....  ...+.|||.-|.+||++.   +..+|.++|+|++||++||++.|.+||...+.
T Consensus       151 KpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~---~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~  227 (281)
T KOG0580|consen  151 KPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVE---GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH  227 (281)
T ss_pred             CHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcC---CCCccchhhHHHHHHHHHHHHhcCCchhhhhh
Confidence            9999999999999999999986542  345789999999999984   45789999999999999999999999988776


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      .+...+|.+.+..                                           .+...|.+++|||.+||.++|.+|
T Consensus       228 ~etYkrI~k~~~~-------------------------------------------~p~~is~~a~dlI~~ll~~~p~~r  264 (281)
T KOG0580|consen  228 SETYKRIRKVDLK-------------------------------------------FPSTISGGAADLISRLLVKNPIER  264 (281)
T ss_pred             HHHHHHHHHcccc-------------------------------------------CCcccChhHHHHHHHHhccCcccc
Confidence            6555555432210                                           114568899999999999999999


Q ss_pred             CCHHHHHcCccccC
Q psy17952        480 PSSGRLLTHDLVTR  493 (804)
Q Consensus       480 psa~elL~Hp~~~~  493 (804)
                      .+..|++.|||+..
T Consensus       265 ~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  265 LALTEVMDHPWIVA  278 (281)
T ss_pred             ccHHHHhhhHHHHh
Confidence            99999999999854

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-44  Score=391.71  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=202.9

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCCch
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSAS  249 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~l~  249 (804)
                      ||+|+||.||+|++..+++.||+|.+.............+.+|+.+|++++||||+++++++...+..|+|||||.|+. 
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~-   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE-   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc-
Confidence            7999999999999999999999998864332233345667889999999999999999999999999999999998752 


Q ss_pred             hhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeec
Q psy17952        250 DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT  329 (804)
Q Consensus       250 dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~  329 (804)
                                                      |++++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        80 --------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~  127 (312)
T cd05585          80 --------------------------------LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD  127 (312)
T ss_pred             --------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC
Confidence                                            222223345789999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy17952        330 ETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYH  405 (804)
Q Consensus       330 ~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~  405 (804)
                      .++.+||+|||+++....    ....+||+.|+|||++.   +..|+.++|||||||++|||++|++||.+.+..+....
T Consensus       128 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~  204 (312)
T cd05585         128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL---GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK  204 (312)
T ss_pred             CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHc---CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH
Confidence            999999999999875322    23467999999999985   35688999999999999999999999987665544433


Q ss_pred             HHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---CH
Q psy17952        406 IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---SS  482 (804)
Q Consensus       406 I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---sa  482 (804)
                      +....                                           ......+++++.+|+.+||+.||.+||   ++
T Consensus       205 ~~~~~-------------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         205 ILQEP-------------------------------------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             HHcCC-------------------------------------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence            32211                                           001134678899999999999999997   58


Q ss_pred             HHHHcCccccCC
Q psy17952        483 GRLLTHDLVTRP  494 (804)
Q Consensus       483 ~elL~Hp~~~~~  494 (804)
                      .++|+||||...
T Consensus       242 ~e~l~hp~~~~~  253 (312)
T cd05585         242 QEIKNHPFFSQL  253 (312)
T ss_pred             HHHHcCCCcCCC
Confidence            999999999764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.5e-44  Score=402.05  Aligned_cols=256  Identities=22%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+.++.||+|+||+||+|++..+++.||||++.............+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            48899999999999999999999999999999865332233445678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.|+ +.+                                  ++...+.+++..++.++.||+.||+|||++||+||||
T Consensus        82 ~~~gg~L~~----------------------------------~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDl  127 (381)
T cd05626          82 YIPGGDMMS----------------------------------LLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDI  127 (381)
T ss_pred             cCCCCcHHH----------------------------------HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence            99875 222                                  2223456899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC---------------------------------------------------CCCc
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC---------------------------------------------------PANS  350 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~---------------------------------------------------~~~~  350 (804)
                      ||+|||++.++.+||+|||+++...                                                   ...+
T Consensus       128 Kp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (381)
T cd05626         128 KPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS  207 (381)
T ss_pred             cHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccccc
Confidence            9999999999999999999874210                                                   0123


Q ss_pred             cccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhccccc
Q psy17952        351 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE  430 (804)
Q Consensus       351 ~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~  430 (804)
                      .+||+.|||||++.   ...|+.++|||||||++|||++|.+||...+.......+......                  
T Consensus       208 ~~gt~~Y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------  266 (381)
T cd05626         208 LVGTPNYIAPEVLL---RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT------------------  266 (381)
T ss_pred             ccCCccccCHHHHc---CCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc------------------
Confidence            57999999999985   356889999999999999999999999877665544444321100                  


Q ss_pred             CCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc--ccCCCCCCCHHHHHcCccccCC
Q psy17952        431 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL--AKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       431 ~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL--~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                                           ........+++++++||.+||  ..+|..||++.++++||||...
T Consensus       267 ---------------------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         267 ---------------------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             ---------------------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence                                 000111246889999999955  5566669999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=394.41  Aligned_cols=260  Identities=27%  Similarity=0.359  Sum_probs=213.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            48999999999999999999999999999999864322223345668899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.|+ +.++                                  +...+.+++..++.++.||+.||.|||++||+||||
T Consensus        82 ~~~g~~L~~~----------------------------------l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl  127 (333)
T cd05600          82 YVPGGDFRTL----------------------------------LNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL  127 (333)
T ss_pred             CCCCCCHHHH----------------------------------HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence            99865 3322                                  223457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      ||+|||++.++.+||+|||+|..... ....+||+.|+|||++.   ...++.++|||||||++|||++|.+||.+.+..
T Consensus       128 kp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  204 (333)
T cd05600         128 KPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLR---GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN  204 (333)
T ss_pred             CHHHEEECCCCCEEEEeCcCCcccccccCCcccCccccChhHhc---CCCCCCccceecchHHHhhhhhCCCCCCCCCHH
Confidence            99999999999999999999975433 34578999999999985   347899999999999999999999999887766


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      +....+......                 ...|.                  .......+++++.+|+.+||..+|.+||
T Consensus       205 ~~~~~i~~~~~~-----------------~~~~~------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~  249 (333)
T cd05600         205 ETWENLKYWKET-----------------LQRPV------------------YDDPRFNLSDEAWDLITKLINDPSRRFG  249 (333)
T ss_pred             HHHHHHHhcccc-----------------ccCCC------------------CCccccccCHHHHHHHHHHhhChhhhcC
Confidence            655444322100                 00000                  0001134688999999999999999999


Q ss_pred             CHHHHHcCccccCC
Q psy17952        481 SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 sa~elL~Hp~~~~~  494 (804)
                      |+.++++||||...
T Consensus       250 s~~~ll~h~~~~~~  263 (333)
T cd05600         250 SLEDIKNHPFFKEV  263 (333)
T ss_pred             CHHHHHhCcccCCC
Confidence            99999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0192|consensus

Probab=100.00  E-value=6.8e-44  Score=392.68  Aligned_cols=247  Identities=30%  Similarity=0.478  Sum_probs=201.4

Q ss_pred             cccccccccccccceEEEEeeeceeE-EEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-ceEEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREI-VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-TAWLVM  241 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~-vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-~~~lVm  241 (804)
                      ....+.||+|+||+||+|...  |+. ||||++......... .+.+.+|+.+|++|+|||||+++|++.+.. .+++||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            455566999999999988765  444 999998754333222 678999999999999999999999999887 799999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-Ceec
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG-RIHR  319 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g-IiHR  319 (804)
                      ||++|| |.+++..                                ..++.++...+..++.||++||+|||+++ ||||
T Consensus       120 Ey~~~GsL~~~l~~--------------------------------~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHr  167 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHK--------------------------------KRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHR  167 (362)
T ss_pred             EeCCCCcHHHHHhh--------------------------------cccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeec
Confidence            999854 4443320                                02568999999999999999999999999 9999


Q ss_pred             CCCCCCeeecCCC-cEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        320 DVKAGNILLTETG-TVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       320 DLKP~NILl~~~g-~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||||+|||++.++ ++||+|||+|+....    .....||+.|||||++.+. ...|+.|+|||||||+||||+||+.||
T Consensus       168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf  246 (362)
T KOG0192|consen  168 DLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPF  246 (362)
T ss_pred             ccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCC
Confidence            9999999999998 999999999976542    2346899999999999532 457999999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.......+.+..+..                                        +|.. +...++.+..|+.+||..
T Consensus       247 ~~~~~~~~~~~v~~~~~----------------------------------------Rp~~-p~~~~~~l~~l~~~CW~~  285 (362)
T KOG0192|consen  247 EDLAPVQVASAVVVGGL----------------------------------------RPPI-PKECPPHLSSLMERCWLV  285 (362)
T ss_pred             CCCCHHHHHHHHHhcCC----------------------------------------CCCC-CccCCHHHHHHHHHhCCC
Confidence            99888666666643221                                        1111 122578899999999999


Q ss_pred             CCCCCCCHHHHHc
Q psy17952        475 NPADRPSSGRLLT  487 (804)
Q Consensus       475 dP~~Rpsa~elL~  487 (804)
                      ||.+||+..+++.
T Consensus       286 dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  286 DPSRRPSFLEIVS  298 (362)
T ss_pred             CCCcCCCHHHHHH
Confidence            9999999998873

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-44  Score=402.40  Aligned_cols=255  Identities=23%  Similarity=0.401  Sum_probs=207.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+.++.||+|+||.||+|++..+++.||+|.+.............+.+|+.++++++|||||+++++|.+++.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            48899999999999999999999999999999864332223445678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.|+ +.++                                  +...+.+++..++.++.||+.||+|||++||+||||
T Consensus        82 ~~~gg~L~~~----------------------------------l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDl  127 (382)
T cd05625          82 YIPGGDMMSL----------------------------------LIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDI  127 (382)
T ss_pred             CCCCCcHHHH----------------------------------HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            99875 2222                                  223456899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC---------------------------------------------------CCCc
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC---------------------------------------------------PANS  350 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~---------------------------------------------------~~~~  350 (804)
                      ||+|||++.+|.+||+|||+|+...                                                   ...+
T Consensus       128 Kp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (382)
T cd05625         128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHS  207 (382)
T ss_pred             CHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccc
Confidence            9999999999999999999974210                                                   0123


Q ss_pred             cccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhccccc
Q psy17952        351 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE  430 (804)
Q Consensus       351 ~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~  430 (804)
                      .+||+.|||||++.   ...|+.++|||||||++|||++|++||.+.+..+....+......                  
T Consensus       208 ~~gt~~Y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------  266 (382)
T cd05625         208 LVGTPNYIAPEVLL---RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS------------------  266 (382)
T ss_pred             cccCcccCCHHHhc---CCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC------------------
Confidence            57999999999985   356899999999999999999999999887766555444321110                  


Q ss_pred             CCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC---HHHHHcCccccCC
Q psy17952        431 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS---SGRLLTHDLVTRP  494 (804)
Q Consensus       431 ~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps---a~elL~Hp~~~~~  494 (804)
                                           .+.......++++.+||.+|+ .||.+|++   ++++++||||...
T Consensus       267 ---------------------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         267 ---------------------LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             ---------------------cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence                                 000112346889999999976 59999997   9999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-44  Score=396.34  Aligned_cols=252  Identities=23%  Similarity=0.391  Sum_probs=208.0

Q ss_pred             cccccccccccccccceEEEEeeece-eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~-~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            34899999999999999999877655 68999988643322233456678999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ +.+                                  ++...+.+++..+..++.|++.||.|||++||+||
T Consensus       110 ~Ey~~~g~L~~----------------------------------~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  155 (340)
T PTZ00426        110 LEFVIGGEFFT----------------------------------FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR  155 (340)
T ss_pred             EeCCCCCcHHH----------------------------------HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            9999865 322                                  22334578999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      ||||+|||++.++.+||+|||+++.... ..+.+||+.|||||++.   +..++.++|||||||++|||++|.+||.+.+
T Consensus       156 DLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        156 DLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILL---NVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             CCCHHHEEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHh---CCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            9999999999999999999999975432 34568999999999985   3467889999999999999999999998876


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......+..+..                                           ..+..+++.+.+|+++||+.||++
T Consensus       233 ~~~~~~~i~~~~~-------------------------------------------~~p~~~~~~~~~li~~~l~~dp~~  269 (340)
T PTZ00426        233 PLLIYQKILEGII-------------------------------------------YFPKFLDNNCKHLMKKLLSHDLTK  269 (340)
T ss_pred             HHHHHHHHhcCCC-------------------------------------------CCCCCCCHHHHHHHHHHcccCHHH
Confidence            6554444432110                                           011235788999999999999999


Q ss_pred             CC-----CHHHHHcCccccC
Q psy17952        479 RP-----SSGRLLTHDLVTR  493 (804)
Q Consensus       479 Rp-----sa~elL~Hp~~~~  493 (804)
                      |+     |++++++||||..
T Consensus       270 R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        270 RYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             cCCCCCCCHHHHHcCCCcCC
Confidence            95     8999999999975

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.1e-44  Score=384.15  Aligned_cols=257  Identities=23%  Similarity=0.307  Sum_probs=204.7

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            78889999999999999999999999999988643322222334578899999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |.|+ +.+.+.                                ......+++..+..++.|++.||+|||++||+|||||
T Consensus        82 ~~~g~L~~~~~--------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dik  129 (285)
T cd05631          82 MNGGDLKFHIY--------------------------------NMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK  129 (285)
T ss_pred             cCCCcHHHHHH--------------------------------hhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence            9865 322211                                0112368899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+|||++.++.+||+|||++.....   .....||+.|||||++.   +..|+.++|||||||++|||++|++||.+.+.
T Consensus       130 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~~g~~pf~~~~~  206 (285)
T cd05631         130 PENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN---NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE  206 (285)
T ss_pred             HHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhc---CCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence            9999999999999999999875422   23457999999999985   45789999999999999999999999976543


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ......+..               .+.                        .........+++++.+|+.+||+.||.+|
T Consensus       207 ~~~~~~~~~---------------~~~------------------------~~~~~~~~~~s~~~~~li~~~l~~~P~~R  247 (285)
T cd05631         207 RVKREEVDR---------------RVK------------------------EDQEEYSEKFSEDAKSICRMLLTKNPKER  247 (285)
T ss_pred             chhHHHHHH---------------Hhh------------------------cccccCCccCCHHHHHHHHHHhhcCHHHh
Confidence            221111110               000                        00001123568899999999999999999


Q ss_pred             CC-----HHHHHcCccccCC
Q psy17952        480 PS-----SGRLLTHDLVTRP  494 (804)
Q Consensus       480 ps-----a~elL~Hp~~~~~  494 (804)
                      ||     ++++++||||...
T Consensus       248 ~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         248 LGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             cCCCCCCHHHHhcCHhhcCC
Confidence            97     8999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.8e-44  Score=381.64  Aligned_cols=277  Identities=30%  Similarity=0.438  Sum_probs=207.1

Q ss_pred             ccccccccccccccceEEEEeee-ceeEEEEEecccccccchhhhhhHHHHHHHHhhc---CCCceeEeeeEEe-----e
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLV-SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL---KHPNTIEYRGCYL-----R  233 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~-~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~~~~~-----~  233 (804)
                      .|++++.||+|+||.||+|++.. +++.||+|.++..... ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            58999999999999999999865 4688999987643221 12223456788777765   6999999999885     3


Q ss_pred             cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       234 ~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ...+|+||||+.|++.+.+..                                .....+++..+..++.||+.||.|||+
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~--------------------------------~~~~~~~~~~~~~i~~qi~~aL~~lH~  128 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDK--------------------------------VPEPGVPTETIKDMMFQLLRGLDFLHS  128 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHh--------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456899999998876554420                                112358899999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      +||+||||||+|||++.++.+||+|||+|+....   .....||+.|+|||++.   ...++.++|||||||++|||++|
T Consensus       129 ~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g  205 (290)
T cd07862         129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRR  205 (290)
T ss_pred             CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHh---CCCCCCccchHHHHHHHHHHHcC
Confidence            9999999999999999999999999999875432   23467999999999984   35688899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.+..+.+..+......... ..|+....+..      ..+...         .........+..++.+++|+.+
T Consensus       206 ~~~f~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~~~~li~~  269 (290)
T cd07862         206 KPLFRGSSDVDQLGKILDVIGLPGE-EDWPRDVALPR------QAFHSK---------SAQPIEKFVTDIDELGKDLLLK  269 (290)
T ss_pred             CCCcCCCCHHHHHHHHHHHhCCCCh-hhchhhhcccc------hhccCC---------CCCCHHHHccCCCHHHHHHHHH
Confidence            9999998888877777653221111 11111000000      000000         0000001123468889999999


Q ss_pred             hcccCCCCCCCHHHHHcCccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      ||+.||++|||+.++|+||||
T Consensus       270 ~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         270 CLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HhccCchhcCCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.3e-44  Score=392.54  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=203.7

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS  247 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~  247 (804)
                      +.||+|+||.||+|++..+++.||+|++.............+.+|+.+|+.++||||+++++++..++..|+||||+.|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986433223334567789999999999999999999999999999999999875


Q ss_pred             chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCee
Q psy17952        248 ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL  327 (804)
Q Consensus       248 l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NIL  327 (804)
                      .                                 |+++....+.+++.++..++.||+.||+|||++||+||||||+|||
T Consensus        81 ~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl  127 (328)
T cd05593          81 E---------------------------------LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM  127 (328)
T ss_pred             C---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeE
Confidence            2                                 1122223457899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy17952        328 LTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL  403 (804)
Q Consensus       328 l~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l  403 (804)
                      ++.++.+||+|||+++....    ....+||+.|+|||++.   ...++.++|||||||++|||++|+.||.+.+..+..
T Consensus       128 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  204 (328)
T cd05593         128 LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF  204 (328)
T ss_pred             ECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhc---CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH
Confidence            99999999999999875321    23467999999999984   356889999999999999999999999876654443


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---  480 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---  480 (804)
                      ..+.....                                           ..+..++.++.+||.+||++||++|+   
T Consensus       205 ~~~~~~~~-------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  241 (328)
T cd05593         205 ELILMEDI-------------------------------------------KFPRTLSADAKSLLSGLLIKDPNKRLGGG  241 (328)
T ss_pred             HHhccCCc-------------------------------------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence            33221100                                           01134688899999999999999997   


Q ss_pred             --CHHHHHcCccccCC
Q psy17952        481 --SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 --sa~elL~Hp~~~~~  494 (804)
                        ++.++++||||...
T Consensus       242 ~~~~~~il~h~~~~~~  257 (328)
T cd05593         242 PDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCHHHHhcCCCcCCC
Confidence              89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-44  Score=400.28  Aligned_cols=255  Identities=24%  Similarity=0.367  Sum_probs=205.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||||.+...........+.+.+|++++++++|||||+++++|.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            48899999999999999999999999999998864322223345667889999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+.                                 |.+++...+.+++..++.++.|++.||+|||++||+|||||
T Consensus        82 ~~~gg~---------------------------------L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlk  128 (377)
T cd05629          82 FLPGGD---------------------------------LMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK  128 (377)
T ss_pred             CCCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            998651                                 12222234578999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---------------------------------------------------CCcc
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---------------------------------------------------ANSF  351 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---------------------------------------------------~~~~  351 (804)
                      |+|||++.++.+||+|||+|+....                                                   ..+.
T Consensus       129 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (377)
T cd05629         129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST  208 (377)
T ss_pred             HHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence            9999999999999999999852100                                                   0124


Q ss_pred             ccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccC
Q psy17952        352 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER  431 (804)
Q Consensus       352 ~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~  431 (804)
                      +||+.|+|||++.   ...|+.++|||||||++|||++|.+||.+.+..+....+......                   
T Consensus       209 ~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------  266 (377)
T cd05629         209 VGTPDYIAPEIFL---QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET-------------------  266 (377)
T ss_pred             CCCccccCHHHHc---cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc-------------------
Confidence            7999999999985   356899999999999999999999999877665554444321100                   


Q ss_pred             CCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC---CCHHHHHcCccccC
Q psy17952        432 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR---PSSGRLLTHDLVTR  493 (804)
Q Consensus       432 ~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R---psa~elL~Hp~~~~  493 (804)
                                          ........++.++++||.+||. +|.+|   +|+.++++||||..
T Consensus       267 --------------------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         267 --------------------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             --------------------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence                                0001112468899999999998 77765   59999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.3e-44  Score=390.26  Aligned_cols=282  Identities=26%  Similarity=0.362  Sum_probs=209.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----ce
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----TA  237 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----~~  237 (804)
                      +|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||+++++++....     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            38899999999999999999999999999998864221 1223456789999999999999999999876432     47


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+|||||.+++.+.+.                                  ....+++..+..++.||++||.|||++||+
T Consensus        80 ~lv~e~~~~~L~~~l~----------------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  125 (338)
T cd07859          80 YVVFELMESDLHQVIK----------------------------------ANDDLTPEHHQFFLYQLLRALKYIHTANVF  125 (338)
T ss_pred             EEEEecCCCCHHHHHH----------------------------------hcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            9999999876544332                                  234689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+|||++.++.+||+|||+++....       ....+||+.|+|||++.+. ...++.++|||||||++|||++|
T Consensus       126 H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DvwSlGvvl~el~tg  204 (338)
T cd07859         126 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTG  204 (338)
T ss_pred             cCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcc-ccccCchhHHHHHHHHHHHHHcC
Confidence            999999999999999999999999864321       1245799999999998432 24688899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC--CCCCCCCccHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT--PCLQSSDWSDTFAHFV  468 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~--p~~~~~~~s~~l~dli  468 (804)
                      ++||.+.+....+..+........    ...+..+....          ....+..+.....  .....+..++.+.+|+
T Consensus       205 ~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  270 (338)
T cd07859         205 KPLFPGKNVVHQLDLITDLLGTPS----PETISRVRNEK----------ARRYLSSMRKKQPVPFSQKFPNADPLALRLL  270 (338)
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCC----HHHHHHhhhhh----------HHHHHHhhcccCCCchHHhcCCCChHHHHHH
Confidence            999988776665544433211100    01111111000          0000000000000  0011134578899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||+.||++|||++++|+||||...
T Consensus       271 ~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         271 ERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             HHHcCcCcccCCCHHHHhcCchhhhc
Confidence            99999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.6e-44  Score=400.04  Aligned_cols=255  Identities=23%  Similarity=0.377  Sum_probs=206.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||||.+.............+.+|+.+|++++||||+++++.|.+++.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            48999999999999999999999999999998864322222334567899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.|+ +.+                                  ++...+.+++..++.++.||+.||+|||++||+||||
T Consensus        82 ~~~~g~L~~----------------------------------~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDl  127 (376)
T cd05598          82 YIPGGDMMS----------------------------------LLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDI  127 (376)
T ss_pred             CCCCCcHHH----------------------------------HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence            99865 322                                  2233456899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC-----------------------------------------------CCCccccC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC-----------------------------------------------PANSFVGT  354 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~-----------------------------------------------~~~~~~GT  354 (804)
                      ||+|||++.++.+||+|||+|....                                               ...+.+||
T Consensus       128 kp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  207 (376)
T cd05598         128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGT  207 (376)
T ss_pred             CHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCC
Confidence            9999999999999999999974210                                               01135799


Q ss_pred             cccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCC
Q psy17952        355 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPP  434 (804)
Q Consensus       355 ~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp  434 (804)
                      +.|||||++.   ...++.++|||||||++|||++|++||.+.+..+....+......                      
T Consensus       208 ~~y~aPE~~~---~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------------------  262 (376)
T cd05598         208 PNYIAPEVLL---RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT----------------------  262 (376)
T ss_pred             ccccCHHHHc---CCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc----------------------
Confidence            9999999984   456889999999999999999999999887765554444221100                      


Q ss_pred             ccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---CHHHHHcCccccCC
Q psy17952        435 YFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---SSGRLLTHDLVTRP  494 (804)
Q Consensus       435 ~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---sa~elL~Hp~~~~~  494 (804)
                                       ........++.++.+||.+|+ .+|.+|+   |+.++++||||...
T Consensus       263 -----------------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         263 -----------------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             -----------------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence                             000112346888999999976 5999999   99999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.9e-43  Score=380.32  Aligned_cols=303  Identities=75%  Similarity=1.242  Sum_probs=249.9

Q ss_pred             chhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeee
Q psy17952        150 EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG  229 (804)
Q Consensus       150 ~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~  229 (804)
                      .+++.+.+.++...|+..+.||+|+||.||+|++..+++.+|+|.+............++.+|+++++.++|||++++++
T Consensus         3 ~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   82 (308)
T cd06634           3 DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG   82 (308)
T ss_pred             chhHhhhcCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            34556666888999999999999999999999999999999999886433333344567889999999999999999999


Q ss_pred             EEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHH
Q psy17952        230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN  309 (804)
Q Consensus       230 ~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~  309 (804)
                      ++...+..|+||||+.|++.+++.                                 ....++++.++..++.|++.||.
T Consensus        83 ~~~~~~~~~lv~e~~~~~l~~~~~---------------------------------~~~~~l~~~~~~~~~~~l~~~l~  129 (308)
T cd06634          83 CYLREHTAWLVMEYCLGSASDLLE---------------------------------VHKKPLQEVEIAAVTHGALQGLA  129 (308)
T ss_pred             EEEcCCeeEEEEEccCCCHHHHHH---------------------------------HcCCCCCHHHHHHHHHHHHHHHH
Confidence            999999999999999887554332                                 12345889999999999999999


Q ss_pred             HHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       310 yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |||+++++||||||+|||++.++.+||+|||++....+.....||+.|+|||++.+...+.++.++|||||||++|||++
T Consensus       130 ~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  209 (308)
T cd06634         130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (308)
T ss_pred             HHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence            99999999999999999999999999999999987666666789999999999864444567889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||.+.+.......+..+..                                         +......++..+.+||.
T Consensus       210 g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~  248 (308)
T cd06634         210 RKPPLFNMNAMSALYHIAQNES-----------------------------------------PALQSGHWSEYFRNFVD  248 (308)
T ss_pred             CCCCCccccHHHHHHHHhhcCC-----------------------------------------CCcCcccccHHHHHHHH
Confidence            9999987665555444432211                                         11122356788999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhhHHHHHHHH
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKIL  526 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~  526 (804)
                      +||..+|++||++.++++|||+.....+........+.....+......+..+++++
T Consensus       249 ~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (308)
T cd06634         249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKIL  305 (308)
T ss_pred             HHhhCCcccCCCHHHHhhCccccccCChhHHHHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            999999999999999999999998887777777666666677777777777777754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.2e-43  Score=386.61  Aligned_cols=295  Identities=28%  Similarity=0.420  Sum_probs=216.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||++++..++..||+|.+....  .......+.+|+++|++++||||+++++++..++..|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            356999999999999999999999999999999886432  223446788999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCee
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIH  318 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiH  318 (804)
                      |||+.|+ |.+++                                  .....+++..+..++.|++.||.|||++ +|+|
T Consensus        82 ~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH  127 (331)
T cd06649          82 MEHMDGGSLDQVL----------------------------------KEAKRIPEEILGKVSIAVLRGLAYLREKHQIMH  127 (331)
T ss_pred             eecCCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence            9999864 33322                                  2335688999999999999999999986 6999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||||+|||++.++.+||+|||++.....  .....||+.|+|||++.   +..++.++|||||||++|||++|+.||..
T Consensus       128 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             CCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhc---CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999865422  23567999999999985   35688999999999999999999999977


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccc------cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA------ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~------~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .+..+....+...... .....+..........      .................+.....+......+++++++||.+
T Consensus       205 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  283 (331)
T cd06649         205 PDAKELEAIFGRPVVD-GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK  283 (331)
T ss_pred             CCHHHHHHHhcccccc-cccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHH
Confidence            6654432222110000 0000000000000000      00000000011111122233333444445688999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||++||++|||+.++|+||||....
T Consensus       284 ~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         284 CLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             HccCCcccCCCHHHHhcChHHhhcc
Confidence            9999999999999999999997643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.7e-44  Score=389.92  Aligned_cols=248  Identities=25%  Similarity=0.428  Sum_probs=203.9

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS  247 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~  247 (804)
                      +.||+|+||.||++++..+++.||+|.+.............+.+|+.+++.++||||++++++|...+..|+||||+.|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986432222334456778999999999999999999999999999999999875


Q ss_pred             chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCee
Q psy17952        248 ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL  327 (804)
Q Consensus       248 l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NIL  327 (804)
                      .                                 |+.+....+.+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        81 ~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl  127 (323)
T cd05595          81 E---------------------------------LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM  127 (323)
T ss_pred             c---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence            2                                 1112223457899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy17952        328 LTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL  403 (804)
Q Consensus       328 l~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l  403 (804)
                      ++.++.+||+|||++.....    ....+||+.|+|||++.   ++.++.++|||||||++|||++|+.||.+.+.....
T Consensus       128 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~  204 (323)
T cd05595         128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF  204 (323)
T ss_pred             EcCCCCEEecccHHhccccCCCCccccccCCcCcCCccccc---CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999864321    23467999999999984   457889999999999999999999999876655444


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---  480 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---  480 (804)
                      ..+.....                                           ..+..+++++.+||.+||++||.+||   
T Consensus       205 ~~~~~~~~-------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  241 (323)
T cd05595         205 ELILMEEI-------------------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGG  241 (323)
T ss_pred             HHHhcCCC-------------------------------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCC
Confidence            33321110                                           01134688999999999999999998   


Q ss_pred             --CHHHHHcCccccCC
Q psy17952        481 --SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 --sa~elL~Hp~~~~~  494 (804)
                        ++.++++|+||...
T Consensus       242 ~~~~~~~l~h~~~~~~  257 (323)
T cd05595         242 PSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCCHHHHHcCCCcCCC
Confidence              99999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-43  Score=403.79  Aligned_cols=280  Identities=26%  Similarity=0.357  Sum_probs=210.9

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----  234 (804)
                      +...|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+|+.++|||||+++++|...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3456999999999999999999999999999999875321       2235799999999999999998887532     


Q ss_pred             ---CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        235 ---HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       235 ---~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                         ..+++|||||+|++.+++..                              +......+++..++.++.||+.||+||
T Consensus       137 ~~~~~l~lvmE~~~~~l~~~~~~------------------------------~~~~~~~l~~~~~~~~~~qi~~gL~yL  186 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQTVHKYMKH------------------------------YARNNHALPLFLVKLYSYQLCRALAYI  186 (440)
T ss_pred             CCceEEEEEEecCCccHHHHHHH------------------------------HhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence               24679999999876554421                              112345789999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCC-cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETG-TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g-~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |++||+||||||+|||++.++ .+||+|||+|+....   ..+.+||+.|||||++.+  ...|+.++|||||||++|||
T Consensus       187 H~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el  264 (440)
T PTZ00036        187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG--ATNYTTHIDLWSLGCIIAEM  264 (440)
T ss_pred             HHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC--CCCCCcHHHHHHHHHHHHHH
Confidence            999999999999999999665 799999999975432   235689999999999853  34689999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccc--cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA--ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~--~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      ++|.+||.+.+..+.+..+.+.....    ....+..+....  ...|. ....   .+.        ...+...++++.
T Consensus       265 ltG~~pf~~~~~~~~~~~i~~~~~~p----~~~~~~~~~~~~~~~~~~~-~~~~---~l~--------~~~p~~~~~~~~  328 (440)
T PTZ00036        265 ILGYPIFSGQSSVDQLVRIIQVLGTP----TEDQLKEMNPNYADIKFPD-VKPK---DLK--------KVFPKGTPDDAI  328 (440)
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCC----CHHHHHHhchhhhcccCCc-cCch---hHH--------HHhccCCCHHHH
Confidence            99999999988887777766532111    011111110000  00000 0000   000        011234578999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +||.+||++||.+|||+.|+|+||||...
T Consensus       329 ~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        329 NFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            99999999999999999999999999653

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3e-43  Score=390.95  Aligned_cols=291  Identities=26%  Similarity=0.351  Sum_probs=210.4

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----  235 (804)
                      .+.|++++.||+|+||.||+|++..+++.||||.+..... .......+.+|+.+++.++||||+++++++...+     
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3569999999999999999999999999999998864321 2233456789999999999999999999986543     


Q ss_pred             -ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 -TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 -~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                       ..|+||||+.|++.+.+.                                    ..+++..+..++.|++.||.|||++
T Consensus        99 ~~~~lv~e~~~~~l~~~~~------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~  142 (359)
T cd07876          99 QDVYLVMELMDANLCQVIH------------------------------------MELDHERMSYLLYQMLCGIKHLHSA  142 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHh------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhC
Confidence             479999999887543221                                    2477889999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||+||||||+|||++.++.+||+|||+++....   .....||+.|+|||++.   +..|+.++|||||||++|||++|+
T Consensus       143 ~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~  219 (359)
T cd07876         143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGELVKGS  219 (359)
T ss_pred             CcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhcc---CCCCCcchhhHHHHHHHHHHHhCC
Confidence            999999999999999999999999999975432   23467999999999985   356889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhH-HhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVI-KTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i-~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .||.+.+....+..+......... ..+... ..+.......+.+.. .....++.-.............++++++||.+
T Consensus       220 ~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  297 (359)
T cd07876         220 VIFQGTDHIDQWNKVIEQLGTPSA-EFMNRLQPTVRNYVENRPQYPG-ISFEELFPDWIFPSESERDKLKTSQARDLLSK  297 (359)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCCcH-HHHHHHHHHHHHHHhhCCCCCC-cchhhhccccccccccccccccchhHHHHHHH
Confidence            999988766655554432111000 000000 000000000010000 00000000000000001112346789999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||+.||++|||+.|+|+||||..
T Consensus       298 mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         298 MLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HhccCcccCCCHHHHhcCchhhh
Confidence            99999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0603|consensus

Probab=100.00  E-value=1.6e-44  Score=403.11  Aligned_cols=458  Identities=21%  Similarity=0.275  Sum_probs=305.7

Q ss_pred             ccccccccceEEEEee---eceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEEEeec
Q psy17952        169 EIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYC  244 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lVmEy~  244 (804)
                      .+|+|+||.|++++..   ..+..+|+|...+....... ......|..++..++ ||.+|+++.+|+.+...|++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            4799999999987543   45677899877643221111 124456888888887 999999999999999999999999


Q ss_pred             CCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q psy17952        245 LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG  324 (804)
Q Consensus       245 ~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~  324 (804)
                      .|+                                 ++|....+...+++...+.+...++-|++++|+.+|+|||+|++
T Consensus        80 rgg---------------------------------~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~e  126 (612)
T KOG0603|consen   80 RGG---------------------------------DLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLE  126 (612)
T ss_pred             ccc---------------------------------hhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccccc
Confidence            886                                 34444455667888999999999999999999999999999999


Q ss_pred             CeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy17952        325 NILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALY  404 (804)
Q Consensus       325 NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~  404 (804)
                      ||+++.+|.+|+.|||+++........|||..|||||++.     .+..++|+||||++++||++|..||..    +.+.
T Consensus       127 nilld~~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~  197 (612)
T KOG0603|consen  127 NVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMK  197 (612)
T ss_pred             ceeecccCccccCCchhhhHhHhhhhcccchhhhhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCch----HHHH
Confidence            9999999999999999998766555559999999999984     367789999999999999999999976    4444


Q ss_pred             HHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH--
Q psy17952        405 HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS--  482 (804)
Q Consensus       405 ~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa--  482 (804)
                      +|.+.+.+                                           .+...+..+.+++..++.++|..|..+  
T Consensus       198 ~Il~~~~~-------------------------------------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~  234 (612)
T KOG0603|consen  198 RILKAELE-------------------------------------------MPRELSAEARSLFRQLFKRNPENRLGAGP  234 (612)
T ss_pred             HHhhhccC-------------------------------------------CchhhhHHHHHHHHHHHhhCHHHHhccCc
Confidence            44332211                                           123457788999999999999999765  


Q ss_pred             ---HHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhh-HHHHHHHHHhcCCCCCCCCCCCCCcccccC--------CC
Q psy17952        483 ---GRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLN-YRKMKKILMADGADTESTIDPDDTPDEQAG--------ND  550 (804)
Q Consensus       483 ---~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~--------~~  550 (804)
                         .++++|+||....-    .++..+....  .+.... .....    .......+...|.+.+...+.        ..
T Consensus       235 ~~~~eik~h~f~~~i~~----~~l~~r~~~~--~fkp~~~~e~~~----~~fd~eft~~~P~dsp~~~~~~s~~~if~g~  304 (612)
T KOG0603|consen  235 DGVDEIKQHEFFQSIDW----NELEARSRPP--PFKPGSITERDV----AQFDPEFTSQVPADSPLLSASGSDHTIFSGP  304 (612)
T ss_pred             chhHHHhccchheeeeH----hhHhhcCCCC--CCCCcccchhhh----hhcCchhccCCcccCCCCCCCccccchhcCC
Confidence               68999999864210    0000000000  000000 00000    000000111111111110000        00


Q ss_pred             CCCCCcc------------------ccccccccccccCCCCCCCCCCcccccccCCCCCCccccccccccCCCCcccccc
Q psy17952        551 SSKSNSI------------------TSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLF  612 (804)
Q Consensus       551 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  612 (804)
                      +..+..+                  ....++..+.+...  .++...........................+|+|++++.
T Consensus       305 sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~--~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~  382 (612)
T KOG0603|consen  305 SFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCES--SPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSH  382 (612)
T ss_pred             CccChHHhhccccCCcchhhccccccCCCCccceeeeec--cccccchhheeccccccccccccchhhhhcCCCcceeec
Confidence            0000000                  00111111111110  000000000000000111111222333556788888777


Q ss_pred             cc-------hhhhhhccCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCceEE-cCCCceeecCcc
Q psy17952        613 SP-------QLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLDTPD  684 (804)
Q Consensus       613 ~~-------~lv~e~~~g~~~~~~~~~~~~~~e~~~~~i~~~i~~~l~ylH~~~ivHrDlkp~NiLl-~~~~~~k~~~~~  684 (804)
                      +.       ++|||++.|+++.++++.+..++ .+|++|+++|+.||.|||++|||||||||+|||+ ++.|++||-+++
T Consensus       383 ~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  383 DVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             ceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEec
Confidence            74       69999999999999999998888 9999999999999999999999999999999999 588999999888


Q ss_pred             ccccc----------------ccccCCCcccccceeeeec-------ccCCCCCCCCCchhhhcc
Q psy17952        685 EQAGN----------------DSSKSNSITSEHSVQSVGV-------GVNPHDPTPNSSSQAHNR  726 (804)
Q Consensus       685 ~~~~~----------------~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~  726 (804)
                      ..+..                +.++-.-.|-.-|.||+|+       |..|-.-.|+. -+.|+|
T Consensus       462 ~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~  525 (612)
T KOG0603|consen  462 FWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR  525 (612)
T ss_pred             hhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh
Confidence            86655                2256667788899999997       66666655554 455554

>KOG0610|consensus

Probab=100.00  E-value=1.4e-43  Score=376.98  Aligned_cols=256  Identities=29%  Similarity=0.428  Sum_probs=217.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||.|.-|+||+|+...++..+|+|+|.+......++..++..|-+||+.++||.++.||..|+.++..|+|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            48999999999999999999999999999999987655555666778889999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||+||-...+.                               ..+..+.|+++.++.++.+|+.||+|||-.|||.||||
T Consensus       158 yCpGGdL~~Lr-------------------------------qkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLK  206 (459)
T KOG0610|consen  158 YCPGGDLHSLR-------------------------------QKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLK  206 (459)
T ss_pred             cCCCccHHHHH-------------------------------hhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCC
Confidence            99987221111                               01235679999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccc------------------------------------c-C-------------------
Q psy17952        323 AGNILLTETGTVKLADFGSASI------------------------------------K-C-------------------  346 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~------------------------------------~-~-------------------  346 (804)
                      |+||||-++|++.|+||-++..                                    . .                   
T Consensus       207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae  286 (459)
T KOG0610|consen  207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE  286 (459)
T ss_pred             cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence            9999999999999999987620                                    0 0                   


Q ss_pred             C----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhH
Q psy17952        347 P----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI  422 (804)
Q Consensus       347 ~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i  422 (804)
                      +    .++++||-.|.|||+|.+   ...+.++|+|+|||.+|||+.|..||.|.+..+.+.+|+.....+         
T Consensus       287 p~~~RSnSFVGThEYlAPEvI~G---~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F---------  354 (459)
T KOG0610|consen  287 PTGARSNSFVGTHEYLAPEVIRG---EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF---------  354 (459)
T ss_pred             CCCccccccccccccccceeeec---CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC---------
Confidence            0    125789999999999954   457889999999999999999999999999999888886432110         


Q ss_pred             HhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC----HHHHHcCccccC
Q psy17952        423 KTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS----SGRLLTHDLVTR  493 (804)
Q Consensus       423 ~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps----a~elL~Hp~~~~  493 (804)
                                                    |  ..+..|..++|||+++|.+||.+|..    |+|+-+||||..
T Consensus       355 ------------------------------p--~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  355 ------------------------------P--EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG  397 (459)
T ss_pred             ------------------------------C--CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence                                          0  11256788999999999999999998    999999999975

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-43  Score=387.26  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|+++.+++.||||.+.............+.+|+.+++.+ +||||+++++++...+.+|+|||||.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999988643222223445677899998876 699999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |.+++...+.+++..+..++.|++.||+|||++||+||||||+||
T Consensus        81 g~---------------------------------L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NI  127 (320)
T cd05590          81 GD---------------------------------LMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNV  127 (320)
T ss_pred             ch---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence            52                                 111222345789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++...    .....+||+.|+|||++.   ...++.++|||||||++|||++|+.||.+.+....
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~  204 (320)
T cd05590         128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ---EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL  204 (320)
T ss_pred             EECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHc---CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence            99999999999999986432    123467999999999984   35688899999999999999999999988776555


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+..+..                                           .....++.++.+|+.+||++||.+||++
T Consensus       205 ~~~i~~~~~-------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         205 FEAILNDEV-------------------------------------------VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHhcCCC-------------------------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            544432110                                           0112357889999999999999999998


Q ss_pred             ------HHHHcCccccCC
Q psy17952        483 ------GRLLTHDLVTRP  494 (804)
Q Consensus       483 ------~elL~Hp~~~~~  494 (804)
                            .++++||||...
T Consensus       242 ~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         242 LTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence                  999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG1035|consensus

Probab=100.00  E-value=1.3e-43  Score=415.39  Aligned_cols=441  Identities=26%  Similarity=0.371  Sum_probs=283.7

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeE----EEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTA----WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~----~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+.++.|+|+++++.+-..+...    .+..|||.+-....+....+.++.+..+.+..+.++||+|+|+...-|.-+-
T Consensus       234 ~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~  313 (1351)
T KOG1035|consen  234 ESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLS  313 (1351)
T ss_pred             HHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEe
Confidence            356778999999999976544332    3445677665444455667889999999999999999999999876666655


Q ss_pred             cc---cEEEcCCCceEEe--ccCccccc---CCCCccccccccCcchhhhhcccCcc--CCcccccccccCCCCC-----
Q psy17952         82 AG---NILLTETGTVKLA--DFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQY--DGKVDVWSLGITPGSL-----  146 (804)
Q Consensus        82 p~---Nill~~~~~~kl~--DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~--~~~vDvwslG~~~g~l-----  146 (804)
                      -.   +--.+..+.+...  ||+.++..   +.......+.-|-|||...   ...+  +...|+|.+|......     
T Consensus       314 ~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~---~~~~~~~r~~dL~~lgll~~~~~~~~~  390 (1351)
T KOG1035|consen  314 ASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLK---ENTAKKSRLTDLWCLGLLLLQLSQGED  390 (1351)
T ss_pred             cccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccc---cccchhhhhhHHHHHHHHHhhhhhcCc
Confidence            55   3334555666665  88776542   1222234556678888752   2223  3456999887432110     


Q ss_pred             -----------CCc------------------c--------hh----------cc--ccC----------------CC--
Q psy17952        147 -----------KDP------------------E--------IA----------EL--FDK----------------ED--  159 (804)
Q Consensus       147 -----------~~~------------------~--------i~----------el--f~~----------------~d--  159 (804)
                                 .+.                  +        +.          +.  |..                ..  
T Consensus       391 i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~  470 (1351)
T KOG1035|consen  391 ISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNESSEFAPNDETSVPQFRLRFSGAMSPL  470 (1351)
T ss_pred             ccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccccccccccCccccccCccCCCCccccCcc
Confidence                       000                  0        00          00  000                00  


Q ss_pred             ------cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee
Q psy17952        160 ------PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR  233 (804)
Q Consensus       160 ------p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~  233 (804)
                            -...|+.++.||+||||.||+++++-+|+.||||+|....  .......+.+|+.+|++|+|||||+|+.+|..
T Consensus       471 ~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  471 QRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVE  548 (1351)
T ss_pred             ccchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence                  0123789999999999999999999999999999997543  34556778999999999999999999988765


Q ss_pred             cCceEEEEeecC---------------------------CCchhhHHHHH-------hhhh-------------------
Q psy17952        234 DHTAWLVMEYCL---------------------------GSASDIIEVHW-------IERE-------------------  260 (804)
Q Consensus       234 ~~~~~lVmEy~~---------------------------G~l~dll~~~~-------~~~~-------------------  260 (804)
                      ...-.-++|-..                           ..+...-...|       ..+.                   
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence            433222222210                           00000000000       0000                   


Q ss_pred             -----hhhcc----------------cchhhhh------------hhhhhcccccchhhccCCCC-CHHHHHHHHHHHHH
Q psy17952        261 -----FHVEG----------------MGNRLQQ------------LKCFTEHFALFNFEVHKRPL-KEEEIAAICSGVLR  306 (804)
Q Consensus       261 -----~~~~~----------------~~~~l~~------------l~~~~~~~~L~~~~~~~~~l-~e~~i~~i~~qil~  306 (804)
                           ...++                ..+....            .+.+.+...+.+++...... ....++++++||++
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILE  708 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHH
Confidence                 00000                0000000            01111222233333333222 36789999999999


Q ss_pred             HHHHHHHCCCeecCCCCCCeeecCCCcEEEEeccccccc-----------C-----------CCCccccCcccccchhhc
Q psy17952        307 GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK-----------C-----------PANSFVGTPYWMAPEVIL  364 (804)
Q Consensus       307 gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~-----------~-----------~~~~~~GT~~Y~APEvl~  364 (804)
                      ||.|+|++|||||||||.||++++++.|||+|||+|+..           .           ..++.+||.-|+|||++.
T Consensus       709 GLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  709 GLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999999999999999999999999999999999999641           0           113568999999999997


Q ss_pred             ccCCCCCCCcccHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHH
Q psy17952        365 AMDEGQYDGKVDVWSLGITCIELAERKPPYF-NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA  443 (804)
Q Consensus       365 ~~~~~~y~~ksDIWSlGvil~ELltG~~PF~-~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~  443 (804)
                      +.....|+.|+|+||||||++||+.   ||. .+.....+..+.++..|..                   +         
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-------------------~---------  837 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-------------------A---------  837 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-------------------c---------
Confidence            6443479999999999999999984   563 2333334444332222211                   0         


Q ss_pred             HHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       444 l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                                .+..+..+ .-+.+|..||+.||++||||.|+|++.|+..
T Consensus       838 ----------~f~~~~~~-~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  838 ----------DFFDPEHP-EEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             ----------ccccccch-HHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence                      00111222 2346999999999999999999999999874

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-43  Score=389.23  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=203.0

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS  247 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~  247 (804)
                      +.||+|+||.||+|++..+++.||+|.+.............+.+|+++++.++||||+++++++...+..|+||||+.|+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986433222334456788999999999999999999999999999999999875


Q ss_pred             chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCe
Q psy17952        248 ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNI  326 (804)
Q Consensus       248 l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRDLKP~NI  326 (804)
                      .                                 |+.+....+.+++..+..++.||+.||.|||+ +||+||||||+||
T Consensus        81 ~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NI  127 (325)
T cd05594          81 E---------------------------------LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL  127 (325)
T ss_pred             c---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeE
Confidence            2                                 11222234578999999999999999999998 7999999999999


Q ss_pred             eecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++....    ....+||+.|||||++.   +..++.++|||||||++|||++|+.||.+.+....
T Consensus       128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~  204 (325)
T cd05594         128 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL  204 (325)
T ss_pred             EECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHc---cCCCCCccccccccceeeeeccCCCCCCCCCHHHH
Confidence            999999999999999864321    23467999999999984   35688999999999999999999999987665444


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC--
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP--  480 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp--  480 (804)
                      ...+.....                                           .....+++++.+|+.+||++||++|+  
T Consensus       205 ~~~i~~~~~-------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~  241 (325)
T cd05594         205 FELILMEEI-------------------------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGG  241 (325)
T ss_pred             HHHHhcCCC-------------------------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCC
Confidence            333321100                                           01124678899999999999999997  


Q ss_pred             ---CHHHHHcCccccCC
Q psy17952        481 ---SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 ---sa~elL~Hp~~~~~  494 (804)
                         ++.++++||||...
T Consensus       242 ~~~~~~~il~h~~~~~~  258 (325)
T cd05594         242 GPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCHHHHhcCCCcCCC
Confidence               99999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-43  Score=395.90  Aligned_cols=271  Identities=25%  Similarity=0.350  Sum_probs=204.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++++.||+|+||.||+|++..+++.||+|...         ...+.+|+++|++|+|||||+++++|......++||
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            45999999999999999999999999999999643         134678999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |++.+++.+.+                                  .....+++.++..|+.||+.||+|||++|||||||
T Consensus       163 e~~~~~L~~~l----------------------------------~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDi  208 (391)
T PHA03212        163 PRYKTDLYCYL----------------------------------AAKRNIAICDILAIERSVLRAIQYLHENRIIHRDI  208 (391)
T ss_pred             ecCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99977643322                                  23456889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      ||+|||++.++.+||+|||+|+....     ....+||+.|+|||++.   ...|+.++|||||||++|||++|..||++
T Consensus       209 KP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        209 KAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLA---RDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhc---CCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            99999999999999999999964321     22468999999999985   35689999999999999999999998865


Q ss_pred             CC-------hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHH-hhccCC------CCCC-CCCCcc
Q psy17952        397 MN-------AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY-HIAQND------TPCL-QSSDWS  461 (804)
Q Consensus       397 ~~-------~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~-~i~~~~------~p~~-~~~~~s  461 (804)
                      ..       ....+..+.....+......+..                .......+ ......      .+.. .....+
T Consensus       286 ~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (391)
T PHA03212        286 KDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA----------------QANLDEIYIGLAKKSSRKPGSRPLWTNLYELP  349 (391)
T ss_pred             cccccccCchhHHHHHHHHHhcCChhhcCcch----------------hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhh
Confidence            32       12223333321111000000000                00000000 000000      0000 011246


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        462 DTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .++.+||.+||++||++||||.|+|+||||...
T Consensus       350 ~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        350 IDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            789999999999999999999999999999764

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=391.20  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=208.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            48899999999999999999999999999999864332222344667889999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++                                  ...+.+++..++.++.||+.||+|||++||+||||
T Consensus        82 ~~~~~~L~~~l----------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dl  127 (350)
T cd05573          82 YMPGGDLMNLL----------------------------------IRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI  127 (350)
T ss_pred             CCCCCCHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99864 32222                                  23357899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC---------------------------------CccccCcccccchhhcccCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA---------------------------------NSFVGTPYWMAPEVILAMDE  368 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~---------------------------------~~~~GT~~Y~APEvl~~~~~  368 (804)
                      ||+|||++.++.+||+|||++......                                 ....||+.|+|||++.   .
T Consensus       128 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~  204 (350)
T cd05573         128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR---G  204 (350)
T ss_pred             CHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc---C
Confidence            999999999999999999998643221                                 2357999999999985   3


Q ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhc
Q psy17952        369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA  448 (804)
Q Consensus       369 ~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~  448 (804)
                      ..++.++|||||||++|||++|+.||.+.+.......+......                 .                  
T Consensus       205 ~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----------------~------------------  249 (350)
T cd05573         205 TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKES-----------------L------------------  249 (350)
T ss_pred             CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCc-----------------c------------------
Confidence            47899999999999999999999999887765554444321100                 0                  


Q ss_pred             cCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC-HHHHHcCccccC
Q psy17952        449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS-SGRLLTHDLVTR  493 (804)
Q Consensus       449 ~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps-a~elL~Hp~~~~  493 (804)
                          .......+++++.+||.+||. ||.+||+ +.++++||||..
T Consensus       250 ----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         250 ----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence                000112368899999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-43  Score=385.06  Aligned_cols=247  Identities=29%  Similarity=0.421  Sum_probs=203.1

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||||.+.............+..|.++++.+ +||||+++++++...+..|+|||||.|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999988643222233445677899999866 799999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |...+...+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        81 ~~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Ni  127 (321)
T cd05591          81 GD---------------------------------LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNI  127 (321)
T ss_pred             Cc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence            52                                 111222345689999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||++.....    ....+||+.|+|||++.   ...|+.++|||||||++|||++|++||.+.+....
T Consensus       128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~  204 (321)
T cd05591         128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ---ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL  204 (321)
T ss_pred             EECCCCCEEEeecccceecccCCccccccccCccccCHHHHc---CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999864321    23467999999999984   35688999999999999999999999988776666


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC--
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP--  480 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp--  480 (804)
                      +..+......                                           .+...+.++.+|+.+||++||++||  
T Consensus       205 ~~~i~~~~~~-------------------------------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~  241 (321)
T cd05591         205 FESILHDDVL-------------------------------------------YPVWLSKEAVSILKAFMTKNPNKRLGC  241 (321)
T ss_pred             HHHHHcCCCC-------------------------------------------CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            5555332110                                           0123578899999999999999999  


Q ss_pred             -----CHHHHHcCccccC
Q psy17952        481 -----SSGRLLTHDLVTR  493 (804)
Q Consensus       481 -----sa~elL~Hp~~~~  493 (804)
                           ++.++++||||..
T Consensus       242 ~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         242 VASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CCCCCCHHHHhcCCccCC
Confidence                 9999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.6e-43  Score=392.57  Aligned_cols=259  Identities=24%  Similarity=0.409  Sum_probs=210.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            45999999999999999999999999999999986432222223345678999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||.|+ +.+++                                   ....+++..+..++.||+.||+|||++||+|||
T Consensus       123 Ey~~gg~L~~~l-----------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD  167 (370)
T cd05596         123 EYMPGGDLVNLM-----------------------------------SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRD  167 (370)
T ss_pred             cCCCCCcHHHHH-----------------------------------HhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence            999865 32222                                   123578899999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccC-CCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~-~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||+|||++.++.+||+|||++.....     ....+||+.|||||++.+.. ...++.++|||||||++|||++|++||
T Consensus       168 Lkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  247 (370)
T cd05596         168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (370)
T ss_pred             CCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence            999999999999999999999865432     23467999999999986422 234788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+.......+......                                       ........+|.++++||.+||+.
T Consensus       248 ~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~s~~~~~li~~~L~~  288 (370)
T cd05596         248 YADSLVGTYSKIMDHKNS---------------------------------------LTFPDDIEISKQAKDLICAFLTD  288 (370)
T ss_pred             CCCCHHHHHHHHHcCCCc---------------------------------------CCCCCcCCCCHHHHHHHHHHccC
Confidence            887765555444321100                                       00011234689999999999999


Q ss_pred             CCCC--CCCHHHHHcCccccCC
Q psy17952        475 NPAD--RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       475 dP~~--Rpsa~elL~Hp~~~~~  494 (804)
                      +|.+  |+|+.++++||||...
T Consensus       289 ~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         289 REVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             hhhccCCCCHHHHhcCcccCCC
Confidence            9998  9999999999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-43  Score=392.60  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=207.5

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+.++.||+|+||.||+|++..+++.||||.+.............+.+|+.++.+++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            48899999999999999999999999999999864332223345667889999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+.                                 |.+++.+.+.+++..++.++.|++.||+|||++||+|||||
T Consensus        82 ~~~gg~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLk  128 (360)
T cd05627          82 FLPGGD---------------------------------MMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK  128 (360)
T ss_pred             CCCCcc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC
Confidence            998751                                 22222345678999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---------------------------------------CCccccCcccccchhh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---------------------------------------ANSFVGTPYWMAPEVI  363 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---------------------------------------~~~~~GT~~Y~APEvl  363 (804)
                      |+|||++.+|.+||+|||+++....                                       ..+.+||+.|+|||++
T Consensus       129 p~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  208 (360)
T cd05627         129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF  208 (360)
T ss_pred             HHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH
Confidence            9999999999999999999853211                                       1135799999999998


Q ss_pred             cccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHH
Q psy17952        364 LAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA  443 (804)
Q Consensus       364 ~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~  443 (804)
                      .   +..|+.++|||||||++|||++|++||.+.+.......+......                 .             
T Consensus       209 ~---~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~-----------------~-------------  255 (360)
T cd05627         209 M---QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKET-----------------L-------------  255 (360)
T ss_pred             c---CCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCc-----------------e-------------
Confidence            5   456899999999999999999999999887766655554321100                 0             


Q ss_pred             HHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---CHHHHHcCccccCC
Q psy17952        444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---SSGRLLTHDLVTRP  494 (804)
Q Consensus       444 l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---sa~elL~Hp~~~~~  494 (804)
                               .......+++++++||.+|+ .||.+|+   ++.++++||||...
T Consensus       256 ---------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         256 ---------VFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             ---------ecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence                     00011236889999999987 4999998   48999999999763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-43  Score=384.37  Aligned_cols=252  Identities=27%  Similarity=0.412  Sum_probs=205.7

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCC-ceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP-NTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIV~l~~~~~~~~~~~lVmE  242 (804)
                      |++++.||+|+||.||+|++..+++.||||.+...........+.+..|+++++.++|+ +|+++++++...+.+|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            78899999999999999999999999999988643222233446678899999999765 58889999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+.                                 |.+++...+.+++..+..++.||+.||+|||++||+|||||
T Consensus        82 ~~~~g~---------------------------------L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk  128 (324)
T cd05587          82 YVNGGD---------------------------------LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK  128 (324)
T ss_pred             CCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            998652                                 11222234568999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||++....    .....+||+.|+|||++.   ...++.++||||+||++|||++|++||.+.+
T Consensus       129 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         129 LDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             HHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhc---CCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999986422    123467999999999985   3568899999999999999999999998776


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+....+.....                                           ..+..++.++.+|+.+||.+||.+
T Consensus       206 ~~~~~~~i~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~  242 (324)
T cd05587         206 EDELFQSIMEHNV-------------------------------------------SYPKSLSKEAVSICKGLLTKHPAK  242 (324)
T ss_pred             HHHHHHHHHcCCC-------------------------------------------CCCCCCCHHHHHHHHHHhhcCHHH
Confidence            6555444432110                                           011245788999999999999999


Q ss_pred             CCCH-----HHHHcCccccCC
Q psy17952        479 RPSS-----GRLLTHDLVTRP  494 (804)
Q Consensus       479 Rpsa-----~elL~Hp~~~~~  494 (804)
                      |+++     +++++||||...
T Consensus       243 R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         243 RLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             cCCCCCCCHHHHhcCCCcCCC
Confidence            9986     899999999763

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-43  Score=384.56  Aligned_cols=251  Identities=26%  Similarity=0.409  Sum_probs=204.0

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHH---hhcCCCceeEeeeEEeecCceEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL---RQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL---~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      |++++.||+|+||.||+|.+..+++.||||.++..........+.+.+|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67889999999999999999999999999998643222223345566676655   567899999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+...                                 ..+ ....+++..+..++.||+.||+|||++||+|||
T Consensus        81 ~E~~~~~~L~---------------------------------~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrd  126 (324)
T cd05589          81 MEYAAGGDLM---------------------------------MHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD  126 (324)
T ss_pred             EcCCCCCcHH---------------------------------HHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecC
Confidence            9999876211                                 111 234689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||+++....    ....+||+.|||||++.   +..++.++|||||||++|||++|+.||.+
T Consensus       127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         127 LKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             CCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhc---CCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999864321    23568999999999984   35688899999999999999999999988


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+.+..+..+..                                           .....++..+.+||.+||++||
T Consensus       204 ~~~~~~~~~i~~~~~-------------------------------------------~~p~~~~~~~~~li~~~L~~dP  240 (324)
T cd05589         204 DDEEEVFDSIVNDEV-------------------------------------------RYPRFLSREAISIMRRLLRRNP  240 (324)
T ss_pred             CCHHHHHHHHHhCCC-------------------------------------------CCCCCCCHHHHHHHHHHhhcCH
Confidence            776555544432110                                           0112457889999999999999


Q ss_pred             CCCC-----CHHHHHcCccccCC
Q psy17952        477 ADRP-----SSGRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rp-----sa~elL~Hp~~~~~  494 (804)
                      .+||     ++.++++||||...
T Consensus       241 ~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         241 ERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             hHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999     79999999999753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.1e-43  Score=388.28  Aligned_cols=291  Identities=24%  Similarity=0.337  Sum_probs=212.4

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------  234 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346999999999999999999999999999999886432 2223345678999999999999999999987643      


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ...|+||||+.+++.+.+.                                    ..+++..+..++.|++.||+|||++
T Consensus       102 ~~~~lv~e~~~~~l~~~~~------------------------------------~~~~~~~~~~~~~qi~~aL~~LH~~  145 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQ------------------------------------MELDHERMSYLLYQMLCGIKHLHSA  145 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHH------------------------------------hcCCHHHHHHHHHHHHHHHHHHhhC
Confidence            3579999999887544321                                    2467888999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||+||||||+|||++.++.+||+|||+|+....   .....||+.|+|||++.   +..++.++|||||||++|||++|+
T Consensus       146 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~  222 (364)
T cd07875         146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIKGG  222 (364)
T ss_pred             CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHh---CCCCCchhhHHhHHHHHHHHHhCC
Confidence            999999999999999999999999999975432   23467999999999985   356889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHh-hcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKT-ISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~-i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .||.+.+..+....+...-....+ ..+..+.. +.......|.+.. .....++.-.............++.+++||.+
T Consensus       223 ~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  300 (364)
T cd07875         223 VLFPGTDHIDQWNKVIEQLGTPCP-EFMKKLQPTVRTYVENRPKYAG-YSFEKLFPDVLFPADSEHNKLKASQARDLLSK  300 (364)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCCCH-HHHHhhhHHHHHHHhhCCCcCC-CChHhhCccccccccccccccccHHHHHHHHH
Confidence            999988877777666543221110 00010000 0000011111100 00000000000000011112346789999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||+.||.+|||+.++|+||||..
T Consensus       301 mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         301 MLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hcCcCcccCCCHHHHhcCccccc
Confidence            99999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0589|consensus

Probab=100.00  E-value=1.7e-43  Score=388.24  Aligned_cols=253  Identities=33%  Similarity=0.553  Sum_probs=217.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc-eEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT-AWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~-~~lV  240 (804)
                      +.|+.++++|+|+||.+++++++..+..+++|++..... .........+|+.++++++|||||.+.+.|..++. ++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~-t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL-TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc-CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            459999999999999999999999999999999976443 33444578899999999999999999999999888 9999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |+||+|| +.+.+..                                .+...++|+.+..++.|++.|++|||+++|+||
T Consensus        83 m~Y~eGg~l~~~i~~--------------------------------~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHR  130 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKE--------------------------------QKGVLFPEERILKWFVQILLAVNYLHENRVLHR  130 (426)
T ss_pred             EeecCCCCHHHHHHH--------------------------------HhhccccHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence            9999975 3333321                                123568999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      |||+.||+++.++.|||.|||+|+...+.    .+.+|||+||.||++.   +-+|+.|+|||||||++|||++-+++|.
T Consensus       131 DlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~---d~pYn~KSDiWsLGC~~yEm~~lk~aF~  207 (426)
T KOG0589|consen  131 DLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILS---DIPYNEKSDIWSLGCCLYEMCTLKPAFK  207 (426)
T ss_pred             cchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhC---CCCCCccCcchhhcchHHHHHhcccccC
Confidence            99999999999999999999999876543    4689999999999984   4689999999999999999999999999


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+......+|.++...                                          +.+..+|.+++.+|+.||.++
T Consensus       208 a~~m~~Li~ki~~~~~~------------------------------------------Plp~~ys~el~~lv~~~l~~~  245 (426)
T KOG0589|consen  208 ASNMSELILKINRGLYS------------------------------------------PLPSMYSSELRSLVKSMLRKN  245 (426)
T ss_pred             ccchHHHHHHHhhccCC------------------------------------------CCCccccHHHHHHHHHHhhcC
Confidence            88877777766553211                                          123567999999999999999


Q ss_pred             CCCCCCHHHHHcCcccc
Q psy17952        476 PADRPSSGRLLTHDLVT  492 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~  492 (804)
                      |+.||++.++|.+|.+.
T Consensus       246 P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  246 PEHRPSALELLRRPHLL  262 (426)
T ss_pred             CccCCCHHHHhhChhhh
Confidence            99999999999998664

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6e-43  Score=390.75  Aligned_cols=260  Identities=24%  Similarity=0.403  Sum_probs=208.4

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ...|++++.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++++.++..+|+|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            34699999999999999999999999999999988643222222335577899999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ +.+++                                   ....+++..+..++.||+.||+|||++||+||
T Consensus       122 ~Ey~~gg~L~~~l-----------------------------------~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHr  166 (370)
T cd05621         122 MEYMPGGDLVNLM-----------------------------------SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHR  166 (370)
T ss_pred             EcCCCCCcHHHHH-----------------------------------HhcCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            9999865 33222                                   12357899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccC-CCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~-~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.++.+||+|||+|.....     ..+.+||+.|||||++.+.. .+.++.++||||+||++|||++|++|
T Consensus       167 DLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~P  246 (370)
T cd05621         167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP  246 (370)
T ss_pred             CCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCC
Confidence            9999999999999999999999975432     23567999999999986422 12478899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+......                                       ........++..+++|+.+||.
T Consensus       247 f~~~~~~~~~~~i~~~~~~---------------------------------------~~~p~~~~~s~~~~~li~~~L~  287 (370)
T cd05621         247 FYADSLVGTYSKIMDHKNS---------------------------------------LNFPEDVEISKHAKNLICAFLT  287 (370)
T ss_pred             CCCCCHHHHHHHHHhCCcc---------------------------------------cCCCCcccCCHHHHHHHHHHcc
Confidence            9887766555544322110                                       0001123468889999999998


Q ss_pred             cCCCC--CCCHHHHHcCccccCC
Q psy17952        474 KNPAD--RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~--Rpsa~elL~Hp~~~~~  494 (804)
                      .+|.+  |+|+.++++||||...
T Consensus       288 ~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         288 DREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CchhccCCCCHHHHhcCcccCCC
Confidence            66654  8999999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.3e-43  Score=378.52  Aligned_cols=282  Identities=22%  Similarity=0.371  Sum_probs=213.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|+++++||+|+||.||+|++..+++.||+|.++.....  .....+.+|+.++++++||||+++++++..++..|+||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            3589999999999999999999999999999988643221  22245678999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.+++.+.+.                                 .....+++..+..++.||+.||+|||++||+||||
T Consensus        84 e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dl  130 (309)
T cd07872          84 EYLDKDLKQYMD---------------------------------DCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL  130 (309)
T ss_pred             eCCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            999876544321                                 11235788999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||++.....    .....+|+.|+|||++.+  ...++.++|||||||++|||++|++||.+.
T Consensus       131 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         131 KPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--SSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             CHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999865322    223578999999999853  345788999999999999999999999888


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccc-cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~-~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      +..+.+..+........ ...|+.+....... ...+++.             ...........+.++++||.+||+.||
T Consensus       209 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~L~~dp  274 (309)
T cd07872         209 TVEDELHLIFRLLGTPT-EETWPGISSNDEFKNYNFPKYK-------------PQPLINHAPRLDTEGIELLTKFLQYES  274 (309)
T ss_pred             ChHHHHHHHHHHhCCCC-HHHHhhhcchhhhhhhhcCccC-------------CCchhhhccCCCHHHHHHHHHhccCCh
Confidence            77666555544221111 11222111100000 0000000             000011123468899999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy17952        477 ADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+|||+.|+|+||||...
T Consensus       275 ~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         275 KKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhCCCHHHHhcChhhhhc
Confidence            999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.8e-43  Score=382.54  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      |++++.||+|+||.||+|++..+++.||||.+.............+..|..++..+ +||+|+++++++...+.+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            78899999999999999999999999999988643222223345567788888877 58999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|+.                                 |.+++...+.+++.++..++.||+.||+|||++||+|||||
T Consensus        82 ~~~~g~---------------------------------L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  128 (323)
T cd05616          82 YVNGGD---------------------------------LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK  128 (323)
T ss_pred             CCCCCC---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCC
Confidence            998651                                 11222234568999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||+++...    .....+||+.|+|||++.   ...|+.++|||||||++|||++|+.||.+.+
T Consensus       129 p~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         129 LDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             HHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhc---CCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999987432    123568999999999985   4578999999999999999999999998877


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......+.....                                           ..+...+.++.+|+.+||++||.+
T Consensus       206 ~~~~~~~i~~~~~-------------------------------------------~~p~~~s~~~~~li~~~l~~~p~~  242 (323)
T cd05616         206 EDELFQSIMEHNV-------------------------------------------AYPKSMSKEAVAICKGLMTKHPGK  242 (323)
T ss_pred             HHHHHHHHHhCCC-------------------------------------------CCCCcCCHHHHHHHHHHcccCHHh
Confidence            6655544432110                                           011246788999999999999999


Q ss_pred             CCCH-----HHHHcCccccC
Q psy17952        479 RPSS-----GRLLTHDLVTR  493 (804)
Q Consensus       479 Rpsa-----~elL~Hp~~~~  493 (804)
                      |+++     .++++||||..
T Consensus       243 R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         243 RLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             cCCCCCCCHHHHhcCCCcCC
Confidence            9984     89999999965

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.4e-43  Score=381.37  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=199.4

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhh-cCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ-LKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||+|.++...............|..++.. ++||||+++++++.+.+..|+|||||.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999998864322112234556778888875 4899999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |..++...+.+++.++..++.|++.||+|||++||+||||||+||
T Consensus        81 g~---------------------------------L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Ni  127 (316)
T cd05620          81 GD---------------------------------LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNV  127 (316)
T ss_pred             Cc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence            52                                 111222345789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++...    .....+||+.|+|||++.   ...|+.++|||||||++|||++|+.||.+.+....
T Consensus       128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~  204 (316)
T cd05620         128 MLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ---GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL  204 (316)
T ss_pred             EECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHc---CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999986422    223568999999999985   35688999999999999999999999987665444


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+....                                          +. ....++.++++|+.+||+.||++||++
T Consensus       205 ~~~~~~~~------------------------------------------~~-~~~~~~~~~~~li~~~l~~dP~~R~~~  241 (316)
T cd05620         205 FESIRVDT------------------------------------------PH-YPRWITKESKDILEKLFERDPTRRLGV  241 (316)
T ss_pred             HHHHHhCC------------------------------------------CC-CCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence            33332110                                          00 012357889999999999999999998


Q ss_pred             -HHHHcCccccCC
Q psy17952        483 -GRLLTHDLVTRP  494 (804)
Q Consensus       483 -~elL~Hp~~~~~  494 (804)
                       +++++||||...
T Consensus       242 ~~~~~~h~~f~~~  254 (316)
T cd05620         242 VGNIRGHPFFKTI  254 (316)
T ss_pred             hHHHHcCCCcCCC
Confidence             588899999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.1e-43  Score=383.69  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=198.9

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||||.++............+.+|+.+++++ +||||++++++|.+.+.+|+|||||.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999998753323333445678899999988 799999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |+.+....+.+++..+..++.|++.||.|||++||+||||||+||
T Consensus        81 g~---------------------------------L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  127 (329)
T cd05588          81 GD---------------------------------LMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV  127 (329)
T ss_pred             CC---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence            52                                 112222346799999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++...    .....+||+.|+|||++.   +..++.++|||||||++|||++|+.||....... 
T Consensus       128 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-  203 (329)
T cd05588         128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD-  203 (329)
T ss_pred             EECCCCCEEECcCccccccccCCCccccccCCccccCHHHHc---CCCCCCccceechHHHHHHHHHCCCCcccccccc-
Confidence            99999999999999986421    123468999999999985   3568899999999999999999999995321100 


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC-
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS-  481 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps-  481 (804)
                              .+...  .                      ...+++....... ..+..++.++.+||.+||++||.+|+| 
T Consensus       204 --------~~~~~--~----------------------~~~~~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         204 --------NPDQN--T----------------------EDYLFQVILEKQI-RIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             --------ccccc--c----------------------hHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                    00000  0                      0000000000001 112346889999999999999999997 


Q ss_pred             -----HHHHHcCccccC
Q psy17952        482 -----SGRLLTHDLVTR  493 (804)
Q Consensus       482 -----a~elL~Hp~~~~  493 (804)
                           ++++++||||..
T Consensus       251 ~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         251 HPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             CCCCCHHHHhcCCCCCC
Confidence                 789999999954

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-43  Score=381.99  Aligned_cols=249  Identities=26%  Similarity=0.403  Sum_probs=201.7

Q ss_pred             ccccccccccceEEEEee---eceeEEEEEecccccc-cchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        167 LREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGK-QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~-~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      ++.||+|+||.||+|++.   .+++.||||.+..... ........+.+|+.+|+.++||||++++++|..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999864   4688999998864221 112233456789999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|+.                                 |+++....+.+++..+..++.||+.||+|||++||+|||||
T Consensus        81 ~~~~~~---------------------------------L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  127 (323)
T cd05584          81 YLSGGE---------------------------------LFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLK  127 (323)
T ss_pred             CCCCch---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            998752                                 22222334568899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||+++....    ....+||+.|+|||++.   ...++.++|||||||++|||++|++||.+.+
T Consensus       128 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         128 PENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM---RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             HHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhcc---CCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999864321    23457999999999984   3467889999999999999999999998776


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ....+..+..+..                                           ..+...++.+.+||.+||++||++
T Consensus       205 ~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~  241 (323)
T cd05584         205 RKKTIDKILKGKL-------------------------------------------NLPPYLTPEARDLLKKLLKRNPSS  241 (323)
T ss_pred             HHHHHHHHHcCCC-------------------------------------------CCCCCCCHHHHHHHHHHcccCHhH
Confidence            6555444432210                                           011235788999999999999999


Q ss_pred             CC-----CHHHHHcCccccCC
Q psy17952        479 RP-----SSGRLLTHDLVTRP  494 (804)
Q Consensus       479 Rp-----sa~elL~Hp~~~~~  494 (804)
                      ||     +++++++||||...
T Consensus       242 R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         242 RLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             cCCCCCCCHHHHhcCCCcCCC
Confidence            99     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-42  Score=379.62  Aligned_cols=295  Identities=27%  Similarity=0.432  Sum_probs=214.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.++||+|+||.||+|.+..++..+|+|.+....  .......+.+|+++|++++||||++++++|..++..|+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            356999999999999999999999999999999876432  223346688999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCee
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIH  318 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiH  318 (804)
                      |||+.|+ |.+++                                  ...+.+++..+..++.|++.||.|||+. +|+|
T Consensus        82 ~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH  127 (333)
T cd06650          82 MEHMDGGSLDQVL----------------------------------KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH  127 (333)
T ss_pred             EecCCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence            9999864 33332                                  2345688999999999999999999985 7999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||||+|||++.++.+||+|||++.....  .....||+.|+|||++.   +..++.++|||||||++|||++|+.||..
T Consensus       128 ~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             cCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhc---CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999999864322  23467999999999984   34688899999999999999999999976


Q ss_pred             CChHHHHHHHHh--cCCCCCCCCchhhHHhhccccc-CCCCc-cchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        397 MNAMSALYHIAQ--NDTPCLQSSDWSVIKTISSTAE-RKPPY-FNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       397 ~~~~~~l~~I~~--~~~p~~~~~~~~~i~~i~~~~~-~~pp~-~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      .+.......+..  ...+.... ............. ..|.. ..+........+.....+......++.++++|+.+||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  283 (333)
T cd06650         205 PDAKELELMFGCPVEGDPAESE-TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCL  283 (333)
T ss_pred             cchhHHHHHhcCcccCCccccc-cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhc
Confidence            554333222110  00000000 0000000000000 00000 0001111112222333333444457899999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ++||++|||+.|++.||||+...
T Consensus       284 ~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         284 IKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cCCcccCcCHHHHhhCHHHhcCc
Confidence            99999999999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.4e-43  Score=389.04  Aligned_cols=277  Identities=30%  Similarity=0.464  Sum_probs=212.8

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----ceE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----TAW  238 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----~~~  238 (804)
                      |+..+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++...+     ..|
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            788999999999999999999999999999885422 12233456889999999999999999999998776     789


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +||||+.+++.+.+                                  .....+++..+..++.||+.||.|||++||+|
T Consensus        81 lv~e~~~~~l~~~~----------------------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  126 (372)
T cd07853          81 VVTELMQSDLHKII----------------------------------VSPQPLSSDHVKVFLYQILRGLKYLHSAGILH  126 (372)
T ss_pred             EEeeccccCHHHHH----------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            99999987644322                                  23456899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+|||++.++.+||+|||+|+.....     ....+|+.|+|||++.+  ...|+.++|||||||++|||++|++|
T Consensus       127 ~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~p  204 (372)
T cd07853         127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG--SRHYTSAVDIWSVGCIFAELLGRRIL  204 (372)
T ss_pred             CCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC--CCCCCcHHHHHhHHHHHHHHHcCCCC
Confidence            999999999999999999999999754321     23568999999999854  24578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcC-CCCCCCCchhh-H----HhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        394 YFNMNAMSALYHIAQND-TPCLQSSDWSV-I----KTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~-~p~~~~~~~~~-i----~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      |.+.+....+..+.... .|...  .+.. .    ..+.... ..++..     ..+         .......++++.+|
T Consensus       205 f~~~~~~~~~~~i~~~~g~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~-----~~~---------~~~~~~~~~~~~~l  267 (372)
T cd07853         205 FQAQSPIQQLDLITDLLGTPSLE--AMRSACEGARAHILRGP-HKPPSL-----PVL---------YTLSSQATHEAVHL  267 (372)
T ss_pred             CCCCCHHHHHHHHHHHcCCCCHH--HHHHhhHHHHHHHHhCC-CCCCch-----HHh---------cccCCCCCHHHHHH
Confidence            99888877776665421 11110  0000 0    0000000 000000     000         01123458899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |.+||+.||++|||+.++|+||||...
T Consensus       268 i~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         268 LCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-42  Score=386.04  Aligned_cols=287  Identities=27%  Similarity=0.404  Sum_probs=210.4

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----  235 (804)
                      .+.|++++.||+|+||.||+|++..+++.||||.+..... .......+.+|+.+++.++||||+++++++....     
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3569999999999999999999999999999998864322 2233456789999999999999999999886543     


Q ss_pred             -ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 -TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 -~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                       ..|+||||+.+++.+.+.                                    ..+++..+..++.|++.||+|||++
T Consensus        95 ~~~~lv~e~~~~~l~~~~~------------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~  138 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQ------------------------------------MELDHERMSYLLYQMLCGIKHLHSA  138 (355)
T ss_pred             ceeEEEhhhhcccHHHHHh------------------------------------hcCCHHHHHHHHHHHHHHHHHHHhC
Confidence             479999999887543321                                    2477888999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||+||||||+|||++.++.+||+|||+|+....   .....||+.|+|||++.   +..|+.++|||||||++|||++|+
T Consensus       139 givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~  215 (355)
T cd07874         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMVRHK  215 (355)
T ss_pred             CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHc---CCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999975432   23468999999999985   356889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcC-CCCCC--CCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQND-TPCLQ--SSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAH  466 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~-~p~~~--~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~d  466 (804)
                      .||.+.+..+....+...- .++..  ......+....   ...+.+... ......  .....+  .......+.++++
T Consensus       216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~  289 (355)
T cd07874         216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV---ENRPKYAGL-TFPKLF--PDSLFPADSEHNKLKASQARD  289 (355)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHH---hcCCccccc-cchhhc--cccccccccccccccchHHHH
Confidence            9999887766655544321 11110  00000000000   000110000 000000  000000  1112234678999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||.+||+.||++|||+.|+|+||||..
T Consensus       290 li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         290 LLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             HHHHHhcCCchhcCCHHHHhcCcchhc
Confidence            999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-42  Score=380.20  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=199.0

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhh-cCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ-LKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||||.++..........+.+..|..++.. .+||||+++++++...+..|+||||+.|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999998864322222334456677777765 4899999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |.+++...+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        81 g~---------------------------------L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Ni  127 (316)
T cd05592          81 GD---------------------------------LMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNV  127 (316)
T ss_pred             Cc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHe
Confidence            52                                 112222345789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+|+...    .....+||+.|+|||++.   +..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus       128 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~  204 (316)
T cd05592         128 LLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK---GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL  204 (316)
T ss_pred             EECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999986432    123468999999999985   35688999999999999999999999988776554


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+....                                          + ..+..++.++.+|+.+||+.||++||++
T Consensus       205 ~~~i~~~~------------------------------------------~-~~~~~~~~~~~~ll~~~l~~~P~~R~~~  241 (316)
T cd05592         205 FDSILNDR------------------------------------------P-HFPRWISKEAKDCLSKLFERDPTKRLGV  241 (316)
T ss_pred             HHHHHcCC------------------------------------------C-CCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence            44332110                                          0 0112357889999999999999999986


Q ss_pred             -HHHHcCccccC
Q psy17952        483 -GRLLTHDLVTR  493 (804)
Q Consensus       483 -~elL~Hp~~~~  493 (804)
                       ++++.||||..
T Consensus       242 ~~~l~~h~~~~~  253 (316)
T cd05592         242 DGDIRQHPFFRG  253 (316)
T ss_pred             hHHHHcCcccCC
Confidence             58889999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-42  Score=370.63  Aligned_cols=277  Identities=30%  Similarity=0.406  Sum_probs=204.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc---CCCceeEeeeEEee-----c
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL---KHPNTIEYRGCYLR-----D  234 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~~~~~~-----~  234 (804)
                      .|++++.||+|+||.||+|+++.+++.||+|.++..... ......+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            388999999999999999999999999999988643221 11223456777777665   79999999998864     2


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ...+++|||+.+++.+++..                                .....+++..+..++.|++.||.|||++
T Consensus        80 ~~~~lv~e~~~~~l~~~~~~--------------------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~  127 (288)
T cd07863          80 TKVTLVFEHVDQDLRTYLDK--------------------------------VPPPGLPAETIKDLMRQFLRGLDFLHAN  127 (288)
T ss_pred             ceEEEEEcccccCHHHHHHh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45899999998875444320                                1123589999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||+||||||+|||++.++.+||+|||+++....   .....||+.|+|||++.   ...++.++||||+||++|||++|+
T Consensus       128 ~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~  204 (288)
T cd07863         128 CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRK  204 (288)
T ss_pred             CeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhh---CCCCCCcchhhhHHHHHHHHHhCC
Confidence            999999999999999999999999999875432   23457899999999985   356889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+....+..+........ ...|........  ....+.             .........+.+++.+.+|+.+|
T Consensus       205 ~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~  268 (288)
T cd07863         205 PLFCGNSEADQLGKIFDLIGLPP-EDDWPRDVTLPR--GAFSPR-------------GPRPVQSVVPEIEESGAQLLLEM  268 (288)
T ss_pred             cCcCCCCHHHHHHHHHHHhCCCC-hhhCcccccccc--cccCCC-------------CCCchHHhCcCcCHHHHHHHHHH
Confidence            99988777666655543211000 001100000000  000000             00000011235688899999999


Q ss_pred             cccCCCCCCCHHHHHcCccc
Q psy17952        472 LAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~  491 (804)
                      |++||++|||+.+++.||||
T Consensus       269 L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         269 LTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             hccCcccCCCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5e-43  Score=384.43  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=209.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|++..+++.||||.++............+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            48899999999999999999999999999999875332223344567889999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.|+ |.+++.                                 .....+++..+..++.||+.||.|||++||+||||
T Consensus        82 ~~~~~~L~~~l~---------------------------------~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dl  128 (330)
T cd05601          82 YQPGGDLLSLLN---------------------------------RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDI  128 (330)
T ss_pred             CCCCCCHHHHHH---------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccC
Confidence            99865 333221                                 11256899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccC---CCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMD---EGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~---~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||+|||++.++.+||+|||+|......     ....||+.|+|||++....   ...++.++|||||||++|||++|+.|
T Consensus       129 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~P  208 (330)
T cd05601         129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP  208 (330)
T ss_pred             chHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCC
Confidence            999999999999999999999754322     2347999999999985321   34578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+....+..+......                                       ........++.++.+|+.+||.
T Consensus       209 f~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~~~~~~~li~~ll~  249 (330)
T cd05601         209 FHEGTSAKTYNNIMNFQRF---------------------------------------LKFPEDPKVSSDFLDLIQSLLC  249 (330)
T ss_pred             CCCCCHHHHHHHHHcCCCc---------------------------------------cCCCCCCCCCHHHHHHHHHHcc
Confidence            9877665555444321100                                       0000113468899999999998


Q ss_pred             cCCCCCCCHHHHHcCccccCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                       ||.+|||+.++++||||...
T Consensus       250 -~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         250 -GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             -ChhhCCCHHHHhCCCCcCCC
Confidence             99999999999999999753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-42  Score=380.06  Aligned_cols=248  Identities=27%  Similarity=0.413  Sum_probs=203.3

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||+||+|++..+++.||||.+.............+.+|+.+++.+ +||||+++++++...+.+|+|||||.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999988643222233445677899999888 699999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |..++...+.+++.++..++.|++.||.|||++||+||||||+||
T Consensus        81 ~~---------------------------------L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni  127 (318)
T cd05570          81 GD---------------------------------LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNV  127 (318)
T ss_pred             CC---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHe
Confidence            52                                 112223345789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++....    ....+||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.+....
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~  204 (318)
T cd05570         128 LLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS---YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL  204 (318)
T ss_pred             EECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhc---CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH
Confidence            999999999999999864321    23467999999999985   35688999999999999999999999987765554


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+.....                                           .....+++++.+||.+||+.||.+|||+
T Consensus       205 ~~~i~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         205 FQSILEDEV-------------------------------------------RYPRWLSKEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             HHHHHcCCC-------------------------------------------CCCCcCCHHHHHHHHHHccCCHHHcCCC
Confidence            443322110                                           0112357889999999999999999999


Q ss_pred             -----HHHHcCccccCC
Q psy17952        483 -----GRLLTHDLVTRP  494 (804)
Q Consensus       483 -----~elL~Hp~~~~~  494 (804)
                           .+++.||||...
T Consensus       242 ~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         242 LPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCHHHHhcCCCcCCC
Confidence                 999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.7e-43  Score=381.71  Aligned_cols=247  Identities=28%  Similarity=0.445  Sum_probs=199.3

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHH-HHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||+||+|++..+++.||||.+.............+.+|.. +++.++||||+++++++...+..|+|||||.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999986432222223344556655 46789999999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |+.++...+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        81 g~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NI  127 (323)
T cd05575          81 GE---------------------------------LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENI  127 (323)
T ss_pred             CC---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence            52                                 122223345789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++....    ....+||+.|+|||++.   +..++.++|||||||++|||++|.+||.+.+..+.
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  204 (323)
T cd05575         128 LLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM  204 (323)
T ss_pred             EECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhc---CCCCCccccccccchhhhhhhcCCCCCCCCCHHHH
Confidence            999999999999999864321    23467999999999984   45688999999999999999999999987765554


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+.....                                           ......+..+.+||.+||++||.+||++
T Consensus       205 ~~~i~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~  241 (323)
T cd05575         205 YDNILNKPL-------------------------------------------RLKPNISVSARHLLEGLLQKDRTKRLGA  241 (323)
T ss_pred             HHHHHcCCC-------------------------------------------CCCCCCCHHHHHHHHHHhhcCHHhCCCC
Confidence            444322110                                           0112457889999999999999999998


Q ss_pred             ----HHHHcCccccC
Q psy17952        483 ----GRLLTHDLVTR  493 (804)
Q Consensus       483 ----~elL~Hp~~~~  493 (804)
                          .+++.||||..
T Consensus       242 ~~~~~~il~~~~~~~  256 (323)
T cd05575         242 KDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCHHHHHcCCCcCC
Confidence                69999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-42  Score=383.45  Aligned_cols=283  Identities=25%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------C
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------H  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------~  235 (804)
                      +.|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|++++||||+++++++...      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            459999999999999999999999999999998864321 122335577899999999999999999987643      3


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|++||++.+++.+++                                   ....+++..+..++.||+.||.|||++|
T Consensus        94 ~~~~~~~~~~~~l~~~~-----------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~  138 (343)
T cd07878          94 EVYLVTNLMGADLNNIV-----------------------------------KCQKLSDEHVQFLIYQLLRGLKYIHSAG  138 (343)
T ss_pred             cEEEEeecCCCCHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            57999999976654332                                   1346899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+|||++.++.+||+|||+++.... ....+||+.|+|||++.+  ...++.++|||||||++|||++|+.||
T Consensus       139 ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf  216 (343)
T cd07878         139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLKGKALF  216 (343)
T ss_pred             eecccCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhcC--CccCCchhhhHhHHHHHHHHHHCCCCC
Confidence            99999999999999999999999999975433 345689999999999853  246888999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHHHHHHhc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~dli~~cL  472 (804)
                      .+.+..+.+..+........    ......+.....          ...+.........  .......++.+.+|+.+||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL  282 (343)
T cd07878         217 PGNDYIDQLKRIMEVVGTPS----PEVLKKISSEHA----------RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKML  282 (343)
T ss_pred             CCCCHHHHHHHHHHHhCCCC----HHHHHhcchhhH----------HHHhhccccccchhHHHhccCCCHHHHHHHHHHc
Confidence            88777666666544221110    011111110000          0000000000000  0001235678899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      +.||.+|||+.|+|.||||.....
T Consensus       283 ~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         283 VLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             CCChhhCCCHHHHhcCcchhccCC
Confidence            999999999999999999986543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4717|consensus

Probab=100.00  E-value=6.4e-43  Score=376.75  Aligned_cols=252  Identities=26%  Similarity=0.462  Sum_probs=218.5

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|.+.+.||+|.|++|-+|++..||+.||||++.+..... .....+.+|++.|+.++|||||++|++..+...+|||+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4888899999999999999999999999999998654333 334678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE-VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~-~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      +-.||                                 +||+|+ .+...+.|+.+++++.||+.|+.|||...+|||||
T Consensus        98 LGD~G---------------------------------Dl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDL  144 (864)
T KOG4717|consen   98 LGDGG---------------------------------DLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDL  144 (864)
T ss_pred             ecCCc---------------------------------hHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccC
Confidence            98764                                 345554 34567999999999999999999999999999999


Q ss_pred             CCCCeee-cCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCC-CcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        322 KAGNILL-TETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       322 KP~NILl-~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~-~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      ||+|+.+ ..-|-|||+|||++-...+.   .++||+..|-|||++++   ..|+ +++||||||||||-|.+|++||..
T Consensus       145 KPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLG---DsYDAPAVDiWSLGVILyMLVCGq~PFqe  221 (864)
T KOG4717|consen  145 KPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLG---DSYDAPAVDIWSLGVILYMLVCGQPPFQE  221 (864)
T ss_pred             CcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhc---CccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence            9999876 56789999999999766654   57899999999999986   4576 479999999999999999999999


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .++.+.+.+|+.-+..                                           .+...|.+.+|||..||+.||
T Consensus       222 ANDSETLTmImDCKYt-------------------------------------------vPshvS~eCrdLI~sMLvRdP  258 (864)
T KOG4717|consen  222 ANDSETLTMIMDCKYT-------------------------------------------VPSHVSKECRDLIQSMLVRDP  258 (864)
T ss_pred             ccchhhhhhhhccccc-------------------------------------------CchhhhHHHHHHHHHHHhcCc
Confidence            9999998888643210                                           123568999999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy17952        477 ADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+|.|.+++..|+|+...
T Consensus       259 kkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  259 KKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             hhhccHHHHhccccccCC
Confidence            999999999999999753

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.9e-42  Score=378.35  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=199.3

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhh-cCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ-LKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||+||+|++..+++.||||.++...............|..+++. ++||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999998864321112233456778888876 4899999999999999999999999986


Q ss_pred             C-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        247 S-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       247 ~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      + +.+                                  ++.....+++.++..++.|++.||+|||++||+||||||+|
T Consensus        81 g~L~~----------------------------------~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~N  126 (316)
T cd05619          81 GDLMF----------------------------------HIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN  126 (316)
T ss_pred             CcHHH----------------------------------HHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHH
Confidence            5 222                                  22234568899999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy17952        326 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS  401 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~  401 (804)
                      ||++.++.+||+|||+++...    .....+||+.|+|||++.   +..|+.++||||+||++|||++|+.||.+.+..+
T Consensus       127 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~  203 (316)
T cd05619         127 ILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL---GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE  203 (316)
T ss_pred             EEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999986432    123467999999999984   3568999999999999999999999998766544


Q ss_pred             HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC
Q psy17952        402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS  481 (804)
Q Consensus       402 ~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps  481 (804)
                      ....+....                                          +. .+..++.++++|+.+||+.||.+||+
T Consensus       204 ~~~~i~~~~------------------------------------------~~-~~~~~~~~~~~li~~~l~~~P~~R~~  240 (316)
T cd05619         204 LFQSIRMDN------------------------------------------PC-YPRWLTREAKDILVKLFVREPERRLG  240 (316)
T ss_pred             HHHHHHhCC------------------------------------------CC-CCccCCHHHHHHHHHHhccCHhhcCC
Confidence            433332110                                          00 11235788999999999999999999


Q ss_pred             HH-HHHcCccccCC
Q psy17952        482 SG-RLLTHDLVTRP  494 (804)
Q Consensus       482 a~-elL~Hp~~~~~  494 (804)
                      +. ++++||||...
T Consensus       241 ~~~~l~~h~~~~~~  254 (316)
T cd05619         241 VKGDIRQHPFFREI  254 (316)
T ss_pred             ChHHHHcCcccCCC
Confidence            96 89999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.4e-42  Score=369.08  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=198.9

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCCc-
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-  248 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~l-  248 (804)
                      ||+|+||+||+|.+..+++.||+|++...........+.+..|++++++++||||+++.+++..++..|+||||+.|+. 
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999864332222334567889999999999999999999999999999999998753 


Q ss_pred             hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        249 SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       249 ~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                      .+.+.                              ........+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        81 ~~~~~------------------------------~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili  130 (280)
T cd05608          81 RYHIY------------------------------NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL  130 (280)
T ss_pred             HHHHH------------------------------hccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            22211                              011124568999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy17952        329 TETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALY  404 (804)
Q Consensus       329 ~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~  404 (804)
                      +.++.+||+|||++.....    .....||+.|+|||++.   ...++.++|||||||++|||++|+.||..........
T Consensus       131 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  207 (280)
T cd05608         131 DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ---GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK  207 (280)
T ss_pred             CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhc---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH
Confidence            9999999999999864322    23457999999999985   4578889999999999999999999996543211111


Q ss_pred             HHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC----
Q psy17952        405 HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP----  480 (804)
Q Consensus       405 ~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp----  480 (804)
                      .+..               .+                      ..  .+......+++.+.+|+.+||+.||++||    
T Consensus       208 ~~~~---------------~~----------------------~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  248 (280)
T cd05608         208 ELKQ---------------RI----------------------LN--DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRD  248 (280)
T ss_pred             HHHH---------------hh----------------------cc--cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence            1100               00                      00  00111234688999999999999999999    


Q ss_pred             -CHHHHHcCccccC
Q psy17952        481 -SSGRLLTHDLVTR  493 (804)
Q Consensus       481 -sa~elL~Hp~~~~  493 (804)
                       |++++++||||..
T Consensus       249 ~~~~~~l~h~~~~~  262 (280)
T cd05608         249 GNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHHhcChhhhc
Confidence             8999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-42  Score=379.56  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=197.6

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||+|.+.............+.+|+.++.++ +||||+++++++...+..|+|||||.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999998754323333445677899988876 799999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +..                                 ..+....+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        81 ~~L---------------------------------~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Ni  127 (329)
T cd05618          81 GDL---------------------------------MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV  127 (329)
T ss_pred             CCH---------------------------------HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence            521                                 11122345789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++...    .....+||+.|+|||++.   +..++.++|||||||++|||++|+.||....... 
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-  203 (329)
T cd05618         128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD-  203 (329)
T ss_pred             EECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHc---CCCCCCccceecccHHHHHHhhCCCCCccCCCcC-
Confidence            99999999999999986432    123468999999999985   3568889999999999999999999995321000 


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC-
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS-  481 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps-  481 (804)
                              .+. ....                       ..++........ ..+...+..+.+||.+||+.||++||| 
T Consensus       204 --------~~~-~~~~-----------------------~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         204 --------NPD-QNTE-----------------------DYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --------Ccc-cccH-----------------------HHHHHHHhcCCC-CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                    000 0000                       000000000000 112346888999999999999999998 


Q ss_pred             -----HHHHHcCccccC
Q psy17952        482 -----SGRLLTHDLVTR  493 (804)
Q Consensus       482 -----a~elL~Hp~~~~  493 (804)
                           ++++++||||..
T Consensus       251 ~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         251 HPQTGFADIQGHPFFRN  267 (329)
T ss_pred             CCCCCHHHHhcCCCCCC
Confidence                 589999999965

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-42  Score=379.08  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=199.9

Q ss_pred             cccccccccccccceEEEEee---eceeEEEEEecccccc-cchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        164 FEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGK-QCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~-~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      |++++.||+|+||.||+|++.   .+++.||+|.+..... ......+.+.+|+.+++.+ +||||+++++++..++.+|
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            788999999999999999864   4788999998864221 1122345677899999999 4999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|+.                                 |++++.....+++.++..++.||+.||+|||++||+|
T Consensus        82 lv~e~~~~g~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  128 (332)
T cd05614          82 LILDYVSGGE---------------------------------MFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVY  128 (332)
T ss_pred             EEEeCCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence            9999998752                                 1122223457899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+|||++.++.+||+|||+++....     ....+||+.|||||++.+  ...++.++|||||||++|||++|+.|
T Consensus       129 rDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~p  206 (332)
T cd05614         129 RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG--KGGHGKAVDWWSLGILIFELLTGASP  206 (332)
T ss_pred             cCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC--CCCCCCccccccchhhhhhhhcCCCC
Confidence            99999999999999999999999875321     224679999999999853  23477899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...........+               ...+                      .... + .....+++.+.+|+.+||+
T Consensus       207 f~~~~~~~~~~~~---------------~~~~----------------------~~~~-~-~~~~~~~~~~~~li~~~l~  247 (332)
T cd05614         207 FTLEGERNTQSEV---------------SRRI----------------------LKCD-P-PFPSFIGPEAQDLLHKLLR  247 (332)
T ss_pred             CCCCCCCCCHHHH---------------HHHH----------------------hcCC-C-CCCCCCCHHHHHHHHHHcC
Confidence            9643211100000               0000                      0000 0 0123468899999999999


Q ss_pred             cCCCCCC-----CHHHHHcCccccCC
Q psy17952        474 KNPADRP-----SSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rp-----sa~elL~Hp~~~~~  494 (804)
                      .||++||     +++++++||||...
T Consensus       248 ~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         248 KDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999     88899999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-42  Score=384.91  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=208.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++++.++...|+|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            35699999999999999999999999999999988643222223345577899999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ |.+++                                   ....+++..+..++.||+.||+|||++||+||
T Consensus       122 ~Ey~~gg~L~~~~-----------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  166 (371)
T cd05622         122 MEYMPGGDLVNLM-----------------------------------SNYDVPEKWARFYTAEVVLALDAIHSMGFIHR  166 (371)
T ss_pred             EcCCCCCcHHHHH-----------------------------------HhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            9999865 32222                                   12357889999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccC-CCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~-~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.++.+||+|||+|.....     ....+||+.|||||++.+.. .+.++.++|||||||++|||++|.+|
T Consensus       167 DLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  246 (371)
T cd05622         167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (371)
T ss_pred             CCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence            9999999999999999999999875432     23567999999999986422 12478899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......|......                                       .+......++..+++||.+||.
T Consensus       247 f~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~s~~~~~li~~~L~  287 (371)
T cd05622         247 FYADSLVGTYSKIMNHKNS---------------------------------------LTFPDDNDISKEAKNLICAFLT  287 (371)
T ss_pred             CCCCCHHHHHHHHHcCCCc---------------------------------------ccCCCcCCCCHHHHHHHHHHcC
Confidence            9887765555444321100                                       0011123578999999999998


Q ss_pred             cCCCC--CCCHHHHHcCccccCC
Q psy17952        474 KNPAD--RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~--Rpsa~elL~Hp~~~~~  494 (804)
                      .+|.+  |++++++++|+||...
T Consensus       288 ~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         288 DREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             ChhhhcCCCCHHHHhcCcccCCC
Confidence            54443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.6e-42  Score=370.81  Aligned_cols=282  Identities=23%  Similarity=0.371  Sum_probs=212.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+++++||+|+||.||+|++..+++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            489999999999999999999999999999988643221  222456789999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.+++.+.+.                                 .....+++..+..++.|++.||+|||++||+|||||
T Consensus        85 ~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlk  131 (301)
T cd07873          85 YLDKDLKQYLD---------------------------------DCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK  131 (301)
T ss_pred             ccccCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            99886544332                                 123457899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||++.....    .....+|+.|+|||++.+  ...++.++|||||||++|||++|++||.+.+
T Consensus       132 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         132 PQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG--STDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             HHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhC--CCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999865321    123467899999999853  3457889999999999999999999998877


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+.+..+...-... ....|..+...........+...            ...........++.+++||.+||+.||.+
T Consensus       210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~ml~~dp~~  276 (301)
T cd07873         210 VEEQLHFIFRILGTP-TEETWPGILSNEEFKSYNYPKYR------------ADCLHNHAPRLDSDGAELLSKLLQFEGRK  276 (301)
T ss_pred             HHHHHHHHHHHcCCC-ChhhchhhhccccccccccCccc------------cccHHhhcCCCCHHHHHHHHHHhcCCccc
Confidence            666555444321111 11112211000000000000000            00001122456889999999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy17952        479 RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~~  494 (804)
                      |||++++|+||||...
T Consensus       277 R~t~~eil~h~~f~~~  292 (301)
T cd07873         277 RISAEEAMKHPYFHCL  292 (301)
T ss_pred             CcCHHHHhcCcccccc
Confidence            9999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-42  Score=380.30  Aligned_cols=247  Identities=27%  Similarity=0.417  Sum_probs=199.3

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHH-HHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||+||+|++..+++.||+|.+.............+.+|.. +++.++||||+++++++..++..|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999886432222223345566655 46789999999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |+.+....+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        81 ~~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NI  127 (325)
T cd05604          81 GE---------------------------------LFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENI  127 (325)
T ss_pred             CC---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence            62                                 112223456789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+++...    .....+||+.|||||++.   +..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus       128 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~  204 (325)
T cd05604         128 LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR---KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM  204 (325)
T ss_pred             EECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHc---CCCCCCcCccccccceehhhhcCCCCCCCCCHHHH
Confidence            99999999999999986432    123467999999999984   45688999999999999999999999987765554


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+.....                                           ...+..+..+.+++.+||++||.+||++
T Consensus       205 ~~~~~~~~~-------------------------------------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~  241 (325)
T cd05604         205 YDNILHKPL-------------------------------------------VLRPGASLTAWSILEELLEKDRQRRLGA  241 (325)
T ss_pred             HHHHHcCCc-------------------------------------------cCCCCCCHHHHHHHHHHhccCHHhcCCC
Confidence            444322110                                           0112357889999999999999999987


Q ss_pred             ----HHHHcCccccC
Q psy17952        483 ----GRLLTHDLVTR  493 (804)
Q Consensus       483 ----~elL~Hp~~~~  493 (804)
                          .+++.||||..
T Consensus       242 ~~~~~~i~~h~~f~~  256 (325)
T cd05604         242 KEDFLEIQEHPFFES  256 (325)
T ss_pred             CCCHHHHhcCCCcCC
Confidence                58999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4e-42  Score=374.47  Aligned_cols=286  Identities=26%  Similarity=0.413  Sum_probs=197.6

Q ss_pred             ccccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cCceEEEEe
Q psy17952        167 LREIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DHTAWLVME  242 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~~~~lVmE  242 (804)
                      .++||+|+||+||+|+++  .+++.||+|.+....     ....+.+|+.+|++++||||++++++|..  +...|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999976  467899999875321     12346789999999999999999998854  456899999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.+++.+++....                         ..........+++..++.++.||+.||+|||++||+|||||
T Consensus        81 ~~~~~l~~~~~~~~-------------------------~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlk  135 (317)
T cd07868          81 YAEHDLWHIIKFHR-------------------------ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK  135 (317)
T ss_pred             ccCCCHHHHHHhcc-------------------------cccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCC
Confidence            99988766553110                         00001123468999999999999999999999999999999


Q ss_pred             CCCeee----cCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        323 AGNILL----TETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       323 P~NILl----~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |+|||+    +.++.+||+|||+|+....       ....+||+.|||||++.+  ...|+.++||||+||++|||++|+
T Consensus       136 p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~  213 (317)
T cd07868         136 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSE  213 (317)
T ss_pred             HHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC--CCCcCchhhHHHHHHHHHHHHhCC
Confidence            999999    4567899999999965321       234679999999999853  245888999999999999999999


Q ss_pred             CCCCCCCh---------HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhh--HHHHhhccCCCCCCCCCCc
Q psy17952        392 PPYFNMNA---------MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAM--SALYHIAQNDTPCLQSSDW  460 (804)
Q Consensus       392 ~PF~~~~~---------~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~--~~l~~i~~~~~p~~~~~~~  460 (804)
                      +||...+.         ...+..+...... .....|..++.+......... +.....  ..+..     .........
T Consensus       214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~  286 (317)
T cd07868         214 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGF-PADKDWEDIKKMPEHSTLMKD-FRRNTYTNCSLIK-----YMEKHKVKP  286 (317)
T ss_pred             CCccCCcccccccccccHHHHHHHHHhcCC-CChHHhHHHhhccchhhhhhh-hhccccCcccccc-----hHHhcCCCC
Confidence            99965432         1223333221110 111122222211110000000 000000  00000     000011224


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       461 s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +.++.+||.+||+.||.+|||++|+|+||||
T Consensus       287 ~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         287 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            5678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4e-42  Score=376.74  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=204.0

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      |+..+.||+|+||.||+|+++.+++.||+|++...........+.+..|+.+++.+. ||+|+++++++...+.+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            678899999999999999999999999999886432222233456778999998886 5678889999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|+.                                 |.+++...+.+++.++..++.||+.||.|||++||+|||||
T Consensus        82 y~~~g~---------------------------------L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDik  128 (323)
T cd05615          82 YVNGGD---------------------------------LMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLK  128 (323)
T ss_pred             CCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            998752                                 11222334578999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||+++....    ....+||+.|+|||++.   ...++.++|||||||++|||++|.+||.+.+
T Consensus       129 p~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         129 LDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA---YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             HHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHc---CCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999875321    23467999999999984   3568899999999999999999999998876


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......+.....                                           ..+..++.++.+|+.+||++||.+
T Consensus       206 ~~~~~~~i~~~~~-------------------------------------------~~p~~~~~~~~~li~~~l~~~p~~  242 (323)
T cd05615         206 EDELFQSIMEHNV-------------------------------------------SYPKSLSKEAVSICKGLMTKHPSK  242 (323)
T ss_pred             HHHHHHHHHhCCC-------------------------------------------CCCccCCHHHHHHHHHHcccCHhh
Confidence            6555444432110                                           001235788999999999999999


Q ss_pred             CCC-----HHHHHcCccccC
Q psy17952        479 RPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       479 Rps-----a~elL~Hp~~~~  493 (804)
                      |++     ..++++||||..
T Consensus       243 R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         243 RLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             CCCCCCCCHHHHhcCcccCC
Confidence            997     478999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.4e-42  Score=377.78  Aligned_cols=247  Identities=27%  Similarity=0.409  Sum_probs=198.0

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHH-HHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||+|.+.............+.+|.. +++.++||||+++++++.+.+..|+|||||.|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999886432222223344556654 67889999999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +..                                 +........+++..+..++.||++||.|||++||+||||||+||
T Consensus        81 ~~L---------------------------------~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NI  127 (321)
T cd05603          81 GEL---------------------------------FFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI  127 (321)
T ss_pred             CCH---------------------------------HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            521                                 11122345688999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.+|.+||+|||+++....    ....+||+.|+|||++.   ...++.++|||||||++|||++|.+||.+.+....
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  204 (321)
T cd05603         128 LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR---KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM  204 (321)
T ss_pred             EECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhc---CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH
Confidence            999999999999999875321    23467999999999984   35688999999999999999999999987765444


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+....                                           ...+...+.++.+++.+||++||.+||++
T Consensus       205 ~~~i~~~~-------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~  241 (321)
T cd05603         205 YDNILHKP-------------------------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGA  241 (321)
T ss_pred             HHHHhcCC-------------------------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCC
Confidence            43332210                                           01112457889999999999999999976


Q ss_pred             ----HHHHcCccccC
Q psy17952        483 ----GRLLTHDLVTR  493 (804)
Q Consensus       483 ----~elL~Hp~~~~  493 (804)
                          .++++|+||..
T Consensus       242 ~~~~~~~~~~~~~~~  256 (321)
T cd05603         242 KADFLEIKNHVFFSP  256 (321)
T ss_pred             CCCHHHHhCCCCcCC
Confidence                49999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=381.32  Aligned_cols=247  Identities=29%  Similarity=0.450  Sum_probs=198.7

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc---CCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL---KHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      ||+|+||+||+|++..+++.||||.+...............+|..++..+   +||||+++++++......|+||||+.|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999998643222222334456677777765   699999999999999999999999986


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |..++...+.+++..+..++.||++||+|||++||+||||||+||
T Consensus        81 g~---------------------------------L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Ni  127 (330)
T cd05586          81 GE---------------------------------LFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENI  127 (330)
T ss_pred             Ch---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            52                                 112223456789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||++....    .....+||+.|||||++.+  ...++.++|||||||++|||++|+.||.+.+..+.
T Consensus       128 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~  205 (330)
T cd05586         128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD--EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM  205 (330)
T ss_pred             EECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcC--CCCCCCccceeccccEEEEeccCCCCCCCCCHHHH
Confidence            99999999999999986432    1235689999999999853  23478899999999999999999999987765554


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC--
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP--  480 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp--  480 (804)
                      ...+..+..                                          ......+++++.+|+.+||++||.+||  
T Consensus       206 ~~~i~~~~~------------------------------------------~~~~~~~~~~~~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         206 YRNIAFGKV------------------------------------------RFPKNVLSDEGRQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             HHHHHcCCC------------------------------------------CCCCccCCHHHHHHHHHHcCCCHHHCCCC
Confidence            444322110                                          011123578899999999999999998  


Q ss_pred             --CHHHHHcCccccC
Q psy17952        481 --SSGRLLTHDLVTR  493 (804)
Q Consensus       481 --sa~elL~Hp~~~~  493 (804)
                        ++.++++||||..
T Consensus       244 ~~~~~~ll~h~~~~~  258 (330)
T cd05586         244 HRDAVELKEHPFFAD  258 (330)
T ss_pred             CCCHHHHhcCccccC
Confidence              7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=368.57  Aligned_cols=256  Identities=24%  Similarity=0.316  Sum_probs=204.7

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||+|+||.||++.+..+++.||||++.............+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            78899999999999999999999999999988643222222334567899999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+.+.                                ......+++..+..++.|++.||.|||+.||+|||||
T Consensus        82 ~~~~~L~~~~~--------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  129 (285)
T cd05605          82 MNGGDLKFHIY--------------------------------NMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK  129 (285)
T ss_pred             cCCCcHHHHHH--------------------------------hcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Confidence            9865 322211                                0123468999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+|||+++++.+||+|||++.....   ....+||+.|+|||++.   ...++.++||||+||++|||++|+.||.+.+.
T Consensus       130 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~  206 (285)
T cd05605         130 PENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK---NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE  206 (285)
T ss_pred             HHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhc---CCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence            9999999999999999999875432   23457999999999984   35688899999999999999999999976544


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ......+...               +..                       . +......+++.+.+|+.+||..||.+|
T Consensus       207 ~~~~~~~~~~---------------~~~-----------------------~-~~~~~~~~~~~~~~li~~~l~~~P~~R  247 (285)
T cd05605         207 KVKREEVERR---------------VKE-----------------------D-QEEYSEKFSEAARSICRQLLTKDPGFR  247 (285)
T ss_pred             hhHHHHHHHH---------------hhh-----------------------c-ccccCcccCHHHHHHHHHHccCCHHHh
Confidence            3222221110               000                       0 001123468889999999999999999


Q ss_pred             C-----CHHHHHcCccccC
Q psy17952        480 P-----SSGRLLTHDLVTR  493 (804)
Q Consensus       480 p-----sa~elL~Hp~~~~  493 (804)
                      |     +++++++||||..
T Consensus       248 ~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         248 LGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             cCCCCCCHHHHhcCcCccC
Confidence            9     9999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.5e-42  Score=379.58  Aligned_cols=257  Identities=28%  Similarity=0.429  Sum_probs=200.9

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ...|+.+++||+|+||.||+|++..+++.||||.+....  .......+.+|+++|+.++||||+++++++...+.+|+|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            345889999999999999999999999999999875321  223346788999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+...                                     .....++..+..++.||+.||.|||++||+|||
T Consensus       151 ~e~~~~~~L~-------------------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD  193 (353)
T PLN00034        151 LEFMDGGSLE-------------------------------------GTHIADEQFLADVARQILSGIAYLHRRHIVHRD  193 (353)
T ss_pred             EecCCCCccc-------------------------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCEeecC
Confidence            9999875211                                     012346778889999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhccc-CCCC-CCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAM-DEGQ-YDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~-~~~~-y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||+|||++.++.+||+|||+++....    ....+||+.|+|||++... ..+. ++.++|||||||++|||++|+.||
T Consensus       194 lkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf  273 (353)
T PLN00034        194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF  273 (353)
T ss_pred             CCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999875432    2356899999999987421 1122 345899999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      ......+....                ...+.                      .. .+......++.++++||.+||+.
T Consensus       274 ~~~~~~~~~~~----------------~~~~~----------------------~~-~~~~~~~~~~~~l~~li~~~l~~  314 (353)
T PLN00034        274 GVGRQGDWASL----------------MCAIC----------------------MS-QPPEAPATASREFRHFISCCLQR  314 (353)
T ss_pred             CCCCCccHHHH----------------HHHHh----------------------cc-CCCCCCCccCHHHHHHHHHHccC
Confidence            63221110000                00000                      00 01111235688999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||++|||+.|+|+||||....
T Consensus       315 ~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        315 EPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             ChhhCcCHHHHhcCcccccCC
Confidence            999999999999999998753

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.4e-42  Score=377.40  Aligned_cols=247  Identities=27%  Similarity=0.453  Sum_probs=198.0

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHH-HHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||+|.+.............+.+|.. +++.++||||+++++++...+..|+|||||.|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999886432111222234455544 56789999999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |.+++...+.+++..+..++.||++||+|||++||+||||||+||
T Consensus        81 ~~---------------------------------L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Ni  127 (325)
T cd05602          81 GE---------------------------------LFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI  127 (325)
T ss_pred             Cc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence            52                                 112222345688999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA  402 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~  402 (804)
                      |++.++.+||+|||+|+...    .....+||+.|||||++.   +..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus       128 li~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  204 (325)
T cd05602         128 LLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM  204 (325)
T ss_pred             EECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHc---CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999986432    123467999999999985   35688999999999999999999999988766554


Q ss_pred             HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH
Q psy17952        403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS  482 (804)
Q Consensus       403 l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa  482 (804)
                      ...+....                                           ....+.++..+.+|+.+||++||.+||++
T Consensus       205 ~~~i~~~~-------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~  241 (325)
T cd05602         205 YDNILNKP-------------------------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGA  241 (325)
T ss_pred             HHHHHhCC-------------------------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            44432210                                           01123467889999999999999999988


Q ss_pred             H----HHHcCccccC
Q psy17952        483 G----RLLTHDLVTR  493 (804)
Q Consensus       483 ~----elL~Hp~~~~  493 (804)
                      .    ++++|+||..
T Consensus       242 ~~~~~~i~~~~~~~~  256 (325)
T cd05602         242 KDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCHHHHhcCcccCC
Confidence            6    8999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-42  Score=375.55  Aligned_cols=261  Identities=24%  Similarity=0.391  Sum_probs=205.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||++++..+++.||+|.+...........+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            48999999999999999999999999999999864322223334567889999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ |.+++.                                 .....+++..+..++.||+.||+|||++||+||||
T Consensus        82 ~~~g~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl  128 (331)
T cd05597          82 YYVGGDLLTLLS---------------------------------KFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDI  128 (331)
T ss_pred             cCCCCcHHHHHH---------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCC
Confidence            99764 332221                                 11346899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccC--CCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||+|||++.++.+||+|||++......     ...+||+.|||||++....  .+.++.++|||||||++|||++|+.||
T Consensus       129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf  208 (331)
T cd05597         129 KPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF  208 (331)
T ss_pred             CHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC
Confidence            999999999999999999998643221     2247999999999985321  245788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+......                 ..                    .+ .....+++.+++|+.+||..
T Consensus       209 ~~~~~~~~~~~i~~~~~~-----------------~~--------------------~~-~~~~~~~~~~~~li~~ll~~  250 (331)
T cd05597         209 YAESLVETYGKIMNHKEH-----------------FQ--------------------FP-PDVTDVSEEAKDLIRRLICS  250 (331)
T ss_pred             CCCCHHHHHHHHHcCCCc-----------------cc--------------------CC-CccCCCCHHHHHHHHHHccC
Confidence            877665554444321100                 00                    00 01123688999999998876


Q ss_pred             CCCC--CCCHHHHHcCccccCC
Q psy17952        475 NPAD--RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       475 dP~~--Rpsa~elL~Hp~~~~~  494 (804)
                      ++.+  |+++.++++||||...
T Consensus       251 ~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         251 PETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             cccccCCCCHHHHhcCCCCCCC
Confidence            4444  8899999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.3e-42  Score=375.32  Aligned_cols=249  Identities=27%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +.||+|+||.||+|++..+++.||+|.+.............+.+|+.++.++ +||||+++++++...+.+|+|||||.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999998754333334456678899999888 699999999999999999999999987


Q ss_pred             CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        247 SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       247 ~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                      +.                                 |..++...+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        81 ~~---------------------------------L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni  127 (327)
T cd05617          81 GD---------------------------------LMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNV  127 (327)
T ss_pred             Cc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            52                                 111222345789999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh---
Q psy17952        327 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA---  399 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~---  399 (804)
                      |++.++.+||+|||+++...    .....+||+.|+|||++.   +..|+.++|||||||++|||++|..||.....   
T Consensus       128 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~  204 (327)
T cd05617         128 LLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR---GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD  204 (327)
T ss_pred             EEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHC---CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc
Confidence            99999999999999986422    123468999999999985   45788999999999999999999999953211   


Q ss_pred             ---HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        400 ---MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       400 ---~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                         .+.+..+.                                         ... +...+...+..+.+++.+||++||
T Consensus       205 ~~~~~~~~~~~-----------------------------------------~~~-~~~~p~~~~~~~~~li~~~L~~dP  242 (327)
T cd05617         205 MNTEDYLFQVI-----------------------------------------LEK-PIRIPRFLSVKASHVLKGFLNKDP  242 (327)
T ss_pred             cccHHHHHHHH-----------------------------------------HhC-CCCCCCCCCHHHHHHHHHHhccCH
Confidence               11111110                                         000 111123467889999999999999


Q ss_pred             CCCCC------HHHHHcCccccCC
Q psy17952        477 ADRPS------SGRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rps------a~elL~Hp~~~~~  494 (804)
                      ++|++      ..+++.||||...
T Consensus       243 ~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         243 KERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99998      4699999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-42  Score=377.28  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             ccccccccccceEEEEee---eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        167 LREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      ++.||+|+||.||++++.   .+++.||+|.+..... .......+.+|+++|++++||||+++++++..++..|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            367999999999999864   5789999998864321 122334567899999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      |.|+.                                 |++++.....+++..+..++.||++||.|||++||+||||||
T Consensus        80 ~~~~~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  126 (318)
T cd05582          80 LRGGD---------------------------------LFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP  126 (318)
T ss_pred             CCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence            98651                                 122222345689999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +|||++.++.+||+|||++.....    ....+||+.|+|||++.   ...++.++|||||||++|||++|+.||.+.+.
T Consensus       127 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~  203 (318)
T cd05582         127 ENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN---RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR  203 (318)
T ss_pred             HHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHc---CCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence            999999999999999999865422    23467999999999984   34678899999999999999999999988776


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ...+..+.+....                                           .+..+++++.+|+.+||+.||++|
T Consensus       204 ~~~~~~i~~~~~~-------------------------------------------~p~~~~~~~~~li~~~l~~~P~~R  240 (318)
T cd05582         204 KETMTMILKAKLG-------------------------------------------MPQFLSPEAQSLLRALFKRNPANR  240 (318)
T ss_pred             HHHHHHHHcCCCC-------------------------------------------CCCCCCHHHHHHHHHHhhcCHhHc
Confidence            6555444321100                                           012357889999999999999999


Q ss_pred             CC-----HHHHHcCccccCC
Q psy17952        480 PS-----SGRLLTHDLVTRP  494 (804)
Q Consensus       480 ps-----a~elL~Hp~~~~~  494 (804)
                      ||     ..+++.||||...
T Consensus       241 ~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         241 LGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CCCCCCCHHHHhCCCCcCCC
Confidence            99     6779999999763

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-41  Score=362.86  Aligned_cols=280  Identities=24%  Similarity=0.423  Sum_probs=211.0

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++++.||+|+||.||+|++..+++.||||.++.... .......+.+|+.++++++||||+++++++..++..|+||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            7889999999999999999999999999998864322 122335678899999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.|++.+.+.                               .......+++..+..++.|+++||+|||++||+||||||
T Consensus        81 ~~~~l~~~~~-------------------------------~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p  129 (285)
T cd07861          81 LSMDLKKYLD-------------------------------SLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKP  129 (285)
T ss_pred             CCCCHHHHHh-------------------------------cCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCH
Confidence            9887544332                               011234689999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +|||++.++.+||+|||++.....    .....+++.|+|||++.+  ...++.++|||||||++|||++|++||.+.+.
T Consensus       130 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~  207 (285)
T cd07861         130 QNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG--SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE  207 (285)
T ss_pred             HHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcC--CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            999999999999999999864322    123467899999998853  23578899999999999999999999988777


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ...+..+....... ....|+....+.......+.+.             ..........+++++.+||.+||+.||++|
T Consensus       208 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  273 (285)
T cd07861         208 IDQLFRIFRILGTP-TEDVWPGVTSLPDYKNTFPKWK-------------KGSLRSAVKNLDEDGLDLLEKMLIYDPAKR  273 (285)
T ss_pred             HHHHHHHHHHhCCC-ChhhhhcchhhHHHHhhccccC-------------cchhHHhcCCCCHHHHHHHHHHhcCChhhC
Confidence            66655544322111 1111111111100000000000             000001123478999999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy17952        480 PSSGRLLTHDLV  491 (804)
Q Consensus       480 psa~elL~Hp~~  491 (804)
                      ||+.+++.||||
T Consensus       274 pt~~~ll~~~~~  285 (285)
T cd07861         274 ISAKKALNHPYF  285 (285)
T ss_pred             CCHHHHhcCCCC
Confidence            999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-41  Score=392.21  Aligned_cols=285  Identities=22%  Similarity=0.322  Sum_probs=204.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC------CceeEeeeEEeec-
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH------PNTIEYRGCYLRD-  234 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H------pNIV~l~~~~~~~-  234 (804)
                      ..|++++.||+|+||+||+|.+..+++.||||+++...    ........|+.+++.++|      +++++++++|... 
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            56999999999999999999999999999999985321    122345567777777655      4588898888764 


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-  313 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-  313 (804)
                      ..+|+|||++.+++.+.+                                  ...+.+++..+..|+.||+.||+|||+ 
T Consensus       205 ~~~~iv~~~~g~~l~~~l----------------------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~  250 (467)
T PTZ00284        205 GHMCIVMPKYGPCLLDWI----------------------------------MKHGPFSHRHLAQIIFQTGVALDYFHTE  250 (467)
T ss_pred             ceEEEEEeccCCCHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            578999999977654433                                  234578999999999999999999998 


Q ss_pred             CCCeecCCCCCCeeecCCC----------------cEEEEecccccccC-CCCccccCcccccchhhcccCCCCCCCccc
Q psy17952        314 LGRIHRDVKAGNILLTETG----------------TVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVD  376 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g----------------~vKL~DFGla~~~~-~~~~~~GT~~Y~APEvl~~~~~~~y~~ksD  376 (804)
                      .|||||||||+|||++.++                .+||+|||++.... .....+||+.|||||++.   +..|+.++|
T Consensus       251 ~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~~~~~D  327 (467)
T PTZ00284        251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL---GLGWMYSTD  327 (467)
T ss_pred             CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhh---cCCCCcHHH
Confidence            5999999999999998765                49999999886433 234578999999999985   356899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhh------HHhhcccccCCCCccchhhhHHHHhhccC
Q psy17952        377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSV------IKTISSTAERKPPYFNMNAMSALYHIAQN  450 (804)
Q Consensus       377 IWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~------i~~i~~~~~~~pp~~~~~~~~~l~~i~~~  450 (804)
                      ||||||++|||++|++||.+.+..+.+..+.+...+...  .|..      ...+........+..+...   +..+...
T Consensus       328 iwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  402 (467)
T PTZ00284        328 MWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS--EWAGRCGTEEARLLYNSAGQLRPCTDPKH---LARIARA  402 (467)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--HHHhhccchhHHHHhhhcccccccCCHHH---HHhhhcc
Confidence            999999999999999999988877766666543221110  1100      0000000000001111110   0011000


Q ss_pred             CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       451 ~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      . + ......++.+.|||.+||++||.+|||+.|+|+||||...
T Consensus       403 ~-~-~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        403 R-P-VREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             c-c-hhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            0 0 0011125678999999999999999999999999999764

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-41  Score=358.73  Aligned_cols=257  Identities=43%  Similarity=0.811  Sum_probs=206.3

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.+.|++.+.||+|+||.||+|++..+++.||+|.++...   ......+.+|+.+++.++||||+++++++...+..|
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            45557999999999999999999999999999999876432   223355778999999999999999999999999999


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||++|+ +.+++                                  ...+.+++.++..++.|++.||.|||++||+
T Consensus        83 lv~e~~~~~~L~~~~----------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  128 (267)
T cd06645          83 ICMEFCGGGSLQDIY----------------------------------HVTGPLSESQIAYVSRETLQGLYYLHSKGKM  128 (267)
T ss_pred             EEEeccCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            999999864 33322                                  2345789999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||||+||+++.++.+||+|||++.....    .....||+.|+|||++.....+.++.++|+|||||++|||++|.+|
T Consensus       129 H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p  208 (267)
T cd06645         129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             cCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999864321    2345799999999997432345688899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |........+..+....                    ..++                  .......++..+.+|+.+||+
T Consensus       209 ~~~~~~~~~~~~~~~~~--------------------~~~~------------------~~~~~~~~~~~~~~li~~~l~  250 (267)
T cd06645         209 MFDLHPMRALFLMTKSN--------------------FQPP------------------KLKDKMKWSNSFHHFVKMALT  250 (267)
T ss_pred             cccccchhhHHhhhccC--------------------CCCC------------------cccccCCCCHHHHHHHHHHcc
Confidence            97655433332221110                    0000                  001122467889999999999


Q ss_pred             cCCCCCCCHHHHHcCcc
Q psy17952        474 KNPADRPSSGRLLTHDL  490 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~  490 (804)
                      .||++|||++++++|||
T Consensus       251 ~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         251 KNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCchhCcCHHHHhcCCC
Confidence            99999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-41  Score=363.63  Aligned_cols=279  Identities=27%  Similarity=0.410  Sum_probs=207.8

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+..+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            38889999999999999999999999999998864321 12223457789999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|++.+.+.                                 ...+.+++..+..++.||++||.|||++||+|||||
T Consensus        80 ~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~  126 (284)
T cd07839          80 YCDQDLKKYFD---------------------------------SCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK  126 (284)
T ss_pred             cCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            99887544321                                 123468999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM-  397 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~-  397 (804)
                      |+||+++.++.+||+|||+++....    .....+|+.|+|||++.+  ...++.++|||||||++|||++|..||+.. 
T Consensus       127 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~tg~~p~~~~~  204 (284)
T cd07839         127 PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIFAELANAGRPLFPGN  204 (284)
T ss_pred             HHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhC--CcccCcHHHHHHHHHHHHHHHhcCCCCcCCC
Confidence            9999999999999999999875322    123467899999999853  345788999999999999999998886543 


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+..+.+...+. ....|..+..+.... ..+.+....   ..         ......+++++++||.+||+.||.
T Consensus       205 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~---~~---------~~~~~~~~~~~~~li~~~l~~~P~  270 (284)
T cd07839         205 DVDDQLKRIFRLLGTP-TEESWPGVSKLPDYK-PYPMYPATT---SL---------VNVVPKLNSTGRDLLQNLLVCNPV  270 (284)
T ss_pred             CHHHHHHHHHHHhCCC-ChHHhHHhhhccccc-ccCCCCCcc---hh---------hhhcccCCHHHHHHHHHHhcCChh
Confidence            4344444443321111 111222221111110 000000000   00         001234688999999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||++++|.||||
T Consensus       271 ~R~t~~~il~h~~f  284 (284)
T cd07839         271 QRISAEEALQHPYF  284 (284)
T ss_pred             hcCCHHHHhcCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-41  Score=389.82  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=208.7

Q ss_pred             ccccccccccccccccceEEEEeeec-eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVS-REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~-~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ...|.+.+.||+|+||.||+|.+..+ ++.||+|.+...   .......+.+|+.+|+.++|||||++++++..++..||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34599999999999999999998877 788999976432   22334567789999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+ |.+.+.                              .......++++.++..++.||+.||.|||++||+|
T Consensus       143 v~E~~~gg~L~~~l~------------------------------~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH  192 (478)
T PTZ00267        143 IMEYGSGGDLNKQIK------------------------------QRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMH  192 (478)
T ss_pred             EEECCCCCCHHHHHH------------------------------HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEE
Confidence            99999864 433332                              01123456899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+|||++.++.+||+|||+|+....      ..+.+||+.|+|||++.   ...++.++|||||||++|||++|+.
T Consensus       193 rDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~  269 (478)
T PTZ00267        193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE---RKRYSKKADMWSLGVILYELLTLHR  269 (478)
T ss_pred             CCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhC---CCCCCcHHhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999975422      23467999999999984   4568999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+.+..+..+..+                                          .....+++++.+||.+||
T Consensus       270 Pf~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~s~~~~~li~~~L  307 (478)
T PTZ00267        270 PFKGPSQREIMQQVLYGKYD------------------------------------------PFPCPVSSGMKALLDPLL  307 (478)
T ss_pred             CCCCCCHHHHHHHHHhCCCC------------------------------------------CCCccCCHHHHHHHHHHh
Confidence            99877665555544332110                                          011246788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+||++|||+.++|.|+|+..
T Consensus       308 ~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        308 SKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             ccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999854

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-41  Score=372.78  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=206.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||++++..+++.||+|.+.............+.+|+.++..++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            48899999999999999999999999999998864322222233457789999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++.                                 .....+++..++.++.||+.||+|||++||+||||
T Consensus        82 y~~~g~L~~~l~---------------------------------~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDl  128 (332)
T cd05623          82 YYVGGDLLTLLS---------------------------------KFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDI  128 (332)
T ss_pred             ccCCCcHHHHHH---------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence            99864 333221                                 11346899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccC--CCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||+|||++.++.+||+|||++.....     ....+||+.|||||++.+..  .+.|+.++|||||||++|||++|+.||
T Consensus       129 kp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf  208 (332)
T cd05623         129 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF  208 (332)
T ss_pred             CHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCC
Confidence            99999999999999999999864322     12357999999999985321  245788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+......                   .                  ..|. .....++++++|+.+||..
T Consensus       209 ~~~~~~~~~~~i~~~~~~-------------------~------------------~~p~-~~~~~s~~~~~li~~ll~~  250 (332)
T cd05623         209 YAESLVETYGKIMNHKER-------------------F------------------QFPA-QVTDVSEDAKDLIRRLICS  250 (332)
T ss_pred             CCCCHHHHHHHHhCCCcc-------------------c------------------cCCC-ccccCCHHHHHHHHHHccC
Confidence            887766665555322100                   0                  0000 1134688999999999976


Q ss_pred             CCCC--CCCHHHHHcCccccC
Q psy17952        475 NPAD--RPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~--Rpsa~elL~Hp~~~~  493 (804)
                      +|.+  |+++.++++||||..
T Consensus       251 ~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         251 REHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             hhhhcCCCCHHHHhCCCCcCC
Confidence            5554  789999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=359.07  Aligned_cols=262  Identities=42%  Similarity=0.761  Sum_probs=212.2

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .|.+.|++++.||.|+||.||++.+..+++.||+|.+...   .....+.+.+|+.++++++||||+++++.+..+...|
T Consensus         2 ~~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             CchhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            3566799999999999999999999889999999987532   2334467889999999999999999999999999999


Q ss_pred             EEEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.|+. .+++.                                 .....+++..+..++.|++.||.|||++||+
T Consensus        79 lv~e~~~~~~L~~~~~---------------------------------~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~  125 (280)
T cd06611          79 ILIEFCDGGALDSIML---------------------------------ELERGLTEPQIRYVCRQMLEALNFLHSHKVI  125 (280)
T ss_pred             EEeeccCCCcHHHHHH---------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999998753 22221                                 1134689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||||||+||+++.++.+||+|||++.....    .....||+.|+|||++...  ....++.++|+|||||++|||++|+
T Consensus       126 h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~  205 (280)
T cd06611         126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME  205 (280)
T ss_pred             cCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999864322    2345799999999998531  2345778999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+....+..+..+..+.                                        ......++.++.+|+.+|
T Consensus       206 ~p~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~li~~~  245 (280)
T cd06611         206 PPHHELNPMRVLLKILKSEPPT----------------------------------------LDQPSKWSSSFNDFLKSC  245 (280)
T ss_pred             CCcccCCHHHHHHHHhcCCCCC----------------------------------------cCCcccCCHHHHHHHHHH
Confidence            9998766555444432221110                                        011234688999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCCC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      |+.||.+|||+.++|+|||+.....
T Consensus       246 l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         246 LVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             hccChhhCcCHHHHhcChhhcccch
Confidence            9999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-41  Score=380.02  Aligned_cols=274  Identities=26%  Similarity=0.339  Sum_probs=204.0

Q ss_pred             cccccccccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..|++++.||+|+||.||+|...  .+++.||+|.+...        ....+|+++|++++|||||+++++|......|+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            35999999999999999999754  45678999987531        234689999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||++.+++.+.+                                  ...+.+++.++..|+.||+.||.|||++|||||
T Consensus       164 v~e~~~~~l~~~l----------------------------------~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr  209 (392)
T PHA03207        164 VMPKYKCDLFTYV----------------------------------DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR  209 (392)
T ss_pred             EehhcCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999987654332                                  234578999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.++.+||+|||+|+....      .....||+.|+|||++.   ...|+.++|||||||++|||++|+.|
T Consensus       210 Dlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~el~~g~~p  286 (392)
T PHA03207        210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA---LDPYCAKTDIWSAGLVLFEMSVKNVT  286 (392)
T ss_pred             CCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhc---CCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999864322      12457999999999984   35688999999999999999999999


Q ss_pred             CCCCCh---HHHHHHHHhcCCC---CCCC-CchhhHHhhcccc-cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        394 YFNMNA---MSALYHIAQNDTP---CLQS-SDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       394 F~~~~~---~~~l~~I~~~~~p---~~~~-~~~~~i~~i~~~~-~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |.+...   ...+..+.+....   ..+. ......+...... ...+++              ...+......++.++.
T Consensus       287 f~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~  352 (392)
T PHA03207        287 LFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY--------------TIPPVIRKYGMHMDVE  352 (392)
T ss_pred             CCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCc--------------cccchhhccCcchhHH
Confidence            987542   2333333321110   0000 0000000000000 000000              0000111234678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +||.+||+.||++|||+.++|+||||.+.
T Consensus       353 ~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        353 YLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            99999999999999999999999999763

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.1e-41  Score=357.43  Aligned_cols=262  Identities=41%  Similarity=0.732  Sum_probs=211.6

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      |++.|++++.||+|+||.||+|.+..++..+|+|.+...   .....+.+.+|+++++.++||||+++++++..++..|+
T Consensus         3 ~~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~   79 (282)
T cd06643           3 PEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   79 (282)
T ss_pred             HHHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence            556689999999999999999999999999999987532   22345668899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+.|+..+.+-                                .....++++..+..++.|+++||.|||+.||+||
T Consensus        80 v~e~~~~~~l~~~~--------------------------------~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~  127 (282)
T cd06643          80 LIEFCAGGAVDAVM--------------------------------LELERPLTEPQIRVVCKQTLEALNYLHENKIIHR  127 (282)
T ss_pred             EEEecCCCcHHHHH--------------------------------HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999876322110                                0123568999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.++.+||+|||++.....    .....||+.|+|||++...  ....++.++|||||||++|||++|++|
T Consensus       128 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  207 (282)
T cd06643         128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP  207 (282)
T ss_pred             CCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence            9999999999999999999999864322    2346799999999997421  234577899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+.......+.+...+                                        .......++.++.+||.+||.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~l~  247 (282)
T cd06643         208 HHELNPMRVLLKIAKSEPP----------------------------------------TLAQPSRWSSEFKDFLKKCLE  247 (282)
T ss_pred             ccccCHHHHHHHHhhcCCC----------------------------------------CCCCccccCHHHHHHHHHHcc
Confidence            9876655544444321110                                        001123468899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .||.+|||++++++||||.....
T Consensus       248 ~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         248 KNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             CChhhCcCHHHHhcCCCEeccCC
Confidence            99999999999999999986533

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-42  Score=379.14  Aligned_cols=271  Identities=24%  Similarity=0.345  Sum_probs=200.5

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||+|....         .....|+.++++++|||||++++++......|+|||
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            49999999999999999999999999999997432         124579999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|++.+.+.                                 .....+++..+..|+.||+.||.|||++||||||||
T Consensus       138 ~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  184 (357)
T PHA03209        138 HYSSDLYTYLT---------------------------------KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVK  184 (357)
T ss_pred             ccCCcHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99887554332                                 123568999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+|||++.++.+||+|||+++....   .....||+.|+|||++.   ...|+.++|||||||++|||+++..|++....
T Consensus       185 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~  261 (357)
T PHA03209        185 TENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA---RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP  261 (357)
T ss_pred             HHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecC---CCCCCchhhHHHHHHHHHHHHHcCCccccCCC
Confidence            9999999999999999999875322   23467999999999985   35689999999999999999986655543321


Q ss_pred             H----------HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHh------hccCCCCCCCCCCccHH
Q psy17952        400 M----------SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH------IAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       400 ~----------~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~------i~~~~~p~~~~~~~s~~  463 (804)
                      .          ..+..+.......               ....+.............      ......++.....++.+
T Consensus       262 ~~~~~~~~~~~~~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (357)
T PHA03209        262 STPEEYVKSCHSHLLKIISTLKVH---------------PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPID  326 (357)
T ss_pred             CcHHHHHHHHHHHHHHHHHHhccC---------------hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCch
Confidence            1          1111111110000               000000000000000000      00001112223356778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +.+||.+||+.||.+||||.|+|+||||++
T Consensus       327 ~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        327 GEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            899999999999999999999999999974

>KOG0662|consensus

Probab=100.00  E-value=7.7e-42  Score=326.70  Aligned_cols=282  Identities=27%  Similarity=0.417  Sum_probs=221.7

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|..+++||+|.||+||+|++..+++.||+|.++..+ .+.......+|||-+|+.|+|.|||+++++...+..+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            4788999999999999999999999999999987543 334445678999999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||...+....+                                 .-.+.++.+.++.++.|+++||.|||++++.|||||
T Consensus        82 ~cdqdlkkyfd---------------------------------slng~~d~~~~rsfmlqllrgl~fchshnvlhrdlk  128 (292)
T KOG0662|consen   82 FCDQDLKKYFD---------------------------------SLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLK  128 (292)
T ss_pred             HhhHHHHHHHH---------------------------------hcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCC
Confidence            99765432221                                 224678899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC-C---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP-A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~-~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      |.|+||+.+|.+|++|||+|+...- .   ...+-|.+|++|.++.+.  .-|++..|+||.|||+.|+.. |+|.|.+.
T Consensus       129 pqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfga--kly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  129 PQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             cceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeee--ehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence            9999999999999999999975432 1   234679999999999764  579999999999999999985 88889998


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+++.+|..--.. +....|+.+..+... ...|-|......+.+            -+..+...+|+++++|.-+|.
T Consensus       207 dvddqlkrif~~lg~-p~ed~wps~t~lpdy-k~yp~ypattswsqi------------vp~lns~grdllqkll~cnp~  272 (292)
T KOG0662|consen  207 DVDDQLKRIFRLLGT-PTEDQWPSMTKLPDY-KPYPIYPATTSWSQI------------VPKLNSTGRDLLQKLLKCNPA  272 (292)
T ss_pred             cHHHHHHHHHHHhCC-CccccCCccccCCCC-cccCCccccchHHHH------------hhhhcchhHHHHHHHhccCcc
Confidence            888888888763211 123344444332211 111222111111111            123455678999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy17952        478 DRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~  494 (804)
                      +|.+|+++|+||||+..
T Consensus       273 qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  273 QRISAEAALQHPYFSDF  289 (292)
T ss_pred             cccCHHHHhcCcccccc
Confidence            99999999999999764

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-40  Score=362.80  Aligned_cols=289  Identities=29%  Similarity=0.442  Sum_probs=212.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||++.+..++..+|+|.+....  .......+.+|++++++++||||+++++++..++..|+|||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            4889999999999999999999999999999876422  22344568899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRD  320 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRD  320 (804)
                      |++|+ +.+++                                  ...+.+++..+..++.|+++||.|||+ .+|+|||
T Consensus        80 y~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~d  125 (308)
T cd06615          80 HMDGGSLDQVL----------------------------------KKAGRIPENILGKISIAVLRGLTYLREKHKIMHRD  125 (308)
T ss_pred             ccCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECC
Confidence            99864 33322                                  234568999999999999999999998 6999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |||+|||++.++.+||+|||++.....  ....+|++.|+|||++.   +..++.++|+|||||++|||++|+.||...+
T Consensus       126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~  202 (308)
T cd06615         126 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD  202 (308)
T ss_pred             CChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChhHhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999999865322  34568999999999874   3468889999999999999999999997665


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..... .+.............  ...........+...  .....+..+.....|..+...++.++++|+.+||..||++
T Consensus       203 ~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  277 (308)
T cd06615         203 AKELE-AMFGRPVSEGEAKES--HRPVSGHPPDSPRPM--AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKE  277 (308)
T ss_pred             hhhHH-HhhcCccccccccCC--cccccCCCCCccchh--hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhh
Confidence            43322 222211110000000  000000000000000  0011111122223344444457899999999999999999


Q ss_pred             CCCHHHHHcCccccCCC
Q psy17952        479 RPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~~~  495 (804)
                      |||+.++++||||.+..
T Consensus       278 Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         278 RADLKELTKHPFIKRAE  294 (308)
T ss_pred             CcCHHHHhcChhhhhcc
Confidence            99999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.2e-41  Score=371.16  Aligned_cols=282  Identities=25%  Similarity=0.399  Sum_probs=196.9

Q ss_pred             cccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|.+.     .+++.||+|.+....  .......+.+|+.+|+.+ +|||||++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            4456999999999999999999753     345789999886422  223346688999999999 89999999998876


Q ss_pred             c-CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhh------------hcccccchh--------------
Q psy17952        234 D-HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCF------------TEHFALFNF--------------  285 (804)
Q Consensus       234 ~-~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~------------~~~~~L~~~--------------  285 (804)
                      . +.+|+|||||.| +|.+++...................+....            .....++..              
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 468999999984 566665421100000000000000000000            000000000              


Q ss_pred             --hccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCccc
Q psy17952        286 --EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYW  357 (804)
Q Consensus       286 --~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y  357 (804)
                        .....++++.++..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+....      .....+|+.|
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              01234689999999999999999999999999999999999999999999999999975322      1233567889


Q ss_pred             ccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCcc
Q psy17952        358 MAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF  436 (804)
Q Consensus       358 ~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~  436 (804)
                      ||||++.   ...|+.++|||||||++|||++ |.+||.+......+........                         
T Consensus       243 ~aPE~~~---~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------------------------  294 (338)
T cd05102         243 MAPESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-------------------------  294 (338)
T ss_pred             cCcHHhh---cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-------------------------
Confidence            9999984   4568999999999999999997 9999976543222221111000                         


Q ss_pred             chhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       437 ~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                                      ........++++.+|+.+||+.||++|||+.++++
T Consensus       295 ----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         295 ----------------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                            00011345788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.6e-41  Score=360.90  Aligned_cols=269  Identities=41%  Similarity=0.697  Sum_probs=216.0

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      +...++...|++++.||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+...
T Consensus        13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~   89 (296)
T cd06654          13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (296)
T ss_pred             cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence            445567778999999999999999999999999999999876432   22345678999999999999999999999999


Q ss_pred             CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ...|+||||+.|+ +.+++                                   ....+++.++..++.|++.||.|||+
T Consensus        90 ~~~~lv~e~~~~~~L~~~~-----------------------------------~~~~~~~~~~~~i~~ql~~aL~~LH~  134 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVV-----------------------------------TETCMDEGQIAAVCRECLQALEFLHS  134 (296)
T ss_pred             CEEEEeecccCCCCHHHHH-----------------------------------HhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999865 32222                                   12357888999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||+||||||+|||++.++.+||+|||++.....    .....|++.|+|||.+.   ...++.++|||||||++|+|++
T Consensus       135 ~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~~l~~  211 (296)
T cd06654         135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMIE  211 (296)
T ss_pred             CCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHc---CCCCCccchHHHHHHHHHHHHh
Confidence            9999999999999999999999999999865332    12357899999999984   3557889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |++||...+....+..+.....+                                        +......++..+.+|+.
T Consensus       212 g~~pf~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~  251 (296)
T cd06654         212 GEPPYLNENPLRALYLIATNGTP----------------------------------------ELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             CCCCCCCCCHHHhHHHHhcCCCC----------------------------------------CCCCccccCHHHHHHHH
Confidence            99999776654433322211100                                        00012345788999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCCchhHHHH
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI  504 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~  504 (804)
                      +||..||++|||+.++++||||....+...+....
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~  286 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI  286 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhccCCccccHHHH
Confidence            99999999999999999999998876655444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.1e-41  Score=356.66  Aligned_cols=257  Identities=44%  Similarity=0.807  Sum_probs=204.8

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.+.|++.+.||+|+||.||+|++..+++.||+|.+....   ......+.+|+.++++++||||+++++++...+..|
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            45566999999999999999999999999999999875322   123345778999999999999999999999999999


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.|+ +.+++                                  ...+.+++.++..++.|++.||+|||+.||+
T Consensus        83 iv~e~~~~~~L~~~~----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (267)
T cd06646          83 ICMEYCGGGSLQDIY----------------------------------HVTGPLSELQIAYVCRETLQGLAYLHSKGKM  128 (267)
T ss_pred             EEEeCCCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999864 32222                                  2345689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||||+||+++.++.+||+|||++.....    .....|++.|+|||.+.......++.++||||+||++|||++|++|
T Consensus       129 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p  208 (267)
T cd06646         129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             ccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999875322    2345789999999998543345578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+.......+.+.                    ...++                  .......++..+.+|+.+||.
T Consensus       209 ~~~~~~~~~~~~~~~~--------------------~~~~~------------------~~~~~~~~~~~~~~li~~~l~  250 (267)
T cd06646         209 MFDLHPMRALFLMSKS--------------------NFQPP------------------KLKDKTKWSSTFHNFVKISLT  250 (267)
T ss_pred             ccccchhhhheeeecC--------------------CCCCC------------------CCccccccCHHHHHHHHHHhh
Confidence            9655432221111100                    00000                  001123478899999999999


Q ss_pred             cCCCCCCCHHHHHcCcc
Q psy17952        474 KNPADRPSSGRLLTHDL  490 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~  490 (804)
                      .||++|||++++|+|+|
T Consensus       251 ~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         251 KNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CChhhCcCHHHHhcCCC
Confidence            99999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.1e-41  Score=359.40  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=194.9

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC-c
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-A  248 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~-l  248 (804)
                      ||+|+||.||++++..+|+.||+|.+.............+..|++++++++||||+++++++..+...|+||||+.|+ +
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999999999999886432222222344567999999999999999999999999999999999865 2


Q ss_pred             hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        249 SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       249 ~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                      .+.+.                                ......+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        81 ~~~~~--------------------------------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili  128 (277)
T cd05607          81 KYHIY--------------------------------NVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL  128 (277)
T ss_pred             HHHHH--------------------------------hccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE
Confidence            22211                                0122357889999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy17952        329 TETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYH  405 (804)
Q Consensus       329 ~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~  405 (804)
                      +.++.+||+|||++......   ....||+.|+|||++.   ...++.++||||+||++|||++|+.||.+.........
T Consensus       129 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~  205 (277)
T cd05607         129 DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK---EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE  205 (277)
T ss_pred             cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH
Confidence            99999999999998654322   2357999999999985   34589999999999999999999999965432111111


Q ss_pred             HHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH---
Q psy17952        406 IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS---  482 (804)
Q Consensus       406 I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa---  482 (804)
                      +..               ..                      ... ........+++++++|+.+||++||++|||+   
T Consensus       206 ~~~---------------~~----------------------~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~  247 (277)
T cd05607         206 LKR---------------RT----------------------LED-EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREK  247 (277)
T ss_pred             HHH---------------Hh----------------------hcc-ccccccccCCHHHHHHHHHHhccCHhhCCCCccc
Confidence            100               00                      000 0011123468899999999999999999999   


Q ss_pred             -HHHHcCccccC
Q psy17952        483 -GRLLTHDLVTR  493 (804)
Q Consensus       483 -~elL~Hp~~~~  493 (804)
                       +++++||||..
T Consensus       248 ~~~~~~h~~f~~  259 (277)
T cd05607         248 NDDPRKHEFFKT  259 (277)
T ss_pred             hhhhhcChhhcC
Confidence             67889999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0690|consensus

Probab=100.00  E-value=3.7e-42  Score=354.25  Aligned_cols=253  Identities=27%  Similarity=0.455  Sum_probs=217.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|+.++.||+|.||+|-+|+.+.+++.+|||++++.-..........+.|-++|+..+||.+..+...|+..+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            45899999999999999999999999999999987654444555677788999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.||                                 +||--..+.+.++|+.++.+..+|+.||.|||+++||.|||
T Consensus       248 eyanGG---------------------------------eLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDl  294 (516)
T KOG0690|consen  248 EYANGG---------------------------------ELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDL  294 (516)
T ss_pred             EEccCc---------------------------------eEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeec
Confidence            999987                                 34444455678999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |.+|+|+|.||++||+|||+++...    ...++||||.|.|||++.   ...|+.++|+|.+||++|||++|+.||.+.
T Consensus       295 KLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle---DnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  295 KLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE---DNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             hhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhc---cccccceeehhhhhHHHHHHHhccCccccc
Confidence            9999999999999999999997543    346799999999999994   457999999999999999999999999887


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +....+..|...+.                   +                        .+..+|++++.|+..+|.+||.
T Consensus       372 dh~kLFeLIl~ed~-------------------k------------------------FPr~ls~eAktLLsGLL~kdP~  408 (516)
T KOG0690|consen  372 DHEKLFELILMEDL-------------------K------------------------FPRTLSPEAKTLLSGLLKKDPK  408 (516)
T ss_pred             chhHHHHHHHhhhc-------------------c------------------------CCccCCHHHHHHHHHHhhcChH
Confidence            76555544433211                   1                        1245689999999999999999


Q ss_pred             CCCC-----HHHHHcCccccC
Q psy17952        478 DRPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rps-----a~elL~Hp~~~~  493 (804)
                      +|..     |.++.+|+||..
T Consensus       409 kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  409 KRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             hhcCCCchhHHHHHhhhhhcc
Confidence            9974     678999999965

>KOG4721|consensus

Probab=100.00  E-value=3.8e-42  Score=374.58  Aligned_cols=242  Identities=33%  Similarity=0.593  Sum_probs=200.3

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      +.|++....++-||+|+.|.||+|+.  .++.||||+++...          ..+|+-|++|+|||||.|.|+|....-+
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence            34666667788999999999999974  56889999875321          2478889999999999999999999999


Q ss_pred             EEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |||||||. |-|..++                                  ...++++......|..+|+.|++|||.+.|
T Consensus       188 CIiMEfCa~GqL~~VL----------------------------------ka~~~itp~llv~Wsk~IA~GM~YLH~hKI  233 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVL----------------------------------KAGRPITPSLLVDWSKGIAGGMNYLHLHKI  233 (904)
T ss_pred             EEeeeccccccHHHHH----------------------------------hccCccCHHHHHHHHHHhhhhhHHHHHhhH
Confidence            99999997 5444443                                  345678889999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||||.-||||+.+..|||+|||-++....   ..+|+||..|||||+|.   +.+.+.|+|||||||+|||||||..|
T Consensus       234 IHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIr---nePcsEKVDIwSfGVVLWEmLT~EiP  310 (904)
T KOG4721|consen  234 IHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIR---NEPCSEKVDIWSFGVVLWEMLTGEIP  310 (904)
T ss_pred             hhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhh---cCCcccccceehhHHHHHHHHhcCCC
Confidence            9999999999999999999999999876433   34789999999999994   67899999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.+.++.-+..+                                         ....+.+..+++.|+-||+.||+
T Consensus       311 YkdVdssAIIwGVGsN-----------------------------------------sL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  311 YKDVDSSAIIWGVGSN-----------------------------------------SLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             ccccchheeEEeccCC-----------------------------------------cccccCcccCchHHHHHHHHHHh
Confidence            9876544332221110                                         01112335678999999999999


Q ss_pred             cCCCCCCCHHHHHcCc
Q psy17952        474 KNPADRPSSGRLLTHD  489 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp  489 (804)
                      -.|..|||..++|.|-
T Consensus       350 sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  350 SKPRNRPSFRQILLHL  365 (904)
T ss_pred             cCCCCCccHHHHHHHH
Confidence            9999999999999994

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-40  Score=357.79  Aligned_cols=265  Identities=41%  Similarity=0.743  Sum_probs=212.8

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .|.+.|+++++||+|+||.||+|++..+++.||+|.+...   .....+.+.+|+.+++.++||||+++++++..++..|
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            4667799999999999999999999999999999987632   2334567889999999999999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +||||+.|+..+.+-                                ......+++..+..++.|++.||.|||++||+|
T Consensus        86 lv~e~~~~~~l~~~~--------------------------------~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H  133 (292)
T cd06644          86 IMIEFCPGGAVDAIM--------------------------------LELDRGLTEPQIQVICRQMLEALQYLHSMKIIH  133 (292)
T ss_pred             EEEecCCCCcHHHHH--------------------------------HhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeee
Confidence            999999976422110                                012346889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+||+++.++.+||+|||++.....    .....|++.|+|||++.+.  ....++.++|||||||++|||++|.+
T Consensus       134 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~  213 (292)
T cd06644         134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP  213 (292)
T ss_pred             cCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCC
Confidence            99999999999999999999999864322    2345789999999998531  13457889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||...+.......+.+...+                                        .......++.++.+|+.+||
T Consensus       214 p~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~l  253 (292)
T cd06644         214 PHHELNPMRVLLKIAKSEPP----------------------------------------TLSQPSKWSMEFRDFLKTAL  253 (292)
T ss_pred             CCccccHHHHHHHHhcCCCc----------------------------------------cCCCCcccCHHHHHHHHHHh
Confidence            99776554433333221110                                        00112356788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCCc
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSPS  498 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~~  498 (804)
                      ..||++||++.++++||||.......
T Consensus       254 ~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         254 DKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             cCCcccCcCHHHHhcCccccccccch
Confidence            99999999999999999997655444

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9e-41  Score=363.27  Aligned_cols=286  Identities=26%  Similarity=0.414  Sum_probs=196.0

Q ss_pred             cccccccccceEEEEeee--ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cCceEEEEee
Q psy17952        168 REIGHGSFGAVYYARCLV--SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DHTAWLVMEY  243 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~--~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~~~~lVmEy  243 (804)
                      ++||+|+||.||+|++..  ++..||+|.+....     ....+.+|+.+|++++||||+++++++..  +...|+||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            579999999999998654  56889999876422     12356789999999999999999998854  5678999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.+++.+++.....                         .........+++..+..++.||+.||.|||++||+||||||
T Consensus        82 ~~~~l~~~~~~~~~-------------------------~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp  136 (317)
T cd07867          82 AEHDLWHIIKFHRA-------------------------SKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKP  136 (317)
T ss_pred             eCCcHHHHHHhhhc-------------------------cccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCH
Confidence            99887665531100                         00011234588999999999999999999999999999999


Q ss_pred             CCeee----cCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        324 GNILL----TETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       324 ~NILl----~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +|||+    +.++.+||+|||+|+....       .....||+.|+|||++.+  ...++.++|||||||++|||++|++
T Consensus       137 ~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~el~tg~~  214 (317)
T cd07867         137 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEP  214 (317)
T ss_pred             HHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC--CCccCcHHHHHhHHHHHHHHHhCCC
Confidence            99999    5667999999999975322       234578999999999853  2457889999999999999999999


Q ss_pred             CCCCCCh---------HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccc-hhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        393 PYFNMNA---------MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFN-MNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       393 PF~~~~~---------~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~-~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ||.....         ...+..+..... ......|..+............+.. ......+...     ........+.
T Consensus       215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~  288 (317)
T cd07867         215 IFHCRQEDIKTSNPFHHDQLDRIFSVMG-FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKY-----MEKHKVKPDS  288 (317)
T ss_pred             CcccccccccccccccHHHHHHHHHhcC-CCChhhhhhhhhcccchhhhhhhcccccCCchhhhh-----hhcccCCCCh
Confidence            9965432         111222221111 1111222222111100000000000 0000000000     0001123467


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      .+.+|+.+||+.||.+|||+.|+|+||||
T Consensus       289 ~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         289 KVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            78999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-41  Score=370.56  Aligned_cols=260  Identities=23%  Similarity=0.373  Sum_probs=205.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||++++..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            48999999999999999999999999999998864322222334557789999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ |.+++.                                 .....+++..+..++.|++.||+|||++||+||||
T Consensus        82 y~~gg~L~~~l~---------------------------------~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDl  128 (331)
T cd05624          82 YYVGGDLLTLLS---------------------------------KFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI  128 (331)
T ss_pred             CCCCCcHHHHHH---------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence            99865 332221                                 11346889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccC--CCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||+|||++.++.+||+|||++......     ...+||+.|||||++.+..  .+.++.++|||||||++|||++|+.||
T Consensus       129 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf  208 (331)
T cd05624         129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF  208 (331)
T ss_pred             chHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc
Confidence            999999999999999999998654321     2357999999999985421  135788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+......                   .                  ..|. .....++++++|+.+||..
T Consensus       209 ~~~~~~~~~~~i~~~~~~-------------------~------------------~~p~-~~~~~~~~~~~li~~ll~~  250 (331)
T cd05624         209 YAESLVETYGKIMNHEER-------------------F------------------QFPS-HITDVSEEAKDLIQRLICS  250 (331)
T ss_pred             cCCCHHHHHHHHHcCCCc-------------------c------------------cCCC-ccccCCHHHHHHHHHHccC
Confidence            877765555444321100                   0                  0000 1124688999999999987


Q ss_pred             CCCC--CCCHHHHHcCccccC
Q psy17952        475 NPAD--RPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~--Rpsa~elL~Hp~~~~  493 (804)
                      ++.+  |++++++++||||..
T Consensus       251 ~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         251 RERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             chhhcCCCCHHHHhcCCCcCC
Confidence            6655  579999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.3e-41  Score=366.54  Aligned_cols=295  Identities=28%  Similarity=0.455  Sum_probs=205.8

Q ss_pred             ccccccccc--cccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        165 EDLREIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       165 ~~l~~LG~G--~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      +++++||+|  +||+||++++..+|+.||+|.+..... .......+.+|+.+++.++|||||+++++|..++..|+|||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            356889999  788999999999999999999864321 12334557789999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.++ +.+++..                                .....+++..+..++.|++.||+|||++||+||||
T Consensus        80 ~~~~~~l~~~~~~--------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dl  127 (327)
T cd08227          80 FMAYGSAKDLICT--------------------------------HFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV  127 (327)
T ss_pred             ccCCCcHHHHHHh--------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence            99854 4443321                                01235889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||+|||++.++.+|++|||.+.....           .....++..|+|||++.+. ...|+.++|||||||++|||++|
T Consensus       128 kp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g  206 (327)
T cd08227         128 KASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANG  206 (327)
T ss_pred             ChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcc-cCCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999999999986532110           1123577889999998531 23588999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccc---cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA---ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~---~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      +.||.+............+..+.................   ..............................+++.+.+|
T Consensus       207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  286 (327)
T cd08227         207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF  286 (327)
T ss_pred             CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence            999987665554444443333322110000000000000   00000000000000000000000011223468899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +.+||+.||++|||++++|+||||.+
T Consensus       287 i~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         287 VEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             HHHHHhhCchhcCCHHHHhcChhhhh
Confidence            99999999999999999999999965

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0983|consensus

Probab=100.00  E-value=1.4e-41  Score=343.67  Aligned_cols=258  Identities=32%  Similarity=0.561  Sum_probs=213.4

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .+.+..||.|+-|.|++++.+.+|...|||.+...+.  .+...+++..+.++.... .|.||+.+|+|..+..+++.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            6788999999999999999999999999999986543  344567888888877664 8999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDV  321 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRDL  321 (804)
                      .|..-+..++                                 ..-+++++|..+-++...+++||.||-. +||||||+
T Consensus       172 lMs~C~ekLl---------------------------------krik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDv  218 (391)
T KOG0983|consen  172 LMSTCAEKLL---------------------------------KRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV  218 (391)
T ss_pred             HHHHHHHHHH---------------------------------HHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeeccc
Confidence            8853222221                                 1235689999999999999999999985 68999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM-  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~-  397 (804)
                      ||+|||+|+.|++||||||+|......   ....|.+.|||||.+--.....|+-++|||||||+++||+||+.||.+. 
T Consensus       219 KPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~  298 (391)
T KOG0983|consen  219 KPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK  298 (391)
T ss_pred             CccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence            999999999999999999999654332   2357999999999986544567999999999999999999999999874 


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      .+.+.+..|.+..+|.+.                                        ....+|+.|.+|+..||++|+.
T Consensus       299 tdFe~ltkvln~ePP~L~----------------------------------------~~~gFSp~F~~fv~~CL~kd~r  338 (391)
T KOG0983|consen  299 TDFEVLTKVLNEEPPLLP----------------------------------------GHMGFSPDFQSFVKDCLTKDHR  338 (391)
T ss_pred             ccHHHHHHHHhcCCCCCC----------------------------------------cccCcCHHHHHHHHHHhhcCcc
Confidence            466777777654433221                                        1123899999999999999999


Q ss_pred             CCCCHHHHHcCccccCCCC
Q psy17952        478 DRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~~~  496 (804)
                      +||.-.++|+|||+..-.+
T Consensus       339 ~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  339 KRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             cCcchHHHhcCcceeecch
Confidence            9999999999999986544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-41  Score=361.42  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=202.4

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.++++++|+||+.+++.+.+.+..|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            77889999999999999999999999999988643322222334567899999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+.+.                                ......+++..+..++.|++.||.|||++||+|||||
T Consensus        82 ~~g~~L~~~l~--------------------------------~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dik  129 (285)
T cd05630          82 MNGGDLKFHIY--------------------------------HMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK  129 (285)
T ss_pred             cCCCcHHHHHH--------------------------------HhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence            9865 333221                                0112358899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+|||++.++.+||+|||++......   ....||+.|+|||++.   ...++.++||||+||++|||++|++||.....
T Consensus       130 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~  206 (285)
T cd05630         130 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK---NERYTFSPDWWALGCLLYEMIAGQSPFQQRKK  206 (285)
T ss_pred             HHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHc---CCCCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence            99999999999999999998654322   2357999999999984   45688999999999999999999999975432


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      .......                ....                      .. .+......+++++.+|+.+||+.||++|
T Consensus       207 ~~~~~~~----------------~~~~----------------------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R  247 (285)
T cd05630         207 KIKREEV----------------ERLV----------------------KE-VQEEYSEKFSPDARSLCKMLLCKDPKER  247 (285)
T ss_pred             cchHHHH----------------Hhhh----------------------hh-hhhhcCccCCHHHHHHHHHHhhcCHHHc
Confidence            1100000                0000                      00 0001123467889999999999999999


Q ss_pred             CC-----HHHHHcCccccC
Q psy17952        480 PS-----SGRLLTHDLVTR  493 (804)
Q Consensus       480 ps-----a~elL~Hp~~~~  493 (804)
                      ||     +.++++||||.+
T Consensus       248 ~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         248 LGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             cCCCCCchHHHHcChhhhc
Confidence            99     999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-40  Score=353.99  Aligned_cols=256  Identities=44%  Similarity=0.805  Sum_probs=203.7

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeec---
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRD---  234 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~---  234 (804)
                      +|...|+..+.||+|+||.||+|++..+++.||+|.+....    .....+.+|+.+++++ +||||+++++++...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            56778999999999999999999999999999999875432    2234578899999998 699999999998753   


Q ss_pred             ---CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        235 ---HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       235 ---~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                         ...|++|||+.++ +.+++..                                .....+++..+..++.|++.||+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~--------------------------------~~~~~l~~~~~~~~~~qi~~~l~~  126 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKN--------------------------------TKGNTLKEEWIAYICREILRGLSH  126 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHh--------------------------------ccCCCCCHHHHHHHHHHHHHHHHH
Confidence               4589999999864 3332210                                112458899999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccC--CCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvil  384 (804)
                      ||+++|+||||||+||++++++.+||+|||++.....    .....||+.|+|||++.+..  ...|+.++|||||||++
T Consensus       127 LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l  206 (272)
T cd06637         127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA  206 (272)
T ss_pred             HHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHH
Confidence            9999999999999999999999999999999865322    23467999999999985321  34588899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      |||++|+.||...........+...                                         ..+......++.++
T Consensus       207 ~el~~g~~p~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~  245 (272)
T cd06637         207 IEMAEGAPPLCDMHPMRALFLIPRN-----------------------------------------PAPRLKSKKWSKKF  245 (272)
T ss_pred             HHHHhCCCCccccCHHHHHHHHhcC-----------------------------------------CCCCCCCCCcCHHH
Confidence            9999999999765443332222110                                         01111223467899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      .+|+.+||..||.+|||+.+++.||||
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         246 QSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-40  Score=354.65  Aligned_cols=278  Identities=33%  Similarity=0.512  Sum_probs=210.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+..+.||+|+||.||+|++..+++.||+|.+..... .....+.+.+|+.++++++||||+++++++......|+|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            58899999999999999999999999999998754321 12223457789999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |++|++.+.+                                 ......+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~~~l~~~---------------------------------~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~  127 (286)
T cd07847          81 YCDHTVLNEL---------------------------------EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK  127 (286)
T ss_pred             ccCccHHHHH---------------------------------HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            9998643211                                 1223468999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+||+++.++.+||+|||++......    ....++..|+|||++.+  ...++.++|||||||++|||++|.+||.+.+
T Consensus       128 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         128 PENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG--DTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             hhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhC--CCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998754332    24568899999999853  2457889999999999999999999999887


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccC--CCC-CCCCCCccHHHHHHHHHhcccC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN--DTP-CLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~--~~p-~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+.+..+.+......+. .    ..+...    ..+....      .....  ..+ .......+..+.+|+.+||+.|
T Consensus       206 ~~~~~~~~~~~~~~~~~~-~----~~~~~~----~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  270 (286)
T cd07847         206 DVDQLYLIRKTLGDLIPR-H----QQIFST----NQFFKGL------SIPEPETREPLESKFPNISSPALSFLKGCLQMD  270 (286)
T ss_pred             hHHHHHHHHHHhCCCChH-H----hhhccc----ccccccc------cCCCcccccCHHHHhccCCHHHHHHHHHHhcCC
Confidence            777666654432211110 0    000000    0000000      00000  000 0011346889999999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy17952        476 PADRPSSGRLLTHDLV  491 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~  491 (804)
                      |++|||+.+++.||||
T Consensus       271 p~~Rp~~~eil~~~~f  286 (286)
T cd07847         271 PTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccCCHHHHhcCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7e-41  Score=387.52  Aligned_cols=258  Identities=27%  Similarity=0.382  Sum_probs=207.9

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC----
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH----  235 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~----  235 (804)
                      ..+.|++.+.||+|+||+||+|++..+++.||||.+..... .......+.+|+.++..++|+||+++++.+...+    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34579999999999999999999999999999999864322 2334466789999999999999999988775432    


Q ss_pred             ----ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        236 ----TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       236 ----~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                          .+++||||+.| +|.+.+..                              .......+++..+..++.|++.||+|
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~------------------------------~~~~~~~l~e~~~~~i~~qll~aL~~  158 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKS------------------------------RAKTNRTFREHEAGLLFIQVLLAVHH  158 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHH------------------------------hhccCCCCCHHHHHHHHHHHHHHHHH
Confidence                36899999985 44443321                              11123568999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ||++||+||||||+|||++.++.+||+|||+++....      ....+||+.|+|||++.   ...|+.++|||||||++
T Consensus       159 lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~k~DVwSlGvil  235 (496)
T PTZ00283        159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR---RKPYSKKADMFSLGVLL  235 (496)
T ss_pred             HHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhC---CCCCCcHHHHHHHHHHH
Confidence            9999999999999999999999999999999865321      23568999999999984   35689999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      |||++|+.||.+.+..+.+..+..+..                                          ......+++++
T Consensus       236 yeLltG~~Pf~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l  273 (496)
T PTZ00283        236 YELLTLKRPFDGENMEEVMHKTLAGRY------------------------------------------DPLPPSISPEM  273 (496)
T ss_pred             HHHHHCCCCCCCCCHHHHHHHHhcCCC------------------------------------------CCCCCCCCHHH
Confidence            999999999987765554444332110                                          00123467899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+|+.+||..||.+|||+.++++|||+..
T Consensus       274 ~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        274 QEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             HHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999754

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=350.69  Aligned_cols=251  Identities=34%  Similarity=0.565  Sum_probs=203.7

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEeccccccc--chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+......  .......+.+|++++++++||||+++++++......|+|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            388899999999999999999999999999987543211  122345678899999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.|+ +.+.+                                  ...+.+++..+..++.|++.||.|||+.||+||
T Consensus        83 ~e~~~~~~l~~~~----------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  128 (263)
T cd06625          83 MEYMPGGSVKDQL----------------------------------KAYGALTETVTRKYTRQILEGVEYLHSNMIVHR  128 (263)
T ss_pred             EEECCCCcHHHHH----------------------------------HHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999864 32222                                  223468899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      ||||+||+++.++.+||+|||+++.....       ....|++.|+|||++.+   ..++.++|||||||++|||++|+.
T Consensus       129 dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~  205 (263)
T cd06625         129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG---EGYGRKADVWSVGCTVVEMLTEKP  205 (263)
T ss_pred             CCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceecc---CCCCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999998643221       23568899999999853   458889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+.......+.....                                         ........+..+.+|+.+||
T Consensus       206 p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~~~l  244 (263)
T cd06625         206 PWAEFEAMAAIFKIATQPT-----------------------------------------NPQLPSHVSPDARNFLRRTF  244 (263)
T ss_pred             CccccchHHHHHHHhccCC-----------------------------------------CCCCCccCCHHHHHHHHHHh
Confidence            9977655444333221100                                         00112346788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccc
Q psy17952        473 AKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~  491 (804)
                      .++|.+|||+.++++|+||
T Consensus       245 ~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         245 VENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             hcCcccCCCHHHHhhCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0197|consensus

Probab=100.00  E-value=4.3e-41  Score=370.43  Aligned_cols=245  Identities=28%  Similarity=0.471  Sum_probs=201.6

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +...++.+++||+|.||+|++|....+ ..||+|.++..    ....+.+++|+++|++|+|+|||+|++++..++.+||
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            344588999999999999999986543 36999988642    2223678899999999999999999999999999999


Q ss_pred             EEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||. |+|.+.+..                                ..++.+.-.+...++.||++|++||.++++||
T Consensus       279 VtE~m~~GsLl~yLr~--------------------------------~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IH  326 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRT--------------------------------REGGLLNLPQLLDFAAQIAEGMAYLESKNYIH  326 (468)
T ss_pred             EEEecccCcHHHHhhh--------------------------------cCCCccchHHHHHHHHHHHHHHHHHHhCCccc
Confidence            999997 777665531                                12456788899999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCCC--cccc---CcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPAN--SFVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~~--~~~G---T~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||...||||+++..+||+|||+|+......  ...|   -..|.|||.+.   .+.++.|||||||||+||||+| |+.
T Consensus       327 RDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~---~~~FS~kSDVWSFGVlL~E~fT~G~~  403 (468)
T KOG0197|consen  327 RDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN---YGKFSSKSDVWSFGVLLWELFTYGRV  403 (468)
T ss_pred             hhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHh---hCCcccccceeehhhhHHHHhccCCC
Confidence            9999999999999999999999999433221  1122   23699999984   5789999999999999999998 899


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+++..+.+..+.+|..                                          ...+..+|+++.+++..||
T Consensus       404 py~~msn~ev~~~le~GyR------------------------------------------lp~P~~CP~~vY~lM~~CW  441 (468)
T KOG0197|consen  404 PYPGMSNEEVLELLERGYR------------------------------------------LPRPEGCPDEVYELMKSCW  441 (468)
T ss_pred             CCCCCCHHHHHHHHhccCc------------------------------------------CCCCCCCCHHHHHHHHHHh
Confidence            9999998888877755421                                          1122457899999999999


Q ss_pred             ccCCCCCCCHHHHH
Q psy17952        473 AKNPADRPSSGRLL  486 (804)
Q Consensus       473 ~~dP~~Rpsa~elL  486 (804)
                      ..+|++|||.+.+.
T Consensus       442 ~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  442 HEDPEDRPTFETLR  455 (468)
T ss_pred             hCCcccCCCHHHHH
Confidence            99999999998554

>KOG0666|consensus

Probab=100.00  E-value=9.6e-42  Score=350.06  Aligned_cols=290  Identities=28%  Similarity=0.460  Sum_probs=219.6

Q ss_pred             ccccccccccccccceEEEEeeece----eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-cCce
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-DHTA  237 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-~~~~  237 (804)
                      .|+.+..||+|.||.||+|..+.++    +.+|||+++.... .........||+.+++.++|||||.+..+|.. +..+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            4999999999999999999766553    3789999875432 22334667899999999999999999999987 8899


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+++||.+-+|..+|+.+.                             ..+.+.++...++.|+.||+.|+.|||++=|+
T Consensus       104 ~l~fdYAEhDL~~II~fHr-----------------------------~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvl  154 (438)
T KOG0666|consen  104 WLLFDYAEHDLWHIIKFHR-----------------------------ASKAKQLPRSMVKSILWQILDGVHYLHSNWVL  154 (438)
T ss_pred             EEEehhhhhhHHHHHHHhc-----------------------------cchhccCCHHHHHHHHHHHHhhhHHHhhhhee
Confidence            9999999998888876431                             12235789999999999999999999999999


Q ss_pred             ecCCCCCCeeecCC----CcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        318 HRDVKAGNILLTET----GTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       318 HRDLKP~NILl~~~----g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ||||||.|||+..+    |.|||+|||+|+....       ....+-|.+|+|||++++.  ..|+.++||||+|||+.|
T Consensus       155 HRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa--~hYT~AiDvWAiGCIfaE  232 (438)
T KOG0666|consen  155 HRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA--RHYTKAIDVWAIGCIFAE  232 (438)
T ss_pred             eccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc--ccccchhhhHHHHHHHHH
Confidence            99999999999887    8999999999986432       2346789999999999974  579999999999999999


Q ss_pred             HHhCCCCCCCCCh---------HHHHHHHHhc-CCCCCCCCchhhHHhhccccc----CCCCccchhhhHHHHhhccCCC
Q psy17952        387 LAERKPPYFNMNA---------MSALYHIAQN-DTPCLQSSDWSVIKTISSTAE----RKPPYFNMNAMSALYHIAQNDT  452 (804)
Q Consensus       387 LltG~~PF~~~~~---------~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~----~~pp~~~~~~~~~l~~i~~~~~  452 (804)
                      |++-+|.|.+...         .+++.+|..- ++|  ....|+.++.+..-..    ....+++.......++..+   
T Consensus       233 lLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~P--t~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k---  307 (438)
T KOG0666|consen  233 LLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTP--TDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK---  307 (438)
T ss_pred             HHccCccccchhhhcccCCCchHHHHHHHHHHcCCC--ccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc---
Confidence            9999999976431         3344555442 222  2345555544332100    0001111111222222221   


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       453 p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                            .-++...+|+.++|..||.+|.||.++|+|+||+...
T Consensus       308 ------~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~  344 (438)
T KOG0666|consen  308 ------VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP  344 (438)
T ss_pred             ------CCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence                  1244478999999999999999999999999998754

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-40  Score=354.17  Aligned_cols=258  Identities=33%  Similarity=0.566  Sum_probs=204.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||+|.+....  .......+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            4788999999999999999999999999999875421  22334568899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |++|+..+.                                     ...+++..+..++.|++.||+|||+.||+|||||
T Consensus        80 ~~~~~~l~~-------------------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  122 (279)
T cd06619          80 FMDGGSLDV-------------------------------------YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK  122 (279)
T ss_pred             cCCCCChHH-------------------------------------hhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCC
Confidence            999763221                                     1246788899999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      |+|||++.++.+||+|||++.....  ....+||+.|+|||++.   ...++.++|+|||||++|+|++|+.||......
T Consensus       123 p~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~  199 (279)
T cd06619         123 PSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERIS---GEQYGIHSDVWSLGISFMELALGRFPYPQIQKN  199 (279)
T ss_pred             HHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeec---CCCCCCcchHHHHHHHHHHHHhCCCCchhhccc
Confidence            9999999999999999999865332  23468999999999985   346888999999999999999999999642211


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      ....            ......                      ..+.....+......+++++.+|+.+||+.||++||
T Consensus       200 ~~~~------------~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  245 (279)
T cd06619         200 QGSL------------MPLQLL----------------------QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERP  245 (279)
T ss_pred             cccc------------chHHHH----------------------HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCC
Confidence            0000            000000                      000111112222344688999999999999999999


Q ss_pred             CHHHHHcCccccCCCC
Q psy17952        481 SSGRLLTHDLVTRPRS  496 (804)
Q Consensus       481 sa~elL~Hp~~~~~~~  496 (804)
                      +++++++||||.....
T Consensus       246 ~~~eil~~~~~~~~~~  261 (279)
T cd06619         246 APENLMDHPFIVQYND  261 (279)
T ss_pred             CHHHHhcCcccccccC
Confidence            9999999999976543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0607|consensus

Probab=100.00  E-value=1.2e-41  Score=350.29  Aligned_cols=273  Identities=24%  Similarity=0.380  Sum_probs=211.8

Q ss_pred             cccccccc-cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCce
Q psy17952        160 PEKIFEDL-REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       160 p~~~y~~l-~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~  237 (804)
                      .++.|++. +.||+|+||.|--|....++..+|||++.+.   ....+.++.||++++.+++ |+||++++++|+++..+
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            44567665 5689999999999999999999999998743   3445678999999999996 99999999999999999


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |||||-|.||.                                 |...+.++..|+|.++..++++|+.||.|||.+||.
T Consensus       152 YLVfEKm~GGp---------------------------------lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIA  198 (463)
T KOG0607|consen  152 YLVFEKMRGGP---------------------------------LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIA  198 (463)
T ss_pred             EEEEecccCch---------------------------------HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcc
Confidence            99999999872                                 223344566789999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCC---cEEEEecccccccC------CC-----CccccCcccccchhhccc--CCCCCCCcccHHHHH
Q psy17952        318 HRDVKAGNILLTETG---TVKLADFGSASIKC------PA-----NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLG  381 (804)
Q Consensus       318 HRDLKP~NILl~~~g---~vKL~DFGla~~~~------~~-----~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlG  381 (804)
                      ||||||+|||..+..   -+|||||.+++...      +.     .+.+|+..|||||++...  ....|+.++|.||||
T Consensus       199 HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG  278 (463)
T KOG0607|consen  199 HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG  278 (463)
T ss_pred             cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence            999999999997654   48999999875321      11     256899999999987432  234689999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCC---CC
Q psy17952        382 ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ---SS  458 (804)
Q Consensus       382 vil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~---~~  458 (804)
                      ||||-||+|.+||.|.-..+               .-|..-       +.     =......|++-.+......+   ..
T Consensus       279 vIlYImLsGYpPFvG~Cg~d---------------CGWdrG-------e~-----Cr~CQ~~LFesIQEGkYeFPdkdWa  331 (463)
T KOG0607|consen  279 VILYIMLSGYPPFVGHCGAD---------------CGWDRG-------EV-----CRVCQNKLFESIQEGKYEFPDKDWA  331 (463)
T ss_pred             HHHHHHHhCCCCccCccCCc---------------CCccCC-------Cc-----cHHHHHHHHHHHhccCCcCChhhhH
Confidence            99999999999998743211               111100       00     00112233333333333333   34


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       459 ~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ..|.+.+|+++.+|.+||.+|.++.+.++|||+.+..
T Consensus       332 hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  332 HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            4589999999999999999999999999999998644

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-40  Score=379.59  Aligned_cols=270  Identities=26%  Similarity=0.364  Sum_probs=200.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|.+.+.||+|+||.||+|++..+++.||||...         ...+.+|+++|++|+|||||++++++...+..|+|||
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5899999999999999999999999999999532         1345789999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ++.|++.+.+.                                 .....+++.++..|+.||+.||.|||++||||||||
T Consensus       241 ~~~~~L~~~l~---------------------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLK  287 (461)
T PHA03211        241 KYRSDLYTYLG---------------------------------ARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIK  287 (461)
T ss_pred             ccCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCC
Confidence            99876544331                                 123468999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |+|||++.++.+||+|||+|+....      ....+||+.|||||++.   +..++.++|||||||++|||++|..|++.
T Consensus       288 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        288 TENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA---GDPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             HHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHc---CCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence            9999999999999999999875322      12357999999999985   35689999999999999999999877654


Q ss_pred             CCh-------HHHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhh-ccCCCCCC------CCCCcc
Q psy17952        397 MNA-------MSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI-AQNDTPCL------QSSDWS  461 (804)
Q Consensus       397 ~~~-------~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i-~~~~~p~~------~~~~~s  461 (804)
                      ...       ...+.++.+. ....                ...++............. .....+..      .....+
T Consensus       365 ~~~~~~~~~~~~~l~~~i~~~~~~~----------------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (461)
T PHA03211        365 ASRGDERRPYDAQILRIIRQAQVHV----------------DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLD  428 (461)
T ss_pred             CCcccccCCcHHHHHHHHHhhcccc----------------ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhcccc
Confidence            321       1223333221 1100                000000000000000000 00000000      011346


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        462 DTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .++.+||.+||+.||.+|||+.|+|+||||..
T Consensus       429 ~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        429 LDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            68999999999999999999999999999964

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-40  Score=359.34  Aligned_cols=266  Identities=41%  Similarity=0.697  Sum_probs=213.4

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      ....++.+.|++++.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..+
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (297)
T cd06656          12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVG   88 (297)
T ss_pred             cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            455677788999999999999999999999999999999886422   22335678899999999999999999999999


Q ss_pred             CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +..|+||||++|+ +.+++                                   .+..+++.++..++.|++.||.|||+
T Consensus        89 ~~~~lv~e~~~~~~L~~~~-----------------------------------~~~~~~~~~~~~~~~~l~~~L~~LH~  133 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVV-----------------------------------TETCMDEGQIAAVCRECLQALDFLHS  133 (297)
T ss_pred             CEEEEeecccCCCCHHHHH-----------------------------------HhCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999865 22211                                   12457889999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      .||+||||||+|||++.++.+||+|||++......    ....|++.|+|||.+.   ...++.++|+|||||++|+|++
T Consensus       134 ~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slGvil~~l~t  210 (297)
T cd06656         134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMVE  210 (297)
T ss_pred             CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHc---CCCCCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999998654322    2357899999999984   3567889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||.+.+....+..+.....                     +                   +......++..+.+|+.
T Consensus       211 g~~pf~~~~~~~~~~~~~~~~~---------------------~-------------------~~~~~~~~~~~~~~li~  250 (297)
T cd06656         211 GEPPYLNENPLRALYLIATNGT---------------------P-------------------ELQNPERLSAVFRDFLN  250 (297)
T ss_pred             CCCCCCCCCcchheeeeccCCC---------------------C-------------------CCCCccccCHHHHHHHH
Confidence            9999976543322221111100                     0                   00112345788999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCCchhH
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSPSVLV  501 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~  501 (804)
                      +||..||++|||+.++++||||........+.
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  282 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKLAKPLSSLT  282 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhcccccccccC
Confidence            99999999999999999999998776554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-40  Score=356.36  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+++|++++|+||+.+.+++..++..|+||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67788999999999999999999999999988643222222334577899999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+.+.                                ......+++..+..++.|++.||.|||++||+|||||
T Consensus        82 ~~~~~L~~~~~--------------------------------~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dik  129 (285)
T cd05632          82 MNGGDLKFHIY--------------------------------NMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK  129 (285)
T ss_pred             ccCccHHHHHH--------------------------------HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence            9865 222211                                0123468999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+|||+++++.+||+|||++.....   .....||+.|+|||++.   +..++.++|+|||||++|||++|..||.+...
T Consensus       130 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~  206 (285)
T cd05632         130 PENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN---NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE  206 (285)
T ss_pred             HHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999865322   23457999999999984   35688999999999999999999999977654


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ......+...-               .                      .  ........++.++.+|+.+||+.||++|
T Consensus       207 ~~~~~~~~~~~---------------~----------------------~--~~~~~~~~~~~~~~~li~~~l~~~P~~R  247 (285)
T cd05632         207 KVKREEVDRRV---------------L----------------------E--TEEVYSAKFSEEAKSICKMLLTKDPKQR  247 (285)
T ss_pred             HHHHHHHHHhh---------------h----------------------c--cccccCccCCHHHHHHHHHHccCCHhHc
Confidence            33322221100               0                      0  0001123467889999999999999999


Q ss_pred             CC-----HHHHHcCccccCC
Q psy17952        480 PS-----SGRLLTHDLVTRP  494 (804)
Q Consensus       480 ps-----a~elL~Hp~~~~~  494 (804)
                      ||     +.+++.|+||...
T Consensus       248 ~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         248 LGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             CCCcccChHHHHcChhhhcC
Confidence            99     8999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-40  Score=354.90  Aligned_cols=279  Identities=25%  Similarity=0.407  Sum_probs=210.8

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+.++.||.|+||.||+|++..+++.||||.+..... .......+.+|++++++++||||+++++++...+..|+||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            7889999999999999999999999999998864321 222335678999999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.+++.+.+.                                ......+++..+..++.|++.||+|||++|++||||||
T Consensus        81 ~~~~l~~~~~--------------------------------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p  128 (284)
T cd07860          81 LHQDLKKFMD--------------------------------ASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP  128 (284)
T ss_pred             cccCHHHHHH--------------------------------hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence            9876544332                                01234688999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +||+++.++.+||+|||++.....    .....+++.|+|||++.+  ...++.++|||||||++|||++|+.||.+.+.
T Consensus       129 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~  206 (284)
T cd07860         129 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE  206 (284)
T ss_pred             HHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEec--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            999999999999999999865322    123457889999998753  23467889999999999999999999988877


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ...+..+........ ...|+.+..+.......+.+.. ..   +.         ......+.++++||.+||+.||++|
T Consensus       207 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~---~~---------~~~~~~~~~~~~li~~~l~~~P~~R  272 (284)
T cd07860         207 IDQLFRIFRTLGTPD-EVVWPGVTSLPDYKPSFPKWAR-QD---FS---------KVVPPLDEDGRDLLSQMLHYDPNKR  272 (284)
T ss_pred             HHHHHHHHHHhCCCC-hhhhhhhhHHHHHHhhcccccc-cC---HH---------HHcccCCHHHHHHHHHhcCCCcccC
Confidence            666666554322111 1111111111111001111000 00   00         0012457889999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy17952        480 PSSGRLLTHDLV  491 (804)
Q Consensus       480 psa~elL~Hp~~  491 (804)
                      ||++++|+||||
T Consensus       273 pt~~~~l~~~~f  284 (284)
T cd07860         273 ISAKAALAHPFF  284 (284)
T ss_pred             CCHHHHhcCCCC
Confidence            999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=349.68  Aligned_cols=258  Identities=45%  Similarity=0.798  Sum_probs=210.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+..+.||.|+||.||+|++..+++.||+|.+....  .......+.+|+++++.++||||+++++++..+...|+|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            5889999999999999999999999999999876422  22334567899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+.+                                  . ..++++..+..++.|++.||.|||+++|+||||
T Consensus        80 ~~~~~~L~~~~----------------------------------~-~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl  124 (274)
T cd06609          80 YCGGGSCLDLL----------------------------------K-PGKLDETYIAFILREVLLGLEYLHEEGKIHRDI  124 (274)
T ss_pred             eeCCCcHHHHH----------------------------------h-hcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99864 32222                                  1 226889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||++++++.++|+|||+++....    .....|++.|+|||++.+   ..++.++|||||||++|+|++|++||...
T Consensus       125 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~sDv~slG~il~~l~tg~~p~~~~  201 (274)
T cd06609         125 KAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ---SGYDEKADIWSLGITAIELAKGEPPLSDL  201 (274)
T ss_pred             CHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99999999999999999999865432    234678999999999853   45889999999999999999999999766


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +.......+....                                         .+......++.++.+++.+||..||+
T Consensus       202 ~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~l~~~l~~~p~  240 (274)
T cd06609         202 HPMRVLFLIPKNN-----------------------------------------PPSLEGNKFSKPFKDFVSLCLNKDPK  240 (274)
T ss_pred             chHHHHHHhhhcC-----------------------------------------CCCCcccccCHHHHHHHHHHhhCChh
Confidence            5444333332211                                         11111122678899999999999999


Q ss_pred             CCCCHHHHHcCccccCCCCCchhH
Q psy17952        478 DRPSSGRLLTHDLVTRPRSPSVLV  501 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~~~~~~~~  501 (804)
                      +|||++++++||||..........
T Consensus       241 ~Rpt~~~il~~~~~~~~~~~~~~~  264 (274)
T cd06609         241 ERPSAKELLKHKFIKKAKKTSYLT  264 (274)
T ss_pred             hCcCHHHHhhChhhcCCCcccHHH
Confidence            999999999999998866554333

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-40  Score=354.27  Aligned_cols=242  Identities=18%  Similarity=0.237  Sum_probs=195.0

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee----cCceEEEEee
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR----DHTAWLVMEY  243 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----~~~~~lVmEy  243 (804)
                      ..||+|++|.||+|..  +|+.||||.++..........+.+.+|+.+|++++|||||++++++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999976  788999999875443333335677899999999999999999999877    3578999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDV  321 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRDL  321 (804)
                      |.|+ |.+++                                  ...+.+++.....++.|++.||.|||+ .+++||||
T Consensus       104 ~~~g~L~~~l----------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdl  149 (283)
T PHA02988        104 CTRGYLREVL----------------------------------DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL  149 (283)
T ss_pred             CCCCcHHHHH----------------------------------hhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcC
Confidence            9875 33322                                  233467888999999999999999998 49999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      ||+|||++.++.+||+|||+++.... .....||+.|+|||++.+. .+.|+.++|||||||++|||++|+.||.+.+..
T Consensus       150 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~  228 (283)
T PHA02988        150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDI-FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK  228 (283)
T ss_pred             ChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhc-cccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999999999875432 2346799999999998531 256899999999999999999999999887765


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      +....+......                                        + ..+...++++++|+.+||+.||++||
T Consensus       229 ~~~~~i~~~~~~----------------------------------------~-~~~~~~~~~l~~li~~cl~~dp~~Rp  267 (283)
T PHA02988        229 EIYDLIINKNNS----------------------------------------L-KLPLDCPLEIKCIVEACTSHDSIKRP  267 (283)
T ss_pred             HHHHHHHhcCCC----------------------------------------C-CCCCcCcHHHHHHHHHHhcCCcccCc
Confidence            555444322110                                        0 01124578899999999999999999


Q ss_pred             CHHHHHc
Q psy17952        481 SSGRLLT  487 (804)
Q Consensus       481 sa~elL~  487 (804)
                      |+++++.
T Consensus       268 s~~ell~  274 (283)
T PHA02988        268 NIKEILY  274 (283)
T ss_pred             CHHHHHH
Confidence            9999984

>KOG0604|consensus

Probab=100.00  E-value=1.9e-41  Score=346.71  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             cccc-cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeec----Cce
Q psy17952        164 FEDL-REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRD----HTA  237 (804)
Q Consensus       164 y~~l-~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~----~~~  237 (804)
                      |.+- ++||-|-.|.|..|.++.|++.+|+|.+...        ....+|+++--.. .|||||.++++|++.    ..+
T Consensus        63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             heehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4433 6799999999999999999999999987521        3457888876555 599999999998753    457


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR--PLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~--~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+|||+++||                                 +||..+..++  .|+|.++..|++||..|+.|||+.+
T Consensus       135 LiVmE~meGG---------------------------------eLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n  181 (400)
T KOG0604|consen  135 LIVMECMEGG---------------------------------ELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN  181 (400)
T ss_pred             Eeeeecccch---------------------------------HHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc
Confidence            7899999987                                 4555555544  4999999999999999999999999


Q ss_pred             CeecCCCCCCeeecC---CCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~---~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |.||||||+|+|.+.   +..+||+|||+|+....   ..+.|-||+|.|||++   ...+|+..+|+||+||++|-||.
T Consensus       182 IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl---g~eKydkscdmwSlgVimYIlLC  258 (400)
T KOG0604|consen  182 IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL---GPEKYDKSCDMWSLGVIMYILLC  258 (400)
T ss_pred             hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh---CchhcCCCCCccchhHHHHHhhc
Confidence            999999999999975   44799999999987553   2467899999999998   34679999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.|||.......                              .+|-     +....+..+..+|.......|+..+|+|+
T Consensus       259 GyPPFYS~hg~a------------------------------ispg-----Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR  303 (400)
T KOG0604|consen  259 GYPPFYSNHGLA------------------------------ISPG-----MKRRIRTGQYEFPEPEWSCVSEAAKDLIR  303 (400)
T ss_pred             CCCcccccCCcc------------------------------CChh-----HHhHhhccCccCCChhHhHHHHHHHHHHH
Confidence            999997543210                              0000     00011112223444445567899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ++|..+|++|.|+.+++.|||+.+.
T Consensus       304 ~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  304 KLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHhcCCchhheeHHHhhcCchhccc
Confidence            9999999999999999999999864

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=347.10  Aligned_cols=257  Identities=47%  Similarity=0.898  Sum_probs=208.1

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      |.+.|++.+.||+|+||.||+|.+..+++.+|+|.+....   ....+.+.+|+.++++++||||+++++++...+.+|+
T Consensus         1 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             CccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            4567999999999999999999999999999999876432   2245678899999999999999999999999999999


Q ss_pred             EEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||+.|+. .+++.                                 .....+++.++..++.|++.||.|||++||+|
T Consensus        78 ~~e~~~~~~l~~~~~---------------------------------~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h  124 (262)
T cd06613          78 VMEYCGGGSLQDIYQ---------------------------------VTRGPLSELQIAYVCRETLKGLAYLHETGKIH  124 (262)
T ss_pred             EEeCCCCCcHHHHHH---------------------------------hhccCCCHHHHHHHHHHHHHHHHHHHhCCcee
Confidence            999998753 22221                                 11256899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||||+||+++.++.+||+|||++.....    .....|+..|+|||.+.+.....++.++|+|||||++|||++|++||
T Consensus       125 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~  204 (262)
T cd06613         125 RDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM  204 (262)
T ss_pred             cCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999865332    23457899999999985432236888999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+.......+.....+                    ++.                  ......++.++.+|+.+||..
T Consensus       205 ~~~~~~~~~~~~~~~~~~--------------------~~~------------------~~~~~~~~~~~~~li~~~l~~  246 (262)
T cd06613         205 FDLHPMRALFLISKSNFP--------------------PPK------------------LKDKEKWSPVFHDFIKKCLTK  246 (262)
T ss_pred             CCCCHHHHHHHHHhccCC--------------------Ccc------------------ccchhhhhHHHHHHHHHHcCC
Confidence            887665554444322100                    000                  001123577899999999999


Q ss_pred             CCCCCCCHHHHHcCcc
Q psy17952        475 NPADRPSSGRLLTHDL  490 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~  490 (804)
                      ||.+|||+.+++.|+|
T Consensus       247 ~p~~Rpt~~~il~~~~  262 (262)
T cd06613         247 DPKKRPTATKLLQHPF  262 (262)
T ss_pred             ChhhCCCHHHHhcCCC
Confidence            9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0576|consensus

Probab=100.00  E-value=1.4e-41  Score=377.33  Aligned_cols=263  Identities=43%  Similarity=0.821  Sum_probs=227.2

Q ss_pred             CCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       157 ~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.+|.+.|+.+..+|+|+||.||+|+++.+++..|+|.++....   ..+.-+.+|+-+++.++|||||-|++.|..++.
T Consensus        10 rrnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   10 RRNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             hcCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            34888899999999999999999999999999999999875432   334567789999999999999999999999999


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      +|++||||.|| +.|+.                                  .-.++++|.++..+++..+.||+|||++|
T Consensus        87 lwicMEycgggslQdiy----------------------------------~~TgplselqiayvcRetl~gl~ylhs~g  132 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIY----------------------------------HVTGPLSELQIAYVCRETLQGLKYLHSQG  132 (829)
T ss_pred             cEEEEEecCCCccccee----------------------------------eecccchhHHHHHHHhhhhccchhhhcCC
Confidence            99999999865 43322                                  13578999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEeccccccc----CCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~----~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      -+|||||-.|||+++.|.+|++|||.+...    ....++.|||+|||||+-.-...+.|+.++|||++|++..||..-+
T Consensus       133 k~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLq  212 (829)
T KOG0576|consen  133 KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQ  212 (829)
T ss_pred             cccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcC
Confidence            999999999999999999999999998543    2356899999999999986556788999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +|.++..++..++.+.+...                    .||.                  ......|++.|.+|++.|
T Consensus       213 pplfdlhpmr~l~LmTkS~~--------------------qpp~------------------lkDk~kws~~fh~fvK~a  254 (829)
T KOG0576|consen  213 PPLFDLHPMRALFLMTKSGF--------------------QPPT------------------LKDKTKWSEFFHNFVKGA  254 (829)
T ss_pred             CcccccchHHHHHHhhccCC--------------------CCCc------------------ccCCccchHHHHHHHHHH
Confidence            99999999988887754321                    1111                  112356899999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |.++|.+|||++.+|+|||+.+.
T Consensus       255 ltknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  255 LTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             hcCCCccCCChhhheeceeeccc
Confidence            99999999999999999999876

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-41  Score=352.05  Aligned_cols=255  Identities=38%  Similarity=0.625  Sum_probs=202.9

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||+|+||+||++++..+++.||+|.+...... ........+|+.++++++||||+++++++......++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence            78899999999999999999999999999998754322 22223445699999999999999999999999999999999


Q ss_pred             cCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.| ++.+++.                                  ..+.+++..+..++.|+++||.|||++||+|||||
T Consensus        80 ~~~~~L~~~l~----------------------------------~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dik  125 (260)
T PF00069_consen   80 CPGGSLQDYLQ----------------------------------KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIK  125 (260)
T ss_dssp             ETTEBHHHHHH----------------------------------HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBS
T ss_pred             ccccccccccc----------------------------------ccccccccccccccccccccccccccccccccccc
Confidence            987 4443332                                  24568899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEeccccccc----CCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~----~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||++...    .......||+.|+|||++.  ....++.++||||+|+++|+|++|..||...+
T Consensus       126 p~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~  203 (260)
T PF00069_consen  126 PENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQ--QGKKYTRKSDIWSLGIILYELLTGKLPFEESN  203 (260)
T ss_dssp             GGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHT--TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc
Confidence            99999999999999999998642    2234567999999999984  13567889999999999999999999998764


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+....+.+...+           .                   +..      ........+..+.+++.+||..||++
T Consensus       204 ~~~~~~~~~~~~~~-----------~-------------------~~~------~~~~~~~~~~~l~~li~~~l~~~p~~  247 (260)
T PF00069_consen  204 SDDQLEIIEKILKR-----------P-------------------LPS------SSQQSREKSEELRDLIKKMLSKDPEQ  247 (260)
T ss_dssp             HHHHHHHHHHHHHT-----------H-------------------HHH------HTTSHTTSHHHHHHHHHHHSSSSGGG
T ss_pred             chhhhhhhhhcccc-----------c-------------------ccc------cccccchhHHHHHHHHHHHccCChhH
Confidence            33333332211000           0                   000      00000112478999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy17952        479 RPSSGRLLTHDLV  491 (804)
Q Consensus       479 Rpsa~elL~Hp~~  491 (804)
                      |||+.++++||||
T Consensus       248 R~~~~~l~~~~~~  260 (260)
T PF00069_consen  248 RPSAEELLKHPWF  260 (260)
T ss_dssp             STTHHHHHTSGGG
T ss_pred             CcCHHHHhcCCCC
Confidence            9999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-40  Score=356.34  Aligned_cols=262  Identities=37%  Similarity=0.652  Sum_probs=212.9

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      +...++.+.|+..+.||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (296)
T cd06655          12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVG   88 (296)
T ss_pred             HhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence            344566678999999999999999999999999999999886422   22345678999999999999999999999999


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      +..|+||||+.|+...-                                 ++ ....+++.++..++.|++.||+|||++
T Consensus        89 ~~~~lv~e~~~~~~L~~---------------------------------~~-~~~~l~~~~~~~i~~~l~~al~~LH~~  134 (296)
T cd06655          89 DELFVVMEYLAGGSLTD---------------------------------VV-TETCMDEAQIAAVCRECLQALEFLHAN  134 (296)
T ss_pred             ceEEEEEEecCCCcHHH---------------------------------HH-HhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999999998753211                                 11 123588999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      |++||||||+||+++.++.+||+|||++......    ....|++.|+|||.+.   ...++.++|||||||++|+|++|
T Consensus       135 ~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slGvil~~lltg  211 (296)
T cd06655         135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMVEG  211 (296)
T ss_pred             CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhc---CCCCCchhhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998653322    2357899999999884   35678899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||.+.+....+..+.....+.                                        ......+++.+.+||.+
T Consensus       212 ~~pf~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~li~~  251 (296)
T cd06655         212 EPPYLNENPLRALYLIATNGTPE----------------------------------------LQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCCCCCCCHHHHHHHHHhcCCcc----------------------------------------cCCcccCCHHHHHHHHH
Confidence            99998776655444332211110                                        01123467889999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ||..||.+|||+.+++.||||.....
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhccc
Confidence            99999999999999999999976544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-40  Score=352.92  Aligned_cols=282  Identities=24%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||+|.+..+++.||||.+......  .....+.+|++++++++||||+++++++.+++..|+||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            3589999999999999999999999999999988643221  12234678999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.+++.+++.                                 .....+++..+..++.|+++||.|||++||+||||
T Consensus        83 e~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl  129 (291)
T cd07844          83 EYLDTDLKQYMD---------------------------------DCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDL  129 (291)
T ss_pred             ecCCCCHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Confidence            999886544332                                 11346789999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+++....    .....+++.|+|||++.+  ...++.++||||+||++|||++|++||.+.
T Consensus       130 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         130 KPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG--STEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             CHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhc--CcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999864321    123457889999998753  245788999999999999999999999766


Q ss_pred             C-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 N-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      + ..+.+..+...... .....|..+..........-+....   ..+.    ...   .......++.+++.+||+.||
T Consensus       208 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----~~~---~~~~~~~~~~~li~~~L~~~p  276 (291)
T cd07844         208 TDVEDQLHKIFRVLGT-PTEETWPGVSSNPEFKPYSFPFYPP---RPLI----NHA---PRLDRIPHGEELALKFLQYEP  276 (291)
T ss_pred             ccHHHHHHHHHHhcCC-CChhhhhhhhhccccccccccccCC---hhHH----HhC---cCCCCchhHHHHHHHHhccCc
Confidence            5 33333333221110 0011111111100000000000000   0000    000   011123788999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy17952        477 ADRPSSGRLLTHDLV  491 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~  491 (804)
                      ++|||+.++|+||||
T Consensus       277 ~~Rps~~e~l~~~~f  291 (291)
T cd07844         277 KKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccCHHHHhcCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.8e-40  Score=355.84  Aligned_cols=285  Identities=29%  Similarity=0.435  Sum_probs=214.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--Cce
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTA  237 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~  237 (804)
                      +-+.|++.+.||+|+||.||+|.+..+++.||+|.++..... ......+.+|+.++++++||||+++++++...  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            445699999999999999999999999999999987643221 12223457899999999999999999998765  568


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+||||+.+++.+++..                                 ....+++.++..++.|++.||.|||++|++
T Consensus        84 ~lv~e~~~~~l~~~l~~---------------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  130 (309)
T cd07845          84 FLVMEYCEQDLASLLDN---------------------------------MPTPFSESQVKCLMLQLLRGLQYLHENFII  130 (309)
T ss_pred             EEEEecCCCCHHHHHHh---------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            99999998876554421                                 124689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||||+||+++.++.+||+|||++......    ....+++.|+|||++.+  ...++.++|||||||++|||++|++|
T Consensus       131 H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~~  208 (309)
T cd07845         131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG--CTTYTTAIDMWAVGCILAELLAHKPL  208 (309)
T ss_pred             cCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcC--CCCcCchHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998754321    22356888999999853  24578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHHHHHHh
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~dli~~c  471 (804)
                      |.+.+....+..+.+...... ...|+.+........              +........  .......++.+.+||.+|
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~m  273 (309)
T cd07845         209 LPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPLVGK--------------FTLPKQPYNNLKHKFPWLSEAGLRLLNFL  273 (309)
T ss_pred             CCCCCHHHHHHHHHHhcCCCC-hhhchhhhccccccc--------------ccccCCCCCchHHhccccCHHHHHHHHHH
Confidence            999888887777665322111 111211111110000              000000000  000122578899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      |+.||++|||+.++|+||||....
T Consensus       274 l~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         274 LMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hcCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-39  Score=343.32  Aligned_cols=250  Identities=30%  Similarity=0.534  Sum_probs=201.9

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-cCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-DHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-~~~~~lVmE  242 (804)
                      |++++.||+|+||.||++.+..+++.||+|++.... ......+.+.+|++++++++|||++++++.+.. +..+|++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            889999999999999999999999999999986422 122334567889999999999999999998764 446899999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |++|+ +.+.+.                                ......+++.++..++.|++.||+|||++||+||||
T Consensus        81 ~~~~~~l~~~l~--------------------------------~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di  128 (257)
T cd08223          81 FCEGGDLYHKLK--------------------------------EQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDL  128 (257)
T ss_pred             ccCCCcHHHHHH--------------------------------HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence            99864 332221                                011345899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||+++.++.+||+|||++.....    .....|++.|+|||++.   ...++.++|||||||++|+|++|+.||...
T Consensus       129 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  205 (257)
T cd08223         129 KTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS---NKPYNYKSDVWALGCCVYEMATLKHAFNAK  205 (257)
T ss_pred             CchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhc---CCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999865422    23457899999999984   356788999999999999999999999776


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +.....+.+..+..+                                          .....+++.+.+|+.+||+.||+
T Consensus       206 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~~l~~~p~  243 (257)
T cd08223         206 DMNSLVYRIIEGKLP------------------------------------------PMPKDYSPELGELIATMLSKRPE  243 (257)
T ss_pred             CHHHHHHHHHhcCCC------------------------------------------CCccccCHHHHHHHHHHhccCcc
Confidence            554444333221110                                          01134678899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.++++||||
T Consensus       244 ~Rp~~~~~l~~~~~  257 (257)
T cd08223         244 KRPSVKSILRQPYI  257 (257)
T ss_pred             cCCCHHHHhcCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.4e-40  Score=350.73  Aligned_cols=260  Identities=31%  Similarity=0.515  Sum_probs=204.0

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHH-HhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF-LRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|++.+.||+|+||.||+|++..+++.||||.++....  ......+..|+.+ ++.++||||+++++++..++..|++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            48889999999999999999999999999998864321  1122345667665 66678999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRD  320 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiHRD  320 (804)
                      ||++|++.+++...                              ......+++..+..++.||+.||+|||++ +++|||
T Consensus        80 e~~~~~l~~~l~~~------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~d  129 (283)
T cd06617          80 EVMDTSLDKFYKKV------------------------------YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRD  129 (283)
T ss_pred             hhhcccHHHHHHHh------------------------------ccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCC
Confidence            99998766554310                              11235689999999999999999999997 999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~-~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||++......   ....||..|+|||++.+... ..++.++|+|||||++|||++|+.||..
T Consensus       130 lkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         130 VKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             CCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            9999999999999999999998754321   23568999999998854222 4578899999999999999999999964


Q ss_pred             CC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        397 MN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       397 ~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      .. ..+.+..+.+.                                         ..+......+|.++.+|+.+||..+
T Consensus       210 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~l~~li~~~l~~~  248 (283)
T cd06617         210 WKTPFQQLKQVVEE-----------------------------------------PSPQLPAEKFSPEFQDFVNKCLKKN  248 (283)
T ss_pred             cccCHHHHHHHHhc-----------------------------------------CCCCCCccccCHHHHHHHHHHccCC
Confidence            22 22222211111                                         1111222346889999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCC
Q psy17952        476 PADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~~~~  495 (804)
                      |.+|||+.+++.||||....
T Consensus       249 p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         249 YKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             hhhCcCHHHHhcCchhhhcc
Confidence            99999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.5e-40  Score=352.77  Aligned_cols=251  Identities=29%  Similarity=0.444  Sum_probs=206.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|++++++++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            48899999999999999999999999999998864332233445678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+.+                                  ...+.+++..+..++.|+++||.|||++||+||||
T Consensus        82 ~~~~~~L~~~~----------------------------------~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl  127 (290)
T cd05580          82 YVPGGELFSHL----------------------------------RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDL  127 (290)
T ss_pred             cCCCCCHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence            99654 33322                                  23457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      ||+|||++.++.+||+|||++..... ....+||+.|+|||.+.   ...++.++|||||||++|+|++|+.||...+..
T Consensus       128 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  204 (290)
T cd05580         128 KPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIIL---SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI  204 (290)
T ss_pred             CHHHEEECCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhc---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999875433 23457999999999884   345788999999999999999999999776644


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      .....+..+..                                           ..+..++..+++++.+||..||.+|+
T Consensus       205 ~~~~~~~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~R~  241 (290)
T cd05580         205 QIYEKILEGKV-------------------------------------------RFPSFFSPDAKDLIRNLLQVDLTKRL  241 (290)
T ss_pred             HHHHHHhcCCc-------------------------------------------cCCccCCHHHHHHHHHHccCCHHHcc
Confidence            33333321110                                           01123578899999999999999999


Q ss_pred             -----CHHHHHcCccccC
Q psy17952        481 -----SSGRLLTHDLVTR  493 (804)
Q Consensus       481 -----sa~elL~Hp~~~~  493 (804)
                           +++++++||||..
T Consensus       242 ~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         242 GNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             CcccCCHHHHHcCccccc
Confidence                 9999999999965

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-39  Score=351.29  Aligned_cols=282  Identities=27%  Similarity=0.434  Sum_probs=212.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLV  240 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~lV  240 (804)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++...  +..|+|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            489999999999999999999999999999998643322 22234567899999999999999999998877  899999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||+.+++.+++..                                 ....+++..+..++.||+.||+|||++||+|||
T Consensus        85 ~e~~~~~L~~~~~~---------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~d  131 (293)
T cd07843          85 MEYVEHDLKSLMET---------------------------------MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD  131 (293)
T ss_pred             ehhcCcCHHHHHHh---------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            99998876554421                                 123589999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||++.....    .....+++.|+|||.+.+  ...++.++|||||||++|||++|.+||..
T Consensus       132 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         132 LKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG--AKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             CCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcC--CccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999865332    223568899999998853  23467899999999999999999999998


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+....+..+...... .....|..+..+........+...       +....   ...+...+++.+.+||.+||+.||
T Consensus       210 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~~~~li~~~l~~~p  278 (293)
T cd07843         210 KSEIDQLNKIFKLLGT-PTEKIWPGFSELPGAKKKTFTKYP-------YNQLR---KKFPALSLSDNGFDLLNRLLTYDP  278 (293)
T ss_pred             CChHHHHHHHHHHhCC-CchHHHHHhhccchhccccccccc-------chhhh---ccccccCCChHHHHHHHHHhccCc
Confidence            8877766665442211 111223222211111100000000       00000   011111258889999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy17952        477 ADRPSSGRLLTHDLV  491 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~  491 (804)
                      ++|||+.|+|.||||
T Consensus       279 ~~R~t~~ell~~~~f  293 (293)
T cd07843         279 AKRISAEDALKHPYF  293 (293)
T ss_pred             cccCCHHHHhcCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-39  Score=350.21  Aligned_cols=282  Identities=25%  Similarity=0.379  Sum_probs=204.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++++.||+|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.++||||+++++++..++..|+||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            358999999999999999999999999999998764322  122235678999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.+++.+.+.                                 .....+++..+..++.|++.||.|||++||+||||
T Consensus        83 e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl  129 (291)
T cd07870          83 EYMHTDLAQYMI---------------------------------QHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL  129 (291)
T ss_pred             ecccCCHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            999876543221                                 12345788889999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+++....    .....+++.|+|||++.+  ...++.++|||||||++|||++|.+||.+.
T Consensus       130 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG--ATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             ChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeec--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999999865321    233568999999998753  234778999999999999999999999765


Q ss_pred             ChH-HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAM-SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~-~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      +.. +.+..+...... .....+.....+..   ..+.++.......+..       .......+.++.+|+.+||+.||
T Consensus       208 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ll~~~l~~dp  276 (291)
T cd07870         208 SDVFEQLEKIWTVLGV-PTEDTWPGVSKLPN---YKPEWFLPCKPQQLRV-------VWKRLSRPPKAEDLASQMLMMFP  276 (291)
T ss_pred             hhHHHHHHHHHHHcCC-CChhhhhhhhhccc---ccchhccccCCcchhh-------hccccCCChHHHHHHHHHhCcCc
Confidence            532 333333221110 00111111111100   0000000000000000       00111236789999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy17952        477 ADRPSSGRLLTHDLV  491 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~  491 (804)
                      ++|||+.|++.||||
T Consensus       277 ~~R~t~~~~l~h~~~  291 (291)
T cd07870         277 KDRISAQDALLHPYF  291 (291)
T ss_pred             ccCcCHHHHhcCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-39  Score=347.82  Aligned_cols=255  Identities=43%  Similarity=0.799  Sum_probs=208.2

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ++..|+.++.||+|+||.||+|.+..+++.||||.+...  ........+.+|+.++++++||||+++++++.+++..|+
T Consensus         2 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             hHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            566799999999999999999999999999999987632  222345678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+.+                                   ..+++++.++..++.|++.||+|||+.+++|
T Consensus        80 v~e~~~~~~L~~~i-----------------------------------~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH  124 (277)
T cd06640          80 IMEYLGGGSALDLL-----------------------------------RAGPFDEFQIATMLKEILKGLDYLHSEKKIH  124 (277)
T ss_pred             EEecCCCCcHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            99999875 22221                                   1346888999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      +||+|+||+++.++.++|+|||++.....    .....+|..|+|||++.   ...++.++|+|||||++|||++|.+||
T Consensus       125 ~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06640         125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDSKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             cCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhc---cCCCccHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999865332    22356889999999984   346788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+.......+..+..                                         + .....++..+.+|+.+||+.
T Consensus       202 ~~~~~~~~~~~~~~~~~-----------------------------------------~-~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         202 SDMHPMRVLFLIPKNNP-----------------------------------------P-TLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             CCcChHhHhhhhhcCCC-----------------------------------------C-CCchhhhHHHHHHHHHHccc
Confidence            77655443322211100                                         0 11123567889999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      +|++||++.++++|+||.+...
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         240 DPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             CcccCcCHHHHHhChHhhhcch
Confidence            9999999999999999976544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.5e-40  Score=363.44  Aligned_cols=288  Identities=26%  Similarity=0.363  Sum_probs=208.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      +.|+.++.||+|+||.||+|++..+++.||||.+..... .......+.+|+.++++++||||++++++|....      
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            459999999999999999999999999999998753221 2233456778999999999999999999886543      


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+|||||.|++.+.+.                                    ..+++..+..++.|++.||+|||++|
T Consensus        95 ~~~lv~e~~~~~l~~~~~------------------------------------~~l~~~~~~~~~~ql~~aL~~LH~~g  138 (353)
T cd07850          95 DVYLVMELMDANLCQVIQ------------------------------------MDLDHERMSYLLYQMLCGIKHLHSAG  138 (353)
T ss_pred             cEEEEEeccCCCHHHHHh------------------------------------hcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            579999999887544331                                    12788899999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |+||||||+|||++.++.+||+|||+++.....   ....||+.|+|||++.   +..++.++|||||||++|+|++|+.
T Consensus       139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~  215 (353)
T cd07850         139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGTV  215 (353)
T ss_pred             eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHh---CCCCCCchhhHhHHHHHHHHHHCCC
Confidence            999999999999999999999999999754322   3456899999999985   3568899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHh-hcccccCCCCccchhhhHHHHhhccCCCCCC---CCCCccHHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKT-ISSTAERKPPYFNMNAMSALYHIAQNDTPCL---QSSDWSDTFAHFV  468 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~-i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~---~~~~~s~~l~dli  468 (804)
                      ||...+.......+...-..... .....+.. +.......+. ........+.  .....+..   .....++.+.+||
T Consensus       216 pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li  291 (353)
T cd07850         216 LFPGTDHIDQWNKIIEQLGTPSD-EFMSRLQPTVRNYVENRPK-YAGYSFEELF--PDVLFPPDSESHNKLKASQARDLL  291 (353)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCH-HHHHHhhhhhhHHhhcCCC-CCCcchhhhC--cccccCcccccccccchhHHHHHH
Confidence            99887766655555432111000 00000000 0000000000 0000000000  00000000   0223567899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+||+.||++|||+.|+|.|||+..
T Consensus       292 ~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         292 SKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             HHHcCCChhhCcCHHHHhcChhHhh
Confidence            9999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-39  Score=341.89  Aligned_cols=250  Identities=30%  Similarity=0.512  Sum_probs=204.5

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+++++.++||||+++++++...+..|+||||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            6788999999999999999999999999998764322 233456788999999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+++..                                .....+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~  128 (256)
T cd08529          81 AENGDLHKLLKM--------------------------------QRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIK  128 (256)
T ss_pred             CCCCcHHHHHHH--------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9864 4333320                                013468899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+||+++.++.+||+|||+++.....    ....|++.|+|||++.   .+.++.++|+|||||++|||++|+.||...+
T Consensus       129 ~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         129 SLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE---DKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             cceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998754322    2357899999999984   3567889999999999999999999997766


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......+.++..+                                         . ....++..+.+++.+||+.+|++
T Consensus       206 ~~~~~~~~~~~~~~-----------------------------------------~-~~~~~~~~~~~~i~~~l~~~p~~  243 (256)
T cd08529         206 QGALILKIIRGVFP-----------------------------------------P-VSQMYSQQLAQLIDQCLTKDYRQ  243 (256)
T ss_pred             HHHHHHHHHcCCCC-----------------------------------------C-CccccCHHHHHHHHHHccCCccc
Confidence            54444333221110                                         0 11245788999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy17952        479 RPSSGRLLTHDLV  491 (804)
Q Consensus       479 Rpsa~elL~Hp~~  491 (804)
                      ||++.++++|||+
T Consensus       244 Rp~~~~ll~~~~~  256 (256)
T cd08529         244 RPDTFQLLRNPSL  256 (256)
T ss_pred             CcCHHHHhhCCCC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-39  Score=345.12  Aligned_cols=249  Identities=31%  Similarity=0.573  Sum_probs=201.3

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccc------hhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC------AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~------~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+.......      ....+.+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            667789999999999999999899999999875432211      12235678899999999999999999999999999


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +++|||++|+ +.+++                                  ...+.+++..+..++.|++.||+|||++|+
T Consensus        82 ~lv~e~~~~~~L~~~l----------------------------------~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i  127 (267)
T cd06628          82 NIFLEYVPGGSVAALL----------------------------------NNYGAFEETLVRNFVRQILKGLNYLHNRGI  127 (267)
T ss_pred             EEEEEecCCCCHHHHH----------------------------------HhccCccHHHHHHHHHHHHHHHHHHHhcCc
Confidence            9999999864 32222                                  233568889999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      +||||||+|||+++++.+||+|||+++....          .....|++.|+|||.+.   .+.++.++|+|||||++|+
T Consensus       128 vH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~il~~  204 (267)
T cd06628         128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK---QTSYTRKADIWSLGCLVVE  204 (267)
T ss_pred             ccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhc---cCCCCchhhhHHHHHHHHH
Confidence            9999999999999999999999999864431          11346889999999984   3567889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|+.||.+.+....+..+....                                         .+. ....++..+.+
T Consensus       205 l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------------------~~~-~~~~~~~~~~~  242 (267)
T cd06628         205 MLTGKHPFPDCTQLQAIFKIGENA-----------------------------------------SPE-IPSNISSEAID  242 (267)
T ss_pred             HhhCCCCCCCccHHHHHHHHhccC-----------------------------------------CCc-CCcccCHHHHH
Confidence            999999998765444333322110                                         000 11346788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      ||.+||+.||.+||++.++++||||
T Consensus       243 li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         243 FLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.9e-40  Score=355.62  Aligned_cols=268  Identities=38%  Similarity=0.666  Sum_probs=215.4

Q ss_pred             cCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       156 ~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      ...++.+.|.....||+|+||.||++.+..+++.||||.+...   .....+.+.+|+.+++.++||||+++++.+...+
T Consensus        16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~   92 (292)
T cd06658          16 SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD   92 (292)
T ss_pred             ccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence            3455667788889999999999999999999999999987532   2233456889999999999999999999999999


Q ss_pred             ceEEEEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+||||+.|+. .+++                                   ..+.+++..+..++.||+.||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~~-----------------------------------~~~~l~~~~~~~~~~qi~~~l~~LH~~  137 (292)
T cd06658          93 ELWVVMEFLEGGALTDIV-----------------------------------THTRMNEEQIATVCLSVLRALSYLHNQ  137 (292)
T ss_pred             eEEEEEeCCCCCcHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            9999999998753 2211                                   123578899999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||+||||||+||+++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|||||||++|||++|
T Consensus       138 ~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slGvil~el~~g  214 (292)
T cd06658         138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS---RLPYGTEVDIWSLGIMVIEMIDG  214 (292)
T ss_pred             CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHc---cCCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999999999999999999986432    123457899999999984   35688899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||.+.+....+..+.....                      +                  ........+..+.+|+.+
T Consensus       215 ~~p~~~~~~~~~~~~~~~~~~----------------------~------------------~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         215 EPPYFNEPPLQAMRRIRDNLP----------------------P------------------RVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             CCCCCCCCHHHHHHHHHhcCC----------------------C------------------ccccccccCHHHHHHHHH
Confidence            999987665444333221100                      0                  000112357889999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCCCchhHHHH
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI  504 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~  504 (804)
                      ||..||.+|||++++++||||.....+....+++
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~~~~  288 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGPPSCIVPLM  288 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCCccccchhh
Confidence            9999999999999999999999877776555444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5e-40  Score=394.04  Aligned_cols=259  Identities=29%  Similarity=0.503  Sum_probs=204.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~l  239 (804)
                      ..|++++.||+|+||.||+|++..+++.||+|.+..... .......+.+|+.+|++|+|||||+++++|...  ..+||
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            459999999999999999999999999999998864322 233446788999999999999999999988653  56899


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL----  314 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~----  314 (804)
                      |||||.| +|.+++...                              ....+.+++..++.|+.||+.||.|||+.    
T Consensus        92 VMEY~~gGSL~~lL~k~------------------------------~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~  141 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKC------------------------------YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGP  141 (1021)
T ss_pred             EEeCCCCCcHHHHHHHH------------------------------hhccCCCCHHHHHHHHHHHHHHHHHHHhccccc
Confidence            9999985 554444311                              11235689999999999999999999985    


Q ss_pred             ---CCeecCCCCCCeeecC-----------------CCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCC
Q psy17952        315 ---GRIHRDVKAGNILLTE-----------------TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQY  371 (804)
Q Consensus       315 ---gIiHRDLKP~NILl~~-----------------~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y  371 (804)
                         +||||||||+||||+.                 .+.+||+|||++.....   ....+||+.|+|||++.+. ...+
T Consensus       142 ~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-~~~~  220 (1021)
T PTZ00266        142 NGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-TKSY  220 (1021)
T ss_pred             ccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-CCCC
Confidence               4999999999999964                 23589999999975432   2345799999999998542 3458


Q ss_pred             CCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCC
Q psy17952        372 DGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND  451 (804)
Q Consensus       372 ~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~  451 (804)
                      +.++||||||||||||++|..||...+....+.......                                         
T Consensus       221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~-----------------------------------------  259 (1021)
T PTZ00266        221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG-----------------------------------------  259 (1021)
T ss_pred             CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC-----------------------------------------
Confidence            889999999999999999999997655444333222110                                         


Q ss_pred             CCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       452 ~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                       +.......+.++.+||.+||..+|.+|||+.|+|.|+|+...
T Consensus       260 -p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        260 -PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             -CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence             011112457889999999999999999999999999999754

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-39  Score=348.46  Aligned_cols=256  Identities=44%  Similarity=0.793  Sum_probs=203.3

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee----
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR----  233 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~----  233 (804)
                      ++...|++.+.||+|+||.||+|++..+++.+|+|.+....    .....+..|+.+++++ +||||+++++++..    
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            45667999999999999999999999999999999875321    2234577899999998 69999999999853    


Q ss_pred             --cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        234 --DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       234 --~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                        ....|++|||+.+ ++.+++..                                .....+++..+..++.||++||.|
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~qi~~al~~  136 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKN--------------------------------TKGNALKEDWIAYICREILRGLAH  136 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHH--------------------------------ccCCCCCHHHHHHHHHHHHHHHHH
Confidence              4578999999986 44443320                                112357888999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccC--CCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvil  384 (804)
                      ||++||+||||||+||+++.++.+||+|||++....    ......|++.|+|||++....  ...++.++|||||||++
T Consensus       137 LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l  216 (282)
T cd06636         137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA  216 (282)
T ss_pred             HHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence            999999999999999999999999999999986432    123467999999999975311  34578899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      |||++|.+||.+.........+...                                         ..+......++.++
T Consensus       217 ~el~~g~~p~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~  255 (282)
T cd06636         217 IEMAEGAPPLCDMHPMRALFLIPRN-----------------------------------------PPPKLKSKKWSKKF  255 (282)
T ss_pred             HHHHhCCCCccccCHHhhhhhHhhC-----------------------------------------CCCCCcccccCHHH
Confidence            9999999999765543333222110                                         01112234578899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      .+||.+||..||.+|||+.++|+||||
T Consensus       256 ~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         256 IDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-39  Score=342.38  Aligned_cols=251  Identities=47%  Similarity=0.857  Sum_probs=205.0

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      |++.|+..+.||+|+||.||+|....+++.+|+|.++...     ..+.+.+|++++++++||||+++++++..+...|+
T Consensus         1 ~~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             CcccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            4567999999999999999999999889999999875321     15678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||+.|+ +.+++.                                 .....+++..+..++.|++.||.|||+.+|+|
T Consensus        76 ~~e~~~~~~L~~~l~---------------------------------~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H  122 (256)
T cd06612          76 VMEYCGAGSVSDIMK---------------------------------ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH  122 (256)
T ss_pred             EEecCCCCcHHHHHH---------------------------------hCccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999864 333221                                 12356899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||+|+||+++.++.+||+|||++......    ....|+..|+|||++.   +..++.++|||||||++|+|++|++||
T Consensus       123 ~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~s~G~il~~l~~g~~p~  199 (256)
T cd06612         123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGYNNKADIWSLGITAIEMAEGKPPY  199 (256)
T ss_pred             CCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHh---cCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998754322    2356899999999984   346888999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      ...+.......+....                      ++                  .......++..+.+|+.+||+.
T Consensus       200 ~~~~~~~~~~~~~~~~----------------------~~------------------~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd06612         200 SDIHPMRAIFMIPNKP----------------------PP------------------TLSDPEKWSPEFNDFVKKCLVK  239 (256)
T ss_pred             CCcchhhhhhhhccCC----------------------CC------------------CCCchhhcCHHHHHHHHHHHhc
Confidence            7655443322221100                      00                  0001234678899999999999


Q ss_pred             CCCCCCCHHHHHcCccc
Q psy17952        475 NPADRPSSGRLLTHDLV  491 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~  491 (804)
                      ||++|||+.++|.||||
T Consensus       240 ~P~~Rps~~~il~~~~~  256 (256)
T cd06612         240 DPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ChhhCcCHHHHhcCCCC
Confidence            99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-39  Score=343.83  Aligned_cols=257  Identities=41%  Similarity=0.688  Sum_probs=205.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||.|+||+||+|.+..++..+|+|.+.....  ......+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            48899999999999999999988999999998754222  2245678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++..                               ......+++..+..++.|++.||.|||++||+||||
T Consensus        80 ~~~~~~l~~~~~~-------------------------------~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l  128 (267)
T cd06610          80 YLSGGSLLDIMKS-------------------------------SYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDI  128 (267)
T ss_pred             ccCCCcHHHHHHH-------------------------------hcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            99865 3332210                               001246889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC--------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~--------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||+||++++++.+||+|||++......        ....|++.|+|||++..  ...++.++|+|||||++|||++|+.|
T Consensus       129 ~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~~Dv~slG~i~~~l~~g~~p  206 (267)
T cd06610         129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ--VHGYDFKADIWSFGITAIELATGAAP  206 (267)
T ss_pred             CHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc--ccCcCcccchHhHhHHHHHHHhCCCC
Confidence            999999999999999999998643321        23478999999999853  23578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+.......+.+...+.                      +.               .......+++.+.+|+.+||+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~----------------------~~---------------~~~~~~~~~~~~~~li~~~l~  249 (267)
T cd06610         207 YSKYPPMKVLMLTLQNDPPS----------------------LE---------------TGADYKKYSKSFRKMISLCLQ  249 (267)
T ss_pred             ccccChhhhHHHHhcCCCCC----------------------cC---------------CccccccccHHHHHHHHHHcC
Confidence            97766544433332221110                      00               000123568899999999999


Q ss_pred             cCCCCCCCHHHHHcCccc
Q psy17952        474 KNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~  491 (804)
                      +||++|||+.++++||||
T Consensus       250 ~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         250 KDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             CChhhCcCHHHHhhCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-39  Score=348.42  Aligned_cols=281  Identities=26%  Similarity=0.414  Sum_probs=210.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++......|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            378899999999999999999999999999988643221 2334678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.+++.+++.                                 ....++++.++..++.||+.||+|||+.||+|+|||
T Consensus        80 ~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  126 (286)
T cd07832          80 YMPSDLSEVLR---------------------------------DEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK  126 (286)
T ss_pred             ccCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC
Confidence            99555444332                                 112468999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |+||+++.++.+||+|||++......     ....||..|+|||++.+  ...++.++||||+||++|||++|.+||.+.
T Consensus       127 p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--ARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             HHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeec--cccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            99999999999999999998754322     23578999999998753  345688999999999999999999999887


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +....+..+...-.... ...|.....+.......   +...         ............+..+.+|+.+||..||.
T Consensus       205 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~  271 (286)
T cd07832         205 NDIEQLAIVFRTLGTPN-EETWPGLTSLPDYNKIT---FPES---------KPIPLEEIFPDASPEALDLLKGLLVYDPS  271 (286)
T ss_pred             CHHHHHHHHHHHcCCCC-hHHHhhccCcchhhccc---CCCC---------CcchHHHhCCCccHHHHHHHHHHhccChh
Confidence            77666655543211100 01111110000000000   0000         00000001124568999999999999999


Q ss_pred             CCCCHHHHHcCcccc
Q psy17952        478 DRPSSGRLLTHDLVT  492 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~  492 (804)
                      +|||++++|+||||+
T Consensus       272 ~R~~~~~~l~h~~~~  286 (286)
T cd07832         272 KRLSAAEALRHPYFT  286 (286)
T ss_pred             hCCCHHHHhhCcCcC
Confidence            999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4279|consensus

Probab=100.00  E-value=4.9e-41  Score=371.85  Aligned_cols=248  Identities=29%  Similarity=0.536  Sum_probs=203.6

Q ss_pred             ccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC-C
Q psy17952        169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-S  247 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G-~  247 (804)
                      +||+|.||+||.|+++.|....|||.+..   ......+-+..||.+-++|+|.|||+|+|++..++.+-|.||-++| +
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe---kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE---KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc---ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            59999999999999999999999998863   2334556788899999999999999999999999999999999985 5


Q ss_pred             chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        248 ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPL--KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       248 l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l--~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      |.+++...                                 -+++  .|..+..+.+||++||.|||.+.|||||||-+|
T Consensus       659 LSsLLrsk---------------------------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDN  705 (1226)
T KOG4279|consen  659 LSSLLRSK---------------------------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDN  705 (1226)
T ss_pred             HHHHHHhc---------------------------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCc
Confidence            66665432                                 3556  788899999999999999999999999999999


Q ss_pred             eeec-CCCcEEEEeccccccc----CCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-h
Q psy17952        326 ILLT-ETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN-A  399 (804)
Q Consensus       326 ILl~-~~g~vKL~DFGla~~~----~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~-~  399 (804)
                      +||+ -.|.+||+|||-++..    .-..++.||..|||||+|-.. ...|+.++|||||||++.||+||+|||.... +
T Consensus       706 VLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG-~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp  784 (1226)
T KOG4279|consen  706 VLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQG-PRGYGKAADIWSFGCTMVEMATGRPPFVELGSP  784 (1226)
T ss_pred             EEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccC-CcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence            9996 4789999999987543    234578999999999999532 3468999999999999999999999997643 3


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ..+++++..                    .+.-|                     ..+...|.++++||.+|+..||.+|
T Consensus       785 qAAMFkVGm--------------------yKvHP---------------------~iPeelsaeak~FilrcFepd~~~R  823 (1226)
T KOG4279|consen  785 QAAMFKVGM--------------------YKVHP---------------------PIPEELSAEAKNFILRCFEPDPCDR  823 (1226)
T ss_pred             hHhhhhhcc--------------------eecCC---------------------CCcHHHHHHHHHHHHHHcCCCcccC
Confidence            333333210                    00001                     1124568999999999999999999


Q ss_pred             CCHHHHHcCccccCC
Q psy17952        480 PSSGRLLTHDLVTRP  494 (804)
Q Consensus       480 psa~elL~Hp~~~~~  494 (804)
                      |+|.++|..||+...
T Consensus       824 ~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  824 PSAKDLLQDPFLQHN  838 (1226)
T ss_pred             ccHHHhccCcccccC
Confidence            999999999999754

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.6e-40  Score=349.86  Aligned_cols=252  Identities=46%  Similarity=0.805  Sum_probs=205.1

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|+.++.||+|+||.||+|.+..+++.||+|.+....  .....+.+.+|+.++++++||||+++++++..++..|+
T Consensus         2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            4567999999999999999999999999999999876332  22344678899999999999999999999999999999


Q ss_pred             EEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+. .+.+                                   ....+++..+..++.|++.||.|||++||+|
T Consensus        80 v~e~~~~~~L~~~~-----------------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH  124 (277)
T cd06642          80 IMEYLGGGSALDLL-----------------------------------KPGPLEETYIATILREILKGLDYLHSERKIH  124 (277)
T ss_pred             EEEccCCCcHHHHh-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence            999998752 2211                                   1346889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      +||||+||++++++.+||+|||++......    ....|+..|+|||++.   ...++.++|+|||||++|||++|++||
T Consensus       125 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06642         125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDFKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             cCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhC---cCCCchhhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998654321    2356899999999984   346788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      ...........+..+.                                         .+ ......+.++.+|+.+||+.
T Consensus       202 ~~~~~~~~~~~~~~~~-----------------------------------------~~-~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         202 SDLHPMRVLFLIPKNS-----------------------------------------PP-TLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             cccchhhHHhhhhcCC-----------------------------------------CC-CCCcccCHHHHHHHHHHccC
Confidence            7554333222211100                                         01 11234578899999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy17952        475 NPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +|++|||+.++++|||+..
T Consensus       240 ~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         240 DPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             CcccCcCHHHHHHhHHHHH
Confidence            9999999999999999865

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.9e-40  Score=350.50  Aligned_cols=280  Identities=29%  Similarity=0.471  Sum_probs=208.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+.++.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            488999999999999999999989999999987643222 1234567889999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|++.+-+                                 ......+++.++..++.||+.||.|||+.||+|||||
T Consensus        81 ~~~~~~l~~~---------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~  127 (286)
T cd07846          81 FVDHTVLDDL---------------------------------EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK  127 (286)
T ss_pred             cCCccHHHHH---------------------------------HhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            9987632211                                 1123458899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+||++++++.+||+|||++......    ....|+..|+|||++.+  ...++.++|||||||++|||++|++||...+
T Consensus       128 p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         128 PENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             HHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcc--ccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence            99999999999999999998653221    23568899999999853  3457789999999999999999999998777


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhc-ccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTIS-STAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~-~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      ..+....+.......... ......... ......+....            ........+.++..+.+|+.+||..||+
T Consensus       206 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~~P~  272 (286)
T cd07846         206 DIDQLYHIIKCLGNLIPR-HQEIFQKNPLFAGMRLPEVKE------------IEPLEKRFPKLSGLVLDLAKQCLRIDPD  272 (286)
T ss_pred             hHHHHHHHHHHhCCCchh-hHHHhccchHhhccccccccC------------cchHHHhCCCcCHHHHHHHHHHhcCCcc
Confidence            666555554322111000 000000000 00000000000            0000001235688999999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.++++||||
T Consensus       273 ~Rp~~~~il~~~~~  286 (286)
T cd07846         273 DRPSSSQLLHHEFF  286 (286)
T ss_pred             cchhHHHHhcCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2e-39  Score=346.54  Aligned_cols=279  Identities=25%  Similarity=0.396  Sum_probs=211.1

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+.++.||.|+||.||+|++..+++.||||.+.....  ......+.+|+.++++++||||+++++++...+..|+||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            7899999999999999999999999999998864322  12235567899999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.|++.+++..                               ......+++..+..++.|+++||.|||++||+||||||
T Consensus        80 ~~~~l~~~~~~-------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p  128 (284)
T cd07836          80 MDKDLKKYMDT-------------------------------HGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKP  128 (284)
T ss_pred             CCccHHHHHHh-------------------------------cCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH
Confidence            99876554421                               01124689999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +||++++++.+||+|||++.....    .....+|+.|+|||++.+  ...++.++|||||||++|+|++|++||.+.+.
T Consensus       129 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  206 (284)
T cd07836         129 QNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG--SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN  206 (284)
T ss_pred             HHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999999999864322    123568899999998753  23568899999999999999999999988876


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      .+....+....... ....|..+..........|.. ....   ...         ..+..+..+++++.+||+.||.+|
T Consensus       207 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~---------~~~~~~~~~~~~i~~~l~~~p~~R  272 (284)
T cd07836         207 EDQLLKIFRIMGTP-TESTWPGISQLPEYKPTFPRY-PPQD---LQQ---------LFPHADPLGIDLLHRLLQLNPELR  272 (284)
T ss_pred             HHHHHHHHHHhCCC-ChhhHHHHhcCchhcccccCC-ChHH---HHH---------HhhhcCcHHHHHHHHHhcCCcccC
Confidence            66655554321111 111222222111110111110 0000   000         012347889999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy17952        480 PSSGRLLTHDLV  491 (804)
Q Consensus       480 psa~elL~Hp~~  491 (804)
                      |++.++++||||
T Consensus       273 ~~~~~~l~~~~f  284 (284)
T cd07836         273 ISAHDALQHPWF  284 (284)
T ss_pred             CCHHHHhcCCCC
Confidence            999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0669|consensus

Probab=100.00  E-value=2.8e-41  Score=337.84  Aligned_cols=293  Identities=27%  Similarity=0.430  Sum_probs=221.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--------  233 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--------  233 (804)
                      ..|+.+.+||+|.||+||+|+++.+++.||+|++-.... ....-...++|+.+|..|+|+|++.+++.|..        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            358999999999999999999999999999998653222 22334567899999999999999999887643        


Q ss_pred             cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       234 ~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ...+|+||.+|+.+|..++.                                 .....++..++.+++.++++||.|+|+
T Consensus        96 r~t~ylVf~~cehDLaGlLs---------------------------------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr  142 (376)
T KOG0669|consen   96 RATFYLVFDFCEHDLAGLLS---------------------------------NRKVRFSLSEIKKVMKGLMNGLYYIHR  142 (376)
T ss_pred             cceeeeeHHHhhhhHHHHhc---------------------------------CccccccHHHHHHHHHHHHHHHHHHHH
Confidence            23589999999876655442                                 112468889999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCCC--------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~--------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      ..|+|||+||+|+||+.+|.+||+|||+|+.....        ...+-|.+|++||.+++  ...|+++.|||..|||+.
T Consensus       143 ~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG--~r~yg~~iDiWgAgCima  220 (376)
T KOG0669|consen  143 NKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG--DREYGPPIDIWGAGCIMA  220 (376)
T ss_pred             hhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc--ccccCCcchhHhHHHHHH
Confidence            99999999999999999999999999999653321        23456999999999987  457999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhh------HHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCC
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSV------IKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD  459 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~------i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~  459 (804)
                      ||.+|.+-|.+.++..++..|.+-.+.... .-|+-      ++.+..     +| ........+....   .|.    .
T Consensus       221 eMwtrspimqgnteqqql~~Is~LcGs~tk-evWP~~d~lpL~~sie~-----eP-l~~~~~rkv~n~~---kp~----~  286 (376)
T KOG0669|consen  221 EMWTRSPIMQGNTEQQQLHLISQLCGSITK-EVWPNVDNLPLYQSIEL-----EP-LPKGQKRKVKNRL---KPY----V  286 (376)
T ss_pred             HHHccCccccCChHHHHHHHHHHHhccCCc-ccCCCcccchHHHhccC-----CC-CCcchhhhhhhhc---ccc----c
Confidence            999999999999998888887664332211 12222      222211     11 0001111111111   111    1


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCCCC-chhHHHH
Q psy17952        460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSP-SVLVDLI  504 (804)
Q Consensus       460 ~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~-~~~~~~~  504 (804)
                      -.+++.||+.++|..||.+|++++++|+|.||.....+ +.+.+.+
T Consensus       287 kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~ml  332 (376)
T KOG0669|consen  287 KDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDML  332 (376)
T ss_pred             CChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHHHH
Confidence            25788999999999999999999999999999876665 4444443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-39  Score=351.39  Aligned_cols=272  Identities=22%  Similarity=0.363  Sum_probs=197.4

Q ss_pred             cccccccccccccccccceEEEEeee----------------ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCc
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLV----------------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN  223 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~----------------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpN  223 (804)
                      +...|++.++||+|+||.||+|++..                ++..||+|.+....  .......+.+|+.+|++++|||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence            34568999999999999999997532                34579999876432  2233467889999999999999


Q ss_pred             eeEeeeEEeecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHH
Q psy17952        224 TIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICS  302 (804)
Q Consensus       224 IV~l~~~~~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~  302 (804)
                      |+++++++.+.+..|+||||+.| ++.+++.........         ..     .. ...........+++..+..++.
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---------~~-----~~-~~~~~~~~~~~~~~~~~~~i~~  145 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE---------EN-----GN-DAVPPAHCLPAISYSSLLHVAL  145 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccc---------cc-----cc-cccccccccccccHHHHHHHHH
Confidence            99999999999999999999975 555554321000000         00     00 0000011224578899999999


Q ss_pred             HHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCccc
Q psy17952        303 GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVD  376 (804)
Q Consensus       303 qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksD  376 (804)
                      ||+.||.|||++||+||||||+|||++.++.+||+|||+++.....      ....+++.|||||++.   .+.++.++|
T Consensus       146 ~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~D  222 (304)
T cd05096         146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL---MGKFTTASD  222 (304)
T ss_pred             HHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh---cCCCCchhh
Confidence            9999999999999999999999999999999999999998753221      2345678899999984   356899999


Q ss_pred             HHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC
Q psy17952        377 VWSLGITCIELAE--RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC  454 (804)
Q Consensus       377 IWSlGvil~ELlt--G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~  454 (804)
                      ||||||++|||++  +..||.+.+....+..+....               ... .                   .....
T Consensus       223 v~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~---------------~~~-~-------------------~~~~~  267 (304)
T cd05096         223 VWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFF---------------RDQ-G-------------------RQVYL  267 (304)
T ss_pred             hHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHh---------------hhc-c-------------------ccccc
Confidence            9999999999986  667887765544433321100               000 0                   00000


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy17952        455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL  486 (804)
Q Consensus       455 ~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL  486 (804)
                      .....++..+.+|+.+||+.||++|||+.++.
T Consensus       268 ~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         268 FRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             cCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            11234578899999999999999999999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-39  Score=345.37  Aligned_cols=276  Identities=26%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeec--CceEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRD--HTAWLV  240 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~--~~~~lV  240 (804)
                      |++++.||+|+||.||+|.+..+++.||+|.++......  ......+|+.+++++. ||||+++++++.+.  +..|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            678899999999999999999999999999876432211  1123467999999985 99999999999987  889999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||+.|++.+.+.                                 .....+++.++..++.|++.||.|||++||+|||
T Consensus        79 ~e~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~d  125 (282)
T cd07831          79 FELMDMNLYELIK---------------------------------GRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRD  125 (282)
T ss_pred             EecCCccHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence            9999887544332                                 1134689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |||+||+++. +.+||+|||+++....   .....+|+.|+|||++..  .+.++.++|||||||++|||++|.+||.+.
T Consensus       126 l~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         126 IKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT--DGYYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             cCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhc--CCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence            9999999999 9999999999875422   234568999999998743  345688999999999999999999999888


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+.........  .+  .......... ...+......         .........+.++.+||.+||.+||+
T Consensus       203 ~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~  268 (282)
T cd07831         203 NELDQIAKIHDVLGTPDA--EV--LKKFRKSRHM-NYNFPSKKGT---------GLRKLLPNASAEGLDLLKKLLAYDPD  268 (282)
T ss_pred             CHHHHHHHHHHHcCCCCH--HH--HHhhcccccc-cccCcccccc---------cHHHHcccccHHHHHHHHHHhccCcc
Confidence            776665555432111100  00  0000000000 0000000000         00001234689999999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||++++++||||
T Consensus       269 ~R~~~~~~l~~~~~  282 (282)
T cd07831         269 ERITAKQALRHPYF  282 (282)
T ss_pred             cccCHHHHhhCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-39  Score=349.29  Aligned_cols=262  Identities=29%  Similarity=0.512  Sum_probs=205.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|++..+++.||+|.+...  ........+.+|+.++++++||||+++++++..++..|+|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            489999999999999999999999999999987532  122334678899999999999999999999999999999999


Q ss_pred             ecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecC
Q psy17952        243 YCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRD  320 (804)
Q Consensus       243 y~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRD  320 (804)
                      ||+|+. ..++..                               ......+++..+..++.|++.||.|||+ .||+|||
T Consensus        80 ~~~~~~l~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~d  128 (286)
T cd06622          80 YMDAGSLDKLYAG-------------------------------GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD  128 (286)
T ss_pred             ecCCCCHHHHHHh-------------------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCC
Confidence            998753 222210                               0012368999999999999999999997 5999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccC---CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMD---EGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~---~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      |||+|||++.++.+||+|||++.....  .....|++.|+|||++.+..   ...++.++|||||||++|||++|+.||.
T Consensus       129 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  208 (286)
T cd06622         129 VKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP  208 (286)
T ss_pred             CCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence            999999999999999999999865322  23457889999999985321   1235789999999999999999999996


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+.......+..                                      +.....+. ....++.++.+|+.+||+.+
T Consensus       209 ~~~~~~~~~~~~~--------------------------------------~~~~~~~~-~~~~~~~~~~~li~~~l~~~  249 (286)
T cd06622         209 PETYANIFAQLSA--------------------------------------IVDGDPPT-LPSGYSDDAQDFVAKCLNKI  249 (286)
T ss_pred             CcchhhHHHHHHH--------------------------------------HhhcCCCC-CCcccCHHHHHHHHHHcccC
Confidence            5433222111110                                      00000111 12347889999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCCC
Q psy17952        476 PADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      |++||++++++.||||.....
T Consensus       250 p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         250 PNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             cccCCCHHHHhcChhhhhccC
Confidence            999999999999999976544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=354.03  Aligned_cols=256  Identities=28%  Similarity=0.424  Sum_probs=207.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.............+.+|+++++.++||||+++++++......|+|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            48899999999999999999999999999998865433222345678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++.                                ......+++..+..++.|++.||+|||+.|++||||
T Consensus        82 ~~~~~~L~~~~~--------------------------------~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  129 (316)
T cd05574          82 YCPGGELFRLLQ--------------------------------RQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL  129 (316)
T ss_pred             ecCCCCHHHHHH--------------------------------hCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99864 333221                                011246899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC---------------------------------CCccccCcccccchhhcccCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP---------------------------------ANSFVGTPYWMAPEVILAMDE  368 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~---------------------------------~~~~~GT~~Y~APEvl~~~~~  368 (804)
                      ||+||+++.++.+||+|||++.....                                 ...+.||..|+|||++.   +
T Consensus       130 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~  206 (316)
T cd05574         130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS---G  206 (316)
T ss_pred             ChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc---C
Confidence            99999999999999999998753211                                 11347899999999985   3


Q ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhc
Q psy17952        369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA  448 (804)
Q Consensus       369 ~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~  448 (804)
                      ..++.++|||||||++|+|++|+.||.+.+....+..+.....                                     
T Consensus       207 ~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------------------------  249 (316)
T cd05574         207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-------------------------------------  249 (316)
T ss_pred             CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-------------------------------------
Confidence            4578899999999999999999999987765554444322110                                     


Q ss_pred             cCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC----HHHHHcCccccCC
Q psy17952        449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS----SGRLLTHDLVTRP  494 (804)
Q Consensus       449 ~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps----a~elL~Hp~~~~~  494 (804)
                          ........++.+.+|+.+||+.||++|||    ++++|+||||...
T Consensus       250 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         250 ----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             ----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence                00011225789999999999999999999    9999999999753

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-39  Score=352.41  Aligned_cols=268  Identities=38%  Similarity=0.670  Sum_probs=215.9

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .++...|+....||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..++..
T Consensus        17 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          17 GDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             ccchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            455566888889999999999999999999999999875422   12335678999999999999999999999999999


Q ss_pred             EEEEeecCCCch-hhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGSAS-DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~l~-dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |++|||+.|+.. +++                                   ....+++..+..++.|++.||.|||++||
T Consensus        94 ~iv~e~~~~~~L~~~~-----------------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~i  138 (297)
T cd06659          94 WVLMEFLQGGALTDIV-----------------------------------SQTRLNEEQIATVCESVLQALCYLHSQGV  138 (297)
T ss_pred             EEEEecCCCCCHHHHH-----------------------------------hhcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            999999987521 111                                   12457899999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+|||++.++.+||+|||++.....    .....|++.|+|||++.   ...++.++|||||||++|||++|+.
T Consensus       139 vH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~g~~  215 (297)
T cd06659         139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RTPYGTEVDIWSLGIMVIEMVDGEP  215 (297)
T ss_pred             ecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999864321    23467999999999984   3467889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||...+....+..+.....+                                        .......++..+.+|+.+||
T Consensus       216 p~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~~i~~~l  255 (297)
T cd06659         216 PYFSDSPVQAMKRLRDSPPP----------------------------------------KLKNAHKISPVLRDFLERML  255 (297)
T ss_pred             CCCCCCHHHHHHHHhccCCC----------------------------------------CccccCCCCHHHHHHHHHHh
Confidence            99876655544433211100                                        00011245788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCCchhHHHHHH
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRR  506 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~  506 (804)
                      +.+|.+|||+.++++||||.+..-+..+..+.++
T Consensus       256 ~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~  289 (297)
T cd06659         256 TREPQERATAQELLDHPFLLQTGLPECLVPLIQQ  289 (297)
T ss_pred             cCCcccCcCHHHHhhChhhccCCCcccccchHHH
Confidence            9999999999999999999988776666555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-39  Score=342.91  Aligned_cols=250  Identities=34%  Similarity=0.629  Sum_probs=200.5

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEeccccccc---chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ---CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~---~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      |+..+.||+|+||.||+|.+ .+++.+|+|.+......   .......+.+|++++++++||||+++++++...+..|++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            67889999999999999975 47889999987643211   122345688899999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.|+ +.++                                  +....++++..+..++.|++.||+|||+.||+|+
T Consensus        81 ~e~~~~~~L~~~----------------------------------l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  126 (265)
T cd06631          81 MEFVPGGSISSI----------------------------------LNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR  126 (265)
T ss_pred             EecCCCCcHHHH----------------------------------HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999875 3222                                  2233568899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccC----------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKC----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~----------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||||+||++++++.+||+|||++....          ......||+.|+|||++.   ...++.++|+|||||++|+|++
T Consensus       127 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~  203 (265)
T cd06631         127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN---ESGYGRKSDIWSIGCTVFEMAT  203 (265)
T ss_pred             CcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhc---CCCCcchhhHHHHHHHHHHHHh
Confidence            999999999999999999999986421          112356899999999984   3467889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||...+.......+.....+                                       .+. ....++.++.+|+.
T Consensus       204 g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------~~~-~~~~~~~~~~~~i~  243 (265)
T cd06631         204 GKPPLASMDRLAAMFYIGAHRGL---------------------------------------MPR-LPDSFSAAAIDFVT  243 (265)
T ss_pred             CCCccccCChHHHHHHhhhccCC---------------------------------------CCC-CCCCCCHHHHHHHH
Confidence            99999776544433332211000                                       000 12346889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccc
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +||..+|++|||+.++|+||||
T Consensus       244 ~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         244 SCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0986|consensus

Probab=100.00  E-value=1.6e-40  Score=355.53  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=207.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|...+.||+||||.||-|+.+.||+.+|+|++.+............+.|-.||.+++.|.||.+-.+|++.+.+++||
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45888899999999999999999999999999886533222223345788999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ..|.||-.          .||+..                     .....|+|+.++.++.+|+.||++||+.+||.|||
T Consensus       265 tlMNGGDL----------kfHiyn---------------------~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDL  313 (591)
T KOG0986|consen  265 TLMNGGDL----------KFHIYN---------------------HGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDL  313 (591)
T ss_pred             EeecCCce----------eEEeec---------------------cCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccC
Confidence            99998721          122111                     12357999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC---CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~---~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      ||+|||+|+.|+++|+|+|+|....   +..+.+||.+|||||++.   ++.|+..+|+|||||++|||+.|+.||....
T Consensus       314 KPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~---ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  314 KPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQ---NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             ChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHc---CCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            9999999999999999999997543   334569999999999994   4679999999999999999999999995422


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ...                .|+.++..                      ...+ +...+..+|++++++.+.+|++||++
T Consensus       391 eKv----------------k~eEvdrr----------------------~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~  431 (591)
T KOG0986|consen  391 EKV----------------KREEVDRR----------------------TLED-PEEYSDKFSEEAKSLCEGLLTKDPEK  431 (591)
T ss_pred             hhh----------------hHHHHHHH----------------------Hhcc-hhhcccccCHHHHHHHHHHHccCHHH
Confidence            110                00001000                      0000 11123568999999999999999999


Q ss_pred             CC-----CHHHHHcCccccC
Q psy17952        479 RP-----SSGRLLTHDLVTR  493 (804)
Q Consensus       479 Rp-----sa~elL~Hp~~~~  493 (804)
                      |.     +++++-+||||+.
T Consensus       432 RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  432 RLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             hccCCCcCcchhhhCccccc
Confidence            97     4579999999975

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.6e-39  Score=350.81  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            48889999999999999999999999999998865432223344677899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++                                  ...+.+++..+..++.|++.||.|||++||+||||
T Consensus        82 ~~~g~~L~~~l----------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl  127 (305)
T cd05609          82 YVEGGDCATLL----------------------------------KNIGALPVDMARMYFAETVLALEYLHNYGIVHRDL  127 (305)
T ss_pred             cCCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence            99875 32222                                  23456899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-------------------CCccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-------------------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      ||+|||++.++.+||+|||+++....                   .....|++.|+|||.+.   ...++.++|+|||||
T Consensus       128 ~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~  204 (305)
T cd05609         128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL---RQGYGKPVDWWAMGI  204 (305)
T ss_pred             chHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhcc---CCCCCchhhHHHHHH
Confidence            99999999999999999999863110                   01246788999999974   356888999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       383 il~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ++|||++|..||.+.+..+.+..+..+..+                                       .+. ....++.
T Consensus       205 vl~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------------------~~~-~~~~~~~  244 (305)
T cd05609         205 ILYEFLVGCVPFFGDTPEELFGQVISDDIE---------------------------------------WPE-GDEALPA  244 (305)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcccC---------------------------------------CCC-ccccCCH
Confidence            999999999999876655444433222110                                       010 0124678


Q ss_pred             HHHHHHHHhcccCCCCCCC---HHHHHcCccccCC
Q psy17952        463 TFAHFVSSCLAKNPADRPS---SGRLLTHDLVTRP  494 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rps---a~elL~Hp~~~~~  494 (804)
                      ++.+||.+||+.||++|||   +.++|+||||...
T Consensus       245 ~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         245 DAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             HHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            8999999999999999998   7999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.9e-39  Score=350.81  Aligned_cols=284  Identities=27%  Similarity=0.393  Sum_probs=204.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC----
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH----  235 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~----  235 (804)
                      ..+.|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            334599999999999999999999999999999987543211 112234568999999999999999999887654    


Q ss_pred             ----ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        236 ----TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       236 ----~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                          ..|+||||+.+++.+.+.                                 .....+++.++..++.||++||+||
T Consensus        89 ~~~~~~~lv~e~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~al~~l  135 (310)
T cd07865          89 RYKGSFYLVFEFCEHDLAGLLS---------------------------------NKNVKFTLSEIKKVMKMLLNGLYYI  135 (310)
T ss_pred             CCCceEEEEEcCCCcCHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHH
Confidence                359999999876544332                                 1123589999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  383 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvi  383 (804)
                      |++||+||||||+|||++.++.+||+|||++.....        .....++..|+|||.+.+  ...++.++|||||||+
T Consensus       136 H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~  213 (310)
T cd07865         136 HRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDMWGAGCI  213 (310)
T ss_pred             HHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC--CcccCchhhhHHHHHH
Confidence            999999999999999999999999999999864321        123467889999998743  2346789999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccc-cCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       384 l~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~-~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      +|||++|.+||.+.+....+..+.+........ .++......... ...+.....       .    ..........+.
T Consensus       214 l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-------~----~~~~l~~~~~~~  281 (310)
T cd07865         214 MAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE-VWPGVDKLELFKKMELPQGQKR-------K----VKERLKPYVKDP  281 (310)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh-hcccccchhhhhhccCCCccch-------h----hHHhcccccCCH
Confidence            999999999998877665554443321111000 000000000000 000000000       0    000011112367


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      .+.+||.+||..||.+|||++++|+||||
T Consensus       282 ~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         282 HALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            78999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=358.68  Aligned_cols=281  Identities=26%  Similarity=0.382  Sum_probs=207.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----Cc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----HT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----~~  236 (804)
                      +.|++.+.||+|+||.||+|.+..+++.||||.++...  .......+.+|+.++++++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            45999999999999999999999999999999886422  122345678899999999999999999876544     35


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|++|||+.+++.+++                                   ....+++..+..++.|++.||.|||++||
T Consensus        83 ~~lv~e~~~~~l~~~~-----------------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~~i  127 (336)
T cd07849          83 VYIVQELMETDLYKLI-----------------------------------KTQHLSNDHIQYFLYQILRGLKYIHSANV  127 (336)
T ss_pred             EEEEehhcccCHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            7999999987643322                                   23468999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||++.++.+||+|||++......       ....||+.|+|||++.+  ...++.++||||+||++|||++
T Consensus       128 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslGvil~el~~  205 (336)
T cd07849         128 LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKAIDIWSVGCILAEMLS  205 (336)
T ss_pred             eccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC--CCCCCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999998653221       23578999999998743  3457889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC-CC-CCCCCccHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT-PC-LQSSDWSDTFAHF  467 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~-p~-~~~~~~s~~l~dl  467 (804)
                      |++||.+.+....+..+...-...    ....+..+.....          ...+........ +. ...+..++++.+|
T Consensus       206 G~~~f~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  271 (336)
T cd07849         206 NRPLFPGKDYLHQLNLILGVLGTP----SQEDLNCIISLRA----------RNYIKSLPFKPKVPWNKLFPNADPKALDL  271 (336)
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCC----CHHHHHHhhchhh----------hhHHhhcCcCCcccHHHHhcccCcHHHHH
Confidence            999998876655444433211000    0011111110000          000000000000 00 0012357889999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +.+||+.||++|||+.++++||||....
T Consensus       272 i~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         272 LDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHcCCChhhCcCHHHHhcCccccccC
Confidence            9999999999999999999999998654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-39  Score=347.59  Aligned_cols=264  Identities=31%  Similarity=0.510  Sum_probs=205.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|+..+.||+|+||.||++.+..+++.||+|.+......  .....+.+|+.++.++. ||||+++++++..++..|++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            367788999999999999999999999999988643222  33456789999999996 999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRD  320 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiHRD  320 (804)
                      ||+.+++.++....                             .......+++..+..++.|++.||+|||+. +|+|||
T Consensus        83 e~~~~~l~~l~~~~-----------------------------~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~d  133 (288)
T cd06616          83 ELMDISLDKFYKYV-----------------------------YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD  133 (288)
T ss_pred             ecccCCHHHHHHHH-----------------------------HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccC
Confidence            99987655443210                             011235689999999999999999999974 999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |||+|||++.++.+||+|||+++....   .....||+.|+|||++.......++.++|||||||++|||++|++||...
T Consensus       134 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             CCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            999999999999999999999864322   23356899999999985321136888999999999999999999999654


Q ss_pred             Ch-HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~-~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      +. .+.+..+..+..                      +.                .+......++.++.+|+.+||++||
T Consensus       214 ~~~~~~~~~~~~~~~----------------------~~----------------~~~~~~~~~~~~l~~li~~~l~~~p  255 (288)
T cd06616         214 NSVFDQLTQVVKGDP----------------------PI----------------LSNSEEREFSPSFVNFINLCLIKDE  255 (288)
T ss_pred             chHHHHHhhhcCCCC----------------------Cc----------------CCCcCCCccCHHHHHHHHHHccCCh
Confidence            31 111111111100                      00                0001113468899999999999999


Q ss_pred             CCCCCHHHHHcCccccCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ++|||+++++.||||....
T Consensus       256 ~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         256 SKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             hhCcCHHHHhcChhhhchh
Confidence            9999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=352.55  Aligned_cols=287  Identities=25%  Similarity=0.394  Sum_probs=205.6

Q ss_pred             ccccccccccccccceEEEEeee--ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLV--SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~--~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~  238 (804)
                      .|++.+.||+|+||.||+|.+..  +++.||+|.+.............+.+|+.++++++||||+++++++...  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            37889999999999999999988  8999999988753212223345678899999999999999999999988  7899


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +||||+.+++.+++...                             .......+++..+..++.|++.||.|||+++|+|
T Consensus        81 lv~e~~~~~l~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h  131 (316)
T cd07842          81 LLFDYAEHDLWQIIKFH-----------------------------RQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLH  131 (316)
T ss_pred             EEEeCCCcCHHHHHHhh-----------------------------ccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence            99999988765544210                             0111246899999999999999999999999999


Q ss_pred             cCCCCCCeeecC----CCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        319 RDVKAGNILLTE----TGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       319 RDLKP~NILl~~----~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |||||+|||++.    ++.+||+|||++.....       ....++|+.|+|||++.+  ...++.++|||||||++|||
T Consensus       132 ~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l  209 (316)
T cd07842         132 RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG--ARHYTKAIDIWAIGCIFAEL  209 (316)
T ss_pred             CCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhC--CCCCCcHHHHHHHHHHHHHH
Confidence            999999999999    89999999999875321       224578999999998753  24578899999999999999


Q ss_pred             HhCCCCCCCCChHH---------HHHHHHhcCCCCCCCCchhhHHhhccccc-----CCCCccchhhhHHHHhhccCCCC
Q psy17952        388 AERKPPYFNMNAMS---------ALYHIAQNDTPCLQSSDWSVIKTISSTAE-----RKPPYFNMNAMSALYHIAQNDTP  453 (804)
Q Consensus       388 ltG~~PF~~~~~~~---------~l~~I~~~~~p~~~~~~~~~i~~i~~~~~-----~~pp~~~~~~~~~l~~i~~~~~p  453 (804)
                      ++|++||.+.+...         .+..+...-.+ .....|...........     ...++ .........        
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--------  279 (316)
T cd07842         210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT-PTEKDWPDIKKMPEYDTLMKDFKTKTY-PSNSLAKWM--------  279 (316)
T ss_pred             HhcCCCCcCCcccccccchhHHHHHHHHHHHhCC-CchhHHHHHhhcccchhhhhhccCCCC-CCccHHHHH--------
Confidence            99999997654321         11111111000 00011111110000000     00000 000000000        


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       454 ~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                       ......+..+.+++.+||+.||++|||+.+++.||||
T Consensus       280 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         280 -EKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             -HhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence             0002567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-39  Score=364.51  Aligned_cols=282  Identities=23%  Similarity=0.350  Sum_probs=198.3

Q ss_pred             cccccccccccccccccceEEEEeeece-----eEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSR-----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~-----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|++..++     +.||+|.+.....  ......+.+|+.+++.+ +|||||++++++..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            4456999999999999999999875443     5799998864322  23346688999999999 89999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhh------------------------hhhhc----------
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQL------------------------KCFTE----------  278 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l------------------------~~~~~----------  278 (804)
                      .+..|+|||||.| ++.+.+...-.............+...                        ..+.+          
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999985 565555321000000000000000000                        00000          


Q ss_pred             ccccc--hhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------Cc
Q psy17952        279 HFALF--NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NS  350 (804)
Q Consensus       279 ~~~L~--~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~  350 (804)
                      .....  .......++++..+..|+.||++||.|||++||+||||||+|||+++++.+||+|||+++.....      ..
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence            00000  00012346899999999999999999999999999999999999999999999999998653221      12


Q ss_pred             cccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccc
Q psy17952        351 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA  429 (804)
Q Consensus       351 ~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~  429 (804)
                      ..+++.|||||++.   .+.|+.++|||||||++|||++ |+.||........+..+.....                  
T Consensus       274 ~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~------------------  332 (374)
T cd05106         274 ARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY------------------  332 (374)
T ss_pred             CCCccceeCHHHhc---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc------------------
Confidence            23556799999984   4568999999999999999997 9999976543332222221100                  


Q ss_pred             cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        430 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       430 ~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                                             ........++++.+++.+||+.||.+|||+.++++
T Consensus       333 -----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 -----------------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -----------------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   00011234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.1e-39  Score=343.14  Aligned_cols=245  Identities=22%  Similarity=0.373  Sum_probs=195.6

Q ss_pred             ccccccccccccccceEEEEee---eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|++.+.||+|+||.||+|...   ..+..||+|.++...  .......+.+|+.++++++||||+++++++...+..|+
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            4899999999999999999765   456789999886432  12334568899999999999999999999999999999


Q ss_pred             EEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||++|+. .+++.                                 .....+++..+..++.|++.||+|||++|++|
T Consensus        84 v~e~~~~~~L~~~l~---------------------------------~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH  130 (266)
T cd05064          84 VTEYMSNGALDSFLR---------------------------------KHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH  130 (266)
T ss_pred             EEEeCCCCcHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            999998763 22221                                 12346899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+|||++.++.+|++|||.+......     ....+++.|+|||++.   .+.++.++|||||||++|||++ |..
T Consensus       131 ~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~ell~~g~~  207 (266)
T cd05064         131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ---YHHFSSASDVWSFGIVMWEVMSYGER  207 (266)
T ss_pred             ccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHh---hCCccchhHHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999987543211     1234567899999984   4578899999999999999775 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+.+..+..+..                                          ......++..+.+++.+||
T Consensus       208 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~c~  245 (266)
T cd05064         208 PYWDMSGQDVIKAVEDGFR------------------------------------------LPAPRNCPNLLHQLMLDCW  245 (266)
T ss_pred             CcCcCCHHHHHHHHHCCCC------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence            9988766554444322110                                          0012346788999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      +.+|.+|||+.++++
T Consensus       246 ~~~p~~RP~~~~i~~  260 (266)
T cd05064         246 QKERGERPRFSQIHS  260 (266)
T ss_pred             CCCchhCCCHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0587|consensus

Probab=100.00  E-value=6.5e-40  Score=374.42  Aligned_cols=262  Identities=43%  Similarity=0.756  Sum_probs=220.3

Q ss_pred             CCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee--
Q psy17952        157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR--  233 (804)
Q Consensus       157 ~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~--  233 (804)
                      -.||...|++.+.||.|.+|.||+++.+.+++.+|+|++......    -+++..|.++|+.+ .|||++.++++|..  
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            456777899999999999999999999999999999988653222    24567788888877 59999999999864  


Q ss_pred             ---cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHH
Q psy17952        234 ---DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN  309 (804)
Q Consensus       234 ---~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~  309 (804)
                         ++.+|||||||.| +..|+++..                                ....+.|+.++.|++.++.||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~--------------------------------~g~rl~E~~IaYI~re~lrgl~  137 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNT--------------------------------KGNRLKEEWIAYILREILRGLA  137 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhh--------------------------------cccchhhHHHHHHHHHHHHHHH
Confidence               5679999999985 566666521                                1456889999999999999999


Q ss_pred             HHHHCCCeecCCCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccC--CCCCCCcccHHHHHHH
Q psy17952        310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGIT  383 (804)
Q Consensus       310 yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvi  383 (804)
                      +||.+.+||||||-.|||++.+|.|||+|||++....    ..++++|||+|||||++....  ...|+.++|+||||++
T Consensus       138 HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGIT  217 (953)
T KOG0587|consen  138 HLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGIT  217 (953)
T ss_pred             HHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccce
Confidence            9999999999999999999999999999999997654    346789999999999996432  2247779999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCC-CCCCccH
Q psy17952        384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL-QSSDWSD  462 (804)
Q Consensus       384 l~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~-~~~~~s~  462 (804)
                      ..||..|.||+.++.++.+++.|..+.+                                         |.+ .+..|+.
T Consensus       218 aIEladG~PPl~DmHPmraLF~IpRNPP-----------------------------------------PkLkrp~kWs~  256 (953)
T KOG0587|consen  218 AIEMAEGAPPLCDMHPMRALFLIPRNPP-----------------------------------------PKLKRPKKWSK  256 (953)
T ss_pred             eehhcCCCCCccCcchhhhhccCCCCCC-----------------------------------------ccccchhhHHH
Confidence            9999999999999988888777644322                                         222 2467999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +|.+||..||.+|-++||+..++|.|||+++..
T Consensus       257 ~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  257 KFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             HHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            999999999999999999999999999999543

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-39  Score=349.52  Aligned_cols=283  Identities=28%  Similarity=0.405  Sum_probs=211.0

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEeccccccc--chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      |+..+.||+|+||.||+|.+..+++.||||.+......  .......+..|++++++++||||+++++++.+.+..|+||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            78889999999999999999999999999998643322  1222345678999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~-~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.|++.+++.                                  .. ..+++..+..++.||++||.|||++||+|||
T Consensus        82 e~~~~~L~~~i~----------------------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d  127 (298)
T cd07841          82 EFMETDLEKVIK----------------------------------DKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD  127 (298)
T ss_pred             cccCCCHHHHHh----------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Confidence            999555444332                                  12 2689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||+++.....    ....+++.|+|||.+.+  ...++.++|||||||++|||++|.+||.+
T Consensus       128 l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         128 LKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG--ARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             CChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhC--CCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            9999999999999999999998654321    23457889999998743  34578899999999999999999999988


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+.+..+...... .....|.......       .+....       ..............+..+.+||.+||++||
T Consensus       206 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  270 (298)
T cd07841         206 DSDIDQLGKIFEALGT-PTEENWPGVTSLP-------DYVEFK-------PFPPTPLKQIFPAASDDALDLLQRLLTLNP  270 (298)
T ss_pred             CccHHHHHHHHHHcCC-Cchhhhhhccccc-------cccccc-------ccCCcchhhhcccccHHHHHHHHHHhcCCc
Confidence            7766655555432110 0011111110000       000000       000000001113457889999999999999


Q ss_pred             CCCCCHHHHHcCccccCCCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPRSP  497 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~~~  497 (804)
                      ++|||+.++|.|+||.....+
T Consensus       271 ~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         271 NKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ccCcCHHHHhhCccccCCCCC
Confidence            999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-39  Score=347.38  Aligned_cols=282  Identities=26%  Similarity=0.392  Sum_probs=209.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCc-----
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHT-----  236 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~-----  236 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++ ||||+++++++.....     
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            48899999999999999999999999999998764321 1223356788999999995 6999999999887665     


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|+||||+.|++.+.+...                             .......+++..+..++.||+.||.|||++||
T Consensus        81 ~~lv~e~~~~~l~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i  131 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSN-----------------------------GRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGV  131 (295)
T ss_pred             EEEEeeccCcCHHHHHHHh-----------------------------cccCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            8999999998765544210                             00012468999999999999999999999999


Q ss_pred             eecCCCCCCeeecC-CCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        317 IHRDVKAGNILLTE-TGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       317 iHRDLKP~NILl~~-~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      +||||||+||+++. ++.+||+|||++.....    .....+++.|+|||++.+  ...++.++|||||||++|||++|.
T Consensus       132 ~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~  209 (295)
T cd07837         132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG--STHYSTPVDIWSVGCIFAEMSRKQ  209 (295)
T ss_pred             eecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhC--CCCCCchHHHHHHHHHHHHHHcCC
Confidence            99999999999998 88999999999864321    123467899999998853  345788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcC-CCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQND-TPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~-~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +||.+.+....+..+.+.. .|.  ...|.......... ..+.+             ....+......++.++.+||.+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~-------------~~~~~~~~~~~~~~~~~~~i~~  273 (295)
T cd07837         210 PLFPGDSELQQLLHIFKLLGTPT--EQVWPGVSKLRDWH-EFPQW-------------KPQDLSRAVPDLSPEGLDLLQK  273 (295)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCC--hhhCcchhhccchh-hcCcc-------------cchhHHHhccccCHHHHHHHHH
Confidence            9999888777666655421 110  00111000000000 00000             0000011123468899999999


Q ss_pred             hcccCCCCCCCHHHHHcCcccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      ||..||.+|||+.++|.||||.
T Consensus       274 ~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         274 MLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HccCChhhcCCHHHHhcCCCcC
Confidence            9999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=342.68  Aligned_cols=258  Identities=44%  Similarity=0.776  Sum_probs=205.0

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecC---
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDH---  235 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~---  235 (804)
                      +.+.|++.+.||+|+||.||+|.+..+++.+|+|.+....    .....+.+|+.+++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4567999999999999999999999899999999876432    1235678999999999 6999999999997654   


Q ss_pred             ---ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        236 ---TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       236 ---~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                         ..|+||||+.|+ +.+++..                              .......+++..+..++.|++.||.||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~~~~~ql~~al~~l  129 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKG------------------------------LRKKGKRLKEEWIAYILRETLRGLAYL  129 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHH------------------------------HhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence               489999999864 4333321                              011235689999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~  385 (804)
                      |++||+||||+|+||+++.++.+||+|||++.....    .....||+.|+|||++...  ....++.++|||||||++|
T Consensus       130 H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~  209 (275)
T cd06608         130 HENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI  209 (275)
T ss_pred             hcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHH
Confidence            999999999999999999999999999999864322    2345789999999997532  1235778999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      +|++|++||...+....+..+.....+                                        .......++.++.
T Consensus       210 ~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~  249 (275)
T cd06608         210 ELADGKPPLCDMHPMRALFKIPRNPPP----------------------------------------TLKSPENWSKKFN  249 (275)
T ss_pred             HHHhCCCCccccchHHHHHHhhccCCC----------------------------------------CCCchhhcCHHHH
Confidence            999999999766555444443221100                                        0011123688999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +|+.+||..||++|||+.++++|||+
T Consensus       250 ~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         250 DFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.9e-39  Score=343.38  Aligned_cols=256  Identities=44%  Similarity=0.796  Sum_probs=208.0

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      |+++.|+.++.||+|+||.||+|.+..+++.||||.+....  .......+.+|+.++++++||||+++++++..++..|
T Consensus         1 ~~~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             CHHHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            45677999999999999999999999999999999875322  2234466889999999999999999999999999999


Q ss_pred             EEEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.|+. .+++                                   ....+++..+..++.|++.|+.|||++|++
T Consensus        79 lv~e~~~~~~l~~~i-----------------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~  123 (277)
T cd06641          79 IIMEYLGGGSALDLL-----------------------------------EPGPLDETQIATILREILKGLDYLHSEKKI  123 (277)
T ss_pred             EEEEeCCCCcHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHccCCee
Confidence            9999998752 2211                                   124678999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |+||||+||+++.++.++|+|||++.....    .....|+..|+|||.+.   ...++.++|+|||||++|+|++|.+|
T Consensus       124 h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p  200 (277)
T cd06641         124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             cCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999865332    12357899999999884   34678899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+.......+....                                         .+ .....++.++.+++.+||+
T Consensus       201 ~~~~~~~~~~~~~~~~~-----------------------------------------~~-~~~~~~~~~~~~~i~~~l~  238 (277)
T cd06641         201 HSELHPMKVLFLIPKNN-----------------------------------------PP-TLEGNYSKPLKEFVEACLN  238 (277)
T ss_pred             CCccchHHHHHHHhcCC-----------------------------------------CC-CCCcccCHHHHHHHHHHcc
Confidence            97655433332221110                                         00 1123457889999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .+|.+||++.++++||||.+...
T Consensus       239 ~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         239 KEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             CChhhCcCHHHHHhCHHHhhhhh
Confidence            99999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.3e-39  Score=345.05  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=201.7

Q ss_pred             cccccccccccccccceEEEEeeece-----eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSR-----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~-----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      ..|++++.||+|+||.||+|.....+     ..||+|.+....  .......+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            35899999999999999999876554     789999876322  23344668899999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|++|||+.| ++.+.+.....                  ..+.............+++..+..++.|++.||.|||++|
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~  144 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSP------------------HSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH  144 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCC------------------CcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999985 55444431100                  0000000000111256889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||+++++.+||+|||++.....      .....+|+.|+|||.+.   .+.++.++|||||||++|||++
T Consensus       145 i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~slG~il~el~~  221 (283)
T cd05048         145 FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL---YGKFTTESDIWSFGVVLWEIFS  221 (283)
T ss_pred             eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc---cCcCchhhhHHHHHHHHHHHHc
Confidence            99999999999999999999999999864322      12346788999999874   3568899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||.+.+..+....+.....                                          ......+++++.+|+
T Consensus       222 ~g~~p~~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~~~~l~  259 (283)
T cd05048         222 YGLQPYYGFSNQEVIEMIRSRQL------------------------------------------LPCPEDCPARVYALM  259 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCc------------------------------------------CCCcccCCHHHHHHH
Confidence             9999988766554443322110                                          001235688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||.+|||+.+++++
T Consensus       260 ~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         260 IECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=346.06  Aligned_cols=281  Identities=28%  Similarity=0.460  Sum_probs=211.0

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|++++++++||||+++++++..++..|+|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            4899999999999999999999999999999876422 122334678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.+++.+.+                                 ..+...+++.++..++.||+.||.|||++||+|||||
T Consensus        81 ~~~~~~l~~~---------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  127 (288)
T cd07833          81 YVERTLLELL---------------------------------EASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK  127 (288)
T ss_pred             cCCCCHHHHH---------------------------------HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9998743322                                 1223458999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |+||+++.++.+||+|||++.....     .....|++.|+|||++.+  ...++.++|||||||++|+|++|++||.+.
T Consensus       128 ~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         128 PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG--DTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             HHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcC--CCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999865432     234678999999999853  226788999999999999999999999887


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcc-cccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISS-TAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~-~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      +..+.+..+.....+..+ ..+.....-.. .....++....   ...        .......++.++.+|+.+||..||
T Consensus       206 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~li~~~l~~~p  273 (288)
T cd07833         206 SDIDQLYLIQKCLGPLPP-SHQELFSSNPRFAGVAFPEPSQP---ESL--------ERRYPGKVSSPALDFLKACLRMDP  273 (288)
T ss_pred             CHHHHHHHHHHHhCCCCH-HHhhhcccCccccccccCCCCCc---HHH--------HHhcCCccchHHHHHHHHHhccCc
Confidence            776666555432211111 00000000000 00000000000   000        001112347899999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy17952        477 ADRPSSGRLLTHDLV  491 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~  491 (804)
                      ++|||++++++||||
T Consensus       274 ~~Rps~~~il~~~~f  288 (288)
T cd07833         274 KERLTCDELLQHPYF  288 (288)
T ss_pred             hhcccHHHHhcCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.7e-39  Score=337.81  Aligned_cols=251  Identities=31%  Similarity=0.511  Sum_probs=205.7

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+.++.||.|+||.||.+++..+++.+++|.+..... .......+.+|+.++++++||||+++++++...+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            38899999999999999999999999999998764322 22344668899999999999999999999999999999999


Q ss_pred             ecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.| ++.+.+..                                .....+++.++..++.|++.||.|||+.|++||||
T Consensus        80 ~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl  127 (256)
T cd08221          80 YANGGTLYDKIVR--------------------------------QKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI  127 (256)
T ss_pred             ecCCCcHHHHHHh--------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence            9986 44333210                                01245889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||+++.++.+||+|||++.....    .....||+.|+|||++.+   ..++.++|+|||||++|||++|..||...
T Consensus       128 ~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~---~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08221         128 KTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG---VKYNFKSDIWALGCVLYELLTLKRTFDAT  204 (256)
T ss_pred             ChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCC---CCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999865432    234679999999999853   45778999999999999999999999776


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+..+..+                                          ......+.++.+|+.+||..||.
T Consensus       205 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~  242 (256)
T cd08221         205 NPLNLVVKIVQGNYT------------------------------------------PVVSVYSSELISLVHSLLQQDPE  242 (256)
T ss_pred             CHHHHHHHHHcCCCC------------------------------------------CCccccCHHHHHHHHHHcccCcc
Confidence            655544444322110                                          01134578899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.++|+|+|+
T Consensus       243 ~R~s~~~ll~~~~l  256 (256)
T cd08221         243 KRPTADEVLDQPLL  256 (256)
T ss_pred             cCCCHHHHhhCcCC
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0612|consensus

Probab=100.00  E-value=1.4e-40  Score=387.04  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=214.0

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.|.+++++.|++.||+|++++..........-|..|-.+|.--+.+.||.++.+|.++.++|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            49999999999999999999999999999999875322222233557789999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |++||  |++                               ....+..++||+.++.|+..|+.||+-||+.|.||||||
T Consensus       156 Y~pGG--Dll-------------------------------tLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiK  202 (1317)
T KOG0612|consen  156 YMPGG--DLL-------------------------------TLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIK  202 (1317)
T ss_pred             cccCc--hHH-------------------------------HHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCC
Confidence            99987  222                               122233479999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCC--CCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~--~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      |+|||||..|++||+|||.+-....     ....+|||-|.+||++..+..  +.|+..+|+||+||++|||+.|..||+
T Consensus       203 PDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  203 PDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             cceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            9999999999999999998743322     245689999999999975432  579999999999999999999999999


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+..+...+|..-...                 .                    .+|  ...+.|+++++||.+++. +
T Consensus       283 adslveTY~KIm~hk~~-----------------l--------------------~FP--~~~~VSeeakdLI~~ll~-~  322 (1317)
T KOG0612|consen  283 ADSLVETYGKIMNHKES-----------------L--------------------SFP--DETDVSEEAKDLIEALLC-D  322 (1317)
T ss_pred             HHHHHHHHHHHhchhhh-----------------c--------------------CCC--cccccCHHHHHHHHHHhc-C
Confidence            88888877777542100                 0                    112  224579999999999885 6


Q ss_pred             CCCCCC---HHHHHcCccccCC
Q psy17952        476 PADRPS---SGRLLTHDLVTRP  494 (804)
Q Consensus       476 P~~Rps---a~elL~Hp~~~~~  494 (804)
                      |+.|..   ++++-+||||...
T Consensus       323 ~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  323 REVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             hhhhcccccHHHHHhCccccCC
Confidence            888888   9999999999763

>KOG0596|consensus

Probab=100.00  E-value=1.3e-39  Score=355.73  Aligned_cols=256  Identities=28%  Similarity=0.419  Sum_probs=196.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ..|+++++||+||-+.||++..- ..+.+|+|++... ..+......+..|+.+|.+|+ |.+||++++|-..++.+|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            35999999999999999999753 3457888877543 334556678999999999996 89999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||-+-+|..++...                                 .+.++.-.++.|..|++.|+.++|.+||||.|
T Consensus       439 mE~Gd~DL~kiL~k~---------------------------------~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSD  485 (677)
T KOG0596|consen  439 MECGDIDLNKILKKK---------------------------------KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSD  485 (677)
T ss_pred             eecccccHHHHHHhc---------------------------------cCCCchHHHHHHHHHHHHHHHHHHHhceeecC
Confidence            999766666655422                                 12233337888999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCC--------CCCCcccHHHHHHHHHH
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEG--------QYDGKVDVWSLGITCIE  386 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~--------~y~~ksDIWSlGvil~E  386 (804)
                      |||.|+|+- .|.+||+|||+|....+.      .+.+||+.||+||.+..+..+        +.+.++||||||||||+
T Consensus       486 LKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq  564 (677)
T KOG0596|consen  486 LKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ  564 (677)
T ss_pred             CCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence            999999986 589999999999765443      356899999999999754322        25678999999999999


Q ss_pred             HHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAERKPPYFNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 LltG~~PF~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |+.|++||.... ...-+..|                   ....-               +|   .+|...   -..++.
T Consensus       565 MvYgktPf~~~~n~~aKl~aI-------------------~~P~~---------------~I---efp~~~---~~~~li  604 (677)
T KOG0596|consen  565 MVYGKTPFGQIINQIAKLHAI-------------------TDPNH---------------EI---EFPDIP---ENDELI  604 (677)
T ss_pred             HHhcCCchHHHHHHHHHHHhh-------------------cCCCc---------------cc---cccCCC---CchHHH
Confidence            999999995421 11111111                   10000               00   011111   123489


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ++++.||++||.+|||+.++|+|||+.-
T Consensus       605 ~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  605 DVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            9999999999999999999999999875

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.7e-39  Score=345.13  Aligned_cols=259  Identities=39%  Similarity=0.694  Sum_probs=201.9

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEe-----
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYL-----  232 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~-----  232 (804)
                      ++.+.|++++.||+|+||.||+|.+..+++.+|+|.++...    .....+.+|+.+++++ +||||+++++++.     
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            45567999999999999999999999999999999875321    1124567899999999 6999999999874     


Q ss_pred             ecCceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       233 ~~~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      .++..|+||||+.|+ +.+++..                              .......+++..+..++.|++.||.||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~~~~~~i~~~l~~l  140 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKG------------------------------FLKRGERMEEPIIAYILHEALMGLQHL  140 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHH------------------------------hhccCccccHHHHHHHHHHHHHHHHHH
Confidence            345689999999864 4333320                              111234688999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~  385 (804)
                      |+++|+||||||+||+++.++.+||+|||++.....    .....||+.|+|||++...  ....++.++||||+||++|
T Consensus       141 H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~  220 (286)
T cd06638         141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI  220 (286)
T ss_pred             HhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHH
Confidence            999999999999999999999999999999865322    2345799999999997421  1245788999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      ||++|+.||.+.+....+..+....                      ++                  .......++..+.
T Consensus       221 el~~g~~p~~~~~~~~~~~~~~~~~----------------------~~------------------~~~~~~~~~~~~~  260 (286)
T cd06638         221 ELGDGDPPLADLHPMRALFKIPRNP----------------------PP------------------TLHQPELWSNEFN  260 (286)
T ss_pred             HHhcCCCCCCCCchhHHHhhccccC----------------------CC------------------cccCCCCcCHHHH
Confidence            9999999997655433322211100                      00                  0011123577899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +|+.+||+.||++|||+.+++.|+||
T Consensus       261 ~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         261 DFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHHHHccCCcccCCCHHHHhhcccC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-40  Score=378.82  Aligned_cols=288  Identities=20%  Similarity=0.250  Sum_probs=197.0

Q ss_pred             ccccccccccccccccceEEEEeeecee-EEEEEec--------------ccccccchhhhhhHHHHHHHHhhcCCCcee
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSRE-IVAIKKM--------------SYLGKQCAEKWADILKEIRFLRQLKHPNTI  225 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~-~vAIK~i--------------~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV  225 (804)
                      ...|++++.||+|+||+||+|..+.... .+++|.+              .............+.+|+.+|++++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3569999999999999999997654322 2222211              100011122335578999999999999999


Q ss_pred             EeeeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHH
Q psy17952        226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVL  305 (804)
Q Consensus       226 ~l~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil  305 (804)
                      ++++++...+..|+|||++.+++.+.+...                          .   ..........+++.|+.||+
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~--------------------------~---~~~~~~~~~~~~~~i~~ql~  277 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDFDLYSFMYDE--------------------------A---FDWKDRPLLKQTRAIMKQLL  277 (501)
T ss_pred             cEeEEEEECCeeEEEEeccccCHHHHHhhc--------------------------c---ccccccccHHHHHHHHHHHH
Confidence            999999999999999999987654433200                          0   00112234667889999999


Q ss_pred             HHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHH
Q psy17952        306 RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  380 (804)
Q Consensus       306 ~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSl  380 (804)
                      .||+|||++|||||||||+|||++.++.+||+|||+|+....     ....+||+.|+|||++.   +..|+.++|||||
T Consensus       278 ~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSl  354 (501)
T PHA03210        278 CAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA---GDGYCEITDIWSC  354 (501)
T ss_pred             HHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc---CCCCCcHHHHHHH
Confidence            999999999999999999999999999999999999975432     12467999999999985   3568999999999


Q ss_pred             HHHHHHHHhCCCCCCC-C--ChHHHHHHHHhcCCCC---CCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC
Q psy17952        381 GITCIELAERKPPYFN-M--NAMSALYHIAQNDTPC---LQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC  454 (804)
Q Consensus       381 Gvil~ELltG~~PF~~-~--~~~~~l~~I~~~~~p~---~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~  454 (804)
                      ||++|||++|..|+.+ .  +....+..+......+   .+......+..+.......              ......+.
T Consensus       355 Gvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~--------------~~~~~~~~  420 (501)
T PHA03210        355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDH--------------AGHSVPPL  420 (501)
T ss_pred             HHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhccc--------------CccchhhH
Confidence            9999999998865433 2  3334444443321110   0000000111000000000              00000011


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       455 ~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ......+.++.++|.+||++||.+|||+.|+|.||||...
T Consensus       421 ~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        421 IRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1123457789999999999999999999999999999764

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=339.75  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             ccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHH-hhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL-RQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      ++.||+|+||.||+|.+..+++.||+|.+.............+..|..++ ...+||||+++++++..++..|+||||+.
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            35799999999999999999999999987643222122223345555544 45689999999999999999999999998


Q ss_pred             CC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q psy17952        246 GS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG  324 (804)
Q Consensus       246 G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~  324 (804)
                      |+ +.+++                                  ...+.+++..+..++.|++.||.|||+.||+||||||+
T Consensus        81 ~~~L~~~l----------------------------------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~  126 (260)
T cd05611          81 GGDCASLI----------------------------------KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE  126 (260)
T ss_pred             CCCHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence            65 32222                                  22356899999999999999999999999999999999


Q ss_pred             CeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy17952        325 NILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALY  404 (804)
Q Consensus       325 NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~  404 (804)
                      ||+++.++.+||+|||++..........|++.|+|||.+.+   ..++.++|||||||++|||++|.+||...+......
T Consensus       127 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  203 (260)
T cd05611         127 NLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD  203 (260)
T ss_pred             HeEECCCCcEEEeecccceeccccccCCCCcCccChhhhcC---CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999999876554556679999999999853   447889999999999999999999997766554443


Q ss_pred             HHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH--
Q psy17952        405 HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS--  482 (804)
Q Consensus       405 ~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa--  482 (804)
                      .+..+...                                       .+......++.++.+|+.+||+.||++|||+  
T Consensus       204 ~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  244 (260)
T cd05611         204 NILSRRIN---------------------------------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG  244 (260)
T ss_pred             HHHhcccC---------------------------------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCc
Confidence            33221100                                       0111112467889999999999999999955  


Q ss_pred             -HHHHcCccccC
Q psy17952        483 -GRLLTHDLVTR  493 (804)
Q Consensus       483 -~elL~Hp~~~~  493 (804)
                       .|+|.||||..
T Consensus       245 ~~~~l~~~~~~~  256 (260)
T cd05611         245 YQEIKSHPFFKS  256 (260)
T ss_pred             HHHHHcChHhhc
Confidence             79999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-39  Score=361.66  Aligned_cols=283  Identities=24%  Similarity=0.350  Sum_probs=198.8

Q ss_pred             cccccccccccccccccceEEEEe-----eeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~-----~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|.+     ..++..||||.++...  .....+.+.+|+.+|+.+ +|||||++++++..
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            445689999999999999999974     3456789999886432  123346788999999999 89999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhh-hhccc----------------chhhhhhh---------------------
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREF-HVEGM----------------GNRLQQLK---------------------  274 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~-~~~~~----------------~~~l~~l~---------------------  274 (804)
                      .+..|+|||||+| +|.+.+......... .....                ...+....                     
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999985 555555321000000 00000                00000000                     


Q ss_pred             --hhhcccccchh-hccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC---
Q psy17952        275 --CFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---  348 (804)
Q Consensus       275 --~~~~~~~L~~~-~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---  348 (804)
                        .+.....+... ......++++.+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.....   
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence              00000000000 112346899999999999999999999999999999999999999999999999998653221   


Q ss_pred             ---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHh
Q psy17952        349 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKT  424 (804)
Q Consensus       349 ---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~  424 (804)
                         ....++..|+|||++.   ...++.++|||||||++|||++ |.+||.+......+........             
T Consensus       271 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-------------  334 (375)
T ss_pred             cccCCCCCCcceeChhHhc---CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-------------
Confidence               1233556799999984   4578999999999999999998 8999976543333322221110             


Q ss_pred             hcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        425 ISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       425 i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                                                  ........+.++.+|+.+||+.||++|||+.++++.
T Consensus       335 ----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         335 ----------------------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----------------------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                        000112246789999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4645|consensus

Probab=100.00  E-value=3.3e-41  Score=396.73  Aligned_cols=255  Identities=34%  Similarity=0.587  Sum_probs=212.2

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      ++..-.||.|.||.||-|.+..+|+..|+|-+...... ......+.+|..+|..++|||+|+++|+=.+++.+||.|||
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            44556799999999999999999999999987643322 44456678999999999999999999999999999999999


Q ss_pred             cCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |.| +|.++++                                  +.+..+|...+.+..|+++|+.|||++||||||||
T Consensus      1316 C~~GsLa~ll~----------------------------------~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK 1361 (1509)
T KOG4645|consen 1316 CEGGSLASLLE----------------------------------HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIK 1361 (1509)
T ss_pred             hccCcHHHHHH----------------------------------hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCC
Confidence            985 5555543                                  23446677778899999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC--------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~--------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+|||++.+|.+|++|||.|......        +...|||.|||||+|.+........++||||+||++.||+||+.||
T Consensus      1362 ~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1362 PANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred             ccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence            99999999999999999999653321        3578999999999998876556677999999999999999999999


Q ss_pred             CCC-ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        395 FNM-NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       395 ~~~-~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      ... +.-..+|++..+..|.                                         .+ ...|.+.+|||.+||+
T Consensus      1442 ~~~dne~aIMy~V~~gh~Pq-----------------------------------------~P-~~ls~~g~dFle~Cl~ 1479 (1509)
T KOG4645|consen 1442 AELDNEWAIMYHVAAGHKPQ-----------------------------------------IP-ERLSSEGRDFLEHCLE 1479 (1509)
T ss_pred             hhccchhHHHhHHhccCCCC-----------------------------------------Cc-hhhhHhHHHHHHHHHh
Confidence            764 4566667766554442                                         11 1268899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .||++|.++.|+|.|.|-....
T Consensus      1480 ~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1480 QDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             cCchhhhHHHHHHHhhcccccc
Confidence            9999999999999998876543

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6e-39  Score=345.44  Aligned_cols=283  Identities=24%  Similarity=0.385  Sum_probs=209.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|++++++++||||+++++++......|+|||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            48999999999999999999999999999998764322 12233567789999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+++++.+.+..                                .....+++..+..++.||+.||+|||++||+|||||
T Consensus        82 ~~~~~l~~~~~~--------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~  129 (294)
T PLN00009         82 YLDLDLKKHMDS--------------------------------SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK  129 (294)
T ss_pred             cccccHHHHHHh--------------------------------CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            998765443210                                012235788899999999999999999999999999


Q ss_pred             CCCeeecC-CCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        323 AGNILLTE-TGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       323 P~NILl~~-~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |+||+++. ++.+||+|||++.....    .....|++.|+|||++.+  ...++.++|||||||++|+|++|.+||.+.
T Consensus       130 p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        130 PQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG--SRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             cceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999985 45799999999864321    123467899999999853  245788999999999999999999999888


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+.++........ ...|.....+.......+.+.             ...........++++.+|+.+||..||+
T Consensus       208 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~~l~~~P~  273 (294)
T PLN00009        208 SEIDELFKIFRILGTPN-EETWPGVTSLPDYKSAFPKWP-------------PKDLATVVPTLEPAGVDLLSKMLRLDPS  273 (294)
T ss_pred             CHHHHHHHHHHHhCCCC-hhhccccccchhhhhhcccCC-------------CCCHHHhCcCCChHHHHHHHHHccCChh
Confidence            77776666543211100 111110000000000000000             0000011234688899999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy17952        478 DRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~  494 (804)
                      +||++.+++.||||...
T Consensus       274 ~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        274 KRITARAALEHEYFKDL  290 (294)
T ss_pred             hCcCHHHHhcCchHhHH
Confidence            99999999999999754

>KOG0586|consensus

Probab=100.00  E-value=4.4e-40  Score=365.84  Aligned_cols=255  Identities=29%  Similarity=0.469  Sum_probs=214.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|.+++.||+|.|++|.+|++..|+..||||.+++.... ....+.+.+|+++|+.|+|||||+++.+......+|+||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            3589999999999999999999999999999998765433 334456889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.|+                                 ++|++..+.+.+.+..++.++.|+++|++|||+++||||||
T Consensus       135 eya~~g---------------------------------e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdL  181 (596)
T KOG0586|consen  135 EYASGG---------------------------------ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDL  181 (596)
T ss_pred             EeccCc---------------------------------hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceecccc
Confidence            999876                                 56777788888999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~-~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |.+||||+.+.++||+|||++.....   ..++||++.|.|||++.+   ..|+ +.+|+||+|+++|-|+.|..||.+.
T Consensus       182 k~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g---~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  182 KAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNG---KKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             chhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcC---cccCCcceehhhhhhhheeeeecccccCCc
Confidence            99999999999999999999976543   467999999999999965   3454 5799999999999999999999875


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +-.+.-.+...                                  ..+++         +--.|.+..++|.++|..+|.
T Consensus       259 ~lk~Lr~rvl~----------------------------------gk~rI---------p~~ms~dce~lLrk~lvl~Ps  295 (596)
T KOG0586|consen  259 NLKELRPRVLR----------------------------------GKYRI---------PFYMSCDCEDLLRKFLVLNPS  295 (596)
T ss_pred             ccccccchhee----------------------------------eeecc---------cceeechhHHHHHHhhccCcc
Confidence            53221111100                                  00111         112467788999999999999


Q ss_pred             CCCCHHHHHcCccccCCCC
Q psy17952        478 DRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~~~  496 (804)
                      +|+++++++.|.|......
T Consensus       296 kr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  296 KRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             ccCCHHHhhhhcccchhhh
Confidence            9999999999999875443

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.4e-39  Score=344.08  Aligned_cols=261  Identities=38%  Similarity=0.680  Sum_probs=210.4

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .++...|...+.||+|+||.||++.+..+++.+|+|.+....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          15 GDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             CcchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence            345556788899999999999999999999999999875322   22345678999999999999999999999999999


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+++||+.|+ +.+.+                                  . .+.+++..+..++.|++.||+|||++||
T Consensus        92 ~~v~e~~~~~~L~~~~----------------------------------~-~~~~~~~~~~~~~~ql~~~l~~lH~~~i  136 (285)
T cd06648          92 WVVMEFLEGGALTDIV----------------------------------T-HTRMNEEQIATVCLAVLKALSFLHAQGV  136 (285)
T ss_pred             EEEEeccCCCCHHHHH----------------------------------H-hCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            9999999864 22221                                  1 1467889999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+||+++.++.+||+|||++.....    .....|++.|+|||++.   ...++.++|||||||++|||++|+.
T Consensus       137 ~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~ell~g~~  213 (285)
T cd06648         137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS---RLPYGTEVDIWSLGIMVIEMVDGEP  213 (285)
T ss_pred             ecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhc---CCCCCCcccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999998764321    22357999999999984   3568889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+.......+.....+                      .                  .......+..+.+|+.+||
T Consensus       214 p~~~~~~~~~~~~~~~~~~~----------------------~------------------~~~~~~~~~~l~~li~~~l  253 (285)
T cd06648         214 PYFNEPPLQAMKRIRDNLPP----------------------K------------------LKNLHKVSPRLRSFLDRML  253 (285)
T ss_pred             CCcCCCHHHHHHHHHhcCCC----------------------C------------------CcccccCCHHHHHHHHHHc
Confidence            99876655444433221100                      0                  0011235788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCCch
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSPSV  499 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~~~  499 (804)
                      ..||++|||+.++++||||.....+..
T Consensus       254 ~~~p~~Rpt~~~il~~~~~~~~~~~~~  280 (285)
T cd06648         254 VRDPAQRATAAELLNHPFLAKAGPPSS  280 (285)
T ss_pred             ccChhhCcCHHHHccCcccccCCCcch
Confidence            999999999999999999988776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0193|consensus

Probab=100.00  E-value=6.7e-40  Score=362.16  Aligned_cols=253  Identities=27%  Similarity=0.437  Sum_probs=204.4

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .|.....+...||+|+||+||+|++-.   .||||.+...... .+..+.|.+|+..+++-+|-||+-+.|++..+.. .
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            344456778999999999999998654   5999998765443 4578899999999999999999999999988877 8


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      ||+.+|+|+ |...++                                 +.+..|.....+.|++||+.|+.|||.++||
T Consensus       464 IiTqwCeGsSLY~hlH---------------------------------v~etkfdm~~~idIAqQiaqGM~YLHAK~II  510 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLH---------------------------------VQETKFDMNTTIDIAQQIAQGMDYLHAKNII  510 (678)
T ss_pred             eeehhccCchhhhhcc---------------------------------chhhhhhHHHHHHHHHHHHHhhhhhhhhhhh
Confidence            999999985 333322                                 1223567778899999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |||||..||++.++++|||+|||++.....      .....|...|||||++...+..+|+..+|||||||++|||++|.
T Consensus       511 HrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~  590 (678)
T KOG0193|consen  511 HRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE  590 (678)
T ss_pred             hhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence            999999999999999999999999965322      23456888999999998666678999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||...+....++++.+|..-                                      ..+.....+.+.++++|+..|
T Consensus       591 lPysi~~~dqIifmVGrG~l~--------------------------------------pd~s~~~s~~pk~mk~Ll~~C  632 (678)
T KOG0193|consen  591 LPYSIQNRDQIIFMVGRGYLM--------------------------------------PDLSKIRSNCPKAMKRLLSDC  632 (678)
T ss_pred             CCcCCCChhheEEEecccccC--------------------------------------ccchhhhccCHHHHHHHHHHH
Confidence            999866655555555433110                                      001112345677899999999


Q ss_pred             cccCCCCCCCHHHHHc
Q psy17952        472 LAKNPADRPSSGRLLT  487 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~  487 (804)
                      |.++|++||+..++|.
T Consensus       633 ~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  633 WKFDREERPLFPQLLS  648 (678)
T ss_pred             HhcCcccCccHHHHHH
Confidence            9999999999999985

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.5e-39  Score=343.40  Aligned_cols=260  Identities=39%  Similarity=0.721  Sum_probs=204.0

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeec---
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRD---  234 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~---  234 (804)
                      ++...|++.+.||+|+||.||+|.+..+++.+|+|.+....    .....+.+|+.+++++ +||||+++++++...   
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            34566999999999999999999999999999999875421    1224567899999999 899999999998754   


Q ss_pred             --CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        235 --HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       235 --~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                        +..|+||||+.|+ +.++++.                              .......+++..+..++.|++.||+||
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~------------------------------~~~~~~~~~~~~~~~~~~qi~~al~~l  144 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKG------------------------------LLICGQRLDEAMISYILYGALLGLQHL  144 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHH------------------------------hhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence              3589999999864 4343321                              011235688999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccC--CCCCCCcccHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvil~  385 (804)
                      |++||+||||||+||+++.++.+||+|||++.....    .....|++.|+|||++....  ...++.++|||||||++|
T Consensus       145 H~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~  224 (291)
T cd06639         145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI  224 (291)
T ss_pred             HhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHH
Confidence            999999999999999999999999999999865322    23457899999999974311  113678999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      ||++|++||...+....+..+..+..+.                                        ......++..+.
T Consensus       225 el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~  264 (291)
T cd06639         225 ELGDGDPPLFDMHPVKTLFKIPRNPPPT----------------------------------------LLHPEKWCRSFN  264 (291)
T ss_pred             HHhhCCCCCCCCcHHHHHHHHhcCCCCC----------------------------------------CCcccccCHHHH
Confidence            9999999998766554444432221110                                        001124567899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCcccc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      +||.+||+.||++|||+.++++||||.
T Consensus       265 ~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         265 HFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.5e-39  Score=337.33  Aligned_cols=251  Identities=28%  Similarity=0.524  Sum_probs=204.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||++++..+++.||+|.+..... .......+.+|+.++++++||||+++++++...+..|+|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            38899999999999999999999999999998764322 12334578899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+.+.                                ......+++.++..++.|++.||.|||++|++|+||
T Consensus        80 ~~~~~~l~~~~~--------------------------------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l  127 (256)
T cd08218          80 YCEGGDLYKKIN--------------------------------AQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDI  127 (256)
T ss_pred             cCCCCcHHHHHH--------------------------------hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence            99864 333221                                011235789999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      +|+|||++.++.+||+|||++......    ....|++.|+|||++.   ...++.++|+|||||++|+|++|+.||...
T Consensus       128 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08218         128 KSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE---NRPYNNKSDIWALGCVLYEMCTLKHAFEAG  204 (256)
T ss_pred             CHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhC---CCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence            999999999999999999998654321    2346899999999984   356788999999999999999999999766


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+..+..+                                          .....++.++.++|.+||+.+|.
T Consensus       205 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~~l~~~p~  242 (256)
T cd08218         205 NMKNLVLKIIRGSYP------------------------------------------PVSSHYSYDLRNLVSQLFKRNPR  242 (256)
T ss_pred             CHHHHHHHHhcCCCC------------------------------------------CCcccCCHHHHHHHHHHhhCChh
Confidence            555444443322110                                          01234578899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +||++.+++.||||
T Consensus       243 ~Rp~~~~vl~~~~~  256 (256)
T cd08218         243 DRPSVNSILEKNFI  256 (256)
T ss_pred             hCcCHHHHhhCcCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-39  Score=341.95  Aligned_cols=250  Identities=31%  Similarity=0.476  Sum_probs=203.1

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||.|+||.||+|++..+++.||+|.+...........+.+.+|++++++++||||+++++++......|+||||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            78899999999999999999999999999988653322334456788999999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.|+..                                 .+++....++++..+..++.|+++||.|||++||+|+||||
T Consensus        82 ~~~~~L---------------------------------~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~  128 (258)
T cd05578          82 LLGGDL---------------------------------RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP  128 (258)
T ss_pred             CCCCCH---------------------------------HHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence            987521                                 11122235789999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        324 GNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      +||++++++.+||+|||++......   ....|+..|+|||++.   ...++.++|+|||||++|+|++|..||...+..
T Consensus       129 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  205 (258)
T cd05578         129 DNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC---RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT  205 (258)
T ss_pred             HHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHc---ccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence            9999999999999999998654332   3457889999999984   345788999999999999999999999765421


Q ss_pred             --HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        401 --SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       401 --~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                        ..+.....                  .                        ........++..+.++|.+||..||.+
T Consensus       206 ~~~~~~~~~~------------------~------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~  243 (258)
T cd05578         206 IRDQIRAKQE------------------T------------------------ADVLYPATWSTEAIDAINKLLERDPQK  243 (258)
T ss_pred             HHHHHHHHhc------------------c------------------------ccccCcccCcHHHHHHHHHHccCChhH
Confidence              11111000                  0                        000112346789999999999999999


Q ss_pred             CCCH--HHHHcCccc
Q psy17952        479 RPSS--GRLLTHDLV  491 (804)
Q Consensus       479 Rpsa--~elL~Hp~~  491 (804)
                      ||++  .|+++||||
T Consensus       244 R~~~~~~~l~~~~~~  258 (258)
T cd05578         244 RLGDNLKDLKNHPYF  258 (258)
T ss_pred             cCCccHHHHhcCCCC
Confidence            9999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.2e-39  Score=339.36  Aligned_cols=251  Identities=32%  Similarity=0.549  Sum_probs=198.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEeccccccc--chhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~  238 (804)
                      .|++.+.||+|+||.||+|++..+++.||||.+......  .......+.+|+.++++++||||+++++++.+.  ..+|
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            488899999999999999999999999999987532211  123346778899999999999999999998764  4688


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      ++|||++|+ +.+.+                                  .....+++..+..++.|++.||+|||+++|+
T Consensus        83 ~v~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  128 (265)
T cd06652          83 IFMEHMPGGSIKDQL----------------------------------KSYGALTENVTRKYTRQILEGVSYLHSNMIV  128 (265)
T ss_pred             EEEEecCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            999999864 32222                                  2234578899999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+|||++.++.+||+|||++.....       .....||..|+|||++.   +..++.++|||||||++|||++|
T Consensus       129 H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~g  205 (265)
T cd06652         129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS---GEGYGRKADIWSVGCTVVEMLTE  205 (265)
T ss_pred             cCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhc---CCCCCcchhHHHHHHHHHHHhhC
Confidence            999999999999999999999999864321       22356899999999984   34578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||.+.+.......+....                                        ..+ ......+..+.+++.+
T Consensus       206 ~~p~~~~~~~~~~~~~~~~~----------------------------------------~~~-~~~~~~~~~~~~~i~~  244 (265)
T cd06652         206 KPPWAEFEAMAAIFKIATQP----------------------------------------TNP-VLPPHVSDHCRDFLKR  244 (265)
T ss_pred             CCCCCccchHHHHHHHhcCC----------------------------------------CCC-CCchhhCHHHHHHHHH
Confidence            99997654443332221100                                        000 0112457788999999


Q ss_pred             hcccCCCCCCCHHHHHcCcccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      ||. +|++|||++++++|||+.
T Consensus       245 ~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         245 IFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             Hhc-ChhhCCCHHHHhcCcccC
Confidence            995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.2e-39  Score=340.83  Aligned_cols=254  Identities=33%  Similarity=0.539  Sum_probs=199.7

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEeccccccc---chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ---CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~---~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      |+..+.||+|+||.||++.+..+++.||+|.+......   .......+.+|+.++++++||||+++++++...+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            77789999999999999999999999999988643211   112346788999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.|+ +.+++                                  ...+++++..+..++.|++.||.|||++|++||
T Consensus        82 ~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~  127 (268)
T cd06630          82 VEWMAGGSVSHLL----------------------------------SKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR  127 (268)
T ss_pred             EeccCCCcHHHHH----------------------------------HHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999865 32222                                  223568899999999999999999999999999


Q ss_pred             CCCCCCeeecCCC-cEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        320 DVKAGNILLTETG-TVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       320 DLKP~NILl~~~g-~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||+||+++.++ .+||+|||++.....        .....||..|+|||++.   ...++.++|+||+||++|+|++|
T Consensus       128 ~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g  204 (268)
T cd06630         128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR---GEQYGRSCDVWSVGCVIIEMATA  204 (268)
T ss_pred             CCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhc---cCCCCcccchHHHHHHHHHHHhC
Confidence            9999999998776 599999999864322        12356889999999984   35678899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||...+.......+.+                +                      .............+.++.+|+.+
T Consensus       205 ~~p~~~~~~~~~~~~~~~----------------~----------------------~~~~~~~~~~~~~~~~~~~~i~~  246 (268)
T cd06630         205 KPPWNAEKHSNHLALIFK----------------I----------------------ASATTAPSIPEHLSPGLRDVTLR  246 (268)
T ss_pred             CCCCCCCCCcchHHHHHH----------------H----------------------hccCCCCCCchhhCHHHHHHHHH
Confidence            999964332111111100                0                      00000011123457889999999


Q ss_pred             hcccCCCCCCCHHHHHcCcccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      ||..||++|||+.++++||||.
T Consensus       247 ~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         247 CLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.1e-39  Score=347.66  Aligned_cols=270  Identities=41%  Similarity=0.705  Sum_probs=214.0

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .++...|++++.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.++++++||||+++++++...+..
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            445567999999999999999999998899999999875322   22345678999999999999999999999999999


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+||||+.|+ +.+++                                   .+..+++.++..++.|++.||.|||++|+
T Consensus        92 ~lv~e~~~~~~L~~~~-----------------------------------~~~~l~~~~~~~i~~~l~~al~~LH~~gi  136 (293)
T cd06647          92 WVVMEYLAGGSLTDVV-----------------------------------TETCMDEGQIAAVCRECLQALEFLHSNQV  136 (293)
T ss_pred             EEEEecCCCCcHHHHH-----------------------------------hhcCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            9999999865 22221                                   12357888999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+||+++.++.+||+|||++....+.    ....|++.|+|||.+.   .+.++.++|+|||||++|+|++|+.
T Consensus       137 ~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Dv~slG~ll~~ll~g~~  213 (293)
T cd06647         137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMVEGEP  213 (293)
T ss_pred             eeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhc---cCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999988643322    2346899999999984   3567889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||...+....+..+.....                     +                   ........+..+.+|+.+||
T Consensus       214 pf~~~~~~~~~~~~~~~~~---------------------~-------------------~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         214 PYLNENPLRALYLIATNGT---------------------P-------------------ELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             CCCCCChhhheeehhcCCC---------------------C-------------------CCCCccccCHHHHHHHHHHc
Confidence            9976554332221111000                     0                   00012235778999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHH
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK  508 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~  508 (804)
                      ..+|++||++.+++.|+||........+..++...+
T Consensus       254 ~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~~~~~  289 (293)
T cd06647         254 EMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAAK  289 (293)
T ss_pred             cCChhhCcCHHHHhcCHHHhcCcccccccchHHHhh
Confidence            999999999999999999998776665655554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-39  Score=343.05  Aligned_cols=279  Identities=26%  Similarity=0.419  Sum_probs=210.6

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++++.||.|++|.||+|.+..+|..||+|++..... .......+.+|+++++.++||||+++++++.+.+..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            6788999999999999999999999999998864321 122234577899999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.+++.+++..                                .....+++..+..++.|+++||+|||+++++||||+|
T Consensus        80 ~~~~l~~~~~~--------------------------------~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p  127 (283)
T cd07835          80 LDLDLKKYMDS--------------------------------SPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKP  127 (283)
T ss_pred             cCcCHHHHHhh--------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCH
Confidence            97765443320                                0113588999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +||+++.++.+||+|||++.....    .....+++.|+|||++.+  ...++.++|||||||++|||++|++||.+.+.
T Consensus       128 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  205 (283)
T cd07835         128 QNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG--SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE  205 (283)
T ss_pred             HHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeec--CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999864321    123457899999998753  23578899999999999999999999988887


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ...+..+.+...... ...|..+..+.......+.+.             ..........++..+.+++.+||+.||.+|
T Consensus       206 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  271 (283)
T cd07835         206 IDQLFRIFRTLGTPD-EDVWPGVTSLPDYKPTFPKWA-------------RQDLSKVVPNLDEDGLDLLSKMLVYDPAKR  271 (283)
T ss_pred             HHHHHHHHHHhCCCC-hHHhhhhhhchhhhhhccccc-------------ccchhhhcCCCCHHHHHHHHHHhcCChhhC
Confidence            776666654321111 111111111110000000000             000111124567899999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy17952        480 PSSGRLLTHDLV  491 (804)
Q Consensus       480 psa~elL~Hp~~  491 (804)
                      ||+.+++.||||
T Consensus       272 pt~~~il~~~~~  283 (283)
T cd07835         272 ISAKAALQHPYF  283 (283)
T ss_pred             cCHHHHhcCCCC
Confidence            999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-39  Score=343.78  Aligned_cols=265  Identities=31%  Similarity=0.521  Sum_probs=205.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++++.||+|+||+||++.+..+++.||+|.+....  .......+.+|+++++.++||||+++++++...+..|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            35899999999999999999999999999999875432  2233467889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRD  320 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRD  320 (804)
                      ||+.|+..+                                 +++...+.+++..+..++.|++.||.|||+ .+|+|||
T Consensus        83 e~~~~~~L~---------------------------------~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~d  129 (284)
T cd06620          83 EFMDCGSLD---------------------------------RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD  129 (284)
T ss_pred             ecCCCCCHH---------------------------------HHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccC
Confidence            999875221                                 112234568899999999999999999997 6999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC--CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~--~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |||+||+++.++.++|+|||++....  .....+||..|+|||++.   .+.++.++|||||||++|+|++|..||...+
T Consensus       130 l~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         130 IKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQ---GGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             CCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHc---cCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999986432  123467999999999985   3468889999999999999999999997544


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+....     .+      ...                   ...+..+.....+......++.++.+|+.+||+.||++
T Consensus       207 ~~~~~~~-----~~------~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  256 (284)
T cd06620         207 IDDDGQD-----DP------MGI-------------------LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE  256 (284)
T ss_pred             hhhhhhh-----hh------hHH-------------------HHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCccc
Confidence            3210000     00      000                   00001111111122222336788999999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy17952        479 RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~~  494 (804)
                      |||+.++++|+||.+.
T Consensus       257 Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         257 RPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CcCHHHHhcCcccccc
Confidence            9999999999998664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.3e-39  Score=339.34  Aligned_cols=251  Identities=33%  Similarity=0.584  Sum_probs=197.0

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEeccccccc--chhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cCceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DHTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~~~~  238 (804)
                      .|+..+.||+|+||.||+|.+..++..||+|.+......  ..+....+.+|+.++++++||||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            378899999999999999999999999999987643211  12234567889999999999999999998875  35789


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      ++|||+.|+ +.+.+                                  .....+++..+..++.|++.||+|||+++|+
T Consensus        83 l~~e~~~~~~L~~~l----------------------------------~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~  128 (266)
T cd06651          83 IFMEYMPGGSVKDQL----------------------------------KAYGALTESVTRKYTRQILEGMSYLHSNMIV  128 (266)
T ss_pred             EEEeCCCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            999999864 33322                                  2234578899999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+||+++.++.+||+|||+++....       .....|+..|+|||.+.   ...++.++||||+||++|||++|
T Consensus       129 H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i~~el~~g  205 (266)
T cd06651         129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS---GEGYGRKADVWSLGCTVVEMLTE  205 (266)
T ss_pred             eCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhC---CCCCCchhhhHHHHHHHHHHHHC
Confidence            999999999999999999999999864321       12346889999999984   35678899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||...........+....                                        ..+. .....++.+++|+ +
T Consensus       206 ~~pf~~~~~~~~~~~~~~~~----------------------------------------~~~~-~~~~~~~~~~~li-~  243 (266)
T cd06651         206 KPPWAEYEAMAAIFKIATQP----------------------------------------TNPQ-LPSHISEHARDFL-G  243 (266)
T ss_pred             CCCccccchHHHHHHHhcCC----------------------------------------CCCC-CchhcCHHHHHHH-H
Confidence            99997654433322221100                                        0000 0123467788898 6


Q ss_pred             hcccCCCCCCCHHHHHcCcccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      ||..+|++|||++|+++||||.
T Consensus       244 ~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         244 CIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HhcCChhhCcCHHHHhcCcccc
Confidence            7778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-38  Score=339.14  Aligned_cols=256  Identities=30%  Similarity=0.549  Sum_probs=201.3

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEeccccccc-------chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-------CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-------~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      |...+.||+|+||.||+|.+..+++.||+|.+......       .....+.+.+|+.++++++||||+++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            67788999999999999999999999999987532111       11123467789999999999999999999999999


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .++||||+.|+ +.+.+                                  ...+.+++..+..++.|++.||.|||++|
T Consensus        83 ~~lv~e~~~~~~L~~~l----------------------------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  128 (272)
T cd06629          83 LSIFLEYVPGGSIGSCL----------------------------------RTYGRFEEQLVRFFTEQVLEGLAYLHSKG  128 (272)
T ss_pred             eEEEEecCCCCcHHHHH----------------------------------hhccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            99999999865 32222                                  22356889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ++||||||+||+++.++.+||+|||++.....      .....|+..|+|||++... ...++.++|+|||||++|||++
T Consensus       129 i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Dv~slG~~l~~l~~  207 (272)
T cd06629         129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY-SQGYSAKVDIWSLGCVVLEMFA  207 (272)
T ss_pred             eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccc-cCCCCccchhHHHHHHHHHHHh
Confidence            99999999999999999999999999865322      1234688999999998532 1247889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||...+....+..+.....                    .+                 ..+......++.++.+|+.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~--------------------~~-----------------~~~~~~~~~~~~~~~~li~  250 (272)
T cd06629         208 GRRPWSDEEAIAAMFKLGNKRS--------------------AP-----------------PIPPDVSMNLSPVALDFLN  250 (272)
T ss_pred             CCCCCcCcchHHHHHHhhcccc--------------------CC-----------------cCCccccccCCHHHHHHHH
Confidence            9999976554433332211000                    00                 0011112346889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccc
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +||..+|.+|||++++|+|||+
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         251 ACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHhcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.6e-39  Score=355.72  Aligned_cols=281  Identities=27%  Similarity=0.428  Sum_probs=209.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee----cCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR----DHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----~~~~  237 (804)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+|++++||||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            568999999999999999999999999999998864321 12334567789999999999999999998763    3468


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+||||+.|++.+.+                                  ...+.+++..+..++.||+.||.|||++||+
T Consensus        84 ~lv~e~~~~~l~~~~----------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  129 (334)
T cd07855          84 YVVMDLMESDLHHII----------------------------------HSDQPLTEEHIRYFLYQLLRGLKYIHSANVI  129 (334)
T ss_pred             EEEEehhhhhHHHHh----------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            999999987643322                                  2245689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC--------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~--------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||||||+|||++.++.+||+|||++......        ....||..|+|||.+.+  ...++.++|||||||++|||++
T Consensus       130 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~el~~  207 (334)
T cd07855         130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS--LPEYTTAIDMWSVGCIFAEMLG  207 (334)
T ss_pred             cCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcC--CcccccccchHHHHHHHHHHHc
Confidence            9999999999999999999999998653221        23478999999999743  2457889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHh-hccC-CCC-CCCCCCccHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH-IAQN-DTP-CLQSSDWSDTFA  465 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~-i~~~-~~p-~~~~~~~s~~l~  465 (804)
                      |++||.+.+....+..+... ..|..     ..+..+..           ........ .... ..+ .......++++.
T Consensus       208 g~~pf~~~~~~~~~~~~~~~~g~~~~-----~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (334)
T cd07855         208 RRQLFPGKNYVHQLKLILSVLGSPSE-----EVLNRIGS-----------DRVRKYIQNLPRKQPVPWSKIFPKASPEAL  271 (334)
T ss_pred             CCCccCCCChHHHHHHHHHHhCCChh-----Hhhhhhch-----------hhHHHHHhhcccCCCCCHHHHcccCCHHHH
Confidence            99999888766655544332 11110     00000000           00000000 0000 000 001134588999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +||.+||+.||.+|||+++++.||||....
T Consensus       272 ~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         272 DLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             HHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence            999999999999999999999999997543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-39  Score=355.05  Aligned_cols=283  Identities=25%  Similarity=0.375  Sum_probs=209.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----Cc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----HT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----~~  236 (804)
                      ..|++++.||+|+||.||+|++..+++.||||.+..... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            358999999999999999999999999999998864322 122335677899999999999999999987654     34


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|+||||+.+++.+.+                                  ...+.+++..+..++.|++.||.|||++++
T Consensus        84 ~~lv~e~~~~~L~~~~----------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  129 (337)
T cd07858          84 VYIVYELMDTDLHQII----------------------------------RSSQTLSDDHCQYFLYQLLRGLKYIHSANV  129 (337)
T ss_pred             EEEEEeCCCCCHHHHH----------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            8999999987654332                                  234578999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+|||++.++.+||+|||++......    ....||..|+|||++..  ...++.++|||||||++|+|++|++
T Consensus       130 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~  207 (337)
T cd07858         130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKP  207 (337)
T ss_pred             ecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhc--CCCCCCcccHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999998754322    34578999999999853  2357889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~dli~~  470 (804)
                      ||.+.+.......+.....+... ..+..   +..          ......+........+  .......++++.+|+.+
T Consensus       208 pf~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  273 (337)
T cd07858         208 LFPGKDYVHQLKLITELLGSPSE-EDLGF---IRN----------EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEK  273 (337)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCh-HHhhh---cCc----------hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHH
Confidence            99887665544444321111000 00000   000          0000000000000000  01123578899999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||+.||++|||+.++|+||||....
T Consensus       274 ~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         274 MLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HhcCChhhccCHHHHHcCcchhhhc
Confidence            9999999999999999999997543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.5e-39  Score=343.18  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=190.5

Q ss_pred             ccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHH---HhhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF---LRQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~i---L~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      .||+|+||.||++.+..+++.+|+|.+...............+|..+   +...+||||+.+++++...+..|+||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999998864322211111223444433   334579999999999999999999999998


Q ss_pred             CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        246 GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       246 G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      |+..                                 .+++...+.+++..+..++.|++.||+|||++||+||||||+|
T Consensus        81 ~~~L---------------------------------~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~N  127 (279)
T cd05633          81 GGDL---------------------------------HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPAN  127 (279)
T ss_pred             CCCH---------------------------------HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHH
Confidence            7621                                 1122234578999999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy17952        326 ILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL  403 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l  403 (804)
                      ||++.++.+||+|||++.....  .....||+.|+|||.+..  +..++.++||||+||++|||++|..||.........
T Consensus       128 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  205 (279)
T cd05633         128 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK--GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH  205 (279)
T ss_pred             EEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcC--CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH
Confidence            9999999999999999864322  223579999999998742  345788999999999999999999999653211100


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---  480 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---  480 (804)
                       .+                .....                       ..+......+++++.+||.+||..||++||   
T Consensus       206 -~~----------------~~~~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  245 (279)
T cd05633         206 -EI----------------DRMTL-----------------------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCL  245 (279)
T ss_pred             -HH----------------HHHhh-----------------------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCC
Confidence             00                00000                       000011234688999999999999999999   


Q ss_pred             --CHHHHHcCccccCC
Q psy17952        481 --SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 --sa~elL~Hp~~~~~  494 (804)
                        |++++++||||...
T Consensus       246 ~~~~~~~~~h~~~~~~  261 (279)
T cd05633         246 GRGAQEVKEHVFFKGI  261 (279)
T ss_pred             CCCHHHHHhCccccCC
Confidence              69999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4236|consensus

Probab=100.00  E-value=2.7e-40  Score=357.17  Aligned_cols=259  Identities=26%  Similarity=0.387  Sum_probs=214.2

Q ss_pred             Ccccccccc--cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        159 DPEKIFEDL--REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       159 dp~~~y~~l--~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +....|++.  +.||+|.||+||-|.++.+|+.||||.|++..-... ....+.+|+.||+++.||.||.+...|++.+.
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPER  637 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence            334457765  789999999999999999999999999987654332 23678899999999999999999999999999


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +++|||-+.|+..+.|-                                ...++.|+|...+.++.||+.||.|||-++|
T Consensus       638 vFVVMEKl~GDMLEMIL--------------------------------SsEkgRL~er~TkFlvtQIL~ALr~LH~knI  685 (888)
T KOG4236|consen  638 VFVVMEKLHGDMLEMIL--------------------------------SSEKGRLPERITKFLVTQILVALRYLHFKNI  685 (888)
T ss_pred             EEEEehhhcchHHHHHH--------------------------------HhhcccchHHHHHHHHHHHHHHHHHhhhcce
Confidence            99999999997655441                                1346789999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCC---cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        317 IHRDVKAGNILLTETG---TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g---~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      +|+||||+|||+.+..   .+||||||+|++...   ..+.+|||.|.|||++.   ++.|+..-|+||.|||+|--|+|
T Consensus       686 vHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLr---nkGyNrSLDMWSVGVIiYVsLSG  762 (888)
T KOG4236|consen  686 VHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLR---NKGYNRSLDMWSVGVIIYVSLSG  762 (888)
T ss_pred             eeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHh---hccccccccceeeeEEEEEEecc
Confidence            9999999999997643   699999999987543   35789999999999995   46799999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||....+..  .+|. +..                                      ...|..+....|+++.|||..
T Consensus       763 TFPFNEdEdIn--dQIQ-NAa--------------------------------------FMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  763 TFPFNEDEDIN--DQIQ-NAA--------------------------------------FMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             cccCCCccchh--HHhh-ccc--------------------------------------cccCCCchhhcCHHHHHHHHH
Confidence            99996544322  1111 110                                      012333445678999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +|+..=.+|+|.++.|.|||+..-
T Consensus       802 LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  802 LLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHhcchHhhccchhhhcc
Confidence            999999999999999999999754

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=339.18  Aligned_cols=253  Identities=40%  Similarity=0.743  Sum_probs=203.8

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC---CCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK---HPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|+.++.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.++++++   |||++++++++..+...|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4888999999999999999999999999999875421  2233456788999999997   9999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+++                                   ..+.+++..+..++.|+++||.|||+.||+|
T Consensus        80 v~e~~~~~~L~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H  124 (277)
T cd06917          80 IMEYAEGGSVRTLM-----------------------------------KAGPIAEKYISVIIREVLVALKYIHKVGVIH  124 (277)
T ss_pred             EEecCCCCcHHHHH-----------------------------------HccCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999875 32221                                   1236889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||+|+||+++.++.++|+|||++.....    .....|+..|+|||.+..  +..++.++|+|||||++|+|++|.+||
T Consensus       125 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~ll~g~~p~  202 (277)
T cd06917         125 RDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE--GKYYDTKADIWSLGITIYEMATGNPPY  202 (277)
T ss_pred             CCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhcc--CCccccchhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999865432    233579999999998742  234688999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+.......+..                                         ...+......++.++.+|+.+||+.
T Consensus       203 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~  241 (277)
T cd06917         203 SDVDAFRAMMLIPK-----------------------------------------SKPPRLEDNGYSKLLREFVAACLDE  241 (277)
T ss_pred             CCCChhhhhhcccc-----------------------------------------CCCCCCCcccCCHHHHHHHHHHcCC
Confidence            76543322211100                                         0011112223678999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||++|||+.+++.|+||.+..
T Consensus       242 ~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         242 EPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             CcccCcCHHHHhhChHhhccc
Confidence            999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-38  Score=336.69  Aligned_cols=246  Identities=28%  Similarity=0.426  Sum_probs=199.6

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC-c
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-A  248 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~-l  248 (804)
                      ||.|+||.||+|++..+++.||+|.+...........+.+.+|+.+++.++||||+++++.+.++...|++|||+.|+ +
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999999999999986543333334467889999999999999999999999999999999999864 3


Q ss_pred             hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        249 SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       249 ~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                      .+.                                  +.....+++..+..++.||+.||+|||++|++|+||||+||++
T Consensus        81 ~~~----------------------------------l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv  126 (262)
T cd05572          81 WTI----------------------------------LRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL  126 (262)
T ss_pred             HHH----------------------------------HhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE
Confidence            222                                  2234468899999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--hHHHH
Q psy17952        329 TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN--AMSAL  403 (804)
Q Consensus       329 ~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~--~~~~l  403 (804)
                      +.++.+||+|||++.....   .....|++.|+|||.+.   ...++.++|+||+||++|+|++|..||....  .....
T Consensus       127 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  203 (262)
T cd05572         127 DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL---NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY  203 (262)
T ss_pred             cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhc---CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH
Confidence            9999999999999875433   23457899999999974   3467889999999999999999999997655  33322


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC--
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS--  481 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps--  481 (804)
                      ..+..+.                                        ..+ ..+...++++.+||.+||..||++|||  
T Consensus       204 ~~~~~~~----------------------------------------~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  242 (262)
T cd05572         204 NDILKGN----------------------------------------GKL-EFPNYIDKAAKDLIKQLLRRNPEERLGNL  242 (262)
T ss_pred             HHHhccC----------------------------------------CCC-CCCcccCHHHHHHHHHHccCChhhCcCCc
Confidence            2221100                                        000 011223788999999999999999999  


Q ss_pred             ---HHHHHcCccccC
Q psy17952        482 ---SGRLLTHDLVTR  493 (804)
Q Consensus       482 ---a~elL~Hp~~~~  493 (804)
                         +.|+++||||..
T Consensus       243 ~~~~~~l~~~~~~~~  257 (262)
T cd05572         243 KGGIKDIKKHKWFNG  257 (262)
T ss_pred             ccCHHHHhcChhhhC
Confidence               999999999974

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.9e-39  Score=339.74  Aligned_cols=252  Identities=35%  Similarity=0.568  Sum_probs=203.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.....  ......+.+|++++++++||||+++++++...+..|++||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            47889999999999999999999999999998764322  2344678899999999999999999999999999999999


Q ss_pred             ecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecC
Q psy17952        243 YCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRD  320 (804)
Q Consensus       243 y~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRD  320 (804)
                      |+.| ++.+++.                                 .....+++..+..++.|+++||+|||+ .|++|||
T Consensus        80 ~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~d  126 (265)
T cd06605          80 YMDGGSLDKILK---------------------------------EVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD  126 (265)
T ss_pred             ecCCCcHHHHHH---------------------------------HccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCC
Confidence            9985 4433332                                 012578899999999999999999999 9999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |||+||+++.++.+||+|||++.....  .....|+..|+|||.+.+   ..++.++|||||||++|+|++|..||...+
T Consensus       127 l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  203 (265)
T cd06605         127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQG---NDYSVKSDIWSLGLSLIELATGRFPYPPEN  203 (265)
T ss_pred             CCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999999999999864322  123678999999999853   468889999999999999999999996542


Q ss_pred             h-----HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        399 A-----MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       399 ~-----~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      .     .+.+..+                                         .....+......+++++.+||.+||.
T Consensus       204 ~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~li~~~l~  242 (265)
T cd06605         204 DPPDGIFELLQYI-----------------------------------------VNEPPPRLPSGKFSPDFQDFVNLCLI  242 (265)
T ss_pred             cccccHHHHHHHH-----------------------------------------hcCCCCCCChhhcCHHHHHHHHHHcC
Confidence            1     1111111                                         11111222222378899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccC
Q psy17952        474 KNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .||++|||+.+++.||||++
T Consensus       243 ~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         243 KDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             CCchhCcCHHHHhhCchhhc
Confidence            99999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.9e-38  Score=334.63  Aligned_cols=254  Identities=35%  Similarity=0.622  Sum_probs=202.5

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            488899999999999999999989999999988644322 3456778999999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.++                                  ......+++..+..++.|++.||.|||+.||+||||
T Consensus        80 ~~~~~~L~~~----------------------------------~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl  125 (264)
T cd06626          80 YCSGGTLEEL----------------------------------LEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI  125 (264)
T ss_pred             cCCCCcHHHH----------------------------------HhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence            99864 3222                                  223345788999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC--------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~--------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||+||++++++.+||+|||++......        ....+++.|+|||++.+.....++.++|||||||++|||++|+.|
T Consensus       126 ~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p  205 (264)
T cd06626         126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP  205 (264)
T ss_pred             CHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence            999999999999999999998653221        134678899999998542212378899999999999999999999


Q ss_pred             CCCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        394 YFNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       394 F~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      |.... .....+.+.....+                                        ........+..+.+|+.+||
T Consensus       206 f~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~l  245 (264)
T cd06626         206 WSELDNEFQIMFHVGAGHKP----------------------------------------PIPDSLQLSPEGKDFLDRCL  245 (264)
T ss_pred             ccCCcchHHHHHHHhcCCCC----------------------------------------CCCcccccCHHHHHHHHHHc
Confidence            96543 22222222111000                                        00011234788899999999


Q ss_pred             ccCCCCCCCHHHHHcCccc
Q psy17952        473 AKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +.||.+|||+.+++.|||+
T Consensus       246 ~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         246 ESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cCCcccCCCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-38  Score=344.95  Aligned_cols=280  Identities=27%  Similarity=0.422  Sum_probs=205.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      +.|++.+.||+|+||.||+|.+..+++.+|||.+...... ......+.+|++++++++||||+++++++....      
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4599999999999999999999999999999987543211 112235678999999999999999998875433      


Q ss_pred             --ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        236 --TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       236 --~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                        .+|+||||+.+++.+.+.                                 .....+++..+..++.|+++||.|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~i~~~l~~al~~lH~  133 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLE---------------------------------NPSVKLTESQIKCYMLQLLEGINYLHE  133 (311)
T ss_pred             CceEEEEEecCCcCHHHHHh---------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence              469999999876433221                                 123468999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCCC---------------CccccCcccccchhhcccCCCCCCCcccHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVW  378 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---------------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIW  378 (804)
                      +||+||||||+|||+++++.+||+|||++......               ....||+.|+|||++.+  ...++.++|||
T Consensus       134 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~  211 (311)
T cd07866         134 NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG--ERRYTTAVDIW  211 (311)
T ss_pred             CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC--CCccCchhHhH
Confidence            99999999999999999999999999998643211               12367889999998753  34578899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhccccc-CCCCccchhhhHHHHhhccCCCCCCCC
Q psy17952        379 SLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE-RKPPYFNMNAMSALYHIAQNDTPCLQS  457 (804)
Q Consensus       379 SlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~-~~pp~~~~~~~~~l~~i~~~~~p~~~~  457 (804)
                      ||||++|||++|++||.+.+.......+....... ....|.....+..... .......             .......
T Consensus       212 slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~  277 (311)
T cd07866         212 GIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP-TEETWPGWRSLPGCEGVHSFTNYP-------------RTLEERF  277 (311)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChhhchhhhhcccccccccCCCCC-------------ccHHHHc
Confidence            99999999999999999888776665554321110 0111111111111100 0000000             0000011


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       458 ~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      ..++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       278 ~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         278 GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            2356789999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-38  Score=334.96  Aligned_cols=246  Identities=30%  Similarity=0.530  Sum_probs=200.1

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||+|+||.||++.+..+++.+|+|.+....  .....+.+.+|+.+++.++||||+++++++.+++.+|++|||
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            788999999999999999999999999999875322  123346678899999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ++|+ +.+.+.                                ......++++.+..++.|++.||.|||++||+|+|||
T Consensus        80 ~~~~~l~~~~~--------------------------------~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~  127 (255)
T cd08219          80 CDGGDLMQKIK--------------------------------LQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIK  127 (255)
T ss_pred             CCCCcHHHHHH--------------------------------hccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            9864 322221                                0123457899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||+++++.++|+|||++.....    .....|++.|+|||++.   ...++.++|+|||||++|+|++|..||...+
T Consensus       128 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  204 (255)
T cd08219         128 SKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE---NMPYNNKSDIWSLGCILYELCTLKHPFQANS  204 (255)
T ss_pred             cceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHc---cCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence            9999999999999999999865432    22457999999999984   3457889999999999999999999998766


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......+.++..+                                          .....++..+.+|+.+||+.||++
T Consensus       205 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~  242 (255)
T cd08219         205 WKNLILKVCQGSYK------------------------------------------PLPSHYSYELRSLIKQMFKRNPRS  242 (255)
T ss_pred             HHHHHHHHhcCCCC------------------------------------------CCCcccCHHHHHHHHHHHhCCccc
Confidence            54444333221110                                          011245778999999999999999


Q ss_pred             CCCHHHHHcC
Q psy17952        479 RPSSGRLLTH  488 (804)
Q Consensus       479 Rpsa~elL~H  488 (804)
                      |||+.++++-
T Consensus       243 Rp~~~~il~~  252 (255)
T cd08219         243 RPSATTILSR  252 (255)
T ss_pred             CCCHHHHhhc
Confidence            9999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG1989|consensus

Probab=100.00  E-value=3e-39  Score=372.98  Aligned_cols=248  Identities=28%  Similarity=0.435  Sum_probs=200.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeE-Eeec------
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGC-YLRD------  234 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~-~~~~------  234 (804)
                      .+++.+.|.+|||+.||+|++...+..||+|++-..   +....+.+.+||++|++|+ |||||.|++. ....      
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            478889999999999999999998899999988643   4556678899999999997 9999999993 3221      


Q ss_pred             CceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      -.++|.||||. |+|.|++..+              +                  ...|+|.++++|+.|+++|+.+||.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~R--------------l------------------q~~lte~eVLkIf~dv~~AVa~mH~  162 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTR--------------L------------------QTRLTEDEVLKIFYDVCEAVAAMHY  162 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHH--------------H------------------hccCChHHHHHHHHHHHHHHHHHhc
Confidence            24689999999 5777766421              1                  2349999999999999999999999


Q ss_pred             CC--CeecCCCCCCeeecCCCcEEEEecccccccCCC--C-----------ccccCcccccchhhcccCCCCCCCcccHH
Q psy17952        314 LG--RIHRDVKAGNILLTETGTVKLADFGSASIKCPA--N-----------SFVGTPYWMAPEVILAMDEGQYDGKVDVW  378 (804)
Q Consensus       314 ~g--IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~--~-----------~~~GT~~Y~APEvl~~~~~~~y~~ksDIW  378 (804)
                      ..  |||||||-|||||+.+|..||||||.|+.....  .           ...-|+.|+|||+|--.++...+.|+|||
T Consensus       163 ~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIW  242 (738)
T KOG1989|consen  163 LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIW  242 (738)
T ss_pred             CCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHH
Confidence            98  999999999999999999999999998643221  1           12468999999999766667789999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCC
Q psy17952        379 SLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS  458 (804)
Q Consensus       379 SlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~  458 (804)
                      +|||+||-|+....||.+....    .|+                   ..                      ....+..+
T Consensus       243 ALGclLYkLCy~t~PFe~sg~l----aIl-------------------ng----------------------~Y~~P~~p  277 (738)
T KOG1989|consen  243 ALGCLLYKLCYFTTPFEESGKL----AIL-------------------NG----------------------NYSFPPFP  277 (738)
T ss_pred             HHHHHHHHHHHhCCCcCcCcce----eEE-------------------ec----------------------cccCCCCc
Confidence            9999999999999999653211    111                   11                      11111225


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy17952        459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDL  490 (804)
Q Consensus       459 ~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~  490 (804)
                      .+|+.+++||..||+.||.+||++.|++.+-+
T Consensus       278 ~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  278 NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             cHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            68999999999999999999999999997644

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-38  Score=336.70  Aligned_cols=252  Identities=35%  Similarity=0.589  Sum_probs=200.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++...+..|++||
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            48899999999999999999999999999998765333334445668899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++..                              .......+++..+..++.|++.||.|||++||+||||
T Consensus        83 ~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl  132 (267)
T cd08228          83 LADAGDLSQMIKY------------------------------FKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDI  132 (267)
T ss_pred             ecCCCcHHHHHHH------------------------------hhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCC
Confidence            99864 4333320                              0112345889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.++|+|||++.....    .....|++.|+|||.+.   +..++.++|+|||||++|||++|..||...
T Consensus       133 ~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         133 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhc---cCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            99999999999999999999865432    12457899999999984   345788999999999999999999999654


Q ss_pred             Ch--HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        398 NA--MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       398 ~~--~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..  ......+...                                         ..+......++..+.+|+.+||..+
T Consensus       210 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~li~~cl~~~  248 (267)
T cd08228         210 KMNLFSLCQKIEQC-----------------------------------------DYPPLPTEHYSEKLRELVSMCIYPD  248 (267)
T ss_pred             cccHHHHHHHHhcC-----------------------------------------CCCCCChhhcCHHHHHHHHHHCCCC
Confidence            21  1111111110                                         0111122345788999999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy17952        476 PADRPSSGRLLTH  488 (804)
Q Consensus       476 P~~Rpsa~elL~H  488 (804)
                      |++|||+.++++.
T Consensus       249 p~~Rp~~~~vl~~  261 (267)
T cd08228         249 PDQRPDIGYVHQI  261 (267)
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-38  Score=332.89  Aligned_cols=251  Identities=35%  Similarity=0.645  Sum_probs=201.8

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccc--cchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK--QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~--~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      |+..+.||+|+||.||+|.+..+++.||+|.+.....  ...+..+.+.+|+.+++.++||||+++++++......|++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            6777899999999999999998999999998764321  11234467889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||++|+ +.+++                                  .....+++..+..++.|++.||.|||+.||+|||
T Consensus        82 e~~~~~~L~~~~----------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  127 (258)
T cd06632          82 ELVPGGSLAKLL----------------------------------KKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD  127 (258)
T ss_pred             EecCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            999864 32222                                  2234688999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |||+||+++.++.+||+|||++.....   .....|++.|+|||.+..  ...++.++|+|||||++|+|++|++||...
T Consensus       128 l~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         128 IKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ--QGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             CCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcC--CCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            999999999999999999999865332   234678999999999843  123788999999999999999999999765


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      ........+....                                        ..+ .....+++.+.+|+.+||..+|.
T Consensus       206 ~~~~~~~~~~~~~----------------------------------------~~~-~~~~~~~~~~~~li~~~l~~~p~  244 (258)
T cd06632         206 EGVAAVFKIGRSK----------------------------------------ELP-PIPDHLSDEAKDFILKCLQRDPS  244 (258)
T ss_pred             cHHHHHHHHHhcc----------------------------------------cCC-CcCCCcCHHHHHHHHHHhhcCcc
Confidence            5433332221100                                        000 11234678899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.+++.|||+
T Consensus       245 ~Rp~~~~~l~~~~~  258 (258)
T cd06632         245 LRPTAAELLEHPFV  258 (258)
T ss_pred             cCcCHHHHhcCCCC
Confidence            99999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-38  Score=352.37  Aligned_cols=279  Identities=25%  Similarity=0.399  Sum_probs=206.7

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----  234 (804)
                      +...|++.+.||.|+||.||+|.+..+++.||+|++....   ....+.+.+|++++++++||||+++++++...     
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            4567999999999999999999999999999999875432   23446678999999999999999999876654     


Q ss_pred             ---------CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHH
Q psy17952        235 ---------HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVL  305 (804)
Q Consensus       235 ---------~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil  305 (804)
                               ...|+||||+.+++.+.+                                   ....+++..+..++.||+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~-----------------------------------~~~~l~~~~~~~~~~qi~  124 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYMETDLANVL-----------------------------------EQGPLSEEHARLFMYQLL  124 (342)
T ss_pred             cccccccccceEEEEeecccccHHHHH-----------------------------------HcCCCCHHHHHHHHHHHH
Confidence                     357999999987543322                                   124588999999999999


Q ss_pred             HHHHHHHHCCCeecCCCCCCeeecC-CCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccH
Q psy17952        306 RGLNYLHSLGRIHRDVKAGNILLTE-TGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDV  377 (804)
Q Consensus       306 ~gL~yLH~~gIiHRDLKP~NILl~~-~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDI  377 (804)
                      +||.|||++||+||||||+||+++. ++.+||+|||+++.....       ....||..|+|||++.+  ...++.++||
T Consensus       125 ~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di  202 (342)
T cd07854         125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS--PNNYTKAIDM  202 (342)
T ss_pred             HHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhC--ccccCchhhH
Confidence            9999999999999999999999975 557899999998643211       22368899999998743  3457889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhH-HhhcccccCCCCccchhhhHHHHhhccCCCC-CC
Q psy17952        378 WSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI-KTISSTAERKPPYFNMNAMSALYHIAQNDTP-CL  455 (804)
Q Consensus       378 WSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i-~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p-~~  455 (804)
                      |||||++|||++|+.||.+.+.......+...... .....+... ..+....              .........+ ..
T Consensus       203 wSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~  267 (342)
T cd07854         203 WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV-VREEDRNELLNVIPSFV--------------RNDGGEPRRPLRD  267 (342)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC-CChHHhhhhhhhhhhhh--------------hhcccccCCCHHH
Confidence            99999999999999999988877666555433211 000000000 0000000              0000000000 00


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       456 ~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .....+.++.+|+.+||+.||.+|||+.++|+||||..
T Consensus       268 ~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         268 LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            11346789999999999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-38  Score=340.62  Aligned_cols=250  Identities=23%  Similarity=0.313  Sum_probs=196.0

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC-c
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-A  248 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~-l  248 (804)
                      ||+|+||+||+|.+..+++.||+|.+.............+.+|+.+|++++||||+++++++...+..|+||||+.|+ +
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            799999999999999999999999886432222223445678999999999999999999999999999999999864 3


Q ss_pred             hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        249 SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       249 ~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                      .+.+.                                ......+++.++..++.|++.||.|||++||+||||||+|||+
T Consensus        81 ~~~l~--------------------------------~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~  128 (277)
T cd05577          81 KYHIY--------------------------------NVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL  128 (277)
T ss_pred             HHHHH--------------------------------HcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence            32221                                0012368999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy17952        329 TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYH  405 (804)
Q Consensus       329 ~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~  405 (804)
                      ++++.+||+|||++.....   .....|+..|+|||++.   .+.++.++|||||||++|+|++|+.||...........
T Consensus       129 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  205 (277)
T cd05577         129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ---GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE  205 (277)
T ss_pred             CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhc---CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH
Confidence            9999999999999865332   22356888999999984   34588899999999999999999999965432111111


Q ss_pred             HHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC-----
Q psy17952        406 IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP-----  480 (804)
Q Consensus       406 I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp-----  480 (804)
                      +...               +                      .  ..+......+++.+.+||.+||+.||++||     
T Consensus       206 ~~~~---------------~----------------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  246 (277)
T cd05577         206 LKRR---------------T----------------------L--EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGG  246 (277)
T ss_pred             HHhc---------------c----------------------c--cccccCCccCCHHHHHHHHHHccCChhHccCCCcc
Confidence            1000               0                      0  001112234688999999999999999999     


Q ss_pred             CHHHHHcCccccC
Q psy17952        481 SSGRLLTHDLVTR  493 (804)
Q Consensus       481 sa~elL~Hp~~~~  493 (804)
                      ++.++++||||..
T Consensus       247 ~~~~ll~h~~~~~  259 (277)
T cd05577         247 SADEVREHPLFKD  259 (277)
T ss_pred             cHHHHHhChhhhc
Confidence            9999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.7e-38  Score=339.02  Aligned_cols=262  Identities=44%  Similarity=0.798  Sum_probs=213.0

Q ss_pred             cccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee
Q psy17952        154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR  233 (804)
Q Consensus       154 lf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~  233 (804)
                      .....++.+.|+..+.||+|+||.||+|.+..+++.||+|.+.....    ....+.+|+++++.++||||+++++++..
T Consensus        11 ~~~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          11 IVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             hcCCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            34456677789999999999999999999998899999998864322    34567899999999999999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccC-CCCCHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK-RPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~-~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      ....|++|||+.| ++.+++.                                  .. ..+++..+..++.|++.||.||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~----------------------------------~~~~~l~~~~~~~i~~~i~~~L~~l  132 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIIT----------------------------------QNFVRMNEPQIAYVCREVLQGLEYL  132 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHH----------------------------------HhccCCCHHHHHHHHHHHHHHHHHH
Confidence            9999999999985 4444332                                  12 2688999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |+.||+|+||||+||+++.++.+||+|||++......    ....|++.|+|||++.   ...++.++|+|||||++|+|
T Consensus       133 H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Dv~slGvil~~l  209 (286)
T cd06614         133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK---RKDYGPKVDIWSLGIMCIEM  209 (286)
T ss_pred             HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhc---CCCCCCccccHHHHHHHHHH
Confidence            9999999999999999999999999999987543221    3346889999999874   35688899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|+.||.+.+.......+.....+                                        +......++..+.+|
T Consensus       210 ~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~l  249 (286)
T cd06614         210 AEGEPPYLREPPLRALFLITTKGIP----------------------------------------PLKNPEKWSPEFKDF  249 (286)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhcCCC----------------------------------------CCcchhhCCHHHHHH
Confidence            9999999776654443333221110                                        001112367889999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      +.+||+.+|.+|||+.+++.|+||.+...
T Consensus       250 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            99999999999999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-38  Score=338.33  Aligned_cols=259  Identities=22%  Similarity=0.387  Sum_probs=200.2

Q ss_pred             cccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.|.+.+.||+|+||.||+|.+..     +++.||||.++....  .+..+.+.+|+++|+.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            358899999999999999998753     357899998764322  2234678899999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.| ++.+.+....           .....         +.........+++..+..++.|++.||.|||++|
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~-----------~~~~~---------~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~  142 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHG-----------PDAAF---------LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH  142 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcC-----------Cchhh---------hcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence            9999999985 4544443110           00000         0000112346889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||++.++.+||+|||++.....      .....+++.|+|||++.   .+.++.++|||||||++|||++
T Consensus       143 i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~e~~~  219 (280)
T cd05049         143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVVLWEIFT  219 (280)
T ss_pred             eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhc---cCCcchhhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999864321      12345678899999984   4568999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||.+.+..+....+.++..                                          ......++..+.+|+
T Consensus       220 ~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li  257 (280)
T cd05049         220 YGKQPWYGLSNEEVIECITQGRL------------------------------------------LQRPRTCPSEVYDIM  257 (280)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCc------------------------------------------CCCCCCCCHHHHHHH
Confidence             9999987665554443322110                                          011134678899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||+.||++|||+.|++.
T Consensus       258 ~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         258 LGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=338.38  Aligned_cols=280  Identities=27%  Similarity=0.444  Sum_probs=209.0

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceEEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLVM  241 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~lVm  241 (804)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|++++++++|||++++++++...  +..|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            678899999999999999999999999999987532 1223345678999999999999999999999888  8999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.+++.+++.                                 .....+++..+..++.||++||+|||+.|++|+||
T Consensus        80 e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl  126 (287)
T cd07840          80 EYMDHDLTGLLD---------------------------------SPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDI  126 (287)
T ss_pred             ccccccHHHHHh---------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence            999876544331                                 11246889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      ||+|||+++++.+||+|||++......     ....++..|+|||.+.+  ...++.++|||||||++|||++|+.||..
T Consensus       127 ~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         127 KGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG--ATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             cHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEc--cccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999998654322     23467889999998753  23578899999999999999999999988


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+....+..+....... ....|..+..+.......+......   .+..        ......+..+.+++.+||..||
T Consensus       205 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~~~i~~~l~~~P  272 (287)
T cd07840         205 STELEQLEKIFELCGSP-TDENWPGVSKLPWFENLKPKKPYKR---RLRE--------FFKHLIDPSALDLLDKLLTLDP  272 (287)
T ss_pred             CChHHHHHHHHHHhCCC-chhhccccccchhhhhccccccchh---HHHH--------HhcccCCHHHHHHHHHHcCCCh
Confidence            87766655554321111 1111211111100000000000000   0000        0011147899999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy17952        477 ADRPSSGRLLTHDLV  491 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~  491 (804)
                      .+|||+.+++.||||
T Consensus       273 ~~Rp~~~~~l~~~~~  287 (287)
T cd07840         273 KKRISADQALQHEYF  287 (287)
T ss_pred             hhCcCHHHHhhCcCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.2e-38  Score=332.62  Aligned_cols=251  Identities=29%  Similarity=0.489  Sum_probs=202.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|++++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            38889999999999999999999999999998864322 23345678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++..                                .....+++..+..++.|++.||+|||++||+||||
T Consensus        80 ~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl  127 (256)
T cd08220          80 YAPGGTLAEYIQK--------------------------------RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL  127 (256)
T ss_pred             cCCCCCHHHHHHH--------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            99864 4333320                                01235889999999999999999999999999999


Q ss_pred             CCCCeeecCCC-cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETG-TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g-~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||+++.++ .+||+|||++.....   .....|++.|+|||.+.   ...++.++|||||||++|+|++|..||.+.
T Consensus       128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE---GKPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             CHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhcc---CCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence            99999998654 689999999875432   22457899999999984   345788999999999999999999999766


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +.......+.....                                         + .....++.++.+|+.+||..||+
T Consensus       205 ~~~~~~~~~~~~~~-----------------------------------------~-~~~~~~~~~l~~li~~~l~~~p~  242 (256)
T cd08220         205 NLPALVLKIMSGTF-----------------------------------------A-PISDRYSPDLRQLILSMLNLDPS  242 (256)
T ss_pred             chHHHHHHHHhcCC-----------------------------------------C-CCCCCcCHHHHHHHHHHccCChh
Confidence            54443333221110                                         0 01124678899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.++++|||+
T Consensus       243 ~Rpt~~~ll~~p~~  256 (256)
T cd08220         243 KRPQLSQIMAQPIC  256 (256)
T ss_pred             hCCCHHHHhhCCCC
Confidence            99999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-38  Score=348.49  Aligned_cols=283  Identities=26%  Similarity=0.373  Sum_probs=209.9

Q ss_pred             cccccc-ccccccccccceEEEEeeeceeEEEEEecccccccchh-----------hhhhHHHHHHHHhhcCCCceeEee
Q psy17952        161 EKIFED-LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE-----------KWADILKEIRFLRQLKHPNTIEYR  228 (804)
Q Consensus       161 ~~~y~~-l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~-----------~~~~~~~Ei~iL~~L~HpNIV~l~  228 (804)
                      .++|.. .+.||+|+||+||+|++..+++.||||+++........           ....+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345654 46799999999999999999999999987643221100           012467899999999999999999


Q ss_pred             eEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHH
Q psy17952        229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGL  308 (804)
Q Consensus       229 ~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL  308 (804)
                      +++...+..|+||||+.|++.+.+.                                  ....++++.+..++.|++.||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~l~----------------------------------~~~~~~~~~~~~~~~ql~~aL  132 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMASDLKKVVD----------------------------------RKIRLTESQVKCILLQILNGL  132 (335)
T ss_pred             EEEecCCcEEEEEeccccCHHHHHH----------------------------------hcCCCCHHHHHHHHHHHHHHH
Confidence            9999999999999999887554432                                  234688999999999999999


Q ss_pred             HHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccC--------------C----CCccccCcccccchhhcccCCCC
Q psy17952        309 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--------------P----ANSFVGTPYWMAPEVILAMDEGQ  370 (804)
Q Consensus       309 ~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~--------------~----~~~~~GT~~Y~APEvl~~~~~~~  370 (804)
                      +|||++||+||||||+|||++.++.+||+|||++....              .    .....+++.|+|||.+.+  ...
T Consensus       133 ~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~  210 (335)
T PTZ00024        133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG--AEK  210 (335)
T ss_pred             HHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc--CCC
Confidence            99999999999999999999999999999999986432              0    112357889999999853  234


Q ss_pred             CCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccC
Q psy17952        371 YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN  450 (804)
Q Consensus       371 y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~  450 (804)
                      ++.++|||||||++|||++|++||.+.+..+.+..+....... ....|+....+....    ++..          ...
T Consensus       211 ~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~----~~~~----------~~~  275 (335)
T PTZ00024        211 YHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP-NEDNWPQAKKLPLYT----EFTP----------RKP  275 (335)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-chhhCcchhhccccc----ccCc----------CCc
Confidence            7889999999999999999999999888777666554421110 011111110000000    0000          000


Q ss_pred             CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       451 ~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ..........++++.+||.+||+.||++|||++++|.||||...
T Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        276 KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            00001123457889999999999999999999999999999764

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-38  Score=332.94  Aligned_cols=252  Identities=33%  Similarity=0.553  Sum_probs=202.1

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cCceEEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DHTAWLVM  241 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~~~~lVm  241 (804)
                      |++++.||.|+||.||+|.+..+++.||+|.+..... .....+.+..|++++++++||||+++++++..  ....|++|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            7889999999999999999999999999998764322 23344678899999999999999999998764  45689999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH-----HCC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH-----SLG  315 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH-----~~g  315 (804)
                      ||+.| ++.+++...                              ......+++..+..++.|++.||.|||     +.+
T Consensus        81 e~~~~~~L~~~l~~~------------------------------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~  130 (265)
T cd08217          81 EYCEGGDLAQLIQKC------------------------------KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT  130 (265)
T ss_pred             hhccCCCHHHHHHHH------------------------------hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc
Confidence            99985 444443210                              012456899999999999999999999     899


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |+||||||+||+++.++.+||+|||++......    ....|++.|+|||++.   ...++.++|+|||||++|+|++|+
T Consensus       131 i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~---~~~~~~~~Dv~slG~il~~l~~g~  207 (265)
T cd08217         131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN---HMSYDEKSDIWSLGCLIYELCALS  207 (265)
T ss_pred             ceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhc---CCCCCchhHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999998754332    2457899999999984   345788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||...+.......+..+.                                          .......++..+.+++.+|
T Consensus       208 ~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~l~~~~  245 (265)
T cd08217         208 PPFTARNQLQLASKIKEGK------------------------------------------FRRIPYRYSSELNEVIKSM  245 (265)
T ss_pred             CcccCcCHHHHHHHHhcCC------------------------------------------CCCCccccCHHHHHHHHHH
Confidence            9997765333222221110                                          0011234678899999999


Q ss_pred             cccCCCCCCCHHHHHcCccc
Q psy17952        472 LAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~  491 (804)
                      |+.+|++|||+.++++|||+
T Consensus       246 l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         246 LNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3e-38  Score=338.11  Aligned_cols=263  Identities=22%  Similarity=0.422  Sum_probs=198.8

Q ss_pred             cccccccccccccccceEEEEee----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ..|++.+.||+|+||.||+|...    .+++.||+|.+...  ........+.+|+.++++++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            35889999999999999999854    35578999988642  2233446788999999999999999999999999999


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+||||+.+ ++.+++....    ..        ....+     ...........+++.++..++.|++.||.|||++||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~----~~--------~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  145 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRS----PH--------SDVGC-----SSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF  145 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CC--------Ccccc-----ccccccccccccCHHHHHHHHHHHHHHHHHHHhcCe
Confidence            999999985 4544432100    00        00000     000001113358899999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||++.++.+||+|||+++....      .....++..|+|||++.   .+.++.++|||||||++|||++ 
T Consensus       146 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~~  222 (283)
T cd05090         146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM---YGKFSSDSDIWSFGVVLWEIFSF  222 (283)
T ss_pred             ehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhc---cCCCCchhhhHHHHHHHHHHHcC
Confidence            9999999999999999999999999965322      12345677899999984   3568899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||.+.+.......+.....                                          ......+++.+.+++.
T Consensus       223 g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~  260 (283)
T cd05090         223 GLQPYYGFSNQEVIEMVRKRQL------------------------------------------LPCSEDCPPRMYSLMT  260 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCc------------------------------------------CCCCCCCCHHHHHHHH
Confidence            9999987665444433321110                                          0011345788999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||+.||++||++.+++++
T Consensus       261 ~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         261 ECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcccCcccCcCHHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-38  Score=331.35  Aligned_cols=240  Identities=28%  Similarity=0.425  Sum_probs=189.1

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS  247 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~  247 (804)
                      +.||+|+||.||+|++..+++.||+|.+...  ........+.+|++++++++||||+++++++......|+||||+.|+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            4699999999999999999999999987532  12233456889999999999999999999999999999999999865


Q ss_pred             -chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        248 -ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       248 -l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                       +.+.+.                                 .....+++..+..++.|+++||.|||++||+||||||+||
T Consensus        79 ~L~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni  125 (252)
T cd05084          79 DFLTFLR---------------------------------TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC  125 (252)
T ss_pred             cHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence             322221                                 1233588999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccCCCC------ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCh
Q psy17952        327 LLTETGTVKLADFGSASIKCPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNA  399 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~~~------~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~  399 (804)
                      |++.++.+||+|||++.......      ...++..|+|||.+.   .+.++.++|||||||++|||++ |.+||...+.
T Consensus       126 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~  202 (252)
T cd05084         126 LVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN---YGRYSSESDVWSFGILLWEAFSLGAVPYANLSN  202 (252)
T ss_pred             EEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhc---CCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence            99999999999999986432211      112245699999984   4568889999999999999998 9999976554


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ......+....                                          +......++..+.+|+.+||+.||++|
T Consensus       203 ~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (252)
T cd05084         203 QQTREAIEQGV------------------------------------------RLPCPELCPDAVYRLMERCWEYDPGQR  240 (252)
T ss_pred             HHHHHHHHcCC------------------------------------------CCCCcccCCHHHHHHHHHHcCCChhhC
Confidence            33332221110                                          001122457889999999999999999


Q ss_pred             CCHHHHHc
Q psy17952        480 PSSGRLLT  487 (804)
Q Consensus       480 psa~elL~  487 (804)
                      ||+.++++
T Consensus       241 ps~~~~~~  248 (252)
T cd05084         241 PSFSTVHQ  248 (252)
T ss_pred             cCHHHHHH
Confidence            99999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.1e-38  Score=336.98  Aligned_cols=256  Identities=22%  Similarity=0.369  Sum_probs=196.2

Q ss_pred             cccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.|++.+.||+|+||.||+|.+.     .++..||||.+....  .......+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45899999999999999999864     245689999875322  12234568899999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .++||||+.| ++.+++....                        ...........+++..+..++.|++.||.|||+.|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  139 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLR------------------------PEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK  139 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcC------------------------ccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999985 4444432100                        00000001234678889999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ++||||||+|||+++++.+||+|||+++....      .....+++.|||||++.   .+.++.++|||||||++|||++
T Consensus       140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~  216 (277)
T cd05062         140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIAT  216 (277)
T ss_pred             cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh---cCCcCchhHHHHHHHHHHHHHc
Confidence            99999999999999999999999999864321      11235678899999984   3568899999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||.+.+....+..+..+..+                                          ......++.+.+|+
T Consensus       217 ~~~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li  254 (277)
T cd05062         217 LAEQPYQGMSNEQVLRFVMEGGLL------------------------------------------DKPDNCPDMLFELM  254 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCcC------------------------------------------CCCCCCCHHHHHHH
Confidence             78999876655444333221110                                          01123567899999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||++|||+.+++++
T Consensus       255 ~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         255 RMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.1e-38  Score=336.87  Aligned_cols=261  Identities=20%  Similarity=0.340  Sum_probs=199.6

Q ss_pred             ccccccccccccccceEEEEeeec-----eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVS-----REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~-----~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .|++.++||+|+||.||+|.+..+     ++.||+|.++...  .....+.+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            488999999999999999987643     5789999986432  122345678999999999999999999999999999


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ++++||+.+ ++.+++....         ..   ...      .........+..+++..+..++.|++.||.|||++||
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~---------~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi  145 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRS---------PH---SDV------GSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHV  145 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcC---------CC---ccc------cccccccccccccCHHHHHHHHHHHHHHHHHHHHcCc
Confidence            999999975 4444432100         00   000      0011111224568899999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||+++++.+||+|||+++.....      ....+++.|+|||++.   .+.++.++|||||||++|||++ 
T Consensus       146 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~~~  222 (283)
T cd05091         146 VHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM---YGKFSIDSDIWSYGVVLWEVFSY  222 (283)
T ss_pred             cccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHh---cCCCCcchhHHHHHHHHHHHHcC
Confidence            99999999999999999999999998653221      2335678999999984   3568889999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||.+.+..+....+.....+                                          ....+++..+.+|+.
T Consensus       223 g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~~li~  260 (283)
T cd05091         223 GLQPYCGYSNQDVIEMIRNRQVL------------------------------------------PCPDDCPAWVYTLML  260 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcC------------------------------------------CCCCCCCHHHHHHHH
Confidence            88999876665554444322110                                          012346788999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||+.+|.+||+++++++.
T Consensus       261 ~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         261 ECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHhCCCcccCCCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-38  Score=350.42  Aligned_cols=283  Identities=27%  Similarity=0.405  Sum_probs=197.4

Q ss_pred             cccccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      |.+.|++.+.||+|+||.||+|++..     +++.||+|+++...  .......+.+|+.+++++ +||||+++++++..
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            45679999999999999999997543     45789999886422  223345678899999999 89999999998764


Q ss_pred             -cCceEEEEeecCC-CchhhHHHHHhhhh-hhhccc---------c--hhhhhhh--------hhhccc-------ccch
Q psy17952        234 -DHTAWLVMEYCLG-SASDIIEVHWIERE-FHVEGM---------G--NRLQQLK--------CFTEHF-------ALFN  284 (804)
Q Consensus       234 -~~~~~lVmEy~~G-~l~dll~~~~~~~~-~~~~~~---------~--~~l~~l~--------~~~~~~-------~L~~  284 (804)
                       +..+|++|||+.| ++.+++........ +.....         +  ..+....        .+....       ..-+
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             4578999999985 55555532100000 000000         0  0000000        000000       0000


Q ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccc
Q psy17952        285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWM  358 (804)
Q Consensus       285 ~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~  358 (804)
                      ......++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....      .....++..||
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            111234789999999999999999999999999999999999999999999999999975321      12345677899


Q ss_pred             cchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccc
Q psy17952        359 APEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFN  437 (804)
Q Consensus       359 APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~  437 (804)
                      |||++.   ...++.++|||||||++|||++ |.+||.+....+.+....+..                           
T Consensus       243 aPE~~~---~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------------------------  292 (337)
T cd05054         243 APESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG---------------------------  292 (337)
T ss_pred             CcHHhc---CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc---------------------------
Confidence            999984   4578999999999999999998 999997643322222111100                           


Q ss_pred             hhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        438 MNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       438 ~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                                    .........++++.+++.+||+.+|++||++.++++|
T Consensus       293 --------------~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         293 --------------TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          0000112457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4e-38  Score=339.87  Aligned_cols=281  Identities=27%  Similarity=0.406  Sum_probs=206.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.++..... ......+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            3588999999999999999999999999999988643221 222345678999999999999999999887654      


Q ss_pred             ----ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        236 ----TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       236 ----~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                          .+|+||||+.|++.+.+.                                 .....+++..+..++.|++.||.||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~aL~~L  132 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLE---------------------------------SGLVHFSEDHIKSFMKQLLEGLNYC  132 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHh---------------------------------cCCCCCCHHHHHHHHHHHHHHHHHH
Confidence                789999999886544331                                 1134688999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      |+.||+||||||+||++++++.+||+|||++......     ....+++.|+|||.+.+  ...++.++|||||||++||
T Consensus       133 H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~~~e  210 (302)
T cd07864         133 HKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGE  210 (302)
T ss_pred             HhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcC--CCCCCchhHHHHHHHHHHH
Confidence            9999999999999999999999999999998654221     22356888999998743  2356789999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|++||...+....+..+.+...... ...|+.+....       .+.........     ...........+..+.+
T Consensus       211 l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  277 (302)
T cd07864         211 LFTKKPIFQANQELAQLELISRLCGSPC-PAVWPDVIKLP-------YFNTMKPKKQY-----RRRLREEFSFIPTPALD  277 (302)
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCC-hhhcccccccc-------ccccccccccc-----ccchhhhcCCCCHHHHH
Confidence            9999999987776665555543211100 01111110000       00000000000     00000111235789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      |+.+||+.||.+|||+.+++.||||
T Consensus       278 li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         278 LLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             HHHHHccCChhhCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.7e-38  Score=335.64  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=189.9

Q ss_pred             ccccccc--ccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        164 FEDLREI--GHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       164 y~~l~~L--G~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      |++.+.+  |+|+||.||++++..+++.+|+|.+.....      ..  .|+.....+ +||||++++++|...+..|+|
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF------NA--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc------ch--hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            5555555  999999999999999999999998753211      11  122222222 799999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||++|+ +.+++                                  .....++++++..++.|+++||.|||+.||+||
T Consensus        88 ~e~~~~~~L~~~l----------------------------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  133 (267)
T PHA03390         88 MDYIKDGDLFDLL----------------------------------KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN  133 (267)
T ss_pred             EEcCCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            9999864 33322                                  233478999999999999999999999999999


Q ss_pred             CCCCCCeeecCCC-cEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        320 DVKAGNILLTETG-TVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       320 DLKP~NILl~~~g-~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      ||||+||+++.++ .++|+|||++..........||+.|+|||++.   ...++.++||||+||++|||++|+.||....
T Consensus       134 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        134 DIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIK---GHNYDVSFDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             CCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            9999999999998 99999999987665555678999999999984   3568889999999999999999999997543


Q ss_pred             hHHH-HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        399 AMSA-LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       399 ~~~~-l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      .... ...+..                                     . ..  .+.......+..+.+||.+||+.||.
T Consensus       211 ~~~~~~~~~~~-------------------------------------~-~~--~~~~~~~~~~~~~~~li~~~l~~~p~  250 (267)
T PHA03390        211 DEELDLESLLK-------------------------------------R-QQ--KKLPFIKNVSKNANDFVQSMLKYNIN  250 (267)
T ss_pred             cchhhHHHHHH-------------------------------------h-hc--ccCCcccccCHHHHHHHHHHhccChh
Confidence            2110 000000                                     0 00  00011125788999999999999999


Q ss_pred             CCCC-HHHHHcCcccc
Q psy17952        478 DRPS-SGRLLTHDLVT  492 (804)
Q Consensus       478 ~Rps-a~elL~Hp~~~  492 (804)
                      +||+ .+++|+||||.
T Consensus       251 ~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        251 YRLTNYNEIIKHPFLK  266 (267)
T ss_pred             hCCchHHHHhcCCccc
Confidence            9997 59999999985

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.8e-38  Score=379.36  Aligned_cols=262  Identities=26%  Similarity=0.364  Sum_probs=200.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.++||+|+||.||+|++..+++.||||++............++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            35899999999999999999999999999999986433233334467889999999999999999999999999999999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||+| ++.+++...|....                     +.  ......++...+..++.||++||+|||++||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~---------------------l~--e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRD  138 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKES---------------------LS--KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRD  138 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccc---------------------cc--hhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            99986 45555432111000                     00  00123467788899999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----------------------CCccccCcccccchhhcccCCCCCCCcccHH
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVW  378 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----------------------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIW  378 (804)
                      |||+|||++.++.+||+|||+|+....                      ....+||+.|||||++.   +..++.++|||
T Consensus       139 LKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~---g~~~S~kSDIW  215 (932)
T PRK13184        139 LKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL---GVPASESTDIY  215 (932)
T ss_pred             CchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc---CCCCCcHhHHH
Confidence            999999999999999999999864310                      11257999999999984   45688999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCC
Q psy17952        379 SLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS  458 (804)
Q Consensus       379 SlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~  458 (804)
                      ||||++|||++|.+||..............                      ..|.                  ......
T Consensus       216 SLGVILyELLTG~~PF~~~~~~ki~~~~~i----------------------~~P~------------------~~~p~~  255 (932)
T PRK13184        216 ALGVILYQMLTLSFPYRRKKGRKISYRDVI----------------------LSPI------------------EVAPYR  255 (932)
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhhhhhhc----------------------cChh------------------hccccc
Confidence            999999999999999976443222111000                      0000                  001123


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy17952        459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       459 ~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp  489 (804)
                      .+++.+.+++.+||+.||++||++.+.+.+.
T Consensus       256 ~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~  286 (932)
T PRK13184        256 EIPPFLSQIAMKALAVDPAERYSSVQELKQD  286 (932)
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            5678899999999999999999888777653

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.3e-38  Score=336.97  Aligned_cols=251  Identities=21%  Similarity=0.270  Sum_probs=191.5

Q ss_pred             ccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHH---HHHHhhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE---IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~E---i~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      .||+|+||.||+|++..+++.||+|.+................|   +.+++...||||+++++++...+..|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999998864322111111122333   344555689999999999999999999999998


Q ss_pred             CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        246 GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       246 G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      |+...                                 .+....+.+++..+..++.|++.||.|||+++|+||||||+|
T Consensus        81 g~~L~---------------------------------~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~n  127 (278)
T cd05606          81 GGDLH---------------------------------YHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN  127 (278)
T ss_pred             CCcHH---------------------------------HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHH
Confidence            76321                                 112234568999999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy17952        326 ILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL  403 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l  403 (804)
                      ||++.++.+||+|||++.....  ....+||+.|+|||++.+  +..++.++||||+||++|||++|+.||.+.......
T Consensus       128 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~  205 (278)
T cd05606         128 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH  205 (278)
T ss_pred             EEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH
Confidence            9999999999999999864322  234679999999999842  235888999999999999999999999764221100


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---  480 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---  480 (804)
                      ...                ...                       ....+ .....+|.++.+++.+||..||.+||   
T Consensus       206 ~~~----------------~~~-----------------------~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~~~~  245 (278)
T cd05606         206 EID----------------RMT-----------------------LTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCL  245 (278)
T ss_pred             HHH----------------HHh-----------------------hccCC-CCCCcCCHHHHHHHHHHhhcCHHhccCCC
Confidence            000                000                       00000 11123588999999999999999999   


Q ss_pred             --CHHHHHcCccccCC
Q psy17952        481 --SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 --sa~elL~Hp~~~~~  494 (804)
                        ++.++++||||...
T Consensus       246 ~~~~~~ll~~~~~~~~  261 (278)
T cd05606         246 GRGAQEVKEHPFFRSL  261 (278)
T ss_pred             CCCHHHHHhCccccCC
Confidence              99999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=336.62  Aligned_cols=277  Identities=29%  Similarity=0.463  Sum_probs=210.2

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|++++++++||||+++++++......|+||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67788999999999999999999999999987643221 12345678899999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.+++.+.+.                                 .....+++..+..++.|++.||.|||++||+|+||||
T Consensus        80 ~~~~l~~~l~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p  126 (283)
T cd05118          80 MDTDLYKLIK---------------------------------DRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKP  126 (283)
T ss_pred             cCCCHHHHHH---------------------------------hhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCH
Confidence            9886544332                                 1124689999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +||+++.++.+||+|||.+......    ....++..|+|||.+.+  ...++.++|+|||||++|+|++|++||.+.+.
T Consensus       127 ~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~  204 (283)
T cd05118         127 ENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG--DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE  204 (283)
T ss_pred             HHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999998654332    23568889999999853  23578899999999999999999999988887


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCC--CCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND--TPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~--~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      .+.+..+........ ...|..+.......              ........  .........+.++.+||.+||+.||.
T Consensus       205 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  269 (283)
T cd05118         205 IDQLFKIFRTLGTPD-PEVWPKFTSLARNY--------------KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH  269 (283)
T ss_pred             HHHHHHHHHHcCCCc-hHhcccchhhhhhh--------------hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcc
Confidence            776665543211100 01111110000000              00000000  00011234688999999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +||++.++++||||
T Consensus       270 ~Rp~~~~ll~~~~~  283 (283)
T cd05118         270 KRITAEQALAHPYF  283 (283)
T ss_pred             cCcCHHHHhhCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-38  Score=349.77  Aligned_cols=281  Identities=26%  Similarity=0.370  Sum_probs=207.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      ..|+..+.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||+++++++....      
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            358899999999999999999999999999998764221 1222345789999999999999999999987543      


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+||||+.+++.++                                    ....++++.+..++.|++.||+|||++|
T Consensus        94 ~~~lv~e~~~~~l~~~------------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~  137 (342)
T cd07879          94 DFYLVMPYMQTDLQKI------------------------------------MGHPLSEDKVQYLVYQMLCGLKYIHSAG  137 (342)
T ss_pred             eEEEEecccccCHHHH------------------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4699999986542211                                    1235788999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+|||++.++.+||+|||+++.... .....||+.|+|||++.+  ...++.++|||||||++|||++|+.||
T Consensus       138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slGvil~el~~g~~pf  215 (342)
T cd07879         138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILN--WMHYNQTVDIWSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcC--ccccCchHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999875432 234578999999999843  235788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHHHHHHhc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~dli~~cL  472 (804)
                      .+.+....+..+........+    ...+.+.....          .............  ....+..+..+.+||.+||
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  281 (342)
T cd07879         216 KGKDYLDQLTQILKVTGVPGP----EFVQKLEDKAA----------KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML  281 (342)
T ss_pred             CCCCHHHHHHHHHHhcCCCCH----HHHHHhcccch----------HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHc
Confidence            987766666555442211100    00111100000          0000000000000  0001245788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +.||.+|||++++|.||||...+
T Consensus       282 ~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         282 ELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             CCChhhCcCHHHHhcCcchhhcc
Confidence            99999999999999999997643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.5e-38  Score=339.05  Aligned_cols=267  Identities=39%  Similarity=0.680  Sum_probs=212.4

Q ss_pred             CCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       157 ~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      ..++...|+...+||+|+||.||++....+++.||||++....   ......+.+|+.+++.++||||+++++++...+.
T Consensus        15 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   91 (292)
T cd06657          15 PGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE   91 (292)
T ss_pred             CCChHHHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE
Confidence            3355556777889999999999999999999999999875321   2234568899999999999999999999999999


Q ss_pred             eEEEEeecCCCch-hhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGSAS-DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~l~-dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.|+.. +++                                   ..+.+++..+..++.|++.||+|||++|
T Consensus        92 ~~lv~e~~~~~~L~~~~-----------------------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~g  136 (292)
T cd06657          92 LWVVMEFLEGGALTDIV-----------------------------------THTRMNEEQIAAVCLAVLKALSVLHAQG  136 (292)
T ss_pred             EEEEEecCCCCcHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999987532 111                                   1235788999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |+||||||+||+++.++.++|+|||++.....    .....||+.|+|||.+.   ...++.++|+||+||++|||++|.
T Consensus       137 ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slGvil~el~tg~  213 (292)
T cd06657         137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIEMVDGE  213 (292)
T ss_pred             eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhc---CCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999998754322    23357899999999874   346788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+..+....+....                      ++.                  .......+..+.+++.+|
T Consensus       214 ~p~~~~~~~~~~~~~~~~~----------------------~~~------------------~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         214 PPYFNEPPLKAMKMIRDNL----------------------PPK------------------LKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             CCCCCCCHHHHHHHHHhhC----------------------Ccc------------------cCCcccCCHHHHHHHHHH
Confidence            9998765544433322110                      000                  001123577889999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCCCCchhHHHH
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI  504 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~  504 (804)
                      |+.||.+||++.++|.||||.....++....++
T Consensus       254 l~~~P~~R~~~~~ll~~~~~~~~~~~~~~~~~~  286 (292)
T cd06657         254 LVRDPAQRATAAELLKHPFLAKAGPPSCIVPLM  286 (292)
T ss_pred             HhCCcccCcCHHHHhcChHHhccCCCcccccHH
Confidence            999999999999999999998877666544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-37  Score=334.04  Aligned_cols=263  Identities=32%  Similarity=0.551  Sum_probs=202.8

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLV  240 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~lV  240 (804)
                      .|+..+.||.|+||.||+|.+..+++.+|+|.+.....  ......+.+|++++++++||||++++++|...  +.+|+|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            47889999999999999999999999999998764322  23346688999999999999999999988653  468999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||++|+ +.+++..                              .......+++..+..++.|++.||.|||+.|++||
T Consensus        80 ~e~~~~~~L~~~l~~------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~  129 (287)
T cd06621          80 MEYCEGGSLDSIYKK------------------------------VKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR  129 (287)
T ss_pred             EEecCCCCHHHHHHH------------------------------HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999864 4333320                              01123468899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|+||+++.++.+||+|||++.....  .....++..|+|||.+.   ...++.++|||||||++|+|++|+.||...
T Consensus       130 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         130 DIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ---GKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             CCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999864322  22456888999999984   356888999999999999999999999654


Q ss_pred             Ch-----HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        398 NA-----MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       398 ~~-----~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ..     .+....+....                      ++..              .........+++.+.+|+.+||
T Consensus       207 ~~~~~~~~~~~~~~~~~~----------------------~~~~--------------~~~~~~~~~~~~~~~~li~~~l  250 (287)
T cd06621         207 GEPPLGPIELLSYIVNMP----------------------NPEL--------------KDEPGNGIKWSEEFKDFIKQCL  250 (287)
T ss_pred             cCCCCChHHHHHHHhcCC----------------------chhh--------------ccCCCCCCchHHHHHHHHHHHc
Confidence            21     11111110000                      0000              0001112346889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ..||++|||+.|++.||||.+...
T Consensus       251 ~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         251 EKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCCcccCCCHHHHHhCcccccccc
Confidence            999999999999999999966443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.2e-38  Score=337.06  Aligned_cols=257  Identities=23%  Similarity=0.405  Sum_probs=197.9

Q ss_pred             cccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.|.+.+.||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            34888999999999999999863     34567999987632   22334668899999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.| ++.+++......                     ............+++..+..++.|++.||+|||++|
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~---------------------~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~  140 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPD---------------------AVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH  140 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCc---------------------cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999985 444444211000                     000011112345899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||++.++.+||+|||+++....      .....+++.|+|||++.   ...++.++|||||||++|||++
T Consensus       141 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~t  217 (288)
T cd05093         141 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSLGVVLWEIFT  217 (288)
T ss_pred             eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhc---cCCCCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999864321      12234577899999984   3568889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |.+||...+..+.+..+.++..+                                          .....++.++.+|+
T Consensus       218 ~g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li  255 (288)
T cd05093         218 YGKQPWYQLSNNEVIECITQGRVL------------------------------------------QRPRTCPKEVYDLM  255 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCcC------------------------------------------CCCCCCCHHHHHHH
Confidence             99999877655544444322110                                          01123578899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||+.||.+|||+.+++.
T Consensus       256 ~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         256 LGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHccCChhhCCCHHHHHH
Confidence            9999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-38  Score=343.83  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=191.7

Q ss_pred             cccccccccccccccceEEEEeeeceeE----EEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREI----VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~----vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ..|+.++.||+|+||.||+|++..+++.    ||+|.+...  ......+.+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            4589999999999999999998766654    899987532  2223346788999999999999999999998764 57


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ++++||+.++ +.+.+.                                 .....+++..+..++.||+.||+|||++||
T Consensus        84 ~~v~e~~~~g~l~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i  130 (316)
T cd05108          84 QLITQLMPFGCLLDYVR---------------------------------EHKDNIGSQYLLNWCVQIAKGMNYLEERRL  130 (316)
T ss_pred             eeeeecCCCCCHHHHHH---------------------------------hccccCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence            8999999754 333221                                 123457888999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||++.++.+||+|||+++.....      ....++..|+|||++.   ...++.++|||||||++|||++ 
T Consensus       131 iH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slGv~l~el~t~  207 (316)
T cd05108         131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTF  207 (316)
T ss_pred             eccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhc---cCCCCchhhhHHHHHHHHHHHcC
Confidence            99999999999999999999999999754321      1223467899999984   4568899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||.+....+.. .+.....                   .                      ......++.++.+++.
T Consensus       208 g~~p~~~~~~~~~~-~~~~~~~-------------------~----------------------~~~~~~~~~~~~~li~  245 (316)
T cd05108         208 GSKPYDGIPASEIS-SILEKGE-------------------R----------------------LPQPPICTIDVYMIMV  245 (316)
T ss_pred             CCCCCCCCCHHHHH-HHHhCCC-------------------C----------------------CCCCCCCCHHHHHHHH
Confidence            99999776543322 2211100                   0                      0011235678899999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||+.||.+|||+.+++.+
T Consensus       246 ~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         246 KCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0696|consensus

Probab=100.00  E-value=1.4e-39  Score=343.44  Aligned_cols=253  Identities=27%  Similarity=0.407  Sum_probs=212.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|..+.+||+|+||+|.+|..+.+.+.+|||++++.-.......+-.+.|-++|... +-|.+++++.+|++-+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            378899999999999999999999999999998754333333344556788888766 5689999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.||                                 +|..-+++-+.+.|..+..++.+|+-||-|||++|||.|||
T Consensus       430 EyvnGG---------------------------------DLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDL  476 (683)
T KOG0696|consen  430 EYVNGG---------------------------------DLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDL  476 (683)
T ss_pred             EEecCc---------------------------------hhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeec
Confidence            999987                                 22222344567888999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |.+|||++.+|++||+|||+++...    ...++||||.|+|||++.   ..+|+.++|+||+||+||||++|++||.+.
T Consensus       477 KLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~---YqPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  477 KLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             cccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEE---ecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999997543    245799999999999984   568999999999999999999999999999


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      ++.+....|..-..                                           ..+..+|.++.++.+..|.+.|.
T Consensus       554 DE~elF~aI~ehnv-------------------------------------------syPKslSkEAv~ickg~ltK~P~  590 (683)
T KOG0696|consen  554 DEDELFQAIMEHNV-------------------------------------------SYPKSLSKEAVAICKGLLTKHPG  590 (683)
T ss_pred             CHHHHHHHHHHccC-------------------------------------------cCcccccHHHHHHHHHHhhcCCc
Confidence            98888777753211                                           01235689999999999999999


Q ss_pred             CCCCH-----HHHHcCccccCC
Q psy17952        478 DRPSS-----GRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa-----~elL~Hp~~~~~  494 (804)
                      +|..+     .++-.||||++.
T Consensus       591 kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  591 KRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             cccCCCCccccchhhCcchhhc
Confidence            99866     578889999763

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-38  Score=348.21  Aligned_cols=282  Identities=29%  Similarity=0.406  Sum_probs=212.8

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----ce
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----TA  237 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----~~  237 (804)
                      .|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++++++||||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            37889999999999999999999999999998864321 1233467889999999999999999999988765     78


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |++|||+.+++.+++                                  .....+++..+..++.|++.||+|||++||+
T Consensus        80 ~lv~e~~~~~l~~~l----------------------------------~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~  125 (330)
T cd07834          80 YIVTELMETDLHKVI----------------------------------KSPQPLTDDHIQYFLYQILRGLKYLHSANVI  125 (330)
T ss_pred             EEEecchhhhHHHHH----------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            999999987543332                                  2334789999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+|||++.++.+||+|||++......       ....+|+.|+|||++.+.  ..++.++|+|||||++|+|++|
T Consensus       126 H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~il~~l~~g  203 (330)
T cd07834         126 HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS--SRYTKAIDIWSVGCIFAELLTR  203 (330)
T ss_pred             cCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecc--cCCCcchhHHHHHHHHHHHHcC
Confidence            9999999999999999999999998754322       245689999999998542  2678899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCC--CCCCCCCCccHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND--TPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~--~p~~~~~~~s~~l~dli  468 (804)
                      .+||.+.+..+.+..+......... ..+..   ...          ......+.......  ......+..+.++.+||
T Consensus       204 ~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~---~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  269 (330)
T cd07834         204 KPLFPGRDYIDQLNLIVEVLGTPSE-EDLKF---ITS----------EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLL  269 (330)
T ss_pred             CCCcCCCCHHHHHHHHHHhcCCCCh-hHhhh---ccc----------cchhhHHhhcccCCcchhHHhcccCCHHHHHHH
Confidence            9999988877766665542211110 00000   000          00000000000000  00001234688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||++||.+|||++++++||||....
T Consensus       270 ~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         270 EKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HHHccCChhhCCCHHHHHhCccHHhhc
Confidence            999999999999999999999997643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8e-38  Score=334.05  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=196.6

Q ss_pred             cccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.|++.+.||+|+||.||+|.+..     ++..||+|.+.....  ......+.+|+.++++++||||+++++++.+.+.
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            458999999999999999999887     778999998753221  2223568899999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.| ++.+++....                           ........+++..+..++.||+.||+|||+++
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~---------------------------~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  136 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENR---------------------------PRPERPSSLTMKDLLFCARDVAKGCKYLEENH  136 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhC---------------------------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999975 5544443110                           00011235889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCC---cEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        316 RIHRDVKAGNILLTETG---TVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g---~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++||||||+|||++.++   .+||+|||+++.....      ....+++.|+|||++.   .+.++.++|||||||++||
T Consensus       137 ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~e  213 (277)
T cd05036         137 FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL---DGIFTSKTDVWSFGVLLWE  213 (277)
T ss_pred             EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh---cCCcCchhHHHHHHHHHHH
Confidence            99999999999998765   5999999998754211      1223456799999984   3568999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |++ |..||.+.+..+....+.....                                          .......+..+.
T Consensus       214 l~~~g~~pf~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~  251 (277)
T cd05036         214 IFSLGYMPYPGRTNQEVMEFVTGGGR------------------------------------------LDPPKGCPGPVY  251 (277)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCCc------------------------------------------CCCCCCCCHHHH
Confidence            997 9999987665443333221100                                          001134578899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +|+.+||+.||++|||+.++++|
T Consensus       252 ~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         252 RIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.7e-38  Score=329.35  Aligned_cols=242  Identities=26%  Similarity=0.417  Sum_probs=193.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+++.. .+..+|+|.+....    .....+.+|+.+|++++||||+++++++......|+|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            4888999999999999999765 44579999875321    123567889999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+.+.                                 ...+.+++..+..++.|++.||.|||++||+||||
T Consensus        80 ~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl  126 (256)
T cd05114          80 FMENGCLLNYLR---------------------------------QRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL  126 (256)
T ss_pred             cCCCCcHHHHHH---------------------------------hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence            99865 332221                                 11245789999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||+||+++.++.+||+|||+++.....     ....++..|+|||++.   ...++.++|||||||++|||++ |++||.
T Consensus       127 ~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~s~G~~l~el~~~g~~p~~  203 (256)
T cd05114         127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN---FSKYSSKSDVWSFGVLMWEVFTEGKMPFE  203 (256)
T ss_pred             CcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcc---cCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999998653221     1234566899999984   3468889999999999999999 999998


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+..+.+..+.++..+                                          ..+...+..+.+|+.+||+.|
T Consensus       204 ~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~~li~~c~~~~  241 (256)
T cd05114         204 KKSNYEVVEMISRGFRL------------------------------------------YRPKLASMTVYEVMYSCWHEK  241 (256)
T ss_pred             CCCHHHHHHHHHCCCCC------------------------------------------CCCCCCCHHHHHHHHHHccCC
Confidence            77665555554332110                                          001224678899999999999


Q ss_pred             CCCCCCHHHHHc
Q psy17952        476 PADRPSSGRLLT  487 (804)
Q Consensus       476 P~~Rpsa~elL~  487 (804)
                      |.+|||++++++
T Consensus       242 p~~Rps~~~l~~  253 (256)
T cd05114         242 PEGRPTFAELLR  253 (256)
T ss_pred             cccCcCHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.5e-38  Score=333.04  Aligned_cols=253  Identities=35%  Similarity=0.590  Sum_probs=199.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|++..+++.+|||.+.............+.+|+.+++.++||||+++++++..++..|++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            48889999999999999999999999999998765433333445678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+++..                              .......+++..+..++.||+.||.|||++||+||||
T Consensus        83 ~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl  132 (267)
T cd08229          83 LADAGDLSRMIKH------------------------------FKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDI  132 (267)
T ss_pred             ecCCCCHHHHHHH------------------------------hhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            99864 4333320                              0112346899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||+++.++.+||+|||++.....    .....|++.|+|||.+.   ...++.++|+|||||++|||++|..||.+.
T Consensus       133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         133 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhc---CCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99999999999999999999865432    12457999999999984   346788999999999999999999999654


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      ....  ..+               .+.+.                      ....+......+++.+.+|+.+||..||.
T Consensus       210 ~~~~--~~~---------------~~~~~----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~  250 (267)
T cd08229         210 KMNL--YSL---------------CKKIE----------------------QCDYPPLPSDHYSEELRQLVNMCINPDPE  250 (267)
T ss_pred             cchH--HHH---------------hhhhh----------------------cCCCCCCCcccccHHHHHHHHHhcCCCcc
Confidence            3210  000               00000                      00111122234688999999999999999


Q ss_pred             CCCCHHHHHc
Q psy17952        478 DRPSSGRLLT  487 (804)
Q Consensus       478 ~Rpsa~elL~  487 (804)
                      +|||+.+++.
T Consensus       251 ~Rpt~~~i~~  260 (267)
T cd08229         251 KRPDITYVYD  260 (267)
T ss_pred             cCCCHHHHHH
Confidence            9999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-38  Score=348.54  Aligned_cols=284  Identities=24%  Similarity=0.353  Sum_probs=208.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------C
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------H  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------~  235 (804)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++++++||||+++++++...      .
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            45999999999999999999999999999999886422 1122335677899999999999999999988643      3


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|++++++.+++.+++.                                   ...+++..+..++.|++.||+|||++|
T Consensus        96 ~~~lv~~~~~~~L~~~~~-----------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~  140 (345)
T cd07877          96 DVYLVTHLMGADLNNIVK-----------------------------------CQKLTDDHVQFLIYQILRGLKYIHSAD  140 (345)
T ss_pred             cEEEEehhcccCHHHHHh-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            478999998666443321                                   235889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC-CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+||+++.++.+||+|||++...... ....||+.|+|||++.+  ...++.++|||||||++|||++|++||
T Consensus       141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf  218 (345)
T cd07877         141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLF  218 (345)
T ss_pred             eeecCCChHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHhC--ccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998754332 34578999999998743  245788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      ...+....+..+.........    .....+..       .........+..+.+.. ........++++.+||.+||+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~  286 (345)
T cd07877         219 PGTDHIDQLKLILRLVGTPGA----ELLKKISS-------ESARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVL  286 (345)
T ss_pred             CCCCHHHHHHHHHHHhCCCCH----HHHhhccc-------HhHHHHHHHhcccCCcc-hhhhcCCCCHHHHHHHHHHcCC
Confidence            877766655554432211000    00000000       00000000000000000 0000123578899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||.+|||+.++|.||||.+..
T Consensus       287 dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         287 DSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             ChhhcCCHHHHhcChhhhhcC
Confidence            999999999999999998643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7e-38  Score=330.02  Aligned_cols=251  Identities=34%  Similarity=0.611  Sum_probs=204.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|++......  .....+.+|+..+++++||||+++++++......|+|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            378899999999999999999999999999988653321  345678899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRD  320 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRD  320 (804)
                      |+.|+ +.+++                                  .....+++..+..++.|+++||+|||+ .|++|||
T Consensus        80 ~~~~~~L~~~l----------------------------------~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~  125 (264)
T cd06623          80 YMDGGSLADLL----------------------------------KKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRD  125 (264)
T ss_pred             ecCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCC
Confidence            99854 33322                                  223578999999999999999999999 9999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |+|+||+++.++.+||+|||++......    ....++..|+|||.+.   ...++.++|+|||||++|+|++|++||..
T Consensus       126 l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~  202 (264)
T cd06623         126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ---GESYSYAADIWSLGLTLLECALGKFPFLP  202 (264)
T ss_pred             CCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhC---CCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999999999999998654322    2456889999999974   35678899999999999999999999966


Q ss_pred             CC---hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        397 MN---AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       397 ~~---~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      .+   ..+....+..                                         ...+......++..+.+++.+||.
T Consensus       203 ~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~l~~li~~~l~  241 (264)
T cd06623         203 PGQPSFFELMQAICD-----------------------------------------GPPPSLPAEEFSPEFRDFISACLQ  241 (264)
T ss_pred             ccccCHHHHHHHHhc-----------------------------------------CCCCCCCcccCCHHHHHHHHHHcc
Confidence            53   1111111110                                         011111112278899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccC
Q psy17952        474 KNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+|++|||+.+++.|||+..
T Consensus       242 ~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         242 KDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             CChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG1006|consensus

Probab=100.00  E-value=4.4e-40  Score=331.94  Aligned_cols=261  Identities=30%  Similarity=0.481  Sum_probs=212.0

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHH-HhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF-LRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .+.+..||.|+||+|++-.++.+|+.+|||+++....  ....++++.|.+. ++.-+.||||++||+...++..|+.||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            5678899999999999999999999999999986433  3445678888875 455578999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDV  321 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHRDL  321 (804)
                      +|.-++..+.+.                             -+..++..++|..+-.|+.-.+.||+||-. ..|||||+
T Consensus       144 LMd~SlDklYk~-----------------------------vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDv  194 (361)
T KOG1006|consen  144 LMDISLDKLYKR-----------------------------VYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDV  194 (361)
T ss_pred             HHhhhHHHHHHH-----------------------------HHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccC
Confidence            998765443321                             123456679999999999999999999975 68999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      ||+|||++..|.+||||||++......   +.-.|...|||||.+... ...|+-+||+||||++|||++||+.||.+.+
T Consensus       195 KPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~-~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  195 KPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPS-DKGYDIRSDVWSLGITLYEVATGNFPYRKWD  273 (361)
T ss_pred             ChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCc-cCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence            999999999999999999998654321   224688999999999653 3369999999999999999999999998764


Q ss_pred             -hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        399 -AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       399 -~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                       ..+++..+..+++|.+..                                     ......+|..+..||.-||.+|-+
T Consensus       274 svfeql~~Vv~gdpp~l~~-------------------------------------~~~~~~~s~~~~~fintCl~Kd~~  316 (361)
T KOG1006|consen  274 SVFEQLCQVVIGDPPILLF-------------------------------------DKECVHYSFSMVRFINTCLIKDRS  316 (361)
T ss_pred             HHHHHHHHHHcCCCCeecC-------------------------------------cccccccCHHHHHHHHHHhhcccc
Confidence             455566666555543211                                     011234789999999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy17952        478 DRPSSGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~  493 (804)
                      +||.-.+++++||+..
T Consensus       317 ~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  317 DRPKYDDLKKFPFYRM  332 (361)
T ss_pred             cCcchhhhhcCchhhh
Confidence            9999999999999865

>KOG2345|consensus

Probab=100.00  E-value=3.3e-39  Score=323.35  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=201.8

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----C
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----H  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----~  235 (804)
                      .++|.+.+.||+|||+.||+++...+++.+|+|++....   .+..+..++|++.-++++|||+++++++...+     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            457999999999999999999999999999999987543   34557789999999999999999998876543     3


Q ss_pred             ceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..||++.|.. |++.|.++..                              ..++..++|.++..|+.+|++||++||+.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~------------------------------k~kg~~~sE~~iL~if~gic~gL~~lH~~  146 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERL------------------------------KIKGNFVSEAQILWIFLGICRGLEALHEK  146 (302)
T ss_pred             eEEEEeehhccccHHHHHHHH------------------------------hhcCCccCHHHHHHHHHHHHHHHHHHhcc
Confidence            4899999985 7777766421                              12344699999999999999999999999


Q ss_pred             C--CeecCCCCCCeeecCCCcEEEEecccccccCC---C----------CccccCcccccchhhcccCCCCCCCcccHHH
Q psy17952        315 G--RIHRDVKAGNILLTETGTVKLADFGSASIKCP---A----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  379 (804)
Q Consensus       315 g--IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~----------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWS  379 (804)
                      .  ..||||||.|||+++++.++|.|||.++...-   .          .+-..|..|+|||++....+...+.++||||
T Consensus       147 ~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWS  226 (302)
T KOG2345|consen  147 EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWS  226 (302)
T ss_pred             CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhh
Confidence            9  99999999999999999999999999864321   0          1235788999999986555556788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCC
Q psy17952        380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD  459 (804)
Q Consensus       380 lGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~  459 (804)
                      |||+||+|+.|..||...      +.  +|+.         +--++.                      .+....+....
T Consensus       227 LGCtLYa~mf~~sPfe~~------~~--~GgS---------laLAv~----------------------n~q~s~P~~~~  267 (302)
T KOG2345|consen  227 LGCTLYAMMFGESPFERI------YQ--QGGS---------LALAVQ----------------------NAQISIPNSSR  267 (302)
T ss_pred             hhHHHHHHHHcCCcchHH------hh--cCCe---------EEEeee----------------------ccccccCCCCC
Confidence            999999999999999421      11  1110         000000                      00111122345


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        460 WSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       460 ~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +|+.+.+||+.||+.||.+||++.+++.+
T Consensus       268 yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  268 YSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            89999999999999999999999999865

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.7e-38  Score=332.48  Aligned_cols=247  Identities=31%  Similarity=0.518  Sum_probs=192.9

Q ss_pred             ccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      ...||+|+||.||+|++..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..|++|||+.|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            357999999999999999999999999875422   23346788999999999999999999999999999999999986


Q ss_pred             C-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        247 S-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPL--KEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       247 ~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l--~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      + +.+.+..                                 ....+  ++..+..++.||+.||.|||++||+||||||
T Consensus        90 ~~L~~~l~~---------------------------------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p  136 (268)
T cd06624          90 GSLSALLRS---------------------------------KWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG  136 (268)
T ss_pred             CCHHHHHHH---------------------------------hcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence            4 4333221                                 11234  7888999999999999999999999999999


Q ss_pred             CCeeecC-CCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        324 GNILLTE-TGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       324 ~NILl~~-~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      +||+++. ++.+||+|||++.....    .....|++.|+|||++... ...++.++|||||||++|+|++|.+||....
T Consensus       137 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG-PRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             HHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccc-cccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999976 67999999999864322    2235689999999998431 2347889999999999999999999996532


Q ss_pred             hHHH-HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        399 AMSA-LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       399 ~~~~-l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      .... ...+..                                        ....+ ......++++.+|+.+||..+|.
T Consensus       216 ~~~~~~~~~~~----------------------------------------~~~~~-~~~~~~~~~~~~li~~~l~~~p~  254 (268)
T cd06624         216 EPQAAMFKVGM----------------------------------------FKIHP-EIPESLSAEAKNFILRCFEPDPD  254 (268)
T ss_pred             ChhhhHhhhhh----------------------------------------hccCC-CCCcccCHHHHHHHHHHcCCCch
Confidence            2111 100000                                        00001 11234678899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.+++.||||
T Consensus       255 ~Rpt~~~ll~~~~~  268 (268)
T cd06624         255 KRASAHDLLQDPFL  268 (268)
T ss_pred             hCCCHHHHHhCCCC
Confidence            99999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-38  Score=330.99  Aligned_cols=250  Identities=32%  Similarity=0.546  Sum_probs=199.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEeccccc--ccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLG--KQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~  238 (804)
                      .|++.+.||+|+||.||+|++..+++.||+|.+....  .........+.+|+.++++++||||+++++++.+.  +.++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            3888999999999999999999999999999874321  11233456788999999999999999999998764  4588


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      ++|||+.|+ +.+.+                                  ...+.+++..+..++.|++.||.|||++||+
T Consensus        83 ~v~e~~~~~~L~~~~----------------------------------~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~  128 (264)
T cd06653          83 IFVEYMPGGSIKDQL----------------------------------KAYGALTENVTRRYTRQILQGVSYLHSNMIV  128 (264)
T ss_pred             EEEEeCCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            999999864 32222                                  2234688999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+||+++.++.+||+|||+++....       .....||..|+|||++.+   ..++.++|+|||||++|||++|
T Consensus       129 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g  205 (264)
T cd06653         129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG---EGYGRKADVWSVACTVVEMLTE  205 (264)
T ss_pred             cCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC---CCCCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999864321       123568999999999843   4578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.........+....                                         .+...+..+++.+.+|+.+
T Consensus       206 ~~p~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~p~~~~~~~~~~i~~  244 (264)
T cd06653         206 KPPWAEYEAMAAIFKIATQP-----------------------------------------TKPMLPDGVSDACRDFLKQ  244 (264)
T ss_pred             CCCCCccCHHHHHHHHHcCC-----------------------------------------CCCCCCcccCHHHHHHHHH
Confidence            99997665444333221100                                         0011123467899999999


Q ss_pred             hcccCCCCCCCHHHHHcCccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      ||+ +|.+|||+.+++.|||.
T Consensus       245 ~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         245 IFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             Hhc-CcccCccHHHHhcCCCC
Confidence            999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-37  Score=329.16  Aligned_cols=238  Identities=23%  Similarity=0.330  Sum_probs=188.1

Q ss_pred             ccccccccceEEEEe--eeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        169 EIGHGSFGAVYYARC--LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~--~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +||+|+||.||+|..  ..+++.+|+|.++... ......+.+.+|+.+++.++||||+++++++. ....++||||+.+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            699999999999964  4567899999876432 22334567889999999999999999999875 4567999999986


Q ss_pred             C-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        247 S-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       247 ~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      + +.++                                  +.....+++..+..++.|++.||+|||++||+||||||+|
T Consensus        80 ~~L~~~----------------------------------l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~n  125 (257)
T cd05116          80 GPLNKF----------------------------------LQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARN  125 (257)
T ss_pred             CcHHHH----------------------------------HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhh
Confidence            5 3222                                  2234568899999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        326 ILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      ||++.++.+||+|||+++.....       ....+++.|+|||.+.   ...++.++|||||||++|||++ |.+||.+.
T Consensus       126 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         126 VLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             EEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc---cCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999998653221       1123457899999874   3567889999999999999998 99999877


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+.++..+                                          ..+...++++.+||.+||+.||+
T Consensus       203 ~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~~~~~~~p~  240 (257)
T cd05116         203 KGNEVTQMIESGERM------------------------------------------ECPQRCPPEMYDLMKLCWTYGVD  240 (257)
T ss_pred             CHHHHHHHHHCCCCC------------------------------------------CCCCCCCHHHHHHHHHHhccCch
Confidence            665554444321110                                          01124678899999999999999


Q ss_pred             CCCCHHHHHc
Q psy17952        478 DRPSSGRLLT  487 (804)
Q Consensus       478 ~Rpsa~elL~  487 (804)
                      +|||++++..
T Consensus       241 ~Rp~~~~i~~  250 (257)
T cd05116         241 ERPGFAVVEL  250 (257)
T ss_pred             hCcCHHHHHH
Confidence            9999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-38  Score=347.54  Aligned_cols=281  Identities=25%  Similarity=0.375  Sum_probs=209.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      +.|++++.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+|++++||||+++++++..+.      
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            45899999999999999999999999999999875321 12223356789999999999999999999987654      


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+||||+.+++.+++                                   ....+++..+..++.|+++||.|||+.|
T Consensus        94 ~~~lv~e~~~~~l~~~~-----------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~g  138 (343)
T cd07880          94 DFYLVMPFMGTDLGKLM-----------------------------------KHEKLSEDRIQFLVYQMLKGLKYIHAAG  138 (343)
T ss_pred             eEEEEEecCCCCHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35899999965543322                                   1246889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+|||++.++.+||+|||++..... .....+|+.|+|||++.+  ...++.++|+|||||++|+|++|.+||
T Consensus       139 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf  216 (343)
T cd07880         139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILN--WMHYTQTVDIWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             eecCCCCHHHEEEcCCCCEEEeecccccccccCccccccCCcccCHHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999875432 234578999999999853  235788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCC--CCCCCCCCccHHHHHHHHHhc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND--TPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~--~p~~~~~~~s~~l~dli~~cL  472 (804)
                      .+.+.......+.+......    ......+....          ............  .........++.+.++|.+||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  282 (343)
T cd07880         217 KGHDHLDQLMEIMKVTGTPS----KEFVQKLQSED----------AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKML  282 (343)
T ss_pred             CCCCHHHHHHHHHHhcCCCC----HHHHHhhcchh----------HHHHHHhccccCcchHHHhccCCChHHHHHHHHHc
Confidence            88776666555544321110    01111110000          000000000000  000112356788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +.||++|||+.+++.||||...
T Consensus       283 ~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         283 VLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             CCChhhCCCHHHHhcCccHhhh
Confidence            9999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.1e-38  Score=345.70  Aligned_cols=284  Identities=29%  Similarity=0.401  Sum_probs=208.8

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeec--Cce
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRD--HTA  237 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~--~~~  237 (804)
                      .+.|++.+.||+|+||.||+|.+..+++.+|+|++..... .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3468999999999999999999999999999998753221 122335577899999999 999999999988653  368


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+||||+.+++.+.+.                                   .+.+++..+..++.||+.||.|||++||+
T Consensus        85 ~lv~e~~~~~L~~~~~-----------------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~  129 (337)
T cd07852          85 YLVFEYMETDLHAVIR-----------------------------------ANILEDVHKRYIMYQLLKALKYIHSGNVI  129 (337)
T ss_pred             EEEecccccCHHHHHh-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            9999999876543321                                   12577888899999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC---------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~---------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||||||+|||++.++.+||+|||++......         ..+.||+.|+|||++.+  ...++.++|||||||++|||+
T Consensus       130 H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~el~  207 (337)
T cd07852         130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG--STRYTKGVDMWSVGCILGEML  207 (337)
T ss_pred             cCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeec--cccccccchHHHHHHHHHHHH
Confidence            9999999999999999999999998643221         23578999999998753  345788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|++||.+....+....+........ ...+..+......          ........ ............++.++.+|+
T Consensus       208 tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~-~~~~~~~~~~~~~~~~l~~li  275 (337)
T cd07852         208 LGKPLFPGTSTLNQLEKIIEVIGPPS-AEDIESIKSPFAA----------TMLDSLPS-RPRKPLDELLPKASDDALDLL  275 (337)
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCC-HHHHHHHHhhhHH----------Hhhhhccc-ccccchhhhccCCCHHHHHHH
Confidence            99999988776666655544321110 0111111000000          00000000 000001111233688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||+.||++|||+.++++|||+...
T Consensus       276 ~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         276 KKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHhccCCcccccCHHHHhhChhhhhh
Confidence            99999999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.9e-38  Score=331.42  Aligned_cols=246  Identities=28%  Similarity=0.455  Sum_probs=199.5

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC-c
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-A  248 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~-l  248 (804)
                      ||+|+||.||+|++..+++.+|+|.+...........+.+.+|++++++++||||+++++++......|++|||+.|+ +
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            699999999999999999999999886433322344567889999999999999999999999999999999999864 3


Q ss_pred             hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        249 SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       249 ~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                      .+++.                                  ..+.+++..+..++.||++||.|||++||+||||+|+||++
T Consensus        81 ~~~l~----------------------------------~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~  126 (265)
T cd05579          81 ASLLE----------------------------------NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI  126 (265)
T ss_pred             HHHHH----------------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE
Confidence            33321                                  23468999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCCC------------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        329 TETGTVKLADFGSASIKCPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       329 ~~~g~vKL~DFGla~~~~~~------------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      +.++.+||+|||++......            ....+++.|+|||.+.   ...++.++|||||||++|||++|..||..
T Consensus       127 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL---GQGHSKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999998643221            2346889999999984   34478899999999999999999999976


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      ....+....+..+..                                         +.......+..+.+|+.+||+.+|
T Consensus       204 ~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p  242 (265)
T cd05579         204 ETPEEIFQNILNGKI-----------------------------------------EWPEDVEVSDEAIDLISKLLVPDP  242 (265)
T ss_pred             CCHHHHHHHHhcCCc-----------------------------------------CCCccccCCHHHHHHHHHHhcCCH
Confidence            665444333322110                                         000111247889999999999999


Q ss_pred             CCCCCH---HHHHcCccccC
Q psy17952        477 ADRPSS---GRLLTHDLVTR  493 (804)
Q Consensus       477 ~~Rpsa---~elL~Hp~~~~  493 (804)
                      .+|||+   .++|+||||+.
T Consensus       243 ~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         243 EKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             hhcCCCccHHHHhcCccccC
Confidence            999999   99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-37  Score=330.23  Aligned_cols=244  Identities=23%  Similarity=0.371  Sum_probs=195.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...    ......+.+|+++++.++||||+++++++..++..+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            378889999999999999999999999999987532    2234568899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+.+..                                .....+++..+..++.|+++||+|||++||+||||
T Consensus        83 ~~~~~~L~~~~~~--------------------------------~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl  130 (263)
T cd05052          83 FMTYGNLLDYLRE--------------------------------CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL  130 (263)
T ss_pred             eCCCCcHHHHHHh--------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence            99754 4333210                                11245788999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||+|||+++++.+||+|||++......     ....+++.|+|||.+.   ...++.++|||||||++|||++ |..||.
T Consensus       131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~t~g~~p~~  207 (263)
T cd05052         131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYP  207 (263)
T ss_pred             CcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999998654321     1223466799999884   3568889999999999999998 999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+..+....+..+.                                          +.......+.++.+++.+||+.|
T Consensus       208 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~cl~~~  245 (263)
T cd05052         208 GIDLSQVYELLEKGY------------------------------------------RMERPEGCPPKVYELMRACWQWN  245 (263)
T ss_pred             CCCHHHHHHHHHCCC------------------------------------------CCCCCCCCCHHHHHHHHHHccCC
Confidence            765444333221110                                          00112346789999999999999


Q ss_pred             CCCCCCHHHHHc
Q psy17952        476 PADRPSSGRLLT  487 (804)
Q Consensus       476 P~~Rpsa~elL~  487 (804)
                      |++|||+.++++
T Consensus       246 p~~Rp~~~~l~~  257 (263)
T cd05052         246 PSDRPSFAEIHQ  257 (263)
T ss_pred             cccCCCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=326.92  Aligned_cols=249  Identities=27%  Similarity=0.432  Sum_probs=196.7

Q ss_pred             cccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeec
Q psy17952        168 REIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC  244 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~  244 (804)
                      +.||+|+||.||+|.+...   +..||+|.+.......  ..+.+.+|+++++.++||||+++++++......|+||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4699999999999999866   8899999886533221  3567889999999999999999999999999999999999


Q ss_pred             CC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        245 LG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       245 ~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      .| ++.+.+......                         ........+++.++..++.|++.||+|||++||+||||||
T Consensus        79 ~~~~L~~~l~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p  133 (262)
T cd00192          79 EGGDLLDYLRKSRPV-------------------------FPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAA  133 (262)
T ss_pred             cCCcHHHHHhhcccc-------------------------ccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCc
Confidence            64 444433210000                         0001136789999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFN  396 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~  396 (804)
                      +||+++.++.+||+|||.+.....      .....+++.|+|||.+.   ...++.++|||||||++|||++ |..||.+
T Consensus       134 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~  210 (262)
T cd00192         134 RNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK---DGIFTSKSDVWSFGVLLWEIFTLGATPYPG  210 (262)
T ss_pred             ceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhc---cCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999875433      23456889999999884   3468889999999999999999 6999987


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+.......+..+.                                          ........+.++.+++.+||+.||
T Consensus       211 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p  248 (262)
T cd00192         211 LSNEEVLEYLRKGY------------------------------------------RLPKPEYCPDELYELMLSCWQLDP  248 (262)
T ss_pred             CCHHHHHHHHHcCC------------------------------------------CCCCCccCChHHHHHHHHHccCCc
Confidence            76554444332210                                          001123457889999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy17952        477 ADRPSSGRLLTH  488 (804)
Q Consensus       477 ~~Rpsa~elL~H  488 (804)
                      ++|||+.+++++
T Consensus       249 ~~Rps~~~l~~~  260 (262)
T cd00192         249 EDRPTFSELVER  260 (262)
T ss_pred             ccCcCHHHHHHh
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-38  Score=348.90  Aligned_cols=283  Identities=26%  Similarity=0.380  Sum_probs=212.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc-----
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT-----  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~-----  236 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+.++++++||||+++.+++...+.     
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            35899999999999999999999999999999875421 122334567889999999999999999998876654     


Q ss_pred             -eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 -AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 -~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                       .|+||||+.+++.+++.                                   ...+++..+..++.|+++||+|||++|
T Consensus        94 ~~~lv~e~~~~~L~~~~~-----------------------------------~~~l~~~~~~~~~~ql~~aL~~LH~~g  138 (343)
T cd07851          94 DVYLVTHLMGADLNNIVK-----------------------------------CQKLSDDHIQFLVYQILRGLKYIHSAG  138 (343)
T ss_pred             cEEEEEecCCCCHHHHHh-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence             89999999776544332                                   246899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+||+++.++.+||+|||++..... .....+|+.|+|||++.+  ...++.++|||||||++|||++|++||
T Consensus       139 i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf  216 (343)
T cd07851         139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGKTLF  216 (343)
T ss_pred             eecCCCCHHHeEECCCCCEEEccccccccccccccCCcccccccCHHHHhC--CCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999875432 344678999999999853  235788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC--CCCCCccHHHHHHHHHhc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC--LQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~--~~~~~~s~~l~dli~~cL  472 (804)
                      .+.+....+..+........ .   ..+..+....          ...-.........+.  .....+++.+.+|+.+||
T Consensus       217 ~~~~~~~~~~~i~~~~~~~~-~---~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l  282 (343)
T cd07851         217 PGSDHIDQLKRIMNLVGTPD-E---ELLQKISSES----------ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKML  282 (343)
T ss_pred             CCCChHHHHHHHHHhcCCCC-H---HHHhhccchh----------HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhC
Confidence            88877666665544321100 0   0111110000          000000000000000  001235889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ..||.+|||+.++++||||.+...
T Consensus       283 ~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         283 VLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             CCChhhCCCHHHHhcCCCccccCC
Confidence            999999999999999999986543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.6e-38  Score=353.41  Aligned_cols=282  Identities=24%  Similarity=0.345  Sum_probs=199.8

Q ss_pred             cccccccccccccccccceEEEEeeec-----eeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVS-----REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~-----~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|.+...     +..||||++....  .....+.+++|+.+|++++ |||||++++++..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            455699999999999999999986533     3579999886432  2233467899999999996 9999999999999


Q ss_pred             cCceEEEEeecC-CCchhhHHHHHhhhhh--hh--------cc------------------cchhh--hhh--hh-----
Q psy17952        234 DHTAWLVMEYCL-GSASDIIEVHWIEREF--HV--------EG------------------MGNRL--QQL--KC-----  275 (804)
Q Consensus       234 ~~~~~lVmEy~~-G~l~dll~~~~~~~~~--~~--------~~------------------~~~~l--~~l--~~-----  275 (804)
                      .+..|+|||||. |+|.+++.........  ..        .+                  .+...  .+.  ..     
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            999999999998 4566665432100000  00        00                  00000  000  00     


Q ss_pred             -----------------------hhcccccchhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecC
Q psy17952        276 -----------------------FTEHFALFNFE--VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE  330 (804)
Q Consensus       276 -----------------------~~~~~~L~~~~--~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~  330 (804)
                                             ......+.++.  .....+++.++..++.||++||+|||+++|+||||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                   00000011111  12346899999999999999999999999999999999999999


Q ss_pred             CCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy17952        331 TGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMSAL  403 (804)
Q Consensus       331 ~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~~l  403 (804)
                      ++.+||+|||+++....      .....+++.|||||++.   ...++.++|||||||++|||++ |..||........+
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF---DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc---CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            99999999999865321      12345778899999984   3568899999999999999997 99999765433322


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHH
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSG  483 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~  483 (804)
                      +......                                         ........++.++.+++.+||+.||++|||+.
T Consensus       350 ~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         350 YNKIKSG-----------------------------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             HHHHhcC-----------------------------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence            2221110                                         00011234678899999999999999999999


Q ss_pred             HHHc
Q psy17952        484 RLLT  487 (804)
Q Consensus       484 elL~  487 (804)
                      ++.+
T Consensus       389 ~l~~  392 (400)
T cd05105         389 HLSD  392 (400)
T ss_pred             HHHH
Confidence            8775

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.5e-38  Score=339.96  Aligned_cols=261  Identities=26%  Similarity=0.366  Sum_probs=194.3

Q ss_pred             ccccccccccccccceEEEEeeeceeE--EEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREI--VAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~--vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|++.+.||+|+||.||+|.+..++..  +|+|.+...  ........+.+|+.++.++ +||||+++++++..++..|+
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            478899999999999999998877754  577766432  1223345678899999999 89999999999999999999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.| ++.+++...                  ..................+++..+..++.|++.||+|||++||+|
T Consensus        86 v~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H  147 (303)
T cd05088          86 AIEYAPHGNLLDFLRKS------------------RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH  147 (303)
T ss_pred             EEEeCCCCcHHHHHHhc------------------ccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9999975 454444210                  000000000000112346899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF  394 (804)
                      |||||+|||++.++.+||+|||++.....   .....++..|+|||++.   ...++.++|||||||++|||++ |.+||
T Consensus       148 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~  224 (303)
T cd05088         148 RDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPY  224 (303)
T ss_pred             cccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHh---ccCCcccccchhhhhHHHHHHhcCCCCc
Confidence            99999999999999999999999864321   11223466799999874   3467889999999999999998 99999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+....                                          ........++++.+|+.+||+.
T Consensus       225 ~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~  262 (303)
T cd05088         225 CGMTCAELYEKLPQGY------------------------------------------RLEKPLNCDDEVYDLMRQCWRE  262 (303)
T ss_pred             ccCChHHHHHHHhcCC------------------------------------------cCCCCCCCCHHHHHHHHHHcCC
Confidence            7665443332221100                                          0001123577899999999999


Q ss_pred             CCCCCCCHHHHHcC
Q psy17952        475 NPADRPSSGRLLTH  488 (804)
Q Consensus       475 dP~~Rpsa~elL~H  488 (804)
                      +|++|||++++|++
T Consensus       263 ~p~~Rp~~~~il~~  276 (303)
T cd05088         263 KPYERPSFAQILVS  276 (303)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999865

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0584|consensus

Probab=100.00  E-value=5.4e-39  Score=357.41  Aligned_cols=258  Identities=29%  Similarity=0.499  Sum_probs=206.4

Q ss_pred             CCccccc-ccccccccccccceEEEEeeeceeEEEEEeccccc-ccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        158 EDPEKIF-EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLG-KQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       158 ~dp~~~y-~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~-~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .+|..+| +.-..||+|+|-+||+|.+..+|..||=-.++... .+..+..+++..|+.+|+.|+|||||+++++|.+..
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD  114 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence            3455444 45578999999999999999999988843332111 233455688999999999999999999999998876


Q ss_pred             c--eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        236 T--AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       236 ~--~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      .  +.+|+|++.+|                                 .|..|..+-+.++...++.|++||++||.|||+
T Consensus       115 n~~in~iTEL~TSG---------------------------------tLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs  161 (632)
T KOG0584|consen  115 NKTINFITELFTSG---------------------------------TLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS  161 (632)
T ss_pred             CceeeeeeecccCC---------------------------------cHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc
Confidence            5  78899999754                                 233344455678888999999999999999999


Q ss_pred             CC--CeecCCCCCCeeecC-CCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        314 LG--RIHRDVKAGNILLTE-TGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       314 ~g--IiHRDLKP~NILl~~-~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      +.  |||||||.+||+|+. .|.|||+|+|||+....  +.+.+|||.|||||+.    ...|+..+||||||+++.||+
T Consensus       162 ~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmY----EE~YnE~VDVYaFGMCmLEMv  237 (632)
T KOG0584|consen  162 QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMY----EENYNELVDVYAFGMCMLEMV  237 (632)
T ss_pred             CCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHH----hhhcchhhhhhhhhHHHHHHH
Confidence            86  999999999999974 58999999999986543  4567999999999998    367999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHH-HHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~-I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      |+..||.......++|+ +..|..|.                             ++++            --.+++++|
T Consensus       238 T~eYPYsEC~n~AQIYKKV~SGiKP~-----------------------------sl~k------------V~dPevr~f  276 (632)
T KOG0584|consen  238 TSEYPYSECTNPAQIYKKVTSGIKPA-----------------------------ALSK------------VKDPEVREF  276 (632)
T ss_pred             hccCChhhhCCHHHHHHHHHcCCCHH-----------------------------Hhhc------------cCCHHHHHH
Confidence            99999987655555554 43333221                             1111            115789999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |.+||.. .++|||+.|+|.||||...
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999 9999999999999999864

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=329.80  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=193.6

Q ss_pred             cccccccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc----
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT----  236 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~----  236 (804)
                      |++.+.||+|+||.||+|....+   +..||+|.+..... .......+.+|+.+++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56788999999999999987653   47899998864322 22334678899999999999999999998766544    


Q ss_pred             --eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        237 --AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       237 --~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                        .+++|||+.++ +.+++....                            .......+++..+..++.|++.||.|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~----------------------------~~~~~~~~~~~~~~~~~~~i~~aL~~lH~  131 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSR----------------------------LGGLPEKLPLQTLLKFMVDIALGMEYLSN  131 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhh----------------------------ccCCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence              79999999854 433332100                            00112368899999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ++|+||||||+|||+++++.+||+|||+++.....      ....++..|+|||.+.   ...++.++|||||||++|||
T Consensus       132 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~SlG~il~el  208 (273)
T cd05035         132 RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSDVWAFGVTMWEI  208 (273)
T ss_pred             CCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcc---cCCCCcccchHHHHHHHHHH
Confidence            99999999999999999999999999998754321      1234567899999873   45688899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |.+||.+.+..+.+..+..+..+                                          .....++.++.+
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~  246 (273)
T cd05035         209 ATRGQTPYPGVENHEIYDYLRHGNRL------------------------------------------KQPEDCLDELYD  246 (273)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCcCCCHHHHH
Confidence            99 89999776655444333221100                                          011346788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ++.+||+.||.+|||+.+++.+
T Consensus       247 li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         247 LMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.9e-38  Score=329.11  Aligned_cols=250  Identities=30%  Similarity=0.520  Sum_probs=200.6

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|+||.||++.+..++..||+|.+..... .....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            7888999999999999999999999999998764321 122345678999999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+.+.                                ......+++..+..++.|+++||.|||+++|+|||||
T Consensus        81 ~~~~~L~~~~~--------------------------------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~  128 (257)
T cd08225          81 CDGGDLMKRIN--------------------------------RQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIK  128 (257)
T ss_pred             CCCCcHHHHHH--------------------------------hccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence            9764 333221                                0112357899999999999999999999999999999


Q ss_pred             CCCeeecCCCc-EEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        323 AGNILLTETGT-VKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       323 P~NILl~~~g~-vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |+||++++++. +||+|||.+......    ....|++.|+|||++.   ...++.++|+|||||++|||++|..||...
T Consensus       129 ~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         129 SQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ---NRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             HHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            99999998864 699999998654322    2346899999999874   346788999999999999999999999766


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+..+..                                          ......++.++.+++.+||..+|+
T Consensus       206 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~  243 (257)
T cd08225         206 NLHQLVLKICQGYF------------------------------------------APISPNFSRDLRSLISQLFKVSPR  243 (257)
T ss_pred             cHHHHHHHHhcccC------------------------------------------CCCCCCCCHHHHHHHHHHhccChh
Confidence            54443332221100                                          001134578899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy17952        478 DRPSSGRLLTHDLV  491 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~  491 (804)
                      +|||+.++++||||
T Consensus       244 ~Rpt~~~ll~~~~~  257 (257)
T cd08225         244 DRPSITSILKRPFL  257 (257)
T ss_pred             hCcCHHHHhhCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=333.13  Aligned_cols=276  Identities=31%  Similarity=0.411  Sum_probs=204.8

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc---CCCceeEeeeEEeecCc----
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL---KHPNTIEYRGCYLRDHT----  236 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~~~~~~~~~----  236 (804)
                      |++.+.||+|+||.||+|++..+++.||+|.+...... ......+.+|+.+++++   +||||+++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            67889999999999999999888999999988643221 22234566788777666   69999999999988776    


Q ss_pred             -eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 -AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 -~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                       .|++|||+.+++.+.+..                                .....+++..+..++.|++.||.|||+.+
T Consensus        80 ~~~l~~e~~~~~l~~~l~~--------------------------------~~~~~l~~~~~~~~~~~i~~al~~LH~~~  127 (287)
T cd07838          80 KLTLVFEHVDQDLATYLSK--------------------------------CPKPGLPPETIKDLMRQLLRGVDFLHSHR  127 (287)
T ss_pred             eeEEEehhcccCHHHHHHH--------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence             999999998775544321                                01235889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      ++|+||||+||+++.++.+||+|||++......   ....+++.|+|||++.   ...++.++|+|||||++|||++|.+
T Consensus       128 i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~s~G~~l~~l~~~~~  204 (287)
T cd07838         128 IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL---QSSYATPVDMWSVGCIFAELFRRRP  204 (287)
T ss_pred             eeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhc---cCCCCCcchhhhHHHHHHHHHhCCC
Confidence            999999999999999999999999998654322   2346888999999985   3567889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+.+..+......... ..|...      ....++.+..         .....+.......++.+.+|+.+||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l  268 (287)
T cd07838         205 LFRGTSEADQLDKIFDVIGLPSE-EEWPRN------VSLPRSSFPS---------YTPRSFKSFVPEICEEGLDLLKKML  268 (287)
T ss_pred             cccCCChHHHHHHHHHHcCCCCh-HhcCCC------cccchhhccc---------ccccchhhhhhhhhHHHHHHHHHHh
Confidence            99888877766665442111000 000000      0000000000         0000001111245788899999999


Q ss_pred             ccCCCCCCCHHHHHcCccc
Q psy17952        473 AKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +.||.+||++.++++||||
T Consensus       269 ~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         269 TFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccCCccCCCHHHHhcCcCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=324.99  Aligned_cols=248  Identities=41%  Similarity=0.694  Sum_probs=204.5

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|++++++++|||++++++++......|++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            78889999999999999999999999999988654322 23456789999999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+++                                  .....+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~~L~~~~----------------------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  126 (254)
T cd06627          81 AENGSLRQII----------------------------------KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK  126 (254)
T ss_pred             CCCCcHHHHH----------------------------------HhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            9864 33222                                  223568999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+||+++.++.+||+|||++......    ....|+..|+|||.+.+   ..++.++||||+|+++|+|++|..||...+
T Consensus       127 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         127 AANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM---SGASTASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             HHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence            99999999999999999998754432    23578999999998743   347889999999999999999999997765


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......+.+...                                         + ......++.+.+|+.+||..+|++
T Consensus       204 ~~~~~~~~~~~~~-----------------------------------------~-~~~~~~~~~~~~~i~~~l~~~p~~  241 (254)
T cd06627         204 PMAALFRIVQDDH-----------------------------------------P-PLPEGISPELKDFLMQCFQKDPNL  241 (254)
T ss_pred             HHHHHHHHhccCC-----------------------------------------C-CCCCCCCHHHHHHHHHHHhCChhh
Confidence            4444333321110                                         0 012345788999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy17952        479 RPSSGRLLTHDLV  491 (804)
Q Consensus       479 Rpsa~elL~Hp~~  491 (804)
                      |||+.++++||||
T Consensus       242 R~~~~~~l~~~~~  254 (254)
T cd06627         242 RPTAKQLLKHPWI  254 (254)
T ss_pred             CcCHHHHhcCCCC
Confidence            9999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=331.15  Aligned_cols=257  Identities=23%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             cccccccccccccccccceEEEEeeece-----eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSR-----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~-----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      +.+.|++.+.||+|+||.||+|.+....     ..||+|.+....  .......+.+|+.+|+.++||||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            3456899999999999999999887543     789999875432  223345678999999999999999999999999


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ...|+||||+.+ ++.+.+.....                        ..........+++..+..++.|++.||.|||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  137 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRP------------------------EAENNPGLGPPTLQKFIQMAAEIADGMAYLAA  137 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhccc------------------------chhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999974 55444421000                        00000123457889999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      +||+||||||+|||++.++.+||+|||+++....      .....+|..|+|||.+.   .+.++.++|||||||++|||
T Consensus       138 ~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el  214 (277)
T cd05032         138 KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK---DGVFTTKSDVWSFGVVLWEM  214 (277)
T ss_pred             CCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHh---cCCCCcccchHHHHHHHHHh
Confidence            9999999999999999999999999999864322      22345788999999884   35688899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |.+||.+.+..+....+..+..                                          ......++..+.+
T Consensus       215 ~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~  252 (277)
T cd05032         215 ATLAEQPYQGLSNEEVLKFVIDGGH------------------------------------------LDLPENCPDKLLE  252 (277)
T ss_pred             hccCCCCCccCCHHHHHHHHhcCCC------------------------------------------CCCCCCCCHHHHH
Confidence            98 9999977665544433321110                                          0011235788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~  487 (804)
                      |+.+||+.+|++|||+.+++.
T Consensus       253 li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         253 LMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.3e-38  Score=339.39  Aligned_cols=278  Identities=29%  Similarity=0.467  Sum_probs=196.8

Q ss_pred             cccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC-chhhH
Q psy17952        174 SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDII  252 (804)
Q Consensus       174 ~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~-l~dll  252 (804)
                      ++|.||.+++..+++.||||+++... ........+.+|+.++++++||||+++++++...+..|++|||+.++ +.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            45666777777799999999986432 22344567899999999999999999999999999999999999854 43333


Q ss_pred             HHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCC
Q psy17952        253 EVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG  332 (804)
Q Consensus       253 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g  332 (804)
                      ..                                .....+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus        91 ~~--------------------------------~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~  138 (314)
T cd08216          91 KT--------------------------------HFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG  138 (314)
T ss_pred             HH--------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC
Confidence            21                                0123578999999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy17952        333 TVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS  401 (804)
Q Consensus       333 ~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~  401 (804)
                      .+||+|||.+.....           .....++..|+|||++.. ....|+.++|||||||++|||++|+.||.+.....
T Consensus       139 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~  217 (314)
T cd08216         139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ  217 (314)
T ss_pred             ceEEecCccceeeccccccccccccccccccccccccCHHHhcC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999998753211           123467889999999853 12358889999999999999999999998766554


Q ss_pred             HHHHHHhcCCCCCCC-CchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        402 ALYHIAQNDTPCLQS-SDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       402 ~l~~I~~~~~p~~~~-~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      .+.....+..+..-. .......  ........+.....        .....+......++.++.+|+.+||+.||++||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  287 (314)
T cd08216         218 MLLEKVRGTVPCLLDKSTYPLYE--DSMSQSRSSNEHPN--------NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP  287 (314)
T ss_pred             HHHHHHhccCccccccCchhhhc--CCcCcccccccccc--------hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence            433332222211100 0000000  00000000000000        000011111234578899999999999999999


Q ss_pred             CHHHHHcCccccCCC
Q psy17952        481 SSGRLLTHDLVTRPR  495 (804)
Q Consensus       481 sa~elL~Hp~~~~~~  495 (804)
                      |+.++|.||||...+
T Consensus       288 t~~~ll~~p~~~~~~  302 (314)
T cd08216         288 SASQLLNHSFFKQCK  302 (314)
T ss_pred             CHHHHhcCchHhhhc
Confidence            999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-37  Score=322.85  Aligned_cols=248  Identities=50%  Similarity=0.877  Sum_probs=203.6

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|+||.||++.+..+++.+++|++.....   .....+.+|+.++++++||||+++++++..+...|++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            7788999999999999999998999999998864322   3446788999999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+++.                                 .....+++..+..++.|++.||.|||++|++||||+
T Consensus        79 ~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~  125 (253)
T cd05122          79 CSGGSLKDLLK---------------------------------STNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK  125 (253)
T ss_pred             CCCCcHHHHHh---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCC
Confidence            9854 333221                                 112578999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+||+++.++.+||+|||++......   ....|+..|+|||.+.+   ..++.++|+|||||++|+|++|+.||...+.
T Consensus       126 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  202 (253)
T cd05122         126 AANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING---KPYDYKADIWSLGITAIELAEGKPPYSELPP  202 (253)
T ss_pred             HHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence            99999999999999999998765433   45678999999999843   4578899999999999999999999987655


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ...+..+.....+                                        .......++..+.+|+.+||+.||++|
T Consensus       203 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R  242 (253)
T cd05122         203 MKALFKIATNGPP----------------------------------------GLRNPEKWSDEFKDFLKKCLQKNPEKR  242 (253)
T ss_pred             HHHHHHHHhcCCC----------------------------------------CcCcccccCHHHHHHHHHHccCChhhC
Confidence            4444333221100                                        000112357889999999999999999


Q ss_pred             CCHHHHHcCcc
Q psy17952        480 PSSGRLLTHDL  490 (804)
Q Consensus       480 psa~elL~Hp~  490 (804)
                      ||+.++|.|||
T Consensus       243 ~t~~~~l~~~~  253 (253)
T cd05122         243 PTAEQLLKHPF  253 (253)
T ss_pred             CCHHHHhcCCC
Confidence            99999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-37  Score=333.78  Aligned_cols=261  Identities=21%  Similarity=0.367  Sum_probs=198.5

Q ss_pred             cccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.++||||+++++++...+.
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            469999999999999999997653     34579999876432  12233457889999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.| +|.+.+...                  .      ...........++...+..++.|++.||.|||+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~------------------~------~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  139 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSL------------------R------PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK  139 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHh------------------c------cccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999974 555444210                  0      00000011234677889999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||++.++.+||+|||+++....      .....++..|+|||.+.   .+.++.++|||||||++|||++
T Consensus       140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~DvwslG~~l~el~~  216 (288)
T cd05061         140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK---DGVFTTSSDMWSFGVVLWEITS  216 (288)
T ss_pred             CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhc---cCCCChHhHHHHHHHHHHHHHh
Confidence            99999999999999999999999999874321      12234577899999984   3568889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |.+||.+.+..+....+..+..+                                          ......++.+.+++
T Consensus       217 ~~~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li  254 (288)
T cd05061         217 LAEQPYQGLSNEQVLKFVMDGGYL------------------------------------------DQPDNCPERVTDLM  254 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCCHHHHHHH
Confidence             78999776554443333221110                                          00123467899999


Q ss_pred             HHhcccCCCCCCCHHHHHc------CccccC
Q psy17952        469 SSCLAKNPADRPSSGRLLT------HDLVTR  493 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~------Hp~~~~  493 (804)
                      .+||+.||++|||+.++++      ||||..
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         255 RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             HHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            9999999999999999986      777753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-37  Score=330.01  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=190.8

Q ss_pred             ccccccccccccceEEEEeeecee--EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------Cc
Q psy17952        165 EDLREIGHGSFGAVYYARCLVSRE--IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------HT  236 (804)
Q Consensus       165 ~~l~~LG~G~fG~Vy~a~~~~~~~--~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------~~  236 (804)
                      .+.+.||+|+||.||+|+...++.  .||+|.++... ......+.+.+|+.+++.++||||+++++++...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            456889999999999999877765  68999876432 2233456788999999999999999999876432      24


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+++|||+.++ +.+.+...                            ........+++..+..++.|++.||+|||++|
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  132 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYS----------------------------RLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS  132 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHh----------------------------cccCCcccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            68999999854 33322100                            00012345889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||++.++.+||+|||+++.....      ....+++.|+|||.+.   ...++.++|||||||++|||++
T Consensus       133 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~el~~  209 (272)
T cd05075         133 FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA---DRVYTTKSDVWSFGVTMWEIAT  209 (272)
T ss_pred             eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHcc---CCCcChHHHHHHHHHHHHHHHc
Confidence            999999999999999999999999998754321      1234677899999984   3568889999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |++||.+.........+..+..                                          ......+++.+.+++
T Consensus       210 ~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li  247 (272)
T cd05075         210 RGQTPYPGVENSEIYDYLRQGNR------------------------------------------LKQPPDCLDGLYSLM  247 (272)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHHHHH
Confidence             8999977655443333322110                                          001134578899999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||++|||+.+++++
T Consensus       248 ~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         248 SSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.3e-38  Score=343.87  Aligned_cols=293  Identities=24%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             ccccccc--cccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeec
Q psy17952        167 LREIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC  244 (804)
Q Consensus       167 l~~LG~G--~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~  244 (804)
                      ...||+|  +||+||+|++..+++.||+|.+..... .....+.+.+|+.+++.++||||++++++|...+..|+||||+
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            3467777  999999999999999999998764322 2234567889999999999999999999999999999999999


Q ss_pred             CCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        245 LGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       245 ~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      .++ +.+++..                                .....+++..+..++.|++.||+|||++||+||||||
T Consensus        82 ~~~~l~~~l~~--------------------------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp  129 (328)
T cd08226          82 AYGSANSLLKT--------------------------------YFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKA  129 (328)
T ss_pred             cCCCHHHHHHh--------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            864 3333220                                0123588999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC----C-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP----A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~----~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +|||++.++.+|++|||.+.....    .       ....++..|||||++.+. ...++.++|||||||++|||++|++
T Consensus       130 ~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~~l~el~~g~~  208 (328)
T cd08226         130 SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD-LYGYNVKSDIYSVGITACELATGRV  208 (328)
T ss_pred             HHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999985432110    0       112356679999998532 2347889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCC-Cchhh-HHhhcccccCCCCccchhhhHHH--HhhccCCCCCCCCCCccHHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQS-SDWSV-IKTISSTAERKPPYFNMNAMSAL--YHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~-~~~~~-i~~i~~~~~~~pp~~~~~~~~~l--~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      ||.+......+..+.......... ..+.. .......................  ...............+++.+.+|+
T Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (328)
T cd08226         209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV  288 (328)
T ss_pred             CCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence            998776555544443322111000 00000 00000000000000000000000  000000000111234678899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+||+.||++|||+.++|+||||..
T Consensus       289 ~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         289 ELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             HHHccCCcccCCCHHHHhhCHHHHH
Confidence            9999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-37  Score=334.41  Aligned_cols=264  Identities=23%  Similarity=0.384  Sum_probs=197.9

Q ss_pred             ccccccccccccccccceEEEEeeece----------------eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCce
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSR----------------EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT  224 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~----------------~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI  224 (804)
                      .+.|++++.||+|+||.||+|.+..++                ..||+|.+....  .....+.+.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence            346899999999999999999876543                568999876432  12345678899999999999999


Q ss_pred             eEeeeEEeecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHH
Q psy17952        225 IEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSG  303 (804)
Q Consensus       225 V~l~~~~~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~q  303 (804)
                      +++++++..++..+++|||+.| ++.+++...                  ..  .....   ......+++..+..++.|
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------~~--~~~~~---~~~~~~~~~~~~~~~~~~  138 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH------------------VA--ETSGL---ACNSKSLSFSTLLYMATQ  138 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhc------------------cc--ccccc---cccCCCCCHHHHHHHHHH
Confidence            9999999999999999999975 444433210                  00  00000   112346899999999999


Q ss_pred             HHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccH
Q psy17952        304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDV  377 (804)
Q Consensus       304 il~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDI  377 (804)
                      ++.||.|||++||+||||||+|||++.++.+||+|||+++....      .....+|+.|||||++.   .+.++.++||
T Consensus       139 i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv  215 (296)
T cd05051         139 IASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL---LGKFTTKSDV  215 (296)
T ss_pred             HHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh---cCCCCccchh
Confidence            99999999999999999999999999999999999999864321      22345678899999984   3468899999


Q ss_pred             HHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCC
Q psy17952        378 WSLGITCIELAE--RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL  455 (804)
Q Consensus       378 WSlGvil~ELlt--G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~  455 (804)
                      |||||++|||++  |..||...+....+..+......                . ..+                  ....
T Consensus       216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~----------------~-~~~------------------~~~~  260 (296)
T cd05051         216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD----------------D-GRQ------------------IYLP  260 (296)
T ss_pred             hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccc----------------c-ccc------------------ccCC
Confidence            999999999998  78898766655444333211000                0 000                  0000


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       456 ~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      .....++++.+|+.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         261 RPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            12345789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.2e-38  Score=343.53  Aligned_cols=280  Identities=26%  Similarity=0.365  Sum_probs=206.3

Q ss_pred             cccccccccccccceEEEEeeec--eeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee----cCc
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVS--REIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR----DHT  236 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~--~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~----~~~  236 (804)
                      |++.+.||+|+||.||++++..+  +..||+|.+..... .....+.+.+|+.+++++ +||||+++++++..    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            78889999999999999999888  88999998764221 122345678899999999 59999999986543    245


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|++|||+.+++.+.+                                  .....+++..++.++.||+.||+|||++||
T Consensus        81 ~~~~~e~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi  126 (332)
T cd07857          81 LYLYEELMEADLHQII----------------------------------RSGQPLTDAHFQSFIYQILCGLKYIHSANV  126 (332)
T ss_pred             EEEEEecccCCHHHHH----------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            7899999987654332                                  134568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      +||||||+|||++.++.+||+|||+|.....        .....||+.|+|||++.+  ...++.++||||+||++|+|+
T Consensus       127 vH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slGv~l~~l~  204 (332)
T cd07857         127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS--FQSYTKAIDVWSVGCILAELL  204 (332)
T ss_pred             ccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC--CCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999864321        123579999999998743  245788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAH  466 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~d  466 (804)
                      +|++||.+.+....+..+...-.....    ..+..+...     .     ..............  .......+..+.+
T Consensus       205 ~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-----~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
T cd07857         205 GRKPVFKGKDYVDQLNQILQVLGTPDE----ETLSRIGSP-----K-----AQNYIRSLPNIPKKPFESIFPNANPLALD  270 (332)
T ss_pred             hCCcCCCCCCHHHHHHHHHHHhCCCCH----HHHHhhhhh-----h-----HHHHHHhccccCCcchHhhCCCCCHHHHH
Confidence            999999887776666655543211110    011111000     0     00000000000000  0112235788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |+.+||+.||.+|||+.+++.|||+.+.
T Consensus       271 li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         271 LLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            9999999999999999999999999653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-38  Score=332.49  Aligned_cols=278  Identities=30%  Similarity=0.455  Sum_probs=211.3

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |+..+.||+|+||.||+|....+++.||+|.+.... ......+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            567789999999999999999999999999886532 1223345677899999999999999999999999999999999


Q ss_pred             cCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        244 CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       244 ~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      +.+++.+++..                                 ....+++..+..++.|++.||.|||++||+||||||
T Consensus        80 ~~~~l~~~i~~---------------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~  126 (282)
T cd07829          80 CDMDLKKYLDK---------------------------------RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKP  126 (282)
T ss_pred             cCcCHHHHHHh---------------------------------hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence            98876554431                                 114688999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      +||++++++.+||+|||++......    ....++..|+|||.+.+  ...++.++|||||||++|||++|.+||.+.+.
T Consensus       127 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  204 (282)
T cd07829         127 QNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG--SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE  204 (282)
T ss_pred             heEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcC--CcCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence            9999999999999999998654322    23456788999999853  23678899999999999999999999988877


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      .+.+..+.+..... ....|..+..+.......+.+...             ......+..+..+.+|+.+||+.||++|
T Consensus       205 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~~P~~R  270 (282)
T cd07829         205 IDQLFKIFQILGTP-TEESWPGVTKLPDYKPTFPKFPPK-------------DLEKVLPRLDPEGIDLLSKMLQYNPAKR  270 (282)
T ss_pred             HHHHHHHHHHhCCC-cHHHHHhhcccccccccccccCcc-------------chHHhcccccHHHHHHHHHhhccCcccC
Confidence            76666554422111 111222221111001111111000             0001112347889999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy17952        480 PSSGRLLTHDLV  491 (804)
Q Consensus       480 psa~elL~Hp~~  491 (804)
                      |++.+++.||||
T Consensus       271 p~~~~~l~~p~~  282 (282)
T cd07829         271 ISAKEALKHPYF  282 (282)
T ss_pred             CCHHHHhhCcCC
Confidence            999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0590|consensus

Probab=100.00  E-value=1.1e-39  Score=381.12  Aligned_cols=408  Identities=28%  Similarity=0.388  Sum_probs=296.5

Q ss_pred             CCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-hcCccccccccccEEEcC
Q psy17952         13 HPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDII-EVHKRPLKEEEIAAICSGVLRGLNYLH-SLGRIHRDVKAGNILLTE   89 (804)
Q Consensus        13 HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~-~~~~~~l~~~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~Nill~~   89 (804)
                      |+|++++++.....+..++++||..|+. .+.+ .......+......++.|+..++.|+| ..++.|||+||+|.+++.
T Consensus        80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~  159 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE  159 (601)
T ss_pred             cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc
Confidence            9999999999999999999999988654 3333 222226788889999999999999999 999999999999999999


Q ss_pred             CC-ceEEeccCcccccCC-C------Ccccc-ccccCcchhhhhcccCccCCcccccccccCCCCCCCcchh--------
Q psy17952         90 TG-TVKLADFGSASIKCP-A------NSFVG-TPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIA--------  152 (804)
Q Consensus        90 ~~-~~kl~DFG~a~~~~~-~------~~~~g-t~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~--------  152 (804)
                      .+ .+|++|||+|..... .      ...+| ++.|+|||...+  ....+..+|+||.|+++..+...+..        
T Consensus       160 s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~--~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  160 SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG--KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc--hhhcCCCcccccccccccccccCCCCcccccccc
Confidence            99 999999999964322 1      12478 999999999743  13457789999999875432211100        


Q ss_pred             -----------------------------------------------------c---cccCCC----cc----------c
Q psy17952        153 -----------------------------------------------------E---LFDKED----PE----------K  162 (804)
Q Consensus       153 -----------------------------------------------------e---lf~~~d----p~----------~  162 (804)
                                                                           .   -+....    +.          +
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~  317 (601)
T KOG0590|consen  238 GRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSE  317 (601)
T ss_pred             ccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCcccccc
Confidence                                                                 0   000000    00          1


Q ss_pred             cc-ccccccccccccceEEEEeeeceeEEEEEeccc---ccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        163 IF-EDLREIGHGSFGAVYYARCLVSREIVAIKKMSY---LGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       163 ~y-~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~---~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .| ...+.+|.|+||.|+.+......+.++.|....   ...........+..|..+-..|+|||++.....+.+....+
T Consensus       318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~  397 (601)
T KOG0590|consen  318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL  397 (601)
T ss_pred             ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence            12 245679999999888888777777666665431   11111111222667888888999999988777666666555


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      -.||||++++                                  |.++...+.++..++..+++|++.||+|+|+.||.|
T Consensus       398 ~~mE~~~~Dl----------------------------------f~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giah  443 (601)
T KOG0590|consen  398 QSMEYCPYDL----------------------------------FSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAH  443 (601)
T ss_pred             hhhhcccHHH----------------------------------HHHHhcccccchhhhhHHHHHHHHHHHHHHhcCcee
Confidence            5699998632                                  333333456888899999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCc-ccHHHHHHHHHHHHh
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAE  389 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~k-sDIWSlGvil~ELlt  389 (804)
                      |||||+|+|++.+|.+||+|||.+....-        ....+|+..|+|||++.   ...|++. +||||.||++..|.+
T Consensus       444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~---~~~ydpr~vDiwS~~ii~~~m~~  520 (601)
T KOG0590|consen  444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLT---GKEYDPRAVDVWSCGIIYICMIL  520 (601)
T ss_pred             ccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccc---ccccCcchhhhhhccceEEEEec
Confidence            99999999999999999999999864321        24578999999999984   4678874 999999999999999


Q ss_pred             CCCCCCCCChHHHHH-HHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 G~~PF~~~~~~~~l~-~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      |+.||.-....+..+ ...                        ....++  .         ...+.......+..-+.+|
T Consensus       521 ~~~~Wk~a~~~~~~~~~~~------------------------~~~~~~--~---------~~~~~~~~~~lp~~~~~~~  565 (601)
T KOG0590|consen  521 GRFPWKVAKKSDNSFKTNN------------------------YSDQRN--I---------FEGPNRLLSLLPRETRIII  565 (601)
T ss_pred             CCCccccccccccchhhhc------------------------cccccc--c---------ccChHHHHHhchhhHHHHH
Confidence            999995432211110 000                        000000  0         0001111234567788999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .++|+.||.+|.|++++++.+||+..
T Consensus       566 ~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  566 YRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHHccCChhheecHHHHhhChHhhhc
Confidence            99999999999999999999999753

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=331.92  Aligned_cols=278  Identities=28%  Similarity=0.482  Sum_probs=207.9

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      |++.+.||+|+||.||+|....+++.||||++......  .......+|+..+++++ ||||+++++++..++..|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67789999999999999999989999999987542211  11223467999999999 9999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.|++.+.+..                                .....+++.++..++.|++.||.|||++|++|+|||
T Consensus        79 ~~~~~l~~~~~~--------------------------------~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~  126 (283)
T cd07830          79 YMEGNLYQLMKD--------------------------------RKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLK  126 (283)
T ss_pred             cCCCCHHHHHHh--------------------------------cccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            997765443320                                012367899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+||+++.++.+||+|||++.....   .....|+..|+|||++..  ...++.++|+|||||++|||++|++||...+.
T Consensus       127 ~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~  204 (283)
T cd07830         127 PENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR--STSYSSPVDIWALGCIMAELYTLRPLFPGSSE  204 (283)
T ss_pred             hhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeec--CcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence            9999999999999999999865432   234578999999998743  34578899999999999999999999988887


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhccccc-CCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~-~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .+..+.+.....+... ..|........... ..+....             ..........+..+.+|+.+||+.||++
T Consensus       205 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~  270 (283)
T cd07830         205 IDQLYKICSVLGTPTK-QDWPEGYKLASKLGFRFPQFAP-------------TSLHQLIPNASPEAIDLIKDMLRWDPKK  270 (283)
T ss_pred             HHHHHHHHHhcCCCCh-hhhhhHhhhhcccccccccccc-------------ccHHHHcccCCHHHHHHHHHhcccCccc
Confidence            7776665543222111 11111111110000 0000000             0000001123688999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy17952        479 RPSSGRLLTHDLV  491 (804)
Q Consensus       479 Rpsa~elL~Hp~~  491 (804)
                      |||+.|++.||||
T Consensus       271 Rpt~~ei~~~~~~  283 (283)
T cd07830         271 RPTASQALQHPYF  283 (283)
T ss_pred             CCCHHHHhhCCCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-37  Score=327.52  Aligned_cols=251  Identities=35%  Similarity=0.589  Sum_probs=199.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.++............+.+|++++++++|+||+++++++..++..|+|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            48899999999999999999999999999998764333333445678899999999999999999999999999999999


Q ss_pred             ecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.| ++.+++..                              .......+++..+..++.|++.||.|||+.||+||||
T Consensus        83 ~~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl  132 (267)
T cd08224          83 LADAGDLSRMIKH------------------------------FKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDI  132 (267)
T ss_pred             cCCCCCHHHHHHH------------------------------hcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCc
Confidence            9986 44333320                              0112346889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||+++.++.+||+|||++.....    .....|++.|+|||.+.   +..++.++|||||||++|+|++|+.||...
T Consensus       133 ~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         133 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             ChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhc---cCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            99999999999999999999864322    23457899999999984   356888999999999999999999999653


Q ss_pred             Ch--HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        398 NA--MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       398 ~~--~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..  .+....+..                                         ...+..+...++..+.+++.+||..+
T Consensus       210 ~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~i~~cl~~~  248 (267)
T cd08224         210 KMNLYSLCKKIEK-----------------------------------------CDYPPLPADHYSEELRDLVSRCINPD  248 (267)
T ss_pred             CccHHHHHhhhhc-----------------------------------------CCCCCCChhhcCHHHHHHHHHHcCCC
Confidence            21  111111100                                         00111122356788999999999999


Q ss_pred             CCCCCCHHHHHc
Q psy17952        476 PADRPSSGRLLT  487 (804)
Q Consensus       476 P~~Rpsa~elL~  487 (804)
                      |++|||+.+++.
T Consensus       249 p~~Rp~~~~il~  260 (267)
T cd08224         249 PEKRPDISYVLQ  260 (267)
T ss_pred             cccCCCHHHHHH
Confidence            999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-37  Score=327.39  Aligned_cols=243  Identities=26%  Similarity=0.433  Sum_probs=193.0

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||.||+|.+.. +..+|||.+.....    ....+.+|+.++++++||||+++++++......|+|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            48899999999999999997654 44699998763221    12467899999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+.+.                                 .....+++..+..++.||+.||.|||+.||+||||
T Consensus        80 ~~~~~~l~~~i~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl  126 (256)
T cd05113          80 YMSNGCLLNYLR---------------------------------EHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDL  126 (256)
T ss_pred             cCCCCcHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            99865 333221                                 11236889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCCC-----ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~~-----~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||+|||++.++.+||+|||+++......     ...++..|+|||++.   .+.++.++|||||||++|||++ |..||.
T Consensus       127 ~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slG~~l~~l~~~g~~p~~  203 (256)
T cd05113         127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL---YSKFSSKSDVWAFGVLMWEVYSLGKMPYE  203 (256)
T ss_pred             CcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHh---cCcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            9999999999999999999986533211     223556799999984   3568889999999999999998 999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+..+....+.++..+                                          ......++.+.+++.+||+.|
T Consensus       204 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~cl~~~  241 (256)
T cd05113         204 RFNNSETVEKVSQGLRL------------------------------------------YRPHLASEKVYAIMYSCWHEK  241 (256)
T ss_pred             cCCHHHHHHHHhcCCCC------------------------------------------CCCCCCCHHHHHHHHHHcCCC
Confidence            76655444444322110                                          011234788999999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy17952        476 PADRPSSGRLLTH  488 (804)
Q Consensus       476 P~~Rpsa~elL~H  488 (804)
                      |.+|||+.+++.+
T Consensus       242 p~~Rp~~~~ll~~  254 (256)
T cd05113         242 AEERPTFQQLLSS  254 (256)
T ss_pred             cccCCCHHHHHHh
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=328.09  Aligned_cols=246  Identities=23%  Similarity=0.413  Sum_probs=196.1

Q ss_pred             ccccccccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|++.+.||+|+||.||+|+...+   ...||||.++...  .......+.+|+.++++++||||+++++++...+..|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            488999999999999999988654   4579999876422  23334568899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||+.|+ +.+.+.                                 ...+.+++..+..++.|++.||.|||+++|+|
T Consensus        83 v~e~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H  129 (266)
T cd05033          83 ITEYMENGSLDKFLR---------------------------------ENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH  129 (266)
T ss_pred             EEEcCCCCCHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999864 333221                                 12346889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      |||||+|||++.++.+||+|||++......      ....+++.|+|||.+.   ...++.++|||||||++|||++ |.
T Consensus       130 ~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Dv~slG~~l~~l~~~g~  206 (266)
T cd05033         130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA---YRKFTSASDVWSFGIVMWEVMSYGE  206 (266)
T ss_pred             CCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhc---cCCCccccchHHHHHHHHHHHccCC
Confidence            999999999999999999999998754311      1123467899999874   3568889999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||......+....+.++..                                          ......+++.+.+|+.+|
T Consensus       207 ~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~c  244 (266)
T cd05033         207 RPYWDMSNQDVIKAVEDGYR------------------------------------------LPPPMDCPSALYQLMLDC  244 (266)
T ss_pred             CCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHHHHHHHH
Confidence            99977665444433322100                                          001134678899999999


Q ss_pred             cccCCCCCCCHHHHHcC
Q psy17952        472 LAKNPADRPSSGRLLTH  488 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~H  488 (804)
                      |+.+|++||++.+++++
T Consensus       245 l~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         245 WQKDRNERPTFSQIVST  261 (266)
T ss_pred             cCCCcccCcCHHHHHHH
Confidence            99999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-37  Score=333.35  Aligned_cols=262  Identities=24%  Similarity=0.394  Sum_probs=199.4

Q ss_pred             cccccccccccccccceEEEEeeece-----eEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecC
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSR-----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~-----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~  235 (804)
                      ..|++.+.||+|+||.||++......     ..+|+|.+....  .......+.+|+.+++++ +||||+++++++..++
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            45899999999999999999876443     789999876422  223345688999999999 8999999999999999


Q ss_pred             ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|++|||+.+ ++.+++...                  ....+...++......+.+++..+..++.|++.||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~  151 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRAR------------------RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK  151 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhc------------------CCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999999975 444444210                  00000001111223345789999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||+||||||+|||++.++.+||+|||+++.....      ....++..|+|||++.   ...++.++|||||||++|||+
T Consensus       152 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~  228 (293)
T cd05053         152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLLWEIF  228 (293)
T ss_pred             CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc---cCCcCcccceeehhhHHHHHh
Confidence            9999999999999999999999999998753221      1223567899999874   356888999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      + |..||.+.+..+....+..+..                                          .......+..+.+|
T Consensus       229 ~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~l  266 (293)
T cd05053         229 TLGGSPYPGIPVEELFKLLKEGYR------------------------------------------MEKPQNCTQELYHL  266 (293)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcCCc------------------------------------------CCCCCCCCHHHHHH
Confidence            7 9999987665444333321110                                          00112357889999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+||..||.+|||+.+++++
T Consensus       267 i~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         267 MRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcccCcccCcCHHHHHHH
Confidence            999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0614|consensus

Probab=100.00  E-value=1.9e-39  Score=350.34  Aligned_cols=254  Identities=24%  Similarity=0.396  Sum_probs=218.7

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .++.+..||-||||.|-++........+|+|++++...-+.+..+.+..|-+||.+++.|.||++|..|.+..++|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            36778889999999999988766666799999876544445556778899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      -|-||                                 +++...+.++.|++..++.|+..+++|++|||++|||.||||
T Consensus       501 aClGG---------------------------------ElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLK  547 (732)
T KOG0614|consen  501 ACLGG---------------------------------ELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLK  547 (732)
T ss_pred             hhcCc---------------------------------hhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCC
Confidence            99887                                 455566678899999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |+|+|++.+|.+||.|||+|+....   ..++||||.|.|||+++.   ...+.++|.||||+++||||+|.|||.+.++
T Consensus       548 PENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn---KGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  548 PENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN---KGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             hhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhc---cCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence            9999999999999999999976543   457999999999999973   4678899999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      +.....|.++-..            +                             ..+...+..+.+||+++...+|.+|
T Consensus       625 mktYn~ILkGid~------------i-----------------------------~~Pr~I~k~a~~Lik~LCr~~P~ER  663 (732)
T KOG0614|consen  625 MKTYNLILKGIDK------------I-----------------------------EFPRRITKTATDLIKKLCRDNPTER  663 (732)
T ss_pred             HHHHHHHHhhhhh------------h-----------------------------hcccccchhHHHHHHHHHhcCcHhh
Confidence            9988888765210            0                             0113356778899999999999999


Q ss_pred             CC-----HHHHHcCccccC
Q psy17952        480 PS-----SGRLLTHDLVTR  493 (804)
Q Consensus       480 ps-----a~elL~Hp~~~~  493 (804)
                      ..     ..++-+|.||..
T Consensus       664 LG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  664 LGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             hccccCChHHHHhhhhhhc
Confidence            86     789999999964

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-37  Score=333.49  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=196.7

Q ss_pred             ccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        163 IFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .|.+.+.||+|+||.||+|.+.     .++..+|+|.+...   .......+.+|+.++++++||||+++++++...+..
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            4788899999999999999854     34567999987532   223345688999999999999999999999999999


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccc--hhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF--NFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~--~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ++||||+.| ++.+.+......          ..          .+.  +.....+.+++..+..++.||+.||+|||++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~----------~~----------~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  142 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPD----------AM----------ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ  142 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcc----------cc----------cccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            999999975 555544311000          00          000  0011234589999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||+||||||+|||++.++.+||+|||++.....      .....|++.|+|||++.   ...++.++|||||||++|||+
T Consensus       143 ~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~  219 (291)
T cd05094         143 HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVILWEIF  219 (291)
T ss_pred             CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc---cCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999999864322      12345788999999884   356888999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      + |.+||...+..+....+..+..+                                          .....++..+.+|
T Consensus       220 t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~l  257 (291)
T cd05094         220 TYGKQPWFQLSNTEVIECITQGRVL------------------------------------------ERPRVCPKEVYDI  257 (291)
T ss_pred             hCCCCCCCCCCHHHHHHHHhCCCCC------------------------------------------CCCccCCHHHHHH
Confidence            9 99999776654443333211100                                          0112357889999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q psy17952        468 VSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~  487 (804)
                      +.+||+.||++|||+.++++
T Consensus       258 i~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         258 MLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHcccChhhCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-37  Score=330.58  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=190.8

Q ss_pred             cccccccccccccccceEEEEeeecee----EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~----~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      +.|+.++.||+|+||+||+|.+..+++    .||+|.+....  .......+.+|+.+++.++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            348999999999999999999877766    48999875322  23334668899999999999999999998875 457


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +++|||++++ +.+.+.                                 ...+.+++..+..++.|++.||+|||++||
T Consensus        84 ~l~~~~~~~g~l~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i  130 (279)
T cd05109          84 QLVTQLMPYGCLLDYVR---------------------------------ENKDRIGSQDLLNWCVQIAKGMSYLEEVRL  130 (279)
T ss_pred             EEEEEcCCCCCHHHHHh---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            8999999854 322221                                 123468999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||+++++.+||+|||+++.....      ....+++.|+|||.+.   ...++.++|||||||++|||++ 
T Consensus       131 iH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~el~t~  207 (279)
T cd05109         131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL---HRRFTHQSDVWSYGVTVWELMTF  207 (279)
T ss_pred             eccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhc---cCCCCchhHHHHHHHHHHHHHcC
Confidence            99999999999999999999999998754321      1123467899999984   3568899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||...........+..+..                                          ......++.++.+++.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~  245 (279)
T cd05109         208 GAKPYDGIPAREIPDLLEKGER------------------------------------------LPQPPICTIDVYMIMV  245 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCc------------------------------------------CCCCccCCHHHHHHHH
Confidence            8999866544332222211100                                          0011345788999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q psy17952        470 SCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~  487 (804)
                      +||..||++|||+.+++.
T Consensus       246 ~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         246 KCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.1e-38  Score=332.91  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.++++++ ||||+++++++..++..|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            4888999999999999999999999999999876432222333466788999999998 999999999999999999999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.| ++.+.+                                  ...+.+++..+..++.|++.||.|||++|++|+|
T Consensus        82 e~~~~~~L~~~l----------------------------------~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~d  127 (280)
T cd05581          82 EYAPNGELLQYI----------------------------------RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRD  127 (280)
T ss_pred             cCCCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence            99965 433322                                  2344789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC------------------------CCccccCcccccchhhcccCCCCCCCccc
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVD  376 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~------------------------~~~~~GT~~Y~APEvl~~~~~~~y~~ksD  376 (804)
                      |||+||+++.++.++|+|||++.....                        .....|+..|+|||++.   ...++.++|
T Consensus       128 l~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~D  204 (280)
T cd05581         128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN---EKPAGKSSD  204 (280)
T ss_pred             CCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhC---CCCCChhhh
Confidence            999999999999999999999864321                        11346789999999874   345788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCC
Q psy17952        377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ  456 (804)
Q Consensus       377 IWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~  456 (804)
                      +|||||++++|++|..||...+....+..+....                                           ...
T Consensus       205 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------------------------------~~~  241 (280)
T cd05581         205 LWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE-------------------------------------------YSF  241 (280)
T ss_pred             HHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC-------------------------------------------CCC
Confidence            9999999999999999997655433322221100                                           011


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCH----HHHHcCccc
Q psy17952        457 SSDWSDTFAHFVSSCLAKNPADRPSS----GRLLTHDLV  491 (804)
Q Consensus       457 ~~~~s~~l~dli~~cL~~dP~~Rpsa----~elL~Hp~~  491 (804)
                      +..+++.+.+|+.+||..||.+|||+    .++|+||||
T Consensus       242 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            13457889999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-37  Score=326.38  Aligned_cols=247  Identities=28%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +...|++.++||+|+||.||+|.+.. ++.+|+|.+....   ......+.+|+.+++.++||||+++++++......|+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            44569999999999999999999887 8899999876432   2234567899999999999999999999999999999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.| ++.+++.                                ......+++..+..++.|++.||.|||++||+|
T Consensus        80 v~e~~~~~~L~~~~~--------------------------------~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h  127 (261)
T cd05148          80 ITELMEKGSLLAFLR--------------------------------SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH  127 (261)
T ss_pred             EEeecccCCHHHHHh--------------------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            9999986 4433331                                012345789999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      |||||+|||++.++.+||+|||++......    ....++..|+|||++.   .+.++.++|||||||++|+|++ |+.|
T Consensus       128 ~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~~l~~l~~~g~~p  204 (261)
T cd05148         128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS---HGTFSTKSDVWSFGILLYEMFTYGQVP  204 (261)
T ss_pred             cccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHc---cCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999998653221    1234567899999984   3568889999999999999998 8999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+.+..+..+..                                          .......++.+.+++.+||+
T Consensus       205 ~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~i~~~l~  242 (261)
T cd05148         205 YPGMNNHEVYDQITAGYR------------------------------------------MPCPAKCPQEIYKIMLECWA  242 (261)
T ss_pred             CCcCCHHHHHHHHHhCCc------------------------------------------CCCCCCCCHHHHHHHHHHcC
Confidence            987665554444321100                                          01123457889999999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .||.+|||+.++++
T Consensus       243 ~~p~~Rpt~~~l~~  256 (261)
T cd05148         243 AEPEDRPSFKALRE  256 (261)
T ss_pred             CCchhCcCHHHHHH
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.5e-37  Score=330.95  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=196.8

Q ss_pred             ccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        163 IFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .|...++||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+++++.++||||+++++++...+..
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            4788899999999999999753     34668999987532   223346788999999999999999999999999999


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |++|||+.| ++.+++.......           ...        .-........+++..+..++.|++.||+|||++||
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~-----------~~~--------~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i  143 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDA-----------KIL--------AGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF  143 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcch-----------hhh--------cccccCCccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            999999975 5555543211000           000        00001122458899999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||+++++.+||+|||++.....      .....+++.|+|||++.   ...++.++|||||||++|||++ 
T Consensus       144 ~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~  220 (280)
T cd05092         144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL---YRKFTTESDIWSFGVVLWEIFTY  220 (280)
T ss_pred             ecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc---cCCcCchhhHHHHHHHHHHHHcC
Confidence            9999999999999999999999999864321      12234578899999885   3568899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||......+....+.++..                                          .......++.+.+|+.
T Consensus       221 g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~  258 (280)
T cd05092         221 GKQPWYQLSNTEAIECITQGRE------------------------------------------LERPRTCPPEVYAIMQ  258 (280)
T ss_pred             CCCCCccCCHHHHHHHHHcCcc------------------------------------------CCCCCCCCHHHHHHHH
Confidence            9999977665554433322110                                          0011245788999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q psy17952        470 SCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~  487 (804)
                      +||+.||.+||++++++.
T Consensus       259 ~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         259 GCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHccCChhhCCCHHHHHH
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.3e-37  Score=325.60  Aligned_cols=245  Identities=22%  Similarity=0.390  Sum_probs=194.7

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|+++++||+|+||.||+|... ++..||+|.+....    ...+.+.+|+.+++.++||||+++++++...+..|++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            345899999999999999999854 55679999875321    2245788999999999999999999999999999999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.| ++.+++..                                .....+++..+..++.|++.||+|||+.+++||
T Consensus        80 ~e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~  127 (261)
T cd05072          80 TEYMAKGSLLDFLKS--------------------------------DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR  127 (261)
T ss_pred             EecCCCCcHHHHHHH--------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999975 44433320                                113457888999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||||+||+++.++.+||+|||++......     ....++..|+|||++.   .+.++.++|||||||++|||++ |..|
T Consensus       128 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~t~g~~p  204 (261)
T cd05072         128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLYEIVTYGKIP  204 (261)
T ss_pred             ccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhc---cCCCChhhhhhhhHHHHHHHHccCCCC
Confidence            99999999999999999999999754321     2234567899999984   3568889999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+....                                          +......++.++.+|+.+||.
T Consensus       205 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~  242 (261)
T cd05072         205 YPGMSNSDVMSALQRGY------------------------------------------RMPRMENCPDELYDIMKTCWK  242 (261)
T ss_pred             CCCCCHHHHHHHHHcCC------------------------------------------CCCCCCCCCHHHHHHHHHHcc
Confidence            97765554443332110                                          000112467889999999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .||++|||++++++
T Consensus       243 ~~p~~Rp~~~~i~~  256 (261)
T cd05072         243 EKAEERPTFDYLQS  256 (261)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.3e-37  Score=339.93  Aligned_cols=284  Identities=29%  Similarity=0.445  Sum_probs=209.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-cCceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-DHTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-~~~~~l  239 (804)
                      .+.|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.++++++||||+++.++|.. ....|+
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            3459999999999999999999999999999998753221 12234567889999999999999999999875 567899


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      +|||+.+++.+++                                   ...++++..+..++.|+++||.|||++||+||
T Consensus        88 v~e~~~~~L~~~~-----------------------------------~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~  132 (328)
T cd07856          88 VTELLGTDLHRLL-----------------------------------TSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR  132 (328)
T ss_pred             EeehhccCHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999976543322                                   12457888899999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      ||||+|||++.++.+||+|||++..... .....+++.|+|||++.+  ...++.++|||||||++|||++|++||...+
T Consensus       133 dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~~f~~~~  210 (328)
T cd07856         133 DLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLT--WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD  210 (328)
T ss_pred             CCCHHHEeECCCCCEEeCccccccccCCCcCCCcccccccCceeeec--cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999875432 234578999999998742  2467889999999999999999999998776


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCC-CC-CCCCCCccHHHHHHHHHhcccCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND-TP-CLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~-~p-~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .......+.+......    .+....+...          +...-........ .+ ......+++.+.++|.+||+.+|
T Consensus       211 ~~~~~~~~~~~~~~~~----~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  276 (328)
T cd07856         211 HVNQFSIITDLLGTPP----DDVINTICSE----------NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP  276 (328)
T ss_pred             HHHHHHHHHHHhCCCC----HHHHHhccch----------hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCCh
Confidence            5444433332110000    0111110000          0000000000000 00 00113467899999999999999


Q ss_pred             CCCCCHHHHHcCccccCCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ++|||+++++.||||.....
T Consensus       277 ~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         277 QKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             hhCCCHHHHhcCCccccccC
Confidence            99999999999999976443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-37  Score=334.38  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=195.7

Q ss_pred             ccccccccccccccceEEEEeeecee--EEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSRE--IVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~--~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|++.+.||+|+||.||+|....++.  .+|+|.++...  .....+.+.+|+.+++++ +||||+++++++...+..|+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            48889999999999999999877764  46888765321  223345688999999999 79999999999999999999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.+ ++.+++.......                  ..............+++..+..++.|++.||+|||++||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~------------------~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH  142 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLE------------------TDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIH  142 (297)
T ss_pred             EEEecCCCcHHHHHHhccccc------------------cccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            9999974 5555543110000                  00000000112246899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF  394 (804)
                      |||||+|||++.++.+||+|||++.....   ......+..|+|||++.   ...++.++|||||||++|||++ |.+||
T Consensus       143 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~t~g~~pf  219 (297)
T cd05089         143 RDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTPY  219 (297)
T ss_pred             CcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999864321   11122345799999874   3568889999999999999997 99999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+.++..                                          ......++..+.+|+.+||+.
T Consensus       220 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~  257 (297)
T cd05089         220 CGMTCAELYEKLPQGYR------------------------------------------MEKPRNCDDEVYELMRQCWRD  257 (297)
T ss_pred             CCCCHHHHHHHHhcCCC------------------------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence            87665544433321100                                          001134678899999999999


Q ss_pred             CCCCCCCHHHHHcC
Q psy17952        475 NPADRPSSGRLLTH  488 (804)
Q Consensus       475 dP~~Rpsa~elL~H  488 (804)
                      ||.+|||++++++.
T Consensus       258 ~p~~Rp~~~~i~~~  271 (297)
T cd05089         258 RPYERPPFAQISVQ  271 (297)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999998754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-38  Score=329.91  Aligned_cols=239  Identities=19%  Similarity=0.287  Sum_probs=185.2

Q ss_pred             cccccccccceEEEEeeecee-------EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        168 REIGHGSFGAVYYARCLVSRE-------IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~-------~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.||+|+||.||+|.+..++.       .||+|.+...   .....+.+..|+.+++.++|||||++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            469999999999998865543       4888876432   223345678899999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.|+ +.+++.                                 ..+..+++..+..++.||+.||+|||++||+||
T Consensus        78 ~e~~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~  124 (258)
T cd05078          78 QEYVKFGSLDTYLK---------------------------------KNKNLINISWKLEVAKQLAWALHFLEDKGLTHG  124 (258)
T ss_pred             EecCCCCcHHHHHh---------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999865 322221                                 122357899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCc--------EEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        320 DVKAGNILLTETGT--------VKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       320 DLKP~NILl~~~g~--------vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||||+|||++.++.        +|++|||++....+.....+++.|+|||++.+  ...++.++|||||||++|||++|.
T Consensus       125 dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~  202 (258)
T cd05078         125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN--PQNLSLAADKWSFGTTLWEIFSGG  202 (258)
T ss_pred             CCccceEEEecccccccCCCceEEecccccccccCCchhccccCCccCchhccC--CCCCCchhhHHHHHHHHHHHHcCC
Confidence            99999999987764        69999999876666566789999999999853  235788999999999999999994


Q ss_pred             -CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        392 -PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       392 -~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                       +||...+...... +...                                          .+. .+...+.++.+|+.+
T Consensus       203 ~~~~~~~~~~~~~~-~~~~------------------------------------------~~~-~~~~~~~~~~~li~~  238 (258)
T cd05078         203 DKPLSALDSQKKLQ-FYED------------------------------------------RHQ-LPAPKWTELANLINQ  238 (258)
T ss_pred             CCChhhccHHHHHH-HHHc------------------------------------------ccc-CCCCCcHHHHHHHHH
Confidence             6664433222111 0000                                          000 011235778999999


Q ss_pred             hcccCCCCCCCHHHHHcC
Q psy17952        471 CLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~H  488 (804)
                      ||+.||++|||++++++.
T Consensus       239 ~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         239 CMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HhccChhhCCCHHHHHHh
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-37  Score=327.09  Aligned_cols=240  Identities=20%  Similarity=0.304  Sum_probs=185.1

Q ss_pred             cccccccccceEEEEeee------------ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        168 REIGHGSFGAVYYARCLV------------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~------------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      +.||+|+||.||+|....            ....||+|.+....   ......+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999997432            23358888765321   233456788999999999999999999999999


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..++||||+.++..+.+.                                ......+++..+..++.||++||+|||++|
T Consensus        78 ~~~lv~e~~~~~~l~~~~--------------------------------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  125 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFM--------------------------------HRKSDVLTTPWKFKVAKQLASALSYLEDKD  125 (262)
T ss_pred             CCEEEEecccCCCHHHHH--------------------------------HhcCCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence            999999999876432210                                012346899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCc-------EEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        316 RIHRDVKAGNILLTETGT-------VKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~-------vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |+||||||+|||++.++.       +|++|||++..........||..|+|||.+..  ...++.++|||||||++|||+
T Consensus       126 ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~  203 (262)
T cd05077         126 LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVED--SKNLSIAADKWSFGTTLWEIC  203 (262)
T ss_pred             eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhcC--CCCCCchhHHHHHHHHHHHHH
Confidence            999999999999987664       89999999876555556678999999998742  356888999999999999998


Q ss_pred             -hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 -ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 -tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                       .|..||......+.. .+...                                         .  .......++++.+|
T Consensus       204 ~~~~~p~~~~~~~~~~-~~~~~-----------------------------------------~--~~~~~~~~~~~~~l  239 (262)
T cd05077         204 YNGEIPLKDKTLAEKE-RFYEG-----------------------------------------Q--CMLVTPSCKELADL  239 (262)
T ss_pred             hCCCCCCCCcchhHHH-HHHhc-----------------------------------------C--ccCCCCChHHHHHH
Confidence             588888654322211 00000                                         0  00011235788999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+||+.||.+||++.+++++
T Consensus       240 i~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         240 MTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHcCCChhhCcCHHHHHHh
Confidence            999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.1e-37  Score=322.86  Aligned_cols=252  Identities=34%  Similarity=0.588  Sum_probs=205.1

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+++++.++|||++++.+.+......++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            7888999999999999999999999999998864322 223456688999999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ++|+ +.+.+..                              .......+++..+..++.|++.||.|||++|++|+||+
T Consensus        81 ~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~  130 (258)
T cd08215          81 ADGGDLSQKIKK------------------------------QKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK  130 (258)
T ss_pred             cCCCcHHHHHHH------------------------------hhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence            9864 4333321                              00123578999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+||+++.++.+||+|||++......    ....|++.|+|||.+.   ...++.++|+||+|+++|+|++|..||...+
T Consensus       131 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         131 PQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ---NKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             hHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence            99999999999999999998654332    3457899999999874   3457889999999999999999999997665


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+....+.+...                                         + .....++..+.+++.+||..+|++
T Consensus       208 ~~~~~~~~~~~~~-----------------------------------------~-~~~~~~~~~~~~~i~~~l~~~p~~  245 (258)
T cd08215         208 LLELALKILKGQY-----------------------------------------P-PIPSQYSSELRNLVSSLLQKDPEE  245 (258)
T ss_pred             HHHHHHHHhcCCC-----------------------------------------C-CCCCCCCHHHHHHHHHHcCCChhh
Confidence            4433332221110                                         0 011256788999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy17952        479 RPSSGRLLTHDLV  491 (804)
Q Consensus       479 Rpsa~elL~Hp~~  491 (804)
                      |||+.++|+||||
T Consensus       246 Rp~~~~ll~~~~~  258 (258)
T cd08215         246 RPSIAQILQSPFI  258 (258)
T ss_pred             CcCHHHHhcCCCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0194|consensus

Probab=100.00  E-value=5.6e-38  Score=350.77  Aligned_cols=246  Identities=31%  Similarity=0.527  Sum_probs=198.9

Q ss_pred             ccccccccccccceEEEEeeecee---E-EEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        165 EDLREIGHGSFGAVYYARCLVSRE---I-VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       165 ~~l~~LG~G~fG~Vy~a~~~~~~~---~-vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.++||+|+||.||+|+.+..+.   . ||||...............+++|+++|++++|||||+++|+......+|+|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            445899999999999999876422   3 899987643334456678899999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||+|.|| |.+.+.                                 ..+..++..+...++.+.+.||+|||++++|||
T Consensus       240 mEl~~gGsL~~~L~---------------------------------k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHR  286 (474)
T KOG0194|consen  240 MELCNGGSLDDYLK---------------------------------KNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHR  286 (474)
T ss_pred             EEecCCCcHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcch
Confidence            9999875 333222                                 122358999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC---Cccc-cCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA---NSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPY  394 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~-GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF  394 (804)
                      ||-..|+|++.++.+||+|||+|+.....   ...+ --..|+|||.+.   .+.|+.++|||||||++||+.+ |..||
T Consensus       287 DIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~---~~~~s~kTDV~sfGV~~~Eif~~g~~Py  363 (474)
T KOG0194|consen  287 DIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLN---TGIFSFKTDVWSFGVLLWEIFENGAEPY  363 (474)
T ss_pred             hHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhc---cCccccccchhheeeeEEeeeccCCCCC
Confidence            99999999999999999999998765321   1111 224799999984   4689999999999999999998 89999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+....++...|..+..+                                         ...+...+.++..++.+||..
T Consensus       364 ~g~~~~~v~~kI~~~~~r-----------------------------------------~~~~~~~p~~~~~~~~~c~~~  402 (474)
T KOG0194|consen  364 PGMKNYEVKAKIVKNGYR-----------------------------------------MPIPSKTPKELAKVMKQCWKK  402 (474)
T ss_pred             CCCCHHHHHHHHHhcCcc-----------------------------------------CCCCCCCHHHHHHHHHHhccC
Confidence            999888777766443321                                         111123467788899999999


Q ss_pred             CCCCCCCHHHHHc
Q psy17952        475 NPADRPSSGRLLT  487 (804)
Q Consensus       475 dP~~Rpsa~elL~  487 (804)
                      ||++|||+.++.+
T Consensus       403 ~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  403 DPEDRPTMSTIKK  415 (474)
T ss_pred             ChhhccCHHHHHH
Confidence            9999999998764

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-37  Score=331.88  Aligned_cols=266  Identities=23%  Similarity=0.364  Sum_probs=197.2

Q ss_pred             cccccccccccccccccceEEEEeeec--------------eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCcee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVS--------------REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI  225 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~--------------~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV  225 (804)
                      |...|++.+.||+|+||.||+|++..+              ...||+|.++...  .......+.+|++++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            456799999999999999999987543              2358999886432  223345688999999999999999


Q ss_pred             EeeeEEeecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHH
Q psy17952        226 EYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGV  304 (804)
Q Consensus       226 ~l~~~~~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qi  304 (804)
                      ++++++......|+||||+.| ++.+++.....                      ...+........+++..+..++.|+
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~~~~~~~~~~~~i~~~i  138 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREI----------------------ESTFTHANNIPSVSIANLLYMAVQI  138 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccc----------------------cccccccccCCcccHHHHHHHHHHH
Confidence            999999999999999999985 45444421000                      0011111122357889999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHH
Q psy17952        305 LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVW  378 (804)
Q Consensus       305 l~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIW  378 (804)
                      +.||.|||++|++||||||+|||++.++.+||+|||++......      ....+++.|+|||++.   .+.++.++|||
T Consensus       139 ~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvw  215 (295)
T cd05097         139 ASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL---LGKFTTASDVW  215 (295)
T ss_pred             HHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc---cCCcCchhhHH
Confidence            99999999999999999999999999999999999998643221      2234567899999874   35688999999


Q ss_pred             HHHHHHHHHHh--CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCC
Q psy17952        379 SLGITCIELAE--RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ  456 (804)
Q Consensus       379 SlGvil~ELlt--G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~  456 (804)
                      ||||++|||++  |..||...+..+.+..+.+-...               .  ..                  ......
T Consensus       216 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~---------------~--~~------------------~~~~~~  260 (295)
T cd05097         216 AFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN---------------Q--GR------------------QIYLSQ  260 (295)
T ss_pred             HHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhh---------------c--cc------------------cccCCC
Confidence            99999999988  67888766554443332110000               0  00                  000011


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       457 ~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      ....++.+.+|+.+||+.||++|||++++++
T Consensus       261 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         261 TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.9e-37  Score=333.82  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=194.1

Q ss_pred             cccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecC
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~  235 (804)
                      +.|++.+.||+|+||.||+|.+.     .++..||+|.++...  .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            45889999999999999999753     345689999876432  123346788999999999 7999999999999999


Q ss_pred             ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+||||+.|+ +.+++..                                .....+++.++..++.|++.||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~--------------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~  160 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRR--------------------------------KRESFLTLEDLLSFSYQVAKGMAFLASK  160 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHh--------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            999999999854 3332210                                0112388999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      +|+||||||+|||++.++.+||+|||+++.....      ....+++.|+|||.+.   .+.++.++|||||||++|||+
T Consensus       161 ~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslGvil~el~  237 (302)
T cd05055         161 NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGILLWEIF  237 (302)
T ss_pred             CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhc---cCCCCcHhHHHHHHHHHHHHH
Confidence            9999999999999999999999999998643221      1234678899999884   356888999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      + |.+||.+.+....+.......                                         .+.......++++.+|
T Consensus       238 t~g~~p~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~l  276 (302)
T cd05055         238 SLGSNPYPGMPVDSKFYKLIKEG-----------------------------------------YRMAQPEHAPAEIYDI  276 (302)
T ss_pred             hCCCCCcCCCCchHHHHHHHHcC-----------------------------------------CcCCCCCCCCHHHHHH
Confidence            8 999997765443333222110                                         0001112357889999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q psy17952        468 VSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~  487 (804)
                      +.+||.++|++|||+.++++
T Consensus       277 i~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         277 MKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4e-37  Score=332.08  Aligned_cols=259  Identities=32%  Similarity=0.555  Sum_probs=201.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++.+.||+|+||.||+|.+..+++.||||.+.....  ......+.+|+.++.++. ||||+++++++......|++
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            348899999999999999999999999999998864321  223355677887777665 99999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeec
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHR  319 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHR  319 (804)
                      |||+.+.+.+++.                                 .....+++..+..++.|++.||+|||+ .||+||
T Consensus        93 ~e~~~~~l~~l~~---------------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~  139 (296)
T cd06618          93 MELMSTCLDKLLK---------------------------------RIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR  139 (296)
T ss_pred             eeccCcCHHHHHH---------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecC
Confidence            9999776544332                                 012468899999999999999999997 699999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccC-CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~-~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+||++++++.+||+|||++.....   .....|++.|+|||.+.+.. .+.++.++|||||||++|||++|+.||.
T Consensus       140 dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  219 (296)
T cd06618         140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK  219 (296)
T ss_pred             CCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999864322   12345788999999985321 2447889999999999999999999996


Q ss_pred             CCCh-HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        396 NMNA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       396 ~~~~-~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .... .+.+..+.....+                                        .......++.++.+|+.+||..
T Consensus       220 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~~l~~  259 (296)
T cd06618         220 NCKTEFEVLTKILQEEPP----------------------------------------SLPPNEGFSPDFCSFVDLCLTK  259 (296)
T ss_pred             cchhHHHHHHHHhcCCCC----------------------------------------CCCCCCCCCHHHHHHHHHHccC
Confidence            5322 2222222211100                                        0001124678899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||.+|||+.++++|||+....
T Consensus       260 ~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         260 DHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ChhhCCCHHHHhcChhhhccc
Confidence            999999999999999997643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.2e-37  Score=323.51  Aligned_cols=238  Identities=24%  Similarity=0.367  Sum_probs=186.4

Q ss_pred             ccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        169 EIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      .||+|+||.||+|.+.  .++..||+|.+....  .....+.+.+|+.++++++||||+++++++. ....|+||||++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            4899999999999765  345679999876432  2233456889999999999999999999875 4578999999986


Q ss_pred             C-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        247 S-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       247 ~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      + +.+.+.                                 .....+++..+..++.|++.||.|||++|++||||||+|
T Consensus        79 ~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n  125 (257)
T cd05115          79 GPLNKFLS---------------------------------GKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARN  125 (257)
T ss_pred             CCHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchhe
Confidence            5 322211                                 123468999999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccCCCC-------ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        326 ILLTETGTVKLADFGSASIKCPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~~~~-------~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      ||++.++.+||+|||++.......       ...+++.|+|||.+.   ...++.++|||||||++|||++ |.+||.+.
T Consensus       126 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  202 (257)
T cd05115         126 VLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGITMWEAFSYGQKPYKKM  202 (257)
T ss_pred             EEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHc---cCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence            999999999999999986432211       112357899999874   3568889999999999999996 99999877


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+.++..+                                          ......++++.+++.+||..||+
T Consensus       203 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~c~~~~~~  240 (257)
T cd05115         203 KGPEVMSFIEQGKRL------------------------------------------DCPAECPPEMYALMKDCWIYKWE  240 (257)
T ss_pred             CHHHHHHHHHCCCCC------------------------------------------CCCCCCCHHHHHHHHHHcCCChh
Confidence            665554444322110                                          01124578899999999999999


Q ss_pred             CCCCHHHHHc
Q psy17952        478 DRPSSGRLLT  487 (804)
Q Consensus       478 ~Rpsa~elL~  487 (804)
                      +||++.++.+
T Consensus       241 ~Rp~~~~i~~  250 (257)
T cd05115         241 DRPNFAKVEE  250 (257)
T ss_pred             hCcCHHHHHH
Confidence            9999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-37  Score=324.04  Aligned_cols=243  Identities=28%  Similarity=0.429  Sum_probs=192.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+. ++..+|+|.+.....    ....+.+|+.++++++||||+++++++...+..|+|||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            3889999999999999999875 466899998753221    12457889999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |++|+ +.+.+.                                 .....+++..+..++.|++.||.|||++||+||||
T Consensus        80 ~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl  126 (256)
T cd05059          80 YMANGCLLNYLR---------------------------------ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL  126 (256)
T ss_pred             cCCCCCHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence            99865 333221                                 12346889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCCC-----ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~~-----~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||+||+++.++.+||+|||+++......     ...++..|+|||.+.   ...++.++|||||||++|||++ |.+||.
T Consensus       127 ~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~  203 (256)
T cd05059         127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD---YSRFSSKSDVWSFGVLMWEVFSEGKMPYE  203 (256)
T ss_pred             cHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhc---cCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence            9999999999999999999987543211     112345799999984   3568889999999999999999 899997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+..+....+..+..                                          ......++..+.+++.+||..+
T Consensus       204 ~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~cl~~~  241 (256)
T cd05059         204 RFSNSEVVESVSAGYR------------------------------------------LYRPKLAPTEVYTIMYSCWHEK  241 (256)
T ss_pred             CCCHHHHHHHHHcCCc------------------------------------------CCCCCCCCHHHHHHHHHHhcCC
Confidence            6655444333321100                                          0011236788999999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy17952        476 PADRPSSGRLLTH  488 (804)
Q Consensus       476 P~~Rpsa~elL~H  488 (804)
                      |++|||+.++++.
T Consensus       242 p~~Rpt~~~~l~~  254 (256)
T cd05059         242 PEDRPAFKKLLSQ  254 (256)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.4e-37  Score=325.20  Aligned_cols=245  Identities=24%  Similarity=0.411  Sum_probs=191.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +...|++.++||+|+||.||+|.+..++ .||+|++.....    ..+.+.+|+++++.++||||+++++++. ....|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            4456999999999999999999876654 599998864221    2246789999999999999999998875 456899


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+++..                                .....+++..+..++.|++.||+|||+.+|+|
T Consensus        78 v~e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H  125 (262)
T cd05071          78 VTEYMSKGSLLDFLKG--------------------------------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH  125 (262)
T ss_pred             EEEcCCCCcHHHHHhh--------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999864 3333210                                01235788999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+|||++.++.+||+|||+++.....     ....++..|+|||++.   .+.++.++|||||||++|||++ |.+
T Consensus       126 ~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~~l~ellt~g~~  202 (262)
T cd05071         126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRV  202 (262)
T ss_pred             cccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhc---cCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999998643221     1234667899999874   4568899999999999999999 899


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+....+....+..+.                                          +.......+..+.+|+.+||
T Consensus       203 p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l  240 (262)
T cd05071         203 PYPGMVNREVLDQVERGY------------------------------------------RMPCPPECPESLHDLMCQCW  240 (262)
T ss_pred             CCCCCChHHHHHHHhcCC------------------------------------------CCCCccccCHHHHHHHHHHc
Confidence            997765544433332110                                          00012345788999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      ++||++|||+++++.
T Consensus       241 ~~~p~~Rp~~~~~~~  255 (262)
T cd05071         241 RKEPEERPTFEYLQA  255 (262)
T ss_pred             cCCcccCCCHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.1e-37  Score=325.91  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=187.1

Q ss_pred             cccccccccceEEEEeee--ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        168 REIGHGSFGAVYYARCLV--SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~--~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      ++||+|+||.||+|....  ....+|+|.+...  ........+++|+.+++.++||||+++++++......|+||||+.
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            469999999999996533  3457888876532  122334567899999999999999999999999999999999998


Q ss_pred             C-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q psy17952        246 G-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG  324 (804)
Q Consensus       246 G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~  324 (804)
                      | ++.+++....                             ......+++..+..++.||+.||+|||++||+||||||+
T Consensus        79 ~g~L~~~l~~~~-----------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  129 (269)
T cd05042          79 LGDLKNYLRSNR-----------------------------GMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR  129 (269)
T ss_pred             CCcHHHHHHhcc-----------------------------ccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHh
Confidence            5 4444432100                             001123567888999999999999999999999999999


Q ss_pred             CeeecCCCcEEEEecccccccCC------CCccccCcccccchhhccc----CCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        325 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       325 NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~----~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      |||++.++.+||+|||++.....      .....+++.|+|||++...    ....++.++|||||||++|||++ |.+|
T Consensus       130 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p  209 (269)
T cd05042         130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP  209 (269)
T ss_pred             heEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999864322      1223467789999997431    12356789999999999999999 7889


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |......+.+..+........                                    ..+ .....++..+.+++..|| 
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~-~~~~~~~~~~~~~~~~~~-  251 (269)
T cd05042         210 YPDLSDEQVLKQVVREQDIKL------------------------------------PKP-QLDLKYSDRWYEVMQFCW-  251 (269)
T ss_pred             CCcCCHHHHHHHHhhccCccC------------------------------------CCC-cccccCCHHHHHHHHHHh-
Confidence            977766555544433211100                                    001 112346788899999999 


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .||++|||+++++.
T Consensus       252 ~dp~~Rpt~~~v~~  265 (269)
T cd05042         252 LDPETRPTAEEVHE  265 (269)
T ss_pred             cCcccccCHHHHHH
Confidence            59999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-37  Score=327.90  Aligned_cols=244  Identities=25%  Similarity=0.386  Sum_probs=189.1

Q ss_pred             ccccccccccccccceEEEEeeecee----EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~----~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .|++++.||+|+||+||+|....+++    .+|+|.+...  ........+..|+.++++++||||+++++++. ....+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence            48889999999999999999877766    4777776421  12233456778889999999999999999875 45678


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      ++|||+.+ ++.+++.                                 ...+.+++..+..++.||+.||.|||++|++
T Consensus        85 ~i~e~~~~gsL~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii  131 (279)
T cd05111          85 LVTQLSPLGSLLDHVR---------------------------------QHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV  131 (279)
T ss_pred             EEEEeCCCCcHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            99999975 4433321                                 1234689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      ||||||+|||++.++.+||+|||+++.....      ....|+..|+|||.+.   .+.++.++|||||||++|||++ |
T Consensus       132 H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~il~el~t~g  208 (279)
T cd05111         132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL---FGRYTHQSDVWSYGVTVWEMMSYG  208 (279)
T ss_pred             ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhc---cCCcCchhhHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999754221      2235677899999984   3568999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||.+.........+..+..+                                          .....++.++.+++.+
T Consensus       209 ~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~  246 (279)
T cd05111         209 AEPYAGMRPHEVPDLLEKGERL------------------------------------------AQPQICTIDVYMVMVK  246 (279)
T ss_pred             CCCCCCCCHHHHHHHHHCCCcC------------------------------------------CCCCCCCHHHHHHHHH
Confidence            9999776544332222111100                                          0112245678899999


Q ss_pred             hcccCCCCCCCHHHHHc
Q psy17952        471 CLAKNPADRPSSGRLLT  487 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~  487 (804)
                      ||..||++|||+.++++
T Consensus       247 c~~~~p~~Rps~~el~~  263 (279)
T cd05111         247 CWMIDENVRPTFKELAN  263 (279)
T ss_pred             HcCCCcccCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-37  Score=323.69  Aligned_cols=245  Identities=27%  Similarity=0.413  Sum_probs=193.6

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ...|++.+.||+|+||.||+|... +++.||+|.++...    ...+.+.+|+.++++++||||+++++++...+..|+|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            345899999999999999999864 45679999876422    1235678999999999999999999999999999999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.| ++.+.+..                                .....+++..+..++.|++.||.|||++||+||
T Consensus        80 ~e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  127 (261)
T cd05068          80 TELMKYGSLLEYLQG--------------------------------GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR  127 (261)
T ss_pred             eecccCCcHHHHHhc--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999964 44433310                                012357899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC--Ccccc---CcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA--NSFVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~--~~~~G---T~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||||+||+++.++.+||+|||++......  ....|   +..|+|||++.   ...++.++|||||||++|||++ |+.|
T Consensus       128 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~t~g~~p  204 (261)
T cd05068         128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL---YNRFSIKSDVWSFGILLTEIVTYGRMP  204 (261)
T ss_pred             cCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccc---cCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999998754321  11223   35799999874   3568889999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+....+..+.....                                          .......+..+.+++.+||+
T Consensus       205 ~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l~  242 (261)
T cd05068         205 YPGMTNAEVLQQVDQGYR------------------------------------------MPCPPGCPKELYDIMLDCWK  242 (261)
T ss_pred             CCCCCHHHHHHHHHcCCC------------------------------------------CCCCCcCCHHHHHHHHHHhh
Confidence            987665554444322100                                          00112457889999999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .||.+||++.++++
T Consensus       243 ~~P~~Rp~~~~l~~  256 (261)
T cd05068         243 EDPDDRPTFETLQW  256 (261)
T ss_pred             cCcccCCCHHHHHH
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-37  Score=322.63  Aligned_cols=238  Identities=26%  Similarity=0.417  Sum_probs=187.5

Q ss_pred             cccccccccceEEEEeeece---eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeec
Q psy17952        168 REIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC  244 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~---~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~  244 (804)
                      ++||+|+||.||+|....++   ..+|+|.+......  .....+.+|++++++++|||||++++++. ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999876655   78999988643222  33456889999999999999999999876 45689999999


Q ss_pred             CCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        245 LGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       245 ~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      .|+ +.+.+                                  .....+++..+..++.|++.||.|||+++|+||||||
T Consensus        78 ~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p  123 (257)
T cd05060          78 PLGPLLKYL----------------------------------KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAA  123 (257)
T ss_pred             CCCcHHHHH----------------------------------HhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCccc
Confidence            864 33322                                  2334688999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCCCCc-------cccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        324 GNILLTETGTVKLADFGSASIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~~~~-------~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      +|||++.++.+||+|||+++.......       ..++..|+|||.+.   .+.++.++|||||||++|||++ |.+||.
T Consensus       124 ~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~~g~~p~~  200 (257)
T cd05060         124 RNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN---YGKFSSKSDVWSYGVTLWEAFSYGAKPYG  200 (257)
T ss_pred             ceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhc---CCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence            999999999999999999875432211       12346799999884   4568889999999999999998 999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+..+....+.+..                                          +......++..+.+++.+||..|
T Consensus       201 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~cl~~~  238 (257)
T cd05060         201 EMKGAEVIAMLESGE------------------------------------------RLPRPEECPQEIYSIMLSCWKYR  238 (257)
T ss_pred             cCCHHHHHHHHHcCC------------------------------------------cCCCCCCCCHHHHHHHHHHhcCC
Confidence            766544433332211                                          00112345788999999999999


Q ss_pred             CCCCCCHHHHHc
Q psy17952        476 PADRPSSGRLLT  487 (804)
Q Consensus       476 P~~Rpsa~elL~  487 (804)
                      |++|||+.++++
T Consensus       239 p~~Rp~~~~l~~  250 (257)
T cd05060         239 PEDRPTFSELES  250 (257)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.4e-37  Score=333.16  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=196.9

Q ss_pred             cccccccccccccccccceEEEEeee-------ceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLV-------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCY  231 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~  231 (804)
                      +...|.+.+.||+|+||.||+|++..       ....+|+|.++...  .......+.+|+.+++++ +||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34568999999999999999998642       34579999876322  233456688999999999 699999999999


Q ss_pred             eecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      ...+..|++|||+.| ++.+++.....        .+  . .     .  ...........+++.++..++.|++.||.|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~--------~~--~-~-----~--~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  149 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRP--------PG--P-D-----Y--TFDITKVPEEQLSFKDLVSCAYQVARGMEY  149 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCC--------Cc--c-c-----c--cccccCCcccccCHHHHHHHHHHHHHHHHH
Confidence            999999999999985 45444431100        00  0 0     0  000001123468899999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ||++||+||||||+|||++.++.+||+|||+++.....      ....+++.|||||++.   .+.++.++|||||||++
T Consensus       150 lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l  226 (314)
T cd05099         150 LESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF---DRVYTHQSDVWSFGILM  226 (314)
T ss_pred             HHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc---cCCcCccchhhHHHHHH
Confidence            99999999999999999999999999999999754221      1123456799999984   35688899999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++ |..||.+.+..+....+.....                                          .......+.+
T Consensus       227 ~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~  264 (314)
T cd05099         227 WEIFTLGGSPYPGIPVEELFKLLREGHR------------------------------------------MDKPSNCTHE  264 (314)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHH
Confidence            99999 8999977665544433321100                                          0011345778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      +.+|+.+||..||++|||+.+++.
T Consensus       265 l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         265 LYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.2e-37  Score=328.08  Aligned_cols=239  Identities=21%  Similarity=0.314  Sum_probs=183.0

Q ss_pred             ccccccccceEEEEeeec------------------------eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCce
Q psy17952        169 EIGHGSFGAVYYARCLVS------------------------REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT  224 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~~~~------------------------~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI  224 (804)
                      .||+|+||.||+|....+                        ...||+|.+....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            599999999999975432                        2358888875321   2233567889999999999999


Q ss_pred             eEeeeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHH
Q psy17952        225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGV  304 (804)
Q Consensus       225 V~l~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qi  304 (804)
                      +++++++......|+|||||+|+..+.+-                                ....+.+++..+..++.||
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l--------------------------------~~~~~~~~~~~~~~i~~qi  126 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCL--------------------------------RKEKGRVPVAWKITVAQQL  126 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHH--------------------------------HhcCCCCCHHHHHHHHHHH
Confidence            99999999999999999999976322110                                0123568899999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCCeeecCCC-------cEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccH
Q psy17952        305 LRGLNYLHSLGRIHRDVKAGNILLTETG-------TVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDV  377 (804)
Q Consensus       305 l~gL~yLH~~gIiHRDLKP~NILl~~~g-------~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDI  377 (804)
                      +.||+|||++||+||||||+|||++..+       .+|++|||++..........+++.|+|||.+.+  ...++.++||
T Consensus       127 ~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~--~~~~~~~~Dv  204 (274)
T cd05076         127 ASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPG--GNSLSTAADK  204 (274)
T ss_pred             HHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcC--CCCCCcHHHH
Confidence            9999999999999999999999997654       489999999865444444578899999998853  2457889999


Q ss_pred             HHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCC
Q psy17952        378 WSLGITCIELA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ  456 (804)
Q Consensus       378 WSlGvil~ELl-tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~  456 (804)
                      |||||++|||+ +|.+||.+....+....+ ...                                       ..    .
T Consensus       205 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~---------------------------------------~~----~  240 (274)
T cd05076         205 WSFGTTLLEICFDGEVPLKERTPSEKERFY-EKK---------------------------------------HR----L  240 (274)
T ss_pred             HHHHHHHHHHHhCCCCCccccChHHHHHHH-Hhc---------------------------------------cC----C
Confidence            99999999994 799999765432211110 000                                       00    0


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       457 ~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ....+..+.+++.+||+.+|++|||+.++|++
T Consensus       241 ~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         241 PEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            01235678999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.2e-37  Score=323.10  Aligned_cols=244  Identities=26%  Similarity=0.440  Sum_probs=191.7

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|+++++||+|+||.||+|.+. .+..+|+|.+.....    ..+.+.+|+.++++++||||+++++++. ....|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            3456999999999999999999765 556799998764221    2246889999999999999999999875 456899


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||+.|+ +.+++..                                .....+++..+..++.|++.||.|||++||+|
T Consensus        78 v~e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H  125 (260)
T cd05070          78 VTEYMSKGSLLDFLKD--------------------------------GEGRALKLPNLVDMAAQVAAGMAYIERMNYIH  125 (260)
T ss_pred             EEEecCCCcHHHHHHh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999864 4333210                                01235789999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+||++++++.+||+|||++......     ....++..|+|||++.   ...++.++|||||||++|||++ |.+
T Consensus       126 ~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~g~~  202 (260)
T cd05070         126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELVTKGRV  202 (260)
T ss_pred             CCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHh---cCCCcchhhhHHHHHHHHHHHhcCCC
Confidence            999999999999999999999998653221     1234556799999874   3568889999999999999999 899


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+..+..                                          .......+..+.+|+.+||
T Consensus       203 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l  240 (260)
T cd05070         203 PYPGMNNREVLEQVERGYR------------------------------------------MPCPQDCPISLHELMLQCW  240 (260)
T ss_pred             CCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCcCCHHHHHHHHHHc
Confidence            9987765554444322110                                          0011345788999999999


Q ss_pred             ccCCCCCCCHHHHH
Q psy17952        473 AKNPADRPSSGRLL  486 (804)
Q Consensus       473 ~~dP~~Rpsa~elL  486 (804)
                      .+||.+|||++++.
T Consensus       241 ~~~p~~Rpt~~~l~  254 (260)
T cd05070         241 KKDPEERPTFEYLQ  254 (260)
T ss_pred             ccCcccCcCHHHHH
Confidence            99999999999876

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0608|consensus

Probab=100.00  E-value=3e-38  Score=347.40  Aligned_cols=256  Identities=23%  Similarity=0.395  Sum_probs=207.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|-.++.||-|+||+|.+++...|...+|+|.+++.+.........+..|-.||...+.+.||+||..|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            57888999999999999999999999999999876555555556677889999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |+.||                                 ++.....+.+-|+|+.++.++.++..|+++.|..|.||||||
T Consensus       710 YIPGG---------------------------------DmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiK  756 (1034)
T KOG0608|consen  710 YIPGG---------------------------------DMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK  756 (1034)
T ss_pred             ccCCc---------------------------------cHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccC
Confidence            99987                                 122223345678999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEeccccccc---------C-------------------------------------CCCccccCcc
Q psy17952        323 AGNILLTETGTVKLADFGSASIK---------C-------------------------------------PANSFVGTPY  356 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~---------~-------------------------------------~~~~~~GT~~  356 (804)
                      |+|||||.+|++||+||||+.-.         .                                     ...+.+||+.
T Consensus       757 PDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~n  836 (1034)
T KOG0608|consen  757 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPN  836 (1034)
T ss_pred             ccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCc
Confidence            99999999999999999997310         0                                     0124589999


Q ss_pred             cccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCcc
Q psy17952        357 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF  436 (804)
Q Consensus       357 Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~  436 (804)
                      |+|||+|.   ...|+..+|+||.|||||||+.|++||...++.+..++|..+.          ..              
T Consensus       837 yiapevl~---r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~----------~~--------------  889 (1034)
T KOG0608|consen  837 YIAPEVLA---RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR----------NF--------------  889 (1034)
T ss_pred             ccChHHhc---ccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh----------hc--------------
Confidence            99999995   3568999999999999999999999998776655544443211          10              


Q ss_pred             chhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC---CHHHHHcCccccCC
Q psy17952        437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP---SSGRLLTHDLVTRP  494 (804)
Q Consensus       437 ~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp---sa~elL~Hp~~~~~  494 (804)
                              .++       ..-..+|.++.++|.++. .++++|.   .++|+-.||||+..
T Consensus       890 --------l~~-------~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  890 --------LHI-------PYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             --------ccc-------ccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence                    000       112457889999988754 5677776   46789999999754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.9e-37  Score=369.17  Aligned_cols=148  Identities=28%  Similarity=0.412  Sum_probs=128.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|+++++||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            35899999999999999999999999999999986533333344467889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.|+ |.+++                                  ...+.+++..++.|+.||+.||+|||++||||||
T Consensus        84 Ey~~g~~L~~li----------------------------------~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrD  129 (669)
T cd05610          84 EYLIGGDVKSLL----------------------------------HIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD  129 (669)
T ss_pred             eCCCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCC
Confidence            999764 33322                                  2234678899999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEeccccc
Q psy17952        321 VKAGNILLTETGTVKLADFGSAS  343 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~  343 (804)
                      |||+|||++.++.+||+|||+++
T Consensus       130 LKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         130 LKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             ccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-37  Score=331.83  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=199.0

Q ss_pred             cccccccccccccceEEEEee---eceeEEEEEeccccccc-chhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        164 FEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQ-CAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~-~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      |++.+.||+|+||.||+|++.   .+|+.||+|.+...... .....+.+.+|+.+++++ +||||+.+++++..+...|
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            788999999999999999875   47899999987642211 112235677899999999 5999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +||||+.|+.                                 |.+++.....+++..+..++.|+++||.|||+.|++|
T Consensus        82 lv~e~~~~~~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H  128 (290)
T cd05613          82 LILDYINGGE---------------------------------LFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIY  128 (290)
T ss_pred             EEEecCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            9999998651                                 1222223456889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+|||++.++.+||+|||++.....     .....|+..|+|||.+... ...++.++|||||||++|+|++|..|
T Consensus       129 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p  207 (290)
T cd05613         129 RDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG-DGGHDKAVDWWSMGVLMYELLTGASP  207 (290)
T ss_pred             cCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCC-CCCCCccccHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999865322     1245789999999998532 23467899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+.......+..               .+                      .....+  ....++..+.+|+.+||+
T Consensus       208 ~~~~~~~~~~~~~~~---------------~~----------------------~~~~~~--~~~~~~~~~~~ll~~~l~  248 (290)
T cd05613         208 FTVDGEKNSQAEISR---------------RI----------------------LKSEPP--YPQEMSALAKDIIQRLLM  248 (290)
T ss_pred             CCcCCccccHHHHHH---------------Hh----------------------hccCCC--CCccCCHHHHHHHHHHhc
Confidence            964322111111100               00                      000000  123467889999999999


Q ss_pred             cCCCCCC-----CHHHHHcCccccCC
Q psy17952        474 KNPADRP-----SSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rp-----sa~elL~Hp~~~~~  494 (804)
                      .||++||     ++.+++.||||...
T Consensus       249 ~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         249 KDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CCHHHhcCCCCCCHHHHHcCcccccC
Confidence            9999997     89999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0671|consensus

Probab=100.00  E-value=3e-38  Score=333.53  Aligned_cols=290  Identities=24%  Similarity=0.333  Sum_probs=211.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC--C----ceeEeeeEEeec
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH--P----NTIEYRGCYLRD  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H--p----NIV~l~~~~~~~  234 (804)
                      ..+|++++.+|+|.||.|..|.+..++..||||+++..    ....+..+-|+++|+++.+  |    -+|.+.++|.-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            56799999999999999999999999999999998643    3445667889999999943  3    378889999999


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      +..|||+|.++-++.|.+.                                ..+..+++.+.++.++.|++++++|||+.
T Consensus       164 ghiCivfellG~S~~dFlk--------------------------------~N~y~~fpi~~ir~m~~QL~~sv~fLh~~  211 (415)
T KOG0671|consen  164 GHICIVFELLGLSTFDFLK--------------------------------ENNYIPFPIDHIRHMGYQLLESVAFLHDL  211 (415)
T ss_pred             CceEEEEeccChhHHHHhc--------------------------------cCCccccchHHHHHHHHHHHHHHHHHHhc
Confidence            9999999998656544442                                11345799999999999999999999999


Q ss_pred             CCeecCCCCCCeeecC--------------------CCcEEEEecccccccCCC-CccccCcccccchhhcccCCCCCCC
Q psy17952        315 GRIHRDVKAGNILLTE--------------------TGTVKLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDG  373 (804)
Q Consensus       315 gIiHRDLKP~NILl~~--------------------~g~vKL~DFGla~~~~~~-~~~~GT~~Y~APEvl~~~~~~~y~~  373 (804)
                      +++|-||||+|||+.+                    +-.|||+|||.|+..... .+.+.|..|+|||++++.   .++.
T Consensus       212 kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgL---GwS~  288 (415)
T KOG0671|consen  212 KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGL---GWSQ  288 (415)
T ss_pred             ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheecc---CcCC
Confidence            9999999999999842                    235899999999876543 457899999999999864   5888


Q ss_pred             cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcc-----cccCCCCccchhhhHHHHhhc
Q psy17952        374 KVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISS-----TAERKPPYFNMNAMSALYHIA  448 (804)
Q Consensus       374 ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~-----~~~~~pp~~~~~~~~~l~~i~  448 (804)
                      ++||||+||||+||.+|...|..-+..+-+.++..--+|.+.    ..+.....     ...-.-+...+..  ......
T Consensus       289 pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~----~mi~r~~~~Kyf~~~rldw~e~~~~~--~~k~v~  362 (415)
T KOG0671|consen  289 PCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPS----RMIKKTRKEKYFRRGRLDWPEVSSKG--KSKYVF  362 (415)
T ss_pred             ccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcH----HHhhhhhhHhhhhcccccCccccccc--cchhhh
Confidence            999999999999999999999887766655444332222211    11111100     0000000000000  000001


Q ss_pred             cCCCCC----CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        449 QNDTPC----LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       449 ~~~~p~----~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +...|.    ......-.++.|||++||..||.+|+|+.|+|.||||++..
T Consensus       363 ~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  363 EPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             cCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            111110    01111234588999999999999999999999999998754

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.7e-37  Score=319.04  Aligned_cols=249  Identities=39%  Similarity=0.663  Sum_probs=200.9

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceEEEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLVM  241 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~lVm  241 (804)
                      |...+.||+|+||.||+|.+..+++.|++|.+...... ....+.+.+|+.++++++||||+++++++...  ...+++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            67789999999999999999999999999987643221 23456788999999999999999999999988  8899999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.|+ +.+++                                  .....+++..+..++.|++.||.|||+.|++|+|
T Consensus        81 e~~~~~~L~~~~----------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~d  126 (260)
T cd06606          81 EYVSGGSLSSLL----------------------------------KKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRD  126 (260)
T ss_pred             EecCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            999654 33322                                  1233789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+|+||+++.++.+||+|||.+.....      .....++..|+|||.+.   ...++.++|||||||++|+|++|..||
T Consensus       127 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~  203 (260)
T cd06606         127 IKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR---GEEYGRAADIWSLGCTVIEMATGKPPW  203 (260)
T ss_pred             CCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999865432      23357889999999984   344788999999999999999999999


Q ss_pred             CCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        395 FNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       395 ~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      ...+ .......+...                                         .........++..+.+|+.+||+
T Consensus       204 ~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~l~~~i~~~l~  242 (260)
T cd06606         204 SELGNPMAALYKIGSS-----------------------------------------GEPPEIPEHLSEEAKDFLRKCLR  242 (260)
T ss_pred             CCCCchHHHHHhcccc-----------------------------------------CCCcCCCcccCHHHHHHHHHhCc
Confidence            7654 22221111100                                         00011123457889999999999


Q ss_pred             cCCCCCCCHHHHHcCccc
Q psy17952        474 KNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~  491 (804)
                      .||.+||++.++++||||
T Consensus       243 ~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         243 RDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CChhhCCCHHHHhhCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.7e-37  Score=332.82  Aligned_cols=262  Identities=25%  Similarity=0.418  Sum_probs=195.1

Q ss_pred             cccccccccccccccceEEEEeee-------ceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV-------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      ..|.+.+.||+|+||.||+|++..       +...+|+|.+....  .......+.+|+.+++.+ +||||+++++++..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            468999999999999999998653       23569999886432  223345688899999999 79999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..|+||||+.+ ++.+++....      ..+...      +      .-........+++.++..++.|++.||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~------~~~~~~------~------~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH  157 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARR------PPGMEY------C------YNPTQVPEEQLSFKDLVSCAYQVARGMEYLA  157 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcC------Cccccc------c------cccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999985 5555443110      000000      0      0000012345889999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++|++||||||+|||++.++.+||+|||+++.....      ....+++.|+|||++.   ...++.++|||||||++||
T Consensus       158 ~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~e  234 (307)
T cd05098         158 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWE  234 (307)
T ss_pred             HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc---cCCCCcHHHHHHHHHHHHH
Confidence            999999999999999999999999999998643211      1123456899999884   3568889999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |++ |..||.+.+..+....+..+.                                          +.......+.++.
T Consensus       235 l~~~g~~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~  272 (307)
T cd05098         235 IFTLGGSPYPGVPVEELFKLLKEGH------------------------------------------RMDKPSNCTNELY  272 (307)
T ss_pred             HHcCCCCCCCcCCHHHHHHHHHcCC------------------------------------------CCCCCCcCCHHHH
Confidence            998 889987655433332221110                                          0011134578999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +|+.+||..+|.+|||+.+++.+
T Consensus       273 ~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         273 MMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcccChhhCcCHHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1026|consensus

Probab=100.00  E-value=9.3e-38  Score=359.02  Aligned_cols=259  Identities=25%  Similarity=0.421  Sum_probs=208.3

Q ss_pred             ccccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      ....+..++||+|+||+||+|+...     ....||||.++.  +.....+++|.||+++|..|+|||||+|+|++..++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd--~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD--KAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc--cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            3346778999999999999998653     346799998864  333446789999999999999999999999999999


Q ss_pred             ceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      .+|+|+|||. |+|.+++..+-.....                    +..-...+.+|+..+...|+.||+.|++||-++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~--------------------~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~  622 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADK--------------------LASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH  622 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCcccc--------------------ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            9999999997 8887776532110000                    000000156699999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC--Ccc----ccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA--NSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~--~~~----~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      .+|||||-..|+||.++..|||+|||+++..-..  ...    .=-..|||||.|+   .++|+++|||||+||+|||++
T Consensus       623 ~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl---y~kFTteSDVWs~GVvLWEIF  699 (774)
T KOG1026|consen  623 HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL---YGKFTTESDVWSFGVVLWEIF  699 (774)
T ss_pred             cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh---cCcccchhhhhhhhhhhhhhh
Confidence            9999999999999999999999999999753221  111    1235799999995   578999999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      + |+.||.+.+..+++..|.++..                                          ...+...+.++.+|
T Consensus       700 syG~QPy~glSn~EVIe~i~~g~l------------------------------------------L~~Pe~CP~~vY~L  737 (774)
T KOG1026|consen  700 SYGKQPYYGLSNQEVIECIRAGQL------------------------------------------LSCPENCPTEVYSL  737 (774)
T ss_pred             ccccCcccccchHHHHHHHHcCCc------------------------------------------ccCCCCCCHHHHHH
Confidence            8 9999999999998888865431                                          01124568899999


Q ss_pred             HHHhcccCCCCCCCHHHHH
Q psy17952        468 VSSCLAKNPADRPSSGRLL  486 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL  486 (804)
                      +..||+.+|++|||..|+-
T Consensus       738 M~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  738 MLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHhhcCcccCCCHHHHH
Confidence            9999999999999999874

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.5e-37  Score=329.53  Aligned_cols=265  Identities=23%  Similarity=0.375  Sum_probs=195.4

Q ss_pred             cccccccccccccccccceEEEEeee----------------ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCc
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLV----------------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN  223 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~----------------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpN  223 (804)
                      |.+.|++.+.||+|+||.||++++..                ++..||+|.+....  .......+.+|+.+|+.++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence            45669999999999999999986432                34579999876421  2233467889999999999999


Q ss_pred             eeEeeeEEeecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHH
Q psy17952        224 TIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICS  302 (804)
Q Consensus       224 IV~l~~~~~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~  302 (804)
                      |+++++++...+..|+||||+.| ++.+++.....                       .-.........+++..+..++.
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~  137 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEP-----------------------QEAAEKADVVTISYSTLIFMAT  137 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCc-----------------------ccccccccccccCHHHHHHHHH
Confidence            99999999999999999999975 55444321000                       0000011234588899999999


Q ss_pred             HHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCccc
Q psy17952        303 GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVD  376 (804)
Q Consensus       303 qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksD  376 (804)
                      |++.||+|||++||+||||||+|||++.++.+||+|||+++.....      ....+++.|+|||+..   .+.++.++|
T Consensus       138 ~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~D  214 (296)
T cd05095         138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL---LGKFTTASD  214 (296)
T ss_pred             HHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh---cCCccchhh
Confidence            9999999999999999999999999999999999999998753221      1234467899999874   356889999


Q ss_pred             HHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC
Q psy17952        377 VWSLGITCIELAE--RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC  454 (804)
Q Consensus       377 IWSlGvil~ELlt--G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~  454 (804)
                      ||||||++|||++  |..||...+..+.......            .....   .                    .....
T Consensus       215 iwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~------------~~~~~---~--------------------~~~~~  259 (296)
T cd05095         215 VWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE------------FFRDQ---G--------------------RQVYL  259 (296)
T ss_pred             hhHHHHHHHHHHHhCCCCCccccChHHHHHHHHH------------HHhhc---c--------------------ccccC
Confidence            9999999999998  7889976554443322110            00000   0                    00000


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       455 ~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      .....+++.+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         260 PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            112335688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-36  Score=323.35  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=186.4

Q ss_pred             cccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        168 REIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      +.||+|+||.||+|...  .++..+|+|.++....  ......+.+|+.++++++||||+++++++......|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46999999999999754  3557899998764322  2223467889999999999999999999999999999999998


Q ss_pred             C-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q psy17952        246 G-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG  324 (804)
Q Consensus       246 G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~  324 (804)
                      | ++.+++....                             ......+++..+..++.|++.||+|||++|++||||||+
T Consensus        79 ~g~L~~~l~~~~-----------------------------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~  129 (269)
T cd05087          79 LGDLKGYLRSCR-----------------------------KAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR  129 (269)
T ss_pred             CCcHHHHHHHhh-----------------------------hcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence            5 4444332100                             001224567788899999999999999999999999999


Q ss_pred             CeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCC----CCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        325 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDE----GQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       325 NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~----~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||+++.++.+||+|||++.....      .....|++.|+|||++.+...    ..++.++|||||||++|||++ |.+|
T Consensus       130 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p  209 (269)
T cd05087         130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP  209 (269)
T ss_pred             eEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence            99999999999999999864322      123467888999999853211    135779999999999999996 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+..+...........                  ..                  ..|. .....++.+.+++.+|+ 
T Consensus       210 ~~~~~~~~~~~~~~~~~~~------------------~~------------------~~~~-~~~~~~~~~~~l~~~c~-  251 (269)
T cd05087         210 YRHLSDEQVLTYTVREQQL------------------KL------------------PKPR-LKLPLSDRWYEVMQFCW-  251 (269)
T ss_pred             CCCCChHHHHHHHhhcccC------------------CC------------------CCCc-cCCCCChHHHHHHHHHh-
Confidence            9776554433322111000                  00                  0011 11235778999999999 


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .+|++|||+++++.
T Consensus       252 ~~P~~Rpt~~~l~~  265 (269)
T cd05087         252 LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCcccCCCHHHHHH
Confidence            68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-37  Score=328.83  Aligned_cols=244  Identities=32%  Similarity=0.532  Sum_probs=190.0

Q ss_pred             ccccccccccccceEEEEee----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        165 EDLREIGHGSFGAVYYARCL----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       165 ~~l~~LG~G~fG~Vy~a~~~----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ++.+.||.|+||.||+|...    ..+..|+||.++..  ......+.+.+|++.+++++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            35678999999999999887    45778999998542  2233467889999999999999999999999988889999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.+ +|.+.+..                                .....+++..+..|+.||++||.|||+++|+|+
T Consensus        80 ~e~~~~g~L~~~L~~--------------------------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~  127 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKS--------------------------------KNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHG  127 (259)
T ss_dssp             EE--TTEBHHHHHHH--------------------------------TCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             ccccccccccccccc--------------------------------ccccccccccccccccccccccccccccccccc
Confidence            999984 55554431                                013568899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      ||+|+|||++.++.+||+|||++.....      .....+...|+|||.+..   ..++.++||||||+++|||++ |+.
T Consensus       128 ~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~ksDVysfG~~l~ei~~~~~~  204 (259)
T PF07714_consen  128 NLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD---GEYTKKSDVYSFGMLLYEILTLGKF  204 (259)
T ss_dssp             T-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH---SEESHHHHHHHHHHHHHHHHTTSSG
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence            9999999999999999999999876521      123456778999999853   458889999999999999999 789


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+.++..                                          ......++..+.+++.+||
T Consensus       205 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~C~  242 (259)
T PF07714_consen  205 PFSDYDNEEIIEKLKQGQR------------------------------------------LPIPDNCPKDIYSLIQQCW  242 (259)
T ss_dssp             TTTTSCHHHHHHHHHTTEE------------------------------------------TTSBTTSBHHHHHHHHHHT
T ss_pred             ccccccccccccccccccc------------------------------------------ceeccchhHHHHHHHHHHc
Confidence            9988776665555432210                                          0112346888999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      ..||++|||+.++++
T Consensus       243 ~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  243 SHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -SSGGGS--HHHHHH
T ss_pred             CCChhhCcCHHHHHh
Confidence            999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.2e-37  Score=328.32  Aligned_cols=268  Identities=25%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             ccccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .+.|+..+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.++++++||||+++++++..+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            4568999999999999999998753     67889999876422  2233456888999999999999999999999999


Q ss_pred             ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|++|||+.| ++.+.+........            ...................+++.++..++.|++.||.|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~  149 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQ------------CSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER  149 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCcccc------------ccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence            99999999985 55554431100000            000000000011112234688999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |++||||||+|||++.++.+||+|||++.....      .....+++.|+|||++.   ...++.++|||||||++|||+
T Consensus       150 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~  226 (288)
T cd05050         150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEIF  226 (288)
T ss_pred             CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh---cCCCCchhHHHHHHHHHHHHH
Confidence            999999999999999999999999999864321      11234566799999874   356889999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      + |..||.+.+..+....+..+..+                                          ......+.++.+|
T Consensus       227 ~~~~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~l  264 (288)
T cd05050         227 SYGMQPYYGMAHEEVIYYVRDGNVL------------------------------------------SCPDNCPLELYNL  264 (288)
T ss_pred             hCCCCCCCCCCHHHHHHHHhcCCCC------------------------------------------CCCCCCCHHHHHH
Confidence            7 88899877665544443221100                                          0112357889999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q psy17952        468 VSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~  487 (804)
                      +.+||+.||++|||+.|+++
T Consensus       265 i~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         265 MRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4e-37  Score=340.02  Aligned_cols=283  Identities=24%  Similarity=0.360  Sum_probs=195.0

Q ss_pred             cccccccccccccccccceEEEEe-----eeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~-----~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|++     ..+++.||||.++...  .......+.+|+.+|.++ +|||||++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            445699999999999999999984     3567899999886422  223346688999999999 68999999998765


Q ss_pred             c-CceEEEEeecCC-CchhhHHHHHhhhhhhhc----------ccchhhhhhhhhh---------------cccccc---
Q psy17952        234 D-HTAWLVMEYCLG-SASDIIEVHWIEREFHVE----------GMGNRLQQLKCFT---------------EHFALF---  283 (804)
Q Consensus       234 ~-~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~----------~~~~~l~~l~~~~---------------~~~~L~---  283 (804)
                      . ...+++||||.| ++.+++............          +.+..........               +...+.   
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 568999999985 566655421000000000          0000000000000               000000   


Q ss_pred             -----hhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccc
Q psy17952        284 -----NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFV  352 (804)
Q Consensus       284 -----~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~  352 (804)
                           ........+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||++.....      .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                 0001124588999999999999999999999999999999999999999999999999865321      12234


Q ss_pred             cCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccC
Q psy17952        353 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER  431 (804)
Q Consensus       353 GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~  431 (804)
                      +++.|+|||++.   ...++.++|||||||++|||++ |..||.+......+.......                     
T Consensus       243 ~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------------  298 (343)
T cd05103         243 LPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---------------------  298 (343)
T ss_pred             CCcceECcHHhc---CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc---------------------
Confidence            567899999984   3568889999999999999997 999997643222211111100                     


Q ss_pred             CCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        432 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       432 ~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                                         ..+ ......++++.+++.+||+.||++|||+.++++|
T Consensus       299 -------------------~~~-~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         299 -------------------TRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -------------------CCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                               000 0011246789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.4e-37  Score=322.60  Aligned_cols=245  Identities=24%  Similarity=0.429  Sum_probs=192.9

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|+++++||+|+||.||+|... +++.||+|.+.....    ....+.+|+.++++++||||+++++++ ..+..|+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~   77 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYI   77 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEE
Confidence            4556999999999999999999854 567899998763221    235688999999999999999999886 4567899


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||+.|+ +.+.+.                                ......+++.++..++.|++.||+|||+.|++|
T Consensus        78 v~e~~~~~~L~~~~~--------------------------------~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H  125 (260)
T cd05067          78 ITEYMENGSLVDFLK--------------------------------TPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH  125 (260)
T ss_pred             EEEcCCCCCHHHHHH--------------------------------hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence            99999754 333221                                012346888999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+||+++.++.++|+|||++.....     .....++..|+|||++.   .+.++.++|||||||++|||++ |++
T Consensus       126 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slG~~l~el~~~g~~  202 (260)
T cd05067         126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTYGRI  202 (260)
T ss_pred             ccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhc---cCCcCcccchHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999865431     12234667899999884   3567889999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+.....                                          .......+.++.+|+.+||
T Consensus       203 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l  240 (260)
T cd05067         203 PYPGMTNPEVIQNLERGYR------------------------------------------MPRPDNCPEELYELMRLCW  240 (260)
T ss_pred             CCCCCChHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence            9987665544433321100                                          0011235788999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      ..||++|||+++++.
T Consensus       241 ~~~p~~Rp~~~~l~~  255 (260)
T cd05067         241 KEKPEERPTFEYLRS  255 (260)
T ss_pred             cCChhhCCCHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.6e-37  Score=321.78  Aligned_cols=241  Identities=24%  Similarity=0.367  Sum_probs=189.8

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe-ecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL-RDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~-~~~~~~lVm  241 (804)
                      .|++.+.||+|+||.||++..  .+..||+|.++..     ...+.+.+|+.++++++||||+++++++. .++..|++|
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            488999999999999999865  4778999987532     12356789999999999999999999764 456789999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.| ++.+.+..                                .....+++..+..++.|++.||+|||++||+|||
T Consensus        80 e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  127 (256)
T cd05082          80 EYMAKGSLVDYLRS--------------------------------RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD  127 (256)
T ss_pred             ECCCCCcHHHHHHh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence            99986 44333210                                1123478999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMN  398 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~  398 (804)
                      |||+||+++.++.+||+|||++..... .....++..|+|||++.   ...++.++|||||||++|||++ |++||...+
T Consensus       128 lkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~  204 (256)
T cd05082         128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             cchheEEEcCCCcEEecCCccceeccccCCCCccceeecCHHHHc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999999875432 23345567899999884   3568889999999999999997 999997665


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+....+.++..                                          .......++.+.+|+.+||+.||++
T Consensus       205 ~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~  242 (256)
T cd05082         205 LKDVVPRVEKGYK------------------------------------------MDAPDGCPPVVYDVMKQCWHLDAAT  242 (256)
T ss_pred             HHHHHHHHhcCCC------------------------------------------CCCCCCCCHHHHHHHHHHhcCChhh
Confidence            4443333321100                                          0111345788999999999999999


Q ss_pred             CCCHHHHHc
Q psy17952        479 RPSSGRLLT  487 (804)
Q Consensus       479 Rpsa~elL~  487 (804)
                      |||+.++++
T Consensus       243 Rpt~~~l~~  251 (256)
T cd05082         243 RPSFLQLRE  251 (256)
T ss_pred             CcCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-36  Score=327.43  Aligned_cols=267  Identities=22%  Similarity=0.368  Sum_probs=195.2

Q ss_pred             cccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      |++.+.||+|+||.||+|.+..     ....+|+|.+....  .......+.+|+.+++.++||||+++++++..++..|
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            7788999999999999998753     23568898875322  1233467889999999999999999999999999999


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      ++|||+.| ++.+++.....   ......+.....       ...+........+++..+..++.|++.||.|||++||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iv  149 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRK---VGPSYLGSDGNR-------NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV  149 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCC---cccccccccccc-------ccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            99999985 45444431000   000000000000       00001112234689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      ||||||+|||+++++.+||+|||+++.....      ....++..|+|||.+.   ...++.++|||||||++|||++ |
T Consensus       150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc---cCCcchHhHHHHHHHHHHHHHhcC
Confidence            9999999999999999999999998643221      2234667899999874   3468889999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||.+.........+....                                          .......++.++.+|+.+
T Consensus       227 ~~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~i~~  264 (290)
T cd05045         227 GNPYPGIAPERLFNLLKTGY------------------------------------------RMERPENCSEEMYNLMLT  264 (290)
T ss_pred             CCCCCCCCHHHHHHHHhCCC------------------------------------------CCCCCCCCCHHHHHHHHH
Confidence            99997765443322221100                                          000123467889999999


Q ss_pred             hcccCCCCCCCHHHHHc
Q psy17952        471 CLAKNPADRPSSGRLLT  487 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~  487 (804)
                      ||+.||++||+++++++
T Consensus       265 cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         265 CWKQEPDKRPTFADISK  281 (290)
T ss_pred             HccCCcccCCCHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7e-37  Score=345.03  Aligned_cols=283  Identities=23%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             cccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~  233 (804)
                      +.+.|.+.+.||+|+||.||+|++.     .+++.||+|++.....  ....+.+.+|+.+|.++. |||||++++++..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            4456888999999999999999853     4567899999864322  223356889999999997 9999999999999


Q ss_pred             cCceEEEEeecC-CCchhhHHHHHhhhhhhh----cccchhhhh------------------------------------
Q psy17952        234 DHTAWLVMEYCL-GSASDIIEVHWIEREFHV----EGMGNRLQQ------------------------------------  272 (804)
Q Consensus       234 ~~~~~lVmEy~~-G~l~dll~~~~~~~~~~~----~~~~~~l~~------------------------------------  272 (804)
                      .+..|+|||||. |+|.+++...........    ......+..                                    
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999998 566666642110000000    000000000                                    


Q ss_pred             -----------------------h-hhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        273 -----------------------L-KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       273 -----------------------l-~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                                             . .........-........+++..+..|+.|++.||+|||+.+|+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                   0 0000000000011223468899999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy17952        329 TETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMS  401 (804)
Q Consensus       329 ~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~  401 (804)
                      +.++.+||+|||+++....      .....|++.|||||.+.   ...++.++|||||||++|||++ |..||......+
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF---NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc---CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999874321      12346788999999984   3568889999999999999998 899997654433


Q ss_pred             HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCC
Q psy17952        402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS  481 (804)
Q Consensus       402 ~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rps  481 (804)
                      .+........                                         +.......+.++.+|+.+||..+|.+||+
T Consensus       350 ~~~~~~~~~~-----------------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs  388 (401)
T cd05107         350 QFYNAIKRGY-----------------------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPD  388 (401)
T ss_pred             HHHHHHHcCC-----------------------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence            3332221100                                         00011345789999999999999999999


Q ss_pred             HHHHHcC
Q psy17952        482 SGRLLTH  488 (804)
Q Consensus       482 a~elL~H  488 (804)
                      +.+++..
T Consensus       389 ~~ell~~  395 (401)
T cd05107         389 FSQLVHL  395 (401)
T ss_pred             HHHHHHH
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0665|consensus

Probab=100.00  E-value=5.3e-38  Score=324.84  Aligned_cols=283  Identities=30%  Similarity=0.402  Sum_probs=216.5

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----  235 (804)
                      ..+|..++.+|.|.- .|.-|.+..++++||+|++... ......+.+..+|..++..++|+|||+++.+|....     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            346889999999998 7888999999999999998654 222344567889999999999999999999997654     


Q ss_pred             -ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 -TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 -~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                       .+|+|||||.+++..++.                                    -.++-+.+..|+.|++.|++|||+.
T Consensus        94 ~e~y~v~e~m~~nl~~vi~------------------------------------~elDH~tis~i~yq~~~~ik~lhs~  137 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVIL------------------------------------MELDHETISYILYQMLCGIKHLHSA  137 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHH------------------------------------HhcchHHHHHHHHHHHHHHHHHHhc
Confidence             579999999988766553                                    1245678899999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||+||||||+||++..++.+||.|||+|+.....   +.++.|++|.|||+++++   .|...+||||+||++.||++|+
T Consensus       138 ~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~---~~ke~vdiwSvGci~gEli~~~  214 (369)
T KOG0665|consen  138 GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGELILGT  214 (369)
T ss_pred             ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheecc---CCcccchhhhhhhHHHHHhhce
Confidence            9999999999999999999999999999765543   457899999999999864   3888999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccc----cCCCCccchhhhHHHHhhccCCCCCCC--CCCccHHH
Q psy17952        392 PPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTA----ERKPPYFNMNAMSALYHIAQNDTPCLQ--SSDWSDTF  464 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~----~~~pp~~~~~~~~~l~~i~~~~~p~~~--~~~~s~~l  464 (804)
                      ..|.|.+..++..++... ++|..     ...+.+....    +..|.+.. .....+  .+....+...  +..-+..+
T Consensus       215 Vlf~g~d~idQ~~ki~~~lgtpd~-----~F~~qL~~~~r~yv~~~~~y~~-~~f~~~--fpD~~f~~~~e~~~~~~~~a  286 (369)
T KOG0665|consen  215 VLFPGKDHIDQWNKIIEQLGTPDP-----SFMKQLQPTVRNYVENRPQYQA-ISFSEL--FPDSLFPVVLEGSKLDCSLA  286 (369)
T ss_pred             EEecCchHHHHHHHHHHHhcCCCH-----HHHHHhhHHHHHHhhcChHhhc-cchhhh--CCcccccccccCCccchHHH
Confidence            999999988888777653 33322     2222222111    11111111 011111  1111111111  11235678


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      +|++.+||..||++|.|++++|+|||++
T Consensus       287 rdll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  287 RDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhccChhhcccHHHHhcCCeee
Confidence            9999999999999999999999999996

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.4e-37  Score=321.20  Aligned_cols=252  Identities=32%  Similarity=0.529  Sum_probs=203.3

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|++++++++||||+++++++......|+||||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            78899999999999999999999999999988643222 23346678999999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.|+ +.+.+..                              .......+++..+..++.|++.||.|||+.|++|||||
T Consensus        81 ~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~  130 (256)
T cd08530          81 APFGDLSKAISK------------------------------RKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK  130 (256)
T ss_pred             cCCCCHHHHHHH------------------------------HHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            9764 3332210                              00123568899999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCCC--CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~~--~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      |+||+++.++.+||+|||++......  ....|++.|+|||.+.   ...++.++|+||||+++|||++|+.||...+..
T Consensus       131 ~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~  207 (256)
T cd08530         131 SANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWK---GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ  207 (256)
T ss_pred             cceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999998654332  2346889999999984   356788999999999999999999999776544


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      .....+..+..                                         +. ....++.++++++.+||..+|++||
T Consensus       208 ~~~~~~~~~~~-----------------------------------------~~-~~~~~~~~~~~li~~~l~~~p~~Rp  245 (256)
T cd08530         208 DLRYKVQRGKY-----------------------------------------PP-IPPIYSQDLQNFIRSMLQVKPKLRP  245 (256)
T ss_pred             HHHHHHhcCCC-----------------------------------------CC-CchhhCHHHHHHHHHHcCCCcccCC
Confidence            33322221110                                         11 1124678899999999999999999


Q ss_pred             CHHHHHcCccc
Q psy17952        481 SSGRLLTHDLV  491 (804)
Q Consensus       481 sa~elL~Hp~~  491 (804)
                      |+.++++||++
T Consensus       246 ~~~~~l~~p~~  256 (256)
T cd08530         246 NCDKILASPAV  256 (256)
T ss_pred             CHHHHhcCCCC
Confidence            99999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-36  Score=322.37  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=194.1

Q ss_pred             ccccccccccccccceEEEEeeecee---EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~---~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|+..+.||+|+||.||+|++..++.   .+|+|.+....  .....+.+.+|++++++++||||+++.+++...+..|+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            47888999999999999999876654   79999876421  22334678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+++.                                 .+.+.+++.++..++.|++.||+|||+.||+|
T Consensus        84 v~e~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H  130 (268)
T cd05063          84 ITEYMENGALDKYLR---------------------------------DHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH  130 (268)
T ss_pred             EEEcCCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            99999865 322221                                 12356889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCCC-------ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~~-------~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      |||||+|||++.++.+||+|||++.......       ....++.|+|||++.   .+.++.++|||||||++|||++ |
T Consensus       131 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Dv~slG~il~ell~~g  207 (268)
T cd05063         131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA---YRKFTSASDVWSFGIVMWEVMSFG  207 (268)
T ss_pred             cccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhh---cCCcChHhHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999986442211       112345799999984   3568889999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||...+..+....+.....                                          .......+..+.+|+.+
T Consensus       208 ~~p~~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~~~~li~~  245 (268)
T cd05063         208 ERPYWDMSNHEVMKAINDGFR------------------------------------------LPAPMDCPSAVYQLMLQ  245 (268)
T ss_pred             CCCCCcCCHHHHHHHHhcCCC------------------------------------------CCCCCCCCHHHHHHHHH
Confidence            999977665544444322110                                          00112357789999999


Q ss_pred             hcccCCCCCCCHHHHHc
Q psy17952        471 CLAKNPADRPSSGRLLT  487 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~  487 (804)
                      ||+.+|++||++.++++
T Consensus       246 c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         246 CWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HcCCCcccCcCHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-36  Score=319.92  Aligned_cols=241  Identities=26%  Similarity=0.372  Sum_probs=190.1

Q ss_pred             cccccccccceEEEEeee-ce--eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeec
Q psy17952        168 REIGHGSFGAVYYARCLV-SR--EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC  244 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~-~~--~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~  244 (804)
                      +.||+|+||.||+|.+.. .+  ..||||.++.....  ...+.+.+|+.++++++||||+++++.+.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 33  36999988653322  445678899999999999999999999988 8899999999


Q ss_pred             CCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        245 LGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       245 ~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      .|+ +.+.+..                                .....+++..+..++.|++.||+|||++|++||||||
T Consensus        78 ~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p  125 (257)
T cd05040          78 PLGSLLDRLRK--------------------------------DALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAA  125 (257)
T ss_pred             CCCcHHHHHHh--------------------------------cccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCc
Confidence            754 3332210                                0014688999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        324 GNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      +|||++.++.+||+|||++......       ....++..|+|||.+.   ...++.++|||||||++|||++ |..||.
T Consensus       126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Di~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         126 RNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR---TRTFSHASDVWMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             ccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhc---ccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999998654321       1245778899999874   3568889999999999999998 999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+..+....+.....                                         ........+..+.+++.+||+.+
T Consensus       203 ~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~~~l~~~  241 (257)
T cd05040         203 GLSGSQILKKIDKEGE-----------------------------------------RLERPEACPQDIYNVMLQCWAHN  241 (257)
T ss_pred             CCCHHHHHHHHHhcCC-----------------------------------------cCCCCccCCHHHHHHHHHHCCCC
Confidence            7666554444321000                                         00011235788999999999999


Q ss_pred             CCCCCCHHHHHc
Q psy17952        476 PADRPSSGRLLT  487 (804)
Q Consensus       476 P~~Rpsa~elL~  487 (804)
                      |++|||+.+++.
T Consensus       242 p~~Rps~~~~~~  253 (257)
T cd05040         242 PADRPTFAALRE  253 (257)
T ss_pred             cccCCCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-36  Score=329.78  Aligned_cols=263  Identities=24%  Similarity=0.411  Sum_probs=197.6

Q ss_pred             ccccccccccccccccceEEEEee-------eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEe
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYL  232 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~-------~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~  232 (804)
                      ...|++.+.||+|+||.||+|++.       .++..||+|.+...  ........+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            345889999999999999999753       23457999987532  1233446788999999999 8999999999999


Q ss_pred             ecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       233 ~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      ..+..|++|||+.+ ++.+++......        +..        ....+.  ......++...+..++.||++||.||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~--------~~~~~~--~~~~~~~~~~~~~~~~~qi~~al~~L  153 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPP--------GME--------YSYDIA--RVPDEQMTFKDLVSCTYQVARGMEYL  153 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCc--------ccc--------cccccc--cCCcccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999975 555554311000        000        000000  01234688899999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      |++||+||||||+|||++.++.+||+|||+++....      .....+++.|+|||++.   ...|+.++|||||||++|
T Consensus       154 H~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~  230 (304)
T cd05101         154 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMW  230 (304)
T ss_pred             HHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc---cCCCCchhhHHHHHHHHH
Confidence            999999999999999999999999999999875422      12234667899999984   356888999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        386 ELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       386 ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      ||++ |..||.+.+..+....+..+..                                          .......+..+
T Consensus       231 el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~  268 (304)
T cd05101         231 EIFTLGGSPYPGIPVEELFKLLKEGHR------------------------------------------MDKPANCTNEL  268 (304)
T ss_pred             HHHcCCCCCcccCCHHHHHHHHHcCCc------------------------------------------CCCCCCCCHHH
Confidence            9998 8899977655444333321100                                          00113467889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+|+.+||..+|.+|||+.++++.
T Consensus       269 ~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         269 YMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcccChhhCCCHHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-36  Score=323.02  Aligned_cols=245  Identities=25%  Similarity=0.424  Sum_probs=193.6

Q ss_pred             ccccccccccccccceEEEEeeece---eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~---~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|++.+.||+|+||.||+|++..++   ..+|+|.++...  .......+.+|+.++++++||||+++++++..++..|+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4888999999999999999987554   379999876422  12334678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||++|+ +.+.+.                                 ...+.+++.++..++.|++.||.|||++||+|
T Consensus        83 v~e~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h  129 (267)
T cd05066          83 VTEYMENGSLDAFLR---------------------------------KHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH  129 (267)
T ss_pred             EEEcCCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            99999865 332221                                 12245789999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCCC-------ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~~-------~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      |||||+|||++.++.+||+|||++.......       ...++..|+|||.+.   .+.++.++|+|||||++||+++ |
T Consensus       130 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~~l~ell~~g  206 (267)
T cd05066         130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMWEVMSYG  206 (267)
T ss_pred             hhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhc---cCccCchhhhHHHHHHHHHHhcCC
Confidence            9999999999999999999999987543211       122356899999984   3568889999999999999886 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||.+.+..+....+.++..                                          .......++.+.+++.+
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~  244 (267)
T cd05066         207 ERPYWEMSNQDVIKAIEEGYR------------------------------------------LPAPMDCPAALHQLMLD  244 (267)
T ss_pred             CCCcccCCHHHHHHHHhCCCc------------------------------------------CCCCCCCCHHHHHHHHH
Confidence            999987655444333321100                                          00113457889999999


Q ss_pred             hcccCCCCCCCHHHHHc
Q psy17952        471 CLAKNPADRPSSGRLLT  487 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~  487 (804)
                      ||+++|.+|||+.++++
T Consensus       245 ~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         245 CWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HcccCchhCCCHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=323.33  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=189.6

Q ss_pred             cccccccccceEEEEeeecee--EEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEEeec
Q psy17952        168 REIGHGSFGAVYYARCLVSRE--IVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYC  244 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~--~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVmEy~  244 (804)
                      +.||+|+||.||+|++..++.  .+|+|.+...  ......+.+.+|+++++++ +||||+++++++...+..|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            368999999999999887775  4688876532  1223345678999999999 7999999999999999999999999


Q ss_pred             CC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        245 LG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       245 ~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      .+ ++.+++.....                  +...............++++++..++.|++.||+|||++|++||||||
T Consensus        79 ~~~~L~~~i~~~~~------------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp  140 (270)
T cd05047          79 PHGNLLDFLRKSRV------------------LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA  140 (270)
T ss_pred             CCCcHHHHHHhccc------------------cccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccc
Confidence            74 55554431100                  000000000011234588999999999999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCh
Q psy17952        324 GNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNA  399 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~  399 (804)
                      +|||++.++.+||+|||++.....   ......++.|+|||++.   ...++.++|||||||++|||++ |..||.+.+.
T Consensus       141 ~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~  217 (270)
T cd05047         141 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  217 (270)
T ss_pred             ceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHc---cCCCCchhhHHHHHHHHHHHHcCCCCCccccCH
Confidence            999999999999999999853221   11123456799999884   3568889999999999999997 9999977655


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      .+....+..+..                                          .......+.++.+++.+||..||.+|
T Consensus       218 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R  255 (270)
T cd05047         218 AELYEKLPQGYR------------------------------------------LEKPLNCDDEVYDLMRQCWREKPYER  255 (270)
T ss_pred             HHHHHHHhCCCC------------------------------------------CCCCCcCCHHHHHHHHHHcccChhhC
Confidence            443333211100                                          00112356789999999999999999


Q ss_pred             CCHHHHHc
Q psy17952        480 PSSGRLLT  487 (804)
Q Consensus       480 psa~elL~  487 (804)
                      ||++++++
T Consensus       256 ps~~~il~  263 (270)
T cd05047         256 PSFAQILV  263 (270)
T ss_pred             CCHHHHHH
Confidence            99999885

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.2e-37  Score=327.06  Aligned_cols=262  Identities=23%  Similarity=0.403  Sum_probs=192.8

Q ss_pred             cccccccccccccccceEEEEe----eeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--C
Q psy17952        162 KIFEDLREIGHGSFGAVYYARC----LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--H  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~----~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~  235 (804)
                      +.|++++.||+|+||.||+|+.    ..+++.||+|.+....  .......+.+|+++++.++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3589999999999999999974    4578899999886432  223345788999999999999999999998775  5


Q ss_pred             ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+||||++|+ +.+++.                                 .....+++..+..++.|++.||+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~~i~~aL~~lH~~  128 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLP---------------------------------RNKNKINLKQQLKYAVQICKGMDYLGSR  128 (284)
T ss_pred             ceEEEEEccCCCCHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            689999999865 322221                                 1123578999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ||+||||||+|||++.++.+||+|||+++.....       ....|+..|+|||++.   +..++.++|||||||++|||
T Consensus       129 gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~il~el  205 (284)
T cd05079         129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI---QSKFYIASDVWSFGVTLYEL  205 (284)
T ss_pred             CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc---cCCCCccccchhhhhhhhhh
Confidence            9999999999999999999999999998653221       2345777899999984   35688899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      +++..|+....  ........   |........                     .....+.. .........++..+.+|
T Consensus       206 lt~~~~~~~~~--~~~~~~~~---~~~~~~~~~---------------------~~~~~~~~-~~~~~~~~~~~~~~~~l  258 (284)
T cd05079         206 LTYCDSESSPM--TLFLKMIG---PTHGQMTVT---------------------RLVRVLEE-GKRLPRPPNCPEEVYQL  258 (284)
T ss_pred             hcCCCCCcccc--chhhhhcc---cccccccHH---------------------HHHHHHHc-CccCCCCCCCCHHHHHH
Confidence            99887764321  11111100   000000000                     00000011 11111234578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+||+.||.+|||+.+++++
T Consensus       259 i~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         259 MRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-36  Score=320.25  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=191.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +...|++.+.||+|+||.||+|.+..++ .+|+|.+....    ...+.+.+|++++++++||||+++++++. .+..|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            3455899999999999999999876554 59999875322    12356788999999999999999998875 456899


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||+.| ++.+.+..                                .....+++..+..++.|++.||.|||+.||+|
T Consensus        78 v~e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H  125 (260)
T cd05069          78 VTEFMGKGSLLDFLKE--------------------------------GDGKYLKLPQLVDMAAQIADGMAYIERMNYIH  125 (260)
T ss_pred             EEEcCCCCCHHHHHhh--------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence            9999986 44443320                                01234788999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+|||+++++.+||+|||++......     ....++..|+|||.+.   .+.++.++|||||||++|||++ |.+
T Consensus       126 ~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~~l~el~t~g~~  202 (260)
T cd05069         126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELVTKGRV  202 (260)
T ss_pred             cccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhc---cCCcChHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998653221     1234667899999874   3568889999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+....+....+.....                                          .......+..+.+|+.+||
T Consensus       203 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l  240 (260)
T cd05069         203 PYPGMVNREVLEQVERGYR------------------------------------------MPCPQGCPESLHELMKLCW  240 (260)
T ss_pred             CCCCCCHHHHHHHHHcCCC------------------------------------------CCCCcccCHHHHHHHHHHc
Confidence            9987665554443322100                                          0011245788999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      .+||++||+++++++
T Consensus       241 ~~~p~~Rp~~~~i~~  255 (260)
T cd05069         241 KKDPDERPTFEYIQS  255 (260)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-36  Score=323.70  Aligned_cols=257  Identities=21%  Similarity=0.394  Sum_probs=196.5

Q ss_pred             ccccccccccccccccceEEEEeeec-----eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVS-----REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~-----~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .+.|+.++.||+|+||.||+|+.+.+     .+.||+|.+....  .......+.+|++++++++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            35589999999999999999997643     4679999775321  1223467889999999999999999999999989


Q ss_pred             ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+||||+.| ++.+++....                         ..........+++..+..++.|++.||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~-------------------------~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~  136 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATK-------------------------SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA  136 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcc-------------------------cccccccccCCCHHHHHHHHHHHHHHHHHhhhc
Confidence            99999999985 4444332100                         000000122689999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||+||||||+|||++.++.+||+|||++.....     .....+++.|+|||.+.   .+.++.++|||||||++|+|++
T Consensus       137 ~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~  213 (275)
T cd05046         137 RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ---EDDFSTKSDVWSFGVLMWEVFT  213 (275)
T ss_pred             CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhc---cCCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999864321     22346778899999874   3457789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||.+.+.......+..+..                                         +......++..+.+++
T Consensus       214 ~~~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~~i  252 (275)
T cd05046         214 QGELPFYGLSDEEVLNRLQAGKL-----------------------------------------ELPVPEGCPSRLYKLM  252 (275)
T ss_pred             CCCCCccccchHHHHHHHHcCCc-----------------------------------------CCCCCCCCCHHHHHHH
Confidence             8899976554443333221110                                         0001124578899999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||++|||+.+++..
T Consensus       253 ~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         253 TRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HHHcCCCcccCCCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-37  Score=319.36  Aligned_cols=242  Identities=30%  Similarity=0.481  Sum_probs=197.1

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC-Cc
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SA  248 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G-~l  248 (804)
                      ||+|+||.||++.+..+++.+|+|.+.............+..|+.++++++||||+++++.+..+...|+||||+.| ++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            79999999999999888999999988654333333456788999999999999999999999999999999999964 43


Q ss_pred             hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        249 SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       249 ~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                      .+.+                                  .....+++..+..++.|++.||.|||+.+++|+||||+||++
T Consensus        81 ~~~l----------------------------------~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~  126 (250)
T cd05123          81 FSHL----------------------------------SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL  126 (250)
T ss_pred             HHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE
Confidence            3322                                  233468999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy17952        329 TETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALY  404 (804)
Q Consensus       329 ~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~  404 (804)
                      +.++.++|+|||++.....    .....|+..|+|||.+.   +..++.++|+|||||++|+|++|..||...+......
T Consensus       127 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~  203 (250)
T cd05123         127 DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL---GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE  203 (250)
T ss_pred             cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhC---CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999865432    23457899999999984   3456789999999999999999999997655433322


Q ss_pred             HHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH--
Q psy17952        405 HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS--  482 (804)
Q Consensus       405 ~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa--  482 (804)
                      .+.+...                                           ..+...+..+.+|+.+||..||++|||+  
T Consensus       204 ~~~~~~~-------------------------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         204 KILKDPL-------------------------------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHhcCCC-------------------------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2221100                                           0112347889999999999999999999  


Q ss_pred             -HHHHcCccc
Q psy17952        483 -GRLLTHDLV  491 (804)
Q Consensus       483 -~elL~Hp~~  491 (804)
                       .++++||||
T Consensus       241 ~~~l~~~~~f  250 (250)
T cd05123         241 AEEIKAHPFF  250 (250)
T ss_pred             HHHHHhCCCC
Confidence             999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=318.72  Aligned_cols=242  Identities=25%  Similarity=0.386  Sum_probs=192.8

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|...  ++.||+|.+.....    ..+++.+|+.++++++||||+++++++...+..|+|||
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            4888999999999999999754  78899998864321    34678899999999999999999999999999999999


Q ss_pred             ecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.+ ++.+.+..                                .....+++..+..++.|++.||.|||++||+||||
T Consensus        81 ~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di  128 (256)
T cd05039          81 YMAKGSLVDYLRS--------------------------------RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL  128 (256)
T ss_pred             ecCCCcHHHHHHh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhc
Confidence            9985 44333220                                11236899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCh
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNA  399 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~  399 (804)
                      ||+||+++.++.+||+|||+++..... ....++..|+|||.+.   .+.++.++|||||||++|||++ |..||...+.
T Consensus       129 ~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  205 (256)
T cd05039         129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  205 (256)
T ss_pred             ccceEEEeCCCCEEEcccccccccccccccCCCcccccCchhhc---CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999998764322 1233456799999874   3568889999999999999997 9999976654


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ......+..+.                                          +......+++.+.+|+.+||..+|++|
T Consensus       206 ~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R  243 (256)
T cd05039         206 KDVVPHVEKGY------------------------------------------RMEAPEGCPPEVYKVMKDCWELDPAKR  243 (256)
T ss_pred             HHHHHHHhcCC------------------------------------------CCCCccCCCHHHHHHHHHHhccChhhC
Confidence            43332221110                                          000112457889999999999999999


Q ss_pred             CCHHHHHc
Q psy17952        480 PSSGRLLT  487 (804)
Q Consensus       480 psa~elL~  487 (804)
                      ||+.+++.
T Consensus       244 p~~~~l~~  251 (256)
T cd05039         244 PTFKQLRE  251 (256)
T ss_pred             cCHHHHHH
Confidence            99999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-36  Score=322.18  Aligned_cols=245  Identities=24%  Similarity=0.435  Sum_probs=194.0

Q ss_pred             ccccccccccccccceEEEEeeecee---EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~---~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|++.+.||+|+||.||+|.+..+++   .||||.+...  ........+.+|+.++++++||||+++++++.++...|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            37889999999999999999887664   6999987642  123345678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+++.                                 ...+.+++.++..++.|++.||.|||++|++|
T Consensus        83 v~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H  129 (269)
T cd05065          83 ITEFMENGALDSFLR---------------------------------QNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH  129 (269)
T ss_pred             EEecCCCCcHHHHHh---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            99999865 322221                                 12345889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCCC-------ccc--cCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPAN-------SFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~~-------~~~--GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |||||+|||++.++.+||+|||++.......       ...  ++..|+|||.+.   .+.++.++|||||||++|||++
T Consensus       130 ~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~~l~e~l~  206 (269)
T cd05065         130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMWEVMS  206 (269)
T ss_pred             cccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhc---cCcccchhhhhhhHHHHHHHhc
Confidence            9999999999999999999999986432211       111  235799999984   4568889999999999999886


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||.+.+..+....+....                                          +......++..+.+++
T Consensus       207 ~g~~p~~~~~~~~~~~~i~~~~------------------------------------------~~~~~~~~~~~~~~li  244 (269)
T cd05065         207 YGERPYWDMSNQDVINAIEQDY------------------------------------------RLPPPMDCPTALHQLM  244 (269)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC------------------------------------------cCCCcccCCHHHHHHH
Confidence             999998766554443332110                                          0001134578899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||+.+|.+||++.+++.
T Consensus       245 ~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         245 LDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.6e-36  Score=318.68  Aligned_cols=241  Identities=28%  Similarity=0.434  Sum_probs=183.2

Q ss_pred             cccccccccceEEEEeee---ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe-ecCceEEEEee
Q psy17952        168 REIGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL-RDHTAWLVMEY  243 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~---~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~-~~~~~~lVmEy  243 (804)
                      +.||+|+||.||+|.+..   .+..||||.+...  ......+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998654   3467999987532  12234467889999999999999999999765 45678999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.++ +.+++.                                 .....+++..+..++.|+++||+|||+.+|+|||||
T Consensus        79 ~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  125 (262)
T cd05058          79 MKHGDLRNFIR---------------------------------SETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLA  125 (262)
T ss_pred             CCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence            9854 333321                                 112345677888999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      |+|||++.++.+||+|||+++....        .....+++.|+|||.+.   ...++.++|||||||++|||++ |.+|
T Consensus       126 ~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~~~~~  202 (262)
T cd05058         126 ARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPP  202 (262)
T ss_pred             cceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhc---cCccchHHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999864321        11334677899999874   3568889999999999999999 5677


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+..+....+..+..                                          .......++.+.+++.+||.
T Consensus       203 ~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~cl~  240 (262)
T cd05058         203 YPDVDSFDITVYLLQGRR------------------------------------------LLQPEYCPDPLYEVMLSCWH  240 (262)
T ss_pred             CCCCCHHHHHHHHhcCCC------------------------------------------CCCCCcCCHHHHHHHHHHcC
Confidence            766554433322221110                                          00112346789999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .+|++||++.+++..
T Consensus       241 ~~p~~Rp~~~~il~~  255 (262)
T cd05058         241 PKPEMRPTFSELVSR  255 (262)
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999853

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=328.52  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=182.5

Q ss_pred             ccccccccccccccccceEEEEeeec---eeEEEEEecccccccchhh--------hhhHHHHHHHHhhcCCCceeEeee
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEK--------WADILKEIRFLRQLKHPNTIEYRG  229 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~--------~~~~~~Ei~iL~~L~HpNIV~l~~  229 (804)
                      .+.|++.+.||+|+||.||+|.+..+   +..+|+|............        ......+...+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35699999999999999999998877   6677777543221110000        011223444566779999999998


Q ss_pred             EEeecC----ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHH
Q psy17952        230 CYLRDH----TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVL  305 (804)
Q Consensus       230 ~~~~~~----~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil  305 (804)
                      ++....    ..|++||++..++.+++.                                  .....++..+..|+.|++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~i~~qi~  136 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVENTKEIFK----------------------------------RIKCKNKKLIKNIMKDML  136 (294)
T ss_pred             eeeEecCCceEEEEEEehhccCHHHHHH----------------------------------hhccCCHHHHHHHHHHHH
Confidence            765543    346788877655433221                                  112357888999999999


Q ss_pred             HHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccC-----------CCCccccCcccccchhhcccCCCCCCCc
Q psy17952        306 RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-----------PANSFVGTPYWMAPEVILAMDEGQYDGK  374 (804)
Q Consensus       306 ~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~-----------~~~~~~GT~~Y~APEvl~~~~~~~y~~k  374 (804)
                      .||+|||+++|+||||||+|||++.++.+||+|||+|+...           ......||+.|+|||++.   +..|+.+
T Consensus       137 ~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~---~~~~~~~  213 (294)
T PHA02882        137 TTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN---GACVTRR  213 (294)
T ss_pred             HHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC---CCCCCcH
Confidence            99999999999999999999999999999999999986432           112357999999999984   4568999


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC
Q psy17952        375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC  454 (804)
Q Consensus       375 sDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~  454 (804)
                      +|||||||++|||++|++||.+.+....+....+.          ..++.+.                      +.   .
T Consensus       214 ~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~----------~~~~~~~----------------------~~---~  258 (294)
T PHA02882        214 GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC----------DFIKRLH----------------------EG---K  258 (294)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH----------HHHHHhh----------------------hh---h
Confidence            99999999999999999999776332222111110          0001110                      00   0


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       455 ~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      ......++.+.+++..||..+|++||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        259 IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            011234688999999999999999999999874

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9e-37  Score=322.11  Aligned_cols=253  Identities=27%  Similarity=0.508  Sum_probs=197.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEeccccccc--chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +|.+.+.||+|+||.||++++..++..+++|.++.....  .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            478889999999999999999888777777765432211  112234567899999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.|+ +.+++..                              .......+++..+..++.|+++||.|||++|++|+
T Consensus        81 ~e~~~~~~l~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~  130 (260)
T cd08222          81 TEYCEGRDLDCKLEE------------------------------LKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHR  130 (260)
T ss_pred             EEeCCCCCHHHHHHH------------------------------HhhcccccCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            9999864 3333210                              01123568999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+||+++. +.+||+|||++.....    .....|++.|+|||.+.   ...++.++|+||||+++|+|++|..||.
T Consensus       131 ~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         131 DLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK---HQGYDSKSDIWSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             CCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999975 6799999999865432    22456899999999874   3457889999999999999999999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+.......+..+..                                         +. ....++.++.++|.+||..|
T Consensus       207 ~~~~~~~~~~~~~~~~-----------------------------------------~~-~~~~~~~~~~~li~~~l~~~  244 (260)
T cd08222         207 GQNFLSVVLRIVEGPT-----------------------------------------PS-LPETYSRQLNSIMQSMLNKD  244 (260)
T ss_pred             CccHHHHHHHHHcCCC-----------------------------------------CC-CcchhcHHHHHHHHHHhcCC
Confidence            6554433333221110                                         00 12346788999999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy17952        476 PADRPSSGRLLTHDLV  491 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~  491 (804)
                      |++||++.++++||||
T Consensus       245 p~~Rp~~~~il~~~~~  260 (260)
T cd08222         245 PSLRPSAAEILRNPFI  260 (260)
T ss_pred             hhhCcCHHHHhhCCCC
Confidence            9999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-36  Score=317.05  Aligned_cols=244  Identities=27%  Similarity=0.463  Sum_probs=194.4

Q ss_pred             cccccccccccccceEEEEeeece----eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +++.+.||.|+||.||+|++..++    ..||+|.+.....  ......+..|+.+++.++||||+++++++...+..|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            356789999999999999998766    8999998864321  1245678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCC-CCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~-l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||+.|+ +.+.+..                                 .... +++..+..++.|++.||+|||+.|++
T Consensus        79 i~e~~~~~~l~~~~~~---------------------------------~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~  125 (258)
T smart00219       79 VMEYMEGGDLLDYLRK---------------------------------NRPKELSLSDLLSFALQIARGMEYLESKNFI  125 (258)
T ss_pred             EEeccCCCCHHHHHHh---------------------------------hhhccCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence            99999864 3333210                                 1112 89999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCCC-----ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~~-----~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      ||||||+||+++.++.+||+|||++.......     ...+++.|+|||.+.   ...++.++||||+||++|||++ |.
T Consensus       126 h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~i~~~l~~~g~  202 (258)
T smart00219      126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK---DGKFTSKSDVWSFGVLLWEIFTLGE  202 (258)
T ss_pred             ecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhc---cCCCCcchhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999986543221     123678999999883   4568889999999999999998 88


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||...+.......+.+...+                                          ......+..+.+++.+|
T Consensus       203 ~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~i~~~  240 (258)
T smart00219      203 SPYPGMSNEEVLEYLKKGYRL------------------------------------------PKPENCPPEIYKLMLQC  240 (258)
T ss_pred             CCCCCCCHHHHHHHHhcCCCC------------------------------------------CCCCcCCHHHHHHHHHH
Confidence            998765554444433221100                                          01123578899999999


Q ss_pred             cccCCCCCCCHHHHHc
Q psy17952        472 LAKNPADRPSSGRLLT  487 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~  487 (804)
                      |..||++|||+.++++
T Consensus       241 l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      241 WAEDPEDRPTFSELVE  256 (258)
T ss_pred             CcCChhhCcCHHHHHh
Confidence            9999999999999885

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-36  Score=316.08  Aligned_cols=239  Identities=26%  Similarity=0.408  Sum_probs=189.5

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS  247 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~  247 (804)
                      ++||+|+||.||+|.+.. ++.||+|.++....  ......+.+|++++++++||||+++++++......|+||||+.|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999877 99999998764322  234567889999999999999999999999999999999999865


Q ss_pred             -chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        248 -ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       248 -l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                       +.+.+.                                 .....+++..+..++.|++.||.|||+++++||||||+||
T Consensus        78 ~l~~~l~---------------------------------~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ni  124 (251)
T cd05041          78 SLLTFLR---------------------------------KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC  124 (251)
T ss_pred             cHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceE
Confidence             322221                                 1123578889999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCh
Q psy17952        327 LLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNA  399 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~  399 (804)
                      |++.++.+||+|||++......      ....++..|+|||.+.   .+.++.++|||||||++|||++ |..||.+...
T Consensus       125 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~  201 (251)
T cd05041         125 LVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN---YGRYTSESDVWSYGILLWETFSLGDTPYPGMSN  201 (251)
T ss_pred             EEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhc---cCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence            9999999999999998653311      1123456799999874   3568889999999999999999 8999977654


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ......+....                                          ........+..+.+|+.+||+.+|.+|
T Consensus       202 ~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R  239 (251)
T cd05041         202 QQTRERIESGY------------------------------------------RMPAPQLCPEEIYRLMLQCWAYDPENR  239 (251)
T ss_pred             HHHHHHHhcCC------------------------------------------CCCCCccCCHHHHHHHHHHhccChhhC
Confidence            43333221110                                          000113457889999999999999999


Q ss_pred             CCHHHHHc
Q psy17952        480 PSSGRLLT  487 (804)
Q Consensus       480 psa~elL~  487 (804)
                      ||+.++++
T Consensus       240 p~~~ell~  247 (251)
T cd05041         240 PSFSEIYN  247 (251)
T ss_pred             cCHHHHHH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-36  Score=332.55  Aligned_cols=262  Identities=24%  Similarity=0.402  Sum_probs=196.2

Q ss_pred             cccccccccccccccceEEEEeeec-------eeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVS-------REIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~-------~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      ..|++.+.||+|+||.||+|++...       ...||+|.+...  ........+.+|+.+++++ +||||+++++++..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            3589999999999999999986532       236899977532  2233456788999999999 79999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..|++|||+.+ ++.+++....      ..++..            .+.........++..++..++.|++.||.|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~------------~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH  151 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARR------PPGMDY------------SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA  151 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcC------Cccccc------------ccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999975 5544442100      000000            00000012345788899999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++||+||||||+|||++.++.+||+|||+++.....      ....++..|||||++.   ...++.++|||||||++||
T Consensus       152 ~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~e  228 (334)
T cd05100         152 SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLLWE  228 (334)
T ss_pred             HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc---cCCcCchhhhHHHHHHHHH
Confidence            999999999999999999999999999998653221      1223456799999984   3568889999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |++ |..||.+.+..+....+.....                                          .......+.++.
T Consensus       229 l~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~  266 (334)
T cd05100         229 IFTLGGSPYPGIPVEELFKLLKEGHR------------------------------------------MDKPANCTHELY  266 (334)
T ss_pred             HHhcCCCCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHH
Confidence            998 8999977665444433321110                                          001124577899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +|+.+||+.+|.+|||+.+++.+
T Consensus       267 ~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         267 MIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHcccChhhCcCHHHHHHH
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-36  Score=324.03  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=187.7

Q ss_pred             cccccccccccccceEEEE----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--Cce
Q psy17952        164 FEDLREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTA  237 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~  237 (804)
                      |+.++.||+|+||+||++.    ...+++.||+|.+....  .......+.+|+++|++++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            4899999999999998765    33567889999876421  122345678999999999999999999987653  458


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |++|||+.|+ +.+.+                                   ....+++.++..++.|++.||.|||++||
T Consensus        84 ~lv~e~~~~~~l~~~~-----------------------------------~~~~l~~~~~~~i~~~l~~~l~~lH~~~i  128 (283)
T cd05080          84 QLIMEYVPLGSLRDYL-----------------------------------PKHKLNLAQLLLFAQQICEGMAYLHSQHY  128 (283)
T ss_pred             EEEecCCCCCCHHHHH-----------------------------------HHcCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            9999999865 22221                                   12358999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||+++++.+||+|||+++.....       ....++..|+|||.+.   ...++.++|||||||++|||++
T Consensus       129 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~el~t  205 (283)
T cd05080         129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK---ENKFSYASDVWSFGVTLYELLT  205 (283)
T ss_pred             eccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc---ccCCCcccccHHHHHHHHHHHh
Confidence            99999999999999999999999998754321       1234567899999874   3568889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||......  +..+.........                ..         .+...............++.++.+|+.
T Consensus       206 g~~p~~~~~~~--~~~~~~~~~~~~~----------------~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (283)
T cd05080         206 HCDSKQSPPKK--FEEMIGPKQGQMT----------------VV---------RLIELLERGMRLPCPKNCPQEVYILMK  258 (283)
T ss_pred             CCCCCCCCcch--hhhhhcccccccc----------------hh---------hhhhhhhcCCCCCCCCCCCHHHHHHHH
Confidence            99998543211  1111100000000                00         000000000001112456889999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q psy17952        470 SCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~  487 (804)
                      +||+.||++|||+++++.
T Consensus       259 ~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         259 NCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             HHhccChhhCCCHHHHHH
Confidence            999999999999999884

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.7e-36  Score=315.25  Aligned_cols=240  Identities=27%  Similarity=0.398  Sum_probs=188.4

Q ss_pred             cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC
Q psy17952        168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS  247 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~  247 (804)
                      +.||+|+||.||+|.. .++..+|+|.+....  .......+.+|++++++++||||+++++++...+..|+||||+.|+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            3699999999999985 467889999876432  1223346789999999999999999999999999999999999865


Q ss_pred             -chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCe
Q psy17952        248 -ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI  326 (804)
Q Consensus       248 -l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NI  326 (804)
                       +.+.+.                                 .....+++..+..++.|++.||.|||++|++||||||+||
T Consensus        78 ~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ni  124 (250)
T cd05085          78 DFLSFLR---------------------------------KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC  124 (250)
T ss_pred             cHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheE
Confidence             222111                                 1234578999999999999999999999999999999999


Q ss_pred             eecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChH
Q psy17952        327 LLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAM  400 (804)
Q Consensus       327 Ll~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~  400 (804)
                      +++.++.+||+|||++......     ....+++.|+|||++.   .+.++.++|||||||++|||++ |..||.+.+..
T Consensus       125 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~  201 (250)
T cd05085         125 LVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN---YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ  201 (250)
T ss_pred             EEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhc---cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence            9999999999999998643221     1223456799999984   3567889999999999999998 99999876654


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      .....+..+.                                          ........+..+.+|+.+||..+|++||
T Consensus       202 ~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp  239 (250)
T cd05085         202 QAREQVEKGY------------------------------------------RMSCPQKCPDDVYKVMQRCWDYKPENRP  239 (250)
T ss_pred             HHHHHHHcCC------------------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCC
Confidence            4433332110                                          0001123578899999999999999999


Q ss_pred             CHHHHHcC
Q psy17952        481 SSGRLLTH  488 (804)
Q Consensus       481 sa~elL~H  488 (804)
                      |+.++++.
T Consensus       240 ~~~~l~~~  247 (250)
T cd05085         240 KFSELQKE  247 (250)
T ss_pred             CHHHHHHH
Confidence            99998753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-36  Score=320.86  Aligned_cols=245  Identities=26%  Similarity=0.391  Sum_probs=192.9

Q ss_pred             cccccccccccccccceEEEEeeecee----EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~----~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ..|++.+.||+|+||.||+|.+..+++    .||+|.+....  .......+.+|+.++++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            458999999999999999999877664    58999775432  13344678899999999999999999999887 789


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ++||||+.|+ +.+.+.                                 .....+++..+..++.|++.||+|||++||
T Consensus        84 ~~v~e~~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  130 (279)
T cd05057          84 QLITQLMPLGCLLDYVR---------------------------------NHKDNIGSQYLLNWCVQIAKGMSYLEEKRL  130 (279)
T ss_pred             EEEEecCCCCcHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            9999999754 333221                                 123458999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCCC------ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~------~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||++.++.+||+|||+++......      ...++..|+|||.+.   ...++.++|+|||||++|||++ 
T Consensus       131 ~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~el~~~  207 (279)
T cd05057         131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVTVWELMTF  207 (279)
T ss_pred             EecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhh---cCCcCchhhHHHHHHHHHHHhcC
Confidence            999999999999999999999999997543221      122356799999874   3568889999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |++||.+.+..+....+..+..                                          .......+..+.+++.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~  245 (279)
T cd05057         208 GAKPYEGIPAVEIPDLLEKGER------------------------------------------LPQPPICTIDVYMVLV  245 (279)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCC------------------------------------------CCCCCCCCHHHHHHHH
Confidence            9999977665443333322110                                          0011235678899999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q psy17952        470 SCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~  487 (804)
                      +||..||.+|||+.++++
T Consensus       246 ~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         246 KCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHcCCChhhCCCHHHHHH
Confidence            999999999999999863

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-36  Score=322.32  Aligned_cols=261  Identities=26%  Similarity=0.437  Sum_probs=190.0

Q ss_pred             cccccccccccccccceEEEE----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cC
Q psy17952        162 KIFEDLREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~  235 (804)
                      +.|++++.||+|+||.||+|.    +..+++.||+|.+...   .....+.+.+|++++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            358899999999999999997    3457889999987643   23334678899999999999999999998654  34


Q ss_pred             ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+||||+.|+ +.+++.                                 .....+++..+..++.|++.||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~---------------------------------~~~~~l~~~~~~~~~~~l~~aL~~LH~~  127 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQ---------------------------------KHRERLDHRKLLLYASQICKGMEYLGSK  127 (284)
T ss_pred             ceEEEEEecCCCCHHHHHH---------------------------------hcCcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            689999999754 433221                                 1134588999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCCC-------ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~-------~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ||+||||||+|||++.++.+||+|||++.......       ...++..|+|||++.   .+.++.++|||||||++|||
T Consensus       128 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el  204 (284)
T cd05081         128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYEL  204 (284)
T ss_pred             CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc---cCCcChHHHHHHHHHHHHHH
Confidence            99999999999999999999999999987543211       112345699999984   35688899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|..|+..... .....+.. ..+ ....                       ...+...............++.++.+|
T Consensus       205 ~~~~~~~~~~~~-~~~~~~~~-~~~-~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (284)
T cd05081         205 FTYSDKSCSPPA-EFMRMMGN-DKQ-GQMI-----------------------VYHLIELLKNNGRLPAPPGCPAEIYAI  258 (284)
T ss_pred             hhcCCcCCCcch-hhhhhccc-ccc-cccc-----------------------hHHHHHHHhcCCcCCCCCCCCHHHHHH
Confidence            999887643321 11111100 000 0000                       000001111111112234578899999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q psy17952        468 VSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~  487 (804)
                      +.+||..+|++|||+.++++
T Consensus       259 i~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         259 MKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-36  Score=317.72  Aligned_cols=237  Identities=22%  Similarity=0.327  Sum_probs=182.7

Q ss_pred             cccccccccceEEEEeeece----------eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        168 REIGHGSFGAVYYARCLVSR----------EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~----------~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      +.||+|+||.||+|.+..++          ..+++|.+....    .....+.+|+.++++++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46999999999999998776          357888664321    114678899999999999999999999888 788


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+||||+.|+ +.+++.                                 .....+++..+..++.||+.||.|||++||
T Consensus        76 ~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  122 (259)
T cd05037          76 IMVEEYVKFGPLDVFLH---------------------------------REKNNVSLHWKLDVAKQLASALHYLEDKKL  122 (259)
T ss_pred             EEEEEcCCCCcHHHHHH---------------------------------hhccCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            9999999865 222221                                 112268899999999999999999999999


Q ss_pred             eecCCCCCCeeecCCC-------cEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETG-------TVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g-------~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||++.++       .+||+|||++..........++..|+|||++.+. ...++.++|||||||++|||++
T Consensus       123 ~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~~~~~l~~  201 (259)
T cd05037         123 VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNG-QASLTIAADKWSFGTTLLEICS  201 (259)
T ss_pred             ecccCccceEEEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhcCC-CCCcchhhHHHHHHHHHHHHHh
Confidence            9999999999999888       7999999999765544456788899999998532 1367889999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||...+..........                                        ....+    ...+..+.+|+
T Consensus       202 ~~~~p~~~~~~~~~~~~~~~----------------------------------------~~~~~----~~~~~~~~~li  237 (259)
T cd05037         202 NGEEPLSTLSSSEKERFYQD----------------------------------------QHRLP----MPDCAELANLI  237 (259)
T ss_pred             CCCCCcccCCchhHHHHHhc----------------------------------------CCCCC----CCCchHHHHHH
Confidence             5778755432111100000                                        00000    11137789999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||..||.+|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         238 NQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHhccChhhCCCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1187|consensus

Probab=100.00  E-value=1.8e-36  Score=335.49  Aligned_cols=194  Identities=37%  Similarity=0.519  Sum_probs=162.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc-eEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT-AWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~-~~lVm  241 (804)
                      .|..-..||+|+||.||+|..... ..||||++.......   ..+|.+|+.+|.+++|||+|+|+|||.+.+. .+||+
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            366667899999999999975544 899999876533221   2459999999999999999999999999884 99999


Q ss_pred             eecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---C
Q psy17952        242 EYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLG---R  316 (804)
Q Consensus       242 Ey~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~-~l~e~~i~~i~~qil~gL~yLH~~g---I  316 (804)
                      ||+. |+|.+.+.                              .   ... +++|....+|+.++|+||+|||...   |
T Consensus       152 Eym~nGsL~d~L~------------------------------~---~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~i  198 (361)
T KOG1187|consen  152 EYMPNGSLEDHLH------------------------------G---KKGEPLDWETRLKIALGAARGLAYLHEGCPPPI  198 (361)
T ss_pred             EccCCCCHHHHhC------------------------------C---CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence            9997 66655432                              1   122 7899999999999999999999854   9


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC-CCc---c-ccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP-ANS---F-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~---~-~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |||||||+|||||++..+||+|||+|+.... ...   . .||.+|+|||++.   .+..+.|+|||||||+|.||++|+
T Consensus       199 iHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~---~g~lt~KsDVySFGVvllElitgr  275 (361)
T KOG1187|consen  199 IHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS---TGKLTEKSDVYSFGVVLLELITGR  275 (361)
T ss_pred             ecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhc---cCCcCcccccccchHHHHHHHhCC
Confidence            9999999999999999999999999976543 222   2 7999999999984   367899999999999999999999


Q ss_pred             CCCCC
Q psy17952        392 PPYFN  396 (804)
Q Consensus       392 ~PF~~  396 (804)
                      .|...
T Consensus       276 ~~~d~  280 (361)
T KOG1187|consen  276 KAVDQ  280 (361)
T ss_pred             cccCC
Confidence            88754

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-36  Score=316.04  Aligned_cols=246  Identities=25%  Similarity=0.418  Sum_probs=194.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|++.+.||+|+||.||+|.+. .++.||||.+....    .....+.+|+.++++++||||+++++++......|+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            3456899999999999999999865 45779999876422    123568899999999999999999999999899999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+.+..                                .....+++..+..++.|++.||.|||++||+|
T Consensus        79 v~e~~~~~~L~~~i~~--------------------------------~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h  126 (261)
T cd05034          79 VTEYMSKGSLLDFLKS--------------------------------GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH  126 (261)
T ss_pred             EEeccCCCCHHHHHhc--------------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999864 3332210                                01235889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+||+++.++.+||+|||++......     ....++..|+|||.+.   ++.++.++|||||||++|||++ |+.
T Consensus       127 ~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~il~~l~t~g~~  203 (261)
T cd05034         127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN---YGRFTIKSDVWSFGILLTEIVTYGRV  203 (261)
T ss_pred             CCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhc---cCCcCchhHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998653321     1223567899999884   3567889999999999999998 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+....+..+..+..                                          .......+.++.+++.+||
T Consensus       204 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~i~~~l  241 (261)
T cd05034         204 PYPGMTNREVLEQVERGYR------------------------------------------MPRPPNCPEELYDLMLQCW  241 (261)
T ss_pred             CCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence            9987665554444422100                                          0011234678999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      ..||++||+++++..
T Consensus       242 ~~~p~~Rp~~~~l~~  256 (261)
T cd05034         242 DKDPEERPTFEYLQS  256 (261)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.5e-36  Score=318.97  Aligned_cols=246  Identities=28%  Similarity=0.489  Sum_probs=189.8

Q ss_pred             cccccccccceEEEEeeece------eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        168 REIGHGSFGAVYYARCLVSR------EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~------~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.||+|+||.||+|++....      +.+|||.+...  ........+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc--cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36999999999999876544      68999987532  11233467889999999999999999999999999999999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.| ++.+.+.....                           .......+++.++..++.|++.||.|||+++++|||
T Consensus        79 e~~~~~~L~~~l~~~~~---------------------------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~d  131 (269)
T cd05044          79 ELMEGGDLLSYLRDARV---------------------------ERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRD  131 (269)
T ss_pred             eccCCCcHHHHHHHhhh---------------------------cccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            99985 44443321100                           000123478899999999999999999999999999


Q ss_pred             CCCCCeeecCCC-----cEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        321 VKAGNILLTETG-----TVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       321 LKP~NILl~~~g-----~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |||+|||++.++     .+||+|||+++....      .....++..|+|||++.   .+.++.++|||||||++|||++
T Consensus       132 l~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~ellt  208 (269)
T cd05044         132 LAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL---DGKFTTQSDVWSFGVLMWEILT  208 (269)
T ss_pred             CChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHc---cCCcccchhHHHHHHHHHHHHH
Confidence            999999999887     899999999864321      12335678899999984   4568899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||...+..+....+..+..                                          .......+..+.+|+
T Consensus       209 ~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li  246 (269)
T cd05044         209 LGQQPYPALNNQEVLQHVTAGGR------------------------------------------LQKPENCPDKIYQLM  246 (269)
T ss_pred             cCCCCCcccCHHHHHHHHhcCCc------------------------------------------cCCcccchHHHHHHH
Confidence             9999977665544433321110                                          001123578899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||+.+|.+||++.++++
T Consensus       247 ~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         247 TNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.3e-36  Score=314.64  Aligned_cols=243  Identities=28%  Similarity=0.445  Sum_probs=192.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ....+.+|++++++++||||+++++++......|+|||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            4788999999999999999875 466899998753221    12457889999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+.|+ +.+.+.                                 ...+.++++.+..++.|++.||+|||+++++||||
T Consensus        80 ~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl  126 (256)
T cd05112          80 FMEHGCLSDYLR---------------------------------AQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL  126 (256)
T ss_pred             cCCCCcHHHHHH---------------------------------hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence            99865 222211                                 12346789999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||+||+++.++.+||+|||++......     ....++..|+|||++.   .+.++.++|||||||++|||++ |.+||.
T Consensus       127 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~---~~~~~~~~Dv~slG~~l~el~~~g~~p~~  203 (256)
T cd05112         127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS---FSKYSSKSDVWSFGVLMWEVFSEGKTPYE  203 (256)
T ss_pred             ccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhc---cCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999998643221     1233566899999884   3568889999999999999998 999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      ..+....+..+..+..                                          .......+..+.+|+.+||+.+
T Consensus       204 ~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~l~~~~l~~~  241 (256)
T cd05112         204 NRSNSEVVETINAGFR------------------------------------------LYKPRLASQSVYELMQHCWKER  241 (256)
T ss_pred             cCCHHHHHHHHhCCCC------------------------------------------CCCCCCCCHHHHHHHHHHcccC
Confidence            6655444333321100                                          0011224788999999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy17952        476 PADRPSSGRLLTH  488 (804)
Q Consensus       476 P~~Rpsa~elL~H  488 (804)
                      |++|||+.++++.
T Consensus       242 p~~Rp~~~~~l~~  254 (256)
T cd05112         242 PEDRPSFSLLLHQ  254 (256)
T ss_pred             hhhCCCHHHHHHh
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.7e-36  Score=319.20  Aligned_cols=253  Identities=21%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             cccccccccccccccceEEEEeee----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-cCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-DHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-~~~  236 (804)
                      +.|++.+.||+|+||.||+|.+..    ++..||+|.+...  ........+.+|+.++++++||||+++++++.. ...
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            458899999999999999999876    3678999987632  223345678899999999999999999998765 577


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .++++||+.+ ++.+++....                         .. .......+++..+..++.|++.||+|||+++
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~-------------------------~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  137 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCR-------------------------LG-EANNPQALSTQQLVHMAIQIACGMSYLHKRG  137 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhcc-------------------------cc-ccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            8999999974 4444332100                         00 0001246899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ++||||||+|||+++++.+||+|||+++...+.      ....++..|+|||++.   ...++.++|||||||++||+++
T Consensus       138 i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~~l~el~~  214 (280)
T cd05043         138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV---NKEYSSASDVWSFGVLLWELMT  214 (280)
T ss_pred             EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHh---cCCCCchhhHHHhHHHHHHHhc
Confidence            999999999999999999999999999754221      2234667899999984   3468889999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |++||.+.+..+....+..+.                                          +......+++++.+++
T Consensus       215 ~g~~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li  252 (280)
T cd05043         215 LGQTPYVEIDPFEMAAYLKDGY------------------------------------------RLAQPINCPDELFAVM  252 (280)
T ss_pred             CCCCCcCcCCHHHHHHHHHcCC------------------------------------------CCCCCCcCCHHHHHHH
Confidence             999997765544322221110                                          0001123578899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||..||++|||+.++++
T Consensus       253 ~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         253 ACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHHcCCChhhCCCHHHHHH
Confidence            9999999999999999884

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.4e-36  Score=317.55  Aligned_cols=250  Identities=23%  Similarity=0.399  Sum_probs=185.6

Q ss_pred             cccccccccceEEEEeeece--eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        168 REIGHGSFGAVYYARCLVSR--EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~~~~--~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      +.||+|+||.||++.....+  ..+++|.+....  .......+.+|+.+++.++||||+++++++......|+|||||.
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            36999999999999754332  346677654322  12334678999999999999999999999999999999999998


Q ss_pred             C-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q psy17952        246 G-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG  324 (804)
Q Consensus       246 G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~  324 (804)
                      | ++.+.+...                              ......+++..+..++.||+.||+|||+++|+||||||+
T Consensus        79 ~~~L~~~l~~~------------------------------~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~  128 (268)
T cd05086          79 LGDLKSYLSQE------------------------------QWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALR  128 (268)
T ss_pred             CCcHHHHHHhh------------------------------hcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccc
Confidence            5 443333210                              001234667788899999999999999999999999999


Q ss_pred             CeeecCCCcEEEEecccccccC------CCCccccCcccccchhhcccC----CCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        325 NILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       325 NILl~~~g~vKL~DFGla~~~~------~~~~~~GT~~Y~APEvl~~~~----~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      |||++.++.+||+|||++....      .....+|++.|+|||++....    ...++.++|||||||++|||++ |.+|
T Consensus       129 nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p  208 (268)
T cd05086         129 NCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP  208 (268)
T ss_pred             eEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence            9999999999999999985421      123457889999999874321    1235778999999999999997 5778


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+..+.+..+........                                    ..|.. ...+++.+.+++..|| 
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~-~~~~~~~~~~l~~~c~-  250 (268)
T cd05086         209 YSHLSDREVLNHVIKDQQVKL------------------------------------FKPQL-ELPYSERWYEVLQFCW-  250 (268)
T ss_pred             CCCCCHHHHHHHHHhhccccc------------------------------------CCCcc-CCCCcHHHHHHHHHHh-
Confidence            877666655554433211100                                    00111 1236788999999999 


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .+|++|||++++++
T Consensus       251 ~~P~~Rp~~~~i~~  264 (268)
T cd05086         251 LSPEKRATAEEVHR  264 (268)
T ss_pred             hCcccCCCHHHHHH
Confidence            68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.9e-36  Score=316.96  Aligned_cols=246  Identities=25%  Similarity=0.388  Sum_probs=191.8

Q ss_pred             cccccccccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      +.|.+.+.||+|+||.||+|.+...   ...||||......  .....+.+.+|+.++++++||||+++++++.+ ...|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            4478889999999999999987654   3468999775322  13344678899999999999999999998875 5678


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.++ +.+++.                                 .....+++..+..++.|++.||+|||++|++
T Consensus        83 lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~  129 (270)
T cd05056          83 IVMELAPLGELRSYLQ---------------------------------VNKYSLDLASLILYSYQLSTALAYLESKRFV  129 (270)
T ss_pred             EEEEcCCCCcHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            999999854 333221                                 1123578999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      ||||||+|||++.++.+||+|||+++.....     ....+++.|+|||.+.   ...++.++|||||||++|||++ |.
T Consensus       130 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~g~  206 (270)
T cd05056         130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMLGV  206 (270)
T ss_pred             ccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhc---cCCCCchhhhHHHHHHHHHHHHcCC
Confidence            9999999999999999999999998653221     1223456899999874   3468889999999999999996 99


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||.+.+..+....+.++..+                                          ......+..+.+|+.+|
T Consensus       207 ~pf~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~~  244 (270)
T cd05056         207 KPFQGVKNNDVIGRIENGERL------------------------------------------PMPPNCPPTLYSLMTKC  244 (270)
T ss_pred             CCCCCCCHHHHHHHHHcCCcC------------------------------------------CCCCCCCHHHHHHHHHH
Confidence            999877655544433221100                                          01134578899999999


Q ss_pred             cccCCCCCCCHHHHHcC
Q psy17952        472 LAKNPADRPSSGRLLTH  488 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~H  488 (804)
                      |..+|.+|||+.+++..
T Consensus       245 l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         245 WAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             cCCChhhCcCHHHHHHH
Confidence            99999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.1e-36  Score=314.41  Aligned_cols=241  Identities=25%  Similarity=0.392  Sum_probs=189.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||++.  .+++.||+|.+...     .....+.+|+.+++.++||||+++++++..+ ..|++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            458999999999999999885  47788999987532     1235678999999999999999999998654 579999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.| ++.+++..                                .....+++..+..++.|++.||.|||++|++|||
T Consensus        78 e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~d  125 (254)
T cd05083          78 ELMSKGNLVNFLRT--------------------------------RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD  125 (254)
T ss_pred             ECCCCCCHHHHHHh--------------------------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            99986 44333210                                1123578899999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC-CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMN  398 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~-~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~  398 (804)
                      |||+|||++.++.+||+|||++...... .....+..|+|||.+.   .+.++.++|+|||||++|||++ |++||...+
T Consensus       126 l~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  202 (254)
T cd05083         126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALK---HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS  202 (254)
T ss_pred             cCcceEEEcCCCcEEECCCccceeccccCCCCCCCceecCHHHhc---cCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence            9999999999999999999998754322 2334567899999874   3568889999999999999998 999997765


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+....+.++.                                          .......+++.+.+|+.+||+.+|.+
T Consensus       203 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~  240 (254)
T cd05083         203 LKEVKECVEKGY------------------------------------------RMEPPEGCPADVYVLMTSCWETEPKK  240 (254)
T ss_pred             HHHHHHHHhCCC------------------------------------------CCCCCCcCCHHHHHHHHHHcCCChhh
Confidence            544333221110                                          00012346788999999999999999


Q ss_pred             CCCHHHHHc
Q psy17952        479 RPSSGRLLT  487 (804)
Q Consensus       479 Rpsa~elL~  487 (804)
                      ||++++++.
T Consensus       241 Rp~~~~l~~  249 (254)
T cd05083         241 RPSFHKLRE  249 (254)
T ss_pred             CcCHHHHHH
Confidence            999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.2e-36  Score=323.75  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=188.7

Q ss_pred             ccccccccccccccceEEEEeeecee----EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~----~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .|+.++.||+|+||.||+|.+..+++    .||+|.+....  .......+.+|+.+++.++||||+++++++... ..+
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            47889999999999999999887776    47888775322  122234678999999999999999999988654 467


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +++||+.++ +.+.+.                                 .....+++..+..++.|++.||.|||++||+
T Consensus        85 ~v~e~~~~g~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv  131 (303)
T cd05110          85 LVTQLMPHGCLLDYVH---------------------------------EHKDNIGSQLLLNWCVQIAKGMMYLEERRLV  131 (303)
T ss_pred             eeehhcCCCCHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            999999854 333221                                 1234578899999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      ||||||+|||++.++.+||+|||+++.....      ....++..|+|||.+.   ...++.++|||||||++|||++ |
T Consensus       132 H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~el~t~g  208 (303)
T cd05110         132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH---YRKFTHQSDVWSYGVTIWELMTFG  208 (303)
T ss_pred             ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhc---cCCCChHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999753221      1234577899999984   3568889999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||.+.........+..+..                                         + .....++..+.+++.+
T Consensus       209 ~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~-~~~~~~~~~~~~li~~  246 (303)
T cd05110         209 GKPYDGIPTREIPDLLEKGER-----------------------------------------L-PQPPICTIDVYMVMVK  246 (303)
T ss_pred             CCCCCCCCHHHHHHHHHCCCC-----------------------------------------C-CCCCCCCHHHHHHHHH
Confidence            999976543332221111100                                         0 0112346788999999


Q ss_pred             hcccCCCCCCCHHHHHcC
Q psy17952        471 CLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~H  488 (804)
                      ||..+|++||++.++++.
T Consensus       247 c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         247 CWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.5e-36  Score=315.70  Aligned_cols=227  Identities=20%  Similarity=0.214  Sum_probs=180.6

Q ss_pred             ccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCCC-chhh
Q psy17952        173 GSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDI  251 (804)
Q Consensus       173 G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G~-l~dl  251 (804)
                      |.||.||+|++..+++.||+|.+....        ...+|...+....||||+++++++...+..|+||||+.|+ +.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999886421        1234555566677999999999999999999999999865 3222


Q ss_pred             HHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCC
Q psy17952        252 IEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET  331 (804)
Q Consensus       252 l~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~  331 (804)
                      +                                  .....+++..+..++.|+++||+|||++||+||||||+||+++.+
T Consensus        76 l----------------------------------~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~  121 (237)
T cd05576          76 I----------------------------------SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR  121 (237)
T ss_pred             H----------------------------------HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence            2                                  223458999999999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q psy17952        332 GTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQND  410 (804)
Q Consensus       332 g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~  410 (804)
                      +.+|++|||++..... .....++..|+|||.+.   .+.++.++|+||+||++|||++|..||......     +    
T Consensus       122 ~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~----  189 (237)
T cd05576         122 GHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG---ISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I----  189 (237)
T ss_pred             CCEEEecccchhccccccccCCcCccccCCcccC---CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c----
Confidence            9999999998754332 23456778899999873   356788999999999999999999887431100     0    


Q ss_pred             CCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH-----HHH
Q psy17952        411 TPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSS-----GRL  485 (804)
Q Consensus       411 ~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa-----~el  485 (804)
                                     ...                       .....+..+++.+++|+.+||+.||++|||+     +++
T Consensus       190 ---------------~~~-----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~  231 (237)
T cd05576         190 ---------------NTH-----------------------TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI  231 (237)
T ss_pred             ---------------ccc-----------------------cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence                           000                       0000112357889999999999999999996     999


Q ss_pred             HcCccc
Q psy17952        486 LTHDLV  491 (804)
Q Consensus       486 L~Hp~~  491 (804)
                      ++||||
T Consensus       232 ~~h~~~  237 (237)
T cd05576         232 KSHPFF  237 (237)
T ss_pred             HcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.6e-36  Score=322.09  Aligned_cols=258  Identities=28%  Similarity=0.417  Sum_probs=195.6

Q ss_pred             cccccccccccccceEEEEee---eceeEEEEEeccccccc-chhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        164 FEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQ-CAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~-~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      |++.+.||+|+||.||++++.   .+++.||||.+...... .......+.+|+.+++++ +||||+++++++..+...|
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            788899999999999999864   46788999987632211 122335577899999999 5999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +||||+.|+.                                 |+++......+++..+..++.|+++||.|||+.|++|
T Consensus        82 lv~e~~~~~~---------------------------------L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H  128 (288)
T cd05583          82 LILDYVNGGE---------------------------------LFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIY  128 (288)
T ss_pred             EEEecCCCCc---------------------------------HHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            9999998652                                 1111223356889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+||+++.++.+||+|||+++.....     ....|++.|+|||.+.+. ...++.++||||||+++|||++|..|
T Consensus       129 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~il~el~tg~~p  207 (288)
T cd05583         129 RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG-SGGHDKAVDWWSLGVLTFELLTGASP  207 (288)
T ss_pred             cCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCC-CCCCcchhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998653221     235689999999997532 12367799999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...........+.+               .+.                      ....  .....++..+.+|+.+||+
T Consensus       208 ~~~~~~~~~~~~~~~---------------~~~----------------------~~~~--~~~~~~~~~l~~li~~~l~  248 (288)
T cd05583         208 FTVDGEQNSQSEISR---------------RIL----------------------KSKP--PFPKTMSAEARDFIQKLLE  248 (288)
T ss_pred             cccCcccchHHHHHH---------------HHH----------------------ccCC--CCCcccCHHHHHHHHHHhc
Confidence            954321111111100               000                      0000  0113357889999999999


Q ss_pred             cCCCCCCC---HHHHHcCccccCC
Q psy17952        474 KNPADRPS---SGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rps---a~elL~Hp~~~~~  494 (804)
                      .||++|||   +.++|+||||...
T Consensus       249 ~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         249 KDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             CCHhhccCcchHHHHhcCcccccC
Confidence            99999998   5677999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-35  Score=314.52  Aligned_cols=251  Identities=27%  Similarity=0.531  Sum_probs=196.9

Q ss_pred             cccccccccccccceEEEEeee-ceeEEEEEecccccc-------cchhhhhhHHHHHHHHhh-cCCCceeEeeeEEeec
Q psy17952        164 FEDLREIGHGSFGAVYYARCLV-SREIVAIKKMSYLGK-------QCAEKWADILKEIRFLRQ-LKHPNTIEYRGCYLRD  234 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~-~~~~vAIK~i~~~~~-------~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~~~~~~~  234 (804)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++.+ ++||||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            7889999999999999999887 678999998753221       222334567789998875 7999999999999999


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +..|++|||+.| ++.+++..                              .......+++..+..++.|++.||.|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~------------------------------~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  131 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNS------------------------------LKEKKQRFTEERIWNIFVQMVLALRYLHK  131 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHH------------------------------HHhccCCCCHHHHHHHHHHHHHHHHHhcc
Confidence            999999999986 44443320                              01123468899999999999999999996


Q ss_pred             -CCCeecCCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 -LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 -~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                       .+|+||||||+|||++.++.+||+|||++......   ....|+..|+|||.+.   .+.++.++|+|||||++|||++
T Consensus       132 ~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Dv~slG~ll~~l~~  208 (269)
T cd08528         132 EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK---NEPYGEKADVWAFGCILYQMCT  208 (269)
T ss_pred             CCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhc---CCCCchHHHHHHHHHHHHHHHh
Confidence             78999999999999999999999999998754332   3457899999999984   3568889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |++||...+.......+....                                         ........+++.+.+|+.
T Consensus       209 g~~p~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~  247 (269)
T cd08528         209 LQPPFYSTNMLSLATKIVEAV-----------------------------------------YEPLPEGMYSEDVTDVIT  247 (269)
T ss_pred             CCCcccccCHHHHHHHHhhcc-----------------------------------------CCcCCcccCCHHHHHHHH
Confidence            999997655443333222110                                         000111246788999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||+.||++|||+.|+..+
T Consensus       248 ~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         248 SCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHCCCCCccCCCHHHHHHH
Confidence            9999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-35  Score=312.65  Aligned_cols=245  Identities=22%  Similarity=0.395  Sum_probs=191.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|++.+.||+|+||.||++... .+..+|+|.+...    ......+.+|++++++++|+||+++++++.. ...|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            4556899999999999999999754 4556999987532    1234568899999999999999999999877 78899


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||+.| ++.+++..                                .....+++..+..++.|++.||.|||+.|++|
T Consensus        78 v~e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H  125 (260)
T cd05073          78 ITEFMAKGSLLDFLKS--------------------------------DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH  125 (260)
T ss_pred             EEEeCCCCcHHHHHHh--------------------------------CCccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9999975 44443320                                01234678889999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+||+++.++.+||+|||++......     ....++..|+|||++.   .+.++.++|+|||||++|+|++ |.+
T Consensus       126 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~t~g~~  202 (260)
T cd05073         126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGRI  202 (260)
T ss_pred             cccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhc---cCCcCccccchHHHHHHHHHHhcCCC
Confidence            999999999999999999999998643221     1234567799999984   3568889999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+.......+.++.                                          +.......+.++.+++.+||
T Consensus       203 p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~i~~~l  240 (260)
T cd05073         203 PYPGMSNPEVIRALERGY------------------------------------------RMPRPENCPEELYNIMMRCW  240 (260)
T ss_pred             CCCCCCHHHHHHHHhCCC------------------------------------------CCCCcccCCHHHHHHHHHHc
Confidence            998765544433332110                                          00111345788999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      +.||++||++.+++.
T Consensus       241 ~~~p~~Rp~~~~l~~  255 (260)
T cd05073         241 KNRPEERPTFEYIQS  255 (260)
T ss_pred             ccCcccCcCHHHHHH
Confidence            999999999998763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-35  Score=315.04  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=190.2

Q ss_pred             cccccccccccccceEEEEeee---ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----
Q psy17952        164 FEDLREIGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----  235 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~---~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----  235 (804)
                      |++.+.||+|+||.||+|....   +++.||||.+.... ......+.+.+|++++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            5678899999999999998653   57899999876422 22334567889999999999999999999886532     


Q ss_pred             -ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        236 -TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       236 -~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                       ..++++||+.++ +.+.+....                            .......+++..+..++.|++.||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~----------------------------~~~~~~~l~~~~~~~~~~~i~~~l~~lH~  131 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSR----------------------------IGEEPFTLPLQTLVRFMIDIASGMEYLSS  131 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhc----------------------------ccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence             247889999754 333221000                            00112357889999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      +||+||||||+|||++.++.+||+|||+++....      .....+++.|++||.+.   .+.++.++|||||||++|||
T Consensus       132 ~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~sDi~slG~il~el  208 (273)
T cd05074         132 KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLA---DNVYTTHSDVWAFGVTMWEI  208 (273)
T ss_pred             CCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHh---cCccchhhhhHHHHHHHHHH
Confidence            9999999999999999999999999999875321      12234567899999874   35678899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |++||.+.+..+....+..+..                                          .......++.+.+
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~  246 (273)
T cd05074         209 MTRGQTPYAGVENSEIYNYLIKGNR------------------------------------------LKQPPDCLEDVYE  246 (273)
T ss_pred             hhCCCCCCCCCCHHHHHHHHHcCCc------------------------------------------CCCCCCCCHHHHH
Confidence            99 8999977655443333322110                                          0011245788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ++.+||..+|++|||+.++++.
T Consensus       247 l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         247 LMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0668|consensus

Probab=100.00  E-value=7.5e-37  Score=302.56  Aligned_cols=278  Identities=23%  Similarity=0.377  Sum_probs=208.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeec--CceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRD--HTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~--~~~~  238 (804)
                      +.|++++++|+|.|++||.|.+..+++.++||.+++..      ...+.||+.||+.|. |||||++++...+.  ...-
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            34999999999999999999999999999999987543      256889999999998 99999999988765  3567


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |++||+...                                    +|..-...|+..+++.++.|++.||.||||+||+|
T Consensus       112 LiFE~v~n~------------------------------------Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImH  155 (338)
T KOG0668|consen  112 LIFEYVNNT------------------------------------DFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMH  155 (338)
T ss_pred             hHhhhhccc------------------------------------cHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence            899998643                                    11112245778899999999999999999999999


Q ss_pred             cCCCCCCeeecCC-CcEEEEecccccccCCCC---ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTET-GTVKLADFGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~-g~vKL~DFGla~~~~~~~---~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||+||.|++||.. ..++|+|+|+|.+..+..   -.+.+.+|.-||++..  -..|+.+-|+|||||++..|+..+-||
T Consensus       156 RDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd--y~~YDYSLD~WS~GcmlA~miFrkepF  233 (338)
T KOG0668|consen  156 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPF  233 (338)
T ss_pred             ccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheee--chhccccHHHHHHHHHHHHHHhccCcc
Confidence            9999999999965 479999999998877654   3578999999999864  457899999999999999999999998


Q ss_pred             C-CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccch-h---hhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        395 F-NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNM-N---AMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       395 ~-~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~-~---~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      + |.+..+++-+|++--+..      +...-+..-....+|.++. -   ......+....+.    ..-.++++.||+.
T Consensus       234 FhG~dN~DQLVkIakVLGt~------el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n----~hl~~peaiDlld  303 (338)
T KOG0668|consen  234 FHGHDNYDQLVKIAKVLGTD------ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSEN----QHLVSPEAIDLLD  303 (338)
T ss_pred             cCCCCCHHHHHHHHHHhChH------HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccc----cccCChHHHHHHH
Confidence            6 456677777776521110      1111111111111222110 0   0000111111111    1124799999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ++|..|-.+|+||.|++.||||..
T Consensus       304 klLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  304 KLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             HHHhhccccccchHHHhcCchHHH
Confidence            999999999999999999999953

>KOG1095|consensus

Probab=100.00  E-value=8.5e-36  Score=354.02  Aligned_cols=252  Identities=28%  Similarity=0.454  Sum_probs=199.9

Q ss_pred             cccccccccccccccceEEEEeeece-----eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSR-----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~-----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      ...+..+.||+|+||.||.|......     ..||||.+...  .+.....+|++|..+|+.++|||||+++|++.+...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            34677889999999999999865432     34999988754  234566889999999999999999999999999999


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+|++|||.|| |..+|+..                  ++     .    ......++..+...++.||++|++||++++
T Consensus       770 ~~i~leyM~gGDL~sflr~~------------------r~-----~----~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~  822 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRES------------------RP-----A----PFQPSNLSMRDLLAFALDVAKGMNYLESKH  822 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhc------------------cc-----c----cCCCCCCCHHHHHHHHHHHhhhhHHHHhCC
Confidence            99999999865 33333210                  00     0    001346889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-C-Cccc--cC--cccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-A-NSFV--GT--PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~-~~~~--GT--~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      .|||||-..|+||+....|||+|||+|+.... . ...-  +.  ..|||||.+.   .+.++.|+|||||||+|||++|
T Consensus       823 fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~---d~iFtskSDvWsFGVllWEifs  899 (1025)
T KOG1095|consen  823 FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK---DGIFTSKSDVWSFGVLLWEIFS  899 (1025)
T ss_pred             CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHh---hcccccccchhhhHHHHHHHHh
Confidence            99999999999999999999999999983211 1 1111  22  4799999995   4789999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||.+.+..+.+.....+..                                          ..++..+++.+.++|
T Consensus       900 lG~~PY~~~~n~~v~~~~~~ggR------------------------------------------L~~P~~CP~~ly~lM  937 (1025)
T KOG1095|consen  900 LGATPYPSRSNFEVLLDVLEGGR------------------------------------------LDPPSYCPEKLYQLM  937 (1025)
T ss_pred             CCCCCCCCcchHHHHHHHHhCCc------------------------------------------cCCCCCCChHHHHHH
Confidence             8999999887776655443320                                          111234678888999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      ..||+.+|++||+...++.
T Consensus       938 ~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  938 LQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HHHccCChhhCccHHHHHh
Confidence            9999999999999999986

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-35  Score=314.33  Aligned_cols=260  Identities=27%  Similarity=0.458  Sum_probs=191.3

Q ss_pred             ccccccccccccccceEEEEee----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cCc
Q psy17952        163 IFEDLREIGHGSFGAVYYARCL----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DHT  236 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~~  236 (804)
                      .|+.++.||+|+||.||+|...    .+++.||||.+......  .....+.+|+++++.++||||+++++++..  ...
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            4788899999999999999864    34789999988643221  345678899999999999999999998877  557


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|++|||+.| ++.+++.                                 .....+++..+..++.|++.||+|||++|
T Consensus        83 ~~lv~e~~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~~~~~l~~aL~~lH~~~  129 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQ---------------------------------RHRDQINLKRLLLFSSQICKGMDYLGSQR  129 (284)
T ss_pred             eEEEEecCCCCCHHHHHH---------------------------------hCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            8999999975 4433321                                 11235889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |+||||||+|||++.++.+||+|||++......       ....++..|+|||.+.   ...++.++|||||||++|||+
T Consensus       130 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Di~slG~~l~el~  206 (284)
T cd05038         130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR---TSKFSSASDVWSFGVTLYELF  206 (284)
T ss_pred             eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc---cCCCCcccchHHHhhhhheee
Confidence            999999999999999999999999998754321       1123456799999884   346788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|..||........  .+. +..+  ...                      ....+................+.++.+|+
T Consensus       207 tg~~p~~~~~~~~~--~~~-~~~~--~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (284)
T cd05038         207 TYGDPSQSPPAEFL--RMI-GIAQ--GQM----------------------IVTRLLELLKEGERLPRPPSCPDEVYDLM  259 (284)
T ss_pred             ccCCCcccccchhc--ccc-cccc--ccc----------------------cHHHHHHHHHcCCcCCCCccCCHHHHHHH
Confidence            99999865321110  000 0000  000                      00000001111111111234578899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||+.||.+|||+.+++.
T Consensus       260 ~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         260 KLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHhccChhhCCCHHHHHH
Confidence            9999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0695|consensus

Probab=100.00  E-value=1.5e-35  Score=306.16  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=202.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|.++++||+|+|++|.+++.+.|.+.+|+|++++.-..+.+...-+..|-.+..+. +||.+|.++.||++...+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            3589999999999999999999999999999998765444444444556676676655 799999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      .||++||-                                 |.--..+++.++|+.++.+..+|+.||.|||++|||.||
T Consensus       330 ieyv~ggd---------------------------------lmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrd  376 (593)
T KOG0695|consen  330 IEYVNGGD---------------------------------LMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRD  376 (593)
T ss_pred             EEEecCcc---------------------------------eeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeee
Confidence            99999871                                 211233567899999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      ||.+|+|+|..|.+||+|+|+++...    ...++||||.|.|||++.   +..|+..+|+|+|||+++||++|+.||.-
T Consensus       377 lkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilr---geeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  377 LKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR---GEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             ccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhc---ccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            99999999999999999999997543    245799999999999995   45799999999999999999999999942


Q ss_pred             --C-----ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        397 --M-----NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       397 --~-----~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                        +     +..+-+++++                  .....+                        .+...|-.+..+++
T Consensus       454 vgm~n~d~ntedylfqvi------------------lekqir------------------------iprslsvkas~vlk  491 (593)
T KOG0695|consen  454 VGMDNPDMNTEDYLFQVI------------------LEKQIR------------------------IPRSLSVKASHVLK  491 (593)
T ss_pred             ecCCCcccchhHHHHHHH------------------hhhccc------------------------ccceeehhhHHHHH
Confidence              1     1111122111                  000000                        11234666777899


Q ss_pred             HhcccCCCCCCCH------HHHHcCccccC
Q psy17952        470 SCLAKNPADRPSS------GRLLTHDLVTR  493 (804)
Q Consensus       470 ~cL~~dP~~Rpsa------~elL~Hp~~~~  493 (804)
                      ..|.+||.+|..+      .++-.|+||..
T Consensus       492 gflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  492 GFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             HhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            9999999999754      68888999863

>KOG4250|consensus

Probab=100.00  E-value=7.5e-36  Score=335.93  Aligned_cols=210  Identities=32%  Similarity=0.525  Sum_probs=168.3

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------ce
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------TA  237 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------~~  237 (804)
                      +..-+.||+||||.||+++++.+|+.||||.++...  ....++...+|+++|++|+|||||+++++-++..      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            456678999999999999999999999999887543  2334466789999999999999999998765543      45


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .+|||||.|| |...++                               ...+..+|+|.++..++..+..||.|||.+||
T Consensus        93 vlvmEyC~gGsL~~~L~-------------------------------~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~I  141 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLN-------------------------------SPENAYGLPESEFLDLLSDLVSALRHLRENGI  141 (732)
T ss_pred             eEEEeecCCCcHHHHhc-------------------------------CcccccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence            7999999876 222211                               12234579999999999999999999999999


Q ss_pred             eecCCCCCCeeec--CCCc--EEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLT--ETGT--VKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~--~~g~--vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+||++-  .+|+  -||+|||.|+.....   .+++||+.|.+||+...  .+.|+..+|.|||||++|+.+|
T Consensus       142 vHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~--q~~y~~tVDLWS~GvtlY~caT  219 (732)
T KOG4250|consen  142 VHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYER--QKKYTATVDLWSFGVTLYECAT  219 (732)
T ss_pred             eeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhh--ccCcCceeehhhhhhHHHHHhc
Confidence            9999999999973  4453  599999999876543   57899999999999842  3678889999999999999999


Q ss_pred             CCCCCCCC----ChHHHHHHHHh
Q psy17952        390 RKPPYFNM----NAMSALYHIAQ  408 (804)
Q Consensus       390 G~~PF~~~----~~~~~l~~I~~  408 (804)
                      |..||...    +..+.++.+..
T Consensus       220 G~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  220 GELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             cCCCCCcCCCccccchhhhhhhc
Confidence            99999532    22335555543

>KOG0664|consensus

Probab=100.00  E-value=1e-36  Score=307.72  Aligned_cols=277  Identities=28%  Similarity=0.433  Sum_probs=211.7

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----ceE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----TAW  238 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----~~~  238 (804)
                      .+--+.||-|+||+||-+.+..+|+.||+|++.... +.....+.+.+|+.+|..++|.|+...++.....+     .+|
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345578999999999999999999999999885332 22334467889999999999999999887765443     356


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +++|++..++                                  ...+.....++.+.++-++.||++||+|||+.+|+|
T Consensus       134 V~TELmQSDL----------------------------------HKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILH  179 (449)
T KOG0664|consen  134 VLTELMQSDL----------------------------------HKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILH  179 (449)
T ss_pred             HHHHHHHhhh----------------------------------hheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhh
Confidence            7777665433                                  333456778999999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCCC-----ccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~~-----~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||.|+|++++..+||||||+|+...+..     ..+-|-+|+|||++.+.  ..|+.++||||.|||+.||+.++..
T Consensus       180 RDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGa--RhYs~AvDiWSVGCIFaELLgRrIL  257 (449)
T KOG0664|consen  180 RDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGA--RRYTGAVDIWSVGCIFAELLQRKIL  257 (449)
T ss_pred             ccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcc--hhhcCccceehhhHHHHHHHhhhhh
Confidence            9999999999999999999999998765432     24678899999999764  5799999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccc----cC---CCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        394 YFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTA----ER---KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~----~~---~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |...++.+++..|..- ++|..     +.++......    .+   ++|.+     .-+|.+..       ...-..+..
T Consensus       258 FQAq~PiqQL~lItdLLGTPs~-----EaMr~ACEGAk~H~LR~~~k~Ps~-----~vLYtlsS-------~~~~~heav  320 (449)
T KOG0664|consen  258 FQAAGPIEQLQMIIDLLGTPSQ-----EAMKYACEGAKNHVLRAGLRAPDT-----QRLYKIAS-------PDDKNHEAV  320 (449)
T ss_pred             hhccChHHHHHHHHHHhCCCcH-----HHHHHHhhhhHHHhhccCCCCCCc-----cceeeecC-------CcccchHHH
Confidence            9999999999888653 33321     1121111110    01   11111     11222111       112356788


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +++.++|..||.+|.+.++++.|++..+.
T Consensus       321 ~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  321 DLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HHHHHHhCCCCcccccHhhhccccccccc
Confidence            89999999999999999999999998653

>KOG0576|consensus

Probab=100.00  E-value=7.6e-37  Score=339.77  Aligned_cols=399  Identities=35%  Similarity=0.533  Sum_probs=301.8

Q ss_pred             HHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          4 GSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         4 ~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      +--+++..+|||||-|++.|..++.+||+||||.|+.++.+..-.+++++.++..+++..+.||+|||+.+-||||||-.
T Consensus        62 ei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGa  141 (829)
T KOG0576|consen   62 EIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGA  141 (829)
T ss_pred             ceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCccccccccc
Confidence            34567888999999999999999999999999986655555445689999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccc----cCCCCccccccccCcchhhhhcccCccCCcccccccccCCCCC---CCcch-----
Q psy17952         84 NILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL---KDPEI-----  151 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l---~~~~i-----  151 (804)
                      |||+++.|-+|++|||.+..    .....++.|||+|||||+--.-+.+.|+.++|+|++|+|..++   ..+..     
T Consensus       142 nilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm  221 (829)
T KOG0576|consen  142 NILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM  221 (829)
T ss_pred             ceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence            99999999999999999853    2345678999999999998545667899999999999886443   22110     


Q ss_pred             --h-----ccc---cCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC
Q psy17952        152 --A-----ELF---DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH  221 (804)
Q Consensus       152 --~-----elf---~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H  221 (804)
                        .     ..|   ..+|+.+.|+.+..+++|++++++|.+...+...+ .+.+...        ....-++++|.+++|
T Consensus       222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~  292 (829)
T KOG0576|consen  222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNN  292 (829)
T ss_pred             HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccC
Confidence              0     111   12466677899999999999999999988777666 6766432        233458899999999


Q ss_pred             Cc-eeEeeeEEeecCceEEEEeecCCC--chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHH
Q psy17952        222 PN-TIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIA  298 (804)
Q Consensus       222 pN-IV~l~~~~~~~~~~~lVmEy~~G~--l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~  298 (804)
                      || .+.+++-+..+...+++|++|.++  ..+...                                 ...-.+.+-+..
T Consensus       293 P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~---------------------------------~se~~~~~~~~~  339 (829)
T KOG0576|consen  293 PNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT---------------------------------VSEIALEQYQFA  339 (829)
T ss_pred             CCCcccccccCCcccccchhhhhhcCCccccccCC---------------------------------hhhHhhhhhhhh
Confidence            99 778888888888999999999865  211110                                 000123334455


Q ss_pred             HHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcc
Q psy17952        299 AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKV  375 (804)
Q Consensus       299 ~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ks  375 (804)
                      .+.+.-+++++|+|+.-=+|||    |||..+ +..|..|||.......   .++..+|+.++|||++.   .+.++.+.
T Consensus       340 ~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~---~~~~~~~p  411 (829)
T KOG0576|consen  340 YPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQ---ENTIDGCP  411 (829)
T ss_pred             hhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhc---ccccccCC
Confidence            6777778999999998889999    887765 7899999998865443   45688999999999884   46789999


Q ss_pred             cHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCC
Q psy17952        376 DVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL  455 (804)
Q Consensus       376 DIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~  455 (804)
                      |.||+|+-..+|.-|.+|-..  ++..+..+..+                       |                 ..+.+
T Consensus       412 ~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~-----------------------p-----------------~s~~L  449 (829)
T KOG0576|consen  412 DSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNG-----------------------P-----------------NSPML  449 (829)
T ss_pred             CccCCCcchhhcCCCCCCCCC--CccccCCCCCC-----------------------C-----------------Ccccc
Confidence            999999988888888888533  11111000000                       0                 00111


Q ss_pred             CC-CCccHHHH-HHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        456 QS-SDWSDTFA-HFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       456 ~~-~~~s~~l~-dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .. ..|+..+. ++...|+..-|..|+....++.|.+|...
T Consensus       450 ~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  450 TDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             chhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            11 22333333 38889999999999999999999988764

>KOG1151|consensus

Probab=100.00  E-value=2.1e-35  Score=314.03  Aligned_cols=262  Identities=26%  Similarity=0.427  Sum_probs=203.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccc----cchhhhhhHHHHHHHHhhcCCCceeEeeeEEe-ecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK----QCAEKWADILKEIRFLRQLKHPNTIEYRGCYL-RDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~----~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~-~~~~  236 (804)
                      ++|-++..||+|||+.||+|.+....+.||||+-.....    ..........||-+|-+.|+||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            568889999999999999999999999999997543222    22333456789999999999999999999986 5567


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG-  315 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g-  315 (804)
                      +|-|+|||+|+-.|+.                                 ....+.++|++++.|+-||+.||.||-... 
T Consensus       543 FCTVLEYceGNDLDFY---------------------------------LKQhklmSEKEARSIiMQiVnAL~YLNEikp  589 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFY---------------------------------LKQHKLMSEKEARSIIMQIVNALKYLNEIKP  589 (775)
T ss_pred             ceeeeeecCCCchhHH---------------------------------HHhhhhhhHHHHHHHHHHHHHHHHHHhccCC
Confidence            8999999999743321                                 223456899999999999999999999865 


Q ss_pred             -CeecCCCCCCeeecC---CCcEEEEecccccccCCC-----------CccccCcccccchhhcc-cCCCCCCCcccHHH
Q psy17952        316 -RIHRDVKAGNILLTE---TGTVKLADFGSASIKCPA-----------NSFVGTPYWMAPEVILA-MDEGQYDGKVDVWS  379 (804)
Q Consensus       316 -IiHRDLKP~NILl~~---~g~vKL~DFGla~~~~~~-----------~~~~GT~~Y~APEvl~~-~~~~~y~~ksDIWS  379 (804)
                       |||-||||.|||+.+   .|.+||+|||++++....           ....||-+|++||.+.- ......+.|+||||
T Consensus       590 PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWS  669 (775)
T KOG1151|consen  590 PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWS  669 (775)
T ss_pred             CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEe
Confidence             999999999999953   578999999999875432           23579999999998753 23346788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCC
Q psy17952        380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD  459 (804)
Q Consensus       380 lGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~  459 (804)
                      +|||+|..+.|+.||.......   .|.+..+         +   +..+...+|                      ..+.
T Consensus       670 vGVIFyQClYGrKPFGhnqsQQ---dILqeNT---------I---lkAtEVqFP----------------------~KPv  712 (775)
T KOG1151|consen  670 VGVIFYQCLYGRKPFGHNQSQQ---DILQENT---------I---LKATEVQFP----------------------PKPV  712 (775)
T ss_pred             eehhhhhhhccCCCCCCchhHH---HHHhhhc---------h---hcceeccCC----------------------CCCc
Confidence            9999999999999996532211   1111110         0   001111111                      1245


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       460 ~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .|.++++||++||+..-++|....++..||+|..
T Consensus       713 VsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  713 VSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             cCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            6899999999999999999999999999999853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.1e-34  Score=339.53  Aligned_cols=292  Identities=20%  Similarity=0.261  Sum_probs=178.8

Q ss_pred             cccccccccccccccccceEEEEeeec----eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeE-----
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVS----REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGC-----  230 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~----~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~-----  230 (804)
                      ..+.|++.+.||+|+||.||+|++..+    +..||||++.....     .+....|  .++...+.+++.+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            344699999999999999999999988    89999998753211     0111111  1222223333333222     


Q ss_pred             -EeecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHH
Q psy17952        231 -YLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGL  308 (804)
Q Consensus       231 -~~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL  308 (804)
                       ...+...|+||||+.+ ++.+++....    +        ...+..+... ... .........+..+..++.||+.||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~----~--------~~~v~~~l~~-~~~-~l~~~~~r~~~~i~~i~~qll~aL  268 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKE----F--------PYNVEPYLLG-KVQ-DLPKGLERENKIIQTIMRQILFAL  268 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcC----C--------chhHHHHhcc-chh-hccccchhhHHHHHHHHHHHHHHH
Confidence             1345679999999985 4555553110    0        0000000000 000 001112234566788999999999


Q ss_pred             HHHHHCCCeecCCCCCCeeecC-CCcEEEEecccccccCC-----CCccccCcccccchhhcccCC--------------
Q psy17952        309 NYLHSLGRIHRDVKAGNILLTE-TGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDE--------------  368 (804)
Q Consensus       309 ~yLH~~gIiHRDLKP~NILl~~-~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~--------------  368 (804)
                      +|||++||+||||||+|||++. ++.+||+|||+|+....     ...++||+.|||||.+.....              
T Consensus       269 ~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~s  348 (566)
T PLN03225        269 DGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS  348 (566)
T ss_pred             HHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCcccccccccc
Confidence            9999999999999999999986 57999999999974321     245789999999997643211              


Q ss_pred             -----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHH
Q psy17952        369 -----GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA  443 (804)
Q Consensus       369 -----~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~  443 (804)
                           ..++.++|||||||++|||+++..|+  .+....+..+......     ....+......  ...+     ....
T Consensus       349 p~l~~~~~~~k~DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~-----~~~~~~~~~~~--~~~~-----~~~~  414 (566)
T PLN03225        349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDY-----DLVAWRKLVEP--RASP-----DLRR  414 (566)
T ss_pred             chhccccCCCCcccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCC-----cHHHHHHhhcc--ccch-----hhhh
Confidence                 12445679999999999999876654  3333333333221110     00111100000  0000     0000


Q ss_pred             HHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       444 l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+.+         .......+.+||.+||++||++|||+.++|+||||....
T Consensus       415 ~~~~---------~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        415 GFEV---------LDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             hhhh---------ccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence            0000         011244577999999999999999999999999998644

>KOG0984|consensus

Probab=100.00  E-value=9.8e-35  Score=284.03  Aligned_cols=222  Identities=29%  Similarity=0.501  Sum_probs=180.2

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhh-cCCCceeEeeeEEeecCceE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ-LKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~~~~~~~~~~~  238 (804)
                      +.+....+..||+|+||.|-+-++..+|...|+|.+...-.  .....+.++|+.+..+ ...|.+|.+||.+.+.+..|
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            34446677899999999999999999999999999864322  2334667889987654 57999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCe
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRI  317 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIi  317 (804)
                      +.||.|.-++..+..                              ....+.+.++|..+-+|+..++.||.|||++ .||
T Consensus       122 IcME~M~tSldkfy~------------------------------~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vI  171 (282)
T KOG0984|consen  122 ICMELMDTSLDKFYR------------------------------KVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVI  171 (282)
T ss_pred             EeHHHhhhhHHHHHH------------------------------HHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhh
Confidence            999999876543322                              1123567899999999999999999999985 899


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC--Cc-cccCcccccchhhccc-CCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA--NS-FVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~--~~-~~GT~~Y~APEvl~~~-~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||+||+||||+.+|.+||||||++......  .+ -.|...|||||.+... +...|+-||||||||++++||++++.|
T Consensus       172 HRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P  251 (282)
T KOG0984|consen  172 HRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP  251 (282)
T ss_pred             hccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence            9999999999999999999999999765432  22 4688899999998643 234799999999999999999999999


Q ss_pred             CCCC-ChHHHHHHHHhcCCCC
Q psy17952        394 YFNM-NAMSALYHIAQNDTPC  413 (804)
Q Consensus       394 F~~~-~~~~~l~~I~~~~~p~  413 (804)
                      |... ++.+++.++.....|.
T Consensus       252 Y~~w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  252 YESWGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             ccccCCHHHHHHHHhcCCCCC
Confidence            9764 6777777776654443

>KOG0196|consensus

Probab=100.00  E-value=3.6e-35  Score=330.93  Aligned_cols=247  Identities=26%  Similarity=0.451  Sum_probs=205.7

Q ss_pred             cccccccccccccccceEEEEeeece---eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~---~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      ....+.+.||.|.||+||+|+.+..+   ..||||.++..  ...+.+.+|+.|+.||.+++||||++|.|+......++
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            34577889999999999999988766   46999998642  34556788999999999999999999999999999999


Q ss_pred             EEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      ||+|||+ |+|..++.                                 .+.+.|+.-++..+++.|+.|++||-+.|.|
T Consensus       707 IiTEyMENGsLDsFLR---------------------------------~~DGqftviQLVgMLrGIAsGMkYLsdm~YV  753 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLR---------------------------------QNDGQFTVIQLVGMLRGIASGMKYLSDMNYV  753 (996)
T ss_pred             EEhhhhhCCcHHHHHh---------------------------------hcCCceEeehHHHHHHHHHHHhHHHhhcCch
Confidence            9999997 55544432                                 2345688888999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCCC----c-cccC--cccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPAN----S-FVGT--PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~~----~-~~GT--~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      ||||-..|||++.+-.+|++|||+++......    + .-|-  ..|.|||.|.   ..+++.+|||||+||+|||.++ 
T Consensus       754 HRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa---~RKFTsASDVWSyGIVmWEVmSy  830 (996)
T KOG0196|consen  754 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMWEVMSY  830 (996)
T ss_pred             hhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhh---hcccCchhhccccceEEEEeccc
Confidence            99999999999999999999999998764322    1 1222  4799999994   5689999999999999999665 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||++++..+.+..|.++-                    +                      .+++.+++..+.+|+.
T Consensus       831 GERPYWdmSNQdVIkaIe~gy--------------------R----------------------LPpPmDCP~aL~qLMl  868 (996)
T KOG0196|consen  831 GERPYWDMSNQDVIKAIEQGY--------------------R----------------------LPPPMDCPAALYQLML  868 (996)
T ss_pred             CCCcccccchHHHHHHHHhcc--------------------C----------------------CCCCCCCcHHHHHHHH
Confidence            999999999888877775431                    1                      1123567889999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      .||++|-.+||..+|++.+
T Consensus       869 dCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  869 DCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999864

>KOG1094|consensus

Probab=100.00  E-value=3.5e-34  Score=314.11  Aligned_cols=258  Identities=27%  Similarity=0.427  Sum_probs=196.6

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      +-|.+...+.++||+|.||.|.+|.-- .+..||||+++...  ....+.+|.+||++|.+|+|||||+++++|..++.+
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            346667788999999999999999643 36899999987543  234467899999999999999999999999999999


Q ss_pred             EEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +++|||++ |+|.+++..+                                ....+.-+....|+.||++||+||-+.++
T Consensus       611 cmI~EYmEnGDLnqFl~ah--------------------------------eapt~~t~~~vsi~tqiasgmaYLes~nf  658 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAH--------------------------------ELPTAETAPGVSICTQIASGMAYLESLNF  658 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhc--------------------------------cCcccccchhHHHHHHHHHHHHHHHhhch
Confidence            99999997 5544433211                                00112334556699999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      |||||.+.|+|++.++++||+|||+|+..-..      ...+-...|||||.|+   .++++++||+|+|||++||+++ 
T Consensus       659 VHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil---lgkFttaSDvWafgvTlwE~~~~  735 (807)
T KOG1094|consen  659 VHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVTLWEVFML  735 (807)
T ss_pred             hhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHH---hccccchhhhhhhHHHHHHHHHH
Confidence            99999999999999999999999999854322      2234456899999986   4689999999999999999765 


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       ...||...++.+...+...    .+.               . ++               .......+.-++.++.+++
T Consensus       736 C~e~Py~~lt~e~vven~~~----~~~---------------~-~~---------------~~~~l~~P~~cp~~lyelm  780 (807)
T KOG1094|consen  736 CREQPYSQLTDEQVVENAGE----FFR---------------D-QG---------------RQVVLSRPPACPQGLYELM  780 (807)
T ss_pred             HhhCchhhhhHHHHHHhhhh----hcC---------------C-CC---------------cceeccCCCcCcHHHHHHH
Confidence             7889987665544333211    000               0 00               0001122345678889999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||..|.++|||.+++-.|
T Consensus       781 l~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  781 LRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             HHHhchhhhcCCCHHHHHHH
Confidence            99999999999999998644

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.6e-33  Score=319.95  Aligned_cols=293  Identities=20%  Similarity=0.303  Sum_probs=187.0

Q ss_pred             ccccccccccccccccceEEEEee----------------eceeEEEEEecccccccchh-----------hhhhHHHHH
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCL----------------VSREIVAIKKMSYLGKQCAE-----------KWADILKEI  213 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~----------------~~~~~vAIK~i~~~~~~~~~-----------~~~~~~~Ei  213 (804)
                      .+.|++.++||+|+||.||+|...                ..++.||||++.........           ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            445999999999999999999752                23467999998642211100           112234577


Q ss_pred             HHHhhcCCCce-----eEeeeEEee--------cCceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcc
Q psy17952        214 RFLRQLKHPNT-----IEYRGCYLR--------DHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH  279 (804)
Q Consensus       214 ~iL~~L~HpNI-----V~l~~~~~~--------~~~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~  279 (804)
                      .++.+++|.|+     ++++++|..        .+..||||||+. |+|.++++...-       .....+.   .+...
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------~~~~~L~---e~l~~  293 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLG-------PFPGCLE---EFMMA  293 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccC-------CCcchHH---HHHhc
Confidence            78888877655     566776643        356899999998 466666542100       0000000   00000


Q ss_pred             cccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC---Cc--cccC
Q psy17952        280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NS--FVGT  354 (804)
Q Consensus       280 ~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---~~--~~GT  354 (804)
                      ............+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++......   ..  ..+|
T Consensus       294 g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~t  373 (507)
T PLN03224        294 GKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLD  373 (507)
T ss_pred             CCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCC
Confidence            011111112345778899999999999999999999999999999999999999999999998653321   11  2358


Q ss_pred             cccccchhhcccCCC-----------------CCC--CcccHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCC
Q psy17952        355 PYWMAPEVILAMDEG-----------------QYD--GKVDVWSLGITCIELAERKP-PYFNMNAMSALYHIAQNDTPCL  414 (804)
Q Consensus       355 ~~Y~APEvl~~~~~~-----------------~y~--~ksDIWSlGvil~ELltG~~-PF~~~~~~~~l~~I~~~~~p~~  414 (804)
                      +.|+|||++......                 .|+  .+.||||+||++|+|++|.. ||.+...............   
T Consensus       374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~---  450 (507)
T PLN03224        374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL---  450 (507)
T ss_pred             cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH---
Confidence            999999998531100                 122  24799999999999999975 7754322111110000000   


Q ss_pred             CCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC---CCCCCHHHHHcCccc
Q psy17952        415 QSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP---ADRPSSGRLLTHDLV  491 (804)
Q Consensus       415 ~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP---~~Rpsa~elL~Hp~~  491 (804)
                        ..|.   ..                      .............++..+||+.+||.++|   .+|+|++|+|+||||
T Consensus       451 --~~~r---~~----------------------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        451 --NRWR---MY----------------------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             --HHHH---hh----------------------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence              0000   00                      00000001123458899999999999876   689999999999999


Q ss_pred             cC
Q psy17952        492 TR  493 (804)
Q Consensus       492 ~~  493 (804)
                      ..
T Consensus       504 ~~  505 (507)
T PLN03224        504 LP  505 (507)
T ss_pred             CC
Confidence            64

>KOG4257|consensus

Probab=100.00  E-value=6.2e-34  Score=313.37  Aligned_cols=242  Identities=27%  Similarity=0.454  Sum_probs=191.5

Q ss_pred             ccccccccccccceEEEEeeec----eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        165 EDLREIGHGSFGAVYYARCLVS----REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       165 ~~l~~LG~G~fG~Vy~a~~~~~----~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ..-+.||.|.||.||+|....-    .-.||||..+...  ..+..+.|+.|..+|++++|||||+++|++.. ...|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            4457899999999999986532    3358999775422  23446889999999999999999999999865 578999


Q ss_pred             EeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||++. |.|..+++                                 .++..|+......++.||+.||.|||+...|||
T Consensus       469 mEL~~~GELr~yLq---------------------------------~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHR  515 (974)
T KOG4257|consen  469 MELAPLGELREYLQ---------------------------------QNKDSLPLRTLTLYCYQICTALAYLESKRFVHR  515 (974)
T ss_pred             EecccchhHHHHHH---------------------------------hccccchHHHHHHHHHHHHHHHHHHHhhchhhh
Confidence            99997 54433332                                 234567888889999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCCCcc---ccC--cccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPANSF---VGT--PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~~~~---~GT--~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||-..|||+.+...|||+|||+++......-+   .|-  .-|||||-+.   -.+++.+||||-|||++||++. |..|
T Consensus       516 DIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN---fRrFTtASDVWMFgVCmWEIl~lGvkP  592 (974)
T KOG4257|consen  516 DIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN---FRRFTTASDVWMFGVCMWEILSLGVKP  592 (974)
T ss_pred             hhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccc---hhcccchhhHHHHHHHHHHHHHhcCCc
Confidence            99999999999999999999999976543222   222  3599999984   3578999999999999999876 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+....+.+-.|.+|+.+                                          +.++.+++.+..|+.+||.
T Consensus       593 fqgvkNsDVI~~iEnGeRl------------------------------------------P~P~nCPp~LYslmskcWa  630 (974)
T KOG4257|consen  593 FQGVKNSDVIGHIENGERL------------------------------------------PCPPNCPPALYSLMSKCWA  630 (974)
T ss_pred             cccccccceEEEecCCCCC------------------------------------------CCCCCCChHHHHHHHHHhc
Confidence            9887655554444333211                                          1224567888899999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .||.+||+..++..
T Consensus       631 yeP~kRPrftei~~  644 (974)
T KOG4257|consen  631 YEPSKRPRFTEIKA  644 (974)
T ss_pred             cCcccCCcHHHHHH
Confidence            99999999998763

>KOG4278|consensus

Probab=100.00  E-value=9.2e-34  Score=311.01  Aligned_cols=242  Identities=23%  Similarity=0.402  Sum_probs=197.2

Q ss_pred             ccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeec
Q psy17952        165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC  244 (804)
Q Consensus       165 ~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~  244 (804)
                      ..-.+||-|.||.||.|.++.-.-.||||.++    .+....++|++|+.+|+.++|||+|+|+|+|.....+|||+|||
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK----EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhh----hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            44578999999999999999999999999875    34455688999999999999999999999999999999999998


Q ss_pred             C-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q psy17952        245 L-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA  323 (804)
Q Consensus       245 ~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP  323 (804)
                      . |+|.|++..+                                ++.-++.-....++.||.+|++||-.+++|||||-.
T Consensus       346 ~yGNLLdYLRec--------------------------------nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAA  393 (1157)
T KOG4278|consen  346 CYGNLLDYLREC--------------------------------NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAA  393 (1157)
T ss_pred             cCccHHHHHHHh--------------------------------chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence            6 7777766421                                223355666788899999999999999999999999


Q ss_pred             CCeeecCCCcEEEEecccccccCCC--CccccC---cccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        324 GNILLTETGTVKLADFGSASIKCPA--NSFVGT---PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       324 ~NILl~~~g~vKL~DFGla~~~~~~--~~~~GT---~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      .|+|+.++..||++|||+++.....  ....|.   .-|.|||-+.   ...++.|+|||+|||+|||++| |-.||.+.
T Consensus       394 RNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA---yNtFSiKSDVWAFGVLLWEIATYGMsPYPGi  470 (1157)
T KOG4278|consen  394 RNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNTFSIKSDVWAFGVLLWEIATYGMSPYPGI  470 (1157)
T ss_pred             hhccccccceEEeeccchhhhhcCCceecccCccCcccccCccccc---ccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence            9999999999999999999876432  122333   4699999873   3567889999999999999998 88999887


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +.......+                                          ..+.....+..+++...+|+..||+++|+
T Consensus       471 dlSqVY~LL------------------------------------------EkgyRM~~PeGCPpkVYeLMraCW~WsPs  508 (1157)
T KOG4278|consen  471 DLSQVYGLL------------------------------------------EKGYRMDGPEGCPPKVYELMRACWNWSPS  508 (1157)
T ss_pred             cHHHHHHHH------------------------------------------hccccccCCCCCCHHHHHHHHHHhcCCcc
Confidence            654433222                                          11222223356788899999999999999


Q ss_pred             CCCCHHHHHc
Q psy17952        478 DRPSSGRLLT  487 (804)
Q Consensus       478 ~Rpsa~elL~  487 (804)
                      +||+.+++-+
T Consensus       509 DRPsFaeiHq  518 (1157)
T KOG4278|consen  509 DRPSFAEIHQ  518 (1157)
T ss_pred             cCccHHHHHH
Confidence            9999999854

>KOG1290|consensus

Probab=100.00  E-value=3.2e-33  Score=302.19  Aligned_cols=297  Identities=27%  Similarity=0.416  Sum_probs=206.2

Q ss_pred             CCCCCCcchhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC--
Q psy17952        143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--  220 (804)
Q Consensus       143 ~g~l~~~~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--  220 (804)
                      .|.++...|.+.|.    ..+|-+.++||.|.|++||+|.++.+.+.||+|+++.    .....+..+.||++|++++  
T Consensus        63 kGGYHpV~IGD~F~----~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~  134 (590)
T KOG1290|consen   63 KGGYHPVRIGDVFN----GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREG  134 (590)
T ss_pred             cCCCceeecccccc----CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhc
Confidence            45555555555553    1469999999999999999999999999999998752    2344567889999999883  


Q ss_pred             ---CC---ceeEeeeEEee----cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCC
Q psy17952        221 ---HP---NTIEYRGCYLR----DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR  290 (804)
Q Consensus       221 ---Hp---NIV~l~~~~~~----~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~  290 (804)
                         |+   .||+|++.|..    ..++|+|+|++.-+|..+|..                                ...+
T Consensus       135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~--------------------------------s~Yr  182 (590)
T KOG1290|consen  135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKY--------------------------------SNYR  182 (590)
T ss_pred             CCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHH--------------------------------hCCC
Confidence               33   69999999975    447999999997776665541                                1346


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCeeecCC--------------------------------------
Q psy17952        291 PLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTET--------------------------------------  331 (804)
Q Consensus       291 ~l~e~~i~~i~~qil~gL~yLH~-~gIiHRDLKP~NILl~~~--------------------------------------  331 (804)
                      .++...++.|++||+.||.|||+ +||||-||||+|||+..+                                      
T Consensus       183 Glpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~  262 (590)
T KOG1290|consen  183 GLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAA  262 (590)
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhc
Confidence            78999999999999999999996 699999999999998300                                      


Q ss_pred             --------------------------------------------------------------------------------
Q psy17952        332 --------------------------------------------------------------------------------  331 (804)
Q Consensus       332 --------------------------------------------------------------------------------  331 (804)
                                                                                                      
T Consensus       263 ~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~  342 (590)
T KOG1290|consen  263 EPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENF  342 (590)
T ss_pred             cccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCcccc
Confidence                                                                                            


Q ss_pred             ------------------------------------------------CcEEEEecccccccCC-CCccccCcccccchh
Q psy17952        332 ------------------------------------------------GTVKLADFGSASIKCP-ANSFVGTPYWMAPEV  362 (804)
Q Consensus       332 ------------------------------------------------g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEv  362 (804)
                                                                      -.+||+|||-|+.... -+.-+.|..|+|||+
T Consensus       343 ~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEV  422 (590)
T KOG1290|consen  343 RGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEV  422 (590)
T ss_pred             ccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcce
Confidence                                                            0145666666654322 123467899999999


Q ss_pred             hcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC---CC---hHHHHHHHHh--cCCCCCCCCchhhHHhhcccccCCCC
Q psy17952        363 ILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN---MN---AMSALYHIAQ--NDTPCLQSSDWSVIKTISSTAERKPP  434 (804)
Q Consensus       363 l~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~---~~---~~~~l~~I~~--~~~p~~~~~~~~~i~~i~~~~~~~pp  434 (804)
                      |++   ..|++.+||||++|++|||+||...|.-   .+   +.+-+..|+.  +..|          ..+....+....
T Consensus       423 llG---sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iP----------r~ia~~Gk~SRd  489 (590)
T KOG1290|consen  423 LLG---SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIP----------RKIALGGKYSRD  489 (590)
T ss_pred             eec---CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhcc----------HHHHhcCcchHh
Confidence            985   5799999999999999999999998842   11   2333333332  1111          011111111122


Q ss_pred             ccchhhhHHHHhhccCCC-CC--------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        435 YFNMNAMSALYHIAQNDT-PC--------LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       435 ~~~~~~~~~l~~i~~~~~-p~--------~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +|+....  |.+|.+-.+ |.        ..+..-..+|.+|+.-||+.+|++||||+++|+|||+...
T Consensus       490 FFnr~G~--LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  490 FFNRRGE--LRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPV  556 (590)
T ss_pred             hhccccc--eecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCC
Confidence            3322210  111110000 00        0011124568999999999999999999999999999754

>KOG0670|consensus

Probab=100.00  E-value=2.2e-34  Score=311.91  Aligned_cols=285  Identities=22%  Similarity=0.298  Sum_probs=208.8

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC------CceeEeeeEEeec
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH------PNTIEYRGCYLRD  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H------pNIV~l~~~~~~~  234 (804)
                      ...|.+....|+|-||.|..|.+...|..||||+|.....    ....=++|++||++|+.      -++++|+..|...
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3468889999999999999999999999999999975321    12345789999999953      4799999999999


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      +++|||+|-+.-+|.++++..                               -..-.|....++.|+.|+..||..|-.+
T Consensus       507 nHLClVFE~LslNLRevLKKy-------------------------------G~nvGL~ikaVRsYaqQLflALklLK~c  555 (752)
T KOG0670|consen  507 NHLCLVFEPLSLNLREVLKKY-------------------------------GRNVGLHIKAVRSYAQQLFLALKLLKKC  555 (752)
T ss_pred             ceeEEEehhhhchHHHHHHHh-------------------------------CcccceeehHHHHHHHHHHHHHHHHHhc
Confidence            999999998877777666521                               1233577788999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCC-cEEEEecccccccCCC--CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        315 GRIHRDVKAGNILLTETG-TVKLADFGSASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g-~vKL~DFGla~~~~~~--~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||+|.||||.|||+++.. .+||||||.|......  ..+.-+..|.|||+|+|   -+|+...|+||.||+||||.||+
T Consensus       556 ~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG---~~yd~~iD~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  556 GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILG---LPYDYPIDTWSVGCTLYELYTGK  632 (752)
T ss_pred             CeeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeec---CcccCCccceeeceeeEEeeccc
Confidence            999999999999998764 6799999999764432  33556778999999986   47999999999999999999999


Q ss_pred             CCCCCCChHHHHHHH--HhcCCCCCCCCchhhHHhhcccccCCCCccc------------------------hhhhHHHH
Q psy17952        392 PPYFNMNAMSALYHI--AQNDTPCLQSSDWSVIKTISSTAERKPPYFN------------------------MNAMSALY  445 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I--~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~------------------------~~~~~~l~  445 (804)
                      ..|.|.+...++...  ++|..|.          .+..........|+                        .+....+.
T Consensus       633 IlFpG~TNN~MLrl~me~KGk~p~----------KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~  702 (752)
T KOG0670|consen  633 ILFPGRTNNQMLRLFMELKGKFPN----------KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLG  702 (752)
T ss_pred             eecCCCCcHHHHHHHHHhcCCCcH----------HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHH
Confidence            999998766555444  3444331          00000000000010                        00000010


Q ss_pred             hhccC-CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        446 HIAQN-DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       446 ~i~~~-~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ..... ....-.....-..|++|+.+||..||++|.|..|+|+||||+.
T Consensus       703 s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  703 SELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            00000 0000011123456899999999999999999999999999974

>KOG0199|consensus

Probab=100.00  E-value=1.7e-33  Score=313.45  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             CcccccccccccccccccceEEEEeeec-e--eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVS-R--EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~-~--~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .|++...+.++||+|.||+|++|.++.. |  -.||||++......  ....+|++|+.+|.+|+|||+|+|||+..+ .
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            4566678889999999999999988753 2  46999998743322  256789999999999999999999999887 7


Q ss_pred             ceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ...+|||++. |+|.|-+..                                ..+..|.-.....|+.||+.||.||-++
T Consensus       184 p~mMV~ELaplGSLldrLrk--------------------------------a~~~~llv~~Lcdya~QiA~aM~YLesk  231 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRK--------------------------------AKKAILLVSRLCDYAMQIAKAMQYLESK  231 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhh--------------------------------ccccceeHHHHHHHHHHHHHHHHHHhhh
Confidence            8899999998 555443320                                1345677788899999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCCCc-cc------cCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-FV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~------GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      +.|||||-..|+|+-....|||||||+.+....... ++      --..|.|||.|.   ...++.++|||++||++|||
T Consensus       232 rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr---h~kFShaSDvWmyGVTiWEM  308 (1039)
T KOG0199|consen  232 RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR---HRKFSHASDVWMYGVTIWEM  308 (1039)
T ss_pred             hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc---cccccccchhhhhhhhHHhh
Confidence            999999999999999999999999999976543221 11      124699999984   57899999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |.-||.|.+...++.+|-.++.                                          ......+|+++.+
T Consensus       309 FtyGEePW~G~~g~qIL~~iD~~er------------------------------------------LpRPk~csedIY~  346 (1039)
T KOG0199|consen  309 FTYGEEPWVGCRGIQILKNIDAGER------------------------------------------LPRPKYCSEDIYQ  346 (1039)
T ss_pred             hccCCCCCCCCCHHHHHHhcccccc------------------------------------------CCCCCCChHHHHH
Confidence            98 7999999988887776642210                                          0112356889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      ++.+||..+|++|||...+...-+.
T Consensus       347 imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  347 IMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHhccCCccccccHHHHHHhHHH
Confidence            9999999999999999988654443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-32  Score=284.24  Aligned_cols=240  Identities=39%  Similarity=0.595  Sum_probs=191.3

Q ss_pred             cccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC-CchhhH
Q psy17952        174 SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDII  252 (804)
Q Consensus       174 ~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G-~l~dll  252 (804)
                      +||.||+|.+..+++.+|+|.+.......  ....+.+|++.+++++|+||+++++++......+++|||+.+ ++.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999999899999999876432221  146788999999999999999999999999999999999987 443332


Q ss_pred             HHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCC
Q psy17952        253 EVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG  332 (804)
Q Consensus       253 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g  332 (804)
                      .                                  ....+++..+..++.|++.|+.|||+.+|+|+||+|+||+++.++
T Consensus        79 ~----------------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~  124 (244)
T smart00220       79 K----------------------------------KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG  124 (244)
T ss_pred             H----------------------------------hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC
Confidence            1                                  122378899999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q psy17952        333 TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQN  409 (804)
Q Consensus       333 ~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~  409 (804)
                      .++|+|||++.....   .....|+..|+|||.+.   ...++.++||||||+++|+|++|..||........+......
T Consensus       125 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~  201 (244)
T smart00220      125 HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL---GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK  201 (244)
T ss_pred             cEEEccccceeeeccccccccccCCcCCCCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence            999999999875443   24467899999999884   356788999999999999999999999763333322222111


Q ss_pred             CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy17952        410 DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       410 ~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp  489 (804)
                      ...                                       ........++.++.+++.+||..||++||++.++++||
T Consensus       202 ~~~---------------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~  242 (244)
T smart00220      202 PKP---------------------------------------PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHP  242 (244)
T ss_pred             cCC---------------------------------------CCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCC
Confidence            000                                       00000111678899999999999999999999999999


Q ss_pred             cc
Q psy17952        490 LV  491 (804)
Q Consensus       490 ~~  491 (804)
                      ||
T Consensus       243 ~~  244 (244)
T smart00220      243 FF  244 (244)
T ss_pred             CC
Confidence            97

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.9e-32  Score=342.23  Aligned_cols=184  Identities=22%  Similarity=0.368  Sum_probs=155.5

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |...+.||+|+||.||+|++..++..||||++.....       ....|++++++++|||||++++++.+.+..|+||||
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            5566789999999999999999999999998753221       123578899999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeec
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH---SLGRIHR  319 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH---~~gIiHR  319 (804)
                      |+|+ +.++++                                     .+++..+..|+.|+++||+|||   +.+|+||
T Consensus       765 ~~~g~L~~~l~-------------------------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  807 (968)
T PLN00113        765 IEGKNLSEVLR-------------------------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG  807 (968)
T ss_pred             CCCCcHHHHHh-------------------------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence            9864 333221                                     3678889999999999999999   6799999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+|||++.++..++. ||.+..........||+.|||||++.   ...|+.++|||||||++|||++|+.||.
T Consensus       808 dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRE---TKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             CCCHHhEEECCCCceEEE-eccccccccCCCccccccccCccccc---CCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            999999999999988876 77765544444567899999999974   4578999999999999999999999984

>KOG1152|consensus

Probab=99.97  E-value=1.3e-32  Score=301.72  Aligned_cols=198  Identities=32%  Similarity=0.510  Sum_probs=171.8

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccch-----hhhhhHHHHHHHHhhcC---CCceeEeeeEEeecC
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA-----EKWADILKEIRFLRQLK---HPNTIEYRGCYLRDH  235 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~-----~~~~~~~~Ei~iL~~L~---HpNIV~l~~~~~~~~  235 (804)
                      |..++.+|+|+||.|++|.++.+...|+||.|.+.+-...     .+.-.+-.||+||..|+   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            8999999999999999999999999999999875432211     11223456999999998   999999999999999


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ++||+||--.-+                                .+||+++..+..++|.+++.|++||+.|+++||++|
T Consensus       643 ~yyl~te~hg~g--------------------------------IDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~  690 (772)
T KOG1152|consen  643 YYYLETEVHGEG--------------------------------IDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG  690 (772)
T ss_pred             eeEEEecCCCCC--------------------------------cchhhhhhccCccchHHHHHHHHHHHhccccccccC
Confidence            999999964322                                268889988999999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEeccccccc--CCCCccccCcccccchhhcccCCCCCCC-cccHHHHHHHHHHHHhCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIK--CPANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKP  392 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~--~~~~~~~GT~~Y~APEvl~~~~~~~y~~-ksDIWSlGvil~ELltG~~  392 (804)
                      |||||||-+|+.++.+|-+||+|||.|...  .+-..++||..|.|||++.   +.+|-. .-|||++|++||.+.....
T Consensus       691 ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~---g~~y~gk~qdiwalgillytivyken  767 (772)
T KOG1152|consen  691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLG---GEKYLGKPQDIWALGILLYTIVYKEN  767 (772)
T ss_pred             ceecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhC---CCccCCCcchhhhhhheeeEEEeccC
Confidence            999999999999999999999999998653  4557899999999999985   345654 5899999999999999999


Q ss_pred             CCCC
Q psy17952        393 PYFN  396 (804)
Q Consensus       393 PF~~  396 (804)
                      ||.+
T Consensus       768 pyyn  771 (772)
T KOG1152|consen  768 PYYN  771 (772)
T ss_pred             CCcC
Confidence            9865

>KOG0595|consensus

Probab=99.97  E-value=1.8e-32  Score=292.32  Aligned_cols=134  Identities=40%  Similarity=0.675  Sum_probs=119.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .||++|+|||||+|+++.++++.+|||||||.|+.+..+...++.+++..++.++.||+.||++||+++||||||||.||
T Consensus        61 ~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNi  140 (429)
T KOG0595|consen   61 KILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNI  140 (429)
T ss_pred             HHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceE
Confidence            47899999999999999999999999999999655544445667999999999999999999999999999999999999


Q ss_pred             EEcCC------CceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         86 LLTET------GTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        86 ll~~~------~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |++..      -.+||+|||+|++..+   ..+.||||.|||||++   ...+|+.|+|+||+|++
T Consensus       141 LLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~---~~~~YdAKADLWSiG~I  203 (429)
T KOG0595|consen  141 LLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVI---MSQQYDAKADLWSIGTI  203 (429)
T ss_pred             EeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHH---HhccccchhhHHHHHHH
Confidence            99764      2579999999997543   4568999999999998   36789999999999997

>KOG0615|consensus

Probab=99.97  E-value=2.8e-32  Score=290.38  Aligned_cols=169  Identities=30%  Similarity=0.457  Sum_probs=132.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+||++|+|||||+++++|+..++.|+|||||+|+.+...-..++.+.++..+.++.|++.|+.|||+.||+||||||+|
T Consensus       227 ieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeN  306 (475)
T KOG0615|consen  227 IEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPEN  306 (475)
T ss_pred             HHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcce
Confidence            47999999999999999999999999999999866443333456789999999999999999999999999999999999


Q ss_pred             EEEcCC---CceEEeccCccccc---CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCC
Q psy17952         85 ILLTET---GTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKE  158 (804)
Q Consensus        85 ill~~~---~~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~  158 (804)
                      ||+..+   ..+||+|||+|+..   +...++||||.|.|||++.......|..++|+||+||++-....+.+  .|+..
T Consensus       307 ILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p--PFS~~  384 (475)
T KOG0615|consen  307 ILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP--PFSEE  384 (475)
T ss_pred             EEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC--Ccccc
Confidence            999776   68999999999874   34567899999999999954333345569999999998533322211  12111


Q ss_pred             Ccccccccccccccccccc
Q psy17952        159 DPEKIFEDLREIGHGSFGA  177 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~  177 (804)
                      .-  .-...++|++|.|..
T Consensus       385 ~~--~~sl~eQI~~G~y~f  401 (475)
T KOG0615|consen  385 YT--DPSLKEQILKGRYAF  401 (475)
T ss_pred             cC--CccHHHHHhcCcccc
Confidence            00  012457788888753

>KOG1027|consensus

Probab=99.97  E-value=3.3e-32  Score=310.22  Aligned_cols=246  Identities=28%  Similarity=0.406  Sum_probs=184.3

Q ss_pred             cccccccccccccc-eEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEE
Q psy17952        164 FEDLREIGHGSFGA-VYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       164 y~~l~~LG~G~fG~-Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      |.--+.+|.|+-|+ ||+|.  -.++.||||.+-.      +....+.|||..|+.- .|||||++++.=.++...||+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            45557799999886 47765  4678999997642      3334567999999988 5999999999988999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |+|..+|.|+++....+                          ...    ...-....++.|+++||++||+.+||||||
T Consensus       583 ELC~~sL~dlie~~~~d--------------------------~~~----~~~i~~~~~l~q~~~GlaHLHsl~iVHRDL  632 (903)
T KOG1027|consen  583 ELCACSLQDLIESSGLD--------------------------VEM----QSDIDPISVLSQIASGLAHLHSLKIVHRDL  632 (903)
T ss_pred             hHhhhhHHHHHhccccc--------------------------hhh----cccccHHHHHHHHHHHHHHHHhcccccccC
Confidence            99999999988632000                          000    011345778899999999999999999999


Q ss_pred             CCCCeeecC---CC--cEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        322 KAGNILLTE---TG--TVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       322 KP~NILl~~---~g--~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||.||||+.   ++  .++|+|||+++....       ..+..||-+|+|||++...   .-+.++||+|+||++|..++
T Consensus       633 kPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~---~~~~avDiFslGCvfyYvlt  709 (903)
T KOG1027|consen  633 KPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED---RKTQAVDIFSLGCVFYYVLT  709 (903)
T ss_pred             CCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcc---ccCcccchhhcCceEEEEec
Confidence            999999976   34  689999999975432       2345799999999999642   33458999999999999998


Q ss_pred             C-CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 R-KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 G-~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      | ..||.+.-.  .-.+|..+...                               +.++       ....++  ++.|||
T Consensus       710 gG~HpFGd~~~--R~~NIl~~~~~-------------------------------L~~L-------~~~~d~--eA~dLI  747 (903)
T KOG1027|consen  710 GGSHPFGDSLE--RQANILTGNYT-------------------------------LVHL-------EPLPDC--EAKDLI  747 (903)
T ss_pred             CCccCCCchHH--hhhhhhcCccc-------------------------------eeee-------ccCchH--HHHHHH
Confidence            6 899954322  12233322110                               0000       001112  899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCcccc
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      .+||..||..||+|.++|.||||=
T Consensus       748 ~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  748 SRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             HHhcCCCcccCCCHHHHhCCCccC
Confidence            999999999999999999999984

>KOG1167|consensus

Probab=99.97  E-value=1e-31  Score=287.84  Aligned_cols=282  Identities=27%  Similarity=0.438  Sum_probs=201.9

Q ss_pred             ccccccccccccccccceEEEEeee---ceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCc
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHT  236 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~---~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~  236 (804)
                      .+.|..+.+||+|+|++||++.+..   .++.||+|.+....     ...++..|++.|..+. +.||+++.+++..++.
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            4558999999999999999999887   78899999986533     2356889999999985 8999999999999999


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..+||||.+-. -.++                                     ...++-.+++.+++.++.||.++|.+|
T Consensus       110 v~ivlp~~~H~~f~~l-------------------------------------~~~l~~~~i~~Yl~~ll~Al~~~h~~G  152 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDL-------------------------------------YRSLSLAEIRWYLRNLLKALAHLHKNG  152 (418)
T ss_pred             eEEEecccCccCHHHH-------------------------------------HhcCCHHHHHHHHHHHHHHhhhhhccC
Confidence            99999999743 1111                                     124667889999999999999999999


Q ss_pred             CeecCCCCCCeeecC-CCcEEEEecccccc-----------------cCC-----------------C------------
Q psy17952        316 RIHRDVKAGNILLTE-TGTVKLADFGSASI-----------------KCP-----------------A------------  348 (804)
Q Consensus       316 IiHRDLKP~NILl~~-~g~vKL~DFGla~~-----------------~~~-----------------~------------  348 (804)
                      ||||||||+|+|.+. .+.-.|+|||+|..                 ..+                 .            
T Consensus       153 IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~  232 (418)
T KOG1167|consen  153 IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPS  232 (418)
T ss_pred             ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccc
Confidence            999999999999975 46778999999841                 000                 0            


Q ss_pred             --CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCCCchhhHHhh
Q psy17952        349 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM-NAMSALYHIAQNDTPCLQSSDWSVIKTI  425 (804)
Q Consensus       349 --~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~-~~~~~l~~I~~~~~p~~~~~~~~~i~~i  425 (804)
                        ....|||+|+|||++...  +.-++++||||.|||+..++++..||+.. ++..++.+|+.--++       ..+...
T Consensus       233 ~~anrAGT~GfRaPEvL~k~--~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~-------~~mrk~  303 (418)
T KOG1167|consen  233 ERANRAGTPGFRAPEVLFRC--PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGS-------AEMRKC  303 (418)
T ss_pred             eecccCCCCCCCchHHHhhc--cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhCh-------HHHHHH
Confidence              023699999999999754  45578999999999999999999999754 455556555431111       000000


Q ss_pred             cccccC----CCCc-cch-h---hhHHH--HhhccCCC----CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy17952        426 SSTAER----KPPY-FNM-N---AMSAL--YHIAQNDT----PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDL  490 (804)
Q Consensus       426 ~~~~~~----~pp~-~~~-~---~~~~l--~~i~~~~~----p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~  490 (804)
                      .....+    .+.. +.. .   ....+  ..+.+.+.    +......++..+.||+.+||..||.+|.||+++|+|||
T Consensus       304 A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF  383 (418)
T KOG1167|consen  304 AALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF  383 (418)
T ss_pred             hhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence            000000    0000 000 0   00000  00011111    11112234668899999999999999999999999999


Q ss_pred             ccC
Q psy17952        491 VTR  493 (804)
Q Consensus       491 ~~~  493 (804)
                      |..
T Consensus       384 F~~  386 (418)
T KOG1167|consen  384 FDE  386 (418)
T ss_pred             Ccc
Confidence            983

>KOG0200|consensus

Probab=99.97  E-value=3.3e-30  Score=304.57  Aligned_cols=259  Identities=27%  Similarity=0.492  Sum_probs=193.4

Q ss_pred             cccccccccccccceEEEEeee-------ceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecC
Q psy17952        164 FEDLREIGHGSFGAVYYARCLV-------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDH  235 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~  235 (804)
                      .++.+.||+|.||.|++|....       ....||||.++....  ....+.+..|+.+|+.+ +|||||.+.+++..++
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3556699999999999997441       145799998764332  24567889999999998 5999999999999999


Q ss_pred             ceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..++|+|||. |++.+++........+  ..-+                ........++..+...++.||+.|++||++.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~--~~~~----------------~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~  437 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESI--DGSG----------------VFPNERDALTTKDLLSFAYQIANGMEYLASV  437 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccc--cccC----------------CCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence            9999999997 7776666532100000  0000                0000003589999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCCC-----ccccCc--ccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTP--YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~-----~~~GT~--~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      .+|||||-..|||++.+..+||+|||+|+......     ...||.  .|||||.+.   ...|+.|+|||||||+|||+
T Consensus       438 ~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~---~~~ft~kSDVWSfGI~L~Ei  514 (609)
T KOG0200|consen  438 PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF---DRVFTSKSDVWSFGILLWEI  514 (609)
T ss_pred             CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc---cCcccccchhhHHHHHHHHH
Confidence            99999999999999999999999999998533221     112322  499999984   46799999999999999999


Q ss_pred             Hh-CCCCCCCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        388 AE-RKPPYFNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       388 lt-G~~PF~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      ++ |..||.+.. ..+....+..|                                          .....+...++++.
T Consensus       515 fsLG~~PYp~~~~~~~l~~~l~~G------------------------------------------~r~~~P~~c~~eiY  552 (609)
T KOG0200|consen  515 FTLGGTPYPGIPPTEELLEFLKEG------------------------------------------NRMEQPEHCSDEIY  552 (609)
T ss_pred             hhCCCCCCCCCCcHHHHHHHHhcC------------------------------------------CCCCCCCCCCHHHH
Confidence            98 899998754 22222222211                                          11122234588999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      +++..||..+|++||+..++..
T Consensus       553 ~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  553 DLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHhCCCcccCCCHHHHHH
Confidence            9999999999999999998773

>KOG0598|consensus

Probab=99.97  E-value=2.5e-31  Score=281.50  Aligned_cols=138  Identities=36%  Similarity=0.571  Sum_probs=127.3

Q ss_pred             hHHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          3 AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         3 ~~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      |=+.||.+++||+||+|+..|++...+|||+||+.|+.+....++++.|+|+.++.|+.+|+.||.|||++|||||||||
T Consensus        74 ~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKP  153 (357)
T KOG0598|consen   74 AERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKP  153 (357)
T ss_pred             HHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCH
Confidence            56789999999999999999999999999999999987777777889999999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +|||+|.+|+++|+|||+|+..    ..+.++|||+.|||||++.   ...|+..+|+||+|++.
T Consensus       154 ENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~---~~gy~~~vDWWsLGill  215 (357)
T KOG0598|consen  154 ENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILL---GKGYDKAVDWWSLGILL  215 (357)
T ss_pred             HHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHh---cCCCCcccchHhHHHHH
Confidence            9999999999999999999853    3456689999999999984   35799999999999983

>KOG0591|consensus

Probab=99.97  E-value=9.8e-33  Score=280.88  Aligned_cols=164  Identities=38%  Similarity=0.629  Sum_probs=135.8

Q ss_pred             HHHHHhcCCCCeeeEeE-EEEeCCe-EEEEEeccC-CCcHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh--cC--
Q psy17952          5 SSLLRQLKHPNTIEYRG-CYLRDHT-AWLVMEYCL-GSASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHS--LG--   74 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~-~~~~~~~-~~lV~Ey~~-g~l~~~~~~~---~~~l~~~~~~~~~~qi~~aL~ylH~--~~--   74 (804)
                      -++|++|+|||||++++ .|..++. +|||||||. |++...++..   +..++|..+++++.|++.||..||+  .+  
T Consensus        69 i~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~  148 (375)
T KOG0591|consen   69 ISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGT  148 (375)
T ss_pred             HHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccc
Confidence            36899999999999999 6666665 999999997 6666666533   4679999999999999999999998  55  


Q ss_pred             ccccccccccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcc
Q psy17952         75 RIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPE  150 (804)
Q Consensus        75 IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~  150 (804)
                      |+||||||.||+++++|.|||+|||+++..+    .+.+++|||+||+||.+   ....|++++|+||+||..       
T Consensus       149 VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i---~~~~Y~~kSDiWslGCll-------  218 (375)
T KOG0591|consen  149 VMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERI---HESGYNFKSDIWSLGCLL-------  218 (375)
T ss_pred             eeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHH---hcCCCCcchhHHHHHHHH-------
Confidence            9999999999999999999999999998643    34568999999999998   456799999999999983       


Q ss_pred             hhccccCCCc---ccccccccccccccccceE
Q psy17952        151 IAELFDKEDP---EKIFEDLREIGHGSFGAVY  179 (804)
Q Consensus       151 i~elf~~~dp---~~~y~~l~~LG~G~fG~Vy  179 (804)
                       .|+..-..|   .+.|++.++|-+|-|..+.
T Consensus       219 -yEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  219 -YEMCALQSPFYGDNLLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             -HHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence             333222222   2568899999999887664

>KOG0593|consensus

Probab=99.97  E-value=2.5e-32  Score=280.44  Aligned_cols=163  Identities=31%  Similarity=0.553  Sum_probs=144.9

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|++|+|||+|.|+.+|.....++||+|||+.+.++-+......++++.++.|+.|+++|+.|||++++|||||||+||
T Consensus        53 rmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI  132 (396)
T KOG0593|consen   53 RMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI  132 (396)
T ss_pred             HHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence            57999999999999999999999999999999999999988888999999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC-C---CCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccc-cCCCc
Q psy17952         86 LLTETGTVKLADFGSASIKC-P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELF-DKEDP  160 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~-~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf-~~~dp  160 (804)
                      |++.+|.+||||||+|+... +   ...++-|.||+|||++.+  ..+|+..+|+||+||+.+++.+++-  +| .+.|.
T Consensus       133 Lit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG--DtqYG~pVDiWAiGCv~aEl~~G~p--L~PG~SDi  208 (396)
T KOG0593|consen  133 LITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG--DTQYGKPVDIWAIGCVFAELLTGEP--LWPGRSDI  208 (396)
T ss_pred             EEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc--cCcCCCcccchhhhHHHHHHhcCCc--CCCCcchH
Confidence            99999999999999998754 2   234789999999999965  5689999999999999877776642  33 35577


Q ss_pred             cccccccccccc
Q psy17952        161 EKIFEDLREIGH  172 (804)
Q Consensus       161 ~~~y~~l~~LG~  172 (804)
                      .+.|.+.+.||.
T Consensus       209 DQLy~I~ktLG~  220 (396)
T KOG0593|consen  209 DQLYLIRKTLGN  220 (396)
T ss_pred             HHHHHHHHHHcc
Confidence            778888888874

>KOG0577|consensus

Probab=99.97  E-value=4.8e-32  Score=296.95  Aligned_cols=142  Identities=81%  Similarity=1.316  Sum_probs=136.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++|+|||+|.|.|||..+...|||||||.|+-.|++..++.++.+..+..++.+.+.||.|||+++.||||||..|
T Consensus        77 VrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGN  156 (948)
T KOG0577|consen   77 VRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGN  156 (948)
T ss_pred             HHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccc
Confidence            36789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         85 ILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ||+++.|.|||+|||.|...+++++++|||+|||||+++.|+.|+|+.++||||+|+|.-++
T Consensus       157 ILLse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL  218 (948)
T KOG0577|consen  157 ILLSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  218 (948)
T ss_pred             eEecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence            99999999999999999999999999999999999999999999999999999999996544

>KOG0581|consensus

Probab=99.97  E-value=2.7e-31  Score=281.36  Aligned_cols=139  Identities=37%  Similarity=0.632  Sum_probs=123.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCC-eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDH-TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~-~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~   83 (804)
                      +||+..+|||||++||+|+.+. .++|+||||+|+.++.+....++++|..+..++.+|++||.|||+ ++||||||||+
T Consensus       129 ~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPs  208 (364)
T KOG0581|consen  129 EILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPS  208 (364)
T ss_pred             HHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHH
Confidence            4677789999999999999999 599999999976666655555889999999999999999999995 99999999999


Q ss_pred             cEEEcCCCceEEeccCcccc--cCCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLK  147 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~  147 (804)
                      |||++..|+|||||||+++.  .+...+++||..|||||-+   +...|+.++||||+|.+..++.
T Consensus       209 NlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi---~g~~Ys~~sDIWSLGLsllE~a  271 (364)
T KOG0581|consen  209 NLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERI---SGESYSVKSDIWSLGLSLLELA  271 (364)
T ss_pred             HeeeccCCCEEeccccccHHhhhhhcccccccccccChhhh---cCCcCCcccceecccHHHHHHh
Confidence            99999999999999999975  4566889999999999998   4568999999999999865443

>KOG1025|consensus

Probab=99.97  E-value=9.2e-31  Score=296.03  Aligned_cols=243  Identities=26%  Similarity=0.394  Sum_probs=194.2

Q ss_pred             cccccccccccccceEEEEeeecee----EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~----~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .+..++||+|+||+||+|.....|+    +||||.+..  ....+...+++.|+-+|.+|+|||++++++++.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~--~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE--FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeec--cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            4556889999999999999876664    689998753  233445578999999999999999999999998766 889


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |++|+++ .|.|.++                                 .++.++-.++...|..||++||.|||.+++||
T Consensus       775 vtq~mP~G~LlDyvr---------------------------------~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVH  821 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVR---------------------------------EHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVH  821 (1177)
T ss_pred             HHHhcccchHHHHHH---------------------------------HhhccccHHHHHHHHHHHHHHHHHHHhcchhh
Confidence            9999984 4555443                                 24567788899999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCCCcc----cc--CcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPANSF----VG--TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~----~G--T~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      |||-..|||+.+-..+||+|||+|+...+....    .|  -+.|||-|.+.   ...|+.++|||||||++||++| |.
T Consensus       822 rdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~---~~~~thqSDVWsfGVtiWElmTFGa  898 (1177)
T KOG1025|consen  822 RDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR---IRKYTHQSDVWSFGVTIWELMTFGA  898 (1177)
T ss_pred             hhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhh---ccCCCchhhhhhhhhhHHHHHhcCC
Confidence            999999999999999999999999876553221    12  24689999884   5689999999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .|+++....++-..+..++                                          ...+++..+-++.-++.+|
T Consensus       899 ~Py~gi~~~eI~dlle~ge------------------------------------------RLsqPpiCtiDVy~~mvkC  936 (1177)
T KOG1025|consen  899 KPYDGIPAEEIPDLLEKGE------------------------------------------RLSQPPICTIDVYMVMVKC  936 (1177)
T ss_pred             CccCCCCHHHhhHHHhccc------------------------------------------cCCCCCCccHHHHHHHHHH
Confidence            9998876554433222211                                          1122345677888899999


Q ss_pred             cccCCCCCCCHHHHHc
Q psy17952        472 LAKNPADRPSSGRLLT  487 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~  487 (804)
                      |..|+..||++.++-.
T Consensus       937 wmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  937 WMIDADSRPTFKELAE  952 (1177)
T ss_pred             hccCcccCccHHHHHH
Confidence            9999999999988764

>KOG2052|consensus

Probab=99.97  E-value=2.6e-30  Score=277.55  Aligned_cols=186  Identities=31%  Similarity=0.499  Sum_probs=146.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHh--hcCCCceeEeeeEEeecC----
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR--QLKHPNTIEYRGCYLRDH----  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~--~L~HpNIV~l~~~~~~~~----  235 (804)
                      +...+.+.||+|.||+||+|++  .|+.||||++...+   .   ....||.+|.+  .|+|+||..|+++-..+.    
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd---E---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD---E---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccc---h---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            4567889999999999999975  57899999986422   1   34567777776  569999999998765443    


Q ss_pred             ceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      .+|||++|-+ |+|.|++.                                   ...++.+...+++..++.||++||-.
T Consensus       283 QLwLvTdYHe~GSL~DyL~-----------------------------------r~tv~~~~ml~LalS~AsGLaHLH~e  327 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLN-----------------------------------RNTVTTEGMLKLALSIASGLAHLHME  327 (513)
T ss_pred             EEEEeeecccCCcHHHHHh-----------------------------------hccCCHHHHHHHHHHHhhhHHHHHHH
Confidence            5899999987 77666543                                   24688899999999999999999952


Q ss_pred             --------CCeecCCCCCCeeecCCCcEEEEecccccccC--------CCCccccCcccccchhhccc-CCCCCC--Ccc
Q psy17952        315 --------GRIHRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAM-DEGQYD--GKV  375 (804)
Q Consensus       315 --------gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~--------~~~~~~GT~~Y~APEvl~~~-~~~~y~--~ks  375 (804)
                              .|.|||||+.|||+..+|++.|+|+|+|-...        +.+..+||..|||||+|-.. +...++  ..+
T Consensus       328 I~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~A  407 (513)
T KOG2052|consen  328 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRA  407 (513)
T ss_pred             HhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHH
Confidence                    39999999999999999999999999995322        23567999999999998421 111122  259


Q ss_pred             cHHHHHHHHHHHHhC
Q psy17952        376 DVWSLGITCIELAER  390 (804)
Q Consensus       376 DIWSlGvil~ELltG  390 (804)
                      ||||||.++||++.+
T Consensus       408 DIYafgLVlWEiarR  422 (513)
T KOG2052|consen  408 DIYAFGLVLWEIARR  422 (513)
T ss_pred             HHHHHHHHHHHHHHH
Confidence            999999999999853

>KOG3653|consensus

Probab=99.97  E-value=2.6e-30  Score=279.40  Aligned_cols=188  Identities=31%  Similarity=0.468  Sum_probs=151.8

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHh--hcCCCceeEeeeEEeecC----ce
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR--QLKHPNTIEYRGCYLRDH----TA  237 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~--~L~HpNIV~l~~~~~~~~----~~  237 (804)
                      .++++.||+|.||.||+|..  +++.||||++...      ..+.+..|-+|.+  .++|+||++|+++-....    .+
T Consensus       212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            57788999999999999974  4589999988642      2355667777665  568999999998866554    78


Q ss_pred             EEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--
Q psy17952        238 WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL--  314 (804)
Q Consensus       238 ~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~--  314 (804)
                      |||+||-+ |+|.|++..                                   ..+++.+..+++..+++||+|||+.  
T Consensus       284 wLVt~fh~kGsL~dyL~~-----------------------------------ntisw~~~cria~SmarGLa~LHee~p  328 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKA-----------------------------------NTISWNSLCRIAESMARGLAHLHEELP  328 (534)
T ss_pred             eEEeeeccCCcHHHHHHh-----------------------------------ccccHHHHHHHHHHHHHHHHHhcccCC
Confidence            99999986 888777642                                   3578899999999999999999972  


Q ss_pred             -------CCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCC-CC--CcccHH
Q psy17952        315 -------GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQ-YD--GKVDVW  378 (804)
Q Consensus       315 -------gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~-y~--~ksDIW  378 (804)
                             .|+|||||+.||||.+|++..|+|||+|....+.      -..+||..|||||++.+.-+-+ -+  .+.|||
T Consensus       329 ~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvY  408 (534)
T KOG3653|consen  329 RGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVY  408 (534)
T ss_pred             cCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHH
Confidence                   5999999999999999999999999999765432      2368999999999996532111 01  259999


Q ss_pred             HHHHHHHHHHhCCCCC
Q psy17952        379 SLGITCIELAERKPPY  394 (804)
Q Consensus       379 SlGvil~ELltG~~PF  394 (804)
                      |+|.+||||+++..-+
T Consensus       409 amgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  409 AMGLVLWEIASRCTDA  424 (534)
T ss_pred             HHHHHHHHHHhhcccc
Confidence            9999999999987655

>KOG0616|consensus

Probab=99.96  E-value=1.9e-30  Score=266.26  Aligned_cols=135  Identities=31%  Similarity=0.548  Sum_probs=124.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ++||+.+.||++|+|++.|.+...+|+||||+.|+.+..+..+.++|++..++.|+.||+.||+|||+++||+|||||+|
T Consensus        95 k~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPEN  174 (355)
T KOG0616|consen   95 KRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPEN  174 (355)
T ss_pred             HHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHH
Confidence            57999999999999999999999999999999987655555566899999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc-CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIK-CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+|.+|.+||.|||+|+.. ..+.+.||||.|+|||++   ..+.|+.++|+||+|+.
T Consensus       175 iLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii---~sk~ynkavDWWalGVL  230 (355)
T KOG0616|consen  175 LLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEII---QSKGYNKAVDWWALGVL  230 (355)
T ss_pred             eeeccCCcEEEEeccceEEecCcEEEecCCccccChHHh---hcCCCCcchhHHHHHHH
Confidence            99999999999999999864 456788999999999998   45789999999999997

>KOG0600|consensus

Probab=99.96  E-value=5.6e-30  Score=278.82  Aligned_cols=139  Identities=35%  Similarity=0.591  Sum_probs=124.0

Q ss_pred             HHHHhcCCCCeeeEeEEEEeC--CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~--~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      -||++|+|||||+|.+..+..  ..+|||+|||+.||..++....-.|++.+++.|+.||+.||+|||++||+|||||.+
T Consensus       168 ~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~S  247 (560)
T KOG0600|consen  168 KILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGS  247 (560)
T ss_pred             HHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeecccccc
Confidence            378999999999999987776  689999999999999888765668999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      |||||++|.+||+|||+|++...     ..+.+-|.+|+|||++++  ...|+..+|+||+||+++++
T Consensus       248 NiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG--~t~Yg~aVDlWS~GCIl~El  313 (560)
T KOG0600|consen  248 NILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG--ATSYGTAVDLWSVGCILAEL  313 (560)
T ss_pred             ceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcC--CcccccceeehhhhHHHHHH
Confidence            99999999999999999985332     345688999999999986  45799999999999995443

>KOG0661|consensus

Probab=99.96  E-value=7.7e-31  Score=283.65  Aligned_cols=163  Identities=31%  Similarity=0.553  Sum_probs=142.5

Q ss_pred             HHHhcC-CCCeeeEeEEEEeCC-eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          7 LLRQLK-HPNTIEYRGCYLRDH-TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         7 iL~~l~-HpnIV~l~~~~~~~~-~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      -|++|+ |||||+|++++.+.+ .+|+|||||+-+|+++++.+...|++..++.|++||+.||+|+|.+|+.|||+||+|
T Consensus        61 sL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPEN  140 (538)
T KOG0661|consen   61 SLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPEN  140 (538)
T ss_pred             HHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhh
Confidence            467888 999999999998888 899999999999999999888899999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc---CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccC-CCc
Q psy17952         85 ILLTETGTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDK-EDP  160 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~-~dp  160 (804)
                      ||+.....+||+|||+|+..   .+...++.|+||+|||+++  +.+.|+.++|+||+||+..++..  +.-+|.. .+.
T Consensus       141 iLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLL--rs~~Ys~pvD~wA~GcI~aEl~s--LrPLFPG~sE~  216 (538)
T KOG0661|consen  141 ILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLL--RSGYYSSPVDMWAVGCIMAELYS--LRPLFPGASEI  216 (538)
T ss_pred             eEecccceeEecccccccccccCCCcchhhhcccccchHHhh--hccccCCchHHHHHHHHHHHHHH--hcccCCCCcHH
Confidence            99998899999999999863   3556789999999999995  67899999999999998654432  2234543 455


Q ss_pred             ccccccccccccc
Q psy17952        161 EKIFEDLREIGHG  173 (804)
Q Consensus       161 ~~~y~~l~~LG~G  173 (804)
                      ++.|++.++||.-
T Consensus       217 Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  217 DQIYKICEVLGTP  229 (538)
T ss_pred             HHHHHHHHHhCCC
Confidence            6779999999853

>KOG0590|consensus

Probab=99.96  E-value=7.1e-30  Score=298.67  Aligned_cols=423  Identities=24%  Similarity=0.299  Sum_probs=274.7

Q ss_pred             cccccccccccccccccceEEEEeee-ceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCce
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLV-SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~-~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~  237 (804)
                      +...|++.+.||+|+|+.|-.+.... +...+|+|.+.... ........+..|..+=+.+. |+|++.+++........
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            45568999999999999998877644 34467888776543 22333345556888777787 99999999999999999


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhh-ccCC-CCCHHHHHHHHHHHHHHHHHHH-HC
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE-VHKR-PLKEEEIAAICSGVLRGLNYLH-SL  314 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~-~~~~-~l~e~~i~~i~~qil~gL~yLH-~~  314 (804)
                      ++.++|..|+                                 ++|+.+ .... ..+...+..++.|+..|+.|+| ..
T Consensus        97 ~~~~~~s~g~---------------------------------~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~  143 (601)
T KOG0590|consen   97 LLSLSYSDGG---------------------------------SLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN  143 (601)
T ss_pred             ccccCccccc---------------------------------ccccccccCCccCCCCcchhhhhhhhccCccccCccc
Confidence            9999998775                                 233333 2222 5778889999999999999999 99


Q ss_pred             CCeecCCCCCCeeecCCC-cEEEEecccccccCC-C------Ccccc-CcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETG-TVKLADFGSASIKCP-A------NSFVG-TPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g-~vKL~DFGla~~~~~-~------~~~~G-T~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      ++.||||||+|.+++..+ .+|++|||+|..... .      ...+| ++.|+|||...+.  ....+..|+||+|+++.
T Consensus       144 ~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~--~~~~~~~d~~S~g~~l~  221 (601)
T KOG0590|consen  144 GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK--AYRGPSVDVWSLGIVLS  221 (601)
T ss_pred             ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccch--hhcCCCccccccccccc
Confidence            999999999999999999 999999999976543 2      23578 9999999998531  23355799999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      -|++|..|+.........+.            .|     +..                     ............+....
T Consensus       222 ~~~~g~~p~~~~~~~~~~~~------------~~-----~~~---------------------~~~~~~~~~~~~~~~~~  263 (601)
T KOG0590|consen  222 AMLTGELPWDFPSRKDGRYS------------SW-----KSN---------------------KGRFTQLPWNSISDQAH  263 (601)
T ss_pred             ccccCCCCccccccccccce------------ee-----ccc---------------------ccccccCccccCChhhh
Confidence            99999999854332110000            00     000                     00001122345677888


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccC-CCCCchhHHHHHHHHHHHhhhhhhhHHHHHHHHHhcCCCCCCCCCCCCCcc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPD  544 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~  544 (804)
                      +++.++|..+|..|.+..++-.++|+.. ........            .               ......   ......
T Consensus       264 ~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n------------~---------------~~~~~~---~~~~~~  313 (601)
T KOG0590|consen  264 DLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSN------------P---------------CADSLT---IAKSPI  313 (601)
T ss_pred             hcccccccCCchhcccccccccccccccccccccccc------------c---------------cccccc---cccCcc
Confidence            9999999999999999999999999976 11100000            0               000000   000000


Q ss_pred             cccCCCCCCCCcccccccccccccc--CCCCCCCCCCcccc-----cccCCCCCCccccccccccCCCCcccccccc---
Q psy17952        545 EQAGNDSSKSNSITSEHSVQSVGVG--VNPHDPTPNSSSQA-----HNRHHHHHPVTHLSQHSYNNNNSNYSSLFSP---  614 (804)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---  614 (804)
                      .....+. .........+.+.+...  ..+....+......     .....................|+++.....-   
T Consensus       314 ~~~~~y~-~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~  392 (601)
T KOG0590|consen  314 GFSEKYG-KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE  392 (601)
T ss_pred             ccccccC-CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh
Confidence            0000000 00000111111100000  00111011110000     0000000001112222334455554433331   


Q ss_pred             ----hhhhhhccCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCceEEcCCCceeecCcccccc
Q psy17952        615 ----QLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAG  688 (804)
Q Consensus       615 ----~lv~e~~~g~~~~~~~~~~~~~~e~~~~~i~~~i~~~l~ylH~~~ivHrDlkp~NiLl~~~~~~k~~~~~~~~~  688 (804)
                          .-+||||.+ ++..++-..+.++-.+|...+.|++.||+|||+.||.||||||+|+|++.+|.+|+-+++..-.
T Consensus       393 ~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  393 IDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             cccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCccee
Confidence                244999999 8887766666899999999999999999999999999999999999999999999999988543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.8e-29  Score=308.47  Aligned_cols=198  Identities=19%  Similarity=0.208  Sum_probs=143.1

Q ss_pred             hhcCC-CceeEeeeEE-------eecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhcc
Q psy17952        217 RQLKH-PNTIEYRGCY-------LRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH  288 (804)
Q Consensus       217 ~~L~H-pNIV~l~~~~-------~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~  288 (804)
                      +.++| +||++++++|       .....++++|||+.++|.+++.                                 ..
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~---------------------------------~~   73 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLD---------------------------------NP   73 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHh---------------------------------cc
Confidence            34456 5788888877       3334678889998887655442                                 11


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecC-------------------CCcEEEEecccccccCC--
Q psy17952        289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE-------------------TGTVKLADFGSASIKCP--  347 (804)
Q Consensus       289 ~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~-------------------~g~vKL~DFGla~~~~~--  347 (804)
                      ...+++.++..|++||++||+|||++|||||||||+||||+.                   ++.+||+|||+++....  
T Consensus        74 ~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~  153 (793)
T PLN00181         74 DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILS  153 (793)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccccc
Confidence            346899999999999999999999999999999999999954                   44566777777653110  


Q ss_pred             ------------------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q psy17952        348 ------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQN  409 (804)
Q Consensus       348 ------------------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~  409 (804)
                                        ....+||++|||||++.   ...|+.++|||||||+||||++|.+||....  ..+..+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~  228 (793)
T PLN00181        154 ERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN---GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR  228 (793)
T ss_pred             ccchhhhhccccCCCcccccccCCCcceEChhhhc---cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh
Confidence                              01246899999999985   3568999999999999999999998874321  111111000


Q ss_pred             CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy17952        410 DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       410 ~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp  489 (804)
                                           ..|+.                    . ........+++.+||++||.+|||+.|+|+||
T Consensus       229 ---------------------~~~~~--------------------~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        229 ---------------------VLPPQ--------------------I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             ---------------------hcChh--------------------h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence                                 00000                    0 00133456899999999999999999999999


Q ss_pred             cccCC
Q psy17952        490 LVTRP  494 (804)
Q Consensus       490 ~~~~~  494 (804)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=5.3e-28  Score=247.63  Aligned_cols=205  Identities=40%  Similarity=0.650  Sum_probs=170.2

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |...+.||+|+||.||++.+..+++.+|+|.+......  .....+.+|++.+++++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            56678899999999999999988999999988643211  2456788999999999999999999999999999999999


Q ss_pred             cCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        244 CLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       244 ~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~-l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      +.| ++.+++.                                  .... +++..+..++.|++.++.|||+++++|+||
T Consensus        79 ~~~~~L~~~~~----------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di  124 (225)
T smart00221       79 CEGGDLFDYLR----------------------------------KKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDL  124 (225)
T ss_pred             cCCCCHHHHHH----------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            987 4433332                                  1123 788999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      +|.||+++.++.++|+|||++......     ....++..|++||.+.  ....++.++|+||||++++||++|+.||..
T Consensus       125 ~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      125 KPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999999999999999999998754332     3567888999999874  345677899999999999999999999977


Q ss_pred             -CChHHHHHHH
Q psy17952        397 -MNAMSALYHI  406 (804)
Q Consensus       397 -~~~~~~l~~I  406 (804)
                       .+....+...
T Consensus       203 ~~~~~~~~~~~  213 (225)
T smart00221      203 EGEFTSLLSDV  213 (225)
T ss_pred             cchhHHHHHHH
Confidence             5555444433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0575|consensus

Probab=99.96  E-value=3.2e-29  Score=279.25  Aligned_cols=134  Identities=38%  Similarity=0.708  Sum_probs=120.9

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      +|.++|+|||||+++++|++.+++|||+|+|. |++..+++ +..+++|.+++.|+.||+.||.|||+++|||||||-.|
T Consensus        70 eIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN  148 (592)
T KOG0575|consen   70 EIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN  148 (592)
T ss_pred             HHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence            57789999999999999999999999999997 55656555 67899999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ++++.+.+|||+|||+|....    ...+.||||.|.|||++.   ...+++-+|+||+||++
T Consensus       149 lfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~---k~gHsfEvDiWSlGcvm  208 (592)
T KOG0575|consen  149 LFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLN---KSGHSFEVDIWSLGCVM  208 (592)
T ss_pred             eeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhc---cCCCCCchhhhhhhhHH
Confidence            999999999999999997643    345689999999999984   45689999999999984

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1e-27  Score=240.58  Aligned_cols=209  Identities=42%  Similarity=0.732  Sum_probs=174.1

Q ss_pred             cccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC-Cc
Q psy17952        170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SA  248 (804)
Q Consensus       170 LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G-~l  248 (804)
                      ||+|++|.||++....+++.+++|.........  ..+.+.+|++.++.++|++|+++++++......+++|||+.| ++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999876432211  346788999999999999999999999999999999999984 44


Q ss_pred             hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeee
Q psy17952        249 SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL  328 (804)
Q Consensus       249 ~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl  328 (804)
                      .+++..                                 ....+++..+..++.+++++|+|||+.|++|+||+|.||++
T Consensus        79 ~~~~~~---------------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~  125 (215)
T cd00180          79 KDLLKE---------------------------------NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL  125 (215)
T ss_pred             HHHHHh---------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE
Confidence            333220                                 01357889999999999999999999999999999999999


Q ss_pred             cC-CCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy17952        329 TE-TGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL  403 (804)
Q Consensus       329 ~~-~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l  403 (804)
                      +. ++.++|+|||.+......    ....++..|++||.+..  ...++.++|+||+|+++++|                
T Consensus       126 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~D~~~lg~~~~~l----------------  187 (215)
T cd00180         126 DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG--KGYYSEKSDIWSLGVILYEL----------------  187 (215)
T ss_pred             eCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcc--cCCCCchhhhHHHHHHHHHH----------------
Confidence            99 899999999998754432    34568889999999842  12567899999999999998                


Q ss_pred             HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHH
Q psy17952        404 YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSG  483 (804)
Q Consensus       404 ~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~  483 (804)
                                                                                ..+.+++.+||..||++||++.
T Consensus       188 ----------------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~  209 (215)
T cd00180         188 ----------------------------------------------------------PELKDLIRKMLQKDPEKRPSAK  209 (215)
T ss_pred             ----------------------------------------------------------HHHHHHHHHHhhCCcccCcCHH
Confidence                                                                      0134689999999999999999


Q ss_pred             HHHcCc
Q psy17952        484 RLLTHD  489 (804)
Q Consensus       484 elL~Hp  489 (804)
                      ++++|+
T Consensus       210 ~l~~~~  215 (215)
T cd00180         210 EILEHL  215 (215)
T ss_pred             HHhhCC
Confidence            999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0659|consensus

Probab=99.96  E-value=9.3e-30  Score=257.87  Aligned_cols=139  Identities=34%  Similarity=0.530  Sum_probs=126.0

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      +|++++|||||+|+|+|.+...+.||+|||+.+|..+++.....++..+++.|+.|+++||+|||++.|+||||||.|+|
T Consensus        54 ~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLL  133 (318)
T KOG0659|consen   54 LLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLL  133 (318)
T ss_pred             HHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceE
Confidence            58999999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCcccccC-CC---CccccccccCcchhhhhcccCccCCcccccccccCCCCCC
Q psy17952         87 LTETGTVKLADFGSASIKC-PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLK  147 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~~~-~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~  147 (804)
                      ++.+|.+||+|||+|+... +.   ...+-|.+|+|||++++  ...|+..+|+||.||+.+++.
T Consensus       134 is~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfG--sr~Yg~~VDmWavGCI~AELl  196 (318)
T KOG0659|consen  134 ISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFG--SRQYGTGVDMWAVGCIFAELL  196 (318)
T ss_pred             EcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhcc--chhcCCcchhhhHHHHHHHHH
Confidence            9999999999999998532 21   22378999999999976  457999999999999965543

>KOG0663|consensus

Probab=99.95  E-value=2.7e-29  Score=261.29  Aligned_cols=165  Identities=32%  Similarity=0.552  Sum_probs=140.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEeC--CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~--~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ++|.+.+|||||.+..+....  +.+|||||||+.++..++...+.+|+..+++.++.|+++|++|||.+.|+||||||+
T Consensus       127 niLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~S  206 (419)
T KOG0663|consen  127 NILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTS  206 (419)
T ss_pred             HHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchh
Confidence            567888999999999988754  579999999999999999988889999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccc-cCC---CCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccc-cCC
Q psy17952         84 NILLTETGTVKLADFGSASI-KCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELF-DKE  158 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~-~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf-~~~  158 (804)
                      |+|+++.|-+||||||+|+. .++   ....+-|.+|+|||++++  ...|+..+|+||+||+.+++....  -+| .+.
T Consensus       207 NLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG--~~tyst~iDMWSvGCI~aE~l~~k--Plf~G~s  282 (419)
T KOG0663|consen  207 NLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLG--AKTYSTAVDMWSVGCIFAELLTQK--PLFPGKS  282 (419)
T ss_pred             heeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcC--CcccCcchhhhhHHHHHHHHHhcC--CCCCCCc
Confidence            99999999999999999984 333   455789999999999976  467999999999999977664432  234 334


Q ss_pred             Cccccccccccccccc
Q psy17952        159 DPEKIFEDLREIGHGS  174 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~  174 (804)
                      ...+..++.+.||..+
T Consensus       283 E~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  283 EIDQLDKIFKLLGTPS  298 (419)
T ss_pred             hHHHHHHHHHHhCCCc
Confidence            5566677777787643

>KOG0658|consensus

Probab=99.95  E-value=3.3e-29  Score=264.95  Aligned_cols=162  Identities=31%  Similarity=0.543  Sum_probs=132.3

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCC-----eEEEEEeccCCCcHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcCccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDH-----TAWLVMEYCLGSASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLGRIH   77 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~-----~~~lV~Ey~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~IiH   77 (804)
                      .||+.++|||||+|..+|....     .+.||||||..++.++++..   +..++.-.++-|..||.+||.|||++||.|
T Consensus        69 ~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcH  148 (364)
T KOG0658|consen   69 QIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICH  148 (364)
T ss_pred             HHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCccc
Confidence            5899999999999999886432     46799999999999988753   578899999999999999999999999999


Q ss_pred             cccccccEEEcCC-CceEEeccCccccc---CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhc
Q psy17952         78 RDVKAGNILLTET-GTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAE  153 (804)
Q Consensus        78 RDlKp~Nill~~~-~~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~e  153 (804)
                      |||||.|+|+|.+ |.+||||||.|+..   .+..++.-|++|+|||++++  ...|+.++|+||.||+.+++..++.  
T Consensus       149 RDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifg--a~~Yt~~IDiWSaGCV~aELl~g~p--  224 (364)
T KOG0658|consen  149 RDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVMAELLKGQP--  224 (364)
T ss_pred             CCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcC--ccccCceeEEhhhhHHHHHHhcCCc--
Confidence            9999999999986 89999999999864   34556889999999999976  4679999999999999777655432  


Q ss_pred             cccCCCccc-ccccccccc
Q psy17952        154 LFDKEDPEK-IFEDLREIG  171 (804)
Q Consensus       154 lf~~~dp~~-~y~~l~~LG  171 (804)
                      +|..++..+ .-++++.+|
T Consensus       225 lFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  225 LFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             ccCCCCHHHHHHHHHHHhC
Confidence            354433332 233444444

>KOG1345|consensus

Probab=99.95  E-value=2.9e-28  Score=247.08  Aligned_cols=201  Identities=23%  Similarity=0.366  Sum_probs=159.0

Q ss_pred             cCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeee-EEee
Q psy17952        156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRG-CYLR  233 (804)
Q Consensus       156 ~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~-~~~~  233 (804)
                      .+-+..+.|.+.+.||+|-||.+.+|+++.++..+++|.+...    .....+|.+|...--.| .|.|||.-|+ .|++
T Consensus        18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            3445667799999999999999999999999999999987532    22346788998876666 4899998554 6888


Q ss_pred             cCceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+.++++||||+ |+|..-+                                   ....+-|...+.++.|+++|+.|+|
T Consensus        94 ~d~YvF~qE~aP~gdL~snv-----------------------------------~~~GigE~~~K~v~~ql~SAi~fMH  138 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNV-----------------------------------EAAGIGEANTKKVFAQLLSAIEFMH  138 (378)
T ss_pred             CceEEEeeccCccchhhhhc-----------------------------------CcccccHHHHHHHHHHHHHHHHHhh
Confidence            888899999998 5542211                                   1245778889999999999999999


Q ss_pred             HCCCeecCCCCCCeeecC--CCcEEEEecccccccCCCC-ccccCcccccchhhcccCCCCC--CCcccHHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTE--TGTVKLADFGSASIKCPAN-SFVGTPYWMAPEVILAMDEGQY--DGKVDVWSLGITCIEL  387 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~--~g~vKL~DFGla~~~~~~~-~~~GT~~Y~APEvl~~~~~~~y--~~ksDIWSlGvil~EL  387 (804)
                      ++++||||||.+||||-.  ...+||||||+++.....- ..--+..|.|||++....++.|  ++.+|+|.||+++|..
T Consensus       139 sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~c  218 (378)
T KOG1345|consen  139 SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYC  218 (378)
T ss_pred             ccchhhcccccceEEEecCCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeee
Confidence            999999999999999942  3489999999986543221 1223456899998865444443  6789999999999999


Q ss_pred             HhCCCCCC
Q psy17952        388 AERKPPYF  395 (804)
Q Consensus       388 ltG~~PF~  395 (804)
                      ++|++||.
T Consensus       219 ltG~~PWQ  226 (378)
T KOG1345|consen  219 LTGKFPWQ  226 (378)
T ss_pred             ecCCCcch
Confidence            99999995

>KOG0578|consensus

Probab=99.95  E-value=1.9e-28  Score=271.07  Aligned_cols=139  Identities=46%  Similarity=0.862  Sum_probs=122.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|+..+|+|||++++.|.-.+.+|.|||||+|+ |.++..  +..++|.++..+|++++.||+|||.++|||||||..|
T Consensus       322 ~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDn  399 (550)
T KOG0578|consen  322 LVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDN  399 (550)
T ss_pred             HHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccce
Confidence            4789999999999999999999999999999865 555543  4569999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCc
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDP  149 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~  149 (804)
                      ||++.+|.+||.|||||....    ...+.+|||+|||||++   ....|++++||||+|++.-++..+
T Consensus       400 ILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVv---trk~YG~KVDIWSLGIMaIEMveG  465 (550)
T KOG0578|consen  400 ILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVV---TRKPYGPKVDIWSLGIMAIEMVEG  465 (550)
T ss_pred             eEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhh---hhcccCccccchhhhhHHHHHhcC
Confidence            999999999999999997532    44567999999999998   456899999999999995554443

>KOG0192|consensus

Probab=99.95  E-value=4.7e-28  Score=267.14  Aligned_cols=138  Identities=41%  Similarity=0.647  Sum_probs=119.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC-eEEEEEeccCC-CcHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcC-cccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH-TAWLVMEYCLG-SASDIIEV-HKRPLKEEEIAAICSGVLRGLNYLHSLG-RIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~-~~~lV~Ey~~g-~l~~~~~~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~-IiHRDl   80 (804)
                      ..+|..|+|||||+|+|++.... .+.||||||.+ ++.+++.. .+..++...+..++.||++||+|||+++ ||||||
T Consensus        90 ~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDL  169 (362)
T KOG0192|consen   90 ASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDL  169 (362)
T ss_pred             HHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeeccc
Confidence            46889999999999999999887 79999999985 55566655 3789999999999999999999999999 999999


Q ss_pred             ccccEEEcCCC-ceEEeccCcccccC---CC-CccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         81 KAGNILLTETG-TVKLADFGSASIKC---PA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        81 Kp~Nill~~~~-~~kl~DFG~a~~~~---~~-~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||.|||++.++ ++||+|||+++...   .. +...||+.|||||++.+. ...|+.|+|+||||+++
T Consensus       170 K~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvl  236 (362)
T KOG0192|consen  170 KSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVL  236 (362)
T ss_pred             ChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHH
Confidence            99999999997 99999999997643   22 236899999999998422 45799999999999984

>KOG0583|consensus

Probab=99.95  E-value=7.1e-28  Score=267.62  Aligned_cols=135  Identities=41%  Similarity=0.711  Sum_probs=120.4

Q ss_pred             HHHHhcC-CCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~-HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|+.++ ||||+++++++.+...+|+|||||.| ++++.+.. .++++|..++.++.|++.|++|||++||+||||||+
T Consensus        71 ~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~E  149 (370)
T KOG0583|consen   71 SILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPE  149 (370)
T ss_pred             HHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHH
Confidence            4788998 99999999999999999999999985 78888876 899999999999999999999999999999999999


Q ss_pred             cEEEcCC-CceEEeccCccccc----CCCCccccccccCcchhhhhcccCcc-CCcccccccccCC
Q psy17952         84 NILLTET-GTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~-~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~-~~~vDvwslG~~~  143 (804)
                      |||++.+ +.+||+|||++...    ....+.+|||.|+|||++.+  .+.| +.++|+||+|+++
T Consensus       150 Nilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViL  213 (370)
T KOG0583|consen  150 NILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVIL  213 (370)
T ss_pred             HEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHH
Confidence            9999999 99999999999764    23456799999999999853  2326 5789999999984

>KOG0592|consensus

Probab=99.95  E-value=9.4e-28  Score=263.40  Aligned_cols=135  Identities=35%  Similarity=0.609  Sum_probs=121.3

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      +++|.+| +||.||+|+..|.++..+|+|+||+. |+|+++++ +.+.|++...+.|+.||+.||+|||++|||||||||
T Consensus       124 k~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKP  202 (604)
T KOG0592|consen  124 KEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKP  202 (604)
T ss_pred             HHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCCh
Confidence            5789999 89999999999999999999999997 67788775 458999999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC-----------------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC-----------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~-----------------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +|||+|.+|++||+|||.|+...                 ...+++||..|.+||+|   ..+..+..+|+|+|||+.
T Consensus       203 ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL---~~~~~~~~sDiWAlGCil  277 (604)
T KOG0592|consen  203 ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL---NDSPAGPSSDLWALGCIL  277 (604)
T ss_pred             hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHh---cCCCCCcccchHHHHHHH
Confidence            99999999999999999997421                 11358999999999998   456778899999999984

>KOG0588|consensus

Probab=99.94  E-value=5e-28  Score=270.23  Aligned_cols=162  Identities=31%  Similarity=0.541  Sum_probs=132.7

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      ||+.|+||||++|++++++...+|||+||+.|+.+......++++++.+...++.||+.|+.|||+.+|+||||||+|+|
T Consensus        65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL  144 (786)
T KOG0588|consen   65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL  144 (786)
T ss_pred             HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence            78899999999999999999999999999987655555567899999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCcccccCCC---CccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCCCcccc
Q psy17952         87 LTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKI  163 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~dp~~~  163 (804)
                      +|..+++||+|||+|....+.   .+.||+|.|.|||++.+  ....++++||||+|+++..+..+.+  .|+.   .+.
T Consensus       145 Ld~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~L--PFdD---dNi  217 (786)
T KOG0588|consen  145 LDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKL--PFDD---DNI  217 (786)
T ss_pred             hhcccCEeeeccceeecccCCccccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCC--CCCC---ccH
Confidence            999999999999999875443   45799999999999843  2334789999999998644433332  1332   223


Q ss_pred             cccccccccccc
Q psy17952        164 FEDLREIGHGSF  175 (804)
Q Consensus       164 y~~l~~LG~G~f  175 (804)
                      =.++.++-+|.|
T Consensus       218 r~LLlKV~~G~f  229 (786)
T KOG0588|consen  218 RVLLLKVQRGVF  229 (786)
T ss_pred             HHHHHHHHcCcc
Confidence            355666777766

>KOG0594|consensus

Probab=99.94  E-value=1.3e-27  Score=253.11  Aligned_cols=141  Identities=33%  Similarity=0.534  Sum_probs=124.7

Q ss_pred             HHHHHhcCCCC-eeeEeEEEEeCC------eEEEEEeccCCCcHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy17952          5 SSLLRQLKHPN-TIEYRGCYLRDH------TAWLVMEYCLGSASDIIEVHK---RPLKEEEIAAICSGVLRGLNYLHSLG   74 (804)
Q Consensus         5 ~~iL~~l~Hpn-IV~l~~~~~~~~------~~~lV~Ey~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~   74 (804)
                      ..+|+.|+|+| ||+|++++.+++      .+|+||||++-++..++....   ..++...++.++.||+.||+|||+++
T Consensus        61 isllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~  140 (323)
T KOG0594|consen   61 ISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG  140 (323)
T ss_pred             HHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            46899999999 999999998877      899999999999999887665   46888999999999999999999999


Q ss_pred             ccccccccccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCCC
Q psy17952         75 RIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLK  147 (804)
Q Consensus        75 IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~  147 (804)
                      |+||||||.|||++++|.+||+|||+|+...    ...+.++|.+|+|||++++  ...|+..+|+||+||+..++.
T Consensus       141 IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlG--s~~Ys~~vDiWs~GcIfaEm~  215 (323)
T KOG0594|consen  141 ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLG--STSYSTSVDIWSLGCIFAEMF  215 (323)
T ss_pred             eecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcC--CCcCCCCcchHhHHHHHHHHH
Confidence            9999999999999999999999999997432    2345689999999999976  346999999999999965543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.5e-27  Score=234.67  Aligned_cols=156  Identities=38%  Similarity=0.553  Sum_probs=119.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCC
Q psy17952        289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDE  368 (804)
Q Consensus       289 ~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~  368 (804)
                      +.++++.++..|+.||+.||.|||+++      ||+|||++.++.+|+  ||+++...... ..||+.|||||++.   +
T Consensus        11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g~~~y~aPE~~~---~   78 (176)
T smart00750       11 GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRVDPYFMAPEVIQ---G   78 (176)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-CCCcccccChHHhc---C
Confidence            456999999999999999999999998      999999999999999  99987654432 37899999999985   4


Q ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhh
Q psy17952        369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI  447 (804)
Q Consensus       369 ~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~-I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i  447 (804)
                      ..|+.++|||||||++|||++|++||........... +.....+.                  .+.             
T Consensus        79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~-------------  127 (176)
T smart00750       79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------------------DPR-------------  127 (176)
T ss_pred             CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------------------Ccc-------------
Confidence            5789999999999999999999999976543322221 11110000                  000             


Q ss_pred             ccCCCCCCCCCCccH--HHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy17952        448 AQNDTPCLQSSDWSD--TFAHFVSSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       448 ~~~~~p~~~~~~~s~--~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                           .......+++  ++.+|+.+||..||.+|||+.+++.|+|+.
T Consensus       128 -----~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      128 -----DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             -----ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                 0000111233  689999999999999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0198|consensus

Probab=99.94  E-value=6.5e-27  Score=251.36  Aligned_cols=140  Identities=41%  Similarity=0.610  Sum_probs=117.0

Q ss_pred             HHHHHHhcCCCCeeeEeEEEEeCC--eEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          4 GSSLLRQLKHPNTIEYRGCYLRDH--TAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         4 ~~~iL~~l~HpnIV~l~~~~~~~~--~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      .-.+|.+|+|||||+++|......  .++|.||||. |++.+++....+.+++..++.|..||++||+|||++|||||||
T Consensus        64 Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~Di  143 (313)
T KOG0198|consen   64 EIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDI  143 (313)
T ss_pred             HHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCc
Confidence            457899999999999999755544  6999999997 5666777665558999999999999999999999999999999


Q ss_pred             ccccEEEcC-CCceEEeccCcccccC-------CCCccccccccCcchhhhhcccCcc-CCcccccccccCCCCC
Q psy17952         81 KAGNILLTE-TGTVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITPGSL  146 (804)
Q Consensus        81 Kp~Nill~~-~~~~kl~DFG~a~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~-~~~vDvwslG~~~g~l  146 (804)
                      ||+|||++. ++.+||+|||+++...       ....+.|||.|||||++..   +.. ++.+|+||+|||.-++
T Consensus       144 K~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvEM  215 (313)
T KOG0198|consen  144 KPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVEM  215 (313)
T ss_pred             ccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEec
Confidence            999999999 7999999999987433       1235789999999999842   322 3489999999994433

>KOG0582|consensus

Probab=99.94  E-value=4.3e-27  Score=252.97  Aligned_cols=142  Identities=47%  Similarity=0.803  Sum_probs=121.0

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..|..++|||||+++.+|..+..+|+||.||. |+++++++.. +..++|..+..+++++++||.|||++|.||||+|+.
T Consensus        76 ~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAg  155 (516)
T KOG0582|consen   76 QTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAG  155 (516)
T ss_pred             HHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccc
Confidence            45778899999999999999999999999997 6677777643 467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-------CC-CccccccccCcchhhhhcccCccCCcccccccccCCCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-------PA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKD  148 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-------~~-~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~  148 (804)
                      ||||+.+|.|||+|||++....       .. ..++|||+|||||++.. +-..|+.|+||||||+|..++..
T Consensus       156 nILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q-~~~GYdfKaDIwSfGITA~ELA~  227 (516)
T KOG0582|consen  156 NILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ-QLHGYDFKADIWSFGITACELAH  227 (516)
T ss_pred             cEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh-cccCccchhhhhhhhHHHHHHhc
Confidence            9999999999999999875321       11 45799999999999622 22459999999999999654433

>KOG0605|consensus

Probab=99.94  E-value=4.3e-27  Score=258.51  Aligned_cols=159  Identities=30%  Similarity=0.486  Sum_probs=132.3

Q ss_pred             hHHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          3 AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         3 ~~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      |=++||...+.|+||+|+..|.+.+++||||||..|+....+..+++.|+++.++.|+.+++.|++-+|++|+|||||||
T Consensus       190 aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKP  269 (550)
T KOG0605|consen  190 AERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKP  269 (550)
T ss_pred             HHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCCh
Confidence            56889999999999999999999999999999999887766667789999999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc-C-------------------------C-------------------------CCccc
Q psy17952         83 GNILLTETGTVKLADFGSASIK-C-------------------------P-------------------------ANSFV  111 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~-~-------------------------~-------------------------~~~~~  111 (804)
                      +|+|||..|++||+|||+|... +                         +                         +.+.+
T Consensus       270 dNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StV  349 (550)
T KOG0605|consen  270 DNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTV  349 (550)
T ss_pred             hheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhccc
Confidence            9999999999999999998410 0                         0                         01247


Q ss_pred             cccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCCCccccccc
Q psy17952        112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFED  166 (804)
Q Consensus       112 gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~dp~~~y~~  166 (804)
                      |||-|||||++.+   ..|+..+|+||+||+.-++..+  ...|..++|...|+.
T Consensus       350 GTPDYiAPEVll~---kgY~~~cDwWSLG~ImyEmLvG--yPPF~s~tp~~T~rk  399 (550)
T KOG0605|consen  350 GTPDYIAPEVLLG---KGYGKECDWWSLGCIMYEMLVG--YPPFCSETPQETYRK  399 (550)
T ss_pred             CCccccchHHHhc---CCCCccccHHHHHHHHHHHHhC--CCCCCCCCHHHHHHH
Confidence            9999999999953   4599999999999985443322  123556666655544

>KOG1024|consensus

Probab=99.94  E-value=3.5e-26  Score=241.58  Aligned_cols=253  Identities=21%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             cccccccccccccccceEEEEeeec-----eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-C
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVS-----REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-H  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~-----~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-~  235 (804)
                      .+++....+-+|.||.||.|..+..     .+.|-+|.++..  ...-....++.|...+..+.|||+..+.++...+ .
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            3477778899999999999966532     245666766432  2233456788999999999999999998877654 4


Q ss_pred             ceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..++++.+.. |+|..++..+                  +.        +.....+.++..+...++.|++.|++|||++
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~C------------------r~--------~~~~~aqtvtt~qlV~masQla~am~hlh~~  415 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQIC------------------RG--------DDPSYAQTVTTIQLVLMASQLAMAMEHLHNH  415 (563)
T ss_pred             cceEEEeccCcchHHHHHHHh------------------cc--------CCCccccchhHHHHHHHHHHHHHHHHHHHhc
Confidence            5677777775 5554444321                  10        0112234577888999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCCCc------cccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~------~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||||.||...|.+|++.-.+||+|=.+++..-|..-      .-....|||||.+.   +..|+.++|+|||||+||||+
T Consensus       416 ~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~---n~~yssasDvWsfGVllWELm  492 (563)
T KOG1024|consen  416 GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ---NSHYSSASDVWSFGVLLWELM  492 (563)
T ss_pred             CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHh---hhhhcchhhhHHHHHHHHHHH
Confidence            999999999999999999999999999986554321      12345799999984   568999999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      | |+.||.+.++.+....+..|.                                          ...++-++++++-.+
T Consensus       493 tlg~~PyaeIDPfEm~~ylkdGy------------------------------------------RlaQP~NCPDeLf~v  530 (563)
T KOG1024|consen  493 TLGKLPYAEIDPFEMEHYLKDGY------------------------------------------RLAQPFNCPDELFTV  530 (563)
T ss_pred             hcCCCCccccCHHHHHHHHhccc------------------------------------------eecCCCCCcHHHHHH
Confidence            8 999999888777655553321                                          112234678999999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q psy17952        468 VSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~  487 (804)
                      +..||..+|++||+.+|+..
T Consensus       531 MacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  531 MACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHHHhcCcccCCCHHHHHH
Confidence            99999999999999999764

>KOG0597|consensus

Probab=99.94  E-value=1.8e-27  Score=260.69  Aligned_cols=145  Identities=41%  Similarity=0.693  Sum_probs=128.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      -+|++.|+|||||.++++|++...+|+|.|||.|++..++.+ .+.++|+.++.++.|++.||.|||+++|+|||+||.|
T Consensus        52 v~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqn  130 (808)
T KOG0597|consen   52 VRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQN  130 (808)
T ss_pred             HHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcce
Confidence            478999999999999999999999999999999988877754 5789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCCCC----ccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCCCc
Q psy17952         85 ILLTETGTVKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP  160 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~~~----~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~dp  160 (804)
                      ||+++.|++|+||||+|+......    +..|||.|||||++   ....|+..+|+||+||+        ++|++....|
T Consensus       131 iLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv---~e~pyd~~sDlWslGci--------lYE~~~G~PP  199 (808)
T KOG0597|consen  131 ILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELV---EEQPYDHTSDLWSLGCI--------LYELYVGQPP  199 (808)
T ss_pred             eeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHH---cCCCccchhhHHHHHHH--------HHHHhcCCCC
Confidence            999999999999999998754432    35799999999997   56789999999999998        4555554444


Q ss_pred             c
Q psy17952        161 E  161 (804)
Q Consensus       161 ~  161 (804)
                      +
T Consensus       200 F  200 (808)
T KOG0597|consen  200 F  200 (808)
T ss_pred             c
Confidence            3

>KOG0197|consensus

Probab=99.94  E-value=8.8e-27  Score=257.39  Aligned_cols=136  Identities=30%  Similarity=0.558  Sum_probs=119.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      +.||++|+|+|||+|+++++.++.+|||||||. |+|+++++. ....+...+...++.|||+||+||.++++|||||-.
T Consensus       252 a~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAA  331 (468)
T KOG0197|consen  252 AQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAA  331 (468)
T ss_pred             HHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhh
Confidence            579999999999999999999999999999996 889999986 356799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCCC--Ccccc---ccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCPA--NSFVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~~--~~~~g---t~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      .|||++++..+||+|||+|+.....  ....|   ...|+|||.+   ..+.|+.++||||||+++
T Consensus       332 RNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~---~~~~FS~kSDVWSFGVlL  394 (468)
T KOG0197|consen  332 RNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEAL---NYGKFSSKSDVWSFGVLL  394 (468)
T ss_pred             hheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHH---hhCCcccccceeehhhhH
Confidence            9999999999999999999953221  12223   3459999998   467899999999999984

>KOG0660|consensus

Probab=99.93  E-value=2.5e-27  Score=250.35  Aligned_cols=164  Identities=30%  Similarity=0.508  Sum_probs=134.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEe-----CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLR-----DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~-----~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      .+|+.++|+|||.+++++..     -+.+|+|+|+|+.+|..+++. +..++++.++.+++|+++||+|+|+.||+||||
T Consensus        73 klLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDL  151 (359)
T KOG0660|consen   73 KLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDL  151 (359)
T ss_pred             HHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhccccccccc
Confidence            36788899999999999976     346999999998888888763 455999999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhcc
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL  154 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~el  154 (804)
                      ||+|+|++.+..+|+||||+|+....      -+.++-|.+|+|||+++  ....|+..+|+||+||+++++....  .+
T Consensus       152 KPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll--~~~~Yt~aiDiWSvGCI~AEmL~gk--pl  227 (359)
T KOG0660|consen  152 KPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLL--NSSEYTKAIDIWSVGCILAEMLTGK--PL  227 (359)
T ss_pred             chhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHh--ccccccchhhhhhhhHHHHHHHcCC--CC
Confidence            99999999999999999999987532      13478999999999985  4568999999999999987776543  24


Q ss_pred             ccCCCccc-cccccccccccc
Q psy17952        155 FDKEDPEK-IFEDLREIGHGS  174 (804)
Q Consensus       155 f~~~dp~~-~y~~l~~LG~G~  174 (804)
                      |...+.-. .-.+++.||..+
T Consensus       228 FpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  228 FPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             CCCCchHHHHHHHHHhcCCCC
Confidence            54444332 234556666654

>KOG0694|consensus

Probab=99.93  E-value=3.4e-27  Score=265.68  Aligned_cols=138  Identities=33%  Similarity=0.575  Sum_probs=121.7

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ++|+... +||++++|+.+|.+++.+|.||||+.|+.... .++...|++.+++.|+..|+.||.|||++||||||||-+
T Consensus       419 krI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLd  497 (694)
T KOG0694|consen  419 KRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLD  497 (694)
T ss_pred             HHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchh
Confidence            4566666 59999999999999999999999999876322 234578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccc----cCCCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      |||+|..|++||+|||+++.    .+.++++||||.|||||++   ....|+..+|+||+|+..-++
T Consensus       498 NiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil---~e~~Yt~aVDWW~lGVLlyeM  561 (694)
T KOG0694|consen  498 NLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVL---TEQSYTRAVDWWGLGVLLYEM  561 (694)
T ss_pred             heEEcccCcEEecccccccccCCCCCccccccCChhhcChhhh---ccCcccchhhHHHHHHHHHHH
Confidence            99999999999999999985    3467789999999999998   456899999999999984333

>KOG0579|consensus

Probab=99.93  E-value=6.5e-27  Score=257.84  Aligned_cols=141  Identities=45%  Similarity=0.835  Sum_probs=123.8

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      +||...+|||||+|++.|+.++.+||..|||.|+-.+.+.. -..++++.+++.+|+|++.||.|||+++|||||||..|
T Consensus        81 eILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGN  160 (1187)
T KOG0579|consen   81 EILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGN  160 (1187)
T ss_pred             hhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccc
Confidence            68999999999999999999999999999999987776543 35689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc----CCCCccccccccCcchhhh--hcccCccCCcccccccccCCCCC
Q psy17952         85 ILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~--~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ||++-+|.++|+|||++.-.    ....+++|||||||||++-  -+...+|+.++||||||+|+-++
T Consensus       161 iL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM  228 (1187)
T KOG0579|consen  161 ILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM  228 (1187)
T ss_pred             eEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence            99999999999999998543    2346799999999999872  23456899999999999996443

>KOG0585|consensus

Probab=99.93  E-value=2.1e-26  Score=248.99  Aligned_cols=142  Identities=34%  Similarity=0.536  Sum_probs=114.6

Q ss_pred             HHHHhcCCCCeeeEeEEEEe--CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~--~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      +||++|.|||||+|+.+.-+  .+.+|||+|||..+-.......+..+++.++++|+++++.||+|||..|||||||||+
T Consensus       160 ailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPs  239 (576)
T KOG0585|consen  160 AILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPS  239 (576)
T ss_pred             HHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence            68999999999999998754  4579999999986644433222333999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC---C------CCccccccccCcchhhhhcccC-ccCCcccccccccCCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC---P------ANSFVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITPGSLK  147 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~---~------~~~~~gt~~y~APE~l~~~~~~-~~~~~vDvwslG~~~g~l~  147 (804)
                      |+|++.+|++||+|||++-...   .      -...+|||.|||||++..-... ..+.+.|+||+|+|+-++.
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll  313 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL  313 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence            9999999999999999985320   0      0125899999999998542222 3467899999999965443

>KOG0599|consensus

Probab=99.93  E-value=1.6e-26  Score=234.45  Aligned_cols=162  Identities=35%  Similarity=0.549  Sum_probs=132.0

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      +||+++ -||||++|.|+|+++..+++|+|.|. |.|.|++. .+..+++...+.++.|+.+|++|||.++|+||||||+
T Consensus        74 ~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpE  152 (411)
T KOG0599|consen   74 SILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPE  152 (411)
T ss_pred             HHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChh
Confidence            688888 69999999999999999999999997 77888775 5678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC---CccccccccCcchhhh-hcc--cCccCCcccccccccCCCCCCCcchhccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVIL-AMD--EGQYDGKVDVWSLGITPGSLKDPEIAELFDK  157 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~-~~~--~~~~~~~vDvwslG~~~g~l~~~~i~elf~~  157 (804)
                      |||++++.++||+|||+|....+.   ...||||+|+|||.+- .|.  ...|+..+|.||+|++.        ..++..
T Consensus       153 NILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm--------yTLLaG  224 (411)
T KOG0599|consen  153 NILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM--------YTLLAG  224 (411)
T ss_pred             heeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH--------HHHHcC
Confidence            999999999999999999754433   3579999999999982 222  23488899999999873        223323


Q ss_pred             CCcc---ccccccccccccccc
Q psy17952        158 EDPE---KIFEDLREIGHGSFG  176 (804)
Q Consensus       158 ~dp~---~~y~~l~~LG~G~fG  176 (804)
                      ..|+   +..-.++.|-+|.|.
T Consensus       225 cpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  225 CPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             CCchhHHHHHHHHHHHHhcccc
Confidence            3332   233456777777653

>KOG0033|consensus

Probab=99.93  E-value=1.5e-26  Score=231.53  Aligned_cols=136  Identities=32%  Similarity=0.530  Sum_probs=116.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|-+.|+|||||+|.+.+..+...|||+|+|+|+.+-+-.....-++|..+..+++||++||.|||.++|||||+||+|
T Consensus        61 arIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~n  140 (355)
T KOG0033|consen   61 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPEN  140 (355)
T ss_pred             HHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence            46778899999999999999999999999999987544333334678999999999999999999999999999999999


Q ss_pred             EEEcC---CCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTE---TGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~---~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +|+..   .-.+||+|||+|....   ....++|||.|||||++   +..+|+..+|+|+.|+++
T Consensus       141 llLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvv---rkdpy~kpvDiW~cGViL  202 (355)
T KOG0033|consen  141 LLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVL---KKDPYSKPVDIWACGVIL  202 (355)
T ss_pred             eeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHh---hcCCCCCcchhhhhhHHH
Confidence            99954   3379999999997543   23357899999999997   567899999999999874

>KOG0611|consensus

Probab=99.93  E-value=3.7e-26  Score=241.71  Aligned_cols=163  Identities=29%  Similarity=0.533  Sum_probs=134.3

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      +||..||||||++.+.+|+..+.+.|||||.. |.|++++. ..+.+++...+.+++||+.|+-|||.++|+|||||-+|
T Consensus       105 eIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLEN  183 (668)
T KOG0611|consen  105 EIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLEN  183 (668)
T ss_pred             HHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhh
Confidence            68999999999999999999999999999997 56778775 45789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc---CCCCccccccccCcchhhhhcccCcc-CCcccccccccCCCCCCCcchhccccCCCc
Q psy17952         85 ILLTETGTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITPGSLKDPEIAELFDKEDP  160 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~-~~~vDvwslG~~~g~l~~~~i~elf~~~dp  160 (804)
                      ||+|.++.+||+|||++-+.   ..-.++||+|-|.+||++++   .+| ++.+|.||+|+.+-.+.....  .|+..|.
T Consensus       184 ILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG---~PY~GPEVDsWsLGvLLYtLVyGtM--PFDG~Dh  258 (668)
T KOG0611|consen  184 ILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNG---TPYKGPEVDSWSLGVLLYTLVYGTM--PFDGRDH  258 (668)
T ss_pred             eeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCC---CCCCCCccchhhHHHHHHHHhhccc--ccCCchH
Confidence            99999999999999999652   33457899999999999865   344 678999999987422222111  1333332


Q ss_pred             ccccccccccccccccc
Q psy17952        161 EKIFEDLREIGHGSFGA  177 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~  177 (804)
                         -.++++|.+|+|-.
T Consensus       259 ---k~lvrQIs~GaYrE  272 (668)
T KOG0611|consen  259 ---KRLVRQISRGAYRE  272 (668)
T ss_pred             ---HHHHHHhhcccccC
Confidence               35678899998743

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=3.7e-24  Score=226.98  Aligned_cols=260  Identities=37%  Similarity=0.558  Sum_probs=195.3

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCC-ceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP-NTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIV~l~~~~~~~~~~~lVmE  242 (804)
                      |...+.||.|+||.||++.+.   ..+|+|.+.............+.+|+.+++.+.|+ +|+++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            677889999999999999887   78899988754433322456789999999999988 79999999977777899999


Q ss_pred             ecCCCchh-hHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        243 YCLGSASD-IIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK---RPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       243 y~~G~l~d-ll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~---~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |+.|+... ++                                  ...   ..+++..+..++.|++.++.|+|+.+++|
T Consensus        79 ~~~~~~l~~~~----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~h  124 (384)
T COG0515          79 YVDGGSLEDLL----------------------------------KKIGRKGPLSESEALFILAQILSALEYLHSKGIIH  124 (384)
T ss_pred             cCCCCcHHHHH----------------------------------HhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            99875321 11                                  111   36889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCC-cEEEEecccccccCC----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        319 RDVKAGNILLTETG-TVKLADFGSASIKCP----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       319 RDLKP~NILl~~~g-~vKL~DFGla~~~~~----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ||+||+|||++..+ .+|++|||+++....          ....+||+.|+|||.+.+.....++..+|+||+|++++++
T Consensus       125 rd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~  204 (384)
T COG0515         125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL  204 (384)
T ss_pred             cCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHH
Confidence            99999999999988 799999999864322          2456899999999998531113577789999999999999


Q ss_pred             HhCCCCCCCCCh----HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        388 AERKPPYFNMNA----MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       388 ltG~~PF~~~~~----~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      ++|..||.....    ......+.....+.                  ..+..               .+... ......
T Consensus       205 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~---------------~~~~~-~~~~~~  250 (384)
T COG0515         205 LTGLPPFEGEKNSSATSQTLKIILELPTPS------------------LASPL---------------SPSNP-ELISKA  250 (384)
T ss_pred             HhCCCCCCCCCccccHHHHHHHHHhcCCcc------------------ccccc---------------Ccccc-chhhHH
Confidence            999999866543    22222221111110                  00000               00000 112357


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +.+++.+|+..+|..|.++.+...+++....
T Consensus       251 ~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         251 ASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             HHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            8899999999999999999999988666543

>KOG4721|consensus

Probab=99.92  E-value=5.8e-26  Score=248.61  Aligned_cols=132  Identities=39%  Similarity=0.726  Sum_probs=120.3

Q ss_pred             HHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      |++|+|||||.|+|+|+....++||||||. |.|+.+++ ...+++...+..+..+|+.||.|||.++|||||||.-|||
T Consensus       166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiL  244 (904)
T KOG4721|consen  166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNIL  244 (904)
T ss_pred             HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceE
Confidence            789999999999999999999999999996 78888886 4578999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCccccc---CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         87 LTETGTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |..+..|||+|||-++..   +...+++||..|||||++   ++.+.+.|+||||||+++
T Consensus       245 Is~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvI---rnePcsEKVDIwSfGVVL  301 (904)
T KOG4721|consen  245 ISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVI---RNEPCSEKVDIWSFGVVL  301 (904)
T ss_pred             eeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHh---hcCCcccccceehhHHHH
Confidence            999999999999998753   233468999999999998   577899999999999984

>KOG0574|consensus

Probab=99.92  E-value=2.2e-26  Score=235.71  Aligned_cols=138  Identities=51%  Similarity=0.939  Sum_probs=126.0

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      +||++.+.|+||+|||.|.....+|||||||. |+..++++.+..+++++++..++...++||+|||...-||||||..|
T Consensus        80 SIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGN  159 (502)
T KOG0574|consen   80 SIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGN  159 (502)
T ss_pred             HHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhccccc
Confidence            68999999999999999999999999999995 88889998888999999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ||++.+|..||+|||+|...+    ..++++|||+|||||++   ..-.|++++|+||+|+|.-++
T Consensus       160 ILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---~EIGY~~~ADIWSLGITaIEM  222 (502)
T KOG0574|consen  160 ILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---EEIGYDTKADIWSLGITAIEM  222 (502)
T ss_pred             EEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHH---HHhccchhhhHhhhcchhhhh
Confidence            999999999999999997532    45678999999999998   344689999999999996544

>KOG0589|consensus

Probab=99.92  E-value=1.1e-25  Score=247.98  Aligned_cols=135  Identities=42%  Similarity=0.721  Sum_probs=120.8

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCe-EEEEEeccCCC-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHT-AWLVMEYCLGS-ASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~-~~lV~Ey~~g~-l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      .+++++.|||||.+++.|..++. ++|||+||+|+ +.+.+...+ .-++++++..|+.|++.|+.|||+++|.|||||+
T Consensus        55 ~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~  134 (426)
T KOG0589|consen   55 DLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKC  134 (426)
T ss_pred             HHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchh
Confidence            57889999999999999988887 99999999965 555665555 5799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      .||++++++.+||.|||+|+...    .+.+++|||+||.||++   .+.+|+.|+|+||+||..
T Consensus       135 ~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil---~d~pYn~KSDiWsLGC~~  196 (426)
T KOG0589|consen  135 ANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEIL---SDIPYNEKSDIWSLGCCL  196 (426)
T ss_pred             hhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHh---CCCCCCccCcchhhcchH
Confidence            99999999999999999998753    45578999999999998   466899999999999984

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.92  E-value=7.4e-25  Score=240.07  Aligned_cols=138  Identities=28%  Similarity=0.506  Sum_probs=118.8

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|+.++||||++++++|..++.+||||||+.|+.+..+......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus        47 ~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NI  126 (323)
T cd05571          47 RVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENL  126 (323)
T ss_pred             HHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence            57889999999999999999999999999998654433334457899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         86 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      |++.++.+||+|||+++...    .....+||+.|+|||++.   ...++.++|+||+|++..++
T Consensus       127 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el  188 (323)
T cd05571         127 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEM  188 (323)
T ss_pred             EECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhc---CCCCCccccCcccchhhhhh
Confidence            99999999999999987421    223467999999999973   45689999999999995444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=6.4e-25  Score=244.61  Aligned_cols=135  Identities=33%  Similarity=0.513  Sum_probs=116.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.++..+|||||||.|+ +.+++. ....+++..++.++.|++.||+|||+++|+||||||+
T Consensus        52 ~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~  130 (363)
T cd05628          52 RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD  130 (363)
T ss_pred             HHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHH
Confidence            36788999999999999999999999999999865 455554 4578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC---------------------------------------CCccccccccCcchhhhh
Q psy17952         84 NILLTETGTVKLADFGSASIKCP---------------------------------------ANSFVGTPYWMAPEVILA  124 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~---------------------------------------~~~~~gt~~y~APE~l~~  124 (804)
                      |||++.++.+||+|||+++....                                       ....+||+.|+|||++. 
T Consensus       131 NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-  209 (363)
T cd05628         131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-  209 (363)
T ss_pred             HeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-
Confidence            99999999999999999863210                                       12357999999999983 


Q ss_pred             cccCccCCcccccccccCC
Q psy17952        125 MDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus       125 ~~~~~~~~~vDvwslG~~~  143 (804)
                        ...++.++|+||+|++.
T Consensus       210 --~~~~~~~~DvwSlGvil  226 (363)
T cd05628         210 --QTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             --CCCCCCchhhhhhHHHH
Confidence              45688999999999984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.92  E-value=8.6e-25  Score=241.69  Aligned_cols=138  Identities=26%  Similarity=0.500  Sum_probs=119.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+++.+|||||||.|+ +.+++. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        82 ~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~  160 (340)
T PTZ00426         82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE  160 (340)
T ss_pred             HHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH
Confidence            46889999999999999999999999999999755 555554 4568999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      |||++.+|.+||+|||++.... .....+||+.|||||++.   ...++.++|+||+|+++-++
T Consensus       161 NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~el  221 (340)
T PTZ00426        161 NLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILL---NVGHGKAADWWTLGIFIYEI  221 (340)
T ss_pred             HEEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHh---CCCCCccccccchhhHHHHH
Confidence            9999999999999999997533 234568999999999983   34678899999999985333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.4e-24  Score=239.65  Aligned_cols=159  Identities=19%  Similarity=0.171  Sum_probs=123.0

Q ss_pred             cccccccccccccccceEEEEeee-ceeEEEEEecccccc--cchhhhhhHHHHHHHHhhcCCCceeE-eeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV-SREIVAIKKMSYLGK--QCAEKWADILKEIRFLRQLKHPNTIE-YRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~-~~~~vAIK~i~~~~~--~~~~~~~~~~~Ei~iL~~L~HpNIV~-l~~~~~~~~~~  237 (804)
                      ..|++.+.||+|+||+||+|++.. +++.||||++.....  ........+.+|+++|++++|+|||. ++++    +..
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~   93 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD   93 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence            459999999999999999999876 678889998642211  11223456889999999999999985 5432    468


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+|||||.|+.....                                   .  ...   ...++.|+++||.|||++||+
T Consensus        94 ~LVmE~~~G~~L~~~-----------------------------------~--~~~---~~~~~~~i~~aL~~lH~~gIi  133 (365)
T PRK09188         94 GLVRGWTEGVPLHLA-----------------------------------R--PHG---DPAWFRSAHRALRDLHRAGIT  133 (365)
T ss_pred             EEEEEccCCCCHHHh-----------------------------------C--ccc---hHHHHHHHHHHHHHHHHCCCe
Confidence            999999998632100                                   0  001   146789999999999999999


Q ss_pred             ecCC-CCCCeeecCCCcEEEEecccccccCCC------------CccccCcccccchhhc
Q psy17952        318 HRDV-KAGNILLTETGTVKLADFGSASIKCPA------------NSFVGTPYWMAPEVIL  364 (804)
Q Consensus       318 HRDL-KP~NILl~~~g~vKL~DFGla~~~~~~------------~~~~GT~~Y~APEvl~  364 (804)
                      |||| ||+|||++.++.+||+|||+|+.....            ....|++.|+|||.+.
T Consensus       134 HrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        134 HNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999 999999999999999999999743221            2457889999999984

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=1.6e-24  Score=242.91  Aligned_cols=136  Identities=28%  Similarity=0.477  Sum_probs=116.4

Q ss_pred             HHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          4 GSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         4 ~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      -..+|++++|||||+++++|.+++.+|||||||.|+ +.+++. ..+.+++..++.++.||+.||+|||+++|+||||||
T Consensus        51 E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp  129 (382)
T cd05625          51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKP  129 (382)
T ss_pred             HHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            346889999999999999999999999999999864 555554 456789999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC---------------------------------------------------CCCccc
Q psy17952         83 GNILLTETGTVKLADFGSASIKC---------------------------------------------------PANSFV  111 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~---------------------------------------------------~~~~~~  111 (804)
                      +|||++.+|.+||+|||++....                                                   .....+
T Consensus       130 ~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (382)
T cd05625         130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV  209 (382)
T ss_pred             HHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence            99999999999999999974100                                                   011347


Q ss_pred             cccccCcchhhhhcccCccCCcccccccccCC
Q psy17952        112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus       112 gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||+.|+|||++.   ...|+.++|+||+|++.
T Consensus       210 gt~~Y~aPE~~~---~~~~~~~~DiwSlGvil  238 (382)
T cd05625         210 GTPNYIAPEVLL---RTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             cCcccCCHHHhc---CCCCCCeeeEEechHHH
Confidence            999999999984   45689999999999984

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.9e-24  Score=241.94  Aligned_cols=138  Identities=29%  Similarity=0.466  Sum_probs=117.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||+++++|.+.+.+|||||||.| ++.+++. ....+++..++.++.|++.||+|||+++|+||||||+
T Consensus        52 ~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~  130 (377)
T cd05629          52 RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPD  130 (377)
T ss_pred             HHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence            3578899999999999999999999999999985 4555554 4567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC---------------------------------------------------CCcccc
Q psy17952         84 NILLTETGTVKLADFGSASIKCP---------------------------------------------------ANSFVG  112 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~---------------------------------------------------~~~~~g  112 (804)
                      |||++.++.+||+|||+++....                                                   ..+.+|
T Consensus       131 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  210 (377)
T cd05629         131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVG  210 (377)
T ss_pred             HEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCC
Confidence            99999999999999999852100                                                   012479


Q ss_pred             ccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952        113 TPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus       113 t~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      |+.|+|||++.   ...++.++|+||+|++.-++
T Consensus       211 t~~y~aPE~~~---~~~~~~~~DiwSlGvil~el  241 (377)
T cd05629         211 TPDYIAPEIFL---QQGYGQECDWWSLGAIMFEC  241 (377)
T ss_pred             CccccCHHHHc---cCCCCCceeeEecchhhhhh
Confidence            99999999973   45689999999999995444

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=2.1e-24  Score=237.14  Aligned_cols=135  Identities=29%  Similarity=0.516  Sum_probs=117.4

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|+.++||||++++++|..++.+||||||+.|+.+.........+++..+..++.||+.||+|||+++|+||||||+||
T Consensus        47 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI  126 (328)
T cd05593          47 RVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENL  126 (328)
T ss_pred             HHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence            57899999999999999999999999999998665444434456899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.++.+||+|||+++...    .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       127 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil  185 (328)
T cd05593         127 MLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVM  185 (328)
T ss_pred             EECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhc---CCCCCccCCccccchHH
Confidence            99999999999999987421    123457999999999973   45688999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=2.4e-24  Score=236.09  Aligned_cols=138  Identities=28%  Similarity=0.508  Sum_probs=118.4

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~N   84 (804)
                      .+|+.++||||++++++|..++.+||||||+.|+.+.........++++.++.++.||+.||+|||+ ++|+||||||+|
T Consensus        47 ~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~N  126 (325)
T cd05594          47 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  126 (325)
T ss_pred             HHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCe
Confidence            5788899999999999999999999999999876554444455689999999999999999999997 899999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ||++.++.+||+|||+++...    .....+||+.|||||++.   ...++.++|+||+|+++-++
T Consensus       127 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el  189 (325)
T cd05594         127 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEM  189 (325)
T ss_pred             EEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHc---cCCCCCccccccccceeeee
Confidence            999999999999999986421    123457999999999973   45688999999999995444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.7e-24  Score=240.87  Aligned_cols=135  Identities=33%  Similarity=0.575  Sum_probs=116.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+++.+|||||||.|+ +.+++. ....+++..++.++.|++.||+|||+++|+||||||+
T Consensus        52 ~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~  130 (364)
T cd05599          52 RDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPD  130 (364)
T ss_pred             HHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH
Confidence            46889999999999999999999999999999865 455544 4567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------------------------------------------CCccccccccCcchh
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------------------------------------------ANSFVGTPYWMAPEV  121 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------------------------------------------~~~~~gt~~y~APE~  121 (804)
                      |||++.+|.+||+|||++.....                                          ....+||+.|+|||+
T Consensus       131 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  210 (364)
T cd05599         131 NLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV  210 (364)
T ss_pred             HeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHH
Confidence            99999999999999999853110                                          012469999999999


Q ss_pred             hhhcccCccCCcccccccccCC
Q psy17952        122 ILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus       122 l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +.   ...++.++|+||+|++.
T Consensus       211 ~~---~~~~~~~~DiwSlG~il  229 (364)
T cd05599         211 FL---QTGYNKECDWWSLGVIM  229 (364)
T ss_pred             Hc---CCCCCCeeeeecchhHH
Confidence            73   45689999999999984

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0662|consensus

Probab=99.91  E-value=1.3e-25  Score=215.59  Aligned_cols=163  Identities=29%  Similarity=0.476  Sum_probs=135.5

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|++|+|.|||+|+++...+..+-||+|||.+++..++..-.+.++.+.++.++.|+++||.|||+++|.||||||.|+
T Consensus        53 cllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnl  132 (292)
T KOG0662|consen   53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNL  132 (292)
T ss_pred             HHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceE
Confidence            57899999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCccccc-C---CCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCCCcc
Q psy17952         86 LLTETGTVKLADFGSASIK-C---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPE  161 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~-~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~dp~  161 (804)
                      ||+.+|.+|++|||+++-- .   ..+..+.|.+|++|.++++.  +-|+..+|+||.||++.++.+.- ..+|...|..
T Consensus       133 lin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfga--kly~tsidmwsagcifaelanag-rplfpg~dvd  209 (292)
T KOG0662|consen  133 LINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAG-RPLFPGNDVD  209 (292)
T ss_pred             EeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeee--ehhccchHhhhcchHHHHHhhcC-CCCCCCCcHH
Confidence            9999999999999999741 1   22345789999999999764  57999999999999976654432 2245444433


Q ss_pred             cc-cccccccc
Q psy17952        162 KI-FEDLREIG  171 (804)
Q Consensus       162 ~~-y~~l~~LG  171 (804)
                      +. -++.+.||
T Consensus       210 dqlkrif~~lg  220 (292)
T KOG0662|consen  210 DQLKRIFRLLG  220 (292)
T ss_pred             HHHHHHHHHhC
Confidence            32 23334444

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.1e-24  Score=235.17  Aligned_cols=134  Identities=28%  Similarity=0.506  Sum_probs=117.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++++|||||+++++|..++.+|||||||.|+ +.+.+. ....+++..++.++.|++.||.|||+++|+||||||+|
T Consensus        45 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~N  123 (312)
T cd05585          45 TVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN  123 (312)
T ss_pred             HHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHH
Confidence            5788999999999999999999999999999865 445554 45689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||+++...    .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       124 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil  183 (312)
T cd05585         124 ILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL---GHGYTKAVDWWTLGVLL  183 (312)
T ss_pred             eEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHc---CCCCCCccceechhHHH
Confidence            999999999999999997532    223457999999999973   45689999999999984

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=2.4e-24  Score=240.96  Aligned_cols=139  Identities=27%  Similarity=0.469  Sum_probs=117.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||+++++|.+++.+|||||||.| ++.+++. ..+.+++..++.++.||+.||+|||+++|+||||||+
T Consensus        52 ~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~  130 (376)
T cd05598          52 RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPD  130 (376)
T ss_pred             HHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHH
Confidence            3688999999999999999999999999999985 5556554 4567899999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-----------------------------------------------CCCcccccccc
Q psy17952         84 NILLTETGTVKLADFGSASIKC-----------------------------------------------PANSFVGTPYW  116 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-----------------------------------------------~~~~~~gt~~y  116 (804)
                      |||++.++.+||+|||+|....                                               .....+||+.|
T Consensus       131 Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  210 (376)
T cd05598         131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY  210 (376)
T ss_pred             HEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccc
Confidence            9999999999999999973100                                               01135799999


Q ss_pred             CcchhhhhcccCccCCcccccccccCCCCCC
Q psy17952        117 MAPEVILAMDEGQYDGKVDVWSLGITPGSLK  147 (804)
Q Consensus       117 ~APE~l~~~~~~~~~~~vDvwslG~~~g~l~  147 (804)
                      ||||++.   ...++.++|+||+|+++-++.
T Consensus       211 ~aPE~~~---~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         211 IAPEVLL---RTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             cCHHHHc---CCCCCcceeeeeccceeeehh
Confidence            9999973   456889999999999964443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.91  E-value=1.8e-24  Score=237.70  Aligned_cols=135  Identities=27%  Similarity=0.481  Sum_probs=118.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+++.+|+|||||.| ++.+.+. ....++++.++.++.|++.||+|||+++|+||||||+
T Consensus        69 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~  147 (329)
T PTZ00263         69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE  147 (329)
T ss_pred             HHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence            4678999999999999999999999999999986 4555554 4568999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++.+||+|||++.... ......||+.|+|||++.   ...++.++|+||+|++.
T Consensus       148 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  205 (329)
T PTZ00263        148 NLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQ---SKGHGKAVDWWTMGVLL  205 (329)
T ss_pred             HEEECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHc---CCCCCCcceeechHHHH
Confidence            9999999999999999997532 233468999999999973   45678999999999983

>KOG0984|consensus

Probab=99.91  E-value=4.2e-25  Score=216.61  Aligned_cols=140  Identities=35%  Similarity=0.575  Sum_probs=118.3

Q ss_pred             HHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHh-cCccccccccc
Q psy17952          8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE---VHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAG   83 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~   83 (804)
                      ++...+|++|.++|.+.++..+||+||.|..++..+.+   .+.+.++|.-+-+++..++.||.|||+ .+|||||+||+
T Consensus        99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPs  178 (282)
T KOG0984|consen   99 MRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPS  178 (282)
T ss_pred             ccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcc
Confidence            34556999999999999999999999999988766544   235689999999999999999999996 58999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC--CCCc-cccccccCcchhhh-hcccCccCCcccccccccCCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC--PANS-FVGTPYWMAPEVIL-AMDEGQYDGKVDVWSLGITPGSLK  147 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~--~~~~-~~gt~~y~APE~l~-~~~~~~~~~~vDvwslG~~~g~l~  147 (804)
                      |||++..|+||+||||++.+..  -+.+ -.|...|||||.+. ...+..|+.++|+||+|+|.-++.
T Consensus       179 NiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA  246 (282)
T KOG0984|consen  179 NILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA  246 (282)
T ss_pred             eEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence            9999999999999999998643  2233 57999999999985 233447999999999999965543

>KOG1187|consensus

Probab=99.91  E-value=6.6e-25  Score=243.35  Aligned_cols=139  Identities=40%  Similarity=0.551  Sum_probs=118.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC-eEEEEEeccC-CCcHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcC---cccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH-TAWLVMEYCL-GSASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLG---RIHR   78 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~-~~~lV~Ey~~-g~l~~~~~~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~---IiHR   78 (804)
                      -++|..++|||+|+|+|||.+.+ ..+||+|||. |+|.+.+..... +++|..+.+|+.++|+||+|||+..   ||||
T Consensus       122 i~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr  201 (361)
T KOG1187|consen  122 VEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHR  201 (361)
T ss_pred             HHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence            36788999999999999999888 5999999997 677777765555 8999999999999999999999743   9999


Q ss_pred             ccccccEEEcCCCceEEeccCcccccCC-CCc---c-ccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         79 DVKAGNILLTETGTVKLADFGSASIKCP-ANS---F-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        79 DlKp~Nill~~~~~~kl~DFG~a~~~~~-~~~---~-~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ||||+|||+|.+.+.||+|||+|+.... ...   . .||.+|+|||.+   ..+..+.++||||||+.+.++
T Consensus       202 DiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~---~~g~lt~KsDVySFGVvllEl  271 (361)
T KOG1187|consen  202 DIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYA---STGKLTEKSDVYSFGVVLLEL  271 (361)
T ss_pred             CCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhh---ccCCcCcccccccchHHHHHH
Confidence            9999999999999999999999965322 221   2 799999999997   347789999999999985433

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.91  E-value=2.8e-24  Score=235.05  Aligned_cols=137  Identities=34%  Similarity=0.526  Sum_probs=117.6

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      +++.++|||||+++++|.+.+.+|||||||.|+.+.........+++..++.++.||++||+|||+++|+||||||+||+
T Consensus        49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIl  128 (321)
T cd05603          49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENIL  128 (321)
T ss_pred             HHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence            57889999999999999999999999999987654443344567999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         87 LTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ++.+|.+||+|||+++..    ......+||+.|+|||++.   ...++.++|+||+|++.-++
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el  189 (321)
T cd05603         129 LDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR---KEPYDRTVDWWCLGAVLYEM  189 (321)
T ss_pred             ECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhc---CCCCCCcCcccccchhhhhh
Confidence            999999999999998642    1223457999999999973   45688999999999995443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.91  E-value=1.6e-24  Score=234.88  Aligned_cols=136  Identities=34%  Similarity=0.539  Sum_probs=120.6

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|+.++|||||++++++.++...|+|||||.+++.+++......++++.++.++.|++.||+|||+++|+||||||+||
T Consensus        55 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni  134 (303)
T cd07869          55 SLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL  134 (303)
T ss_pred             HHHhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            57899999999999999999999999999999999888877677899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.++.+||+|||++....    ......||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       135 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il  194 (303)
T cd07869         135 LISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYSTCLDMWGVGCIF  194 (303)
T ss_pred             EECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcC--CCCCCcHHHHHHHHHHH
Confidence            99999999999999986422    2234578999999999732  34578899999999984

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0610|consensus

Probab=99.91  E-value=1.2e-24  Score=232.62  Aligned_cols=138  Identities=35%  Similarity=0.536  Sum_probs=120.2

Q ss_pred             chHHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          2 PAGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         2 ~~~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      |+-++||+.++||+++.||+.|++++..|||||||.|+.+..+++++  ..|+++.++.|+.+|+.||+|||-.|||+||
T Consensus       125 ~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRD  204 (459)
T KOG0610|consen  125 QTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRD  204 (459)
T ss_pred             HHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeecc
Confidence            45689999999999999999999999999999999987777666554  5799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccc-------c------------------------------C-----------------
Q psy17952         80 VKAGNILLTETGTVKLADFGSASI-------K------------------------------C-----------------  105 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~-------~------------------------------~-----------------  105 (804)
                      |||+|||+.++|++-|+||-++..       .                              .                 
T Consensus       205 LKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~  284 (459)
T KOG0610|consen  205 LKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV  284 (459)
T ss_pred             CCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence            999999999999999999977520       0                              0                 


Q ss_pred             ------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952        106 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus       106 ------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                            ...+++||-.|+|||++   +....+.++|+|+||+.
T Consensus       285 aep~~~RSnSFVGThEYlAPEvI---~G~GHgsAVDWWtfGIf  324 (459)
T KOG0610|consen  285 AEPTGARSNSFVGTHEYLAPEVI---RGEGHGSAVDWWTFGIF  324 (459)
T ss_pred             cCCCCccccccccccccccceee---ecCCCCchhhHHHHHHH
Confidence                  01136899999999998   34568999999999997

>KOG0666|consensus

Probab=99.91  E-value=1.6e-25  Score=230.89  Aligned_cols=144  Identities=36%  Similarity=0.628  Sum_probs=124.1

Q ss_pred             hHHH--HHHhcCCCCeeeEeEEEEe-CCeEEEEEeccCCCcHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy17952          3 AGSS--LLRQLKHPNTIEYRGCYLR-DHTAWLVMEYCLGSASDIIEVHK----RPLKEEEIAAICSGVLRGLNYLHSLGR   75 (804)
Q Consensus         3 ~~~~--iL~~l~HpnIV~l~~~~~~-~~~~~lV~Ey~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~I   75 (804)
                      |-++  ++++|+|||||.|..+|.. +..+||++||++.+|+++++.+.    ..++..-++.++-||+.|+.|||++-|
T Consensus        74 AcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWv  153 (438)
T KOG0666|consen   74 ACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWV  153 (438)
T ss_pred             HHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhhe
Confidence            4444  4689999999999999977 78999999999999999887543    358899999999999999999999999


Q ss_pred             cccccccccEEEcCC----CceEEeccCcccc-cC------CCCccccccccCcchhhhhcccCccCCcccccccccCCC
Q psy17952         76 IHRDVKAGNILLTET----GTVKLADFGSASI-KC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPG  144 (804)
Q Consensus        76 iHRDlKp~Nill~~~----~~~kl~DFG~a~~-~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g  144 (804)
                      +||||||+|||+..+    |.|||+|||+++. .+      ....++.|.+|+|||++++.  ..|+.++|+||+||+++
T Consensus       154 lHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa--~hYT~AiDvWAiGCIfa  231 (438)
T KOG0666|consen  154 LHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA--RHYTKAIDVWAIGCIFA  231 (438)
T ss_pred             eeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc--ccccchhhhHHHHHHHH
Confidence            999999999999877    8999999999985 22      23456889999999999874  57999999999999965


Q ss_pred             CCCC
Q psy17952        145 SLKD  148 (804)
Q Consensus       145 ~l~~  148 (804)
                      ++..
T Consensus       232 ElLt  235 (438)
T KOG0666|consen  232 ELLT  235 (438)
T ss_pred             HHHc
Confidence            5543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.91  E-value=3e-24  Score=235.33  Aligned_cols=134  Identities=32%  Similarity=0.533  Sum_probs=115.7

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      +++.++|||||+++++|..++.+|+|||||.|+.+..+......+++..++.++.||++||+|||++||+||||||+|||
T Consensus        49 ~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nil  128 (325)
T cd05602          49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL  128 (325)
T ss_pred             HHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence            46788999999999999999999999999986544433344567899999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         87 LTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ++.++.+||+|||+++...    .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       129 i~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  186 (325)
T cd05602         129 LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAVL  186 (325)
T ss_pred             ECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHc---CCCCCCccccccccHHH
Confidence            9999999999999986421    223467999999999973   45688999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=2e-24  Score=236.77  Aligned_cols=135  Identities=30%  Similarity=0.539  Sum_probs=117.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|+.++||||++++++|..++.+|||||||.|+.+.........+++..++.++.||+.||+|||+++|+||||||+||
T Consensus        47 ~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI  126 (323)
T cd05595          47 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL  126 (323)
T ss_pred             HHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence            57889999999999999999999999999998665544444556899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |+++++.+||+|||++....    ......||+.|+|||++   ..+.++.++|+||+|++.
T Consensus       127 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil  185 (323)
T cd05595         127 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL---EDNDYGRAVDWWGLGVVM  185 (323)
T ss_pred             EEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccc---cCCCCCchhchhhhHHHH
Confidence            99999999999999986421    12235799999999997   345788999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.91  E-value=3.9e-24  Score=237.93  Aligned_cols=140  Identities=31%  Similarity=0.482  Sum_probs=119.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.|+ +.+++. ....+++..++.++.|++.||+|||+++|+||||||+
T Consensus        52 ~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~  130 (360)
T cd05627          52 RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPD  130 (360)
T ss_pred             HHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH
Confidence            46788999999999999999999999999999865 555554 4568999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC---------------------------------------CCccccccccCcchhhhh
Q psy17952         84 NILLTETGTVKLADFGSASIKCP---------------------------------------ANSFVGTPYWMAPEVILA  124 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~---------------------------------------~~~~~gt~~y~APE~l~~  124 (804)
                      |||++.+|.+||+|||++.....                                       ....+||+.|+|||++. 
T Consensus       131 NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-  209 (360)
T cd05627         131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-  209 (360)
T ss_pred             HEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-
Confidence            99999999999999999853210                                       11357999999999973 


Q ss_pred             cccCccCCcccccccccCCCCCCC
Q psy17952        125 MDEGQYDGKVDVWSLGITPGSLKD  148 (804)
Q Consensus       125 ~~~~~~~~~vDvwslG~~~g~l~~  148 (804)
                        ...++.++|+||+|++.-++..
T Consensus       210 --~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         210 --QTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             --CCCCCCcceeccccceeeeccc
Confidence              4568899999999999655544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.91  E-value=3.1e-24  Score=235.27  Aligned_cols=137  Identities=31%  Similarity=0.533  Sum_probs=118.0

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      +++.++|||||+++++|..++.+|||||||.|+.+.........+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIl  128 (325)
T cd05604          49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL  128 (325)
T ss_pred             HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence            57789999999999999999999999999987654444345678999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         87 LTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ++.+|.+||+|||+++..    ......+||+.|||||++   ....++.++|+||+|++.-++
T Consensus       129 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el  189 (325)
T cd05604         129 LDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI---RKQPYDNTVDWWCLGAVLYEM  189 (325)
T ss_pred             ECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHH---cCCCCCCcCccccccceehhh
Confidence            999999999999998642    122346799999999997   345688999999999995444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=3.5e-24  Score=240.35  Aligned_cols=135  Identities=28%  Similarity=0.473  Sum_probs=115.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+.+.+|||||||.|+ +.+++. ....+++..++.++.||+.||+|||+++|+||||||+
T Consensus        52 ~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~  130 (381)
T cd05626          52 RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPD  130 (381)
T ss_pred             HHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHH
Confidence            36789999999999999999999999999999865 555554 4567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC---------------------------------------------------CCCcccc
Q psy17952         84 NILLTETGTVKLADFGSASIKC---------------------------------------------------PANSFVG  112 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~---------------------------------------------------~~~~~~g  112 (804)
                      |||++.++.+||+|||++....                                                   .....+|
T Consensus       131 Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  210 (381)
T cd05626         131 NILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG  210 (381)
T ss_pred             HEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence            9999999999999999874210                                                   0123579


Q ss_pred             ccccCcchhhhhcccCccCCcccccccccCC
Q psy17952        113 TPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus       113 t~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |+.|||||++.   ...|+.++|+||+|++.
T Consensus       211 t~~Y~aPE~~~---~~~~~~~~DiwSlG~il  238 (381)
T cd05626         211 TPNYIAPEVLL---RKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             CccccCHHHHc---CCCCCCccceeehhhHH
Confidence            99999999974   35688999999999984

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0690|consensus

Probab=99.91  E-value=2e-25  Score=230.85  Aligned_cols=158  Identities=28%  Similarity=0.506  Sum_probs=135.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .++|+..+||++..|...|.+.+.++.||||+.|+.+.+...+...+++++.+.|-.+|+.||.|||+++|++||||-+|
T Consensus       219 ~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN  298 (516)
T KOG0690|consen  219 NRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN  298 (516)
T ss_pred             HHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence            57899999999999999999999999999999988766666678899999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCCCc
Q psy17952         85 ILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP  160 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~dp  160 (804)
                      +|+|++|++||+|||+++..    ...+++||||.|+|||++   ...-|++++|+|.+|++.-++....+  .|...|.
T Consensus       299 LlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVl---eDnDYgraVDWWG~GVVMYEMmCGRL--PFyn~dh  373 (516)
T KOG0690|consen  299 LLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVL---EDNDYGRAVDWWGVGVVMYEMMCGRL--PFYNKDH  373 (516)
T ss_pred             heeccCCceEeeecccchhcccccceeccccCChhhcCchhh---ccccccceeehhhhhHHHHHHHhccC--cccccch
Confidence            99999999999999999752    345679999999999998   56789999999999998544444333  2444455


Q ss_pred             ccccccc
Q psy17952        161 EKIFEDL  167 (804)
Q Consensus       161 ~~~y~~l  167 (804)
                      ++.|+++
T Consensus       374 ~kLFeLI  380 (516)
T KOG0690|consen  374 EKLFELI  380 (516)
T ss_pred             hHHHHHH
Confidence            5555553

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.91  E-value=4.6e-24  Score=233.69  Aligned_cols=137  Identities=33%  Similarity=0.539  Sum_probs=117.2

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      +++.++|||||+++++|...+.+|+|||||.|+.+..+......+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus        49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIl  128 (323)
T cd05575          49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL  128 (323)
T ss_pred             HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE
Confidence            56789999999999999999999999999986544433345678999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         87 LTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ++.++.+||+|||++....    .....+||+.|+|||++.   ...++.++|+||+|++.-++
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el  189 (323)
T cd05575         129 LDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR---KQPYDRTVDWWCLGAVLYEM  189 (323)
T ss_pred             ECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhc---CCCCCccccccccchhhhhh
Confidence            9999999999999986421    223457999999999973   45688999999999985443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5e-24  Score=234.30  Aligned_cols=137  Identities=34%  Similarity=0.510  Sum_probs=119.4

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|+.++|||||+++++|...+.+|||||||.|+ +.+++ .....+++..++.++.|++.||.|||+++|+||||||+|
T Consensus        53 ~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N  131 (333)
T cd05600          53 DILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPEN  131 (333)
T ss_pred             HHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence            5788999999999999999999999999999865 55554 445689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      ||++.++.+||+|||++.... .....+||+.|+|||++.   ...++.++|+||+|++.-++
T Consensus       132 il~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el  191 (333)
T cd05600         132 FLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLR---GKGYDFTVDYWSLGCMLYEF  191 (333)
T ss_pred             EEECCCCCEEEEeCcCCcccccccCCcccCccccChhHhc---CCCCCCccceecchHHHhhh
Confidence            999999999999999997532 334568999999999973   44789999999999985444

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.91  E-value=2.3e-24  Score=232.03  Aligned_cols=137  Identities=31%  Similarity=0.509  Sum_probs=120.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .++|++++|||||++++++.+++..|+||||+.|++.+++......+++..++.++.|++.||+|||+++|+||||||+|
T Consensus        54 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N  133 (288)
T cd07871          54 VSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN  133 (288)
T ss_pred             HHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence            36789999999999999999999999999999999888887666678999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||+++...    ......||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       134 il~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l  194 (288)
T cd07871         134 LLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYSTPIDMWGVGCIL  194 (288)
T ss_pred             EEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcC--CcccCcHHHHHHHHHHH
Confidence            999999999999999986432    1223578999999998742  34688899999999984

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.90  E-value=5.2e-24  Score=238.20  Aligned_cols=137  Identities=31%  Similarity=0.536  Sum_probs=116.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+++.++|||||+++++|.+++.+|+|||||.| ++.+++..  ..+++..++.++.||+.||+|||+++|+||||||+
T Consensus        94 ~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~  171 (370)
T cd05621          94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD  171 (370)
T ss_pred             HHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence            4578889999999999999999999999999985 56665543  46899999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcc-cCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~-~~~~~~~vDvwslG~~~  143 (804)
                      |||+++++.+||+|||+|.....     ....+||+.|||||++.... .+.++.++|+||+|++.
T Consensus       172 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~il  237 (370)
T cd05621         172 NMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL  237 (370)
T ss_pred             HEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHH
Confidence            99999999999999999975321     13467999999999985321 13478899999999983

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=5.2e-24  Score=233.37  Aligned_cols=135  Identities=31%  Similarity=0.469  Sum_probs=116.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|+.++|||||+++++|..++.+|+||||+.|+ +.+.+ ...+.++++.+..++.|++.||+|||+++|+||||||+
T Consensus        51 ~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  129 (323)
T cd05584          51 RNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPE  129 (323)
T ss_pred             HHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence            36799999999999999999999999999999865 44444 44567899999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||+++...    ......||+.|+|||++.   ...++.++|+||+|++.
T Consensus       130 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  190 (323)
T cd05584         130 NILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM---RSGHGKAVDWWSLGALM  190 (323)
T ss_pred             HeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhcc---CCCCCCcceecccHHHH
Confidence            9999999999999999986421    123357999999999973   34578899999999984

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=6e-24  Score=233.61  Aligned_cols=135  Identities=30%  Similarity=0.556  Sum_probs=116.1

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+++.+ +|||||+++++|.+++.+|||||||.|+.+..+.....++++..++.++.|++.||+|||+++|+||||||+
T Consensus        46 ~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  125 (329)
T cd05588          46 KHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLD  125 (329)
T ss_pred             HHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence            3466677 799999999999999999999999986544433344578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++..    ......+||+.|+|||++.   ...++.++|+||+|++
T Consensus       126 Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~  185 (329)
T cd05588         126 NVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVL  185 (329)
T ss_pred             HeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHc---CCCCCCccceechHHH
Confidence            999999999999999998642    1223468999999999973   4568899999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.4e-24  Score=232.32  Aligned_cols=135  Identities=31%  Similarity=0.462  Sum_probs=117.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||++++++.++..+|+||||+.| ++.+++. ..+.+++..+..++.|++.||+|||+++|+||||||+
T Consensus        52 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  130 (291)
T cd05612          52 KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPE  130 (291)
T ss_pred             HHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence            3578999999999999999999999999999985 5556554 4567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||++.... .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       131 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il  188 (291)
T cd05612         131 NILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQ---SKGHNKAVDWWALGILI  188 (291)
T ss_pred             HeEECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHc---CCCCCchhhHHHHHHHH
Confidence            9999999999999999997532 233467999999999973   45678999999999984

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0986|consensus

Probab=99.90  E-value=2.3e-24  Score=231.74  Aligned_cols=147  Identities=27%  Similarity=0.389  Sum_probs=126.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      +.||++++.|+||.|-.+|++.+.++|||..|.|+.+.+.....  ..|++++++.|+.+|+.||++||+.+|++|||||
T Consensus       236 k~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKP  315 (591)
T KOG0986|consen  236 KQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKP  315 (591)
T ss_pred             HHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCCh
Confidence            56899999999999999999999999999999987766654333  4799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc---CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCCC
Q psy17952         83 GNILLTETGTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKED  159 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~d  159 (804)
                      +|||+|+.|+++|+|+|+|--.   .+....+||.+|||||++   .++.|+..+|+|++||+        +.++.....
T Consensus       316 eNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl---~ne~Y~~s~Dwf~lGCl--------lYemi~G~s  384 (591)
T KOG0986|consen  316 ENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVL---QNEVYDFSPDWFSLGCL--------LYEMIAGHS  384 (591)
T ss_pred             hheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHH---cCCcccCCccHHHHHhH--------HHHHHcccC
Confidence            9999999999999999999532   334456999999999998   45679999999999998        555554444


Q ss_pred             ccc
Q psy17952        160 PEK  162 (804)
Q Consensus       160 p~~  162 (804)
                      |++
T Consensus       385 PFr  387 (591)
T KOG0986|consen  385 PFR  387 (591)
T ss_pred             chh
Confidence            443

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=9.8e-24  Score=230.49  Aligned_cols=138  Identities=30%  Similarity=0.493  Sum_probs=118.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||+++++|.+++.+|+|||||.| ++.+.+. ....++++.++.++.||+.||.|||+++|+||||||+
T Consensus        49 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  127 (318)
T cd05582          49 RDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPE  127 (318)
T ss_pred             HHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH
Confidence            3588999999999999999999999999999985 5555553 4567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      |||++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|+||+|++.-++
T Consensus       128 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~el  191 (318)
T cd05582         128 NILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN---RRGHTQSADWWSFGVLMFEM  191 (318)
T ss_pred             HeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHc---CCCCCCccceeccceEeeee
Confidence            9999999999999999987532    223467999999999973   34678899999999985443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0194|consensus

Probab=99.90  E-value=4.8e-24  Score=239.08  Aligned_cols=135  Identities=37%  Similarity=0.650  Sum_probs=119.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      +++|++++|||||+|+|+...+..+|||||+|.| +|.++++..+..++..+...++.|.++||+|||++++|||||-..
T Consensus       212 ArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAAR  291 (474)
T KOG0194|consen  212 ARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAAR  291 (474)
T ss_pred             HHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHH
Confidence            6899999999999999999999999999999985 678888776667999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC---CC-ccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP---AN-SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~---~~-~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|++.++.+||+|||+++....   .. ...-...|+|||.+   ..+.|+.++||||+|++
T Consensus       292 NcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl---~~~~~s~kTDV~sfGV~  351 (474)
T KOG0194|consen  292 NCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETL---NTGIFSFKTDVWSFGVL  351 (474)
T ss_pred             HheecCCCeEEeCccccccCCcceeeccccccCcceecChhhh---ccCccccccchhheeee
Confidence            99999999999999999975431   11 11244579999998   45689999999999998

>KOG0614|consensus

Probab=99.90  E-value=1.5e-25  Score=243.16  Aligned_cols=159  Identities=30%  Similarity=0.459  Sum_probs=135.9

Q ss_pred             HHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          4 GSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         4 ~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      -+.||.+.+.|+||+||-.|.++.++|+.||-|.|+.+..+...++.|++...+.|+..+++|++|||++|||+|||||+
T Consensus       470 Er~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPE  549 (732)
T KOG0614|consen  470 ERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPE  549 (732)
T ss_pred             HHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChh
Confidence            47899999999999999999999999999999987755444456789999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccc---cCCCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccCCCc
Q psy17952         84 NILLTETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP  160 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~~dp  160 (804)
                      |+++|.+|.+||.|||+|+.   ...++++||||.|.|||+++   ++..+.++|.||+|+..-++....  ..|+..||
T Consensus       550 NllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIIL---nKGHD~avDyWaLGIli~ELL~G~--pPFs~~dp  624 (732)
T KOG0614|consen  550 NLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIIL---NKGHDRAVDYWALGILIYELLTGS--PPFSGVDP  624 (732)
T ss_pred             heeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhh---ccCcchhhHHHHHHHHHHHHHcCC--CCCCCCch
Confidence            99999999999999999975   34677899999999999995   355889999999998744443322  23667777


Q ss_pred             ccccccc
Q psy17952        161 EKIFEDL  167 (804)
Q Consensus       161 ~~~y~~l  167 (804)
                      .+.|..+
T Consensus       625 mktYn~I  631 (732)
T KOG0614|consen  625 MKTYNLI  631 (732)
T ss_pred             HHHHHHH
Confidence            7777654

>KOG0580|consensus

Probab=99.90  E-value=4.9e-25  Score=220.84  Aligned_cols=132  Identities=30%  Similarity=0.528  Sum_probs=117.2

Q ss_pred             HhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEE
Q psy17952          9 RQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL   86 (804)
Q Consensus         9 ~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nil   86 (804)
                      ..|+||||.+++++|.++..+||++||.. |.++..+.. ....+++.....|+.|++.||.|||.++||||||||+|+|
T Consensus        77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL  156 (281)
T KOG0580|consen   77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL  156 (281)
T ss_pred             cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence            45789999999999999999999999996 777777753 3457999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeccCcccc--cCCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         87 LTETGTVKLADFGSASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        87 l~~~~~~kl~DFG~a~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ++..|.+|++|||-+-.  .+...+.|||.-|.+||++   +...++..+|+|++|+..
T Consensus       157 lg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv---~~~~hd~~Vd~w~lgvl~  212 (281)
T KOG0580|consen  157 LGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMV---EGRGHDKFVDLWSLGVLC  212 (281)
T ss_pred             cCCCCCeeccCCCceeecCCCCceeeecccccCCHhhc---CCCCccchhhHHHHHHHH
Confidence            99999999999998754  3455678999999999997   455788999999999864

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=1e-23  Score=231.79  Aligned_cols=134  Identities=32%  Similarity=0.573  Sum_probs=114.9

Q ss_pred             HHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          7 LLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         7 iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      ++.++ +|||||+++++|.+++.+|||||||.|+.+.........+++..++.++.|++.||+|||+++|+||||||+||
T Consensus        48 ~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Ni  127 (329)
T cd05618          48 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV  127 (329)
T ss_pred             HHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence            44444 89999999999999999999999998665444434557899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +++.++.+||+|||+++..    ......+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  186 (329)
T cd05618         128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVLM  186 (329)
T ss_pred             EECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHc---CCCCCCccceecccHHH
Confidence            9999999999999998642    1223467999999999973   45688899999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.90  E-value=1.3e-23  Score=230.07  Aligned_cols=135  Identities=34%  Similarity=0.538  Sum_probs=114.5

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|+.+ +||||++++++|.+++.+|||||||.|+.+.........+++..+..++.|++.||.|||+++|+||||||+|
T Consensus        47 ~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~N  126 (321)
T cd05591          47 RILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDN  126 (321)
T ss_pred             HHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            345544 8999999999999999999999999865443333345679999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||++....    .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       127 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il  186 (321)
T cd05591         127 ILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ---ELEYGPSVDWWALGVLM  186 (321)
T ss_pred             eEECCCCCEEEeecccceecccCCccccccccCccccCHHHHc---CCCCCCccceechhHHH
Confidence            999999999999999986421    123457999999999973   45688999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.90  E-value=1e-23  Score=230.49  Aligned_cols=131  Identities=31%  Similarity=0.529  Sum_probs=113.0

Q ss_pred             hcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEEcC
Q psy17952         10 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE   89 (804)
Q Consensus        10 ~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~   89 (804)
                      ..+||||++++++|..++.+|+|||||.|+.+..+......+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus        52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~  131 (316)
T cd05592          52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK  131 (316)
T ss_pred             ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC
Confidence            34899999999999999999999999986544443344568999999999999999999999999999999999999999


Q ss_pred             CCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         90 TGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        90 ~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ++.+||+|||++....    .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       132 ~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il  186 (316)
T cd05592         132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK---GQKYNESVDWWSFGVLL  186 (316)
T ss_pred             CCCEEEccCcCCeECCCCCCccccccCCccccCHHHHc---CCCCCCcccchhHHHHH
Confidence            9999999999997421    223467999999999973   45688999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=8.1e-24  Score=238.35  Aligned_cols=135  Identities=33%  Similarity=0.540  Sum_probs=119.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++|+|||||+++++|..+...++||||+.+++..++.. +..+++..++.++.||+.||+|||+++|+||||||+|
T Consensus       134 ~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~N  212 (391)
T PHA03212        134 AHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN  212 (391)
T ss_pred             HHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHh
Confidence            468999999999999999999999999999999888877754 4678999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||+|....     .....+||+.|+|||++.   ...|+.++|+||+|++.
T Consensus       213 Ill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil  273 (391)
T PHA03212        213 IFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLA---RDPYGPAVDIWSAGIVL  273 (391)
T ss_pred             EEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhc---CCCCCcHHHHHHHHHHH
Confidence            999999999999999996421     222457999999999973   45689999999999984

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.90  E-value=1.2e-23  Score=230.41  Aligned_cols=134  Identities=31%  Similarity=0.524  Sum_probs=113.9

Q ss_pred             HHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          7 LLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         7 iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      +|+.+ +||||++++++|.+.+.+|||||||.|+.+..+......+++..+..++.|++.||+|||+++|+||||||+||
T Consensus        48 ~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NI  127 (320)
T cd05590          48 ILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNV  127 (320)
T ss_pred             HHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence            44444 79999999999999999999999998654433333456899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.++.+||+|||+++...    ......||+.|+|||++.   ...++.++|+||+|++.
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  186 (320)
T cd05590         128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ---EMLYGPSVDWWAMGVLL  186 (320)
T ss_pred             EECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHc---CCCCCCccchhhhHHHH
Confidence            99999999999999986421    223457999999999973   45688999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0201|consensus

Probab=99.90  E-value=4.1e-25  Score=237.79  Aligned_cols=135  Identities=54%  Similarity=0.921  Sum_probs=118.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      -.+|.++++|||.++|+.|.....+||+||||.|+. .+.++ ....+++..+..++++++.||.|||+.+.||||||++
T Consensus        62 i~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaa  140 (467)
T KOG0201|consen   62 ISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAA  140 (467)
T ss_pred             HHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceeccccccc
Confidence            357899999999999999999999999999998654 45443 4456699999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+..+|.+||+|||++...    ....+++|||+|||||++.   ...|+.++|+||+|+|.
T Consensus       141 nil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~---~~~Y~~KADIWSLGITa  201 (467)
T KOG0201|consen  141 NILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIK---QSGYDTKADIWSLGITA  201 (467)
T ss_pred             ceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhc---cccccchhhhhhhhHHH
Confidence            999999999999999999653    2346789999999999983   45799999999999994

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.90  E-value=1.6e-23  Score=234.32  Aligned_cols=137  Identities=31%  Similarity=0.543  Sum_probs=116.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.++..+|+|||||.|+ +.+++.  ...+++..++.++.||+.||+|||+++|+||||||+
T Consensus        94 ~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~  171 (371)
T cd05622          94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD  171 (371)
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            45788899999999999999999999999999854 555554  346899999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcc-cCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~-~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++.+||+|||++.....     ....+||+.|||||++.... .+.++.++|+||+|++.
T Consensus       172 NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvil  237 (371)
T cd05622         172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL  237 (371)
T ss_pred             HEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHH
Confidence            99999999999999999975321     23467999999999985321 13478899999999984

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.90  E-value=1.6e-23  Score=229.96  Aligned_cols=135  Identities=31%  Similarity=0.550  Sum_probs=115.5

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+++++ +||||++++++|.+.+.+|||||||.|+.+.........+++..++.++.||+.||+|||+++|+||||||+|
T Consensus        47 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~N  126 (327)
T cd05617          47 HVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDN  126 (327)
T ss_pred             HHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            456666 6999999999999999999999999865544333445689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||++...    ......+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       127 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil  186 (327)
T cd05617         127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR---GEEYGFSVDWWALGVLM  186 (327)
T ss_pred             EEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHC---CCCCCchheeehhHHHH
Confidence            99999999999999998642    1223467999999999973   45688999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=2.4e-23  Score=228.73  Aligned_cols=139  Identities=31%  Similarity=0.487  Sum_probs=116.9

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|+.+ +||||++++++|..++.+|+|||||.| ++.+.+. ....++++.++.++.||+.||+|||+++|+||||||
T Consensus        55 ~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp  133 (332)
T cd05614          55 RNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKL  133 (332)
T ss_pred             HHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH
Confidence            4577888 599999999999999999999999986 4555554 456799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      +|||++.++.+||+|||++....     .....+||+.|||||++.+  ...++.++|+||+|++.-++
T Consensus       134 ~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el  200 (332)
T cd05614         134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG--KGGHGKAVDWWSLGILIFEL  200 (332)
T ss_pred             HHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC--CCCCCCccccccchhhhhhh
Confidence            99999999999999999986421     1224579999999999742  23478899999999985333

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0665|consensus

Probab=99.90  E-value=9.4e-25  Score=226.75  Aligned_cols=139  Identities=36%  Similarity=0.563  Sum_probs=123.7

Q ss_pred             HHHhcCCCCeeeEeEEEEeCC------eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDH------TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~------~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      +|..++|+|||+++.+|+...      .+|+|||||.+++..++.   ..++.+.++.+++|+++|++|||+.+|+||||
T Consensus        68 l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdL  144 (369)
T KOG0665|consen   68 LMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDL  144 (369)
T ss_pred             hhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeeccc
Confidence            678899999999999997643      589999999999988775   46889999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccCCC---CccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcch
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEI  151 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i  151 (804)
                      ||+||++..++.+||.|||+|+.....   +.++.|.+|.|||+++++.   |...+|+||+||+.|++....+
T Consensus       145 kPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~---~ke~vdiwSvGci~gEli~~~V  215 (369)
T KOG0665|consen  145 KPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGELILGTV  215 (369)
T ss_pred             CcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC---CcccchhhhhhhHHHHHhhceE
Confidence            999999999999999999999864433   5678999999999998763   8889999999999988877654

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.90  E-value=9.7e-24  Score=226.18  Aligned_cols=135  Identities=27%  Similarity=0.536  Sum_probs=120.0

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|++++|||||+++++|..++.+|+||||+.+++++.+......++++.++.++.|++.||.|||+++|+||||||+||
T Consensus        52 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni  131 (287)
T cd07848          52 KMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL  131 (287)
T ss_pred             HHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            57889999999999999999999999999999988887766667899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +++.++.+||+|||++.....     .....||+.|+|||++.   ...++.++|+||+|++.
T Consensus       132 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslGvil  191 (287)
T cd07848         132 LISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL---GAPYGKAVDMWSVGCIL  191 (287)
T ss_pred             EEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHc---CCCCCCchhHHhHHHHH
Confidence            999999999999999975321     12357999999999973   45688999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.90  E-value=1.5e-23  Score=229.05  Aligned_cols=133  Identities=30%  Similarity=0.486  Sum_probs=114.1

Q ss_pred             HHHh-cCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          7 LLRQ-LKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         7 iL~~-l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      +|+. ++||||++++++|.+++.+|||||||.|+ +.+.+ ..+..+++..+..++.|+++||+|||+++|+||||||+|
T Consensus        48 ~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~N  126 (316)
T cd05620          48 VLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDN  126 (316)
T ss_pred             HHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence            4443 48999999999999999999999999865 44444 345689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||+++..    ......+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       127 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil  186 (316)
T cd05620         127 VMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ---GLKYTFSVDWWSFGVLL  186 (316)
T ss_pred             eEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHc---CCCCCcccchhhhHHHH
Confidence            99999999999999998642    1223467999999999973   45689999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.90  E-value=1.6e-23  Score=234.10  Aligned_cols=137  Identities=30%  Similarity=0.541  Sum_probs=116.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+++.+|||||||.|+ +.+++.  ...+++..+..++.|++.||+|||+++|+||||||+
T Consensus        94 ~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~  171 (370)
T cd05596          94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD  171 (370)
T ss_pred             HHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            46788999999999999999999999999999854 555554  346899999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcc-cCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~-~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++.+||+|||++.....     ....+||+.|||||++.... ...++.++|+||+|++.
T Consensus       172 NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvil  237 (370)
T cd05596         172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL  237 (370)
T ss_pred             HEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHH
Confidence            99999999999999999865321     23467999999999984321 23478899999999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0032|consensus

Probab=99.89  E-value=1.2e-23  Score=233.94  Aligned_cols=133  Identities=41%  Similarity=0.727  Sum_probs=116.4

Q ss_pred             HHHHhcC-CCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~-HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      +||++|. |||||+++++|++.+.+|||||+|.|+ +.+.+...  .+++..+..++.|++.|++|||+.||+||||||+
T Consensus        87 ~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE  164 (382)
T KOG0032|consen   87 AILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE  164 (382)
T ss_pred             HHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH
Confidence            6899998 999999999999999999999999965 55555444  3999999999999999999999999999999999


Q ss_pred             cEEEcCC----CceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTET----GTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~----~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |+|+...    +.+|++|||+|.....   ....+|||+|+|||++.   ...|+..+|+||+|+.+
T Consensus       165 N~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~---~~~y~~~~DiWS~Gvi~  228 (382)
T KOG0032|consen  165 NLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLG---GRPYGDEVDVWSIGVIL  228 (382)
T ss_pred             HeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhc---CCCCCcccchhHHHHHH
Confidence            9998643    4799999999987554   33469999999999983   46899999999999863

>KOG0667|consensus

Probab=99.89  E-value=5.9e-24  Score=239.70  Aligned_cols=161  Identities=28%  Similarity=0.495  Sum_probs=132.1

Q ss_pred             HHHHhcC------CCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          6 SLLRQLK------HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         6 ~iL~~l~------HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      .||..|+      --|||+++++|...+.+|||+|..+.+|+++++..+ .+++...++.++.||+.||.+||+++|||.
T Consensus       234 ~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHc  313 (586)
T KOG0667|consen  234 RILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHC  313 (586)
T ss_pred             HHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            4566776      358999999999999999999999999999998765 579999999999999999999999999999


Q ss_pred             ccccccEEEcCCC--ceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccc
Q psy17952         79 DVKAGNILLTETG--TVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELF  155 (804)
Q Consensus        79 DlKp~Nill~~~~--~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf  155 (804)
                      ||||+||||.+-+  .+||+|||+|.... ...+++.+++|+|||+++++   +|+.++|+|||||+..++..+.  -+|
T Consensus       314 DLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGl---pY~~~IDmWSLGCIlAEL~tG~--PLf  388 (586)
T KOG0667|consen  314 DLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGL---PYDTAIDMWSLGCILAELFTGE--PLF  388 (586)
T ss_pred             cCChhheeeccCCcCceeEEecccccccCCcceeeeeccccccchhhccC---CCCCccceeehhhhHHhHhcCc--ccc
Confidence            9999999997644  79999999997643 33478999999999999864   7999999999999977766552  244


Q ss_pred             cCCCcc-cccccccccc
Q psy17952        156 DKEDPE-KIFEDLREIG  171 (804)
Q Consensus       156 ~~~dp~-~~y~~l~~LG  171 (804)
                      ..++.. +...+.+.+|
T Consensus       389 pG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  389 PGDNEYDQLARIIEVLG  405 (586)
T ss_pred             CCCCHHHHHHHHHHHhC
Confidence            443332 2234444544

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=1.5e-23  Score=242.25  Aligned_cols=136  Identities=34%  Similarity=0.567  Sum_probs=117.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|+.++|||||+++++|..++.+|||||||.| +|.+.+..   ...++++..+..++.|++.||+|||+++|+||||
T Consensus       116 ~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDl  195 (478)
T PTZ00267        116 LHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL  195 (478)
T ss_pred             HHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCc
Confidence            4678899999999999999999999999999985 55555543   2457999999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||+|||++.++.+||+|||+++....      ....+||+.|+|||++   ....++.++|+||+|++.
T Consensus       196 kp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l  261 (478)
T PTZ00267        196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW---ERKRYSKKADMWSLGVIL  261 (478)
T ss_pred             CHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHh---CCCCCCcHHhHHHHHHHH
Confidence            99999999999999999999975321      2345799999999997   345689999999999983

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.3e-23  Score=228.74  Aligned_cols=132  Identities=30%  Similarity=0.495  Sum_probs=113.1

Q ss_pred             CCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEEcCC
Q psy17952         12 KHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET   90 (804)
Q Consensus        12 ~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~~   90 (804)
                      +||||++++++|.+++.+|+||||+.|+ +.+.+ ..+..+++..++.++.||++||+|||+++|+||||||+|||++.+
T Consensus        54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~  132 (330)
T cd05586          54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT  132 (330)
T ss_pred             CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence            7999999999999999999999999865 44444 456789999999999999999999999999999999999999999


Q ss_pred             CceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCCCCC
Q psy17952         91 GTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSL  146 (804)
Q Consensus        91 ~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l  146 (804)
                      +.+||+|||++...    ......+||+.|||||++.+  ...++.++|+||+|++.-++
T Consensus       133 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~el  190 (330)
T cd05586         133 GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD--EKGYTKHVDFWSLGVLVFEM  190 (330)
T ss_pred             CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcC--CCCCCCccceeccccEEEEe
Confidence            99999999998642    12234679999999999742  33478899999999985444

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.89  E-value=2.4e-23  Score=223.73  Aligned_cols=136  Identities=26%  Similarity=0.323  Sum_probs=116.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||+++++|.+++.+|+|||||.|+ +.+.+... ...+++..+..++.|++.||+|||+++|+||||||
T Consensus        51 ~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp  130 (285)
T cd05631          51 KRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKP  130 (285)
T ss_pred             HHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH
Confidence            46888999999999999999999999999999865 44444433 34699999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +|||+++++.+||+|||++....   ......||+.|||||++.   ...++.++|+||+|+++
T Consensus       131 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil  191 (285)
T cd05631         131 ENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN---NEKYTFSPDWWGLGCLI  191 (285)
T ss_pred             HHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhc---CCCCCcccCchhHHHHH
Confidence            99999999999999999987532   123457999999999983   45789999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	804
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-131
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-128
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-51
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-47
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-47
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-47
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-46
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-46
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-46
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-46
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-46
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-45
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-44
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-44
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-44
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-42
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-41
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-41
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-41
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-41
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-40
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-40
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-39
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-39
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-38
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-38
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-38
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-38
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-38
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-34
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-33
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-31
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-27
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-27
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-23
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-22
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-22
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-22
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-22
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-22
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-22
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-22
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-21
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-21
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-20
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-20
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-20
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-20
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-20
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-20
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-20
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-20
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-20
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-20
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-20
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-20
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-20
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-20
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-20
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-20
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-20
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-20
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-20
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-20
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-20
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-20
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-20
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-20
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-20
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-20
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-20
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-20
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-19
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-19
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-19
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-18
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-18
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-18
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-18
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-18
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-18
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-17
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-17
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-17
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-17
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-17
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-17
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-17
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-17
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-17
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-17
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-17
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-17
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-17
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-17
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-17
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-17
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-17
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-17
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-17
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-17
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-17
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-17
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-17
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-17
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-17
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-17
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-17
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-17
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-17
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-17
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-17
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-17
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-17
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-17
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-17
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-17
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-17
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-17
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-17
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-17
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-17
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-17
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-17
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-16
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-16
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-16
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-15
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-15
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-15
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-15
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-14
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-14
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3soa_A	444	Full-Length Human Camkii Length = 444		2e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-12
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-12
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-12
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-12
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-12
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-12
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-12
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-12
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-12
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-12
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-12
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		9e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-11
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-09
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-07

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  466 bits (1200), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 237/401 (59%), Positives = 272/401 (67%), Gaps = 74/401 (18%)
Query: 130 YDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI 189
           + G +D    G   GSLKDP++AELF K+DPEK+F DLREIGHGSFGAVY+AR + + E+
Sbjct: 22  FQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV 81
Query: 190 VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSAS 249
           VAIKKMSY GKQ  EKW DI+KE+RFL++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSAS
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 141
Query: 250 DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN 309
           D++EVH                                 K+PL+E EIAA+  G L+GL 
Sbjct: 142 DLLEVH---------------------------------KKPLQEVEIAAVTHGALQGLA 168
Query: 310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEG 369
           YLHS   IHRDVKAGNILL+E G VKL DFGSASI  PAN FVGTPYWMAPEVILAMDEG
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEG 228
Query: 370 QYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA 429
           QYDGKVDVWSLGITCIELAERKPP FNMNAMSALYHIAQN++P LQS  W          
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---------- 278
Query: 430 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
                                          S+ F +FV SCL K P DRP+S  LL H 
Sbjct: 279 -------------------------------SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307
Query: 490 LVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADG 530
            V R R P+V++DLI+RTK AVR+LDNL YRKMKKIL  + 
Sbjct: 308 FVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEA 348

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 48/65 (73%), Positives = 55/65 (84%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASD++EVHK+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNILL+E 
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190
Query: 676 GTVKL 680
           G VKL
Sbjct: 191 GLVKL 195

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  456 bits (1172), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 230/383 (60%), Positives = 263/383 (68%), Gaps = 74/383 (19%)
Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA 207
           DP++AELF K+DPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  EKW 
Sbjct: 1   DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 208 DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
           DI+KE+RFL++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSASD++EVH            
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH------------ 108
Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
                                K+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNIL
Sbjct: 109 ---------------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147
Query: 328 LTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           L+E G VKL DFGSASI  PAN FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
           AERKPP FNMNAMSALYHIAQN++P LQS  W                            
Sbjct: 208 AERKPPLFNMNAMSALYHIAQNESPALQSGHW---------------------------- 239
Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRT 507
                        S+ F +FV SCL K P DRP+S  LL H  V R R P+V++DLI+RT
Sbjct: 240 -------------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286
Query: 508 KAAVRDLDNLNYRKMKKILMADG 530
           K AVR+LDNL YRKMKKIL  + 
Sbjct: 287 KDAVRELDNLQYRKMKKILFQEA 309

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 48/65 (73%), Positives = 55/65 (84%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASD++EVHK+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNILL+E 
Sbjct: 92  LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
Query: 676 GTVKL 680
           G VKL
Sbjct: 152 GLVKL 156

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  201 bits (512), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 124/352 (35%), Positives = 169/352 (48%), Gaps = 86/352 (24%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           + PE++F+ L ++G GS+G+VY A    + +IVAIK++            +I+KEI  ++
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQ 79
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           Q   P+ ++Y G Y ++   W+VMEYC  GS SDII +                      
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--------------------- 118
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L E+EIA I    L+GL YLH + +IHRD+KAGNILL   G  KL
Sbjct: 119 ------------NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKL 166
Query: 337 ADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           ADFG A          N  +GTP+WMAPEVI    E  Y+   D+WSLGIT IE+AE KP
Sbjct: 167 ADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI---QEIGYNCVADIWSLGITAIEMAEGKP 223
Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           PY +++ M A++ I  N  P                  RKP                   
Sbjct: 224 PYADIHPMRAIFMIPTNPPPTF----------------RKPEL----------------- 250
Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI 504
                  WSD F  FV  CL K+P  R ++ +LL H  V   +  S+L DLI
Sbjct: 251 -------WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 37/66 (56%), Positives = 45/66 (68%), Gaps = 1/66 (1%)
Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEYC  GS SDII +  + L E+EIA I    L+GL YLH + +IHRD+KAGNILL  
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160
Query: 675 TGTVKL 680
            G  KL
Sbjct: 161 EGHAKL 166

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  188 bits (478), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 116/361 (32%), Positives = 168/361 (46%), Gaps = 81/361 (22%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP +++E + E+G G+FG VY A+   ++E  A+     +  +  E+  D + EI  L  
Sbjct: 16  DPNEVWEIVGELGDGAFGKVYKAK---NKETGALAAAKVIETKSEEELEDYIVEIEILAT 72
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HP  ++  G Y  D   W+++E+C G A D I +                        
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---------------------- 110
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                      R L E +I  +C  +L  LN+LHS   IHRD+KAGN+L+T  G ++LAD
Sbjct: 111 ----------DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLAD 160
Query: 339 FGSASIKCPA----NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         +SF+GTPYWMAPEV++   M +  YD K D+WSLGIT IE+A+ +P
Sbjct: 161 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA++D P L                                      
Sbjct: 221 PHHELNPMRVLLKIAKSDPPTL-------------------------------------- 242
Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVR 512
             L  S WS  F  F+   L KNP  RPS+ +LL H  V+   S   L +L+   KA V 
Sbjct: 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVM 300
Query: 513 D 513
           +
Sbjct: 301 E 301

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/66 (43%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 616 LVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C G A D I +   R L E +I  +C  +L  LN+LHS   IHRD+KAGN+L+T 
Sbjct: 93  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152
Query: 675 TGTVKL 680
            G ++L
Sbjct: 153 EGDIRL 158

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  188 bits (477), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 116/361 (32%), Positives = 168/361 (46%), Gaps = 81/361 (22%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP +++E + E+G G+FG VY A+   ++E  A+     +  +  E+  D + EI  L  
Sbjct: 8   DPNEVWEIVGELGDGAFGKVYKAK---NKETGALAAAKVIETKSEEELEDYIVEIEILAT 64
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HP  ++  G Y  D   W+++E+C G A D I +                        
Sbjct: 65  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---------------------- 102
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                      R L E +I  +C  +L  LN+LHS   IHRD+KAGN+L+T  G ++LAD
Sbjct: 103 ----------DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLAD 152
Query: 339 FGSASIKCPA----NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         +SF+GTPYWMAPEV++   M +  YD K D+WSLGIT IE+A+ +P
Sbjct: 153 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212
Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA++D P L                                      
Sbjct: 213 PHHELNPMRVLLKIAKSDPPTL-------------------------------------- 234
Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVR 512
             L  S WS  F  F+   L KNP  RPS+ +LL H  V+   S   L +L+   KA V 
Sbjct: 235 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVM 292
Query: 513 D 513
           +
Sbjct: 293 E 293

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/66 (43%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 616 LVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C G A D I +   R L E +I  +C  +L  LN+LHS   IHRD+KAGN+L+T 
Sbjct: 85  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 144
Query: 675 TGTVKL 680
            G ++L
Sbjct: 145 EGDIRL 150

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  186 bits (471), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 122/358 (34%), Positives = 169/358 (47%), Gaps = 88/358 (24%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K DPE++F  L +IG GSFG V+      ++++VAIK +     +   +     +EI  L
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVL 74
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKC 275
            Q   P   +Y G YL+D   W++MEY  G SA D++E                      
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---------------------- 112
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                          PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G VK
Sbjct: 113 -------------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK 159
Query: 336 LADFGSAS----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           LADFG A      +   N FVGTP+WMAPEVI    +  YD K D+WSLGIT IEL    
Sbjct: 160 LADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIEL---- 212
Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                                                A  +PP+  ++ M  L+ I +N+
Sbjct: 213 -------------------------------------ARGEPPHSELHPMKVLFLIPKNN 235
Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
            P L+  ++S     FV +CL K P+ RP++  LL H  + R  +  S L +LI R K
Sbjct: 236 PPTLEG-NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYK 292

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/66 (53%), Positives = 47/66 (71%), Gaps = 3/66 (4%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++MEY  G SA D++E    PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E
Sbjct: 97  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 154
Query: 675 TGTVKL 680
            G VKL
Sbjct: 155 HGEVKL 160

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  184 bits (468), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 121/356 (33%), Positives = 169/356 (47%), Gaps = 88/356 (24%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DPE++F  L +IG GSFG V+      ++++VAIK +     +   +     +EI  L Q
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQ 61
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
              P   +Y G YL+D   W++MEY  G SA D++E                        
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------------------------ 97
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                        PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G VKLA
Sbjct: 98  -----------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 146
Query: 338 DFGSAS----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG A      +   N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IELA  +  
Sbjct: 147 DFGVAGQLTDTQIKRNTFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIELARGE-- 201
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
                                                  PP+  ++ M  L+ I +N+ P
Sbjct: 202 ---------------------------------------PPHSELHPMKVLFLIPKNNPP 222
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
            L+  ++S     FV +CL K P+ RP++  LL H  + R  +  S L +LI R K
Sbjct: 223 TLEG-NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYK 277

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/66 (53%), Positives = 47/66 (71%), Gaps = 3/66 (4%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++MEY  G SA D++E    PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E
Sbjct: 82  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 139
Query: 675 TGTVKL 680
            G VKL
Sbjct: 140 HGEVKL 145

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  184 bits (467), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 121/356 (33%), Positives = 168/356 (47%), Gaps = 88/356 (24%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DPE++F  L +IG GSFG V+      ++++VAIK +     +   +     +EI  L Q
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQ 61
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
              P   +Y G YL+D   W++MEY  G SA D++E                        
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------------------------ 97
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                        PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G VKLA
Sbjct: 98  -----------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 146
Query: 338 DFGSAS----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG A      +   N FVGTP+WMAPEVI    +  YD K D+WSLGIT IEL      
Sbjct: 147 DFGVAGQLTDTQIKRNXFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIEL------ 197
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
                                              A  +PP+  ++ M  L+ I +N+ P
Sbjct: 198 -----------------------------------ARGEPPHSELHPMKVLFLIPKNNPP 222
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
            L+  ++S     FV +CL K P+ RP++  LL H  + R  +  S L +LI R K
Sbjct: 223 TLEG-NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYK 277

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/66 (53%), Positives = 47/66 (71%), Gaps = 3/66 (4%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++MEY  G SA D++E    PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E
Sbjct: 82  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 139
Query: 675 TGTVKL 680
            G VKL
Sbjct: 140 HGEVKL 145

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  184 bits (467), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 134/380 (35%), Positives = 178/380 (46%), Gaps = 97/380 (25%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP  IFE +  +G+G++G VY  R + + ++ AIK M   G +  E    I +EI  L++
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE----IKQEINMLKK 76
Query: 219 LKH-PNTIEYRGCYLR------DHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRL 270
             H  N   Y G +++      D   WLVME+C  GS +D+I+             GN  
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK----------NTKGN-- 124
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                                LKEE IA IC  +LRGL++LH    IHRD+K  N+LLTE
Sbjct: 125 --------------------TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 164
Query: 331 TGTVKLADFG-SASIKCPA---NSFVGTPYWMAPEVILAMDE---GQYDGKVDVWSLGIT 383
              VKL DFG SA +       N+F+GTPYWMAPEVI A DE     YD K D+WSLGIT
Sbjct: 165 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI-ACDENPDATYDFKSDLWSLGIT 223
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
            IE+AE  PP  +M+ M AL+ I +N  P L+S  W                        
Sbjct: 224 AIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW------------------------ 259
Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT-RPRSPSV--- 499
                            S  F  F+ SCL KN + RP++ +L+ H  +  +P    V   
Sbjct: 260 -----------------SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302
Query: 500 LVDLIRRTKAAVRDLDNLNY 519
           L D I RTK    + D   Y
Sbjct: 303 LKDHIDRTKKKRGEKDETEY 322

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 46/67 (68%), Gaps = 2/67 (2%)
Query: 616 LVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LVME+C  GS +D+I+  K   LKEE IA IC  +LRGL++LH    IHRD+K  N+LLT
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 674 ETGTVKL 680
           E   VKL
Sbjct: 164 ENAEVKL 170

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 120/356 (33%), Positives = 168/356 (47%), Gaps = 88/356 (24%)
Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR 214
           F   DPE++F  L +IG GSFG V+      ++++VAIK +     +   +     +EI 
Sbjct: 20  FQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEIT 77
Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQL 273
            L Q   P   +Y G YL+D   W++MEY  G SA D++E                    
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-------------------- 117
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                            PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G 
Sbjct: 118 ---------------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE 162
Query: 334 VKLADFGSAS----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           VKLADFG A      +   N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IEL  
Sbjct: 163 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIEL-- 217
Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
                                                  A  +PP+  ++ M  L+ I +
Sbjct: 218 ---------------------------------------ARGEPPHSELHPMKVLFLIPK 238
Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLI 504
           N+ P L+  ++S     FV +CL K P+ RP++  LL H  + R  +  S L +LI
Sbjct: 239 NNPPTLEG-NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 293

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/66 (53%), Positives = 47/66 (71%), Gaps = 3/66 (4%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++MEY  G SA D++E    PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E
Sbjct: 102 IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 159
Query: 675 TGTVKL 680
            G VKL
Sbjct: 160 HGEVKL 165

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 116/355 (32%), Positives = 167/355 (47%), Gaps = 86/355 (24%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DPE++F  L  IG GSFG V+      ++++VAIK +     +   +     +EI  L Q
Sbjct: 20  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQ 77
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
                  +Y G YL+    W++MEY                     G G+ L  L+    
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYL--------------------GGGSALDLLRA--- 114
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                       P  E +IA +   +L+GL+YLHS  +IHRD+KA N+LL+E G VKLAD
Sbjct: 115 -----------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLAD 163
Query: 339 FGSAS----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG A      +   N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IELA+ +PP 
Sbjct: 164 FGVAGQLTDTQIKRNTFVGTPFWMAPEVI---QQSAYDSKADIWSLGITAIELAKGEPPN 220
Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
            +M+ M  L+ I +N+ P L                                        
Sbjct: 221 SDMHPMRVLFLIPKNNPPTL---------------------------------------- 240
Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
               D++ +F  F+ +CL K+P+ RP++  LL H  + +  +  S L +LI R K
Sbjct: 241 --VGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLTELIDRFK 293

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 31/65 (47%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           ++MEY LG  S +  +   P  E +IA +   +L+GL+YLHS  +IHRD+KA N+LL+E 
Sbjct: 98  IIMEY-LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ 156
Query: 676 GTVKL 680
           G VKL
Sbjct: 157 GDVKL 161

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  180 bits (457), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 124/355 (34%), Positives = 164/355 (46%), Gaps = 86/355 (24%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DPE++F  L  IG GSFG VY      ++E+VAIK +     +   +     +EI  L Q
Sbjct: 16  DPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQ 73
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
              P    Y G YL+    W++MEY                     G G+ L  LK    
Sbjct: 74  CDSPYITRYFGSYLKSTKLWIIMEYL--------------------GGGSALDLLK---- 109
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                       PL+E  IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G VKLAD
Sbjct: 110 ----------PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLAD 159
Query: 339 FGSAS----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG A      +   N FVGTP+WMAPEVI    +  YD K D+WSLGIT IEL       
Sbjct: 160 FGVAGQLTDTQIKRNXFVGTPFWMAPEVI---KQSAYDFKADIWSLGITAIEL------- 209
Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
                                             A+ +PP  +++ M  L+ I +N  P 
Sbjct: 210 ----------------------------------AKGEPPNSDLHPMRVLFLIPKNSPPT 235
Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
           L+    S  F  FV +CL K+P  RP++  LL H  +TR  +  S L +LI R K
Sbjct: 236 LEGQH-SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYK 289

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 45/65 (69%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           ++MEY LG  S +  +   PL+E  IA I   +L+GL+YLHS  +IHRD+KA N+LL+E 
Sbjct: 94  IIMEY-LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 152
Query: 676 GTVKL 680
           G VKL
Sbjct: 153 GDVKL 157

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  178 bits (452), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 113/361 (31%), Positives = 164/361 (45%), Gaps = 82/361 (22%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           +PE  +E + E+G G+FG VY A+   ++E   +     +  +  E+  D + EI  L  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQ---NKETSVLAAAKVIDTKSEEELEDYMVEIDILAS 90
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HPN ++    +  ++  W+++E+C G A D + +                        
Sbjct: 91  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---------------------- 128
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                     +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T  G +KLAD
Sbjct: 129 ----------ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 339 FGSASIKCPA----NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         +SF+GTPYWMAPEV++     +  YD K DVWSLGIT IE+AE +P
Sbjct: 179 FGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238
Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA+++ P L                                      
Sbjct: 239 PHHELNPMRVLLKIAKSEPPTLA------------------------------------- 261
Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVR 512
              Q S WS  F  F+  CL KN   R ++ +LL H  VT   +  +  +LI   KA V 
Sbjct: 262 ---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR-ELIAEAKAEVT 317
Query: 513 D 513
           +
Sbjct: 318 E 318

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 31/66 (46%), Positives = 42/66 (63%), Gaps = 1/66 (1%)
Query: 616 LVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C G A D + +  +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T 
Sbjct: 111 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 170
Query: 675 TGTVKL 680
            G +KL
Sbjct: 171 DGDIKL 176

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  178 bits (451), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 113/359 (31%), Positives = 163/359 (45%), Gaps = 82/359 (22%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           +PE  +E + E+G G+FG VY A+   ++E   +     +  +  E+  D + EI  L  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQ---NKETSVLAAAKVIDTKSEEELEDYMVEIDILAS 90
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HPN ++    +  ++  W+++E+C G A D + +                        
Sbjct: 91  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---------------------- 128
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                     +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T  G +KLAD
Sbjct: 129 ----------ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 339 FGSASIKCPA----NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         +SF+GTPYWMAPEV++     +  YD K DVWSLGIT IE+AE +P
Sbjct: 179 FGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238
Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA+++ P L                                      
Sbjct: 239 PHHELNPMRVLLKIAKSEPPTLA------------------------------------- 261
Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAV 511
              Q S WS  F  F+  CL KN   R ++ +LL H  VT   +  +  +LI   KA V
Sbjct: 262 ---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR-ELIAEAKAEV 316

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 31/66 (46%), Positives = 42/66 (63%), Gaps = 1/66 (1%)
Query: 616 LVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C G A D + +  +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T 
Sbjct: 111 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 170
Query: 675 TGTVKL 680
            G +KL
Sbjct: 171 DGDIKL 176

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  176 bits (446), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/359 (31%), Positives = 162/359 (45%), Gaps = 82/359 (22%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           +PE  +E + E+G G+FG VY A+   ++E   +     +  +  E+  D + EI  L  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQ---NKETSVLAAAKVIDTKSEEELEDYMVEIDILAS 90
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HPN ++    +  ++  W+++E+C G A D + +                        
Sbjct: 91  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---------------------- 128
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                     +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T  G +KLAD
Sbjct: 129 ----------ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 339 FGSASIKCPA----NSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         + F+GTPYWMAPEV++     +  YD K DVWSLGIT IE+AE +P
Sbjct: 179 FGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238
Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA+++ P L                                      
Sbjct: 239 PHHELNPMRVLLKIAKSEPPTLA------------------------------------- 261
Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAV 511
              Q S WS  F  F+  CL KN   R ++ +LL H  VT   +  +  +LI   KA V
Sbjct: 262 ---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR-ELIAEAKAEV 316

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 31/66 (46%), Positives = 42/66 (63%), Gaps = 1/66 (1%)
Query: 616 LVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C G A D + +  +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T 
Sbjct: 111 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 170
Query: 675 TGTVKL 680
            G +KL
Sbjct: 171 DGDIKL 176

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  167 bits (423), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 119/360 (33%), Positives = 162/360 (45%), Gaps = 86/360 (23%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   I+ EI  +R+
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRE 73
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            K+PN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 107
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL   G+VKL 
Sbjct: 108 ---------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158
Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 159 DFGFCAQITPEQSKRSXMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ                     N   +SA+         
Sbjct: 216 YLNENPLRALYLIATNGTPELQ---------------------NPEKLSAI--------- 245
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
                     F  F++ CL  +   R S+  LL H  +   +  S L  LI   K A ++
Sbjct: 246 ----------FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKN 295

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G S +D+  V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL  
Sbjct: 94  VVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 675 TGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
            G+VKL         D      IT E S +S  VG
Sbjct: 152 DGSVKL--------TDFGFCAQITPEQSKRSXMVG 178

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  167 bits (422), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 119/360 (33%), Positives = 162/360 (45%), Gaps = 86/360 (23%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   I+ EI  +R+
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRE 73
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            K+PN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 107
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL   G+VKL 
Sbjct: 108 ---------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158
Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 159 DFGFCAQITPEQSKRSEMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ                     N   +SA+         
Sbjct: 216 YLNENPLRALYLIATNGTPELQ---------------------NPEKLSAI--------- 245
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
                     F  F++ CL  +   R S+  LL H  +   +  S L  LI   K A ++
Sbjct: 246 ----------FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKN 295

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G S +D+  V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL  
Sbjct: 94  VVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 675 TGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
            G+VKL         D      IT E S +S  VG
Sbjct: 152 DGSVKL--------TDFGFCAQITPEQSKRSEMVG 178

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  167 bits (422), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 119/360 (33%), Positives = 162/360 (45%), Gaps = 86/360 (23%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   I+ EI  +R+
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRE 73
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            K+PN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 107
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL   G+VKL 
Sbjct: 108 ---------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158
Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ                     N   +SA+         
Sbjct: 216 YLNENPLRALYLIATNGTPELQ---------------------NPEKLSAI--------- 245
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
                     F  F++ CL  +   R S+  LL H  +   +  S L  LI   K A ++
Sbjct: 246 ----------FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKN 295

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G S +D+  V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL  
Sbjct: 94  VVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 675 TGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
            G+VKL         D      IT E S +S  VG
Sbjct: 152 DGSVKL--------TDFGFCAQITPEQSKRSTMVG 178

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  166 bits (420), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 118/360 (32%), Positives = 162/360 (45%), Gaps = 86/360 (23%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   I+ EI  +R+
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRE 74
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            K+PN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 108
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL   G+VKL 
Sbjct: 109 ---------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 159
Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 160 DFGFCAQITPEQSKRSXMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMIEGEPP 216
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ                     N   +SA+         
Sbjct: 217 YLNENPLRALYLIATNGTPELQ---------------------NPEKLSAI--------- 246
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
                     F  F++ CL  +   R S+  L+ H  +   +  S L  LI   K A ++
Sbjct: 247 ----------FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATKN 296

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G S +D+  V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL  
Sbjct: 95  VVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 152
Query: 675 TGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
            G+VKL         D      IT E S +S  VG
Sbjct: 153 DGSVKL--------TDFGFCAQITPEQSKRSXMVG 179

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  164 bits (415), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 117/360 (32%), Positives = 162/360 (45%), Gaps = 86/360 (23%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   I+ EI  +R+
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRE 74
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            K+PN + Y   YL     W+VMEY  G S +D+                          
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-------------------------- 108
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V +  + E +IAA+C   L+ L +LHS   IHR++K+ NILL   G+VKL 
Sbjct: 109 ---------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLT 159
Query: 338 DFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG  +   P  S     VGTPYWMAPEV+       Y  KVD+WSLGI  IE+ E +PP
Sbjct: 160 DFGFCAQITPEQSKRSTMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIMAIEMIEGEPP 216
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           Y N N + ALY IA N TP LQ                     N   +SA+         
Sbjct: 217 YLNENPLRALYLIATNGTPELQ---------------------NPEKLSAI--------- 246
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
                     F  F++ CL  +   R S+  L+ H  +   +  S L  LI   K A ++
Sbjct: 247 ----------FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATKN 296

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G S +D+  V +  + E +IAA+C   L+ L +LHS   IHR++K+ NILL  
Sbjct: 95  VVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGM 152
Query: 675 TGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVG 709
            G+VKL         D      IT E S +S  VG
Sbjct: 153 DGSVKL--------TDFGFCAQITPEQSKRSTMVG 179

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 112/341 (32%), Positives = 153/341 (44%), Gaps = 73/341 (21%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G+   V  A C   +E VAIK+++   ++C     ++LKEI+ + Q  HPN + Y  
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 230 CYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
            ++     WLVM+   G S  DII+ H + +  H  G+                      
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGV---------------------- 117
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA 348
              L E  IA I   VL GL YLH  G+IHRDVKAGNILL E G+V++ADFG ++     
Sbjct: 118 ---LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 349 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                     +FVGTP WMAPEV+  +    YD K D+WS GIT IELA    PY     
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVR--GYDFKADIWSFGITAIELATGAAPYHKYPP 232
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           M  L    QND P L++                                  D   L+   
Sbjct: 233 MKVLMLTLQNDPPSLET-------------------------------GVQDKEMLKK-- 259
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
           +  +F   +S CL K+P  RP++  LL H    + ++   L
Sbjct: 260 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/65 (53%), Positives = 40/65 (61%), Gaps = 7/65 (10%)
Query: 623 GSASDIIE------VHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           GS  DII+       HK   L E  IA I   VL GL YLH  G+IHRDVKAGNILL E 
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED 157
Query: 676 GTVKL 680
           G+V++
Sbjct: 158 GSVQI 162

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 111/336 (33%), Positives = 151/336 (44%), Gaps = 73/336 (21%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G+   V  A C   +E VAIK+++   ++C     ++LKEI+ + Q  HPN + Y  
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 230 CYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
            ++     WLVM+   G S  DII+ H + +  H  G+                      
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGV---------------------- 112
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA 348
              L E  IA I   VL GL YLH  G+IHRDVKAGNILL E G+V++ADFG ++     
Sbjct: 113 ---LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 169
Query: 349 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                     +FVGTP WMAPEV+  +    YD K D+WS GIT IELA    PY     
Sbjct: 170 GDITRNKVRKTFVGTPCWMAPEVMEQVR--GYDFKADIWSFGITAIELATGAAPYHKYPP 227
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           M  L    QND P L++                                  D   L+   
Sbjct: 228 MKVLMLTLQNDPPSLET-------------------------------GVQDKEMLKK-- 254
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR 495
           +  +F   +S CL K+P  RP++  LL H    + +
Sbjct: 255 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/65 (53%), Positives = 40/65 (61%), Gaps = 7/65 (10%)
Query: 623 GSASDIIE------VHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           GS  DII+       HK   L E  IA I   VL GL YLH  G+IHRDVKAGNILL E 
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED 152
Query: 676 GTVKL 680
           G+V++
Sbjct: 153 GSVQI 157

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  159 bits (402), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 112/360 (31%), Positives = 166/360 (46%), Gaps = 86/360 (23%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + D  DP    ++  +IG GS G V  A    S ++VA+KKM    +Q  E    +  E+
Sbjct: 143 VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEV 199
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQ 272
             +R  +H N +E    YL     W+VME+  G A +DI+                    
Sbjct: 200 VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-------------------- 239
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                          H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  G
Sbjct: 240 --------------THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 284
Query: 333 TVKLADFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            VKL+DFG     S + P     VGTPYWMAPE+I  +    Y  +VD+WSLGI  IE+ 
Sbjct: 285 RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMV 341
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
           + +PPYFN   + A+  I  N  P L+                     N++ +S      
Sbjct: 342 DGEPPYFNEPPLKAMKMIRDNLPPRLK---------------------NLHKVS------ 374
Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
               P L+          F+   L ++PA R ++  LL H  + +   P+ +V L+R+ +
Sbjct: 375 ----PSLKG---------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNR 421

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME+  G A   I  H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  
Sbjct: 225 VVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 283
Query: 676 GTVKL 680
           G VKL
Sbjct: 284 GRVKL 288

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 112/360 (31%), Positives = 166/360 (46%), Gaps = 86/360 (23%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + D  DP    ++  +IG GS G V  A    S ++VA+KKM    +Q  E    +  E+
Sbjct: 66  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEV 122
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQ 272
             +R  +H N +E    YL     W+VME+  G A +DI+                    
Sbjct: 123 VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-------------------- 162
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                          H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  G
Sbjct: 163 --------------THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 207
Query: 333 TVKLADFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            VKL+DFG     S + P     VGTPYWMAPE+I  +    Y  +VD+WSLGI  IE+ 
Sbjct: 208 RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMV 264
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
           + +PPYFN   + A+  I  N  P L+                     N++ +S      
Sbjct: 265 DGEPPYFNEPPLKAMKMIRDNLPPRLK---------------------NLHKVS------ 297
Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
               P L+          F+   L ++PA R ++  LL H  + +   P+ +V L+R+ +
Sbjct: 298 ----PSLKG---------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNR 344

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME+  G A   I  H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  
Sbjct: 148 VVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 206
Query: 676 GTVKL 680
           G VKL
Sbjct: 207 GRVKL 211

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  158 bits (399), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 112/360 (31%), Positives = 166/360 (46%), Gaps = 86/360 (23%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + D  DP    ++  +IG GS G V  A    S ++VA+KKM    +Q  E    +  E+
Sbjct: 21  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEV 77
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQ 272
             +R  +H N +E    YL     W+VME+  G A +DI+                    
Sbjct: 78  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-------------------- 117
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                          H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  G
Sbjct: 118 --------------THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 162
Query: 333 TVKLADFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            VKL+DFG     S + P     VGTPYWMAPE+I  +    Y  +VD+WSLGI  IE+ 
Sbjct: 163 RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMV 219
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
           + +PPYFN   + A+  I  N  P L+                     N++ +S      
Sbjct: 220 DGEPPYFNEPPLKAMKMIRDNLPPRLK---------------------NLHKVS------ 252
Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
               P L+          F+   L ++PA R ++  LL H  + +   P+ +V L+R+ +
Sbjct: 253 ----PSLKG---------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNR 299

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME+  G A   I  H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  
Sbjct: 103 VVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 161
Query: 676 GTVKL 680
           G VKL
Sbjct: 162 GRVKL 166

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  158 bits (399), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 112/360 (31%), Positives = 166/360 (46%), Gaps = 86/360 (23%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + D  DP    ++  +IG GS G V  A    S ++VA+KKM    +Q  E    +  E+
Sbjct: 23  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEV 79
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQ 272
             +R  +H N +E    YL     W+VME+  G A +DI+                    
Sbjct: 80  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-------------------- 119
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                          H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  G
Sbjct: 120 --------------THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 164
Query: 333 TVKLADFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            VKL+DFG     S + P     VGTPYWMAPE+I  +    Y  +VD+WSLGI  IE+ 
Sbjct: 165 RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMV 221
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
           + +PPYFN   + A+  I  N  P L+                     N++ +S      
Sbjct: 222 DGEPPYFNEPPLKAMKMIRDNLPPRLK---------------------NLHKVS------ 254
Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
               P L+          F+   L ++PA R ++  LL H  + +   P+ +V L+R+ +
Sbjct: 255 ----PSLKG---------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNR 301

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME+  G A   I  H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  
Sbjct: 105 VVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 163
Query: 676 GTVKL 680
           G VKL
Sbjct: 164 GRVKL 168

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  157 bits (398), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 112/360 (31%), Positives = 166/360 (46%), Gaps = 86/360 (23%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + D  DP    ++  +IG GS G V  A    S ++VA+KKM    +Q  E    +  E+
Sbjct: 12  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEV 68
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQ 272
             +R  +H N +E    YL     W+VME+  G A +DI+                    
Sbjct: 69  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-------------------- 108
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                          H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  G
Sbjct: 109 --------------THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 153
Query: 333 TVKLADFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            VKL+DFG     S + P     VGTPYWMAPE+I  +    Y  +VD+WSLGI  IE+ 
Sbjct: 154 RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMV 210
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
           + +PPYFN   + A+  I  N  P L+                     N++ +S      
Sbjct: 211 DGEPPYFNEPPLKAMKMIRDNLPPRLK---------------------NLHKVS------ 243
Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
               P L+          F+   L ++PA R ++  LL H  + +   P+ +V L+R+ +
Sbjct: 244 ----PSLKG---------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNR 290

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME+  G A   I  H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  
Sbjct: 94  VVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 152
Query: 676 GTVKL 680
           G VKL
Sbjct: 153 GRVKL 157

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  157 bits (398), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 112/360 (31%), Positives = 166/360 (46%), Gaps = 86/360 (23%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + D  DP    ++  +IG GS G V  A    S ++VA+KKM    +Q  E    +  E+
Sbjct: 16  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEV 72
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQ 272
             +R  +H N +E    YL     W+VME+  G A +DI+                    
Sbjct: 73  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-------------------- 112
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                          H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  G
Sbjct: 113 --------------THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 157
Query: 333 TVKLADFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            VKL+DFG     S + P     VGTPYWMAPE+I  +    Y  +VD+WSLGI  IE+ 
Sbjct: 158 RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMV 214
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
           + +PPYFN   + A+  I  N  P L+                     N++ +S      
Sbjct: 215 DGEPPYFNEPPLKAMKMIRDNLPPRLK---------------------NLHKVS------ 247
Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
               P L+          F+   L ++PA R ++  LL H  + +   P+ +V L+R+ +
Sbjct: 248 ----PSLKG---------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNR 294

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME+  G A   I  H R + EE+IAA+C  VL+ L+ LH+ G IHRD+K+ +ILLT  
Sbjct: 98  VVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 156
Query: 676 GTVKL 680
           G VKL
Sbjct: 157 GRVKL 161

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 108/357 (30%), Positives = 157/357 (43%), Gaps = 86/357 (24%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + D+ DP  + +   +IG GS G V  AR   S   VA+K M    +Q  E    +  E+
Sbjct: 37  VVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---LFNEV 93
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQ 272
             +R  +H N +E    YL     W++ME+  G A +DI                     
Sbjct: 94  VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI--------------------- 132
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                         V +  L EE+IA +C  VL+ L YLH+ G IHRD+K+ +ILLT  G
Sbjct: 133 --------------VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178
Query: 333 TVKLADFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            VKL+DFG     S   P     VGTPYWMAPEVI       Y  +VD+WSLGI  IE+ 
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI---SRSLYATEVDIWSLGIMVIEMV 235
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
           + +PPYF+ + + A+  +  +  P L++S                               
Sbjct: 236 DGEPPYFSDSPVQAMKRLRDSPPPKLKNS------------------------------- 264
Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIR 505
              +P L+          F+   L ++P +R ++  LL H  + +   P  LV LI+
Sbjct: 265 HKVSPVLRD---------FLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQ 312

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/66 (50%), Positives = 45/66 (68%), Gaps = 3/66 (4%)
Query: 616 LVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ME+  G A +DI  V +  L EE+IA +C  VL+ L YLH+ G IHRD+K+ +ILLT 
Sbjct: 119 VLMEFLQGGALTDI--VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL 176
Query: 675 TGTVKL 680
            G VKL
Sbjct: 177 DGRVKL 182

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  142 bits (357), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 106/355 (29%), Positives = 156/355 (43%), Gaps = 86/355 (24%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP +   +  +IG GS G V  A    + + VA+KKM    +Q  E    +  E+  +R 
Sbjct: 42  DPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRD 98
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             H N ++    YL     W+VME+  G A +DI+                         
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV------------------------- 133
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                     H R + EE+IA +C  VLR L+YLH+ G IHRD+K+ +ILLT  G +KL+
Sbjct: 134 ---------THTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLS 183
Query: 338 DFG---SASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG     S + P     VGTPYWMAPEVI  +    Y  +VD+WSLGI  IE+ + +PP
Sbjct: 184 DFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP---YGTEVDIWSLGIMVIEMIDGEPP 240
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           YFN   + A+  I  +  P ++                            L+ +      
Sbjct: 241 YFNEPPLQAMRRIRDSLPPRVKD---------------------------LHKV------ 267
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
                  S     F+   L + P+ R ++  LL H  +     PS +V L+R+ +
Sbjct: 268 -------SSVLRGFLDLMLVREPSQRATAQELLGHPFLKLAGPPSCIVPLMRQYR 315

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME+  G A   I  H R + EE+IA +C  VLR L+YLH+ G IHRD+K+ +ILLT  
Sbjct: 119 VVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 177
Query: 676 GTVKL 680
           G +KL
Sbjct: 178 GRIKL 182

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  132 bits (333), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 143/307 (46%), Gaps = 50/307 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F   ++IG G F  VY A CL+    VA+KK+       A+  AD +KEI  L+QL HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+Y   ++ D+   +V+E  L  A D+  +                           + 
Sbjct: 94  VIKYYASFIEDNELNIVLE--LADAGDLSRM---------------------------IK 124
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
           +F+  KR + E  +      +   L ++HS   +HRD+K  N+ +T TG VKL D G   
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184
Query: 341 -SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF--NM 397
             +S    A+S VGTPY+M+PE I    E  Y+ K D+WSLG    E+A  + P++   M
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERI---HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241
Query: 398 NAMSALYHIAQNDTPCLQSSDWS------VIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           N  S    I Q D P L S  +S      V   I+   E++P       ++ +Y +A+  
Sbjct: 242 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP------DVTYVYDVAKRM 295
Query: 452 TPCLQSS 458
             C  SS
Sbjct: 296 HACTASS 302

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 103/376 (27%), Positives = 158/376 (42%), Gaps = 83/376 (22%)
Query: 164 FEDLREIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK-EIRFLRQLK 220
           +E L  IG G      V  AR   + E V +++++   + C+ +    L+ E+   +   
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFN 68
Query: 221 HPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           HPN + YR  ++ D+  W+V  +   GSA D+I  H+++      GM             
Sbjct: 69  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD------GM------------- 109
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA-- 337
                         E  IA I  GVL+ L+Y+H +G +HR VKA +IL++  G V L+  
Sbjct: 110 -------------NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 156
Query: 338 -----------------DFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
                            DF   S+K           W++PEV+    +G YD K D++S+
Sbjct: 157 RSNLSMISHGQRQRVVHDFPKYSVKVLP--------WLSPEVLQQNLQG-YDAKSDIYSV 207
Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GIT  ELA    P+ +M A   L        PCL  +     + ++ +  R        A
Sbjct: 208 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV------A 261
Query: 441 MSALYHIAQNDTPCLQSSD---------WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
            S L       TP   + D         +S  F HFV  CL +NP  RPS+  LL H   
Sbjct: 262 NSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 321
Query: 492 --TRPRSPSVLVDLIR 505
              + R+   L +L+R
Sbjct: 322 KQIKRRASEALPELLR 337

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/59 (45%), Positives = 37/59 (62%), Gaps = 1/59 (1%)
Query: 623 GSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           GSA D+I  H    + E  IA I  GVL+ L+Y+H +G +HR VKA +IL++  G V L
Sbjct: 95  GSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 153

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 103/376 (27%), Positives = 158/376 (42%), Gaps = 83/376 (22%)
Query: 164 FEDLREIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK-EIRFLRQLK 220
           +E L  IG G      V  AR   + E V +++++   + C+ +    L+ E+   +   
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFN 84
Query: 221 HPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           HPN + YR  ++ D+  W+V  +   GSA D+I  H+++      GM             
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD------GM------------- 125
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA-- 337
                         E  IA I  GVL+ L+Y+H +G +HR VKA +IL++  G V L+  
Sbjct: 126 -------------NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172
Query: 338 -----------------DFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
                            DF   S+K           W++PEV+    +G YD K D++S+
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLP--------WLSPEVLQQNLQG-YDAKSDIYSV 223
Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GIT  ELA    P+ +M A   L        PCL  +     + ++ +  R        A
Sbjct: 224 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV------A 277
Query: 441 MSALYHIAQNDTPCLQSSD---------WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
            S L       TP   + D         +S  F HFV  CL +NP  RPS+  LL H   
Sbjct: 278 NSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337
Query: 492 --TRPRSPSVLVDLIR 505
              + R+   L +L+R
Sbjct: 338 KQIKRRASEALPELLR 353

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/59 (45%), Positives = 37/59 (62%), Gaps = 1/59 (1%)
Query: 623 GSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           GSA D+I  H    + E  IA I  GVL+ L+Y+H +G +HR VKA +IL++  G V L
Sbjct: 111 GSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 169

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 95/351 (27%), Positives = 158/351 (45%), Gaps = 53/351 (15%)
Query: 150 EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI 209
           ++ EL D +     FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I
Sbjct: 61  KVGELKDDD-----FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQI 113
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
           ++E++ L +   P  + + G +  D    + ME+  G + D                   
Sbjct: 114 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD------------------- 154
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILL 328
            Q LK                 + E+ +  +   V++GL YL    +I HRDVK  NIL+
Sbjct: 155 -QVLKKAGR-------------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 200
Query: 329 TETGTVKLADFGSAS--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
              G +KL DFG +   I   ANSFVGT  +M+PE +       Y  + D+WS+G++ +E
Sbjct: 201 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVE 257
Query: 387 LA-ERKP-PYFNMNAMSALYHI-AQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMS 442
           +A  R P P  +   +  ++    + D         +  + +SS   + +PP   M    
Sbjct: 258 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP---MAIFE 314
Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
            L +I     P L S+ +S  F  FV+ CL KNPA+R    +L+ H  + R
Sbjct: 315 LLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 365

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/337 (27%), Positives = 151/337 (44%), Gaps = 48/337 (14%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 96
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                   + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 97  ----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP-PYFNMN 398
              I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +E+A  R P P  +  
Sbjct: 153 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 399 AMSALYHI-AQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +  ++    + D         +  + +SS   + +PP   M     L +I     P L 
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP---MAIFELLDYIVNEPPPKLP 266
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
           S  +S  F  FV+ CL KNPA+R    +L+ H  + R
Sbjct: 267 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/337 (27%), Positives = 151/337 (44%), Gaps = 48/337 (14%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 96
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                   + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 97  ----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP-PYFNMN 398
              I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +E+A  R P P  +  
Sbjct: 153 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 399 AMSALYHI-AQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +  ++    + D         +  + +SS   + +PP   M     L +I     P L 
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP---MAIFELLDYIVNEPPPKLP 266
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
           S  +S  F  FV+ CL KNPA+R    +L+ H  + R
Sbjct: 267 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 93/343 (27%), Positives = 153/343 (44%), Gaps = 48/343 (13%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 96
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                   + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 97  ----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP-PYFNMN 398
              I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +E+A  R P P  +  
Sbjct: 153 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 399 AMSALYHI-AQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +  ++    + D         +  + +SS   + +PP   M     L +I     P L 
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP---MAIFELLDYIVNEPPPKLP 266
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
           S  +S  F  FV+ CL KNPA+R    +L+ H  + R  +  V
Sbjct: 267 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 93/343 (27%), Positives = 153/343 (44%), Gaps = 48/343 (13%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 96
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                   + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 97  ----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP-PYFNMN 398
              I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +E+A  R P P  +  
Sbjct: 153 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 399 AMSALYHI-AQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +  ++    + D         +  + +SS   + +PP   M     L +I     P L 
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP---MAIFELLDYIVNEPPPKLP 266
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
           S  +S  F  FV+ CL KNPA+R    +L+ H  + R  +  V
Sbjct: 267 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 145/333 (43%), Gaps = 60/333 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKK-MSYLGKQCAEKWADILKEIRFLRQLKHP 222
           +E + +IG GS+G V+  R   + +IVAIKK +        +K A  L+EIR L+QLKHP
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHP 62
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +     + R     LV EYC                                 +H  L
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC---------------------------------DHTVL 89
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
              + ++R + E  + +I    L+ +N+ H    IHRDVK  NIL+T+   +KL DFG A
Sbjct: 90  HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA 149
Query: 343 SIKC-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
            +   P++ +   V T ++ +PE+++   + QY   VDVW++G    EL    P +   +
Sbjct: 150 RLLTGPSDYYDDEVATRWYRSPELLVG--DTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207
Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI--AQNDTPC-L 455
            +  LY I                KT+     R    F+ N   +   I   ++  P  L
Sbjct: 208 DVDQLYLIR---------------KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL 252
Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           +  + S      +  CL  +P +R +  +LL H
Sbjct: 253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/66 (34%), Positives = 37/66 (56%)
Query: 615 QLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
            LV EYC  +    ++ ++R + E  + +I    L+ +N+ H    IHRDVK  NIL+T+
Sbjct: 78  HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK 137
Query: 675 TGTVKL 680
              +KL
Sbjct: 138 HSVIKL 143

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 99/354 (27%), Positives = 154/354 (43%), Gaps = 55/354 (15%)
Query: 150 EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI 209
           ++ EL D +     FE + E+G G+ G V   +   S  I+A +K+ +L  + A +   I
Sbjct: 9   KVGELKDDD-----FERISELGAGNGGVVTKVQHRPSGLIMA-RKLIHLEIKPAIR-NQI 61
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
           ++E++ L +   P  + + G +  D    + ME+  G + D                   
Sbjct: 62  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD------------------- 102
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILL 328
            Q LK           E  + P  EE +  +   VLRGL YL    +I HRDVK  NIL+
Sbjct: 103 -QVLK-----------EAKRIP--EEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 148
Query: 329 TETGTVKLADFGSAS--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
              G +KL DFG +   I   ANSFVGT  +MAPE    +    Y  + D+WS+G++ +E
Sbjct: 149 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPE---RLQGTHYSVQSDIWSMGLSLVE 205
Query: 387 LA-ERKP-PYFNMNAMSALYHIA-----QNDTPCLQSSDWSVIKTISSTAERKPPYFNMN 439
           LA  R P P  +   + A++        + +   +        + +S       P   M 
Sbjct: 206 LAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRP--AMA 263
Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
               L +I     P L +  ++  F  FV+ CL KNPA+R     L  H  + R
Sbjct: 264 IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFIKR 317

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 1/66 (1%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTE 674
           + ME+  G + D +    + + EE +  +   VLRGL YL    +I HRDVK  NIL+  
Sbjct: 91  ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS 150
Query: 675 TGTVKL 680
            G +KL
Sbjct: 151 RGEIKL 156

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 141/333 (42%), Gaps = 72/333 (21%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLKKAGR----- 100
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                   + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 101 --------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
              I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +E+A  + P       
Sbjct: 153 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYP------- 202
Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
                                I    +  + +PP   M     L +I     P L S  +
Sbjct: 203 ---------------------IPPPDAKEDSRPP---MAIFELLDYIVNEPPPKLPSGVF 238
Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
           S  F  FV+ CL KNPA+R    +L+ H  + R
Sbjct: 239 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 92/343 (26%), Positives = 154/343 (44%), Gaps = 48/343 (13%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 92
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 123
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
             +  + P  E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 124 --KAGRIP--EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP-PYFNMN 398
              I   ANSFVGT  +M+PE +       Y  + D+WS+G++ +E+A  R P P  +  
Sbjct: 180 GQLIDSMANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 399 AMSALYHI-AQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +  ++    + D         +  + ++    + +PP   M     L +I     P L 
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP---MAIFELLDYIVNEPPPKLP 293
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
           S  +S  F  FV+ CL KNPA+R    +L+ H  + R  +  V
Sbjct: 294 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 137/296 (46%), Gaps = 52/296 (17%)
Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           G L  PE  E F K         + +IG G++G VY AR  ++ E+VA+KK+  L  +  
Sbjct: 1   GPLGSPEFMENFQK---------VEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETE 50
Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
              +  ++EI  L++L HPN ++       ++  +LV E+          +H        
Sbjct: 51  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF----------LH-------- 92
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                  Q LK F +  AL    +   PL    I +    +L+GL + HS   +HRD+K 
Sbjct: 93  -------QDLKKFMDASALTGIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 324 GNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWS 379
            N+L+   G +KLADFG A +   P  ++   V T ++ APE++L      Y   VD+WS
Sbjct: 139 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK--YYSTAVDIWS 196
Query: 380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           LG    E+  R+  +   + +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 197 LGCIFAEMVTRRALFPGDSEIDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 248

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 46/247 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G++G VY  R L ++  +AIK++     + ++    + +EI   + LKH N ++Y G
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP---LHEEIALHKHLKHKNIVQYLG 86
Query: 230 CYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
            +  +    + ME   G S S ++   W                                
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKW-------------------------------- 114
Query: 289 KRPLKEEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGS---- 341
             PLK+ E  I      +L GL YLH    +HRD+K  N+L+ T +G +K++DFG+    
Sbjct: 115 -GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 342 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA-M 400
           A I     +F GT  +MAPE+I     G Y    D+WSLG T IE+A  KPP++ +    
Sbjct: 174 AGINPCTETFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232
Query: 401 SALYHIA 407
           +A++ + 
Sbjct: 233 AAMFKVG 239

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 137/296 (46%), Gaps = 52/296 (17%)
Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           G L  PE  E F K         + +IG G++G VY AR  ++ E+VA+KK+  L  +  
Sbjct: 1   GPLGSPEFMENFQK---------VEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETE 50
Query: 204 EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV 263
              +  ++EI  L++L HPN ++       ++  +LV E+          +H        
Sbjct: 51  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF----------LH-------- 92
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                  Q LK F +  AL    +   PL    I +    +L+GL + HS   +HRD+K 
Sbjct: 93  -------QDLKKFMDASALTGIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 324 GNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWS 379
            N+L+   G +KLADFG A +   P  ++   V T ++ APE++L      Y   VD+WS
Sbjct: 139 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWS 196
Query: 380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           LG    E+  R+  +   + +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 197 LGCIFAEMVTRRALFPGDSEIDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 248

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          VH               Q LK F +  AL 
Sbjct: 63  IVKLLDVIHTENKLYLVFEH----------VH---------------QDLKTFMDASALT 97
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 98  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 151 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 209 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 240

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 66
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 67  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKTFMDASALT 101
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 102 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 213 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 244

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 66
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E                   HV+      Q LK F +  AL 
Sbjct: 67  IVKLLDVIHTENKLYLVFE-------------------HVD------QDLKKFMDASALT 101
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 102 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 213 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 244

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL++ HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 87/335 (25%), Positives = 141/335 (42%), Gaps = 60/335 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKK-MSYLGKQCAEKWADILKEIRFLRQLKHP 222
           +E+L  +G GS+G V   R   +  IVAIKK +     +  +K A  ++EI+ L+QL+H 
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLRHE 84
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +       +    +LV E                                 F +H  L
Sbjct: 85  NLVNLLEVCKKKKRWYLVFE---------------------------------FVDHTIL 111
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
            + E+    L  + +      ++ G+ + HS   IHRD+K  NIL++++G VKL DFG A
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
Query: 343 -SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
            ++  P   +   V T ++ APE+++   + +Y   VDVW++G    E+   +P +   +
Sbjct: 172 RTLAAPGEVYDDEVATRWYRAPELLVG--DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA---LYHIAQNDTPCL 455
            +  LYHI      CL            +   R    FN N + A   L  I + +    
Sbjct: 230 DIDQLYHIMM----CL-----------GNLIPRHQELFNKNPVFAGVRLPEIKEREPLER 274
Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDL 490
           +    S+        CL  +P  RP    LL HD 
Sbjct: 275 RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYTHEVVTLWYRAPEILLGXK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 90/353 (25%), Positives = 150/353 (42%), Gaps = 83/353 (23%)
Query: 150 EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI 209
           ++ EL D +     FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I
Sbjct: 18  KVGELKDDD-----FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQI 70
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
           ++E++ L +   P  + + G +  D    + ME+  G + D                   
Sbjct: 71  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD------------------- 111
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILL 328
            Q LK           +  + P  E+ +  +   V++GL YL    +I HRDVK  NIL+
Sbjct: 112 -QVLK-----------KAGRIP--EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 157
Query: 329 TETGTVKLADFGSAS--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
              G +KL DFG +   I   ANSFVGT  +M+PE    +    Y  + D+WS+G++ +E
Sbjct: 158 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVE 214
Query: 387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH 446
           +A  + P  + +   A++ +                                     L +
Sbjct: 215 MAVGRYPIGSGSGSMAIFEL-------------------------------------LDY 237
Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
           I     P L S  +S  F  FV+ CL KNPA+R    +L+ H  + R  +  V
Sbjct: 238 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 45/241 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G++G VY  R L ++  +AIK++     + ++    + +EI   + LKH N ++Y G
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP---LHEEIALHKHLKHKNIVQYLG 72
Query: 230 CYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
            +  +    + ME   G S S ++   W                                
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKW-------------------------------- 100
Query: 289 KRPLKEEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGS---- 341
             PLK+ E  I      +L GL YLH    +HRD+K  N+L+ T +G +K++DFG+    
Sbjct: 101 -GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 159
Query: 342 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
           A I     +F GT  +MAPE+I     G Y    D+WSLG T IE+A  KPP++ +    
Sbjct: 160 AGINPCTETFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQ 218
Query: 402 A 402
           A
Sbjct: 219 A 219

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 67
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 68  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 102
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 103 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 156 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 213
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 214 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 245

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 66  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 100
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 101 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 154 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 211
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 212 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 243

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 96  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 132
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 133 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 179
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 180 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 234
Query: 398 NAMSALY 404
           N     Y
Sbjct: 235 NTYQETY 241

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 66
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 67  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 101
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 102 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 213 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 244

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 64
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 99
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 100 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 153 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 210
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 211 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 242

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 67
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 68  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 102
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 103 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 156 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 213
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 214 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 245

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 66  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 100
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 101 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 153
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 154 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 211
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 212 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 243

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 64
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 99
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 100 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 152
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 153 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 210
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 211 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 242

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 97
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 98  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 151 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 209 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 240

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 64
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 99
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 100 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 153 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 210
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 211 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 242

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 66
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 67  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 101
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 102 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 213 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 244

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 66  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 100
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 101 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 154 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 211
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 212 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 243

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 64
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 99
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 100 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 153 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 210
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 211 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 242

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 97
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 98  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 151 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 209 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 240

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 97
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 98  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 151 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 209 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 240

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 97
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 98  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 151 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 209 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 240

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 96  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 132
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 133 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 179
Query: 342 ASIKCPA---NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P+   +   GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 180 WSVHAPSSRRDDLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 234
Query: 398 NAMSALY 404
           N     Y
Sbjct: 235 NTYQETY 241

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 87  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 123
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 124 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 170
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 171 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 225
Query: 398 NAMSALY 404
           N     Y
Sbjct: 226 NTYQETY 232

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKDFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 71  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 107
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 108 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 154
Query: 342 ASIKCPA---NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P+   ++  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 155 WSVHAPSSRRDTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 209
Query: 398 NAMSALY 404
           N     Y
Sbjct: 210 NTYQETY 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 157/344 (45%), Gaps = 55/344 (15%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L++IG GSFG     +         IK+++ + +  +++  +  +E+  L  +KHPN ++
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           YR  +  + + ++VM+YC G                    G+  +++    +   LF   
Sbjct: 88  YRESFEENGSLYIVMDYCEG--------------------GDLFKRIN--AQKGVLF--- 122
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC 346
                 +E++I      +   L ++H    +HRD+K+ NI LT+ GTV+L DFG A +  
Sbjct: 123 ------QEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 347 P----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS- 401
                A + +GTPY+++PE+    +   Y+ K D+W+LG    EL   K   F   +M  
Sbjct: 177 STVELARACIGTPYYLSPEIC---ENKPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKN 232
Query: 402 -ALYHIAQNDTPCLQSSDWSVIKTISSTAERKP---PYFN--MNAMSALYHIAQNDTPCL 455
             L  I+ +  P      + +   +S   +R P   P  N  +        I +  +P L
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 456 QSSDWS-DTFAHFVSSCLAKNPADRPSSGR----LLTHDLVTRP 494
            + ++   TF+ F S  +   PA RP+SG+    ++    +T+P
Sbjct: 293 IAEEFCLKTFSKFGSQPI---PAKRPASGQNSISVMPAQKITKP 333

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L  IG GS+G     R     +I+  K++ Y     AEK   ++ E+  LR+LKHPN
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPN 66
Query: 224 TIEY--RGCYLRDHTAWLVMEYCLGS--ASDII----EVHWIEREFHVEGMGNRLQQLKC 275
            + Y  R     + T ++VMEYC G   AS I     E  +++ EF +  M      LK 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK- 125
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                     E H+R                  +  H++  +HRD+K  N+ L     VK
Sbjct: 126 ----------ECHRRS-----------------DGGHTV--LHRDLKPANVFLDGKQNVK 156
Query: 336 LADFGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           L DFG A I       A +FVGTPY+M+PE    M+   Y+ K D+WSLG    EL    
Sbjct: 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPE---QMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 392 PPY 394
           PP+
Sbjct: 214 PPF 216

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 73  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 109
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 110 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 156
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 157 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 211
Query: 398 NAMSALY 404
           N     Y
Sbjct: 212 NTYQETY 218

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 44/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGT---------VYRE---------LQKLSKFD----- 106
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 107 -----------EQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFG-W 154
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
           S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP+
Sbjct: 155 SVHAPSSRRAALCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 75  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 111
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 112 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 158
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 159 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 213
Query: 398 NAMSALY 404
           N     Y
Sbjct: 214 NTYQETY 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 70  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 106
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 107 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 153
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 154 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 208
Query: 398 NAMSALY 404
           N     Y
Sbjct: 209 NTYQETY 215

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L  IG GS+G     R     +I+  K++ Y     AEK   ++ E+  LR+LKHPN
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPN 66
Query: 224 TIEY--RGCYLRDHTAWLVMEYCLGS--ASDII----EVHWIEREFHVEGMGNRLQQLKC 275
            + Y  R     + T ++VMEYC G   AS I     E  +++ EF +  M      LK 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK- 125
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                     E H+R                  +  H++  +HRD+K  N+ L     VK
Sbjct: 126 ----------ECHRRS-----------------DGGHTV--LHRDLKPANVFLDGKQNVK 156
Query: 336 LADFGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           L DFG A I       A +FVGTPY+M+PE    M+   Y+ K D+WSLG    EL    
Sbjct: 157 LGDFGLARILNHDTSFAKAFVGTPYYMSPE---QMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 392 PPY 394
           PP+
Sbjct: 214 PPF 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/334 (24%), Positives = 135/334 (40%), Gaps = 76/334 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
            E + E+G G++G V   R + S +I+A+K++        +K   +  +I  +R +  P 
Sbjct: 53  LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPF 111
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
           T+ + G   R+   W+ ME  + ++ D      I++                        
Sbjct: 112 TVTFYGALFREGDVWICME-LMDTSLDKFYKQVIDK------------------------ 146
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFGSA 342
                 + + E+ +  I   +++ L +LHS L  IHRDVK  N+L+   G VK+ DFG +
Sbjct: 147 -----GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201
Query: 343 S--IKCPANSF-VGTPYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
              +   A +   G   +MAPE I   +++  Y  K D+WSLGIT IELA  + PY    
Sbjct: 202 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY---- 257
Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
                               W                        L  + +  +P L + 
Sbjct: 258 ------------------DSWG------------------TPFQQLKQVVEEPSPQLPAD 281
Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
            +S  F  F S CL KN  +RP+   L+ H   T
Sbjct: 282 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 315

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/246 (31%), Positives = 115/246 (46%), Gaps = 45/246 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKF------ 109
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 110 ----------DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-W 158
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMN 398
           S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  N
Sbjct: 159 SVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEAN 213
Query: 399 AMSALY 404
                Y
Sbjct: 214 TYQETY 219

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 73  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 109
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 110 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 156
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 157 WSVHAPSSRRAALCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 211
Query: 398 NAMSALY 404
           N     Y
Sbjct: 212 NTYQETY 218

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/246 (31%), Positives = 115/246 (46%), Gaps = 45/246 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD----- 109
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 110 -----------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-W 157
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMN 398
           S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  N
Sbjct: 158 SVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEAN 212
Query: 399 AMSALY 404
                Y
Sbjct: 213 TYQETY 218

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/246 (31%), Positives = 115/246 (46%), Gaps = 45/246 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD----- 105
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 106 -----------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-W 153
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMN 398
           S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  N
Sbjct: 154 SVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEAN 208
Query: 399 AMSALY 404
                Y
Sbjct: 209 TYQETY 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 75  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 111
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 112 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 158
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 159 WSVHAPSSRRTTLCGTLDYLPPEXI----EGRXHDEKVDLWSLGVLCYEFLVGKPP-FEA 213
Query: 398 NAMSALY 404
           N     Y
Sbjct: 214 NTYQETY 220

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/333 (25%), Positives = 138/333 (41%), Gaps = 82/333 (24%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A +K+ +L  + A +   I++E++ L +   P 
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIR-NQIIRELQVLHECNSPY 68
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G + D                    Q LK         
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLD--------------------QVLK--------- 99
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                   + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 100 ----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 155
Query: 343 S--IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
              I   AN FVGT  +M+PE    +    Y  + D+WS+G++ +E+A  + P       
Sbjct: 156 GQLIDEMANEFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYP------- 205
Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
                                          +PP   M     L +I     P L S+ +
Sbjct: 206 -------------------------------RPP---MAIFELLDYIVNEPPPKLPSAVF 231
Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
           S  F  FV+ CL KNPA+R    +L+ H  + R
Sbjct: 232 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 264

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/246 (31%), Positives = 114/246 (46%), Gaps = 45/246 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD----- 109
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 110 -----------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-W 157
Query: 343 SIKCPA---NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMN 398
           S+  P+   +   GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  N
Sbjct: 158 SVHAPSSRRDDLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEAN 212
Query: 399 AMSALY 404
                Y
Sbjct: 213 TYQETY 218

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 70  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 106
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 107 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 153
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 154 WSVHAPSSRRAALCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 208
Query: 398 NAMSALY 404
           N     Y
Sbjct: 209 NTYQETY 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 71  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 107
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 108 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 154
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 209
Query: 398 NAMSALY 404
           N     Y
Sbjct: 210 NTYQETY 216

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 75  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 111
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 112 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 158
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 159 WSVHAPSSRRTDLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 213
Query: 398 NAMSALY 404
           N     Y
Sbjct: 214 NTYQETY 220

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 70  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 106
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 107 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 153
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 154 WSVHAPSSRRTELCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 208
Query: 398 NAMSALY 404
           N     Y
Sbjct: 209 NTYQETY 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 72  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 108
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 109 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 155
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 156 WSVHAPSSRRXXLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 210
Query: 398 NAMSALY 404
           N     Y
Sbjct: 211 NTYQETY 217

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 70  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 106
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 107 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 153
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 154 WSVHAPSSRRTDLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 208
Query: 398 NAMSALY 404
           N     Y
Sbjct: 209 NTYQETY 215

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 70  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 106
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 107 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 153
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 154 WSVHAPSSRRTDLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 208
Query: 398 NAMSALY 404
           N     Y
Sbjct: 209 NTYQETY 215

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+ K+  L  +     +  ++EI  L++L HPN
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHPN 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 98
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 99  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 152 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 210 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 241

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+ K+  L  +     +  ++EI  L++L HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHPN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+          +H               Q LK F +  AL 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF----------LH---------------QDLKKFMDASALT 97
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 98  GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 151 AFGVPVRTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 209 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 240

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L  IG GS+G     R     +I+  K++ Y     AEK   ++ E+  LR+LKHPN
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPN 66
Query: 224 TIEY--RGCYLRDHTAWLVMEYCLGS--ASDII----EVHWIEREFHVEGMGNRLQQLKC 275
            + Y  R     + T ++VMEYC G   AS I     E  +++ EF +  M      LK 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK- 125
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                     E H+R                  +  H++  +HRD+K  N+ L     VK
Sbjct: 126 ----------ECHRRS-----------------DGGHTV--LHRDLKPANVFLDGKQNVK 156
Query: 336 LADFGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           L DFG A I    +  A  FVGTPY+M+PE    M+   Y+ K D+WSLG    EL    
Sbjct: 157 LGDFGLARILNHDEDFAKEFVGTPYYMSPE---QMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 392 PPY 394
           PP+
Sbjct: 214 PPF 216

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 70  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 106
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 107 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 153
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 154 WSVHAPSSRRTXLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 208
Query: 398 NAMSALY 404
           N     Y
Sbjct: 209 NTYQETY 215

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 73  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 109
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 110 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 156
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 157 WSVHAPSSRRXXLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 211
Query: 398 NAMSALY 404
           N     Y
Sbjct: 212 NTYQETY 218

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 66
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+      D ++   +         G  L  +K +     LF
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALT--------GIPLPLIKSY-----LF 113
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                               +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 114 Q-------------------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 213 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 244

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/246 (31%), Positives = 114/246 (46%), Gaps = 45/246 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD----- 106
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 107 -----------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-W 154
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMN 398
           S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  N
Sbjct: 155 SVHAPSSRRXXLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEAN 209
Query: 399 AMSALY 404
                Y
Sbjct: 210 TYQETY 215

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 71  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 107
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 108 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 154
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S   P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 155 WSCHAPSSRRTTLSGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 209
Query: 398 NAMSALY 404
           N     Y
Sbjct: 210 NTYQETY 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+      D ++   +         G  L  +K +     LF
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALT--------GIPLPLIKSY-----LF 112
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                               +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 113 Q-------------------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 154 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 211
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 212 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 243

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 72  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 108
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+A+FG 
Sbjct: 109 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG- 155
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 156 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 210
Query: 398 NAMSALY 404
           N     Y
Sbjct: 211 NTYQETY 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 66
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+                             LK F +  AL 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLS-------------------------MDLKKFMDASALT 101
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 102 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 154
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 213 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 244

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/247 (32%), Positives = 117/247 (47%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 73  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKFD---- 109
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+A+FG 
Sbjct: 110 ------------EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG- 156
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 157 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 211
Query: 398 NAMSALY 404
           N     Y
Sbjct: 212 NTYQETY 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/334 (24%), Positives = 133/334 (39%), Gaps = 76/334 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
            E + E+G G++G V   R + S +I+A+K++        +K   +  +I  +R +  P 
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPF 67
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
           T+ + G   R+   W+ ME  + ++ D      I++                        
Sbjct: 68  TVTFYGALFREGDVWICME-LMDTSLDKFYKQVIDK------------------------ 102
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFGSA 342
                 + + E+ +  I   +++ L +LHS L  IHRDVK  N+L+   G VK+ DFG +
Sbjct: 103 -----GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157
Query: 343 SI---KCPANSFVGTPYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                    +   G   +MAPE I   +++  Y  K D+WSLGIT IELA  + PY    
Sbjct: 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY---- 213
Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
                               W                        L  + +  +P L + 
Sbjct: 214 ------------------DSWG------------------TPFQQLKQVVEEPSPQLPAD 237
Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
            +S  F  F S CL KN  +RP+   L+ H   T
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 43/276 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 64
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+                             LK F +  AL 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLS-------------------------MDLKKFMDASALT 99
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
              +   PL    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 100 GIPL---PL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 152
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P  ++   V T ++ APE++L      Y   VD+WSLG    E+  R+  +   + 
Sbjct: 153 AFGVPVRTYXHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSE 210
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           +  L+ I +     L + D  V   ++S  + KP +
Sbjct: 211 IDQLFRIFRT----LGTPDEVVWPGVTSMPDYKPSF 242

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 114/246 (46%), Gaps = 45/246 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 224 TIEYRGCYLRDHT-AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G Y  D T  +L++EY         EV+              LQ+L  F E    
Sbjct: 75  ILRLYG-YFHDATRVYLILEYAPRG-----EVY------------KELQKLSKFDE---- 112
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                       +  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 113 ------------QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-W 159
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMN 398
           S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  N
Sbjct: 160 SVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEAN 214
Query: 399 AMSALY 404
                Y
Sbjct: 215 TYQETY 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 99/357 (27%), Positives = 151/357 (42%), Gaps = 83/357 (23%)
Query: 144 GSLK-DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           G LK  PE    F  ED     +DL EIG G++G+V       S +I+A+K++     + 
Sbjct: 7   GKLKISPEQHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            +K   +  ++  +R    P  +++ G   R+   W+ ME  L S S             
Sbjct: 63  EQKQLLMDLDV-VMRSSDCPYIVQFYGALFREGDCWICME--LMSTS------------- 106
Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL-HSLGRIHRDV 321
                          + F  + + V    + EE +  I    ++ LN+L  +L  IHRD+
Sbjct: 107 --------------FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI 152
Query: 322 KAGNILLTETGTVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAMDEGQ-YDGKV 375
           K  NILL  +G +KL DFG +     SI    ++  G   +MAPE I      Q YD + 
Sbjct: 153 KPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRS 210
Query: 376 DVWSLGITCIELAERKPPYFNMNAM-SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPP 434
           DVWSLGIT  ELA  + PY   N++   L  + + D P L +S+           ER   
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE-----------ER--- 256
Query: 435 YFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                                   ++S +F +FV+ CL K+ + RP    LL H  +
Sbjct: 257 ------------------------EFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/247 (32%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR    + I+A+K +     + A     + +E+     L+HPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 224 TIEYRGCYLRDHT-AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            +   G Y  D T  +L++EY  LG+         + RE         LQ+L  F     
Sbjct: 67  ILRLYG-YFHDATRVYLILEYAPLGT---------VYRE---------LQKLSKF----- 102
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                       E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG 
Sbjct: 103 -----------DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG- 150
Query: 342 ASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNM 397
            S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  
Sbjct: 151 WSVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEA 205
Query: 398 NAMSALY 404
           N     Y
Sbjct: 206 NTYQETY 212

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 113/246 (45%), Gaps = 45/246 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 224 TIEYRGCYLRDHT-AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G Y  D T  +L++EY         EV+              LQ+L  F E    
Sbjct: 75  ILRLYG-YFHDATRVYLILEYAPRG-----EVY------------KELQKLSKFDE---- 112
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                       +  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 113 ------------QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-W 159
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFNMN 398
           S+  P++      GT  ++ PE+I    EG+ +D KVD+WSLG+ C E    KPP F  N
Sbjct: 160 SVHAPSSRRXXLXGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPP-FEAN 214
Query: 399 AMSALY 404
                Y
Sbjct: 215 TYQETY 220

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 110/238 (46%), Gaps = 44/238 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQ-CAEK--WADILKEIRFLRQL 219
           FE LR IG GSFG V    C+V + +   +  M Y+ KQ C E+    ++ KE++ ++ L
Sbjct: 17  FEILRAIGKGSFGKV----CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           +HP  +     +  +   ++V++  LG           +  +H       LQQ       
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGG----------DLRYH-------LQQ------- 108
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                  VH    KEE +      ++  L+YL +   IHRD+K  NILL E G V + DF
Sbjct: 109 ------NVH---FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDF 159
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
             A++   +    +  GT  +MAPE+  +     Y   VD WSLG+T  EL   + PY
Sbjct: 160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 43/235 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GSFG VY  +       VA+K +  +     E++     E+  LR+ +H N + + G
Sbjct: 44  IGSGSFGTVYKGKW---HGDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D+ A +V ++C GS+        + +  HV+               F +F      
Sbjct: 100 YMTKDNLA-IVTQWCEGSS--------LYKHLHVQ------------ETKFQMF------ 132
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--- 346
                 ++  I     +G++YLH+   IHRD+K+ NI L E  TVK+ DFG A++K    
Sbjct: 133 ------QLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186
Query: 347 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                    G+  WMAPEVI   D   +  + DV+S GI   EL   + PY ++N
Sbjct: 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 112/236 (47%), Gaps = 44/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGT---------VYRE---------LQKLSRF------ 109
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 110 ----------DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG-W 158
Query: 343 SIKCPA---NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
           S+  P+   ++  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E     PP+
Sbjct: 159 SVHAPSSRRDTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ IG GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +K+ADFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ IG GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG-----------------DMFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +K+ADFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ IG GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG-----------------DMFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +K+ADFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 112/236 (47%), Gaps = 44/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 224 TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +   G +      +L++EY  LG+         + RE         LQ+L  F      
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGT---------VYRE---------LQKLSRF------ 109
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG  
Sbjct: 110 ----------DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG-W 158
Query: 343 SIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
           S+  P++   +  GT  ++ PE+I    EG+ +D KVD+WSLG+ C E     PP+
Sbjct: 159 SVHAPSSRRTTLCGTLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 113/241 (46%), Gaps = 46/241 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLK- 220
           +E + EIG G++G VY AR   S   VA+K +             I  ++E+  LR+L+ 
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 221 --HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ-LKCFT 277
             HPN +              +M+ C  S +D        RE  V  +   + Q L+ + 
Sbjct: 71  FEHPNVVR-------------LMDVCATSRTD--------REIKVTLVFEHVDQDLRTYL 109
Query: 278 EHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           +          K P   L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTV
Sbjct: 110 D----------KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159
Query: 335 KLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           KLADFG A I   +      V T ++ APEV+L   +  Y   VD+WS+G    E+  RK
Sbjct: 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRK 216
Query: 392 P 392
           P
Sbjct: 217 P 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 29/45 (64%)
Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/239 (32%), Positives = 115/239 (48%), Gaps = 45/239 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--- 220
           +E + EIG G++G VY AR   S   VA+K +     +     + + +E+  LR+L+   
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEAFE 64
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ-LKCFTEH 279
           HPN +              +M+ C  S +D        RE  V  +   + Q L+ + + 
Sbjct: 65  HPNVVR-------------LMDVCATSRTD--------REIKVTLVFEHVDQDLRTYLD- 102
Query: 280 FALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                    K P   L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 103 ---------KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 153
Query: 337 ADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           ADFG A I   +   +  V T ++ APEV+L   +  Y   VD+WS+G    E+  RKP
Sbjct: 154 ADFGLARIYSYQMALDPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 29/45 (64%)
Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 153

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 110/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 6   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 61
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS+            +H             
Sbjct: 62  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSL-----------YH------------- 96
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
              H +   FE+ K       +  I     RG++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 97  -HLHASETKFEMKK-------LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 148
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D   Y  + DV++ GI   EL  
Sbjct: 149 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 208
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 209 GQLPYSNIN 217

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 40/70 (57%), Gaps = 3/70 (4%)
Query: 614 PQL--VMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
           PQL  V ++C GS+    +   +   + +++  I     RG++YLH+   IHRD+K+ NI
Sbjct: 80  PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 139
Query: 671 LLTETGTVKL 680
            L E  TVK+
Sbjct: 140 FLHEDNTVKI 149

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/239 (32%), Positives = 114/239 (47%), Gaps = 45/239 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--- 220
           +E + EIG G++G VY AR   S   VA+K +     +     + + +E+  LR+L+   
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEAFE 64
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ-LKCFTEH 279
           HPN +              +M+ C  S +D        RE  V  +   + Q L+ + + 
Sbjct: 65  HPNVVR-------------LMDVCATSRTD--------REIKVTLVFEHVDQDLRTYLD- 102
Query: 280 FALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                    K P   L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 103 ---------KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 153
Query: 337 ADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           ADFG A I   +      V T ++ APEV+L   +  Y   VD+WS+G    E+  RKP
Sbjct: 154 ADFGLARIYSYQMALAPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 29/45 (64%)
Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 153

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 62
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F              
Sbjct: 63  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 106
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 107 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 149
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 150 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 210 GQLPYSNIN 218

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 29  DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 84
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F              
Sbjct: 85  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 128
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 129 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 171
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 172 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 231
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 232 GQLPYSNIN 240

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 4   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 59
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F              
Sbjct: 60  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 103
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 104 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 146
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 147 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 206
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 207 GQLPYSNIN 215

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 85
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F              
Sbjct: 86  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 129
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 130 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 172
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 173 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 233 GQLPYSNIN 241

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 62
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F              
Sbjct: 63  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 106
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 107 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 149
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 150 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 210 GQLPYSNIN 218

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/239 (32%), Positives = 114/239 (47%), Gaps = 45/239 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--- 220
           +E + EIG G++G VY AR   S   VA+K +     +     + + +E+  LR+L+   
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEAFE 64
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ-LKCFTEH 279
           HPN +              +M+ C  S +D        RE  V  +   + Q L+ + + 
Sbjct: 65  HPNVVR-------------LMDVCATSRTD--------REIKVTLVFEHVDQDLRTYLD- 102
Query: 280 FALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                    K P   L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 103 ---------KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 153
Query: 337 ADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           ADFG A I   +      V T ++ APEV+L   +  Y   VD+WS+G    E+  RKP
Sbjct: 154 ADFGLARIYSYQMALFPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 29/45 (64%)
Query: 636 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           L  E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 153

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 57
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F +            
Sbjct: 58  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKFEMI----------- 104
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                               ++  I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 105 --------------------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 144
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 205 GQLPYSNIN 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 135/338 (39%), Gaps = 83/338 (24%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF-LRQLKHP 222
            E+L E+G G+ G V+  R   +  ++A+K+M   G +  E+   IL ++   L+    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCP 84
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             ++  G ++ +   ++ ME  +G+ +              E +  R+Q           
Sbjct: 85  YIVQCFGTFITNTDVFIAMEL-MGTCA--------------EKLKKRMQG---------- 119
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRDVKAGNILLTETGTVKLADFGS 341
                   P+ E  +  +   +++ L YL    G IHRDVK  NILL E G +KL DFG 
Sbjct: 120 --------PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 342 ASIKC---PANSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAERKPPYFN 396
           +         +   G   +MAPE I   D  +  YD + DVWSLGI+ +ELA  + PY N
Sbjct: 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 397 MNA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL 455
                  L  + Q + P L                               H+        
Sbjct: 232 CKTDFEVLTKVLQEEPPLLPG-----------------------------HMG------- 255
Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
               +S  F  FV  CL K+   RP   +LL H  + R
Sbjct: 256 ----FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K  +I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +K+ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 LAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/343 (25%), Positives = 136/343 (39%), Gaps = 86/343 (25%)
Query: 161 EKIFEDLRE---IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           EKI ED +    +G GSF  VY A  + +   VAIK +       A     +  E++   
Sbjct: 8   EKI-EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           QLKHP+ +E    +   +  +LV+E C                    G  NR  + +   
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHN------------------GEMNRYLKNRV-- 106
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                       +P  E E       ++ G+ YLHS G +HRD+   N+LLT    +K+A
Sbjct: 107 ------------KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIA 154
Query: 338 DFGSAS-IKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG A+ +K P     +  GTP +++PE+      G    + DVWSLG     L   +PP
Sbjct: 155 DFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL---ESDVWSLGCMFYTLLIGRPP 211
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           +               DT  ++++   V+                        +A  + P
Sbjct: 212 F---------------DTDTVKNTLNKVV------------------------LADYEMP 232
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS 496
              S +  D     +   L +NPADR S   +L H  ++R  S
Sbjct: 233 SFLSIEAKD----LIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 1/66 (1%)
Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LV+E C  G  +  ++   +P  E E       ++ G+ YLHS G +HRD+   N+LLT 
Sbjct: 88  LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR 147
Query: 675 TGTVKL 680
              +K+
Sbjct: 148 NMNIKI 153

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K    +  GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWTLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 108/249 (43%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++       ++      E+  
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS+            +H             
Sbjct: 74  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSL-----------YH------------- 108
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
              H +   FE+ K       +  I     RG++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 109 -HLHASETKFEMKK-------LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A+ K             G+  WMAPEVI   D   Y  + DV++ GI   EL  
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 221 GQLPYSNIN 229

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 40/70 (57%), Gaps = 3/70 (4%)
Query: 614 PQL--VMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
           PQL  V ++C GS+    +   +   + +++  I     RG++YLH+   IHRD+K+ NI
Sbjct: 92  PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151
Query: 671 LLTETGTVKL 680
            L E  TVK+
Sbjct: 152 FLHEDNTVKI 161

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +K+ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 128
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 129 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 172
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K    +  GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 173 FAKRVKGRTWTLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 110/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 57
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G       A +V ++C GS S    +H IE +F              
Sbjct: 58  LRKTRHVNILLFMGYSTAPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 101
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 102 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 144
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 205 GQLPYSNIN 213

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++ + VA+K +  + L     +K   + +E+R ++ L HPN 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNI 75
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +LVMEY  G                                   +F+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGE---------------------------------VFD 102
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V    +KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 103 YLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
               N   +F G+P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 163 FTFGNKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++ + VA+K +  + L     +K   + +E+R ++ L HPN 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNI 75
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +LVMEY  G                                   +F+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGE---------------------------------VFD 102
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V    +KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 103 YLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
               N   +F G+P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 163 FTFGNKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFXEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +K+ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 163
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 164 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K    +  GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 208 FAKRVKGATWTLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 46/226 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +++IG G+FG     R   S E+VA+K +   G++ A   A++ +EI   R L+HPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIER-GEKIA---ANVKREIINHRSLRHPN 76
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++   L      +VMEY  G                   +  R+     F+E  A F
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGE-----------------LFERICNAGRFSEDEARF 119
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFG- 340
            F+                 ++ G++Y H++   HRD+K  N LL  +    +K+ DFG 
Sbjct: 120 FFQ----------------QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 163
Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGIT 383
             S+ +     S VGTP ++APEV+L   + +YDGKV DVWS G+T
Sbjct: 164 SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDGKVADVWSCGVT 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K  +I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 LAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +K+ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE +R +G GSFG V   +    +E      M  L KQ   K   I   L E R  + + 
Sbjct: 44  FERIRTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++V+EY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +K+ADFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLAGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 110/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 85
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F              
Sbjct: 86  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 129
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 130 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 172
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A+ K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 173 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 233 GQLPYSNIN 241

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P   +    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +K+ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P   +    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +K+ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 110/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 22  DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 77
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F              
Sbjct: 78  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKF-------------- 121
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
             E   L +               I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 122 --EMIKLID---------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 164
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A+ K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 165 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 224
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 225 GQLPYSNIN 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFXEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFXEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 108/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++ + VA+K +  + L     +K   + +E+R ++ L HPN 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNI 75
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +LVMEY  G                                   +F+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGE---------------------------------VFD 102
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V    +KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 103 YLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
               N   +F G P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 163 FTFGNKLDAFCGAPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFXEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 129
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ E G +++ DFG
Sbjct: 130 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 174 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 36  FERIKTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 135
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 136 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 180 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 64  FERIKTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 163
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 164 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 208 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 110/249 (44%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 57
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G   +   A +V ++C GS S    +H IE +F +            
Sbjct: 58  LRKTRHVNILLFMGYSTKPQLA-IVTQWCEGS-SLYHHLHIIETKFEMI----------- 104
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                               ++  I     +G++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 105 --------------------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 144
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A+ K             G+  WMAPEVI   D+  Y  + DV++ GI   EL  
Sbjct: 145 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 205 GQLPYSNIN 213

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 108/249 (43%), Gaps = 43/249 (17%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
           D E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGV 73
Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           LR+ +H N + + G       A +V ++C GS S    +H  E +F ++           
Sbjct: 74  LRKTRHVNILLFMGYSTAPQLA-IVTQWCEGS-SLYHHLHASETKFEMK----------- 120
Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                               ++  I     RG++YLH+   IHRD+K+ NI L E  TVK
Sbjct: 121 --------------------KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160
Query: 336 LADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG A+ K             G+  WMAPEVI   D   Y  + DV++ GI   EL  
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 390 RKPPYFNMN 398
            + PY N+N
Sbjct: 221 GQLPYSNIN 229

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 41/71 (57%), Gaps = 3/71 (4%)
Query: 613 SPQL--VMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 669
           +PQL  V ++C GS+    +   +   + +++  I     RG++YLH+   IHRD+K+ N
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150
Query: 670 ILLTETGTVKL 680
           I L E  TVK+
Sbjct: 151 IFLHEDNTVKI 161

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++ + VA++ +  + L     +K   + +E+R ++ L HPN 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK---LFREVRIMKVLNHPNI 75
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +LVMEY  G                                   +F+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGE---------------------------------VFD 102
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V    +KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 103 YLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
               N   +F G+P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 163 FTFGNKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLXGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++   VAIK +  + L     +K   + +E+R ++ L HPN 
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK---LFREVRIMKILNHPNI 73
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +L+MEY  G                                   +F+
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGE---------------------------------VFD 100
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 342
           + V    +KE+E  +    ++  + Y H    +HRD+KA N+LL     +K+ADFG +  
Sbjct: 101 YLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 160
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
            ++    ++F G+P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 161 FTVGGKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVK---HKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVK---HKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FERIKTLGTGSFGRVMLVK---HKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   + + +    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P   +    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGE-----------------MFSHLRRIGRFXEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +K+ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++ + VA+K +  + L     +K   + +E+R ++ L HPN 
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNI 68
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +LVMEY  G                                   +F+
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGE---------------------------------VFD 95
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V    +KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 96  YLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNE 155
Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
               N   +F G+P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 156 FTFGNKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 116/244 (47%), Gaps = 50/244 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLK 220
           +E + EIG G++G V+ AR L +    VA+K++     Q  E+   +  ++E+  LR L+
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLE 69
Query: 221 ---HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
              HPN +              + + C  S +D                  R  +L    
Sbjct: 70  TFEHPNVVR-------------LFDVCTVSRTD------------------RETKLTLVF 98
Query: 278 EH----FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           EH       +  +V +  +  E I  +   +LRGL++LHS   +HRD+K  NIL+T +G 
Sbjct: 99  EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
Query: 334 VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           +KLADFG A   S +    S V T ++ APEV+L   +  Y   VD+WS+G    E+  R
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRR 215
Query: 391 KPPY 394
           KP +
Sbjct: 216 KPLF 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           E I  +   +LRGL++LHS   +HRD+K  NIL+T +G +KL
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE ++ +G GSFG V   +    +E      M  L KQ   K   I   L E R L+ + 
Sbjct: 36  FERIKTLGTGSFGRVMLVK---HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGE-----------------MFSHLRRIGRFXEPH 135
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 136 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 180 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 143
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 144 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 188 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 82
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 83  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 116
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 117 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR 172
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 231 KHYLDQLNHILGILGSPSQEDLNCI 255

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++ + VA++ +  + L     +K   + +E+R ++ L HPN 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK---LFREVRIMKVLNHPNI 75
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +LVMEY  G                                   +F+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGE---------------------------------VFD 102
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V    +KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 103 YLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 345 KCPANS---FVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
               N    F G+P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 163 FTFGNKLDEFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRT--LREIKILLRFRHEN 86
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 87  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 121 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR 176
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCI 259

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 45/237 (18%)
Query: 168 REIGHGSFGAVYYAR-CLVSREI-VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           + IG G+F  V  AR  L  RE+ V I   + L     +K   + +E+R ++ L HPN +
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQK---LFREVRIMKILNHPNIV 77
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +       + T +LVMEY  G                                   +F++
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGE---------------------------------VFDY 104
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA--- 342
            V    +KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG +   
Sbjct: 105 LVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF 164
Query: 343 SIKCPANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
           ++    ++F G+P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 165 TVGNKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 82
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 83  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 116
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 117 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 172
Query: 344 IKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 231 KHYLDQLNHILGILGSPSQEDLNCI 255

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 102/241 (42%), Gaps = 41/241 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHP 222
           F  L+ IG GSFG V  AR        A+K +        ++   I+ E    L+ +KHP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             +     +      + V++Y  G           E  +H       LQ+ +CF E  A 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGG----------ELFYH-------LQRERCFLEPRAR 142
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
           F            EIA+        L YLHSL  ++RD+K  NILL   G + L DFG  
Sbjct: 143 F---------YAAEIAS-------ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
Query: 343 SIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                 NS    F GTP ++APEV   + +  YD  VD W LG    E+    PP+++ N
Sbjct: 187 KENIEHNSTTSTFCGTPEYLAPEV---LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
Query: 399 A 399
Sbjct: 244 T 244

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++   VAIK +  + L     +K   + +E+R ++ L HPN 
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK---LFREVRIMKILNHPNI 76
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +L+MEY  G                                   +F+
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGE---------------------------------VFD 103
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 342
           + V    +KE+E  +    ++  + Y H    +HRD+KA N+LL     +K+ADFG +  
Sbjct: 104 YLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
            ++    ++F G P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 164 FTVGGKLDAFCGAPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 90
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 91  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 124
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 125 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 180
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 181 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 238
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 239 KHYLDQLNHILGILGSPSQEDLNCI 263

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 82
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 83  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 116
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 117 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 172
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 231 KHYLDQLNHILGILGSPSQEDLNCI 255

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 84
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 85  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 118
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 119 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 174
Query: 344 IKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 233 KHYLDQLNHILGILGSPSQEDLNCI 257

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 116/244 (47%), Gaps = 50/244 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLK 220
           +E + EIG G++G V+ AR L +    VA+K++     Q  E+   +  ++E+  LR L+
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLE 69
Query: 221 ---HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
              HPN +              + + C  S +D                  R  +L    
Sbjct: 70  TFEHPNVVR-------------LFDVCTVSRTD------------------RETKLTLVF 98
Query: 278 EH----FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           EH       +  +V +  +  E I  +   +LRGL++LHS   +HRD+K  NIL+T +G 
Sbjct: 99  EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
Query: 334 VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           +KLADFG A   S +    S V T ++ APEV+L   +  Y   VD+WS+G    E+  R
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRR 215
Query: 391 KPPY 394
           KP +
Sbjct: 216 KPLF 219

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           E I  +   +LRGL++LHS   +HRD+K  NIL+T +G +KL
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 117/269 (43%), Gaps = 56/269 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 102
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV----EGMGNRLQQLKCFTEH 279
            I                       +DII    IE+   V      MG  L +L   T+H
Sbjct: 103 II---------------------GINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQH 140
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                       L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DF
Sbjct: 141 ------------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDF 188
Query: 340 GSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           G A +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 393 PYFNMNAMSALYHI-------AQNDTPCL 414
            +   + +  L HI       +Q D  C+
Sbjct: 247 IFPGKHYLDQLNHILGILGSPSQEDLNCI 275

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFAEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 46/226 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ +++IG G+FG     R  +++E+VA+K   Y+ +  A    ++ +EI   R L+HPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAID-ENVQREIINHRSLRHPN 77
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++   L      ++MEY  G                   +  R+     F+E  A F
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGE-----------------LYERICNAGRFSEDEARF 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFG- 340
            F+                 +L G++Y HS+   HRD+K  N LL  +    +K+ DFG 
Sbjct: 121 FFQ----------------QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY 164
Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGIT 383
             S+ +     S VGTP ++APEV+L     +YDGK+ DVWS G+T
Sbjct: 165 SKSSVLHSQPKSTVGTPAYIAPEVLL---RQEYDGKIADVWSCGVT 207

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 102
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 103 II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 136
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 137 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 192
Query: 344 IKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 193 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 251 KHYLDQLNHILGILGSPSQEDLNCI 275

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 50/242 (20%)
Query: 162 KIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           ++++ ++++G G++G V   R     V R I  I+K S          + +L+E+  L+ 
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV----STSSNSKLLEEVAVLKL 92
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           L HPN ++    +      +LVME   G                                
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGE------------------------------ 122
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVK 335
              LF+  +H+    E + A I   VL G+ YLH    +HRD+K  N+LL    +   +K
Sbjct: 123 ---LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179
Query: 336 LADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           + DFG +++   +      +GT Y++APEV+      +YD K DVWS+G+    L    P
Sbjct: 180 IVDFGLSAVFENQKKMKERLGTAYYIAPEVL----RKKYDEKCDVWSIGVILFILLAGYP 235
Query: 393 PY 394
           P+
Sbjct: 236 PF 237

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 116/244 (47%), Gaps = 50/244 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLK 220
           +E + EIG G++G V+ AR L +    VA+K++     Q  E+   +  ++E+  LR L+
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLE 69
Query: 221 ---HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
              HPN +              + + C  S +D                  R  +L    
Sbjct: 70  TFEHPNVVR-------------LFDVCTVSRTD------------------RETKLTLVF 98
Query: 278 EH----FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           EH       +  +V +  +  E I  +   +LRGL++LHS   +HRD+K  NIL+T +G 
Sbjct: 99  EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
Query: 334 VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           +KLADFG A   S +    S V T ++ APEV+L   +  Y   VD+WS+G    E+  R
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRR 215
Query: 391 KPPY 394
           KP +
Sbjct: 216 KPLF 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           E I  +   +LRGL++LHS   +HRD+K  NIL+T +G +KL
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFXEPH 163
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 164 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 208 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFXEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 115/238 (48%), Gaps = 46/238 (19%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           +IG GSFG V+ A    S   VA+K +       AE+  + L+E+  +++L+HPN + + 
Sbjct: 44  KIGAGSFGTVHRAEWHGSD--VAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   +     +V EY L   S       + R  H  G                       
Sbjct: 101 GAVTQPPNLSIVTEY-LSRGS-------LYRLLHKSGA---------------------- 130
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLTETGTVKLADFGSASIKC 346
           +  L E    ++   V +G+NYLH+     +HRD+K+ N+L+ +  TVK+ DFG + +K 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK- 189
Query: 347 PANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
            A+ F+      GTP WMAPEV+   DE   + K DV+S G+   ELA  + P+ N+N
Sbjct: 190 -ASXFLXSKXAAGTPEWMAPEVL--RDEPS-NEKSDVYSFGVILWELATLQQPWGNLN 243

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 46/226 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +++IG G+FG     R   + E+VA+K +   G++  E   ++ +EI   R L+HPN
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIER-GEKIDE---NVKREIINHRSLRHPN 76
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++   L      +VMEY  G                   +  R+     F+E  A F
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGE-----------------LFERICNAGRFSEDEARF 119
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFG- 340
            F+                 ++ G++Y H++   HRD+K  N LL  +    +K+ADFG 
Sbjct: 120 FFQ----------------QLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGY 163
Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGIT 383
             ++ +     S VGTP ++APEV+L   + +YDGKV DVWS G+T
Sbjct: 164 SKASVLHSQPKSAVGTPAYIAPEVLL---KKEYDGKVADVWSCGVT 206

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 113/236 (47%), Gaps = 42/236 (17%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           +IG GSFG V+ A    S   VA+K +       AE+  + L+E+  +++L+HPN + + 
Sbjct: 44  KIGAGSFGTVHRAEWHGSD--VAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   +     +V EY L   S       + R  H  G                       
Sbjct: 101 GAVTQPPNLSIVTEY-LSRGS-------LYRLLHKSGA---------------------- 130
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLTETGTVKLADFGSASIKC 346
           +  L E    ++   V +G+NYLH+     +HR++K+ N+L+ +  TVK+ DFG + +K 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190
Query: 347 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                + S  GTP WMAPEV+   DE   + K DV+S G+   ELA  + P+ N+N
Sbjct: 191 STFLSSKSAAGTPEWMAPEVL--RDEPS-NEKSDVYSFGVILWELATLQQPWGNLN 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFXEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA---DILK 211
            D +   K +E L  +G G F  VY AR   + +IVAIKK+  LG +   K       L+
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALR 61
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           EI+ L++L HPN I     +       LV ++             +E +  V    N L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDF-------------METDLEVIIKDNSLV 108
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
                               L    I A     L+GL YLH    +HRD+K  N+LL E 
Sbjct: 109 --------------------LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 148
Query: 332 GTVKLADFGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G +KLADFG A S   P  ++   V T ++ APE++       Y   VD+W++G    EL
Sbjct: 149 GVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGAR--MYGVGVDMWAVGCILAEL 206
Query: 388 AERKP 392
             R P
Sbjct: 207 LLRVP 211

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFXEPH 137
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 138 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 181
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 182 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 136/293 (46%), Gaps = 43/293 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E  E  + + + IG+GSFG V+ A+ + S E VAIKK+        +++ +  +E++ +R
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-----DKRFKN--RELQIMR 87
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            +KHPN ++ +  +           Y  G   D + ++ +  E+  E +          +
Sbjct: 88  IVKHPNVVDLKAFF-----------YSNGDKKDEVFLNLV-LEYVPETVYRA-------S 128
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKL 336
            H+A       K+ +    I      +LR L Y+HS+G  HRD+K  N+LL   +G +KL
Sbjct: 129 RHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL 183
Query: 337 ADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            DFGSA I     P  S + + Y+ APE+I       Y   +D+WS G    EL + +P 
Sbjct: 184 IDFGSAKILIAGEPNVSXICSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQGQPL 241
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISST-AERKPPYFNMNAMSALY 445
           +   + +  L  I +     L +     IKT++    E K P    +  S ++
Sbjct: 242 FPGESGIDQLVEIIK----VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 127/313 (40%), Gaps = 57/313 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKH 221
           F+ LR IG GS+  V   R   +  I A+K  K   +       W    K + F +   H
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNH 80
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P  +    C+  +   + V+EY  G   D++        FH++                 
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGG--DLM--------FHMQ----------------- 113
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                  +R L EE      + +   LNYLH  G I+RD+K  N+LL   G +KL D+G 
Sbjct: 114 ------RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 167
Query: 342 ASIKC-PANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
                 P ++   F GTP ++APE++   D   Y   VD W+LG+   E+   + P F++
Sbjct: 168 CKEGLRPGDTTSXFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSP-FDI 223
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP---- 453
                   +  +D P   + D+ + + I     R P   ++ A S L      D      
Sbjct: 224 --------VGSSDNPDQNTEDY-LFQVILEKQIRIPRSMSVKAASVLKSFLNKDPKERLG 274
Query: 454 CLQSSDWSDTFAH 466
           CL  + ++D   H
Sbjct: 275 CLPQTGFADIQGH 287

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 32/65 (49%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
            V+EY  G         +R L EE      + +   LNYLH  G I+RD+K  N+LL   
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 676 GTVKL 680
           G +KL
Sbjct: 158 GHIKL 162

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 113/250 (45%), Gaps = 41/250 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 82
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 83  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 116
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 117 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR 172
Query: 344 IKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
Query: 397 MNAMSALYHI 406
            + +  L HI
Sbjct: 231 KHYLDQLNHI 240

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 113/250 (45%), Gaps = 41/250 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 82
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 83  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 116
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 117 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLAR 172
Query: 344 IKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
Query: 397 MNAMSALYHI 406
            + +  L HI
Sbjct: 231 KHYLDQLNHI 240

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  L+ IG G++G V  A   V +  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRT--LREIQILLRFRHEN 102
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I  R   LR  T        L +  D+    +I ++     +   L+  +   +H   F
Sbjct: 103 VIGIRDI-LRAST--------LEAMRDV----YIVQDLMETDLYKLLKSQQLSNDHICYF 149
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
            ++                 +LRGL Y+HS   +HRD+K  N+L+  T  +K+ DFG A 
Sbjct: 150 LYQ-----------------ILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR 192
Query: 344 IKCPANSFVG-------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           I  P +   G       T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 193 IADPEHDHTGFLTEXVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 251 KHYLDQLNHILGILGSPSQEDLNCI 275

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 71/256 (27%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE++  +G G+FG V  AR  +     AIKK+    +   EK + IL E+  L  L H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQY 63
Query: 224 TIEYRGCYL-------------RDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNR 269
            + Y   +L             +  T ++ MEYC  G+  D+I         H E +  +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---------HSENLNQQ 114
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                   E++ LF                    +L  L+Y+HS G IHRD+K  NI + 
Sbjct: 115 RD------EYWRLFR------------------QILEALSYIHSQGIIHRDLKPMNIFID 150
Query: 330 ETGTVKLADFGSA-------------SIKCPAN-----SFVGTPYWMAPEVILAMDEGQY 371
           E+  VK+ DFG A             S   P +     S +GT  ++A EV+     G Y
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHY 208
Query: 372 DGKVDVWSLGITCIEL 387
           + K+D++SLGI   E+
Sbjct: 209 NEKIDMYSLGIIFFEM 224

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/64 (37%), Positives = 36/64 (56%), Gaps = 1/64 (1%)
Query: 618 MEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           MEYC  G+  D+I       + +E   +   +L  L+Y+HS G IHRD+K  NI + E+ 
Sbjct: 94  MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153
Query: 677 TVKL 680
            VK+
Sbjct: 154 NVKI 157

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 46/226 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +++IG G+FG     R   S E+VA+K +   G++  E   ++ +EI   R L+HPN
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDE---NVKREIINHRSLRHPN 75
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++   L      +VMEY  G                   +  R+     F+E  A F
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGE-----------------LFERICNAGRFSEDEARF 118
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFG- 340
            F+                 ++ G++Y H++   HRD+K  N LL  +    +K+ DFG 
Sbjct: 119 FFQ----------------QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 162
Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGIT 383
             S+ +     S VGTP ++APEV+L   + +YDGKV DVWS G+T
Sbjct: 163 SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDGKVADVWSCGVT 205

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   ++A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFXEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 116/264 (43%), Gaps = 48/264 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L   +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLAFRHEN 84
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 85  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 118
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 119 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLAR 174
Query: 344 IKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232
Query: 397 MNAMSALYHI-------AQNDTPC 413
            + +  L HI       +Q D  C
Sbjct: 233 KHYLDQLNHILGILGSPSQEDLNC 256

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q   +    L+EI+ L   +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLAFRHEN 84
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 85  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 118
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 119 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 174
Query: 344 IKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P          +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 233 KHYLDQLNHILGILGSPSQEDLNCI 257

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 128/320 (40%), Gaps = 58/320 (18%)
Query: 139 LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL 198
           L  TPG       A   D+      ++  R +G GSFG V   +  ++ +  A+K +S  
Sbjct: 32  LHATPGMFVQHSTAIFSDR------YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 85
Query: 199 GKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
             +       +L+E++ L+QL HPN ++    +      +LV E   G            
Sbjct: 86  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---------- 135
Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                                  LF+  + ++   E + A I   VL G+ Y+H    +H
Sbjct: 136 -----------------------LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 172
Query: 319 RDVKAGNILL---TETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQ 370
           RD+K  N+LL   ++   +++ DFG      AS K      +GT Y++APEV+     G 
Sbjct: 173 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEVL----HGT 226
Query: 371 YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE 430
           YD K DVWS G+    L    PP+   N    L  + +      +   W  +   +    
Sbjct: 227 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKVSESAKDLI 285
Query: 431 RK----PPYFNMNAMSALYH 446
           RK     P   ++A  AL H
Sbjct: 286 RKMLTYVPSMRISARDALDH 305

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 128/320 (40%), Gaps = 58/320 (18%)
Query: 139 LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL 198
           L  TPG       A   D+      ++  R +G GSFG V   +  ++ +  A+K +S  
Sbjct: 33  LHATPGMFVQHSTAIFSDR------YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 86
Query: 199 GKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
             +       +L+E++ L+QL HPN ++    +      +LV E   G            
Sbjct: 87  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---------- 136
Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                                  LF+  + ++   E + A I   VL G+ Y+H    +H
Sbjct: 137 -----------------------LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 173
Query: 319 RDVKAGNILL---TETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQ 370
           RD+K  N+LL   ++   +++ DFG      AS K      +GT Y++APEV+     G 
Sbjct: 174 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEVL----HGT 227
Query: 371 YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE 430
           YD K DVWS G+    L    PP+   N    L  + +      +   W  +   +    
Sbjct: 228 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKVSESAKDLI 286
Query: 431 RK----PPYFNMNAMSALYH 446
           RK     P   ++A  AL H
Sbjct: 287 RKMLTYVPSMRISARDALDH 306

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 86
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 87  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 121 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR 176
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCI 259

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 115/287 (40%), Gaps = 51/287 (17%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GS+G V  A    +R   A KK+    K   E      +EI  ++ L HPN I    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIP---KYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  +   +LVME C G                                   LF   VHK
Sbjct: 74  TFEDNTDIYLVMELCTGGE---------------------------------LFERVVHK 100
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL-LTET--GTVKLADFGSASIKC 346
           R  +E + A I   VL  + Y H L   HRD+K  N L LT++    +KL DFG A+   
Sbjct: 101 RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160
Query: 347 PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
           P       VGTPY+++P+V+    EG Y  + D WS G+    L    PP+        +
Sbjct: 161 PGKMMRTKVGTPYYVSPQVL----EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 216
Query: 404 YHIAQNDTPCLQSSDWSVIKTISSTAER----KPPYFNMNAMSALYH 446
             I +  T      DW  +   + +  R    K P   + ++ AL H
Sbjct: 217 LKIREG-TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/69 (39%), Positives = 32/69 (46%), Gaps = 6/69 (8%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVME C G       VHKR  +E + A I   VL  + Y H L   HRD+K  N L    
Sbjct: 83  LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT- 141
Query: 676 GTVKLDTPD 684
                D+PD
Sbjct: 142 -----DSPD 145

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 128/320 (40%), Gaps = 58/320 (18%)
Query: 139 LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL 198
           L  TPG       A   D+      ++  R +G GSFG V   +  ++ +  A+K +S  
Sbjct: 9   LHATPGMFVQHSTAIFSDR------YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 199 GKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
             +       +L+E++ L+QL HPN ++    +      +LV E   G            
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---------- 112
Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                                  LF+  + ++   E + A I   VL G+ Y+H    +H
Sbjct: 113 -----------------------LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 149
Query: 319 RDVKAGNILL---TETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQ 370
           RD+K  N+LL   ++   +++ DFG      AS K      +GT Y++APEV+     G 
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEVL----HGT 203
Query: 371 YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE 430
           YD K DVWS G+    L    PP+   N    L  + +      +   W  +   +    
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKVSESAKDLI 262
Query: 431 RK----PPYFNMNAMSALYH 446
           RK     P   ++A  AL H
Sbjct: 263 RKMLTYVPSMRISARDALDH 282

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 80
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 81  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 114
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 115 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 170
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 171 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 229 KHYLDQLNHILGILGSPSQEDLNCI 253

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 44/243 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSFG V   +  ++++  A+K ++    +  +  + IL+E+  L++L HPN ++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLFE 88
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
             L D +++    Y +G             E +  G                LF+  + +
Sbjct: 89  I-LEDSSSF----YIVG-------------ELYTGG---------------ELFDEIIKR 115
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT---VKLADFGSASI-- 344
           +   E + A I   V  G+ Y+H    +HRD+K  NILL        +K+ DFG ++   
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 345 -KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
                   +GT Y++APEV+     G YD K DVWS G+    L    PP++  N    L
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 404 YHI 406
             +
Sbjct: 232 KRV 234

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 87
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 88  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 121
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 122 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 177
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 178 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 236 KHYLDQLNHILGILGSPSQEDLNCI 260

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 88
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 89  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 122
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 123 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 178
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 179 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 236
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 237 KHYLDQLNHILGILGSPSQEDLNCI 261

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 79
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 80  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 113
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 114 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 169
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 170 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 227
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 228 KHYLDQLNHILGILGSPSQEDLNCI 252

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 86
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 87  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 121 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCI 259

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+++ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++APE+I++     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPEIIISKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 86
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 87  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
             +     L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 121 KCQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCI 259

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP  +APE+IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEALAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 115/287 (40%), Gaps = 51/287 (17%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GS+G V  A    +R   A KK+    K   E      +EI  ++ L HPN I    
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIP---KYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  +   +LVME C G                                   LF   VHK
Sbjct: 91  TFEDNTDIYLVMELCTGGE---------------------------------LFERVVHK 117
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL-LTET--GTVKLADFGSASIKC 346
           R  +E + A I   VL  + Y H L   HRD+K  N L LT++    +KL DFG A+   
Sbjct: 118 RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 177
Query: 347 PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
           P       VGTPY+++P+V+    EG Y  + D WS G+    L    PP+        +
Sbjct: 178 PGKMMRTKVGTPYYVSPQVL----EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 233
Query: 404 YHIAQNDTPCLQSSDWSVIKTISSTAER----KPPYFNMNAMSALYH 446
             I +  T      DW  +   + +  R    K P   + ++ AL H
Sbjct: 234 LKIREG-TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 279

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/69 (39%), Positives = 32/69 (46%), Gaps = 6/69 (8%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVME C G       VHKR  +E + A I   VL  + Y H L   HRD+K  N L    
Sbjct: 100 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT- 158
Query: 676 GTVKLDTPD 684
                D+PD
Sbjct: 159 -----DSPD 162

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           F+ ++ +G GSFG V   +   S    A   M  L KQ   K   I   L E R L+ + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  +   ++VMEY  G                   M + L+++  F+E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGE-----------------MFSHLRRIGRFSEPH 142
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F                  + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG
Sbjct: 143 ARF----------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 341 SAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            A  +K       GTP ++AP +IL+     Y+  VD W+LG+   E+A   PP+F
Sbjct: 187 FAKRVKGRTWXLCGTPEYLAPAIILSKG---YNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 57/249 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE++  +G G+FG V  AR  +     AIKK+    +   EK + IL E+  L  L H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQY 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT-----E 278
            + Y                            W+ER   V+ M    ++   F      E
Sbjct: 64  VVRYYAA-------------------------WLERRNFVKPMTAVKKKSTLFIQMEYCE 98
Query: 279 HFALFNFEVHKRPLKEE--EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
           +  L++  +H   L ++  E   +   +L  L+Y+HS G IHRD+K  NI + E+  VK+
Sbjct: 99  NRTLYDL-IHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157
Query: 337 ADFGSA-------------SIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVW 378
            DFG A             S   P +     S +GT  ++A EV+     G Y+ K+D++
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHYNEKIDMY 215
Query: 379 SLGITCIEL 387
           SLGI   E+
Sbjct: 216 SLGIIFFEM 224

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 1/64 (1%)
Query: 618 MEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           MEYC   +  D+I       + +E   +   +L  L+Y+HS G IHRD+K  NI + E+ 
Sbjct: 94  MEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153
Query: 677 TVKL 680
            VK+
Sbjct: 154 NVKI 157

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 41/250 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 80
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 81  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 114
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 115 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 170
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 171 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228
Query: 397 MNAMSALYHI 406
            + +  L HI
Sbjct: 229 KHYLDQLNHI 238

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 119/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAI+K+S    Q   +    L+EI+ L + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRT--LREIKILLRFRHEN 86
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 87  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 121 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 344 IKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +        +V T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCI 259

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 42/240 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L +IG G++G V+ A+   + EIVA+K++  L        +  L+EI  L++LKH N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        D    LV E+C                          Q LK +       
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCD-------------------------QDLKKY------- 90
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
            F+     L  E + +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 91  -FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLAR 149
Query: 344 -----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                ++C +   V T ++  P+V+       Y   +D+WS G    ELA    P F  N
Sbjct: 150 AFGIPVRCYSAEVV-TLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAARPLFPGN 206

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 38/240 (15%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+   GK    +      E++ +
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNR------ELQIM 67
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R+L H N +  R  +           Y  G   D + ++ +    +V     R+ +    
Sbjct: 68  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLD--YVPETVYRVAR---- 110
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
                  ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +K
Sbjct: 111 -------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163
Query: 336 LADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 38/240 (15%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+   GK    +      E++ +
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNR------ELQIM 67
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R+L H N +  R  +           Y  G   D + ++ +    +V     R+ +    
Sbjct: 68  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLD--YVPETVYRVAR---- 110
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
                  ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +K
Sbjct: 111 -------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163
Query: 336 LADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 221

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 48/257 (18%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 107
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 108 LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 156
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 157 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 198
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 199 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 256
Query: 390 RKPPYFNMNAMSALYHI 406
            +P +   + +  L  I
Sbjct: 257 GQPIFPGDSGVDQLVEI 273

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 118/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 86
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 87  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 121 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 344 IKCPANSFVG-------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +   G       T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 177 VADPDHDHTGFLXEXVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCI 259

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 118/265 (44%), Gaps = 48/265 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHEN 87
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I                       +DII    IE+   V  + + ++     T+ + L 
Sbjct: 88  II---------------------GINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLL 121
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                 + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A 
Sbjct: 122 K----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 177
Query: 344 IKCPANSFVG-------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +  P +   G       T ++ APE++L  +   Y   +D+WS+G    E+   +P +  
Sbjct: 178 VADPDHDHTGFLXEXVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235
Query: 397 MNAMSALYHI-------AQNDTPCL 414
            + +  L HI       +Q D  C+
Sbjct: 236 KHYLDQLNHILGILGSPSQEDLNCI 260

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 103
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 104 LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 152
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 153 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 252
Query: 390 RKP 392
            +P
Sbjct: 253 GQP 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 105
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 106 LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 154
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 155 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 196
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 197 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 254
Query: 390 RKP 392
            +P
Sbjct: 255 GQP 257

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 97
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 98  LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 146
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 147 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 188
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 189 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 246
Query: 390 RKP 392
            +P
Sbjct: 247 GQP 249

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 48/245 (19%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +
Sbjct: 20  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIM 72
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQ 271
           R+L H N +  R  +           Y  G   D + ++ +     E  + V    +R +
Sbjct: 73  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 121
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TE 330
           Q      +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +
Sbjct: 122 QTLPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPD 163
Query: 331 TGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           T  +KL DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL
Sbjct: 164 TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAEL 221
Query: 388 AERKP 392
              +P
Sbjct: 222 LLGQP 226

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 48/245 (19%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +
Sbjct: 94  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIM 146
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQ 271
           R+L H N +  R  +           Y  G   D + ++ +     E  + V    +R +
Sbjct: 147 RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 195
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TE 330
           Q      +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +
Sbjct: 196 QTLPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPD 237
Query: 331 TGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           T  +KL DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL
Sbjct: 238 TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAEL 295
Query: 388 AERKP 392
              +P
Sbjct: 296 LLGQP 300

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 114/252 (45%), Gaps = 34/252 (13%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P+++ + LR +G G++G+V  A     R+ VA+KK+S   +          +E+R L+
Sbjct: 25  EVPQRL-QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA-RRTYRELRLLK 82
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            LKH N I     +               S  D  EV+ +        MG  L  +    
Sbjct: 83  HLKHENVIGLLDVFT-----------PATSIEDFSEVYLV-----TTLMGADLNNI---- 122
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    V  + L +E +  +   +LRGL Y+HS G IHRD+K  N+ + E   +++ 
Sbjct: 123 ---------VKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 338 DFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL + K  +  
Sbjct: 174 DFGLARQADEEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLQGKALFPG 231
Query: 397 MNAMSALYHIAQ 408
            + +  L  I +
Sbjct: 232 SDYIDQLKRIME 243

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 18/50 (36%), Positives = 30/50 (60%)
Query: 631 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           V  + L +E +  +   +LRGL Y+HS G IHRD+K  N+ + E   +++
Sbjct: 123 VKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRI 172

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 114/240 (47%), Gaps = 38/240 (15%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIM 67
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R+L H N +  R  +           Y  G   D++ ++ +    +V     R+ +    
Sbjct: 68  RKLDHCNIVRLRYFF-----------YSSGEKKDVVYLNLVLD--YVPETVYRVAR---- 110
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
                  ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +K
Sbjct: 111 -------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163
Query: 336 LADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 164 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/335 (23%), Positives = 128/335 (38%), Gaps = 78/335 (23%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF-LRQLKHP 222
            E + E+G G++G V   R + S +I A+K++       +++   +L ++    R +  P
Sbjct: 36  LEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR--ATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            T+ + G   R+   W+  E    ++ D      I++                       
Sbjct: 94  FTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDK----------------------- 129
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFGS 341
                  + + E+ +  I   +++ L +LHS L  IHRDVK  N+L+   G VK  DFG 
Sbjct: 130 ------GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGI 183
Query: 342 ASI---KCPANSFVGTPYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           +         +   G   + APE I   +++  Y  K D+WSLGIT IELA  + PY   
Sbjct: 184 SGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPY--- 240
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQS 457
                                W                        L  + +  +P L +
Sbjct: 241 -------------------DSWG------------------TPFQQLKQVVEEPSPQLPA 263
Query: 458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             +S  F  F S CL KN  +RP+   L  H   T
Sbjct: 264 DKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFT 298

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 38/240 (15%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+   GK    +      E++ +
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNR------ELQIM 67
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R+L H N +  R  +           Y  G   D + ++ +    +V     R+ +    
Sbjct: 68  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLD--YVPATVYRVAR---- 110
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
                  ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +K
Sbjct: 111 -------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163
Query: 336 LADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 164 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 221

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 45/238 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++ + VA+K +  + L     +K   + +E+R  + L HPN 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK---LFREVRIXKVLNHPNI 75
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +LV EY  G                                   +F+
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGE---------------------------------VFD 102
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V     KE+E  A    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 103 YLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNE 162
Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMN 398
               N   +F G P + APE+       +YDG +VDVWSLG+    L     P+   N
Sbjct: 163 FTFGNKLDAFCGAPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKH 221
           F+ LR IG GS+  V   R   +  I A+K  K   +       W    K + F +   H
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNH 65
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P  +    C+  +   + V+EY  G   D++        FH++                 
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGG--DLM--------FHMQ----------------- 98
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                  +R L EE      + +   LNYLH  G I+RD+K  N+LL   G +KL D+G 
Sbjct: 99  ------RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 152
Query: 342 ASIKC-PANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
                 P ++   F GTP ++APE++   D   Y   VD W+LG+   E+   + P F++
Sbjct: 153 CKEGLRPGDTTSXFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSP-FDI 208
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                   +  +D P   + D+ + + I     R P   ++ A S L      D
Sbjct: 209 --------VGSSDNPDQNTEDY-LFQVILEKQIRIPRSLSVKAASVLKSFLNKD 253

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 32/65 (49%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
            V+EY  G         +R L EE      + +   LNYLH  G I+RD+K  N+LL   
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 676 GTVKL 680
           G +KL
Sbjct: 143 GHIKL 147

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 82
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 83  LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 131
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 132 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 173
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 174 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 231
Query: 390 RKP 392
            +P
Sbjct: 232 GQP 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 46/226 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +++IG G+FG     R   S E+VA+K +   G++  E   ++ +EI   R L+HPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDE---NVKREIINHRSLRHPN 76
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++   L      +VMEY  G                   +  R+     F+E  A F
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGE-----------------LFERICNAGRFSEDEARF 119
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFG- 340
            F+                 ++ G++Y H++   HRD+K  N LL  +    +K+  FG 
Sbjct: 120 FFQ----------------QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGY 163
Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGIT 383
             S+ +     S VGTP ++APEV+L   + +YDGKV DVWS G+T
Sbjct: 164 SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDGKVADVWSCGVT 206

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKH 221
           F+ LR IG GS+  V   R   +  I A+K  K   +       W    K + F +   H
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNH 69
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P  +    C+  +   + V+EY  G   D++        FH++                 
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGG--DLM--------FHMQ----------------- 102
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                  +R L EE      + +   LNYLH  G I+RD+K  N+LL   G +KL D+G 
Sbjct: 103 ------RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156
Query: 342 ASIKC-PANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
                 P ++   F GTP ++APE++   D   Y   VD W+LG+   E+   + P F++
Sbjct: 157 CKEGLRPGDTTSXFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSP-FDI 212
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                   +  +D P   + D+ + + I     R P   ++ A S L      D
Sbjct: 213 --------VGSSDNPDQNTEDY-LFQVILEKQIRIPRSLSVKAASVLKSFLNKD 257

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 32/65 (49%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
            V+EY  G         +R L EE      + +   LNYLH  G I+RD+K  N+LL   
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 676 GTVKL 680
           G +KL
Sbjct: 147 GHIKL 151

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 36/253 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P+++ + LR +G G++G+V  A     R+ VA+KK+S   +          +E+R L+
Sbjct: 25  EVPQRL-QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA-RRTYRELRLLK 82
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            LKH N I     +               S  D  EV+ +        MG  L  + KC 
Sbjct: 83  HLKHENVIGLLDVFT-----------PATSIEDFSEVYLV-----TTLMGADLNNIVKC- 125
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L +E +  +   +LRGL Y+HS G IHRD+K  N+ + E   +++
Sbjct: 126 -------------QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRI 172
Query: 337 ADFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL + K  + 
Sbjct: 173 LDFGLARQADEEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLQGKALFP 230
Query: 396 NMNAMSALYHIAQ 408
             + +  L  I +
Sbjct: 231 GSDYIDQLKRIME 243

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 126/320 (39%), Gaps = 58/320 (18%)
Query: 139 LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL 198
           L  TPG       A   D+      ++  R +G GSFG V   +  ++ +  A+K +S  
Sbjct: 9   LHATPGXFVQHSTAIFSDR------YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 199 GKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
             +       +L+E++ L+QL HPN  +    +      +LV E   G            
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGE---------- 112
Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                                  LF+  + ++   E + A I   VL G+ Y H    +H
Sbjct: 113 -----------------------LFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVH 149
Query: 319 RDVKAGNILL---TETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQ 370
           RD+K  N+LL   ++   +++ DFG      AS K      +GT Y++APEV+     G 
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--IGTAYYIAPEVL----HGT 203
Query: 371 YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE 430
           YD K DVWS G+    L    PP+   N    L  + +      +   W  +   +    
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKVSESAKDLI 262
Query: 431 RKP----PYFNMNAMSALYH 446
           RK     P   ++A  AL H
Sbjct: 263 RKXLTYVPSXRISARDALDH 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 44/243 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSFG V   +  ++++  A+K ++    +  +  + IL+E+  L++L HPN ++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMK--- 85
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                     + E    S+S      +I  E +  G                LF+  + +
Sbjct: 86  ----------LFEILEDSSS-----FYIVGELYTGG---------------ELFDEIIKR 115
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT---VKLADFGSASI-- 344
           +   E + A I   V  G+ Y+H    +HRD+K  NILL        +K+ DFG ++   
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 345 -KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
                   +GT Y++APEV+     G YD K DVWS G+    L    PP++  N    L
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 404 YHI 406
             +
Sbjct: 232 KRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 44/243 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSFG V   +  ++++  A+K ++    +  +  + IL+E+  L++L HPN ++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMK--- 85
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                     + E    S+S      +I  E +  G                LF+  + +
Sbjct: 86  ----------LFEILEDSSS-----FYIVGELYTGG---------------ELFDEIIKR 115
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT---VKLADFGSASI-- 344
           +   E + A I   V  G+ Y+H    +HRD+K  NILL        +K+ DFG ++   
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 345 -KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
                   +GT Y++APEV+     G YD K DVWS G+    L    PP++  N    L
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 404 YHI 406
             +
Sbjct: 232 KRV 234

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/352 (23%), Positives = 140/352 (39%), Gaps = 86/352 (24%)
Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
           PG+++ P   +    ED   I++    +G G+F  V  A    ++++VAIK ++   K  
Sbjct: 2   PGAVEGPRWKQ---AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KKAL 56
Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
             K   +  EI  L ++KHPN +     Y      +L+M+   G                
Sbjct: 57  EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE-------------- 102
Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                              LF+  V K    E + + +   VL  + YLH LG +HRD+K
Sbjct: 103 -------------------LFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 323 AGNIL---LTETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVD 376
             N+L   L E   + ++DFG + ++ P +      GTP ++APEV+    +  Y   VD
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---QKPYSKAVD 200
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS+G+    L    PP+++           +ND    +       + + +  E   PY+
Sbjct: 201 CWSIGVIAYILLCGYPPFYD-----------ENDAKLFE-------QILKAEYEFDSPYW 242
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           +                     D SD+   F+   + K+P  R +  + L H
Sbjct: 243 D---------------------DISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 53/294 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKH 221
           F+ LR IG GS+  V   R   +  I A++  K   +       W    K + F +   H
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNH 112
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P  +    C+  +   + V+EY  G   D++        FH++                 
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGG--DLM--------FHMQ----------------- 145
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                  +R L EE      + +   LNYLH  G I+RD+K  N+LL   G +KL D+G 
Sbjct: 146 ------RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199
Query: 342 ASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
                      ++F GTP ++APE++   D   Y   VD W+LG+   E+   + P F++
Sbjct: 200 CKEGLRPGDTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSP-FDI 255
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                   +  +D P   + D+ + + I     R P   ++ A S L      D
Sbjct: 256 --------VGSSDNPDQNTEDY-LFQVILEKQIRIPRSLSVKAASVLKSFLNKD 300

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 32/65 (49%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
            V+EY  G         +R L EE      + +   LNYLH  G I+RD+K  N+LL   
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 676 GTVKL 680
           G +KL
Sbjct: 190 GHIKL 194

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 52/295 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++  R +G GSFG V   +  ++ +  A+K +S    +       +L+E++ L+QL HPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +      +LV E   G                                   LF
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGE---------------------------------LF 120
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFG 340
           +  + ++   E + A I   VL G+ Y+H    +HRD+K  N+LL   ++   +++ DFG
Sbjct: 121 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 180
Query: 341 -----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
                 AS K      +GT Y++APEV+     G YD K DVWS G+    L    PP+ 
Sbjct: 181 LSTHFEASKKMKDK--IGTAYYIAPEVL----HGTYDEKCDVWSTGVILYILLSGCPPFN 234
Query: 396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERK----PPYFNMNAMSALYH 446
             N    L  + +      +   W  +   +    RK     P   ++A  AL H
Sbjct: 235 GANEYDILKKVEKGKY-TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 288

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 114/240 (47%), Gaps = 38/240 (15%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIM 67
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R+L H N +  R  +           Y  G   D + ++ +    +V     R+ +    
Sbjct: 68  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLD--YVPETVYRVAR---- 110
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
                  ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +K
Sbjct: 111 -------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163
Query: 336 LADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA       P  S++ + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 221

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 114/249 (45%), Gaps = 41/249 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +  IG+G++G V  AR  ++ + VAIKK+              L+E++ L+  KH N
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPN-AFDVVTNAKRTLRELKILKHFKHDN 114
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I  +   LR    +       G    +  V        ++ M + L Q+          
Sbjct: 115 IIAIKDI-LRPTVPY-------GEFKSVYVV--------LDLMESDLHQI---------- 148
Query: 284 NFEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
              +H  +PL  E +      +LRGL Y+HS   IHRD+K  N+L+ E   +K+ DFG A
Sbjct: 149 ---IHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205
Query: 343 SIKC--PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
              C  PA        +V T ++ APE++L++ E  Y   +D+WS+G    E+  R+  +
Sbjct: 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE--YTQAIDLWSVGCIFGEMLARRQLF 263
Query: 395 FNMNAMSAL 403
              N +  L
Sbjct: 264 PGKNYVHQL 272

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 54/290 (18%)
Query: 167 LRE-IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           +RE +G GSFG V  A    +++ VA+K +S    + ++    + +EI +L+ L+HP+ I
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +            +V+EY  G                                   LF++
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGE----------------------------------LFDY 98
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
            V K+ + E+E       ++  + Y H    +HRD+K  N+LL +   VK+ADFG ++I 
Sbjct: 99  IVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
Query: 346 CPANSF---VGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITC-IELAERKP------PY 394
              N      G+P + APEVI   +   Y G +VDVWS GI   + L  R P      P 
Sbjct: 159 TDGNFLKTSCGSPNYAAPEVI---NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215
Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVI-----KTISSTAERKPPYFNMN 439
                 S +Y +    +P  QS    +I     + I+    R+ P+FN+N
Sbjct: 216 LFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 115/252 (45%), Gaps = 41/252 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +  IG+G++G V  AR  ++ + VAIKK+              L+E++ L+  KH N
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPN-AFDVVTNAKRTLRELKILKHFKHDN 115
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I  +   LR    +       G    +  V        ++ M + L Q+          
Sbjct: 116 IIAIKDI-LRPTVPY-------GEFKSVYVV--------LDLMESDLHQI---------- 149
Query: 284 NFEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
              +H  +PL  E +      +LRGL Y+HS   IHRD+K  N+L+ E   +K+ DFG A
Sbjct: 150 ---IHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 206
Query: 343 SIKC--PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
              C  PA        +V T ++ APE++L++ E  Y   +D+WS+G    E+  R+  +
Sbjct: 207 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE--YTQAIDLWSVGCIFGEMLARRQLF 264
Query: 395 FNMNAMSALYHI 406
              N +  L  I
Sbjct: 265 PGKNYVHQLQLI 276

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 48/257 (18%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 103
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 104 LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 152
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 153 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 252
Query: 390 RKPPYFNMNAMSALYHI 406
            +P +   + +  L  I
Sbjct: 253 GQPIFPGDSGVDQLVEI 269

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 42/240 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L +IG G++G V+ A+   + EIVA+K++  L        +  L+EI  L++LKH N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKN 62
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        D    LV E+C                          Q LK +       
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCD-------------------------QDLKKY------- 90
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
            F+     L  E + +    +L+GL + HS   +HRD+K  N+L+   G +KLA+FG A 
Sbjct: 91  -FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
Query: 344 -----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                ++C +   V T ++  P+V+       Y   +D+WS G    ELA    P F  N
Sbjct: 150 AFGIPVRCYSAEVV-TLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAGRPLFPGN 206

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 36/253 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P+++ + LR +G G++G+V  A     R+ VA+KK+S   +          +E+R L+
Sbjct: 17  EVPQRL-QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA-RRTYRELRLLK 74
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            LKH N I     +               S  D  EV+ +        MG  L  + KC 
Sbjct: 75  HLKHENVIGLLDVFT-----------PATSIEDFSEVYLV-----TTLMGADLNNIVKC- 117
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L +E +  +   +LRGL Y+HS G IHRD+K  N+ + E   +++
Sbjct: 118 -------------QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 164
Query: 337 ADFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL + K  + 
Sbjct: 165 LDFGLARQADEEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLQGKALFP 222
Query: 396 NMNAMSALYHIAQ 408
             + +  L  I +
Sbjct: 223 GSDYIDQLKRIME 235

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 90/347 (25%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKXVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++                    
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME------------------- 122
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 123 -----------------LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 279
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 280 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 13/80 (16%)
Query: 611 LFSPQ----------LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 660
           +F+PQ          LVME    +   +I++    L  E ++ +   +L G+ +LHS G 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHERMSYLLYQMLXGIKHLHSAGI 147
Query: 661 IHRDVKAGNILLTETGTVKL 680
           IHRD+K  NI++    T+K+
Sbjct: 148 IHRDLKPSNIVVKSDXTLKI 167

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 113/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 81
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 82  LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 130
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 131 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 172
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 173 VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 230
Query: 390 RKP 392
            +P
Sbjct: 231 GQP 233

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 46/226 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E +++IG G+FG     R   S E+VA+K +   G++  E   ++ +EI   R L+HPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDE---NVKREIINHRSLRHPN 76
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++   L      +VMEY  G                   +  R+     F+E  A F
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGE-----------------LFERICNAGRFSEDEARF 119
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFG- 340
            F+                 ++ G++Y H++   HRD+K  N LL  +    +K+  FG 
Sbjct: 120 FFQ----------------QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGY 163
Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGIT 383
             S+ +       VGTP ++APEV+L   + +YDGKV DVWS G+T
Sbjct: 164 SKSSVLHSQPKDTVGTPAYIAPEVLL---KKEYDGKVADVWSCGVT 206

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 93/343 (27%), Positives = 139/343 (40%), Gaps = 64/343 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKXVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 279
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
             A ++   L++S   D     +S  L  +PA R S    L H
Sbjct: 280 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQH 318

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 113/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 88
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 89  LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 137
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 138 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 179
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 180 VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 237
Query: 390 RKP 392
            +P
Sbjct: 238 GQP 240

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 55/265 (20%)
Query: 144 GSLKDPEIA----ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV---SREIVAIKKMS 196
           GS+K+  I     E  +K DP + FE L+ +G GSFG V+  + +    +R++ A+K + 
Sbjct: 3   GSIKEIAITHHVKEGHEKADPSQ-FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL- 60
Query: 197 YLGKQCAEKWADILK---EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
              K+   K  D ++   E   L ++ HP  ++    +  +   +L++++  G       
Sbjct: 61  ---KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG------ 111
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                       +  RL +   FTE                E++    + +   L++LHS
Sbjct: 112 -----------DLFTRLSKEVMFTE----------------EDVKFYLAELALALDHLHS 144
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEG 369
           LG I+RD+K  NILL E G +KL DFG    S   +  A SF GT  +MAPEV+   +  
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV---NRR 201
Query: 370 QYDGKVDVWSLGITCIELAERKPPY 394
            +    D WS G+   E+     P+
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 113/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 81
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 82  LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 130
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 131 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 172
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 173 VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 230
Query: 390 RKP 392
            +P
Sbjct: 231 GQP 233

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 55/265 (20%)
Query: 144 GSLKDPEIA----ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV---SREIVAIKKMS 196
           GS+K+  I     E  +K DP + FE L+ +G GSFG V+  + +    +R++ A+K + 
Sbjct: 4   GSIKEIAITHHVKEGHEKADPSQ-FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL- 61
Query: 197 YLGKQCAEKWADILK---EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
              K+   K  D ++   E   L ++ HP  ++    +  +   +L++++  G       
Sbjct: 62  ---KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG------ 112
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                       +  RL +   FTE                E++    + +   L++LHS
Sbjct: 113 -----------DLFTRLSKEVMFTE----------------EDVKFYLAELALALDHLHS 145
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEG 369
           LG I+RD+K  NILL E G +KL DFG    S   +  A SF GT  +MAPEV+   +  
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV---NRR 202
Query: 370 QYDGKVDVWSLGITCIELAERKPPY 394
            +    D WS G+   E+     P+
Sbjct: 203 GHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 113/243 (46%), Gaps = 48/243 (19%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 77
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQQL 273
           L H N +  R  +           Y  G   D + ++ +     E  + V    +R +Q 
Sbjct: 78  LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 126
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETG 332
                +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +T 
Sbjct: 127 LPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPDTA 168
Query: 333 TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            +KL DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL  
Sbjct: 169 VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLL 226
Query: 390 RKP 392
            +P
Sbjct: 227 GQP 229

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 55/265 (20%)
Query: 144 GSLKDPEIA----ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV---SREIVAIKKMS 196
           GS+K+  I     E  +K DP + FE L+ +G GSFG V+  + +    +R++ A+K + 
Sbjct: 3   GSIKEIAITHHVKEGHEKADPSQ-FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL- 60
Query: 197 YLGKQCAEKWADILK---EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
              K+   K  D ++   E   L ++ HP  ++    +  +   +L++++  G       
Sbjct: 61  ---KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG------ 111
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                       +  RL +   FTE                E++    + +   L++LHS
Sbjct: 112 -----------DLFTRLSKEVMFTE----------------EDVKFYLAELALALDHLHS 144
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEG 369
           LG I+RD+K  NILL E G +KL DFG    S   +  A SF GT  +MAPEV+   +  
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV---NRR 201
Query: 370 QYDGKVDVWSLGITCIELAERKPPY 394
            +    D WS G+   E+     P+
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 103/239 (43%), Gaps = 56/239 (23%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G FG    A  +  RE   +  M  L +   E     LKE++ +R L+HPN +++ G
Sbjct: 18  LGKGCFGQ---AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D     + EY  G                + G+   +     +++  +        
Sbjct: 75  VLYKDKRLNFITEYIKGGT--------------LRGIIKSMDSQYPWSQRVSF------- 113
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA------- 342
                ++IA+       G+ YLHS+  IHRD+ + N L+ E   V +ADFG A       
Sbjct: 114 ----AKDIAS-------GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162
Query: 343 -------SIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
                  S+K P      + VG PYWMAPE+I   +   YD KVDV+S GI   E+  R
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI---NGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 38/240 (15%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIM 67
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R+L H N +  R  +           Y  G   D + ++ +    +V     R+ +    
Sbjct: 68  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLD--YVPETVYRVAR---- 110
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
                  ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +K
Sbjct: 111 -------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163
Query: 336 LADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 164 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 38/240 (15%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +
Sbjct: 16  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIM 68
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R+L H N +  R  +           Y  G   D + ++ +    +V     R+ +    
Sbjct: 69  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLD--YVPETVYRVAR---- 111
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
                  ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +K
Sbjct: 112 -------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 164
Query: 336 LADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 165 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 93/343 (27%), Positives = 139/343 (40%), Gaps = 64/343 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKXVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 279
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
             A ++   L++S   D     +S  L  +PA R S    L H
Sbjct: 280 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQH 318

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 114/245 (46%), Gaps = 48/245 (19%)
Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +
Sbjct: 19  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIM 71
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI-----EREFHVEGMGNRLQ 271
           R+L H N +  R  +           Y  G   D + ++ +     E  + V    +R +
Sbjct: 72  RKLDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 120
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TE 330
           Q      +  L+ +++                  R L Y+HS G  HRD+K  N+LL  +
Sbjct: 121 QTLPVI-YVKLYMYQL-----------------FRSLAYIHSFGICHRDIKPQNLLLDPD 162
Query: 331 TGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           T  +KL DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL
Sbjct: 163 TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAEL 220
Query: 388 AERKP 392
              +P
Sbjct: 221 LLGQP 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 112/238 (47%), Gaps = 38/238 (15%)
Query: 160 PEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +++ +  +E++ +R+
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN--RELQIMRK 69
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           L H N +  R  +           Y  G   D + ++ +    +V     R+ +      
Sbjct: 70  LDHCNIVRLRYFF-----------YSSGEKKDEVYLNLVLD--YVPETVYRVAR------ 110
Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLA 337
                ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +KL 
Sbjct: 111 -----HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 165
Query: 338 DFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           DFGSA       P  S + + Y+ APE+I    +  Y   +DVWS G    EL   +P
Sbjct: 166 DFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQP 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 50/250 (20%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEKWADILKEIR 214
           ED +KIFE    +G G+F  V  A    + ++ A+K   K +  GK+ +     I  EI 
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS-----IENEIA 72
Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            LR++KH N +     Y   +  +LVM+   G                            
Sbjct: 73  VLRKIKHENIVALEDIYESPNHLYLVMQLVSGGE-------------------------- 106
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TET 331
                  LF+  V K    E++ + +   VL  + YLH +G +HRD+K  N+L     E 
Sbjct: 107 -------LFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEE 159
Query: 332 GTVKLADFGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
             + ++DFG + ++   +   +  GTP ++APEV+    +  Y   VD WS+G+    L 
Sbjct: 160 SKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIAYILL 216
Query: 389 ERKPPYFNMN 398
              PP+++ N
Sbjct: 217 CGYPPFYDEN 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++ +G GSFG V  A    + + VA+K ++      ++    I +EI +LR L+HP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+     L D          + S  +II V        +E  GN L            F
Sbjct: 66  IIK-----LYD---------VIKSKDEIIMV--------IEYAGNEL------------F 91
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           ++ V +  + E+E       ++  + Y H    +HRD+K  N+LL E   VK+ADFG ++
Sbjct: 92  DYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSN 151
Query: 344 IKCPANSF---VGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGITCIELAERKPPY 394
           I    N      G+P + APEVI     G+ Y G +VDVWS G+    +  R+ P+
Sbjct: 152 IMTDGNFLKTSCGSPNYAAPEVI----SGKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/338 (23%), Positives = 135/338 (39%), Gaps = 85/338 (25%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE-KWADILKEIRFL 216
           ED   I++    +G G+F  V  A    ++++VAIK ++   K+  E K   +  EI  L
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---KEALEGKEGSMENEIAVL 70
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            ++KHPN +     Y      +L+M+   G                              
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---------------------------- 102
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL---LTETGT 333
                LF+  V K    E + + +   VL  + YLH LG +HRD+K  N+L   L E   
Sbjct: 103 -----LFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK 157
Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           + ++DFG + ++ P +      GTP ++APEV+    +  Y   VD WS+G+    L   
Sbjct: 158 IMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIAYILLCG 214
Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
            PP+++           +ND    +       + + +  E   PY++             
Sbjct: 215 YPPFYD-----------ENDAKLFE-------QILKAEYEFDSPYWD------------- 243
Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                   D SD+   F+   + K+P  R +  + L H
Sbjct: 244 --------DISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++ +G GSFG V  A    + + VA+K ++      ++    I +EI +LR L+HP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+     L D          + S  +II V        +E  GN L            F
Sbjct: 76  IIK-----LYD---------VIKSKDEIIMV--------IEYAGNEL------------F 101
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           ++ V +  + E+E       ++  + Y H    +HRD+K  N+LL E   VK+ADFG ++
Sbjct: 102 DYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSN 161
Query: 344 IKCPANSF---VGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGITCIELAERKPPY 394
           I    N      G+P + APEVI     G+ Y G +VDVWS G+    +  R+ P+
Sbjct: 162 IMTDGNFLKTSCGSPNYAAPEVI----SGKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 33/236 (13%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+++  IG G FG V+ A+  +  +   I+++ Y  ++         +E++ L +L H N
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE-------REVKALAKLDHVN 66
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ-QLKC------F 276
            + Y GC       W   +Y   ++ D +E      ++  E   N  + + KC      F
Sbjct: 67  IVHYNGC-------WDGFDYDPETSDDSLE----SSDYDPENSKNSSRSKTKCLFIQMEF 115
Query: 277 TEHFALFNFEVHKRPLKEEEIAAI--CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            +   L  +   +R  K +++ A+     + +G++Y+HS   IHRD+K  NI L +T  V
Sbjct: 116 CDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQV 175
Query: 335 KLADFG-SASIKCPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           K+ DFG   S+K         GT  +M+PE I + D G+   +VD+++LG+   EL
Sbjct: 176 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK---EVDLYALGLILAEL 228

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++ +G GSFG V  A    + + VA+K ++      ++    I +EI +LR L+HP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+     L D          + S  +II V        +E  GN L            F
Sbjct: 75  IIK-----LYD---------VIKSKDEIIMV--------IEYAGNEL------------F 100
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           ++ V +  + E+E       ++  + Y H    +HRD+K  N+LL E   VK+ADFG ++
Sbjct: 101 DYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSN 160
Query: 344 IKCPANSF---VGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGITCIELAERKPPY 394
           I    N      G+P + APEVI     G+ Y G +VDVWS G+    +  R+ P+
Sbjct: 161 IMTDGNFLKTSCGSPNYAAPEVI----SGKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 43/236 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++ +G GSFG V  A    + + VA+K ++      ++    I +EI +LR L+HP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+     L D          + S  +II V        +E  GN L            F
Sbjct: 70  IIK-----LYD---------VIKSKDEIIMV--------IEYAGNEL------------F 95
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           ++ V +  + E+E       ++  + Y H    +HRD+K  N+LL E   VK+ADFG ++
Sbjct: 96  DYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSN 155
Query: 344 IKCPANSF---VGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGITCIELAERKPPY 394
           I    N      G+P + APEVI     G+ Y G +VDVWS G+    +  R+ P+
Sbjct: 156 IMTDGNFLKTSCGSPNYAAPEVI----SGKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/338 (23%), Positives = 134/338 (39%), Gaps = 85/338 (25%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE-KWADILKEIRFL 216
           ED   I++    +G G+F  V  A    ++++VAIK    + K+  E K   +  EI  L
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK---CIAKEALEGKEGSMENEIAVL 70
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            ++KHPN +     Y      +L+M+   G                              
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---------------------------- 102
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL---LTETGT 333
                LF+  V K    E + + +   VL  + YLH LG +HRD+K  N+L   L E   
Sbjct: 103 -----LFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK 157
Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           + ++DFG + ++ P +      GTP ++APEV+    +  Y   VD WS+G+    L   
Sbjct: 158 IMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIAYILLCG 214
Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
            PP+++           +ND    +       + + +  E   PY++             
Sbjct: 215 YPPFYD-----------ENDAKLFE-------QILKAEYEFDSPYWD------------- 243
Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                   D SD+   F+   + K+P  R +  + L H
Sbjct: 244 --------DISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/338 (24%), Positives = 140/338 (41%), Gaps = 85/338 (25%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE-KWADILKEIRFL 216
           ED   I++    +G G+F  V  A    ++++VAIK    + K+  E K   +  EI  L
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK---CIAKEALEGKEGSMENEIAVL 70
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            ++KHPN +     Y      +L+M+  L S  ++ +   +E+ F+ E   +RL      
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQ--LVSGGELFD-RIVEKGFYTERDASRL------ 121
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL---LTETGT 333
                +F                    VL  + YLH LG +HRD+K  N+L   L E   
Sbjct: 122 -----IFQ-------------------VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK 157
Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           + ++DFG + ++ P +      GTP ++APEV+    +  Y   VD WS+G+    L   
Sbjct: 158 IMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIAYILLCG 214
Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
            PP+++           +ND    +       + + +  E   PY++             
Sbjct: 215 YPPFYD-----------ENDAKLFE-------QILKAEYEFDSPYWD------------- 243
Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                   D SD+   F+   + K+P  R +  + L H
Sbjct: 244 --------DISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 90/347 (25%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 74
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++                    
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME------------------- 115
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 116 -----------------LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 158
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 159 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 213
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 273 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 45/246 (18%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---E 212
           +K DP   FE L+ +G GSFG V+  R +   +   +  M  L K+   K  D ++   E
Sbjct: 23  EKADPSH-FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVL-KKATLKVRDRVRTKME 80
Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
              L  + HP  ++    +  +   +L++++  G                   +  RL +
Sbjct: 81  RDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGG-----------------DLFTRLSK 123
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
              FT                EE++    + +  GL++LHSLG I+RD+K  NILL E G
Sbjct: 124 EVMFT----------------EEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEG 167
Query: 333 TVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            +KL DFG    +   +  A SF GT  +MAPEV+   +   +    D WS G+   E+ 
Sbjct: 168 HIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV---NRQGHSHSADWWSYGVLMFEML 224
Query: 389 ERKPPY 394
               P+
Sbjct: 225 TGSLPF 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/43 (48%), Positives = 30/43 (69%)
Query: 638 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           EE++    + +  GL++LHSLG I+RD+K  NILL E G +KL
Sbjct: 129 EEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKL 171

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 90/347 (25%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++                    
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME------------------- 122
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 123 -----------------LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 279
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 280 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 82
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 137
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 138 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 167 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 221
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 222 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 280
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 281 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 60/249 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           F+ L+ +G G+FG V          YYA  ++ +E++  K          ++ A  + E 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTES 59
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 60  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 102
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + FTE  A F                  + ++  L YLHS   ++RD+K  N++L + G 
Sbjct: 103 RVFTEERARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 146
Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ DFG      S      +F GTP ++APEV   +++  Y   VD W LG+   E+  
Sbjct: 147 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMC 203
Query: 390 RKPPYFNMN 398
            + P++N +
Sbjct: 204 GRLPFYNQD 212

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 60/249 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           F+ L+ +G G+FG V          YYA  ++ +E++  K          ++ A  + E 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTES 56
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 99
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + FTE  A F                  + ++  L YLHS   ++RD+K  N++L + G 
Sbjct: 100 RVFTEERARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ DFG      S      +F GTP ++APEV   +++  Y   VD W LG+   E+  
Sbjct: 144 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 390 RKPPYFNMN 398
            + P++N +
Sbjct: 201 GRLPFYNQD 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 60/249 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           F+ L+ +G G+FG V          YYA  ++ +E++  K          ++ A  + E 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTES 56
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 99
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + FTE  A F                  + ++  L YLHS   ++RD+K  N++L + G 
Sbjct: 100 RVFTEERARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ DFG      S      +F GTP ++APEV   +++  Y   VD W LG+   E+  
Sbjct: 144 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 390 RKPPYFNMN 398
            + P++N +
Sbjct: 201 GRLPFYNQD 209

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 110/247 (44%), Gaps = 33/247 (13%)
Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           ++ DL+ +G G++GAV  A    +   VAIKK+ Y   Q         +E+R L+ ++H 
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N I     +  D T        L   +D   V        +  MG  L +L         
Sbjct: 85  NVIGLLDVFTPDET--------LDDFTDFYLV--------MPFMGTDLGKL--------- 119
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
               +    L E+ I  +   +L+GL Y+H+ G IHRD+K GN+ + E   +K+ DFG A
Sbjct: 120 ----MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                     V T ++ APEVIL  +  +Y   VD+WS+G    E+   K  +   + + 
Sbjct: 176 RQADSEMXGXVVTRWYRAPEVIL--NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
Query: 402 ALYHIAQ 408
            L  I +
Sbjct: 234 QLKEIMK 240

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 80
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 135
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 136 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 164
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 165 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 219
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 220 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 278
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 279 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 321

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 110/254 (43%), Gaps = 63/254 (24%)
Query: 155 FDKEDP----EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKW 206
           F+  DP    E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      E  
Sbjct: 2   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHL 58
Query: 207 ADILKEIRFLRQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
            D  +EI  L+ L+H N ++Y+G CY        L+MEY   GS  D ++ H  ER    
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH-AER---- 113
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                         +H  L  +                S + +G+ YL +   IHRD+  
Sbjct: 114 -------------IDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLAT 145
Query: 324 GNILLTETGTVKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
            NIL+     VK+ DFG             +K P  S +   +W APE   ++ E ++  
Sbjct: 146 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSV 199
Query: 374 KVDVWSLGITCIEL 387
             DVWS G+   EL
Sbjct: 200 ASDVWSFGVVLYEL 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 279
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 280 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 63/254 (24%)
Query: 155 FDKEDP----EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKW 206
           F+  DP    E+  + L+++G G+FG+V   R       + E+VA+KK+ +      E  
Sbjct: 30  FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHL 86
Query: 207 ADILKEIRFLRQLKHPNTIEYRG-CYLRDHTAW-LVMEYC-LGSASDIIEVHWIEREFHV 263
            D  +EI  L+ L+H N ++Y+G CY        L+MEY   GS  D ++ H        
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-------- 138
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                     K   +H  L  +                S + +G+ YL +   IHRD+  
Sbjct: 139 ----------KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLAT 173
Query: 324 GNILLTETGTVKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
            NIL+     VK+ DFG             +K P  S +   +W APE   ++ E ++  
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSV 227
Query: 374 KVDVWSLGITCIEL 387
             DVWS G+   EL
Sbjct: 228 ASDVWSFGVVLYEL 241

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 75
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 130
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 131 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 160 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 214
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 215 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 273
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 274 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 63/254 (24%)
Query: 155 FDKEDP----EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKW 206
           F+  DP    E+  + L+++G G+FG+V   R       + E+VA+KK+ +      E  
Sbjct: 6   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHL 62
Query: 207 ADILKEIRFLRQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
            D  +EI  L+ L+H N ++Y+G CY        L+MEY   GS  D ++ H        
Sbjct: 63  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-------- 114
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                     K   +H  L  +                S + +G+ YL +   IHRD+  
Sbjct: 115 ----------KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLAT 149
Query: 324 GNILLTETGTVKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
            NIL+     VK+ DFG             +K P  S +   +W APE   ++ E ++  
Sbjct: 150 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSV 203
Query: 374 KVDVWSLGITCIEL 387
             DVWS G+   EL
Sbjct: 204 ASDVWSFGVVLYEL 217

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 279
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 280 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 82
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 137
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 138 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 167 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 221
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 222 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 280
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 281 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 63/254 (24%)
Query: 155 FDKEDP----EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKW 206
           F+  DP    E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      E  
Sbjct: 4   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHL 60
Query: 207 ADILKEIRFLRQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
            D  +EI  L+ L+H N ++Y+G CY        L+MEY   GS  D ++ H        
Sbjct: 61  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-------- 112
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                     K   +H  L  +                S + +G+ YL +   IHRD+  
Sbjct: 113 ----------KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLAT 147
Query: 324 GNILLTETGTVKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
            NIL+     VK+ DFG             +K P  S +   +W APE   ++ E ++  
Sbjct: 148 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSV 201
Query: 374 KVDVWSLGITCIEL 387
             DVWS G+   EL
Sbjct: 202 ASDVWSFGVVLYEL 215

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 11/175 (6%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           LF++   K  L E+E  +I   +L  +++LH+   +HRD+K  NILL +   ++L+DFG 
Sbjct: 187 LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246
Query: 342 ASIKCPANS---FVGTPYWMAPEVI-LAMDEGQ--YDGKVDVWSLGITCIELAERKPPYF 395
           +    P        GTP ++APE++  +MDE    Y  +VD+W+ G+    L    PP++
Sbjct: 247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306
Query: 396 NMNAMSALYHIAQNDTPCLQSSDW----SVIKTISSTAERKPPYFNMNAMSALYH 446
           +   +  L  I +       S +W    S +K + S   +  P   + A  AL H
Sbjct: 307 HRRQILMLRMIMEGQYQ-FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE++  +G G+FG V  AR  +     AIKK+    +   EK + IL E+  L  L H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQY 63
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIE--VHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            + Y       + AWL     +   + + +    +I+ E+             C  E+  
Sbjct: 64  VVRY-------YAAWLERRNFVKPXTAVKKKSTLFIQXEY-------------C--ENRT 101
Query: 282 LFNFEVHKRPLKEE--EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
           L++  +H   L ++  E   +   +L  L+Y+HS G IHR++K  NI + E+  VK+ DF
Sbjct: 102 LYDL-IHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 340 GSA-------------SIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           G A             S   P +     S +GT  ++A EV+     G Y+ K+D +SLG
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGT--GHYNEKIDXYSLG 218
Query: 382 ITCIE 386
           I   E
Sbjct: 219 IIFFE 223

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 63/254 (24%)
Query: 155 FDKEDP----EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKW 206
           F+  DP    E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      E  
Sbjct: 3   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHL 59
Query: 207 ADILKEIRFLRQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
            D  +EI  L+ L+H N ++Y+G CY        L+MEY   GS  D ++ H        
Sbjct: 60  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-------- 111
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                     K   +H  L  +                S + +G+ YL +   IHRD+  
Sbjct: 112 ----------KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLAT 146
Query: 324 GNILLTETGTVKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
            NIL+     VK+ DFG             +K P  S +   +W APE   ++ E ++  
Sbjct: 147 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSV 200
Query: 374 KVDVWSLGITCIEL 387
             DVWS G+   EL
Sbjct: 201 ASDVWSFGVVLYEL 214

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 74
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 129
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 130 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 158
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 159 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 213
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 273 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 42/254 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR-QLKHP 222
           FE  + +G GSFG V+ A    + +  AIK +        +     + E R L    +HP
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                   +      + VMEY  G   D++        +H++                  
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGG--DLM--------YHIQS----------------- 112
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                HK  L      A  + ++ GL +LHS G ++RD+K  NILL + G +K+ADFG  
Sbjct: 113 ----CHKFDLSRATFYA--AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 166
Query: 343 SIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                     N F GTP ++APE++L     +Y+  VD WS G+   E+   + P+   +
Sbjct: 167 KENMLGDAKTNEFCGTPDYIAPEILLGQ---KYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223
Query: 399 AMSALYHIAQNDTP 412
               L+H  + D P
Sbjct: 224 E-EELFHSIRMDNP 236

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 110/257 (42%), Gaps = 63/257 (24%)
Query: 152 AELFDKEDP----EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCA 203
           A  F+  DP    E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      
Sbjct: 2   AMAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STE 58
Query: 204 EKWADILKEIRFLRQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIERE 260
           E   D  +EI  L+ L+H N ++Y+G CY        L+MEY   GS  D ++ H     
Sbjct: 59  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----- 113
Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
                        K   +H  L  +                S + +G+ YL +   IHRD
Sbjct: 114 -------------KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRD 145
Query: 321 VKAGNILLTETGTVKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQ 370
           +   NIL+     VK+ DFG             +K P  S +   +W APE   ++ E +
Sbjct: 146 LATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESK 199
Query: 371 YDGKVDVWSLGITCIEL 387
           +    DVWS G+   EL
Sbjct: 200 FSVASDVWSFGVVLYEL 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 75
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 130
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 131 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 160 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 214
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 215 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 273
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 274 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 55/238 (23%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    + S +I++                    
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME------------------- 122
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 123 -----------------LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G+   E+
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGVIMGEM 218

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 13/80 (16%)
Query: 611 LFSPQ----------LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 660
           +F+PQ          +VME    + S +I++    L  E ++ +   +L G+ +LHS G 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHERMSYLLYQMLVGIKHLHSAGI 147
Query: 661 IHRDVKAGNILLTETGTVKL 680
           IHRD+K  NI++    T+K+
Sbjct: 148 IHRDLKPSNIVVKSDATLKI 167

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 93/347 (26%), Positives = 140/347 (40%), Gaps = 64/347 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 119
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 174
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 175 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 204 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 258
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 259 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 317
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
             A ++   L++S   D     +S  L  +PA R S    L H  + 
Sbjct: 318 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYIN 360

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 93/346 (26%), Positives = 140/346 (40%), Gaps = 64/346 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   V    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 119
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I++     E   E M   L Q+ 
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQML 174
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 175 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 204 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVR 258
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL---Y 445
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y  +          
Sbjct: 259 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRPKYAGLTFPKLFPDSL 317
Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
             A ++   L++S   D     +S  L  +PA R S    L H  +
Sbjct: 318 FPADSEHNKLKASQARD----LLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 105/249 (42%), Gaps = 60/249 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           F+ L+ +G G+FG V          YYA  ++ +E++  K          ++ A  + E 
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTES 61
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 62  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 104
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + FTE  A F                  + ++  L YLHS   ++RD+K  N++L + G 
Sbjct: 105 RVFTEERARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 148
Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ DFG      S       F GTP ++APEV   +++  Y   VD W LG+   E+  
Sbjct: 149 IKITDFGLCKEGISDGATMKXFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMC 205
Query: 390 RKPPYFNMN 398
            + P++N +
Sbjct: 206 GRLPFYNQD 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 108/254 (42%), Gaps = 53/254 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           IG G FG VY  R     + VA+K   +   +  ++   ++ +E +    LKHPN I  R
Sbjct: 15  IGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G  L++    LVME+  G                  G  NR+   K       L N+ V 
Sbjct: 73  GVCLKEPNLCLVMEFARG------------------GPLNRVLSGKRIPPDI-LVNWAVQ 113
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHS---LGRIHRDVKAGNILL---TETG-----TVKLA 337
                          + RG+NYLH    +  IHRD+K+ NIL+    E G      +K+ 
Sbjct: 114 ---------------IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158
Query: 338 DFGSASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           DFG A    +    S  G   WMAPEVI A     +    DVWS G+   EL   + P+ 
Sbjct: 159 DFGLAREWHRTTKMSAAGAYAWMAPEVIRA---SMFSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 396 NMNAMSALYHIAQN 409
            ++ ++  Y +A N
Sbjct: 216 GIDGLAVAYGVAMN 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 105/249 (42%), Gaps = 60/249 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           F+ L+ +G G+FG V          YYA  ++ +E++  K          ++ A  + E 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTES 56
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 99
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + FTE  A F                  + ++  L YLHS   ++RD+K  N++L + G 
Sbjct: 100 RVFTEERARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ DFG      S       F GTP ++APEV   +++  Y   VD W LG+   E+  
Sbjct: 144 IKITDFGLCKEGISDGATMKXFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 390 RKPPYFNMN 398
            + P++N +
Sbjct: 201 GRLPFYNQD 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 105/249 (42%), Gaps = 60/249 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           F+ L+ +G G+FG V          YYA  ++ +E++  K          ++ A  + E 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTES 56
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 99
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + FTE  A F                  + ++  L YLHS   ++RD+K  N++L + G 
Sbjct: 100 RVFTEERARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ DFG      S       F GTP ++APEV   +++  Y   VD W LG+   E+  
Sbjct: 144 IKITDFGLCKEGISDGATMKXFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 390 RKPPYFNMN 398
            + P++N +
Sbjct: 201 GRLPFYNQD 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 101/237 (42%), Gaps = 36/237 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ-LKHP 222
           FE L+ +G G++G V+  R +   +   +  M  L K    + A   +  R  RQ L+H 
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH- 114
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                    +R     + + Y   + +   ++H I    +   +   L Q + FTEH   
Sbjct: 115 ---------IRQSPFLVTLHYAFQTET---KLHLILDYINGGELFTHLSQRERFTEH--- 159
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-- 340
                        E+      ++  L +LH LG I+RD+K  NILL   G V L DFG  
Sbjct: 160 -------------EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
Query: 341 ---SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               A     A  F GT  +MAP+++   D G +D  VD WSLG+   EL     P+
Sbjct: 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELLTGASPF 262

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 105/249 (42%), Gaps = 60/249 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           F+ L+ +G G+FG V          YYA  ++ +E++  K          ++ A  + E 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTES 56
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 99
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + FTE  A F                  + ++  L YLHS   ++RD+K  N++L + G 
Sbjct: 100 RVFTEERARF----------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ DFG      S       F GTP ++APEV   +++  Y   VD W LG+   E+  
Sbjct: 144 IKITDFGLCKEGISDGATMKXFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 390 RKPPYFNMN 398
            + P++N +
Sbjct: 201 GRLPFYNQD 209

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLG-KQCAEKWADILK-EIRFLRQLKHPNTIEY 227
           IG GS+G V  A    +R I AIK M+    +Q   K  + +K E+R +++L HPN    
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 228 RGCYLRDHTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
              Y  +    LVME C G    D + V   +          + Q   C   +    N  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 287 VH--KRPL----KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT--VKLAD 338
           +H  +  L    +E+ I+ I   +   L+YLH+ G  HRD+K  N L +   +  +KL D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 339 FGSASIKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           FG +      N        +  GTPY++APEV+   +E  Y  K D WS G+    L   
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES-YGPKCDAWSAGVLLHLLLMG 272
Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
             P+  +N    +  +  N   C ++ +++V+  ++
Sbjct: 273 AVPFPGVNDADTISQVL-NKKLCFENPNYNVLSPLA 307

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 111/254 (43%), Gaps = 63/254 (24%)
Query: 155 FDKEDP----EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKW 206
           F+  DP    E+  + LR++G G+FG+V   R    +    E+VA+KK+ +      E  
Sbjct: 2   FEDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHL 58
Query: 207 ADILKEIRFLRQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
            D  +EI  L+ L+H N ++Y+G CY        L+ME+   GS           RE+  
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSL----------REY-- 106
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                 LQ+ K   +H  L  +                S + +G+ YL +   IHRD+  
Sbjct: 107 ------LQKHKERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLAT 145
Query: 324 GNILLTETGTVKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
            NIL+     VK+ DFG             +K P  S +   +W APE   ++ E ++  
Sbjct: 146 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSV 199
Query: 374 KVDVWSLGITCIEL 387
             DVWS G+   EL
Sbjct: 200 ASDVWSFGVVLYEL 213

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 104/248 (41%), Gaps = 42/248 (16%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR-QLKHPNTIEYR 228
           +G GSFG V+ A    + +  AIK +        +     + E R L    +HP      
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
             +      + VMEY  G   D++        +H++                       H
Sbjct: 85  CTFQTKENLFFVMEYLNGG--DLM--------YHIQS---------------------CH 113
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK--- 345
           K  L      A  + ++ GL +LHS G ++RD+K  NILL + G +K+ADFG        
Sbjct: 114 KFDLSRATFYA--AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
Query: 346 -CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALY 404
               N F GTP ++APE++L     +Y+  VD WS G+   E+   + P+   +    L+
Sbjct: 172 DAKTNXFCGTPDYIAPEILLGQ---KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELF 227
Query: 405 HIAQNDTP 412
           H  + D P
Sbjct: 228 HSIRMDNP 235

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 94/180 (52%), Gaps = 17/180 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLGSASDIIE-VHKRPLKEEEIAAICSG 62
            LLR+L+H N I+       +     ++VMEYC+    ++++ V ++     +       
Sbjct: 58  QLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYW 116
           ++ GL YLHS G +H+D+K GN+LLT  GT+K++  G A    P        +  G+P +
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 117 MAPEVILAMDEGQYDG-KVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSF 175
             PE+   +D   + G KVD+WS G+T  ++        F+ ++  K+FE+   IG GS+
Sbjct: 178 QPPEIANGLD--TFSGFKVDIWSAGVTLYNITTGLYP--FEGDNIYKLFEN---IGKGSY 230

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 48/252 (19%)
Query: 170 IGHGSFGAVYY---ARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +G GS+G V     +  L  R +  +KK         E  A++ KEI+ LR+L+H N I+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGE--ANVKKEIQLLRRLRHKNVIQ 70
Query: 227 YRGCYLRD--HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
                  +     ++VMEYC+    ++++    E+ F V        QL           
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLD-SVPEKRFPVCQAHGYFCQL----------- 118
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                               + GL YLHS G +H+D+K GN+LLT  GT+K++  G A  
Sbjct: 119 --------------------IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158
Query: 345 KCP------ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNM 397
             P        +  G+P +  PE+   +D   + G KVD+WS G+T   +     P+   
Sbjct: 159 LHPFAADDTCRTSQGSPAFQPPEIANGLD--TFSGFKVDIWSAGVTLYNITTGLYPFEGD 216
Query: 398 NAMSALYHIAQN 409
           N      +I + 
Sbjct: 217 NIYKLFENIGKG 228

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 24/66 (36%), Positives = 41/66 (62%), Gaps = 1/66 (1%)
Query: 616 LVMEYCLGSASDIIE-VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEYC+    ++++ V ++     +       ++ GL YLHS G +H+D+K GN+LLT 
Sbjct: 85  MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT 144
Query: 675 TGTVKL 680
            GT+K+
Sbjct: 145 GGTLKI 150

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 104/241 (43%), Gaps = 53/241 (21%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      E   D  +EI  L
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 65
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 107
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 108 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 334 VKLADFGSASIKCPANSF--VGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           VK+ DFG   +      F  V  P     +W APE   ++ E ++    DVWS G+   E
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE---SLTESKFSVASDVWSFGVVLYE 209
Query: 387 L 387
           L
Sbjct: 210 L 210

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 19/151 (12%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           L++ + H N I     +    +       ++VME    + S +I++    L  E ++ + 
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHERMSYLL 132
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----Y 115
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A  +    SF+ TP     Y
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA--RTAGTSFMMTPYVVTRY 190
Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGITPGSL 146
           + APEVIL M    Y   VD+WS+G+  G +
Sbjct: 191 YRAPEVILGMG---YKENVDIWSVGVIMGEM 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 55/238 (23%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    + S +I++                    
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME------------------- 122
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 123 -----------------LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G+   E+
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGVIMGEM 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 13/80 (16%)
Query: 611 LFSPQ----------LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 660
           +F+PQ          +VME    + S +I++    L  E ++ +   +L G+ +LHS G 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHERMSYLLYQMLVGIKHLHSAGI 147
Query: 661 IHRDVKAGNILLTETGTVKL 680
           IHRD+K  NI++    T+K+
Sbjct: 148 IHRDLKPSNIVVKSDATLKI 167

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/339 (24%), Positives = 143/339 (42%), Gaps = 59/339 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + DL+ +G G  G V+ A      + VAIKK+     Q  +     L+EI+ +R+L H N
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLDHDN 69
Query: 224 TIEY------RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            ++        G  L D          +GS +++  V +I +E+    + N L+Q     
Sbjct: 70  IVKVFEILGPSGSQLTDD---------VGSLTELNSV-YIVQEYMETDLANVLEQGPLLE 119
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKL 336
           EH  LF +++                 LRGL Y+HS   +HRD+K  N+ + TE   +K+
Sbjct: 120 EHARLFMYQL-----------------LRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 337 ADFGSASIKCPANSFVG-------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            DFG A I  P  S  G       T ++ +P ++L+     Y   +D+W+ G    E+  
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS--PNNYTKAIDMWAAGCIFAEMLT 220
Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
            K  +   + +  +  I ++  P +   D   + ++        P +  N M+  +    
Sbjct: 221 GKTLFAGAHELEQMQLILES-IPVVHEEDRQELLSVI-------PVYIRNDMTEPHKPLT 272
Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
              P +     S     F+   L  +P DR ++   L+H
Sbjct: 273 QLLPGI-----SREAVDFLEQILTFSPMDRLTAEEALSH 306

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R       + E+VA+KK+ +      E   D  +EI  L
Sbjct: 12  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 68
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 110
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 111 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 155
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 209
Query: 384 CIEL 387
             EL
Sbjct: 210 LYEL 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 44/240 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E ++ IG G+FG V   R   +R++ A+K +S          A   +E   +     P 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  D   ++VMEY  G   D++ +                           + 
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNL---------------------------MS 166
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS-- 341
           N++V      E+      + V+  L+ +HS+G IHRDVK  N+LL ++G +KLADFG+  
Sbjct: 167 NYDV-----PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 221
Query: 342 -----ASIKCPANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF 395
                  ++C  ++ VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P++
Sbjct: 222 KMNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R       + E+VA+KK+ +      E   D  +EI  L
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 65
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 107
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 108 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 206
Query: 384 CIEL 387
             EL
Sbjct: 207 LYEL 210

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 41/235 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ L ++G G++G VY A+    R IVA+K++  L  +     +  ++EI  L++L HPN
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIR-LDAEDEGIPSTAIREISLLKELHHPN 80
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        +    LV E+                      M   L+++          
Sbjct: 81  IVSLIDVIHSERCLTLVFEF----------------------MEKDLKKV---------- 108
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
             + +K  L++ +I      +LRG+ + H    +HRD+K  N+L+   G +KLADFG A 
Sbjct: 109 -LDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +   P  S+   V T ++ AP+V+  M   +Y   VD+WS+G    E+   KP +
Sbjct: 168 AFGIPVRSYTHEVVTLWYRAPDVL--MGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++++G G++G V   +  ++    AIK +             +L E+  L+QL HPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +      +LVME   G                                   LF
Sbjct: 66  IMKLYEFFEDKRNYYLVMEVYRGGE---------------------------------LF 92
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFG 340
           +  + ++   E + A I   VL G  YLH    +HRD+K  N+LL   +    +K+ DFG
Sbjct: 93  DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 152
Query: 341 SAS---IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
            ++   +       +GT Y++APEV+      +YD K DVWS G+    L    PP+
Sbjct: 153 LSAHFEVGGKMKERLGTAYYIAPEVL----RKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 44/240 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E ++ IG G+FG V   R   +R++ A+K +S          A   +E   +     P 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  D   ++VMEY  G   D++ +                           + 
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNL---------------------------MS 161
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS-- 341
           N++V      E+      + V+  L+ +HS+G IHRDVK  N+LL ++G +KLADFG+  
Sbjct: 162 NYDV-----PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 342 -----ASIKCPANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF 395
                  ++C  ++ VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P++
Sbjct: 217 KMNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      E   D  +EI  L
Sbjct: 8   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 64
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 106
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 107 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 151
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 205
Query: 384 CIEL 387
             EL
Sbjct: 206 LYEL 209

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 41/235 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ L ++G G++G VY A+    R IVA+K++  L  +     +  ++EI  L++L HPN
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIR-LDAEDEGIPSTAIREISLLKELHHPN 80
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        +    LV E+                      M   L+++          
Sbjct: 81  IVSLIDVIHSERCLTLVFEF----------------------MEKDLKKV---------- 108
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
             + +K  L++ +I      +LRG+ + H    +HRD+K  N+L+   G +KLADFG A 
Sbjct: 109 -LDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +   P  S+   V T ++ AP+V+  M   +Y   VD+WS+G    E+   KP +
Sbjct: 168 AFGIPVRSYTHEVVTLWYRAPDVL--MGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 114/281 (40%), Gaps = 51/281 (18%)
Query: 160 PEKI----FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK----QCAEKWADILK 211
           PEKI    FE LR +G G +G V+  R +       I  M  L K    + A+  A    
Sbjct: 11  PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E   L ++KHP  ++    +      +L++EY  G           E    +E  G  ++
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG----------ELFMQLEREGIFME 120
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
              CF               L E  +A         L +LH  G I+RD+K  NI+L   
Sbjct: 121 DTACFY--------------LAEISMA---------LGHLHQKGIIYRDLKPENIMLNHQ 157
Query: 332 GTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G VKL DFG    S       ++F GT  +MAPE+++      ++  VD WSLG    ++
Sbjct: 158 GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM---RSGHNRAVDWWSLGALMYDM 214
Query: 388 AERKPPYFNMNAMSALYHIAQ---NDTPCLQSSDWSVIKTI 425
               PP+   N    +  I +   N  P L      ++K +
Sbjct: 215 LTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKL 255

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R       + E+VA+KK+ +      E   D  +EI  L
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 83
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 125
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 126 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 170
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 224
Query: 384 CIEL 387
             EL
Sbjct: 225 LYEL 228

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      E   D  +EI  L
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 65
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 107
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 108 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 206
Query: 384 CIEL 387
             EL
Sbjct: 207 LYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R    +    E+VA+KK+ +      E   D  +EI  L
Sbjct: 7   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 63
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 105
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 106 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 150
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 204
Query: 384 CIEL 387
             EL
Sbjct: 205 LYEL 208

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R       + E+VA+KK+ +      E   D  +EI  L
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 83
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 125
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHRD+   NIL+     
Sbjct: 126 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRDLATRNILVENENR 170
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 224
Query: 384 CIEL 387
             EL
Sbjct: 225 LYEL 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 82/143 (57%), Gaps = 7/143 (4%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVL 64
           ++L++L HPN ++        +   L M + L +   ++EV   +PL E++       ++
Sbjct: 88  AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLI 147
Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF----VGTPYWMAPE 120
           +G+ YLH    IHRD+K  N+L+ E G +K+ADFG ++    +++     VGTP +MAPE
Sbjct: 148 KGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPE 207
Query: 121 VILAMDEGQYDGK-VDVWSLGIT 142
             L+     + GK +DVW++G+T
Sbjct: 208 S-LSETRKIFSGKALDVWAMGVT 229

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 84/354 (23%), Positives = 138/354 (38%), Gaps = 104/354 (29%)
Query: 169 EIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQ-----------CAEKWA 207
           EIG GS+G V          YYA  ++S++ + I++  +  +            C +   
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKL-IRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 208 DI---LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVE 264
            I    +EI  L++L HPN ++        +   L M + L +   ++EV  +       
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------- 131
Query: 265 GMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 324
                                    +PL E++       +++G+ YLH    IHRD+K  
Sbjct: 132 -------------------------KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 325 NILLTETGTVKLADFGSASIKCPANSF----VGTPYWMAPEVILAMDEGQYDGK-VDVWS 379
           N+L+ E G +K+ADFG ++    +++     VGTP +MAPE  L+     + GK +DVW+
Sbjct: 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES-LSETRKIFSGKALDVWA 225
Query: 380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMN 439
           +G+T       + P+ +   M            CL S        I S A   P      
Sbjct: 226 MGVTLYCFVFGQCPFMDERIM------------CLHSK-------IKSQALEFP------ 260
Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
                      D P     D ++     ++  L KNP  R     +  H  VTR
Sbjct: 261 -----------DQP-----DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 49/88 (55%), Gaps = 4/88 (4%)
Query: 616 LVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           L M + L +   ++EV   +PL E++       +++G+ YLH    IHRD+K  N+L+ E
Sbjct: 113 LYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172
Query: 675 TGTVKL---DTPDEQAGNDSSKSNSITS 699
            G +K+      +E  G+D+  SN++ +
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLSNTVGT 200

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 44/240 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E ++ IG G+FG V   R   +R++ A+K +S          A   +E   +     P 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  D   ++VMEY  G   D++ +                           + 
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNL---------------------------MS 166
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS-- 341
           N++V      E+      + V+  L+ +HS+G IHRDVK  N+LL ++G +KLADFG+  
Sbjct: 167 NYDV-----PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 221
Query: 342 -----ASIKCPANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF 395
                  ++C  ++ VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P++
Sbjct: 222 KMNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 60/243 (24%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+++  IG G FG V+ A+  +  +   IK++ Y  ++         +E++ L +L H N
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-------REVKALAKLDHVN 65
Query: 224 TIEYRGCY--------------LRDHTA--WLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
            + Y GC+               R  T   ++ ME+C     +     WIE+       G
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE----QWIEKR-----RG 116
Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
            +L ++       AL  FE                 + +G++Y+HS   I+RD+K  NI 
Sbjct: 117 EKLDKV------LALELFE----------------QITKGVDYIHSKKLINRDLKPSNIF 154
Query: 328 LTETGTVKLADFG-SASIKCPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           L +T  VK+ DFG   S+K         GT  +M+PE I + D G+   +VD+++LG+  
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGK---EVDLYALGLIL 211
Query: 385 IEL 387
            EL
Sbjct: 212 AEL 214

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 46/237 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKH 221
           F+ +R +G G FG VY AR   ++ I+A+K +  S L K+  E    + +EI     L+H
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH--QLRREIEIQSHLRH 73
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           PN +     +      +L++E+                       G   ++L        
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFA--------------------PRGELYKEL-------- 105
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
               + H R   E+  A     +   L+Y H    IHRD+K  N+L+   G +K+ADFG 
Sbjct: 106 ----QKHGR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG- 159
Query: 342 ASIKCPA---NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
            S+  P+       GT  ++ PE+I    EG+ +D KVD+W  G+ C E     PP+
Sbjct: 160 WSVHAPSLRRRXMCGTLDYLPPEMI----EGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 103/236 (43%), Gaps = 57/236 (24%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    + S +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVG--CI 214

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 107/247 (43%), Gaps = 56/247 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA-DILKEIRFLRQLKHP 222
           +E L +IG G+FG V+ AR   + + VA+KK+  L +   E +    L+EI+ L+ LKH 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLKHE 77
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +              ++E C   AS                  NR     C    + +
Sbjct: 78  NVVN-------------LIEICRTKASPY----------------NR-----CKGSIYLV 103
Query: 283 FNFEVHKR---------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           F+F  H                EI  +   +L GL Y+H    +HRD+KA N+L+T  G 
Sbjct: 104 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 163
Query: 334 VKLADFGSA-SIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           +KLADFG A +     NS        V T ++  PE++L   E  Y   +D+W  G    
Sbjct: 164 LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIMA 221
Query: 386 ELAERKP 392
           E+  R P
Sbjct: 222 EMWTRSP 228

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 107/247 (43%), Gaps = 56/247 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA-DILKEIRFLRQLKHP 222
           +E L +IG G+FG V+ AR   + + VA+KK+  L +   E +    L+EI+ L+ LKH 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLKHE 77
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +              ++E C   AS                  NR     C    + +
Sbjct: 78  NVVN-------------LIEICRTKASPY----------------NR-----CKASIYLV 103
Query: 283 FNFEVHKR---------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           F+F  H                EI  +   +L GL Y+H    +HRD+KA N+L+T  G 
Sbjct: 104 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 163
Query: 334 VKLADFGSA-SIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           +KLADFG A +     NS        V T ++  PE++L   E  Y   +D+W  G    
Sbjct: 164 LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIMA 221
Query: 386 ELAERKP 392
           E+  R P
Sbjct: 222 EMWTRSP 228

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 113/281 (40%), Gaps = 51/281 (18%)
Query: 160 PEKI----FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK----QCAEKWADILK 211
           PEKI    FE LR +G G +G V+  R +       I  M  L K    + A+  A    
Sbjct: 11  PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E   L ++KHP  ++    +      +L++EY  G           E    +E  G  ++
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG----------ELFMQLEREGIFME 120
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
              CF               L E  +A         L +LH  G I+RD+K  NI+L   
Sbjct: 121 DTACFY--------------LAEISMA---------LGHLHQKGIIYRDLKPENIMLNHQ 157
Query: 332 GTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G VKL DFG    S       + F GT  +MAPE+++      ++  VD WSLG    ++
Sbjct: 158 GHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM---RSGHNRAVDWWSLGALMYDM 214
Query: 388 AERKPPYFNMNAMSALYHIAQ---NDTPCLQSSDWSVIKTI 425
               PP+   N    +  I +   N  P L      ++K +
Sbjct: 215 LTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKL 255

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 73/149 (48%), Gaps = 15/149 (10%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ + H N I     +    T       +LVME    +   +I +    L  E ++ + 
Sbjct: 76  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLL 132
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWM 117
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A   C       +V T Y+ 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYR 192
Query: 118 APEVILAMDEGQYDGKVDVWSLGITPGSL 146
           APEVIL M    Y   VD+WS+G   G L
Sbjct: 193 APEVILGMG---YAANVDIWSVGCIMGEL 218

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 99/238 (41%), Gaps = 51/238 (21%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K ++ L+ IG G+ G V  A   V    VA+KK+S     Q   K A   +E+  L+ + 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA--YRELVLLKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I +     E   E M   L Q+ 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A   C       +V T Y+ APEVIL M    Y   VD+WS+G    EL +
Sbjct: 166 KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG---YAANVDIWSVGCIMGELVK 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++++G G++G V   +  ++    AIK +             +L E+  L+QL HPN
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 82
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +      +LVME   G                                   LF
Sbjct: 83  IMKLYEFFEDKRNYYLVMEVYRGGE---------------------------------LF 109
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFG 340
           +  + ++   E + A I   VL G  YLH    +HRD+K  N+LL   +    +K+ DFG
Sbjct: 110 DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 169
Query: 341 SAS---IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
            ++   +       +GT Y++APEV+      +YD K DVWS G+    L    PP+
Sbjct: 170 LSAHFEVGGKMKERLGTAYYIAPEVL----RKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 103/263 (39%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVA--IKKMSYLGKQCAEKWADILK 211
           F +ED E  +E   E+G G F  V   R     +E  A  IKK      +      +I +
Sbjct: 5   FRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 64
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E+  LR+++HPN I     +       L++E   G                         
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGE----------------------- 101
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
                     LF+F   K  L E+E       +L G++YLHS    H D+K  NI+L + 
Sbjct: 102 ----------LFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDK 151
Query: 332 GT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
                 +KL DFG A      N F    GTP ++APE++     G    + D+WS+G+  
Sbjct: 152 NVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVIT 208
Query: 385 IELAERKPPYFNMNAMSALYHIA 407
             L     P+        L +I+
Sbjct: 209 YILLSGASPFLGETKQETLTNIS 231

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 122/324 (37%), Gaps = 53/324 (16%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 2   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 99
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 100 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 205
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER----KPPYFNMN 439
              L     P+        L +++  +    +   +S    ++    R    K P   M 
Sbjct: 206 TYILLSGASPFLGDTKQETLANVSAVNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKRMT 264
Query: 440 AMSALYH--IAQNDTPCLQSSDWS 461
              +L H  I   DT    SS WS
Sbjct: 265 IQDSLQHPWIKPKDTQQALSSAWS 288

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 55/239 (23%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L ++G G++  VY  +  ++  +VA+K++    ++ A   A  ++E+  L+ LKH N + 
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVT 64
Query: 227 YRGCYLRDHTAWLVMEYC-------LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
                  + +  LV EY        L    +II +H ++                     
Sbjct: 65  LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK--------------------- 103
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
             LF F++                 LRGL Y H    +HRD+K  N+L+ E G +KLADF
Sbjct: 104 --LFLFQL-----------------LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADF 144
Query: 340 GSASIK-CPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G A  K  P  ++   V T ++  P+++L   +  Y  ++D+W +G    E+A  +P +
Sbjct: 145 GLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD--YSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/323 (24%), Positives = 121/323 (37%), Gaps = 51/323 (15%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPC---LQSSDWSVIKTISSTAERKPPYFNMNA 440
              L     P+        L +++  +        S+  ++ K        K P   M  
Sbjct: 207 TYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 441 MSALYH--IAQNDTPCLQSSDWS 461
             +L H  I   DT    SS WS
Sbjct: 267 QDSLQHPWIKPKDTQQALSSAWS 289

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 109/250 (43%), Gaps = 61/250 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           FE L+ +G G+FG V          YYA  ++ +E++  K          ++ A  L E 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTEN 199
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 242
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-IHRDVKAGNILLTETG 332
           + F+E  A F                  + ++  L+YLHS    ++RD+K  N++L + G
Sbjct: 243 RVFSEDRARF----------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 286
Query: 333 TVKLADFG--SASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            +K+ DFG     IK  A   +F GTP ++APEV   +++  Y   VD W LG+   E+ 
Sbjct: 287 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMM 343
Query: 389 ERKPPYFNMN 398
             + P++N +
Sbjct: 344 CGRLPFYNQD 353

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 107/262 (40%), Gaps = 45/262 (17%)
Query: 196 SYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
           S+  ++  E     LKE+  LR++  HPN I+ +  Y  +   +LV +            
Sbjct: 57  SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD------------ 104
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
                                  +   LF++   K  L E+E   I   +L  +  LH L
Sbjct: 105 ---------------------LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVI-LAMDEGQ 370
             +HRD+K  NILL +   +KL DFG +    P     S  GTP ++APE+I  +M++  
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNH 203
Query: 371 --YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW----SVIKT 424
             Y  +VD+WS G+    L    PP+++   M  L  I   +     S +W      +K 
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDTVKD 262
Query: 425 ISSTAERKPPYFNMNAMSALYH 446
           + S      P     A  AL H
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAH 284

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 57/236 (24%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    + S +I++                    
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME------------------- 122
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 123 -----------------LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVG--CI 214

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 13/80 (16%)
Query: 611 LFSPQ----------LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 660
           +F+PQ          +VME    + S +I++    L  E ++ +   +L G+ +LHS G 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHERMSYLLYQMLVGIKHLHSAGI 147
Query: 661 IHRDVKAGNILLTETGTVKL 680
           IHRD+K  NI++    T+K+
Sbjct: 148 IHRDLKPSNIVVKSDATLKI 167

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 119/301 (39%), Gaps = 80/301 (26%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVA-IKKMSYLGKQCAEKWADILKE 212
           F+ LR +G GSFG V          YYA  ++ +EIV  +K++ +              E
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND-----------E 56
Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
              L  + HP  I   G +      +++M+Y  G                   + + L++
Sbjct: 57  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE-----------------LFSLLRK 99
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
            + F              P+ +   A +C      L YLHS   I+RD+K  NILL + G
Sbjct: 100 SQRFPN------------PVAKFYAAEVCLA----LEYLHSKDIIYRDLKPENILLDKNG 143
Query: 333 TVKLADFGSASIKCPANSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            +K+ DFG A    P  ++   GTP ++APEV+       Y+  +D WS GI   E+   
Sbjct: 144 HIKITDFGFAKY-VPDVTYXLCGTPDYIAPEVV---STKPYNKSIDWWSFGILIYEMLAG 199
Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
             P+++ N M                      + I +   R PP+FN +    L  +   
Sbjct: 200 YTPFYDSNTMKTY-------------------EKILNAELRFPPFFNEDVKDLLSRLITR 240
Query: 451 D 451
           D
Sbjct: 241 D 241

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 103/236 (43%), Gaps = 57/236 (24%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    + S +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVG--CI 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 73/144 (50%), Gaps = 14/144 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGV 63
           SLL+ L HPN I+    +      +LV E+  G      II  HK    E + A I   +
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQI 155
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGT---VKLADFGSASIKCPANSF---VGTPYWM 117
           L G+ YLH    +HRD+K  NILL    +   +K+ DFG +S           +GT Y++
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APEV+    + +Y+ K DVWS G+
Sbjct: 216 APEVL----KKKYNEKCDVWSCGV 235

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 57/280 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIK--KMSYLGK-------QCAEKW-ADILKEIRFL 216
           +R++G G++G V   +        AIK  K S   K       +  EK+  +I  EI  L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           + L HPN I+    +      +LV E+  G                    G   +Q+   
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEG--------------------GELFEQI--- 137
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT--- 333
                     +++    E + A I   +L G+ YLH    +HRD+K  NILL    +   
Sbjct: 138 ----------INRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187
Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           +K+ DFG +S           +GT Y++APEV+    + +Y+ K DVWS G+    L   
Sbjct: 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL----KKKYNEKCDVWSCGVIMYILLCG 243
Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE 430
            PP+   N    +  + +        +DW   K IS  A+
Sbjct: 244 YPPFGGQNDQDIIKKVEKG-KYYFDFNDW---KNISDEAK 279

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 107/247 (43%), Gaps = 56/247 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA-DILKEIRFLRQLKHP 222
           +E L +IG G+FG V+ AR   + + VA+KK+  L +   E +    L+EI+ L+ LKH 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLKHE 77
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +              ++E C   AS                  NR     C    + +
Sbjct: 78  NVVN-------------LIEICRTKASPY----------------NR-----CKGSIYLV 103
Query: 283 FNFEVHKR---------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           F+F  H                EI  +   +L GL Y+H    +HRD+KA N+L+T  G 
Sbjct: 104 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 163
Query: 334 VKLADFGSA-SIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           +KLADFG A +     NS        V T ++  PE++L   E  Y   +D+W  G    
Sbjct: 164 LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIMA 221
Query: 386 ELAERKP 392
           E+  R P
Sbjct: 222 EMWTRSP 228

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 107/247 (43%), Gaps = 56/247 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA-DILKEIRFLRQLKHP 222
           +E L +IG G+FG V+ AR   + + VA+KK+  L +   E +    L+EI+ L+ LKH 
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLKHE 76
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N +              ++E C   AS                  NR     C    + +
Sbjct: 77  NVVN-------------LIEICRTKASPY----------------NR-----CKGSIYLV 102
Query: 283 FNFEVHKR---------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           F+F  H                EI  +   +L GL Y+H    +HRD+KA N+L+T  G 
Sbjct: 103 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 162
Query: 334 VKLADFGSA-SIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           +KLADFG A +     NS        V T ++  PE++L   E  Y   +D+W  G    
Sbjct: 163 LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIMA 220
Query: 386 ELAERKP 392
           E+  R P
Sbjct: 221 EMWTRSP 227

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 109/250 (43%), Gaps = 61/250 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           FE L+ +G G+FG V          YYA  ++ +E++  K          ++ A  L E 
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTEN 202
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 203 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 245
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-IHRDVKAGNILLTETG 332
           + F+E  A F                  + ++  L+YLHS    ++RD+K  N++L + G
Sbjct: 246 RVFSEDRARF----------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 289
Query: 333 TVKLADFG--SASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            +K+ DFG     IK  A   +F GTP ++APEV   +++  Y   VD W LG+   E+ 
Sbjct: 290 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMM 346
Query: 389 ERKPPYFNMN 398
             + P++N +
Sbjct: 347 CGRLPFYNQD 356

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/323 (24%), Positives = 121/323 (37%), Gaps = 51/323 (15%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPC---LQSSDWSVIKTISSTAERKPPYFNMNA 440
              L     P+        L +++  +        S+  ++ K        K P   M  
Sbjct: 207 TYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 441 MSALYH--IAQNDTPCLQSSDWS 461
             +L H  I   DT    SS WS
Sbjct: 267 QDSLQHPWIKPKDTQQALSSAWS 289

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/323 (24%), Positives = 121/323 (37%), Gaps = 51/323 (15%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 2   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 99
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 100 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 205
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPC---LQSSDWSVIKTISSTAERKPPYFNMNA 440
              L     P+        L +++  +        S+  ++ K        K P   M  
Sbjct: 206 TYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265
Query: 441 MSALYH--IAQNDTPCLQSSDWS 461
             +L H  I   DT    SS WS
Sbjct: 266 QDSLQHPWIKPKDTQQALSSAWS 288

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 61/250 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           FE L+ +G G+FG V          YYA  ++ +E++  K          ++ A  L E 
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTEN 61
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 62  RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 104
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-IHRDVKAGNILLTETG 332
           + F+E  A F                  + ++  L+YLHS    ++RD+K  N++L + G
Sbjct: 105 RVFSEDRARF----------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 148
Query: 333 TVKLADFG--SASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            +K+ DFG     IK  A    F GTP ++APEV   +++  Y   VD W LG+   E+ 
Sbjct: 149 HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMM 205
Query: 389 ERKPPYFNMN 398
             + P++N +
Sbjct: 206 CGRLPFYNQD 215

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 115/281 (40%), Gaps = 50/281 (17%)
Query: 139 LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKKM 195
           LG  P S    EI ++       K +   R +G G F   Y    + ++E+ A   + K 
Sbjct: 3   LGSDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKS 62
Query: 196 SYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH 255
             L     EK +    EI   + L +P+ + + G +  D   ++V+E C           
Sbjct: 63  MLLKPHQKEKMS---TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC----------- 108
Query: 256 WIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR--PLKEEEIAAICSGVLRGLNYLHS 313
                        R + L            E+HKR   + E E        ++G+ YLH+
Sbjct: 109 -------------RRRSL-----------LELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPA---NSFVGTPYWMAPEVILAMDEG 369
              IHRD+K GN+ L +   VK+ DFG A+ I+          GTP ++APEV+    + 
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC---KK 201
Query: 370 QYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQND 410
            +  +VD+WSLG     L   KPP+           I +N+
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNE 242

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 43/231 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL-KEIRFLRQLKHPNTIEY 227
           ++G G FG VY  +  V+   VA+KK++ +     E+      +EI+ + + +H N +E 
Sbjct: 38  KMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
            G         LV  Y                       G+ L +L C            
Sbjct: 96  LGFSSDGDDLCLVYVYMPN--------------------GSLLDRLSCLD---------- 125
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----- 342
              PL       I  G   G+N+LH    IHRD+K+ NILL E  T K++DFG A     
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
            +     +  VGT  +MAPE +     G+   K D++S G+  +E+    P
Sbjct: 186 FAQTVMXSRIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 61/250 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           FE L+ +G G+FG V          YYA  ++ +E++  K          ++ A  L E 
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTEN 60
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 61  RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 103
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-IHRDVKAGNILLTETG 332
           + F+E  A F                  + ++  L+YLHS    ++RD+K  N++L + G
Sbjct: 104 RVFSEDRARF----------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 147
Query: 333 TVKLADFG--SASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            +K+ DFG     IK  A    F GTP ++APEV   +++  Y   VD W LG+   E+ 
Sbjct: 148 HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMM 204
Query: 389 ERKPPYFNMN 398
             + P++N +
Sbjct: 205 CGRLPFYNQD 214

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/323 (24%), Positives = 121/323 (37%), Gaps = 51/323 (15%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPC---LQSSDWSVIKTISSTAERKPPYFNMNA 440
              L     P+        L +++  +        S+  ++ K        K P   M  
Sbjct: 207 TYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 441 MSALYH--IAQNDTPCLQSSDWS 461
             +L H  I   DT    SS WS
Sbjct: 267 QDSLQHPWIKPKDTQQALSSAWS 289

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 77/141 (54%), Gaps = 12/141 (8%)
Query: 7   LLRQLKHPNTIEYRGCY-----LRD-HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ ++H N I     +     LR+ +  +LVM +     +D+ ++      EE+I  + 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM---QTDLQKIMGLKFSEEKIQYLV 132
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPANSFVGTPYWMAP 119
             +L+GL Y+HS G +HRD+K GN+ + E   +K+ DFG A         +V T ++ AP
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAP 192
Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           EVIL+     Y+  VD+WS+G
Sbjct: 193 EVILSW--MHYNQTVDIWSVG 211

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 108/245 (44%), Gaps = 48/245 (19%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           +G G++G+V  A    S E VAIKK+S     +   K A   +E+  L+ ++H N I   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA--YRELLLLKHMQHENVIGLL 89
Query: 229 GCY-----LRD-HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             +     LR+ +  +LVM +                      M   LQ++         
Sbjct: 90  DVFTPASSLRNFYDFYLVMPF----------------------MQTDLQKIMGLK----- 122
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      EE+I  +   +L+GL Y+HS G +HRD+K GN+ + E   +K+ DFG A
Sbjct: 123 ---------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 343 S-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                    +V T ++ APEVIL+     Y+  VD+WS+G    E+   K  +   + + 
Sbjct: 174 RHADAEMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
Query: 402 ALYHI 406
            L  I
Sbjct: 232 QLTQI 236

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVM +     +D+ ++      EE+I  +   +L+GL Y+HS G +HRD+K GN+ + E 
Sbjct: 106 LVMPFM---QTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED 162
Query: 676 GTVKL 680
             +K+
Sbjct: 163 CELKI 167

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 77/141 (54%), Gaps = 12/141 (8%)
Query: 7   LLRQLKHPNTIEYRGCY-----LRD-HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ ++H N I     +     LR+ +  +LVM +     +D+ ++      EE+I  + 
Sbjct: 94  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM---QTDLQKIMGMEFSEEKIQYLV 150
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPANSFVGTPYWMAP 119
             +L+GL Y+HS G +HRD+K GN+ + E   +K+ DFG A         +V T ++ AP
Sbjct: 151 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAP 210
Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           EVIL+     Y+  VD+WS+G
Sbjct: 211 EVILSW--MHYNQTVDIWSVG 229

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 48/245 (19%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           +G G++G+V  A    S E VAIKK+S     +   K A   +E+  L+ ++H N I   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA--YRELLLLKHMQHENVIGLL 107
Query: 229 GCY-----LRD-HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             +     LR+ +  +LVM +     +D+ ++  +E                        
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFM---QTDLQKIMGME------------------------ 140
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                      EE+I  +   +L+GL Y+HS G +HRD+K GN+ + E   +K+ DFG A
Sbjct: 141 ---------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 191
Query: 343 S-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                    +V T ++ APEVIL+     Y+  VD+WS+G    E+   K  +   + + 
Sbjct: 192 RHADAEMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 249
Query: 402 ALYHI 406
            L  I
Sbjct: 250 QLTQI 254

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVM +     +D+ ++      EE+I  +   +L+GL Y+HS G +HRD+K GN+ + E 
Sbjct: 124 LVMPFM---QTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED 180
Query: 676 GTVKL 680
             +K+
Sbjct: 181 CELKI 185

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 61/250 (24%)
Query: 164 FEDLREIGHGSFGAV----------YYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           FE L+ +G G+FG V          YYA  ++ +E++  K          ++ A  L E 
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTEN 59
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L+  +HP     +  +        VMEY  G           E  FH       L + 
Sbjct: 60  RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG----------ELFFH-------LSRE 102
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-IHRDVKAGNILLTETG 332
           + F+E  A F                  + ++  L+YLHS    ++RD+K  N++L + G
Sbjct: 103 RVFSEDRARF----------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 146
Query: 333 TVKLADFG--SASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
            +K+ DFG     IK  A    F GTP ++APEV   +++  Y   VD W LG+   E+ 
Sbjct: 147 HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMM 203
Query: 389 ERKPPYFNMN 398
             + P++N +
Sbjct: 204 CGRLPFYNQD 213

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 106/262 (40%), Gaps = 45/262 (17%)
Query: 196 SYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
           S+  ++  E     LKE+  LR++  HPN I+ +  Y  +   +LV +            
Sbjct: 57  SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD------------ 104
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
                                  +   LF++   K  L E+E   I   +L  +  LH L
Sbjct: 105 ---------------------LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVI-LAMDEGQ 370
             +HRD+K  NILL +   +KL DFG +    P        GTP ++APE+I  +M++  
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 203
Query: 371 --YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW----SVIKT 424
             Y  +VD+WS G+    L    PP+++   M  L  I   +     S +W      +K 
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDTVKD 262
Query: 425 ISSTAERKPPYFNMNAMSALYH 446
           + S      P     A  AL H
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAH 284

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 46/237 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKH 221
           F+  R +G G FG VY AR   ++ I+A+K +  S L K+  E    + +EI     L+H
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH--QLRREIEIQSHLRH 74
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           PN +     +      +L++E+                       G   ++L        
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFA--------------------PRGELYKEL-------- 106
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
               + H R   E+  A     +   L+Y H    IHRD+K  N+L+   G +K+ADFG 
Sbjct: 107 ----QKHGR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG- 160
Query: 342 ASIKCPA---NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
            S+  P+       GT  ++ PE+I    EG+ +D KVD+W  G+ C E     PP+
Sbjct: 161 WSVHAPSLRRRXMCGTLDYLPPEMI----EGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 74/149 (49%), Gaps = 15/149 (10%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ + H N I     +    T       +LVME    +   +I +    L  E ++ + 
Sbjct: 74  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLL 130
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG---SASIKCPANSFVGTPYWM 117
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG   +AS       +V T Y+ 
Sbjct: 131 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYR 190
Query: 118 APEVILAMDEGQYDGKVDVWSLGITPGSL 146
           APEVIL M    Y   VD+WS+G   G L
Sbjct: 191 APEVILGMG---YKENVDIWSVGCIMGEL 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 100/238 (42%), Gaps = 51/238 (21%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K ++ L+ IG G+ G V  A   V    VA+KK+S     Q   K A   +E+  L+ + 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA--YRELVLLKCVN 79
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME    +   +I +     E   E M   L Q+ 
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHM-----ELDHERMSYLLYQML 134
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 135 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 163
Query: 335 KLADFG---SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG   +AS       +V T Y+ APEVIL M    Y   VD+WS+G    EL +
Sbjct: 164 KILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGELVK 218

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL-KEIRFLRQLKHPNTIEY 227
           ++G G FG VY  +  V+   VA+KK++ +     E+      +EI+ + + +H N +E 
Sbjct: 32  KMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
            G         LV  Y                       G+ L +L C            
Sbjct: 90  LGFSSDGDDLCLVYVYMPN--------------------GSLLDRLSCLD---------- 119
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----- 342
              PL       I  G   G+N+LH    IHRD+K+ NILL E  T K++DFG A     
Sbjct: 120 GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 179
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
            +        VGT  +MAPE +     G+   K D++S G+  +E+    P
Sbjct: 180 FAQXVMXXRIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL-KEIRFLRQLKHPNTIEY 227
           ++G G FG VY  +  V+   VA+KK++ +     E+      +EI+ + + +H N +E 
Sbjct: 38  KMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
            G         LV  Y                       G+ L +L C            
Sbjct: 96  LGFSSDGDDLCLVYVYMPN--------------------GSLLDRLSCLD---------- 125
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----- 342
              PL       I  G   G+N+LH    IHRD+K+ NILL E  T K++DFG A     
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
            +        VGT  +MAPE +     G+   K D++S G+  +E+    P
Sbjct: 186 FAQTVMXXRIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 106/262 (40%), Gaps = 45/262 (17%)
Query: 196 SYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
           S+  ++  E     LKE+  LR++  HPN I+ +  Y  +   +LV +            
Sbjct: 44  SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD------------ 91
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
                                  +   LF++   K  L E+E   I   +L  +  LH L
Sbjct: 92  ---------------------LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVI-LAMDEGQ 370
             +HRD+K  NILL +   +KL DFG +    P        GTP ++APE+I  +M++  
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 190
Query: 371 --YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW----SVIKT 424
             Y  +VD+WS G+    L    PP+++   M  L  I   +     S +W      +K 
Sbjct: 191 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDTVKD 249
Query: 425 ISSTAERKPPYFNMNAMSALYH 446
           + S      P     A  AL H
Sbjct: 250 LVSRFLVVQPQKRYTAEEALAH 271

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 112/266 (42%), Gaps = 50/266 (18%)
Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKK 194
           S  + P S    EI ++       K +   R +G G F   Y    + ++E+ A   + K
Sbjct: 18  SAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK 77
Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
              L     EK +    EI   + L +P+ + + G +  D   ++V+E C          
Sbjct: 78  SMLLKPHQKEKMST---EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---------- 124
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR--PLKEEEIAAICSGVLRGLNYLH 312
                         R + L            E+HKR   + E E        ++G+ YLH
Sbjct: 125 --------------RRRSL-----------LELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 313 SLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPA---NSFVGTPYWMAPEVILAMDE 368
           +   IHRD+K GN+ L +   VK+ DFG A+ I+       +  GTP ++APEV+    +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLC---K 216
Query: 369 GQYDGKVDVWSLGITCIELAERKPPY 394
             +  +VD+WSLG     L   KPP+
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 103/236 (43%), Gaps = 57/236 (24%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    + S +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVG--CI 214

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 59/244 (24%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + L+++G G+FG+V   R       + E+VA+KK+ +      E   D  +EI  L
Sbjct: 10  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEIL 66
Query: 217 RQLKHPNTIEYRG-CY-LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           + L+H N ++Y+G CY        L+MEY   GS  D ++ H                  
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------------ 108
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K   +H  L  +                S + +G+ YL +   IHR++   NIL+     
Sbjct: 109 KERIDHIKLLQY---------------TSQICKGMEYLGTKRYIHRNLATRNILVENENR 153
Query: 334 VKLADFGSA----------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG             +K P  S +   +W APE   ++ E ++    DVWS G+ 
Sbjct: 154 VKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE---SLTESKFSVASDVWSFGVV 207
Query: 384 CIEL 387
             EL
Sbjct: 208 LYEL 211

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 44/240 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++ IG G+FG V   R   S+++ A+K +S          A   +E   +     P 
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 136
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  D   ++VMEY  G   D++ +                           + 
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGG--DLVNL---------------------------MS 167
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG--- 340
           N++V ++  K        + V+  L+ +HS+G IHRDVK  N+LL + G +KLADFG   
Sbjct: 168 NYDVPEKWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 222
Query: 341 ----SASIKCPANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF 395
               +  + C  ++ VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P++
Sbjct: 223 KMDETGMVHC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 100/249 (40%), Gaps = 57/249 (22%)
Query: 165 EDL---REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKW-----ADILKEIRFL 216
           EDL    +IG G+FG V+  R      +VA+K        C E       A  L+E R L
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-------CRETLPPDLKAKFLQEARIL 166
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           +Q  HPN +   G   +    ++VME   G   D +           EG   R++ L   
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGG--DFLTF------LRTEGARLRVKTL--- 215
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                                  +      G+ YL S   IHRD+ A N L+TE   +K+
Sbjct: 216 ---------------------LQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKI 254
Query: 337 ADFGSA-----SIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAE 389
           +DFG +      +   +      P  W APE   A++ G+Y  + DVWS GI   E  + 
Sbjct: 255 SDFGMSREEADGVXAASGGLRQVPVKWTAPE---ALNYGRYSSESDVWSFGILLWETFSL 311
Query: 390 RKPPYFNMN 398
              PY N++
Sbjct: 312 GASPYPNLS 320

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         FV T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMAGFVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         FV T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMAGFVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 15  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 72
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 73  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 115
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 116 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 162
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         FV T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 163 LDFGLARHTDDEMAGFVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 212

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 121/324 (37%), Gaps = 53/324 (16%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L+ E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER----KPPYFNMN 439
              L     P+        L +++  +    +   +S    ++    R    K P   M 
Sbjct: 207 TYILLSGASPFLGDTKQETLANVSAVNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 440 AMSALYH--IAQNDTPCLQSSDWS 461
              +L H  I   DT    SS WS
Sbjct: 266 IQDSLQHPWIKPKDTQQALSSAWS 289

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 50/282 (17%)
Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKK 194
           S  + P S    EI ++       K +   R +G G F   Y    + ++E+ A   + K
Sbjct: 18  SAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK 77
Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
              L     EK +    EI   + L +P+ + + G +  D   ++V+E C          
Sbjct: 78  SMLLKPHQKEKMS---TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---------- 124
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR--PLKEEEIAAICSGVLRGLNYLH 312
                         R + L            E+HKR   + E E        ++G+ YLH
Sbjct: 125 --------------RRRSL-----------LELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 313 SLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPA---NSFVGTPYWMAPEVILAMDE 368
           +   IHRD+K GN+ L +   VK+ DFG A+ I+          GTP ++APEV+    +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC---K 216
Query: 369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQND 410
             +  +VD+WSLG     L   KPP+           I +N+
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNE 258

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            +KH N I     +                A  + E + +    H+ G            
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHLMG------------ 110
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              A  N  V  + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+ 
Sbjct: 111 ---ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 167
Query: 338 DFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 168 DFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 50/282 (17%)
Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKK 194
           S  + P S    EI ++       K +   R +G G F   Y    + ++E+ A   + K
Sbjct: 18  SAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK 77
Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
              L     EK +    EI   + L +P+ + + G +  D   ++V+E C          
Sbjct: 78  SMLLKPHQKEKMST---EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---------- 124
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKR--PLKEEEIAAICSGVLRGLNYLH 312
                         R + L            E+HKR   + E E        ++G+ YLH
Sbjct: 125 --------------RRRSL-----------LELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 313 SLGRIHRDVKAGNILLTETGTVKLADFGSAS-IKCPA---NSFVGTPYWMAPEVILAMDE 368
           +   IHRD+K GN+ L +   VK+ DFG A+ I+          GTP ++APEV+    +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLC---K 216
Query: 369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQND 410
             +  +VD+WSLG     L   KPP+           I +N+
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNE 258

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 41/243 (16%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE-IRFLRQLKHPNTIEY 227
           EIG GSF  VY  + L +   V +       ++  +      KE    L+ L+HPN + +
Sbjct: 33  EIGRGSFKTVY--KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
                  + +W   E  +     I+ V     E    G       LK + + F +   +V
Sbjct: 91  -------YDSW---ESTVKGKKCIVLVT----ELXTSGT------LKTYLKRFKVXKIKV 130
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLT-ETGTVKLADFGSASI 344
                    + + C  +L+GL +LH+     IHRD+K  NI +T  TG+VK+ D G A++
Sbjct: 131 ---------LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 345 K--CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA 402
           K    A + +GTP + APE      E +YD  VDV++ G   +E A  + PY      + 
Sbjct: 182 KRASFAKAVIGTPEFXAPEXY----EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQ 237
Query: 403 LYH 405
           +Y 
Sbjct: 238 IYR 240

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 100/249 (40%), Gaps = 57/249 (22%)
Query: 165 EDL---REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKW-----ADILKEIRFL 216
           EDL    +IG G+FG V+  R      +VA+K        C E       A  L+E R L
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-------CRETLPPDLKAKFLQEARIL 166
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           +Q  HPN +   G   +    ++VME   G   D +           EG   R++ L   
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGG--DFLTF------LRTEGARLRVKTL--- 215
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                                  +      G+ YL S   IHRD+ A N L+TE   +K+
Sbjct: 216 ---------------------LQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKI 254
Query: 337 ADFGSA-----SIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAE 389
           +DFG +      +   +      P  W APE   A++ G+Y  + DVWS GI   E  + 
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPE---ALNYGRYSSESDVWSFGILLWETFSL 311
Query: 390 RKPPYFNMN 398
              PY N++
Sbjct: 312 GASPYPNLS 320

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYAR---CLVSREIVAIKKMSYLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R     +      IKK      +      DI 
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E   G                        
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE---------------------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 101 -----------LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++     G    + D+WS+G+ 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVI 206
Query: 384 CIELAERKPPYFNMNAMSALYHIA 407
              L     P+        L +++
Sbjct: 207 TYILLSGASPFLGDTKQETLANVS 230

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  IG G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 24  EVPER-YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 81
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 82  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 124
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 125 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKI 171
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 221

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 123/327 (37%), Gaps = 90/327 (27%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++EIG G FG V+    L +++ VAIK +    ++ A    D ++E   + +L HP  ++
Sbjct: 12  VQEIGSGQFGLVHLGYWL-NKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G  L      LV E                                 F EH  L ++ 
Sbjct: 67  LYGVCLEQAPICLVFE---------------------------------FMEHGCLSDYL 93
Query: 287 VHKRPL-KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
             +R L   E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++DFG     
Sbjct: 94  RTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFV 153
Query: 346 C--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
                 S  GT +   W +PEV       +Y  K DVWS G+   E  +E K PY N   
Sbjct: 154 LDDQYTSSTGTKFPVKWASPEVF---SFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--- 207
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                            S+  V++ IS+      P     A + +Y I  +         
Sbjct: 208 ----------------RSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNH--------- 239
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
                      C  + P DRP+  RLL
Sbjct: 240 -----------CWKERPEDRPAFSRLL 255

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S    Q         +E+R L+
Sbjct: 25  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLK 82
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 83  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 125
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 126 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKI 172
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 21  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 78
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 79  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 121
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 122 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKI 168
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S    Q         +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NAMHYNQTVDIWSVGCIMAEL 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 47/239 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQL- 219
           F  L  +G GSFG V  A    + E+ AIK    L K    +  D+   + E R L  L 
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIK---ILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           K P   +   C+      + VMEY  G   D++        +H++ +G            
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGG--DLM--------YHIQQVGK----------- 116
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                        KE +     + +  GL +LH  G I+RD+K  N++L   G +K+ADF
Sbjct: 117 ------------FKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADF 164
Query: 340 GSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G              F GTP ++APE+I     G+    VD W+ G+   E+   +PP+
Sbjct: 165 GMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGK---SVDWWAYGVLLYEMLAGQPPF 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 25  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 82
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 83  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 125
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 126 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 172
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 222

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 47/244 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ +G G FG V+ A+  V     AIK++    ++ A +   +++E++ L +L+HP 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEHPG 64
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + Y   +L  +T     E    S+  +          +++    R + LK +       
Sbjct: 65  IVRYFNAWLEKNTT----EKLQPSSPKVY--------LYIQMQLCRKENLKDW------- 105
Query: 284 NFEVHKRPLKEEEIAAICSGVL----RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
              ++ R   EE   ++C  +       + +LHS G +HRD+K  NI  T    VK+ DF
Sbjct: 106 ---MNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162
Query: 340 G----------SASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           G            ++  P  ++      VGT  +M+PE I       Y  KVD++SLG+ 
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG---NSYSHKVDIFSLGLI 219
Query: 384 CIEL 387
             EL
Sbjct: 220 LFEL 223

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 13/142 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGV 63
           S+ R L H + + + G +  +   ++V+E C      ++E+HKR   L E E       +
Sbjct: 69  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMA 118
           + G  YLH    IHRD+K GN+ L E   VK+ DFG A+ K   +     +  GTP ++A
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKTLCGTPNYIA 185
Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEV   + +  +  +VDVWS+G
Sbjct: 186 PEV---LSKKGHSFEVDVWSIG 204

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 115/292 (39%), Gaps = 71/292 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +G G F   +      ++E+ A   + K   L     EK +    EI   R L H + + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVG 81
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G +  +   ++V+E C                        R + L            E
Sbjct: 82  FHGFFEDNDFVFVVLELC------------------------RRRSL-----------LE 106
Query: 287 VHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +HKR   L E E       ++ G  YLH    IHRD+K GN+ L E   VK+ DFG A+ 
Sbjct: 107 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT- 165
Query: 345 KCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           K   +     +  GTP ++APEV   + +  +  +VDVWS+G     L   KPP+     
Sbjct: 166 KVEYDGERKKTLCGTPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----- 217
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                     +T CL+ +   + K   S     P + N  A S +  + Q D
Sbjct: 218 ----------ETSCLKETYLRIKKNEYSI----PKHINPVAASLIQKMLQTD 255

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 90/354 (25%), Positives = 138/354 (38%), Gaps = 72/354 (20%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILK 211
           D  ++FE   E+G G+F  V   RC+        + +I+  KK+S    Q  E+      
Sbjct: 4   DEYQLFE---ELGKGAFSVV--RRCMKIPTGQEYAAKIINTKKLSARDHQKLER------ 52
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E R  R LKHPN +        +   +LV +   G                         
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE----------------------- 89
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--- 328
                     LF   V +    E + +     +L  +N+ H  G +HRD+K  N+LL   
Sbjct: 90  ----------LFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASK 139
Query: 329 TETGTVKLADFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           ++   VKLADFG A I+   +      F GTP +++PEV   + +  Y   VD+W+ G+ 
Sbjct: 140 SKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV---LRKDPYGKPVDMWACGVI 195
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI----KTISSTAERKPPYFNMN 439
              L    PP+++ +    LY   +       S +W  +    K + +      P   + 
Sbjct: 196 LYILLVGYPPFWDED-QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 254
Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
           A  AL H       C +S+  S         CL K  A R   G +LT  L TR
Sbjct: 255 ASEALKH----PWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATR 304

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 38  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 95
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 96  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 138
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 139 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 185
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 186 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 235

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 13/142 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGV 63
           S+ R L H + + + G +  +   ++V+E C      ++E+HKR   L E E       +
Sbjct: 69  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMA 118
           + G  YLH    IHRD+K GN+ L E   VK+ DFG A+ K   +     +  GTP ++A
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKTLCGTPNYIA 185
Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEV   + +  +  +VDVWS+G
Sbjct: 186 PEV---LSKKGHSFEVDVWSIG 204

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 115/292 (39%), Gaps = 71/292 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +G G F   +      ++E+ A   + K   L     EK +    EI   R L H + + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVG 81
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G +  +   ++V+E C                        R + L            E
Sbjct: 82  FHGFFEDNDFVFVVLELC------------------------RRRSL-----------LE 106
Query: 287 VHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +HKR   L E E       ++ G  YLH    IHRD+K GN+ L E   VK+ DFG A+ 
Sbjct: 107 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT- 165
Query: 345 KCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           K   +     +  GTP ++APEV   + +  +  +VDVWS+G     L   KPP+     
Sbjct: 166 KVEYDGERKKTLCGTPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----- 217
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                     +T CL+ +   + K   S     P + N  A S +  + Q D
Sbjct: 218 ----------ETSCLKETYLRIKKNEYSI----PKHINPVAASLIQKMLQTD 255

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 13/142 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGV 63
           S+ R L H + + + G +  +   ++V+E C      ++E+HKR   L E E       +
Sbjct: 73  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLRQI 130
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMA 118
           + G  YLH    IHRD+K GN+ L E   VK+ DFG A+ K   +     +  GTP ++A
Sbjct: 131 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKTLCGTPNYIA 189
Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEV   + +  +  +VDVWS+G
Sbjct: 190 PEV---LSKKGHSFEVDVWSIG 208

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 115/292 (39%), Gaps = 71/292 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +G G F   +      ++E+ A   + K   L     EK +    EI   R L H + + 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVG 85
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G +  +   ++V+E C                        R + L            E
Sbjct: 86  FHGFFEDNDFVFVVLELC------------------------RRRSL-----------LE 110
Query: 287 VHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +HKR   L E E       ++ G  YLH    IHRD+K GN+ L E   VK+ DFG A+ 
Sbjct: 111 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT- 169
Query: 345 KCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           K   +     +  GTP ++APEV   + +  +  +VDVWS+G     L   KPP+     
Sbjct: 170 KVEYDGERKKTLCGTPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----- 221
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                     +T CL+ +   + K   S     P + N  A S +  + Q D
Sbjct: 222 ----------ETSCLKETYLRIKKNEYSI----PKHINPVAASLIQKMLQTD 259

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 39  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 96
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 97  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 139
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 140 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 186
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 187 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 236

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            +KH N I     +                A  + E + +    H+ G            
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHLMG------------ 110
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              A  N  V  + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+ 
Sbjct: 111 ---ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 338 DFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 168 DFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 15  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 72
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 73  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 115
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 116 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 162
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 163 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 212

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 23/156 (14%)
Query: 6   SLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVH------KRP--LKEEE 55
           +LLR+LKHPN I  +  +L   D   WL+ +Y       II+ H      K+P  L    
Sbjct: 70  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129
Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASI-------K 104
           + ++   +L G++YLH+   +HRD+K  NIL+     E G VK+AD G A +        
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 105 CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
              +  V T ++ APE++L      Y   +D+W++G
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIG 223

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 52/255 (20%)
Query: 156 DKEDPEKIFE-DLREIGHGSFGAVYYARCLVSREI--VAIKKMSYLGKQCAEKWADILKE 212
           ++E  E +FE +  ++G G++G VY A+    ++    A+K++   G   +       +E
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CRE 68
Query: 213 IRFLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           I  LR+LKHPN I  +  +L   D   WL+ +Y       II+       FH     N  
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK-------FHRASKAN-- 119
Query: 271 QQLKCFTEHFALFNFEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
                             K+P  L    + ++   +L G++YLH+   +HRD+K  NIL+
Sbjct: 120 ------------------KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 161
Query: 329 T----ETGTVKLADFGSASI-------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 377
                E G VK+AD G A +           +  V T ++ APE++L      Y   +D+
Sbjct: 162 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDI 219
Query: 378 WSLGITCIELAERKP 392
           W++G    EL   +P
Sbjct: 220 WAIGCIFAELLTSEP 234

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 29  EVPER-YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 86
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 87  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 129
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 130 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 176
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 177 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 226

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 57/287 (19%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 86
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 141
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 142 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 170
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 171 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDLWSVGCIMGEMVC 225
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 226 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 271

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 57/287 (19%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 75
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 130
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 131 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 160 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDLWSVGCIMGEMVC 214
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 215 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 260

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEIXINKMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMXGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 24  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 81
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 82  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 124
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 125 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKI 171
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 221

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMXGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 123/327 (37%), Gaps = 90/327 (27%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++EIG G FG V+    L +++ VAIK +    ++ A    D ++E   + +L HP  ++
Sbjct: 12  VQEIGSGQFGLVHLGYWL-NKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G  L      LV E                                 F EH  L ++ 
Sbjct: 67  LYGVCLEQAPICLVFE---------------------------------FMEHGCLSDYL 93
Query: 287 VHKRPL-KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
             +R L   E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++DFG     
Sbjct: 94  RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 153
Query: 346 C--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
                 S  GT +   W +PEV       +Y  K DVWS G+   E  +E K PY N   
Sbjct: 154 LDDQYTSSTGTKFPVKWASPEVF---SFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--- 207
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                            S+  V++ IS+      P     A + +Y I  +         
Sbjct: 208 ----------------RSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNH--------- 239
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
                      C  + P DRP+  RLL
Sbjct: 240 -----------CWKERPEDRPAFSRLL 255

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 46/254 (18%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  + ++G G++G VY A   V+ E VAIK++  L  +        ++E+  L++L+H N
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            IE +     +H   L+ EY                             LK + +     
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAE-------------------------NDLKKYMDK---- 125
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-----TETGTVKLAD 338
           N +V  R +K     +    ++ G+N+ HS   +HRD+K  N+LL     +ET  +K+ D
Sbjct: 126 NPDVSMRVIK-----SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 339 FGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG A +   P   F   + T ++  PE++L      Y   VD+WS+     E+  + P +
Sbjct: 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLG--SRHYSTSVDIWSIACIWAEMLMKTPLF 238
Query: 395 FNMNAMSALYHIAQ 408
              + +  L+ I +
Sbjct: 239 PGDSEIDQLFKIFE 252

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 120/287 (41%), Gaps = 57/287 (19%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+ +
Sbjct: 166 KILDFGLA--RTAGTSFMMTPEVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIK 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
               +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 221 GGVLFPGTDHIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 266

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 30  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 87
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 88  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 130
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 131 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKI 177
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 178 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 34/231 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            +KH N I     +                A  + E + +    H+ G            
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHLMG------------ 110
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              A  N  V  + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+ 
Sbjct: 111 ---ADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKIL 167
Query: 338 DFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG           +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 168 DFGLCRHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 124/327 (37%), Gaps = 90/327 (27%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++EIG G FG V+    L +++ VAIK +    ++ A    D ++E   + +L HP  ++
Sbjct: 10  VQEIGSGQFGLVHLGYWL-NKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G  L      LV E                                 F EH  L ++ 
Sbjct: 65  LYGVCLEQAPICLVFE---------------------------------FMEHGCLSDYL 91
Query: 287 VHKRPL-KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
             +R L   E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++DFG     
Sbjct: 92  RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151
Query: 346 C--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
                 S  GT +   W +PEV       +Y  K DVWS G+   E  +E K PY N   
Sbjct: 152 LDDQYTSSTGTKFPVKWASPEVF---SFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--- 205
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                            S+  V++ IS+      P     A + +Y I            
Sbjct: 206 ----------------RSNSEVVEDISTGFRLYKPRL---ASTHVYQI------------ 234
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
                   ++ C  + P DRP+  RLL
Sbjct: 235 --------MNHCWKERPEDRPAFSRLL 253

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 26  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 83
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 84  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 126
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 127 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173
Query: 337 ADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 174 LDFGLARHTADEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 25  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 82
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 83  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 125
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 126 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 172
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 222

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 26  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 83
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 84  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 126
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 127 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173
Query: 337 ADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 174 LDFGLARHTADEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 13/142 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGV 63
           S+ R L H + + + G +  +   ++V+E C      ++E+HKR   L E E       +
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-----FVGTPYWMA 118
           + G  YLH    IHRD+K GN+ L E   VK+ DFG A+ K   +        GTP ++A
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIA 183
Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEV   + +  +  +VDVWS+G
Sbjct: 184 PEV---LSKKGHSFEVDVWSIG 202

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 114/292 (39%), Gaps = 71/292 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +G G F   +      ++E+ A   + K   L     EK +    EI   R L H + + 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVG 79
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G +  +   ++V+E C                        R + L            E
Sbjct: 80  FHGFFEDNDFVFVVLELC------------------------RRRSL-----------LE 104
Query: 287 VHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +HKR   L E E       ++ G  YLH    IHRD+K GN+ L E   VK+ DFG A+ 
Sbjct: 105 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT- 163
Query: 345 KCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           K   +        GTP ++APEV   + +  +  +VDVWS+G     L   KPP+     
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----- 215
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                     +T CL+ +   + K   S     P + N  A S +  + Q D
Sbjct: 216 ----------ETSCLKETYLRIKKNEYSI----PKHINPVAASLIQKMLQTD 253

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ ++ L  +G G++G+V  +  + S   +A+KK+S   +          +E+R L+
Sbjct: 48  EVPER-YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHA-KRTYRELRLLK 105
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A+ + E + +    H+  MG  L  + KC 
Sbjct: 106 HMKHENVIGLLDVF--------------TPATSLEEFNDVYLVTHL--MGADLNNIVKC- 148
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 149 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 195
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 196 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNMTVDIWSVGCIMAEL 245

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 13/142 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGV 63
           S+ R L H + + + G +  +   ++V+E C      ++E+HKR   L E E       +
Sbjct: 91  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-----FVGTPYWMA 118
           + G  YLH    IHRD+K GN+ L E   VK+ DFG A+ K   +        GTP ++A
Sbjct: 149 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIA 207
Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEV   + +  +  +VDVWS+G
Sbjct: 208 PEV---LSKKGHSFEVDVWSIG 226

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 114/292 (39%), Gaps = 71/292 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +G G F   +      ++E+ A   + K   L     EK +    EI   R L H + + 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVG 103
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G +  +   ++V+E C                        R + L            E
Sbjct: 104 FHGFFEDNDFVFVVLELC------------------------RRRSL-----------LE 128
Query: 287 VHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +HKR   L E E       ++ G  YLH    IHRD+K GN+ L E   VK+ DFG A+ 
Sbjct: 129 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT- 187
Query: 345 KCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           K   +        GTP ++APEV   + +  +  +VDVWS+G     L   KPP+     
Sbjct: 188 KVEYDGERKKVLCGTPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----- 239
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                     +T CL+ +   + K   S     P + N  A S +  + Q D
Sbjct: 240 ----------ETSCLKETYLRIKKNEYSI----PKHINPVAASLIQKMLQTD 277

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 25  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 82
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 83  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 125
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 126 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 172
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 222

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 26  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 83
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 84  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 126
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 127 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173
Query: 337 ADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 174 LDFGLARHTADEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 223

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 123/327 (37%), Gaps = 90/327 (27%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++EIG G FG V+    L +++ VAIK +    K+ +    D ++E   + +L HP  ++
Sbjct: 32  VQEIGSGQFGLVHLGYWL-NKDKVAIKTI----KEGSMSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G  L      LV E                                 F EH  L ++ 
Sbjct: 87  LYGVCLEQAPICLVFE---------------------------------FMEHGCLSDYL 113
Query: 287 VHKRPL-KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
             +R L   E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++DFG     
Sbjct: 114 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 173
Query: 346 C--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
                 S  GT +   W +PEV       +Y  K DVWS G+   E  +E K PY N   
Sbjct: 174 LDDQYTSSTGTKFPVKWASPEVF---SFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--- 227
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                            S+  V++ IS+      P     A + +Y I  +         
Sbjct: 228 ----------------RSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNH--------- 259
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
                      C  + P DRP+  RLL
Sbjct: 260 -----------CWKERPEDRPAFSRLL 275

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 13/142 (9%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR--PLKEEEIAAICSGV 63
           S+ R L H + + + G +  +   ++V+E C      ++E+HKR   L E E       +
Sbjct: 93  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-----FVGTPYWMA 118
           + G  YLH    IHRD+K GN+ L E   VK+ DFG A+ K   +        GTP ++A
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIA 209
Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PEV   + +  +  +VDVWS+G
Sbjct: 210 PEV---LSKKGHSFEVDVWSIG 228

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 114/292 (39%), Gaps = 71/292 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +G G F   +      ++E+ A   + K   L     EK +    EI   R L H + + 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVG 105
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G +  +   ++V+E C                        R + L            E
Sbjct: 106 FHGFFEDNDFVFVVLELC------------------------RRRSL-----------LE 130
Query: 287 VHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +HKR   L E E       ++ G  YLH    IHRD+K GN+ L E   VK+ DFG A+ 
Sbjct: 131 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT- 189
Query: 345 KCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           K   +        GTP ++APEV   + +  +  +VDVWS+G     L   KPP+     
Sbjct: 190 KVEYDGERKKVLCGTPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----- 241
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
                     +T CL+ +   + K   S     P + N  A S +  + Q D
Sbjct: 242 ----------ETSCLKETYLRIKKNEYSI----PKHINPVAASLIQKMLQTD 279

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 24  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 81
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 82  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 124
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 125 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 171
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 221

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 16  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 73
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 74  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 116
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 117 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 163
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 164 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 213

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 16  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 73
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 74  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 116
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 117 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 163
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 164 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 213

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 26  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 83
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 84  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 126
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 127 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 174 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 223

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 17  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 74
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 75  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 117
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 118 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 164
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 165 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 214

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S    Q         +E+R L+
Sbjct: 39  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLK 96
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 97  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 139
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 140 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 186
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 187 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 236

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 21  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 78
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 79  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 121
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 122 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 168
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 31  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHA-KRTYRELRLLK 88
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 89  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 131
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 132 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 178
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 179 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 228

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 31  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 88
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 89  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 131
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 132 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 178
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 179 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 228

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 31  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 88
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 89  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 131
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 132 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 178
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 179 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 228

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 38  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 95
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 96  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 138
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 139 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 185
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 186 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 15  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 72
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 73  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 115
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 116 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 162
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 163 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 212

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 124/327 (37%), Gaps = 90/327 (27%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++EIG G FG V+    L +++ VAIK +    ++ A    D ++E   + +L HP  ++
Sbjct: 15  VQEIGSGQFGLVHLGYWL-NKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G  L      LV E                                 F EH  L ++ 
Sbjct: 70  LYGVCLEQAPICLVFE---------------------------------FMEHGCLSDYL 96
Query: 287 VHKRPL-KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
             +R L   E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++DFG     
Sbjct: 97  RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156
Query: 346 C--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
                 S  GT +   W +PEV       +Y  K DVWS G+   E  +E K PY N   
Sbjct: 157 LDDQYTSSTGTKFPVKWASPEVF---SFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--- 210
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                            S+  V++ IS+      P     A + +Y I            
Sbjct: 211 ----------------RSNSEVVEDISTGFRLYKPRL---ASTHVYQI------------ 239
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
                   ++ C  + P DRP+  RLL
Sbjct: 240 --------MNHCWRERPEDRPAFSRLL 258

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 42  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 99
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 100 HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 142
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 143 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 189
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 190 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 239

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 24  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 81
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 82  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 124
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 125 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 171
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 21  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 78
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 79  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 121
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 122 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 168
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 120/287 (41%), Gaps = 57/287 (19%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 82
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 137
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 138 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+ +
Sbjct: 167 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIK 221
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
               +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 222 GGVLFPGTDHIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 267

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 18  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 75
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 76  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 118
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 119 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 165
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 166 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 215

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 21  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 78
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 79  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 121
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 122 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 168
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 102/236 (43%), Gaps = 57/236 (24%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVG--CI 214

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 120/287 (41%), Gaps = 57/287 (19%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+ TP     Y+ APEVIL M    Y   VD+WS+G    E+ +
Sbjct: 166 KILDFGLA--RTAGTSFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIK 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
               +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 221 GGVLFPGTDHIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 266

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 30  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 87
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 88  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 130
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 131 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 177
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 178 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 227

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 108/269 (40%), Gaps = 56/269 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G++G V  A    + EIVAIKK+    K         L+EI+ L+  KH N I    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA--LRTLREIKILKHFKHENIITIFN 76
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
               D            S  +  EV+ I+     E M   L ++             +  
Sbjct: 77  IQRPD------------SFENFNEVYIIQ-----ELMQTDLHRV-------------IST 106
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KC 346
           + L ++ I       LR +  LH    IHRD+K  N+L+     +K+ DFG A I     
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 347 PANS-----------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
             NS           FV T ++ APEV+L     +Y   +DVWS G    EL  R+P + 
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLT--SAKYSRAMDVWSCGCILAELFLRRPIFP 224
Query: 396 NMNAMSALYHI--------AQNDTPCLQS 416
             +    L  I        + ND  C++S
Sbjct: 225 GRDYRHQLLLIFGIIGTPHSDNDLRCIES 253

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 15  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 72
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 73  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 115
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                          L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 116 -------------AKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 162
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 163 LDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 42  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 99
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 100 HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 142
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 143 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 189
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 190 LDFGLARHTDDEMXGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 239

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 95/242 (39%), Gaps = 52/242 (21%)
Query: 170 IGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           IG G  G V Y R  V   R++ VAIK  K  Y  +Q      D L E   + Q  HPN 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR----DFLSEASIMGQFDHPNI 112
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   R   A +V EY    + D                      L+     F +  
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTF--------------------LRTHDGQFTIM- 151
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                      ++  +  GV  G+ YL  LG +HRD+ A N+L+      K++DFG + +
Sbjct: 152 -----------QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 345 --KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFN 396
               P  ++  T       W APE I       +    DVWS G+   E LA  + PY+N
Sbjct: 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFR---TFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 397 MN 398
           M 
Sbjct: 258 MT 259

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 47/239 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE +R +G GSFG V  AR   + ++ A+K    L K    +  D+   + E R L   +
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVK---VLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 221 -HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            HP   +   C+      + VME+  G   D++        FH+       Q+ + F E 
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNG--GDLM--------FHI-------QKSRRFDEA 124
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A F                  + ++  L +LH  G I+RD+K  N+LL   G  KLADF
Sbjct: 125 RARF----------------YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF 168
Query: 340 GSAS----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G             +F GTP ++APE++  M    Y   VD W++G+   E+     P+
Sbjct: 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM---LYGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 124/327 (37%), Gaps = 90/327 (27%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++EIG G FG V+    L +++ VAIK +    ++ A    D ++E   + +L HP  ++
Sbjct: 13  VQEIGSGQFGLVHLGYWL-NKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G  L      LV E                                 F EH  L ++ 
Sbjct: 68  LYGVCLEQAPICLVTE---------------------------------FMEHGCLSDYL 94
Query: 287 VHKRPL-KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
             +R L   E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++DFG     
Sbjct: 95  RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154
Query: 346 C--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
                 S  GT +   W +PEV       +Y  K DVWS G+   E  +E K PY N   
Sbjct: 155 LDDQYTSSTGTKFPVKWASPEVF---SFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--- 208
Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                            S+  V++ IS+      P     A + +Y I            
Sbjct: 209 ----------------RSNSEVVEDISTGFRLYKPRL---ASTHVYQI------------ 237
Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLL 486
                   ++ C  + P DRP+  RLL
Sbjct: 238 --------MNHCWRERPEDRPAFSRLL 256

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMXGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L++L HP  I+ +  +      ++V+E   G       V  + LKE         +L  
Sbjct: 68  ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 67  LNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V++++    Y+  VD WSLG+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGV 207

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 168 REIGHGSFGAVYYA----RCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G+ G V  A     C  V+ +I++ +K +    + A+   ++  EI  L++L HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I+ +  +      ++V+E   G                                   L
Sbjct: 76  CIIKIKN-FFDAEDYYIVLELMEGGE---------------------------------L 101
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
           F+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+   E   +K+ DF
Sbjct: 102 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G + I        +  GTP ++APEV++++    Y+  VD WSLG+         PP+
Sbjct: 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 104/242 (42%), Gaps = 56/242 (23%)
Query: 161 EKIFEDLREIGHGSFGAV----YYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRF 215
           ++  + +R++G G FG V    Y      + E+VA+K +    G Q    W    +EI  
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWK---QEIDI 69
Query: 216 LRQLKHPNTIEYRGCY--LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           LR L H + I+Y+GC     + +  LVMEY  LGS  D +  H I            L Q
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG-----------LAQ 118
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L  F +                     IC     G+ YLHS   IHR++ A N+LL    
Sbjct: 119 LLLFAQQ--------------------ICE----GMAYLHSQHYIHRNLAARNVLLDNDR 154
Query: 333 TVKLADFGSASIKCPANSFV------GTP-YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            VK+ DFG A      + +        +P +W APE    + E ++    DVWS G+T  
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE---CLKEYKFYYASDVWSFGVTLY 211
Query: 386 EL 387
           EL
Sbjct: 212 EL 213

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L++L HP  I+ +  +      ++V+E   G       V  + LKE         +L  
Sbjct: 67  ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 125
Query: 67  LNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++APE
Sbjct: 126 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 185
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V++++    Y+  VD WSLG+
Sbjct: 186 VLVSVGTAGYNRAVDCWSLGV 206

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 168 REIGHGSFGAVYYA----RCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G+ G V  A     C  V+ +I++ +K +    + A+   ++  EI  L++L HP
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I+ +  +      ++V+E   G                                   L
Sbjct: 75  CIIKIKN-FFDAEDYYIVLELMEGGE---------------------------------L 100
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
           F+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+   E   +K+ DF
Sbjct: 101 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 160
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G + I        +  GTP ++APEV++++    Y+  VD WSLG+         PP+
Sbjct: 161 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 83
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 138
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 139 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 167
Query: 335 KLADFG---SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           K+ DFG   +A        FV T Y+ APEVIL M    Y   VD+WS+G    E+ +  
Sbjct: 168 KILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIKGG 224
Query: 392 PPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
             +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 225 VLFPGTDHIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 268

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L++L HP  I+ +  +      ++V+E   G       V  + LKE         +L  
Sbjct: 207 ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 265
Query: 67  LNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++APE
Sbjct: 266 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 325
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V++++    Y+  VD WSLG+
Sbjct: 326 VLVSVGTAGYNRAVDCWSLGV 346

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 45/238 (18%)
Query: 168 REIGHGSFGAVYYA----RCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G+ G V  A     C  V+  I++ +K +    + A+   ++  EI  L++L HP
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I+ +  +      ++V+E   G                                   L
Sbjct: 215 CIIKIKN-FFDAEDYYIVLELMEGGE---------------------------------L 240
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
           F+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+   E   +K+ DF
Sbjct: 241 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 300
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G + I        +  GTP ++APEV++++    Y+  VD WSLG+         PP+
Sbjct: 301 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L++L HP  I+ +  +      ++V+E   G       V  + LKE         +L  
Sbjct: 68  ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 67  LNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V++++    Y+  VD WSLG+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGV 207

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 168 REIGHGSFGAVYYA----RCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G+ G V  A     C  V+ +I++ +K +    + A+   ++  EI  L++L HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I+ +  +      ++V+E   G                                   L
Sbjct: 76  CIIKIKN-FFDAEDYYIVLELMEGGE---------------------------------L 101
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
           F+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+   E   +K+ DF
Sbjct: 102 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G + I        +  GTP ++APEV++++    Y+  VD WSLG+         PP+
Sbjct: 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMXGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 67
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 94
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 95  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 206
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 207 ------DQPSDSCQEYSDWKEKKT 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 89/354 (25%), Positives = 137/354 (38%), Gaps = 72/354 (20%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILK 211
           D  ++FE   E+G G+F  V   RC+        + +I+  KK+S    Q  E+      
Sbjct: 31  DDYQLFE---ELGKGAFSVV--RRCVKKTPTQEYAAKIINTKKLSARDHQKLER------ 79
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E R  R LKHPN +        +   +LV +   G                         
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE----------------------- 116
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-- 329
                     LF   V +    E + +     +L  +N++H    +HRD+K  N+LL   
Sbjct: 117 ----------LFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASK 166
Query: 330 -ETGTVKLADFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            +   VKLADFG A I+          F GTP +++PEV   + +  Y   VD+W+ G+ 
Sbjct: 167 CKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPEV---LRKDPYGKPVDIWACGVI 222
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI----KTISSTAERKPPYFNMN 439
              L    PP+++ +    LY   +       S +W  +    K + +      P   + 
Sbjct: 223 LYILLVGYPPFWDED-QHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRIT 281
Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
           A  AL H       C +S+  S         CL K  A R   G +LT  LV+R
Sbjct: 282 ADQALKH----PWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSR 331

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L++L HP  I+ +  +      ++V+E   G       V  + LKE         +L  
Sbjct: 74  ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 132
Query: 67  LNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++APE
Sbjct: 133 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 192
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V++++    Y+  VD WSLG+
Sbjct: 193 VLVSVGTAGYNRAVDCWSLGV 213

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 168 REIGHGSFGAVYYA----RCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G+ G V  A     C  V+ +I++ +K +    + A+   ++  EI  L++L HP
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I+ +  +      ++V+E   G                                   L
Sbjct: 82  CIIKIKN-FFDAEDYYIVLELMEGGE---------------------------------L 107
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
           F+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+   E   +K+ DF
Sbjct: 108 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 167
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G + I        +  GTP ++APEV++++    Y+  VD WSLG+         PP+
Sbjct: 168 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 104
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
           C+  D   +  + Y                      +   ++++  F E    F      
Sbjct: 105 CFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 141
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 142 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 191
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 192 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQ---CAEKWADILKEIRFLR 217
           FE L+ IG G+FG V   +   + ++ A+K   K   L +    C  +  D+L       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----G 131
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             K   T+ Y   +  D+  +LVM+Y +G                    G+ L  L  F 
Sbjct: 132 DSKWITTLHY--AFQDDNNLYLVMDYYVG--------------------GDLLTLLSKFE 169
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
           +             L EE      + ++  ++ +H L  +HRD+K  NIL+   G ++LA
Sbjct: 170 DR------------LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLA 217
Query: 338 DFGSA-----SIKCPANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAER 390
           DFGS           ++  VGTP +++PE++ AM+  +G+Y  + D WSLG+   E+   
Sbjct: 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 391 KPPYF 395
           + P++
Sbjct: 278 ETPFY 282

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 169 EIGHGSFGAVYYARCL-VSREIVA--IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           E+G G F  V   R     +E  A  IKK      +      +I +E+  LR+++HPN I
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                +       L++E   G                                   LF+F
Sbjct: 93  TLHDIFENKTDVVLILELVSGGE---------------------------------LFDF 119
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT----VKLADFGS 341
              K  L E+E       +L G++YLHS    H D+K  NI+L +       +KL DFG 
Sbjct: 120 LAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 179
Query: 342 ASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           A      N F    GTP ++APE++     G    + D+WS+G+    L     P+    
Sbjct: 180 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVITYILLSGASPFLGET 236
Query: 399 AMSALYHIA 407
               L +I+
Sbjct: 237 KQETLTNIS 245

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L++L HP  I+ +  +      ++V+E   G       V  + LKE         +L  
Sbjct: 68  ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 67  LNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V++++    Y+  VD WSLG+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGV 207

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 168 REIGHGSFGAVYYA----RCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G+ G V  A     C  V+ +I++ +K +    + A+   ++  EI  L++L HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I+ +  +      ++V+E   G                                   L
Sbjct: 76  CIIKIKN-FFDAEDYYIVLELMEGGE---------------------------------L 101
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
           F+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+   E   +K+ DF
Sbjct: 102 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G + I        +  GTP ++APEV++++    Y+  VD WSLG+         PP+
Sbjct: 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L++L HP  I+ +  +      ++V+E   G       V  + LKE         +L  
Sbjct: 193 ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 67  LNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++APE
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V++++    Y+  VD WSLG+
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGV 332

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 45/238 (18%)
Query: 168 REIGHGSFGAVYYA----RCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           + +G G+ G V  A     C  V+  I++ +K +    + A+   ++  EI  L++L HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I+ +  +      ++V+E   G                                   L
Sbjct: 201 CIIKIKN-FFDAEDYYIVLELMEGGE---------------------------------L 226
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
           F+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+   E   +K+ DF
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G + I        +  GTP ++APEV++++    Y+  VD WSLG+         PP+
Sbjct: 287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 103/237 (43%), Gaps = 46/237 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKH 221
           FE  R +G G FG VY AR   S  IVA+K +  S + K+  E    + +EI     L H
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEH--QLRREIEIQAHLHH 82
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           PN +     +      +L++EY                      +   LQ+   F E   
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGE-----------------LYKELQKSCTFDE--- 122
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                        +  A I   +   L Y H    IHRD+K  N+LL   G +K+ADFG 
Sbjct: 123 -------------QRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG- 168
Query: 342 ASIKCPA---NSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPY 394
            S+  P+    +  GT  ++ PE+I    EG+ ++ KVD+W +G+ C EL    PP+
Sbjct: 169 WSVHAPSLRRKTMCGTLDYLPPEMI----EGRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 107/269 (39%), Gaps = 56/269 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G++G V  A    + EIVAIKK+    K         L+EI+ L+  KH N I    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA--LRTLREIKILKHFKHENIITIFN 76
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
               D            S  +  EV+ I+     E M   L ++             +  
Sbjct: 77  IQRPD------------SFENFNEVYIIQ-----ELMQTDLHRV-------------IST 106
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----- 344
           + L ++ I       LR +  LH    IHRD+K  N+L+     +K+ DFG A I     
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 345 ---------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
                    +     +V T ++ APEV+L     +Y   +DVWS G    EL  R+P + 
Sbjct: 167 ADNSEPTGQQSGMTEYVATRWYRAPEVMLT--SAKYSRAMDVWSCGCILAELFLRRPIFP 224
Query: 396 NMNAMSALYHI--------AQNDTPCLQS 416
             +    L  I        + ND  C++S
Sbjct: 225 GRDYRHQLLLIFGIIGTPHSDNDLRCIES 253

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 100 TFQDDEKLYFGLSYAKNGC-----------------LLKYIRKIGSFDETCTRF------ 136
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 137 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               ANSFVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 187 KQARANSFVGTAQYVSPEL---LTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 105/246 (42%), Gaps = 64/246 (26%)
Query: 161 EKIFEDLREIGHGSFGAV----YYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRF 215
           ++  + +R++G G FG V    Y      + E+VA+K +    G Q    W    +EI  
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK---QEIDI 86
Query: 216 LRQLKHPNTIEYRGCYLRDHTA---WLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQ 271
           LR L H + I+Y+GC   D  A    LVMEY  LGS  D +  H I            L 
Sbjct: 87  LRTLYHEHIIKYKGC-CEDAGAASLQLVMEYVPLGSLRDYLPRHSIG-----------LA 134
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
           QL  F +                     IC     G+ YLH+   IHRD+ A N+LL   
Sbjct: 135 QLLLFAQQ--------------------ICE----GMAYLHAQHYIHRDLAARNVLLDND 170
Query: 332 GTVKLADFGSAS----------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
             VK+ DFG A           ++   +S V   +W APE    + E ++    DVWS G
Sbjct: 171 RLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FWYAPE---CLKEYKFYYASDVWSFG 224
Query: 382 ITCIEL 387
           +T  EL
Sbjct: 225 VTLYEL 230

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 119/287 (41%), Gaps = 57/287 (19%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+  P     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMEPEVVTRYYRAPEVILGMG---YKENVDLWSVGCIMGEMVC 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
            K  +   + +      I Q  TPC +     +  T+ +  E +P Y
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRTYVENRPKY 266

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 107/260 (41%), Gaps = 45/260 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ + ++G G    VY A   +    VAIK +    ++  E      +E+    QL H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 224 TIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +        D   +LVMEY  G + S+ IE H                           
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-------------------------- 106
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-- 340
                   PL  +      + +L G+ + H +  +HRD+K  NIL+    T+K+ DFG  
Sbjct: 107 --------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158
Query: 341 ---SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
              S +     N  +GT  + +PE   A  E   D   D++S+GI   E+   +PP+   
Sbjct: 159 KALSETSLTQTNHVLGTVQYFSPE--QAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGE 215
Query: 398 NAMS-ALYHIAQNDTPCLQS 416
            A+S A+ HI Q+  P + +
Sbjct: 216 TAVSIAIKHI-QDSVPNVTT 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 114/267 (42%), Gaps = 48/267 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ +G G FG V+ A+  V     AIK++    ++ A +   +++E++ L +L+HP 
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEHPG 65
Query: 224 TIEYRGCYLRD---------HTAWLVME---YCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
            + Y   +L              WL  E   + L S S +       R        N + 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 272 QLKCFTEHFALF---------NFE--VHKRPLKEEEIAAICSGVL----RGLNYLHSLGR 316
           QL+  +    L+         N +  +++R   E+    +C  +       + +LHS G 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 317 IHRDVKAGNILLTETGTVKLADFG----------SASIKCPANSF------VGTPYWMAP 360
           +HRD+K  NI  T    VK+ DFG            ++  P  ++      VGT  +M+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSP 245
Query: 361 EVILAMDEGQYDGKVDVWSLGITCIEL 387
           E I       Y  KVD++SLG+   EL
Sbjct: 246 EQIHG---NNYSHKVDIFSLGLILFEL 269

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 39  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 96
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 97  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 139
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 140 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 186
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A          V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 187 LDFGLARHTDDEMXGXVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 236

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            D+G A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDYGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 169 EIGHGSFGAVYYARCL-VSREIVA--IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI 225
           E+G G F  V   R     +E  A  IKK      +      +I +E+  LR+++HPN I
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
                +       L++E   G                                   LF+F
Sbjct: 72  TLHDIFENKTDVVLILELVSGGE---------------------------------LFDF 98
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT----VKLADFGS 341
              K  L E+E       +L G++YLHS    H D+K  NI+L +       +KL DFG 
Sbjct: 99  LAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 342 ASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           A      N F    GTP ++APE++     G    + D+WS+G+    L     P+    
Sbjct: 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGVITYILLSGASPFLGET 215
Query: 399 AMSALYHIA 407
               L +I+
Sbjct: 216 KQETLTNIS 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 43/229 (18%)
Query: 171 GHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL-KEIRFLRQLKHPNTIEYRG 229
           G G FG VY  +  V+   VA+KK++ +     E+      +EI+   + +H N +E  G
Sbjct: 31  GEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                    LV  Y                       G+ L +L C              
Sbjct: 89  FSSDGDDLCLVYVYXPN--------------------GSLLDRLSCLD----------GT 118
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA------S 343
            PL       I  G   G+N+LH    IHRD+K+ NILL E  T K++DFG A      +
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 344 IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
                +  VGT  + APE +     G+   K D++S G+  +E+    P
Sbjct: 179 QXVXXSRIVGTTAYXAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 104/273 (38%), Gaps = 62/273 (22%)
Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAV-----------YYARCLVSREIVAIKKMSYLGKQ 201
           E F ++  E  ++   E+G G F  V           Y A+ +  R+  A ++       
Sbjct: 3   ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV----- 57
Query: 202 CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREF 261
           C E   +I +E+  LRQ+ HPN I     Y       L++E   G               
Sbjct: 58  CRE---EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE------------- 101
Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
                               LF+F   K  L EEE  +    +L G+NYLH+    H D+
Sbjct: 102 --------------------LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 322 KAGNILLTETGT----VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGK 374
           K  NI+L +       +KL DFG A          +  GTP ++APE++     G    +
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL---E 198
Query: 375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIA 407
            D+WS+G+    L     P+        L +I 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANIT 231

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 36/239 (15%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ L ++G+G++  VY      +   VA+K++    ++     A  ++EI  +++LKH N
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELKHEN 64
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        ++   LV E+                      M N    LK + +   + 
Sbjct: 65  IVRLYDVIHTENKLTLVFEF----------------------MDN---DLKKYMDSRTVG 99
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
           N     R L+   +      +L+GL + H    +HRD+K  N+L+ + G +KL DFG A 
Sbjct: 100 N---TPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           +   P N+F   V T ++ AP+V+  M    Y   +D+WS G    E+   KP +   N
Sbjct: 157 AFGIPVNTFSSEVVTLWYRAPDVL--MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 104/242 (42%), Gaps = 56/242 (23%)
Query: 161 EKIFEDLREIGHGSFGAV----YYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRF 215
           ++  + +R++G G FG V    Y      + E+VA+K +    G Q    W    +EI  
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWK---QEIDI 69
Query: 216 LRQLKHPNTIEYRGCY--LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           LR L H + I+Y+GC     + +  LVMEY  LGS  D +  H I            L Q
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG-----------LAQ 118
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L  F +                     IC     G+ YLH+   IHR++ A N+LL    
Sbjct: 119 LLLFAQQ--------------------ICE----GMAYLHAQHYIHRNLAARNVLLDNDR 154
Query: 333 TVKLADFGSASIKCPANSFV------GTP-YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            VK+ DFG A      + +        +P +W APE    + E ++    DVWS G+T  
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE---CLKEYKFYYASDVWSFGVTLY 211
Query: 386 EL 387
           EL
Sbjct: 212 EL 213

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DFG A          V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFGLARHTDDEMTGXVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 119/287 (41%), Gaps = 57/287 (19%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRFLRQLK 220
           K +++L+ IG G+ G V  A   +    VAIKK+S     Q   K A   +E+  ++ + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVN 81
Query: 221 HPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME    +   +I++     E   E M   L Q+ 
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQML 136
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
           C                               G+ +LHS G IHRD+K  NI++    T+
Sbjct: 137 C-------------------------------GIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 335 KLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           K+ DFG A  +    SF+  P     Y+ APEVIL M    Y   VD+WS+G    E+  
Sbjct: 166 KILDFGLA--RTAGTSFMMEPEVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVC 220
Query: 390 RKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
            K  +   + +      I Q  TPC  +    +  T+ +  E +P Y
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPC-PAFMKKLQPTVRNYVENRPKY 266

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 102/233 (43%), Gaps = 53/233 (22%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G+FG V  A+       VAIK++    ++ A      + E+R L ++ HPN ++  G
Sbjct: 17  VGRGAFGVVCKAKWRAKD--VAIKQIESESERKA-----FIVELRQLSRVNHPNIVKLYG 69
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
             L  +   LVMEY  G +                                 L+N     
Sbjct: 70  ACL--NPVCLVMEYAEGGS---------------------------------LYNVLHGA 94
Query: 290 RPLKEEEIAAICSGVLR---GLNYLHSL---GRIHRDVKAGNILLTETGTV-KLADFGSA 342
            PL     A   S  L+   G+ YLHS+     IHRD+K  N+LL   GTV K+ DFG+A
Sbjct: 95  EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
             I+    +  G+  WMAPEV    +   Y  K DV+S GI   E+  R+ P+
Sbjct: 155 CDIQTHMTNNKGSAAWMAPEV---FEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+  ++ L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 94/242 (38%), Gaps = 52/242 (21%)
Query: 170 IGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           IG G  G V Y R  V   R++ VAIK  K  Y  +Q      D L E   + Q  HPN 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR----DFLSEASIMGQFDHPNI 112
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   R   A +V EY    + D                      L+     F +  
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTF--------------------LRTHDGQFTIM- 151
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                      ++  +  GV  G+ YL  LG +HRD+ A N+L+      K++DFG + +
Sbjct: 152 -----------QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 345 ----KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFN 396
                  A +  G      W APE I       +    DVWS G+   E LA  + PY+N
Sbjct: 201 LEDDPDAAXTTTGGKIPIRWTAPEAIAFR---TFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 397 MN 398
           M 
Sbjct: 258 MT 259

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            DF  A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDFYLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 106/246 (43%), Gaps = 62/246 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GS+G VY A    + + VAIKK++ + +   +    IL+EI  L +LK         
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID-CKRILREITILNRLK--------- 83
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                 + +++  Y L    D+++  + E    +E   + L++L               K
Sbjct: 84  ------SDYIIRLYDLIIPDDLLK--FDELYIVLEIADSDLKKL--------------FK 121
Query: 290 RP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----- 342
            P  L EE I  I   +L G N++H  G IHRD+K  N LL +  +VK+ DFG A     
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 343 ---------------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
                                ++K    S V T ++ APE+IL  +   Y   +D+WS G
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE--NYTKSIDIWSTG 239
Query: 382 ITCIEL 387
               EL
Sbjct: 240 CIFAEL 245

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 34/57 (59%), Gaps = 2/57 (3%)
Query: 626 SDIIEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           SD+ ++ K P  L EE I  I   +L G N++H  G IHRD+K  N LL +  +VK+
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKV 170

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 102/233 (43%), Gaps = 53/233 (22%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G+FG V  A+       VAIK++    ++ A      + E+R L ++ HPN ++  G
Sbjct: 16  VGRGAFGVVCKAKWRAKD--VAIKQIESESERKA-----FIVELRQLSRVNHPNIVKLYG 68
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
             L  +   LVMEY  G +                                 L+N     
Sbjct: 69  ACL--NPVCLVMEYAEGGS---------------------------------LYNVLHGA 93
Query: 290 RPLKEEEIAAICSGVLR---GLNYLHSL---GRIHRDVKAGNILLTETGTV-KLADFGSA 342
            PL     A   S  L+   G+ YLHS+     IHRD+K  N+LL   GTV K+ DFG+A
Sbjct: 94  EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
             I+    +  G+  WMAPEV    +   Y  K DV+S GI   E+  R+ P+
Sbjct: 154 CDIQTHMTNNKGSAAWMAPEVF---EGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 108/264 (40%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI     L H N ++
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINAMLNHENVVK 69
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 208
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 209 ------DQPSDSCQEYSDWKEKKT 226

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 101 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 137
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 138 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               ANSFVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 188 KQARANSFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 103/235 (43%), Gaps = 38/235 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KH 221
           + +G G+FG V  A  +       +E V +           E  +D++ E+  ++ + KH
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N I   G   +D   ++++EY                       GN  + L+       
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPGM 140
Query: 282 LFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
            +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+AD
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 339 FGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           FG A      + +  T        WMAPE +    +  Y  + DVWS G+   E+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEI 252

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 93/384 (24%), Positives = 148/384 (38%), Gaps = 79/384 (20%)
Query: 164 FEDLREIGHGSFGAVYYARC---LVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFL 216
           ++   E+G G+F  V   RC   L  +E    I+  KK+S    Q  E+      E R  
Sbjct: 13  YQLFEELGKGAFSVV--RRCVKVLAGQEYAAMIINTKKLSARDHQKLER------EARIC 64
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R LKHPN +        +   +L+ +   G                              
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE---------------------------- 96
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGT 333
                LF   V +    E + +     +L  + + H +G +HR++K  N+LL    +   
Sbjct: 97  -----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA 151
Query: 334 VKLADFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VKLADFG A I+          F GTP +++PEV   + +  Y   VD+W+ G+    L 
Sbjct: 152 VKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEV---LRKDPYGKPVDLWACGVILYILL 207
Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI----KTISSTAERKPPYFNMNAMSAL 444
              PP+++ +    LY   +       S +W  +    K + +      P   + A  AL
Sbjct: 208 VGYPPFWDED-QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 445 YH--IAQNDT--PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS--PS 498
            H  I+   T   C+   +  D        CL K  A R   G +LT  L TR  S    
Sbjct: 267 KHPWISHRSTVASCMHRQETVD--------CLKKFNARRKLKGAILTVMLATRNFSVRKQ 318
Query: 499 VLVDLIRRTKAAVRDLDNLNYRKM 522
            ++ +  +   A+ + D  +Y KM
Sbjct: 319 EIIKVTEQLIEAISNGDFESYTKM 342

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 87/348 (25%), Positives = 135/348 (38%), Gaps = 72/348 (20%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILK 211
           D  ++FE   E+G G+F  V   RC+        + +I+  KK+S    Q  E+      
Sbjct: 4   DEYQLFE---ELGKGAFSVV--RRCMKIPTGQEYAAKIINTKKLSARDHQKLER------ 52
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E R  R LKHPN +        +   +LV +   G                         
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE----------------------- 89
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--- 328
                     LF   V +    E + +     +L  +N+ H  G +HRD+K  N+LL   
Sbjct: 90  ----------LFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASK 139
Query: 329 TETGTVKLADFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           ++   VKLADFG A I+   +      F GTP +++PEV   + +  Y   VD+W+ G+ 
Sbjct: 140 SKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV---LRKDPYGKPVDMWACGVI 195
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI----KTISSTAERKPPYFNMN 439
              L    PP+++ +    LY   +       S +W  +    K + +      P   + 
Sbjct: 196 LYILLVGYPPFWDED-QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 254
Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT 487
           A  AL H       C +S+  S         CL K  A R   G +LT
Sbjct: 255 ASEALKH----PWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILT 298

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 103/242 (42%), Gaps = 56/242 (23%)
Query: 161 EKIFEDLREIGHGSFGAV----YYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRF 215
           ++  + +R++G G FG V    Y      + E+VA+K +    G Q    W    +EI  
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ---REIEI 64
Query: 216 LRQLKHPNTIEYRGCY--LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           LR L H + ++Y+GC     + +  LVMEY  LGS  D +  H +            L Q
Sbjct: 65  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG-----------LAQ 113
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L  F +                     IC     G+ YLH+   IHR + A N+LL    
Sbjct: 114 LLLFAQQ--------------------ICE----GMAYLHAQHYIHRALAARNVLLDNDR 149
Query: 333 TVKLADFGSASIKCPANSFV------GTP-YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            VK+ DFG A      + +        +P +W APE    + E ++    DVWS G+T  
Sbjct: 150 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE---CLKECKFYYASDVWSFGVTLY 206
Query: 386 EL 387
           EL
Sbjct: 207 EL 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 106/269 (39%), Gaps = 56/269 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G++G V  A    + EIVAIKK+    K         L+EI+ L+  KH N I    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA--LRTLREIKILKHFKHENIITIFN 76
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
               D            S  +  EV+ I+     E M   L ++             +  
Sbjct: 77  IQRPD------------SFENFNEVYIIQ-----ELMQTDLHRV-------------IST 106
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----- 344
           + L ++ I       LR +  LH    IHRD+K  N+L+     +K+ DFG A I     
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 345 ---------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
                    +      V T ++ APEV+L     +Y   +DVWS G    EL  R+P + 
Sbjct: 167 ADNSEPTGQQSGMTEXVATRWYRAPEVMLT--SAKYSRAMDVWSCGCILAELFLRRPIFP 224
Query: 396 NMNAMSALYHI--------AQNDTPCLQS 416
             +    L  I        + ND  C++S
Sbjct: 225 GRDYRHQLLLIFGIIGTPHSDNDLRCIES 253

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 108/264 (40%), Gaps = 55/264 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G+ G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+      
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW------ 207
Query: 401 SALYHIAQNDTPCLQSSDWSVIKT 424
                  Q    C + SDW   KT
Sbjct: 208 ------DQPSDSCQEYSDWKEKKT 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 103/242 (42%), Gaps = 56/242 (23%)
Query: 161 EKIFEDLREIGHGSFGAV----YYARCLVSREIVAIKKMSY-LGKQCAEKWADILKEIRF 215
           ++  + +R++G G FG V    Y      + E+VA+K +    G Q    W    +EI  
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ---REIEI 63
Query: 216 LRQLKHPNTIEYRGCY--LRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           LR L H + ++Y+GC     + +  LVMEY  LGS  D +  H +            L Q
Sbjct: 64  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG-----------LAQ 112
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L  F +                     IC     G+ YLH+   IHR + A N+LL    
Sbjct: 113 LLLFAQQ--------------------ICE----GMAYLHAQHYIHRALAARNVLLDNDR 148
Query: 333 TVKLADFGSASIKCPANSFV------GTP-YWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            VK+ DFG A      + +        +P +W APE    + E ++    DVWS G+T  
Sbjct: 149 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE---CLKECKFYYASDVWSFGVTLY 205
Query: 386 EL 387
           EL
Sbjct: 206 EL 207

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+L+  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 15/178 (8%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LLR  +HPN I  +  Y      ++V E   G       + ++   E E +A+   + + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 67  LNYLHSLGRIHRDVKAGNIL-LTETG---TVKLADFGSASIKCPANSFVGTPYW----MA 118
           + YLH+ G +HRD+K  NIL + E+G   ++++ DFG A      N  + TP +    +A
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 119 PEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKED-PEKIFEDLREIGHGSF 175
           PEV   ++   YD   D+WSLG+   ++           +D PE+I   L  IG G F
Sbjct: 189 PEV---LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARIGSGKF 240

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 52/242 (21%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHP 222
           +E   +IG GS+      RC     I     M +  K   +   D  +EI   LR  +HP
Sbjct: 24  YEVKEDIGVGSYSVC--KRC-----IHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHP 76
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N I  +  Y      ++V E   G                    G  L ++         
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKG--------------------GELLDKI--------- 107
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL-LTETG---TVKLAD 338
               + ++   E E +A+   + + + YLH+ G +HRD+K  NIL + E+G   ++++ D
Sbjct: 108 ----LRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD 163
Query: 339 FGSASIKCPANSFVGTPYW----MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           FG A      N  + TP +    +APEV   ++   YD   D+WSLG+    +     P+
Sbjct: 164 FGFAKQLRAENGLLMTPCYTANFVAPEV---LERQGYDAACDIWSLGVLLYTMLTGYTPF 220
Query: 395 FN 396
            N
Sbjct: 221 AN 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 73/143 (51%), Gaps = 11/143 (7%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LLR  +HPN I  +  Y      ++V E   G       + ++   E E +A+   + + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 67  LNYLHSLGRIHRDVKAGNIL-LTETG---TVKLADFGSASIKCPANSFVGTPYW----MA 118
           + YLH+ G +HRD+K  NIL + E+G   ++++ DFG A      N  + TP +    +A
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVA 188
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV   ++   YD   D+WSLG+
Sbjct: 189 PEV---LERQGYDAACDIWSLGV 208

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 11/123 (8%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL-LTETG---TVKLA 337
           L +  + ++   E E +A+   + + + YLH+ G +HRD+K  NIL + E+G   ++++ 
Sbjct: 103 LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 338 DFGSASIKCPANSFVGTPYW----MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           DFG A      N  + TP +    +APEV   ++   YD   D+WSLG+          P
Sbjct: 163 DFGFAKQLRAENGLLXTPCYTANFVAPEV---LERQGYDAACDIWSLGVLLYTXLTGYTP 219
Query: 394 YFN 396
           + N
Sbjct: 220 FAN 222

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 86/347 (24%), Positives = 139/347 (40%), Gaps = 76/347 (21%)
Query: 169 EIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           E+G G+F  V   RC+        + +I+  KK+S      A  +  + +E R  R+L+H
Sbjct: 36  ELGKGAFSVV--RRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQH 87
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR-LQQLKCFTEHF 280
           PN +        +   +LV +   G   ++ E   + REF+ E   +  +QQ        
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGG--ELFE-DIVAREFYSEADASHCIQQ-------- 136
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLA 337
                                  +L  + Y HS G +HR++K  N+LL    +   VKLA
Sbjct: 137 -----------------------ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 338 DFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           DFG A   +     + F GTP +++PEV   + +  Y   VD+W+ G+    L    PP+
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEV---LKKDPYSKPVDIWACGVILYILLVGYPPF 230
Query: 395 F--NMNAMSALYHIAQNDTPCLQSSDWSVI----KTISSTAERKPPYFNMNAMSALYHIA 448
           +  + + + A       D P   S +W  +    K++  +     P   + A  AL    
Sbjct: 231 WDEDQHRLYAQIKAGAYDYP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL---- 283
Query: 449 QNDTP--CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
               P  C +    S         CL K  A R   G +LT  + TR
Sbjct: 284 --KVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATR 328

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 100 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 136
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 137 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 187 KQARANXFVGTAQYVSPEL---LTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 111/286 (38%), Gaps = 59/286 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G+FG V   +  ++   VA+K ++    +  +    I +EI+ L+  +HP+ I+   
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                   ++VMEY  G                                   LF++    
Sbjct: 84  VISTPSDIFMVMEYVSGGE---------------------------------LFDYICKN 110
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
             L E+E   +   +L G++Y H    +HRD+K  N+LL      K+ADFG +++     
Sbjct: 111 GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
Query: 350 SF---VGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMNAMSALYH 405
                 G+P + APEVI       Y G +VD+WS G+                    LY 
Sbjct: 171 FLRXSCGSPNYAAPEVISGR---LYAGPEVDIWSSGVI-------------------LYA 208
Query: 406 IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           +     P       ++ K I       P Y N + +S L H+ Q D
Sbjct: 209 LLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
             FG A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LGFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 102/262 (38%), Gaps = 61/262 (23%)
Query: 155 FDKEDPEKIFEDLRE----IGHGSFGAVYYARCLVSREI-----VAIKKMSYLGKQCAEK 205
            D  D + +FED+ E    IG G+F  V   RC ++RE      V I  ++         
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGAFSVV--RRC-INRETGQQFAVKIVDVAKFTSSPGLS 69
Query: 206 WADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG 265
             D+ +E      LKHP+ +E    Y  D   ++V E+  G                   
Sbjct: 70  TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG------------------- 110
Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRP----LKEEEIAA-ICSGVLRGLNYLHSLGRIHRD 320
                          A   FE+ KR     +  E +A+     +L  L Y H    IHRD
Sbjct: 111 ---------------ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRD 155
Query: 321 VKAGNILLT---ETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
           VK  N+LL     +  VKL DFG A         A   VGTP++MAPEV+       Y  
Sbjct: 156 VKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV---KREPYGK 212
Query: 374 KVDVWSLGITCIELAERKPPYF 395
            VDVW  G+    L     P++
Sbjct: 213 PVDVWGCGVILFILLSGCLPFY 234

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 338 DFGSA----SIKCPANSFVGT--PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A    +I    N+  G     WMAPE +    +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDYYKNTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEI 252

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 97  TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 133
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 134 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               ANSFVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 184 KQARANSFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 113/283 (39%), Gaps = 53/283 (18%)
Query: 141 ITPGSLKDPEIA-ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK--K 194
           I P + +DP  A   F KE      +  R IG G FG V   R  +   R++ VAIK  K
Sbjct: 21  IDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLK 80
Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
           + Y  KQ      D L E   + Q  HPN +   G   R     +V+E+    A D    
Sbjct: 81  VGYTEKQ----RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF-- 134
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
                             L+     F +             ++  +  G+  G+ YL  +
Sbjct: 135 ------------------LRKHDGQFTVI------------QLVGMLRGIAAGMRYLADM 164
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAMD 367
           G +HRD+ A NIL+      K++DFG + +    P   +  T       W APE   A+ 
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPE---AIQ 221
Query: 368 EGQYDGKVDVWSLGITCIE-LAERKPPYFNMNAMSALYHIAQN 409
             ++    DVWS GI   E ++  + PY++M+    +  I + 
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 264

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE+++  D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE+++  D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            D G A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDAGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 49/305 (16%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCAE--KWADILKEIR 214
           E P +  E  + +G G+FG V  A    +S+  V+I+    + K+ A+  +   ++ E++
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 215 FLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
            + QL  H N +   G        +L+ EYC                      G+ L  L
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCC--------------------YGDLLNYL 140
Query: 274 KCFTEHFAL--FNFEVHKRPLKEEEIAAI------CSG--VLRGLNYLHSLGRIHRDVKA 323
           +   E F+     +E  KR  +EE++  +      C    V +G+ +L     +HRD+ A
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200
Query: 324 GNILLTETGTVKLADFGSA-SIKCPANSFV-GTPY----WMAPEVILAMDEGQYDGKVDV 377
            N+L+T    VK+ DFG A  I   +N  V G       WMAPE +    EG Y  K DV
Sbjct: 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDV 257
Query: 378 WSLGITCIELAERK-PPYFNMNAMSALYHIAQN----DTPCLQSSD-WSVIKTISSTAER 431
           WS GI   E+      PY  +   +  Y + QN    D P   + + + ++++  +   R
Sbjct: 258 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 317
Query: 432 KPPYF 436
           K P F
Sbjct: 318 KRPSF 322

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 74/138 (53%), Gaps = 14/138 (10%)
Query: 13  HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE--VHKRPLKEEEIAAICSGVLRGLNYL 70
           HPN ++    +      +LVME  L +  ++ E    K+   E E + I   ++  ++++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVME--LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 71  HSLGRIHRDVKAGNILLTETG---TVKLADFGSASIKCPANSFVGTP----YWMAPEVIL 123
           H +G +HRD+K  N+L T+      +K+ DFG A +K P N  + TP    ++ APE+  
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-- 180
Query: 124 AMDEGQYDGKVDVWSLGI 141
            +++  YD   D+WSLG+
Sbjct: 181 -LNQNGYDESCDLWSLGV 197

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 52/239 (21%)
Query: 166 DLRE--IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HP 222
           DL++  +G GSF          S +  A+K +S          A+  KEI  L+  + HP
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS------KRMEANTQKEITALKLCEGHP 66
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N ++    +      +LVME   G                    G   +++K        
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNG--------------------GELFERIK-------- 98
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---TVKLADF 339
                 K+   E E + I   ++  ++++H +G +HRD+K  N+L T+      +K+ DF
Sbjct: 99  -----KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153
Query: 340 GSASIKCPANSFVGTP----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G A +K P N  + TP    ++ APE+   +++  YD   D+WSLG+    +   + P+
Sbjct: 154 GFARLKPPDNQPLKTPCFTLHYAAPEL---LNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE+++  D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 172
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 173 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
Query: 394 YFN 396
           +F+
Sbjct: 231 FFH 233

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 97/244 (39%), Gaps = 50/244 (20%)
Query: 155 FDKEDPEKIFED----LREIGHGSFGAVYYARCLVSREIVAIKK-MS-YLG-KQCAEKWA 207
           +D   PE  F+     L  +GHGS+G V+  R      + A+K+ MS + G K  A K A
Sbjct: 46  YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA 105
Query: 208 DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
           ++    +     +HP  +     +      +L  E C                      G
Sbjct: 106 EVGSHEKVG---QHPCCVRLEQAWEEGGILYLQTELC----------------------G 140
Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
             LQQ           + E     L E ++       L  L +LHS G +H DVK  NI 
Sbjct: 141 PSLQQ-----------HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 328 LTETGTVKLADFG---SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           L   G  KL DFG               G P +MAPE++    +G Y    DV+SLG+T 
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL----QGSYGTAADVFSLGLTI 245
Query: 385 IELA 388
           +E+A
Sbjct: 246 LEVA 249

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE+++  D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 172 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
Query: 394 YFN 396
           +F+
Sbjct: 230 FFH 232

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 114 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 173
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE+++  D   YD  +D+WSLG     +  RK P
Sbjct: 174 IDWGLAEFYHPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEP 231
Query: 394 YFN 396
           +F+
Sbjct: 232 FFH 234

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 43/234 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N ++
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVK 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                                   LF+  
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGE---------------------------------LFDRI 95
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-- 344
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A++  
Sbjct: 96  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 345 ----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               +   N   GT  ++APE++   +   +   VDVWS GI    +   + P+
Sbjct: 156 YNNRERLLNKMXGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 172
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 173 IDWGLAEFYHPGQEYNVRVASRYFKGPE--LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
Query: 394 YFN 396
           +F+
Sbjct: 231 FFH 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 98  TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 134
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 135 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN+FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 185 KQARANAFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            D G A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDRGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 336
           EH    +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 119 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 178
Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
            D+G A    P   +   V + Y+  PE+++  D   YD  +D+WSLG     +  RK P
Sbjct: 179 IDWGLAEFYHPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEP 236
Query: 394 YFN 396
           +F+
Sbjct: 237 FFH 239

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 43/244 (17%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K+ PE  F+  + +G GSF  V  AR L +    AIK +         K   + +E   +
Sbjct: 6   KKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 64
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            +L HP  ++    +  D   +  + Y                      +   ++++  F
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSF 107
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            E    F                  + ++  L YLH  G IHRD+K  NILL E   +++
Sbjct: 108 DETCTRF----------------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 151
Query: 337 ADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            DFG+A +  P      AN FVGT  +++PE+   + E       D+W+LG    +L   
Sbjct: 152 TDFGTAKVLSPESKQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAG 208
Query: 391 KPPY 394
            PP+
Sbjct: 209 LPPF 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 43/244 (17%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K+ PE  F+  + +G GSF  V  AR L +    AIK +         K   + +E   +
Sbjct: 5   KKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 63
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            +L HP  ++    +  D   +  + Y                      +   ++++  F
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSF 106
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            E    F                  + ++  L YLH  G IHRD+K  NILL E   +++
Sbjct: 107 DETCTRF----------------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 150
Query: 337 ADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            DFG+A +  P      AN FVGT  +++PE+   + E       D+W+LG    +L   
Sbjct: 151 TDFGTAKVLSPESKQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAG 207
Query: 391 KPPY 394
            PP+
Sbjct: 208 LPPF 211

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S   +          +E+R L+
Sbjct: 19  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLK 76
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KCF 276
            +KH N I     +                A  + E + +    H+  MG  L  + KC 
Sbjct: 77  HMKHENVIGLLDVF--------------TPARSLEEFNDVYLVTHL--MGADLNNIVKC- 119
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 120 -------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 166
Query: 337 ADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            D G A         +V T ++ APE++L  +   Y+  VD+WS+G    EL
Sbjct: 167 LDGGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 61/243 (25%)
Query: 169 EIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           E+G G+F  V   RC+        + +I+  KK+S      A  +  + +E R  R+L+H
Sbjct: 13  ELGKGAFSVV--RRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQH 64
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           PN +        +   +LV +   G     DI+      REF+ E   +   Q       
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQ------- 112
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKL 336
                                   +L  + Y HS G +HR++K  N+LL    +   VKL
Sbjct: 113 -----------------------QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 149
Query: 337 ADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           ADFG A   +     + F GTP +++PEV   + +  Y   VD+W+ G+    L    PP
Sbjct: 150 ADFGLAIEVNDSEAWHGFAGTPGYLSPEV---LKKDPYSKPVDIWACGVILYILLVGYPP 206
Query: 394 YFN 396
           +++
Sbjct: 207 FWD 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 61/243 (25%)
Query: 169 EIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           E+G G+F  V   RC+        + +I+  KK+S      A  +  + +E R  R+L+H
Sbjct: 12  ELGKGAFSVV--RRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQH 63
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           PN +        +   +LV +   G     DI+      REF+ E   +   Q       
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQ------- 111
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKL 336
                                   +L  + Y HS G +HR++K  N+LL    +   VKL
Sbjct: 112 -----------------------QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 148
Query: 337 ADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           ADFG A   +     + F GTP +++PEV   + +  Y   VD+W+ G+    L    PP
Sbjct: 149 ADFGLAIEVNDSEAWHGFAGTPGYLSPEV---LKKDPYSKPVDIWACGVILYILLVGYPP 205
Query: 394 YFN 396
           +++
Sbjct: 206 FWD 208

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 185
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 43/244 (17%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K+ PE  F+  + +G GSF  V  AR L +    AIK +         K   + +E   +
Sbjct: 3   KKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 61
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            +L HP  ++    +  D   +  + Y                      +   ++++  F
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSF 104
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            E    F                  + ++  L YLH  G IHRD+K  NILL E   +++
Sbjct: 105 DETCTRF----------------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 148
Query: 337 ADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            DFG+A +  P      AN FVGT  +++PE+   + E       D+W+LG    +L   
Sbjct: 149 TDFGTAKVLSPESKQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAG 205
Query: 391 KPPY 394
            PP+
Sbjct: 206 LPPF 209

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 61/243 (25%)
Query: 169 EIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           E+G G+F  V   RC+        + +I+  KK+S      A  +  + +E R  R+L+H
Sbjct: 13  ELGKGAFSVV--RRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQH 64
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           PN +        +   +LV +   G     DI+      REF+ E   +   Q       
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQ------- 112
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKL 336
                                   +L  + Y HS G +HR++K  N+LL    +   VKL
Sbjct: 113 -----------------------QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 149
Query: 337 ADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           ADFG A   +     + F GTP +++PEV   + +  Y   VD+W+ G+    L    PP
Sbjct: 150 ADFGLAIEVNDSEAWHGFAGTPGYLSPEV---LKKDPYSKPVDIWACGVILYILLVGYPP 206
Query: 394 YFN 396
           +++
Sbjct: 207 FWD 209

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 102
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 103 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 139
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 140 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 189
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 190 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 83/354 (23%), Positives = 126/354 (35%), Gaps = 95/354 (26%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G    V+ AR L     VA+K +     +    +    +E +    L HP  +    
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 230 CYLRDHTA----WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
               +  A    ++VMEY  G +  DI+         H EG                   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV---------HTEG------------------- 111
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-S 343
                 P+  +    + +   + LN+ H  G IHRDVK  NIL++ T  VK+ DFG A +
Sbjct: 112 ------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARA 165
Query: 344 IKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           I    NS       +GT  +++PE          D + DV+SLG    E+   +PP+   
Sbjct: 166 IADSGNSVXQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 398 NAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
           + +S  Y H+ ++  P                                        P  +
Sbjct: 223 SPVSVAYQHVREDPIP----------------------------------------PSAR 242
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV-----TRPRSPSVLVDLIR 505
               S      V   LAKNP +R  +   +  DLV       P +P VL D  R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 2/68 (2%)
Query: 614 PQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +VMEY  G +  DI+   + P+  +    + +   + LN+ H  G IHRDVK  NIL+
Sbjct: 91  PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILI 149
Query: 673 TETGTVKL 680
           + T  VK+
Sbjct: 150 SATNAVKV 157

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 43/244 (17%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K+ PE  F+  + +G GSF  V  AR L +    AIK +         K   + +E   +
Sbjct: 4   KKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            +L HP  ++    +  D   +  + Y                      +   ++++  F
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSF 105
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            E    F                  + ++  L YLH  G IHRD+K  NILL E   +++
Sbjct: 106 DETCTRF----------------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 149
Query: 337 ADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            DFG+A +  P      AN FVGT  +++PE+   + E       D+W+LG    +L   
Sbjct: 150 TDFGTAKVLSPESKQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAG 206
Query: 391 KPPY 394
            PP+
Sbjct: 207 LPPF 210

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 98  TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 134
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 135 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 185 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 98  TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 134
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 135 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 185 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 101 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 137
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 138 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 188 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 100 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 136
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 137 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 187 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 107/237 (45%), Gaps = 42/237 (17%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 338 DFGSA-------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A         K   N  +    WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDXXKKTTNGRLPVK-WMAPE---ALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE +    +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEI 252

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 100 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 136
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 137 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 187 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ IG G+FG V   +   +  I A+K               IL +   L++ +   
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMK---------------ILNKWEMLKRAETAC 120
Query: 224 TIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             E R   +     W+  + Y     + +    ++  +++V G  + L  L  F +    
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHL----YLVMDYYVGG--DLLTLLSKFED---- 170
Query: 283 FNFEVHKRPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                 K P   E++A    G ++  ++ +H L  +HRD+K  N+LL   G ++LADFGS
Sbjct: 171 ------KLP---EDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGS 221
Query: 342 A-----SIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPY 394
                      ++  VGTP +++PE++ AM++  G+Y  + D WSLG+   E+   + P+
Sbjct: 222 CLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281
Query: 395 F 395
           +
Sbjct: 282 Y 282

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 100 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 136
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 137 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 187 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ IG G+FG V   +   +  I A+K               IL +   L++ +   
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMK---------------ILNKWEMLKRAETAC 136
Query: 224 TIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             E R   +     W+  + Y     + +    ++  +++V G  + L  L  F +    
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHL----YLVMDYYVGG--DLLTLLSKFED---- 186
Query: 283 FNFEVHKRPLKEEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                 K P   E++A    G ++  ++ +H L  +HRD+K  N+LL   G ++LADFGS
Sbjct: 187 ------KLP---EDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGS 237
Query: 342 A-----SIKCPANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPY 394
                      ++  VGTP +++PE++ AM++  G+Y  + D WSLG+   E+   + P+
Sbjct: 238 CLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297
Query: 395 F 395
           +
Sbjct: 298 Y 298

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 100 TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 136
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 137 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 187 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 122/321 (38%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG A +    P  ++          W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 81
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 82  TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 118
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 119 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 168
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 169 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 91/405 (22%), Positives = 160/405 (39%), Gaps = 86/405 (21%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HP 222
           +E ++++G G++G V+ +    + E+VA+KK+ +   Q +       +EI  L +L  H 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 223 NTIEYRGCYLR---DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           N +      LR   D   +LV +Y             +E + H     N L+        
Sbjct: 70  NIVNLLNV-LRADNDRDVYLVFDY-------------METDLHAVIRANILE-------- 107
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                  VHK+         +   +++ + YLHS G +HRD+K  NILL     VK+ADF
Sbjct: 108 ------PVHKQ--------YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADF 153
Query: 340 GSA----SIKCPANS---------------------FVGTPYWMAPEVILAMDEGQYDGK 374
           G +    +I+   N+                     +V T ++ APE++L     +Y   
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG--STKYTKG 211
Query: 375 VDVWSLGITCIELAERKPPYFNMNAMSALYHI-------AQNDTPCLQSSDWSVIKTISS 427
           +D+WSLG    E+   KP +   + M+ L  I       +  D   +QS      KT+  
Sbjct: 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQS---PFAKTMIE 268
Query: 428 TAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT 487
           + + K      N                  +D ++     +   L  NP  R S+   L 
Sbjct: 269 SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328
Query: 488 HDLVTRPRSPS--------VLVDLIRRTKAAVRDLDNLNYRKMKK 524
           H  V+   +P+        + + +    K ++ D  NL Y ++ +
Sbjct: 329 HPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISR 373

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 80/328 (24%), Positives = 125/328 (38%), Gaps = 81/328 (24%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           R++G G+FG V+      S     IK ++    Q       I  EI  L+ L HPN I+ 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKI 85
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
              +   H  ++VME C G          +ER    +  G                    
Sbjct: 86  FEVFEDYHNMYIVMETCEGG-------ELLERIVSAQARG-------------------- 118
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET---GTVKLADFGSASI 344
             + L E  +A +   ++  L Y HS   +H+D+K  NIL  +T     +K+ DFG A +
Sbjct: 119 --KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 345 KCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 + +  GT  +MAPEV     +     K D+WS G+           YF +    
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVF----KRDVTFKCDIWSAGVVM---------YFLL---- 219
Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 461
                    T CL  +  S ++ +   A  K P + +             TP  Q+ D  
Sbjct: 220 ---------TGCLPFTGTS-LEEVQQKATYKEPNYAVECRPL--------TP--QAVD-- 257
Query: 462 DTFAHFVSSCLAKNPADRPSSGRLLTHD 489
                 +   L K+P  RPS+ ++L H+
Sbjct: 258 -----LLKQMLTKDPERRPSAAQVLHHE 280

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 50/241 (20%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 88
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY                       GN  + L+  
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLQAR 128
Query: 277 TEHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                 F+F     P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 129 RPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 188
Query: 334 VKLADFGSA-------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           +K+ADFG A         K   N  +    WMAPE   A+ +  Y  + DVWS G+   E
Sbjct: 189 MKIADFGLARDIHHIDXXKKTTNGRLPVK-WMAPE---ALFDRIYTHQSDVWSFGVLLWE 244
Query: 387 L 387
           +
Sbjct: 245 I 245

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 114/255 (44%), Gaps = 40/255 (15%)
Query: 242 EYCL---GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIA 298
           EYCL   G  ++  EV+ I      E M N    +  F E+F + + + +   +  + I 
Sbjct: 103 EYCLTCEGIITNYDEVYII-----YEYMEN--DSILKFDEYFFVLD-KNYTCFIPIQVIK 154
Query: 299 AICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTP 355
            I   VL   +Y+H+   I HRDVK  NIL+ + G VKL+DFG +   +        GT 
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY 214
Query: 356 YWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCL 414
            +M PE     +E  Y+G KVD+WSLGI                    LY +  N  P  
Sbjct: 215 EFMPPEFF--SNESSYNGAKVDIWSLGI-------------------CLYVMFYNVVPF- 252
Query: 415 QSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK 474
            S   S+++  ++   +   Y  ++    LY +    + C  ++  S+    F+   L K
Sbjct: 253 -SLKISLVELFNNIRTKNIEY-PLDRNHFLYPLTNKKSTC-SNNFLSNEDIDFLKLFLRK 309
Query: 475 NPADRPSSGRLLTHD 489
           NPA+R +S   L H+
Sbjct: 310 NPAERITSEDALKHE 324

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 99/265 (37%), Gaps = 46/265 (17%)
Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYAR-CLVSREIVA--IKKMSYLGKQCAEKWADI 209
           E F ++  E  ++   E+G G F  V   R      E  A  IKK      +      +I
Sbjct: 3   EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            +E+  LRQ+ H N I     Y       L++E   G                       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE--------------------- 101
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                       LF+F   K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 102 ------------LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 330 ETGT----VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +       +KL DFG A          +  GTP ++APE++     G    + D+WS+G+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGV 206
Query: 383 TCIELAERKPPYFNMNAMSALYHIA 407
               L     P+        L +I 
Sbjct: 207 ITYILLSGASPFLGDTKQETLANIT 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF  V  AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 97  TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 133
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 134 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 184 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 126
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 127 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIA 186
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 187 DFGLARDINNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 131
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 132 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 191
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE +    +  Y  + DVWS G+   E+
Sbjct: 192 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEI 244

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +++A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIA 199
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE +    +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEI 252

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/354 (23%), Positives = 126/354 (35%), Gaps = 95/354 (26%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G    V+ AR L     VA+K +     +    +    +E +    L HP  +    
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 230 CYLRDHTA----WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
               +  A    ++VMEY  G +  DI+         H EG                   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV---------HTEG------------------- 111
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-S 343
                 P+  +    + +   + LN+ H  G IHRDVK  NI+++ T  VK+ DFG A +
Sbjct: 112 ------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 344 IKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           I    NS       +GT  +++PE          D + DV+SLG    E+   +PP+   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 398 NAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
           + +S  Y H+ ++  P                                        P  +
Sbjct: 223 SPVSVAYQHVREDPIP----------------------------------------PSAR 242
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV-----TRPRSPSVLVDLIR 505
               S      V   LAKNP +R  +   +  DLV       P +P VL D  R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 614 PQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +VMEY  G +  DI+   + P+  +    + +   + LN+ H  G IHRDVK  NI++
Sbjct: 91  PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 673 TETGTVK-LDTPDEQAGNDSSKSNSITSEHSV 703
           + T  VK +D    +A  DS   NS+T   +V
Sbjct: 150 SATNAVKVMDFGIARAIADS--GNSVTQTAAV 179

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 128
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 129 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 188
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 189 DFGLARDINNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 220 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 112/261 (42%), Gaps = 71/261 (27%)
Query: 152 AELFDKEDPEKIFED-----LREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQC 202
           A+L+  +DP  IFE+     + ++G G+FG+V   R       +  +VA+K++ + G   
Sbjct: 9   AQLYACQDP-TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--- 64
Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLVMEY----CLGSASDIIEVHW 256
            ++  D  +EI+ L+ L     ++YRG        +  LVMEY    CL           
Sbjct: 65  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL----------- 113
Query: 257 IEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
             R+F                        + H+  L    +    S + +G+ YL S   
Sbjct: 114 --RDF-----------------------LQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 317 IHRDVKAGNILLTETGTVKLADFGSAS----------IKCPANSFVGTPYWMAPEVILAM 366
           +HRD+ A NIL+     VK+ADFG A           ++ P  S +   +W APE   ++
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE---SL 202
Query: 367 DEGQYDGKVDVWSLGITCIEL 387
            +  +  + DVWS G+   EL
Sbjct: 203 SDNIFSRQSDVWSFGVVLYEL 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 166 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 225
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 226 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 276

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 120 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 179
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 180 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 230

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 175
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 176 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 226

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 122/321 (38%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 122/321 (38%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V Y +     + VAIK +    K+ +    + ++E + +  L H   ++
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    +++ EY                      + N L++++            
Sbjct: 84  LYGVCTKQRPIFIITEYMANGC-----------------LLNYLREMR------------ 114
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--I 344
            H+   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++DFG +   +
Sbjct: 115 -HR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171
Query: 345 KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
                S VG+ +   W  PEV++     ++  K D+W+ G+   E+    K PY      
Sbjct: 172 DDEETSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228
Query: 401 SALYHIAQ 408
               HIAQ
Sbjct: 229 ETAEHIAQ 236

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 99/265 (37%), Gaps = 46/265 (17%)
Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYAR-CLVSREIVA--IKKMSYLGKQCAEKWADI 209
           E F ++  E  ++   E+G G F  V   R      E  A  IKK      +      +I
Sbjct: 3   EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            +E+  LRQ+ H N I     Y       L++E   G                       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE--------------------- 101
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                       LF+F   K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 102 ------------LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 330 ETGT----VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +       +KL DFG A          +  GTP ++APE++     G    + D+WS+G+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGV 206
Query: 383 TCIELAERKPPYFNMNAMSALYHIA 407
               L     P+        L +I 
Sbjct: 207 ITYILLSGASPFLGDTKQETLANIT 231

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 99/265 (37%), Gaps = 46/265 (17%)
Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYAR-CLVSREIVA--IKKMSYLGKQCAEKWADI 209
           E F ++  E  ++   E+G G F  V   R      E  A  IKK      +      +I
Sbjct: 3   EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            +E+  LRQ+ H N I     Y       L++E   G                       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE--------------------- 101
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                       LF+F   K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 102 ------------LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 330 ETGT----VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +       +KL DFG A          +  GTP ++APE++     G    + D+WS+G+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGV 206
Query: 383 TCIELAERKPPYFNMNAMSALYHIA 407
               L     P+        L +I 
Sbjct: 207 ITYILLSGASPFLGDTKQETLANIT 231

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 58/116 (50%), Gaps = 9/116 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPA 348
             E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      
Sbjct: 120 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 179
Query: 349 NSFVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
           NS      TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 180 NSLTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 232

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 121 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 180
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 181 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 231

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 99/265 (37%), Gaps = 46/265 (17%)
Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYAR-CLVSREIVA--IKKMSYLGKQCAEKWADI 209
           E F ++  E  ++   E+G G F  V   R      E  A  IKK      +      +I
Sbjct: 3   EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            +E+  LRQ+ H N I     Y       L++E   G                       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE--------------------- 101
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                       LF+F   K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 102 ------------LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 330 ETGT----VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +       +KL DFG A          +  GTP ++APE++     G    + D+WS+G+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGV 206
Query: 383 TCIELAERKPPYFNMNAMSALYHIA 407
               L     P+        L +I 
Sbjct: 207 ITYILLSGASPFLGDTKQETLANIT 231

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 115 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 174
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 175 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 225

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 175
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 176 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 226

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 114 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 173
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 174 LTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 224

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 99/265 (37%), Gaps = 46/265 (17%)
Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYAR-CLVSREIVA--IKKMSYLGKQCAEKWADI 209
           E F ++  E  ++   E+G G F  V   R      E  A  IKK      +      +I
Sbjct: 3   EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            +E+  LRQ+ H N I     Y       L++E   G                       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE--------------------- 101
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                       LF+F   K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 102 ------------LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 330 ETGT----VKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +       +KL DFG A          +  GTP ++APE++     G    + D+WS+G+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGV 206
Query: 383 TCIELAERKPPYFNMNAMSALYHIA 407
               L     P+        L +I 
Sbjct: 207 ITYILLSGASPFLGDTKQETLANIT 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 42/231 (18%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G GSF     AR L +    AIK +         K   + +E   + +L HP  ++   
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +  D   +  + Y                      +   ++++  F E    F      
Sbjct: 98  TFQDDEKLYFGLSYAKNGE-----------------LLKYIRKIGSFDETCTRF------ 134
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-- 347
                       + ++  L YLH  G IHRD+K  NILL E   +++ DFG+A +  P  
Sbjct: 135 ----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 348 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
               AN FVGT  +++PE+   + E       D+W+LG    +L    PP+
Sbjct: 185 KQARANXFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/354 (23%), Positives = 126/354 (35%), Gaps = 95/354 (26%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G    V+ AR L     VA+K +     +    +    +E +    L HP  +    
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 230 CYLRDHTA----WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
               +  A    ++VMEY  G +  DI+         H EG                   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV---------HTEG------------------- 111
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-S 343
                 P+  +    + +   + LN+ H  G IHRDVK  NI+++ T  VK+ DFG A +
Sbjct: 112 ------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 344 IKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           I    NS       +GT  +++PE          D + DV+SLG    E+   +PP+   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 398 NAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
           + +S  Y H+ ++  P                                        P  +
Sbjct: 223 SPVSVAYQHVREDPIP----------------------------------------PSAR 242
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV-----TRPRSPSVLVDLIR 505
               S      V   LAKNP +R  +   +  DLV       P +P VL D  R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 614 PQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +VMEY  G +  DI+   + P+  +    + +   + LN+ H  G IHRDVK  NI++
Sbjct: 91  PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 673 TETGTVK-LDTPDEQAGNDSSKSNSITSEHSV 703
           + T  VK +D    +A  DS   NS+T   +V
Sbjct: 150 SATNAVKVMDFGIARAIADS--GNSVTQTAAV 179

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 58/116 (50%), Gaps = 9/116 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPA 348
             E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      
Sbjct: 128 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 187
Query: 349 NSFVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
           NS      TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 188 NSLTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 240

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 121/321 (37%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG   +    P  ++          W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 114 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 173
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D+WSLG+    L    PP+++ + ++
Sbjct: 174 LTEPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 224

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 87/363 (23%), Positives = 145/363 (39%), Gaps = 75/363 (20%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK--QCAEKWADILKEIRFLRQLKH 221
           F  +R++G G+FG V   + + +++  A+K +  + K  + A+  ADILK+I+    + +
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQ-NDDINN 95
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N ++Y G ++      L+ E    S  +II  +     FH+                  
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYN-GFHI------------------ 136
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL------------- 328
                        E+I   C  +L+ LNYL  +   H D+K  NILL             
Sbjct: 137 -------------EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 329 ------------TETGTVKLADFGSASIKCPAN-SFVGTPYWMAPEVILAMDEGQYDGKV 375
                       T++  +KL DFG A+ K   + S + T  + APEVIL +    +D   
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLG---WDVSS 240
Query: 376 DVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           D+WS G    EL      +     M  L  +     P  ++  +   KT  S    K   
Sbjct: 241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL 300
Query: 436 F-----NMNAMSALYHIAQNDTPCLQSSDW--SDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                 N ++++++ H+ +    CL        + F  F+ S L  +P  RPS   LL H
Sbjct: 301 KLAWPENASSINSIKHVKK----CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356
Query: 489 DLV 491
             +
Sbjct: 357 KFL 359

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 445 MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++ T  VKL DFG +     +  +  +       WMAPE 
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 564 I---NFRRFTSASDVWMFGV 580

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 58/258 (22%)
Query: 150 EIAELFDKEDPEKI-----FEDLRE-------IGHGSFGAVYYARCLVSREIVAIKKMSY 197
           + AE+ D+ED   +     +E  RE       IG G FG V+     +S E  A+     
Sbjct: 366 DYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQG-IYMSPENPAMAVAIK 424
Query: 198 LGKQCAEKWA--DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEV 254
             K C         L+E   +RQ  HP+ ++  G  + ++  W++ME C LG     ++V
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV 483
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
               R+F ++                 L+ +++                    L YL S 
Sbjct: 484 ----RKFSLD------------LASLILYAYQLST-----------------ALAYLESK 510
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEG 369
             +HRD+ A N+L++ T  VKL DFG +     +  +  +       WMAPE I   +  
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFR 567
Query: 370 QYDGKVDVWSLGITCIEL 387
           ++    DVW  G+   E+
Sbjct: 568 RFTSASDVWMFGVCMWEI 585

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 122/321 (38%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 166 MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 102/239 (42%), Gaps = 44/239 (18%)
Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           K F  +  +G G+F  V+  +  ++ ++ A+K +    K  A + + +  EI  L+++KH
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK---KSPAFRDSSLENEIAVLKKIKH 65
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N +     Y      +LVM+   G                                   
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGE--------------------------------- 92
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLAD 338
           LF+  + +    E++ + +   VL  + YLH  G +HRD+K  N+L     E   + + D
Sbjct: 93  LFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITD 152
Query: 339 FGSASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           FG + ++     ++  GTP ++APEV   + +  Y   VD WS+G+    L    PP++
Sbjct: 153 FGLSKMEQNGIMSTACGTPGYVAPEV---LAQKPYSKAVDCWSIGVITYILLCGYPPFY 208

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 42/237 (17%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++EY                       GN  + L+      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              ++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 140 MEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 338 DFGSA-------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A         K   N  +    WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDXXKKTTNGRLPVK-WMAPE---ALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V Y +     + VAIK +    K+ +    + ++E + +  L H   ++
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    +++ EY                      + N L++++            
Sbjct: 84  LYGVCTKQRPIFIITEYMANGC-----------------LLNYLREMR------------ 114
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--I 344
            H+   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++DFG +   +
Sbjct: 115 -HR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171
Query: 345 KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
                S VG+ +   W  PEV++     ++  K D+W+ G+   E+    K PY      
Sbjct: 172 DDEYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228
Query: 401 SALYHIAQ 408
               HIAQ
Sbjct: 229 ETAEHIAQ 236

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V Y +     + VAIK +    K+ +    + ++E + +  L H   ++
Sbjct: 13  LKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    +++ EY                      + N L++++            
Sbjct: 68  LYGVCTKQRPIFIITEYMANGC-----------------LLNYLREMR------------ 98
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--I 344
            H+   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++DFG +   +
Sbjct: 99  -HR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 155
Query: 345 KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
                S VG+ +   W  PEV++     ++  K D+W+ G+   E+    K PY      
Sbjct: 156 DDEYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 212
Query: 401 SALYHIAQ 408
               HIAQ
Sbjct: 213 ETAEHIAQ 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V Y +     + VAIK +    K+ +    + ++E + +  L H   ++
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    +++ EY                      + N L++++            
Sbjct: 64  LYGVCTKQRPIFIITEYMANGC-----------------LLNYLREMR------------ 94
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--I 344
            H+   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++DFG +   +
Sbjct: 95  -HR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151
Query: 345 KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
                S VG+ +   W  PEV++     ++  K D+W+ G+   E+    K PY      
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208
Query: 401 SALYHIAQ 408
               HIAQ
Sbjct: 209 ETAEHIAQ 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 70/143 (48%), Gaps = 11/143 (7%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LLR  +HPN I  +  Y      +LV E   G       + ++   E E + +   + + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT 133
Query: 67  LNYLHSLGRIHRDVKAGNIL-LTETGT---VKLADFGSASIKCPANSFVGTPYW----MA 118
           + YLHS G +HRD+K  NIL + E+G    +++ DFG A      N  + TP +    +A
Sbjct: 134 VEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVA 193
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV   +    YD   D+WSLGI
Sbjct: 194 PEV---LKRQGYDEGCDIWSLGI 213

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 174 SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYRGCYL 232
           + G   Y+ C   R +     M Y  K   +   D  +EI   LR  +HPN I  +  Y 
Sbjct: 34  TIGVGSYSEC--KRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYD 91
Query: 233 RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPL 292
                +LV E   G                   + +++ + K F+E  A F         
Sbjct: 92  DGKHVYLVTELMRGGE-----------------LLDKILRQKFFSEREASF--------- 125
Query: 293 KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL-LTETGT---VKLADFGSASIKCPA 348
                  +   + + + YLHS G +HRD+K  NIL + E+G    +++ DFG A      
Sbjct: 126 -------VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE 178
Query: 349 NSFVGTPYW----MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           N  + TP +    +APEV   +    YD   D+WSLGI    +     P+ N
Sbjct: 179 NGLLMTPCYTANFVAPEV---LKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 82/354 (23%), Positives = 126/354 (35%), Gaps = 95/354 (26%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G    V+ AR L     VA+K +     +    +    +E +    L HP  +    
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 230 CYLRDHTA----WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
               +  A    ++VMEY  G +  DI+         H EG                   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV---------HTEG------------------- 111
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-S 343
                 P+  +    + +   + LN+ H  G IHRDVK  NI+++ T  VK+ DFG A +
Sbjct: 112 ------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 344 IKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           I    NS       +GT  +++PE          D + DV+SLG    E+   +PP+   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 398 NAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
           + +S  Y H+ ++  P                                        P  +
Sbjct: 223 SPVSVAYQHVREDPIP----------------------------------------PSAR 242
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV-----TRPRSPSVLVDLIR 505
               S      V   LAKNP +R  +   +  DLV       P +P VL D  R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 614 PQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +VMEY  G +  DI+   + P+  +    + +   + LN+ H  G IHRDVK  NI++
Sbjct: 91  PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 673 TETGTVK-LDTPDEQAGNDSSKSNSITSEHSV 703
           + T  VK +D    +A  DS   NS+T   +V
Sbjct: 150 SATNAVKVMDFGIARAIADS--GNSVTQTAAV 179

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK 220
           E  F D R +G G FG V+  +   + ++ A KK++    +  + +   + E + L ++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 221 HPNTIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
                         H+ ++V + Y   + +D+  V  I     + G   R          
Sbjct: 243 --------------HSRFIVSLAYAFETKTDLCLVMTI-----MNGGDIR---------- 273
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
           + ++N +      +E       + ++ GL +LH    I+RD+K  N+LL + G V+++D 
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 340 GSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G A    + +     + GTP +MAPE++L     +YD  VD ++LG+T  E+   + P+
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 122/321 (38%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 69/140 (49%), Gaps = 9/140 (6%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           + +L HP  +++ G   +++  ++V EY   G   + +  H + L+  ++  +C  V  G
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--SFVGTPY---WMAPEV 121
           + +L S   IHRD+ A N L+     VK++DFG           S VGT +   W APEV
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
                  +Y  K DVW+ GI
Sbjct: 177 FHYF---KYSSKSDVWAFGI 193

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 125/326 (38%), Gaps = 86/326 (26%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V   +     + VA+K +    K+ +    +  +E + + +L HP  ++
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G   +++  ++V EY                       G  L  L+            
Sbjct: 68  FYGVCSKEYPIYIVTEYI--------------------SNGCLLNYLRS----------- 96
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC 346
            H + L+  ++  +C  V  G+ +L S   IHRD+ A N L+     VK++DFG      
Sbjct: 97  -HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155
Query: 347 PAN--SFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                S VGT +   W APEV       +Y  K DVW+ GI   E+       F++  M 
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYF---KYSSKSDVWAFGILMWEV-------FSLGKMP 205
Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 461
             Y +  N           V+  +S       P           H+A            S
Sbjct: 206 --YDLYTNS---------EVVLKVSQGHRLYRP-----------HLA------------S 231
Query: 462 DTFAHFVSSCLAKNPADRPSSGRLLT 487
           DT    + SC  + P  RP+  +LL+
Sbjct: 232 DTIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++ Y                       GN  + L+      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE +    +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEI 252

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK 220
           E  F D R +G G FG V+  +   + ++ A KK++    +  + +   + E + L ++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 221 HPNTIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
                         H+ ++V + Y   + +D+  V  I     + G   R          
Sbjct: 243 --------------HSRFIVSLAYAFETKTDLCLVMTI-----MNGGDIR---------- 273
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
           + ++N +      +E       + ++ GL +LH    I+RD+K  N+LL + G V+++D 
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 340 GSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G A    + +     + GTP +MAPE++L     +YD  VD ++LG+T  E+   + P+
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 122/321 (38%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 122/321 (38%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 21  VDPHTYEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 79
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D   
Sbjct: 80  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD--- 132
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 133 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 163
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 164 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 224 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 262
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 263 EGYRLPPP---MDCPAALYQL 280

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 70/143 (48%), Gaps = 11/143 (7%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           LLR  +HPN I  +  Y      +LV E   G       + ++   E E + +   + + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT 133
Query: 67  LNYLHSLGRIHRDVKAGNIL-LTETGT---VKLADFGSASIKCPANSFVGTPYW----MA 118
           + YLHS G +HRD+K  NIL + E+G    +++ DFG A      N  + TP +    +A
Sbjct: 134 VEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVA 193
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV   +    YD   D+WSLGI
Sbjct: 194 PEV---LKRQGYDEGCDIWSLGI 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 174 SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYRGCYL 232
           + G   Y+ C   R +     M Y  K   +   D  +EI   LR  +HPN I  +  Y 
Sbjct: 34  TIGVGSYSEC--KRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYD 91
Query: 233 RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPL 292
                +LV E   G                   + +++ + K F+E  A F         
Sbjct: 92  DGKHVYLVTELMRGGE-----------------LLDKILRQKFFSEREASF--------- 125
Query: 293 KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL-LTETGT---VKLADFGSASIKCPA 348
                  +   + + + YLHS G +HRD+K  NIL + E+G    +++ DFG A      
Sbjct: 126 -------VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE 178
Query: 349 NSFVGTPYW----MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           N  + TP +    +APEV   +    YD   D+WSLGI    +     P+ N
Sbjct: 179 NGLLMTPCYTANFVAPEV---LKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 65  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++ T  VKL DFG +     +  +  +       WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 184 I---NFRRFTSASDVWMFGV 200

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 46/228 (20%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKHPNTI 225
           R IG G FG V+     +S E  A+       K C         L+E   +RQ  HP+ +
Sbjct: 16  RCIGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 226 EYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +  G  + ++  W++ME C LG     ++V    R+F ++                 L+ 
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFLQV----RKFSLD------------LASLILYA 117
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +++                    L YL S   +HRD+ A N+L++ T  VKL DFG +  
Sbjct: 118 YQLST-----------------ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRY 160
Query: 345 KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
              +  +  +       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 161 MEDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 205

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 294 EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANS 350
           E E + I   +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS
Sbjct: 160 EREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 351 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                 TPY++APEV   +   +YD   D WSLG+    L    PP+++ + ++
Sbjct: 220 LTTPCYTPYYVAPEV---LGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLA 270

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK 220
           E  F D R +G G FG V+  +   + ++ A KK++    +  + +   + E + L ++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 221 HPNTIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
                         H+ ++V + Y   + +D+  V  I     + G   R          
Sbjct: 243 --------------HSRFIVSLAYAFETKTDLCLVMTI-----MNGGDIR---------- 273
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
           + ++N +      +E       + ++ GL +LH    I+RD+K  N+LL + G V+++D 
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 340 GSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G A    + +     + GTP +MAPE++L     +YD  VD ++LG+T  E+   + P+
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK 220
           E  F D R +G G FG V+  +   + ++ A KK++    +  + +   + E + L ++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 221 HPNTIEYRGCYLRDHTAWLV-MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
                         H+ ++V + Y   + +D+  V  I     + G   R          
Sbjct: 243 --------------HSRFIVSLAYAFETKTDLCLVMTI-----MNGGDIR---------- 273
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
           + ++N +      +E       + ++ GL +LH    I+RD+K  N+LL + G V+++D 
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 340 GSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G A    + +     + GTP +MAPE++L     +YD  VD ++LG+T  E+   + P+
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 111/266 (41%), Gaps = 49/266 (18%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +  + ++ +G+G FG V+          VAIK +   G    E     L+E + ++
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMG-TWNGNTKVAIKTLK-PGTMSPE---SFLEEAQIMK 59
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           +LKH   ++     + +   ++V EY   GS  D ++          +G G         
Sbjct: 60  KLKHDKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLK----------DGEG--------- 99
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                        R LK   +  + + V  G+ Y+  +  IHRD+++ NIL+      K+
Sbjct: 100 -------------RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKI 146
Query: 337 ADFGSASI----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER- 390
           ADFG A +    +  A      P  W APE  L    G++  K DVWS GI   EL  + 
Sbjct: 147 ADFGLARLIEDNEXTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKG 203
Query: 391 KPPYFNMNAMSALYHIAQN-DTPCLQ 415
           + PY  MN    L  + +    PC Q
Sbjct: 204 RVPYPGMNNREVLEQVERGYRMPCPQ 229

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNY 69
           K P   +   C+      + VMEY  G      I +V +   KE       + +  GL +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFF 457
Query: 70  LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAM 125
           L S G I+RD+K  N++L   G +K+ADFG              F GTP ++APE+I   
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ 517
Query: 126 DEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV 185
             G+    VD W+ G+    +   +    F+ ED +++F+ + E        V Y + + 
Sbjct: 518 PYGK---SVDWWAFGVLLYEMLAGQAP--FEGEDEDELFQSIME------HNVAYPKSM- 565
Query: 186 SREIVAIKK---MSYLGKQ--CAEKWADILKEIRFLRQL 219
           S+E VAI K     + GK+  C  +    +KE  F R +
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 101/239 (42%), Gaps = 47/239 (19%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLR-QL 219
           F  L  +G GSFG V  +    + E+ A+K    L K    +  D+   + E R L    
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVK---ILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           K P   +   C+      + VMEY  G   D++        +H+       QQ+  F E 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGG--DLM--------YHI-------QQVGRFKEP 442
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A+F            EIA        GL +L S G I+RD+K  N++L   G +K+ADF
Sbjct: 443 HAVFY---------AAEIAI-------GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486
Query: 340 GSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           G              F GTP ++APE+I     G+    VD W+ G+   E+   + P+
Sbjct: 487 GMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGK---SVDWWAFGVLLYEMLAGQAPF 542

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V Y +     + VAIK +    K+ +    + ++E + +  L H   ++
Sbjct: 20  LKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    +++ EY                      + N L++++            
Sbjct: 75  LYGVCTKQRPIFIITEYMANGC-----------------LLNYLREMR------------ 105
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--I 344
            H+   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++DFG +   +
Sbjct: 106 -HR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 162
Query: 345 KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
                S VG+ +   W  PEV++     ++  K D+W+ G+   E+    K PY      
Sbjct: 163 DDEYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 219
Query: 401 SALYHIAQ 408
               HIAQ
Sbjct: 220 ETAEHIAQ 227

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 82/354 (23%), Positives = 125/354 (35%), Gaps = 95/354 (26%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G    V+ AR L     VA+K +     +    +    +E +    L HP  +    
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 230 CYLRDHTA----WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
               +  A    ++VMEY  G +  DI+         H EG                   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV---------HTEG------------------- 111
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-S 343
                 P+  +    + +   + LN+ H  G IHRDVK  NI+++ T  VK+ DFG A +
Sbjct: 112 ------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 344 IKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           I    NS       +GT  +++PE          D + DV+SLG    E+   +PP+   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 398 NAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
           +  S  Y H+ ++  P                                        P  +
Sbjct: 223 SPDSVAYQHVREDPIP----------------------------------------PSAR 242
Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV-----TRPRSPSVLVDLIR 505
               S      V   LAKNP +R  +   +  DLV       P +P VL D  R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 614 PQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +VMEY  G +  DI+   + P+  +    + +   + LN+ H  G IHRDVK  NI++
Sbjct: 91  PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 673 TETGTVK-LDTPDEQAGNDSSKSNSITSEHSV 703
           + T  VK +D    +A  DS   NS+T   +V
Sbjct: 150 SATNAVKVMDFGIARAIADS--GNSVTQTAAV 179

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V Y +     + VAIK +    K+ +    + ++E + +  L H   ++
Sbjct: 14  LKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    +++ EY                      + N L++++            
Sbjct: 69  LYGVCTKQRPIFIITEYMANGC-----------------LLNYLREMR------------ 99
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--I 344
            H+   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++DFG +   +
Sbjct: 100 -HR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 156
Query: 345 KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
                S VG+ +   W  PEV++     ++  K D+W+ G+   E+    K PY      
Sbjct: 157 DDEYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 213
Query: 401 SALYHIAQ 408
               HIAQ
Sbjct: 214 ETAEHIAQ 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 112/267 (41%), Gaps = 52/267 (19%)
Query: 168 REIGHGSFGAVYYARCLVSRE-----IVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KH 221
           + +G G+FG V  A     ++      VA+K +       A ++  ++ E++ L  +  H
Sbjct: 33  KSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLK--EGATASEYKALMTELKILTHIGHH 90
Query: 222 PNTIEYRG-CYLRDHTAWLVMEYC--------LGSASDIIEVH---WIEREFHVEGMGNR 269
            N +   G C  +     +++EYC        L S  D+  ++    +  E   E M   
Sbjct: 91  LNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPG 150
Query: 270 LQQLK-------CFTEHFALFNFE----------------VHKRPLKEEEIAAICSGVLR 306
           L+Q K         +E FA   F+                 +K P+  E++ +    V R
Sbjct: 151 LEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVAR 210
Query: 307 GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--IKCPANSFVGTPY----WMAP 360
           G+ +L S   IHRD+ A NILL+E   VK+ DFG A    K P     G       WMAP
Sbjct: 211 GMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAP 270
Query: 361 EVILAMDEGQYDGKVDVWSLGITCIEL 387
           E I    +  Y  K DVWS G+   E+
Sbjct: 271 ESIF---DKIYSTKSDVWSYGVLLWEI 294

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 104/270 (38%), Gaps = 53/270 (19%)
Query: 143 PGSLKDPEIA-ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK--KMS 196
           P + +DP  A   F KE         R IG G FG V   R  +   RE+ VAIK  K+ 
Sbjct: 2   PHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG 61
Query: 197 YLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHW 256
           Y  KQ      D L E   + Q  HPN I   G   +     +V EY    + D      
Sbjct: 62  YTEKQRR----DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF---- 113
Query: 257 IEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
                           LK     F +             ++  +  G+  G+ YL  +G 
Sbjct: 114 ----------------LKKNDGQFTVI------------QLVGMLRGISAGMKYLSDMGY 145
Query: 317 IHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFV----GTPY-WMAPEVILAMDEG 369
           +HRD+ A NIL+      K++DFG + +    P  ++       P  W APE I      
Sbjct: 146 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR--- 202
Query: 370 QYDGKVDVWSLGITCIELAER-KPPYFNMN 398
           ++    DVWS GI   E+    + PY+ M 
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEMT 232

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 6/136 (4%)
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVK 335
           T H  L +F    R +    I+     + R + ++HSLG  HRD+K  N+L+ ++  T+K
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK 182
Query: 336 LADFGSASIKCPANSFVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           L DFGSA    P+   V    + ++ APE++L   E  Y   +D+WS+G    EL   KP
Sbjct: 183 LCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATE--YTPSIDLWSIGCVFGELILGKP 240
Query: 393 PYFNMNAMSALYHIAQ 408
            +    ++  L  I Q
Sbjct: 241 LFSGETSIDQLVRIIQ 256

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQL-K 220
           + +G G+FG V  A  +       +E V +  +  L     EK  +D++ E+  ++ + K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I   G   +D   ++++ Y                       GN  + L+      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYA--------------------SKGNLREYLRARRPPG 139
Query: 281 ALFNFEVHKRPLKE---EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
             +++++++ P ++   +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 338 DFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A      + +  T        WMAPE +    +  Y  + DVWS G+   E+
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEI 252

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 51/281 (18%)
Query: 143 PGSLKDPEIAELFDKEDPEKI--FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           PGS+     A   D+   +++  F+  R  G G+FG V   +   +   VAIKK+     
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDP 60
Query: 201 QCAEKWADILKEIRFLRQLKHPNTIEYRGCYL-------RDHTAWLVMEYCLGSASDIIE 253
           +   +   I+++   L  L HPN ++ +  +        RD    +VMEY   +      
Sbjct: 61  RFRNRELQIMQD---LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT------ 111
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH- 312
           +H   R ++   +      +K F     LF                    ++R +  LH 
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVF-----LFQ-------------------LIRSIGCLHL 147
Query: 313 -SLGRIHRDVKAGNILLTET-GTVKLADFGSASIKCPAN---SFVGTPYWMAPEVILAMD 367
            S+   HRD+K  N+L+ E  GT+KL DFGSA    P+    +++ + Y+ APE+I    
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-- 205
Query: 368 EGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQ 408
              Y   VD+WS+G    E+   +P +   N+   L+ I +
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 104/247 (42%), Gaps = 41/247 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  L +IG G++G VY A+     E  A+KK+  L K+     +  ++EI  L++LKH N
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIR-LEKEDEGIPSTTIREISILKELKHSN 61
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++            LV E+       +++V         EG                  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--------CEG------------------ 95
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                   L+     +    +L G+ Y H    +HRD+K  N+L+   G +K+ADFG A 
Sbjct: 96  -------GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P   +   V T ++ AP+V+  M   +Y   +D+WS+G    E+    P +  ++ 
Sbjct: 149 AFGIPVRKYTHEVVTLWYRAPDVL--MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206
Query: 400 MSALYHI 406
              L  I
Sbjct: 207 ADQLMRI 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQL- 219
           F  L  +G GSFG V  +    + E+ A+K    L K    +  D+   + E R L    
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVK---ILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           K P   +   C+      + VMEY  G   D++        +H+       QQ+  F E 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGG--DLM--------YHI-------QQVGRFKEP 121
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A+F            EIA        GL +L S G I+RD+K  N++L   G +K+ADF
Sbjct: 122 HAVFY---------AAEIAI-------GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165
Query: 340 GSASIKCPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           G     C  N         F GTP ++APE+I     G+    VD W+ G+   E+   +
Sbjct: 166 GM----CKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGK---SVDWWAFGVLLYEMLAGQ 218
Query: 392 PPY 394
            P+
Sbjct: 219 APF 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 81/346 (23%), Positives = 131/346 (37%), Gaps = 77/346 (22%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEI 213
           + +++   E+G G+F  V   RC+        + +I+  KK+S    Q  E+      E 
Sbjct: 21  QSMYQLFEELGKGAFSVV--RRCVKVLAGQEYAAKIINTKKLSARDHQKLER------EA 72
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R  R LKHPN +        +   +L+ +   G                           
Sbjct: 73  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE------------------------- 107
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---E 330
                   LF   V +    E + +     +L  + + H +G +HRD+K  N+LL    +
Sbjct: 108 --------LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLK 159
Query: 331 TGTVKLADFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
              VKLADFG A I+          F GTP +++PEV   + +  Y   VD+W+ G+   
Sbjct: 160 GAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEV---LRKDPYGKPVDLWACGVILY 215
Query: 386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI----KTISSTAERKPPYFNMNAM 441
            L    PP+++ +    LY   +       S +W  +    K + +      P   + A 
Sbjct: 216 ILLVGYPPFWDED-QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAA 274
Query: 442 SALYH--IAQNDT--PCLQSSDWSDTFAHFVSSCLAKNPADRPSSG 483
            AL H  I+   T   C+   +  D        CL K  A R   G
Sbjct: 275 EALKHPWISHRSTVASCMHRQETVD--------CLKKFNARRKLKG 312

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 103/256 (40%), Gaps = 50/256 (19%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G    V+ AR L     VA+K +     +    +    +E +    L HP  +    
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 230 CYLRDHTA----WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
               +  A    ++VMEY  G +  DI+         H EG                   
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIV---------HTEG------------------- 128
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-S 343
                 P+  +    + +   + LN+ H  G IHRDVK  NI+++ T  VK+ DFG A +
Sbjct: 129 ------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 182
Query: 344 IKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           I    NS       +GT  +++PE          D + DV+SLG    E+   +PP+   
Sbjct: 183 IADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGD 239
Query: 398 NAMSALY-HIAQNDTP 412
           + +S  Y H+ ++  P
Sbjct: 240 SPVSVAYQHVREDPIP 255

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 614 PQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +VMEY  G +  DI+   + P+  +    + +   + LN+ H  G IHRDVK  NI++
Sbjct: 108 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 166
Query: 673 TETGTVK-LDTPDEQAGNDSSKSNSITSEHSV 703
           + T  VK +D    +A  DS   NS+T   +V
Sbjct: 167 SATNAVKVMDFGIARAIADS--GNSVTQTAAV 196

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 41/247 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  L +IG G++G VY A+     E  A+KK+  L K+     +  ++EI  L++LKH N
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIR-LEKEDEGIPSTTIREISILKELKHSN 61
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++            LV E+       +++V         EG       L+  T    L 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--------CEG------GLESVTAKSFLL 107
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                               +L G+ Y H    +HRD+K  N+L+   G +K+ADFG A 
Sbjct: 108 Q-------------------LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P   +   V T ++ AP+V+  M   +Y   +D+WS+G    E+    P +  ++ 
Sbjct: 149 AFGIPVRKYTHEVVTLWYRAPDVL--MGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSE 206
Query: 400 MSALYHI 406
              L  I
Sbjct: 207 ADQLMRI 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 93  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 151
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 152 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 211
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 212 I---NFRRFTSASDVWMFGV 228

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 92/239 (38%), Gaps = 44/239 (18%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEI 213
           D E   +  E  R IG G FG V+     +S E  A+       K C         L+E 
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 90
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             +RQ  HP+ ++  G  + ++  W++ME C                         L +L
Sbjct: 91  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCT------------------------LGEL 125
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + F         +V K  L    +      +   L YL S   +HRD+ A N+L++    
Sbjct: 126 RSF--------LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 177
Query: 334 VKLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           VKL DFG +     +  +  +       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 178 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 233

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 105/247 (42%), Gaps = 41/247 (16%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  L +IG G++G VY A+     E  A+KK+  L K+     +  ++EI  L++LKH N
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIR-LEKEDEGIPSTTIREISILKELKHSN 61
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++            LV E+       +++V         EG       L+  T    L 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--------CEG------GLESVTAKSFLL 107
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                               +L G+ Y H    +HRD+K  N+L+   G +K+ADFG A 
Sbjct: 108 Q-------------------LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           +   P   +   + T ++ AP+V+  M   +Y   +D+WS+G    E+    P +  ++ 
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVL--MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206
Query: 400 MSALYHI 406
              L  I
Sbjct: 207 ADQLMRI 213

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 114 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 173
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 174 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 445 MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 564 I---NFRRFTSASDVWMFGV 580

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 104/258 (40%), Gaps = 58/258 (22%)
Query: 150 EIAELFDKEDPEKI-----FEDLRE-------IGHGSFGAVYYARCLVSREIVAIKKMSY 197
           + AE+ D+ED   +     +E  RE       IG G FG V+     +S E  A+     
Sbjct: 366 DYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQG-IYMSPENPAMAVAIK 424
Query: 198 LGKQCAEKWA--DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEV 254
             K C         L+E   +RQ  HP+ ++  G  + ++  W++ME C LG     ++V
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV 483
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
               R+F ++                 L+ +++                    L YL S 
Sbjct: 484 ----RKFSLD------------LASLILYAYQLST-----------------ALAYLESK 510
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEG 369
             +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE I   +  
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFR 567
Query: 370 QYDGKVDVWSLGITCIEL 387
           ++    DVW  G+   E+
Sbjct: 568 RFTSASDVWMFGVCMWEI 585

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 115 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 174
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 175 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 81
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY                       GN  + L+  
Sbjct: 82  MIGKHKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLQAR 121
Query: 277 TEHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                 +++     P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 122 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 181
Query: 334 VKLADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +K+ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 182 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 115 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 174
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 175 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 65  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 184 I---NFRRFTSASDVWMFGV 200

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKHPNTI 225
           R IG G FG V+     +S E  A+       K C         L+E   +RQ  HP+ +
Sbjct: 16  RCIGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +  G  + ++  W++ME C                         L +L+ F         
Sbjct: 75  KLIGV-ITENPVWIIMELCT------------------------LGELRSF--------L 101
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
           +V K  L    +      +   L YL S   +HRD+ A N+L++    VKL DFG +   
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
Query: 346 CPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
             +  +  +       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 162 EDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 205

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 77
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY                       GN  + L+  
Sbjct: 78  MIGKHKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLQAR 117
Query: 277 TEHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                 +++     P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 118 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 177
Query: 334 VKLADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +K+ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 178 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 88
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY                       GN  + L+  
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLQAR 128
Query: 277 TEHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                 +++     P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 129 EPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 188
Query: 334 VKLADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +K+ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 88
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY                       GN  + L+  
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLQAR 128
Query: 277 TEHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                 +++     P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 129 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 188
Query: 334 VKLADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +K+ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 90/372 (24%), Positives = 134/372 (36%), Gaps = 97/372 (26%)
Query: 141 ITPGSLKDPEIA-ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK--K 194
           + P + +DP  A   F KE      +  + IG G FG V   R  V   REI VAIK  K
Sbjct: 7   VDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLK 66
Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
             Y  KQ      D L E   + Q  HPN I   G   +     ++ EY    + D    
Sbjct: 67  AGYTDKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF-- 120
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
                             L+     F +             ++  +  G+  G+ YL  +
Sbjct: 121 ------------------LRKNDGRFTVI------------QLVGMLRGIGSGMKYLSDM 150
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAMD 367
             +HRD+ A NIL+      K++DFG + +    P  ++          W APE I    
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR- 209
Query: 368 EGQYDGKVDVWSLGITCIE-LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
             ++    DVWS GI   E ++  + PY++M                   S+  VIK I 
Sbjct: 210 --KFTSASDVWSYGIVMWEVMSYGERPYWDM-------------------SNQDVIKAIE 248
Query: 427 STAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRL- 485
                 PP   M+   AL+ +  +                    C  K  +DRP  G++ 
Sbjct: 249 EGYRLPPP---MDCPIALHQLMLD--------------------CWQKERSDRPKFGQIV 285
Query: 486 -LTHDLVTRPRS 496
            +   L+  P S
Sbjct: 286 NMLDKLIRNPNS 297

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 114 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 173
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 174 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 114 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 173
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 174 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 67  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 186 I---NFRRFTSASDVWMFGV 202

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKHPNTI 225
           R IG G FG V+     +S E  A+       K C         L+E   +RQ  HP+ +
Sbjct: 18  RCIGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +  G  + ++  W++ME C                         L +L+ F         
Sbjct: 77  KLIGV-ITENPVWIIMELCT------------------------LGELRSF--------L 103
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
           +V K  L    +      +   L YL S   +HRD+ A N+L++    VKL DFG +   
Sbjct: 104 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 163
Query: 346 CPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
             +  +  +       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 164 EDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 207

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 135 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 194
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 195 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 248

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 65  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 184 I---NFRRFTSASDVWMFGV 200

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKHPNTI 225
           R IG G FG V+     +S E  A+       K C         L+E   +RQ  HP+ +
Sbjct: 16  RCIGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +  G  + ++  W++ME C                         L +L+ F         
Sbjct: 75  KLIGV-ITENPVWIIMELCT------------------------LGELRSF--------L 101
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
           +V K  L    +      +   L YL S   +HRD+ A N+L++    VKL DFG +   
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
Query: 346 CPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
             +  +  +       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 162 EDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 205

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 72/261 (27%)
Query: 147 KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQC 202
           +DP I E       E+  + + ++G G+FG+V   R       +  +VA+K++ + G   
Sbjct: 2   QDPTIFE-------ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--- 51
Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLVMEY----CLGSASDIIEVHW 256
            ++  D  +EI+ L+ L     ++YRG        +  LVMEY    CL           
Sbjct: 52  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL----------- 100
Query: 257 IEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
             R+F                        + H+  L    +    S + +G+ YL S   
Sbjct: 101 --RDF-----------------------LQRHRARLDASRLLLYSSQICKGMEYLGSRRC 135
Query: 317 IHRDVKAGNILLTETGTVKLADFGSAS----------IKCPANSFVGTPYWMAPEVILAM 366
           +HRD+ A NIL+     VK+ADFG A           ++ P  S +   +W APE   ++
Sbjct: 136 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE---SL 189
Query: 367 DEGQYDGKVDVWSLGITCIEL 387
            +  +  + DVWS G+   EL
Sbjct: 190 SDNIFSRQSDVWSFGVVLYEL 210

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 114 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 173
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 174 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 114 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 173
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 174 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 62  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 181 I---NFRRFTSASDVWMFGV 197

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKHPNTI 225
           R IG G FG V+     +S E  A+       K C         L+E   +RQ  HP+ +
Sbjct: 13  RCIGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 226 EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
           +  G  + ++  W++ME C                         L +L+ F         
Sbjct: 72  KLIGV-ITENPVWIIMELCT------------------------LGELRSF--------L 98
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
           +V K  L    +      +   L YL S   +HRD+ A N+L++    VKL DFG +   
Sbjct: 99  QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
Query: 346 CPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
             +  +  +       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 159 EDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 202

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 70  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 189 I---NFRRFTSASDVWMFGV 205

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 92/239 (38%), Gaps = 44/239 (18%)
Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEI 213
           D E   +  E  R IG G FG V+     +S E  A+       K C         L+E 
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             +RQ  HP+ ++  G  + ++  W++ME C                         L +L
Sbjct: 68  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCT------------------------LGEL 102
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           + F         +V K  L    +      +   L YL S   +HRD+ A N+L++    
Sbjct: 103 RSF--------LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 154
Query: 334 VKLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           VKL DFG +     +  +  +       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 155 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 210

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 116 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 175
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 176 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 229

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 68  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     +  +  +       WMAPE 
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 187 I---NFRRFTSASDVWMFGV 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 98/251 (39%), Gaps = 52/251 (20%)
Query: 144 GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA 203
           GS +D EI         E+I E  R IG G FG V+     +S E  A+       K C 
Sbjct: 3   GSTRDYEIQR-------ERI-ELGRCIGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCT 53
Query: 204 EKWA--DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREF 261
                   L+E   +RQ  HP+ ++  G  + ++  W++ME C                 
Sbjct: 54  SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCT---------------- 96
Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
                   L +L+ F         +V K  L    +      +   L YL S   +HRD+
Sbjct: 97  --------LGELRSF--------LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 140
Query: 322 KAGNILLTETGTVKLADFGSASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVD 376
            A N+L++    VKL DFG +     +  +  +       WMAPE I   +  ++    D
Sbjct: 141 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRRFTSASD 197
Query: 377 VWSLGITCIEL 387
           VW  G+   E+
Sbjct: 198 VWMFGVCMWEI 208

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSA 342
           +F+V    L + +I      +L+ L+Y HS G +HRDVK  N+++  E   ++L D+G A
Sbjct: 114 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 173
Query: 343 SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
               P   +   V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P+F
Sbjct: 174 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 80
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY                       GN  + L+  
Sbjct: 81  MIGKHKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLQAR 120
Query: 277 TEHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                 +++     P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 121 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 180
Query: 334 VKLADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +K+ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 181 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 72/261 (27%)
Query: 147 KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQC 202
           +DP I E       E+  + + ++G G+FG+V   R       +  +VA+K++ + G   
Sbjct: 3   QDPTIFE-------ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--- 52
Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAWLVMEY----CLGSASDIIEVHW 256
            ++  D  +EI+ L+ L     ++YRG        +  LVMEY    CL           
Sbjct: 53  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL----------- 101
Query: 257 IEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
             R+F                        + H+  L    +    S + +G+ YL S   
Sbjct: 102 --RDF-----------------------LQRHRARLDASRLLLYSSQICKGMEYLGSRRC 136
Query: 317 IHRDVKAGNILLTETGTVKLADFGSAS----------IKCPANSFVGTPYWMAPEVILAM 366
           +HRD+ A NIL+     VK+ADFG A           ++ P  S +   +W APE   ++
Sbjct: 137 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE---SL 190
Query: 367 DEGQYDGKVDVWSLGITCIEL 387
            +  +  + DVWS G+   EL
Sbjct: 191 SDNIFSRQSDVWSFGVVLYEL 211

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCPANS 350
           L + +I      +L+ L+Y HS G +HRDVK  N+++  +   ++L D+G A    PA  
Sbjct: 129 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 188
Query: 351 F---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +   V + Y+  PE+++  D   YD  +D+WSLG     +  R+ P+F+
Sbjct: 189 YNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRREPFFH 235

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 105/254 (41%), Gaps = 38/254 (14%)
Query: 169 EIGHGSFGAVYYARC--LVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           E+G G+FG V+ A C  L+  +   +VA+K +    +   +   D  +E   L  L+H +
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTMLQHQH 104
Query: 224 TIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            + + G         +V EY   G  +  +  H  + +    G                 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE---------------- 148
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-S 341
              +V   PL   ++ A+ S V  G+ YL  L  +HRD+   N L+ +   VK+ DFG S
Sbjct: 149 ---DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 342 ASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPYF 395
             I       VG        WM PE IL     ++  + DVWS G+   E+    K P++
Sbjct: 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 396 NMNAMSALYHIAQN 409
            ++   A+  I Q 
Sbjct: 263 QLSNTEAIDCITQG 276

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 129
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY                       GN  + L+  
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYA--------------------SKGNLREYLQAR 169
Query: 277 TEHFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                 +++     P   L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   
Sbjct: 170 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 229
Query: 334 VKLADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +K+ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCPANS 350
           L + +I      +L+ L+Y HS G +HRDVK  N+++  +   ++L D+G A    PA  
Sbjct: 134 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 193
Query: 351 F---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           +   V + Y+  PE+++  D   YD  +D+WSLG     +  R+ P+F+
Sbjct: 194 YNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRREPFFH 240

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 111/272 (40%), Gaps = 48/272 (17%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARC--LVSRE---IVAIKKMSYLGKQCAEKWADILKE 212
           E P    E +R+IG G+FG V+ AR   L+  E   +VA+K +    +  A+  AD  +E
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQRE 100
Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
              + +  +PN ++  G         L+ EY                       G+  + 
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM--------------------AYGDLNEF 140
Query: 273 LKCFTEH--FALFNFEVHKR---------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
           L+  + H   +L + ++  R         PL   E   I   V  G+ YL     +HRD+
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200
Query: 322 KAGNILLTETGTVKLADFGSASIKCPANSFV-----GTPY-WMAPEVILAMDEGQYDGKV 375
              N L+ E   VK+ADFG +     A+ +        P  WM PE I      +Y  + 
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTES 257
Query: 376 DVWSLGITCIELAERK-PPYFNMNAMSALYHI 406
           DVW+ G+   E+      PY+ M     +Y++
Sbjct: 258 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 111/243 (45%), Gaps = 56/243 (23%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           ++  + +R++G G FG V   R       + E VA+K +    +      AD+ KEI  L
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEIL 77
Query: 217 RQLKHPNTIEYRGCYLRD--HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           R L H N ++Y+G    D  +   L+ME+ L S S  ++ +  + +  +    N  QQLK
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEF-LPSGS--LKEYLPKNKNKI----NLKQQLK 130
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                +A+                 IC    +G++YL S   +HRD+ A N+L+     V
Sbjct: 131 -----YAV----------------QIC----KGMDYLGSRQYVHRDLAARNVLVESEHQV 165
Query: 335 KLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           K+ DFG            ++K   +S V   +W APE ++   + ++    DVWS G+T 
Sbjct: 166 KIGDFGLTKAIETDKEXXTVKDDRDSPV---FWYAPECLM---QSKFYIASDVWSFGVTL 219
Query: 385 IEL 387
            EL
Sbjct: 220 HEL 222

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +RQ  HP+ ++  G  + ++  W++ME C LG     ++V K  L    +      +   
Sbjct: 65  MRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-----SIKCPANSFVGTPYWMAPEV 121
           L YL S   +HRD+ A N+L++    VKL DFG +     S    A+       WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPES 183
Query: 122 ILAMDEGQYDGKVDVWSLGI 141
           I   +  ++    DVW  G+
Sbjct: 184 I---NFRRFTSASDVWMFGV 200

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 46/228 (20%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKHPNTI 225
           R IG G FG V+     +S E  A+       K C         L+E   +RQ  HP+ +
Sbjct: 16  RCIGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 226 EYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +  G  + ++  W++ME C LG     ++V    R+F ++                 L+ 
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFLQV----RKFSLD------------LASLILYA 117
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 342
           +++                    L YL S   +HRD+ A N+L++    VKL DFG +  
Sbjct: 118 YQLST-----------------ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 160
Query: 343 ---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
              S    A+       WMAPE I   +  ++    DVW  G+   E+
Sbjct: 161 MEDSTXXKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEI 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 103/255 (40%), Gaps = 50/255 (19%)
Query: 168 REIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           R IG G FG VY+   +    +R   AIK +S + +   ++    L+E   +R L HPN 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--MQQVEAFLREGLLMRGLNHPNV 84
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           +   G  L                               EG+ + L    C   H  L  
Sbjct: 85  LALIGIMLPP-----------------------------EGLPHVLLPYMC---HGDLLQ 112
Query: 285 F-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           F    +R    +++ +    V RG+ YL     +HRD+ A N +L E+ TVK+ADFG A 
Sbjct: 113 FIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
Query: 344 -------IKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
                       +     P  W A E   ++   ++  K DVWS G+   EL  R  PPY
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALE---SLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229
Query: 395 FNMNAMSALYHIAQN 409
            +++     + +AQ 
Sbjct: 230 RHIDPFDLTHFLAQG 244

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 121/321 (37%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V E     + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 166 MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 108/290 (37%), Gaps = 72/290 (24%)
Query: 170 IGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +G G FG V   R  +   +EI VAIK  K+ Y  KQ      D L E   + Q  HPN 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR----DFLGEASIMGQFDHPNI 96
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   +     +V EY    + D                           +H A F 
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLD-----------------------SFLRKHDAQFT 133
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                      ++  +  G+  G+ YL  +G +HRD+ A NIL+      K++DFG + +
Sbjct: 134 VI---------QLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 184
Query: 345 --KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
               P  ++          W +PE I      ++    DVWS GI   E+          
Sbjct: 185 LEDDPEAAYTTRGGKIPIRWTSPEAIAYR---KFTSASDVWSYGIVLWEV---------- 231
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                   ++  + P  + S+  VIK +       PP   M+  +ALY +
Sbjct: 232 --------MSYGERPYWEMSNQDVIKAVDEGYRLPPP---MDCPAALYQL 270

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 108/290 (37%), Gaps = 72/290 (24%)
Query: 170 IGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +G G FG V   R  +   +EI VAIK  K+ Y  KQ      D L E   + Q  HPN 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR----DFLGEASIMGQFDHPNI 79
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   +     +V EY    + D                           +H A F 
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLD-----------------------SFLRKHDAQFT 116
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                      ++  +  G+  G+ YL  +G +HRD+ A NIL+      K++DFG + +
Sbjct: 117 VI---------QLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 167
Query: 345 --KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
               P  ++          W +PE I      ++    DVWS GI   E+          
Sbjct: 168 LEDDPEAAYTTRGGKIPIRWTSPEAIAYR---KFTSASDVWSYGIVLWEV---------- 214
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                   ++  + P  + S+  VIK +       PP   M+  +ALY +
Sbjct: 215 --------MSYGERPYWEMSNQDVIKAVDEGYRLPPP---MDCPAALYQL 253

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 105/254 (41%), Gaps = 38/254 (14%)
Query: 169 EIGHGSFGAVYYARC--LVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           E+G G+FG V+ A C  L+  +   +VA+K +    +   +   D  +E   L  L+H +
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTMLQHQH 75
Query: 224 TIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            + + G         +V EY   G  +  +  H  + +    G                 
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE---------------- 119
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-S 341
              +V   PL   ++ A+ S V  G+ YL  L  +HRD+   N L+ +   VK+ DFG S
Sbjct: 120 ---DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 176
Query: 342 ASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYF 395
             I       VG        WM PE IL     ++  + DVWS G+   E+    K P++
Sbjct: 177 RDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQPWY 233
Query: 396 NMNAMSALYHIAQN 409
            ++   A+  I Q 
Sbjct: 234 QLSNTEAIDCITQG 247

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 83/344 (24%), Positives = 130/344 (37%), Gaps = 72/344 (20%)
Query: 159 DPEKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILK 211
           D  +++ED   IG G+F  V   RC+        + +I+  KK+S    Q  E+      
Sbjct: 4   DEYQLYED---IGKGAFSVV--RRCVKLCTGHEYAAKIINTKKLSARDHQKLER------ 52
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E R  R LKH N +        +   +LV +   G                         
Sbjct: 53  EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGE----------------------- 89
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-- 329
                     LF   V +    E + +     +L  + + H +G +HRD+K  N+LL   
Sbjct: 90  ----------LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASK 139
Query: 330 -ETGTVKLADFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            +   VKLADFG A I+   +      F GTP +++PEV   + +  Y   VD+W+ G+ 
Sbjct: 140 CKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV---LRKEAYGKPVDIWACGVI 195
Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVI----KTISSTAERKPPYFNMN 439
              L    PP+++ +    LY   +       S +W  +    K + +      P   + 
Sbjct: 196 LYILLVGYPPFWDED-QHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRIT 254
Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSG 483
           A  AL H       C +S+  S         CL K  A R   G
Sbjct: 255 AHEALKH----PWVCQRSTVASMMHRQETVECLKKFNARRKLKG 294

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 108/244 (44%), Gaps = 58/244 (23%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           ++  + +R++G G FG V   R       + E VA+K +    +      AD+ KEI  L
Sbjct: 8   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEIL 65
Query: 217 RQLKHPNTIEYRGCYLRD--HTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           R L H N ++Y+G    D  +   L+ME+   GS  + +  +        +   N  QQL
Sbjct: 66  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--------KNKINLKQQL 117
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           K     +A+                 IC    +G++YL S   +HRD+ A N+L+     
Sbjct: 118 K-----YAV----------------QIC----KGMDYLGSRQYVHRDLAARNVLVESEHQ 152
Query: 334 VKLADFG----------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           VK+ DFG            ++K   +S V   +W APE ++   + ++    DVWS G+T
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPV---FWYAPECLM---QSKFYIASDVWSFGVT 206
Query: 384 CIEL 387
             EL
Sbjct: 207 LHEL 210

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 105/254 (41%), Gaps = 38/254 (14%)
Query: 169 EIGHGSFGAVYYARC--LVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           E+G G+FG V+ A C  L+  +   +VA+K +    +   +   D  +E   L  L+H +
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTMLQHQH 81
Query: 224 TIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            + + G         +V EY   G  +  +  H  + +    G                 
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE---------------- 125
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-S 341
              +V   PL   ++ A+ S V  G+ YL  L  +HRD+   N L+ +   VK+ DFG S
Sbjct: 126 ---DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 182
Query: 342 ASIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYF 395
             I       VG        WM PE IL     ++  + DVWS G+   E+    K P++
Sbjct: 183 RDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQPWY 239
Query: 396 NMNAMSALYHIAQN 409
            ++   A+  I Q 
Sbjct: 240 QLSNTEAIDCITQG 253

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 88
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY   S  ++ E     R   +E          C+
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEY--ASKGNLREYLQARRPPGLE---------YCY 137
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                       +  L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+
Sbjct: 138 NPSHN------PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 191
Query: 337 ADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 192 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 61/251 (24%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK--EIRFLRQLKH 221
           FE L+ IG G+F  V   +   + ++ A+K M+        KW D+LK  E+   R+ + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--------KW-DMLKRGEVSCFREERD 113
Query: 222 PNTIEYRGCYLRDHTA-------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
                 R    + H A       +LVMEY +G                    G+ L  L 
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVG--------------------GDLLTLLS 153
Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            F E       E+ +  L E         ++  ++ +H LG +HRD+K  NILL   G +
Sbjct: 154 KFGERIPA---EMARFYLAE---------IVMAIDSVHRLGYVHRDIKPDNILLDRCGHI 201
Query: 335 KLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDG----KVDVWSLGITC 384
           +LADFGS  +K  A+        VGTP +++PE++ A+  G   G    + D W+LG+  
Sbjct: 202 RLADFGSC-LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 385 IELAERKPPYF 395
            E+   + P++
Sbjct: 261 YEMFYGQTPFY 271

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 105/248 (42%), Gaps = 46/248 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V Y +     + VAIK +    K+ +    + ++E + +  L H   ++
Sbjct: 14  LKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   +    +++ EY                      + N L++++            
Sbjct: 69  LYGVCTKQRPIFIITEYMANGC-----------------LLNYLREMR------------ 99
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS--I 344
            H+   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++DFG +   +
Sbjct: 100 -HR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 156
Query: 345 KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
                S  G+ +   W  PEV++     ++  K D+W+ G+   E+    K PY      
Sbjct: 157 DDEYTSSRGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 213
Query: 401 SALYHIAQ 408
               HIAQ
Sbjct: 214 ETAEHIAQ 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 105/268 (39%), Gaps = 71/268 (26%)
Query: 151 IAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI-VAIKKM-------------- 195
           IAEL   + P  +    R I  GS+GAV     + S  I VAIK++              
Sbjct: 14  IAELHAMQSPYTV---QRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILS 68
Query: 196 -SYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCLGSAS 249
            S+L K+       +L+EIR L    HPN +  R  ++       H  +LV E      +
Sbjct: 69  DSFLCKR-------VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 250 DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN 309
            +I         H + +    Q ++ F  H                        +L GL+
Sbjct: 122 QVI---------HDQRIVISPQHIQYFMYH------------------------ILLGLH 148
Query: 310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGTPYWMAPEVILAM 366
            LH  G +HRD+  GNILL +   + + DF  A   +       +V   ++ APE  L M
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPE--LVM 206
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPY 394
               +   VD+WS G    E+  RK  +
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 108/286 (37%), Gaps = 59/286 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G+FG V      ++   VA+K ++    +  +    I +EI+ L+  +HP+ I+   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                   ++VMEY  G                                   LF++    
Sbjct: 79  VISTPTDFFMVMEYVSGGE---------------------------------LFDYICKH 105
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
             ++E E   +   +L  ++Y H    +HRD+K  N+LL      K+ADFG +++     
Sbjct: 106 GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
Query: 350 SF---VGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMNAMSALYH 405
                 G+P + APEVI       Y G +VD+WS G+                    LY 
Sbjct: 166 FLRDSCGSPNYAAPEVISGR---LYAGPEVDIWSCGVI-------------------LYA 203
Query: 406 IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           +     P       ++ K I       P Y N +  + L H+ Q D
Sbjct: 204 LLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 121/321 (37%), Gaps = 75/321 (23%)
Query: 141 ITPGSLKDP-EIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK-- 193
           + P + +DP +    F KE D   I  D + +G G FG V   R  +   +EI VAIK  
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K+ Y  KQ      D L E   + Q  HPN I   G   +     +V E     + D   
Sbjct: 82  KVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD--- 134
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                   +H A F            ++  +  G+  G+ YL  
Sbjct: 135 --------------------SFLRKHDAQFTVI---------QLVGMLRGIASGMKYLSD 165
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG + +    P  ++          W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
              ++    DVWS GI   E+                  ++  + P  + S+  VIK + 
Sbjct: 226 ---KFTSASDVWSYGIVLWEV------------------MSYGERPYWEMSNQDVIKAVD 264
Query: 427 STAERKPPYFNMNAMSALYHI 447
                 PP   M+  +ALY +
Sbjct: 265 EGYRLPPP---MDCPAALYQL 282

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 168 REIGHGSFGAVYYARCL---------VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLR 217
           + +G G+FG V  A  +         V++  VA+K    L     EK  +D++ E+  ++
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVK---MLKSDATEKDLSDLISEMEMMK 73
Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY   S  ++ E     R   +E          C+
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEY--ASKGNLREYLQARRPPGLE---------YCY 122
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                       +  L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+
Sbjct: 123 NPSHN------PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 176
Query: 337 ADFGSASIKCPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           ADFG A      + +  T        WMAPE   A+ +  Y  + DVWS G+   E+
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 108/286 (37%), Gaps = 59/286 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G+FG V      ++   VA+K ++    +  +    I +EI+ L+  +HP+ I+   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                   ++VMEY  G                                   LF++    
Sbjct: 79  VISTPTDFFMVMEYVSGGE---------------------------------LFDYICKH 105
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 349
             ++E E   +   +L  ++Y H    +HRD+K  N+LL      K+ADFG +++     
Sbjct: 106 GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
Query: 350 SF---VGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPYFNMNAMSALYH 405
                 G+P + APEVI       Y G +VD+WS G+                    LY 
Sbjct: 166 FLRTSCGSPNYAAPEVISGR---LYAGPEVDIWSCGVI-------------------LYA 203
Query: 406 IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           +     P       ++ K I       P Y N +  + L H+ Q D
Sbjct: 204 LLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 105/268 (39%), Gaps = 71/268 (26%)
Query: 151 IAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI-VAIKKM-------------- 195
           IAEL   + P  +    R I  GS+GAV     + S  I VAIK++              
Sbjct: 14  IAELHAMQSPYTV---QRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILS 68
Query: 196 -SYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCLGSAS 249
            S+L K+       +L+EIR L    HPN +  R  ++       H  +LV E      +
Sbjct: 69  DSFLCKR-------VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 250 DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN 309
            +I         H + +    Q ++ F  H                        +L GL+
Sbjct: 122 QVI---------HDQRIVISPQHIQYFMYH------------------------ILLGLH 148
Query: 310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGTPYWMAPEVILAM 366
            LH  G +HRD+  GNILL +   + + DF  A   +       +V   ++ APE  L M
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPE--LVM 206
Query: 367 DEGQYDGKVDVWSLGITCIELAERKPPY 394
               +   VD+WS G    E+  RK  +
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 110
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 111 VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 138
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 139 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 196
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 197 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 246
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 247 ELMTRGAPPYPDVNTFDITVYLLQ 270

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA-I 59
           +S+   LKHP+ +E    Y  D   ++V E+  G A    E+ KR     +  E +A+  
Sbjct: 79  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG-ADLCFEIVKRADAGFVYSEAVASHY 137
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSA----SIKCPANSFVG 112
              +L  L Y H    IHRDVK   +LL     +  VKL  FG A         A   VG
Sbjct: 138 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 197
Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           TP++MAPEV+       Y   VDVW  G+
Sbjct: 198 TPHFMAPEVV---KREPYGKPVDVWGCGV 223

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 106/277 (38%), Gaps = 65/277 (23%)
Query: 138 SLGITP-GSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI-----VA 191
           S G+ P GS+ D ++  LF     E ++E    IG G F  V   RC ++RE      V 
Sbjct: 8   SSGLVPRGSMADDDV--LF-----EDVYELCEVIGKGPFSVV--RRC-INRETGQQFAVK 57
Query: 192 IKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDI 251
           I  ++           D+ +E      LKHP+ +E    Y  D   ++V E+  G     
Sbjct: 58  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG----- 112
Query: 252 IEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRP----LKEEEIAA-ICSGVLR 306
                                        A   FE+ KR     +  E +A+     +L 
Sbjct: 113 -----------------------------ADLCFEIVKRADAGFVYSEAVASHYMRQILE 143
Query: 307 GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSA----SIKCPANSFVGTPYWMA 359
            L Y H    IHRDVK   +LL     +  VKL  FG A         A   VGTP++MA
Sbjct: 144 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 203
Query: 360 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           PEV+       Y   VDVW  G+    L     P++ 
Sbjct: 204 PEVV---KREPYGKPVDVWGCGVILFILLSGCLPFYG 237

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA-I 59
           +S+   LKHP+ +E    Y  D   ++V E+  G A    E+ KR     +  E +A+  
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG-ADLCFEIVKRADAGFVYSEAVASHY 135
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSA----SIKCPANSFVG 112
              +L  L Y H    IHRDVK   +LL     +  VKL  FG A         A   VG
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           TP++MAPEV+       Y   VDVW  G+
Sbjct: 196 TPHFMAPEVV---KREPYGKPVDVWGCGV 221

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 99/263 (37%), Gaps = 61/263 (23%)
Query: 155 FDKEDPEKIFEDLRE----IGHGSFGAVYYARCLVSREI-----VAIKKMSYLGKQCAEK 205
            D  D + +FED+ E    IG G F  V   RC ++RE      V I  ++         
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVV--RRC-INRETGQQFAVKIVDVAKFTSSPGLS 69
Query: 206 WADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG 265
             D+ +E      LKHP+ +E    Y  D   ++V E+  G                   
Sbjct: 70  TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG------------------- 110
Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRP----LKEEEIAA-ICSGVLRGLNYLHSLGRIHRD 320
                          A   FE+ KR     +  E +A+     +L  L Y H    IHRD
Sbjct: 111 ---------------ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRD 155
Query: 321 VKAGNILLT---ETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDG 373
           VK   +LL     +  VKL  FG A         A   VGTP++MAPEV+       Y  
Sbjct: 156 VKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV---KREPYGK 212
Query: 374 KVDVWSLGITCIELAERKPPYFN 396
            VDVW  G+    L     P++ 
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYG 235

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 61
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   ++++E+                       GN L  L
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMT--------------------YGNLLDYL 101
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 102 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 150
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 151 VKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 207
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 208 TYGMSPYPGID-LSQVYELLEKD 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 91
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 92  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 119
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 120 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 177
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 178 LARDMYDKEXXSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 227
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 228 ELMTRGAPPYPDVNTFDITVYLLQ 251

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 65
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   ++++E+                       GN L  L
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFM--------------------TYGNLLDYL 105
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 106 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 154
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 155 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 212 TYGMSPYPGID-LSQVYELLEKD 233

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 92
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 93  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 120
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 121 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 178
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 179 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 228
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 229 ELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 60
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   ++++E+                       GN L  L
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFM--------------------TYGNLLDYL 100
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 101 R-----------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 207 TYGMSPYPGID-LSQVYELLEKD 228

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 111
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 112 VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 139
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 140 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 197
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 198 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 247
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 248 ELMTRGAPPYPDVNTFDITVYLLQ 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/335 (23%), Positives = 124/335 (37%), Gaps = 95/335 (28%)
Query: 168 REIGHGSFGAVYYARCL---VSREIVA-IKKMSYLGKQCAEKWADILKEIRFLRQLKH-P 222
           +E+G G F  V   +C+     +E  A   K    G+ C    A+IL EI  L   K  P
Sbjct: 35  KELGRGKFAVV--RQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLELAKSCP 89
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             I     Y       L++EY  G                               E F+L
Sbjct: 90  RVINLHEVYENTSEIILILEYAAGG------------------------------EIFSL 119
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET---GTVKLADF 339
              E+ +  + E ++  +   +L G+ YLH    +H D+K  NILL+     G +K+ DF
Sbjct: 120 CLPELAEM-VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYD---GKVDVWSLGITCIELAERKPP 393
           G +      C     +GTP ++APE++       YD      D+W++GI    L     P
Sbjct: 179 GMSRKIGHACELREIMGTPEYLAPEIL------NYDPITTATDMWNIGIIAYMLLTHTSP 232
Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           +   +      +I+Q +       D+S  +T SS ++                       
Sbjct: 233 FVGEDNQETYLNISQVNV------DYSE-ETFSSVSQLA--------------------- 264
Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                        F+ S L KNP  RP++   L+H
Sbjct: 265 -----------TDFIQSLLVKNPEKRPTAEICLSH 288

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 60
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   ++++E+                       GN L  L
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMT--------------------YGNLLDYL 100
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 101 R-----------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 207 TYGMSPYPGID-LSQVYELLEKD 228

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 107/258 (41%), Gaps = 65/258 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GS+G VY A    + + VAIKK++ + +   +    IL+EI  L +LK         
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLID-CKRILREITILNRLK--------- 85
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                 + +++  + L    D+++  + E    +E   + L++L               K
Sbjct: 86  ------SDYIIRLHDLIIPEDLLK--FDELYIVLEIADSDLKKL--------------FK 123
Query: 290 RP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----- 342
            P  L E+ +  I   +L G  ++H  G IHRD+K  N LL +  +VK+ DFG A     
Sbjct: 124 TPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINS 183
Query: 343 ------------------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 378
                                   ++K    S V T ++ APE+IL  +   Y   +D+W
Sbjct: 184 DKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE--NYTNSIDIW 241
Query: 379 SLGITCIELAERKPPYFN 396
           S G    EL      + N
Sbjct: 242 STGCIFAELLNMMKSHIN 259

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 92
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 93  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 120
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 121 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 178
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 179 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 228
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 229 ELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 91
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 92  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 119
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 120 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 177
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 178 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 227
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 228 ELMTRGAPPYPDVNTFDITVYLLQ 251

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 65
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 105
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 106 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 154
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 155 VKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 212 TYGMSPYPGID-LSQVYELLEKD 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 90
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 91  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 118
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 119 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 176
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 177 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 226
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 227 ELMTRGAPPYPDVNTFDITVYLLQ 250

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 94/190 (49%), Gaps = 29/190 (15%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDII-EVHKRPLKEEEIAAICSG 62
           +++++++KHPN ++  G   R+   ++++E+   G+  D + E +++ +    +  + + 
Sbjct: 58  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 117
Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--PANSFVGTPY---WM 117
           +   + YL     IHRD+ A N L+ E   VK+ADFG + +       +  G  +   W 
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 177
Query: 118 APEVILAMDEGQYDGKVDVWSLGI----------TPGSLKDP-EIAELFDKED------- 159
           APE   ++   ++  K DVW+ G+          +P    DP ++ EL +K+        
Sbjct: 178 APE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEG 234
Query: 160 -PEKIFEDLR 168
            PEK++E +R
Sbjct: 235 CPEKVYELMR 244

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 45/248 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   R+   ++++E+                       GN L  L+           E +
Sbjct: 74  GVCTREPPFYIIIEFMT--------------------YGNLLDYLR-----------ECN 102
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-- 346
           ++ +    +  + + +   + YL     IHRD+ A N L+ E   VK+ADFG + +    
Sbjct: 103 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162
Query: 347 PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSA 402
              +  G  +   W APE   ++   ++  K DVW+ G+   E+A     PY  ++  S 
Sbjct: 163 TXTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP-SQ 218
Query: 403 LYHIAQND 410
           +Y + + D
Sbjct: 219 VYELLEKD 226

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 89
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 90  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 117
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 118 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 176 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 225
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 226 ELMTRGAPPYPDVNTFDITVYLLQ 249

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 45/248 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           ++G G FG VY          VA+K +    K+   +  + LKE   ++++KHPN ++  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   R+   +++ E+                       GN L  L+           E +
Sbjct: 74  GVCTREPPFYIITEFMT--------------------YGNLLDYLR-----------ECN 102
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-- 346
           ++ +    +  + + +   + YL     IHRD+ A N L+ E   VK+ADFG + +    
Sbjct: 103 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162
Query: 347 PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSA 402
              +  G  +   W APE   ++   ++  K DVW+ G+   E+A     PY  ++  S 
Sbjct: 163 TXTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP-SQ 218
Query: 403 LYHIAQND 410
           +Y + + D
Sbjct: 219 VYELLEKD 226

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 84
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 85  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 112
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 113 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 170
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 171 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 220
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 221 ELMTRGAPPYPDVNTFDITVYLLQ 244

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 87
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 88  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 115
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ YL S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 116 NFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 173
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 223
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 224 ELMTRGAPPYPDVNTFDITVYLLQ 247

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 65
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 105
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 106 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 154
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 155 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 212 TYGMSPYPGID-LSQVYELLEKD 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 65
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--------------------YGNLLDYL 105
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 106 R-----------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 154
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 155 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 212 TYGMSPYPGID-LSQVYELLEKD 233

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 65
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--------------------YGNLLDYL 105
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 106 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 154
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 155 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 212 TYGMSPYPGID-LSQVYELLEKD 233

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 25/193 (12%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE-VHKRPLKEEEIAA-ICSGV 63
           ++L +++H N I+    +       LVME   GS  D+   + + P  +E +A+ I   +
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPE 120
           +  + YL     IHRD+K  NI++ E  T+KL DFGSA+         +F GT  + APE
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199
Query: 121 VILAMDEGQYDG-KVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVY 179
           V++      Y G ++++WSLG+T        +  L  +E+P   F +L E    +    Y
Sbjct: 200 VLMG---NPYRGPELEMWSLGVT--------LYTLVFEENP---FCELEETVEAAIHPPY 245
Query: 180 YARCLVSREIVAI 192
               LVS+E++++
Sbjct: 246 ----LVSKELMSL 254

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 106/241 (43%), Gaps = 46/241 (19%)
Query: 164 FEDLREIGHGSFGAVYYA-RCLVSREIVA--IKKMSYLGKQCAE--KWADILKEIRFLRQ 218
           +  +  +G G+FG V+ A     ++E+V   IKK   L     E  K   +  EI  L +
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           ++H N I+    +       LVME   GS  D                            
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKH-GSGLD---------------------------- 116
Query: 279 HFALFNFEVHKRPLKEEEIAA-ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              LF F + + P  +E +A+ I   ++  + YL     IHRD+K  NI++ E  T+KL 
Sbjct: 117 ---LFAF-IDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLI 172
Query: 338 DFGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPP 393
           DFGSA+         +F GT  + APEV++      Y G ++++WSLG+T   L   + P
Sbjct: 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMG---NPYRGPELEMWSLGVTLYTLVFEENP 229
Query: 394 Y 394
           +
Sbjct: 230 F 230

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 72/268 (26%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG GS+G V  A   + + +VAIKK+  + +   +    IL+EI  L +L H        
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-CKRILREIAILNRLNH-------- 111
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA-LFNFEVH 288
               DH   ++         DI+    I ++  VE        L+     F  LF   V+
Sbjct: 112 ----DHVVKVL---------DIV----IPKD--VEKFDELYVVLEIADSDFKKLFRTPVY 152
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCP 347
              L E  I  +   +L G+ Y+HS G +HRD+K  N L+ +  +VK+ DFG A ++  P
Sbjct: 153 ---LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
Query: 348 AN------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDV 377
            N                                V T ++ APE+IL  +   Y   +DV
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE--NYTEAIDV 267
Query: 378 WSLGITCIELAERKPPYFNMNAMSALYH 405
           WS+G    EL        NM   +  YH
Sbjct: 268 WSIGCIFAEL-------LNMIKENVAYH 288

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 64
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 104
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 105 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 153
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 210
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 211 TYGMSPYPGID-LSQVYELLEKD 232

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 62
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 102
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 103 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 151
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 152 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 209 TYGMSPYPGID-LSQVYELLEKD 230

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 86/357 (24%), Positives = 127/357 (35%), Gaps = 96/357 (26%)
Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADI 209
           F KE      +  + IG G FG V   R  V   REI VAIK  K  Y  KQ      D 
Sbjct: 7   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ----RRDF 62
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
           L E   + Q  HPN I   G   +     ++ EY    + D                   
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF----------------- 105
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
              L+     F +             ++  +  G+  G+ YL  +  +HRD+ A NIL+ 
Sbjct: 106 ---LRKNDGRFTVI------------QLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVN 150
Query: 330 ETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGI 382
                K++DFG + +    P  ++          W APE I      ++    DVWS GI
Sbjct: 151 SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR---KFTSASDVWSYGI 207
Query: 383 TCIE-LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAM 441
              E ++  + PY++M                   S+  VIK I       PP   M+  
Sbjct: 208 VMWEVMSYGERPYWDM-------------------SNQDVIKAIEEGYRLPPP---MDCP 245
Query: 442 SALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRL--LTHDLVTRPRS 496
            AL+ +  +                    C  K  +DRP  G++  +   L+  P S
Sbjct: 246 IALHQLMLD--------------------CWQKERSDRPKFGQIVNMLDKLIRNPNS 282

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 151
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 152 VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 179
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ +L S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 180 NFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 287
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 288 ELMTRGAPPYPDVNTFDITVYLLQ 311

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 60
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 100
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 101 R-----------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 207 TYGMSPYPGID-LSQVYELLEKD 228

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 83/320 (25%), Positives = 129/320 (40%), Gaps = 57/320 (17%)
Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVS--REIVAIKKMSYLGKQCAEK 205
           DP I  + D  D +  F+D+  IG G+FG V  AR      R   AIK+M     +   +
Sbjct: 15  DPTIYPVLDWNDIK--FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 70
Query: 206 WADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
             D   E+  L +L  HPN I   G        +L +EY   G+  D +           
Sbjct: 71  --DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----------- 117
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                R  ++      FA+ N       L  +++    + V RG++YL     IHRD+ A
Sbjct: 118 -----RKSRVLETDPAFAIANSTAS--TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 170
Query: 324 GNILLTETGTVKLADFG-SASIKCPANSFVGT--PYWMAPEVILAMDEGQYDGKVDVWSL 380
            NIL+ E    K+ADFG S   +      +G     WMA E   +++   Y    DVWS 
Sbjct: 171 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE---SLNYSVYTTNSDVWSY 227
Query: 381 GI----------------TCIELAERKPPYFN----MNAMSALYHIAQN---DTPCLQSS 417
           G+                TC EL E+ P  +     +N    +Y + +    + P  + S
Sbjct: 228 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 287
Query: 418 DWSVIKTISSTAERKPPYFN 437
              ++ +++   E +  Y N
Sbjct: 288 FAQILVSLNRMLEERKTYVN 307

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 60
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--------------------YGNLLDYL 100
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 101 R-----------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 207 TYGMSPYPGID-LSQVYELLEKD 228

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 62
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 102
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 103 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 151
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 152 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 209 TYGMSPYPGID-LSQVYELLEKD 230

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 60
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 100
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 101 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 207 TYGMSPYPGID-LSQVYELLEKD 228

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 267
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--------------------YGNLLDYL 307
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHR++ A N L+ E   
Sbjct: 308 R-----------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 356
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 413
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 414 TYGMSPYPGID-LSQVYELLEKD 435

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 55/292 (18%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++++G G F  V     L      A+K++    +Q  E   +  +E    R   HPN + 
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNHPNILR 90
Query: 227 YRGCYLRD----HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                LR+    H AWL++ +                 F    + N +++LK        
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-----------------FKRGTLWNEIERLKDKG----- 128
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
            NF      L E++I  +  G+ RGL  +H+ G  HRD+K  NILL + G   L D GS 
Sbjct: 129 -NF------LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181
Query: 343 SIKC----PANSFVGTPYWM---------APEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +  C     +   +    W          APE+         D + DVWSLG     +  
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
Query: 390 RKPPY---FNMN---AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
            + PY   F      A++    ++   +P   S+ W ++ ++ +    + P+
Sbjct: 242 GEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH 293

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 45/248 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++  
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   R+   +++ E+                       GN L  L+           E +
Sbjct: 89  GVCTREPPFYIITEFM--------------------TYGNLLDYLR-----------ECN 117
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-- 346
           ++ +    +  + + +   + YL     IHRD+ A N L+ E   VK+ADFG + +    
Sbjct: 118 RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177
Query: 347 PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSA 402
              +  G  +   W APE   ++   ++  K DVW+ G+   E+A     PY  ++ +S 
Sbjct: 178 TYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ 233
Query: 403 LYHIAQND 410
           +Y + + D
Sbjct: 234 VYELLEKD 241

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 60
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 100
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 101 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 207 TYGMSPYPGID-LSQVYELLEKD 228

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 83/320 (25%), Positives = 129/320 (40%), Gaps = 57/320 (17%)
Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVS--REIVAIKKMSYLGKQCAEK 205
           DP I  + D  D +  F+D+  IG G+FG V  AR      R   AIK+M     +   +
Sbjct: 5   DPTIYPVLDWNDIK--FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 60
Query: 206 WADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
             D   E+  L +L  HPN I   G        +L +EY   G+  D +           
Sbjct: 61  --DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----------- 107
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                R  ++      FA+ N       L  +++    + V RG++YL     IHRD+ A
Sbjct: 108 -----RKSRVLETDPAFAIANSTAST--LSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 160
Query: 324 GNILLTETGTVKLADFG-SASIKCPANSFVGT--PYWMAPEVILAMDEGQYDGKVDVWSL 380
            NIL+ E    K+ADFG S   +      +G     WMA E   +++   Y    DVWS 
Sbjct: 161 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE---SLNYSVYTTNSDVWSY 217
Query: 381 GI----------------TCIELAERKPPYFN----MNAMSALYHIAQN---DTPCLQSS 417
           G+                TC EL E+ P  +     +N    +Y + +    + P  + S
Sbjct: 218 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 277
Query: 418 DWSVIKTISSTAERKPPYFN 437
              ++ +++   E +  Y N
Sbjct: 278 FAQILVSLNRMLEERKTYVN 297

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 103/247 (41%), Gaps = 65/247 (26%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           E+  + + ++G G+FG+V   R       +  +VA+K++ + G    ++  D  +EI+ L
Sbjct: 6   ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQIL 62
Query: 217 RQLKHPNTIEYRGCYLRDHTA--WLVMEY----CLGSASDIIEVHWIEREFHVEGMGNRL 270
           + L     ++YRG           LVMEY    CL             R+F         
Sbjct: 63  KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCL-------------RDF--------- 100
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                          + H+  L    +    S + +G+ YL S   +HRD+ A NIL+  
Sbjct: 101 --------------LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES 146
Query: 331 TGTVKLADFGSAS----------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
              VK+ADFG A           ++ P  S +   +W APE   ++ +  +  + DVWS 
Sbjct: 147 EAHVKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE---SLSDNIFSRQSDVWSF 200
Query: 381 GITCIEL 387
           G+   EL
Sbjct: 201 GVVLYEL 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 106/249 (42%), Gaps = 47/249 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   R+   +++ E+                       GN L  L+           E +
Sbjct: 77  GVCTREPPFYIITEFM--------------------TYGNLLDYLR-----------ECN 105
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---- 344
           ++ +    +  + + +   + YL     IHRD+ A N L+ E   VK+ADFG + +    
Sbjct: 106 RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165
Query: 345 --KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMS 401
               PA +      W APE   ++   ++  K DVW+ G+   E+A     PY  ++ +S
Sbjct: 166 TYTAPAGAKFPIK-WTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LS 220
Query: 402 ALYHIAQND 410
            +Y + + D
Sbjct: 221 QVYELLEKD 229

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 93
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 94  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 121
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ +L S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 122 NFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 179
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 180 LARDMLDKEFDSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 229
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 230 ELMTRGAPPYPDVNTFDITVYLLQ 253

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 48/264 (18%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 62
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFM--------------------TYGNLLDYL 102
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHRD+ A N L+ E   
Sbjct: 103 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 151
Query: 334 VKLADFGSASI------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           VK+ADFG + +        PA +      W APE   ++   ++  K DVW+ G+   E+
Sbjct: 152 VKVADFGLSRLMTGDTYTAPAGAKFPIK-WTAPE---SLAYNKFSIKSDVWAFGVLLWEI 207
Query: 388 AER-KPPYFNMNAMSALYHIAQND 410
           A     PY  ++ +S +Y + + D
Sbjct: 208 ATYGMSPYPGID-LSQVYELLEKD 230

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 101/240 (42%), Gaps = 42/240 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           L D E+    F+    IGHG FG VY    L     VA+K+ +    Q  E++   ++ +
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
            F R   HP+ +   G             +C      I+   ++E        GN  + L
Sbjct: 90  SFCR---HPHLVSLIG-------------FCDERNEMILIYKYMEN-------GNLKRHL 126
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                    +  ++    +  E+   IC G  RGL+YLH+   IHRDVK+ NILL E   
Sbjct: 127 ---------YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV 177
Query: 334 VKLADFGSASIKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K+ DFG +      +         GT  ++ PE  +   +G+   K DV+S G+   E+
Sbjct: 178 PKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFI---KGRLTEKSDVYSFGVVLFEV 234

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           E+   IC G  RGL+YLH+   IHRDVK+ NILL E    K+
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKI 180

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 92
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 93  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 120
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ +L S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 121 NFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 178
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 179 LARDMYDKEFDSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 228
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 229 ELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 86/357 (24%), Positives = 127/357 (35%), Gaps = 96/357 (26%)
Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADI 209
           F KE      +  + IG G FG V   R  V   REI VAIK  K  Y  KQ      D 
Sbjct: 1   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ----RRDF 56
Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
           L E   + Q  HPN I   G   +     ++ EY    + D                   
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF----------------- 99
Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
              L+     F +             ++  +  G+  G+ YL  +  +HRD+ A NIL+ 
Sbjct: 100 ---LRKNDGRFTVI------------QLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVN 144
Query: 330 ETGTVKLADFGSASI--KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGI 382
                K++DFG + +    P  ++          W APE I      ++    DVWS GI
Sbjct: 145 SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR---KFTSASDVWSYGI 201
Query: 383 TCIE-LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAM 441
              E ++  + PY++M                   S+  VIK I       PP   M+  
Sbjct: 202 VMWEVMSYGERPYWDM-------------------SNQDVIKAIEEGYRLPPP---MDCP 239
Query: 442 SALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRL--LTHDLVTRPRS 496
            AL+ +  +                    C  K  +DRP  G++  +   L+  P S
Sbjct: 240 IALHQLMLD--------------------CWQKERSDRPKFGQIVNMLDKLIRNPNS 276

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 92
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 93  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 120
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ +L S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 121 NFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 178
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 179 LARDMYDKEFDSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 228
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 229 ELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 93
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 94  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 121
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ +L S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 122 NFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 179
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 180 LARDMYDKEFDSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 229
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 230 ELMTRGAPPYPDVNTFDITVYLLQ 253

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 97
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 98  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 125
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ +L S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 126 NFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 183
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 184 LARDMYDKEFDSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 233
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 234 ELMTRGAPPYPDVNTFDITVYLLQ 257

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 9/141 (6%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L +L HPN I+ +  +       LV+E   G       V K    E + A     +L  
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 67  LNYLHSLGRIHRDVKAGNILLTE---TGTVKLADFGSASI---KCPANSFVGTPYWMAPE 120
           + YLH  G +HRD+K  N+L         +K+ADFG + I   +    +  GTP + APE
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE 220
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           ++       Y  +VD+WS+GI
Sbjct: 221 ILRGC---AYGPEVDMWSVGI 238

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 99/239 (41%), Gaps = 48/239 (20%)
Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
            FE   E+G G+   VY  +   +++  A+K +    K+  +K   +  EI  L +L HP
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDK-KIVRTEIGVLLRLSHP 108
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N I+ +  +       LV+E   G                                   L
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGE---------------------------------L 135
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE---TGTVKLADF 339
           F+  V K    E + A     +L  + YLH  G +HRD+K  N+L         +K+ADF
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPY 394
           G + I   +    +  GTP + APE++       Y  +VD+WS+G IT I L   +P Y
Sbjct: 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGC---AYGPEVDMWSVGIITYILLCGFEPFY 251

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 84/350 (24%), Positives = 125/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 82
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +L H N +   G  L+    ++++E   G                        
Sbjct: 83  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 119
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 120 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 171
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 172 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 228
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 229 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 268
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 269 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 297

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 39/195 (20%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAI---- 59
           +++++++KHPN ++  G   R+   +++ E+   G+  D +    R    +E++A+    
Sbjct: 58  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLY 113
Query: 60  -CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV---GTPY 115
             + +   + YL     IHRD+ A N L+ E   VK+ADFG + +    ++F    G  +
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTFTAHAGAKF 172
Query: 116 ---WMAPEVILAMDEGQYDGKVDVWSLGI----------TPGSLKDP-EIAELFDKED-- 159
              W APE   ++   ++  K DVW+ G+          +P    DP ++ EL +K+   
Sbjct: 173 PIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRM 229
Query: 160 ------PEKIFEDLR 168
                 PEK++E +R
Sbjct: 230 ERPEGCPEKVYELMR 244

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 107/249 (42%), Gaps = 47/249 (18%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G   R+   +++ E+                       GN L  L+           E +
Sbjct: 74  GVCTREPPFYIITEFMT--------------------YGNLLDYLR-----------ECN 102
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA 348
           ++ +    +  + + +   + YL     IHRD+ A N L+ E   VK+ADFG + +    
Sbjct: 103 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTG 161
Query: 349 NSFV---GTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMS 401
           ++F    G  +   W APE   ++   ++  K DVW+ G+   E+A     PY  ++  S
Sbjct: 162 DTFTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP-S 217
Query: 402 ALYHIAQND 410
            +Y + + D
Sbjct: 218 QVYELLEKD 226

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 114/263 (43%), Gaps = 46/263 (17%)
Query: 155 FDKEDPEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           +DK + E+    ++ ++G G +G VY          VA+K +    K+   +  + LKE 
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEA 306
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             ++++KHPN ++  G   R+   +++ E+                       GN L  L
Sbjct: 307 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--------------------YGNLLDYL 346
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +           E +++ +    +  + + +   + YL     IHR++ A N L+ E   
Sbjct: 347 R-----------ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 395
Query: 334 VKLADFGSASIKC--PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           VK+ADFG + +       +  G  +   W APE   ++   ++  K DVW+ G+   E+A
Sbjct: 396 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNKFSIKSDVWAFGVLLWEIA 452
Query: 389 ER-KPPYFNMNAMSALYHIAQND 410
                PY  ++ +S +Y + + D
Sbjct: 453 TYGMSPYPGID-LSQVYELLEKD 474

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 74/264 (28%)
Query: 170 IGHGSFGAVYYARCL------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY+   L      +   + ++ +++ +G+      +  L E   ++   HPN
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPN 90
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G  LR   + LV                                +  + +H  L 
Sbjct: 91  VLSLLGICLRSEGSPLV--------------------------------VLPYMKHGDLR 118
Query: 284 NF---EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           NF   E H   +K+  +      V +G+ +L S   +HRD+ A N +L E  TVK+ADFG
Sbjct: 119 NFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 176
Query: 341 SA---------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
            A                 K P         WMA E   ++   ++  K DVWS G+   
Sbjct: 177 LARDMYDKEFDSVHNKTGAKLPVK-------WMALE---SLQTQKFTTKSDVWSFGVLLW 226
Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           EL  R  PPY ++N      ++ Q
Sbjct: 227 ELMTRGAPPYPDVNTFDITVYLLQ 250

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 84/350 (24%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 96
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    +++ME   G                        
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG----------------------- 133
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 134 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 185
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 186 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 242
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 243 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 282
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 283 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 311

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 84/350 (24%), Positives = 125/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 96
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +L H N +   G  L+    ++++E   G                        
Sbjct: 97  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 133
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 134 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 185
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 186 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 242
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 243 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 282
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 283 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 311

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 108/285 (37%), Gaps = 55/285 (19%)
Query: 141 ITPGSLKDP-EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLV--SREI-VAIK--K 194
           I P + +DP E    F KE      +  + IG G FG V      +   REI VAIK  K
Sbjct: 11  IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 70
Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
             Y  KQ      D L E   + Q  HPN I   G   +     ++ E+    + D    
Sbjct: 71  SGYTEKQRR----DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-- 124
Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
                             L+     F +             ++  +  G+  G+ YL  +
Sbjct: 125 ------------------LRQNDGQFTVI------------QLVGMLRGIAAGMKYLADM 154
Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSASI------KCPANSFVGTPY---WMAPEVILA 365
             +HRD+ A NIL+      K++DFG +             S +G      W APE   A
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE---A 211
Query: 366 MDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNAMSALYHIAQN 409
           +   ++    DVWS GI   E ++  + PY++M     +  I Q+
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD 256

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 107/290 (36%), Gaps = 72/290 (24%)
Query: 170 IGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +G G FG V   R  +   +EI VAIK  K+ Y  KQ      D L E   + Q  HPN 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR----DFLGEASIMGQFDHPNI 79
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   +     +V E     + D                           +H A F 
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLD-----------------------SFLRKHDAQFT 116
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                      ++  +  G+  G+ YL  +G +HRD+ A NIL+      K++DFG + +
Sbjct: 117 VI---------QLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 167
Query: 345 --KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
               P  ++          W +PE I      ++    DVWS GI   E+          
Sbjct: 168 LEDDPEAAYTTRGGKIPIRWTSPEAIAYR---KFTSASDVWSYGIVLWEV---------- 214
Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                   ++  + P  + S+  VIK +       PP   M+  +ALY +
Sbjct: 215 --------MSYGERPYWEMSNQDVIKAVDEGYRLPPP---MDCPAALYQL 253

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 84/350 (24%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 81
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    +++ME   G                        
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG----------------------- 118
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 119 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 170
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 171 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 227
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 228 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 267
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 268 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 296

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 100/240 (41%), Gaps = 42/240 (17%)
Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           L D E+    F+    IGHG FG VY    L     VA+K+ +    Q  E++   ++ +
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 214 RFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
            F R   HP+ +   G             +C      I+   ++E        GN  + L
Sbjct: 90  SFCR---HPHLVSLIG-------------FCDERNEMILIYKYMEN-------GNLKRHL 126
Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                    +  ++    +  E+   IC G  RGL+YLH+   IHRDVK+ NILL E   
Sbjct: 127 ---------YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV 177
Query: 334 VKLADFGSASIKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K+ DFG +                GT  ++ PE  +   +G+   K DV+S G+   E+
Sbjct: 178 PKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFI---KGRLTEKSDVYSFGVVLFEV 234

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           E+   IC G  RGL+YLH+   IHRDVK+ NILL E    K+
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKI 180

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 27/243 (11%)
Query: 158 EDPEKIFEDLREIGHGSFGAV-----YYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
           E P K     + +G G FG V     ++ +       VA+K +         +  D+L E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSE 76
Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQ 271
              L+Q+ HP+ I+  G   +D    L++EY   GS    +      RE    G G    
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL------RESRKVGPGYLGS 130
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
                +           +R L   ++ +    + +G+ YL  +  +HRD+ A NIL+ E 
Sbjct: 131 GGSRNSSSLD----HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG 186
Query: 332 GTVKLADFGSASIKCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
             +K++DFG +      +S+V          WMA E +    +  Y  + DVWS G+   
Sbjct: 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLW 243
Query: 386 ELA 388
           E+ 
Sbjct: 244 EIV 246

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 52/257 (20%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +  + ++ +G G FG V+      S + VA+K +    K         L+E   ++
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTK-VAVKTL----KPGTMSVQAFLEEANLMK 63
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            L+H   +       R+   +++ EY   GS  D ++          EG    L +L  F
Sbjct: 64  TLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDF 115
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
           +   A                         G+ Y+     IHRD++A N+L++E+   K+
Sbjct: 116 SAQIA------------------------EGMAYIERKNYIHRDLRAANVLVSESLMCKI 151
Query: 337 ADFGSASIKCPANSFV---GTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           ADFG A +    N +    G  +   W APE   A++ G +  K DVWS GI   E+   
Sbjct: 152 ADFGLARV-IEDNEYTAREGAKFPIKWTAPE---AINFGCFTIKSDVWSFGILLYEIVTY 207
Query: 391 -KPPY---FNMNAMSAL 403
            K PY    N + M+AL
Sbjct: 208 GKIPYPGRTNADVMTAL 224

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 67/293 (22%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYR 228
           IG GSFG V  A   V +E VAIK +    K+     A I  E+R L  + KH   ++Y 
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQI--EVRLLELMNKHDTEMKYY 117
Query: 229 GCYLRDHTAW-----LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
             +L+ H  +     LV E    +  D++      R  +  G+   L      T  FA  
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLL------RNTNFRGVSLNL------TRKFA-- 163
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHS--LGRIHRDVKAGNILLT--ETGTVKLADF 339
                           +C+ +L    +L +  L  IH D+K  NILL   +   +K+ DF
Sbjct: 164 --------------QQMCTALL----FLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
Query: 340 GSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           GS+  +       + + ++ +PEV+L M    YD  +D+WSLG   +E+   +P +   N
Sbjct: 206 GSSCQLGQRIYQXIQSRFYRSPEVLLGMP---YDLAIDMWSLGCILVEMHTGEPLFSGAN 262
Query: 399 AMSALYHI-----------------AQNDTPCLQSSDWSVIKTISSTAERKPP 434
            +  +  I                 A+     L    W++ KT     E KPP
Sbjct: 263 EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 82
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 119
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 120 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 171
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 172 CLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 228
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 229 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 268
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 269 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 297

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 129/320 (40%), Gaps = 57/320 (17%)
Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVS--REIVAIKKMSYLGKQCAEK 205
           DP I  + D  D +  F+D+  IG G+FG V  AR      R   AIK+M     +   +
Sbjct: 12  DPTIYPVLDWNDIK--FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 67
Query: 206 WADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV 263
             D   E+  L +L  HPN I   G        +L +EY   G+  D +           
Sbjct: 68  --DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----------- 114
Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
                R  ++      FA+ N       L  +++    + V RG++YL     IHR++ A
Sbjct: 115 -----RKSRVLETDPAFAIANSTAS--TLSSQQLLHFAADVARGMDYLSQKQFIHRNLAA 167
Query: 324 GNILLTETGTVKLADFG-SASIKCPANSFVGT--PYWMAPEVILAMDEGQYDGKVDVWSL 380
            NIL+ E    K+ADFG S   +      +G     WMA E   +++   Y    DVWS 
Sbjct: 168 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE---SLNYSVYTTNSDVWSY 224
Query: 381 GI----------------TCIELAERKPPYFN----MNAMSALYHIAQN---DTPCLQSS 417
           G+                TC EL E+ P  +     +N    +Y + +    + P  + S
Sbjct: 225 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 284
Query: 418 DWSVIKTISSTAERKPPYFN 437
              ++ +++   E +  Y N
Sbjct: 285 FAQILVSLNRMLEERKTYVN 304

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 67/293 (22%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYR 228
           IG GSFG V  A   V +E VAIK +    K+     A I  E+R L  + KH   ++Y 
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQI--EVRLLELMNKHDTEMKYY 98
Query: 229 GCYLRDHTAW-----LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
             +L+ H  +     LV E    +  D++      R  +  G+   L      T  FA  
Sbjct: 99  IVHLKRHFMFRNHLCLVFEMLSYNLYDLL------RNTNFRGVSLNL------TRKFA-- 144
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHS--LGRIHRDVKAGNILLT--ETGTVKLADF 339
                           +C+ +L    +L +  L  IH D+K  NILL   +   +K+ DF
Sbjct: 145 --------------QQMCTALL----FLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 186
Query: 340 GSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           GS+  +       + + ++ +PEV+L M    YD  +D+WSLG   +E+   +P +   N
Sbjct: 187 GSSCQLGQRIYQXIQSRFYRSPEVLLGMP---YDLAIDMWSLGCILVEMHTGEPLFSGAN 243
Query: 399 AMSALYHI-----------------AQNDTPCLQSSDWSVIKTISSTAERKPP 434
            +  +  I                 A+     L    W++ KT     E KPP
Sbjct: 244 EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 296

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSA--SIKC 346
             E E A I   +   + +LHS    HRDVK  N+L T   +   +KL DFG A  + + 
Sbjct: 106 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 165
Query: 347 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
              +   TPY++APEV   +   +YD   D+WSLG+    L    PP+++
Sbjct: 166 ALQTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 212

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 61/125 (48%), Gaps = 17/125 (13%)
Query: 287 VHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFGSA 342
           +HKR    E E + +   V   L++LH+ G  HRD+K  NIL     +   VK+ DFG  
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLG 161
Query: 343 S-IKCPAN----------SFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAE 389
           S IK   +          +  G+  +MAPEV+ A  E    YD + D+WSLG+    L  
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 390 RKPPY 394
             PP+
Sbjct: 222 GYPPF 226

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSA--SIKC 346
             E E A I   +   + +LHS    HRDVK  N+L T   +   +KL DFG A  + + 
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 347 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
              +   TPY++APEV   +   +YD   D+WSLG+    L    PP+++
Sbjct: 185 ALQTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 17/153 (11%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHT--AWLVMEYC-LGSASDIIE--VHKRPLKEEEIAAICS 61
           +L++L H N ++         T    L+ME+C  GS   ++E   +   L E E   +  
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 62  GVLRGLNYLHSLGRIHRDVKAGNIL--LTETG--TVKLADFGSASIKCPANSFV---GTP 114
            V+ G+N+L   G +HR++K GNI+  + E G    KL DFG+A        FV   GT 
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 115 YWMAPEV----ILAMD-EGQYDGKVDVWSLGIT 142
            ++ P++    +L  D + +Y   VD+WS+G+T
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 56/244 (22%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEKWADI-LKEIRFLRQLKHPNTI 225
           +G G+   V+  R   + ++ AIK    +S+L      +  D+ ++E   L++L H N +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFL------RPVDVQMREFEVLKKLNHKNIV 70
Query: 226 EYRGCYLRDHT--AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           +         T    L+ME+C  GS   ++E                             
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE---------------------------- 102
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL--LTETG--TVKLAD 338
                +   L E E   +   V+ G+N+L   G +HR++K GNI+  + E G    KL D
Sbjct: 103 ---PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159
Query: 339 FGSASIKCPANSFV---GTPYWMAPEV----ILAMD-EGQYDGKVDVWSLGITCIELAER 390
           FG+A        FV   GT  ++ P++    +L  D + +Y   VD+WS+G+T    A  
Sbjct: 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 391 KPPY 394
             P+
Sbjct: 220 SLPF 223

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 82
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 119
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 120 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 171
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 172 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 228
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 229 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 268
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 269 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 297

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 67/293 (22%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYR 228
           IG GSFG V  A   V +E VAIK +    K+     A I  E+R L  + KH   ++Y 
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQI--EVRLLELMNKHDTEMKYY 117
Query: 229 GCYLRDHTAW-----LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
             +L+ H  +     LV E    +  D++      R  +  G+   L      T  FA  
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLL------RNTNFRGVSLNL------TRKFA-- 163
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHS--LGRIHRDVKAGNILLT--ETGTVKLADF 339
                           +C+ +L    +L +  L  IH D+K  NILL   +   +K+ DF
Sbjct: 164 --------------QQMCTALL----FLATPELSIIHCDLKPENILLCNPKRXAIKIVDF 205
Query: 340 GSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           GS+  +       + + ++ +PEV+L M    YD  +D+WSLG   +E+   +P +   N
Sbjct: 206 GSSCQLGQRIYQXIQSRFYRSPEVLLGMP---YDLAIDMWSLGCILVEMHTGEPLFSGAN 262
Query: 399 AMSALYHI-----------------AQNDTPCLQSSDWSVIKTISSTAERKPP 434
            +  +  I                 A+     L    W++ KT     E KPP
Sbjct: 263 EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 52  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 108
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 109 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 145
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 146 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 197
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 198 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 254
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 255 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 294
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 295 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 323

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 32  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 88
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 89  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 125
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 126 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 177
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 178 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 234
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 235 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 274
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 275 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 303

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 112/266 (42%), Gaps = 48/266 (18%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIE 226
           R +  G F  VY A+ + S    A+K++  L  +  EK   I++E+ F+++L  HPN   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRL--LSNE-EEKNRAIIQEVCFMKKLSGHPN--- 87
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                        ++++C  ++    E    + EF +      L +L C  +        
Sbjct: 88  -------------IVQFCSAASIGKEESDTGQAEFLL------LTEL-CKGQLVEFLKKM 127
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLTETGTVKLADFGSASI 344
             + PL  + +  I     R + ++H      IHRD+K  N+LL+  GT+KL DFGSA+ 
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 345 --KCPANSFVG--------------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
               P  S+                TP +  PE+I          K D+W+LG     L 
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 389 ERKPPY---FNMNAMSALYHIAQNDT 411
            R+ P+     +  ++  Y I  +DT
Sbjct: 248 FRQHPFEDGAKLRIVNGKYSIPPHDT 273

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 123/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 122
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 159
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 160 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A  +      +    WM PE  +   EG +  K D
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 268
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 269 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 308
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 309 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 337

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 42  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 98
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 99  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 135
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 136 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 187
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 188 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 244
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 245 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 284
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 285 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 313

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 7/143 (4%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCL-GSASDIIEVHKRP-LKEEEIAAI 59
           A +S++ QL+H N ++  G  + +    ++V EY   GS  D +    R  L  + +   
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMA 118
              V   + YL     +HRD+ A N+L++E    K++DFG              P  W A
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 167
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A+ E ++  K DVWS GI
Sbjct: 168 PE---ALREKKFSTKSDVWSFGI 187

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+ IG G FG V       ++  VA+K +    K  A   A  L E   + QL+H N ++
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQA-FLAEASVMTQLRHSNLVQ 63
Query: 227 YRGCYLRDHTA-WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
             G  + +    ++V EY   GS  D           ++   G  +    C      L  
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVD-----------YLRSRGRSVLGGDC------LLK 106
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           F +                V   + YL     +HRD+ A N+L++E    K++DFG    
Sbjct: 107 FSLD---------------VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151
Query: 345 KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                     P  W APE   A+ E ++  K DVWS GI   E+
Sbjct: 152 ASSTQDTGKLPVKWTAPE---ALREKKFSTKSDVWSFGILLWEI 192

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 17/153 (11%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHT--AWLVMEYC-LGSASDIIE--VHKRPLKEEEIAAICS 61
           +L++L H N ++         T    L+ME+C  GS   ++E   +   L E E   +  
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 62  GVLRGLNYLHSLGRIHRDVKAGNIL--LTETG--TVKLADFGSASIKCPANSFV---GTP 114
            V+ G+N+L   G +HR++K GNI+  + E G    KL DFG+A        FV   GT 
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTE 179
Query: 115 YWMAPEV----ILAMD-EGQYDGKVDVWSLGIT 142
            ++ P++    +L  D + +Y   VD+WS+G+T
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 56/244 (22%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEKWADI-LKEIRFLRQLKHPNTI 225
           +G G+   V+  R   + ++ AIK    +S+L      +  D+ ++E   L++L H N +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFL------RPVDVQMREFEVLKKLNHKNIV 70
Query: 226 EYRGCYLRDHT--AWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           +         T    L+ME+C  GS   ++E                             
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE---------------------------- 102
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL--LTETG--TVKLAD 338
                +   L E E   +   V+ G+N+L   G +HR++K GNI+  + E G    KL D
Sbjct: 103 ---PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159
Query: 339 FGSASIKCPANSFV---GTPYWMAPEV----ILAMD-EGQYDGKVDVWSLGITCIELAER 390
           FG+A        FV   GT  ++ P++    +L  D + +Y   VD+WS+G+T    A  
Sbjct: 160 FGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 391 KPPY 394
             P+
Sbjct: 220 SLPF 223

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 7/143 (4%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCL-GSASDIIEVHKRP-LKEEEIAAI 59
           A +S++ QL+H N ++  G  + +    ++V EY   GS  D +    R  L  + +   
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMA 118
              V   + YL     +HRD+ A N+L++E    K++DFG              P  W A
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 182
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A+ E ++  K DVWS GI
Sbjct: 183 PE---ALREKKFSTKSDVWSFGI 202

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+ IG G FG V       ++  VA+K +    K  A   A  L E   + QL+H N ++
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQA-FLAEASVMTQLRHSNLVQ 78
Query: 227 YRGCYLRDHTA-WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
             G  + +    ++V EY   GS  D           ++   G  +    C      L  
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVD-----------YLRSRGRSVLGGDC------LLK 121
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           F +                V   + YL     +HRD+ A N+L++E    K++DFG    
Sbjct: 122 FSLD---------------VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166
Query: 345 KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                     P  W APE   A+ E ++  K DVWS GI   E+
Sbjct: 167 ASSTQDTGKLPVKWTAPE---ALREKKFSTKSDVWSFGILLWEI 207

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 40/254 (15%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           RE+G G+FG V+ A C        + +VA+K +        +   D  +E   L  L+H 
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK---DFHREAELLTNLQHE 75
Query: 223 NTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           + +++ G  +      +V EY   G  +  +  H  +     EG           TE   
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP--------TE--- 124
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                     L + ++  I   +  G+ YL S   +HRD+   N L+ E   VK+ DFG 
Sbjct: 125 ----------LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM 174
Query: 342 ASIKCPANSF-VGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
           +      + + VG        WM PE I+     ++  + DVWSLG+   E+    K P+
Sbjct: 175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSLGVVLWEIFTYGKQPW 231
Query: 395 FNMNAMSALYHIAQ 408
           + ++    +  I Q
Sbjct: 232 YQLSNNEVIECITQ 245

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 7/143 (4%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCL-GSASDIIEVHKRP-LKEEEIAAI 59
           A +S++ QL+H N ++  G  + +    ++V EY   GS  D +    R  L  + +   
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMA 118
              V   + YL     +HRD+ A N+L++E    K++DFG              P  W A
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 354
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A+ E ++  K DVWS GI
Sbjct: 355 PE---ALREKKFSTKSDVWSFGI 374

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+ IG G FG V       ++  VA+K +    K  A   A  L E   + QL+H N ++
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQA-FLAEASVMTQLRHSNLVQ 250
Query: 227 YRGCYLRDHTA-WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
             G  + +    ++V EY   GS  D           ++   G  +    C      L  
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVD-----------YLRSRGRSVLGGDC------LLK 293
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           F +                V   + YL     +HRD+ A N+L++E    K++DFG    
Sbjct: 294 FSLD---------------VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338
Query: 345 KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                     P  W APE   A+ E ++  K DVWS GI   E+
Sbjct: 339 ASSTQDTGKLPVKWTAPE---ALREKKFSTKSDVWSFGILLWEI 379

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 17  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 73
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 74  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 110
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 111 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 162
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 163 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 219
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 220 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 259
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 260 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 288

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 124/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 81
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 118
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 119 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 170
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D
Sbjct: 171 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 227
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 228 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 267
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 268 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 296

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 123/350 (35%), Gaps = 98/350 (28%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADIL 210
           KE P K    +R +GHG+FG VY  +        S   VA+K    L + C+E+   D L
Sbjct: 43  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFL 99
Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            E   + +  H N +   G  L+    ++++E   G                        
Sbjct: 100 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG----------------------- 136
Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGN 325
             LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N
Sbjct: 137 -DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 188
Query: 326 ILLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVD 376
            LLT  G     K+ DFG A     A  +      +    WM PE  +   EG +  K D
Sbjct: 189 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTD 245
Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
            WS G+   E+       F++  M           P    S+  V++ ++S     PP  
Sbjct: 246 TWSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP-- 285
Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             N    +Y I                    ++ C    P DRP+   +L
Sbjct: 286 -KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 314

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 27/243 (11%)
Query: 158 EDPEKIFEDLREIGHGSFGAV-----YYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
           E P K     + +G G FG V     ++ +       VA+K +         +  D+L E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSE 76
Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQ 271
              L+Q+ HP+ I+  G   +D    L++EY   GS    +      RE    G G    
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL------RESRKVGPGYLGS 130
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
                +           +R L   ++ +    + +G+ YL  +  +HRD+ A NIL+ E 
Sbjct: 131 GGSRNSSSLD----HPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEG 186
Query: 332 GTVKLADFGSASIKCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
             +K++DFG +      +S V          WMA E +    +  Y  + DVWS G+   
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLW 243
Query: 386 ELA 388
           E+ 
Sbjct: 244 EIV 246

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 112/257 (43%), Gaps = 65/257 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G FG V+  +     E VA+K  S   ++   + A+I + +     L+H N + +  
Sbjct: 50  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENILGFIA 103
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D+  W  +              W+  ++H               EH +LF++ +++
Sbjct: 104 ADNKDNGTWTQL--------------WLVSDYH---------------EHGSLFDY-LNR 133
Query: 290 RPLKEEEIAAICSGVLRGLNYLH-----SLGR---IHRDVKAGNILLTETGTVKLADFGS 341
             +  E +  +      GL +LH     + G+    HRD+K+ NIL+ + GT  +AD G 
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193
Query: 342 A--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGITCIELAER 390
           A        +I    N  VGT  +MAPEV+   + M   +   + D++++G+   E+A R
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
Query: 391 ----------KPPYFNM 397
                     + PY+++
Sbjct: 254 CSIGGIHEDYQLPYYDL 270

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 7/143 (4%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCL-GSASDIIEVHKRP-LKEEEIAAI 59
           A +S++ QL+H N ++  G  + +    ++V EY   GS  D +    R  L  + +   
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-WMA 118
              V   + YL     +HRD+ A N+L++E    K++DFG              P  W A
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 173
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A+ E  +  K DVWS GI
Sbjct: 174 PE---ALREAAFSTKSDVWSFGI 193

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 87/224 (38%), Gaps = 45/224 (20%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+ IG G FG V       ++  VA+K +    K  A   A  L E   + QL+H N ++
Sbjct: 17  LQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQA-FLAEASVMTQLRHSNLVQ 69
Query: 227 YRGCYLRDHTA-WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
             G  + +    ++V EY   GS  D           ++   G  +    C      L  
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVD-----------YLRSRGRSVLGGDC------LLK 112
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           F +                V   + YL     +HRD+ A N+L++E    K++DFG    
Sbjct: 113 FSLD---------------VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 157
Query: 345 KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                     P  W APE   A+ E  +  K DVWS GI   E+
Sbjct: 158 ASSTQDTGKLPVKWTAPE---ALREAAFSTKSDVWSFGILLWEI 198

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 112/257 (43%), Gaps = 65/257 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G FG V+  +     E VA+K  S   ++   + A+I + +     L+H N + +  
Sbjct: 37  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENILGFIA 90
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D+  W  +              W+  ++H               EH +LF++ +++
Sbjct: 91  ADNKDNGTWTQL--------------WLVSDYH---------------EHGSLFDY-LNR 120
Query: 290 RPLKEEEIAAICSGVLRGLNYLH-----SLGR---IHRDVKAGNILLTETGTVKLADFGS 341
             +  E +  +      GL +LH     + G+    HRD+K+ NIL+ + GT  +AD G 
Sbjct: 121 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 180
Query: 342 A--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGITCIELAER 390
           A        +I    N  VGT  +MAPEV+   + M   +   + D++++G+   E+A R
Sbjct: 181 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240
Query: 391 ----------KPPYFNM 397
                     + PY+++
Sbjct: 241 CSIGGIHEDYQLPYYDL 257

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 49/240 (20%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLG-----KQCAEKWADILKEIRFLRQLKHP 222
           ++IG G FG V+  R +  + +VAIK +  LG      +  EK+ +  +E+  +  L HP
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N ++  G  L  +   +VME+                             + C   +  L
Sbjct: 84  NIVKLYG--LMHNPPRMVMEF-----------------------------VPCGDLYHRL 112
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLT---ETGTV--K 335
            +      P+K      +   +  G+ Y+ +     +HRD+++ NI L    E   V  K
Sbjct: 113 LD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 336 LADFGSASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +ADFG++     + S  +G   WMAPE I A +E  Y  K D +S  +    +   + P+
Sbjct: 170 VADFGTSQQSVHSVSGLLGNFQWMAPETIGA-EEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 65/146 (44%), Gaps = 19/146 (13%)
Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCL----------GSASDIIEVHKRPLKEEEIAAICS 61
           +H N +   G         ++ EYC            + +D+ +   RPL+  ++    S
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTP-----Y 115
            V +G+ +L S   IHRDV A N+LLT     K+ DFG A  I   +N  V         
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGI 141
           WMAPE I    +  Y  + DVWS GI
Sbjct: 228 WMAPESIF---DCVYTVQSDVWSYGI 250

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 109/264 (41%), Gaps = 39/264 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCA---EKWADILKEI 213
           E P    +  + +G G+FG V  A    + +E   +K    + K  A   EK A ++ E+
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSEL 100
Query: 214 RFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           + +  L +H N +   G         ++ EYC                      G+ L  
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCC--------------------YGDLLNF 140
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
           L+   E  A  + E   RPL+  ++    S V +G+ +L S   IHRDV A N+LLT   
Sbjct: 141 LRRKAE--ADLDKE-DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 197
Query: 333 TVKLADFGSA-SIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
             K+ DFG A  I   +N  V         WMAPE I    +  Y  + DVWS GI   E
Sbjct: 198 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWE 254
Query: 387 LAERK-PPYFNMNAMSALYHIAQN 409
           +      PY  +   S  Y + ++
Sbjct: 255 IFSLGLNPYPGILVNSKFYKLVKD 278

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 52  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 108
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 109 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 168
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 169 IKWTAPE---AINYGTFTIKSDVWSFGI 193

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 109 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 168
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 169 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 210

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 81/349 (23%), Positives = 122/349 (34%), Gaps = 96/349 (27%)
Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILK 211
           KE P K    +R +GHG+FG VY  +        S   VA+K +  +  +  E   D L 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDE--LDFLM 97
Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           E   + +  H N +   G  L+    ++++E   G                         
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG------------------------ 133
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAA-----ICSGVLRGLNYLHSLGRIHRDVKAGNI 326
            LK F         E   RP +   +A      +   +  G  YL     IHRD+ A N 
Sbjct: 134 DLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 186
Query: 327 LLTETG---TVKLADFGSASIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVDV 377
           LLT  G     K+ DFG A     A+ +      +    WM PE  +   EG +  K D 
Sbjct: 187 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDT 243
Query: 378 WSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFN 437
           WS G+   E+       F++  M           P    S+  V++ ++S     PP   
Sbjct: 244 WSFGVLLWEI-------FSLGYM-----------PYPSKSNQEVLEFVTSGGRMDPP--- 282
Query: 438 MNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
            N    +Y I                    ++ C    P DRP+   +L
Sbjct: 283 KNCPGPVYRI--------------------MTQCWQHQPEDRPNFAIIL 311

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 119
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 180 IKWTAPE---AINYGTFTIKSDVWSFGI 204

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 180 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 65/146 (44%), Gaps = 19/146 (13%)
Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCL----------GSASDIIEVHKRPLKEEEIAAICS 61
           +H N +   G         ++ EYC            + +D+ +   RPL+  ++    S
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTP-----Y 115
            V +G+ +L S   IHRDV A N+LLT     K+ DFG A  I   +N  V         
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGI 141
           WMAPE I    +  Y  + DVWS GI
Sbjct: 220 WMAPESIF---DCVYTVQSDVWSYGI 242

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 107/274 (39%), Gaps = 59/274 (21%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCA---EKWADILKEI 213
           E P    +  + +G G+FG V  A    + +E   +K    + K  A   EK A ++ E+
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSEL 92
Query: 214 RFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           + +  L +H N +   G         ++ EYC                            
Sbjct: 93  KIMSHLGQHENIVNLLGACTHGGPVLVITEYC---------------------------- 124
Query: 273 LKCFTEHFALFNFEVHK----------RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
             C+ +   L NF   K          RPL+  ++    S V +G+ +L S   IHRDV 
Sbjct: 125 --CYGD---LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVA 179
Query: 323 AGNILLTETGTVKLADFGSA-SIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVD 376
           A N+LLT     K+ DFG A  I   +N  V         WMAPE I    +  Y  + D
Sbjct: 180 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSD 236
Query: 377 VWSLGITCIELAERK-PPYFNMNAMSALYHIAQN 409
           VWS GI   E+      PY  +   S  Y + ++
Sbjct: 237 VWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 270

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 61/119 (51%), Gaps = 10/119 (8%)
Query: 31  LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           LV +Y  LGS  D +  H+  L  + +      + +G+ YL   G +HR++ A N+LL  
Sbjct: 109 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS 168
Query: 90  TGTVKLADFGSASIKCPAN-----SFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGIT 142
              V++ADFG A +  P +     S   TP  WMA E I     G+Y  + DVWS G+T
Sbjct: 169 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI---HFGKYTHQSDVWSYGVT 224

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPY-W 357
           + +G+ YL   G +HR++ A N+LL     V++ADFG A +  P +     S   TP  W
Sbjct: 142 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 201
Query: 358 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           MA E I     G+Y  + DVWS G+T  EL
Sbjct: 202 MALESI---HFGKYTHQSDVWSYGVTVWEL 228

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 62  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 118
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 119 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 179 IKWTAPE---AINYGTFTIKSDVWSFGI 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 119 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 179 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 220

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 27/243 (11%)
Query: 158 EDPEKIFEDLREIGHGSFGAV-----YYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
           E P K     + +G G FG V     ++ +       VA+K +         +  D+L E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSE 76
Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQ 271
              L+Q+ HP+ I+  G   +D    L++EY   GS    +      RE    G G    
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL------RESRKVGPGYLGS 130
Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
                +           +R L   ++ +    + +G+ YL  +  +HRD+ A NIL+ E 
Sbjct: 131 GGSRNSSSLD----HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG 186
Query: 332 GTVKLADFGSASIKCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
             +K++DFG +      +S V          WMA E +    +  Y  + DVWS G+   
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLW 243
Query: 386 ELA 388
           E+ 
Sbjct: 244 EIV 246

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 119
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 180 IKWTAPE---AINYGTFTIKSDVWSFGI 204

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 180 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 122
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 123 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 183 IKWTAPE---AINYGTFTIKSDVWSFGI 207

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 123 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 183 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 224

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 77  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 133
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 194 VKWYAPECI---NYYKFSSKSDVWSFGV 218

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 120 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 179
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 77  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 133
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 194 VKWYAPECI---NYYKFSSKSDVWSFGV 218

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 120 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 179
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 113
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGI 198

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 115
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 116 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 176 IKWTAPE---AINYGTFTIKSDVWSFGI 200

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 116 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 176 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 65  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 121
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 122 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 182 IKWTAPE---AINYGTFTIKSDVWSFGI 206

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 122 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 182 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 223

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 58  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 114
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 115 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 175 IKWTAPE---AINYGTFTIKSDVWSFGI 199

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 115 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 175 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 113
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGI 198

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 112/257 (43%), Gaps = 65/257 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G FG V+  +     E VA+K  S   ++   + A+I + +     L+H N + +  
Sbjct: 14  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENILGFIA 67
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D+  W  +              W+  ++H               EH +LF++ +++
Sbjct: 68  ADNKDNGTWTQL--------------WLVSDYH---------------EHGSLFDY-LNR 97
Query: 290 RPLKEEEIAAICSGVLRGLNYLH-----SLGR---IHRDVKAGNILLTETGTVKLADFGS 341
             +  E +  +      GL +LH     + G+    HRD+K+ NIL+ + GT  +AD G 
Sbjct: 98  YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 157
Query: 342 A--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGITCIELAER 390
           A        +I    N  VGT  +MAPEV+   + M   +   + D++++G+   E+A R
Sbjct: 158 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217
Query: 391 ----------KPPYFNM 397
                     + PY+++
Sbjct: 218 CSIGGIHEDYQLPYYDL 234

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 67  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 123
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 124 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 184 IKWTAPE---AINYGTFTIKSDVWSFGI 208

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 124 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 184 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 225

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 113
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV--GTPY- 115
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +   A      G  + 
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP 173
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGI 198

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV--GTPY- 356
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +   A      G  + 
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP 173
Query: 357 --WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 112/257 (43%), Gaps = 65/257 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G FG V+  +     E VA+K  S   ++   + A+I + +     L+H N + +  
Sbjct: 12  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENILGFIA 65
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D+  W  +              W+  ++H               EH +LF++ +++
Sbjct: 66  ADNKDNGTWTQL--------------WLVSDYH---------------EHGSLFDY-LNR 95
Query: 290 RPLKEEEIAAICSGVLRGLNYLH-----SLGR---IHRDVKAGNILLTETGTVKLADFGS 341
             +  E +  +      GL +LH     + G+    HRD+K+ NIL+ + GT  +AD G 
Sbjct: 96  YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 155
Query: 342 A--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGITCIELAER 390
           A        +I    N  VGT  +MAPEV+   + M   +   + D++++G+   E+A R
Sbjct: 156 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215
Query: 391 ----------KPPYFNM 397
                     + PY+++
Sbjct: 216 CSIGGIHEDYQLPYYDL 232

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 61  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 117
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP 177
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 178 VKWYAPECI---NYYKFSSKSDVWSFGV 202

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 104 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 163
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 164 DENXYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +      +     +++ EY       +++  K P    L   ++  
Sbjct: 57  AEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 113
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGI 198

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMN 398
             W APE   A++ G +  K DVWS GI   E+    + PY  M 
Sbjct: 174 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 112/257 (43%), Gaps = 65/257 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G FG V+  +     E VA+K  S   ++   + A+I + +     L+H N + +  
Sbjct: 17  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENILGFIA 70
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D+  W  +              W+  ++H               EH +LF++ +++
Sbjct: 71  ADNKDNGTWTQL--------------WLVSDYH---------------EHGSLFDY-LNR 100
Query: 290 RPLKEEEIAAICSGVLRGLNYLH-----SLGR---IHRDVKAGNILLTETGTVKLADFGS 341
             +  E +  +      GL +LH     + G+    HRD+K+ NIL+ + GT  +AD G 
Sbjct: 101 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 160
Query: 342 A--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGITCIELAER 390
           A        +I    N  VGT  +MAPEV+   + M   +   + D++++G+   E+A R
Sbjct: 161 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220
Query: 391 ----------KPPYFNM 397
                     + PY+++
Sbjct: 221 CSIGGIHEDYQLPYYDL 237

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 61/119 (51%), Gaps = 10/119 (8%)
Query: 31  LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           LV +Y  LGS  D +  H+  L  + +      + +G+ YL   G +HR++ A N+LL  
Sbjct: 91  LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS 150
Query: 90  TGTVKLADFGSASIKCPAN-----SFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGIT 142
              V++ADFG A +  P +     S   TP  WMA E I     G+Y  + DVWS G+T
Sbjct: 151 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI---HFGKYTHQSDVWSYGVT 206

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPY-W 357
           + +G+ YL   G +HR++ A N+LL     V++ADFG A +  P +     S   TP  W
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 358 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           MA E I     G+Y  + DVWS G+T  EL
Sbjct: 184 MALESI---HFGKYTHQSDVWSYGVTVWEL 210

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 57  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 113
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 114 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 174 VKWYAPECI---NYYKFSSKSDVWSFGV 198

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 100 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 160 DENYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 50/259 (19%)
Query: 165 EDLR---EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           E LR   ++G G FG V+      +   VAIK +   G    E +   L+E + +++L+H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK-PGTMSPEAF---LQEAQVMKKLRH 321
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
              ++     + +   ++V EY                       G+ L  LK  T  + 
Sbjct: 322 EKLVQLYAV-VSEEPIYIVTEYM--------------------SKGSLLDFLKGETGKY- 359
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                     L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG 
Sbjct: 360 ----------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409
Query: 342 ASI----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYF 395
           A +    +  A      P  W APE  L    G++  K DVWS GI   EL  + + PY 
Sbjct: 410 ARLIEDNEYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYP 466
Query: 396 NMNAMSALYHIAQN-DTPC 413
            M     L  + +    PC
Sbjct: 467 GMVNREVLDQVERGYRMPC 485

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 75  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 131
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 132 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 191
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 192 VKWYAPECI---NYYKFSSKSDVWSFGV 216

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 118 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 177
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 178 DENYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 234

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 112/257 (43%), Gaps = 65/257 (25%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           IG G FG V+  +     E VA+K  S   ++   + A+I + +     L+H N + +  
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENILGFIA 64
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
              +D+  W  +              W+  ++H               EH +LF++ +++
Sbjct: 65  ADNKDNGTWTQL--------------WLVSDYH---------------EHGSLFDY-LNR 94
Query: 290 RPLKEEEIAAICSGVLRGLNYLH-----SLGR---IHRDVKAGNILLTETGTVKLADFGS 341
             +  E +  +      GL +LH     + G+    HRD+K+ NIL+ + GT  +AD G 
Sbjct: 95  YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154
Query: 342 A--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGITCIELAER 390
           A        +I    N  VGT  +MAPEV+   + M   +   + D++++G+   E+A R
Sbjct: 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
Query: 391 ----------KPPYFNM 397
                     + PY+++
Sbjct: 215 CSIGGIHEDYQLPYYDL 231

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 61  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 117
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 177
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 178 VKWYAPECI---NYYKFSSKSDVWSFGV 202

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 104 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 163
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 164 DENYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 220

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 67  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 123
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 184 VKWYAPECI---NYYKFSSKSDVWSFGV 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 110 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 170 DENYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 55  AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 111
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 112 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 171
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 172 VKWYAPECI---NYYKFSSKSDVWSFGV 196

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKC 346
             R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++ 
Sbjct: 98  QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 157
Query: 347 PANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
             N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 158 DENYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KH 221
           + +G G+FG V  A         +   VA+K +   G   +E  A ++ E++ L  +  H
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE-GATHSEHRA-LMSELKILIHIGHH 90
Query: 222 PNTIEYRG-CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            N +   G C        +++E+C                      GN    L+     F
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFC--------------------KFGNLSTYLRSKRNEF 130
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
             +  +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG
Sbjct: 131 VPYK-DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 341 SAS--IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            A    K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 239

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 337 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 394 VERGYRMPC 402

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 337 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 394 VERGYRMPC 402

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHK-RPLKEEEIAAICSG 62
           + ++++L+H   ++     + +   ++V+EY   GS  D ++    + L+  ++  + + 
Sbjct: 64  AQVMKKLRHEKLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY-WM 117
           +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  A      P  W 
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT 182
Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APE  L    G++  K DVWS GI
Sbjct: 183 APEAALY---GRFTIKSDVWSFGI 203

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++  
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
           G    +   ++V EY                       GN L  L+           E +
Sbjct: 95  GVCTLEPPFYIVTEYM--------------------PYGNLLDYLR-----------ECN 123
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-- 346
           +  +    +  + + +   + YL     IHRD+ A N L+ E   VK+ADFG + +    
Sbjct: 124 REEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD 183
Query: 347 PANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
              +  G  +   W APE   ++    +  K DVW+ G+   E+A
Sbjct: 184 TYTAHAGAKFPIKWTAPE---SLAYNTFSIKSDVWAFGVLLWEIA 225

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHK-RPLKEEEIAAICSG 62
           + ++++L+H   ++     + +   ++V+EY   GS  D ++    + L+  ++  + + 
Sbjct: 64  AQVMKKLRHEKLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY-WM 117
           +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  A      P  W 
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APE  L    G++  K DVWS GI
Sbjct: 183 APEAALY---GRFTIKSDVWSFGI 203

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 101 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT 160
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 161 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 217
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 218 VERGYRMPC 226

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 337 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 394 VERGYRMPC 402

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 96/234 (41%), Gaps = 39/234 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KH 221
           + +G G+FG V  A         +   VA+K +   G   +E  A ++ E++ L  +  H
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE-GATHSEHRA-LMSELKILIHIGHH 92
Query: 222 PNTIEYRG-CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            N +   G C        +++E+C                      GN    L+     F
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFC--------------------KFGNLSTYLRSKRNEF 132
Query: 281 ALFNFE-VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
             +  E ++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DF
Sbjct: 133 VPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDF 192
Query: 340 GSAS--IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G A    K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 243

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHK-RPLKEEEIAAICSG 62
           + ++++L+H   ++     + +   ++VMEY   G   D ++    + L+  ++  + + 
Sbjct: 64  AQVMKKLRHEKLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY-WM 117
           +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  A      P  W 
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APE  L    G++  K DVWS GI
Sbjct: 183 APEAALY---GRFTIKSDVWSFGI 203

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 101/255 (39%), Gaps = 37/255 (14%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP 222
           RE+G G+FG V+ A C        + +VA+K    L         D  +E   L  L+H 
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKA---LKDPTLAARKDFQREAELLTNLQHE 77
Query: 223 NTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           + +++ G         +V EY   G  +  +  H  +    V+G   +            
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA----------- 126
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                  K  L   ++  I S +  G+ YL S   +HRD+   N L+     VK+ DFG 
Sbjct: 127 -------KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 342 ASIKCPANSF-VGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
           +      + + VG        WM PE I+     ++  + DVWS G+   E+    K P+
Sbjct: 180 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 395 FNMNAMSALYHIAQN 409
           F ++    +  I Q 
Sbjct: 237 FQLSNTEVIECITQG 251

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 100 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 159
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 160 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 216
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 217 VERGYRMPC 225

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 102 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 161
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 162 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 218
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 219 VERGYRMPC 227

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 102/267 (38%), Gaps = 66/267 (24%)
Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIV----AIK 193
           ++GI  G   +  +  +  + +    F+ ++ +G G+FG VY    +   E V    AIK
Sbjct: 2   AMGIRSGEAPNQALLRILKETE----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           ++       A K  +IL E   +  + +P+     G              CL S   +I 
Sbjct: 58  ELREATSPKANK--EILDEAYVMASVDNPHVCRLLGI-------------CLTSTVQLI- 101
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                          +L    C  ++        HK  +  + +   C  + +G+NYL  
Sbjct: 102 --------------TQLMPFGCLLDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI-------------KCPANSFVGTPYWMAP 360
              +HRD+ A N+L+     VK+ DFG A +             K P         WMA 
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-------WMAL 195
Query: 361 EVILAMDEGQYDGKVDVWSLGITCIEL 387
           E IL      Y  + DVWS G+T  EL
Sbjct: 196 ESIL---HRIYTHQSDVWSYGVTVWEL 219

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 104 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 163
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 164 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 220
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 221 VERGYRMPC 229

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 108/257 (42%), Gaps = 52/257 (20%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +  + ++++G G FG V+      S + VA+K +    K         L+E   ++
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTL----KPGTMSVQAFLEEANLMK 62
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            L+H   +       ++   +++ E+   GS  D ++          EG    L +L  F
Sbjct: 63  TLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSD--------EGGKVLLPKLIDF 114
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
           +   A                         G+ Y+     IHRD++A N+L++E+   K+
Sbjct: 115 SAQIA------------------------EGMAYIERKNYIHRDLRAANVLVSESLMCKI 150
Query: 337 ADFGSASIKCPANSFV---GTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           ADFG A +    N +    G  +   W APE   A++ G +  K +VWS GI   E+   
Sbjct: 151 ADFGLARV-IEDNEYTAREGAKFPIKWTAPE---AINFGCFTIKSNVWSFGILLYEIVTY 206
Query: 391 -KPPY---FNMNAMSAL 403
            K PY    N + MSAL
Sbjct: 207 GKIPYPGRTNADVMSAL 223

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWT 167
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 168 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 224
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 225 VERGYRMPC 233

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 92/255 (36%), Gaps = 54/255 (21%)
Query: 170 IGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           IG G FG V   R          VAIK +   G     +  + L E   + Q +HPN I 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLK--GGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G         ++ E+    A D                      L+     F +    
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSF--------------------LRLNDGQFTVI--- 118
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------ 340
                    ++  +  G+  G+ YL  +  +HRD+ A NIL+      K++DFG      
Sbjct: 119 ---------QLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 169
Query: 341 -SASIKCPANSFVGT--PYWMAPEVILAMDEGQYDGKVDVWSLGITCIE---LAERKPPY 394
            ++S     +S  G     W APE I      ++    D WS GI   E     ER  PY
Sbjct: 170 ENSSDPTETSSLGGKIPIRWTAPEAIAFR---KFTSASDAWSYGIVMWEVMSFGER--PY 224
Query: 395 FNMNAMSALYHIAQN 409
           ++M+    +  I Q+
Sbjct: 225 WDMSNQDVINAIEQD 239

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 419 AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 475
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 476 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 536 VKWYAPECI---NYYKFSSKSDVWSFGV 560

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA 348
           R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++   
Sbjct: 464 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523
Query: 349 NSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
           N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 524 NYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +    +  
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 167
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 168 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 224
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 225 VERGYRMPC 233

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 287 VHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFGSA 342
           +HKR    E E + +   V   L++LH+ G  HRD+K  NIL     +   VK+ DF   
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
Query: 343 S-IKCPAN----------SFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAE 389
           S IK   +          +  G+  +MAPEV+ A  E    YD + D+WSLG+    L  
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 390 RKPPY 394
             PP+
Sbjct: 222 GYPPF 226

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 74
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 75  DNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCLLDY 106
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 107 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 162 GRAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 211
Query: 387 L 387
           L
Sbjct: 212 L 212

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
           A +++++QL +P  +   G  + +  +W LVME   LG  +  ++   R +K++ I  + 
Sbjct: 420 AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELV 476
Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGTPY---- 115
             V  G+ YL     +HRD+ A N+LL      K++DFG S +++   N +    +    
Sbjct: 477 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE I   +  ++  K DVWS G+
Sbjct: 537 VKWYAPECI---NYYKFSSKSDVWSFGV 561

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA 348
           R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K++DFG S +++   
Sbjct: 465 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 524
Query: 349 NSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYFNMNA 399
           N +    +      W APE I   +  ++  K DVWS G+   E  +  + PY  M  
Sbjct: 525 NYYKAQTHGKWPVKWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 579

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 98/245 (40%), Gaps = 57/245 (23%)
Query: 170 IGHGSFGAVYYARCLVS---REI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           IG G FG VY      S   +E+ VAIK  K  Y  KQ      D L E   + Q  H N
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV----DFLGEAGIMGQFSHHN 107
Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I   G   +     ++ EY    A D         +F  E  G            F++ 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALD---------KFLREKDG-----------EFSVL 147
Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                       ++  +  G+  G+ YL ++  +HRD+ A NIL+      K++DFG + 
Sbjct: 148 ------------QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195
Query: 344 I--KCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPP 393
           +    P  ++  +       W APE   A+   ++    DVWS GI   E+    ER  P
Sbjct: 196 VLEDDPEATYTTSGGKIPIRWTAPE---AISYRKFTSASDVWSFGIVMWEVMTYGER--P 250
Query: 394 YFNMN 398
           Y+ ++
Sbjct: 251 YWELS 255

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 17/144 (11%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII---EVHKRPLKEEEIAAI 59
           A +++++ L+H   ++      ++    +      GS  D +   E  K+PL +  +   
Sbjct: 226 AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK--LIDF 283
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTPYWM 117
            + +  G+ ++     IHRD++A NIL++ +   K+ADFG A +  K P         W 
Sbjct: 284 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK-------WT 336
Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APE   A++ G +  K DVWS GI
Sbjct: 337 APE---AINFGSFTIKSDVWSFGI 357

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 19/130 (14%)
Query: 276 FTEHFALFNF----EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
           F    +L +F    E  K+PL +  +    + +  G+ ++     IHRD++A NIL++ +
Sbjct: 257 FMAKGSLLDFLKSDEGSKQPLPK--LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 314
Query: 332 GTVKLADFGSASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
              K+ADFG A +  K P         W APE   A++ G +  K DVWS GI  +E+  
Sbjct: 315 LVCKIADFGLARVGAKFPIK-------WTAPE---AINFGSFTIKSDVWSFGILLMEIVT 364
Query: 390 R-KPPYFNMN 398
             + PY  M+
Sbjct: 365 YGRIPYPGMS 374

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 73
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 74  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 105
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 106 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 160
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 161 TDFGRAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 210
Query: 384 CIEL 387
             EL
Sbjct: 211 VWEL 214

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 49/240 (20%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLG-----KQCAEKWADILKEIRFLRQLKHP 222
           ++IG G FG V+  R +  + +VAIK +  LG      +  EK+ +  +E+  +  L HP
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N ++  G  L  +   +VME+                             + C   +  L
Sbjct: 84  NIVKLYG--LMHNPPRMVMEF-----------------------------VPCGDLYHRL 112
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLT---ETGTV--K 335
            +      P+K      +   +  G+ Y+ +     +HRD+++ NI L    E   V  K
Sbjct: 113 LD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 336 LADFGSASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +ADFG +     + S  +G   WMAPE I A +E  Y  K D +S  +    +   + P+
Sbjct: 170 VADFGLSQQSVHSVSGLLGNFQWMAPETIGA-EEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 168 REIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KH 221
           + +G G+FG V  A         +   VA+K +   G   +E  A ++ E++ L  +  H
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE-GATHSEHRA-LMSELKILIHIGHH 90
Query: 222 PNTIEYRG-CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            N +   G C        +++E+C                      GN    L+     F
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFC--------------------KFGNLSTYLRSKRNEF 130
Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
             +  +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG
Sbjct: 131 VPYK-DLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFG 189
Query: 341 SAS--IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            A    K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 239

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 102/267 (38%), Gaps = 66/267 (24%)
Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIV----AIK 193
           ++GI  G   +  +  +  + +    F+ ++ +G G+FG VY    +   E V    AIK
Sbjct: 2   AMGIRSGEAPNQALLRILKETE----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           ++       A K  +IL E   +  + +P+     G              CL S   +I 
Sbjct: 58  ELREATSPKANK--EILDEAYVMASVDNPHVCRLLGI-------------CLTSTVQLI- 101
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                          +L    C  ++        HK  +  + +   C  + +G+NYL  
Sbjct: 102 --------------TQLMPFGCLLDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI-------------KCPANSFVGTPYWMAP 360
              +HRD+ A N+L+     VK+ DFG A +             K P         WMA 
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-------WMAL 195
Query: 361 EVILAMDEGQYDGKVDVWSLGITCIEL 387
           E IL      Y  + DVWS G+T  EL
Sbjct: 196 ESIL---HRIYTHQSDVWSYGVTVWEL 219

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 92/239 (38%), Gaps = 49/239 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKK-MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           +G G FG V       + E VAIK+    L  +  E+W     EI+ +++L HPN +  R
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC---LEIQIMKKLNHPNVVSAR 78
Query: 229 GC------YLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                      +    L MEYC G                    G+  + L  F     L
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEG--------------------GDLRKYLNQFENCCGL 118
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
                     KE  I  + S +   L YLH    IHRD+K  NI+L    +    K+ D 
Sbjct: 119 ----------KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 340 GSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           G A           FVGT  ++APE+   +++ +Y   VD WS G    E      P+ 
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPEL---LEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 92/239 (38%), Gaps = 49/239 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKK-MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           +G G FG V       + E VAIK+    L  +  E+W     EI+ +++L HPN +  R
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC---LEIQIMKKLNHPNVVSAR 79
Query: 229 GC------YLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                      +    L MEYC G                    G+  + L  F     L
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEG--------------------GDLRKYLNQFENCCGL 119
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
                     KE  I  + S +   L YLH    IHRD+K  NI+L    +    K+ D 
Sbjct: 120 ----------KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 169
Query: 340 GSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           G A           FVGT  ++APE+   +++ +Y   VD WS G    E      P+ 
Sbjct: 170 GYAKELDQGELCTEFVGTLQYLAPEL---LEQKKYTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 102/237 (43%), Gaps = 56/237 (23%)
Query: 173 GSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL 232
           G FG V+ A+ L   E VA+K      KQ    W +   E+  L  +KH N +++ G   
Sbjct: 35  GRFGCVWKAQLL--NEYVAVKIFPIQDKQ---SWQNEY-EVYSLPGMKHENILQFIGAEK 88
Query: 233 RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPL 292
           R            G++ D+    W+   FH +G               +L +F +    +
Sbjct: 89  R------------GTSVDVD--LWLITAFHEKG---------------SLSDF-LKANVV 118
Query: 293 KEEEIAAICSGVLRGLNYLH----------SLGRIHRDVKAGNILLTETGTVKLADFGSA 342
              E+  I   + RGL YLH               HRD+K+ N+LL    T  +ADFG A
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 343 SIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDG--KVDVWSLGITCIELAER 390
            +K  A       +  VGT  +MAPEV+      Q D   ++D++++G+   ELA R
Sbjct: 179 -LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 114/271 (42%), Gaps = 40/271 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCA---EKWADILKEI 213
           E P    +  + +G G+FG V  A    + +E   +K    + K  A   EK A ++ E+
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSEL 85
Query: 214 RFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM------ 266
           + +  L +H N +   G         ++ EYC     D++  +++ R+   E M      
Sbjct: 86  KIMSHLGQHENIVNLLGACTHGGPVLVITEYC--CYGDLL--NFLRRK--AEAMLGPSLA 139
Query: 267 -GNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
            G   + L            +   RPL+  ++    S V +G+ +L S   IHRDV A N
Sbjct: 140 PGQDPEGLD-----------KEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 188
Query: 326 ILLTETGTVKLADFGSA-SIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWS 379
           +LLT     K+ DFG A  I   +N  V         WMAPE I    +  Y  + DVWS
Sbjct: 189 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWS 245
Query: 380 LGITCIELAERK-PPYFNMNAMSALYHIAQN 409
            GI   E+      PY  +   S  Y + ++
Sbjct: 246 YGILLWEIFSLGLNPYPGILVNSKFYKLVKD 276

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 20  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 77
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 78  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 109
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 110 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 164
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 165 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 214
Query: 384 CIEL 387
             EL
Sbjct: 215 VWEL 218

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP----LKEEEIAA 58
           A ++L++QL+H   +       ++   +++ EY       +++  K P    L   ++  
Sbjct: 53  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLD 109
Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 114
           + + +  G+ ++     IHR+++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 110 MAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 169
Query: 115 Y-WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 170 IKWTAPE---AINYGTFTIKSDVWSFGI 194

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 300 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTP 355
           + + +  G+ ++     IHR+++A NIL+++T + K+ADFG A +    +  A      P
Sbjct: 110 MAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 169
Query: 356 Y-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNM 397
             W APE   A++ G +  K DVWS GI   E+    + PY  M
Sbjct: 170 IKWTAPE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 210

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 26  DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 85
           D   ++VMEY  G +    +  K P+ E  IA +   +L  L+YLHS+G ++ D+K  NI
Sbjct: 156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEA-IAYLLE-ILPALSYLHSIGLVYNDLKPENI 213
Query: 86  LLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVI 122
           +LTE   +KL D G+ S         GTP + APE++
Sbjct: 214 MLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIV 249

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 170 IGHGSFGAVYYA--RCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
           I HG  G +Y A  R +  R +V +K + + G   A+  A   ++  FL ++ HP+ ++ 
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVV-LKGLVHSGDAEAQAMAMAERQ--FLAEVVHPSIVQI 144
Query: 228 RGCYLR-----DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                      D   ++VMEY  G                        Q LK        
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGG------------------------QSLK-------- 172
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
              +  K P+ E  IA +   +L  L+YLHS+G ++ D+K  NI+LTE   +KL D G+ 
Sbjct: 173 -RSKGQKLPVAEA-IAYLLE-ILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228
Query: 343 SIKCPANSFVGTPYWMAPEVI 363
           S         GTP + APE++
Sbjct: 229 SRINSFGYLYGTPGFQAPEIV 249

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 74
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 75  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 106
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 107 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 161
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 211
Query: 384 CIEL 387
             EL
Sbjct: 212 VWEL 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 74
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 75  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 106
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 107 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 161
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 211
Query: 384 CIEL 387
             EL
Sbjct: 212 VWEL 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 39  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 96
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 97  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 128
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 129 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 183
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 184 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 233
Query: 384 CIEL 387
             EL
Sbjct: 234 VWEL 237

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 73
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 74  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 105
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 106 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 160
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 161 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 210
Query: 384 CIEL 387
             EL
Sbjct: 211 VWEL 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 84
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 85  DNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCLLDY 116
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 117 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 171
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 172 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 221
Query: 387 L 387
           L
Sbjct: 222 L 222

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 74
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 75  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 106
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 107 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 161
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 211
Query: 384 CIEL 387
             EL
Sbjct: 212 VWEL 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 74
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 75  DNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCLLDY 106
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 107 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 211
Query: 387 L 387
           L
Sbjct: 212 L 212

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 78
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 79  DNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCLLDY 110
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 111 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 166 GRAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 215
Query: 387 L 387
           L
Sbjct: 216 L 216

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 68
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 69  DNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCLLDY 100
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 101 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 155
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 205
Query: 387 L 387
           L
Sbjct: 206 L 206

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 103/253 (40%), Gaps = 63/253 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI-LKEIRFLRQLK-HPNTIEY 227
           +G+GS G V +      R  VA+K+M          + DI L EI+ L +   HPN I Y
Sbjct: 23  LGYGSSGTVVFQGSFQGRP-VAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 74
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
                 D   ++ +E C  +  D++E   +  E                       N ++
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKNVSDE-----------------------NLKL 111
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN---------------------I 326
                KE    ++   +  G+ +LHSL  IHRD+K  N                     I
Sbjct: 112 Q----KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 327 LLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGK----VDVWSLG- 381
           L+++ G  K  D G +S +   N+  GT  W APE++   +  Q   +    +D++S+G 
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 382 ITCIELAERKPPY 394
           +    L++ K P+
Sbjct: 228 VFYYILSKGKHPF 240

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 73
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 74  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCL 105
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 106 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 160
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 161 TDFGRAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 210
Query: 384 CIEL 387
             EL
Sbjct: 211 VWEL 214

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 100/249 (40%), Gaps = 59/249 (23%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI-LKEIRFLRQLK-HPNTIEY 227
           +G+GS G V +      R  VA+K+M          + DI L EI+ L +   HPN I Y
Sbjct: 41  LGYGSSGTVVFQGSFQGRP-VAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 92
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
                 D   ++ +E C  +  D++E   +  E                       N ++
Sbjct: 93  YCSETTDRFLYIALELCNLNLQDLVESKNVSDE-----------------------NLKL 129
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN---------------------I 326
                KE    ++   +  G+ +LHSL  IHRD+K  N                     I
Sbjct: 130 Q----KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 185
Query: 327 LLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCI 385
           L+++ G  K  D G    +   N+  GT  W APE++    + +    +D++S+G +   
Sbjct: 186 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYY 245
Query: 386 ELAERKPPY 394
            L++ K P+
Sbjct: 246 ILSKGKHPF 254

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 61/129 (47%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD+ A NIL+ E    K+ADFG A +    +  
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 171 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 228 VERGYRMPC 236

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 73
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 74  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCL 105
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 106 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 160
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 161 TDFGRAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 210
Query: 384 CIEL 387
             EL
Sbjct: 211 VWEL 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCA---EKWADILKEI 213
           E P    +  + +G G+FG V  A    + +E   +K    + K  A   EK A ++ E+
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSEL 100
Query: 214 RFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           + +  L +H N +   G         ++ EYC     D++  +++ R+  V      L+ 
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYC--CYGDLL--NFLRRKSRV------LET 150
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
              F          +    L   ++    S V +G+ +L S   IHRDV A N+LLT   
Sbjct: 151 DPAFA---------IANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201
Query: 333 TVKLADFGSA-SIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
             K+ DFG A  I   +N  V         WMAPE I    +  Y  + DVWS GI   E
Sbjct: 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWE 258
Query: 387 L 387
           +
Sbjct: 259 I 259

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 98/257 (38%), Gaps = 64/257 (24%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCA---EKWADILKEI 213
           E P    +  + +G G+FG V  A    + +E   +K    + K  A   EK A ++ E+
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSEL 100
Query: 214 RFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           + +  L +H N +   G         ++ EYC                            
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYC---------------------------- 132
Query: 273 LKCFTEHFALFNFEVHKRP----------------LKEEEIAAICSGVLRGLNYLHSLGR 316
             C+ +   L NF   KRP                L   ++    S V +G+ +L S   
Sbjct: 133 --CYGD---LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC 187
Query: 317 IHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTP-----YWMAPEVILAMDEGQ 370
           IHRDV A N+LLT     K+ DFG A  I   +N  V         WMAPE I    +  
Sbjct: 188 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCV 244
Query: 371 YDGKVDVWSLGITCIEL 387
           Y  + DVWS GI   E+
Sbjct: 245 YTVQSDVWSYGILLWEI 261

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 75
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 76  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCL 107
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 108 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 162
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 163 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 212
Query: 384 CIEL 387
             EL
Sbjct: 213 VWEL 216

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 10/129 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCP 347
           L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG   +    +  
Sbjct: 278 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT 337
Query: 348 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
           A      P  W APE  L    G++  K DVWS GI   EL  + + PY  M     L  
Sbjct: 338 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 394
Query: 406 IAQN-DTPC 413
           + +    PC
Sbjct: 395 VERGYRMPC 403

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 100/249 (40%), Gaps = 59/249 (23%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI-LKEIRFLRQLK-HPNTIEY 227
           +G+GS G V +      R  VA+K+M          + DI L EI+ L +   HPN I Y
Sbjct: 41  LGYGSSGTVVFQGSFQGRP-VAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 92
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
                 D   ++ +E C  +  D++E   +  E                       N ++
Sbjct: 93  YCSETTDRFLYIALELCNLNLQDLVESKNVSDE-----------------------NLKL 129
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN---------------------I 326
                KE    ++   +  G+ +LHSL  IHRD+K  N                     I
Sbjct: 130 Q----KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 185
Query: 327 LLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCI 385
           L+++ G  K  D G    +   N+  GT  W APE++    + +    +D++S+G +   
Sbjct: 186 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYY 245
Query: 386 ELAERKPPY 394
            L++ K P+
Sbjct: 246 ILSKGKHPF 254

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 74
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 75  DNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCLLDY 106
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 107 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 211
Query: 387 L 387
           L
Sbjct: 212 L 212

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVL 64
           S++ QL H N I+    +   +   LVMEY  G    D I      L E +       + 
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 65  RGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
            G+ ++H +  +H D+K  NIL    +   +K+ DFG A    P        GTP ++AP
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
Query: 120 EVILAMDEGQYD---GKVDVWSLGI 141
           EV+       YD      D+WS+G+
Sbjct: 258 EVV------NYDFVSFPTDMWSVGV 276

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 92/246 (37%), Gaps = 51/246 (20%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G FG V+      +   +A K +   G +  E   ++  EI  + QL H N I+   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDHANLIQLYD 153
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
            +   +   LVMEY  G                                   LF+  + +
Sbjct: 154 AFESKNDIVLVMEYVDGGE---------------------------------LFDRIIDE 180
Query: 290 R-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKC 346
              L E +       +  G+ ++H +  +H D+K  NIL    +   +K+ DFG A    
Sbjct: 181 SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 347 PANSF---VGTPYWMAPEVILAMDEGQYD---GKVDVWSLGITCIELAERKPPYFNMNAM 400
           P        GTP ++APEV+       YD      D+WS+G+    L     P+   N  
Sbjct: 241 PREKLKVNFGTPEFLAPEVV------NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294
Query: 401 SALYHI 406
             L +I
Sbjct: 295 ETLNNI 300

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 75
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 76  DNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCLLDY 107
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 108 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 212
Query: 387 L 387
           L
Sbjct: 213 L 213

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 74
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 75  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCL 106
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 107 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 161
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 211
Query: 384 CIEL 387
             EL
Sbjct: 212 VWEL 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 74
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 75  DNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCLLDY 106
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 107 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 211
Query: 387 L 387
           L
Sbjct: 212 L 212

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 73
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 74  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------MQLMPFGCL 105
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+
Sbjct: 106 LDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 160
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 161 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 210
Query: 384 CIEL 387
             EL
Sbjct: 211 VWEL 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 92/255 (36%), Gaps = 54/255 (21%)
Query: 170 IGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           IG G FG V   R          VAIK +   G     +  + L E   + Q +HPN I 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLK--GGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G         ++ E+    A D                      L+     F +    
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSF--------------------LRLNDGQFTVI--- 116
Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------ 340
                    ++  +  G+  G+ YL  +  +HRD+ A NIL+      K++DFG      
Sbjct: 117 ---------QLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 167
Query: 341 -SASIKCPANSFVGT--PYWMAPEVILAMDEGQYDGKVDVWSLGITCIE---LAERKPPY 394
            ++S     +S  G     W APE I      ++    D WS GI   E     ER  PY
Sbjct: 168 ENSSDPTYTSSLGGKIPIRWTAPEAIAFR---KFTSASDAWSYGIVMWEVMSFGER--PY 222
Query: 395 FNMNAMSALYHIAQN 409
           ++M+    +  I Q+
Sbjct: 223 WDMSNQDVINAIEQD 237

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA 348
             E ++    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P 
Sbjct: 288 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 347
Query: 349 NSFVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPY 394
            S VGT  +MAPEV   + +G  YD   D +SLG    +L     P+
Sbjct: 348 AS-VGTHGYMAPEV---LQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA 348
             E ++    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 349 NSFVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPY 394
            S VGT  +MAPEV   + +G  YD   D +SLG    +L     P+
Sbjct: 349 AS-VGTHGYMAPEV---LQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 92/244 (37%), Gaps = 62/244 (25%)
Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFL 216
           E  F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +
Sbjct: 11  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 68
Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             + +P+     G              CL S   +I                +L    C 
Sbjct: 69  ASVDNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCL 100
Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++        HK  +  + +   C  +  G+NYL     +HRD+ A N+L+     VK+
Sbjct: 101 LDYV-----REHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 155
Query: 337 ADFGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
            DFG A +             K P         WMA E IL      Y  + DVWS G+T
Sbjct: 156 TDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVT 205
Query: 384 CIEL 387
             EL
Sbjct: 206 VWEL 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCA---EKWADILKEI 213
           E P    +  + +G G+FG V  A    + +E   +K    + K  A   EK A ++ E+
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSEL 100
Query: 214 RFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           + +  L +H N +   G         ++ EYC     D++  +++ R+  V         
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYC--CYGDLL--NFLRRKSRVLET------ 150
Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                  FA+ N     R     ++    S V +G+ +L S   IHRDV A N+LLT   
Sbjct: 151 ----DPAFAIANSTASTR-----DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201
Query: 333 TVKLADFGSA-SIKCPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
             K+ DFG A  I   +N  V         WMAPE I    +  Y  + DVWS GI   E
Sbjct: 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWE 258
Query: 387 L 387
           +
Sbjct: 259 I 259

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII---EVHKRPLKEEEIAAI 59
           A +++++ L+H   ++      ++    +      GS  D +   E  K+PL +  +   
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK--LIDF 116
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPY 115
            + +  G+ ++     IHRD++A NIL++ +   K+ADFG A +    +  A      P 
Sbjct: 117 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 176
Query: 116 -WMAPEVILAMDEGQYDGKVDVWSLGI 141
            W APE   A++ G +  K DVWS GI
Sbjct: 177 KWTAPE---AINFGSFTIKSDVWSFGI 200

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 45/235 (19%)
Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +  +  +++G G FG V+ A        VA+K M   G    E +   L E   ++
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMA-TYNKHTKVAVKTMK-PGSMSVEAF---LAEANVMK 65
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            L+H   ++      ++    +      GS  D ++          EG    L +L  F+
Sbjct: 66  TLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFS 117
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              A                         G+ ++     IHRD++A NIL++ +   K+A
Sbjct: 118 AQIA------------------------EGMAFIEQRNYIHRDLRAANILVSASLVCKIA 153
Query: 338 DFGSASI----KCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           DFG A +    +  A      P  W APE   A++ G +  K DVWS GI  +E+
Sbjct: 154 DFGLARVIEDNEYTAREGAKFPIKWTAPE---AINFGSFTIKSDVWSFGILLMEI 205

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA 348
             E ++    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 349 NSFVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPY 394
            S VGT  +MAPEV   + +G  YD   D +SLG    +L     P+
Sbjct: 349 AS-VGTHGYMAPEV---LQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPA 348
             E ++    + ++ GL ++H+   ++RD+K  NILL E G V+++D G A   S K P 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 349 NSFVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPY 394
            S VGT  +MAPEV   + +G  YD   D +SLG    +L     P+
Sbjct: 349 AS-VGTHGYMAPEV---LQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVME-YCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           + +++ L HP+ ++  G  + +   W++ME Y  G     +E +K  LK   +      +
Sbjct: 60  AVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 118
Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-----WMA 118
            + + YL S+  +HRD+   NIL+     VKL DFG +      + +  +       WM+
Sbjct: 119 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 178
Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   +++  ++    DVW   +
Sbjct: 179 PE---SINFRRFTTASDVWMFAV 198

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 51/239 (21%)
Query: 168 REIGHGSFGAVY---YARCLVSREIVAIKKMSYLGKQCA-EKWADILKEIRFLRQLKHPN 223
           R +G G FG VY   Y      +  VA+K      K C  +     + E   ++ L HP+
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 224 TIEYRGCYLRDHTAWLVME-YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            ++  G  + +   W++ME Y  G        H++ER                       
Sbjct: 71  IVKLIGI-IEEEPTWIIMELYPYGELG-----HYLER----------------------- 101
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                +K  LK   +      + + + YL S+  +HRD+   NIL+     VKL DFG +
Sbjct: 102 -----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 343 SIKCPANSFVGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYF 395
                 + +  +       WM+PE   +++  ++    DVW   +   E L+  K P+F
Sbjct: 157 RYIEDEDYYKASVTRLPIKWMSPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVME-YCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           +++ L HP+ ++  G  + +   W++ME Y  G     +E +K  LK   +      + +
Sbjct: 78  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 136
Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-----WMAPE 120
            + YL S+  +HRD+   NIL+     VKL DFG +      + +  +       WM+PE
Sbjct: 137 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 196
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
              +++  ++    DVW   +
Sbjct: 197 ---SINFRRFTTASDVWMFAV 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 51/239 (21%)
Query: 168 REIGHGSFGAVY---YARCLVSREIVAIKKMSYLGKQCA-EKWADILKEIRFLRQLKHPN 223
           R +G G FG VY   Y      +  VA+K      K C  +     + E   ++ L HP+
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 224 TIEYRGCYLRDHTAWLVME-YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            ++  G  + +   W++ME Y  G        H++ER                       
Sbjct: 87  IVKLIGI-IEEEPTWIIMELYPYGELG-----HYLER----------------------- 117
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                +K  LK   +      + + + YL S+  +HRD+   NIL+     VKL DFG +
Sbjct: 118 -----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 343 SIKCPANSFVGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYF 395
                 + +  +       WM+PE   +++  ++    DVW   +   E L+  K P+F
Sbjct: 173 RYIEDEDYYKASVTRLPIKWMSPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVME-YCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           +++ L HP+ ++  G  + +   W++ME Y  G     +E +K  LK   +      + +
Sbjct: 66  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-----WMAPE 120
            + YL S+  +HRD+   NIL+     VKL DFG +      + +  +       WM+PE
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 121 VILAMDEGQYDGKVDVWSLGI 141
              +++  ++    DVW   +
Sbjct: 185 ---SINFRRFTTASDVWMFAV 202

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 51/239 (21%)
Query: 168 REIGHGSFGAVY---YARCLVSREIVAIKKMSYLGKQCA-EKWADILKEIRFLRQLKHPN 223
           R +G G FG VY   Y      +  VA+K      K C  +     + E   ++ L HP+
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 224 TIEYRGCYLRDHTAWLVME-YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            ++  G  + +   W++ME Y  G        H++ER                       
Sbjct: 75  IVKLIGI-IEEEPTWIIMELYPYGELG-----HYLER----------------------- 105
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                +K  LK   +      + + + YL S+  +HRD+   NIL+     VKL DFG +
Sbjct: 106 -----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 343 SIKCPANSFVGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPYF 395
                 + +  +       WM+PE   +++  ++    DVW   +   E L+  K P+F
Sbjct: 161 RYIEDEDYYKASVTRLPIKWMSPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 99/258 (38%), Gaps = 51/258 (19%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           E+G G+FG V+      +    A K +    +   E    + KEI+ +  L+HP  +   
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET---VRKEIQTMSVLRHPTLVNLH 114
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
             +  D+   +VM Y   S  ++ E                    K   EH         
Sbjct: 115 DAFEDDNE--MVMIYEFMSGGELFE--------------------KVADEH--------- 143
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKC 346
              + E+E       V +GL ++H    +H D+K  NI+ T   +  +KL DFG  +   
Sbjct: 144 -NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 202
Query: 347 PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
           P  S     GT  + APEV      G Y    D+WS+G+    L     P+   N    L
Sbjct: 203 PKQSVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETL 259
Query: 404 YHIAQNDTPCLQSSDWSV 421
            ++        +S DW++
Sbjct: 260 RNV--------KSCDWNM 269

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 3   AGSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII---EVHKRPLKEEEIAAI 59
           A +++++ L+H   ++      ++    +      GS  D +   E  K+PL +  +   
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK--LIDF 289
Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV---GTPY- 115
            + +  G+ ++     IHRD++A NIL++ +   K+ADFG A +    N +    G  + 
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFP 348
Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APE   A++ G +  K DVWS GI
Sbjct: 349 IKWTAPE---AINFGSFTIKSDVWSFGI 373

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 17/134 (12%)
Query: 276 FTEHFALFNF----EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 331
           F    +L +F    E  K+PL +  +    + +  G+ ++     IHRD++A NIL++ +
Sbjct: 263 FMAKGSLLDFLKSDEGSKQPLPK--LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 320
Query: 332 GTVKLADFGSASIKCPANSFV---GTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
              K+ADFG A +    N +    G  +   W APE   A++ G +  K DVWS GI  +
Sbjct: 321 LVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE---AINFGSFTIKSDVWSFGILLM 376
Query: 386 ELAER-KPPYFNMN 398
           E+    + PY  M+
Sbjct: 377 EIVTYGRIPYPGMS 390

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 103/293 (35%), Gaps = 68/293 (23%)
Query: 104 KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKI 163
           K P + F   P    PEV L                    G LK   + EL    D    
Sbjct: 3   KKPQDHFFDVPAEEDPEVHL--------------------GQLKRFSLRELQVASDN--- 39
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F +   +G G FG VY  R L    +VA+K++     Q  E       E+  +    H N
Sbjct: 40  FSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERXQGGE--LQFQTEVEMISMAVHRN 96
Query: 224 TIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            +  RG  +      LV  Y   GS +                         C  E    
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVA------------------------SCLRER--- 129
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL---GRIHRDVKAGNILLTETGTVKLADF 339
                 + PL   +   I  G  RGL YLH       IHRDVKA NILL E     + DF
Sbjct: 130 ---PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 186
Query: 340 GSASIKCPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           G A +    +  V     GT   +APE    +  G+   K DV+  G+  +EL
Sbjct: 187 GLAKLMDYKDXHVXXAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 236

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 243

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 190 XKDPDXVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 190 XKDPDXVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 234

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 49/240 (20%)
Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLG-----KQCAEKWADILKEIRFLRQLKHP 222
           ++IG G FG V+  R +  + +VAIK +  LG      +  EK+ +  +E+  +  L HP
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N ++  G  L  +   +VME+                             + C   +  L
Sbjct: 84  NIVKLYG--LMHNPPRMVMEF-----------------------------VPCGDLYHRL 112
Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLT---ETGTV--K 335
            +      P+K      +   +  G+ Y+ +     +HRD+++ NI L    E   V  K
Sbjct: 113 LD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 336 LADFGSASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
           +ADF  +     + S  +G   WMAPE I A +E  Y  K D +S  +    +   + P+
Sbjct: 170 VADFSLSQQSVHSVSGLLGNFQWMAPETIGA-EEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 199 YKDPDXVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 243

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 243

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 87/363 (23%), Positives = 132/363 (36%), Gaps = 61/363 (16%)
Query: 169 EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYR 228
           E+G G+FG V+      +    A K +    +   E    + KEI+ +  L+HP  +   
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET---VRKEIQTMSVLRHPTLVNLH 220
Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
             +  D+   +VM Y   S  ++ E                    K   EH         
Sbjct: 221 DAFEDDNE--MVMIYEFMSGGELFE--------------------KVADEH--------- 249
Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKC 346
              + E+E       V +GL ++H    +H D+K  NI+ T   +  +KL DFG  +   
Sbjct: 250 -NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 347 PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL 403
           P  S     GT  + APEV      G Y    D+WS+G+    L     P+   N    L
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETL 365
Query: 404 YHIAQNDTPCLQSSDWSVIKTISSTAE---RK----PPYFNMNAMSALYH--IAQNDTPC 454
               +N   C  + D S    IS   +   RK     P   M    AL H  +   + P 
Sbjct: 366 ----RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421
Query: 455 LQSSDWSDTFAHFVSSCLAKN---PADRPSSGRLLTHDLVT--RPRSPSVLVDLIRRTKA 509
             S   S  +     S   K    P   P  GR+  +  +   RP+  S+      R++A
Sbjct: 422 RDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEA 481
Query: 510 AVR 512
             R
Sbjct: 482 QPR 484

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 101/267 (37%), Gaps = 66/267 (24%)
Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIV----AIK 193
           ++GI  G   +  +  +  + +    F+ ++ +  G+FG VY    +   E V    AIK
Sbjct: 2   AMGIRSGEAPNQALLRILKETE----FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           ++       A K  +IL E   +  + +P+     G              CL S   +I 
Sbjct: 58  ELREATSPKANK--EILDEAYVMASVDNPHVCRLLGI-------------CLTSTVQLI- 101
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                          +L    C  ++        HK  +  + +   C  + +G+NYL  
Sbjct: 102 --------------TQLMPFGCLLDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI-------------KCPANSFVGTPYWMAP 360
              +HRD+ A N+L+     VK+ DFG A +             K P         WMA 
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-------WMAL 195
Query: 361 EVILAMDEGQYDGKVDVWSLGITCIEL 387
           E IL      Y  + DVWS G+T  EL
Sbjct: 196 ESIL---HRIYTHQSDVWSYGVTVWEL 219

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 190 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 189 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 248
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 249 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 293

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 190 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 234

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 141 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 200
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 201 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 243

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 191 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 250
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 251 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 288

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 89/414 (21%), Positives = 149/414 (35%), Gaps = 81/414 (19%)
Query: 128 GQYDG-KV--------DVWSLGI-TPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGA 177
           G+YDG K+        D+W   +  P  +K   + + +D          L E+G G+FG 
Sbjct: 16  GKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDI---------LEELGSGAFGV 66
Query: 178 VYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA 237
           V+  RC V +    +    ++          +  EI  + QL HP  I     +   +  
Sbjct: 67  VH--RC-VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEI 297
            L++E+  G                               E F     E +K  + E E+
Sbjct: 124 VLILEFLSGG------------------------------ELFDRIAAEDYK--MSEAEV 151
Query: 298 AAICSGVLRGLNYLHSLGRIHRDVKAGNIL--LTETGTVKLADFGSASIKCP---ANSFV 352
                    GL ++H    +H D+K  NI+    +  +VK+ DFG A+   P        
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 353 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTP 412
            T  + APE++     G Y    D+W++G+    L     P+   + +  L    QN   
Sbjct: 212 ATAEFAAPEIVDREPVGFY---TDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKR 264
Query: 413 CLQSSDWSVIKTISSTAE-------RKPPYFNMNAMSALYHI-----AQNDTPCLQSSDW 460
           C    D     ++S  A+       +K P   +    AL H        N T  + SS +
Sbjct: 265 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY 324
Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT--RPRSPSVLVDLIRRTKAAVR 512
            +     +    A  PA +P+ GR+     +   RP+   +      R +A  R
Sbjct: 325 -NKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKEAVPR 377

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 6   SLLR-QLKHPNTIEYRGCYLRDHTAWLVMEYC-----------------LGSASDIIEVH 47
           ++LR +L+HPN +   G   +D    ++  YC                 +GS  D   V 
Sbjct: 80  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV- 138
Query: 48  KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------S 100
           K  L+  +   + + +  G+ YL S   +H+D+   N+L+ +   VK++D G       +
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 198
Query: 101 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              K   NS +    WMAPE I+    G++    D+WS G+ 
Sbjct: 199 DYYKLLGNSLLPI-RWMAPEAIMY---GKFSIDSDIWSYGVV 236

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIR---FLR- 217
           + E+G   FG VY             + VAIK +    K  AE    + +E R    LR 
Sbjct: 31  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL----KDKAE--GPLREEFRHEAMLRA 84
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +L+HPN +   G   +D    ++  YC  S  D+ E   +       G  +  + +K   
Sbjct: 85  RLQHPNVVCLLGVVTKDQPLSMIFSYC--SHGDLHEFLVMRSPHSDVGSTDDDRTVKS-- 140
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                         L+  +   + + +  G+ YL S   +H+D+   N+L+ +   VK++
Sbjct: 141 -------------ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKIS 187
Query: 338 DFG-------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           D G       +   K   NS +    WMAPE I+    G++    D+WS G+   E+
Sbjct: 188 DLGLFREVYAADYYKLLGNSLLPI-RWMAPEAIMY---GKFSIDSDIWSYGVVLWEV 240

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 176 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 235
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 236 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 280

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-- 343
           +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A   
Sbjct: 182 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 241
Query: 344 IKCPANSFVGTPY----WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K P     G       WMAPE I    +  Y  + DVWS G+   E+
Sbjct: 242 YKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEI 286

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 89/239 (37%), Gaps = 58/239 (24%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA--DILKEIRFLRQLKH 221
           F+ ++ +G G+FG VY    +   E V I       ++     A  +IL E   +  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P+     G              CL S   +I                +L    C  ++  
Sbjct: 111 PHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCLLDYV- 141
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                 HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DFG 
Sbjct: 142 ----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 197
Query: 342 ASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           A +             K P         WMA E IL      Y  + DVWS G+T  EL
Sbjct: 198 AKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWEL 246

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 91/241 (37%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +  G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 74
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                +L    C  ++
Sbjct: 75  DNPHVCRLLGI-------------CLTSTVQLI---------------TQLMPFGCLLDY 106
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 107 V-----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 211
Query: 387 L 387
           L
Sbjct: 212 L 212

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           LRE+G GSFG VY      +R+I+  +  + +  +   + A + + I FL +    + ++
Sbjct: 22  LRELGQGSFGMVYEGN---ARDIIKGEAETRVAVKTVNESASLRERIEFLNE---ASVMK 75
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFALFNF 285
              C+   H   L+     G  + ++       E    G + + L+ L+   E+      
Sbjct: 76  GFTCH---HVVRLLGVVSKGQPTLVV------MELMAHGDLKSYLRSLRPEAEN------ 120
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----- 340
              + P   +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+ DFG     
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 341 --SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
             +A  +      +    WMAPE   ++ +G +    D+WS G+   E+ 
Sbjct: 181 YETAYYRKGGKGLLPV-RWMAPE---SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 94/241 (39%), Gaps = 62/241 (25%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 75
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G  L      ++     G   D +      RE H + +G++          
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYV------RE-HKDNIGSQY--------- 119
Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
             L N+               C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 120 --LLNW---------------CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 340 GSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G A +             K P         WMA E IL      Y  + DVWS G+T  E
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVWE 212
Query: 387 L 387
           L
Sbjct: 213 L 213

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G FG+VY    +     VAIK   ++ K     W ++    R   ++          
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVV--------- 63
Query: 230 CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHK 289
                    L+ +   G +  I  + W ER      +  R++ ++       LF+F   +
Sbjct: 64  ---------LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQ------DLFDFITER 108
Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASI--KC 346
             L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFGS ++    
Sbjct: 109 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 168
Query: 347 PANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
               F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 169 VYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 58/253 (22%)
Query: 164 FEDLREI-----GHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           FED+ ++     G G++  V  A  L + +  A+K +    KQ     + + +E+  L Q
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE---KQAGHSRSRVFREVETLYQ 66
Query: 219 LK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            + + N +E    +  D   +LV E   G +   I  H I+++ H               
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGS---ILAH-IQKQKH--------------- 107
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTV 334
                FN         E E + +   V   L++LH+ G  HRD+K  NIL     +   V
Sbjct: 108 -----FN---------EREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPV 153
Query: 335 KLADFGSASIKCPANSFV-----------GTPYWMAPEVILAMDEGQ--YDGKVDVWSLG 381
           K+ DF   S     NS             G+  +MAPEV+    +    YD + D+WSLG
Sbjct: 154 KICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLG 213
Query: 382 ITCIELAERKPPY 394
           +    +    PP+
Sbjct: 214 VVLYIMLSGYPPF 226

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 6   SLLR-QLKHPNTIEYRGCYLRDHTAWLVMEYC-----------------LGSASDIIEVH 47
           ++LR +L+HPN +   G   +D    ++  YC                 +GS  D   V 
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV- 121
Query: 48  KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------S 100
           K  L+  +   + + +  G+ YL S   +H+D+   N+L+ +   VK++D G       +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 101 ASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              K   NS +    WMAPE I+    G++    D+WS G+ 
Sbjct: 182 DYYKLLGNSLLPI-RWMAPEAIMY---GKFSIDSDIWSYGVV 219

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIR---FLR- 217
           + E+G   FG VY             + VAIK +    K  AE    + +E R    LR 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL----KDKAE--GPLREEFRHEAMLRA 67
Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +L+HPN +   G   +D    ++  YC  S  D+ E   +       G  +  + +K   
Sbjct: 68  RLQHPNVVCLLGVVTKDQPLSMIFSYC--SHGDLHEFLVMRSPHSDVGSTDDDRTVKS-- 123
Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                         L+  +   + + +  G+ YL S   +H+D+   N+L+ +   VK++
Sbjct: 124 -------------ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKIS 170
Query: 338 DFG-------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           D G       +   K   NS +    WMAPE I+    G++    D+WS G+   E+
Sbjct: 171 DLGLFREVYAADYYKLLGNSLLPI-RWMAPEAIMY---GKFSIDSDIWSYGVVLWEV 223

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 93/242 (38%), Gaps = 64/242 (26%)
Query: 164 FEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E V    AIK++       A K  +IL E   +  +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 74
Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G              CL S   +I                   QL  F   
Sbjct: 75  DNPHVCRLLGI-------------CLTSTVQLI------------------TQLMPFG-- 101
Query: 280 FALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
             L ++   HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ D
Sbjct: 102 -XLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD 160
Query: 339 FGSASI-------------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           FG A +             K P         WMA E IL      Y  + DVWS G+T  
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIK-------WMALESIL---HRIYTHQSDVWSYGVTVW 210
Query: 386 EL 387
           EL
Sbjct: 211 EL 212

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 95/255 (37%), Gaps = 54/255 (21%)
Query: 170 IGHGSFGAVYYARCLV--SREI-VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           IG G FG V      +   REI VAIK  K  Y  KQ      D L E   + Q  HPN 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR----DFLSEASIMGQFDHPNV 70
Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I   G   +     ++ E+    + D                      L+     F +  
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSF--------------------LRQNDGQFTVI- 109
Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
                      ++  +  G+  G+ YL  +  +HR + A NIL+      K++DFG +  
Sbjct: 110 -----------QLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRF 158
Query: 345 ------KCPANSFVGTPY---WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPY 394
                      S +G      W APE   A+   ++    DVWS GI   E ++  + PY
Sbjct: 159 LEDDTSDPTYTSALGGKIPIRWTAPE---AIQYRKFTSASDVWSYGIVMWEVMSYGERPY 215
Query: 395 FNMNAMSALYHIAQN 409
           ++M     +  I Q+
Sbjct: 216 WDMTNQDVINAIEQD 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 31/229 (13%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           LRE+G GSFG VY      +R+I+  +  + +  +   + A + + I FL +    + ++
Sbjct: 22  LRELGQGSFGMVYEGN---ARDIIKGEAETRVAVKTVNESASLRERIEFLNE---ASVMK 75
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFALFNF 285
              C+   H   L+     G  + ++       E    G + + L+ L+   E+      
Sbjct: 76  GFTCH---HVVRLLGVVSKGQPTLVV------MELMAHGDLKSYLRSLRPEAEN------ 120
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
              + P   +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+ DFG     
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 346 CPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
              + +      +    WMAPE   ++ +G +    D+WS G+   E+ 
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 101/267 (37%), Gaps = 66/267 (24%)
Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIV----AIK 193
           ++GI  G   +  +  +  + +    F+ ++ +  G+FG VY    +   E V    AIK
Sbjct: 2   AMGIRSGEAPNQALLRILKETE----FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           ++       A K  +IL E   +  + +P+     G              CL S   +I 
Sbjct: 58  ELREATSPKANK--EILDEAYVMASVDNPHVCRLLGI-------------CLTSTVQLI- 101
Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                          +L    C  ++        HK  +  + +   C  + +G+NYL  
Sbjct: 102 --------------MQLMPFGCLLDYV-----REHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSASI-------------KCPANSFVGTPYWMAP 360
              +HRD+ A N+L+     VK+ DFG A +             K P         WMA 
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-------WMAL 195
Query: 361 EVILAMDEGQYDGKVDVWSLGITCIEL 387
           E IL      Y  + DVWS G+T  EL
Sbjct: 196 ESIL---HRIYTHQSDVWSYGVTVWEL 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 61/136 (44%), Gaps = 8/136 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF++   K PL E         V+  + + HS G +HRD+K  NIL+    G  KL DFG
Sbjct: 126 LFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPY-FN 396
           S ++    P   F GT  +  PE I      QY      VWSLGI   ++     P+  +
Sbjct: 186 SGALLHDEPYTDFDGTRVYSPPEWI---SRHQYHALPATVWSLGILLYDMVCGDIPFERD 242
Query: 397 MNAMSALYHIAQNDTP 412
              + A  H   + +P
Sbjct: 243 QEILEAELHFPAHVSP 258

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 53/118 (44%), Gaps = 13/118 (11%)
Query: 31  LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 90
           + ME   G +   +   +  L E+         L GL YLHS   +H DVKA N+LL+  
Sbjct: 162 IFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSD 221
Query: 91  GT-VKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 138
           G+   L DFG A    P          +   GT   MAPEV+L       D KVDVWS
Sbjct: 222 GSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS---CDAKVDVWS 276

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 43/86 (50%), Gaps = 13/86 (15%)
Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGT-VKLADFGSASIKCP---------ANSFVG 353
            L GL YLHS   +H DVKA N+LL+  G+   L DFG A    P          +   G
Sbjct: 194 ALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 354 TPYWMAPEVILAMDEGQYDGKVDVWS 379
           T   MAPEV+L       D KVDVWS
Sbjct: 254 TETHMAPEVVLGRS---CDAKVDVWS 276

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 53/118 (44%), Gaps = 13/118 (11%)
Query: 31  LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 90
           + ME   G +   +   +  L E+         L GL YLHS   +H DVKA N+LL+  
Sbjct: 143 IFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSD 202
Query: 91  GT-VKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 138
           G+   L DFG A    P          +   GT   MAPEV+L       D KVDVWS
Sbjct: 203 GSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS---CDAKVDVWS 257

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 43/86 (50%), Gaps = 13/86 (15%)
Query: 304 VLRGLNYLHSLGRIHRDVKAGNILLTETGT-VKLADFGSASIKCP---------ANSFVG 353
            L GL YLHS   +H DVKA N+LL+  G+   L DFG A    P          +   G
Sbjct: 175 ALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 354 TPYWMAPEVILAMDEGQYDGKVDVWS 379
           T   MAPEV+L       D KVDVWS
Sbjct: 235 TETHMAPEVVLGRS---CDAKVDVWS 257

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 108/250 (43%), Gaps = 36/250 (14%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           LRE+G GSFG VY      +R+I+  +  + +  +   + A + + I FL +    + ++
Sbjct: 19  LRELGQGSFGMVYEGN---ARDIIKGEAETRVAVKTVNESASLRERIEFLNE---ASVMK 72
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFALFNF 285
              C+   H   L+     G  + ++       E    G + + L+ L+   E+      
Sbjct: 73  GFTCH---HVVRLLGVVSKGQPTLVV------MELMAHGDLKSYLRSLRPEAEN------ 117
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----- 340
              + P   +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+ DFG     
Sbjct: 118 NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 177
Query: 341 -SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE---LAERKPPYFN 396
                       +    WMAPE   ++ +G +    D+WS G+   E   LAE+  PY  
Sbjct: 178 XETDXXRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQG 232
Query: 397 MNAMSALYHI 406
           ++    L  +
Sbjct: 233 LSNEQVLKFV 242

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 36/238 (15%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           LRE+G GSFG VY      +R+I+  +  + +  +   + A + + I FL +    + ++
Sbjct: 22  LRELGQGSFGMVYEGN---ARDIIKGEAETRVAVKTVNESASLRERIEFLNE---ASVMK 75
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFALFNF 285
              C+   H   L+     G  + ++       E    G + + L+ L+   E+      
Sbjct: 76  GFTCH---HVVRLLGVVSKGQPTLVV------MELMAHGDLKSYLRSLRPEAEN------ 120
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----- 340
              + P   +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+ DFG     
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 341 -SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE---LAERKPPY 394
                       +    WMAPE   ++ +G +    D+WS G+   E   LAE+  PY
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PY 233

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 108/250 (43%), Gaps = 36/250 (14%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           LRE+G GSFG VY      +R+I+  +  + +  +   + A + + I FL +    + ++
Sbjct: 22  LRELGQGSFGMVYEGN---ARDIIKGEAETRVAVKTVNESASLRERIEFLNE---ASVMK 75
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFALFNF 285
              C+   H   L+     G  + ++       E    G + + L+ L+   E+      
Sbjct: 76  GFTCH---HVVRLLGVVSKGQPTLVV------MELMAHGDLKSYLRSLRPEAEN------ 120
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----- 340
              + P   +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+ DFG     
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 341 -SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE---LAERKPPYFN 396
                       +    WMAPE   ++ +G +    D+WS G+   E   LAE+  PY  
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQG 235
Query: 397 MNAMSALYHI 406
           ++    L  +
Sbjct: 236 LSNEQVLKFV 245

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 157 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 100 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 159
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 160 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 54/124 (43%), Gaps = 29/124 (23%)
Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
           +G  ++Q+ C  E  AL+                     L GL YLH+   +H DVKA N
Sbjct: 153 LGQLIKQMGCLPEDRALYYL----------------GQALEGLEYLHTRRILHGDVKADN 196
Query: 326 ILLTETGT-VKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKV 375
           +LL+  G+   L DFG A    P          +   GT   MAPEV++       D KV
Sbjct: 197 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP---CDAKV 253
Query: 376 DVWS 379
           D+WS
Sbjct: 254 DIWS 257

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 31/228 (13%)
Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           LRE+G GSFG VY      +R+I+  +  + +  +   + A + + I FL +    + ++
Sbjct: 21  LRELGQGSFGMVYEGN---ARDIIKGEAETRVAVKTVNESASLRERIEFLNE---ASVMK 74
Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG-MGNRLQQLKCFTEHFALFNF 285
              C+   H   L+     G  + ++       E    G + + L+ L+   E+      
Sbjct: 75  GFTCH---HVVRLLGVVSKGQPTLVV------MELMAHGDLKSYLRSLRPEAEN------ 119
Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
              + P   +E+  + + +  G+ YL++   +HRD+ A N ++    TVK+ DFG     
Sbjct: 120 NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 179
Query: 346 CPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
              + +      +    WMAPE   ++ +G +    D+WS G+   E+
Sbjct: 180 YETDYYRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 157 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 157 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 161
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 162 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 54/124 (43%), Gaps = 29/124 (23%)
Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
           +G  ++Q+ C  E  AL+                     L GL YLH+   +H DVKA N
Sbjct: 137 LGQLIKQMGCLPEDRALYYL----------------GQALEGLEYLHTRRILHGDVKADN 180
Query: 326 ILLTETGT-VKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKV 375
           +LL+  G+   L DFG A    P          +   GT   MAPEV++       D KV
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP---CDAKV 237
Query: 376 DVWS 379
           D+WS
Sbjct: 238 DIWS 241

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 63/253 (24%)
Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI-LKEIRFLRQLK-HPNTIEY 227
           +G+GS G V +      R  VA+K+M          + DI L EI+ L +   HPN I Y
Sbjct: 23  LGYGSSGTVVFQGSFQGRP-VAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 74
Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV 287
                 D   ++ +E C  +  D++E   +  E                       N ++
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKNVSDE-----------------------NLKL 111
Query: 288 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN---------------------I 326
                KE    ++   +  G+ +LHSL  IHRD+K  N                     I
Sbjct: 112 Q----KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 327 LLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGK----VDVWSLG- 381
           L+++ G  K  D G    +   N+  GT  W APE++   +  Q   +    +D++S+G 
Sbjct: 168 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 382 ITCIELAERKPPY 394
           +    L++ K P+
Sbjct: 228 VFYYILSKGKHPF 240

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 101 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 160
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 161 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 161
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 162 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 203
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 204 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 161
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 162 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 203
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 204 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 190 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 189 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 190 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 189 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 190 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 190 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 111/280 (39%), Gaps = 59/280 (21%)
Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYA--RCLVSREIVAIKKMSYLGK 200
           P  LKD    +LF K D   +  D+ E+G G+FG+V     R    +  VAIK +    K
Sbjct: 322 PEELKD---KKLFLKRD-NLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVL----K 372
Query: 201 QCAEK--WADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
           Q  EK    ++++E + + QL +P  +   G   +     LVME   G            
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGP---------- 421
Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRI 317
                                  L  F V KR  +    +A +   V  G+ YL     +
Sbjct: 422 -----------------------LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 318 HRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTP-------YWMAPEVILAMDEGQ 370
           HR++ A N+LL      K++DFG +      +S+            W APE I   +  +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI---NFRK 515
Query: 371 YDGKVDVWSLGITCIE-LAERKPPYFNMNAMSALYHIAQN 409
           +  + DVWS G+T  E L+  + PY  M     +  I Q 
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 175
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 176 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 189 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 189 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 175
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 176 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFG 340
           LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL DFG
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 176
Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPY 394
           S ++        F GT  +  PE I      +Y G+   VWSLGI   ++     P+
Sbjct: 177 SGALLKDTVYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPF 230

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	804
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-153
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-76
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-135
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-71
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-128
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-70
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-124
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-67
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-123
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-64
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-122
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-65
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-119
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-63
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-113
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-61
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-108
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-61
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-85
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-49
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-84
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-52
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-84
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-51
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-20
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-83
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-82
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-52
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-82
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-50
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-20
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-78
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-51
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-15
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-74
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-48
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-17
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-74
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-47
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-72
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-49
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-19
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-70
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-45
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-14
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-69
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-44
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-15
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-65
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-43
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-16
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-64
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-44
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-17
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-58
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-13
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-55
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-15
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-55
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-13
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-54
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-16
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-53
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-12
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-53
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-12
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-52
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-38
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-14
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-10
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-48
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-12
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-34
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-12
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-47
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-10
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-46
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-11
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-45
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-11
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-45
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-10
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-45
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-11
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-45
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-44
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-44
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-06
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-44
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-11
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-44
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-43
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-14
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-43
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-08
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-43
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-12
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-43
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-11
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-30
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-42
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-08
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-42
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-42
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-09
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-41
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-08
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-41
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-11
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-12
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-40
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-11
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-11
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-40
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-07
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-40
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-40
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-08
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-39
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-10
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-31
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-10
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-39
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-09
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-38
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-38
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-07
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-38
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-31
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-11
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-38
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-38
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-06
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-08
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-38
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-37
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-37
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-37
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-07
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-11
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-37
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-37
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-37
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-37
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-36
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-23
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-36
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-28
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-36
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-07
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-36
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-07
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-36
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-07
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-35
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-07
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-35
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-35
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-07
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-35
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-05
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-35
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-06
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-35
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-09
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-35
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-07
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-06
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-35
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-07
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-34
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-10
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-34
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-10
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-34
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-07
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-34
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-34
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-05
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-34
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-34
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-34
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-07
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-33
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-08
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-33
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-06
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-33
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-33
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-28
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-33
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-06
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-33
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-26
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-08
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-33
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-08
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-33
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-33
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-22
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-07
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-32
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-32
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-07
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-32
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-32
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-28
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-08
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-32
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-32
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-06
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-32
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-22
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-07
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-31
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-07
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-31
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-31
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-04
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-31
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-04
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-31
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-27
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-31
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-31
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-31
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-22
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-08
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-30
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-30
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-30
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-06
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-06
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-30
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-30
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-30
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-10
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-29
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-06
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-29
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-29
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-05
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-07
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-08
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-29
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-07
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-12
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-07
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-05
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-08
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-06
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-08
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-08
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-28
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-06
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-06
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-28
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-04
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-05
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-07
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-27
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-05
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-04
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-05
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-06
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-06
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-27
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-05
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-05
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-05
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-09
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-05
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-05
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-08
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-05
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-08
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-26
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-07
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-06
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-26
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-26
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-25
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-05
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-04
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-25
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-04
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-05
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-04
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-05
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-04
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-25
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-05
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-05
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-05
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-06
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-24
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-05
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-20
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-20
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-17
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-15
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-05

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  449 bits (1157), Expect = e-153
 Identities = 235/387 (60%), Positives = 268/387 (69%), Gaps = 74/387 (19%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
            GSLKDP++AELF K+DPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ 
Sbjct: 35  AGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 94

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFH 262
            EKW DI+KE+RFL++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSASD++EVH       
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH------- 147

Query: 263 VEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 322
                                     K+PL+E EIAA+  G L+GL YLHS   IHRDVK
Sbjct: 148 --------------------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181

Query: 323 AGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           AGNILL+E G VKL DFGSASI  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI
Sbjct: 182 AGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
           TCIEL                                         AERKPP FNMNAMS
Sbjct: 242 TCIEL-----------------------------------------AERKPPLFNMNAMS 260

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
           ALYHIAQN++P LQS  WS+ F +FV SCL K P DRP+S  LL H  V R R P+V++D
Sbjct: 261 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320

Query: 503 LIRRTKAAVRDLDNLNYRKMKKILMAD 529
           LI+RTK AVR+LDNL YRKMKKIL  +
Sbjct: 321 LIQRTKDAVRELDNLQYRKMKKILFQE 347

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  250 bits (641), Expect = 2e-76
 Identities = 110/137 (80%), Positives = 122/137 (89%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
             L++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAA+  G L+
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 165

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAM 125
           GL YLHS   IHRDVKAGNILL+E G VKL DFGSASI  PANSFVGTPYWMAPEVILAM
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 225

Query: 126 DEGQYDGKVDVWSLGIT 142
           DEGQYDGKVDVWSLGIT
Sbjct: 226 DEGQYDGKVDVWSLGIT 242

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (307), Expect = 2e-30
 Identities = 48/65 (73%), Positives = 55/65 (84%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASD++EVHK+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNILL+E 
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190

Query: 676 GTVKL 680
           G VKL
Sbjct: 191 GLVKL 195

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  401 bits (1032), Expect = e-135
 Identities = 115/374 (30%), Positives = 167/374 (44%), Gaps = 83/374 (22%)

Query: 147 KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKW 206
           K  E   +    DP +++E + E+G G+FG VY A+   +  + A K +     +  E+ 
Sbjct: 4   KSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEEL 60

Query: 207 ADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEG 265
            D + EI  L    HP  ++  G Y  D   W+++E+C  G+   I+             
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---------- 110

Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
                                   R L E +I  +C  +L  LN+LHS   IHRD+KAGN
Sbjct: 111 -----------------------DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147

Query: 326 ILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWS 379
           +L+T  G ++LADFG +          +SF+GTPYWMAPEV++   M +  YD K D+WS
Sbjct: 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 207

Query: 380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMN 439
           LGIT IE+A+ +PP+  +N M  L  IA++D P L                         
Sbjct: 208 LGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL------------------------ 243

Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
                             S WS  F  F+   L KNP  RPS+ +LL H  V+   S   
Sbjct: 244 ----------------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

Query: 500 LVDLIRRTKAAVRD 513
           L +L+   KA V +
Sbjct: 288 LRELVAEAKAEVME 301

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  236 bits (603), Expect = 1e-71
 Identities = 61/144 (42%), Positives = 86/144 (59%), Gaps = 7/144 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            +L    HP  ++  G Y  D   W+++E+C  G+   I+    R L E +I  +C  +L
Sbjct: 68  EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPE 120
             LN+LHS   IHRD+KAGN+L+T  G ++LADFG +          +SF+GTPYWMAPE
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 121 VIL--AMDEGQYDGKVDVWSLGIT 142
           V++   M +  YD K D+WSLGIT
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGIT 211

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (293), Expect = 6e-29
 Identities = 27/66 (40%), Positives = 42/66 (63%), Gaps = 1/66 (1%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C  G+   I+    R L E +I  +C  +L  LN+LHS   IHRD+KAGN+L+T 
Sbjct: 93  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152

Query: 675 TGTVKL 680
            G ++L
Sbjct: 153 EGDIRL 158

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  383 bits (986), Expect = e-128
 Identities = 123/377 (32%), Positives = 174/377 (46%), Gaps = 86/377 (22%)

Query: 150 EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI 209
           ++ E    + PE++F+ L ++G GS+G+VY A    + +IVAIK++            +I
Sbjct: 17  KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-----ESDLQEI 71

Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGN 268
           +KEI  ++Q   P+ ++Y G Y ++   W+VMEYC  GS SDII +              
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR------------- 118

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
                                + L E+EIA I    L+GL YLH + +IHRD+KAGNILL
Sbjct: 119 --------------------NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158

Query: 329 TETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
              G  KLADFG A          N+ +GTP+WMAPEVI    E  Y+   D+WSLGIT 
Sbjct: 159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYNCVADIWSLGITA 215

Query: 385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
           IE+AE KPPY +++ M A++ I  N  P  +  +                          
Sbjct: 216 IEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE-------------------------- 249

Query: 445 YHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI 504
                          WSD F  FV  CL K+P  R ++ +LL H  V   +  S+L DLI
Sbjct: 250 --------------LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295

Query: 505 RRTKAAVRDLDNLNYRK 521
                          R+
Sbjct: 296 NEAMDVKLKRQESQQRE 312

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  233 bits (595), Expect = 3e-70
 Identities = 69/142 (48%), Positives = 90/142 (63%), Gaps = 8/142 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S+++Q   P+ ++Y G Y ++   W+VMEYC  GS SDII +  + L E+EIA I    L
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPE 120
           +GL YLH + +IHRD+KAGNILL   G  KLADFG A          N+ +GTP+WMAPE
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           VI    E  Y+   D+WSLGIT
Sbjct: 196 VI---QEIGYNCVADIWSLGIT 214

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (291), Expect = 1e-28
 Identities = 37/66 (56%), Positives = 45/66 (68%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEYC  GS SDII +  + L E+EIA I    L+GL YLH + +IHRD+KAGNILL  
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160

Query: 675 TGTVKL 680
            G  KL
Sbjct: 161 EGHAKL 166

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  373 bits (961), Expect = e-124
 Identities = 124/358 (34%), Positives = 174/358 (48%), Gaps = 88/358 (24%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K DPE++F  L +IG GSFG V+      ++++VAIK +    ++  ++  DI +EI  L
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--EEAEDEIEDIQQEITVL 74

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
            Q   P   +Y G YL+D   W++MEY   GSA D++E                      
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---------------------- 112

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                          PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E G VK
Sbjct: 113 -------------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK 159

Query: 336 LADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           LADFG A      +   N+FVGTP+WMAPEVI    +  YD K D+WSLGIT IELA  +
Sbjct: 160 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIELARGE 216

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           PP+  ++ M  L+ I +N+ P L+                                    
Sbjct: 217 PPHSELHPMKVLFLIPKNNPPTLE------------------------------------ 240

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR-PRSPSVLVDLIRRTK 508
                  ++S     FV +CL K P+ RP++  LL H  + R  +  S L +LI R K
Sbjct: 241 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYK 292

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  223 bits (571), Expect = 5e-67
 Identities = 72/142 (50%), Positives = 93/142 (65%), Gaps = 10/142 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
           ++L Q   P   +Y G YL+D   W++MEY   GSA D++E    PL E +IA I   +L
Sbjct: 72  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREIL 129

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPE 120
           +GL+YLHS  +IHRD+KA N+LL+E G VKLADFG A      +   N+FVGTP+WMAPE
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           VI    +  YD K D+WSLGIT
Sbjct: 190 VI---KQSAYDSKADIWSLGIT 208

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (270), Expect = 7e-26
 Identities = 35/66 (53%), Positives = 47/66 (71%), Gaps = 3/66 (4%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++MEY   GSA D++E    PL E +IA I   +L+GL+YLHS  +IHRD+KA N+LL+E
Sbjct: 97  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 154

Query: 675 TGTVKL 680
            G VKL
Sbjct: 155 HGEVKL 160

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  371 bits (954), Expect = e-123
 Identities = 126/396 (31%), Positives = 179/396 (45%), Gaps = 98/396 (24%)

Query: 143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
             SL + +++ L    DP  IFE +  +G+G++G VY  R + + ++ AIK M   G   
Sbjct: 8   ARSLDEIDLSAL---RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--- 61

Query: 203 AEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTA------WLVMEYC-LGSASDIIEV 254
            ++  +I +EI  L++   H N   Y G +++ +        WLVME+C  GS +D+I+ 
Sbjct: 62  -DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
                                                LKEE IA IC  +LRGL++LH  
Sbjct: 121 T--------------------------------KGNTLKEEWIAYICREILRGLSHLHQH 148

Query: 315 GRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEVILAMD--E 368
             IHRD+K  N+LLTE   VKL DFG +          N+F+GTPYWMAPEVI   +  +
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208

Query: 369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISST 428
             YD K D+WSLGIT IE+                                         
Sbjct: 209 ATYDFKSDLWSLGITAIEM----------------------------------------- 227

Query: 429 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           AE  PP  +M+ M AL+ I +N  P L+S  WS  F  F+ SCL KN + RP++ +L+ H
Sbjct: 228 AEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287

Query: 489 DLVTRPRSPS----VLVDLIRRTKAAVRDLDNLNYR 520
             +    +       L D I RTK    + D   Y 
Sbjct: 288 PFIRDQPNERQVRIQLKDHIDRTKKKRGEKDETEYE 323

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  218 bits (557), Expect = 1e-64
 Identities = 69/152 (45%), Positives = 92/152 (60%), Gaps = 15/152 (9%)

Query: 6   SLLRQL-KHPNTIEYRGCYLRDHTA------WLVMEYC-LGSASDIIEVHK-RPLKEEEI 56
           ++L++   H N   Y G +++ +        WLVME+C  GS +D+I+  K   LKEE I
Sbjct: 72  NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVG 112
           A IC  +LRGL++LH    IHRD+K  N+LLTE   VKL DFG +          N+F+G
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 191

Query: 113 TPYWMAPEVILAMD--EGQYDGKVDVWSLGIT 142
           TPYWMAPEVI   +  +  YD K D+WSLGIT
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 2e-27
 Identities = 37/67 (55%), Positives = 46/67 (68%), Gaps = 2/67 (2%)

Query: 616 LVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LVME+C  GS +D+I+  K   LKEE IA IC  +LRGL++LH    IHRD+K  N+LLT
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163

Query: 674 ETGTVKL 680
           E   VKL
Sbjct: 164 ENAEVKL 170

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  369 bits (950), Expect = e-122
 Identities = 115/370 (31%), Positives = 163/370 (44%), Gaps = 86/370 (23%)

Query: 149 PEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD 208
            ++  +    DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKEL 63

Query: 209 ILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMG 267
           I+ EI  +R+ K+PN + Y   YL     W+VMEY   GS +D+                
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---------------- 107

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
                              V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NIL
Sbjct: 108 -------------------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148

Query: 328 LTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           L   G+VKL DFG        +   ++ VGTPYWMAPEV+       Y  KVD+WSLGI 
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV---TRKAYGPKVDIWSLGIM 205

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
            IE+ E +PPY N N + ALY IA N TP LQ+ +                         
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE------------------------- 240

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                            S  F  F++ CL  +   R S+  LL H  +   +  S L  L
Sbjct: 241 ---------------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285

Query: 504 IRRTKAAVRD 513
           I   K A ++
Sbjct: 286 IAAAKEATKN 295

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  217 bits (556), Expect = 5e-65
 Identities = 62/142 (43%), Positives = 84/142 (59%), Gaps = 10/142 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++R+ K+PN + Y   YL     W+VMEY   GS +D+  V +  + E +IAA+C   L
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECL 126

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMAPE 120
           + L +LHS   IHRD+K+ NILL   G+VKL DFG        +   ++ VGTPYWMAPE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           V+       Y  KVD+WSLGI 
Sbjct: 187 VV---TRKAYGPKVDIWSLGIM 205

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 3e-25
 Identities = 31/66 (46%), Positives = 43/66 (65%), Gaps = 3/66 (4%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY   GS +D+  V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL  
Sbjct: 94  VVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151

Query: 675 TGTVKL 680
            G+VKL
Sbjct: 152 DGSVKL 157

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  363 bits (933), Expect = e-119
 Identities = 96/413 (23%), Positives = 158/413 (38%), Gaps = 54/413 (13%)

Query: 145 SLKDPEIAELFDKEDPEKIFEDLREIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQC 202
            +++     +         +E L  IG G      V  AR   + E V +++++ L    
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACS 66

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREF 261
            E    +  E+   +   HPN + YR  ++ D+  W+V  +   GSA D+I  H      
Sbjct: 67  NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH------ 120

Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
                                         + E  IA I  GVL+ L+Y+H +G +HR V
Sbjct: 121 --------------------------FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSV 154

Query: 322 KAGNILLTETGTVKLADFGSA-----------SIKCPANSFVGTPYWMAPEVILAMDEGQ 370
           KA +IL++  G V L+   S             +       V    W++PEV+    +G 
Sbjct: 155 KASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG- 213

Query: 371 YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE 430
           YD K D++S+GIT  ELA    P+ +M A   L        PCL  +     + ++ +  
Sbjct: 214 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPS 273

Query: 431 RKPPYFNMNAMSALYHIAQNDTPCLQSS---DWSDTFAHFVSSCLAKNPADRPSSGRLLT 487
           R      ++          ++           +S  F HFV  CL +NP  RPS+  LL 
Sbjct: 274 RSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333

Query: 488 HDLV--TRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTID 538
           H      + R+   L +L+R     + + +    +    I        E  +D
Sbjct: 334 HSFFKQIKRRASEALPELLRPVT-PITNFEGSQSQDHSGIFGLVTNLEELEVD 385

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  215 bits (550), Expect = 4e-63
 Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 14/150 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGV 63
            + +   HPN + YR  ++ D+  W+V  +   GSA D+I  H    + E  IA I  GV
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-----------SIKCPANSFVG 112
           L+ L+Y+H +G +HR VKA +IL++  G V L+   S             +       V 
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              W++PEV+    +G YD K D++S+GIT
Sbjct: 198 VLPWLSPEVLQQNLQG-YDAKSDIYSVGIT 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (278), Expect = 2e-26
 Identities = 28/67 (41%), Positives = 40/67 (59%), Gaps = 2/67 (2%)

Query: 616 LVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V  +   GSA D+I  H    + E  IA I  GVL+ L+Y+H +G +HR VKA +IL++
Sbjct: 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 162

Query: 674 ETGTVKL 680
             G V L
Sbjct: 163 VDGKVYL 169

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  345 bits (888), Expect = e-113
 Identities = 109/375 (29%), Positives = 160/375 (42%), Gaps = 90/375 (24%)

Query: 143 PGSLKDPEIAE----LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL 198
            G +   +       + D+ DP  + +   +IG GS G V  AR   S   VA+K M  L
Sbjct: 22  SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD-L 80

Query: 199 GKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWI 257
            KQ  ++   +  E+  +R  +H N +E    YL     W++ME+   G+ +DI      
Sbjct: 81  RKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI------ 132

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
                                        V +  L EE+IA +C  VL+ L YLH+ G I
Sbjct: 133 -----------------------------VSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 318 HRDVKAGNILLTETGTVKLADFG-SASI---KCPANSFVGTPYWMAPEVILAMDEGQYDG 373
           HRD+K+ +ILLT  G VKL+DFG  A I        S VGTPYWMAPEVI       Y  
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RSLYAT 220

Query: 374 KVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKP 433
           +VD+WSLGI  IE+ + +PPYF+ + + A+  +  +  P L+                  
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK------------------ 262

Query: 434 PYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
                                  S   S     F+   L ++P +R ++  LL H  + +
Sbjct: 263 ----------------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

Query: 494 PRSPSVLVDLIRRTK 508
              P  LV LI+  +
Sbjct: 301 TGLPECLVPLIQLYR 315

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  209 bits (533), Expect = 2e-61
 Identities = 65/142 (45%), Positives = 85/142 (59%), Gaps = 10/142 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++R  +H N +E    YL     W++ME+   G+ +DI  V +  L EE+IA +C  VL
Sbjct: 94  VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI--VSQVRLNEEQIATVCEAVL 151

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASI---KCPANSFVGTPYWMAPE 120
           + L YLH+ G IHRD+K+ +ILLT  G VKL+DFG  A I        S VGTPYWMAPE
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           VI       Y  +VD+WSLGI 
Sbjct: 212 VIS---RSLYATEVDIWSLGIM 230

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  102 bits (257), Expect = 5e-24
 Identities = 32/66 (48%), Positives = 45/66 (68%), Gaps = 3/66 (4%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ME+   G+ +DI  V +  L EE+IA +C  VL+ L YLH+ G IHRD+K+ +ILLT 
Sbjct: 119 VLMEFLQGGALTDI--VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL 176

Query: 675 TGTVKL 680
            G VKL
Sbjct: 177 DGRVKL 182

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  331 bits (851), Expect = e-108
 Identities = 111/354 (31%), Positives = 149/354 (42%), Gaps = 73/354 (20%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
                +E    IG G+   V  A C   +E VAIK+++   ++C     ++LKEI+ + Q
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQ 69

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             HPN + Y   ++     WLVM+    GS  DII+                        
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK------------------------ 105

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
               +   E     L E  IA I   VL GL YLH  G+IHRDVKAGNILL E G+V++A
Sbjct: 106 --HIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163

Query: 338 DFG-SASI--------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           DFG SA +             +FVGTP WMAPEV+       YD K D+WS GIT IELA
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM--EQVRGYDFKADIWSFGITAIELA 221

Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
               PY     M  L    QND P L++                                
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKE-------------------------- 255

Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVD 502
                      +  +F   +S CL K+P  RP++  LL H    + ++   L +
Sbjct: 256 -------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  207 bits (528), Expect = 7e-61
 Identities = 68/154 (44%), Positives = 82/154 (53%), Gaps = 19/154 (12%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR-------PLKEEEIA 57
             + Q  HPN + Y   ++     WLVM+    GS  DII+            L E  IA
Sbjct: 65  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASI--------KCPAN 108
            I   VL GL YLH  G+IHRDVKAGNILL E G+V++ADFG SA +             
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 109 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           +FVGTP WMAPEV+       YD K D+WS GIT
Sbjct: 185 TFVGTPCWMAPEVM--EQVRGYDFKADIWSFGIT 216

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  103 bits (258), Expect = 2e-24
 Identities = 36/73 (49%), Positives = 42/73 (57%), Gaps = 8/73 (10%)

Query: 616 LVMEYC-LGSASDIIEVHKR-------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 667
           LVM+    GS  DII+            L E  IA I   VL GL YLH  G+IHRDVKA
Sbjct: 90  LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149

Query: 668 GNILLTETGTVKL 680
           GNILL E G+V++
Sbjct: 150 GNILLGEDGSVQI 162

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  273 bits (699), Expect = 8e-85
 Identities = 84/350 (24%), Positives = 137/350 (39%), Gaps = 50/350 (14%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E  +  FE + E+G G+ G V+      S  ++A K +    K        I++E++ L 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLH 86

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           +   P  + + G +  D    + ME+   GS   +++                       
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--------------------- 125

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVK 335
                          + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +K
Sbjct: 126 -------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 172

Query: 336 LADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           L DFG       S+   ANSFVGT  +M+PE +       Y  + D+WS+G++ +E+A  
Sbjct: 173 LCDFGVSGQLIDSM---ANSFVGTRSYMSPERL---QGTHYSVQSDIWSMGLSLVEMAVG 226

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA-MSALYHIAQ 449
           + P    +A                 +            +         A    L +I  
Sbjct: 227 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN 286

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
              P L S  +S  F  FV+ CL KNPA+R    +L+ H  + R  +  V
Sbjct: 287 EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  176 bits (447), Expect = 5e-49
 Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 14/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           L +   P  + + G +  D    + ME+   GS   +++     + E+ +  +   V++G
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKG 143

Query: 67  LNYLHSLGRI-HRDVKAGNILLTETGTVKLADFG-----SASIKCPANSFVGTPYWMAPE 120
           L YL    +I HRDVK  NIL+   G +KL DFG       S+   ANSFVGT  +M+PE
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPE 200

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
            +       Y  + D+WS+G++
Sbjct: 201 RL---QGTHYSVQSDIWSMGLS 219

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 85.7 bits (212), Expect = 4e-18
 Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 3/67 (4%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLT 673
           + ME+   GS   +++     + E+ +  +   V++GL YL    +I HRDVK  NIL+ 
Sbjct: 108 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 166

Query: 674 ETGTVKL 680
             G +KL
Sbjct: 167 SRGEIKL 173

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  269 bits (691), Expect = 1e-84
 Identities = 81/350 (23%), Positives = 130/350 (37%), Gaps = 82/350 (23%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF-L 216
           E      E + E+G G++G V   R + S +I+A+K++        +K   +L ++   +
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK--RLLMDLDISM 60

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           R +  P T+ + G   R+   W+ ME    S     +                       
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYK----------------------- 97

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-IHRDVKAGNILLTETGTVK 335
                        + + E+ +  I   +++ L +LHS    IHRDVK  N+L+   G VK
Sbjct: 98  -------QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 150

Query: 336 LADFG-----SASIKCPANSFVGTPYWMAPEVIL-AMDEGQYDGKVDVWSLGITCIELAE 389
           + DFG        +    +   G   +MAPE I   +++  Y  K D+WSLGIT IELA 
Sbjct: 151 MCDFGISGYLVDDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
            + PY +                                               L  + +
Sbjct: 209 LRFPYDSWG----------------------------------------TPFQQLKQVVE 228

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
             +P L +  +S  F  F S CL KN  +RP+   L+ H   T   S   
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  184 bits (469), Expect = 1e-52
 Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 12/146 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDI---IEVHKRPLKEEEIAAICSGV 63
            +R +  P T+ + G   R+   W+ ME    S       +    + + E+ +  I   +
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 64  LRGLNYLHSLGR-IHRDVKAGNILLTETGTVKLADFG-----SASIKCPANSFVGTPYWM 117
           ++ L +LHS    IHRDVK  N+L+   G VK+ DFG        +    +   G   +M
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYM 176

Query: 118 APEVIL-AMDEGQYDGKVDVWSLGIT 142
           APE I   +++  Y  K D+WSLGIT
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGIT 202

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 23/80 (28%), Positives = 37/80 (46%), Gaps = 7/80 (8%)

Query: 608 YSSLFSPQ---LVMEYCLGSASDI---IEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR- 660
           Y +LF      + ME    S       +    + + E+ +  I   +++ L +LHS    
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131

Query: 661 IHRDVKAGNILLTETGTVKL 680
           IHRDVK  N+L+   G VK+
Sbjct: 132 IHRDVKPSNVLINALGQVKM 151

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  270 bits (692), Expect = 4e-84
 Identities = 93/364 (25%), Positives = 142/364 (39%), Gaps = 84/364 (23%)

Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA 207
            PE    F  ED     +DL EIG G++G+V       S +I+A+K++     +  +K  
Sbjct: 12  SPEQHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK-- 65

Query: 208 DILKEIRF-LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM 266
            +L ++   +R    P  +++ G   R+   W+ ME    S     +             
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKY------------ 113

Query: 267 GNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGN 325
                             + V    + EE +  I    ++ LN+L    +I HRD+K  N
Sbjct: 114 -----------------VYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156

Query: 326 ILLTETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWS 379
           ILL  +G +KL DFG       SI        G   +MAPE I      Q YD + DVWS
Sbjct: 157 ILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWS 214

Query: 380 LGITCIELAERKPPYFNMNAM-SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNM 438
           LGIT  ELA  + PY   N++   L  + + D P L +S+                    
Sbjct: 215 LGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE------------------- 255

Query: 439 NAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
                               ++S +F +FV+ CL K+ + RP    LL H  +      +
Sbjct: 256 -------------------REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

Query: 499 VLVD 502
           V V 
Sbjct: 297 VEVA 300

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  181 bits (462), Expect = 2e-51
 Identities = 49/147 (33%), Positives = 67/147 (45%), Gaps = 13/147 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII----EVHKRPLKEEEIAAICSG 62
           ++R    P  +++ G   R+   W+ ME    S          V    + EE +  I   
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 63  VLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFG-----SASIKCPANSFVGTPYW 116
            ++ LN+L    +I HRD+K  NILL  +G +KL DFG       SI        G   +
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPY 191

Query: 117 MAPEVILAMDEGQ-YDGKVDVWSLGIT 142
           MAPE I      Q YD + DVWSLGIT
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGIT 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 25/81 (30%), Positives = 36/81 (44%), Gaps = 8/81 (9%)

Query: 608 YSSLFSPQ---LVMEYCLGSASDII----EVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 660
           Y +LF      + ME    S          V    + EE +  I    ++ LN+L    +
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146

Query: 661 I-HRDVKAGNILLTETGTVKL 680
           I HRD+K  NILL  +G +KL
Sbjct: 147 IIHRDIKPSNILLDRSGNIKL 167

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  268 bits (686), Expect = 3e-83
 Identities = 65/365 (17%), Positives = 98/365 (26%), Gaps = 96/365 (26%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR 214
           ++  +          +G GSFG V+  +   +    A+KK+     +         +E+ 
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL---EVFRV-----EELV 102

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQL 273
               L  P  +   G         + ME    GS   +I+                    
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-------------------- 142

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                             L E+         L GL YLH+   +H DVKA N+LL+  G+
Sbjct: 143 --------------QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS 188

Query: 334 -VKLADFGSA---------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
              L DFG A               +   GT   MAPEV+        D KVD+WS    
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV---MGKPCDAKVDIWSSCCM 245

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
            + +     P+           IA    P  +                            
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPP------------------------- 280

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                            +   A  +   L K P  R S+  L             +    
Sbjct: 281 ---------------SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325

Query: 504 IRRTK 508
               K
Sbjct: 326 KGEYK 330

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  183 bits (466), Expect = 7e-52
 Identities = 43/148 (29%), Positives = 56/148 (37%), Gaps = 15/148 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
                L  P  +   G         + ME    GS   +I+     L E+         L
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQAL 160

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGT-VKLADFGSA---------SIKCPANSFVGTP 114
            GL YLH+   +H DVKA N+LL+  G+   L DFG A               +   GT 
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGIT 142
             MAPEV+        D KVD+WS    
Sbjct: 221 THMAPEVV---MGKPCDAKVDIWSSCCM 245

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 3/67 (4%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + ME    GS   +I+     L E+         L GL YLH+   +H DVKA N+LL+ 
Sbjct: 127 IFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185

Query: 675 TGT-VKL 680
            G+   L
Sbjct: 186 DGSRAAL 192

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  263 bits (675), Expect = 7e-82
 Identities = 85/361 (23%), Positives = 135/361 (37%), Gaps = 92/361 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL-RQLKHP 222
            E+L E+G G+ G V+  R   +  ++A+K+M        E+   IL ++  + +    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR--SGNKEENKRILMDLDVVLKSHDCP 84

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             ++  G ++ +   ++ ME     A  + +                             
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRM--------------------------- 117

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFG- 340
                 + P+ E  +  +   +++ L YL    G IHRDVK  NILL E G +KL DFG 
Sbjct: 118 ------QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171

Query: 341 ----SASIKCPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAERKPPY 394
                       +   G   +MAPE I   D  +  YD + DVWSLGI+ +ELA  + PY
Sbjct: 172 SGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

Query: 395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
            N                                               L  + Q + P 
Sbjct: 230 KNCK----------------------------------------TDFEVLTKVLQEEPPL 249

Query: 455 LQSSD-WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLV-----DLIRRTK 508
           L     +S  F  FV  CL K+   RP   +LL H  + R  +  V V     D++ +T+
Sbjct: 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTE 309

Query: 509 A 509
           +
Sbjct: 310 S 310

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  184 bits (469), Expect = 2e-52
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 10/144 (6%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L+    P  ++  G ++ +   ++ ME     A  + +  + P+ E  +  +   +++ 
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136

Query: 67  LNYLHS-LGRIHRDVKAGNILLTETGTVKLADFG-----SASIKCPANSFVGTPYWMAPE 120
           L YL    G IHRDVK  NILL E G +KL DFG             +   G   +MAPE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPE 194

Query: 121 VILAMDEGQ--YDGKVDVWSLGIT 142
            I   D  +  YD + DVWSLGI+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGIS 218

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTE 674
           + ME     A  + +  + P+ E  +  +   +++ L YL    G IHRDVK  NILL E
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160

Query: 675 TGTVKL 680
            G +KL
Sbjct: 161 RGQIKL 166

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  252 bits (646), Expect = 5e-78
 Identities = 77/338 (22%), Positives = 127/338 (37%), Gaps = 83/338 (24%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRG 229
           +G G++G VY  R L ++  +AIK++     + ++    + +EI   + LKH N ++Y G
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLKHKNIVQYLG 86

Query: 230 CYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH 288
            +  +    + ME    GS S ++   W                                
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKW-------------------------------G 115

Query: 289 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSA----S 343
                E+ I      +L GL YLH    +HRD+K  N+L+ T +G +K++DFG++     
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 344 IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM-NAMSA 402
           I     +F GT  +MAPE+I     G Y    D+WSLG T IE+A  KPP++ +    +A
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234

Query: 403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD 462
           ++ +                          P                   P       S 
Sbjct: 235 MFKVGMFKVH--------------------PEI-----------------P----ESMSA 253

Query: 463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
               F+  C   +P  R  +  LL  + +         
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  179 bits (456), Expect = 7e-51
 Identities = 52/145 (35%), Positives = 77/145 (53%), Gaps = 9/145 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEE--IAAICSG 62
           +L + LKH N ++Y G +  +    + ME    GS S ++     PLK+ E  I      
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSA----SIKCPANSFVGTPYWM 117
           +L GL YLH    +HRD+K  N+L+ T +G +K++DFG++     I     +F GT  +M
Sbjct: 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           APE+I     G Y    D+WSLG T
Sbjct: 191 APEIIDKGPRG-YGKAADIWSLGCT 214

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 25/68 (36%), Positives = 36/68 (52%), Gaps = 4/68 (5%)

Query: 617 VMEYCL-GSASDIIEVHKRPLKEEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNILL- 672
            ME    GS S ++     PLK+ E  I      +L GL YLH    +HRD+K  N+L+ 
Sbjct: 97  FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156

Query: 673 TETGTVKL 680
           T +G +K+
Sbjct: 157 TYSGVLKI 164

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  243 bits (621), Expect = 2e-74
 Identities = 66/358 (18%), Positives = 115/358 (32%), Gaps = 99/358 (27%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
                F +L +IG G FG+V+     +   I AIK+         ++  + L+E+     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 66

Query: 219 L-KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           L +H + + Y   +  D    +  EYC  GS +D I  +                     
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN--------------------- 105

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---- 332
                           KE E+  +   V RGL Y+HS+  +H D+K  NI ++ T     
Sbjct: 106 ---------YRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 156

Query: 333 ---------------TVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 377
                            K+ D G  +         G   ++A EV+   +   +  K D+
Sbjct: 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVL--QENYTHLPKADI 214

Query: 378 WSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFN 437
           ++L +T +  A  +P   N +     + I Q   P +                       
Sbjct: 215 FALALTVVCAAGAEPLPRNGDQW---HEIRQGRLPRI----------------------- 248

Query: 438 MNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR 495
                                  S  F   +   +  +P  RPS+  L+ H ++    
Sbjct: 249 -------------------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  170 bits (433), Expect = 7e-48
 Identities = 42/192 (21%), Positives = 71/192 (36%), Gaps = 33/192 (17%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR---PLKEEEIAAICSG 62
                +H + + Y   +  D    +  EYC  GS +D I  + R     KE E+  +   
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETG-------------------TVKLADFGSASI 103
           V RGL Y+HS+  +H D+K  NI ++ T                      K+ D G  + 
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 104 KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKI 163
                   G   ++A EV+   +   +  K D+++L +T        +      E   + 
Sbjct: 184 ISSPQVEEGDSRFLANEVL--QENYTHLPKADIFALALT--------VVCAAGAEPLPRN 233

Query: 164 FEDLREIGHGSF 175
            +   EI  G  
Sbjct: 234 GDQWHEIRQGRL 245

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 617 VMEYC-LGSASDIIEVHKR---PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
             EYC  GS +D I  + R     KE E+  +   V RGL Y+HS+  +H D+K  NI +
Sbjct: 89  QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148

Query: 673 TETGTVKLDTPDEQAGNDSSKS 694
           + T      + +    + +S  
Sbjct: 149 SRTSIPNAASEEGDEDDWASNK 170

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  242 bits (621), Expect = 4e-74
 Identities = 94/341 (27%), Positives = 138/341 (40%), Gaps = 75/341 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F   ++IG G F  VY A CL+    VA+KK+       A+  AD +KEI  L+QL HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I+Y   ++ D+   +V+E                     +  G+  + +K F +     
Sbjct: 94  VIKYYASFIEDNELNIVLELA-------------------DA-GDLSRMIKHFKK----- 128

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                KR + E  +      +   L ++HS   +HRD+K  N+ +T TG VKL D G   
Sbjct: 129 ----QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184

Query: 343 ---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
              S    A+S VGTPY+M+PE I   + G Y+ K D+WSLG    E+A  + P F  + 
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERI--HENG-YNFKSDIWSLGCLLYEMAALQSP-FYGDK 240

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                                                 MN  S    I Q D P L S  
Sbjct: 241 --------------------------------------MNLYSLCKKIEQCDYPPLPSDH 262

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
           +S+     V+ C+  +P  RP    +          + S L
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  169 bits (431), Expect = 3e-47
 Identities = 53/144 (36%), Positives = 78/144 (54%), Gaps = 11/144 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR---PLKEEEIAAICSG 62
           LL+QL HPN I+Y   ++ D+   +V+E    G  S +I+  K+    + E  +      
Sbjct: 85  LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPYWMA 118
           +   L ++HS   +HRD+K  N+ +T TG VKL D G      S    A+S VGTPY+M+
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PE I   + G Y+ K D+WSLG  
Sbjct: 205 PERI--HENG-YNFKSDIWSLGCL 225

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 21/68 (30%), Positives = 34/68 (50%), Gaps = 4/68 (5%)

Query: 617 VMEYC-LGSASDIIEVHKR---PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           V+E    G  S +I+  K+    + E  +      +   L ++HS   +HRD+K  N+ +
Sbjct: 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 169

Query: 673 TETGTVKL 680
           T TG VKL
Sbjct: 170 TATGVVKL 177

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  238 bits (610), Expect = 2e-72
 Identities = 73/359 (20%), Positives = 114/359 (31%), Gaps = 90/359 (25%)

Query: 144 GSLKDPEIAELFDKEDPEKIFED----LREIGHGSFGAVYYARCLVSREIVAIKKMSYLG 199
           G   +   +  +D   PE  F+     L  +GHGS+G V+  R      + A+K+     
Sbjct: 35  GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF 94

Query: 200 KQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
           +   ++ A  L E+    ++ +HP  +     +      +L  E C  S           
Sbjct: 95  RGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHC------ 147

Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                                      E     L E ++       L  L +LHS G +H
Sbjct: 148 ---------------------------EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180

Query: 319 RDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKV 375
            DVK  NI L   G  KL DFG               G P +MAPE++    +G Y    
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL----QGSYGTAA 236

Query: 376 DVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           DV+SLG+T +E+A              L                             PP 
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGWQQLRQG------------------------YLPPE 272

Query: 436 FNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
           F                    ++  S      +   L  +P  R ++  LL   ++ +P
Sbjct: 273 F--------------------TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  175 bits (446), Expect = 2e-49
 Identities = 46/173 (26%), Positives = 63/173 (36%), Gaps = 15/173 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           S  +  +HP  +     +      +L  E C  S     E     L E ++       L 
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGTPYWMAPEVI 122
            L +LHS G +H DVK  NI L   G  KL DFG               G P +MAPE++
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL 228

Query: 123 LAMDEGQYDGKVDVWSLGIT--------PGSLKDPEIAELFDKEDPEKIFEDL 167
               +G Y    DV+SLG+T                  +L     P +    L
Sbjct: 229 ----QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL 277

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 23/65 (35%), Positives = 27/65 (41%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L  E C  S     E     L E ++       L  L +LHS G +H DVK  NI L   
Sbjct: 134 LQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR 193

Query: 676 GTVKL 680
           G  KL
Sbjct: 194 GRCKL 198

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  231 bits (592), Expect = 3e-70
 Identities = 73/352 (20%), Positives = 121/352 (34%), Gaps = 90/352 (25%)

Query: 148 DPEIAELFDKEDPEKIFEDLRE-IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKW 206
             E+         +  F      IG GSF  VY      +   VA  ++    K    + 
Sbjct: 11  IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSER 69

Query: 207 ADILKEIRFLRQLKHPNTIEYRGCYL----RDHTAWLVMEYCL-GSASDIIEVHWIEREF 261
               +E   L+ L+HPN + +   +           LV E    G+    ++        
Sbjct: 70  QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF------ 123

Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHR 319
                                       + +K + + + C  +L+GL +LH+     IHR
Sbjct: 124 ----------------------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155

Query: 320 DVKAGNILLT-ETGTVKLADFGSASIK--CPANSFVGTPYWMAPEVILAMDEGQYDGKVD 376
           D+K  NI +T  TG+VK+ D G A++K    A + +GTP +MAPE+     E +YD  VD
Sbjct: 156 DLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY----EEKYDESVD 211

Query: 377 VWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYF 436
           V++ G+  +E+A  + PY      + +Y    +                           
Sbjct: 212 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------------------------ 247

Query: 437 NMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                           P              +  C+ +N  +R S   LL H
Sbjct: 248 ----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  163 bits (414), Expect = 3e-45
 Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 15/147 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYL----RDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAIC 60
            +L+ L+HPN + +   +           LV E    G+    ++  K  +K + + + C
Sbjct: 77  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWC 135

Query: 61  SGVLRGLNYLHSLGR--IHRDVKAGNILLT-ETGTVKLADFGSASIK--CPANSFVGTPY 115
             +L+GL +LH+     IHRD+K  NI +T  TG+VK+ D G A++K    A + +GTP 
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE 195

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           +MAPE+     E +YD  VDV++ G+ 
Sbjct: 196 FMAPEMY----EEKYDESVDVYAFGMC 218

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 24/69 (34%), Positives = 39/69 (56%), Gaps = 5/69 (7%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILL 672
           LV E    G+    ++  K  +K + + + C  +L+GL +LH+     IHRD+K  NI +
Sbjct: 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164

Query: 673 T-ETGTVKL 680
           T  TG+VK+
Sbjct: 165 TGPTGSVKI 173

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  230 bits (589), Expect = 5e-69
 Identities = 78/362 (21%), Positives = 135/362 (37%), Gaps = 88/362 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  L++IG GSFG     +         IK+++       E+  +  +E+  L  +KHPN
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMKHPN 84

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG--MGNRLQQLKCFTEHFA 281
            ++YR  +  + + ++VM+YC                   EG  +  R+   K       
Sbjct: 85  IVQYRESFEENGSLYIVMDYC-------------------EGGDLFKRINAQK------- 118

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                      +E++I      +   L ++H    +HRD+K+ NI LT+ GTV+L DFG 
Sbjct: 119 -------GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGI 171

Query: 342 ASI----KCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFN 396
           A +       A + +GTPY+++PE+     E + Y+ K D+W+LG    EL   K  +  
Sbjct: 172 ARVLNSTVELARACIGTPYYLSPEIC----ENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +  + +  I     P +                                          
Sbjct: 228 GSMKNLVLKIISGSFPPV------------------------------------------ 245

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDN 516
           S  +S      VS    +NP DRPS   +L    +   R    L   +   +  ++    
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI-AKRIEKFLSPQLIAEEFCLKTFSK 304

Query: 517 LN 518
             
Sbjct: 305 FG 306

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  161 bits (408), Expect = 8e-44
 Identities = 48/143 (33%), Positives = 80/143 (55%), Gaps = 11/143 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVL 64
           +L  +KHPN ++YR  +  + + ++VM+YC  G     I   K    +E++I      + 
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPE 120
             L ++H    +HRD+K+ NI LT+ GTV+L DFG A +       A + +GTPY+++PE
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

Query: 121 VILAMDEGQ-YDGKVDVWSLGIT 142
           +     E + Y+ K D+W+LG  
Sbjct: 196 IC----ENKPYNNKSDIWALGCV 214

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 23/67 (34%), Positives = 36/67 (53%), Gaps = 2/67 (2%)

Query: 616 LVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +VM+YC  G     I   K    +E++I      +   L ++H    +HRD+K+ NI LT
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 159

Query: 674 ETGTVKL 680
           + GTV+L
Sbjct: 160 KDGTVQL 166

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  217 bits (556), Expect = 3e-65
 Identities = 68/351 (19%), Positives = 117/351 (33%), Gaps = 111/351 (31%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+++  IG G FG V+ A+  +  +   IK++ Y   +         +E++ L +L H N
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-NNE------KAEREVKALAKLDHVN 65

Query: 224 TIEYRGCYL----------------RDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGM 266
            + Y GC+                 +    ++ ME+C  G+    IE             
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR----------- 114

Query: 267 GNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 326
                                    L +     +   + +G++Y+HS   I+RD+K  NI
Sbjct: 115 ---------------------RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNI 153

Query: 327 LLTETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGI 382
            L +T  VK+ DFG  +            GT  +M+PE I      Q Y  +VD+++LG+
Sbjct: 154 FLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI----SSQDYGKEVDLYALGL 209

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
              EL       F  +                          +     R           
Sbjct: 210 ILAELLHVCDTAFETS---------------------KFFTDL-----RDGII------- 236

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
                         S  +       +   L+K P DRP++  +L    V +
Sbjct: 237 --------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  156 bits (397), Expect = 5e-43
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 26/158 (16%)

Query: 7   LLRQLKHPNTIEYRGCYL----------------RDHTAWLVMEYC-LGSASDIIEVHK- 48
            L +L H N + Y GC+                 +    ++ ME+C  G+    IE  + 
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 49  RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KC 105
             L +     +   + +G++Y+HS   I+RD+K  NI L +T  VK+ DFG  +      
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176

Query: 106 PANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGIT 142
                 GT  +M+PE I      Q Y  +VD+++LG+ 
Sbjct: 177 KRTRSKGTLRYMSPEQI----SSQDYGKEVDLYALGLI 210

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 2/67 (2%)

Query: 616 LVMEYC-LGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           + ME+C  G+    IE  +   L +     +   + +G++Y+HS   I+RD+K  NI L 
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156

Query: 674 ETGTVKL 680
           +T  VK+
Sbjct: 157 DTKQVKI 163

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  215 bits (549), Expect = 6e-64
 Identities = 79/375 (21%), Positives = 128/375 (34%), Gaps = 112/375 (29%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE++  +G G+FG V  AR  +     AIKK+    +   EK + IL E+  L  L H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQY 63

Query: 224 TIEYRGCYLRDHTA-------------WLVMEYCL-GSASDIIEVHWIEREFHVEGMGNR 269
            + Y   +L                  ++ MEYC  G+  D      I            
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-----LIHS---------- 108

Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                                  + +E   +   +L  L+Y+HS G IHRD+K  NI + 
Sbjct: 109 ------------------ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150

Query: 330 ETGTVKLADFGSA------------------SIKCPANSFVGTPYWMAPEVILAMDEGQY 371
           E+  VK+ DFG A                         S +GT  ++A EV+     G Y
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL--DGTGHY 208

Query: 372 DGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER 431
           + K+D++SLGI   E+    P    M  +                   +++K + S +  
Sbjct: 209 NEKIDMYSLGIIFFEMI--YPFSTGMERV-------------------NILKKLRSVSIE 247

Query: 432 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
            PP F                      +        +   +  +P  RP +  LL    +
Sbjct: 248 FPPDF--------------------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

Query: 492 TRPRSPSVLVDLIRR 506
                  V+ + ++ 
Sbjct: 288 PVKHQDEVIKEALKS 302

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  162 bits (411), Expect = 1e-44
 Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 46/201 (22%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA-------------WLVMEYCL-GSASDIIEVHKRPL 51
            LL  L H   + Y   +L                  ++ MEYC  G+  D+I       
Sbjct: 54  MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113

Query: 52  KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---------- 101
           + +E   +   +L  L+Y+HS G IHRD+K  NI + E+  VK+ DFG A          
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 102 --------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAE 153
                          S +GT  ++A EV+     G Y+ K+D++SLGI           E
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVL--DGTGHYNEKIDMYSLGII--------FFE 223

Query: 154 L----FDKEDPEKIFEDLREI 170
           +        +   I + LR +
Sbjct: 224 MIYPFSTGMERVNILKKLRSV 244

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 24/66 (36%), Positives = 37/66 (56%), Gaps = 1/66 (1%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + MEYC  G+  D+I       + +E   +   +L  L+Y+HS G IHRD+K  NI + E
Sbjct: 92  IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151

Query: 675 TGTVKL 680
           +  VK+
Sbjct: 152 SRNVKI 157

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  200 bits (510), Expect = 1e-58
 Identities = 82/342 (23%), Positives = 124/342 (36%), Gaps = 88/342 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L  IG GS+G     R     +I+  K++ Y     AEK   ++ E+  LR+LKHPN
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPN 66

Query: 224 TIEYRGCYL--RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            + Y    +   + T ++VMEYC G                    G+    +   T+   
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEG--------------------GDLASVITKGTK--- 103

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-----IHRDVKAGNILLTETGTVKL 336
                  ++ L EE +  + + +   L   H         +HRD+K  N+ L     VKL
Sbjct: 104 ------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157

Query: 337 ADFGSA----SIKCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERK 391
            DFG A         A +FVGTPY+M+PE +        Y+ K D+WSLG    EL    
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQM----NRMSYNEKSDIWSLGCLLYELCALM 213

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           PP F   +   L                                           I +  
Sbjct: 214 PP-FTAFSQKELA----------------------------------------GKIREGK 232

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
              +    +SD     ++  L      RPS   +L + L+  
Sbjct: 233 FRRI-PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  142 bits (361), Expect = 3e-38
 Identities = 52/150 (34%), Positives = 74/150 (49%), Gaps = 20/150 (13%)

Query: 7   LLRQLKHPNTIEYRGCYL--RDHTAWLVMEYC-LGSASDIIEVHKR---PLKEEEIAAIC 60
           LLR+LKHPN + Y    +   + T ++VMEYC  G  + +I    +    L EE +  + 
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117

Query: 61  SGVLRGLNYLHSLGR-----IHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFV 111
           + +   L   H         +HRD+K  N+ L     VKL DFG A         A +FV
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177

Query: 112 GTPYWMAPEVILAMDEGQ-YDGKVDVWSLG 140
           GTPY+M+PE +        Y+ K D+WSLG
Sbjct: 178 GTPYYMSPEQM----NRMSYNEKSDIWSLG 203

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 21/74 (28%), Positives = 32/74 (43%), Gaps = 9/74 (12%)

Query: 616 LVMEYC-LGSASDIIEVHKR---PLKEEEIAAICSGVLRGLNYLHSLGR-----IHRDVK 666
           +VMEYC  G  + +I    +    L EE +  + + +   L   H         +HRD+K
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143

Query: 667 AGNILLTETGTVKL 680
             N+ L     VKL
Sbjct: 144 PANVFLDGKQNVKL 157

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  191 bits (487), Expect = 3e-55
 Identities = 71/365 (19%), Positives = 119/365 (32%), Gaps = 111/365 (30%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ +G G FG V+ A+  V     AIK++    ++ A +   +++E++ L +L+HP 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEHPG 64

Query: 224 TIEYRGCYLRDHTA------------WLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRL 270
            + Y   +L  +T             ++ M+ C   +  D     W+             
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-----WMNG----------- 108

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
           +      E                     I   +   + +LHS G +HRD+K  NI  T 
Sbjct: 109 RCTIEERE---------------RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153

Query: 331 TGTVKLADFGSA----------------SIKCPANSFVGTPYWMAPEVILAMDEGQ-YDG 373
              VK+ DFG                           VGT  +M+PE I     G  Y  
Sbjct: 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI----HGNSYSH 209

Query: 374 KVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKP 433
           KVD++SLG+   EL    P    M  +  L  +     P L                   
Sbjct: 210 KVDIFSLGLILFELL--YPFSTQMERVRTLTDVRNLKFPPL------------------- 248

Query: 434 PYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR 493
                                   +         V   L+ +P +RP +  ++ + +   
Sbjct: 249 -----------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

Query: 494 PRSPS 498
              P 
Sbjct: 286 LDFPG 290

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  137 bits (346), Expect = 5e-36
 Identities = 49/226 (21%), Positives = 82/226 (36%), Gaps = 53/226 (23%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA------------WLVMEYC-LGSASDIIEVHKRPLK 52
             L +L+HP  + Y   +L  +T             ++ M+ C   +  D +       +
Sbjct: 55  KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114

Query: 53  EEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA--------- 101
            E      I   +   + +LHS G +HRD+K  NI  T    VK+ DFG           
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 102 -------SIKCPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITPGSLKDPEIAE 153
                           VGT  +M+PE I     G  Y  KVD++SLG+         + E
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQI----HGNSYSHKVDIFSLGLI--------LFE 222

Query: 154 L----FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKM 195
           L      + +  +   D+R      F  ++  +      +  ++ M
Sbjct: 223 LLYPFSTQMERVRTLTDVRN---LKFPPLFTQKYPCEYVM--VQDM 263

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 22/105 (20%), Positives = 37/105 (35%), Gaps = 6/105 (5%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQ---LVMEYC-LGSASDIIEVHKRPLK 637
           +A  +  H   V + +     N               + M+ C   +  D +       +
Sbjct: 55  KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114

Query: 638 EEE--IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            E      I   +   + +LHS G +HRD+K  NI  T    VK+
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  192 bits (490), Expect = 4e-55
 Identities = 69/353 (19%), Positives = 115/353 (32%), Gaps = 93/353 (26%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           +I+  L++IG G    V+       ++I AIK ++ L +   +       EI +L +L+ 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 222 PNT--IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +   I      + D   ++VME      +  +                           
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL--------------------------- 99

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                    K+ +   E  +    +L  ++ +H  G +H D+K  N L+ + G +KL DF
Sbjct: 100 -------KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDF 151

Query: 340 GSASI------KCPANSFVGTPYWMAPEVILAM--------DEGQYDGKVDVWSLGITCI 385
           G A+           +S VGT  +M PE I  M         + +   K DVWSLG    
Sbjct: 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211

Query: 386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
            +   K P+  +                                         N +S L+
Sbjct: 212 YMTYGKTPFQQII----------------------------------------NQISKLH 231

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
            I   +                +  CL ++P  R S   LL H  V     P 
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  143 bits (363), Expect = 9e-38
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 18/153 (11%)

Query: 6   SLLRQLKHPNT--IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           + L +L+  +   I      + D   ++VME      +  ++  K  +   E  +    +
Sbjct: 59  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNM 117

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI------KCPANSFVGTPYWM 117
           L  ++ +H  G +H D+K  N L+ + G +KL DFG A+           +S VGT  +M
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 118 APEVILAM--------DEGQYDGKVDVWSLGIT 142
            PE I  M         + +   K DVWSLG  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 10/93 (10%)

Query: 588 HHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG 647
            H   +  L  +   +            +VME      +  ++  K  +   E  +    
Sbjct: 66  QHSDKIIRLYDYEITDQYIY--------MVMECGNIDLNSWLKKKKS-IDPWERKSYWKN 116

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L  ++ +H  G +H D+K  N L+ + G +KL
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKL 148

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  189 bits (482), Expect = 3e-54
 Identities = 68/352 (19%), Positives = 114/352 (32%), Gaps = 89/352 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  ++++G G F  V     L      A+K++    +   +   +  +E    R   HPN
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPN 87

Query: 224 TIEYRGCYLRD----HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +      LR+    H AWL++ +                       G    +++     
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKR--------------------GTLWNEIE----- 122

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                 +     L E++I  +  G+ RGL  +H+ G  HRD+K  NILL + G   L D 
Sbjct: 123 ----RLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178

Query: 340 GSASIKCPAN-------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           GS +  C                +   T  + APE+         D + DVWSLG     
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238

Query: 387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH 446
           +   + PY  +        +A                      +   P            
Sbjct: 239 MMFGEGPYDMVFQKGDSVALAVQ-------------------NQLSIP------------ 267

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
                    QS   S      ++S +  +P  RP    LL+     +P +P 
Sbjct: 268 ---------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (354), Expect = 7e-37
 Identities = 48/157 (30%), Positives = 69/157 (43%), Gaps = 21/157 (13%)

Query: 7   LLRQLKHPNTIEYRGCYLRD----HTAWLVMEYCL-GSASDIIEVHKR---PLKEEEIAA 58
           + R   HPN +      LR+    H AWL++ +   G+  + IE  K     L E++I  
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---------- 108
           +  G+ RGL  +H+ G  HRD+K  NILL + G   L D GS +  C             
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198

Query: 109 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              +   T  + APE+         D + DVWSLG  
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)

Query: 590 HHP-VTHLSQHSYNNNNSNYSSLFSPQLVMEYCL-GSASDIIEVHKR---PLKEEEIAAI 644
           +HP +  L  +      + + +     L++ +   G+  + IE  K     L E++I  +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAW----LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
             G+ RGL  +H+ G  HRD+K  NILL + G   L
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  189 bits (482), Expect = 2e-53
 Identities = 72/411 (17%), Positives = 125/411 (30%), Gaps = 94/411 (22%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           +I+  L++IG G    V+       ++I AIK ++ L +   +       EI +L +L+ 
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 222 PNT--IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +   I      + D   ++VME      +  +                           
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL--------------------------- 146

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                    K+ +   E  +    +L  ++ +H  G +H D+K  N L+ + G +KL DF
Sbjct: 147 -------KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDF 198

Query: 340 GSASI------KCPANSFVGTPYWMAPEVILAM--------DEGQYDGKVDVWSLGITCI 385
           G A+           +S VG   +M PE I  M         + +   K DVWSLG    
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258

Query: 386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
            +   K P+  +                                         N +S L+
Sbjct: 259 YMTYGKTPFQQII----------------------------------------NQISKLH 278

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIR 505
            I   +                +  CL ++P  R S   LL H  V     P   +    
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 338

Query: 506 RTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSSKSNS 556
             +        +       IL A            ++ +  +     K   
Sbjct: 339 TEEMKYVLGQLVGLNSPNSILKAA-KTLYEHYSGGESHNSSSSKTFEKKRG 388

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  140 bits (355), Expect = 2e-36
 Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 18/153 (11%)

Query: 6   SLLRQLKHPNT--IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           + L +L+  +   I      + D   ++VME      +  +   K+ +   E  +    +
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNM 164

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI------KCPANSFVGTPYWM 117
           L  ++ +H  G +H D+K  N L+ + G +KL DFG A+           +S VG   +M
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 118 APEVILAM--------DEGQYDGKVDVWSLGIT 142
            PE I  M         + +   K DVWSLG  
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 10/93 (10%)

Query: 588 HHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG 647
            H   +  L  +   +            +VME      +  +   K+ +   E  +    
Sbjct: 113 QHSDKIIRLYDYEITDQYIY--------MVMECGNIDLNSWL-KKKKSIDPWERKSYWKN 163

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L  ++ +H  G +H D+K  N L+ + G +KL
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKL 195

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  186 bits (474), Expect = 3e-53
 Identities = 69/353 (19%), Positives = 114/353 (32%), Gaps = 93/353 (26%)

Query: 162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           +I+  L++IG G    V+       ++I AIK ++ L +   +       EI +L +L+ 
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 222 PNT--IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +   I      + D   ++VME      +  +                           
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL--------------------------- 118

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                    K+ +   E  +    +L  ++ +H  G +H D+K  N L+ + G +KL DF
Sbjct: 119 -------KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDF 170

Query: 340 GSASI------KCPANSFVGTPYWMAPEVILAMDEG--------QYDGKVDVWSLGITCI 385
           G A+           +S VGT  +M PE I  M           +   K DVWSLG    
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
            +   K P+  +                                         N +S L+
Sbjct: 231 YMTYGKTPFQQII----------------------------------------NQISKLH 250

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
            I   +                +  CL ++P  R S   LL H  V     P 
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (355), Expect = 5e-37
 Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 18/153 (11%)

Query: 6   SLLRQLKHPNT--IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           + L +L+  +   I      + D   ++VME      +  +   K+ +   E  +    +
Sbjct: 78  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNM 136

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI------KCPANSFVGTPYWM 117
           L  ++ +H  G +H D+K  N L+ + G +KL DFG A+           +S VGT  +M
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 118 APEVILAMDEG--------QYDGKVDVWSLGIT 142
            PE I  M           +   K DVWSLG  
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 18/93 (19%), Positives = 38/93 (40%), Gaps = 10/93 (10%)

Query: 588 HHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG 647
            H   +  L  +   +       ++   +VME      +  +   K+ +   E  +    
Sbjct: 85  QHSDKIIRLYDYEITDQY-----IY---MVMECGNIDLNSWL-KKKKSIDPWERKSYWKN 135

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L  ++ +H  G +H D+K  N L+ + G +KL
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKL 167

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  188 bits (478), Expect = 2e-52
 Identities = 69/395 (17%), Positives = 124/395 (31%), Gaps = 95/395 (24%)

Query: 139 LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL 198
           +G +P   +D    E       +  F     +GHG+ G + Y R +     VA+K++   
Sbjct: 1   MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL-- 57

Query: 199 GKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI 257
             +C        +E++ LR+  +HPN I Y          ++ +E C  +  + +E    
Sbjct: 58  -PECFSF---ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVE---- 109

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
           +++F                                  E   +      GL +LHSL  +
Sbjct: 110 QKDF-----------------------------AHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 318 HRDVKAGNILLTETGT-----VKLADFGSASI-------KCPANSFVGTPYWMAPEVILA 365
           HRD+K  NIL++           ++DFG               +   GT  W+APE++  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 366 MDEGQYDGKVDVWSLG-ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKT 424
             +      VD++S G +    ++E   P+       A   +      CL          
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK------ 254

Query: 425 ISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGR 484
                                                      +   +A +P  RPS+  
Sbjct: 255 ----------------------------------HEDVIARELIEKMIAMDPQKRPSAKH 280

Query: 485 LLTHDLVTRP-RSPSVLVDLIRRTKAAVRDLDNLN 518
           +L H       +      D+  R +    D   + 
Sbjct: 281 VLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVK 315

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  147 bits (372), Expect = 3e-38
 Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 13/150 (8%)

Query: 6   SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVL 64
            LLR+  +HPN I Y          ++ +E C  +  + +E         E   +     
Sbjct: 69  QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTT 128

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGT-----VKLADFGSASI-------KCPANSFVG 112
            GL +LHSL  +HRD+K  NIL++           ++DFG               +   G
Sbjct: 129 SGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           T  W+APE++    +      VD++S G  
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 17/61 (27%), Positives = 28/61 (45%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           + +E C  +  + +E         E   +      GL +LHSL  +HRD+K  NIL++  
Sbjct: 95  IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154

Query: 676 G 676
            
Sbjct: 155 N 155

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  171 bits (435), Expect = 2e-48
 Identities = 68/266 (25%), Positives = 106/266 (39%), Gaps = 54/266 (20%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-CAEKWADILKEIRFLR 217
           D  ++      IG G FG VY A  +   + VA+K   +   +  ++   ++ +E +   
Sbjct: 5   DFAEL-TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            LKHPN I  RG  L++    LVME+  G                    G          
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARG--------------------GP--------- 92

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR---IHRDVKAGNILLTETG-- 332
               L    +  + +  + +      + RG+NYLH       IHRD+K+ NIL+ +    
Sbjct: 93  ----LNRV-LSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147

Query: 333 ------TVKLADFGSASIKCPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
                  +K+ DFG A         S  G   WMAPEVI       +    DVWS G+  
Sbjct: 148 GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVI---RASMFSKGSDVWSYGVLL 204

Query: 385 IELAERKPPYFNMNAMSALYHIAQND 410
            EL   + P+  ++ ++  Y +A N 
Sbjct: 205 WELLTGEVPFRGIDGLAVAYGVAMNK 230

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  130 bits (328), Expect = 8e-34
 Identities = 48/150 (32%), Positives = 68/150 (45%), Gaps = 19/150 (12%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            L   LKHPN I  RG  L++    LVME+   G  + ++    + +  + +      + 
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIA 115

Query: 65  RGLNYLHSLGR---IHRDVKAGNILLTETG--------TVKLADFGSASIKCPAN--SFV 111
           RG+NYLH       IHRD+K+ NIL+ +           +K+ DFG A         S  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           G   WMAPEVI       +    DVWS G+
Sbjct: 176 GAYAWMAPEVI---RASMFSKGSDVWSYGV 202

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 6/66 (9%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR---IHRDVKAGNIL 671
           LVME+   G  + ++    + +  + +      + RG+NYLH       IHRD+K+ NIL
Sbjct: 83  LVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140

Query: 672 LTETGT 677
           + +   
Sbjct: 141 ILQKVE 146

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  171 bits (435), Expect = 4e-48
 Identities = 75/330 (22%), Positives = 122/330 (36%), Gaps = 83/330 (25%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
              +I    + IG GSFG VY  +       VA+K ++ +     ++      E+  LR+
Sbjct: 22  PDGQI-TVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGVLRK 76

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            +H N + + G       A +V ++C GS+                              
Sbjct: 77  TRHVNILLFMGYSTAPQLA-IVTQWCEGSS------------------------------ 105

Query: 279 HFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              L++     +   + +++  I     RG++YLH+   IHRD+K+ NI L E  TVK+ 
Sbjct: 106 ---LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIG 162

Query: 338 DFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           DFG A+ K             G+  WMAPEVI   D   Y  + DV++ GI   EL   +
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
            PY N+N    +  +    +                     P               +++
Sbjct: 223 LPYSNINNRDQIIEMVGRGS-------------------LSPDLSK----------VRSN 253

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
            P              ++ CL K   +RPS
Sbjct: 254 CP--------KRMKRLMAECLKKKRDERPS 275

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  138 bits (349), Expect = 2e-36
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 8/143 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            +LR+ +H N + + G       A +V ++C   S    +   +   + +++  I     
Sbjct: 72  GVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMA 118
           RG++YLH+   IHRD+K+ NI L E  TVK+ DFG A+ K             G+  WMA
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEVI   D   Y  + DV++ GI
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGI 213

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 21/65 (32%), Positives = 35/65 (53%), Gaps = 1/65 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V ++C   S    +   +   + +++  I     RG++YLH+   IHRD+K+ NI L E
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE 155

Query: 675 TGTVK 679
             TVK
Sbjct: 156 DNTVK 160

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  170 bits (432), Expect = 9e-48
 Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 51/278 (18%)

Query: 144 GSLKDPEIAELFDKE-DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLG--- 199
           G++   E  +         +I E  ++IG G FG V+  R +  + +VAIK +       
Sbjct: 1   GAMGGSEFPKSRLPTLADNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59

Query: 200 -KQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
             +  EK+ +  +E+  +  L HPN ++  G         +VME+               
Sbjct: 60  ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPC------------ 105

Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGR- 316
                   G+             L++       P+K      +   +  G+ Y+ +    
Sbjct: 106 --------GD-------------LYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144

Query: 317 -IHRDVKAGNILLTETG-----TVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEG 369
            +HRD+++ NI L           K+ADFG +       +  +G   WMAPE I A +E 
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEE- 203

Query: 370 QYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIA 407
            Y  K D +S  +    +   + P+   +     +   
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  132 bits (333), Expect = 3e-34
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 12/145 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++  L HPN ++  G         +VME+   G     +     P+K      +   + 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132

Query: 65  RGLNYLHSLGR--IHRDVKAGNILLTETG-----TVKLADFGSASIKCP-ANSFVGTPYW 116
            G+ Y+ +     +HRD+++ NI L           K+ADFG +       +  +G   W
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQW 192

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           MAPE I A +E  Y  K D +S  +
Sbjct: 193 MAPETIGAEEE-SYTEKADTYSFAM 216

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 15/66 (22%), Positives = 29/66 (43%), Gaps = 3/66 (4%)

Query: 614 PQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNI 670
           P++VME+   G     +     P+K      +   +  G+ Y+ +     +HRD+++ NI
Sbjct: 96  PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155

Query: 671 LLTETG 676
            L    
Sbjct: 156 FLQSLD 161

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  169 bits (429), Expect = 5e-47
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 47/276 (17%)

Query: 145 SLKDPEIAELFDKEDPEKIFEDL---REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ 201
           + ++       D +D +  + DL    +IG GSFG V+ A        VA+K +      
Sbjct: 17  TTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILM-EQDF 73

Query: 202 CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIERE 260
            AE+  + L+E+  +++L+HPN + + G   +     +V EY   GS   ++        
Sbjct: 74  HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-------- 125

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IH 318
            H  G                       +  L E    ++   V +G+NYLH+     +H
Sbjct: 126 -HKSG----------------------AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162

Query: 319 RDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGK 374
           R++K+ N+L+ +  TVK+ DFG + +K      + S  GTP WMAPEV+    +   + K
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL---RDEPSNEK 219

Query: 375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIAQND 410
            DV+S G+   ELA  + P+ N+N    +  +    
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC 255

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  130 bits (330), Expect = 9e-34
 Identities = 45/145 (31%), Positives = 79/145 (54%), Gaps = 12/145 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVH--KRPLKEEEIAAICSG 62
           +++++L+HPN + + G   +     +V EY   GS   ++     +  L E    ++   
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145

Query: 63  VLRGLNYLHSLGR--IHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYW 116
           V +G+NYLH+     +HR++K+ N+L+ +  TVK+ DFG + +K      + S  GTP W
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 205

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           MAPEV+    +   + K DV+S G+
Sbjct: 206 MAPEVL---RDEPSNEKSDVYSFGV 227

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 21/70 (30%), Positives = 38/70 (54%), Gaps = 5/70 (7%)

Query: 616 LVMEYC-LGSASDIIEVH--KRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNI 670
           +V EY   GS   ++     +  L E    ++   V +G+NYLH+     +HR++K+ N+
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170

Query: 671 LLTETGTVKL 680
           L+ +  TVK+
Sbjct: 171 LVDKKYTVKV 180

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  168 bits (427), Expect = 1e-46
 Identities = 68/358 (18%), Positives = 119/358 (33%), Gaps = 98/358 (27%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
             E++ E    IG G FG VY+ R       VAI+ +  + +   ++     +E+   RQ
Sbjct: 31  PFEQL-EIGELIGKGRFGQVYHGRW---HGEVAIRLID-IERDNEDQLKAFKREVMAYRQ 85

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            +H N + + G  +      ++   C G                                
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRT------------------------------ 115

Query: 279 HFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
              L++     K  L   +   I   +++G+ YLH+ G +H+D+K+ N+     G V + 
Sbjct: 116 ---LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVIT 171

Query: 338 DFGSASIKCPAN---------SFVGTPYWMAPEVI------LAMDEGQYDGKVDVWSLGI 382
           DFG  SI                 G    +APE+I         D+  +    DV++LG 
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
              EL  R+ P+    A + ++ +                         KP         
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQMGTG---------------------MKPN-------- 262

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH--DLVTRPRSPS 498
               ++Q               +  +  C A    +RP+  +L+     L  R R  S
Sbjct: 263 ----LSQIGMG--------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  127 bits (321), Expect = 2e-32
 Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 17/152 (11%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
              RQ +H N + + G  +      ++   C   +   ++   K  L   +   I   ++
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---------SFVGTPY 115
           +G+ YLH+ G +H+D+K+ N+     G V + DFG  SI                 G   
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 116 WMAPEVI------LAMDEGQYDGKVDVWSLGI 141
            +APE+I         D+  +    DV++LG 
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 15/66 (22%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++   C   +   ++   K  L   +   I   +++G+ YLH+ G +H+D+K+ N+    
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN 165

Query: 675 TGTVKL 680
            G V +
Sbjct: 166 -GKVVI 170

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  165 bits (419), Expect = 1e-45
 Identities = 69/341 (20%), Positives = 108/341 (31%), Gaps = 97/341 (28%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
            P  +      +G G FG         + E++ +K++        E     LKE++ +R 
Sbjct: 8   RPSDLIHG-EVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRC 63

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           L+HPN +++ G   +D     + EY  G                    G     +K    
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKG--------------------GTLRGIIK---- 99

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                            +  +    +  G+ YLHS+  IHRD+ + N L+ E   V +AD
Sbjct: 100 --------SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVAD 151

Query: 339 FG------------------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           FG                      +    + VG PYWMAPE+I       YD KVDV+S 
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN---GRSYDEKVDVFSF 208

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           GI   E+  R     +    +  + +                            Y   N 
Sbjct: 209 GIVLCEIIGRVNADPDYLPRTMDFGLNVR--------------------GFLDRYCPPNC 248

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
             + + I                       C   +P  RPS
Sbjct: 249 PPSFFPITV--------------------RCCDLDPEKRPS 269

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  131 bits (331), Expect = 7e-34
 Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 22/155 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++R L+HPN +++ G   +D     + EY   G+   II+         +  +    + 
Sbjct: 59  KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------------SASIKCP 106
            G+ YLHS+  IHRD+ + N L+ E   V +ADFG                      +  
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 107 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
             + VG PYWMAPE+I       YD KVDV+S GI
Sbjct: 179 RYTVVGNPYWMAPEMIN---GRSYDEKVDVFSFGI 210

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 1/65 (1%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
            + EY   G+   II+         +  +    +  G+ YLHS+  IHRD+ + N L+ E
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 143

Query: 675 TGTVK 679
              V 
Sbjct: 144 NKNVV 148

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  162 bits (412), Expect = 3e-45
 Identities = 41/258 (15%), Positives = 86/258 (33%), Gaps = 44/258 (17%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           D +++   L ++     G ++  R       + +K +  +      K  D  +E   LR 
Sbjct: 8   DFKQL-NFLTKLNENHSGELWKGRW--QGNDIVVKVLK-VRDWSTRKSRDFNEECPRLRI 63

Query: 219 LKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             HPN +   G           L+  +                       G+        
Sbjct: 64  FSHPNVLPVLGACQSPPAPHPTLITHWMPY--------------------GS-------- 95

Query: 277 TEHFALFNF--EVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLTETG 332
                L+N   E     + + +       + RG+ +LH+L        + + ++++ E  
Sbjct: 96  -----LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150

Query: 333 TVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           T +++          +   +  P W+APE +    E       D+WS  +   EL  R+ 
Sbjct: 151 TARISMADVKFSF-QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209

Query: 393 PYFNMNAMSALYHIAQND 410
           P+ +++ M     +A   
Sbjct: 210 PFADLSNMEIGMKVALEG 227

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  123 bits (310), Expect = 2e-31
 Identities = 26/142 (18%), Positives = 54/142 (38%), Gaps = 7/142 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYC-LGSASDII-EVHKRPLKEEEIAAICS 61
             LR   HPN +   G           L+  +   GS  +++ E     + + +      
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 62  GVLRGLNYLHSLGR--IHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAP 119
            + RG+ +LH+L        + + ++++ E  T +++          +   +  P W+AP
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-QSPGRMYAPAWVAP 177

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E +    E       D+WS  +
Sbjct: 178 EALQKKPEDTNRRSADMWSFAV 199

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 11/69 (15%), Positives = 31/69 (44%), Gaps = 4/69 (5%)

Query: 616 LVMEYC-LGSASDII-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNIL 671
           L+  +   GS  +++ E     + + +       + RG+ +LH+L        + + +++
Sbjct: 86  LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145

Query: 672 LTETGTVKL 680
           + E  T ++
Sbjct: 146 IDEDMTARI 154

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  165 bits (419), Expect = 4e-45
 Identities = 37/335 (11%), Positives = 84/335 (25%), Gaps = 47/335 (14%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
            E+  + +  +  G    V+  R +   E  A+K  +   +    +   + +      +L
Sbjct: 60  GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYC----LGSASDIIEVHWIEREFHV-EGMGNRLQQLK 274
              +  E R    R       +           S   + + +     +       L+ L 
Sbjct: 120 LGESPEEARD-RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                  L    V +       +  + + ++R    L S G +H      N+ +   G +
Sbjct: 179 S-----TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233

Query: 335 KLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY 394
            L D  +             P   AP   L      +   ++ W LG++   +     P+
Sbjct: 234 MLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 395 FNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
             +   +   +       P   S  +     +    +                       
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT---------------------- 331

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                         +   L  +   R      +  
Sbjct: 332 -------------LIGRFLNFDRRRRLLPLEAMET 353

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 1e-28
 Identities = 20/144 (13%), Positives = 40/144 (27%), Gaps = 8/144 (5%)

Query: 7   LLRQLKHPNTIEYRGCY--LRDHTAWLVMEYCLGSASDIIE------VHKRPLKEEEIAA 58
            +     P   +              L+M         +        V +       +  
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMA 118
           + + ++R    L S G +H      N+ +   G + L D  +             P   A
Sbjct: 199 LTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYA 258

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           P   L      +   ++ W LG++
Sbjct: 259 PREFLNASTATFTHALNAWQLGLS 282

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 16/101 (15%), Positives = 30/101 (29%), Gaps = 12/101 (11%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIE------VHKRPLKEE 639
                 P   LS    +   +NY       L+M         +        V +      
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYL------LLMPAASVDLELLFSTLDFVYVFRGDEGIL 194

Query: 640 EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            +  + + ++R    L S G +H      N+ +   G + L
Sbjct: 195 ALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLML 235

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  162 bits (413), Expect = 5e-45
 Identities = 80/360 (22%), Positives = 124/360 (34%), Gaps = 91/360 (25%)

Query: 149 PEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEK 205
            EI E+       + +   R +G G F   +      ++E+ A K   K   L     EK
Sbjct: 2   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 61

Query: 206 WADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG 265
              +  EI   R L H + + + G +  +   ++V+E C              R      
Sbjct: 62  ---MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR------------RS----- 101

Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
                           L      ++ L E E       ++ G  YLH    IHRD+K GN
Sbjct: 102 ----------------LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 145

Query: 326 ILLTETGTVKLADFG-SASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           + L E   VK+ DFG +  ++          GTP ++APEV+    +  +  +VDVWS+G
Sbjct: 146 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFEVDVWSIG 202

Query: 382 ITCIELAERKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
                L   KPP F  + +   Y  I +N+                      P + N  A
Sbjct: 203 CIMYTLLVGKPP-FETSCLKETYLRIKKNEYSI-------------------PKHINPVA 242

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                                   A  +   L  +P  RP+   LL  +  T    P+ L
Sbjct: 243 ------------------------ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (307), Expect = 8e-31
 Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 9/141 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
           S+ R L H + + + G +  +   ++V+E C   S  ++ +  K  L E E       ++
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIV 125

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPAN---SFVGTPYWMAPE 120
            G  YLH    IHRD+K GN+ L E   VK+ DFG +  ++          GTP ++APE
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185

Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V+    +  +  +VDVWS+G 
Sbjct: 186 VL---SKKGHSFEVDVWSIGC 203

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 65.7 bits (161), Expect = 8e-12
 Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V+E C   S  ++ +  K  L E E       ++ G  YLH    IHRD+K GN+ L E
Sbjct: 92  VVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 150

Query: 675 TGTVKL 680
              VK+
Sbjct: 151 DLEVKI 156

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  166 bits (422), Expect = 2e-44
 Identities = 84/400 (21%), Positives = 145/400 (36%), Gaps = 95/400 (23%)

Query: 143 PGSLKD-----PEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY 197
           PGS+ D     P +            ++  R +G GSFG V   +  ++ +  A+K +S 
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 198 LGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI 257
              +       +L+E++ L+QL HPN ++    +      +LV E   G           
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG----------- 110

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
                    G              LF+  + ++   E + A I   VL G+ Y+H    +
Sbjct: 111 ---------GE-------------LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148

Query: 318 HRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQY 371
           HRD+K  N+LL    +   +++ DFG ++           +GT Y++APEV+     G Y
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL----HGTY 204

Query: 372 DGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER 431
           D K DVWS G+    L    PP FN      +    +      +   W   K +S +A+ 
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKVEKGKYTFELPQW---KKVSESAK- 259

Query: 432 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                                               +   L   P+ R S+   L H+ +
Sbjct: 260 ----------------------------------DLIRKMLTYVPSMRISARDALDHEWI 285

Query: 492 TRPRSPSVLVDLIRRTKAAVRDLDNL----NYRKMKKILM 527
                  + VD+     A    + N+      +K+ +  +
Sbjct: 286 QTYTKEQISVDVPSLDNA----ILNIRQFQGTQKLAQAAL 321

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  125 bits (315), Expect = 2e-30
 Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 14/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           L+QL HPN ++    +      +LV E   G     +II   ++   E + A I   VL 
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLS 137

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAP 119
           G+ Y+H    +HRD+K  N+LL    +   +++ DFG ++           +GT Y++AP
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           EV+     G YD K DVWS G+
Sbjct: 198 EVL----HGTYDEKCDVWSTGV 215

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 57.8 bits (140), Expect = 9e-09
 Identities = 21/70 (30%), Positives = 34/70 (48%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LV E   G     +II   ++   E + A I   VL G+ Y+H    +HRD+K  N+LL 
Sbjct: 103 LVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLE 160

Query: 674 ---ETGTVKL 680
              +   +++
Sbjct: 161 SKSKDANIRI 170

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  162 bits (411), Expect = 3e-44
 Identities = 77/351 (21%), Positives = 125/351 (35%), Gaps = 59/351 (16%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIR 214
             + +K +     IG GS+G V  A    +R I AIK    + + +   +    I  E+R
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-------SASDIIEVHWIEREFHVEGMG 267
            +++L HPN       Y  +    LVME C G       +            +     + 
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
              +  +           E      +E+ I+ I   +   L+YLH+ G  HRD+K  N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200

Query: 328 LT--ETGTVKLADFGSASIKCPANS--------FVGTPYWMAPEVILAMDEGQYDGKVDV 377
            +  ++  +KL DFG +      N+          GTPY++APEV+   +E  Y  K D 
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES-YGPKCDA 259

Query: 378 WSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFN 437
           WS G+    L     P F     +       N   C ++ ++     +S  A        
Sbjct: 260 WSAGVLLHLLLMGAVP-FPGVNDADTISQVLNKKLCFENPNY---NVLSPLAR------- 308

Query: 438 MNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                                         +S+ L +N  +R  + R L H
Sbjct: 309 ----------------------------DLLSNLLNRNVDERFDAMRALQH 331

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (280), Expect = 6e-27
 Identities = 49/187 (26%), Positives = 71/187 (37%), Gaps = 51/187 (27%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG--------------------------- 38
            L+++L HPN       Y  +    LVME C G                           
Sbjct: 80  RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139

Query: 39  -------------SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 85
                        S     E      +E+ I+ I   +   L+YLH+ G  HRD+K  N 
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199

Query: 86  LLT--ETGTVKLADFGSASIKCPANS--------FVGTPYWMAPEVILAMDEGQYDGKVD 135
           L +  ++  +KL DFG +      N+          GTPY++APEV+   +E  Y  K D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES-YGPKCD 258

Query: 136 VWSLGIT 142
            WS G+ 
Sbjct: 259 AWSAGVL 265

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 2/88 (2%)

Query: 595 HLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNY 654
             S      +         P+   E   GS     E      +E+ I+ I   +   L+Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 655 LHSLGRIHRDVKAGNILLT--ETGTVKL 680
           LH+ G  HRD+K  N L +  ++  +KL
Sbjct: 184 LHNQGICHRDIKPENFLFSTNKSFEIKL 211

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  162 bits (411), Expect = 3e-44
 Identities = 80/360 (22%), Positives = 124/360 (34%), Gaps = 91/360 (25%)

Query: 149 PEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEK 205
            EI E+       + +   R +G G F   +      ++E+ A K   K   L     EK
Sbjct: 28  KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 87

Query: 206 WADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG 265
              +  EI   R L H + + + G +  +   ++V+E C              R      
Sbjct: 88  ---MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR------------RS----- 127

Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
                           L      ++ L E E       ++ G  YLH    IHRD+K GN
Sbjct: 128 ----------------LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 171

Query: 326 ILLTETGTVKLADFG-SASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           + L E   VK+ DFG +  ++          GTP ++APEV+    +  +  +VDVWS+G
Sbjct: 172 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFEVDVWSIG 228

Query: 382 ITCIELAERKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
                L   KPP F  + +   Y  I +N+                      P + N  A
Sbjct: 229 CIMYTLLVGKPP-FETSCLKETYLRIKKNEYSI-------------------PKHINPVA 268

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                                   A  +   L  +P  RP+   LL  +  T    P+ L
Sbjct: 269 ------------------------ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (306), Expect = 3e-30
 Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 9/141 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
           S+ R L H + + + G +  +   ++V+E C   S  ++ +  K  L E E       ++
Sbjct: 93  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIV 151

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPAN---SFVGTPYWMAPE 120
            G  YLH    IHRD+K GN+ L E   VK+ DFG +  ++          GTP ++APE
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211

Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V+    +  +  +VDVWS+G 
Sbjct: 212 VL---SKKGHSFEVDVWSIGC 229

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V+E C   S  ++ +  K  L E E       ++ G  YLH    IHRD+K GN+ L E
Sbjct: 118 VVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 176

Query: 675 TGTVKL 680
              VK+
Sbjct: 177 DLEVKI 182

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  161 bits (409), Expect = 4e-44
 Identities = 65/373 (17%), Positives = 112/373 (30%), Gaps = 98/373 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE ++ +G G FG V+ A+  V     AIK++    ++ A +   +++E++ L +L+HP 
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEHPG 65

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM---GNRLQQLKCFTEHF 280
            + Y   +L         E       D      +     ++       R+          
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 281 ALFNFEV------------------------HKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
            L                                  +      I   +   + +LHS G 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 317 IHRDVKAGNILLTETGTVKLADFGSA----------------SIKCPANSFVGTPYWMAP 360
           +HRD+K  NI  T    VK+ DFG                           VGT  +M+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 361 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 420
           E    +    Y  KVD++SLG+   EL                                 
Sbjct: 246 EQ---IHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------------------R 281

Query: 421 VIKTISSTAERK---PPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA 477
           +I  +     R    P  F                     +         V   L+ +P 
Sbjct: 282 IITDV-----RNLKFPLLF---------------------TQKYPQEHMMVQDMLSPSPT 315

Query: 478 DRPSSGRLLTHDL 490
           +RP +  ++ + +
Sbjct: 316 ERPEATDIIENAI 328

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  117 bits (295), Expect = 5e-29
 Identities = 35/156 (22%), Positives = 55/156 (35%), Gaps = 22/156 (14%)

Query: 5   SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR--PLKEEEIAAICS 61
              +      NT+            ++ M+ C   +  D +         +      I  
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----------------SIKC 105
            +   + +LHS G +HRD+K  NI  T    VK+ DFG                      
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231

Query: 106 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
                VGT  +M+PE    +    Y  KVD++SLG+
Sbjct: 232 THTGQVGTKLYMSPEQ---IHGNNYSHKVDIFSLGL 264

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 30/169 (17%), Positives = 51/169 (30%), Gaps = 20/169 (11%)

Query: 573 HDPTPNSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQL---VMEYC-LGSASDI 628
            + T    S           +  +   S  N                 M+ C   +  D 
Sbjct: 92  DESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDW 151

Query: 629 IEVHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL-D---- 681
           +         +      I   +   + +LHS G +HRD+K  NI  T    VK+ D    
Sbjct: 152 MNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211

Query: 682 TPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSS--QAHNRHH 728
           T  +Q   +     +    ++  +  VG      T    S  Q H  ++
Sbjct: 212 TAMDQD-EEEQTVLTPMPAYATHTGQVG------TKLYMSPEQIHGNNY 253

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  160 bits (406), Expect = 1e-43
 Identities = 69/349 (19%), Positives = 112/349 (32%), Gaps = 106/349 (30%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTI 225
            R +  G F  VY A+ + S    A+K++        EK   I++E+ F+++L  HPN +
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLL---SNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 226 EYRGCYLRDHTA--------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           ++                   L+ E C G                               
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKG------------------------------- 118

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLTETGTVK 335
           +          + PL  + +  I     R + ++H      IHRD+K  N+LL+  GT+K
Sbjct: 119 QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178

Query: 336 LADFGSASIKCPANSF----------------VGTPYWMAPEVILAMDEGQYDGKVDVWS 379
           L DFGSA+       +                  TP +  PE+I          K D+W+
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238

Query: 380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMN 439
           LG     L  R+ P F   A   +                                    
Sbjct: 239 LGCILYLLCFRQHP-FEDGAKLRI------------------------------------ 261

Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
            ++  Y I  +DT           F   + + L  NP +R S   ++  
Sbjct: 262 -VNGKYSIPPHDTQ-------YTVFHSLIRAMLQVNPEERLSIAEVVHQ 302

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (312), Expect = 3e-31
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 29/164 (17%)

Query: 6   SLLRQLK-HPNTIEYRGCYLRDHTA--------WLVMEYCLGSASDIIE--VHKRPLKEE 54
             +++L  HPN +++                   L+ E C G   + ++    + PL  +
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136

Query: 55  EIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLTETGTVKLADFGSASIKCPANSF-- 110
            +  I     R + ++H      IHRD+K  N+LL+  GT+KL DFGSA+       +  
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 111 --------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
                           TP +  PE+I          K D+W+LG
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 72.5 bits (178), Expect = 9e-14
 Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 4/69 (5%)

Query: 616 LVMEYCLGSASDIIE--VHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNIL 671
           L+ E C G   + ++    + PL  + +  I     R + ++H      IHRD+K  N+L
Sbjct: 111 LLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170

Query: 672 LTETGTVKL 680
           L+  GT+KL
Sbjct: 171 LSNQGTIKL 179

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  164 bits (416), Expect = 2e-43
 Identities = 78/378 (20%), Positives = 137/378 (36%), Gaps = 84/378 (22%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K    ++++ ++++G G++G V   R  V+    AIK +           + +L+E+  L
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTSSNSKLLEEVAVL 90

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           + L HPN ++    +      +LVME   G                    G         
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKG--------------------GE-------- 122

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGT 333
                LF+  +H+    E + A I   VL G+ YLH    +HRD+K  N+LL    +   
Sbjct: 123 -----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177

Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           +K+ DFG +++          +GT Y++APEV+      +YD K DVWS+G+    L   
Sbjct: 178 IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL----RKKYDEKCDVWSIGVILFILLAG 233

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
            PP F       +    +       S +W   K +S  A                     
Sbjct: 234 YPP-FGGQTDQEILRKVEKGKYTFDSPEW---KNVSEGA--------------------- 268

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAA 510
                            +   L  +   R S+ + L H  +    S       +     A
Sbjct: 269 --------------KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314

Query: 511 VRDLDNLN-YRKMKKILM 527
           + ++      +K+ +  +
Sbjct: 315 IENMRKFQNSQKLAQAAL 332

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  124 bits (313), Expect = 3e-30
 Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 14/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           L+ L HPN ++    +      +LVME   G     +II   +    E + A I   VL 
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLS 147

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
           G+ YLH    +HRD+K  N+LL    +   +K+ DFG +++          +GT Y++AP
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           EV+      +YD K DVWS+G+
Sbjct: 208 EVL----RKKYDEKCDVWSIGV 225

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 24/70 (34%), Positives = 34/70 (48%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LVME   G     +II   +    E + A I   VL G+ YLH    +HRD+K  N+LL 
Sbjct: 113 LVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170

Query: 674 ---ETGTVKL 680
              +   +K+
Sbjct: 171 SKEKDALIKI 180

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  159 bits (403), Expect = 2e-43
 Identities = 57/348 (16%), Positives = 108/348 (31%), Gaps = 62/348 (17%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
            +     ++     +G G+   V+  R   + ++ AIK  +             ++E   
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVDVQMREFEV 60

Query: 216 LRQLKHPNTIEYRGCY--LRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQ 272
           L++L H N ++              L+ME+C  GS   ++     E              
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPS------------ 104

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--- 329
                          +   L E E   +   V+ G+N+L   G +HR++K GNI+     
Sbjct: 105 ---------------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149

Query: 330 -ETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVI-----LAMDEGQYDGKVDVWSL 380
                 KL DFG+A          S  GT  ++ P++          + +Y   VD+WS+
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           G+T    A    P+         +   + +   +        K I+              
Sbjct: 210 GVTFYHAATGSLPFRP-------FEGPRRNKEVMY-------KIITGKPSGAISGVQKAE 255

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
              +         C  S          +++ L  +        +    
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 8e-32
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 17/152 (11%)

Query: 8   LRQLKHPNTIEYRGCY--LRDHTAWLVMEYCL-GSASDIIEVHKRP--LKEEEIAAICSG 62
           L++L H N ++              L+ME+C  GS   ++E       L E E   +   
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASI---KCPANSFVGTPY 115
           V+ G+N+L   G +HR++K GNI+           KL DFG+A          S  GT  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 116 WMAPEVI-----LAMDEGQYDGKVDVWSLGIT 142
           ++ P++          + +Y   VD+WS+G+T
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 7/72 (9%)

Query: 616 LVMEYCL-GSASDIIEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           L+ME+C  GS   ++E       L E E   +   V+ G+N+L   G +HR++K GNI+ 
Sbjct: 86  LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145

Query: 673 T----ETGTVKL 680
                     KL
Sbjct: 146 VIGEDGQSVYKL 157

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  161 bits (410), Expect = 2e-43
 Identities = 71/396 (17%), Positives = 139/396 (35%), Gaps = 100/396 (25%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           ++  + +    + +G+GS G V +      R  VA+K+M        +     L EI+ L
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRML---IDFCD---IALMEIKLL 62

Query: 217 RQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
            +   HPN I Y      D   ++ +E C  +  D++E     +    E +         
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVE----SKNVSDENLKL------- 111

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG--- 332
                            KE    ++   +  G+ +LHSL  IHRD+K  NIL++ +    
Sbjct: 112 ----------------QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFT 155

Query: 333 ----------TVKLADFG--------SASIKCPANSFVGTPYWMAPEVILAMDEGQ---- 370
                      + ++DFG         +S +   N+  GT  W APE++   +  Q    
Sbjct: 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRR 215

Query: 371 YDGKVDVWSLG-ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA 429
               +D++S+G +    L++ K P+ +  +  +           ++       +++ + A
Sbjct: 216 LTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHD---RSLIAEA 272

Query: 430 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
                                                 +S  +  +P  RP++ ++L H 
Sbjct: 273 T-----------------------------------DLISQMIDHDPLKRPTAMKVLRHP 297

Query: 490 LVTRP-RSPSVLVDLIRRTKAAVRDLDNLNYRKMKK 524
           L     +    L+ +  R +   RD  +    K   
Sbjct: 298 LFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDA 333

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (309), Expect = 5e-30
 Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 32/168 (19%)

Query: 6   SLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK------RPLKEEEIAA 58
            LL +   HPN I Y      D   ++ +E C  +  D++E         +  KE    +
Sbjct: 60  KLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG-------------TVKLADFG------ 99
           +   +  G+ +LHSL  IHRD+K  NIL++ +               + ++DFG      
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 100 --SASIKCPANSFVGTPYWMAPEVILAMDEGQ----YDGKVDVWSLGI 141
              +S +   N+  GT  W APE++   +  Q        +D++S+G 
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 6/77 (7%)

Query: 616 LVMEYCLGSASDIIEVHK------RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 669
           + +E C  +  D++E         +  KE    ++   +  G+ +LHSL  IHRD+K  N
Sbjct: 86  IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQN 145

Query: 670 ILLTETGTVKLDTPDEQ 686
           IL++ +     D     
Sbjct: 146 ILVSTSSRFTADQQTGA 162

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  155 bits (394), Expect = 2e-42
 Identities = 72/264 (27%), Positives = 109/264 (41%), Gaps = 56/264 (21%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           D ++I E    +G G+FG V  A+     + VAIK++     +   +    + E+R L +
Sbjct: 6   DYKEI-EVEEVVGRGAFGVVCKAKW--RAKDVAIKQI-----ESESERKAFIVELRQLSR 57

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           + HPN ++  G  L      LVMEY  G                    G+          
Sbjct: 58  VNHPNIVKLYGACLNPV--CLVMEYAEG--------------------GS---------- 85

Query: 279 HFALFNFEVHKRP---LKEEEIAAICSGVLRGLNYLHSLGR---IHRDVKAGNILLTETG 332
              L+N      P          + C    +G+ YLHS+     IHRD+K  N+LL   G
Sbjct: 86  ---LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142

Query: 333 TV-KLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           TV K+ DFG+A        +  G+  WMAPEV    +   Y  K DV+S GI   E+  R
Sbjct: 143 TVLKICDFGTACDIQTHMTNNKGSAAWMAPEVF---EGSNYSEKCDVFSWGIILWEVITR 199

Query: 391 KPPYFNMN--AMSALYHIAQNDTP 412
           + P+  +   A   ++ +     P
Sbjct: 200 RKPFDEIGGPAFRIMWAVHNGTRP 223

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  121 bits (305), Expect = 2e-30
 Identities = 49/144 (34%), Positives = 69/144 (47%), Gaps = 13/144 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRP--LKEEEIAAICSG 62
             L ++ HPN ++  G  L      LVMEY   GS  +++   +           + C  
Sbjct: 53  RQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110

Query: 63  VLRGLNYLHSLGR---IHRDVKAGNILLTETGTV-KLADFGSASIKCPA-NSFVGTPYWM 117
             +G+ YLHS+     IHRD+K  N+LL   GTV K+ DFG+A        +  G+  WM
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWM 170

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APEV    +   Y  K DV+S GI
Sbjct: 171 APEVF---EGSNYSEKCDVFSWGI 191

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 24/69 (34%), Positives = 34/69 (49%), Gaps = 6/69 (8%)

Query: 616 LVMEYC-LGSASDIIEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGR---IHRDVKAGN 669
           LVMEY   GS  +++   +           + C    +G+ YLHS+     IHRD+K  N
Sbjct: 76  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135

Query: 670 ILLTETGTV 678
           +LL   GTV
Sbjct: 136 LLLVAGGTV 144

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  160 bits (406), Expect = 2e-42
 Identities = 75/386 (19%), Positives = 143/386 (37%), Gaps = 90/386 (23%)

Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
            L+ +    + +  +  +G GSFG V   +  ++++  A+K ++       +  + IL+E
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILRE 71

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG---NR 269
           +  L++L HPN ++         + ++V E   G                    G   + 
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG--------------------GELFDE 111

Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
           + + K F+E                 + A I   V  G+ Y+H    +HRD+K  NILL 
Sbjct: 112 IIKRKRFSE----------------HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 330 ---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
              +   +K+ DFG ++           +GT Y++APEV+     G YD K DVWS G+ 
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----RGTYDEKCDVWSAGVI 211

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
              L    PP F       +    +          W   +TIS  A+             
Sbjct: 212 LYILLSGTPP-FYGKNEYDILKRVETGKYAFDLPQW---RTISDDAK------------- 254

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                                   +   L  +P+ R ++ + L H  + +  S +  +  
Sbjct: 255 ----------------------DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292

Query: 504 IRRTKAAVRDLDNLN-YRKMKKILMA 528
           +   ++A+ ++      +K+ +  + 
Sbjct: 293 LPSLESAMTNIRQFQAEKKLAQAALL 318

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  124 bits (312), Expect = 4e-30
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           L++L HPN ++         + ++V E   G     +II+  ++   E + A I   V  
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFS 132

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAP 119
           G+ Y+H    +HRD+K  NILL    +   +K+ DFG ++           +GT Y++AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           EV+     G YD K DVWS G+
Sbjct: 193 EVL----RGTYDEKCDVWSAGV 210

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 21/70 (30%), Positives = 34/70 (48%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V E   G     +II+  ++   E + A I   V  G+ Y+H    +HRD+K  NILL 
Sbjct: 98  IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 674 ---ETGTVKL 680
              +   +K+
Sbjct: 156 SKEKDCDIKI 165

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  153 bits (390), Expect = 4e-42
 Identities = 77/344 (22%), Positives = 128/344 (37%), Gaps = 92/344 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKH 221
           F+    +G GSF  VY A  + +   VAIK +    + K    +   +  E++   QLKH
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ--RVQNEVKIHCQLKH 70

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P+ +E    +   +  +LV+E C               E                     
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHN------------GE--------------------- 97

Query: 282 LFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           +  + +   +P  E E       ++ G+ YLHS G +HRD+   N+LLT    +K+ADFG
Sbjct: 98  MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157

Query: 341 -SASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYF 395
            +  +K P     +  GTP +++PE+         +  + DVWSLG     L   +PP F
Sbjct: 158 LATQLKMPHEKHYTLCGTPNYISPEIA----TRSAHGLESDVWSLGCMFYTLLIGRPP-F 212

Query: 396 NMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC 454
           + + +    + +   D                      P + ++ A              
Sbjct: 213 DTDTVKNTLNKVVLADYEM-------------------PSFLSIEA-------------- 239

Query: 455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
                        +   L +NPADR S   +L H  ++R  S  
Sbjct: 240 ----------KDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (304), Expect = 1e-30
 Identities = 45/142 (31%), Positives = 73/142 (51%), Gaps = 10/142 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            +  QLKHP+ +E    +   +  +LV+E C  G  +  ++   +P  E E       ++
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPAN---SFVGTPYWMAPE 120
            G+ YLHS G +HRD+   N+LLT    +K+ADFG +  +K P     +  GTP +++PE
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

Query: 121 VILAMDEGQ-YDGKVDVWSLGI 141
           +         +  + DVWSLG 
Sbjct: 183 IA----TRSAHGLESDVWSLGC 200

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 67.9 bits (167), Expect = 1e-12
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 1/66 (1%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LV+E C  G  +  ++   +P  E E       ++ G+ YLHS G +HRD+   N+LLT 
Sbjct: 88  LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR 147

Query: 675 TGTVKL 680
              +K+
Sbjct: 148 NMNIKI 153

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  153 bits (390), Expect = 4e-42
 Identities = 82/331 (24%), Positives = 123/331 (37%), Gaps = 89/331 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKH 221
           FE  R +G G FG VY AR   S+ I+A+K +  + L K   E    + +E+     L+H
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSHLRH 68

Query: 222 PNTIEYRGCYLRDHTAW-LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           PN +   G Y  D T   L++EY                       G             
Sbjct: 69  PNILRLYG-YFHDATRVYLILEYAPL--------------------GT------------ 95

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
            ++          E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG
Sbjct: 96  -VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

Query: 341 SASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
             S+  P++      GT  ++ PE+I   +   +D KVD+WSLG+ C E    KPP+   
Sbjct: 155 W-SVHAPSSRRTDLCGTLDYLPPEMI---EGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQS 457
                   I++ +                      P +    A                 
Sbjct: 211 TYQETYKRISRVEFTF-------------------PDFVTEGA----------------- 234

Query: 458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                     +S  L  NP+ RP    +L H
Sbjct: 235 -------RDLISRLLKHNPSQRPMLREVLEH 258

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  111 bits (280), Expect = 2e-27
 Identities = 47/141 (33%), Positives = 74/141 (52%), Gaps = 11/141 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
            +   L+HPN +   G Y  D T   L++EY   G+    ++   +   E+  A   + +
Sbjct: 61  EIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPE 120
              L+Y HS   IHRD+K  N+LL   G +K+ADFG  S+  P++      GT  ++ PE
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDLCGTLDYLPPE 177

Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           +I   +   +D KVD+WSLG+
Sbjct: 178 MI---EGRMHDEKVDLWSLGV 195

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 20/66 (30%), Positives = 34/66 (51%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           L++EY   G+    ++   +   E+  A   + +   L+Y HS   IHRD+K  N+LL  
Sbjct: 86  LILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS 144

Query: 675 TGTVKL 680
            G +K+
Sbjct: 145 AGELKI 150

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  157 bits (399), Expect = 3e-41
 Identities = 77/387 (19%), Positives = 127/387 (32%), Gaps = 92/387 (23%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK----------KMSYLGKQCAEKW 206
           +    + +  +R++G G++G V   +        AIK          + S   K   +  
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 207 ADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM 266
            +I  EI  L+ L HPN I+    +      +LV E+  G                    
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG-------------------- 130

Query: 267 GNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 326
           G              LF   +++    E + A I   +L G+ YLH    +HRD+K  NI
Sbjct: 131 GE-------------LFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177

Query: 327 LLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           LL        +K+ DFG +S           +GT Y++APEV+    + +Y+ K DVWS 
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL----KKKYNEKCDVWSC 233

Query: 381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           G+    L    PP F       +    +        +DW   K IS  A           
Sbjct: 234 GVIMYILLCGYPP-FGGQNDQDIIKKVEKGKYYFDFNDW---KNISDEA----------- 278

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                                      +   L  +   R ++   L    + +  +    
Sbjct: 279 ------------------------KELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314

Query: 501 VDLIRRTKAAVRDLDNLNYRKMKKILM 527
            D      A          +K+ +  +
Sbjct: 315 SDQKTLCGALSNMRKFEGSQKLAQAAI 341

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (308), Expect = 2e-29
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 14/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           L+ L HPN I+    +      +LV E+  G      II   +    E + A I   +L 
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILS 157

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASI---KCPANSFVGTPYWMAP 119
           G+ YLH    +HRD+K  NILL        +K+ DFG +S           +GT Y++AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           EV+    + +Y+ K DVWS G+
Sbjct: 218 EVL----KKKYNEKCDVWSCGV 235

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 23/70 (32%), Positives = 32/70 (45%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LV E+  G      II   +    E + A I   +L G+ YLH    +HRD+K  NILL 
Sbjct: 123 LVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180

Query: 674 ---ETGTVKL 680
                  +K+
Sbjct: 181 NKNSLLNIKI 190

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  153 bits (389), Expect = 7e-41
 Identities = 56/350 (16%), Positives = 103/350 (29%), Gaps = 66/350 (18%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
            +     ++     +G G+   V+  R   + ++ AIK  +             ++E   
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVDVQMREFEV 60

Query: 216 LRQLKHPNTIEYRGCY--LRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           L++L H N ++              L+ME+C                      G+     
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC--------------------GS----- 95

Query: 274 KCFTEHFALFNFEVHK---RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 329
                   L+           L E E   +   V+ G+N+L   G +HR++K GNI+   
Sbjct: 96  --------LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147

Query: 330 ---ETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVI-----LAMDEGQYDGKVDVW 378
                   KL DFG+A          S  GT  ++ P++          + +Y   VD+W
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207

Query: 379 SLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNM 438
           S+G+T    A    P+           +                K I+            
Sbjct: 208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMY--------------KIITGKPSGAISGVQK 253

Query: 439 NAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                +         C  S          +++ L  +        +    
Sbjct: 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  125 bits (316), Expect = 3e-31
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 17/152 (11%)

Query: 8   LRQLKHPNTIEYRGCY--LRDHTAWLVMEYCL-GSASDIIEVHKR--PLKEEEIAAICSG 62
           L++L H N ++              L+ME+C  GS   ++E       L E E   +   
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASI---KCPANSFVGTPY 115
           V+ G+N+L   G +HR++K GNI+           KL DFG+A          S  GT  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 116 WMAPEVI-----LAMDEGQYDGKVDVWSLGIT 142
           ++ P++          + +Y   VD+WS+G+T
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 7/72 (9%)

Query: 616 LVMEYCL-GSASDIIEVHKR--PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           L+ME+C  GS   ++E       L E E   +   V+ G+N+L   G +HR++K GNI+ 
Sbjct: 86  LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145

Query: 673 T----ETGTVKL 680
                     KL
Sbjct: 146 VIGEDGQSVYKL 157

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (382), Expect = 8e-41
 Identities = 67/351 (19%), Positives = 115/351 (32%), Gaps = 89/351 (25%)

Query: 163 IFEDL---REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           +  D+     +G G +G V+        E VA+K  S    +  + W     E+     L
Sbjct: 6   VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFS---SRDEKSWF-RETELYNTVML 59

Query: 220 KHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           +H N + +    +    +    WL+  Y  +GS  D +                      
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---------------------- 97

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL--------GRIHRDVKAGNI 326
                            L       I   +  GL +LH             HRD+K+ NI
Sbjct: 98  -------------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144

Query: 327 LLTETGTVKLADFGSA--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKV 375
           L+ + G   +AD G A         +    N  VGT  +MAPEV+   + +D      +V
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204

Query: 376 DVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           D+W+ G+   E+A R      +      ++    D      S   + K +    +R P  
Sbjct: 205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFY----DVVPNDPSFEDMRKVVCVDQQR-PN- 258

Query: 436 FNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
                      I          +  +      +  C  +NP+ R ++ R+ 
Sbjct: 259 -----------IPNRWFSDPTLTSLAKL----MKECWYQNPSARLTALRIK 294

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  132 bits (333), Expect = 3e-34
 Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 26/159 (16%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHKRPLKEEEIAAICS 61
               L+H N + +    +    +    WL+  Y  +GS  D +      L       I  
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVL 112

Query: 62  GVLRGLNYLHSL--------GRIHRDVKAGNILLTETGTVKLADFGSA--------SIKC 105
            +  GL +LH             HRD+K+ NIL+ + G   +AD G A         +  
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172

Query: 106 PANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGI 141
             N  VGT  +MAPEV+   + +D      +VD+W+ G+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 11/74 (14%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL--------GRIHRDVK 666
           L+  Y  +GS  D +      L       I   +  GL +LH             HRD+K
Sbjct: 83  LITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140

Query: 667 AGNILLTETGTVKL 680
           + NIL+ + G   +
Sbjct: 141 SKNILVKKNGQCCI 154

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  157 bits (397), Expect = 3e-40
 Identities = 70/341 (20%), Positives = 108/341 (31%), Gaps = 72/341 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS-YLGKQCAEKWADILKEIRFLRQLKHP 222
           +E    +G G FG V       + E VAIK+    L  +  E+W     EI+ +++L HP
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHP 72

Query: 223 N------TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           N        +       +    L MEYC  G     +     + E               
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFE--------------- 113

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG--- 332
                       +   LKE  I  + S +   L YLH    IHRD+K  NI+L       
Sbjct: 114 ------------NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRL 161

Query: 333 TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELA 388
             K+ D G A           FVGT  ++APE++    E + Y   VD WS G    E  
Sbjct: 162 IHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL----EQKKYTVTVDYWSFGTLAFECI 217

Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
               P+         +   +                       +      +   A+   +
Sbjct: 218 TGFRPFLPNWQPVQWHGKVRE-------------------KSNEHIVVYDDLTGAVKFSS 258

Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
              TP   S   +     ++   L  +   R +  +     
Sbjct: 259 VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  128 bits (322), Expect = 8e-31
 Identities = 45/153 (29%), Positives = 63/153 (41%), Gaps = 20/153 (13%)

Query: 6   SLLRQLKHPN------TIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRP--LKEEEI 56
            ++++L HPN        +       +    L MEYC  G     +   +    LKE  I
Sbjct: 64  QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---TVKLADFGSASIKCP---ANSF 110
             + S +   L YLH    IHRD+K  NI+L         K+ D G A           F
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183

Query: 111 VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGIT 142
           VGT  ++APE++    E + Y   VD WS G  
Sbjct: 184 VGTLQYLAPELL----EQKKYTVTVDYWSFGTL 212

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 64.7 bits (157), Expect = 8e-11
 Identities = 24/71 (33%), Positives = 31/71 (43%), Gaps = 6/71 (8%)

Query: 616 LVMEYC-LGSASDIIEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           L MEYC  G     +   +    LKE  I  + S +   L YLH    IHRD+K  NI+L
Sbjct: 95  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154

Query: 673 TETG---TVKL 680
                    K+
Sbjct: 155 QPGPQRLIHKI 165

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  148 bits (376), Expect = 4e-40
 Identities = 89/339 (26%), Positives = 122/339 (35%), Gaps = 87/339 (25%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K D  + +     IG GS+G V  A    +R   A KK+    K   E      +EI  +
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP---KYFVEDVDRFKQEIEIM 60

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           + L HPN I     +  +   +LVME C G                    G         
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTG--------------------G--------- 91

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGT 333
            E   LF   VHKR  +E + A I   VL  + Y H L   HRD+K  N L         
Sbjct: 92  -E---LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP 147

Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAE 389
           +KL DFG A+   P       VGTPY+++P+V+    EG Y  + D WS G +  + L  
Sbjct: 148 LKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL----EGLYGPECDEWSAGVMMYVLLCG 203

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
             PP F+    S +    +  T      DW     +S  AE                   
Sbjct: 204 Y-PP-FSAPTDSEVMLKIREGTFTFPEKDW---LNVSPQAE------------------- 239

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                             +   L K+P  R +S + L H
Sbjct: 240 ----------------SLIRRLLTKSPKQRITSLQALEH 262

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  118 bits (299), Expect = 7e-30
 Identities = 48/142 (33%), Positives = 68/142 (47%), Gaps = 14/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           ++ L HPN I     +  +   +LVME C G      ++   KR  +E + A I   VL 
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLS 117

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
            + Y H L   HRD+K  N L         +KL DFG A+   P       VGTPY+++P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           +V+    EG Y  + D WS G+
Sbjct: 178 QVL----EGLYGPECDEWSAGV 195

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 51.4 bits (124), Expect = 4e-07
 Identities = 22/60 (36%), Positives = 28/60 (46%), Gaps = 4/60 (6%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LVME C G      ++   KR  +E + A I   VL  + Y H L   HRD+K  N L  
Sbjct: 83  LVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  149 bits (379), Expect = 5e-40
 Identities = 69/352 (19%), Positives = 122/352 (34%), Gaps = 87/352 (24%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
             ++I + +++IG G +G V+  +     E VA+K            W     EI     
Sbjct: 35  IAKQI-QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFF---TTEEASWFR-ETEIYQTVL 87

Query: 219 LKHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQL 273
           ++H N + +    ++   +    +L+ +Y   GS  D +                     
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--------------------- 126

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--------IHRDVKAGN 325
                             L  + +  +    + GL +LH+            HRD+K+ N
Sbjct: 127 --------------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172

Query: 326 ILLTETGTVKLADFGSA--------SIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGK 374
           IL+ + GT  +AD G A         +  P N+ VGT  +M PEV+   L  +  Q    
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232

Query: 375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPP 434
            D++S G+   E+A R      +      Y +  +D      S   + + +     R  P
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEE----YQLPYHDLVPSDPSYEDMREIVCIKKLR--P 286

Query: 435 YFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
            F                    S +        ++ C A NPA R ++ R+ 
Sbjct: 287 SFP---------------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  126 bits (317), Expect = 9e-32
 Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 26/159 (16%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHKRPLKEEEIAAICS 61
               ++H N + +    ++   +    +L+ +Y   GS  D +      L  + +  +  
Sbjct: 84  QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAY 141

Query: 62  GVLRGLNYLHSLGR--------IHRDVKAGNILLTETGTVKLADFGSA--------SIKC 105
             + GL +LH+            HRD+K+ NIL+ + GT  +AD G A         +  
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201

Query: 106 PANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGI 141
           P N+ VGT  +M PEV+   L  +  Q     D++S G+
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 19/74 (25%), Positives = 33/74 (44%), Gaps = 11/74 (14%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--------IHRDVK 666
           L+ +Y   GS  D +      L  + +  +    + GL +LH+            HRD+K
Sbjct: 112 LITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169

Query: 667 AGNILLTETGTVKL 680
           + NIL+ + GT  +
Sbjct: 170 SKNILVKKNGTCCI 183

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  147 bits (374), Expect = 7e-40
 Identities = 75/332 (22%), Positives = 119/332 (35%), Gaps = 91/332 (27%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKH 221
           F+  R +G G FG VY AR   ++ I+A+K +  S L K+  E    + +EI     L+H
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH--QLRREIEIQSHLRH 73

Query: 222 PNTIEYRGCYLRDHTAW-LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           PN +     Y  D     L++E+                     G               
Sbjct: 74  PNILRMYN-YFHDRKRIYLMLEFAPR------------------GE-------------- 100

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
            L+          E+  A     +   L+Y H    IHRD+K  N+L+   G +K+ADFG
Sbjct: 101 -LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159

Query: 341 SASIKCPAN---SFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPYFN 396
             S+  P+    +  GT  ++ PE+I    EG+ +D KVD+W  G+ C E     PP+ +
Sbjct: 160 W-SVHAPSLRRRTMCGTLDYLPPEMI----EGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +       I   D                      PP+ +  +                
Sbjct: 215 PSHTETHRRIVNVDLKF-------------------PPFLSDGS---------------- 239

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                      +S  L  +P  R     ++ H
Sbjct: 240 --------KDLISKLLRYHPPQRLPLKGVMEH 263

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 2e-26
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 13/142 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAW-LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
            +   L+HPN +     Y  D     L++E+   G     ++ H R   E+  A     +
Sbjct: 66  EIQSHLRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEEL 123

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPE 120
              L+Y H    IHRD+K  N+L+   G +K+ADFG  S+  P+    +  GT  ++ PE
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRTMCGTLDYLPPE 182

Query: 121 VILAMDEGQ-YDGKVDVWSLGI 141
           +I    EG+ +D KVD+W  G+
Sbjct: 183 MI----EGKTHDEKVDLWCAGV 200

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           L++E+   G     ++ H R   E+  A     +   L+Y H    IHRD+K  N+L+  
Sbjct: 91  LMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY 149

Query: 675 TGTVKL 680
            G +K+
Sbjct: 150 KGELKI 155

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  150 bits (381), Expect = 1e-39
 Identities = 43/349 (12%), Positives = 88/349 (25%), Gaps = 64/349 (18%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE---IRFL 216
             +       +G     A   A    + E   +    +  +  +     + +E   +R L
Sbjct: 76  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHV-EGMGNRLQQLK 274
           R +K+    +    ++         +   +          W+   F +   M + LQ   
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF- 194

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                  L +     + L       +   V+R L  LH  G +H  ++  +I+L + G V
Sbjct: 195 ----GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 250

Query: 335 KLADFGSASI-----KCPANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIEL 387
            L  F            P       P   A  ++              D W+LG+    +
Sbjct: 251 FLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                P  +  A+     I ++                                      
Sbjct: 311 WCADLPNTDDAALGGSEWIFRSC------------------------------------- 333

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS 496
                      +        +   L     DR    + +      + R+
Sbjct: 334 ----------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (267), Expect = 7e-25
 Identities = 26/151 (17%), Positives = 46/151 (30%), Gaps = 15/151 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLGSASDIIEV------HKRPLKEEEIAA 58
           L++  +    I  R         + + +      +     EV        + L       
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 215

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-----KCPANSFVGT 113
           +   V+R L  LH  G +H  ++  +I+L + G V L  F            P       
Sbjct: 216 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAP 275

Query: 114 PYWMAPEVILAM--DEGQYDGKVDVWSLGIT 142
           P   A  ++              D W+LG+ 
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 6/71 (8%)

Query: 616 LVMEYCLGSASDIIEV------HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 669
            +      +     EV        + L       +   V+R L  LH  G +H  ++  +
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 241

Query: 670 ILLTETGTVKL 680
           I+L + G V L
Sbjct: 242 IVLDQRGGVFL 252

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  147 bits (373), Expect = 4e-39
 Identities = 72/355 (20%), Positives = 114/355 (32%), Gaps = 89/355 (25%)

Query: 159 DPEKIFEDL---REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF 215
               I   +     IG G FG V+  +     E VA+K  S    +    W     EI  
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFR-EAEIYQ 89

Query: 216 LRQLKHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRL 270
              L+H N + +     +D+      WLV +Y   GS  D +                  
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------------------ 131

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--------IHRDVK 322
                            ++  +  E +  +      GL +LH             HRD+K
Sbjct: 132 -----------------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 323 AGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVI---LAMDEGQY 371
           + NIL+ + GT  +AD G A              N  VGT  +MAPEV+   + M   + 
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234

Query: 372 DGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER 431
             + D++++G+   E+A R             Y +   D      S   + K +     R
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHED----YQLPYYDLVPSDPSVEEMRKVVCEQKLR 290

Query: 432 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
            P             I      C      +      +  C   N A R ++ R+ 
Sbjct: 291 -PN------------IPNRWQSCEALRVMAKI----MRECWYANGAARLTALRIK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  124 bits (312), Expect = 4e-31
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 26/159 (16%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHKRPLKEEEIAAICS 61
               L+H N + +     +D+      WLV +Y   GS  D +  ++  +  E +  +  
Sbjct: 89  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLAL 146

Query: 62  GVLRGLNYLHSLGR--------IHRDVKAGNILLTETGTVKLADFGSASIKC-------- 105
               GL +LH             HRD+K+ NIL+ + GT  +AD G A            
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206

Query: 106 PANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGI 141
             N  VGT  +MAPEV+   + M   +   + D++++G+
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 11/74 (14%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--------IHRDVK 666
           LV +Y   GS  D +  ++  +  E +  +      GL +LH             HRD+K
Sbjct: 117 LVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 667 AGNILLTETGTVKL 680
           + NIL+ + GT  +
Sbjct: 175 SKNILVKKNGTCCI 188

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  148 bits (374), Expect = 5e-39
 Identities = 44/350 (12%), Positives = 88/350 (25%), Gaps = 65/350 (18%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
             +       +G     A   A    + E   +    +  +  +     + +E+  LR L
Sbjct: 71  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYC----LGSASDIIEVHWIEREFHV-EGMGNRLQQLK 274
           +     +    +LR    + +++      +          W+   F +   M + LQ   
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                  L +     + L       +   V+R L  LH  G +H  ++  +I+L + G V
Sbjct: 191 EV-----LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 245

Query: 335 KLADFGSASIKCPANSFVGTPYWMAPEVIL--------AMDEGQYDGKVDVWSLGITCIE 386
            L  F              +  +  PE+                     D W+LG+    
Sbjct: 246 FLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH 446
           +     P    +A                   +   K I                     
Sbjct: 306 IWCADLP-ITKDAALGGSEW-----------IFRSCKNIPQPVR---------------- 337

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS 496
                                +   L     DR    + +      + R+
Sbjct: 338 -------------------ALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (273), Expect = 7e-26
 Identities = 24/152 (15%), Positives = 44/152 (28%), Gaps = 16/152 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA--WLVMEYCLGSASDIIE------VHKRPLKEEEIAA 58
           L++  +    I  R           + +      +     E         + L       
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMA 118
           +   V+R L  LH  G +H  ++  +I+L + G V L  F              +  +  
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEP 270

Query: 119 PEVIL--------AMDEGQYDGKVDVWSLGIT 142
           PE+                     D W+LG+ 
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLV 302

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 14/101 (13%), Positives = 30/101 (29%), Gaps = 12/101 (11%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIE------VHKRPLKEE 639
           +      +  +     +    +         +      +     E         + L   
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRF------FLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206

Query: 640 EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
               +   V+R L  LH  G +H  ++  +I+L + G V L
Sbjct: 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 247

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  144 bits (366), Expect = 2e-38
 Identities = 84/340 (24%), Positives = 136/340 (40%), Gaps = 72/340 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK-WADI--LKEIRFLRQLK 220
           +E + +IG GS+G V+  R   + +IVAIKK      +  +        L+EIR L+QLK
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLK 60

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HPN +     + R     LV EYC                            +    +  
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCD-------------------------HTVLHELDR- 94

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                  ++R + E  + +I    L+ +N+ H    IHRDVK  NIL+T+   +KL DFG
Sbjct: 95  -------YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG 147

Query: 341 SA-SIKCPANSFVGTPY----WM-APEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
            A  +  P++ +         W  +PE+++   + QY   VDVW++G  C+  EL    P
Sbjct: 148 FARLLTGPSDYY--DDEVATRWYRSPELLVG--DTQYGPPVDVWAIG--CVFAELLSGVP 201

Query: 393 PYFN-MNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERK-PPYFNMNAMSALYHIAQ 449
             +   + +  LY I +             V  T    +  K P   +M  +   +    
Sbjct: 202 -LWPGKSDVDQLYLIRKTLGDLI--PRHQQVFSTNQYFSGVKIPDPEDMEPLELKF---- 254

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
                    + S      +  CL  +P +R +  +LL H 
Sbjct: 255 --------PNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  111 bits (281), Expect = 3e-27
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 30/179 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +L+QLKHPN +     + R     LV EYC  +    ++ ++R + E  + +I    L+
Sbjct: 54  RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPY----WM-AP 119
            +N+ H    IHRDVK  NIL+T+   +KL DFG A  +  P++ +         W  +P
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSP 171

Query: 120 EVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           E+++   + QY   VDVW++G           + PG     ++ +L+       I + L
Sbjct: 172 ELLVG--DTQYGPPVDVWAIGCVFAELLSGVPLWPG---KSDVDQLY------LIRKTL 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 23/65 (35%), Positives = 37/65 (56%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EYC  +    ++ ++R + E  + +I    L+ +N+ H    IHRDVK  NIL+T+ 
Sbjct: 79  LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138

Query: 676 GTVKL 680
             +KL
Sbjct: 139 SVIKL 143

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  144 bits (366), Expect = 2e-38
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 48/237 (20%)

Query: 160 PEKIFED---LREIGHGSFGAVYYARCLVSREIVAIK-----KMSYLGKQCAEKWADILK 211
           P+ + ++    + +G G+ G V  A    + + VAIK     K +    + A+   ++  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64

Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQ 271
           EI  L++L HP  I+ +  +      ++V+E   G                    G    
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEG--------------------G---- 99

Query: 272 QLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-- 329
                 E   LF+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+  
Sbjct: 100 ------E---LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150

Query: 330 -ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
            E   +K+ DFG + I    +      GTP ++APEV++++    Y+  VD WSLG+
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  118 bits (297), Expect = 3e-29
 Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 17/145 (11%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE-----VHKRPLKEEEIAAICSG 62
           L++L HP  I+ +  +      ++V+E   G      E     V  + LKE         
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG-----ELFDKVVGNKRLKEATCKLYFYQ 122

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYW 116
           +L  + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I    +      GTP +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           +APEV++++    Y+  VD WSLG+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGV 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 23/73 (31%), Positives = 33/73 (45%), Gaps = 13/73 (17%)

Query: 616 LVMEYCLGSASDIIE-----VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
           +V+E   G      E     V  + LKE         +L  + YLH  G IHRD+K  N+
Sbjct: 91  IVLELMEGG-----ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 145

Query: 671 LLT---ETGTVKL 680
           LL+   E   +K+
Sbjct: 146 LLSSQEEDCLIKI 158

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  144 bits (365), Expect = 3e-38
 Identities = 73/359 (20%), Positives = 115/359 (32%), Gaps = 89/359 (24%)

Query: 155 FDKEDPEKIFEDLRE---IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK 211
              E+       L+       G FG V+ A+     E VA+K      KQ  +       
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQN----EY 67

Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHWIEREFHVEGM 266
           E+  L  +KH N +++ G   R  +     WL+  +   GS                   
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS------------------- 108

Query: 267 GNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS----------LGR 316
                          L +F +    +   E+  I   + RGL YLH              
Sbjct: 109 ---------------LSDF-LKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152

Query: 317 IHRDVKAGNILLTETGTVKLADFGSASIKCPANSF------VGTPYWMAPEVI--LAMDE 368
            HRD+K+ N+LL    T  +ADFG A       S       VGT  +MAPEV+      +
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212

Query: 369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSAL-YHIAQNDTPCLQSSDWSVIKTISS 427
                ++D++++G+   ELA R            L +       P L+     V+     
Sbjct: 213 RDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH---- 268

Query: 428 TAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             ++K P                     Q           +  C   +   R S+G + 
Sbjct: 269 --KKKRPVLR---------------DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  123 bits (310), Expect = 5e-31
 Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 35/197 (17%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA----WLVMEYC-LGSASDIIEVHKRPLKEEEIAAICS 61
            L  +KH N +++ G   R  +     WL+  +   GS SD +      +   E+  I  
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAE 128

Query: 62  GVLRGLNYLHS----------LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF- 110
            + RGL YLH               HRD+K+ N+LL    T  +ADFG A       S  
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 111 -----VGTPYWMAPEVI--LAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAEL 154
                VGT  +MAPEV+      +     ++D++++G+         T       E    
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 155 FDKEDPE-KIFEDLREI 170
           F++E  +    ED++E+
Sbjct: 249 FEEEIGQHPSLEDMQEV 265

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 21/76 (27%), Positives = 31/76 (40%), Gaps = 13/76 (17%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS----------LGRIHRD 664
           L+  +   GS SD +      +   E+  I   + RGL YLH               HRD
Sbjct: 99  LITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156

Query: 665 VKAGNILLTETGTVKL 680
           +K+ N+LL    T  +
Sbjct: 157 IKSKNVLLKNNLTACI 172

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  142 bits (361), Expect = 4e-38
 Identities = 57/238 (23%), Positives = 90/238 (37%), Gaps = 45/238 (18%)

Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
            L+ +   + +F   R++G G+FG V+      S     IK ++    +       I  E
Sbjct: 13  NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN--KDRSQVPMEQIEAE 70

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHWIEREFHVEGMGNRL 270
           I  L+ L HPN I+    +   H  ++VME C G      I+                  
Sbjct: 71  IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS---------------AQ 115

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 329
            + K  +E +                 A +   ++  L Y HS   +H+D+K  NIL   
Sbjct: 116 ARGKALSEGYV----------------AELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159

Query: 330 --ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
                 +K+ DFG A +           GT  +MAPEV     +     K D+WS G+
Sbjct: 160 TSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF----KRDVTFKCDIWSAGV 213

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  118 bits (298), Expect = 1e-29
 Identities = 44/144 (30%), Positives = 64/144 (44%), Gaps = 14/144 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRP--LKEEEIAAICSGV 63
           L+ L HPN I+    +   H  ++VME C G      I+    R   L E  +A +   +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWM 117
           +  L Y HS   +H+D+K  NIL         +K+ DFG A +           GT  +M
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APEV     +     K D+WS G+
Sbjct: 194 APEVF----KRDVTFKCDIWSAGV 213

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 21/72 (29%), Positives = 32/72 (44%), Gaps = 7/72 (9%)

Query: 616 LVMEYCLGSA--SDIIEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           +VME C G      I+    R   L E  +A +   ++  L Y HS   +H+D+K  NIL
Sbjct: 97  IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156

Query: 672 LT---ETGTVKL 680
                    +K+
Sbjct: 157 FQDTSPHSPIKI 168

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (280), Expect = 3e-27
 Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 35/186 (18%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGV 63
           ++L+++KH N +     Y      +LVM+   G      I+E  +    E++ + +   V
Sbjct: 58  AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQV 115

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPA--NSFVGTPYWMA 118
           L  + YLH  G +HRD+K  N+L     E   + + DFG + ++     ++  GTP ++A
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVA 175

Query: 119 PEVILAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFEDLRE 169
           PEV+    +  Y   VD WS+G+          P           F +E   K+FE   +
Sbjct: 176 PEVLA---QKPYSKAVDCWSIGVITYILLCGYPP-----------FYEETESKLFE---K 218

Query: 170 IGHGSF 175
           I  G +
Sbjct: 219 IKEGYY 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 48.3 bits (116), Expect = 5e-06
 Identities = 19/59 (32%), Positives = 30/59 (50%), Gaps = 4/59 (6%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           LVM+   G      I+E  +    E++ + +   VL  + YLH  G +HRD+K  N+L 
Sbjct: 83  LVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLY 139

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  145 bits (368), Expect = 8e-38
 Identities = 76/345 (22%), Positives = 123/345 (35%), Gaps = 85/345 (24%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK-----KMSYLGKQCAEKWADIL 210
             +     +   + +G G+ G V  A    + + VAI+     K +    + A+   ++ 
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            EI  L++L HP  I+ +  +      ++V+E   G                    G   
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEG--------------------G--- 224

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 329
                  E   LF+  V  + LKE         +L  + YLH  G IHRD+K  N+LL+ 
Sbjct: 225 -------E---LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 274

Query: 330 --ETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-IT 383
             E   +K+ DFG + I        +  GTP ++APEV++++    Y+  VD WSLG I 
Sbjct: 275 QEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
            I L+   PP+       +L     +         W     +S  A              
Sbjct: 335 FICLSGY-PPFSEHRTQVSLKDQITSGKYNFIPEVW---AEVSEKAL------------- 377

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                                   V   L  +P  R ++   L H
Sbjct: 378 ----------------------DLVKKLLVVDPKARFTTEEALRH 400

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  120 bits (303), Expect = 3e-29
 Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 11/144 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGV 63
            +L++L HP  I+ +  +      ++V+E   G      ++    + LKE         +
Sbjct: 192 EILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQM 248

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPA---NSFVGTPYWM 117
           L  + YLH  G IHRD+K  N+LL+   E   +K+ DFG + I        +  GTP ++
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APEV++++    Y+  VD WSLG+
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGV 332

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 21/70 (30%), Positives = 33/70 (47%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V+E   G      ++    + LKE         +L  + YLH  G IHRD+K  N+LL+
Sbjct: 216 IVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273

Query: 674 ---ETGTVKL 680
              E   +K+
Sbjct: 274 SQEEDCLIKI 283

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 9e-38
 Identities = 64/241 (26%), Positives = 97/241 (40%), Gaps = 46/241 (19%)

Query: 152 AELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWAD 208
             +F +E+ +  ++   E+G G F  V   R   +    A   IKK      +      D
Sbjct: 1   GTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60

Query: 209 ILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGN 268
           I +E+  L++++HPN I     Y       L++E   G                    G 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG--------------------G- 99

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
                    E   LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L
Sbjct: 100 ---------E---LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

Query: 329 T----ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
                    +K+ DFG A      N F    GTP ++APE++   +      + D+WS+G
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV---NYEPLGLEADMWSIG 204

Query: 382 I 382
           +
Sbjct: 205 V 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (284), Expect = 1e-27
 Identities = 45/143 (31%), Positives = 67/143 (46%), Gaps = 14/143 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           L++++HPN I     Y       L++E   G      + E  K  L EEE       +L 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILN 125

Query: 66  GLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASIKCPANSF---VGTPYWMA 118
           G+ YLHSL   H D+K  NI+L         +K+ DFG A      N F    GTP ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE++   +      + D+WS+G+
Sbjct: 186 PEIV---NYEPLGLEADMWSIGV 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 23/71 (32%), Positives = 32/71 (45%), Gaps = 8/71 (11%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           L++E   G      + E  K  L EEE       +L G+ YLHSL   H D+K  NI+L 
Sbjct: 91  LILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148

Query: 674 ----ETGTVKL 680
                   +K+
Sbjct: 149 DRNVPKPRIKI 159

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  142 bits (360), Expect = 1e-37
 Identities = 64/240 (26%), Positives = 94/240 (39%), Gaps = 46/240 (19%)

Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADI 209
           E F ++  E  ++   E+G G F  V   R   +    A   IKK      +      +I
Sbjct: 3   EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62

Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            +E+  LRQ+ H N I     Y       L++E   G                    G  
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG--------------------G-- 100

Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                   E   LF+F   K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 101 --------E---LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149

Query: 330 ----ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
                   +KL DFG A        F    GTP ++APE++   +      + D+WS+G+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV---NYEPLGLEADMWSIGV 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (286), Expect = 9e-28
 Identities = 45/146 (30%), Positives = 64/146 (43%), Gaps = 20/146 (13%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE-----VHKRPLKEEEIAAICSG 62
           LRQ+ H N I     Y       L++E   G      E       K  L EEE  +    
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGG-----ELFDFLAQKESLSEEEATSFIKQ 123

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASIKCPANSF---VGTPY 115
           +L G+NYLH+    H D+K  NI+L         +KL DFG A        F    GTP 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGI 141
           ++APE++   +      + D+WS+G+
Sbjct: 184 FVAPEIV---NYEPLGLEADMWSIGV 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 23/74 (31%), Positives = 32/74 (43%), Gaps = 14/74 (18%)

Query: 616 LVMEYCLGSASDIIE-----VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
           L++E   G      E       K  L EEE  +    +L G+NYLH+    H D+K  NI
Sbjct: 92  LILELVSGG-----ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146

Query: 671 LLT----ETGTVKL 680
           +L         +KL
Sbjct: 147 MLLDKNIPIPHIKL 160

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  141 bits (357), Expect = 1e-37
 Identities = 75/342 (21%), Positives = 127/342 (37%), Gaps = 91/342 (26%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           +    + +  +  +G GSFG V   +  ++++  A+K ++       +  + IL+E+  L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELL 75

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG---NRLQQL 273
           ++L HPN ++         + ++V E   G                    G   + + + 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTG--------------------GELFDEIIKR 115

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---E 330
           K F+EH A                A I   V  G+ Y+H    +HRD+K  NILL    +
Sbjct: 116 KRFSEHDA----------------ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159

Query: 331 TGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIE 386
              +K+ DFG ++           +GT Y++APEV+     G YD K DVWS G I  I 
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----RGTYDEKCDVWSAGVILYIL 215

Query: 387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH 446
           L+   PP F       +    +          W   +TIS  A+                
Sbjct: 216 LSGT-PP-FYGKNEYDILKRVETGKYAFDLPQW---RTISDDAK---------------- 254

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                                +   L  +P+ R ++ + L H
Sbjct: 255 -------------------DLIRKMLTFHPSLRITATQCLEH 277

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (298), Expect = 1e-29
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           L++L HPN ++         + ++V E   G     +II+  ++   E + A I   V  
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFS 132

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
           G+ Y+H    +HRD+K  NILL    +   +K+ DFG ++           +GT Y++AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           EV+     G YD K DVWS G+
Sbjct: 193 EVL----RGTYDEKCDVWSAGV 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 21/70 (30%), Positives = 34/70 (48%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V E   G     +II+  ++   E + A I   V  G+ Y+H    +HRD+K  NILL 
Sbjct: 98  IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 674 ---ETGTVKL 680
              +   +K+
Sbjct: 156 SKEKDCDIKI 165

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  144 bits (365), Expect = 2e-37
 Identities = 81/345 (23%), Positives = 132/345 (38%), Gaps = 83/345 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + D + IG+GSFG VY A+   S E+VAIKK+     Q         +E++ +R+L H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKR---FKNRELQIMRKLDHCN 108

Query: 224 TIEYRGCYLRDHTAW------LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            +  R  +             LV++Y                      +   + ++    
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY----------------------VPETVYRV---- 142

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKL 336
                 ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  +T  +KL
Sbjct: 143 ----ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 198

Query: 337 ADFGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
            DFGSA          S++ + Y+ APE+I    +  Y   +DVWS G  C+  EL   +
Sbjct: 199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAG--CVLAELLLGQ 254

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           P +   + +  L  I               IK + +     P    +  M+  Y   +  
Sbjct: 255 PIFPGDSGVDQLVEI---------------IKVLGT-----PTREQIREMNPNY--TEFK 292

Query: 452 TPCLQSSDWSDTFAH--------FVSSCLAKNPADRPSSGRLLTH 488
            P +++  W+  F            S  L   P  R +      H
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  101 bits (253), Expect = 6e-23
 Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 15/148 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAW------LVMEYC---LGSASDIIEVHKRPLKEEEI 56
            ++R+L H N +  R  +             LV++Y    +   +      K+ L    +
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPAN---SFVG 112
                 + R L Y+HS G  HRD+K  N+LL  +T  +KL DFGSA          S++ 
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           + Y+ APE+I    +  Y   +DVWS G
Sbjct: 219 SRYYRAPELIFGATD--YTSSIDVWSAG 244

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 4/69 (5%)

Query: 616 LVMEYC---LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           LV++Y    +   +      K+ L    +      + R L Y+HS G  HRD+K  N+LL
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189

Query: 673 -TETGTVKL 680
             +T  +KL
Sbjct: 190 DPDTAVLKL 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  141 bits (358), Expect = 3e-37
 Identities = 77/340 (22%), Positives = 125/340 (36%), Gaps = 72/340 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK-WADI--LKEIRFLRQLK 220
           +E+L  +G GS+G V   R   +  IVAIKK      +  +        ++EI+ L+QL+
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQLR 82

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N +       +    +LV E+                             +    E  
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVD-------------------------HTILDDLEL- 116

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                      L  + +      ++ G+ + HS   IHRD+K  NIL++++G VKL DFG
Sbjct: 117 -------FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG 169

Query: 341 SA-SIKCPANSFVGTPY----WM-APEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
            A ++  P   +         W  APE+++   + +Y   VDVW++G  C+  E+   + 
Sbjct: 170 FARTLAAPGEVY--DDEVATRWYRAPELLVG--DVKYGKAVDVWAIG--CLVTEMFMGE- 222

Query: 393 PYFN-MNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERK-PPYFNMNAMSALYHIAQ 449
           P F   + +  LYHI               +       A  + P       +   Y    
Sbjct: 223 PLFPGDSDIDQLYHIMMCLGNLI--PRHQELFNKNPVFAGVRLPEIKEREPLERRY---- 276

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD 489
                      S+        CL  +P  RP    LL HD
Sbjct: 277 --------PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  111 bits (279), Expect = 7e-27
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 30/179 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            LL+QL+H N +       +    +LV E+   +  D +E+    L  + +      ++ 
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPY----WM-AP 119
           G+ + HS   IHRD+K  NIL++++G VKL DFG A ++  P   +         W  AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAP 193

Query: 120 EVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           E+++   + +Y   VDVW++G           + PG   D +I +L+       I   L
Sbjct: 194 ELLVG--DVKYGKAVDVWAIGCLVTEMFMGEPLFPG---DSDIDQLY------HIMMCL 241

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 21/65 (32%), Positives = 36/65 (55%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+   +  D +E+    L  + +      ++ G+ + HS   IHRD+K  NIL++++
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS 160

Query: 676 GTVKL 680
           G VKL
Sbjct: 161 GVVKL 165

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  140 bits (354), Expect = 5e-37
 Identities = 60/249 (24%), Positives = 98/249 (39%), Gaps = 46/249 (18%)

Query: 147 KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMS------YLGK 200
           +D  +          + +E    +G G    V       + +  A+K +       +  +
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61

Query: 201 QCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIER 259
           +  E     LKE+  LR++  HPN I+ +  Y  +   +LV +                 
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------- 108

Query: 260 EFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR 319
                  G          E   LF++   K  L E+E   I   +L  +  LH L  +HR
Sbjct: 109 -------G----------E---LFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR 148

Query: 320 DVKAGNILLTETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVI---LAMDEGQYDG 373
           D+K  NILL +   +KL DFG +    P        GTP ++APE+I   +  +   Y  
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 208

Query: 374 KVDVWSLGI 382
           +VD+WS G+
Sbjct: 209 EVDMWSTGV 217

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (292), Expect = 8e-29
 Identities = 50/186 (26%), Positives = 77/186 (41%), Gaps = 34/186 (18%)

Query: 8   LRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVL 64
           LR++  HPN I+ +  Y  +   +LV +          + E  K  L E+E   I   +L
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALL 134

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF---VGTPYWMAPEV 121
             +  LH L  +HRD+K  NILL +   +KL DFG +    P        GTP ++APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 122 I---LAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFEDLRE 169
           I   +  +   Y  +VD+WS G+          P           F       +      
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----------FWHRKQMLMLR---M 240

Query: 170 IGHGSF 175
           I  G++
Sbjct: 241 IMSGNY 246

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 19/96 (19%)

Query: 595 HLSQH--------SYNNNNSNYSSLFSPQLVMEYCLGSA--SDIIEVHKRPLKEEEIAAI 644
            +S H        +Y  N   +       LV +          + E  K  L E+E   I
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFF-------LVFDLMKKGELFDYLTE--KVTLSEKETRKI 129

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
              +L  +  LH L  +HRD+K  NILL +   +KL
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  141 bits (356), Expect = 5e-37
 Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 44/229 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK-----KMSYLGKQCAEKWADILKEIRFLRQ 218
           +  +  +G G+FG V+ A      + V +K     K+         K   +  EI  L +
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           ++H N I+    +       LVME                   H  G+            
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEK------------------HGSGL------------ 115

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
              LF F      L E   + I   ++  + YL     IHRD+K  NI++ E  T+KL D
Sbjct: 116 --DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173

Query: 339 FGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGIT 383
           FGSA+         +F GT  + APEV++      Y G ++++WSLG+T
Sbjct: 174 FGSAAYLERGKLFYTFCGTIEYCAPEVLMGN---PYRGPELEMWSLGVT 219

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  112 bits (281), Expect = 4e-27
 Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 27/179 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL--GSASDIIEVHKRPLKEEEIAAICSGV 63
           ++L +++H N I+    +       LVME           I+ H R L E   + I   +
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQL 139

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPE 120
           +  + YL     IHRD+K  NI++ E  T+KL DFGSA+         +F GT  + APE
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199

Query: 121 VILAMDEGQYDG-KVDVWSLGITPGSLKDPEIAELFD---KEDPEKIFEDLREIGHGSF 175
           V++      Y G ++++WSLG+T           L+    +E+P   F +L E    + 
Sbjct: 200 VLMGN---PYRGPELEMWSLGVT-----------LYTLVFEENP---FCELEETVEAAI 241

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 24/68 (35%), Positives = 33/68 (48%), Gaps = 3/68 (4%)

Query: 615 QLVMEYCL--GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           QLVME           I+ H R L E   + I   ++  + YL     IHRD+K  NI++
Sbjct: 105 QLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163

Query: 673 TETGTVKL 680
            E  T+KL
Sbjct: 164 AEDFTIKL 171

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  139 bits (352), Expect = 6e-37
 Identities = 62/232 (26%), Positives = 93/232 (40%), Gaps = 46/232 (19%)

Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADILKEIRFLR 217
           E  +E   E+G G F  V   R   + +  A   IKK      +      +I +E+  LR
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +++HPN I     +       L++E   G                    G          
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSG--------------------G---------- 93

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGT 333
           E   LF+F   K  L E+E       +L G++YLHS    H D+K  NI+L         
Sbjct: 94  E---LFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 150

Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +KL DFG A      N F    GTP ++APE++   +      + D+WS+G+
Sbjct: 151 IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV---NYEPLGLEADMWSIGV 199

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  112 bits (282), Expect = 1e-27
 Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 14/143 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           LR+++HPN I     +       L++E   G      + E  K  L E+E       +L 
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILD 119

Query: 66  GLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASIKCPANSF---VGTPYWMA 118
           G++YLHS    H D+K  NI+L         +KL DFG A      N F    GTP ++A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE++   +      + D+WS+G+
Sbjct: 180 PEIV---NYEPLGLEADMWSIGV 199

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 51.0 bits (123), Expect = 5e-07
 Identities = 22/71 (30%), Positives = 32/71 (45%), Gaps = 8/71 (11%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           L++E   G      + E  K  L E+E       +L G++YLHS    H D+K  NI+L 
Sbjct: 85  LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142

Query: 674 ----ETGTVKL 680
                   +KL
Sbjct: 143 DKNVPNPRIKL 153

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  140 bits (356), Expect = 9e-37
 Identities = 65/240 (27%), Positives = 95/240 (39%), Gaps = 46/240 (19%)

Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVA---IKKMSYLGKQCAEKWADI 209
           E F ++  E  ++   E+G G F  V   R   +    A   IKK      +      +I
Sbjct: 3   ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62

Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            +E+  LRQ+ HPN I     Y       L++E   G                    G  
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSG--------------------G-- 100

Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                   E   LF+F   K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 101 --------E---LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149

Query: 330 ----ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
                   +KL DFG A        F    GTP ++APE++   +      + D+WS+G+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV---NYEPLGLEADMWSIGV 206

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  113 bits (284), Expect = 3e-27
 Identities = 45/143 (31%), Positives = 66/143 (46%), Gaps = 14/143 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLR 65
           LRQ+ HPN I     Y       L++E   G      + +  K  L EEE  +    +L 
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILD 126

Query: 66  GLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASIKCPANSF---VGTPYWMA 118
           G+NYLH+    H D+K  NI+L         +KL DFG A        F    GTP ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE++   +      + D+WS+G+
Sbjct: 187 PEIV---NYEPLGLEADMWSIGV 206

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 22/71 (30%), Positives = 33/71 (46%), Gaps = 8/71 (11%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           L++E   G      + +  K  L EEE  +    +L G+NYLH+    H D+K  NI+L 
Sbjct: 92  LILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149

Query: 674 ----ETGTVKL 680
                   +KL
Sbjct: 150 DKNIPIPHIKL 160

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  143 bits (362), Expect = 1e-36
 Identities = 93/448 (20%), Positives = 155/448 (34%), Gaps = 84/448 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           +++L+ IG G+ G V  A   V    VAIKK+S    +  +         +E+  ++ + 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS----RPFQNQTHAKRAYRELVLMKCVN 119

Query: 221 HPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    T       +LVME                       M   L Q  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL----------------------MDANLCQ-- 155

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                       V +  L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 156 ------------VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203

Query: 335 KLADFGSASIKCPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAE 389
           K+ DFG A     +     +V T Y+ APEVIL M    Y   VD+WS+G  CI  E+  
Sbjct: 204 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVG--CIMGEMVR 258

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE---RKPPYFNMNAMSALYH 446
            K  +   + +     + +     L +     +K +  T        P +       L+ 
Sbjct: 259 HKILFPGRDYIDQWNKVIE----QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 314

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH----------DLVTRPRS 496
            +        +   +      +S  L  +PA R S    L H          ++   P  
Sbjct: 315 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQ 374

Query: 497 P-SVLVDLIRRTKAAVRDL---DNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSS 552
                +D    T    ++L   + +N  +  K  +  G  + S        +       S
Sbjct: 375 IYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGA----AVNSSESLPPS 430

Query: 553 KSNSITSEHSVQSVGVGVNPHDPTPNSS 580
            S +  S  S               ++ 
Sbjct: 431 SSVNDISSMSTDQTLASDTDSSLEASAG 458

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  102 bits (256), Expect = 3e-23
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 15/143 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           L++ + H N I     +    T       +LVME      +++ +V +  L  E ++ + 
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DANLCQVIQMELDHERMSYLL 170

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS---FVGTPYWM 117
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A     +     +V T Y+ 
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230

Query: 118 APEVILAMDEGQYDGKVDVWSLG 140
           APEVIL M    Y   VD+WS+G
Sbjct: 231 APEVILGM---GYKENVDIWSVG 250

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 22/65 (33%), Positives = 38/65 (58%), Gaps = 3/65 (4%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVME      +++ +V +  L  E ++ +   +L G+ +LHS G IHRD+K  NI++   
Sbjct: 144 LVMELM---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200

Query: 676 GTVKL 680
            T+K+
Sbjct: 201 CTLKI 205

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  139 bits (353), Expect = 1e-36
 Identities = 78/401 (19%), Positives = 138/401 (34%), Gaps = 112/401 (27%)

Query: 146 LKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK 205
           +KD    + +D      +    + +G GSF          S +  A+K +S   K+    
Sbjct: 1   MKDSPFYQHYD------LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KR---M 48

Query: 206 WADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVE 264
            A+  KEI  L+  + HPN ++    +      +LVME   G                  
Sbjct: 49  EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG------------------ 90

Query: 265 GMG---NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
             G    R+++ K F+E  A                + I   ++  ++++H +G +HRD+
Sbjct: 91  --GELFERIKKKKHFSETEA----------------SYIMRKLVSAVSHMHDVGVVHRDL 132

Query: 322 KAGNILLT---ETGTVKLADFGSASIKCPANS----FVGTPYWMAPEVILAMDEGQYDGK 374
           K  N+L T   +   +K+ DFG A +K P N        T ++ APE++   ++  YD  
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL---NQNGYDES 189

Query: 375 VDVWSLG-ITCIELAERKPPYF------NMNAMSALYHIAQNDTPCLQSSDWSVIKTISS 427
            D+WSLG I    L+  + P+          +   +    +      +   W     +S 
Sbjct: 190 CDLWSLGVILYTMLS-GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK---NVSQ 245

Query: 428 TAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT 487
            A  K                                   +   L  +P  R     L  
Sbjct: 246 EA--K---------------------------------DLIQGLLTVDPNKRLKMSGLRY 270

Query: 488 H----DLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKK 524
           +    D      +P +  D++  + AAV       +    K
Sbjct: 271 NEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNK 311

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  114 bits (288), Expect = 6e-28
 Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 15/145 (10%)

Query: 7   LLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGV 63
            L+  + HPN ++    +      +LVME   G      I +  K+   E E + I   +
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKL 115

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANS----FVGTPYW 116
           +  ++++H +G +HRD+K  N+L T   +   +K+ DFG A +K P N        T ++
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
            APE++   ++  YD   D+WSLG+
Sbjct: 176 AAPELL---NQNGYDESCDLWSLGV 197

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 22/99 (22%)

Query: 595 HLSQH--------SYNNNNSNYSSLFSPQLVMEYCLGSA--SDIIEVHKRPLKEEEIAAI 644
               H         +++    +       LVME   G      I +  K+   E E + I
Sbjct: 61  LCEGHPNIVKLHEVFHDQLHTF-------LVMELLNGGELFERIKK--KKHFSETEASYI 111

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKL 680
              ++  ++++H +G +HRD+K  N+L T   +   +K+
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  140 bits (355), Expect = 2e-36
 Identities = 74/347 (21%), Positives = 131/347 (37%), Gaps = 55/347 (15%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +   + +G GSFG V     + S +  A+KK+    +          +E+  ++ L H N
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHVN 61

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF------- 276
            I+    +                 + +   +      H   + N  Q            
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 277 -TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTV 334
            T H  L +F    R +    I+     + R + ++HSLG  HRD+K  N+L+ ++  T+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181

Query: 335 KLADFGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAE 389
           KL DFGSA    P+    +++ + ++ APE++L   E  Y   +D+WS+G  C+  EL  
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATE--YTPSIDLWSIG--CVFGELIL 237

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
            KP +    ++  L  I               I+ + +     P    M  M+  Y   +
Sbjct: 238 GKPLFSGETSIDQLVRI---------------IQIMGT-----PTKEQMIRMNPHY--TE 275

Query: 450 NDTPCLQSSDWSDTFAH--------FVSSCLAKNPADRPSSGRLLTH 488
              P L++ DW               +   L   P  R +    + H
Sbjct: 276 VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 89.8 bits (223), Expect = 3e-19
 Identities = 35/117 (29%), Positives = 65/117 (55%), Gaps = 9/117 (7%)

Query: 31  LVMEYCLGSASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 87
           ++MEY   +   +++      R +    I+     + R + ++HSLG  HRD+K  N+L+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174

Query: 88  -TETGTVKLADFGSASIKCPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
            ++  T+KL DFGSA    P+    +++ + ++ APE++L   E  Y   +D+WS+G
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATE--YTPSIDLWSIG 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 19/69 (27%), Positives = 37/69 (53%), Gaps = 4/69 (5%)

Query: 616 LVMEYCLGSASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           ++MEY   +   +++      R +    I+     + R + ++HSLG  HRD+K  N+L+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174

Query: 673 -TETGTVKL 680
            ++  T+KL
Sbjct: 175 NSKDNTLKL 183

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  138 bits (349), Expect = 7e-36
 Identities = 87/391 (22%), Positives = 130/391 (33%), Gaps = 98/391 (25%)

Query: 156 DKEDPEKIFEDL----REIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADI 209
           D  D + +FED+      IG G F  V       + +  A+K   ++           D+
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73

Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHWIEREFHVEGMG 267
            +E      LKHP+ +E    Y  D   ++V E+  G+    +I++              
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-------------- 119

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
            R      ++E  A                +     +L  L Y H    IHRDVK   +L
Sbjct: 120 -RADAGFVYSEAVA----------------SHYMRQILEALRYCHDNNIIHRDVKPHCVL 162

Query: 328 LT---ETGTVKLADFG-SASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSL 380
           L     +  VKL  FG +  +          VGTP++MAPEV+       Y   VDVW  
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV---KREPYGKPVDVWGC 219

Query: 381 G-ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMN 439
           G I  I L+    P++       L+         +    W     IS +A  K       
Sbjct: 220 GVILFILLSGC-LPFYGTKER--LFEGIIKGKYKMNPRQW---SHISESA--K------- 264

Query: 440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD-LVTRPRSPS 498
                                       V   L  +PA+R +    L H  L  R R   
Sbjct: 265 --------------------------DLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298

Query: 499 VLVDLIRRTKAAVRDLDNLN-YRKMKKILMA 528
            +          V  L   N  RK+K  ++A
Sbjct: 299 KIHL-----PETVEQLRKFNARRKLKGAVLA 324

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (291), Expect = 3e-28
 Identities = 44/145 (30%), Positives = 63/145 (43%), Gaps = 14/145 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLK--EEEIAAICSGV 63
              LKHP+ +E    Y  D   ++V E+  G+    +I++         E   +     +
Sbjct: 80  CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFG-SASIKCPANSF---VGTPYW 116
           L  L Y H    IHRDVK   +LL     +  VKL  FG +  +          VGTP++
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           MAPEV+       Y   VDVW  G+
Sbjct: 200 MAPEVV---KREPYGKPVDVWGCGV 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 20/72 (27%), Positives = 30/72 (41%), Gaps = 7/72 (9%)

Query: 616 LVMEYCLGS--ASDIIEVHKRPLK--EEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           +V E+  G+    +I++         E   +     +L  L Y H    IHRDVK   +L
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162

Query: 672 LT---ETGTVKL 680
           L     +  VKL
Sbjct: 163 LASKENSAPVKL 174

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  138 bits (349), Expect = 9e-36
 Identities = 88/441 (19%), Positives = 147/441 (33%), Gaps = 94/441 (21%)

Query: 138 SLGITPGSLKDPEIAELFDKEDP--EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKM 195
            +    G  +    +E            ++   E+G G+F  V       +    A K +
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 196 SYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH 255
           +   K  A  +  + +E R  R+L+HPN +        +   +LV +   G      E  
Sbjct: 63  N-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG-----E-- 114

Query: 256 WIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 315
                                     LF   V +    E + +     +L  + Y HS G
Sbjct: 115 --------------------------LFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 316 RIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEG 369
            +HR++K  N+LL    +   VKLADFG A     + ++    GTP +++PEV+    + 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL---KKD 205

Query: 370 QYDGKVDVWSLG-ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISST 428
            Y   VD+W+ G I  I L    PP F       LY   +       S +W    T++  
Sbjct: 206 PYSKPVDIWACGVILYILLVGY-PP-FWDEDQHRLYAQIKAGAYDYPSPEW---DTVTPE 260

Query: 429 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           A+                                     + S L  NP  R ++ + L  
Sbjct: 261 AK-----------------------------------SLIDSMLTVNPKKRITADQALKV 285

Query: 489 D-LVTRPRSPSVLVDLIRRTKAAVRDLDNLN-YRKMKKILMADGADTESTIDPDDTPDEQ 546
             +  R R  S +       +  V  L   N  RK+K  ++     T +  +       +
Sbjct: 286 PWICNRERVASAIHR-----QDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNK 340

Query: 547 AGNDSSKSNSITSEHSVQSVG 567
                  S    S  S Q++ 
Sbjct: 341 K-EQGPPSTIKESSESSQTID 360

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  115 bits (291), Expect = 4e-28
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 13/142 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLR 65
            R+L+HPN +        +   +LV +   G     DI+   +    E + +     +L 
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILE 139

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
            + Y HS G +HR++K  N+LL    +   VKLADFG A     + ++    GTP +++P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           EV+    +  Y   VD+W+ G+
Sbjct: 200 EVL---KKDPYSKPVDIWACGV 218

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 51.5 bits (124), Expect = 6e-07
 Identities = 20/70 (28%), Positives = 32/70 (45%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LV +   G     DI+   +    E + +     +L  + Y HS G +HR++K  N+LL 
Sbjct: 105 LVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162

Query: 674 ---ETGTVKL 680
              +   VKL
Sbjct: 163 SKAKGAAVKL 172

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  135 bits (343), Expect = 1e-35
 Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 43/231 (18%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
                 ++   E+G G+F  V       +    A K ++   K  A  +  + +E R  R
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICR 60

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +L+HPN +        +   +LV +   G      E                        
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGG-----E------------------------ 91

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTV 334
               LF   V +    E + +     +L  + Y HS G +HR++K  N+LL    +   V
Sbjct: 92  ----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 147

Query: 335 KLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           KLADFG A     + ++    GTP +++PEV+    +  Y   VD+W+ G+
Sbjct: 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL---KKDPYSKPVDIWACGV 195

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  116 bits (292), Expect = 7e-29
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 33/175 (18%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLR 65
            R+L+HPN +        +   +LV +   G     DI+   +    E + +     +L 
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILE 116

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
            + Y HS G +HR++K  N+LL    +   VKLADFG A     + ++    GTP +++P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176

Query: 120 EVILAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFE 165
           EV+    +  Y   VD+W+ G+          P           F  ED  +++ 
Sbjct: 177 EVL---KKDPYSKPVDIWACGVILYILLVGYPP-----------FWDEDQHRLYA 217

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 20/70 (28%), Positives = 32/70 (45%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LV +   G     DI+   +    E + +     +L  + Y HS G +HR++K  N+LL 
Sbjct: 82  LVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139

Query: 674 ---ETGTVKL 680
              +   VKL
Sbjct: 140 SKAKGAAVKL 149

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  137 bits (346), Expect = 1e-35
 Identities = 71/366 (19%), Positives = 117/366 (31%), Gaps = 102/366 (27%)

Query: 155 FDKEDPEKIFEDLR---EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADI 209
               +P    ++L+    IG G +GAVY          VA+K  S+  +Q    EK    
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEK---- 56

Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTA-----WLVMEYC-LGSASDIIEVHWIEREFHV 263
              I  +  ++H N   +     R          LVMEY   GS                
Sbjct: 57  --NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS---------------- 98

Query: 264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR------- 316
                             L  + +            +   V RGL YLH+          
Sbjct: 99  ------------------LXKY-LSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKP 139

Query: 317 --IHRDVKAGNILLTETGTVKLADFGSASIK------------CPANSFVGTPYWMAPEV 362
              HRD+ + N+L+   GT  ++DFG +                 A S VGT  +MAPEV
Sbjct: 140 AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV 199

Query: 363 ----ILAMDEGQYDGKVDVWSLGITCIELAERK---PPYFNMNAMSALYHIAQNDTPCLQ 415
               +   D      +VD+++LG+   E+  R     P  ++      +     + P  +
Sbjct: 200 LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFE 259

Query: 416 SSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN 475
                V +      E++ P F                   ++S    +    +  C  ++
Sbjct: 260 DMQVLVSR------EKQRPKFPEA--------------WKENSLAVRSLKETIEDCWDQD 299

Query: 476 PADRPS 481
              R +
Sbjct: 300 AEARLT 305

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  111 bits (278), Expect = 9e-27
 Identities = 42/166 (25%), Positives = 63/166 (37%), Gaps = 33/166 (19%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA-----WLVMEYC-LGSASDIIEVHKRPLKEEEIAAIC 60
            +  ++H N   +     R          LVMEY   GS    +              + 
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLA 117

Query: 61  SGVLRGLNYLHSLGR---------IHRDVKAGNILLTETGTVKLADFGSASIK------- 104
             V RGL YLH+             HRD+ + N+L+   GT  ++DFG +          
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 105 -----CPANSFVGTPYWMAPEV----ILAMDEGQYDGKVDVWSLGI 141
                  A S VGT  +MAPEV    +   D      +VD+++LG+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 21/75 (28%), Positives = 29/75 (38%), Gaps = 12/75 (16%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR---------IHRDV 665
           LVMEY   GS    +              +   V RGL YLH+             HRD+
Sbjct: 89  LVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146

Query: 666 KAGNILLTETGTVKL 680
            + N+L+   GT  +
Sbjct: 147 NSRNVLVKNDGTCVI 161

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  137 bits (348), Expect = 1e-35
 Identities = 75/342 (21%), Positives = 128/342 (37%), Gaps = 66/342 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           +++L+ IG G+ G V  A   +    VAIKK+S    +  +         +E+  ++ + 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS----RPFQNQTHAKRAYRELVLMKCVN 82

Query: 221 HPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       ++VME                       M   L Q  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL----------------------MDANLCQ-- 118

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                       V +  L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+
Sbjct: 119 ------------VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166

Query: 335 KLADFGSASIKCPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAE 389
           K+ DFG A     +     +V T Y+ APEVIL M    Y   VD+WS+G  CI  E+ +
Sbjct: 167 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVG--CIMGEMIK 221

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE---RKPPYFNMNAMSALYH 446
               +   + +     + +     L +     +K +  T        P +   +   L+ 
Sbjct: 222 GGVLFPGTDHIDQWNKVIE----QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 277

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                     +   +      +S  L  + + R S    L H
Sbjct: 278 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 45/143 (31%), Positives = 73/143 (51%), Gaps = 15/143 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           L++ + H N I     +    +       ++VME      +++ +V +  L  E ++ + 
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DANLCQVIQMELDHERMSYLL 133

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS---FVGTPYWM 117
             +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A     +     +V T Y+ 
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193

Query: 118 APEVILAMDEGQYDGKVDVWSLG 140
           APEVIL M    Y   VD+WS+G
Sbjct: 194 APEVILGM---GYKENVDIWSVG 213

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 21/65 (32%), Positives = 38/65 (58%), Gaps = 3/65 (4%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VME      +++ +V +  L  E ++ +   +L G+ +LHS G IHRD+K  NI++   
Sbjct: 107 IVMELM---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 163

Query: 676 GTVKL 680
            T+K+
Sbjct: 164 CTLKI 168

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  138 bits (349), Expect = 2e-35
 Identities = 82/345 (23%), Positives = 139/345 (40%), Gaps = 84/345 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + + + IG+GSFG V+ A+ + S E VAIKK+     Q         +E++ +R +KHPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----LQDKR---FKNRELQIMRIVKHPN 93

Query: 224 TIEYRGCYLRDHTAW------LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            ++ +  +  +          LV+EY                      +   + +     
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEY----------------------VPETVYRA---- 127

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKL 336
                 ++   K+ +    I      +LR L Y+HS+G  HRD+K  N+LL   +G +KL
Sbjct: 128 ----SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL 183

Query: 337 ADFGSASIKCPANSFVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
            DFGSA I       V    + Y+ APE+I       Y   +D+WS G  C+  EL + +
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATN--YTTNIDIWSTG--CVMAELMQGQ 239

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           P +   + +  L  I               IK + +     P    +  M+  Y   ++ 
Sbjct: 240 PLFPGESGIDQLVEI---------------IKVLGT-----PSREQIKTMNPNY--MEHK 277

Query: 452 TPCLQSSDWSDTFAH--------FVSSCLAKNPADRPSSGRLLTH 488
            P ++   +S  F           +S  L   P+ R ++   L H
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  101 bits (254), Expect = 4e-23
 Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 15/148 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAW------LVMEYC---LGSASDIIEVHKRPLKEEEI 56
            ++R +KHPN ++ +  +  +          LV+EY    +  AS      K+ +    I
Sbjct: 84  QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPANSFVG--- 112
                 +LR L Y+HS+G  HRD+K  N+LL   +G +KL DFGSA I       V    
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           + Y+ APE+I       Y   +D+WS G
Sbjct: 204 SRYYRAPELIFGATN--YTTNIDIWSTG 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 4/69 (5%)

Query: 616 LVMEYC---LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           LV+EY    +  AS      K+ +    I      +LR L Y+HS+G  HRD+K  N+LL
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

Query: 673 -TETGTVKL 680
              +G +KL
Sbjct: 175 DPPSGVLKL 183

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  137 bits (348), Expect = 2e-35
 Identities = 73/289 (25%), Positives = 118/289 (40%), Gaps = 62/289 (21%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-CAEK--WADILKEIRFLRQLK 220
           FE LR IG GSFG V   +   ++++ A+K   Y+ KQ C E+    ++ KE++ ++ L+
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMK---YMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HP  +     +  +   ++V++  LG           +  +H       LQQ   F E  
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGG----------DLRYH-------LQQNVHFKEET 116

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                           I  +       L+YL +   IHRD+K  NILL E G V + DF 
Sbjct: 117 VKLF------------ICELVMA----LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160

Query: 341 SASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
            A++   +    +  GT  +MAPE+  +     Y   VD WSLG+T  EL   + PY   
Sbjct: 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

Query: 398 NA--MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
           ++     + H  +                        P  ++   +S L
Sbjct: 221 SSTSSKEIVHTFETTVV------------------TYPSAWSQEMVSLL 251

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 97.0 bits (242), Expect = 1e-21
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 21/148 (14%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV-----HKRPLKEEE----IA 57
           +++ L+HP  +     +  +   ++V++  LG      ++          KEE     I 
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG-----DLRYHLQQNVHFKEETVKLFIC 122

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KCPANSFVGTP 114
            +       L+YL +   IHRD+K  NILL E G V + DF  A++   +    +  GT 
Sbjct: 123 ELVMA----LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK 178

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGIT 142
            +MAPE+  +     Y   VD WSLG+T
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVT 206

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 22/74 (29%), Positives = 32/74 (43%), Gaps = 18/74 (24%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 666
           +V++  LG      ++          KEE     I  +       L+YL +   IHRD+K
Sbjct: 92  MVVDLLLGG-----DLRYHLQQNVHFKEETVKLFICELVMA----LDYLQNQRIIHRDMK 142

Query: 667 AGNILLTETGTVKL 680
             NILL E G V +
Sbjct: 143 PDNILLDEHGHVHI 156

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  137 bits (346), Expect = 2e-35
 Identities = 87/395 (22%), Positives = 139/395 (35%), Gaps = 94/395 (23%)

Query: 142 TPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ 201
              SL      +  +++     FE   E+G G+   VY  +   +++  A+K +    K 
Sbjct: 33  GTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK---KT 89

Query: 202 CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREF 261
             +K   +  EI  L +L HPN I+ +  +       LV+E   G             E 
Sbjct: 90  VDKK--IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG------------GE- 134

Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
                               LF+  V K    E + A     +L  + YLH  G +HRD+
Sbjct: 135 --------------------LFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDL 174

Query: 322 KAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKV 375
           K  N+L         +K+ADFG + I           GTP + APE++       Y  +V
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR---GCAYGPEV 231

Query: 376 DVWSLG-ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPP 434
           D+WS+G IT I L     P+++      ++    N      S  W     +S  A+    
Sbjct: 232 DMWSVGIITYILLCGF-EPFYDERGDQFMFRRILNCEYYFISPWW---DEVSLNAK---- 283

Query: 435 YFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
                                            V   +  +P  R ++ + L H  VT  
Sbjct: 284 -------------------------------DLVRKLIVLDPKKRLTTFQALQHPWVTGK 312

Query: 495 RSPSVLVDLIRRTKAAVRDLDNLN-YRKMKKILMA 528
            +  V +D       A + L   N  RK+K  + A
Sbjct: 313 AANFVHMD------TAQKKLQEFNARRKLKAAVKA 341

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  111 bits (280), Expect = 9e-27
 Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 13/144 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGV 63
            +L +L HPN I+ +  +       LV+E   G      I+E  K    E + A     +
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQI 157

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTPYWM 117
           L  + YLH  G +HRD+K  N+L         +K+ADFG + I           GTP + 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           APE++       Y  +VD+WS+GI
Sbjct: 218 APEILR---GCAYGPEVDMWSVGI 238

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 20/59 (33%), Positives = 28/59 (47%), Gaps = 4/59 (6%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           LV+E   G      I+E  K    E + A     +L  + YLH  G +HRD+K  N+L 
Sbjct: 125 LVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLY 181

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  136 bits (344), Expect = 3e-35
 Identities = 38/316 (12%), Positives = 91/316 (28%), Gaps = 73/316 (23%)

Query: 147 KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSYLGKQ 201
           K P I    + +   K+      +G G+F  VY A         +++   +K        
Sbjct: 50  KLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PA 106

Query: 202 CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREF 261
              ++    + +  L+       +++   +L  + + LV E                   
Sbjct: 107 NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT------------- 153

Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
               + N +   K   E             + +  + +    +L  +  +H    IH D+
Sbjct: 154 ----LLNAINLYKNTPEK-----------VMPQGLVISFAMRMLYMIEQVHDCEIIHGDI 198

Query: 322 KAGNILLTET-----------GTVKLADFGSASIK--CPAN----SFVGTPYWMAPEVIL 364
           K  N +L                + L D G +      P      +   T  +   E++ 
Sbjct: 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS 258

Query: 365 AMDEGQYDGKVDVWSLGITCIELAERKPP-----------------YFNMNAMSALYHIA 407
                 ++ ++D + +  T   +                         +++  +  +H+ 
Sbjct: 259 NK---PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVM 315

Query: 408 QNDTPCLQSSDWSVIK 423
            N   C       +++
Sbjct: 316 LNIPDCHHLPSLDLLR 331

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  104 bits (261), Expect = 3e-24
 Identities = 24/157 (15%), Positives = 57/157 (36%), Gaps = 25/157 (15%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHK----RPLKEEEIAAICSG 62
           L+       +++   +L  + + LV E    G+  + I ++K    + + +  + +    
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTET-----------GTVKLADFGSASIK--CPAN- 108
           +L  +  +H    IH D+K  N +L                + L D G +      P   
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 109 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              +   T  +   E++       ++ ++D + +  T
Sbjct: 241 IFTAKCETSGFQCVEMLSNK---PWNYQIDYFGVAAT 274

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 20/108 (18%), Positives = 38/108 (35%), Gaps = 13/108 (12%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCL-GSASDIIEVHK----RPLKEEE 640
           +    H         +   N +        LV E    G+  + I ++K    + + +  
Sbjct: 122 KPSMQHMFMKFYSA-HLFQNGSV-------LVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAG 688
           + +    +L  +  +H    IH D+K  N +L      + D  D  AG
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  136 bits (344), Expect = 4e-35
 Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 45/248 (18%)

Query: 147 KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK-----KMSYLGKQ 201
            + E+ +    ++  + ++    IG G    V       +    A+K           +Q
Sbjct: 79  PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138

Query: 202 CAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIERE 260
             E      +E   LRQ+  HP+ I     Y      +LV +                  
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK-------------- 184

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
                 G          E   LF++   K  L E+E  +I   +L  +++LH+   +HRD
Sbjct: 185 ------G----------E---LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRD 225

Query: 321 VKAGNILLTETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVI---LAMDEGQYDGK 374
           +K  NILL +   ++L+DFG +    P        GTP ++APE++   +      Y  +
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285

Query: 375 VDVWSLGI 382
           VD+W+ G+
Sbjct: 286 VDLWACGV 293

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  114 bits (287), Expect = 1e-27
 Identities = 47/189 (24%), Positives = 76/189 (40%), Gaps = 40/189 (21%)

Query: 8   LRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE-----VHKRPLKEEEIAAICS 61
           LRQ+  HP+ I     Y      +LV +          E       K  L E+E  +I  
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG-----ELFDYLTEKVALSEKETRSIMR 207

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF---VGTPYWMA 118
            +L  +++LH+   +HRD+K  NILL +   ++L+DFG +    P        GTP ++A
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 119 PEVI---LAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFED 166
           PE++   +      Y  +VD+W+ G+          P           F       +   
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP-----------FWHRRQILML-- 314

Query: 167 LREIGHGSF 175
            R I  G +
Sbjct: 315 -RMIMEGQY 322

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 20/70 (28%), Positives = 33/70 (47%), Gaps = 10/70 (14%)

Query: 616 LVMEYCLGSASDIIE-----VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
           LV +          E       K  L E+E  +I   +L  +++LH+   +HRD+K  NI
Sbjct: 177 LVFDLMRKG-----ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENI 231

Query: 671 LLTETGTVKL 680
           LL +   ++L
Sbjct: 232 LLDDNMQIRL 241

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  138 bits (349), Expect = 5e-35
 Identities = 79/411 (19%), Positives = 142/411 (34%), Gaps = 94/411 (22%)

Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK 220
            + ++   E+G G+F  V     +++ +  A   ++   K  A     + +E R  R LK
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN-TKKLSARDHQKLEREARICRLLK 68

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HPN +        +   +L+ +   G                               E  
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGG------------------------------E-- 96

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLA 337
            LF   V +    E + +     +L  + + H +G +HR++K  N+LL    +   VKLA
Sbjct: 97  -LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLA 155

Query: 338 DFG-SASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP 392
           DFG +  ++    ++    GTP +++PEV+    +  Y   VD+W+ G I  I L    P
Sbjct: 156 DFGLAIEVEGEQQAWFGFAGTPGYLSPEVL---RKDPYGKPVDLWACGVILYILLVGY-P 211

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P F       LY   +       S +W    T++  A  K                    
Sbjct: 212 P-FWDEDQHRLYQQIKAGAYDFPSPEW---DTVTPEA--K-------------------- 245

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD-LVTRPRSPSVLVDLIRRTKAAV 511
                          ++  L  NP+ R ++   L H  +  R    S +       +  V
Sbjct: 246 -------------DLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHR-----QETV 287

Query: 512 RDLDNLN-YRKMKKILMADGADTESTI--DPDDTPDEQAGNDSSKSNSITS 559
             L   N  RK+K  ++     T +      +     +   ++  +    S
Sbjct: 288 DCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFES 338

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  115 bits (289), Expect = 3e-27
 Identities = 38/143 (26%), Positives = 69/143 (48%), Gaps = 14/143 (9%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLR 65
            R LKHPN +        +   +L+ +   G     DI+   +    E + +     +L 
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILE 121

Query: 66  GLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFG-SASIKCPANSF---VGTPYWMA 118
            + + H +G +HR++K  N+LL    +   VKLADFG +  ++    ++    GTP +++
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV+    +  Y   VD+W+ G+
Sbjct: 182 PEVL---RKDPYGKPVDLWACGV 201

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 17/70 (24%), Positives = 32/70 (45%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           L+ +   G     DI+   +    E + +     +L  + + H +G +HR++K  N+LL 
Sbjct: 87  LIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144

Query: 674 ---ETGTVKL 680
              +   VKL
Sbjct: 145 SKLKGAAVKL 154

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  136 bits (344), Expect = 7e-35
 Identities = 47/232 (20%), Positives = 84/232 (36%), Gaps = 45/232 (19%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           +      ++ L E+G G+FG V+      +  +   K ++            +  EI  +
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN---TPYPLDKYTVKNEISIM 102

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            QL HP  I     +   +   L++E+  G                    G         
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSG--------------------G--------- 133

Query: 277 TEHFALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--ETGT 333
            E   LF+    +   + E E+         GL ++H    +H D+K  NI+    +  +
Sbjct: 134 -E---LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189

Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           VK+ DFG A+   P         T  + APE++   D        D+W++G+
Sbjct: 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV---DREPVGFYTDMWAIGV 238

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (278), Expect = 2e-26
 Identities = 36/142 (25%), Positives = 61/142 (42%), Gaps = 9/142 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVL 64
           S++ QL HP  I     +   +   L++E+  G    D I      + E E+        
Sbjct: 100 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
            GL ++H    +H D+K  NI+    +  +VK+ DFG A+   P         T  + AP
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E++   D        D+W++G+
Sbjct: 220 EIV---DREPVGFYTDMWAIGV 238

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 3/68 (4%)

Query: 616 LVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 673
           L++E+  G    D I      + E E+         GL ++H    +H D+K  NI+   
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184

Query: 674 -ETGTVKL 680
            +  +VK+
Sbjct: 185 KKASSVKI 192

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  133 bits (338), Expect = 1e-34
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 44/237 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLKH 221
           F+ L ++G+G++  VY      +   VA+K++    K  +E+      ++EI  +++LKH
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKH 62

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N +        ++   LV E+     +D                      LK + +   
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM---DND----------------------LKKYMDSR- 96

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                   R L+   +      +L+GL + H    +HRD+K  N+L+ + G +KL DFG 
Sbjct: 97  --TVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154

Query: 342 A-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
           A +   P N+F   V T ++ AP+V++      Y   +D+WS G  CI  E+   KP
Sbjct: 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMG--SRTYSTSIDIWSCG--CILAEMITGKP 207

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  103 bits (260), Expect = 2e-24
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 31/182 (17%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC---LGSASD--IIEVHKRPLKEEEIAAIC 60
           SL+++LKH N +        ++   LV E+    L    D   +    R L+   +    
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYW 116
             +L+GL + H    +HRD+K  N+L+ + G +KL DFG A +   P N+F   V T ++
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFE 165
            AP+V++      Y   +D+WS G           + PG     +  +L        IF+
Sbjct: 175 RAPDVLMG--SRTYSTSIDIWSCGCILAEMITGKPLFPG---TNDEEQLK------LIFD 223

Query: 166 DL 167
            +
Sbjct: 224 IM 225

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 59.9 bits (146), Expect = 8e-10
 Identities = 20/70 (28%), Positives = 33/70 (47%), Gaps = 5/70 (7%)

Query: 616 LVMEYC---LGSASD--IIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
           LV E+    L    D   +    R L+   +      +L+GL + H    +HRD+K  N+
Sbjct: 80  LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNL 139

Query: 671 LLTETGTVKL 680
           L+ + G +KL
Sbjct: 140 LINKRGQLKL 149

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  133 bits (336), Expect = 1e-34
 Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 56/232 (24%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD----ILKEIRFLRQLKHPN 223
             +G GS+G V       +    A+K +    K+   +  +    + KEI+ LR+L+H N
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILK---KKKLRRIPNGEANVKKEIQLLRRLRHKN 67

Query: 224 TIEYRGCY--LRDHTA---WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            I+       L +      ++VMEYC+    +                            
Sbjct: 68  VIQ---LVDVLYNEEKQKMYMVMEYCVCGMQE---------------------------- 96

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
              + +    KR     +       ++ GL YLHS G +H+D+K GN+LLT  GT+K++ 
Sbjct: 97  ---MLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISA 152

Query: 339 FGSASIKCPANS------FVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGIT 383
            G A    P  +        G+P +  PE+        + G KVD+WS G+T
Sbjct: 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIA--NGLDTFSGFKVDIWSAGVT 202

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (280), Expect = 4e-27
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 27/173 (15%)

Query: 6   SLLRQLKHPNTIEYRGCY--LRDHTA---WLVMEYCLGSASDIIE--VHKRPLKEEEIAA 58
            LLR+L+H N I+       L +      ++VMEYC+    ++++    KR     +   
Sbjct: 58  QLLRRLRHKNVIQ---LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHG 113

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS------FVG 112
               ++ GL YLHS G +H+D+K GN+LLT  GT+K++  G A    P  +        G
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173

Query: 113 TPYWMAPEVILAMDEGQYDG-KVDVWSLGIT-----PGSL--KDPEIAELFDK 157
           +P +  PE+        + G KVD+WS G+T      G    +   I +LF+ 
Sbjct: 174 SPAFQPPEIA--NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 25/67 (37%), Positives = 40/67 (59%), Gaps = 3/67 (4%)

Query: 616 LVMEYCLGSASDIIE--VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +VMEYC+    ++++    KR     +       ++ GL YLHS G +H+D+K GN+LLT
Sbjct: 85  MVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143

Query: 674 ETGTVKL 680
             GT+K+
Sbjct: 144 TGGTLKI 150

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  133 bits (338), Expect = 1e-34
 Identities = 46/231 (19%), Positives = 81/231 (35%), Gaps = 46/231 (19%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           ++  + +    ++G G FG V+      S++    K +     +  ++   + KEI  L 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQ-VLVKKEISILN 56

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             +H N +     +       ++ E+  G                               
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISG--------------------L---------- 86

Query: 278 EHFALFNFEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--ETGTV 334
           +   +F         L E EI +    V   L +LHS    H D++  NI+     + T+
Sbjct: 87  D---IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTI 143

Query: 335 KLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           K+ +FG A    P ++F      P + APEV             D+WSLG 
Sbjct: 144 KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH---QHDVVSTATDMWSLGT 191

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  110 bits (277), Expect = 1e-26
 Identities = 37/143 (25%), Positives = 57/143 (39%), Gaps = 11/143 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGV 63
           S+L   +H N +     +       ++ E+  G      I       L E EI +    V
Sbjct: 53  SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQV 111

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKCPANSF---VGTPYWMA 118
              L +LHS    H D++  NI+     + T+K+ +FG A    P ++F      P + A
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV             D+WSLG 
Sbjct: 172 PEVH---QHDVVSTATDMWSLGT 191

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 18/69 (26%), Positives = 29/69 (42%), Gaps = 5/69 (7%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++ E+  G      I       L E EI +    V   L +LHS    H D++  NI+  
Sbjct: 78  MIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136

Query: 674 --ETGTVKL 680
              + T+K+
Sbjct: 137 TRRSSTIKI 145

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  134 bits (339), Expect = 2e-34
 Identities = 64/352 (18%), Positives = 120/352 (34%), Gaps = 80/352 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWAD------------I 209
           +  +R +  G F  +         +  A+KK   S L K+     ++             
Sbjct: 33  YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCLGSASDIIEVHWIEREFHVEGMG- 267
             E++ +  +K+   +   G  + ++   +++ EY                         
Sbjct: 91  KNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMEN--------------------DS 129

Query: 268 --NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAG 324
                +              + +   +  + I  I   VL   +Y+H+     HRDVK  
Sbjct: 130 ILKFDEYFFVLD--------KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181

Query: 325 NILLTETGTVKLADFGSASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLG 381
           NIL+ + G VKL+DFG +            GT  +M PE     +E  Y+G KVD+WSLG
Sbjct: 182 NILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFF--SNESSYNGAKVDIWSLG 239

Query: 382 ITCIELAERKPPYFNMNAMSALYH-IAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA 440
           I    +     P+    ++  L++ I   +       +  +    +  +     + +   
Sbjct: 240 ICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED 299

Query: 441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
           +                         F+   L KNPA+R +S   L H+ + 
Sbjct: 300 I------------------------DFLKLFLRKNPAERITSEDALKHEWLA 327

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (272), Expect = 8e-26
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 24/173 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCLG--------SASDIIEVHKRPLKEEEI 56
            ++  +K+   +   G  + ++   +++ EY               + + +   +  + I
Sbjct: 95  QIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 57  AAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA--NSFVGT 113
             I   VL   +Y+H+     HRDVK  NIL+ + G VKL+DFG +            GT
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGT 213

Query: 114 PYWMAPEVILAMDEGQYDG-KVDVWSLGIT-----PGSL---KDPEIAELFDK 157
             +M PE     +E  Y+G KVD+WSLGI         +       + ELF+ 
Sbjct: 214 YEFMPPEFF--SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 9/74 (12%)

Query: 616 LVMEYCLG--------SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVK 666
           ++ EY               + + +   +  + I  I   VL   +Y+H+     HRDVK
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179

Query: 667 AGNILLTETGTVKL 680
             NIL+ + G VKL
Sbjct: 180 PSNILMDKNGRVKL 193

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  133 bits (336), Expect = 2e-34
 Identities = 61/241 (25%), Positives = 87/241 (36%), Gaps = 52/241 (21%)

Query: 156 DKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---- 211
           D+E  E  +     +G G FG V+    L  R  VAIK    + +     W+ +      
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK---VIPRNRVLGWSPLSDSVTC 81

Query: 212 --EIRFLRQL----KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG 265
             E+  L ++     HP  I     +       LV+E                    +  
Sbjct: 82  PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLER------------------PLPA 123

Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
                       +   LF++   K PL E         V+  + + HS G +HRD+K  N
Sbjct: 124 Q-----------D---LFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDEN 169

Query: 326 ILL-TETGTVKLADFGSASIKCPAN--SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLG 381
           IL+    G  KL DFGS ++        F GT  +  PE I      QY      VWSLG
Sbjct: 170 ILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISR---HQYHALPATVWSLG 226

Query: 382 I 382
           I
Sbjct: 227 I 227

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (266), Expect = 3e-25
 Identities = 50/178 (28%), Positives = 65/178 (36%), Gaps = 27/178 (15%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL--GSASDIIEVHKRPLKEEEIAAICSGVL 64
           +     HP  I     +       LV+E  L      D I      L E         V+
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVV 149

Query: 65  RGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPAN--SFVGTPYWMAPEV 121
             + + HS G +HRD+K  NIL+    G  KL DFGS ++        F GT  +  PE 
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEW 209

Query: 122 ILAMDEGQYDG-KVDVWSLGITPGSLKDPEIAELFD---KEDPEKIFEDLREIGHGSF 175
           I      QY      VWSLGI            L+D    + P   FE  +EI     
Sbjct: 210 ISR---HQYHALPATVWSLGIL-----------LYDMVCGDIP---FERDQEILEAEL 250

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 22/68 (32%), Positives = 29/68 (42%), Gaps = 4/68 (5%)

Query: 616 LVMEYCL--GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL- 672
           LV+E  L      D I      L E         V+  + + HS G +HRD+K  NIL+ 
Sbjct: 115 LVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173

Query: 673 TETGTVKL 680
              G  KL
Sbjct: 174 LRRGCAKL 181

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  133 bits (336), Expect = 2e-34
 Identities = 72/342 (21%), Positives = 126/342 (36%), Gaps = 65/342 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + DL+ +G G  G V+ A      + VAIKK+     Q  +     L+EI+ +R+L H N
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH---ALREIKIIRRLDHDN 69

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++         +        L   + +  V         E M   L  +          
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIV--------QEYMETDLANV---------- 111

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSA 342
              + + PL EE        +LRGL Y+HS   +HRD+K  N+ + TE   +K+ DFG A
Sbjct: 112 ---LEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168

Query: 343 SIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKPP 393
            I  P  S        + T ++ +P ++L+ +   Y   +D+W+ G  CI  E+   K  
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAG--CIFAEMLTGKTL 224

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
           +   + +  +  I       +        + + S                  +I  +   
Sbjct: 225 FAGAHELEQMQLI----LESIPVVHEEDRQELLSVIPV--------------YIRND--M 264

Query: 454 CLQSSDWSDTFAH-------FVSSCLAKNPADRPSSGRLLTH 488
                  +            F+   L  +P DR ++   L+H
Sbjct: 265 TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 22/154 (14%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV------------HKRPLKEE 54
           ++R+L H N ++         +        L   + +  V             + PL EE
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 55  EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPANS---- 109
                   +LRGL Y+HS   +HRD+K  N+ + TE   +K+ DFG A I  P  S    
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

Query: 110 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
               + T ++ +P ++L+ +   Y   +D+W+ G
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAG 212

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 19/57 (33%), Positives = 31/57 (54%), Gaps = 2/57 (3%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           +V EY     ++++   + PL EE        +LRGL Y+HS   +HRD+K  N+ +
Sbjct: 99  IVQEYMETDLANVL--EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI 153

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  132 bits (334), Expect = 4e-34
 Identities = 63/257 (24%), Positives = 100/257 (38%), Gaps = 50/257 (19%)

Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY 197
           S       L   ++A   +KE  E  ++    +G G FG+VY    +     VAIK   +
Sbjct: 19  SHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK---H 75

Query: 198 LGKQCAEKWAD------ILKEIRFLRQLKH--PNTIEYRGCYLRDHTAWLVMEYCLGSAS 249
           + K     W +      +  E+  L+++       I     + R  +  L++E       
Sbjct: 76  VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER------ 129

Query: 250 DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN 309
                         E + +             LF+F   +  L+EE   +    VL  + 
Sbjct: 130 -------------PEPVQD-------------LFDFITERGALQEELARSFFWQVLEAVR 163

Query: 310 YLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAM 366
           + H+ G +HRD+K  NIL+    G +KL DFGS ++        F GT  +  PE I   
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY- 222

Query: 367 DEGQYDG-KVDVWSLGI 382
              +Y G    VWSLGI
Sbjct: 223 --HRYHGRSAAVWSLGI 237

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  107 bits (268), Expect = 2e-25
 Identities = 51/181 (28%), Positives = 73/181 (40%), Gaps = 29/181 (16%)

Query: 6   SLLRQLKH--PNTIEYRGCYLRDHTAWLVMEYCLGSAS--DIIEVHKRPLKEEEIAAICS 61
            LL+++       I     + R  +  L++E         D I      L+EE   +   
Sbjct: 98  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFW 156

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKC--PANSFVGTPYWMA 118
            VL  + + H+ G +HRD+K  NIL+    G +KL DFGS ++        F GT  +  
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP 216

Query: 119 PEVILAMDEGQYDG-KVDVWSLGITPGSLKDPEIAELFD---KEDPEKIFEDLREIGHGS 174
           PE I      +Y G    VWSLGI            L+D    + P   FE   EI  G 
Sbjct: 217 PEWIRY---HRYHGRSAAVWSLGIL-----------LYDMVCGDIP---FEHDEEIIRGQ 259

Query: 175 F 175
            
Sbjct: 260 V 260

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 21/68 (30%), Positives = 32/68 (47%), Gaps = 4/68 (5%)

Query: 616 LVMEYCLGSAS--DIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL- 672
           L++E         D I      L+EE   +    VL  + + H+ G +HRD+K  NIL+ 
Sbjct: 125 LILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183

Query: 673 TETGTVKL 680
              G +KL
Sbjct: 184 LNRGELKL 191

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  137 bits (346), Expect = 5e-34
 Identities = 49/232 (21%), Positives = 84/232 (36%), Gaps = 45/232 (19%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
            +     ++   E+G G+FG V+      +    A K +             + KEI+ +
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQTM 208

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             L+HP  +     +  D+   ++ E+  G                 E            
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSG----------------GE------------ 240

Query: 277 TEHFALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--ETGT 333
                LF     +   + E+E       V +GL ++H    +H D+K  NI+ T   +  
Sbjct: 241 -----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE 295

Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +KL DFG  +   P  S     GT  + APEV    +        D+WS+G+
Sbjct: 296 LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA---EGKPVGYYTDMWSVGV 344

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (279), Expect = 1e-25
 Identities = 35/142 (24%), Positives = 61/142 (42%), Gaps = 9/142 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVL 64
             +  L+HP  +     +  D+   ++ E+  G    + +      + E+E       V 
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKCPANSF---VGTPYWMAP 119
           +GL ++H    +H D+K  NI+ T   +  +KL DFG  +   P  S     GT  + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           EV    +        D+WS+G+
Sbjct: 326 EVA---EGKPVGYYTDMWSVGV 344

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 16/68 (23%), Positives = 31/68 (45%), Gaps = 3/68 (4%)

Query: 616 LVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 673
           ++ E+  G    + +      + E+E       V +GL ++H    +H D+K  NI+ T 
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290

Query: 674 -ETGTVKL 680
             +  +KL
Sbjct: 291 KRSNELKL 298

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  131 bits (332), Expect = 6e-34
 Identities = 71/343 (20%), Positives = 115/343 (33%), Gaps = 91/343 (26%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYR 228
           +G G+   V     L++ +  A+K +    KQ     + + +E+  L Q + H N +E  
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIE---KQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG---NRLQQLKCFTEHFALFNF 285
             +  +   +LV E   G                    G   + + + + F E  A    
Sbjct: 78  EFFEEEDRFYLVFEKMRG--------------------GSILSHIHKRRHFNELEA---- 113

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSA 342
                       + +   V   L++LH+ G  HRD+K  NIL     +   VK+ DF   
Sbjct: 114 ------------SVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161

Query: 343 SIKCPANSF-----------VGTPYWMAPEVILAMDEGQ--YDGKVDVWSLG-ITCIELA 388
           S                    G+  +MAPEV+ A  E    YD + D+WSLG I  I L+
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221

Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
              PP+         +   +    C                              L+   
Sbjct: 222 GY-PPFVGRCGSDCGWDRGEACPACQN---------------------------MLFESI 253

Query: 449 QNDTPCLQSSDW---SDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           Q         DW   S      +S  L ++   R S+ ++L H
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  111 bits (281), Expect = 3e-27
 Identities = 46/154 (29%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 7   LLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGV 63
           +L Q + H N +E    +  +   +LV E   G    S I +  +R   E E + +   V
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDV 120

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---------- 110
              L++LH+ G  HRD+K  NIL     +   VK+ DF   S                  
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 111 -VGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGI 141
             G+  +MAPEV+ A  E    YD + D+WSLG+
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 23/70 (32%), Positives = 33/70 (47%), Gaps = 7/70 (10%)

Query: 616 LVMEYCLGS--ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LV E   G    S I +  +R   E E + +   V   L++LH+ G  HRD+K  NIL  
Sbjct: 88  LVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE 145

Query: 674 ---ETGTVKL 680
              +   VK+
Sbjct: 146 HPNQVSPVKI 155

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  131 bits (332), Expect = 2e-33
 Identities = 76/344 (22%), Positives = 132/344 (38%), Gaps = 82/344 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           +     +G G++G+V  A    S E VAIKK+S    +  +         +E+  L+ ++
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQ 81

Query: 221 HPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       +LVM +                      M   LQ+  
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPF----------------------MQTDLQK-- 117

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                       +      EE+I  +   +L+GL Y+HS G +HRD+K GN+ + E   +
Sbjct: 118 ------------IMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCEL 165

Query: 335 KLADFGSASIKCPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
           K+ DFG A       + +V T ++ APEVIL+     Y+  VD+WS+G  CI  E+   K
Sbjct: 166 KILDFGLARHADAEMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVG--CIMAEMLTGK 221

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
             +   + +  L  I +             ++ ++  A +              +I    
Sbjct: 222 TLFKGKDYLDQLTQILK----VTGVPGTEFVQKLNDKAAKS-------------YIQS-- 262

Query: 452 TPCLQSSDWSDTFAH-------FVSSCLAKNPADRPSSGRLLTH 488
            P     D++  F          +   L  +   R ++ + LTH
Sbjct: 263 LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  100 bits (251), Expect = 5e-23
 Identities = 45/141 (31%), Positives = 75/141 (53%), Gaps = 12/141 (8%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ ++H N I     +    +       +LVM +     +D+ ++      EE+I  + 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM---QTDLQKIMGLKFSEEKIQYLV 132

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-FVGTPYWMAP 119
             +L+GL Y+HS G +HRD+K GN+ + E   +K+ DFG A       + +V T ++ AP
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAP 192

Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           EVIL+     Y+  VD+WS+G
Sbjct: 193 EVILSW--MHYNQTVDIWSVG 211

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 15/100 (15%)

Query: 586 RHHHHHPVTHL-----SQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEE 640
           +H  H  V  L        S  N    Y       LVM +     +D+ ++      EE+
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFY-------LVMPFM---QTDLQKIMGLKFSEEK 127

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           I  +   +L+GL Y+HS G +HRD+K GN+ + E   +K+
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 167

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  129 bits (326), Expect = 2e-33
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 49/225 (21%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-ILKEIRFLRQLKHPNTIE 226
           + +G G++G V  A   V+ E VA+K    +  + A    + I KEI   + L H N ++
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                    G          E   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSG--------------------G----------E---LFDRI 96

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIK 345
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG +   +
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156

Query: 346 CPA-----NSFVGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGIT 383
                   N   GT  ++APE++    + + +    VDVWS GI 
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELL----KRREFHAEPVDVWSCGIV 197

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 2e-24
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 28/184 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            + + L H N +++ G     +  +L +EYC  G   D IE     + E +       ++
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLM 115

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA-----NSFVGTPYWMA 118
            G+ YLH +G  HRD+K  N+LL E   +K++DFG +   +        N   GT  ++A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 119 PEVILAMDEGQ-YDG-KVDVWSLGIT-----PGSLKDPEIAELFDKEDPEKIFEDLREIG 171
           PE++    + + +    VDVWS GI       G L  P     +D   P    ++  +  
Sbjct: 176 PELL----KRREFHAEPVDVWSCGIVLTAMLAGEL--P-----WD--QPSDSCQEYSDWK 222

Query: 172 HGSF 175
               
Sbjct: 223 EKKT 226

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           L +EYC  G   D IE     + E +       ++ G+ YLH +G  HRD+K  N+LL E
Sbjct: 82  LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140

Query: 675 TGTVKL 680
              +K+
Sbjct: 141 RDNLKI 146

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  129 bits (326), Expect = 2e-33
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 54/243 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLRQ 218
           +E L +IG G++G V+ A+   + EIVA+K++    +   +   +      L+EI  L++
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV----RLDDDD--EGVPSSALREICLLKE 57

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           LKH N +        D    LV E+C                          Q LK +  
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCD-------------------------QDLKKY-- 90

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                 F+     L  E + +    +L+GL + HS   +HRD+K  N+L+   G +KLA+
Sbjct: 91  ------FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLAN 144

Query: 339 FGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
           FG A +   P   +   V T ++  P+V+       Y   +D+WS G  CI  ELA    
Sbjct: 145 FGLARAFGIPVRCYSAEVVTLWYRPPDVLFG--AKLYSTSIDMWSAG--CIFAELANAGR 200

Query: 393 PYF 395
           P F
Sbjct: 201 PLF 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (275), Expect = 1e-26
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 27/178 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            LL++LKH N +        D    LV E+C        +     L  E + +    +L+
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEV 121
           GL + HS   +HRD+K  N+L+   G +KLA+FG A +   P   +   V T ++  P+V
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 122 ILAMDEGQYDGKVDVWSLG-ITPGSLKDPEIAELFDKEDP-----------EKIFEDL 167
           +       Y   +D+WS G I          AEL +   P           ++IF  L
Sbjct: 173 LFG--AKLYSTSIDMWSAGCI---------FAELANAGRPLFPGNDVDDQLKRIFRLL 219

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 20/65 (30%), Positives = 32/65 (49%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+C        +     L  E + +    +L+GL + HS   +HRD+K  N+L+   
Sbjct: 78  LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137

Query: 676 GTVKL 680
           G +KL
Sbjct: 138 GELKL 142

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  129 bits (326), Expect = 2e-33
 Identities = 59/251 (23%), Positives = 98/251 (39%), Gaps = 75/251 (29%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWAD----------------- 208
            EIG GS+G V  A         A+K +S   L +Q                        
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 209 ----ILKEIRFLRQLKHPNTIEYRGCYLRD-------HTAWLVMEYCLGSASDIIEVHWI 257
               + +EI  L++L HPN ++     L +          ++V E               
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVK-----LVEVLDDPNEDHLYMVFELVNQ----------- 122

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
                    G              +       +PL E++       +++G+ YLH    I
Sbjct: 123 ---------GP-------------VMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQKII 159

Query: 318 HRDVKAGNILLTETGTVKLADFGSASIKCPANSF----VGTPYWMAPEVILAMDEGQYDG 373
           HRD+K  N+L+ E G +K+ADFG ++    +++     VGTP +MAPE +    +  + G
Sbjct: 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKI-FSG 218

Query: 374 -KVDVWSLGIT 383
             +DVW++G+T
Sbjct: 219 KALDVWAMGVT 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  114 bits (288), Expect = 3e-28
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 28/172 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRD-------HTAWLVMEYCL-GSASDIIEVHKRPLKEEEIA 57
           ++L++L HPN ++     L +          ++V E    G   ++     +PL E++  
Sbjct: 88  AILKKLDHPNVVK-----LVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSEDQAR 140

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF----VGT 113
                +++G+ YLH    IHRD+K  N+L+ E G +K+ADFG ++    +++     VGT
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGT 200

Query: 114 PYWMAPEVILAMDEGQYDG-KVDVWSLGIT-----PGSL--KDPEIAELFDK 157
           P +MAPE +    +  + G  +DVW++G+T      G     D  I  L  K
Sbjct: 201 PAFMAPESLSETRKI-FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 20/66 (30%), Positives = 35/66 (53%), Gaps = 3/66 (4%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V E    G   ++     +PL E++       +++G+ YLH    IHRD+K  N+L+ E
Sbjct: 115 MVFELVNQGPVMEV--PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172

Query: 675 TGTVKL 680
            G +K+
Sbjct: 173 DGHIKI 178

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  130 bits (330), Expect = 3e-33
 Identities = 82/374 (21%), Positives = 142/374 (37%), Gaps = 88/374 (23%)

Query: 143 PGSLKDPEIAELFDKEDPEKI--FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           PGS+     A   D+   +++  F+  R  G G+FG V   +   +   VAIKK+     
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDP 60

Query: 201 QCAEKWADILKEIRFLRQLKHPNTIEYRGCYL-------RDHTAWLVMEYCLGSASDIIE 253
           +   +    L+ ++ L  L HPN ++ +  +        RD    +VMEY          
Sbjct: 61  RFRNR---ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV---PDT--- 111

Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH- 312
           +H   R ++                   +F F++                 +R +  LH 
Sbjct: 112 LHRCCRNYYRRQ-----VAPP--PILIKVFLFQL-----------------IRSIGCLHL 147

Query: 313 -SLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPAN---SFVGTPYWMAPEVILAMD 367
            S+   HRD+K  N+L+    GT+KL DFGSA    P+    +++ + Y+ APE+I    
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQ 207

Query: 368 EGQYDGKVDVWSLGITCI--ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTI 425
              Y   VD+WS+G  CI  E+   +P +   N+   L+ I               ++ +
Sbjct: 208 H--YTTAVDIWSVG--CIFAEMMLGEPIFRGDNSAGQLHEI---------------VRVL 248

Query: 426 SSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH-----------FVSSCLAK 474
                  P    +  ++  +     D    +   WS+ F+             +S+ L  
Sbjct: 249 GC-----PSREVLRKLNPSH--TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301

Query: 475 NPADRPSSGRLLTH 488
            P +R      L H
Sbjct: 302 LPEERMKPYEALCH 315

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 18/150 (12%)

Query: 7   LLRQLKHPNTIEYRGCYL-------RDHTAWLVMEYC---LGSASDIIEVHKRPLKEEEI 56
            L  L HPN ++ +  +        RD    +VMEY    L          +       I
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 57  AAICSGVLRGLNYLH--SLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPAN---SF 110
                 ++R +  LH  S+   HRD+K  N+L+    GT+KL DFGSA    P+    ++
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191

Query: 111 VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
           + + Y+ APE+I       Y   VD+WS+G
Sbjct: 192 ICSRYYRAPELIFGNQH--YTTAVDIWSVG 219

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 24/101 (23%), Positives = 39/101 (38%), Gaps = 7/101 (6%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC---LGSASDIIEVHKRPLKEEEIA 642
              HH  +  L  + Y     +   ++   +VMEY    L          +       I 
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYL-NVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132

Query: 643 AICSGVLRGLNYLH--SLGRIHRDVKAGNILL-TETGTVKL 680
                ++R +  LH  S+   HRD+K  N+L+    GT+KL
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  129 bits (327), Expect = 4e-33
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 45/222 (20%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKM--SYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           L+ IG G+F  V  AR +++   VAIK +  + L     +K   + +E+R ++ L HPN 
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK---LFREVRIMKILNHPNI 76

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           ++       + T +L+MEY  G                    G              +F+
Sbjct: 77  VKLFEVIETEKTLYLIMEYASG--------------------GE-------------VFD 103

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V    +KE+E  +    ++  + Y H    +HRD+KA N+LL     +K+ADFG ++ 
Sbjct: 104 YLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163

Query: 345 KCPA---NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGI 382
                  ++F G P + APE+       +YDG +VDVWSLG+
Sbjct: 164 FTVGGKLDAFCGAPPYAAPELFQGK---KYDGPEVDVWSLGV 202

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  108 bits (273), Expect = 5e-26
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 16/164 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            +++ L HPN ++       + T +L+MEY   G   D +  H R +KE+E  +    ++
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIV 124

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEV 121
             + Y H    +HRD+KA N+LL     +K+ADFG ++        ++F G P + APE+
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184

Query: 122 ILAMDEGQYDG-KVDVWSLGI-----TPGSL--KDPEIAELFDK 157
                  +YDG +VDVWSLG+       GSL      + EL ++
Sbjct: 185 FQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           L+MEY   G   D +  H R +KE+E  +    ++  + Y H    +HRD+KA N+LL  
Sbjct: 91  LIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA 149

Query: 675 TGTVKL 680
              +K+
Sbjct: 150 DMNIKI 155

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  130 bits (329), Expect = 5e-33
 Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 55/262 (20%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA--EKWADILKEIRFL 216
           + E +     +IG G+FG V+  R      +VA+K      ++    +  A  L+E R L
Sbjct: 112 NHEDL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARIL 166

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           +Q  HPN +   G   +    ++VME   G                    G+ L  L+  
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQG--------------------GDFLTFLRT- 205

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                          L+ + +  +      G+ YL S   IHRD+ A N L+TE   +K+
Sbjct: 206 -----------EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKI 254

Query: 337 ADFGSA--------SIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           +DFG +        +           P  W APE +     G+Y  + DVWS GI   E 
Sbjct: 255 SDFGMSREEADGVYAASGGLRQV---PVKWTAPEALN---YGRYSSESDVWSFGILLWET 308

Query: 388 AER-KPPYFNMNAMSALYHIAQ 408
                 PY N++       + +
Sbjct: 309 FSLGASPYPNLSNQQTREFVEK 330

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  101 bits (253), Expect = 4e-23
 Identities = 41/147 (27%), Positives = 63/147 (42%), Gaps = 16/147 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            +L+Q  HPN +   G   +    ++VME    G     +      L+ + +  +     
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA--------SIKCPANSFVGTPY- 115
            G+ YL S   IHRD+ A N L+TE   +K++DFG +        +           P  
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV---PVK 280

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W APE +     G+Y  + DVWS GI 
Sbjct: 281 WTAPEALN---YGRYSSESDVWSFGIL 304

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 1/65 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VME    G     +      L+ + +  +      G+ YL S   IHRD+ A N L+TE
Sbjct: 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE 248

Query: 675 TGTVK 679
              +K
Sbjct: 249 KNVLK 253

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  128 bits (324), Expect = 6e-33
 Identities = 65/252 (25%), Positives = 98/252 (38%), Gaps = 60/252 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---------EIR 214
           F+  + +G GSF  V  AR L +    AIK +         K   I+K         E  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILE--------K-RHIIKENKVPYVTRERD 82

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            + +L HP  ++    +  D   +  + Y              E   +       ++++ 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG----------ELLKY-------IRKIG 125

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            F E    F              A I S     L YLH  G IHRD+K  NILL E   +
Sbjct: 126 SFDETCTRFY------------TAEIVSA----LEYLHGKGIIHRDLKPENILLNEDMHI 169

Query: 335 KLADFGSA------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           ++ DFG+A      S +  ANSFVGT  +++PE++            D+W+LG    +L 
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS---ACKSSDLWALGCIIYQLV 226

Query: 389 ERKPPYFNMNAM 400
              PP+   N  
Sbjct: 227 AGLPPFRAGNEY 238

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.5 bits (241), Expect = 6e-22
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 33/175 (18%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV--HKRPLK--EEEIAAI-CSG 62
           + +L HP  ++    +  D   +  + Y         E+  + R +   +E       + 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG-----ELLKYIRKIGSFDETCTRFYTAE 138

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA------SIKCPANSFVGTPYW 116
           ++  L YLH  G IHRD+K  NILL E   +++ DFG+A      S +  ANSFVGT  +
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFE 165
           ++PE++            D+W+LG          I +L      F   +   IF+
Sbjct: 199 VSPELLTEKS---ACKSSDLWALGCI--------IYQLVAGLPPFRAGNEYLIFQ 242

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 15/33 (45%), Positives = 21/33 (63%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           ++  L YLH  G IHRD+K  NILL E   +++
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 171

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  130 bits (328), Expect = 6e-33
 Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 55/241 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           + DL+ +G G++GAV  A    +   VAIKK+     +  +         +E+R L+ ++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMR 82

Query: 221 HPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +  D T       +LVM +                      MG  L +L 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPF----------------------MGTDLGKL- 119

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                       +    L E+ I  +   +L+GL Y+H+ G IHRD+K GN+ + E   +
Sbjct: 120 ------------MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 167

Query: 335 KLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
           K+ DFG A         +V T ++ APEVIL     +Y   VD+WS+G  CI  E+   K
Sbjct: 168 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWM--RYTQTVDIWSVG--CIMAEMITGK 223

Query: 392 P 392
            
Sbjct: 224 T 224

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 46/141 (32%), Positives = 71/141 (50%), Gaps = 11/141 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ ++H N I     +  D T       +LVM +       ++      L E+ I  + 
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLV 134

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-NSFVGTPYWMAP 119
             +L+GL Y+H+ G IHRD+K GN+ + E   +K+ DFG A         +V T ++ AP
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAP 194

Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           EVIL     +Y   VD+WS+G
Sbjct: 195 EVILNWM--RYTQTVDIWSVG 213

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 21/65 (32%), Positives = 35/65 (53%), Gaps = 2/65 (3%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVM +       ++      L E+ I  +   +L+GL Y+H+ G IHRD+K GN+ + E 
Sbjct: 107 LVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 164

Query: 676 GTVKL 680
             +K+
Sbjct: 165 CELKI 169

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  128 bits (325), Expect = 9e-33
 Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 49/239 (20%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLKH 221
           +E L  +G G F  VY AR   + +IVAIKK+    +  A+   +   L+EI+ L++L H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           PN I     +       LV ++     +D                      L+   +   
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFME---TD----------------------LEVIIKD-- 104

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                 +   L    I A     L+GL YLH    +HRD+K  N+LL E G +KLADFG 
Sbjct: 105 ------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158

Query: 342 A-SIKCPANSF---VGTPYWMAPEVILAMDEG--QYDGKVDVWSLGITCI--ELAERKP 392
           A S   P  ++   V T ++ APE++     G   Y   VD+W++G  CI  EL  R P
Sbjct: 159 AKSFGSPNRAYTHQVVTRWYRAPELLF----GARMYGVGVDMWAVG--CILAELLLRVP 211

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  106 bits (268), Expect = 3e-25
 Identities = 57/179 (31%), Positives = 82/179 (45%), Gaps = 30/179 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            LL++L HPN I     +       LV ++       II+ +   L    I A     L+
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEV 121
           GL YLH    +HRD+K  N+LL E G +KLADFG A S   P  ++   V T ++ APE+
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 122 ILAMDEG--QYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           +     G   Y   VD+W++G             PG   D ++ +L       +IFE L
Sbjct: 184 LF----GARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLT------RIFETL 229

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 25/72 (34%), Positives = 36/72 (50%), Gaps = 3/72 (4%)

Query: 609 SSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 668
           S++    LV ++       II+ +   L    I A     L+GL YLH    +HRD+K  
Sbjct: 85  SNIS---LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN 141

Query: 669 NILLTETGTVKL 680
           N+LL E G +KL
Sbjct: 142 NLLLDENGVLKL 153

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  128 bits (323), Expect = 1e-32
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 49/225 (21%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-ILKEIRFLRQLKHPNTIE 226
           + +G G++G V  A   V+ E VA+K    +  + A    + I KEI   + L H N ++
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G     +  +L +EYC G                    G          E   LF+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSG--------------------G----------E---LFDRI 96

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIK 345
                + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG +   +
Sbjct: 97  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156

Query: 346 CPA-----NSFVGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGIT 383
                   N   GT  ++APE++    + + +    VDVWS GI 
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELL----KRREFHAEPVDVWSCGIV 197

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  101 bits (253), Expect = 2e-23
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 28/184 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            + + L H N +++ G     +  +L +EYC  G   D IE     + E +       ++
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLM 115

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPA-----NSFVGTPYWMA 118
            G+ YLH +G  HRD+K  N+LL E   +K++DFG +   +        N   GT  ++A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 119 PEVILAMDEGQ-YDG-KVDVWSLGIT-----PGSLKDPEIAELFDKEDPEKIFEDLREIG 171
           PE++    + + +    VDVWS GI       G L  P     +D   P    ++  +  
Sbjct: 176 PELL----KRREFHAEPVDVWSCGIVLTAMLAGEL--P-----WD--QPSDSCQEYSDWK 222

Query: 172 HGSF 175
               
Sbjct: 223 EKKT 226

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           L +EYC  G   D IE     + E +       ++ G+ YLH +G  HRD+K  N+LL E
Sbjct: 82  LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140

Query: 675 TGTVKL 680
              +K+
Sbjct: 141 RDNLKI 146

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  127 bits (322), Expect = 2e-32
 Identities = 55/228 (24%), Positives = 87/228 (38%), Gaps = 50/228 (21%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKH-PNT 224
           +E+G G F  V       + +  A K  K    G+ C     +IL EI  L   K  P  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA---EILHEIAVLELAKSCPRV 91

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I     Y       L++EY  G                    G          E   +F+
Sbjct: 92  INLHEVYENTSEIILILEYAAG--------------------G----------E---IFS 118

Query: 285 FEVHKRP--LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADF 339
             + +    + E ++  +   +L G+ YLH    +H D+K  NILL      G +K+ DF
Sbjct: 119 LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178

Query: 340 GSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           G +     A      +GTP ++APE++   +        D+W++GI  
Sbjct: 179 GMSRKIGHACELREIMGTPEYLAPEIL---NYDPITTATDMWNIGIIA 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  108 bits (273), Expect = 5e-26
 Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 12/143 (8%)

Query: 8   LRQLKH-PNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVL 64
           L   K  P  I     Y       L++EY  G    S  +      + E ++  +   +L
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141

Query: 65  RGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFGSASIKCPANSF---VGTPYWMA 118
            G+ YLH    +H D+K  NILL      G +K+ DFG +     A      +GTP ++A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE++   +        D+W++GI
Sbjct: 202 PEIL---NYDPITTATDMWNIGI 221

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 20/70 (28%), Positives = 33/70 (47%), Gaps = 5/70 (7%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL- 672
           L++EY  G    S  +      + E ++  +   +L G+ YLH    +H D+K  NILL 
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165

Query: 673 --TETGTVKL 680
                G +K+
Sbjct: 166 SIYPLGDIKI 175

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  127 bits (321), Expect = 2e-32
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 49/237 (20%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI--LKEIRFLRQLKH 221
           +  L ++G G++  VY  +  ++  +VA+K++    +   E+ A    ++E+  L+ LKH
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLKH 59

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N +        + +  LV EY      D                      LK + +   
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL---DKD----------------------LKQYLDD-- 92

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
                     +    +      +LRGL Y H    +HRD+K  N+L+ E G +KLADFG 
Sbjct: 93  ------CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146

Query: 342 ASIKC-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
           A  K  P  ++   V T ++  P+++L      Y  ++D+W +G  CI  E+A  +P
Sbjct: 147 ARAKSIPTKTYDNEVVTLWYRPPDILLG--STDYSTQIDMWGVG--CIFYEMATGRP 199

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  105 bits (265), Expect = 5e-25
 Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 26/177 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           SLL+ LKH N +        + +  LV EY        ++     +    +      +LR
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-PANSF---VGTPYWMAPEV 121
           GL Y H    +HRD+K  N+L+ E G +KLADFG A  K  P  ++   V T ++  P++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

Query: 122 ILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           +L      Y  ++D+W +G           + PG        +L        IF  L
Sbjct: 172 LLG--STDYSTQIDMWGVGCIFYEMATGRPLFPG---STVEEQLH------FIFRIL 217

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 20/65 (30%), Positives = 30/65 (46%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV EY        ++     +    +      +LRGL Y H    +HRD+K  N+L+ E 
Sbjct: 77  LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER 136

Query: 676 GTVKL 680
           G +KL
Sbjct: 137 GELKL 141

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  127 bits (322), Expect = 3e-32
 Identities = 64/250 (25%), Positives = 96/250 (38%), Gaps = 62/250 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+    +G G++G V  A    + EIVAIKK+    K         L+EI+ L+  KH N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL--RTLREIKILKHFKHEN 70

Query: 224 TIEYRGCYLRDHTA-----WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            I        D        +++ E                       M   L ++     
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQEL----------------------MQTDLHRV----- 103

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                   +  + L ++ I       LR +  LH    IHRD+K  N+L+     +K+ D
Sbjct: 104 --------ISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD 155

Query: 339 FGSASIKCPANSF--------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           FG A I   + +               V T ++ APEV+L   +  Y   +DVWS G  C
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK--YSRAMDVWSCG--C 211

Query: 385 I--ELAERKP 392
           I  EL  R+P
Sbjct: 212 ILAELFLRRP 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 25/154 (16%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA-----WLVMEYCLGSASDIIEV-HKRPLKEEEIAAIC 60
           +L+  KH N I        D        +++ E      +D+  V   + L ++ I    
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHIQYFI 118

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF---------- 110
              LR +  LH    IHRD+K  N+L+     +K+ DFG A I   + +           
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 111 ----VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
               V T ++ APEV+L   +  Y   +DVWS G
Sbjct: 179 MVEFVATRWYRAPEVMLTSAK--YSRAMDVWSCG 210

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 14/46 (30%), Positives = 22/46 (47%)

Query: 635 PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            L ++ I       LR +  LH    IHRD+K  N+L+     +K+
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKV 153

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  128 bits (324), Expect = 3e-32
 Identities = 76/388 (19%), Positives = 126/388 (32%), Gaps = 108/388 (27%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIE 226
           + +G G  G V       ++E  A+K          +      +E+    +  + P+ + 
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPHIVR 119

Query: 227 YRGCY----LRDHTAWLVMEYCLGSA--SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
               Y           +VME   G    S I +                 +  + FTE  
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----------------RGDQAFTERE 162

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLA 337
           A                + I   +   + YLHS+   HRDVK  N+L T       +KL 
Sbjct: 163 A----------------SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 206

Query: 338 DFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPP 393
           DFG A      NS      TPY++APEV+      +YD   D+WSLG I  I L    PP
Sbjct: 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVL---GPEKYDKSCDMWSLGVIMYILLC-GYPP 262

Query: 394 YFNMNAM---SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
           +++ + +     +    +       + +WS    +S     K                  
Sbjct: 263 FYSNHGLAISPGMKTRIRMGQYEFPNPEWS---EVSEEV--K------------------ 299

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR----PRSPSVLVDLIRR 506
                            + + L   P  R +    + H  + +    P++P     +++ 
Sbjct: 300 ---------------MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 344

Query: 507 TKAAVRDLDNLNYRKMKKILMADGADTE 534
            K    D+      +M   L     D E
Sbjct: 345 DKERWEDV----KEEMTSALATMRVDYE 368

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  115 bits (291), Expect = 7e-28
 Identities = 46/147 (31%), Positives = 64/147 (43%), Gaps = 15/147 (10%)

Query: 7   LLRQLKHPNTIEYRGCY----LRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAIC 60
             R  + P+ +     Y           +VME   G    S I +   +   E E + I 
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSF---VGTP 114
             +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS      TP
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGI 141
           Y++APEV+      +YD   D+WSLG+
Sbjct: 228 YYVAPEVL---GPEKYDKSCDMWSLGV 251

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 28/99 (28%), Positives = 38/99 (38%), Gaps = 16/99 (16%)

Query: 595 HLSQH--------SYNNNNSNYSSLFSPQLVMEYCLGSA--SDIIEVHKRPLKEEEIAAI 644
             SQ          Y N  +    L    +VME   G    S I +   +   E E + I
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLL---IVMECLDGGELFSRIQDRGDQAFTEREASEI 166

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKL 680
              +   + YLHS+   HRDVK  N+L T       +KL
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  127 bits (322), Expect = 3e-32
 Identities = 58/289 (20%), Positives = 100/289 (34%), Gaps = 57/289 (19%)

Query: 100 SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKED 159
           +  +   A+     P        LA+D        D   +    G++        +    
Sbjct: 39  AKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNS-----FYT--- 90

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
                     +G G FG V+      +   +A K +     +  +   ++  EI  + QL
Sbjct: 91  ----VSKTEILGGGRFGQVHKCEETATGLKLAAKIIK---TRGMKDKEEVKNEISVMNQL 143

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            H N I+    +   +   LVMEY  G                    G          E 
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDG--------------------G----------E- 172

Query: 280 FALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--ETGTVKL 336
             LF+  + +   L E +       +  G+ ++H +  +H D+K  NIL    +   +K+
Sbjct: 173 --LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKI 230

Query: 337 ADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
            DFG A    P        GTP ++APEV+   +        D+WS+G+
Sbjct: 231 IDFGLARRYKPREKLKVNFGTPEFLAPEVV---NYDFVSFPTDMWSVGV 276

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (274), Expect = 7e-26
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 11/143 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGV 63
           S++ QL H N I+    +   +   LVMEY  G      II+     L E +       +
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQI 196

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKCPANSF---VGTPYWMA 118
             G+ ++H +  +H D+K  NIL    +   +K+ DFG A    P        GTP ++A
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PEV+   +        D+WS+G+
Sbjct: 257 PEVV---NYDFVSFPTDMWSVGV 276

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 19/69 (27%), Positives = 31/69 (44%), Gaps = 5/69 (7%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           LVMEY  G      II+     L E +       +  G+ ++H +  +H D+K  NIL  
Sbjct: 163 LVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCV 221

Query: 674 --ETGTVKL 680
             +   +K+
Sbjct: 222 NRDAKQIKI 230

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 57.5 bits (140), Expect = 5e-09
 Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LV E+        ++      +    I +    +L+GL + HS   +HRD+K  N+L+  
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138

Query: 675 TGTVKL 680
            G +KL
Sbjct: 139 EGAIKL 144

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  127 bits (321), Expect = 4e-32
 Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 55/243 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   +++  VAIKK+S    Q   +    L+EI+ L + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRFRHEN 86

Query: 224 TIEYRGCYL-----RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            I            +    ++V +                       M   L +L     
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDL----------------------METDLYKL----- 119

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                   +  + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ D
Sbjct: 120 --------LKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171

Query: 339 FG---SASIKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAE 389
           FG    A        F    V T ++ APE++L      Y   +D+WS+G  CI  E+  
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVG--CILAEMLS 227

Query: 390 RKP 392
            +P
Sbjct: 228 NRP 230

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 93.9 bits (234), Expect = 8e-21
 Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 16/146 (10%)

Query: 7   LLRQLKHPNTIEYRGCYL-----RDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICS 61
           +L + +H N I            +    ++V +        ++    + L  + I     
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLY 135

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG---SASIKCPANSF----VGTP 114
            +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG    A        F    V T 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLG 140
           ++ APE++L      Y   +D+WS+G
Sbjct: 196 WYRAPEIMLNSK--GYTKSIDIWSVG 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 18/50 (36%), Positives = 28/50 (56%)

Query: 631 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +  + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+
Sbjct: 120 LKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  127 bits (321), Expect = 4e-32
 Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 55/241 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           +++L  +G G++G+V  A    +   VA+KK+S    +  +         +E+R L+ +K
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS----RPFQSIIHAKRTYRELRLLKHMK 86

Query: 221 HPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           H N I     +    +       +LV                         MG  L  + 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHL----------------------MGADLNNI- 123

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                       V  + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +
Sbjct: 124 ------------VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171

Query: 335 KLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK 391
           K+ DFG A         +V T ++ APE++L      Y+  VD+WS+G  CI  EL   +
Sbjct: 172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVG--CIMAELLTGR 227

Query: 392 P 392
            
Sbjct: 228 T 228

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 97.8 bits (244), Expect = 5e-22
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 11/141 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
           LL+ +KH N I     +    +       +LV        ++I+    + L ++ +  + 
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLI 138

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-NSFVGTPYWMAP 119
             +LRGL Y+HS   IHRD+K  N+ + E   +K+ DFG A         +V T ++ AP
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAP 198

Query: 120 EVILAMDEGQYDGKVDVWSLG 140
           E++L      Y+  VD+WS+G
Sbjct: 199 EIMLNW--MHYNQTVDIWSVG 217

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 14/100 (14%)

Query: 586 RHHHHHPVTHL-----SQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEE 640
           +H  H  V  L        S    N  Y       LV        ++I+    + L ++ 
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMGADLNNIV--KCQKLTDDH 133

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (330), Expect = 9e-32
 Identities = 70/338 (20%), Positives = 114/338 (33%), Gaps = 99/338 (29%)

Query: 167 LREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN-- 223
              I HG  G +Y A    V+   V +K + + G   A+  A  + E +FL ++ HP+  
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMA--MAERQFLAEVVHPSIV 142

Query: 224 ----TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
                +E+   +  D   ++VMEY                   V G     Q LK     
Sbjct: 143 QIFNFVEHTDRH-GDPVGYIVMEY-------------------VGG-----QSLK----- 172

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                     + L   E  A    +L  L+YLHS+G ++ D+K  NI+LTE   +KL D 
Sbjct: 173 ------RSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225

Query: 340 GSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
           G+ S         GTP + APE++            D++++G T   L    P   N   
Sbjct: 226 GAVSRINSFGYLYGTPGFQAPEIV----RTGPTVATDIYTVGRTLAALTLDLPT-RNGRY 280

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           +  L      D P L                +                            
Sbjct: 281 VDGL----PEDDPVL----------------KTYD------------------------- 295

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSP 497
              ++   +   +  +P  R ++   ++  L    R  
Sbjct: 296 ---SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  108 bits (271), Expect = 2e-24
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 14/139 (10%)

Query: 10  QLKHPN------TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           ++ HP+       +E+   +  D   ++VMEY  G    +     + L   E  A    +
Sbjct: 135 EVVHPSIVQIFNFVEHTDRH-GDPVGYIVMEYVGGQ--SLKRSKGQKLPVAEAIAYLLEI 191

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVIL 123
           L  L+YLHS+G ++ D+K  NI+LTE   +KL D G+ S         GTP + APE++ 
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLYGTPGFQAPEIV- 249

Query: 124 AMDEGQYDGKVDVWSLGIT 142
                      D++++G T
Sbjct: 250 ---RTGPTVATDIYTVGRT 265

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 68.0 bits (166), Expect = 7e-12
 Identities = 24/65 (36%), Positives = 35/65 (53%), Gaps = 3/65 (4%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +VMEY  G    +     + L   E  A    +L  L+YLHS+G ++ D+K  NI+LTE 
Sbjct: 161 IVMEYVGGQ--SLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE 218

Query: 676 GTVKL 680
             +KL
Sbjct: 219 Q-LKL 222

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  123 bits (312), Expect = 1e-31
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 48/223 (21%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---EIRFLRQLKHPNT 224
             +G G+FG V      ++   VA+K ++   +Q       + K   EI+ L+  +HP+ 
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I+           ++VMEY  G             E                     LF+
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSG------------GE---------------------LFD 100

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +      ++E E   +   +L  ++Y H    +HRD+K  N+LL      K+ADFG +++
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160

Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGI 382
                   +  G+P + APEVI     G+ Y G +VD+WS G+
Sbjct: 161 MSDGEFLRTSCGSPNYAAPEVI----SGRLYAGPEVDIWSCGV 199

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  100 bits (251), Expect = 1e-23
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 18/165 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
             L+  +HP+ I+           ++VMEY   G   D I      ++E E   +   +L
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQIL 121

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPEV 121
             ++Y H    +HRD+K  N+LL      K+ADFG +++        +  G+P + APEV
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181

Query: 122 ILAMDEGQ-YDG-KVDVWSLGIT-----PGSL--KDPEIAELFDK 157
           I     G+ Y G +VD+WS G+       G+L   D  +  LF K
Sbjct: 182 I----SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 20/66 (30%), Positives = 31/66 (46%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY   G   D I      ++E E   +   +L  ++Y H    +HRD+K  N+LL  
Sbjct: 88  MVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA 146

Query: 675 TGTVKL 680
               K+
Sbjct: 147 HMNAKI 152

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  125 bits (317), Expect = 1e-31
 Identities = 52/254 (20%), Positives = 94/254 (37%), Gaps = 63/254 (24%)

Query: 146 LKDPEIAELFD--KEDPEKIFED---LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK 200
           ++   +  +      +  +  +      +IG GS+          +    A+K +     
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---- 56

Query: 201 QCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIER 259
              +   D  +EI  L +  +HPN I  +  Y      ++V E   G             
Sbjct: 57  ---KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG------------- 100

Query: 260 EFHVEGMG---NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
                  G   +++ + K F+E  A                +A+   + + + YLH+ G 
Sbjct: 101 -------GELLDKILRQKFFSEREA----------------SAVLFTITKTVEYLHAQGV 137

Query: 317 IHRDVKAGNILLT----ETGTVKLADFGSASIKCPANSF----VGTPYWMAPEVILAMDE 368
           +HRD+K  NIL         ++++ DFG A      N        T  ++APEV+   + 
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL---ER 194

Query: 369 GQYDGKVDVWSLGI 382
             YD   D+WSLG+
Sbjct: 195 QGYDAACDIWSLGV 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  115 bits (289), Expect = 5e-28
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 15/145 (10%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVL 64
           LLR  +HPN I  +  Y      ++V E   G      I+   ++   E E +A+   + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTIT 126

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSASIKCPANSF----VGTPYW 116
           + + YLH+ G +HRD+K  NIL         ++++ DFG A      N        T  +
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           +APEV+   +   YD   D+WSLG+
Sbjct: 187 VAPEVL---ERQGYDAACDIWSLGV 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 18/60 (30%), Positives = 30/60 (50%), Gaps = 4/60 (6%)

Query: 616 LVMEYCLGSA--SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V E   G      I+   ++   E E +A+   + + + YLH+ G +HRD+K  NIL  
Sbjct: 93  VVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV 150

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  125 bits (315), Expect = 2e-31
 Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 47/262 (17%)

Query: 147 KDPEIAELFDKEDPEKI----FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC 202
              +  + ++           F+ ++ +G GSFG V   +   S    A+K +    KQ 
Sbjct: 22  AKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQK 78

Query: 203 AEKWAD---ILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIER 259
             K       L E R L+ +  P  ++    +  +   ++VMEY  G           E 
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG----------EM 128

Query: 260 EFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR 319
             H       L+++  F+E  A F                  + ++    YLHSL  I+R
Sbjct: 129 FSH-------LRRIGRFSEPHARF----------------YAAQIVLTFEYLHSLDLIYR 165

Query: 320 DVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 378
           D+K  N+L+ + G +++ DFG A  +K    +  GTP  +APE+IL+     Y+  VD W
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG---YNKAVDWW 222

Query: 379 SLGITCIELAERKPPYFNMNAM 400
           +LG+   E+A   PP+F    +
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPI 244

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 28/172 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV--HKRPLK--EEEIAAICS 61
            +L+ +  P  ++    +  +   ++VMEY  G      E+  H R +    E  A   +
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG-----EMFSHLRRIGRFSEPHARFYA 147

Query: 62  G-VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAP 119
             ++    YLHSL  I+RD+K  N+L+ + G +++ DFG A  +K    +  GTP  +AP
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAP 207

Query: 120 EVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFE 165
           E+IL+     Y+  VD W+LG+         I E+      F  + P +I+E
Sbjct: 208 EIILSKG---YNKAVDWWALGVL--------IYEMAAGYPPFFADQPIQIYE 248

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 10/70 (14%)

Query: 616 LVMEYCLGSASDIIEV--HKRPLK--EEEIAAICSG-VLRGLNYLHSLGRIHRDVKAGNI 670
           +VMEY  G      E+  H R +    E  A   +  ++    YLHSL  I+RD+K  N+
Sbjct: 118 MVMEYVAGG-----EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172

Query: 671 LLTETGTVKL 680
           L+ + G +++
Sbjct: 173 LIDQQGYIQV 182

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  123 bits (311), Expect = 2e-31
 Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 55/240 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLRQ 218
           +  L +IG G++G VY A+     E  A+KK+        EK  +      ++EI  L++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL------EKEDEGIPSTTIREISILKE 56

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           LKH N ++            LV E+                           Q LK    
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLD-------------------------QDLKKL-- 89

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                  +V +  L+     +    +L G+ Y H    +HRD+K  N+L+   G +K+AD
Sbjct: 90  ------LDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIAD 143

Query: 339 FGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
           FG A +   P   +   + T ++ AP+V++     +Y   +D+WS+G  CI  E+    P
Sbjct: 144 FGLARAFGIPVRKYTHEIVTLWYRAPDVLMG--SKKYSTTIDIWSVG--CIFAEMVNGTP 199

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  107 bits (271), Expect = 5e-26
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 26/177 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           S+L++LKH N ++            LV E+       +++V +  L+     +    +L 
Sbjct: 52  SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEV 121
           G+ Y H    +HRD+K  N+L+   G +K+ADFG A +   P   +   + T ++ AP+V
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 122 ILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           ++     +Y   +D+WS+G           + PG     E  +L       +IF  L
Sbjct: 172 LMG--SKKYSTTIDIWSVGCIFAEMVNGTPLFPG---VSEADQLM------RIFRIL 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 62.1 bits (152), Expect = 1e-10
 Identities = 17/65 (26%), Positives = 32/65 (49%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+       +++V +  L+     +    +L G+ Y H    +HRD+K  N+L+   
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136

Query: 676 GTVKL 680
           G +K+
Sbjct: 137 GELKI 141

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  125 bits (315), Expect = 3e-31
 Identities = 67/233 (28%), Positives = 100/233 (42%), Gaps = 60/233 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ +++IG G+FG     R  +++E+VA+K +   G    E    + +EI   R L+HPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDEN---VQREIINHRSLRHPN 77

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + ++   L      ++MEY  G                    G              L+
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASG--------------------GE-------------LY 104

Query: 284 NFEVHKRPLKEEEIAA------ICSGVLRGLNYLHSLGRIHRDVKAGNILLTE--TGTVK 335
               +     E+E  A      + SGV    +Y HS+   HRD+K  N LL       +K
Sbjct: 105 ERICNAGRFSEDE--ARFFFQQLLSGV----SYCHSMQICHRDLKLENTLLDGSPAPRLK 158

Query: 336 LADFG-SASIK--CPANSFVGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGIT 383
           + DFG S S        S VGTP ++APEV+      Q YDG   DVWS G+T
Sbjct: 159 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----LRQEYDGKIADVWSCGVT 207

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (250), Expect = 7e-23
 Identities = 57/173 (32%), Positives = 79/173 (45%), Gaps = 32/173 (18%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAA------ 58
              R L+HPN + ++   L      ++MEY   G   + I  +     E+E  A      
Sbjct: 68  INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDE--ARFFFQQ 124

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTE--TGTVKLADFG-SASIK--CPANSFVGT 113
           + SGV    +Y HS+   HRD+K  N LL       +K+ DFG S S        S VGT
Sbjct: 125 LLSGV----SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 180

Query: 114 PYWMAPEVILAMDEGQ-YDG-KVDVWSLGIT-----PGSL--KDPEIAELFDK 157
           P ++APEV+      Q YDG   DVWS G+T      G+   +DPE    + K
Sbjct: 181 PAYIAPEVL----LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK 229

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 14/72 (19%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAA------ICSGVLRGLNYLHSLGRIHRDVKAG 668
           ++MEY   G   + I  +     E+E  A      + SGV    +Y HS+   HRD+K  
Sbjct: 93  IIMEYASGGELYERI-CNAGRFSEDE--ARFFFQQLLSGV----SYCHSMQICHRDLKLE 145

Query: 669 NILLTETGTVKL 680
           N LL  +   +L
Sbjct: 146 NTLLDGSPAPRL 157

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  124 bits (314), Expect = 3e-31
 Identities = 67/252 (26%), Positives = 99/252 (39%), Gaps = 66/252 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLRQ 218
           +E L +IG G+FG V+ AR   + + VA+KK+        E   +      L+EI+ L+ 
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM------ENEKEGFPITALREIKILQL 72

Query: 219 LKHPN--------TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           LKH N          +         + +LV ++C     D                    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHD-------------------- 109

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
             L     +                EI  +   +L GL Y+H    +HRD+KA N+L+T 
Sbjct: 110 --LAGLLSN--------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 159

Query: 331 TGTVKLADFGSASIKCPANSFVGTPY-------WM-APEVILAMDEGQYDGKVDVWSLGI 382
            G +KLADFG A     A +     Y       W   PE++L   E  Y   +D+W  G 
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAG- 216

Query: 383 TCI--ELAERKP 392
            CI  E+  R P
Sbjct: 217 -CIMAEMWTRSP 227

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  101 bits (254), Expect = 2e-23
 Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 38/189 (20%)

Query: 6   SLLRQLKHPN--------TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIA 57
            +L+ LKH N          +         + +LV ++C    + ++          EI 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-- 115
            +   +L GL Y+H    +HRD+KA N+L+T  G +KLADFG A     A +     Y  
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 116 -----WM-APEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKE 158
                W   PE++L   E  Y   +D+W  G           I  G   + E  +L    
Sbjct: 188 RVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLA--- 239

Query: 159 DPEKIFEDL 167
               I +  
Sbjct: 240 ---LISQLC 245

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 23/79 (29%), Positives = 39/79 (49%), Gaps = 3/79 (3%)

Query: 602 NNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 661
           +  N    S++   LV ++C    + ++          EI  +   +L GL Y+H    +
Sbjct: 90  SPYNRCKGSIY---LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKIL 146

Query: 662 HRDVKAGNILLTETGTVKL 680
           HRD+KA N+L+T  G +KL
Sbjct: 147 HRDMKAANVLITRDGVLKL 165

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  123 bits (312), Expect = 4e-31
 Identities = 69/365 (18%), Positives = 118/365 (32%), Gaps = 103/365 (28%)

Query: 170 IGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYR 228
           +G G  G V       + +  A+K +               +E+    Q    P+ +   
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 229 GCY----LRDHTAWLVMEYCLGSA--SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
             Y           ++ME   G    S I E                 +  + FTE  A 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQE-----------------RGDQAFTEREA- 130

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
                          A I   +   + +LHS    HRDVK  N+L T   +   +KL DF
Sbjct: 131 ---------------AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175

Query: 340 GSASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPYFN 396
           G A         +   TPY++APEV+      +YD   D+WSLG I  I L    PP+++
Sbjct: 176 GFAKETTQNALQTPCYTPYYVAPEVL---GPEKYDKSCDMWSLGVIMYILLC-GFPPFYS 231

Query: 397 MN---AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
                    +    +       + +WS    +S  A+                       
Sbjct: 232 NTGQAISPGMKRRIRLGQYGFPNPEWS---EVSEDAK----------------------- 265

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR----PRSPSVLVDLIRRTKA 509
                         +   L  +P +R +  + + H  + +    P++P     +++  K 
Sbjct: 266 ------------QLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKD 313

Query: 510 AVRDL 514
              ++
Sbjct: 314 HWDEV 318

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  112 bits (283), Expect = 2e-27
 Identities = 49/190 (25%), Positives = 71/190 (37%), Gaps = 35/190 (18%)

Query: 7   LLRQLKHPNTIEYRGCY----LRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAIC 60
             +    P+ +     Y           ++ME   G    S I E   +   E E A I 
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPA--NSFVGTPY 115
             +   + +LHS    HRDVK  N+L T   +   +KL DFG A         +   TPY
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY 194

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFED 166
           ++APEV+      +YD   D+WSLG+          P           F     + I   
Sbjct: 195 YVAPEVL---GPEKYDKSCDMWSLGVIMYILLCGFPP-----------FYSNTGQAISPG 240

Query: 167 L-REIGHGSF 175
           + R I  G +
Sbjct: 241 MKRRIRLGQY 250

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 27/99 (27%), Positives = 37/99 (37%), Gaps = 16/99 (16%)

Query: 595 HLSQH--------SYNNNNSNYSSLFSPQLVMEYCLGSA--SDIIEVHKRPLKEEEIAAI 644
             S           Y N +     L    ++ME   G    S I E   +   E E A I
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLL---IIMECMEGGELFSRIQERGDQAFTEREAAEI 133

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKL 680
              +   + +LHS    HRDVK  N+L T   +   +KL
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  125 bits (316), Expect = 5e-31
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 46/244 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           +E ++ IG G+FG V   R   +R++ A+K +S   K    K +D     +E   +    
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS---KFEMIKRSDSAFFWEERDIMAFAN 127

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  ++    +  D   ++VMEY  G   D+          +       L       E +
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPG--GDL---------VN-------LMSNYDVPEKW 169

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           A F              A +       L+ +HS+G IHRDVK  N+LL ++G +KLADFG
Sbjct: 170 ARFY------------TAEVVL----ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213

Query: 341 SA-----SIKCPANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPY 394
           +            ++ VGTP +++PEV+ +   +G Y  + D WS+G+   E+     P+
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

Query: 395 FNMN 398
           +  +
Sbjct: 274 YADS 277

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 98.6 bits (246), Expect = 5e-22
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 37/180 (20%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV-HKRPLKEEE----IAAIC 60
            ++     P  ++    +  D   ++VMEY  G   D++ +     + E+      A + 
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVV 178

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-----SIKCPANSFVGTPY 115
                 L+ +HS+G IHRDVK  N+LL ++G +KLADFG+            ++ VGTP 
Sbjct: 179 LA----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234

Query: 116 WMAPEVILAMD-EGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFE 165
           +++PEV+ +   +G Y  + D WS+G+         TP           F  +     + 
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-----------FYADSLVGTYS 283

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 11/70 (15%)

Query: 616 LVMEYCLGSASDIIEV-HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
           +VMEY  G   D++ +     + E+      A +       L+ +HS+G IHRDVK  N+
Sbjct: 146 MVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLA----LDAIHSMGFIHRDVKPDNM 199

Query: 671 LLTETGTVKL 680
           LL ++G +KL
Sbjct: 200 LLDKSGHLKL 209

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  123 bits (312), Expect = 7e-31
 Identities = 58/242 (23%), Positives = 92/242 (38%), Gaps = 46/242 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA-----EKWAD---ILKEIRF 215
           +   R I  GS+GAV           VAIK++                     +L+EIR 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 216 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           L    HPN +      LRD    + + +   +   +  V         E M   L Q+  
Sbjct: 83  LNHFHHPNILG-----LRD----IFVHFEEPAMHKLYLV--------TELMRTDLAQV-- 123

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
                        +  +  + I      +L GL+ LH  G +HRD+  GNILL +   + 
Sbjct: 124 ---------IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174

Query: 336 LADFGSASIKCPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAER 390
           + DF  A       +   +V   ++ APE+++      +   VD+WS G  C+  E+  R
Sbjct: 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK--GFTKLVDMWSAG--CVMAEMFNR 230

Query: 391 KP 392
           K 
Sbjct: 231 KA 232

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 10/142 (7%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA-----WLVMEYCLGSASDIIEVHKRPLKEEEIAAICS 61
           LL    HPN +  R  ++          +LV E      + +I   +  +  + I     
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS---FVGTPYWMA 118
            +L GL+ LH  G +HRD+  GNILL +   + + DF  A       +   +V   ++ A
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRA 201

Query: 119 PEVILAMDEGQYDGKVDVWSLG 140
           PE+++      +   VD+WS G
Sbjct: 202 PELVMQFK--GFTKLVDMWSAG 221

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 19/65 (29%), Positives = 31/65 (47%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E      + +I   +  +  + I      +L GL+ LH  G +HRD+  GNILL + 
Sbjct: 111 LVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN 170

Query: 676 GTVKL 680
             + +
Sbjct: 171 NDITI 175

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  122 bits (308), Expect = 8e-31
 Identities = 73/357 (20%), Positives = 113/357 (31%), Gaps = 103/357 (28%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR------QLK 220
            R +G G  G VY A   V   IVA+K MS          +D +   R  R      +L+
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMS------ETLSSDPVFRTRMQREARTAGRLQ 92

Query: 221 HPNTIE-Y-RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM--GNRLQQLKCF 276
            P+ +  +  G    D   ++ M                     + G+     L++    
Sbjct: 93  EPHVVPIHDFGEI--DGQLYVDMRL-------------------INGVDLAAMLRR---- 127

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                       + PL      AI   +   L+  H+ G  HRDVK  NIL++      L
Sbjct: 128 ------------QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYL 175

Query: 337 ADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
            DFG AS           + VGT Y+MAPE            + D+++L     E     
Sbjct: 176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE---SHATYRADIYALTCVLYECLTGS 232

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           PP +  + +S +        P             S+     P  F+              
Sbjct: 233 PP-YQGDQLSVMGAHINQAIP-----------RPSTVRPGIPVAFD-------------- 266

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT--RPRSPSVLVDLIRR 506
                           ++  +AKNP DR  +   L+                D++RR
Sbjct: 267 --------------AVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILRR 309

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (263), Expect = 8e-25
 Identities = 37/141 (26%), Positives = 58/141 (41%), Gaps = 14/141 (9%)

Query: 10  QLKHPNTIE-Y-RGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRG 66
           +L+ P+ +  +  G    D   ++ M    G   + ++     PL      AI   +   
Sbjct: 90  RLQEPHVVPIHDFGEI--DGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSA 146

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEV 121
           L+  H+ G  HRDVK  NIL++      L DFG AS           + VGT Y+MAPE 
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 122 ILAMDEGQYDGKVDVWSLGIT 142
                      + D+++L   
Sbjct: 207 FSE---SHATYRADIYALTCV 224

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 18/66 (27%), Positives = 27/66 (40%), Gaps = 2/66 (3%)

Query: 616 LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           + M    G   + ++     PL      AI   +   L+  H+ G  HRDVK  NIL++ 
Sbjct: 111 VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169

Query: 675 TGTVKL 680
                L
Sbjct: 170 DDFAYL 175

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  122 bits (308), Expect = 1e-30
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 55/240 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLRQ 218
           ++ L ++G G++G VY A+      IVA+K++    +  AE   +      ++EI  L++
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI----RLDAED--EGIPSTAIREISLLKE 75

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           L HPN +        +    LV E+      D                      LK   +
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFM---EKD----------------------LKKVLD 110

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                    +K  L++ +I      +LRG+ + H    +HRD+K  N+L+   G +KLAD
Sbjct: 111 E--------NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLAD 162

Query: 339 FGSA-SIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 392
           FG A +   P  S+   V T ++ AP+V++     +Y   VD+WS+G  CI  E+   KP
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMG--SKKYSTSVDIWSIG--CIFAEMITGKP 218

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  108 bits (273), Expect = 4e-26
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 26/177 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           SLL++L HPN +        +    LV E+       +++ +K  L++ +I      +LR
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF---VGTPYWMAPEV 121
           G+ + H    +HRD+K  N+L+   G +KLADFG A +   P  S+   V T ++ AP+V
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 122 ILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFEDL 167
           ++     +Y   VD+WS+G           + PG     +  +L       KIF  L
Sbjct: 191 LMG--SKKYSTSVDIWSIGCIFAEMITGKPLFPG---VTDDDQLP------KIFSIL 236

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 63.0 bits (154), Expect = 9e-11
 Identities = 19/65 (29%), Positives = 35/65 (53%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+       +++ +K  L++ +I      +LRG+ + H    +HRD+K  N+L+   
Sbjct: 96  LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD 155

Query: 676 GTVKL 680
           G +KL
Sbjct: 156 GALKL 160

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  122 bits (308), Expect = 1e-30
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 49/223 (21%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---EIRFLRQLKHPNT 224
             +G GSFG V  A    +++ VA+K +S   +Q  +K    ++   EI +L+ L+HP+ 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFIS---RQLLKKSDMHMRVEREISYLKLLRHPHI 71

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I+            +V+EY  G                                   LF+
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGGE----------------------------------LFD 97

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           + V K+ + E+E       ++  + Y H    +HRD+K  N+LL +   VK+ADFG ++I
Sbjct: 98  YIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157

Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGI 382
               N   +  G+P + APEVI     G+ Y G +VDVWS GI
Sbjct: 158 MTDGNFLKTSCGSPNYAAPEVI----NGKLYAGPEVDVWSCGI 196

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  103 bits (258), Expect = 5e-24
 Identities = 57/164 (34%), Positives = 81/164 (49%), Gaps = 17/164 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           S L+ L+HP+ I+            +V+EY  G   D I V K+ + E+E       ++ 
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKRMTEDEGRRFFQQIIC 119

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPEVI 122
            + Y H    +HRD+K  N+LL +   VK+ADFG ++I    N   +  G+P + APEVI
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179

Query: 123 LAMDEGQ-YDG-KVDVWSLGIT-----PGSL--KDPEIAELFDK 157
                G+ Y G +VDVWS GI       G L   D  I  LF K
Sbjct: 180 ----NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK 219

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 1/65 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +V+EY  G   D I V K+ + E+E       ++  + Y H    +HRD+K  N+LL + 
Sbjct: 86  MVIEYAGGELFDYI-VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144

Query: 676 GTVKL 680
             VK+
Sbjct: 145 LNVKI 149

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  123 bits (310), Expect = 2e-30
 Identities = 80/383 (20%), Positives = 136/383 (35%), Gaps = 102/383 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           +E ++++G G++G V+ +    + E+VA+KK+        +   D     +EI  L +L 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF----DAFQNSTDAQRTFREIMILTELS 66

Query: 221 -HPNTI---------EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
            H N +           R  YL       V +Y                      M   L
Sbjct: 67  GHENIVNLLNVLRADNDRDVYL-------VFDY----------------------METDL 97

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
             +             +    L+      +   +++ + YLHS G +HRD+K  NILL  
Sbjct: 98  HAV-------------IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA 144

Query: 331 TGTVKLADFG---------------------SASIKCPANSF----VGTPYWMAPEVILA 365
              VK+ADFG                     +              V T ++ APE++L 
Sbjct: 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204

Query: 366 MDEGQYDGKVDVWSLGITCI--ELAERKPPYFNMNAMSALYHI-------AQNDTPCLQS 416
             +  Y   +D+WSLG  CI  E+   KP +   + M+ L  I       +  D   +QS
Sbjct: 205 STK--YTKGIDMWSLG--CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQS 260

Query: 417 SD-WSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN 475
               ++I+++      K      N                  +D ++     +   L  N
Sbjct: 261 PFAKTMIESLK----EKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316

Query: 476 PADRPSSGRLLTHDLVTRPRSPS 498
           P  R S+   L H  V+   +P+
Sbjct: 317 PNKRISANDALKHPFVSIFHNPN 339

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 82.0 bits (203), Expect = 9e-17
 Identities = 43/172 (25%), Positives = 66/172 (38%), Gaps = 52/172 (30%)

Query: 7   LLRQLK-HPNTI---------EYRGCYLRDHTAWLVMEYCLGSASD---IIEVHKRPLKE 53
           +L +L  H N +           R  YL       V +Y     +D   +I      L+ 
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYL-------VFDYM---ETDLHAVI--RANILEP 108

Query: 54  EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------------- 99
                +   +++ + YLHS G +HRD+K  NILL     VK+ADFG              
Sbjct: 109 VHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 100 -------SASIKCPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
                  +              V T ++ APE++L   +  Y   +D+WSLG
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK--YTKGIDMWSLG 218

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 21/68 (30%), Positives = 33/68 (48%), Gaps = 8/68 (11%)

Query: 616 LVMEYCLGSASD---IIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           LV +Y     +D   +I      L+      +   +++ + YLHS G +HRD+K  NILL
Sbjct: 88  LVFDYM---ETDLHAVI--RANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142

Query: 673 TETGTVKL 680
                VK+
Sbjct: 143 NAECHVKV 150

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  123 bits (311), Expect = 2e-30
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 58/275 (21%)

Query: 147 KDPEIAELFDKEDPEKI-----------FEDLREIGHGSFGAVYYARCLVSREIVAIKKM 195
           +D  +A+     +P  +           FE L+ IG G+F  V   +   + ++ A+K M
Sbjct: 35  QDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94

Query: 196 SYLGKQCAEKWADI---LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDII 252
           +   K    K  ++    +E   L         +    +  ++  +LVMEY +G      
Sbjct: 95  N---KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG----- 146

Query: 253 EVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH 312
                +    +   G R           A F             +A I       ++ +H
Sbjct: 147 -----DLLTLLSKFGER------IPAEMARFY------------LAEIVM----AIDSVH 179

Query: 313 SLGRIHRDVKAGNILLTETGTVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAM- 366
            LG +HRD+K  NILL   G ++LADFGS           +   VGTP +++PE++ A+ 
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239

Query: 367 ---DEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                G Y  + D W+LG+   E+   + P++  +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 98.6 bits (246), Expect = 5e-22
 Identities = 44/160 (27%), Positives = 69/160 (43%), Gaps = 42/160 (26%)

Query: 31  LVMEYCLGSASDI---IEVHKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAG 83
           LVMEY +G   D+   +      +  E     +A I       ++ +H LG +HRD+K  
Sbjct: 138 LVMEYYVGG--DLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVHRLGYVHRDIKPD 191

Query: 84  NILLTETGTVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAM----DEGQYDGKV 134
           NILL   G ++LADFGS           +   VGTP +++PE++ A+      G Y  + 
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC 251

Query: 135 DVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFE 165
           D W+LG+         TP           F  +   + + 
Sbjct: 252 DWWALGVFAYEMFYGQTP-----------FYADSTAETYG 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 13/72 (18%)

Query: 616 LVMEYCLGSASDI---IEVHKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAG 668
           LVMEY +G   D+   +      +  E     +A I       ++ +H LG +HRD+K  
Sbjct: 138 LVMEYYVGG--DLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVHRLGYVHRDIKPD 191

Query: 669 NILLTETGTVKL 680
           NILL   G ++L
Sbjct: 192 NILLDRCGHIRL 203

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (314), Expect = 2e-30
 Identities = 55/256 (21%), Positives = 100/256 (39%), Gaps = 58/256 (22%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
             ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   R+   +++ E+                       GN L  L+           E
Sbjct: 281 LLGVCTREPPFYIITEFMTY--------------------GNLLDYLR-----------E 309

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------ 340
            +++ +    +  + + +   + YL     IHR++ A N L+ E   VK+ADFG      
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369

Query: 341 ------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPP 393
                  A  K P         W APE   ++   ++  K DVW+ G+   E+A     P
Sbjct: 370 GDTYTAHAGAKFPIK-------WTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

Query: 394 YFNMNAMSALYHIAQN 409
           Y  ++       + ++
Sbjct: 420 YPGIDLSQVYELLEKD 435

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.8 bits (236), Expect = 1e-20
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 24/150 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASD-IIEVHKRPLKEEEIAAICSGV 63
           ++++++KHPN ++  G   R+   +++ E+   G+  D + E +++ +    +  + + +
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SASIKCPANSFV 111
              + YL     IHR++ A N L+ E   VK+ADFG             A  K P     
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 384

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
               W APE   ++   ++  K DVW+ G+
Sbjct: 385 ----WTAPE---SLAYNKFSIKSDVWAFGV 407

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 15/66 (22%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 616 LVMEY-CLGSASD-IIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++ E+   G+  D + E +++ +    +  + + +   + YL     IHR++ A N L+ 
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352

Query: 674 ETGTVK 679
           E   VK
Sbjct: 353 ENHLVK 358

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  120 bits (304), Expect = 3e-30
 Identities = 65/247 (26%), Positives = 100/247 (40%), Gaps = 55/247 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---------EIR 214
           F+ LR +G GSFG V+  R   +    A+K +         K   +++         E  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--------K-EIVVRLKQVEHTNDERL 58

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            L  + HP  I   G +      +++M+Y  G           E           L++ +
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG----------ELFSL-------LRKSQ 101

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            F    A F              A +C      L YLHS   I+RD+K  NILL + G +
Sbjct: 102 RFPNPVAKFY------------AAEVCLA----LEYLHSKDIIYRDLKPENILLDKNGHI 145

Query: 335 KLADFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           K+ DFG A  +     +  GTP ++APEV+       Y+  +D WS GI   E+     P
Sbjct: 146 KITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP---YNKSIDWWSFGILIYEMLAGYTP 202

Query: 394 YFNMNAM 400
           +++ N M
Sbjct: 203 FYDSNTM 209

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 89.5 bits (223), Expect = 1e-19
 Identities = 49/175 (28%), Positives = 74/175 (42%), Gaps = 34/175 (19%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV--HKRPLK--EEEIAAI-C 60
            +L  + HP  I   G +      +++M+Y  G      E+    R  +     +A    
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG-----ELFSLLRKSQRFPNPVAKFYA 112

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAP 119
           + V   L YLHS   I+RD+K  NILL + G +K+ DFG A  +     +  GTP ++AP
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAP 172

Query: 120 EVILAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFE 165
           EV+       Y+  +D WS GI         TP           F   +  K +E
Sbjct: 173 EVVSTKP---YNKSIDWWSFGILIYEMLAGYTP-----------FYDSNTMKTYE 213

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 42.5 bits (101), Expect = 3e-04
 Identities = 16/33 (48%), Positives = 21/33 (63%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           V   L YLHS   I+RD+K  NILL + G +K+
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKI 147

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  120 bits (304), Expect = 4e-30
 Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 56/247 (22%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
            + +  ++ +R++G G +  V+ A  + + E V +K +         K   I +EI+ L 
Sbjct: 33  GNQDD-YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILE 85

Query: 218 QLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL-KC 275
            L+  PN I      L D    +V +    + + + E                 +QL + 
Sbjct: 86  NLRGGPNIIT-----LAD----IVKDPVSRTPALVFE----------HVNNTDFKQLYQT 126

Query: 276 FT-EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGT 333
            T      + +E+                 L+ L+Y HS+G +HRDVK  N+++  E   
Sbjct: 127 LTDYDIRFYMYEI-----------------LKALDYCHSMGIMHRDVKPHNVMIDHEHRK 169

Query: 334 VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELA 388
           ++L D+G A    P   +   V + Y+  PE+++  D   YD  +D+WSLG  C+   + 
Sbjct: 170 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLG--CMLASMI 225

Query: 389 ERKPPYF 395
            RK P+F
Sbjct: 226 FRKEPFF 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 26/149 (17%)

Query: 6   SLLRQLK-HPNTIEYRGCYLRD-------HTAWLVMEYCLGSASDIIEVHK--RPLKEEE 55
            +L  L+  PN I      L D        T  LV E+      +  +  +  + L + +
Sbjct: 82  KILENLRGGPNIIT-----LADIVKDPVSRTPALVFEHV-----NNTDFKQLYQTLTDYD 131

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-TETGTVKLADFGSASIKCPANSF---V 111
           I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L D+G A    P   +   V
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
            + Y+  PE+++  D   YD  +D+WSLG
Sbjct: 192 ASRYFKGPELLV--DYQMYDYSLDMWSLG 218

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 47.6 bits (114), Expect = 9e-06
 Identities = 20/72 (27%), Positives = 38/72 (52%), Gaps = 8/72 (11%)

Query: 612 FSPQLVMEYCLGSASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 669
            +P LV E+      +  +  +  + L + +I      +L+ L+Y HS+G +HRDVK  N
Sbjct: 106 RTPALVFEHV-----NNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 160

Query: 670 ILL-TETGTVKL 680
           +++  E   ++L
Sbjct: 161 VMIDHEHRKLRL 172

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  119 bits (302), Expect = 5e-30
 Identities = 76/253 (30%), Positives = 108/253 (42%), Gaps = 70/253 (27%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI------LKEIRFLR 217
           +E + EIG G++G VY AR   S   VA+K +    +               ++E+  LR
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLR 66

Query: 218 QLK---HPNTIEYRGCYLRD--HTA--------WLVMEYCLGSASDIIEVHWIEREFHVE 264
           +L+   HPN +      L D   T+         LV E+                     
Sbjct: 67  RLEAFEHPNVVR-----LMDVCATSRTDREIKVTLVFEHVD------------------- 102

Query: 265 GMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 324
                 Q L+ + +             L  E I  +    LRGL++LH+   +HRD+K  
Sbjct: 103 ------QDLRTYLDKAP-------PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149

Query: 325 NILLTETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           NIL+T  GTVKLADFG A I     +    V T ++ APEV+L      Y   VD+WS+G
Sbjct: 150 NILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVG 206

Query: 382 ITCI--ELAERKP 392
             CI  E+  RKP
Sbjct: 207 --CIFAEMFRRKP 217

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 93.4 bits (233), Expect = 7e-21
 Identities = 61/190 (32%), Positives = 87/190 (45%), Gaps = 45/190 (23%)

Query: 6   SLLRQLK---HPNTIEYRGCYLRD--HTA--------WLVMEYCLGSASDIIEVHKRP-L 51
           +LLR+L+   HPN +      L D   T+         LV E+        ++    P L
Sbjct: 63  ALLRRLEAFEHPNVVR-----LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 117

Query: 52  KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF- 110
             E I  +    LRGL++LH+   +HRD+K  NIL+T  GTVKLADFG A I     +  
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177

Query: 111 --VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDK 157
             V T ++ APEV+L      Y   VD+WS+G           +  G   + E  +L   
Sbjct: 178 PVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCG---NSEADQLG-- 229

Query: 158 EDPEKIFEDL 167
               KIF+ +
Sbjct: 230 ----KIFDLI 235

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 30/96 (31%), Positives = 42/96 (43%), Gaps = 5/96 (5%)

Query: 587 HHHHHP-VTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRP-LKEEEIAAI 644
               HP V  L      +       +    LV E+        ++    P L  E I  +
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVT---LVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
               LRGL++LH+   +HRD+K  NIL+T  GTVKL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  119 bits (300), Expect = 1e-29
 Identities = 63/283 (22%), Positives = 95/283 (33%), Gaps = 54/283 (19%)

Query: 141 ITPGSLKDPEIAEL-FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI----VAIKKM 195
                  DP  A L F  E         + IG G FG VY      S       VAIK +
Sbjct: 22  FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL 81

Query: 196 SYLGKQCA--EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
               K     ++  D L E   + Q  H N I   G   +     ++ EY          
Sbjct: 82  ----KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN------- 130

Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                        G   + L+                     ++  +  G+  G+ YL +
Sbjct: 131 -------------GALDKFLR------------EKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGT--PY-WMAPEVILAM 366
           +  +HRD+ A NIL+      K++DFG +           +  G   P  W APE I   
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-- 223

Query: 367 DEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
              ++    DVWS GI   E+    + PY+ ++    +  I  
Sbjct: 224 -YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 36/145 (24%), Positives = 59/145 (40%), Gaps = 11/145 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++ Q  H N I   G   +     ++ EY   G+    +          ++  +  G+ 
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGT--PY-WM 117
            G+ YL ++  +HRD+ A NIL+      K++DFG +           +  G   P  W 
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           APE I      ++    DVWS GI 
Sbjct: 218 APEAIS---YRKFTSASDVWSFGIV 239

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ EY   G+    +          ++  +  G+  G+ YL ++  +HRD+ A NIL+  
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 182

Query: 675 TGTVKL 680
               K+
Sbjct: 183 NLVCKV 188

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  121 bits (305), Expect = 1e-29
 Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 47/246 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE L+ IG G+FG V   +   + ++ A+K ++   K    K A+     +E   L    
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILN---KWEMLKRAETACFREERDVLVNGD 132

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK-CFTEH 279
                     +  D+  +LVM+Y +G           +           L + +    E 
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGG----------DLLTL-------LSKFEDRLPEE 175

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A F             +A +       ++ +H L  +HRD+K  NIL+   G ++LADF
Sbjct: 176 MARFY------------LAEMVIA----IDSVHQLHYVHRDIKPDNILMDMNGHIRLADF 219

Query: 340 GSA-----SIKCPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAERKP 392
           GS           ++  VGTP +++PE++ AM+ G+  Y  + D WSLG+   E+   + 
Sbjct: 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

Query: 393 PYFNMN 398
           P++  +
Sbjct: 280 PFYAES 285

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.9 bits (244), Expect = 1e-21
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 32/154 (20%)

Query: 31  LVMEYCLGSASDI---IEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 87
           LVM+Y +G   D+   +   +  L EE      + ++  ++ +H L  +HRD+K  NIL+
Sbjct: 151 LVMDYYVGG--DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208

Query: 88  TETGTVKLADFGSA-----SIKCPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSLG 140
              G ++LADFGS           ++  VGTP +++PE++ AM+ G+  Y  + D WSLG
Sbjct: 209 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268

Query: 141 I---------TPGSLKDPEIAELFDKEDPEKIFE 165
           +         TP           F  E   + + 
Sbjct: 269 VCMYEMLYGETP-----------FYAESLVETYG 291

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 20/68 (29%), Positives = 36/68 (52%), Gaps = 5/68 (7%)

Query: 616 LVMEYCLGSASDI---IEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           LVM+Y +G   D+   +   +  L EE      + ++  ++ +H L  +HRD+K  NIL+
Sbjct: 151 LVMDYYVGG--DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208

Query: 673 TETGTVKL 680
              G ++L
Sbjct: 209 DMNGHIRL 216

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  122 bits (309), Expect = 2e-29
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLKH 221
           F D R +G G FG V+  +   + ++ A KK++   L K+   + A  + E + L ++  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA--MVEKKILAKVHS 244

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
              +     +       LVM    G           +  +H+  +    +    F E  A
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGG----------DIRYHIYNVD---EDNPGFQEPRA 291

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           +F              A I SG    L +LH    I+RD+K  N+LL + G V+++D G 
Sbjct: 292 IFY------------TAQIVSG----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335

Query: 342 A----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           A    + +     + GTP +MAPE++L  +   YD  VD ++LG+T  E+   + P+   
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEE---YDFSVDYFALGVTLYEMIAARGPFRAR 392

Query: 398 N 398
            
Sbjct: 393 G 393

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.8 bits (223), Expect = 7e-19
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 23/148 (15%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD----IIEVHKRP--LKEEE----IA 57
           L ++     +     +       LVM    G   D    I  V +     +E       A
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPGFQEPRAIFYTA 296

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGT 113
            I SG    L +LH    I+RD+K  N+LL + G V+++D G A    + +     + GT
Sbjct: 297 QIVSG----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           P +MAPE++L  +   YD  VD ++LG+
Sbjct: 353 PGFMAPELLLGEE---YDFSVDYFALGV 377

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 24/75 (32%), Positives = 33/75 (44%), Gaps = 16/75 (21%)

Query: 616 LVMEYCLGSASD----IIEVHKRP--LKEEE----IAAICSGVLRGLNYLHSLGRIHRDV 665
           LVM    G   D    I  V +     +E       A I SG    L +LH    I+RD+
Sbjct: 262 LVMTIMNGG--DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQRNIIYRDL 315

Query: 666 KAGNILLTETGTVKL 680
           K  N+LL + G V++
Sbjct: 316 KPENVLLDDDGNVRI 330

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  120 bits (303), Expect = 2e-29
 Identities = 81/363 (22%), Positives = 135/363 (37%), Gaps = 70/363 (19%)

Query: 156 DKEDPEKIFEDLRE-IGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKE 212
           ++E  E +FE     +G G++G VY A+       +  A+K++   G   +       +E
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CRE 68

Query: 213 IRFLRQLKHPNTIEYRGCYL--RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           I  LR+LKHPN I  +  +L   D   WL+ +Y                    E      
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-------------------E------ 103

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 329
             L    +             L    + ++   +L G++YLH+   +HRD+K  NIL+  
Sbjct: 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMG 163

Query: 330 ---ETGTVKLADFGSA-SIKCPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWS 379
              E G VK+AD G A     P          V T ++ APE++L      Y   +D+W+
Sbjct: 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWA 221

Query: 380 LGITCI--ELAERKPPYFNMNAMSALYHIAQND----------TPCLQSSDWSVIKTISS 427
           +G  CI  EL   +P +          +   +D           P  +  DW  IK +  
Sbjct: 222 IG--CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK--DWEDIKKMPE 277

Query: 428 TAERKPPY-FNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
            +     +  N     +L    +       S  +     H +   L  +P  R +S + +
Sbjct: 278 HSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF-----HLLQKLLTMDPIKRITSEQAM 332

Query: 487 THD 489
              
Sbjct: 333 QDP 335

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.9 bits (236), Expect = 7e-21
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 40/196 (20%)

Query: 7   LLRQLKHPNTIEYRGCYL--RDHTAWLVMEYC---LGSASDIIEVHKR--------PLKE 53
           LLR+LKHPN I  +  +L   D   WL+ +Y    L     II+ H+          L  
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWH---IIKFHRASKANKKPVQLPR 127

Query: 54  EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT----ETGTVKLADFGSA-SIKCPAN 108
             + ++   +L G++YLH+   +HRD+K  NIL+     E G VK+AD G A     P  
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 109 SF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEI 151
                   V T ++ APE++L      Y   +D+W++G           I     +D + 
Sbjct: 188 PLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245

Query: 152 AELFDKEDPEKIFEDL 167
           +  +  +  ++IF  +
Sbjct: 246 SNPYHHDQLDRIFNVM 261

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 23/80 (28%), Positives = 38/80 (47%), Gaps = 18/80 (22%)

Query: 616 LVMEYC---LGSASDIIEVHKR--------PLKEEEIAAICSGVLRGLNYLHSLGRIHRD 664
           L+ +Y    L     II+ H+          L    + ++   +L G++YLH+   +HRD
Sbjct: 97  LLFDYAEHDLWH---IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153

Query: 665 VKAGNILLT----ETGTVKL 680
           +K  NIL+     E G VK+
Sbjct: 154 LKPANILVMGEGPERGRVKI 173

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  122 bits (309), Expect = 2e-29
 Identities = 61/240 (25%), Positives = 92/240 (38%), Gaps = 41/240 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAEKWADILKEIRFLRQLKH 221
           F   R +G G FG V   +   + ++ A KK+    + K+  E  A  L E + L ++  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 243

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
              +     Y       LV+    G           + +FH+  MG        F E  A
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGG----------DLKFHIYHMGQA-----GFPEARA 288

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGS 341
           +F              A IC G    L  LH    ++RD+K  NILL + G ++++D G 
Sbjct: 289 VFY------------AAEICCG----LEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332

Query: 342 A---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           A            VGT  +MAPEV+       Y    D W+LG    E+   + P+    
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNER---YTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.1 bits (234), Expect = 4e-20
 Identities = 39/145 (26%), Positives = 56/145 (38%), Gaps = 20/145 (13%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD----IIEVHKRPLKEEE----IAAI 59
           L ++     +     Y       LV+    G   D    I  + +    E       A I
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGG--DLKFHIYHMGQAGFPEARAVFYAAEI 295

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---SIKCPANSFVGTPYW 116
           C G    L  LH    ++RD+K  NILL + G ++++D G A            VGT  +
Sbjct: 296 CCG----LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGI 141
           MAPEV+       Y    D W+LG 
Sbjct: 352 MAPEVVKNER---YTFSPDWWALGC 373

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 21/73 (28%), Positives = 31/73 (42%), Gaps = 14/73 (19%)

Query: 616 LVMEYCLGSASD----IIEVHKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKA 667
           LV+    G   D    I  + +    E       A IC G    L  LH    ++RD+K 
Sbjct: 261 LVLTLMNGG--DLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRERIVYRDLKP 314

Query: 668 GNILLTETGTVKL 680
            NILL + G +++
Sbjct: 315 ENILLDDHGHIRI 327

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  118 bits (298), Expect = 2e-29
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 60/245 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLRQ 218
           +  + ++G G++G VY A   V+ E VAIK++        E   +      ++E+  L++
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL------EHEEEGVPGTAIREVSLLKE 89

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           L+H N IE +     +H   L+ EY     +D                      LK + +
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYA---END----------------------LKKYMD 124

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-----ETGT 333
                        +    I +    ++ G+N+ HS   +HRD+K  N+LL+     ET  
Sbjct: 125 K---------NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 334 VKLADFGSASIKC-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--EL 387
           +K+ DFG A     P   F   + T ++  PE++L      Y   VD+WS+   CI  E+
Sbjct: 176 LKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG--SRHYSTSVDIWSIA--CIWAEM 231

Query: 388 AERKP 392
             + P
Sbjct: 232 LMKTP 236

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 32/182 (17%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           SLL++L+H N IE +     +H   L+ EY        ++     +    I +    ++ 
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD-KNPDVSMRVIKSFLYQLIN 143

Query: 66  GLNYLHSLGRIHRDVKAGNILLT-----ETGTVKLADFGSASIKC-PANSF---VGTPYW 116
           G+N+ HS   +HRD+K  N+LL+     ET  +K+ DFG A     P   F   + T ++
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203

Query: 117 MAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEKIFE 165
             PE++L      Y   VD+WS+            + PG   D EI +LF      KIFE
Sbjct: 204 RPPEILLG--SRHYSTSVDIWSIACIWAEMLMKTPLFPG---DSEIDQLF------KIFE 252

Query: 166 DL 167
            L
Sbjct: 253 VL 254

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 51.5 bits (124), Expect = 5e-07
 Identities = 18/70 (25%), Positives = 33/70 (47%), Gaps = 6/70 (8%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-- 673
           L+ EY        ++     +    I +    ++ G+N+ HS   +HRD+K  N+LL+  
Sbjct: 110 LIFEYAENDLKKYMD-KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168

Query: 674 ---ETGTVKL 680
              ET  +K+
Sbjct: 169 DASETPVLKI 178

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  117 bits (296), Expect = 3e-29
 Identities = 67/287 (23%), Positives = 105/287 (36%), Gaps = 60/287 (20%)

Query: 141 ITPGSLKDPEIAELFD---KEDPEKIFEDLREIGHGSFGAVYYARCLVSREI---VAIKK 194
           I   +L +PE+ +            I      IG G FG VY+   L +       A+K 
Sbjct: 2   IDLSAL-NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60

Query: 195 MSYLGKQCA--EKWADILKEIRFLRQLKHPNTIEYRG-CYLRDHTAWLVMEYCLGSASDI 251
           +     +     + +  L E   ++   HPN +   G C   + +  +V+ Y        
Sbjct: 61  L----NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM------- 109

Query: 252 IEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNY 310
                                     +H  L NF          +++      V +G+ Y
Sbjct: 110 --------------------------KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143

Query: 311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSA-------SIKCPANSFVGTPY-WMAPEV 362
           L S   +HRD+ A N +L E  TVK+ADFG A              +    P  WMA E 
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE- 202

Query: 363 ILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
             ++   ++  K DVWS G+   EL  R  PPY ++N      ++ Q
Sbjct: 203 --SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGV 63
            +++   HPN +   G C   + +  +V+ Y   G   + I         +++      V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-------SIKCPANSFVGTPY- 115
            +G+ YL S   +HRD+ A N +L E  TVK+ADFG A              +    P  
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           WMA E   ++   ++  K DVWS G+ 
Sbjct: 198 WMALE---SLQTQKFTTKSDVWSFGVL 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 50.7 bits (122), Expect = 8e-07
 Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 1/67 (1%)

Query: 614 PQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +V+ Y   G   + I         +++      V +G+ YL S   +HRD+ A N +L
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161

Query: 673 TETGTVK 679
            E  TVK
Sbjct: 162 DEKFTVK 168

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  117 bits (296), Expect = 3e-29
 Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 71/283 (25%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVS----REIVAIKKMSYLGKQCA--EKWADILK 211
              ++  + +R++G G FG V   R         E VA+K +    K  +     AD+ K
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL----KPESGGNHIADLKK 72

Query: 212 EIRFLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHWIEREFHVEGMGN 268
           EI  LR L H N ++Y+G    D      L+ME+   GS           +E+       
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL----------KEY------- 115

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
            L +               +K  +  ++       + +G++YL S   +HRD+ A N+L+
Sbjct: 116 -LPK---------------NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159

Query: 329 TETGTVKLADFG-SASIKCPANSFVGT-----P-YWMAPEVILAMDEGQYDGKVDVWSLG 381
                VK+ DFG + +I+     +        P +W APE ++   + ++    DVWS G
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM---QSKFYIASDVWSFG 216

Query: 382 ITCIEL---------------AERKPPYFNMNAMSALYHIAQN 409
           +T  EL                   P +  M     +  + + 
Sbjct: 217 VTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  101 bits (254), Expect = 1e-23
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSG 62
            +LR L H N ++Y+G    D      L+ME+   GS  + +  +K  +  ++       
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-----P-Y 115
           + +G++YL S   +HRD+ A N+L+     VK+ DFG + +I+     +        P +
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W APE ++   + ++    DVWS G+T
Sbjct: 195 WYAPECLM---QSKFYIASDVWSFGVT 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 18/66 (27%), Positives = 35/66 (53%), Gaps = 1/66 (1%)

Query: 615 QLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +L+ME+   GS  + +  +K  +  ++       + +G++YL S   +HRD+ A N+L+ 
Sbjct: 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 160

Query: 674 ETGTVK 679
               VK
Sbjct: 161 SEHQVK 166

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  121 bits (304), Expect = 3e-29
 Identities = 86/472 (18%), Positives = 154/472 (32%), Gaps = 111/472 (23%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---EIRFLRQLKHPNT 224
             +G G+FG V   +  ++   VA+K ++   +Q       + K   EI+ L+  +HP+ 
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I+           ++VMEY  G                               E   LF+
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGG------------------------------E---LFD 105

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI 344
           +      L E+E   +   +L G++Y H    +HRD+K  N+LL      K+ADFG +++
Sbjct: 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165

Query: 345 KCPAN---SFVGTPYWMAPEVILAMDEGQ-YDG-KVDVWSLGITC-IELAERKPPYFNMN 398
                   +  G+P + APEVI     G+ Y G +VD+WS G+     L    P  F+ +
Sbjct: 166 MSDGEFLRTSCGSPNYAAPEVI----SGRLYAGPEVDIWSSGVILYALLCGTLP--FDDD 219

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
            +  L+                  K I       P Y N + +S L H+           
Sbjct: 220 HVPTLF------------------KKICDGIFYTPQYLNPSVISLLKHM----------- 250

Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLN 518
                        L  +P  R +   +  H+   +     +  +       +   +D+  
Sbjct: 251 -------------LQVDPMKRATIKDIREHEWFKQDLPKYLFPE---DPSYSSTMIDDEA 294

Query: 519 YRKMKKILMADGADTESTIDPDDTPDEQA---------------GNDSSKSNSITSEHSV 563
            +++ +       +  S +   +  D  A                 D   + S       
Sbjct: 295 LKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLD 354

Query: 564 QSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQ 615
                  +P       +     RH         S+H        +  + S  
Sbjct: 355 DHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQS 406

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 18/165 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
             L+  +HP+ I+           ++VMEY   G   D I      L E+E   +   +L
Sbjct: 68  QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQIL 126

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN---SFVGTPYWMAPEV 121
            G++Y H    +HRD+K  N+LL      K+ADFG +++        +  G+P + APEV
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186

Query: 122 ILAMDEGQ-YDG-KVDVWSLGIT-----PGSL--KDPEIAELFDK 157
           I     G+ Y G +VD+WS G+       G+L   D  +  LF K
Sbjct: 187 I----SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK 227

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 22/66 (33%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY   G   D I      L E+E   +   +L G++Y H    +HRD+K  N+LL  
Sbjct: 93  MVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA 151

Query: 675 TGTVKL 680
               K+
Sbjct: 152 HMNAKI 157

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  117 bits (295), Expect = 3e-29
 Identities = 72/358 (20%), Positives = 119/358 (33%), Gaps = 102/358 (28%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR------QLK 220
           + ++G G    VY A   +    VAIK +                  RF R      QL 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIF------IPPREKEETLKRFEREVHNSSQLS 69

Query: 221 HPNTIE-Y-RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           H N +          D   +LVMEY                   +EG       L  + E
Sbjct: 70  HQNIVSMIDVDEE--DDCYYLVMEY-------------------IEGP-----TLSEYIE 103

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                       PL  +      + +L G+ + H +  +HRD+K  NIL+    T+K+ D
Sbjct: 104 S---------HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFD 154

Query: 339 FGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           FG A           N  +GT  + +PE          D   D++S+GI   E+   +PP
Sbjct: 155 FGIAKALSETSLTQTNHVLGTVQYFSPEQAKG---EATDECTDIYSIGIVLYEMLVGEPP 211

Query: 394 YFNMNAMS-ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           +    A+S A+ HI Q+  P +           +   +  P   +               
Sbjct: 212 FNGETAVSIAIKHI-QDSVPNV----------TTDVRKDIPQSLS--------------- 245

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT-----RPRSPSVLVDLIR 505
                        + +     K+ A+R  + + +  DL +     R       +D ++
Sbjct: 246 -------------NVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMK 290

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 38/123 (30%), Positives = 57/123 (46%), Gaps = 10/123 (8%)

Query: 26  DHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 84
           D   +LVMEY  G   S+ IE    PL  +      + +L G+ + H +  +HRD+K  N
Sbjct: 83  DDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQN 141

Query: 85  ILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 139
           IL+    T+K+ DFG A           N  +GT  + +PE          D   D++S+
Sbjct: 142 ILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG---EATDECTDIYSI 198

Query: 140 GIT 142
           GI 
Sbjct: 199 GIV 201

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 2/66 (3%)

Query: 616 LVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LVMEY  G   S+ IE    PL  +      + +L G+ + H +  +HRD+K  NIL+  
Sbjct: 88  LVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146

Query: 675 TGTVKL 680
             T+K+
Sbjct: 147 NKTLKI 152

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  117 bits (295), Expect = 6e-29
 Identities = 67/269 (24%), Positives = 108/269 (40%), Gaps = 67/269 (24%)

Query: 142 TPGSLKDPEIAELFDKEDPEKIFED----LREIGHGSFGAVYYARCLVSRE----IVAIK 193
           T        +   F+  DP +  E     L+++G G+FG+V   R    ++    +VA+K
Sbjct: 17  TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76

Query: 194 KMSYLGKQCAEK-WADILKEIRFLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSAS 249
           K+    +   E+   D  +EI  L+ L+H N ++Y+G           L+MEY   GS  
Sbjct: 77  KL----QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL- 131

Query: 250 DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN 309
                    R++        LQ+               HK  +   ++    S + +G+ 
Sbjct: 132 ---------RDY--------LQK---------------HKERIDHIKLLQYTSQICKGME 159

Query: 310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-----------WM 358
           YL +   IHRD+   NIL+     VK+ DFG   +  P +      Y           W 
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV-LPQDKEY---YKVKEPGESPIFWY 215

Query: 359 APEVILAMDEGQYDGKVDVWSLGITCIEL 387
           APE +    E ++    DVWS G+   EL
Sbjct: 216 APESLT---ESKFSVASDVWSFGVVLYEL 241

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.8 bits (249), Expect = 6e-23
 Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 21/151 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSG 62
            +L+ L+H N ++Y+G           L+MEY   GS  D ++ HK  +   ++    S 
Sbjct: 94  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY------- 115
           + +G+ YL +   IHRD+   NIL+     VK+ DFG   +  P +      Y       
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV-LPQDKEY---YKVKEPGE 209

Query: 116 ----WMAPEVILAMDEGQYDGKVDVWSLGIT 142
               W APE +    E ++    DVWS G+ 
Sbjct: 210 SPIFWYAPESLT---ESKFSVASDVWSFGVV 237

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 1/66 (1%)

Query: 615 QLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +L+MEY   GS  D ++ HK  +   ++    S + +G+ YL +   IHRD+   NIL+ 
Sbjct: 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 179

Query: 674 ETGTVK 679
               VK
Sbjct: 180 NENRVK 185

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  116 bits (292), Expect = 8e-29
 Identities = 55/254 (21%), Positives = 99/254 (38%), Gaps = 56/254 (22%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
             ++G G +G VY          VA+K +    K+   +  + LKE   ++++KHPN ++
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G   R+   +++ E+                       GN L  L+           E
Sbjct: 74  LLGVCTREPPFYIITEFMTY--------------------GNLLDYLR-----------E 102

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC 346
            +++ +    +  + + +   + YL     IHRD+ A N L+ E   VK+ADFG + +  
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 160

Query: 347 PANSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
                 G  Y           W APE +      ++  K DVW+ G+   E+A     PY
Sbjct: 161 ----MTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPY 213

Query: 395 FNMNAMSALYHIAQ 408
             ++       + +
Sbjct: 214 PGIDLSQVYELLEK 227

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKR-PLKEEEIAAICSGV 63
           ++++++KHPN ++  G   R+   +++ E+   G+  D +    R  +    +  + + +
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-------- 115
              + YL     IHRD+ A N L+ E   VK+ADFG + +        G  Y        
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHAGAKF 174

Query: 116 ---WMAPEVILAMDEGQYDGKVDVWSLGI 141
              W APE +      ++  K DVW+ G+
Sbjct: 175 PIKWTAPESLA---YNKFSIKSDVWAFGV 200

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 44.5 bits (106), Expect = 6e-05
 Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 2/67 (2%)

Query: 616 LVMEY-CLGSASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++ E+   G+  D +    R  +    +  + + +   + YL     IHRD+ A N L+ 
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 145

Query: 674 ETGTVKL 680
           E   VK+
Sbjct: 146 ENHLVKV 152

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  115 bits (291), Expect = 1e-28
 Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 55/236 (23%)

Query: 167 LREIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQLKH 221
           L+++G G+FG+V   R       + E+VA+KK+    +   E+   D  +EI  L+ L+H
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEILKSLQH 70

Query: 222 PNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            N ++Y+G           L+MEY   GS           R++        LQ+      
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSL----------RDY--------LQK------ 106

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                    HK  +   ++    S + +G+ YL +   IHRD+   NIL+     VK+ D
Sbjct: 107 ---------HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157

Query: 339 FGSA-SIKCPANSFVGT-----P-YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           FG    +      F        P +W APE +    E ++    DVWS G+   EL
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYEL 210

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (251), Expect = 2e-23
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSG 62
            +L+ L+H N ++Y+G           L+MEY   GS  D ++ HK  +   ++    S 
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT-----P-Y 115
           + +G+ YL +   IHRD+   NIL+     VK+ DFG    +      F        P +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W APE +    E ++    DVWS G+ 
Sbjct: 183 WYAPESLT---ESKFSVASDVWSFGVV 206

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 1/66 (1%)

Query: 615 QLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +L+MEY   GS  D ++ HK  +   ++    S + +G+ YL +   IHRD+   NIL+ 
Sbjct: 89  KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 148

Query: 674 ETGTVK 679
               VK
Sbjct: 149 NENRVK 154

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  117 bits (296), Expect = 1e-28
 Identities = 69/283 (24%), Positives = 105/283 (37%), Gaps = 55/283 (19%)

Query: 141 ITPGSLKDPEIA-ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIK--K 194
           + P + +DP      F KE         + +G G FG V   R  +  +    VAIK  K
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82

Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
           + Y  KQ      D L E   + Q  HPN I   G   +     +V EY           
Sbjct: 83  VGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM---------- 128

Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                  E+ +L +F   H       ++  +  G+  G+ YL  
Sbjct: 129 -----------------------ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165

Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGT--PY-WMAPEVILAM 366
           +G +HRD+ A NIL+      K++DFG           A +  G   P  W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA-- 223

Query: 367 DEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
              ++    DVWS GI   E+    + PY+ M+    +  + +
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 11/145 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S++ Q  HPN I   G   +     +V EY   GS    +  H       ++  +  G+ 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGT--PY-WM 117
            G+ YL  +G +HRD+ A NIL+      K++DFG           A +  G   P  W 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           +PE I      ++    DVWS GI 
Sbjct: 218 SPEAIA---YRKFTSASDVWSYGIV 239

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 19/66 (28%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V EY   GS    +  H       ++  +  G+  G+ YL  +G +HRD+ A NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182

Query: 675 TGTVKL 680
               K+
Sbjct: 183 NLVCKV 188

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  116 bits (292), Expect = 1e-28
 Identities = 66/258 (25%), Positives = 106/258 (41%), Gaps = 59/258 (22%)

Query: 149 PEIAELFDKEDPEKIFED----LREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGK 200
              A+L+  +DP    E     + ++G G+FG+V   R     +    +VA+K++    +
Sbjct: 6   HHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----Q 61

Query: 201 QCA-EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHW 256
               ++  D  +EI+ L+ L     ++YRG           LVMEY   G          
Sbjct: 62  HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL-------- 113

Query: 257 IEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
             R+F        LQ+               H+  L    +    S + +G+ YL S   
Sbjct: 114 --RDF--------LQR---------------HRARLDASRLLLYSSQICKGMEYLGSRRC 148

Query: 317 IHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT-----PY-WMAPEVILAMDEG 369
           +HRD+ A NIL+     VK+ADFG A  +    + +V       P  W APE +    + 
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS---DN 205

Query: 370 QYDGKVDVWSLGITCIEL 387
            +  + DVWS G+   EL
Sbjct: 206 IFSRQSDVWSFGVVLYEL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 99.3 bits (248), Expect = 8e-23
 Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSG 62
            +L+ L     ++YRG           LVMEY   G   D ++ H+  L    +    S 
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT-----PY- 115
           + +G+ YL S   +HRD+ A NIL+     VK+ADFG A  +    + +V       P  
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W APE +    +  +  + DVWS G+ 
Sbjct: 196 WYAPESLS---DNIFSRQSDVWSFGVV 219

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 615 QLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +LVMEY   G   D ++ H+  L    +    S + +G+ YL S   +HRD+ A NIL+ 
Sbjct: 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 161

Query: 674 ETGTVK 679
               VK
Sbjct: 162 SEAHVK 167

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (292), Expect = 1e-28
 Identities = 64/287 (22%), Positives = 102/287 (35%), Gaps = 83/287 (28%)

Query: 147 KDPEIA--ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE----IVAIK--KMSYL 198
           + P  A   +  + + +KI    + +G G+FG VY    +   E     VAIK  + +  
Sbjct: 2   EAPNQALLRILKETEFKKI----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57

Query: 199 GKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWI 257
            K       +IL E   +  + +P+     G  L   T  L+ +    G           
Sbjct: 58  PKA----NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGC---------- 102

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
                   + + +++               HK  +  + +   C  + +G+NYL     +
Sbjct: 103 --------LLDYVRE---------------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139

Query: 318 HRDVKAGNILLTETGTVKLADFG------------SAS-----IKCPANSFVGTPYWMAP 360
           HRD+ A N+L+     VK+ DFG             A      IK           WMA 
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-----------WMAL 188

Query: 361 EVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHI 406
           E IL      Y  + DVWS G+T  EL      PY  + A      +
Sbjct: 189 ESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 33/155 (21%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++  + +P+     G  L   T  L+ +    G   D +  HK  +  + +   C  + 
Sbjct: 69  YVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SAS-----IKCPA 107
           +G+NYL     +HRD+ A N+L+     VK+ DFG             A      IK   
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184

Query: 108 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                   WMA E IL      Y  + DVWS G+T
Sbjct: 185 --------WMALESIL---HRIYTHQSDVWSYGVT 208

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 19/69 (27%), Positives = 34/69 (49%), Gaps = 1/69 (1%)

Query: 613 SPQLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           + QL+ +    G   D +  HK  +  + +   C  + +G+NYL     +HRD+ A N+L
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149

Query: 672 LTETGTVKL 680
           +     VK+
Sbjct: 150 VKTPQHVKI 158

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  115 bits (291), Expect = 2e-28
 Identities = 71/283 (25%), Positives = 103/283 (36%), Gaps = 55/283 (19%)

Query: 141 ITPGSLKDPEIAEL-FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMS 196
             P + ++P  A   F +E         + IG G  G V Y R  V  +    VAIK + 
Sbjct: 27  AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL- 85

Query: 197 YLGKQCA--EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
              K      +  D L E   + Q  HPN I   G   R   A +V EY           
Sbjct: 86  ---KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM---------- 132

Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                                  E+ +L  F   H       ++  +  GV  G+ YL  
Sbjct: 133 -----------------------ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 314 LGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGT--PY-WMAPEVILAM 366
           LG +HRD+ A N+L+      K++DFG +         A +  G   P  W APE I   
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA-- 227

Query: 367 DEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
               +    DVWS G+   E+    + PY+NM     +  + +
Sbjct: 228 -FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 45/145 (31%), Positives = 63/145 (43%), Gaps = 11/145 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S++ Q  HPN I   G   R   A +V EY   GS    +  H       ++  +  GV 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGT--PY-WM 117
            G+ YL  LG +HRD+ A N+L+      K++DFG +         A +  G   P  W 
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           APE I       +    DVWS G+ 
Sbjct: 222 APEAIA---FRTFSSASDVWSFGVV 243

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 20/66 (30%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V EY   GS    +  H       ++  +  GV  G+ YL  LG +HRD+ A N+L+  
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186

Query: 675 TGTVKL 680
               K+
Sbjct: 187 NLVCKV 192

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  117 bits (295), Expect = 3e-28
 Identities = 68/261 (26%), Positives = 100/261 (38%), Gaps = 79/261 (30%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           +     IG GS+G VY A    + + VAIKK++    +  E   D   IL+EI  L +LK
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN----RMFEDLIDCKRILREITILNRLK 83

Query: 221 HPNTIEYR-----GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
               I           L+    ++V+E                         + L++L  
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEI----------------------ADSDLKKL-- 119

Query: 276 FTEHFALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L EE I  I   +L G N++H  G IHRD+K  N LL +  +V
Sbjct: 120 -----------FKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSV 168

Query: 335 KLADFG---SASIKCPANSF-----------------------VGTPYWMAPEVILAMDE 368
           K+ DFG   + + +   N                         V T ++ APE+IL  + 
Sbjct: 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN 228

Query: 369 GQYDGKVDVWSLGITCIELAE 389
             Y   +D+WS G  CI  AE
Sbjct: 229 --YTKSIDIWSTG--CI-FAE 244

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 40/168 (23%)

Query: 7   LLRQLKHPNTIEYR-----GCYLRDHTAWLVMEYCLGSASD---IIEVHKRPLKEEEIAA 58
           +L +LK    I           L+    ++V+E      SD   + +     L EE I  
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA---DSDLKKLFK-TPIFLTEEHIKT 133

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG---SASIKCPANSF----- 110
           I   +L G N++H  G IHRD+K  N LL +  +VK+ DFG   + + +   N       
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 111 ------------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 140
                             V T ++ APE+IL  +   Y   +D+WS G
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN--YTKSIDIWSTG 239

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 15/33 (45%), Positives = 22/33 (66%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L G N++H  G IHRD+K  N LL +  +VK+
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKV 170

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  117 bits (295), Expect = 4e-28
 Identities = 65/266 (24%), Positives = 102/266 (38%), Gaps = 84/266 (31%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWAD---ILKEIRFLRQLK 220
           +E    IG GS+G V  A   + + +VAIKK+     +  E   D   IL+EI  L +L 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL----RVFEDLIDCKRILREIAILNRLN 110

Query: 221 HPNTIE-----YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           H + ++           +    ++V+E                         +  ++L  
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEI----------------------ADSDFKKL-- 146

Query: 276 FTEHFALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                            L E  I  +   +L G+ Y+HS G +HRD+K  N L+ +  +V
Sbjct: 147 -----------FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSV 195

Query: 335 KLADFGSA-SIKCPANSF------------------------------VGTPYWMAPEVI 363
           K+ DFG A ++  P N                                V T ++ APE+I
Sbjct: 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI 255

Query: 364 LAMDEGQYDGKVDVWSLGITCIELAE 389
           L  +   Y   +DVWS+G  CI  AE
Sbjct: 256 LLQEN--YTEAIDVWSIG--CI-FAE 276

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 57/268 (21%), Positives = 94/268 (35%), Gaps = 67/268 (25%)

Query: 6   SLLRQLKHPNTIE-----YRGCYLRDHTAWLVMEYCLGSASD---IIEVHKRPLKEEEIA 57
           ++L +L H + ++           +    ++V+E      SD   +       L E  I 
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---DSDFKKLFR-TPVYLTELHIK 159

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSF------ 110
            +   +L G+ Y+HS G +HRD+K  N L+ +  +VK+ DFG A ++  P N        
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219

Query: 111 ------------------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITPGS 145
                                   V T ++ APE+IL  +   Y   +DVWS+G I    
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN--YTEAIDVWSIGCI---- 273

Query: 146 LKDPEIAELFDKEDPEKIFEDLREI---GHGSFGAVYYARCLVSREIVAIKK-------M 195
                 AEL +       +   R     G   F      +     +              
Sbjct: 274 -----FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF 328

Query: 196 SYLGKQCAEKWADILKE--IRFLRQLKH 221
           + LG    E    + KE   R++R    
Sbjct: 329 NILGTPSEEDIEALEKEDAKRYIRIFPK 356

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 14/33 (42%), Positives = 23/33 (69%)

Query: 648 VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +L G+ Y+HS G +HRD+K  N L+ +  +VK+
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKV 197

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  113 bits (285), Expect = 4e-28
 Identities = 63/255 (24%), Positives = 94/255 (36%), Gaps = 60/255 (23%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           ++EIG G FG V+    L   + VAIK +    ++ A    D ++E   + +L HP  ++
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
             G  L      LV E+                       G     L+            
Sbjct: 68  LYGVCLEQAPICLVTEFMEH--------------------GCLSDYLR------------ 95

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------ 340
             +     E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++DFG      
Sbjct: 96  TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155

Query: 341 ------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPP 393
                 S   K P         W +PEV       +Y  K DVWS G+   E+    K P
Sbjct: 156 DDQYTSSTGTKFPVK-------WASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIP 205

Query: 394 YFNMNAMSALYHIAQ 408
           Y N +    +  I+ 
Sbjct: 206 YENRSNSEVVEDIST 220

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 43/149 (28%), Positives = 62/149 (41%), Gaps = 23/149 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++ +L HP  ++  G  L      LV E+   G  SD +   +     E +  +C  V 
Sbjct: 55  EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SASIKCPANSFVG 112
            G+ YL     IHRD+ A N L+ E   +K++DFG            S   K P      
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK---- 170

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
              W +PEV       +Y  K DVWS G+
Sbjct: 171 ---WASPEVFS---FSRYSSKSDVWSFGV 193

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 21/66 (31%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LV E+   G  SD +   +     E +  +C  V  G+ YL     IHRD+ A N L+ E
Sbjct: 80  LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 139

Query: 675 TGTVKL 680
              +K+
Sbjct: 140 NQVIKV 145

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  119 bits (301), Expect = 4e-28
 Identities = 61/260 (23%), Positives = 96/260 (36%), Gaps = 50/260 (19%)

Query: 147 KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMS--YLGKQCAE 204
           K+ E+       D    F   R IG G FG VY  R   + ++ A+K +    +  +  E
Sbjct: 178 KNVELNIHLTMND----FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE 233

Query: 205 KWA----DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIERE 260
             A     +L  +        P  +     +        +++   G           +  
Sbjct: 234 TLALNERIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGG----------DLH 280

Query: 261 FHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD 320
           +H       L Q   F+E    F              A I  G    L ++H+   ++RD
Sbjct: 281 YH-------LSQHGVFSEADMRFY------------AAEIILG----LEHMHNRFVVYRD 317

Query: 321 VKAGNILLTETGTVKLADFGSA--SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 378
           +K  NILL E G V+++D G A    K   ++ VGT  +MAPEV+       YD   D +
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ--KGVAYDSSADWF 375

Query: 379 SLGITCIELAERKPPYFNMN 398
           SLG    +L     P+    
Sbjct: 376 SLGCMLFKLLRGHSPFRQHK 395

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.2 bits (221), Expect = 2e-18
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 14/118 (11%)

Query: 31  LVMEYCLGSASDIIEV-----HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 85
            +++   G      ++           E ++    + ++ GL ++H+   ++RD+K  NI
Sbjct: 269 FILDLMNGG-----DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323

Query: 86  LLTETGTVKLADFGSA--SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           LL E G V+++D G A    K   ++ VGT  +MAPEV+       YD   D +SLG 
Sbjct: 324 LLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ--KGVAYDSSADWFSLGC 379

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 15/70 (21%), Positives = 33/70 (47%), Gaps = 10/70 (14%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
            +++   G      ++           E ++    + ++ GL ++H+   ++RD+K  NI
Sbjct: 269 FILDLMNGG-----DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323

Query: 671 LLTETGTVKL 680
           LL E G V++
Sbjct: 324 LLDEHGHVRI 333

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  114 bits (287), Expect = 5e-28
 Identities = 81/362 (22%), Positives = 125/362 (34%), Gaps = 111/362 (30%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR------QLK 220
              +G G    V+ AR L     VA+K +       A+   D    +RF R       L 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------ADLARDPSFYLRFRREAQNAAALN 70

Query: 221 HPNTI------EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
           HP  +      E           ++VMEY                   V+G+   L+ + 
Sbjct: 71  HPAIVAVYDTGEAET--PAGPLPYIVMEY-------------------VDGV--TLRDI- 106

Query: 275 CFTEHFALFNFEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                       VH   P+  +    + +   + LN+ H  G IHRDVK  NI+++ T  
Sbjct: 107 ------------VHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 154

Query: 334 VKLADFG-------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           VK+ DFG       S +      + +GT  +++PE          D + DV+SLG    E
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYE 211

Query: 387 LAERKPPYFNMNAMS-ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
           +   +PP+   + +S A  H+ + D               S+  E      +        
Sbjct: 212 VLTGEPPFTGDSPVSVAYQHV-REDPI-----------PPSARHEGLSADLD-------- 251

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT-----RPRSPSVL 500
                                 V   LAKNP +R  +   +  DLV       P +P VL
Sbjct: 252 --------------------AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291

Query: 501 VD 502
            D
Sbjct: 292 TD 293

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 20/147 (13%)

Query: 10  QLKHPNTI------EYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSG 62
            L HP  +      E           ++VMEY  G    DI+   + P+  +    + + 
Sbjct: 68  ALNHPAIVAVYDTGEAET--PAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIAD 124

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-------SASIKCPANSFVGTPY 115
             + LN+ H  G IHRDVK  NI+++ T  VK+ DFG       S +      + +GT  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           +++PE          D + DV+SLG  
Sbjct: 185 YLSPEQARG---DSVDARSDVYSLGCV 208

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 23/66 (34%), Positives = 36/66 (54%), Gaps = 2/66 (3%)

Query: 616 LVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +VMEY  G    DI+   + P+  +    + +   + LN+ H  G IHRDVK  NI+++ 
Sbjct: 93  IVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151

Query: 675 TGTVKL 680
           T  VK+
Sbjct: 152 TNAVKV 157

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  113 bits (286), Expect = 6e-28
 Identities = 60/265 (22%), Positives = 97/265 (36%), Gaps = 57/265 (21%)

Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEK-WADILKEIRFLRQLK 220
            RE+G G+FG V+ A C        + +VA+K +    K        D  +E   L  L+
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQ 75

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           H + +++ G         +V EY   G             +F        L+        
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDL----------NKF--------LRAHGPDAMI 117

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                    K  L   ++  I S +  G+ YL S   +HRD+   N L+     VK+ DF
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177

Query: 340 GSA-SIKCPANSFVGTPY------------WMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           G +  +         T Y            WM PE I+     ++  + DVWS G+   E
Sbjct: 178 GMSRDVYS-------TDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVILWE 227

Query: 387 ---LAERKPPYFNMNAMSALYHIAQ 408
                ++  P+F ++    +  I Q
Sbjct: 228 IFTYGKQ--PWFQLSNTEVIECITQ 250

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 38/166 (22%), Positives = 60/166 (36%), Gaps = 39/166 (23%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKR 49
            LL  L+H + +++ G         +V EY                 +          K 
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128

Query: 50  PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPAN 108
            L   ++  I S +  G+ YL S   +HRD+   N L+     VK+ DFG +  +     
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS--- 185

Query: 109 SFVGTPY------------WMAPEVILAMDEGQYDGKVDVWSLGIT 142
               T Y            WM PE I+     ++  + DVWS G+ 
Sbjct: 186 ----TDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVI 224

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 18/80 (22%), Positives = 27/80 (33%), Gaps = 16/80 (20%)

Query: 616 LVMEYC----------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 659
           +V EY                 +          K  L   ++  I S +  G+ YL S  
Sbjct: 94  MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153

Query: 660 RIHRDVKAGNILLTETGTVK 679
            +HRD+   N L+     VK
Sbjct: 154 FVHRDLATRNCLVGANLLVK 173

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  114 bits (287), Expect = 6e-28
 Identities = 80/415 (19%), Positives = 134/415 (32%), Gaps = 122/415 (29%)

Query: 124 AMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKE--DPEKIFEDLREIGHGSFGAVYYA 181
           AM  G      +    G+    +++P+              I     E+G G+FG V+ A
Sbjct: 2   AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDI-VLKWELGEGAFGKVFLA 60

Query: 182 RCLVSRE-----IVAIKKMSYLGKQCAEK-WADILKEIRFLRQLKHPNTIEYRGCYLRDH 235
            C          +VA+K +    K+ +E    D  +E   L  L+H + + + G      
Sbjct: 61  ECHNLLPEQDKMLVAVKAL----KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116

Query: 236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF------TEHFALFNFEVHK 289
              +V EY                       G+    L  F               +V  
Sbjct: 117 PLLMVFEYMRH--------------------GD----LNRFLRSHGPDAKLLAGGEDVAP 152

Query: 290 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA------- 342
            PL   ++ A+ S V  G+ YL  L  +HRD+   N L+ +   VK+ DFG +       
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

Query: 343 ----------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE---LAE 389
                      I+           WM PE IL     ++  + DVWS G+   E     +
Sbjct: 213 YYRVGGRTMLPIR-----------WMPPESIL---YRKFTTESDVWSFGVVLWEIFTYGK 258

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
           +  P++ +                   S+   I  I+   E + P         +Y I  
Sbjct: 259 Q--PWYQL-------------------SNTEAIDCITQGRELERP---RACPPEVYAI-- 292

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLI 504
                             +  C  + P  R S   +    L    ++P V +D++
Sbjct: 293 ------------------MRGCWQREPQQRHSIKDVH-ARLQALAQAPPVYLDVL 328

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 40/169 (23%), Positives = 62/169 (36%), Gaps = 46/169 (27%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC---------------LGSASDIIEVHKRP 50
            LL  L+H + + + G         +V EY                    +   +V   P
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154

Query: 51  LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA--------- 101
           L   ++ A+ S V  G+ YL  L  +HRD+   N L+ +   VK+ DFG +         
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 102 --------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                    I+           WM PE IL     ++  + DVWS G+ 
Sbjct: 215 RVGGRTMLPIR-----------WMPPESIL---YRKFTTESDVWSFGVV 249

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 44.6 bits (106), Expect = 9e-05
 Identities = 20/79 (25%), Positives = 31/79 (39%), Gaps = 15/79 (18%)

Query: 616 LVMEYC---------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 660
           +V EY                    +   +V   PL   ++ A+ S V  G+ YL  L  
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179

Query: 661 IHRDVKAGNILLTETGTVK 679
           +HRD+   N L+ +   VK
Sbjct: 180 VHRDLATRNCLVGQGLVVK 198

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  112 bits (283), Expect = 7e-28
 Identities = 59/254 (23%), Positives = 99/254 (38%), Gaps = 58/254 (22%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+E+G G FG V   +     + VA+K +    K+ +    +  +E + + +L HP  ++
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
           + G   +++  ++V EY                       G  L  L+            
Sbjct: 68  FYGVCSKEYPIYIVTEYISN--------------------GCLLNYLR------------ 95

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC 346
            H + L+  ++  +C  V  G+ +L S   IHRD+ A N L+     VK++DFG      
Sbjct: 96  SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG------ 149

Query: 347 PANSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
                +   Y           W APEV       +Y  K DVW+ GI   E+    K PY
Sbjct: 150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFH---YFKYSSKSDVWAFGILMWEVFSLGKMPY 206

Query: 395 FNMNAMSALYHIAQ 408
                   +  ++Q
Sbjct: 207 DLYTNSEVVLKVSQ 220

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 21/148 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
             + +L HP  +++ G   +++  ++V EY   G   + +  H + L+  ++  +C  V 
Sbjct: 55  QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY--------- 115
            G+ +L S   IHRD+ A N L+     VK++DFG           +   Y         
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG------MTRYVLDDQYVSSVGTKFP 168

Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W APEV       +Y  K DVW+ GI
Sbjct: 169 VKWSAPEVFH---YFKYSSKSDVWAFGI 193

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 50.3 bits (121), Expect = 9e-07
 Identities = 20/66 (30%), Positives = 33/66 (50%), Gaps = 1/66 (1%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V EY   G   + +  H + L+  ++  +C  V  G+ +L S   IHRD+ A N L+  
Sbjct: 80  IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR 139

Query: 675 TGTVKL 680
              VK+
Sbjct: 140 DLCVKV 145

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  112 bits (283), Expect = 8e-28
 Identities = 57/268 (21%), Positives = 100/268 (37%), Gaps = 52/268 (19%)

Query: 149 PEIAELFDKE---DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK 205
               E +      + +++ + L+ IG G FG V       ++  VA+K +    K  A  
Sbjct: 6   AAQDEFYRSGWALNMKEL-KLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATA 58

Query: 206 WADILKEIRFLRQLKHPNTIEYRG-CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVE 264
               L E   + QL+H N ++  G         ++V EY                     
Sbjct: 59  Q-AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK------------------ 99

Query: 265 GMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 324
             G+ +  L+              +  L  + +      V   + YL     +HRD+ A 
Sbjct: 100 --GSLVDYLR-----------SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 146

Query: 325 NILLTETGTVKLADFGSASIKCPANSFVGT--PY-WMAPEVILAMDEGQYDGKVDVWSLG 381
           N+L++E    K++DFG    K  +++      P  W APE +    E ++  K DVWS G
Sbjct: 147 NVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFG 201

Query: 382 ITCIELAER-KPPYFNMNAMSALYHIAQ 408
           I   E+    + PY  +     +  + +
Sbjct: 202 ILLWEIYSFGRVPYPRIPLKDVVPRVEK 229

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 11/142 (7%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEYC-LGSASDIIEVHKR-PLKEEEIAAICSG 62
           S++ QL+H N ++  G         ++V EY   GS  D +    R  L  + +      
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT--PY-WMAP 119
           V   + YL     +HRD+ A N+L++E    K++DFG    K  +++      P  W AP
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAP 183

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E +    E ++  K DVWS GI
Sbjct: 184 EALR---EKKFSTKSDVWSFGI 202

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 19/66 (28%), Positives = 29/66 (43%), Gaps = 2/66 (3%)

Query: 616 LVMEYC-LGSASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V EY   GS  D +    R  L  + +      V   + YL     +HRD+ A N+L++
Sbjct: 92  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 151

Query: 674 ETGTVK 679
           E    K
Sbjct: 152 EDNVAK 157

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  113 bits (285), Expect = 1e-27
 Identities = 70/268 (26%), Positives = 109/268 (40%), Gaps = 53/268 (19%)

Query: 144 GSLKDPEIAELFDKEDPEKI----FEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMS 196
           GS+K+  I     KE  EK     FE L+ +G GSFG V+  + +      ++ A+K + 
Sbjct: 3   GSIKEIAITHHV-KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61

Query: 197 YLGKQC--AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV 254
              K             E   L ++ HP  ++    +  +   +L++++  G        
Sbjct: 62  ---KATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG------- 111

Query: 255 HWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL 314
              +           L +   FTE    F             +A +       L++LHSL
Sbjct: 112 ---DLFTR-------LSKEVMFTEEDVKFY------------LAELALA----LDHLHSL 145

Query: 315 GRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQ 370
           G I+RD+K  NILL E G +KL DFG    S   +  A SF GT  +MAPEV+       
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG--- 202

Query: 371 YDGKVDVWSLGITCIELAERKPPYFNMN 398
           +    D WS G+   E+     P+   +
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 87.6 bits (218), Expect = 7e-19
 Identities = 41/120 (34%), Positives = 60/120 (50%), Gaps = 17/120 (14%)

Query: 31  LVMEYCLGSASDIIE----VHKRPLKEEEIAAI-CSGVLRGLNYLHSLGRIHRDVKAGNI 85
           L++++  G      +    + K  +  EE      + +   L++LHSLG I+RD+K  NI
Sbjct: 103 LILDFLRGG-----DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157

Query: 86  LLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           LL E G +KL DFG    S   +  A SF GT  +MAPEV+       +    D WS G+
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG---HTQSADWWSFGV 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 45.2 bits (108), Expect = 5e-05
 Identities = 23/70 (32%), Positives = 37/70 (52%), Gaps = 10/70 (14%)

Query: 616 LVMEYCLGSASDIIE----VHKRPLKEEEIAAI-CSGVLRGLNYLHSLGRIHRDVKAGNI 670
           L++++  G      +    + K  +  EE      + +   L++LHSLG I+RD+K  NI
Sbjct: 103 LILDFLRGG-----DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157

Query: 671 LLTETGTVKL 680
           LL E G +KL
Sbjct: 158 LLDEEGHIKL 167

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  112 bits (282), Expect = 1e-27
 Identities = 55/270 (20%), Positives = 92/270 (34%), Gaps = 66/270 (24%)

Query: 167 LREIGHGSFGAVYYARCLVSRE-----IVAIKKMSYLGKQCA--EKWADILKEIRFLRQL 219
           + E+G   FG VY               VAIK +    K  A      +   E     +L
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL----KDKAEGPLREEFRHEAMLRARL 69

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           +HPN +   G   +D    ++  YC  G             EF        L      ++
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDL----------HEF--------LVMRSPHSD 111

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
             +  +    K  L+  +   + + +  G+ YL S   +H+D+   N+L+ +   VK++D
Sbjct: 112 VGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD 171

Query: 339 FGSAS-----------------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
            G                    I+           WMAPE I+    G++    D+WS G
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIR-----------WMAPEAIM---YGKFSIDSDIWSYG 217

Query: 382 ITCIE---LAERKPPYFNMNAMSALYHIAQ 408
           +   E      +  PY   +    +  I  
Sbjct: 218 VVLWEVFSYGLQ--PYCGYSNQDVVEMIRN 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 36/170 (21%), Positives = 64/170 (37%), Gaps = 47/170 (27%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKR 49
            L  +L+HPN +   G   +D    ++  YC                   ++D     K 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 50  PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS------- 102
            L+  +   + + +  G+ YL S   +H+D+   N+L+ +   VK++D G          
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183

Query: 103 ----------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                     I+           WMAPE I+    G++    D+WS G+ 
Sbjct: 184 YKLLGNSLLPIR-----------WMAPEAIM---YGKFSIDSDIWSYGVV 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 42.6 bits (101), Expect = 3e-04
 Identities = 15/80 (18%), Positives = 31/80 (38%), Gaps = 16/80 (20%)

Query: 616 LVMEYC----------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 659
           ++  YC                   ++D     K  L+  +   + + +  G+ YL S  
Sbjct: 89  MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 148

Query: 660 RIHRDVKAGNILLTETGTVK 679
            +H+D+   N+L+ +   VK
Sbjct: 149 VVHKDLATRNVLVYDKLNVK 168

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  115 bits (290), Expect = 2e-27
 Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 48/247 (19%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           L+ IG G FG V       ++  VA+K +    K  A      L E   + QL+H N ++
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQ-AFLAEASVMTQLRHSNLVQ 250

Query: 227 YRG-CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNF 285
             G         ++V EY                       G+ +  L+           
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAK--------------------GSLVDYLR----------- 279

Query: 286 EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK 345
              +  L  + +      V   + YL     +HRD+ A N+L++E    K++DFG    K
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT--K 337

Query: 346 CPANSFVGT--PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMS 401
             +++      P  W APE +    E ++  K DVWS GI   E+    + PY  +    
Sbjct: 338 EASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394

Query: 402 ALYHIAQ 408
            +  + +
Sbjct: 395 VVPRVEK 401

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 94.3 bits (235), Expect = 2e-20
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 11/142 (7%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEYC-LGSASD-IIEVHKRPLKEEEIAAICSG 62
           S++ QL+H N ++  G         ++V EY   GS  D +    +  L  + +      
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT--PY-WMAP 119
           V   + YL     +HRD+ A N+L++E    K++DFG    K  +++      P  W AP
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAP 355

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E +    E ++  K DVWS GI
Sbjct: 356 EALR---EKKFSTKSDVWSFGI 374

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 18/66 (27%), Positives = 29/66 (43%), Gaps = 2/66 (3%)

Query: 616 LVMEYC-LGSASD-IIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V EY   GS  D +    +  L  + +      V   + YL     +HRD+ A N+L++
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 323

Query: 674 ETGTVK 679
           E    K
Sbjct: 324 EDNVAK 329

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  113 bits (285), Expect = 3e-27
 Identities = 64/280 (22%), Positives = 103/280 (36%), Gaps = 59/280 (21%)

Query: 148 DPEIAELFD---KEDPEKIFEDLREIGHGSFGAVYYARCLVSREI---VAIKKMSYLGKQ 201
           +PE+ +            I      IG G FG VY+   L +       A+K +     +
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL----NR 127

Query: 202 CA--EKWADILKEIRFLRQLKHPNTIEYRG-CYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
                + +  L E   ++   HPN +   G C   + +  +V+ Y               
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM-------------- 173

Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
                              +H  L NF          +++      V +G+ +L S   +
Sbjct: 174 -------------------KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214

Query: 318 HRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT------PY-WMAPEVILAMDEG 369
           HRD+ A N +L E  TVK+ADFG +  +       V        P  WMA E   ++   
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE---SLQTQ 271

Query: 370 QYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
           ++  K DVWS G+   EL  R  PPY ++N      ++ Q
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 91.0 bits (226), Expect = 9e-20
 Identities = 39/147 (26%), Positives = 65/147 (44%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGV 63
            +++   HPN +   G C   + +  +V+ Y   G   + I         +++      V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT------PY- 115
            +G+ +L S   +HRD+ A N +L E  TVK+ADFG +  +       V        P  
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           WMA E   ++   ++  K DVWS G+ 
Sbjct: 262 WMALE---SLQTQKFTTKSDVWSFGVL 285

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 1/67 (1%)

Query: 614 PQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +V+ Y   G   + I         +++      V +G+ +L S   +HRD+ A N +L
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225

Query: 673 TETGTVK 679
            E  TVK
Sbjct: 226 DEKFTVK 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  111 bits (280), Expect = 3e-27
 Identities = 65/279 (23%), Positives = 105/279 (37%), Gaps = 60/279 (21%)

Query: 145 SLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSYLGKQ 201
            +KD  I       +        R IG G FG VY+   +   +     AIK +     +
Sbjct: 10  EVKDVLIPH-----ERVVT-HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL----SR 59

Query: 202 CA--EKWADILKEIRFLRQLKHPNTIEYRG-CYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
               ++    L+E   +R L HPN +   G     +    +++ Y               
Sbjct: 60  ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCH------------ 107

Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                   G+ LQ ++              +R    +++ +    V RG+ YL     +H
Sbjct: 108 --------GDLLQFIRS------------PQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147

Query: 319 RDVKAGNILLTETGTVKLADFGSA-----SIKCPANSFVGT--PY-WMAPEVILAMDEGQ 370
           RD+ A N +L E+ TVK+ADFG A                   P  W A E   ++   +
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE---SLQTYR 204

Query: 371 YDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
           +  K DVWS G+   EL  R  PPY +++     + +AQ
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGV 63
            L+R L HPN +   G     +    +++ Y C G     I   +R    +++ +    V
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-----SIKCPANSFVGT--PY- 115
            RG+ YL     +HRD+ A N +L E+ TVK+ADFG A                   P  
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W A E   ++   ++  K DVWS G+ 
Sbjct: 194 WTALE---SLQTYRFTTKSDVWSFGVL 217

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 1/67 (1%)

Query: 614 PQLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           P +++ Y C G     I   +R    +++ +    V RG+ YL     +HRD+ A N +L
Sbjct: 98  PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157

Query: 673 TETGTVK 679
            E+ TVK
Sbjct: 158 DESFTVK 164

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (279), Expect = 3e-27
 Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 62/277 (22%)

Query: 147 KDPEIAEL-FDK-EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE 204
             P  A L +   E   K    L+E+G G FG V Y +     + VAIK +    K+ + 
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSM 61

Query: 205 KWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVE 264
              + ++E + +  L H   ++  G   +    +++ EY                     
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY--------------------- 100

Query: 265 GMGNRLQQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA 323
            M            +  L N+    +   + +++  +C  V   + YL S   +HRD+ A
Sbjct: 101 -M-----------ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148

Query: 324 GNILLTETGTVKLADFGSASIKCPANSFVGTPY-----------WMAPEVILAMDEGQYD 372
            N L+ + G VK++DFG +         +   Y           W  PEV++     ++ 
Sbjct: 149 RNCLVNDQGVVKVSDFGLSRY------VLDDEYTSSVGSKFPVRWSPPEVLM---YSKFS 199

Query: 373 GKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
            K D+W+ G+   E+    K PY          HIAQ
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 32/148 (21%), Positives = 64/148 (43%), Gaps = 21/148 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++  L H   ++  G   +    +++ EY   G   + +   +   + +++  +C  V 
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY--------- 115
             + YL S   +HRD+ A N L+ + G VK++DFG +         +   Y         
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY------VLDDEYTSSVGSKFP 184

Query: 116 --WMAPEVILAMDEGQYDGKVDVWSLGI 141
             W  PEV++     ++  K D+W+ G+
Sbjct: 185 VRWSPPEVLM---YSKFSSKSDIWAFGV 209

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 17/65 (26%), Positives = 32/65 (49%), Gaps = 1/65 (1%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ EY   G   + +   +   + +++  +C  V   + YL S   +HRD+ A N L+ +
Sbjct: 96  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 155

Query: 675 TGTVK 679
            G VK
Sbjct: 156 QGVVK 160

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  111 bits (281), Expect = 5e-27
 Identities = 67/248 (27%), Positives = 100/248 (40%), Gaps = 58/248 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK---------EIR 214
           F+ L+ +G G+FG V   R   +    A+K +         +   I+          E R
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKIL---------RKEVIIAKDEVAHTVTESR 57

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            L+  +HP     +  +        VMEY  G           E  FH       L + +
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG----------ELFFH-------LSRER 100

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
            FTE  A F              A I S     L YLHS   ++RD+K  N++L + G +
Sbjct: 101 VFTEERARFY------------GAEIVSA----LEYLHSRDVVYRDIKLENLMLDKDGHI 144

Query: 335 KLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           K+ DFG      S      +F GTP ++APEV+   D   Y   VD W LG+   E+   
Sbjct: 145 KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCG 201

Query: 391 KPPYFNMN 398
           + P++N +
Sbjct: 202 RLPFYNQD 209

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 52/177 (29%), Positives = 76/177 (42%), Gaps = 39/177 (22%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV-----HKRPLKEEE----IAA 58
           L+  +HP     +  +        VMEY  G      E+      +R   EE      A 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGG-----ELFFHLSRERVFTEERARFYGAE 113

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTP 114
           I S     L YLHS   ++RD+K  N++L + G +K+ DFG      S      +F GTP
Sbjct: 114 IVSA----LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFE 165
            ++APEV+   D   Y   VD W LG+         + E+      F  +D E++FE
Sbjct: 170 EYLAPEVLEDND---YGRAVDWWGLGVV--------MYEMMCGRLPFYNQDHERLFE 215

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 24/74 (32%), Positives = 34/74 (45%), Gaps = 18/74 (24%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 666
            VMEY  G      E+      +R   EE      A I S     L YLHS   ++RD+K
Sbjct: 82  FVMEYANGG-----ELFFHLSRERVFTEERARFYGAEIVSA----LEYLHSRDVVYRDIK 132

Query: 667 AGNILLTETGTVKL 680
             N++L + G +K+
Sbjct: 133 LENLMLDKDGHIKI 146

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  111 bits (279), Expect = 6e-27
 Identities = 55/267 (20%), Positives = 97/267 (36%), Gaps = 66/267 (24%)

Query: 167 LREIGHGSFGAVY--YARCLVSRE---IVAIKKMSYLGKQCA--EKWADILKEIRFLRQL 219
            RE+G GSFG VY   A+ +V  E    VAIK +     + A   +  + L E   +++ 
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEF 85

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
              + +   G   +     ++ME                        G+    L+     
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTR--------------------GDLKSYLR---SL 122

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                      P    ++  +   +  G+ YL++   +HRD+ A N ++ E  TVK+ DF
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182

Query: 340 GSA-----------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           G                    ++           WM+PE +    +G +    DVWS G+
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVR-----------WMSPESLK---DGVFTTYSDVWSFGV 228

Query: 383 TCIELAER-KPPYFNMNAMSALYHIAQ 408
              E+A   + PY  ++    L  + +
Sbjct: 229 VLWEIATLAEQPYQGLSNEQVLRFVME 255

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 30/164 (18%), Positives = 59/164 (35%), Gaps = 41/164 (25%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG----------SASDIIEVHKRPLKEEE 55
           S++++    + +   G   +     ++ME                +        P    +
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-------------- 101
           +  +   +  G+ YL++   +HRD+ A N ++ E  TVK+ DFG                
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199

Query: 102 ---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
               ++           WM+PE +    +G +    DVWS G+ 
Sbjct: 200 GLLPVR-----------WMSPESLK---DGVFTTYSDVWSFGVV 229

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 15/74 (20%), Positives = 29/74 (39%), Gaps = 10/74 (13%)

Query: 616 LVMEYCLG----------SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 665
           ++ME                +        P    ++  +   +  G+ YL++   +HRD+
Sbjct: 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 164

Query: 666 KAGNILLTETGTVK 679
            A N ++ E  TVK
Sbjct: 165 AARNCMVAEDFTVK 178

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  113 bits (285), Expect = 7e-27
 Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 46/248 (18%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
             ++G G FG V+      +   VAIK +    K         L+E + +++L+H   ++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                  +   ++V EY                       G+ L  LK            
Sbjct: 244 LYAVVSEEPI-YIVTEYMSK--------------------GSLLDFLK-----------G 271

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---- 342
              + L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A    
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

Query: 343 SIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
             +  A      P  W APE   A   G++  K DVWS GI   EL  + + PY  M   
Sbjct: 332 DNEYTARQGAKFPIKWTAPE---AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388

Query: 401 SALYHIAQ 408
             L  + +
Sbjct: 389 EVLDQVER 396

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 89.4 bits (222), Expect = 6e-19
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRP-LKEEEIAAICSGV 63
            ++++L+H   ++       +   ++V EY   GS  D ++      L+  ++  + + +
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPY-WMA 118
             G+ Y+  +  +HRD++A NIL+ E    K+ADFG A      +  A      P  W A
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A   G++  K DVWS GI
Sbjct: 350 PE---AALYGRFTIKSDVWSFGI 369

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 18/67 (26%), Positives = 35/67 (52%), Gaps = 2/67 (2%)

Query: 616 LVMEY-CLGSASDIIEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V EY   GS  D ++      L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ 
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 314

Query: 674 ETGTVKL 680
           E    K+
Sbjct: 315 ENLVCKV 321

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  110 bits (276), Expect = 8e-27
 Identities = 61/264 (23%), Positives = 100/264 (37%), Gaps = 56/264 (21%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREI--VAIK--KMSYLGKQCAEKWADILKEIR 214
           D + +  + +E+G G+FG V      + + +  VA+K  K         +   ++L E  
Sbjct: 14  DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEAN 70

Query: 215 FLRQLKHPNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
            ++QL +P  +   G C     +  LVME   LG                          
Sbjct: 71  VMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGP------------------------- 103

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                    L  +    R +K++ I  +   V  G+ YL     +HRD+ A N+LL    
Sbjct: 104 ---------LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 154

Query: 333 TVKLADFG-SASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
             K++DFG S +++   N +        P  W APE I      ++  K DVWS G+   
Sbjct: 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMW 211

Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           E     + PY  M        + +
Sbjct: 212 EAFSYGQKPYRGMKGSEVTAMLEK 235

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 15/146 (10%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGV 63
           ++++QL +P  +   G C     +  LVME   LG  +  ++ ++  +K++ I  +   V
Sbjct: 70  NVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 126

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-----PY-W 116
             G+ YL     +HRD+ A N+LL      K++DFG S +++   N +        P  W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
            APE I      ++  K DVWS G+ 
Sbjct: 187 YAPECIN---YYKFSSKSDVWSFGVL 209

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 20/66 (30%), Positives = 34/66 (51%), Gaps = 2/66 (3%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LVME   LG  +  ++ ++  +K++ I  +   V  G+ YL     +HRD+ A N+LL  
Sbjct: 94  LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 152

Query: 675 TGTVKL 680
               K+
Sbjct: 153 QHYAKI 158

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  110 bits (278), Expect = 1e-26
 Identities = 70/248 (28%), Positives = 108/248 (43%), Gaps = 62/248 (25%)

Query: 164 FEDLREIGHGSFGAVYYAR-CLVSREIVAIKKMSYLGKQCAEKWAD-----ILKEIRFLR 217
           +E + EIG G++G V+ AR        VA+K++    +    +  +      ++E+  LR
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGE--EGMPLSTIREVAVLR 66

Query: 218 QLK---HPNTIE-----YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            L+   HPN +            R+    LV E+                          
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD------------------------ 102

Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
            Q L  + +          +  +  E I  +   +LRGL++LHS   +HRD+K  NIL+T
Sbjct: 103 -QDLTTYLDKVP-------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 154

Query: 330 ETGTVKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI- 385
            +G +KLADFG A I     +    V T ++ APEV+L      Y   VD+WS+G  CI 
Sbjct: 155 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVG--CIF 209

Query: 386 -ELAERKP 392
            E+  RKP
Sbjct: 210 AEMFRRKP 217

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 94.2 bits (235), Expect = 5e-21
 Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 35/185 (18%)

Query: 6   SLLRQLK---HPNTIE-----YRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP-LKEEEI 56
           ++LR L+   HPN +            R+    LV E+     +  ++    P +  E I
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF---VGT 113
             +   +LRGL++LHS   +HRD+K  NIL+T +G +KLADFG A I     +    V T
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLG-----------ITPGSLKDPEIAELFDKEDPEK 162
            ++ APEV+L      Y   VD+WS+G           +  G     ++ +L       K
Sbjct: 183 LWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLG------K 230

Query: 163 IFEDL 167
           I + +
Sbjct: 231 ILDVI 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 5/96 (5%)

Query: 587 HHHHHP-VTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRP-LKEEEIAAI 644
               HP V  L      +     + L    LV E+     +  ++    P +  E I  +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLT---LVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
              +LRGL++LHS   +HRD+K  NIL+T +G +KL
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  109 bits (274), Expect = 1e-26
 Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 58/255 (22%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
           +  +G G FG V+        + VA+K +    KQ +      L E   ++QL+H   + 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                 ++   +++ EY                       G+ +  LK            
Sbjct: 73  LYAVVTQEPI-YIITEYMEN--------------------GSLVDFLK-----------T 100

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC 346
                L   ++  + + +  G+ ++     IHRD++A NIL+++T + K+ADFG A +  
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-- 158

Query: 347 PANSFVGTPY-----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
                    Y           W APE I     G +  K DVWS GI   E+    + PY
Sbjct: 159 ----IEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPY 211

Query: 395 FNMNAMSALYHIAQN 409
             M     + ++ + 
Sbjct: 212 PGMTNPEVIQNLERG 226

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 23/149 (15%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRP-LKEEEIAAICSGV 63
           +L++QL+H   +       ++   +++ EY   GS  D ++      L   ++  + + +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY-------- 115
             G+ ++     IHRD++A NIL+++T + K+ADFG A +           Y        
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL------IEDNEYTAREGAKF 172

Query: 116 ---WMAPEVILAMDEGQYDGKVDVWSLGI 141
              W APE I     G +  K DVWS GI
Sbjct: 173 PIKWTAPEAIN---YGTFTIKSDVWSFGI 198

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 47.6 bits (114), Expect = 8e-06
 Identities = 17/66 (25%), Positives = 35/66 (53%), Gaps = 2/66 (3%)

Query: 616 LVMEY-CLGSASDIIEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++ EY   GS  D ++      L   ++  + + +  G+ ++     IHRD++A NIL++
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143

Query: 674 ETGTVK 679
           +T + K
Sbjct: 144 DTLSCK 149

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  110 bits (278), Expect = 1e-26
 Identities = 66/249 (26%), Positives = 99/249 (39%), Gaps = 47/249 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQ-L 219
           F+ LR IG GS+  V   R   +  I A+K +    K+      DI     E     Q  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK---KELVNDDEDIDWVQTEKHVFEQAS 67

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            HP  +    C+  +   + V+EY  G           +  FH       +Q+ +   E 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGG----------DLMFH-------MQRQRKLPEE 110

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A F              A I       LNYLH  G I+RD+K  N+LL   G +KL D+
Sbjct: 111 HARFY------------SAEISLA----LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 154

Query: 340 G----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           G            ++F GTP ++APE++   D   Y   VD W+LG+   E+   + P+ 
Sbjct: 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSPFD 211

Query: 396 NMNAMSALY 404
            + +     
Sbjct: 212 IVGSSDNPD 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 42/124 (33%), Positives = 59/124 (47%), Gaps = 25/124 (20%)

Query: 31  LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 81
            V+EY  G      ++      +R L EE      A I       LNYLH  G I+RD+K
Sbjct: 87  FVIEYVNGG-----DLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHERGIIYRDLK 137

Query: 82  AGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 137
             N+LL   G +KL D+G            ++F GTP ++APE++   D   Y   VD W
Sbjct: 138 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YGFSVDWW 194

Query: 138 SLGI 141
           +LG+
Sbjct: 195 ALGV 198

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 26/74 (35%), Positives = 34/74 (45%), Gaps = 18/74 (24%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 666
            V+EY  G      ++      +R L EE      A I       LNYLH  G I+RD+K
Sbjct: 87  FVIEYVNGG-----DLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHERGIIYRDLK 137

Query: 667 AGNILLTETGTVKL 680
             N+LL   G +KL
Sbjct: 138 LDNVLLDSEGHIKL 151

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  110 bits (278), Expect = 2e-26
 Identities = 73/249 (29%), Positives = 102/249 (40%), Gaps = 59/249 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL--KEIR------- 214
           F  L+ IG GSFG V  AR        A+K +         +   IL  KE +       
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---------QKKAILKKKEEKHIMSERN 90

Query: 215 -FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
             L+ +KHP  +     +      + V++Y  G           E  +H       LQ+ 
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG----------ELFYH-------LQRE 133

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
           +CF E  A F              A I S     L YLHSL  ++RD+K  NILL   G 
Sbjct: 134 RCFLEPRARFY------------AAEIASA----LGYLHSLNIVYRDLKPENILLDSQGH 177

Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           + L DFG    +       ++F GTP ++APEV+       YD  VD W LG    E+  
Sbjct: 178 IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP---YDRTVDWWCLGAVLYEMLY 234

Query: 390 RKPPYFNMN 398
             PP+++ N
Sbjct: 235 GLPPFYSRN 243

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.5 bits (220), Expect = 6e-19
 Identities = 44/157 (28%), Positives = 63/157 (40%), Gaps = 45/157 (28%)

Query: 31  LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 81
            V++Y  G      E+      +R   E       A I S     L YLHSL  ++RD+K
Sbjct: 116 FVLDYINGG-----ELFYHLQRERCFLEPRARFYAAEIASA----LGYLHSLNIVYRDLK 166

Query: 82  AGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 137
             NILL   G + L DFG    +       ++F GTP ++APEV+       YD  VD W
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP---YDRTVDWW 223

Query: 138 SLGI---------TPGSLKDPEIAELFDKEDPEKIFE 165
            LG           P           F   +  ++++
Sbjct: 224 CLGAVLYEMLYGLPP-----------FYSRNTAEMYD 249

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 24/74 (32%), Positives = 32/74 (43%), Gaps = 18/74 (24%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 666
            V++Y  G      E+      +R   E       A I S     L YLHSL  ++RD+K
Sbjct: 116 FVLDYINGG-----ELFYHLQRERCFLEPRARFYAAEIASA----LGYLHSLNIVYRDLK 166

Query: 667 AGNILLTETGTVKL 680
             NILL   G + L
Sbjct: 167 PENILLDSQGHIVL 180

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  108 bits (272), Expect = 3e-26
 Identities = 56/244 (22%), Positives = 88/244 (36%), Gaps = 51/244 (20%)

Query: 168 REIGHGSFGAVYYARCLVSREI---VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
            ++G GSFG V              VA+K +        E   D ++E+  +  L H N 
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 225 IEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           I   G          +V E   LGS                  + +RL++          
Sbjct: 84  IRLYGVV--LTPPMKMVTELAPLGS------------------LLDRLRK---------- 113

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-S 341
                H+       ++     V  G+ YL S   IHRD+ A N+LL     VK+ DFG  
Sbjct: 114 -----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168

Query: 342 ASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPY 394
            ++    + +V       P+ W APE +       +    D W  G+T  E+    + P+
Sbjct: 169 RALPQNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPW 225

Query: 395 FNMN 398
             +N
Sbjct: 226 IGLN 229

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 40/146 (27%), Positives = 59/146 (40%), Gaps = 14/146 (9%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGV 63
           + +  L H N I   G          +V E   LGS  D +  H+       ++     V
Sbjct: 73  NAMHSLDHRNLIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-----PY-W 116
             G+ YL S   IHRD+ A N+LL     VK+ DFG   ++    + +V       P+ W
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
            APE +       +    D W  G+T
Sbjct: 191 CAPESLK---TRTFSHASDTWMFGVT 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 51.1 bits (123), Expect = 6e-07
 Identities = 22/67 (32%), Positives = 32/67 (47%), Gaps = 1/67 (1%)

Query: 615 QLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++V E   LGS  D +  H+       ++     V  G+ YL S   IHRD+ A N+LL 
Sbjct: 96  KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA 155

Query: 674 ETGTVKL 680
               VK+
Sbjct: 156 TRDLVKI 162

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  109 bits (275), Expect = 3e-26
 Identities = 63/249 (25%), Positives = 97/249 (38%), Gaps = 59/249 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL--KEIR------- 214
           F   + +G GSFG V+ A    + +  AIK +         K   +L   ++        
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL---------KKDVVLMDDDVECTMVEKR 69

Query: 215 -FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
                 +HP        +      + VMEY  G           +  +H       +Q  
Sbjct: 70  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG----------DLMYH-------IQSC 112

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
             F    A F              A I  G    L +LHS G ++RD+K  NILL + G 
Sbjct: 113 HKFDLSRATFY------------AAEIILG----LQFLHSKGIVYRDLKLDNILLDKDGH 156

Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ADFG    +       N+F GTP ++APE++L      Y+  VD WS G+   E+  
Sbjct: 157 IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK---YNHSVDWWSFGVLLYEMLI 213

Query: 390 RKPPYFNMN 398
            + P+   +
Sbjct: 214 GQSPFHGQD 222

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 37/177 (20%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV-----HKRPLKEEEIAAICS 61
           L    +HP        +      + VMEY  G      ++                   +
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG-----DLMYHIQSCHKFDLSRATFYAA 125

Query: 62  GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWM 117
            ++ GL +LHS G ++RD+K  NILL + G +K+ADFG    +       N+F GTP ++
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 185

Query: 118 APEVILAMDEGQYDGKVDVWSLGI---------TPGSLKDPEIAELFDKEDPEKIFE 165
           APE++L      Y+  VD WS G+         +P           F  +D E++F 
Sbjct: 186 APEILLGQK---YNHSVDWWSFGVLLYEMLIGQSP-----------FHGQDEEELFH 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 20/70 (28%), Positives = 32/70 (45%), Gaps = 10/70 (14%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
            VMEY  G      ++                   + ++ GL +LHS G ++RD+K  NI
Sbjct: 95  FVMEYLNGG-----DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149

Query: 671 LLTETGTVKL 680
           LL + G +K+
Sbjct: 150 LLDKDGHIKI 159

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  109 bits (274), Expect = 3e-26
 Identities = 57/259 (22%), Positives = 97/259 (37%), Gaps = 55/259 (21%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCA--EKWAD 208
             +   E     L+ +G G FG V+    +   E     V IK +    +  +  + +  
Sbjct: 6   LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI----EDKSGRQSFQA 61

Query: 209 ILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMG 267
           +   +  +  L H + +   G      +  LV +Y  LGS                  + 
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGS------------------LL 102

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
           + ++Q               H+  L  + +      + +G+ YL   G +HR++ A N+L
Sbjct: 103 DHVRQ---------------HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147

Query: 328 LTETGTVKLADFGSASIKCPANSFVGTPY------WMAPEVILAMDEGQYDGKVDVWSLG 381
           L     V++ADFG A +  P +  +          WMA E I     G+Y  + DVWS G
Sbjct: 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH---FGKYTHQSDVWSYG 204

Query: 382 ITCIELAER-KPPYFNMNA 399
           +T  EL      PY  +  
Sbjct: 205 VTVWELMTFGAEPYAGLRL 223

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 11/144 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
             +  L H + +   G      +  LV +Y  LGS  D +  H+  L  + +      + 
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPY------WMA 118
           +G+ YL   G +HR++ A N+LL     V++ADFG A +  P +  +          WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
            E I     G+Y  + DVWS G+T
Sbjct: 186 LESIH---FGKYTHQSDVWSYGVT 206

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 21/68 (30%), Positives = 35/68 (51%), Gaps = 1/68 (1%)

Query: 614 PQLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
            QLV +Y  LGS  D +  H+  L  + +      + +G+ YL   G +HR++ A N+LL
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148

Query: 673 TETGTVKL 680
                V++
Sbjct: 149 KSPSQVQV 156

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  112 bits (282), Expect = 4e-26
 Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 46/248 (18%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
             ++G G FG V+      +   VAIK +    K         L+E + +++L+H   ++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                  +   ++V EY                       G+ L  LK            
Sbjct: 327 LYAVVSEEPI-YIVTEYMSK--------------------GSLLDFLK-----------G 354

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA---- 342
              + L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+ADFG A    
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414

Query: 343 SIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAM 400
             +  A      P  W APE   A   G++  K DVWS GI   EL  + + PY  M   
Sbjct: 415 DNEYTARQGAKFPIKWTAPE---AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471

Query: 401 SALYHIAQ 408
             L  + +
Sbjct: 472 EVLDQVER 479

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 88.0 bits (218), Expect = 3e-18
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRP-LKEEEIAAICSGV 63
            ++++L+H   ++       +   ++V EY   GS  D ++      L+  ++  + + +
Sbjct: 314 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA----SIKCPANSFVGTPY-WMA 118
             G+ Y+  +  +HRD++A NIL+ E    K+ADFG A      +  A      P  W A
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432

Query: 119 PEVILAMDEGQYDGKVDVWSLGI 141
           PE   A   G++  K DVWS GI
Sbjct: 433 PE---AALYGRFTIKSDVWSFGI 452

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 18/67 (26%), Positives = 35/67 (52%), Gaps = 2/67 (2%)

Query: 616 LVMEY-CLGSASDIIEVHKRP-LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           +V EY   GS  D ++      L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ 
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 397

Query: 674 ETGTVKL 680
           E    K+
Sbjct: 398 ENLVCKV 404

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  109 bits (274), Expect = 4e-26
 Identities = 63/286 (22%), Positives = 103/286 (36%), Gaps = 83/286 (29%)

Query: 148 DPEIA--ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQ 201
            P  A   +  + + +KI    + +G G+FG VY    +   E     VAIK++    ++
Sbjct: 3   APNQALLRILKETEFKKI----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----RE 54

Query: 202 CA--EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIE 258
               +   +IL E   +  + +P+     G  L   T  L+ +    G            
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGC----------- 102

Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                  + + +++               HK  +  + +   C  + +G+NYL     +H
Sbjct: 103 -------LLDYVRE---------------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140

Query: 319 RDVKAGNILLTETGTVKLADFG------------SAS-----IKCPANSFVGTPYWMAPE 361
           RD+ A N+L+     VK+ DFG             A      IK           WMA E
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-----------WMALE 189

Query: 362 VILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHI 406
            IL      Y  + DVWS G+T  EL      PY  + A      +
Sbjct: 190 SIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 33/155 (21%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++  + +P+     G  L   T  L+ +    G   D +  HK  +  + +   C  + 
Sbjct: 69  YVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SAS-----IKCPA 107
           +G+NYL     +HRD+ A N+L+     VK+ DFG             A      IK   
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184

Query: 108 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                   WMA E IL      Y  + DVWS G+T
Sbjct: 185 --------WMALESIL---HRIYTHQSDVWSYGVT 208

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 19/69 (27%), Positives = 34/69 (49%), Gaps = 1/69 (1%)

Query: 613 SPQLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 671
           + QL+ +    G   D +  HK  +  + +   C  + +G+NYL     +HRD+ A N+L
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149

Query: 672 LTETGTVKL 680
           +     VK+
Sbjct: 150 VKTPQHVKI 158

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  111 bits (279), Expect = 4e-26
 Identities = 59/284 (20%), Positives = 103/284 (36%), Gaps = 60/284 (21%)

Query: 139 LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL 198
           L +   S K  +  E    E P +  +  +++G G FG V+ A      + VA+K M   
Sbjct: 165 LSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM--- 220

Query: 199 GKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIE 258
            K  +      L E   ++ L+H   ++      ++   +++ E+               
Sbjct: 221 -KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAK------------ 266

Query: 259 REFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH 318
                   G+ L  LK                     ++    + +  G+ ++     IH
Sbjct: 267 --------GSLLDFLK-----------SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307

Query: 319 RDVKAGNILLTETGTVKLADFG------------SASIKCPANSFVGTPYWMAPEVILAM 366
           RD++A NIL++ +   K+ADFG                K P         W APE I   
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAIN-- 358

Query: 367 DEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQN 409
             G +  K DVWS GI  +E+    + PY  M+    +  + + 
Sbjct: 359 -FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 35/150 (23%), Positives = 65/150 (43%), Gaps = 25/150 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKR-PLKEEEIAAICSGV 63
           ++++ L+H   ++      ++   +++ E+   GS  D ++  +       ++    + +
Sbjct: 235 NVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SASIKCPANSFV 111
             G+ ++     IHRD++A NIL++ +   K+ADFG                K P     
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--- 350

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
               W APE I     G +  K DVWS GI
Sbjct: 351 ----WTAPEAIN---FGSFTIKSDVWSFGI 373

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 14/66 (21%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 616 LVMEY-CLGSASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++ E+   GS  D ++  +       ++    + +  G+ ++     IHRD++A NIL++
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 318

Query: 674 ETGTVK 679
            +   K
Sbjct: 319 ASLVCK 324

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  108 bits (271), Expect = 5e-26
 Identities = 65/384 (16%), Positives = 115/384 (29%), Gaps = 123/384 (32%)

Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL- 219
           +      + +G G  G V       ++E  A+K +        +      +E+    +  
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRAS 68

Query: 220 KHPNTIEYRGCY----LRDHTAWLVMEYCLGSA--SDIIEVHWIEREFHVEGMGNRLQQL 273
           + P+ +     Y           +VME   G    S I +                 +  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----------------RGD 111

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---E 330
           + FTE  A                + I   +   + YLHS+   HRDVK  N+L T    
Sbjct: 112 QAFTEREA----------------SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 155

Query: 331 TGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAE 389
              +KL DFG                  A E        +YD   D+WSLG I  I L  
Sbjct: 156 NAILKLTDFG-----------------FAKETT----GEKYDKSCDMWSLGVIMYILLC- 193

Query: 390 RKPPYFNMNAM---SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH 446
             PP+++ + +     +    +       + +WS    +S   +                
Sbjct: 194 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS---EVSEEVK---------------- 234

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR----PRSPSVLVD 502
                                + + L   P  R +    + H  + +    P++P     
Sbjct: 235 -------------------MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 275

Query: 503 LIRRTKAAVRDLDNLNYRKMKKIL 526
           +++  K    D+      +M   L
Sbjct: 276 VLKEDKERWEDV----KEEMTSAL 295

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 38/144 (26%), Positives = 53/144 (36%), Gaps = 30/144 (20%)

Query: 7   LLRQLKHPNTIEYRGCY----LRDHTAWLVMEYCLGSA--SDIIEVHKRPLKEEEIAAIC 60
             R  + P+ +     Y           +VME   G    S I +   +   E E + I 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANSFVGTPYWM 117
             +   + YLHS+   HRDVK  N+L T       +KL DFG                  
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG-----------------F 166

Query: 118 APEVILAMDEGQYDGKVDVWSLGI 141
           A E        +YD   D+WSLG+
Sbjct: 167 AKETT----GEKYDKSCDMWSLGV 186

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 28/99 (28%), Positives = 38/99 (38%), Gaps = 16/99 (16%)

Query: 595 HLSQH--------SYNNNNSNYSSLFSPQLVMEYCLGSA--SDIIEVHKRPLKEEEIAAI 644
             SQ          Y N  +    L    +VME   G    S I +   +   E E + I
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLL---IVMECLDGGELFSRIQDRGDQAFTEREASEI 122

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKL 680
              +   + YLHS+   HRDVK  N+L T       +KL
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  108 bits (271), Expect = 6e-26
 Identities = 64/274 (23%), Positives = 102/274 (37%), Gaps = 73/274 (26%)

Query: 167 LREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCA--EKWADILKEIRFLRQLK 220
           +R++G G FG V           + E+VA+K +    K  A  +  +   +EI  LR L 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL----KADAGPQHRSGWKQEIDILRTLY 91

Query: 221 HPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           H + I+Y+GC      A   LVMEY  LGS                              
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGS------------------------------ 121

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
               L ++ + +  +   ++      +  G+ YLH+   IHRD+ A N+LL     VK+ 
Sbjct: 122 ----LRDY-LPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIG 176

Query: 338 DFG-SASIKCPANSFVGT-----P-YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--- 387
           DFG + ++      +        P +W APE +    E ++    DVWS G+T  EL   
Sbjct: 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK---EYKFYYASDVWSFGVTLYELLTH 233

Query: 388 ------------AERKPPYFNMNAMSALYHIAQN 409
                                M  +     + + 
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 93.6 bits (233), Expect = 6e-21
 Identities = 49/147 (33%), Positives = 71/147 (48%), Gaps = 15/147 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA--WLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSG 62
            +LR L H + I+Y+GC      A   LVMEY  LGS  D +  H   L +  +      
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQ 142

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-----P-Y 115
           +  G+ YLH+   IHRD+ A N+LL     VK+ DFG + ++      +        P +
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W APE +    E ++    DVWS G+T
Sbjct: 203 WYAPECLK---EYKFYYASDVWSFGVT 226

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 26/66 (39%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 615 QLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           QLVMEY  LGS  D +  H   L +  +      +  G+ YLH+   IHRD+ A N+LL 
Sbjct: 111 QLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168

Query: 674 ETGTVK 679
               VK
Sbjct: 169 NDRLVK 174

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  108 bits (271), Expect = 7e-26
 Identities = 57/295 (19%), Positives = 100/295 (33%), Gaps = 69/295 (23%)

Query: 141 ITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSY 197
           +    + D    +L D   PE+ F   R +G G FG+V  A+          VA+K +  
Sbjct: 2   LDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK- 60

Query: 198 LGKQCAEKWADILKEIRFLRQLKHPNTIEYRGC------YLRDHTAWLVMEYCLGSASDI 251
                +    + L+E   +++  HP+  +  G         R     +++ +        
Sbjct: 61  ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH----- 115

Query: 252 IEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL 311
                          G+    L              +   L  + +      +  G+ YL
Sbjct: 116 ---------------GDLHAFLLASRI-------GENPFNLPLQTLVRFMVDIACGMEYL 153

Query: 312 HSLGRIHRDVKAGNILLTETGTVKLADFGSAS-----------------IKCPANSFVGT 354
            S   IHRD+ A N +L E  TV +ADFG +                  +K         
Sbjct: 154 SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK--------- 204

Query: 355 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
             W+A E   ++ +  Y    DVW+ G+T  E+  R + PY  +       ++  
Sbjct: 205 --WLALE---SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 34/166 (20%), Positives = 61/166 (36%), Gaps = 43/166 (25%)

Query: 6   SLLRQLKHPNTIEYRGC------YLRDHTAWLVMEYCLGSA------SDIIEVHKRPLKE 53
           + +++  HP+  +  G         R     +++ +           +  I  +   L  
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 54  EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS----------- 102
           + +      +  G+ YL S   IHRD+ A N +L E  TV +ADFG +            
Sbjct: 137 QTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196

Query: 103 ------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                 +K           W+A E   ++ +  Y    DVW+ G+T
Sbjct: 197 CASKLPVK-----------WLALE---SLADNLYTVHSDVWAFGVT 228

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 15/49 (30%), Positives = 23/49 (46%)

Query: 632 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           +   L  + +      +  G+ YL S   IHRD+ A N +L E  TV +
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  108 bits (273), Expect = 7e-26
 Identities = 71/270 (26%), Positives = 106/270 (39%), Gaps = 62/270 (22%)

Query: 150 EIAELFDKEDPEKI----FEDLREIGHGSFGAVYYARCLVSR---EIVAIK---KMSYLG 199
           E+         EK+    FE L+ +G G++G V+  R +      ++ A+K   K + + 
Sbjct: 38  ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 97

Query: 200 KQC------AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
           K         E+   +L+ IR     + P  +     +  +    L+++Y  G       
Sbjct: 98  KAKTTEHTRTER--QVLEHIR-----QSPFLVTLHYAFQTETKLHLILDYINGG------ 144

Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
               E   H       L Q + FTEH                 +  I       L +LH 
Sbjct: 145 ----ELFTH-------LSQRERFTEHEVQIY------------VGEIVLA----LEHLHK 177

Query: 314 LGRIHRDVKAGNILLTETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDE 368
           LG I+RD+K  NILL   G V L DFG      A     A  F GT  +MAP+++   D 
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237

Query: 369 GQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           G +D  VD WSLG+   EL     P+    
Sbjct: 238 G-HDKAVDWWSLGVLMYELLTGASPFTVDG 266

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 91.6 bits (228), Expect = 5e-20
 Identities = 43/125 (34%), Positives = 58/125 (46%), Gaps = 24/125 (19%)

Query: 31  LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 81
           L+++Y  G      E+      +    E E    +  I       L +LH LG I+RD+K
Sbjct: 136 LILDYINGG-----ELFTHLSQRERFTEHEVQIYVGEIVLA----LEHLHKLGIIYRDIK 186

Query: 82  AGNILLTETGTVKLADFG-----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 136
             NILL   G V L DFG      A     A  F GT  +MAP+++   D G +D  VD 
Sbjct: 187 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG-HDKAVDW 245

Query: 137 WSLGI 141
           WSLG+
Sbjct: 246 WSLGV 250

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 23/74 (31%), Positives = 32/74 (43%), Gaps = 18/74 (24%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 666
           L+++Y  G      E+      +    E E    +  I       L +LH LG I+RD+K
Sbjct: 136 LILDYINGG-----ELFTHLSQRERFTEHEVQIYVGEIVLA----LEHLHKLGIIYRDIK 186

Query: 667 AGNILLTETGTVKL 680
             NILL   G V L
Sbjct: 187 LENILLDSNGHVVL 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  108 bits (272), Expect = 8e-26
 Identities = 69/256 (26%), Positives = 102/256 (39%), Gaps = 52/256 (20%)

Query: 157 KEDPEKI----FEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADI 209
              PEKI    FE LR +G G +G V+  R +      +I A+K +            D 
Sbjct: 8   NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDT 65

Query: 210 ---LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGM 266
                E   L ++KHP  ++    +      +L++EY  G           E        
Sbjct: 66  AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG----------ELFMQ---- 111

Query: 267 GNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 326
              L++   F E  A F             +A I       L +LH  G I+RD+K  NI
Sbjct: 112 ---LEREGIFMEDTACFY------------LAEISMA----LGHLHQKGIIYRDLKPENI 152

Query: 327 LLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           +L   G VKL DFG    S       ++F GT  +MAPE+++      ++  VD WSLG 
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG---HNRAVDWWSLGA 209

Query: 383 TCIELAERKPPYFNMN 398
              ++    PP+   N
Sbjct: 210 LMYDMLTGAPPFTGEN 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.0 bits (219), Expect = 5e-19
 Identities = 44/157 (28%), Positives = 65/157 (41%), Gaps = 45/157 (28%)

Query: 31  LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 81
           L++EY  G      E+      +    E+     +A I       L +LH  G I+RD+K
Sbjct: 98  LILEYLSGG-----ELFMQLEREGIFMEDTACFYLAEISMA----LGHLHQKGIIYRDLK 148

Query: 82  AGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 137
             NI+L   G VKL DFG    S       ++F GT  +MAPE+++      ++  VD W
Sbjct: 149 PENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG---HNRAVDWW 205

Query: 138 SLGI---------TPGSLKDPEIAELFDKEDPEKIFE 165
           SLG           P           F  E+ +K  +
Sbjct: 206 SLGALMYDMLTGAPP-----------FTGENRKKTID 231

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 45.6 bits (109), Expect = 3e-05
 Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 18/74 (24%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVK 666
           L++EY  G      E+      +    E+     +A I       L +LH  G I+RD+K
Sbjct: 98  LILEYLSGG-----ELFMQLEREGIFMEDTACFYLAEISMA----LGHLHQKGIIYRDLK 148

Query: 667 AGNILLTETGTVKL 680
             NI+L   G VKL
Sbjct: 149 PENIMLNHQGHVKL 162

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  109 bits (274), Expect = 9e-26
 Identities = 65/249 (26%), Positives = 99/249 (39%), Gaps = 47/249 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQ-L 219
           F+ LR IG GS+  V   R   +  I A++ +    K+      DI     E     Q  
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK---KELVNDDEDIDWVQTEKHVFEQAS 110

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            HP  +    C+  +   + V+EY  G           +  FH       +Q+ +   E 
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGG----------DLMFH-------MQRQRKLPEE 153

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
            A F              A I       LNYLH  G I+RD+K  N+LL   G +KL D+
Sbjct: 154 HARFY------------SAEISLA----LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197

Query: 340 G----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           G            ++F GTP ++APE++   D   Y   VD W+LG+   E+   + P+ 
Sbjct: 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSPFD 254

Query: 396 NMNAMSALY 404
            + +     
Sbjct: 255 IVGSSDNPD 263

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 86.2 bits (214), Expect = 4e-18
 Identities = 44/122 (36%), Positives = 61/122 (50%), Gaps = 21/122 (17%)

Query: 31  LVMEYCLGSASDIIEVH---KRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAG 83
            V+EY  G   D++  H   +R L EE      A I       LNYLH  G I+RD+K  
Sbjct: 130 FVIEYVNGG--DLM-FHMQRQRKLPEEHARFYSAEISLA----LNYLHERGIIYRDLKLD 182

Query: 84  NILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 139
           N+LL   G +KL D+G            ++F GTP ++APE++   D   Y   VD W+L
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YGFSVDWWAL 239

Query: 140 GI 141
           G+
Sbjct: 240 GV 241

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 28/72 (38%), Positives = 36/72 (50%), Gaps = 14/72 (19%)

Query: 616 LVMEYCLGSASDIIEVH---KRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAG 668
            V+EY  G   D++  H   +R L EE      A I       LNYLH  G I+RD+K  
Sbjct: 130 FVIEYVNGG--DLM-FHMQRQRKLPEEHARFYSAEISLA----LNYLHERGIIYRDLKLD 182

Query: 669 NILLTETGTVKL 680
           N+LL   G +KL
Sbjct: 183 NVLLDSEGHIKL 194

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  107 bits (270), Expect = 1e-25
 Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 41/259 (15%)

Query: 167 LREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCA--EKWADILKEIRFLR 217
            + +G G+FG V  A  +            VA+K +    K  A  +  +D++ E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDLSDLVSEMEMMK 95

Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            + KH N I   G   +D   ++++EY               RE+        L+  +  
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYA---------SKGNLREY--------LRARRPP 138

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
              ++     V +  +  +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198

Query: 337 ADFGSA-SIKCPANSFVGT----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           ADFG A  I         T    P  WMAPE   A+ +  Y  + DVWS G+   E+   
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEIFTL 255

Query: 391 -KPPYFNMNAMSALYHIAQ 408
              PY  +        + +
Sbjct: 256 GGSPYPGIPVEELFKLLKE 274

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKRPLKEEE 55
           KH N I   G   +D   ++++EY                 +  + DI  V +  +  ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT- 113
           + +    + RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A  I         T 
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218

Query: 114 ---PY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
              P  WMAPE   A+ +  Y  + DVWS G+
Sbjct: 219 GRLPVKWMAPE---ALFDRVYTHQSDVWSFGV 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 20/80 (25%), Positives = 37/80 (46%), Gaps = 16/80 (20%)

Query: 616 LVMEYC----------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 659
           +++EY                 +  + DI  V +  +  +++ +    + RG+ YL S  
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177

Query: 660 RIHRDVKAGNILLTETGTVK 679
            IHRD+ A N+L+TE   +K
Sbjct: 178 CIHRDLAARNVLVTENNVMK 197

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  108 bits (271), Expect = 1e-25
 Identities = 70/250 (28%), Positives = 99/250 (39%), Gaps = 61/250 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC-----------AEKWADILKE 212
           FE +R +G GSFG V  AR   + ++ A+K +    K              EK   IL  
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEK--RILSL 79

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
            R      HP   +   C+      + VME+  G           +  FH       +Q+
Sbjct: 80  AR-----NHPFLTQLFCCFQTPDRLFFVMEFVNGG----------DLMFH-------IQK 117

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
            + F E  A F              A I S     L +LH  G I+RD+K  N+LL   G
Sbjct: 118 SRRFDEARARFY------------AAEIISA----LMFLHDKGIIYRDLKLDNVLLDHEG 161

Query: 333 TVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
             KLADFG             +F GTP ++APE++  M    Y   VD W++G+   E+ 
Sbjct: 162 HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML---YGPAVDWWAMGVLLYEML 218

Query: 389 ERKPPYFNMN 398
               P+   N
Sbjct: 219 CGHAPFEAEN 228

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 17/120 (14%)

Query: 31  LVMEYCLGSASDIIEV-----HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 85
            VME+  G      ++       R   E       + ++  L +LH  G I+RD+K  N+
Sbjct: 101 FVMEFVNGG-----DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155

Query: 86  LLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           LL   G  KLADFG             +F GTP ++APE++  M    Y   VD W++G+
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML---YGPAVDWWAMGV 212

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 20/70 (28%), Positives = 30/70 (42%), Gaps = 10/70 (14%)

Query: 616 LVMEYCLGSASDIIEV-----HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI 670
            VME+  G      ++       R   E       + ++  L +LH  G I+RD+K  N+
Sbjct: 101 FVMEFVNGG-----DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155

Query: 671 LLTETGTVKL 680
           LL   G  KL
Sbjct: 156 LLDHEGHCKL 165

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (268), Expect = 1e-25
 Identities = 56/297 (18%), Positives = 97/297 (32%), Gaps = 69/297 (23%)

Query: 138 SLGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI---VAIKK 194
           S G+ P    +    +L D      +    + +G G FG+V              VA+K 
Sbjct: 11  SSGLVP-RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKT 69

Query: 195 MSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----TAWLVMEYCLGSAS 249
           M        E   + L E   ++   HPN I   G  +           +++ +      
Sbjct: 70  MKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY--- 125

Query: 250 DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN 309
                            G+    L            E   + +  + +      +  G+ 
Sbjct: 126 -----------------GDLHTYLLYS-------RLETGPKHIPLQTLLKFMVDIALGME 161

Query: 310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS-----------------IKCPANSFV 352
           YL +   +HRD+ A N +L +  TV +ADFG +                  +K       
Sbjct: 162 YLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------- 214

Query: 353 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
               W+A E   ++ +  Y  K DVW+ G+T  E+A R   PY  +       ++  
Sbjct: 215 ----WIAIE---SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 33/165 (20%), Positives = 62/165 (37%), Gaps = 42/165 (25%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDH-----TAWLVMEYCL-GS-----ASDIIEVHKRPLKEE 54
           + ++   HPN I   G  +           +++ +   G          +E   + +  +
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147

Query: 55  EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS------------ 102
            +      +  G+ YL +   +HRD+ A N +L +  TV +ADFG +             
Sbjct: 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207

Query: 103 -----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                +K           W+A E   ++ +  Y  K DVW+ G+T
Sbjct: 208 IAKMPVK-----------WIAIE---SLADRVYTSKSDVWAFGVT 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 14/74 (18%), Positives = 31/74 (41%), Gaps = 6/74 (8%)

Query: 613 SPQLVMEYCL-GS-----ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 666
            P +++ +   G          +E   + +  + +      +  G+ YL +   +HRD+ 
Sbjct: 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLA 174

Query: 667 AGNILLTETGTVKL 680
           A N +L +  TV +
Sbjct: 175 ARNCMLRDDMTVCV 188

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  107 bits (270), Expect = 2e-25
 Identities = 65/269 (24%), Positives = 101/269 (37%), Gaps = 56/269 (20%)

Query: 167 LREIGHGSFGAVYYARC--LVSRE---IVAIKKMSYLGKQCA--EKWADILKEIRFLRQL 219
           +R+IG G+FG V+ AR   L+  E   +VA+K +    K+ A  +  AD  +E   + + 
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAALMAEF 107

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +PN ++  G         L+ EY      D+        EF      + +  L      
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAY--GDL-------NEFLRSMSPHTVCSLSHSDLS 158

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                      PL   E   I   V  G+ YL     +HRD+   N L+ E   VK+ADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218

Query: 340 GSA-----------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           G +                  I+           WM PE I      +Y  + DVW+ G+
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIR-----------WMPPESIF---YNRYTTESDVWAYGV 264

Query: 383 TCIE---LAERKPPYFNMNAMSALYHIAQ 408
              E      +  PY+ M     +Y++  
Sbjct: 265 VLWEIFSYGLQ--PYYGMAHEEVIYYVRD 291

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 39/178 (21%), Positives = 60/178 (33%), Gaps = 55/178 (30%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC------------------------LGSAS 41
           +L+ +  +PN ++  G         L+ EY                         L + +
Sbjct: 102 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161

Query: 42  DIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 101
            +      PL   E   I   V  G+ YL     +HRD+   N L+ E   VK+ADFG +
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221

Query: 102 -----------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                             I+           WM PE I      +Y  + DVW+ G+ 
Sbjct: 222 RNIYSADYYKADGNDAIPIR-----------WMPPESIF---YNRYTTESDVWAYGVV 265

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 41.5 bits (98), Expect = 8e-04
 Identities = 18/71 (25%), Positives = 27/71 (38%)

Query: 609 SSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 668
            S  +   +    L + + +      PL   E   I   V  G+ YL     +HRD+   
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203

Query: 669 NILLTETGTVK 679
           N L+ E   VK
Sbjct: 204 NCLVGENMVVK 214

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  109 bits (274), Expect = 2e-25
 Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 47/243 (19%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLK 220
           FE L+ +G G+FG V   +   +    A+K +    K+      ++   L E R L+  +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK---KEVIVAKDEVAHTLTENRVLQNSR 206

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           HP     +  +        VMEY  G           E  FH       L + + F+E  
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGG----------ELFFH-------LSRERVFSEDR 249

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADF 339
           A F              A I S     L+YLHS    ++RD+K  N++L + G +K+ DF
Sbjct: 250 ARFY------------GAEIVSA----LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293

Query: 340 G----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           G             +F GTP ++APEV+   D   Y   VD W LG+   E+   + P++
Sbjct: 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFY 350

Query: 396 NMN 398
           N +
Sbjct: 351 NQD 353

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.0 bits (208), Expect = 4e-17
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 12/141 (8%)

Query: 8   LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDI-IEVHKRPLKEEEIAAI-CSGVLR 65
           L+  +HP     +  +        VMEY  G   ++   + +  +  E+ A    + ++ 
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAEIVS 259

Query: 66  GLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPE 120
            L+YLHS    ++RD+K  N++L + G +K+ DFG             +F GTP ++APE
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319

Query: 121 VILAMDEGQYDGKVDVWSLGI 141
           V+   D   Y   VD W LG+
Sbjct: 320 VLEDND---YGRAVDWWGLGV 337

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 19/68 (27%), Positives = 37/68 (54%), Gaps = 5/68 (7%)

Query: 616 LVMEYCLGSASDI-IEVHKRPLKEEEIAAI-CSGVLRGLNYLHS-LGRIHRDVKAGNILL 672
            VMEY  G   ++   + +  +  E+ A    + ++  L+YLHS    ++RD+K  N++L
Sbjct: 225 FVMEYANGG--ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 282

Query: 673 TETGTVKL 680
            + G +K+
Sbjct: 283 DKDGHIKI 290

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  106 bits (268), Expect = 2e-25
 Identities = 67/259 (25%), Positives = 100/259 (38%), Gaps = 47/259 (18%)

Query: 167 LREIGHGSFGAVYYARC--LVSRE---IVAIKKMSYLGKQCA--EKWADILKEIRFLRQL 219
            + +G G+FG V  A    L+  +    VA+K +    K  A   +   ++ E++ L  L
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML----KPSAHLTEREALMSELKVLSYL 83

Query: 220 -KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK---- 274
             H N +   G         ++ EYC                      G+ L  L+    
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCY--------------------GDLLNFLRRKRD 123

Query: 275 -CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                  +    E  +  L  E++ +    V +G+ +L S   IHRD+ A NILLT    
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183

Query: 334 VKLADFGSASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            K+ DFG A      +++V       P  WMAPE   ++    Y  + DVWS GI   EL
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE---SIFNCVYTFESDVWSYGIFLWEL 240

Query: 388 AER-KPPYFNMNAMSALYH 405
                 PY  M   S  Y 
Sbjct: 241 FSLGSSPYPGMPVDSKFYK 259

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 43/154 (27%), Positives = 64/154 (41%), Gaps = 27/154 (17%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC------------------LGSASDIIEVHKRPLKE 53
            H N +   G         ++ EYC                    ++  I+E  +  L  
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 54  EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT 113
           E++ +    V +G+ +L S   IHRD+ A NILLT     K+ DFG A      +++V  
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 114 -----PY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
                P  WMAPE   ++    Y  + DVWS GI
Sbjct: 205 GNARLPVKWMAPE---SIFNCVYTFESDVWSYGI 235

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 18/82 (21%)

Query: 616 LVMEYC------------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS 657
           ++ EYC                    ++  I+E  +  L  E++ +    V +G+ +L S
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163

Query: 658 LGRIHRDVKAGNILLTETGTVK 679
              IHRD+ A NILLT     K
Sbjct: 164 KNCIHRDLAARNILLTHGRITK 185

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  105 bits (265), Expect = 2e-25
 Identities = 56/266 (21%), Positives = 91/266 (34%), Gaps = 77/266 (28%)

Query: 167 LREIGHGSFGAVYYARCLVSREI---VAIK--KMSYLGKQCAEKWADILKEIRFLRQLKH 221
            R +G G FG VY       +     VA+K  K               + E   ++ L H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN----KEKFMSEAVIMKNLDH 72

Query: 222 PNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
           P+ ++  G     +   W++ME    G                   +G+ L++       
Sbjct: 73  PHIVKLIGII--EEEPTWIIMELYPYGE------------------LGHYLER------- 105

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
                   +K  LK   +      + + + YL S+  +HRD+   NIL+     VKL DF
Sbjct: 106 --------NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157

Query: 340 G-----------SAS-----IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
           G            AS     IK           WM+PE I      ++    DVW   + 
Sbjct: 158 GLSRYIEDEDYYKASVTRLPIK-----------WMSPESIN---FRRFTTASDVWMFAVC 203

Query: 384 CIELAER-KPPYFNMNAMSALYHIAQ 408
             E+    K P+F +     +  + +
Sbjct: 204 MWEILSFGKQPFFWLENKDVIGVLEK 229

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 87.6 bits (218), Expect = 4e-19
 Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 34/155 (21%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGV 63
            +++ L HP+ ++  G     +   W++ME    G     +E +K  LK   +      +
Sbjct: 65  VIMKNLDHPHIVKLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-----------SAS-----IKCPA 107
            + + YL S+  +HRD+   NIL+     VKL DFG            AS     IK   
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--- 179

Query: 108 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                   WM+PE I      ++    DVW   + 
Sbjct: 180 --------WMSPESIN---FRRFTTASDVWMFAVC 203

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 51.4 bits (124), Expect = 3e-07
 Identities = 19/66 (28%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ME    G     +E +K  LK   +      + + + YL S+  +HRD+   NIL+  
Sbjct: 89  IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS 148

Query: 675 TGTVKL 680
              VKL
Sbjct: 149 PECVKL 154

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (266), Expect = 3e-25
 Identities = 68/293 (23%), Positives = 110/293 (37%), Gaps = 58/293 (19%)

Query: 143 PGSLKDPEIAELFDKE---DPEKIFEDLREIGHGSFGAVYYARC--LVSRE---IVAIKK 194
           P SL       L D +     + +    + +G G FG V  A    L  R     VA+K 
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNL-VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60

Query: 195 MSYLGKQCA--EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDI 251
           +    K+ A   +  D+L E   L+Q+ HP+ I+  G   +D    L++EY   GS    
Sbjct: 61  L----KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL--- 113

Query: 252 IEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL 311
                  R F  E        L       +       +R L   ++ +    + +G+ YL
Sbjct: 114 -------RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166

Query: 312 HSLGRIHRDVKAGNILLTETGTVKLADFGSA-----------------SIKCPANSFVGT 354
             +  +HRD+ A NIL+ E   +K++DFG +                  +K         
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK--------- 217

Query: 355 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYHI 406
             WMA E   ++ +  Y  + DVWS G+   E+      PY  +        +
Sbjct: 218 --WMAIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 78.8 bits (195), Expect = 6e-16
 Identities = 39/178 (21%), Positives = 72/178 (40%), Gaps = 55/178 (30%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC------------------------LGSAS 41
           ++L+Q+ HP+ I+  G   +D    L++EY                           ++S
Sbjct: 78  NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137

Query: 42  DIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 101
            +    +R L   ++ +    + +G+ YL  +  +HRD+ A NIL+ E   +K++DFG +
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 102 -----------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                             +K           WMA E   ++ +  Y  + DVWS G+ 
Sbjct: 198 RDVYEEDSYVKRSQGRIPVK-----------WMAIE---SLFDHIYTTQSDVWSFGVL 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 41.1 bits (97), Expect = 9e-04
 Identities = 14/47 (29%), Positives = 26/47 (55%)

Query: 633 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
           +R L   ++ +    + +G+ YL  +  +HRD+ A NIL+ E   +K
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK 190

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  107 bits (269), Expect = 3e-25
 Identities = 64/260 (24%), Positives = 109/260 (41%), Gaps = 43/260 (16%)

Query: 167 LREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCA--EKWADILKEIRFLR 217
            + +G G FG V  A  +            VA+K +    K  A  +  +D++ E+  ++
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDLSDLVSEMEMMK 141

Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
            + KH N I   G   +D   ++++EY   G+           RE+        L+  + 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGN----------LREY--------LRARRP 183

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
               ++     V +  +  +++ +    + RG+ YL S   IHRD+ A N+L+TE   +K
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243

Query: 336 LADFGSA-SIKCPANSFVGT----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +ADFG A  I         T    P  WMAPE   A+ +  Y  + DVWS G+   E+  
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEIFT 300

Query: 390 R-KPPYFNMNAMSALYHIAQ 408
               PY  +        + +
Sbjct: 301 LGGSPYPGIPVEELFKLLKE 320

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKRPLKEEE 55
           KH N I   G   +D   ++++EY                 +  + DI  V +  +  ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT- 113
           + +    + RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A  I         T 
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264

Query: 114 ---PY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
              P  WMAPE   A+ +  Y  + DVWS G+
Sbjct: 265 GRLPVKWMAPE---ALFDRVYTHQSDVWSFGV 293

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 20/80 (25%), Positives = 37/80 (46%), Gaps = 16/80 (20%)

Query: 616 LVMEYC----------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 659
           +++EY                 +  + DI  V +  +  +++ +    + RG+ YL S  
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223

Query: 660 RIHRDVKAGNILLTETGTVK 679
            IHRD+ A N+L+TE   +K
Sbjct: 224 CIHRDLAARNVLVTENNVMK 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (266), Expect = 3e-25
 Identities = 59/268 (22%), Positives = 89/268 (33%), Gaps = 68/268 (25%)

Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           +R +GHG+FG VY  +        S   VA+K +        +   D L E   + +  H
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEALIISKFNH 92

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N +   G  L+    +++ME   G                    G+    L+       
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAG--------------------GDLKSFLRETRPR-- 130

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---TVKLAD 338
                     L   ++  +   +  G  YL     IHRD+ A N LLT  G     K+ D
Sbjct: 131 ----PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186

Query: 339 FGSA-----------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           FG A                  +K           WM PE  +   EG +  K D WS G
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVK-----------WMPPEAFM---EGIFTSKTDTWSFG 232

Query: 382 ITCIELAER-KPPYFNMNAMSALYHIAQ 408
           +   E+      PY + +    L  +  
Sbjct: 233 VLLWEIFSLGYMPYPSKSNQEVLEFVTS 260

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 38/164 (23%), Positives = 57/164 (34%), Gaps = 41/164 (25%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GS------ASDIIEVHKRPLKEEEIAA 58
            ++ +  H N +   G  L+    +++ME    G        +         L   ++  
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---TVKLADFGSA-------------- 101
           +   +  G  YL     IHRD+ A N LLT  G     K+ DFG A              
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204

Query: 102 ---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
               +K           WM PE  +   EG +  K D WS G+ 
Sbjct: 205 AMLPVK-----------WMPPEAFM---EGIFTSKTDTWSFGVL 234

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 41.1 bits (97), Expect = 9e-04
 Identities = 18/74 (24%), Positives = 26/74 (35%), Gaps = 10/74 (13%)

Query: 616 LVMEYCL-GS------ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 668
           ++ME    G        +         L   ++  +   +  G  YL     IHRD+ A 
Sbjct: 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 169

Query: 669 NILLTETG---TVK 679
           N LLT  G     K
Sbjct: 170 NCLLTCPGPGRVAK 183

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  106 bits (266), Expect = 3e-25
 Identities = 66/265 (24%), Positives = 96/265 (36%), Gaps = 63/265 (23%)

Query: 168 REIGHGSFGAVYYAR--CLVSREIVAIKKMSYLGKQCA--EKWADILKEIRFLRQL-KHP 222
             IG G+FG V  AR      R   AIK+M    K+ A  +   D   E+  L +L  HP
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 223 NTIEYRGCYLRDHTAWLVMEYC----LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           N I   G        +L +EY     L              +F        L++ +    
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNL-------------LDF--------LRKSRVLET 125

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
             A          L  +++    + V RG++YL     IHRD+ A NIL+ E    K+AD
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 185

Query: 339 FGSAS--------------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
           FG +               ++           WMA E   +++   Y    DVWS G+  
Sbjct: 186 FGLSRGQEVYVKKTMGRLPVR-----------WMAIE---SLNYSVYTTNSDVWSYGVLL 231

Query: 385 IELAER-KPPYFNMNAMSALYHIAQ 408
            E+      PY  M        + Q
Sbjct: 232 WEIVSLGGTPYCGMTCAELYEKLPQ 256

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 42/168 (25%), Positives = 62/168 (36%), Gaps = 45/168 (26%)

Query: 6   SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHK 48
            +L +L  HPN I   G        +L +EY                    A  I     
Sbjct: 77  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136

Query: 49  RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS------ 102
             L  +++    + V RG++YL     IHRD+ A NIL+ E    K+ADFG +       
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196

Query: 103 --------IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                   ++           WMA E   +++   Y    DVWS G+ 
Sbjct: 197 KKTMGRLPVR-----------WMAIE---SLNYSVYTTNSDVWSYGVL 230

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 21/80 (26%), Positives = 30/80 (37%), Gaps = 16/80 (20%)

Query: 616 LVMEYC----------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 659
           L +EY                    A  I       L  +++    + V RG++YL    
Sbjct: 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 162

Query: 660 RIHRDVKAGNILLTETGTVK 679
            IHRD+ A NIL+ E    K
Sbjct: 163 FIHRDLAARNILVGENYVAK 182

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  106 bits (267), Expect = 5e-25
 Identities = 61/249 (24%), Positives = 97/249 (38%), Gaps = 59/249 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL--KEIR------- 214
           F  L  +G GSFG V  +    + E+ A+K +         K   ++   ++        
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---------KKDVVIQDDDVECTMVEKR 72

Query: 215 -FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
                 K P   +   C+      + VMEY  G           +  +H       +QQ+
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG----------DLMYH-------IQQV 115

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
             F E  A+F              A I  G    L +L S G I+RD+K  N++L   G 
Sbjct: 116 GRFKEPHAVFY------------AAEIAIG----LFFLQSKGIIYRDLKLDNVMLDSEGH 159

Query: 334 VKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +K+ADFG    +        +F GTP ++APE+I       Y   VD W+ G+   E+  
Sbjct: 160 IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLA 216

Query: 390 RKPPYFNMN 398
            + P+   +
Sbjct: 217 GQAPFEGED 225

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 41/155 (26%)

Query: 31  LVMEYCLGSASDI---IEVHKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAG 83
            VMEY  G   D+   I+   R  KE       A I  G    L +L S G I+RD+K  
Sbjct: 98  FVMEYVNGG--DLMYHIQQVGR-FKEPHAVFYAAEIAIG----LFFLQSKGIIYRDLKLD 150

Query: 84  NILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 139
           N++L   G +K+ADFG    +        +F GTP ++APE+I       Y   VD W+ 
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP---YGKSVDWWAF 207

Query: 140 GI---------TPGSLKDPEIAELFDKEDPEKIFE 165
           G+          P           F+ ED +++F+
Sbjct: 208 GVLLYEMLAGQAP-----------FEGEDEDELFQ 231

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 25/72 (34%), Positives = 34/72 (47%), Gaps = 14/72 (19%)

Query: 616 LVMEYCLGSASDI---IEVHKRPLKEEE----IAAICSGVLRGLNYLHSLGRIHRDVKAG 668
            VMEY  G   D+   I+   R  KE       A I  G    L +L S G I+RD+K  
Sbjct: 98  FVMEYVNGG--DLMYHIQQVGR-FKEPHAVFYAAEIAIG----LFFLQSKGIIYRDLKLD 150

Query: 669 NILLTETGTVKL 680
           N++L   G +K+
Sbjct: 151 NVMLDSEGHIKI 162

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  105 bits (263), Expect = 7e-25
 Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 42/256 (16%)

Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCA--EKWADILKEIRFLRQL 219
            + +G G+FG V  A         +   VA+K +    K+ A   +   ++ E++ L  +
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEHRALMSELKILIHI 87

Query: 220 -KHPNTIEYRG-CYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             H N +   G C        +++E+C  G+             +        L+  +  
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGN----------LSTY--------LRSKRNE 129

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
              + +   +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189

Query: 337 ADFGSA-SIKCPANSFVGT----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            DFG A  I    +         P  WMAPE    + +  Y  + DVWS G+   E+   
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSL 246

Query: 391 -KPPYFNMNAMSALYH 405
              PY  +        
Sbjct: 247 GASPYPGVKIDEEFCR 262

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 26/154 (16%)

Query: 12  KHPNTIEYRG-CYLRDHTAWLVMEYC----------------LGSASDIIEVHKRPLKEE 54
            H N +   G C        +++E+C                +       +++K  L  E
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 55  EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT 113
            +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A  I    +     
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 114 ----PY-WMAPEVILAMDEGQYDGKVDVWSLGIT 142
               P  WMAPE    + +  Y  + DVWS G+ 
Sbjct: 209 DARLPLKWMAPE---TIFDRVYTIQSDVWSFGVL 239

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 45.3 bits (108), Expect = 5e-05
 Identities = 21/80 (26%), Positives = 35/80 (43%), Gaps = 16/80 (20%)

Query: 616 LVMEYC----------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 659
           +++E+C                +       +++K  L  E +      V +G+ +L S  
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168

Query: 660 RIHRDVKAGNILLTETGTVK 679
            IHRD+ A NILL+E   VK
Sbjct: 169 CIHRDLAARNILLSEKNVVK 188

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (265), Expect = 9e-25
 Identities = 58/268 (21%), Positives = 89/268 (33%), Gaps = 68/268 (25%)

Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH 221
           +R +GHG+FG VY  +        S   VA+K +        +   D L E   + +  H
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEALIISKFNH 133

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
            N +   G  L+    ++++E   G                    G+    L+       
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAG--------------------GDLKSFLRETRPR-- 171

Query: 282 LFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---TVKLAD 338
                     L   ++  +   +  G  YL     IHRD+ A N LLT  G     K+ D
Sbjct: 172 ----PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227

Query: 339 FGSA-----------------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           FG A                  +K           WM PE  +   EG +  K D WS G
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVK-----------WMPPEAFM---EGIFTSKTDTWSFG 273

Query: 382 ITCIELAER-KPPYFNMNAMSALYHIAQ 408
           +   E+      PY + +    L  +  
Sbjct: 274 VLLWEIFSLGYMPYPSKSNQEVLEFVTS 301

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 37/164 (22%), Positives = 57/164 (34%), Gaps = 41/164 (25%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-------SASDIIEVHKRPLKEEEIAA 58
            ++ +  H N +   G  L+    ++++E   G         +         L   ++  
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---TVKLADFGSA-------------- 101
           +   +  G  YL     IHRD+ A N LLT  G     K+ DFG A              
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245

Query: 102 ---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
               +K           WM PE  +   EG +  K D WS G+ 
Sbjct: 246 AMLPVK-----------WMPPEAFM---EGIFTSKTDTWSFGVL 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  103 bits (259), Expect = 1e-24
 Identities = 59/251 (23%), Positives = 86/251 (34%), Gaps = 67/251 (26%)

Query: 167 LREIGHGSFGAVYYARCLVSREI---VAIKKMSYLGKQCA--EKWADILKEIRFLRQLKH 221
            R IG G FG V+    +        VAIK      K C         L+E   +RQ  H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQEALTMRQFDH 75

Query: 222 PNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           P+ ++  G     +  W++ME   LG                   + + LQ         
Sbjct: 76  PHIVKLIGVITE-NPVWIIMELCTLGE------------------LRSFLQV-------- 108

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                   K  L    +      +   L YL S   +HRD+ A N+L++    VKL DFG
Sbjct: 109 -------RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161

Query: 341 ------------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
                       ++  K P         WMAPE I      ++    DVW  G+   E+ 
Sbjct: 162 LSRYMEDSTYYKASKGKLPIK-------WMAPESIN---FRRFTSASDVWMFGVCMWEIL 211

Query: 389 ER-KPPYFNMN 398
                P+  + 
Sbjct: 212 MHGVKPFQGVK 222

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 41/150 (27%), Positives = 62/150 (41%), Gaps = 24/150 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
             +RQ  HP+ ++  G     +  W++ME   LG     ++V K  L    +      + 
Sbjct: 68  LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SASIKCPANSFVG 112
             L YL S   +HRD+ A N+L++    VKL DFG            ++  K P      
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---- 182

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              WMAPE I      ++    DVW  G+ 
Sbjct: 183 ---WMAPESIN---FRRFTSASDVWMFGVC 206

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 50.3 bits (121), Expect = 8e-07
 Identities = 20/66 (30%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ME   LG     ++V K  L    +      +   L YL S   +HRD+ A N+L++ 
Sbjct: 92  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 151

Query: 675 TGTVKL 680
              VKL
Sbjct: 152 NDCVKL 157

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  108 bits (271), Expect = 1e-24
 Identities = 59/261 (22%), Positives = 90/261 (34%), Gaps = 67/261 (25%)

Query: 167 LREIGHGSFGAVYYARCLVSREI---VAIKKMSYLGKQCA--EKWADILKEIRFLRQLKH 221
            R IG G FG V+    +        VAIK      K C         L+E   +RQ  H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQEALTMRQFDH 450

Query: 222 PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFA 281
           P+ ++  G    +   W++ME C                                     
Sbjct: 451 PHIVKLIGVITEN-PVWIIMELC---------------------------------TLGE 476

Query: 282 LFNF-EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
           L +F +V K  L    +      +   L YL S   +HRD+ A N+L++    VKL DFG
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536

Query: 341 ------------SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
                       ++  K P         WMAPE   +++  ++    DVW  G+   E+ 
Sbjct: 537 LSRYMEDSTYYKASKGKLPIK-------WMAPE---SINFRRFTSASDVWMFGVCMWEIL 586

Query: 389 ER-KPPYFNMNAMSALYHIAQ 408
                P+  +     +  I  
Sbjct: 587 MHGVKPFQGVKNNDVIGRIEN 607

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 92.2 bits (229), Expect = 2e-19
 Identities = 41/150 (27%), Positives = 65/150 (43%), Gaps = 24/150 (16%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
             +RQ  HP+ ++  G    +   W++ME C LG     ++V K  L    +      + 
Sbjct: 443 LTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------------SASIKCPANSFVG 112
             L YL S   +HRD+ A N+L++    VKL DFG            ++  K P      
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---- 557

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
              WMAPE   +++  ++    DVW  G+ 
Sbjct: 558 ---WMAPE---SINFRRFTSASDVWMFGVC 581

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ME C LG     ++V K  L    +      +   L YL S   +HRD+ A N+L++ 
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 526

Query: 675 TGTVKL 680
              VKL
Sbjct: 527 NDCVKL 532

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (259), Expect = 1e-24
 Identities = 45/268 (16%), Positives = 79/268 (29%), Gaps = 60/268 (22%)

Query: 167 LREIGHGSFGAVYYARCLVSREI-------VAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
              +G G+F  ++        +        V +K    L K          +    + +L
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV---LDKAHRNYSESFFEAASMMSKL 69

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            H + +   G  +      LV E+   GS                  +   L++      
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGS------------------LDTYLKK------ 105

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--------E 330
                    +K  +       +   +   +++L     IH +V A NILL          
Sbjct: 106 ---------NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156

Query: 331 TGTVKLADFGSASIKCPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
              +KL+D G  SI       +     W+ PE I   +    +   D WS G T  E+  
Sbjct: 157 PPFIKLSDPG-ISITVLPKDILQERIPWVPPECI--ENPKNLNLATDKWSFGTTLWEICS 213

Query: 390 R-KPPYFNMNAMSALYHIAQN---DTPC 413
               P   +++   L           P 
Sbjct: 214 GGDKPLSALDSQRKLQFYEDRHQLPAPK 241

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 34/147 (23%), Positives = 57/147 (38%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S++ +L H + +   G  +      LV E+   GS    ++ +K  +       +   + 
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT--------ETGTVKLADFGSASIKCPANSFVGTPY- 115
             +++L     IH +V A NILL             +KL+D G  SI       +     
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG-ISITVLPKDILQERIP 182

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           W+ PE I   +    +   D WS G T
Sbjct: 183 WVPPECI--ENPKNLNLATDKWSFGTT 207

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 17/69 (24%), Positives = 28/69 (40%), Gaps = 1/69 (1%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LV E+   GS    ++ +K  +       +   +   +++L     IH +V A NILL  
Sbjct: 89  LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR 148

Query: 675 TGTVKLDTP 683
               K   P
Sbjct: 149 EEDRKTGNP 157

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  103 bits (259), Expect = 2e-24
 Identities = 58/264 (21%), Positives = 96/264 (36%), Gaps = 56/264 (21%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREI--VAIK--KMSYLGKQCAEKWADILKEIR 214
             + +     E+G G+FG+V      + ++   VAIK  K             ++++E +
Sbjct: 7   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD----TEEMMREAQ 62

Query: 215 FLRQLKHPNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
            + QL +P  +   G C  +     LVME    G                   +   L  
Sbjct: 63  IMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGP------------------LHKFLVG 102

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                           +  +    +A +   V  G+ YL     +HRD+ A N+LL    
Sbjct: 103 ---------------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH 147

Query: 333 TVKLADFG-SASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCI 385
             K++DFG S ++    + +        P  W APE I      ++  + DVWS G+T  
Sbjct: 148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMW 204

Query: 386 ELAER-KPPYFNMNAMSALYHIAQ 408
           E     + PY  M     +  I Q
Sbjct: 205 EALSYGQKPYKKMKGPEVMAFIEQ 228

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 39/146 (26%), Positives = 63/146 (43%), Gaps = 14/146 (9%)

Query: 6   SLLRQLKHPNTIEYRG-CYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGV 63
            ++ QL +P  +   G C  +     LVME    G     +   +  +    +A +   V
Sbjct: 62  QIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-----PY-W 116
             G+ YL     +HRD+ A N+LL      K++DFG S ++    + +        P  W
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
            APE I      ++  + DVWS G+T
Sbjct: 180 YAPECINF---RKFSSRSDVWSYGVT 202

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 1/66 (1%)

Query: 616 LVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LVME    G     +   +  +    +A +   V  G+ YL     +HRD+ A N+LL  
Sbjct: 86  LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 145

Query: 675 TGTVKL 680
               K+
Sbjct: 146 RHYAKI 151

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  107 bits (268), Expect = 3e-24
 Identities = 61/271 (22%), Positives = 103/271 (38%), Gaps = 52/271 (19%)

Query: 150 EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI--VAIKKMSYLGKQCAEK-- 205
           E+ +       + +     E+G G+FG+V      + ++   VAIK +    KQ  EK  
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL----KQGTEKAD 379

Query: 206 WADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG 265
             ++++E + + QL +P  +   G    +    LVME   G                   
Sbjct: 380 TEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGG------------------- 419

Query: 266 MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN 325
            G   + L               +  +    +A +   V  G+ YL     +HR++ A N
Sbjct: 420 -GPLHKFLVG------------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARN 466

Query: 326 ILLTETGTVKLADFG-SASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVW 378
           +LL      K++DFG S ++    + +        P  W APE I      ++  + DVW
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVW 523

Query: 379 SLGITCIELAER-KPPYFNMNAMSALYHIAQ 408
           S G+T  E     + PY  M     +  I Q
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 86.9 bits (215), Expect = 9e-18
 Identities = 37/145 (25%), Positives = 62/145 (42%), Gaps = 12/145 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++ QL +P  +   G    +    LVME    G     +   +  +    +A +   V 
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFVGT-----PY-WM 117
            G+ YL     +HR++ A N+LL      K++DFG S ++    + +        P  W 
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           APE I      ++  + DVWS G+T
Sbjct: 507 APECIN---FRKFSSRSDVWSYGVT 528

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 1/68 (1%)

Query: 614 PQLVMEY-CLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
             LVME    G     +   +  +    +A +   V  G+ YL     +HR++ A N+LL
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469

Query: 673 TETGTVKL 680
                 K+
Sbjct: 470 VNRHYAKI 477

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  106 bits (266), Expect = 6e-24
 Identities = 67/282 (23%), Positives = 111/282 (39%), Gaps = 51/282 (18%)

Query: 129 QYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKI----FEDLREIGHGSFGAVYYARCL 184
           Q   +  +      P       I++  +  + +++    F  L  +G GSFG V  +   
Sbjct: 304 QKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK 363

Query: 185 VSREIVAIKKMSYLGKQCAEKWADI---LKEIR-FLRQLKHPNTIEYRGCYLRDHTAWLV 240
            + E+ A+K +    K    +  D+   + E R      K P   +   C+      + V
Sbjct: 364 GTDELYAVKILK---KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420

Query: 241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAI 300
           MEY  G           +  +H       +QQ+  F E  A+F              A I
Sbjct: 421 MEYVNG----------GDLMYH-------IQQVGRFKEPHAVFY------------AAEI 451

Query: 301 CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPY 356
             G    L +L S G I+RD+K  N++L   G +K+ADFG    +        +F GTP 
Sbjct: 452 AIG----LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 507

Query: 357 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
           ++APE+I       Y   VD W+ G+   E+   + P+   +
Sbjct: 508 YIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQAPFEGED 546

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 86.6 bits (214), Expect = 1e-17
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 13/142 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDI---IEVHKRPLKEEEIAAICSGV 63
           L    K P   +   C+      + VMEY  G   D+   I+   R  KE       + +
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG--DLMYHIQQVGR-FKEPHAVFYAAEI 451

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG----SASIKCPANSFVGTPYWMAP 119
             GL +L S G I+RD+K  N++L   G +K+ADFG    +        +F GTP ++AP
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 511

Query: 120 EVILAMDEGQYDGKVDVWSLGI 141
           E+I       Y   VD W+ G+
Sbjct: 512 EIIAYQP---YGKSVDWWAFGV 530

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 23/68 (33%), Positives = 34/68 (50%), Gaps = 6/68 (8%)

Query: 616 LVMEYCLGSASDI---IEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
            VMEY  G   D+   I+   R  KE       + +  GL +L S G I+RD+K  N++L
Sbjct: 419 FVMEYVNGG--DLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475

Query: 673 TETGTVKL 680
              G +K+
Sbjct: 476 DSEGHIKI 483

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  102 bits (256), Expect = 8e-24
 Identities = 60/231 (25%), Positives = 90/231 (38%), Gaps = 42/231 (18%)

Query: 167 LREIGHGSFGAVYYARCLVSRE-----IVAIKKMSYLGKQCA--EKWADILKEIRFLRQL 219
            + +G G+FG V  A      +      VA+K +    K  A  ++   ++ E++ +  L
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEKEALMSELKIMSHL 106

Query: 220 -KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK-CFT 277
            +H N +   G         ++ EYC                      G+ L  L+    
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCY--------------------GDLLNFLRRKSR 146

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                  F +        ++    S V +G+ +L S   IHRDV A N+LLT     K+ 
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206

Query: 338 DFGSA-SIKCPANSFVGT----PY-WMAPEVILAMDEGQYDGKVDVWSLGI 382
           DFG A  I   +N  V      P  WMAPE I    +  Y  + DVWS GI
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGI 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 43/150 (28%), Positives = 58/150 (38%), Gaps = 23/150 (15%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYCLG--------------SASDIIEVHKRPLKEEEIA 57
           +H N +   G         ++ EYC                       +        ++ 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT--- 113
              S V +G+ +L S   IHRDV A N+LLT     K+ DFG A  I   +N  V     
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 114 -PY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
            P  WMAPE I    +  Y  + DVWS GI
Sbjct: 228 LPVKWMAPESIF---DCVYTVQSDVWSYGI 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 14/78 (17%)

Query: 616 LVMEYCLG--------------SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 661
           ++ EYC                       +        ++    S V +G+ +L S   I
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI 186

Query: 662 HRDVKAGNILLTETGTVK 679
           HRDV A N+LLT     K
Sbjct: 187 HRDVAARNVLLTNGHVAK 204

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  102 bits (255), Expect = 2e-23
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 43/258 (16%)

Query: 167 LREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCA--EKWADILKEIRFLR 217
            + +G G+FG V  A  +            VA+K +    K  A  +  +D++ E+  ++
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLSDLISEMEMMK 129

Query: 218 QL-KHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
            + KH N I   G   +D   ++++EY   G+           RE+        LQ  + 
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGN----------LREY--------LQARRP 171

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
               ++       +  L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231

Query: 336 LADFGSA-SIKCPANSFVGT----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +ADFG A  I         T    P  WMAPE +    +  Y  + DVWS G+   E+  
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFT 288

Query: 390 R-KPPYFNMNAMSALYHI 406
               PY  +        +
Sbjct: 289 LGGSPYPGVPVEELFKLL 306

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 25/152 (16%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC----------------LGSASDIIEVHKRPLKEEE 55
           KH N I   G   +D   ++++EY                 L  + +     +  L  ++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGT- 113
           + +    V RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A  I         T 
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252

Query: 114 ---PY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
              P  WMAPE +    +  Y  + DVWS G+
Sbjct: 253 GRLPVKWMAPEALF---DRIYTHQSDVWSFGV 281

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 20/80 (25%), Positives = 35/80 (43%), Gaps = 16/80 (20%)

Query: 616 LVMEYC----------------LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 659
           +++EY                 L  + +     +  L  +++ +    V RG+ YL S  
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211

Query: 660 RIHRDVKAGNILLTETGTVK 679
            IHRD+ A N+L+TE   +K
Sbjct: 212 CIHRDLAARNVLVTEDNVMK 231

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (253), Expect = 3e-23
 Identities = 63/255 (24%), Positives = 102/255 (40%), Gaps = 34/255 (13%)

Query: 167 LREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCA--EKWADILKEIRFLRQL 219
            + +G G+FG V  A             VA+K +    K+ A   +   ++ E++ + QL
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML----KEKADSSEREALMSELKMMTQL 105

Query: 220 -KHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
             H N +   G        +L+ EYC  G   + +                +  + +   
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK-----------REKFSEDEIEY 154

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
           E+      E     L  E++      V +G+ +L     +HRD+ A N+L+T    VK+ 
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214

Query: 338 DFGSASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER- 390
           DFG A      +++V       P  WMAPE   ++ EG Y  K DVWS GI   E+    
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPE---SLFEGIYTIKSDVWSYGILLWEIFSLG 271

Query: 391 KPPYFNMNAMSALYH 405
             PY  +   +  Y 
Sbjct: 272 VNPYPGIPVDANFYK 286

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 43/159 (27%), Positives = 61/159 (38%), Gaps = 32/159 (20%)

Query: 12  KHPNTIEYRGCYLRDHTAWLVMEYC-----------------------LGSASDIIEVHK 48
            H N +   G        +L+ EYC                               E   
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 49  RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN 108
             L  E++      V +G+ +L     +HRD+ A N+L+T    VK+ DFG A      +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 109 SFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGI 141
           ++V       P  WMAPE   ++ EG Y  K DVWS GI
Sbjct: 227 NYVVRGNARLPVKWMAPE---SLFEGIYTIKSDVWSYGI 262

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 14/47 (29%), Positives = 23/47 (48%)

Query: 633 KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
              L  E++      V +G+ +L     +HRD+ A N+L+T    VK
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK 212

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 62/241 (25%), Positives = 98/241 (40%), Gaps = 53/241 (21%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYL----GKQCAEKWADILKEIR 214
           D   I     ++G G FG VY  +  V+   VA+KK++ +     ++  +++    +EI+
Sbjct: 28  DERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQF---DQEIK 82

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHWIEREFHVEGMGNRLQQL 273
            + + +H N +E  G         LV  Y   GS               +  +       
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL-----------LDRLSCLDGTPP-- 129

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 333
                         H R  K      I  G   G+N+LH    IHRD+K+ NILL E  T
Sbjct: 130 -----------LSWHMR-CK------IAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171

Query: 334 VKLADFGSASIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
            K++DFG A       +        VGT  +MAPE +     G+   K D++S G+  +E
Sbjct: 172 AKISDFGLARAS-EKFAQTVMTSRIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLE 226

Query: 387 L 387
           +
Sbjct: 227 I 227

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 46/151 (30%), Positives = 66/151 (43%), Gaps = 27/151 (17%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDII-EVHKRP-------LKEEEIA 57
           ++ + +H N +E  G         LV  Y   GS  D +  +   P        K     
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK----- 137

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-------F 110
            I  G   G+N+LH    IHRD+K+ NILL E  T K++DFG A       +        
Sbjct: 138 -IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS-EKFAQTVMTSRI 195

Query: 111 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           VGT  +MAPE +     G+   K D++S G+
Sbjct: 196 VGTTAYMAPEAL----RGEITPKSDIYSFGV 222

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 53.3 bits (129), Expect = 1e-07
 Identities = 15/29 (51%), Positives = 19/29 (65%)

Query: 644 ICSGVLRGLNYLHSLGRIHRDVKAGNILL 672
           I  G   G+N+LH    IHRD+K+ NILL
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILL 166

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 96.9 bits (241), Expect = 1e-21
 Identities = 60/284 (21%), Positives = 99/284 (34%), Gaps = 50/284 (17%)

Query: 168 REIGHGSFGAVYYARCLV----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHP 222
           + +G G+FG V  A        +       KM   G   +E    ++ E++ L  +  H 
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHL 86

Query: 223 NTIEYRG-CYLRDHTAWLVMEYC--------LGSASDIIEVHWIEREFHVEGMG------ 267
           N +   G C        +++E+C        L S  +    +  +     +G        
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 268 -------------------NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGL 308
                                +++             +++K  L  E +      V +G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 309 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGT-----PY-WMAPEV 362
            +L S   IHRD+ A NILL+E   VK+ DFG A        +V       P  WMAPE 
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE- 265

Query: 363 ILAMDEGQYDGKVDVWSLGITCIELAER-KPPYFNMNAMSALYH 405
              + +  Y  + DVWS G+   E+      PY  +        
Sbjct: 266 --TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 9/114 (7%)

Query: 35  YCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 94
             +       +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233

Query: 95  LADFGSASIKCPANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           + DFG A        +V       P  WMAPE    + +  Y  + DVWS G+ 
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVL 284

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 3/88 (3%)

Query: 595 HLSQHSYNNNNSNYSSLFSPQLVME---YCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 651
            +      ++ ++  S  S   V E     +       +++K  L  E +      V +G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 652 LNYLHSLGRIHRDVKAGNILLTETGTVK 679
           + +L S   IHRD+ A NILL+E   VK
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVK 233

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 77/387 (19%), Positives = 130/387 (33%), Gaps = 100/387 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK----KMSYLGKQCAEKWADILKEIRFLRQL 219
           +E L+ IG GSFG V  A      + VA+K    +  +  +Q         +EIR L  L
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-RQ-------AAEEIRILEHL 150

Query: 220 KHPNTIEYRGC-------YLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           +  +                R+H   +  E    +  ++I+ +                 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHIC-MTFELLSMNLYELIKKN----------------- 192

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                       F    +      +      +L+ L+ LH    IH D+K  NILL + G
Sbjct: 193 -----------KF----QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237

Query: 333 --TVKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
              +K+ DFGS+   C  +    +++ + ++ APEVIL      Y   +D+WSLG  CI 
Sbjct: 238 RSGIKVIDFGSS---CYEHQRVYTYIQSRFYRAPEVILGAR---YGMPIDMWSLG--CI- 288

Query: 387 LAE-------------------------RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSV 421
           LAE                                  +  A   ++    P   +     
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLS 348

Query: 422 IKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
             ++      +     +               C         F  F+  CL  +PA R +
Sbjct: 349 DGSVVLN-GGRSRRGKLRGPPESREWGNALKGCDDPL-----FLDFLKQCLEWDPAVRMT 402

Query: 482 SGRLLTHDLVTR--PRSPSVLVDLIRR 506
            G+ L H  + R  P+ P+     ++R
Sbjct: 403 PGQALRHPWLRRRLPKPPTGEKTSVKR 429

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 76.7 bits (189), Expect = 8e-15
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 22/140 (15%)

Query: 23  YLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK 81
             R+H   +  E    +  ++I+ +K +      +      +L+ L+ LH    IH D+K
Sbjct: 169 TFRNHIC-MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLK 227

Query: 82  AGNILLTETG--TVKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVD 135
             NILL + G   +K+ DFGS+   C  +    +++ + ++ APEVIL      Y   +D
Sbjct: 228 PENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRFYRAPEVILGAR---YGMPID 281

Query: 136 VWSLGITPGSLKDPEIAELF 155
           +WSLG          +AEL 
Sbjct: 282 MWSLGCI--------LAELL 293

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 64/232 (27%), Positives = 86/232 (37%), Gaps = 43/232 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F +   +G G FG VY  R L    +VA+K++     Q  E       E+  +    H N
Sbjct: 32  FSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRN 88

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +  RG  +      LV  Y                      M N        +    L 
Sbjct: 89  LLRLRGFCMTPTERLLVYPY----------------------MANG-------SVASCLR 119

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR---IHRDVKAGNILLTETGTVKLADFG 340
                + PL   +   I  G  RGL YLH       IHRDVKA NILL E     + DFG
Sbjct: 120 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179

Query: 341 SASIKCPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
            A +    ++ V     GT   +APE       G+   K DV+  G+  +EL
Sbjct: 180 LAKLMDYKDTHVTTAVRGTIGHIAPE--YLST-GKSSEKTDVFGYGVMLLEL 228

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 46/147 (31%), Positives = 58/147 (39%), Gaps = 23/147 (15%)

Query: 11  LKHPNTIEYRGCYLRDHTAWLVMEY-CLGSASDIIEVHKRPLKEEEIA-------AICSG 62
             H N +  RG  +      LV  Y   GS    +    R   E +          I  G
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGS----VASCLRERPESQPPLDWPKRQRIALG 139

Query: 63  VLRGLNYLHSLGR---IHRDVKAGNILLTETGTVKLADFGSASIKCPANSFV-----GTP 114
             RGL YLH       IHRDVKA NILL E     + DFG A +    ++ V     GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGI 141
             +APE       G+   K DV+  G+
Sbjct: 200 GHIAPE--YLST-GKSSEKTDVFGYGV 223

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 20/34 (58%), Positives = 20/34 (58%), Gaps = 3/34 (8%)

Query: 644 ICSGVLRGLNYLHSLGR---IHRDVKAGNILLTE 674
           I  G  RGL YLH       IHRDVKA NILL E
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 64/230 (27%), Positives = 94/230 (40%), Gaps = 42/230 (18%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+    IGHG FG VY    L     VA+K+ +    Q  E++     EI  L   +HP+
Sbjct: 41  FDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF---ETEIETLSFCRHPH 96

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G     +   L+ +Y                      M N          H  L+
Sbjct: 97  LVSLIGFCDERNEMILIYKY----------------------MEN-----GNLKRH--LY 127

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SA 342
             ++    +  E+   IC G  RGL+YLH+   IHRDVK+ NILL E    K+ DFG S 
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 343 SIKCPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
                  + +     GT  ++ PE  +    G+   K DV+S G+   E+
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEV 234

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 35/89 (39%), Positives = 47/89 (52%), Gaps = 9/89 (10%)

Query: 59  ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG-SASIKCPANSFV-----G 112
           IC G  RGL+YLH+   IHRDVK+ NILL E    K+ DFG S        + +     G
Sbjct: 144 ICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGI 141
           T  ++ PE  +    G+   K DV+S G+
Sbjct: 204 TLGYIDPEYFIK---GRLTEKSDVYSFGV 229

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 52.2 bits (126), Expect = 3e-07
 Identities = 20/31 (64%), Positives = 23/31 (74%)

Query: 644 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           IC G  RGL+YLH+   IHRDVK+ NILL E
Sbjct: 144 ICIGAARGLHYLHTRAIIHRDVKSINILLDE 174

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 36/343 (10%), Positives = 69/343 (20%), Gaps = 115/343 (33%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN--- 223
           L   G       + A        VA+  +   G    +   + L     L ++  P    
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 224 ---TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
               +  R          +V E+                   + G       L+      
Sbjct: 96  VLDVVHTRA------GGLVVAEW-------------------IRG-----GSLQ------ 119

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                EV                +    +  H  G          + ++  G V LA   
Sbjct: 120 -----EVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA 174

Query: 341 SASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
           +                M             + + D+  +G +   L   + P       
Sbjct: 175 T----------------MPDA----------NPQDDIRGIGASLYALLVNRWPLPEAGVR 208

Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
           S L    ++                   A +                     P     D 
Sbjct: 209 SGLAPAERDT------------------AGQPIE------------------PADIDRDI 232

Query: 461 SDTFAHFVSSCLAKNPADRPSS------GRLLTHDLVTRPRSP 497
               +   +  +  +   R +S       +       T    P
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 16/139 (11%), Positives = 33/139 (23%), Gaps = 40/139 (28%)

Query: 10  QLKHPN------TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGV 63
           ++  P        +  R          +V E+  G    + EV                +
Sbjct: 87  RIDKPGVARVLDVVHTRA------GGLVVAEWIRGG--SLQEVADTSPSPVGAIRAMQSL 138

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVIL 123
               +  H  G          + ++  G V LA   +                M      
Sbjct: 139 AAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------------MPDA--- 179

Query: 124 AMDEGQYDGKVDVWSLGIT 142
                  + + D+  +G +
Sbjct: 180 -------NPQDDIRGIGAS 191

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 11/70 (15%), Positives = 19/70 (27%), Gaps = 2/70 (2%)

Query: 614 PQLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
             +V E+  G    + EV                +    +  H  G          + ++
Sbjct: 106 GLVVAEWIRGG--SLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS 163

Query: 674 ETGTVKLDTP 683
             G V L  P
Sbjct: 164 IDGDVVLAYP 173

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 82/375 (21%), Positives = 122/375 (32%), Gaps = 97/375 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK----KMSYLGKQCAEKWADILKEIRFLRQL 219
           +E    IG GSFG V  A   V +E VAIK    K ++L  Q          E+R L  +
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQ-------AQIEVRLLELM 107

Query: 220 KHPNTIEYRGC-------YLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
              +T               R+H   LV E  L                      N    
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLC-LVFE-MLSY--------------------NLYDL 145

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS--LGRIHRDVKAGNILLTE 330
           L+             + R +           +   L +L +  L  IH D+K  NILL  
Sbjct: 146 LRNT-----------NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194

Query: 331 TG--TVKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
                +K+ DFGS+   C        ++ + ++ +PEV+L M    YD  +D+WSLG   
Sbjct: 195 PKRSAIKIVDFGSS---CQLGQRIYQYIQSRFYRSPEVLLGMP---YDLAIDMWSLGCIL 248

Query: 385 IELAERKP--PYFNMNAMSAL---------YHIAQNDT------PCLQSSDWSVIKTISS 427
           +E+   +P     N                 HI             L    W++ KT   
Sbjct: 249 VEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDG 308

Query: 428 TAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT---------FAHFVSSCLAKNPAD 478
             E KPP         L++I   +T         ++         F   +   L  +P  
Sbjct: 309 KREYKPPGTRK-----LHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363

Query: 479 RPSSGRLLTHDLVTR 493
           R      L H    +
Sbjct: 364 RIQPYYALQHSFFKK 378

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 31/117 (26%), Positives = 51/117 (43%), Gaps = 22/117 (18%)

Query: 47  HKRPLKEEEIAAICSGVLRGLNYLHS--LGRIHRDVKAGNILLTETG--TVKLADFGSAS 102
           + R +           +   L +L +  L  IH D+K  NILL       +K+ DFGS+ 
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS- 208

Query: 103 IKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELF 155
             C        ++ + ++ +PEV+L M    YD  +D+WSLG          + E+ 
Sbjct: 209 --CQLGQRIYQYIQSRFYRSPEVLLGMP---YDLAIDMWSLGCI--------LVEMH 252

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 71/358 (19%), Positives = 125/358 (34%), Gaps = 83/358 (23%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIK---KMSYLGKQCAEKWADILKEIRFLRQLKH-- 221
           +R++G G F  V+ A+ +V+   VA+K         +           EI+ L+++    
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-------AEDEIKLLQRVNDAD 76

Query: 222 PNTIEYRGCY----LRD---HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
               +  G      L D   H     +   +     + EV             N L  +K
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVM-----VFEVLGE----------NLLALIK 121

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILL----- 328
            +             R +    +  I   +L GL+Y+H   G IH D+K  N+L+     
Sbjct: 122 KY-----------EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170

Query: 329 -TETGTVKLADFGSAS-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
                 +K+AD G+A        + + T  + +PEV+L      +    D+WS      E
Sbjct: 171 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFE 227

Query: 387 LAERK---PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISS----TAERKPPYFNMN 439
           L        P    +      HIAQ            ++  + S      +    +FN  
Sbjct: 228 LITGDFLFEPDEGHSYTKDDDHIAQII---------ELLGELPSYLLRNGKYTRTFFNSR 278

Query: 440 AMSALYHIAQNDTPCLQ---------SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
            +    +I++     L+         S D +   + F+S  L  +P  R  +G L+ H
Sbjct: 279 GLL--RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.1 bits (172), Expect = 6e-13
 Identities = 30/115 (26%), Positives = 48/115 (41%), Gaps = 19/115 (16%)

Query: 49  RPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILL------TETGTVKLADFGSA 101
           R +    +  I   +L GL+Y+H   G IH D+K  N+L+           +K+AD G+A
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

Query: 102 S-IKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELF 155
                   + + T  + +PEV+L      +    D+WS            I EL 
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGA---PWGCGADIWSTACL--------IFELI 229

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 78/378 (20%), Positives = 125/378 (33%), Gaps = 111/378 (29%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIK----KMSYLGKQCAEKWADILKEIRFLRQL 219
           F  +R++G G+FG V   + + +++  A+K       Y  +           E   L+++
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSA-------KIEADILKKI 88

Query: 220 KH-----PNTIEYRGC-YLRDHTAWLVME---YCLGSASDIIEVHWIEREFHVEGMGNRL 270
           ++      N ++Y G     DH   L+ E     L              E          
Sbjct: 89  QNDDINNNNIVKYHGKFMYYDHMC-LIFEPLGPSL-------------YEI--------- 125

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
             +              +      E+I   C  +L+ LNYL  +   H D+K  NILL +
Sbjct: 126 --ITRN-----------NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 331 TG-------------------------TVKLADFGSASIKCPAN----SFVGTPYWMAPE 361
                                       +KL DFG A      +    S + T  + APE
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA---TFKSDYHGSIINTRQYRAPE 229

Query: 362 VILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSV 421
           VIL +    +D   D+WS G    EL      +     M  L  +       +Q    ++
Sbjct: 230 VILNL---GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMES----IIQPIPKNM 282

Query: 422 IKTISSTAERKPPYFNMNAMSALYHIAQNDTP---------CLQSSDWSD--TFAHFVSS 470
           +   + T   K  Y N + +       +N +          CL          F  F+ S
Sbjct: 283 LYEATKTNGSK--YVNKDELK--LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338

Query: 471 CLAKNPADRPSSGRLLTH 488
            L  +P  RPS   LL H
Sbjct: 339 ILQIDPTLRPSPAELLKH 356

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 53/187 (28%)

Query: 6   SLLRQLKH-----PNTIEYRGC-YLRDHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIA 57
            +L+++++      N ++Y G     DH   L+ E  LG S  +II  +       E+I 
Sbjct: 83  DILKKIQNDDINNNNIVKYHGKFMYYDHMC-LIFE-PLGPSLYEIITRNNYNGFHIEDIK 140

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG-------------------------T 92
             C  +L+ LNYL  +   H D+K  NILL +                            
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 93  VKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKD 148
           +KL DFG A      +    S + T  + APEVIL +    +D   D+WS G        
Sbjct: 201 IKLIDFGCA---TFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCV------ 248

Query: 149 PEIAELF 155
             +AEL+
Sbjct: 249 --LAELY 253

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 82.6 bits (203), Expect = 4e-17
 Identities = 50/281 (17%), Positives = 85/281 (30%), Gaps = 51/281 (18%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE-----KWADI 209
           F    P +  +   +IG G FG V+  + +     VAIK ++  G           + +I
Sbjct: 13  FSHCLPTEKLQRCEKIGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 210 LKEIRFLRQL---------KHPNTIEYRGCYLRDHT-------AWLVMEYCLGSASDIIE 253
           L EI   ++L         +    I     +    +       AW       GSA+D  +
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH- 312
               ++ F V         L+               +        +I   +   L     
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQM-----------RTKLSSLATAKSILHQLTASLAVAEA 179

Query: 313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS---------------FVGTPYW 357
           SL   HRD+  GN+LL +T   KL    +       +                  G   +
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVF 239

Query: 358 MAPEVILAMDEGQYDGKVDVWSL-GITCIELAERKPPYFNM 397
               +   +  G  D + D++ L             PY N+
Sbjct: 240 CDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNV 280

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.5 bits (143), Expect = 1e-09
 Identities = 25/145 (17%), Positives = 50/145 (34%), Gaps = 17/145 (11%)

Query: 22  CYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH-SLGRIHRDV 80
            + +D   ++V+E+  G   D+ ++  +        +I   +   L     SL   HRD+
Sbjct: 130 DFFKDDQLFIVLEFEFGG-IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDL 188

Query: 81  KAGNILLTETGTVKLADFGSASIKCPANS---------------FVGTPYWMAPEVILAM 125
             GN+LL +T   KL    +       +                  G   +    +   +
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248

Query: 126 DEGQYDGKVDVWSLGITPGSLKDPE 150
             G  D + D++ L     + +  E
Sbjct: 249 FTGDGDYQFDIYRLMKKENNNRWGE 273

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.4 bits (122), Expect = 5e-07
 Identities = 30/159 (18%), Positives = 56/159 (35%), Gaps = 18/159 (11%)

Query: 537 IDPDDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVT-- 594
           I   + PD   G+       I  E  +      ++       + ++     +  H V   
Sbjct: 50  IIAIEGPDLVNGSHQKTFEEILPEIIISKE---LSLLSGEVCNRTEGFIGLNSVHCVQGS 106

Query: 595 ---HLSQHSYNNNNSNYSSLFSPQ--------LVMEYCLGSASDIIEVHKRPLKEEEIAA 643
               L +   + N++  S+   P         +V+E+  G   D+ ++  +        +
Sbjct: 107 YPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG-IDLEQMRTKLSSLATAKS 165

Query: 644 ICSGVLRGLNYLH-SLGRIHRDVKAGNILLTETGTVKLD 681
           I   +   L     SL   HRD+  GN+LL +T   KL 
Sbjct: 166 ILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 67/397 (16%), Positives = 106/397 (26%), Gaps = 137/397 (34%)

Query: 164 FEDLREIGHGSFGAVYYARCL-VSREIVAIK----KMSYLGKQCAEKWADILKEIRFLRQ 218
           +E +  +G G+FG V            VA+K       Y  +           EI+ L  
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAA-------RSEIQVLEH 67

Query: 219 LKHP------NTIEYRGC-YLRDHTAWLVME---YCLGSASDIIEVHWIEREFHVEGMGN 268
           L           ++         H   +V E                    +F       
Sbjct: 68  LNTTDPNSTFRCVQMLEWFEHHGHIC-IVFELLGLST-------------YDF------- 106

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
               +K                P + + I  +   + + +N+LHS    H D+K  NIL 
Sbjct: 107 ----IKEN-----------GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151

Query: 329 TETG-------------------TVKLADFGSASIKCPAN----SFVGTPYWMAPEVILA 365
            ++                     +K+ DFGSA      +    + V T ++ APEVILA
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDDEHHSTLVSTRHYRAPEVILA 208

Query: 366 MDEGQYDGKVDVWSLGITCIELAE-------------------------RKPPYFNMNAM 400
           +    +    DVWS+G  CI L E                           P +      
Sbjct: 209 L---GWSQPCDVWSIG--CI-LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTR 262

Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
              Y           SS    +                 A   L     +     +    
Sbjct: 263 KRKYFHHDRLDWDEHSSAGRYVS---------------RACKPLKEFMLSQDVEHER--- 304

Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSP 497
                  +   L  +PA R +    L H      +  
Sbjct: 305 ---LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 66.1 bits (162), Expect = 1e-11
 Identities = 33/132 (25%), Positives = 54/132 (40%), Gaps = 37/132 (28%)

Query: 47  HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG--------------- 91
              P + + I  +   + + +N+LHS    H D+K  NIL  ++                
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 92  ----TVKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP 143
                +K+ DFGSA      +    + V T ++ APEVILA+    +    DVWS+G   
Sbjct: 171 LINPDIKVVDFGSA---TYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCI- 223

Query: 144 GSLKDPEIAELF 155
                  + E +
Sbjct: 224 -------LIEYY 228

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.6 bits (101), Expect = 4e-04
 Identities = 14/66 (21%), Positives = 28/66 (42%)

Query: 632 HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDS 691
              P + + I  +   + + +N+LHS    H D+K  NIL  ++   +   P  +    +
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 692 SKSNSI 697
             +  I
Sbjct: 171 LINPDI 176

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 76.5 bits (188), Expect = 8e-15
 Identities = 75/398 (18%), Positives = 129/398 (32%), Gaps = 123/398 (30%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIK--KMSYLGKQCAEKWADILKEIRFLRQLKHPNT 224
           +R++G G F  V+ +  +  ++ VA+K  K +    + A      L EIR L+ +++ + 
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA------LDEIRLLKSVRNSDP 95

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHV----EGMGNRLQQLKCFTEHF 280
                   R+    L+         D  ++  +    H+    E +G+ L +    + + 
Sbjct: 96  -NDPN---REMVVQLL---------DDFKISGVNGT-HICMVFEVLGHHLLKWIIKSNY- 140

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLT---------- 329
                    + L    +  I   VL+GL+YLH+    IH D+K  NILL+          
Sbjct: 141 ---------QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

Query: 330 ---------------------------------------ETGTVKLADFGSASI-KCPAN 349
                                                  E   VK+AD G+A        
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251

Query: 350 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP---PYFNMNAMSALYHI 406
             + T  + + EV++      Y+   D+WS      ELA       P+          HI
Sbjct: 252 EDIQTRQYRSLEVLI---GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308

Query: 407 AQNDTPCLQSSDWSVI-------KTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS- 458
           A             +I       + +    +    +F       L HI +     L    
Sbjct: 309 AL------------IIELLGKVPRKLIVAGKYSKEFFTKKGD--LKHITKLKPWGLFEVL 354

Query: 459 ----DWSD----TFAHFVSSCLAKNPADRPSSGRLLTH 488
               +WS      F  F+   L   P  R ++   L H
Sbjct: 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 39/188 (20%), Positives = 59/188 (31%), Gaps = 57/188 (30%)

Query: 31  LVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLT 88
           +V E         I     + L    +  I   VL+GL+YLH+    IH D+K  NILL+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181

Query: 89  -------------------------------------------------ETGTVKLADFG 99
                                                            E   VK+AD G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241

Query: 100 SASI-KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKE 158
           +A          + T  + + EV++      Y+   D+WS       L   +   LF+  
Sbjct: 242 NACWVHKHFTEDIQTRQYRSLEVLI---GSGYNTPADIWSTACMAFELATGD--YLFEPH 296

Query: 159 DPEKIFED 166
             E+   D
Sbjct: 297 SGEEYTRD 304

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 20/60 (33%), Positives = 28/60 (46%), Gaps = 2/60 (3%)

Query: 616 LVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNILLT 673
           +V E         I     + L    +  I   VL+GL+YLH+    IH D+K  NILL+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 66/380 (17%), Positives = 109/380 (28%), Gaps = 99/380 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLV-SREIVAIK----KMSYLGKQCAEKWADILKEIRFLRQ 218
           +E +  +G G+FG V         +  VA+K       Y  +           EI  L++
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAA-------RLEINVLKK 72

Query: 219 LKHP------NTIEYRGC-YLRDHTAWLVME---YCLGSASDIIEVHWIEREFHVEGMGN 268
           +K          +          H   +  E                    EF       
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMC-IAFELLGKNT-------------FEF------- 111

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
               LK         NF    +P     +  +   +   L +LH     H D+K  NIL 
Sbjct: 112 ----LKEN-------NF----QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156

Query: 329 TETG-------------------TVKLADFGSASIKCPAN----SFVGTPYWMAPEVILA 365
             +                    ++++ADFGSA      +    + V T ++  PEVIL 
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEVILE 213

Query: 366 MDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTI 425
           +    +    DVWS+G    E       +        L  + +     L      +I   
Sbjct: 214 L---GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK----ILGPIPSHMIHRT 266

Query: 426 SSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT-----FAHFVSSCLAKNPADRP 480
                        +  S+     + +   L+S    D+         +   L  +PA R 
Sbjct: 267 RKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326

Query: 481 SSGRLLTHDLVTR--PRSPS 498
           +    L H       P   S
Sbjct: 327 TLAEALLHPFFAGLTPEERS 346

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 29/130 (22%), Positives = 49/130 (37%), Gaps = 37/130 (28%)

Query: 49  RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG----------------- 91
           +P     +  +   +   L +LH     H D+K  NIL   +                  
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 92  --TVKLADFGSASIKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGS 145
             ++++ADFGSA      +    + V T ++  PEVIL +    +    DVWS+G     
Sbjct: 178 NTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCI--- 228

Query: 146 LKDPEIAELF 155
                + E +
Sbjct: 229 -----LFEYY 233

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 58/249 (23%), Positives = 92/249 (36%), Gaps = 60/249 (24%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN---T 224
           R+IG GSFG +Y    + + E VAIK      K        +  E +  + ++      T
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGVGIPT 69

Query: 225 IEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN 284
           I + G    D+   +VME                       +G  L+ L         FN
Sbjct: 70  IRWCGAE-GDYNV-MVMEL----------------------LGPSLEDL---------FN 96

Query: 285 FEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFGS 341
           F   K  LK   +  +   ++  + Y+HS   IHRDVK  N L+    +   V + DFG 
Sbjct: 97  FCSRKFSLKT--VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154

Query: 342 ASIKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           A     A            +  GT  + +    L +++ + D   D+ SLG   +     
Sbjct: 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD---DLESLGYVLMYFNLG 211

Query: 391 KPPYFNMNA 399
             P+  + A
Sbjct: 212 SLPWQGLKA 220

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 33/125 (26%), Positives = 53/125 (42%), Gaps = 19/125 (15%)

Query: 31  LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-- 87
           +VME  LG S  D+     R    + +  +   ++  + Y+HS   IHRDVK  N L+  
Sbjct: 82  MVMEL-LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140

Query: 88  -TETGTVKLADFGSASIKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGKVD 135
             +   V + DFG A     A            +  GT  + +    L +++ + D   D
Sbjct: 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD---D 197

Query: 136 VWSLG 140
           + SLG
Sbjct: 198 LESLG 202

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 51/249 (20%), Positives = 85/249 (34%), Gaps = 58/249 (23%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI-E 226
           ++IG G+FG +   + L + E VAIK      +           E RF +QL   + I +
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL-----EYRFYKQLGSGDGIPQ 69

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                       +V+E                       +G  L+ L         F+  
Sbjct: 70  VYYFGPCGKYNAMVLEL----------------------LGPSLEDL---------FDLC 98

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-----TETGTVKLADFGS 341
                LK   + AI   ++  + Y+HS   I+RDVK  N L+          + + DF  
Sbjct: 99  DRTFSLKTVLMIAIQ--LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156

Query: 342 ASIKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
           A                  S  GT  +M+    L  ++ + D   D+ +LG   +     
Sbjct: 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRD---DLEALGHMFMYFLRG 213

Query: 391 KPPYFNMNA 399
             P+  + A
Sbjct: 214 SLPWQGLKA 222

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 21/127 (16%)

Query: 31  LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-- 87
           +V+E  LG S  D+ ++  R    + +  I   ++  + Y+HS   I+RDVK  N L+  
Sbjct: 82  MVLEL-LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR 140

Query: 88  ---TETGTVKLADFGSASIKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGK 133
                   + + DF  A                  S  GT  +M+    L  ++ + D  
Sbjct: 141 PGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRD-- 198

Query: 134 VDVWSLG 140
            D+ +LG
Sbjct: 199 -DLEALG 204

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 52/249 (20%), Positives = 89/249 (35%), Gaps = 56/249 (22%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI-E 226
           R+IG GSFG +Y    + + E VAIK  +   K        +L E +  R L+    I  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRILQGGTGIPN 67

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
            R   +      LVM+                       +G  L+ L           F 
Sbjct: 68  VRWFGVEGDYNVLVMDL----------------------LGPSLEDL-----------FN 94

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL---TETGTVKLADFGSAS 343
              R L  + +  +   ++  + ++HS   +HRD+K  N L+        V + DFG A 
Sbjct: 95  FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

Query: 344 IKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
                +           +  GT  + +    L +++ + D   D+ SLG   +       
Sbjct: 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSL 211

Query: 393 PYFNMNAMS 401
           P+  + A +
Sbjct: 212 PWQGLKAGT 220

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 30/125 (24%), Positives = 53/125 (42%), Gaps = 19/125 (15%)

Query: 31  LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-- 87
           LVM+  LG S  D+     R L  + +  +   ++  + ++HS   +HRD+K  N L+  
Sbjct: 80  LVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138

Query: 88  -TETGTVKLADFGSASIKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGKVD 135
                 V + DFG A      +           +  GT  + +    L +++ + D   D
Sbjct: 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRD---D 195

Query: 136 VWSLG 140
           + SLG
Sbjct: 196 LESLG 200

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 44/249 (17%), Positives = 79/249 (31%), Gaps = 58/249 (23%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI-E 226
           R IG GSFG ++    L++ + VAIK               +  E R  + L     I  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLLAGCTGIPN 70

Query: 227 YRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE 286
                       LV++                       +G  L+ L          +  
Sbjct: 71  VYYFGQEGLHNVLVIDL----------------------LGPSLEDL---------LDLC 99

Query: 287 VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT-----VKLADFGS 341
             K  +K   +A     +L  +  +H    ++RD+K  N L+    +     + + DFG 
Sbjct: 100 GRKFSVKT--VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157

Query: 342 ASIKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
                              +  GT  +M+    L  ++ + D   D+ +LG   +     
Sbjct: 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD---DLEALGHVFMYFLRG 214

Query: 391 KPPYFNMNA 399
             P+  + A
Sbjct: 215 SLPWQGLKA 223

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.3 bits (105), Expect = 8e-05
 Identities = 26/127 (20%), Positives = 52/127 (40%), Gaps = 21/127 (16%)

Query: 31  LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 89
           LV++  LG S  D++++  R    + +A     +L  +  +H    ++RD+K  N L+  
Sbjct: 83  LVIDL-LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 141

Query: 90  TGT-----VKLADFGSASIKCPAN-----------SFVGTPYWMAPEVILAMDEGQYDGK 133
             +     + + DFG                    +  GT  +M+    L  ++ + D  
Sbjct: 142 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD-- 199

Query: 134 VDVWSLG 140
            D+ +LG
Sbjct: 200 -DLEALG 205

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 40/213 (18%), Positives = 68/213 (31%), Gaps = 47/213 (22%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
             IG G FG +Y A  + S E V       + K        +  E++F ++   P  I+ 
Sbjct: 41  LPIGQGGFGCIYLAD-MNSSESVGSDAPCVV-KVEPSDNGPLFTELKFYQRAAKPEQIQ- 97

Query: 228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEG---------MGNRLQQLKCFTE 278
                     W+           + +                      G+ LQ++     
Sbjct: 98  ---------KWIRTRKLKYLG--VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKI----- 141

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TETGTVKL 336
                 +E + +    + +  +   +L  L Y+H    +H D+KA N+LL       V L
Sbjct: 142 ------YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYL 195

Query: 337 ADFGSASIKCPAN-----------SFVGTPYWM 358
            D+G A   CP                GT  + 
Sbjct: 196 VDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 24/101 (23%), Positives = 39/101 (38%), Gaps = 15/101 (14%)

Query: 31  LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-- 87
           ++M+   G     I E + +    + +  +   +L  L Y+H    +H D+KA N+LL  
Sbjct: 129 MIMDR-FGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187

Query: 88  TETGTVKLADFGSASIKCPAN-----------SFVGTPYWM 117
                V L D+G A   CP                GT  + 
Sbjct: 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 17/75 (22%), Positives = 32/75 (42%), Gaps = 9/75 (12%)

Query: 599 HSYNNNNSNYSSLFSPQLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS 657
           H  N  +  +       ++M+   G     I E + +    + +  +   +L  L Y+H 
Sbjct: 119 HDKNGKSYRF-------MIMDR-FGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE 170

Query: 658 LGRIHRDVKAGNILL 672
              +H D+KA N+LL
Sbjct: 171 HEYVHGDIKASNLLL 185

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 43/247 (17%), Positives = 78/247 (31%), Gaps = 58/247 (23%)

Query: 142 TPGSLKDPEIAELFDKEDPEKIFEDL--------REIGHGSFGAVYYARCLVSREIVAIK 193
           +   L    +          K+ +D+        ++IG G FG +Y A      E  A  
Sbjct: 9   SGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH 68

Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
            +    K   ++   +  E++F +++   + I+                  LG    I  
Sbjct: 69  VV----KVEYQENGPLFSELKFYQRVAKKDCIKKW--------IERKQLDYLG----IPL 112

Query: 254 VHWIEREFHVEG---------MGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGV 304
            +                   +G  LQ++              +    K+  +  +   +
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKI-----------SGQNGT-FKKSTVLQLGIRM 160

Query: 305 LRGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFGSASIKCPAN-----------SF 351
           L  L Y+H    +H D+KA N+LL       V LAD+G +   CP               
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220

Query: 352 VGTPYWM 358
            GT  + 
Sbjct: 221 NGTIEFT 227

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 27/101 (26%), Positives = 40/101 (39%), Gaps = 16/101 (15%)

Query: 31  LVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-- 87
           +VME  LG     I   +    K+  +  +   +L  L Y+H    +H D+KA N+LL  
Sbjct: 129 MVMER-LGIDLQKISGQNGT-FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186

Query: 88  TETGTVKLADFGSASIKCPAN-----------SFVGTPYWM 117
                V LAD+G +   CP                GT  + 
Sbjct: 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.2 bits (137), Expect = 2e-08
 Identities = 102/723 (14%), Positives = 206/723 (28%), Gaps = 226/723 (31%)

Query: 33  MEYCLGSASDIIEVHKRPLKEE----EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 88
            +Y      DI+ V +    +     ++  +   +L      H +           +  T
Sbjct: 14  HQYQYK---DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70

Query: 89  ETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKD 148
                 L       ++     FV          +L ++   Y      +        L  
Sbjct: 71  ------LLSKQEEMVQ----KFVEE--------VLRIN---YK-----F--------LMS 96

Query: 149 PEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE--IVAIKK------------ 194
           P   E        +++ + R+  +       +A+  VSR    + +++            
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYN--DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL 154

Query: 195 ---MSYLGKQC-AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD 250
              +   GK   A    D+    +   Q K    I            WL ++ C  S   
Sbjct: 155 IDGVLGSGKTWVA---LDVCLSYKV--QCKMDFKI-----------FWLNLKNC-NSPET 197

Query: 251 IIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY 310
           ++E+           +   L Q+       +  +  +    L+   I A    +L+   Y
Sbjct: 198 VLEM-----------LQKLLYQIDPNWTSRSDHSSNI---KLRIHSIQAELRRLLKSKPY 243

Query: 311 LHSLGRIHRDV------KAGN----ILLTETGTVKLADFGSASIKCPANSFVGTPYWMAP 360
            + L  +  +V       A N    ILLT T   ++ DF SA+     +           
Sbjct: 244 ENCL-LVLLNVQNAKAWNAFNLSCKILLT-TRFKQVTDFLSAATTTHISL---------D 292

Query: 361 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 420
              + +   +           +    L +    Y +      L        P   S    
Sbjct: 293 HHSMTLTPDE--------VKSL----LLK----YLDCRP-QDLPREVLTTNPRRLSIIAE 335

Query: 421 VIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK-NPADR 479
            I+   +T +    + ++N                      D     + S L    PA+ 
Sbjct: 336 SIRDGLATWDN---WKHVN---------------------CDKLTTIIESSLNVLEPAEY 371

Query: 480 PSSGRLLTHDLVTRPRS----PSVLV----DLIRRTKAAVRDLDNLNYRKMKKILMADGA 531
               R +   L   P S      +L     D+I+     V  + N    K+ K  + +  
Sbjct: 372 ----RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD---VMVVVN----KLHKYSLVEKQ 420

Query: 532 DTESTI---DPDDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHH 588
             ESTI           +  N+ +   SI   +++       +  D  P      +   +
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK---TFDSDDLIPP-----YLDQY 472

Query: 589 HHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEY---------------CLGSASDII---E 630
            +    H+  H  N  +    +LF   + +++                 GS  + +   +
Sbjct: 473 FYS---HIGHHLKNIEHPERMTLF-RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK 528

Query: 631 VHKR------PLKEEEIAAICSGVLRGLNYLHSLG-RIHRDVKAGNI----LLTETGTVK 679
            +K       P  E  + AI       L++L  +   +    K  ++    L+ E   + 
Sbjct: 529 FYKPYICDNDPKYERLVNAI-------LDFLPKIEENLICS-KYTDLLRIALMAEDEAIF 580

Query: 680 LDT 682
            + 
Sbjct: 581 EEA 583

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 3e-04
 Identities = 84/584 (14%), Positives = 163/584 (27%), Gaps = 177/584 (30%)

Query: 208 DILKEIRFLRQLKH----PNTIE--YR--GCYLRDHTAWLVMEYCLGSASDIIEVHWIER 259
           D+ K I    ++ H     + +    R     L      +V ++ +     I    ++  
Sbjct: 40  DMPKSILSKEEIDHIIMSKDAVSGTLRLFWT-LLSKQEEMVQKF-VEEVLRI-NYKFLMS 96

Query: 260 EFHVEGMGNRLQQLKCFTEHFALFN----FEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 315
               E     +       +   L+N    F  +    + +         LR    L  L 
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYLK-----LR--QALLEL- 147

Query: 316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMD-EGQYDGK 374
              R   A N+L+   G   +   G    K    +      W+A +V L+   + + D K
Sbjct: 148 ---RP--AKNVLID--G---VLGSG----K----T------WVALDVCLSYKVQCKMDFK 183

Query: 375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPP 434
           +  W      + L     P   +  +  L +    +         ++   I S       
Sbjct: 184 I-FW------LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 435 YFNMNAMSALYHIAQNDTPCLQSSD--WS-DTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                  S  Y   +N   CL       +   +  F  SC            ++L   L 
Sbjct: 237 LL----KSKPY---EN---CLLVLLNVQNAKAWNAFNLSC------------KIL---LT 271

Query: 492 TRPRSPSVLVDLIRRTKAAVRDL-DNLNYRKMKKILMADGADTESTIDPDDTPDEQAGND 550
           TR +  +  +     T  ++      L   ++K +L     D      P D P  +    
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-LKYLD----CRPQDLP-REV--- 322

Query: 551 SSKSNSITSEHSVQSVGVGVNP----------HDPTPNSSSQAHNRHHHHHPVTHLSQHS 600
                            +  NP           D    +      +H +   +T + + S
Sbjct: 323 -----------------LTTNPRRLSIIAESIRDG-LATWDNW--KHVNCDKLTTIIESS 362

Query: 601 YNNNNSN-----YSSL--FS-----PQLVME--YCLGSASDIIEV----HKRPLKEEEIA 642
            N          +  L  F      P +++   +     SD++ V    HK  L E++  
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422

Query: 643 AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHS 702
                       + S+   + ++K                   +  N+ +   SI   ++
Sbjct: 423 -------ESTISIPSI---YLELKV------------------KLENEYALHRSIVDHYN 454

Query: 703 VQSVGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLIAVGAGEMWA 746
           +       +  D  P    Q    + + H   HL  +   E   
Sbjct: 455 IPK---TFDSDDLIPPYLDQ----YFYSHIGHHLKNIEHPERMT 491

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 35/218 (16%), Positives = 64/218 (29%), Gaps = 57/218 (26%)

Query: 168 REIGHGSFGAVYYARCLVSR--------EIVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
                 + G +Y A    +         +  ++K  +  G+   E+         F R  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF-------FQRAA 100

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHW---IEREFHV---EGMGNRLQQL 273
           K     +++  Y     A             I         + ++       +G  LQ  
Sbjct: 101 KPLQVNKWKKLYSTPLLA-------------IPTCMGFGVHQDKYRFLVLPSLGRSLQSA 147

Query: 274 KCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL--TET 331
                     +    K  L E  +  +   +L  L +LH    +H +V A NI +   + 
Sbjct: 148 ---------LDVS-PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197

Query: 332 GTVKLADFGSASIKCPAN-----------SFVGTPYWM 358
             V LA +G A   CP+               G   ++
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 26/102 (25%), Positives = 41/102 (40%), Gaps = 16/102 (15%)

Query: 31  LVMEYCLG-SASDIIEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL- 87
           LV+   LG S    ++V  K  L E  +  +   +L  L +LH    +H +V A NI + 
Sbjct: 135 LVLPS-LGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193

Query: 88  -TETGTVKLADFGSASIKCPAN-----------SFVGTPYWM 117
             +   V LA +G A   CP+               G   ++
Sbjct: 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	804
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.98
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.98
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.97
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.97
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.96
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.93
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.92
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.92
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.92
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.92
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.92
3niz_A	311	Rhodanese family protein; structural genomics, str	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.92
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.92
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.92
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.92
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.92
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.92
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.92
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.92
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.91
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.91
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.91
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.91
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.91
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.91
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.91
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.91
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.91
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.91
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.91
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.91
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.91
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.91
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.91
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.91
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.91
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.9
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.9
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.9
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.9
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.9
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.9
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.9
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.9
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.9
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.9
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.9
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.9
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.9
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.9
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.9
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.9
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.9
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.9
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.9
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.9
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.9
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.9
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.9
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.9
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.9
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.9
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.9
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.9
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.9
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.9
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.9
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.9
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.9
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.9
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.9
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.9
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.9
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.89
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.89
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.89
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.89
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.89
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.89
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.89
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.89
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.89
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.89
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.89
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.89
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.89
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.89
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.89
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.89
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.89
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.89
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.89
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.89
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.89
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.89
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.89
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.89
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.89
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.89
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.89
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.89
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.89
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.89
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.89
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.89
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.89
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.89
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.89
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.89
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.89
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.89
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.89
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.89
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.89
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.89
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.88
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.88
3bhy_A	283	Death-associated protein kinase 3; death associate	99.88
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.88
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.88
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.88
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.88
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.88
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.88
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.88
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.88
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.88
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.88
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.88
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.88
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.88
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.88
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.88
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.88
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.88
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.88
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.88
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.88
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.88
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.88
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.88
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.88
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.88
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.88
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.88
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.88
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.88
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.88
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.88
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.88
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.88
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.88
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.88
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.88
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.88
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.88
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.88
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.88
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.88
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.88
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.88
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.88
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.88
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.88
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.87
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.87
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.87
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.87
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.87
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.87
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.87
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.87
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.87
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.87
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.87
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.87
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.87
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.87
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.87
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.87
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.87
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.87
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.87
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.87
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.87
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.87
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.87
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.87
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.87
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.87
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.87
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.87
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.87
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.87
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.86
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.86
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.86
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.86
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.86
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.86
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.86
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.86
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.86
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.86
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.86
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.86
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.85
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.85
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.85
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.84

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.9e-61  Score=527.99  Aligned_cols=269  Identities=38%  Similarity=0.664  Sum_probs=228.3

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      ....+|.+.|+++++||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+|++|+|||||+++++|.++
T Consensus        67 ~~~~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  143 (346)
T 4fih_A           67 VDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG  143 (346)
T ss_dssp             SCSSCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCCChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            345678888999999999999999999999999999999986432   23346688999999999999999999999999


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      +.+|||||||+||.                                 |++++. ++.++|.+++.|+.||+.||+|||++
T Consensus       144 ~~~~ivmEy~~gg~---------------------------------L~~~l~-~~~l~e~~~~~~~~qi~~aL~ylH~~  189 (346)
T 4fih_A          144 DELWVVMEFLEGGA---------------------------------LTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQ  189 (346)
T ss_dssp             TEEEEEECCCTTEE---------------------------------HHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEEEEeCCCCCc---------------------------------HHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999999999762                                 122221 34699999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      |||||||||+||||+.+|.+||+|||+|+....    ..+.+||+.|||||++.   ...|+.++|||||||++|||++|
T Consensus       190 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilyeml~G  266 (346)
T 4fih_A          190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIEMVDG  266 (346)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHC---CCCCCcHHHHHHHHHHHHHHHHC
Confidence            999999999999999999999999999976432    34679999999999984   45799999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.+..+.+..|..+..+..                                        .....+|+++++||.+
T Consensus       267 ~~PF~~~~~~~~~~~i~~~~~~~~----------------------------------------~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          267 EPPYFNEPPLKAMKMIRDNLPPRL----------------------------------------KNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             SCTTTTSCHHHHHHHHHHSSCCCC----------------------------------------SCGGGSCHHHHHHHHH
T ss_pred             CCCCCCcCHHHHHHHHHcCCCCCC----------------------------------------CccccCCHHHHHHHHH
Confidence            999999888887777754322110                                        0112468999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCCCchhHHH
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL  503 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~  503 (804)
                      ||++||++|||++|+|+||||++...+..+.++
T Consensus       307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~l~pl  339 (346)
T 4fih_A          307 LLVRDPAQRATAAELLKHPFLAKAGPPASIVPL  339 (346)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGG
T ss_pred             HcCCChhHCcCHHHHhcCHhhcCCCCCcccCcc
Confidence            999999999999999999999987766655443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.6e-60  Score=530.62  Aligned_cols=268  Identities=38%  Similarity=0.674  Sum_probs=229.9

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      ....+|.+.|+++++||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+|++|+|||||+++++|.++
T Consensus       144 ~~~~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  220 (423)
T 4fie_A          144 VDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG  220 (423)
T ss_dssp             SCSSCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCCChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence            456788889999999999999999999999999999999987532   23346688999999999999999999999999


Q ss_pred             CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +.+|||||||.|| |.+++                                   ..+.++|.+++.|+.||+.||+|||+
T Consensus       221 ~~~~iVmEy~~gG~L~~~i-----------------------------------~~~~l~e~~~~~~~~qil~aL~ylH~  265 (423)
T 4fie_A          221 DELWVVMEFLEGGALTDIV-----------------------------------THTRMNEEQIAAVCLAVLQALSVLHA  265 (423)
T ss_dssp             TEEEEEEECCTTEEHHHHH-----------------------------------HHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEeCCCCCcHHHHH-----------------------------------hccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999976 22222                                   13469999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +|||||||||+||||+.+|.+||+|||+|+....    ..+.+||+.|||||++.   ...|+.++|||||||++|||++
T Consensus       266 ~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilyeml~  342 (423)
T 4fie_A          266 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIEMVD  342 (423)
T ss_dssp             TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHT---TCCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHC---CCCCCcHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999976432    34679999999999984   4679999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |++||.+.+..+.+..|..+..+..                                        .....+|+++++||.
T Consensus       343 G~~PF~~~~~~~~~~~i~~~~~~~~----------------------------------------~~~~~~s~~~~dli~  382 (423)
T 4fie_A          343 GEPPYFNEPPLKAMKMIRDNLPPRL----------------------------------------KNLHKVSPSLKGFLD  382 (423)
T ss_dssp             SSCTTTTSCHHHHHHHHHHSCCCCC----------------------------------------SCTTSSCHHHHHHHH
T ss_pred             CCCCCCCcCHHHHHHHHHcCCCCCC----------------------------------------cccccCCHHHHHHHH
Confidence            9999999988888877755432210                                        112357899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCCchhHHH
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL  503 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~  503 (804)
                      +||++||++|||++|+|+||||++...+..+.++
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l~pl  416 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKAGPPASIVPL  416 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCCCCCccccch
Confidence            9999999999999999999999987776655544

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.8e-60  Score=511.46  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=218.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+++|++|+|||||+++++|.+++.+|||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            49999999999999999999999999999999875433333445678999999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.||                                 +|++++.+.+.++|.+++.|+.||+.||+|||++||||||||
T Consensus       113 y~~gG---------------------------------~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlK  159 (311)
T 4aw0_A          113 YAKNG---------------------------------ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK  159 (311)
T ss_dssp             CCTTE---------------------------------EHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             cCCCC---------------------------------CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence            99975                                 234444456789999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |+||||+.+|.+||+|||+|+....      ..+++||+.|||||++.+   ..|+.++|||||||++|||++|++||.+
T Consensus       160 PeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~  236 (311)
T 4aw0_A          160 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE---KSACKSSDLWALGCIIYQLVAGLPPFRA  236 (311)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH---SCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999976432      246799999999999953   5799999999999999999999999999


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+.+.+|.++...                                           .+..+|+++++||.+||++||
T Consensus       237 ~~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~dli~~lL~~dp  273 (311)
T 4aw0_A          237 GNEGLIFAKIIKLEYD-------------------------------------------FPEKFFPKARDLVEKLLVLDA  273 (311)
T ss_dssp             SSHHHHHHHHHHTCCC-------------------------------------------CCTTCCHHHHHHHHHHSCSSG
T ss_pred             CCHHHHHHHHHcCCCC-------------------------------------------CCcccCHHHHHHHHHHccCCH
Confidence            8888777777553211                                           012468899999999999999


Q ss_pred             CCCCCHHH------HHcCccccC
Q psy17952        477 ADRPSSGR------LLTHDLVTR  493 (804)
Q Consensus       477 ~~Rpsa~e------lL~Hp~~~~  493 (804)
                      ++|||++|      +++||||..
T Consensus       274 ~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          274 TKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             GGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             hHCcChHHHcCCHHHHCCCCcCC
Confidence            99999987      588999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-59  Score=516.28  Aligned_cols=255  Identities=28%  Similarity=0.510  Sum_probs=213.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            469999999999999999999999999999999875432 2344678899999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||.|+ |.+++..                                .....++|.+++.|+.||+.||+|||++||||||
T Consensus       103 Ey~~gg~L~~~i~~--------------------------------~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRD  150 (350)
T 4b9d_A          103 DYCEGGDLFKRINA--------------------------------QKGVLFQEDQILDWFVQICLALKHVHDRKILHRD  150 (350)
T ss_dssp             ECCTTCBHHHHHHH--------------------------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETT
T ss_pred             eCCCCCcHHHHHHH--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            999865 3333320                                1234689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+||||+.+|.+||+|||+|+.....    .+.+||+.|||||++.   +..|+.++|||||||++|||++|++||.+
T Consensus       151 lKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~---~~~y~~~~DiwSlGvilyemltG~~PF~~  227 (350)
T 4b9d_A          151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE---NKPYNNKSDIWALGCVLYELCTLKHAFEA  227 (350)
T ss_dssp             CCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999999865432    3568999999999985   45799999999999999999999999999


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+.+.+|.++..|.                                          ....+|+++++||.+||++||
T Consensus       228 ~~~~~~~~~i~~~~~~~------------------------------------------~~~~~s~~~~~li~~~L~~dP  265 (350)
T 4b9d_A          228 GSMKNLVLKIISGSFPP------------------------------------------VSLHYSYDLRSLVSQLFKRNP  265 (350)
T ss_dssp             SSHHHHHHHHHHTCCCC------------------------------------------CCTTSCHHHHHHHHHHTCSSG
T ss_pred             cCHHHHHHHHHcCCCCC------------------------------------------CCccCCHHHHHHHHHHccCCh
Confidence            88888887776543221                                          123578999999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy17952        477 ADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~  494 (804)
                      ++|||++|+|+||||++.
T Consensus       266 ~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          266 RDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             GGSCCHHHHHTSHHHHTT
T ss_pred             hHCcCHHHHhcCHHhhcC
Confidence            999999999999999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-59  Score=498.48  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=202.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||+|+++.+|+.||||+++............+.+|+++|++++|||||+++++|.+++.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            49999999999999999999999999999999875433333445678999999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||+|++.+.+                                  .+.+++++.+++.++.||+.||+|||++||||||||
T Consensus        94 y~~g~L~~~l----------------------------------~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiK  139 (275)
T 3hyh_A           94 YAGNELFDYI----------------------------------VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK  139 (275)
T ss_dssp             CCCEEHHHHH----------------------------------HHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CCCCCHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence            9977544433                                  345689999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.+|.+||+|||+|+....   ..+.+||+.|||||++.+   ..| +.++||||+||++|||++|++||.+.+
T Consensus       140 P~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~---~~y~~~~~DiwSlGvily~lltg~~PF~~~~  216 (275)
T 3hyh_A          140 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYVMLCRRLPFDDES  216 (275)
T ss_dssp             TTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSS---SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcC---CCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence            9999999999999999999976433   346799999999999953   344 579999999999999999999998877


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ....+..|..+..+                                           .+..+|+++++||.+||++||++
T Consensus       217 ~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~~L~~dP~~  253 (275)
T 3hyh_A          217 IPVLFKNISNGVYT-------------------------------------------LPKFLSPGAAGLIKRMLIVNPLN  253 (275)
T ss_dssp             HHHHHHHHHHTCCC-------------------------------------------CCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             HHHHHHHHHcCCCC-------------------------------------------CCCCCCHHHHHHHHHHccCChhH
Confidence            76665555432210                                           11346899999999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy17952        479 RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~~  494 (804)
                      |||++|+|+||||+..
T Consensus       254 R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          254 RISIHEIMQDDWFKVD  269 (275)
T ss_dssp             SCCHHHHHHCHHHHTT
T ss_pred             CcCHHHHHcCcccccC
Confidence            9999999999999754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-58  Score=494.93  Aligned_cols=252  Identities=28%  Similarity=0.449  Sum_probs=206.8

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee----cCceEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR----DHTAWL  239 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----~~~~~l  239 (804)
                      |++.++||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+++|++|+|||||+++++|.+    +..+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            5777889999999999999999999999999864322 23345778999999999999999999999875    346899


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ce
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--RI  317 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g--Ii  317 (804)
                      |||||.|+.                                 |++++.+.+.+++..++.|+.||+.||+|||++|  ||
T Consensus       107 vmEy~~gg~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~Ii  153 (290)
T 3fpq_A          107 VTELMTSGT---------------------------------LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII  153 (290)
T ss_dssp             EEECCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred             EEeCCCCCC---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEE
Confidence            999998652                                 2223334567999999999999999999999999  99


Q ss_pred             ecCCCCCCeeecC-CCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        318 HRDVKAGNILLTE-TGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       318 HRDLKP~NILl~~-~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||||||+||||+. +|.+||+|||+|+....  ..+.+|||.|||||++.    +.|+.++|||||||++|||+||++||
T Consensus       154 HRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~----~~y~~~~DiwSlGvilyelltg~~Pf  229 (290)
T 3fpq_A          154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPY  229 (290)
T ss_dssp             CCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcC----CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999984 79999999999976433  34578999999999873    46999999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+....+........+                    |                    .......++++++||.+||++
T Consensus       230 ~~~~~~~~~~~~i~~~~~--------------------~--------------------~~~~~~~~~~~~~li~~~L~~  269 (290)
T 3fpq_A          230 SECQNAAQIYRRVTSGVK--------------------P--------------------ASFDKVAIPEVKEIIEGCIRQ  269 (290)
T ss_dssp             TTCSSHHHHHHHHTTTCC--------------------C--------------------GGGGGCCCHHHHHHHHHHSCS
T ss_pred             CCCCcHHHHHHHHHcCCC--------------------C--------------------CCCCccCCHHHHHHHHHHccC
Confidence            876655544443321110                    0                    111123578899999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy17952        475 NPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||++|||++|+|+||||++
T Consensus       270 dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          270 NKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             SGGGSCCHHHHHTSGGGC-
T ss_pred             ChhHCcCHHHHhcCccccC
Confidence            9999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-58  Score=501.05  Aligned_cols=258  Identities=27%  Similarity=0.427  Sum_probs=212.4

Q ss_pred             ccCCCcccccccccccccccccceEEEEee---eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEE
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCY  231 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~  231 (804)
                      ..+.+|+ .|++++.||+|+||+||+|++.   .+++.||||.++..... ......+.+|+++|++++|||||+++++|
T Consensus        18 ~~~~~p~-~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~   95 (304)
T 3ubd_A           18 HEKADPS-QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVNHPFIVKLHYAF   95 (304)
T ss_dssp             CCCCCGG-GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCCCTTEECEEEEE
T ss_pred             cccCCcc-ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            3445564 4999999999999999999875   46789999998753322 22234678999999999999999999999


Q ss_pred             eecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      .+++.+|||||||+|+                                 +|++++.+.+.+++.+++.|+.||+.||+||
T Consensus        96 ~~~~~~~ivmEy~~gg---------------------------------~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yl  142 (304)
T 3ubd_A           96 QTEGKLYLILDFLRGG---------------------------------DLFTRLSKEVMFTEEDVKFYLAELALALDHL  142 (304)
T ss_dssp             EETTEEEEEECCCTTC---------------------------------EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             EECCEEEEEEEcCCCC---------------------------------CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            9999999999999975                                 2333444557899999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |++|||||||||+|||++.+|.+||+|||+|+...    ...+.+||+.|||||++.   +..|+.++|||||||++|||
T Consensus       143 H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvilyem  219 (304)
T 3ubd_A          143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN---RRGHTQSADWWSFGVLMFEM  219 (304)
T ss_dssp             HHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHH---TSCCCTHHHHHHHHHHHHHH
T ss_pred             HHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhc---cCCCCCCCcccchHHHHHHH
Confidence            99999999999999999999999999999997532    234679999999999985   46799999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|++||.+.+..+.+..|.++..+                                           .+..+|+++++|
T Consensus       220 ltG~~PF~~~~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~l  256 (304)
T 3ubd_A          220 LTGTLPFQGKDRKETMTMILKAKLG-------------------------------------------MPQFLSPEAQSL  256 (304)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHH
T ss_pred             HhCCCCCCCcCHHHHHHHHHcCCCC-------------------------------------------CCCcCCHHHHHH
Confidence            9999999998888877777543211                                           012468999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHcCccccC
Q psy17952        468 VSSCLAKNPADRPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       468 i~~cL~~dP~~Rps-----a~elL~Hp~~~~  493 (804)
                      |.+||++||++|||     ++|+++||||+.
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            99999999999999     479999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-57  Score=496.76  Aligned_cols=252  Identities=26%  Similarity=0.321  Sum_probs=210.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.++||+|+||+||+|+++.+|+.||||+++...        ...+|+.+|++|+|||||+++++|.+++.+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45889999999999999999999999999999986321        2357999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||+|+                                 +|++++...+++++.+++.|+.||+.||+|||++|||||||
T Consensus       130 Ey~~gg---------------------------------~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl  176 (336)
T 4g3f_A          130 ELLEGG---------------------------------SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV  176 (336)
T ss_dssp             CCCTTC---------------------------------BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred             eccCCC---------------------------------cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence            999975                                 22333334568999999999999999999999999999999


Q ss_pred             CCCCeeecCCC-cEEEEecccccccCC---------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        322 KAGNILLTETG-TVKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       322 KP~NILl~~~g-~vKL~DFGla~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||+||||+.+| .+||+|||+|+....         ....+||+.|||||++.   +..|+.++|||||||++|||++|+
T Consensus       177 Kp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvilyemltG~  253 (336)
T 4g3f_A          177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM---GKPCDAKVDIWSSCCMMLHMLNGC  253 (336)
T ss_dssp             CGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC---CCCCCcHHHHHHHHHHHHHHHHCc
Confidence            99999999998 699999999975432         23468999999999995   457999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+....+..|.....+                      .                  ...+..+|+++++||.+|
T Consensus       254 ~Pf~~~~~~~~~~~i~~~~~~----------------------~------------------~~~~~~~s~~~~~li~~~  293 (336)
T 4g3f_A          254 HPWTQYFRGPLCLKIASEPPP----------------------I------------------REIPPSCAPLTAQAIQEG  293 (336)
T ss_dssp             CSSTTTCCSCCHHHHHHSCCG----------------------G------------------GGSCTTSCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCC----------------------c------------------hhcCccCCHHHHHHHHHH
Confidence            999877655555555432211                      0                  011245789999999999


Q ss_pred             cccCCCCCCCHHHH-------------HcCccccCCCCC
Q psy17952        472 LAKNPADRPSSGRL-------------LTHDLVTRPRSP  497 (804)
Q Consensus       472 L~~dP~~Rpsa~el-------------L~Hp~~~~~~~~  497 (804)
                      |++||++|||+.|+             |+|||+.....|
T Consensus       294 L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          294 LRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             ccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            99999999999997             579999765544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-56  Score=501.59  Aligned_cols=284  Identities=24%  Similarity=0.357  Sum_probs=221.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee------cC
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR------DH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~------~~  235 (804)
                      +.|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+++|+++|++|+|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            46999999999999999999999999999999986432 223345678899999999999999999998764      36


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+|||||||+|+|.++                                  +...+++++.+++.|++||+.||+|||++|
T Consensus       133 ~~~ivmE~~~g~L~~~----------------------------------i~~~~~l~~~~~~~~~~qil~al~ylH~~~  178 (398)
T 4b99_A          133 SVYVVLDLMESDLHQI----------------------------------IHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ  178 (398)
T ss_dssp             CEEEEEECCSEEHHHH----------------------------------HTSSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeCCCCCHHHH----------------------------------HHhcCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence            7899999998765433                                  334578999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccC--------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ||||||||+|||++.+|.+||+|||+|+...        ...+.+||+.|||||++.+  ...|+.++||||+|||+|||
T Consensus       179 iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~--~~~~~~~~DiWSlG~il~el  256 (398)
T 4b99_A          179 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS--LHEYTQAIDLWSVGCIFGEM  256 (398)
T ss_dssp             CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT--CSCCCTHHHHHHHHHHHHHH
T ss_pred             CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC--CCCCCChhheehhHHHHHHH
Confidence            9999999999999999999999999997532        1246799999999999864  24578999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFA  465 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~  465 (804)
                      ++|++||.+.+..+.+..|.......... .|..+....             ....+.........  ....+..|+++.
T Consensus       257 l~G~~pF~g~~~~~~l~~I~~~~g~p~~~-~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~  322 (398)
T 4b99_A          257 LARRQLFPGKNYVHQLQLIMMVLGTPSPA-VIQAVGAER-------------VRAYIQSLPPRQPVPWETVYPGADRQAL  322 (398)
T ss_dssp             HHTSCSSCCSSHHHHHHHHHHHHCCCCGG-GTC-----C-------------HHHHHHSSCCCCCCCHHHHSTTCCHHHH
T ss_pred             HHCCCCCCCCCHHHHHHHHHHhcCCCChH-Hhhhhhhhh-------------hhhhhhcCCCcCCCCHHHhCCCCCHHHH
Confidence            99999999999999998887643221110 010000000             00000000000000  001235689999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      |||.+||++||++||||+|+|+||||++...
T Consensus       323 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          323 SLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             HHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            9999999999999999999999999987543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-54  Score=463.77  Aligned_cols=253  Identities=28%  Similarity=0.467  Sum_probs=201.4

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.+++.++||+|+||+||+|+...   .||||+++... ......+.+.+|+.+|++++|||||++++++.+ +.+|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            3457889999999999999997543   59999886443 234456789999999999999999999998754 578999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+|| |.+++.                                 ..+.++++.++..|+.||++||+|||+++||||
T Consensus       110 mEy~~gGsL~~~l~---------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHR  156 (307)
T 3omv_A          110 TQWCEGSSLYKHLH---------------------------------VQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR  156 (307)
T ss_dssp             EECCSSCBHHHHHH---------------------------------TSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             EEcCCCCCHHHHHh---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            9999865 333221                                 134579999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+||||++++.+||+|||+|+....      ..+.+||+.|||||++.+...+.|+.++|||||||+||||+||++|
T Consensus       157 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P  236 (307)
T 3omv_A          157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP  236 (307)
T ss_dssp             CCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence            9999999999999999999999975432      2356899999999999754456799999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+....+..+......                   .|.                  .......+++++.+|+.+||+
T Consensus       237 f~~~~~~~~~~~~~~~~~~-------------------~p~------------------~~~~~~~~~~~l~~li~~cl~  279 (307)
T 3omv_A          237 YSHINNRDQIIFMVGRGYA-------------------SPD------------------LSKLYKNCPKAMKRLVADCVK  279 (307)
T ss_dssp             TTTCCCHHHHHHHHHTTCC-------------------CCC------------------STTSCTTSCHHHHHHHHHHTC
T ss_pred             CCCCChHHHHHHHHhcCCC-------------------CCC------------------cccccccchHHHHHHHHHHcC
Confidence            9887766555444332110                   000                  011224578999999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .||++|||++|++++
T Consensus       280 ~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          280 KVKEERPLFPQILSS  294 (307)
T ss_dssp             SSSTTSCCHHHHHHH
T ss_pred             CCHhHCcCHHHHHHH
Confidence            999999999988754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.8e-54  Score=474.21  Aligned_cols=281  Identities=22%  Similarity=0.341  Sum_probs=206.8

Q ss_pred             ccccccccccccccccceEEEEee---eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCc
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~  236 (804)
                      .+.|++.++||+|+||+||+|+++   .+++.||||++....     ...++.+|+++|+.+ +|||||+++++|.+.+.
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            456999999999999999999876   468899999885422     224578999999998 69999999999999999


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      +|+|||||+|+ +.+                                  ++   +.+++.+++.|++||+.||+|||++|
T Consensus        95 ~~lvmE~~~g~~L~~----------------------------------~~---~~l~~~~~~~~~~qll~al~ylH~~g  137 (361)
T 4f9c_A           95 VVIAMPYLEHESFLD----------------------------------IL---NSLSFQEVREYMLNLFKALKRIHQFG  137 (361)
T ss_dssp             EEEEEECCCCCCHHH----------------------------------HH---TTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEeCCCcccHHH----------------------------------HH---cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999865 222                                  22   25899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCC-CcEEEEecccccccCC--------------------------------CCccccCcccccchh
Q psy17952        316 RIHRDVKAGNILLTET-GTVKLADFGSASIKCP--------------------------------ANSFVGTPYWMAPEV  362 (804)
Q Consensus       316 IiHRDLKP~NILl~~~-g~vKL~DFGla~~~~~--------------------------------~~~~~GT~~Y~APEv  362 (804)
                      ||||||||+|||++.+ +.+||+|||+|+....                                ..+.+||+.|||||+
T Consensus       138 IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~  217 (361)
T 4f9c_A          138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEV  217 (361)
T ss_dssp             EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHH
T ss_pred             eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence            9999999999999877 8999999999964221                                123589999999999


Q ss_pred             hcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCC-------------------CCCCchhhH
Q psy17952        363 ILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN-MNAMSALYHIAQNDTPC-------------------LQSSDWSVI  422 (804)
Q Consensus       363 l~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~-~~~~~~l~~I~~~~~p~-------------------~~~~~~~~i  422 (804)
                      +.+  ...|+.++||||+||++|||++|++||+. .++.+++..|.+...+.                   .....+...
T Consensus       218 l~~--~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  295 (361)
T 4f9c_A          218 LTK--CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLC  295 (361)
T ss_dssp             HTT--CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHH
T ss_pred             HcC--CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHH
Confidence            864  24589999999999999999999999965 45667777765421100                   000001111


Q ss_pred             HhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        423 KTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       423 ~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ..+.......|....        ...............|++++|||.+||++||++||||+|+|+||||+.
T Consensus       296 ~~~~~~~~~~p~~~~--------~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          296 ERLRGMDSSTPKLTS--------DIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHC------------------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             Hhhcccccccccccc--------ccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            111100000000000        000000011123457899999999999999999999999999999975

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.4e-54  Score=464.10  Aligned_cols=259  Identities=23%  Similarity=0.396  Sum_probs=207.1

Q ss_pred             CcccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR  233 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~  233 (804)
                      .+.+.|.+.++||+|+||+||+|++.     .+++.||||+++..   .....+.+.+|+++|++|+|||||++++++.+
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            34456889999999999999999875     46789999998643   23445779999999999999999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      ++.+|||||||+| +|.+++.......                     .+.........+++.++..|+.||++||+|||
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~---------------------~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH  145 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDA---------------------VLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA  145 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHH---------------------HHC----CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCccc---------------------ccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999985 5655554210000                     00011123457999999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      +++||||||||+||||+.++.+||+|||+|+....      ....+||+.|||||++.   .+.|+.++|||||||++||
T Consensus       146 ~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~---~~~~~~k~DVwS~Gvvl~E  222 (299)
T 4asz_A          146 SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSLGVVLWE  222 (299)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHH
T ss_pred             hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHc---CCCCCchhhHHHHHHHHHH
Confidence            99999999999999999999999999999975322      23357999999999995   3679999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |+| |++||.+.+..+.+..+.++..+                                          ..+..+|+++.
T Consensus       223 llt~G~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~~~  260 (299)
T 4asz_A          223 IFTYGKQPWYQLSNNEVIECITQGRVL------------------------------------------QRPRTCPQEVY  260 (299)
T ss_dssp             HHTTTCCTTTTSCHHHHHHHHHHTCCC------------------------------------------CCCTTCCHHHH
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCccchHHHH
Confidence            998 89999998887777766554321                                          01234688999


Q ss_pred             HHHHHhcccCCCCCCCHHHHH
Q psy17952        466 HFVSSCLAKNPADRPSSGRLL  486 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL  486 (804)
                      +|+.+||+.||++|||+++++
T Consensus       261 ~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          261 ELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHH
Confidence            999999999999999999984

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-54  Score=469.48  Aligned_cols=251  Identities=26%  Similarity=0.436  Sum_probs=190.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-------
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-------  235 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-------  235 (804)
                      .|++++.||+|+||+||+|+++.+++.||||+++...  .....+.+.+|+++|++|+|||||+++++|.+.+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3899999999999999999999999999999986432  2334467899999999999999999999997654       


Q ss_pred             -----ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHH
Q psy17952        236 -----TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN  309 (804)
Q Consensus       236 -----~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~  309 (804)
                           .+|+|||||.|+ |.+++...                               ......++..++.|+.||++||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~-------------------------------~~~~~~~~~~~~~i~~qi~~al~  132 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGR-------------------------------CTIEERERSVCLHIFLQIAEAVE  132 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTC-------------------------------CSGGGSCHHHHHHHHHHHHHHHH
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhc-------------------------------CCCChhHHHHHHHHHHHHHHHHH
Confidence                 379999999864 44433200                               00112456678999999999999


Q ss_pred             HHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC----------------CCccccCcccccchhhcccCCCCCCC
Q psy17952        310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----------------ANSFVGTPYWMAPEVILAMDEGQYDG  373 (804)
Q Consensus       310 yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----------------~~~~~GT~~Y~APEvl~~~~~~~y~~  373 (804)
                      |||++|||||||||+||||+.+|.+||+|||+|+....                ..+.+||+.|||||++.   +..|+.
T Consensus       133 ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~  209 (299)
T 4g31_A          133 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH---GNSYSH  209 (299)
T ss_dssp             HHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT---TCCCCT
T ss_pred             HHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc---CCCCCC
Confidence            99999999999999999999999999999999975321                12468999999999985   457999


Q ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC
Q psy17952        374 KVDVWSLGITCIELAERKPPYFNMNA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT  452 (804)
Q Consensus       374 ksDIWSlGvil~ELltG~~PF~~~~~-~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~  452 (804)
                      ++|||||||++|||++   ||.+... ...+..+....                     .|+.+                
T Consensus       210 ~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~---------------------~p~~~----------------  249 (299)
T 4g31_A          210 KVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLK---------------------FPPLF----------------  249 (299)
T ss_dssp             HHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTC---------------------CCHHH----------------
T ss_pred             HHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCC---------------------CCCCC----------------
Confidence            9999999999999996   8854321 11222221111                     11110                


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       453 p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                           ...++.+.+||.+||++||++|||+.|+|+||||...
T Consensus       250 -----~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          250 -----TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             -----HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             -----cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence                 1235667899999999999999999999999999764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.2e-53  Score=462.41  Aligned_cols=260  Identities=24%  Similarity=0.392  Sum_probs=202.7

Q ss_pred             cccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.|.+.++||+|+||+||+|++.     .+++.||||+++..   .....+.+.+|+++|++|+|||||++++++.+.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34788899999999999999864     46889999998643   23445779999999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      +|||||||+| +|.+++..+....        ..           .........+++++.++..|+.||++||+|||+++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~--------~~-----------~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~  178 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDA--------KL-----------LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH  178 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC------------------------------CCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCccc--------cc-----------ccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            9999999985 5555543110000        00           00001123567999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||||||||+||||+.++.+||+|||+|+....      ....+||+.|||||++.   ...|+.++|||||||+||||+|
T Consensus       179 iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~---~~~~~~~sDvwS~Gvvl~Ellt  255 (329)
T 4aoj_A          179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL---YRKFTTESDVWSFGVVLWEIFT  255 (329)
T ss_dssp             CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHT---TCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhc---CCCCCccccccchHHHHHHHHc
Confidence            99999999999999999999999999975422      23467999999999985   4679999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |++||.+.+..+.+..+.++..+                                          ..+..+++++.+|+
T Consensus       256 ~G~~Pf~~~~~~~~~~~i~~g~~~------------------------------------------~~p~~~~~~~~~li  293 (329)
T 4aoj_A          256 YGKQPWYQLSNTEAIDCITQGREL------------------------------------------ERPRACPPEVYAIM  293 (329)
T ss_dssp             TSCCTTCSSCHHHHHHHHHHTCCC------------------------------------------CCCTTCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCcccccHHHHHHH
Confidence             89999998887777666543211                                          01234688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||++|||++|++.+
T Consensus       294 ~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          294 RGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCcChhHCcCHHHHHHH
Confidence            99999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.5e-53  Score=459.62  Aligned_cols=264  Identities=20%  Similarity=0.332  Sum_probs=208.2

Q ss_pred             cccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      +...++++++||+|+||+||+|+..     .+++.||||+++...  .....+.+.+|+.+|++|+|||||+++|++.++
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            3445788999999999999999853     467899999986432  223346789999999999999999999999999


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +.+|||||||+| +|.+++....                  .........+....+..+++.++..|+.||++||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~------------------~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  163 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRS------------------PHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS  163 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTC------------------SSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhC------------------ccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999985 5555543110                  000000000111234579999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ++||||||||+||||++++.+||+|||+|+....      ....+||+.|||||++.   .+.|+.++|||||||+||||
T Consensus       164 ~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~~s~ksDVwSfGvvl~El  240 (308)
T 4gt4_A          164 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM---YGKFSIDSDIWSYGVVLWEV  240 (308)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh---CCCCCccchhhhHHHHHHHH
Confidence            9999999999999999999999999999975321      23468999999999985   46799999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      +| |.+||.+.+..+.+..+..+..+                                          ..+..+++++.+
T Consensus       241 ~t~g~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~~~~  278 (308)
T 4gt4_A          241 FSYGLQPYCGYSNQDVVEMIRNRQVL------------------------------------------PCPDDCPAWVYA  278 (308)
T ss_dssp             HTTTCCTTTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHH
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCcccchHHHHH
Confidence            98 89999998887776666443211                                          012356889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~H  488 (804)
                      |+.+||+.||++|||+.|++++
T Consensus       279 li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          279 LMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999865

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-52  Score=490.39  Aligned_cols=258  Identities=24%  Similarity=0.317  Sum_probs=220.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+++|+.|+|||||+++++|.+++.+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            456999999999999999999999999999999986432   23346788999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~-~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.||                                 +|++++. ..+.+++.+++.|++||++||+|||++||+||
T Consensus       233 ~E~~~gg---------------------------------~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHR  279 (573)
T 3uto_A          233 YEFMSGG---------------------------------ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL  279 (573)
T ss_dssp             EECCCCC---------------------------------BHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EeecCCC---------------------------------cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999976                                 2333332 34579999999999999999999999999999


Q ss_pred             CCCCCCeeecCC--CcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        320 DVKAGNILLTET--GTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       320 DLKP~NILl~~~--g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||||+|||++.+  +.+||+|||+|+...+.   .+.+||+.|||||++.   +..|+.++|||||||++|||++|.+||
T Consensus       280 DlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~---~~~y~~~~DiWSlGvilyeml~G~~Pf  356 (573)
T 3uto_A          280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVLSYILLSGLSPF  356 (573)
T ss_dssp             CCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             cCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhC---CCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999864  89999999999875543   3568999999999995   457999999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+.+..|.......                                       +......+|+++++||.+||++
T Consensus       357 ~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~dli~~~L~~  397 (573)
T 3uto_A          357 GGENDDETLRNVKSCDWNM---------------------------------------DDSAFSGISEDGKDFIRKLLLA  397 (573)
T ss_dssp             CCSSHHHHHHHHHTTCCCC---------------------------------------CSGGGTTSCHHHHHHHHTTSCS
T ss_pred             CCcCHHHHHHHHHhCCCCC---------------------------------------CcccccCCCHHHHHHHHHHccC
Confidence            9999888888776543211                                       0011235689999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ||.+|||+.|+|+||||+....
T Consensus       398 dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          398 DPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             SGGGSCCHHHHHHSTTTSCCCC
T ss_pred             ChhHCcCHHHHhcCcCcCCCCC
Confidence            9999999999999999987544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-52  Score=491.59  Aligned_cols=254  Identities=20%  Similarity=0.265  Sum_probs=207.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHH---HHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADIL---KEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~---~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+...........+.   +++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            4599999999999999999999999999999998643211111122233   4467778889999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||||.||                                 +|++++.+.+.++|..++.|+.||+.||+|||++||||
T Consensus       269 lVmEy~~GG---------------------------------dL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiH  315 (689)
T 3v5w_A          269 FILDLMNGG---------------------------------DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY  315 (689)
T ss_dssp             EEECCCCSC---------------------------------BHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             EEEecCCCC---------------------------------cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999976                                 33444445678999999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||||+||||+.+|.+||+|||+|+....  ..+.+|||.|||||++..  +..|+.++|||||||++|||++|.+||.+
T Consensus       316 RDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~--~~~y~~~vDiWSLGvilYEmLtG~~PF~~  393 (689)
T 3v5w_A          316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQ  393 (689)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred             cCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999976433  457899999999999852  34699999999999999999999999975


Q ss_pred             CCh---HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        397 MNA---MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       397 ~~~---~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      .+.   ......+....                                           ...+..+|+++++||.+||+
T Consensus       394 ~~~~~~~~i~~~i~~~~-------------------------------------------~~~p~~~S~~a~dLI~~lL~  430 (689)
T 3v5w_A          394 HKTKDKHEIDRMTLTMA-------------------------------------------VELPDSFSPELRSLLEGLLQ  430 (689)
T ss_dssp             GGCCCHHHHHHHHHHCC-------------------------------------------CCCCTTSCHHHHHHHHHHTC
T ss_pred             CChHHHHHHHHhhcCCC-------------------------------------------CCCCccCCHHHHHHHHHHcc
Confidence            321   11111111100                                           01123578999999999999


Q ss_pred             cCCCCCCC-----HHHHHcCccccC
Q psy17952        474 KNPADRPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       474 ~dP~~Rps-----a~elL~Hp~~~~  493 (804)
                      +||.+|++     ++|+++||||..
T Consensus       431 ~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          431 RDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             SCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             CCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999998     799999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.3e-52  Score=458.85  Aligned_cols=311  Identities=76%  Similarity=1.244  Sum_probs=263.8

Q ss_pred             CCCCCCcchhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCC
Q psy17952        143 PGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHP  222 (804)
Q Consensus       143 ~g~l~~~~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~Hp  222 (804)
                      .+...++...+.+...++.+.|+.++.||+|+||.||+|++..+++.||||++...........+.+.+|+++|++++||
T Consensus        35 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  114 (348)
T 1u5q_A           35 AGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP  114 (348)
T ss_dssp             -----CHHHHHHCCCSCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CcCcCChhHHHhhcccchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCC
Confidence            33445566677777888999999999999999999999999999999999998755444445567889999999999999


Q ss_pred             ceeEeeeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHH
Q psy17952        223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICS  302 (804)
Q Consensus       223 NIV~l~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~  302 (804)
                      |||++++++...+..|+|||||.|++.+++.                                 ....++++.++..++.
T Consensus       115 niv~~~~~~~~~~~~~lv~e~~~g~l~~~l~---------------------------------~~~~~l~~~~~~~i~~  161 (348)
T 1u5q_A          115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLE---------------------------------VHKKPLQEVEIAAVTH  161 (348)
T ss_dssp             TBCCEEEEEEETTEEEEEEECCSEEHHHHHH---------------------------------HHTSCCCHHHHHHHHH
T ss_pred             CEeeEEEEEEECCeEEEEEecCCCCHHHHHH---------------------------------HhcCCCCHHHHHHHHH
Confidence            9999999999999999999999987655442                                 1235789999999999


Q ss_pred             HHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        303 GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       303 qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+|+........+||+.|+|||++.+...+.|+.++|||||||
T Consensus       162 qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~  241 (348)
T 1u5q_A          162 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  241 (348)
T ss_dssp             HHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHH
Confidence            99999999999999999999999999999999999999998777667789999999999986544567999999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       383 il~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ++|||++|++||.+.+....+..+.++..+                                         ......+++
T Consensus       242 il~ell~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~  280 (348)
T 1u5q_A          242 TCIELAERKPPLFNMNAMSALYHIAQNESP-----------------------------------------ALQSGHWSE  280 (348)
T ss_dssp             HHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------------------------------------CCCCTTSCH
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------------------------------------CCCCCCCCH
Confidence            999999999999988877766666543221                                         122345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhhHHHHHHHHH
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILM  527 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~  527 (804)
                      .+.+||.+||+.||++|||++++|+|||+.....+....+.+++.+...+++.+..++++++++.
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~  345 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILF  345 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHHHHHHHSTTGGGCGGGGGGG
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchhhHHHHHHHHHHhhcccHHHHHHHHHhc
Confidence            99999999999999999999999999999998888888888888888888888777777766554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-51  Score=454.16  Aligned_cols=266  Identities=24%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             CcccccccccccccccccceEEEEeeec-----eeEEEEEecccccccchhhhhhHHHHHHHHhhcCC-CceeEeeeEEe
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVS-----REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH-PNTIEYRGCYL  232 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~-----~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~~~~~  232 (804)
                      -|.+.|++.++||+|+||+||+|++..+     ++.||||.+....  .....+.+.+|+.+|++++| ||||+++++|.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            4566799999999999999999987653     4789999886432  23345678999999999976 89999999987


Q ss_pred             ec-CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        233 RD-HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       233 ~~-~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      +. +.+|||||||+| +|.+++....-                 .+. ..........+..+++.++..|+.||++||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~-----------------~~~-~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y  200 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRN-----------------EFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF  200 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGG-----------------GBC-CC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhccc-----------------ccc-cccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence            64 578999999985 56555542100                 000 00000001124568999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ||+++||||||||+|||+++++.+||+|||+|+.....      .+.+||+.|||||++.   .+.|+.++|||||||+|
T Consensus       201 LH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~y~~ksDVwS~Gv~l  277 (353)
T 4ase_A          201 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLL  277 (353)
T ss_dssp             HHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             HhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh---cCCCCCcccEeehHHHH
Confidence            99999999999999999999999999999999854322      3467999999999995   36799999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||+| |++||.+.+..+.+..+.....                                        .+ ..+..++++
T Consensus       278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~----------------------------------------~~-~~p~~~~~~  316 (353)
T 4ase_A          278 WEIFSLGASPYPGVKIDEEFCRRLKEGT----------------------------------------RM-RAPDYTTPE  316 (353)
T ss_dssp             HHHTTTSCCSSTTCCCSHHHHHHHHHTC----------------------------------------CC-CCCTTCCHH
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHHcCC----------------------------------------CC-CCCccCCHH
Confidence            99998 9999988664444333322110                                        00 112346889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+|+.+||+.||++|||++|+++|
T Consensus       317 ~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          317 MYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHH
Confidence            9999999999999999999999987

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1e-48  Score=421.53  Aligned_cols=273  Identities=41%  Similarity=0.696  Sum_probs=226.2

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      ....++.+.|++++.||+|+||.||+|++..+++.||||.+.....   ...+.+.+|+.++++++||||++++++|...
T Consensus        13 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             SBSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cCcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            4455677889999999999999999999999999999998864322   2345678999999999999999999999999


Q ss_pred             CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +..|+|||||.|+ +.+++.                                   ...+++.++..++.|++.||.|||+
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~-----------------------------------~~~~~~~~~~~~~~qi~~~l~~lH~  134 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVT-----------------------------------ETCMDEGQIAAVCRECLQALEFLHS  134 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHH-----------------------------------HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEECCCCCCHHHHHh-----------------------------------hcCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999764 333221                                   2358999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||+||||||+|||++.++.+||+|||+|.....    ....+||+.|+|||++.   ...|+.++|||||||++|||++
T Consensus       135 ~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~  211 (297)
T 3fxz_A          135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMIE  211 (297)
T ss_dssp             TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHH---CSCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhc---CCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999875432    23468999999999985   4578999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||.+.+....+..+.....+..                                        .....+++.+.+||.
T Consensus       212 g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          212 GEPPYLNENPLRALYLIATNGTPEL----------------------------------------QNPEKLSAIFRDFLN  251 (297)
T ss_dssp             SSCTTTTSCHHHHHHHHHHHCSCCC----------------------------------------SCGGGSCHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCC----------------------------------------CCccccCHHHHHHHH
Confidence            9999998887776665544322110                                        011346888999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHH
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK  508 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~  508 (804)
                      +||+.||++|||+.|+|+||||....+.....+.....+
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~p~~~~~~  290 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK  290 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCGGGGHHHHHHHH
T ss_pred             HHccCChhHCcCHHHHhhChhhcccCcccccchHHHHHh
Confidence            999999999999999999999998777665555544433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-49  Score=431.36  Aligned_cols=261  Identities=25%  Similarity=0.309  Sum_probs=185.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC----ce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH----TA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~----~~  237 (804)
                      +.|.+.++||+|+||+||+|++  +|+.||||+++...    .......+|+..+.+++|||||++++++..++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            3478889999999999999975  68899999986421    11122345677778899999999999998764    57


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL--  314 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~--  314 (804)
                      |||||||+|| |.++++                                   ..+++++.+..|+.|++.||+|||++  
T Consensus        77 ~lV~Ey~~~gsL~~~l~-----------------------------------~~~l~~~~~~~i~~~ia~gl~ylH~~~~  121 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLN-----------------------------------RYTVTVEGMIKLALSTASGLAHLHMEIV  121 (303)
T ss_dssp             EEEEECCTTCBHHHHHH-----------------------------------HCCBCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred             EEEecCCCCCcHHHHHH-----------------------------------hCCCCHHHHHHHHHHHHHHHHHHHHhhh
Confidence            9999999864 433331                                   24688999999999999999999987  


Q ss_pred             ------CCeecCCCCCCeeecCCCcEEEEecccccccCCC--------CccccCcccccchhhcccC---CCCCCCcccH
Q psy17952        315 ------GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA--------NSFVGTPYWMAPEVILAMD---EGQYDGKVDV  377 (804)
Q Consensus       315 ------gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~--------~~~~GT~~Y~APEvl~~~~---~~~y~~ksDI  377 (804)
                            +||||||||+||||+.++.+||+|||+|+.....        .+.+||+.|||||++.+..   ...|+.++||
T Consensus       122 ~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DV  201 (303)
T 3hmm_A          122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI  201 (303)
T ss_dssp             STTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred             hccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhh
Confidence                  9999999999999999999999999999754321        2458999999999985421   1246789999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC
Q psy17952        378 WSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQ----SSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP  453 (804)
Q Consensus       378 WSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~----~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p  453 (804)
                      |||||+||||+||.+||...+...         .|...    ......+..........|+.                +.
T Consensus       202 wS~Gvvl~El~tg~~~~~~~~~~~---------~p~~~~~~~~~~~~~~~~~~~~~~~rp~~----------------p~  256 (303)
T 3hmm_A          202 YAMGLVFWEIARRCSIGGIHEDYQ---------LPYYDLVPSDPSVEEMRKVVCEQKLRPNI----------------PN  256 (303)
T ss_dssp             HHHHHHHHHHHHTBCBTTBCCCCC---------CTTTTTSCSSCCHHHHHHHHTTSCCCCCC----------------CG
T ss_pred             hhHHHHHHHHHHCCCCCCcccccc---------ccchhcccccchHHHHHHHHhcccCCCCC----------------Cc
Confidence            999999999999999885432110         01000    00000010000000000000                00


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       454 ~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .......++.+.+|+.+||+.||++|||+.|+++.
T Consensus       257 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            01122345678999999999999999999998853

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-48  Score=424.18  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=213.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            459999999999999999999999999999999864322 2344567889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+.                                 |++++...+.+++.++..++.||+.||+|||++||+||||
T Consensus        94 e~~~~~~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDl  140 (328)
T 3fe3_A           94 EYASGGE---------------------------------VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL  140 (328)
T ss_dssp             CCCTTCB---------------------------------HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             ECCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCC
Confidence            9998641                                 2222333467999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|+....   ....+||+.|+|||++.+   ..+ +.++|||||||++|||++|++||.+.
T Consensus       141 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~  217 (328)
T 3fe3_A          141 KAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQ  217 (328)
T ss_dssp             CGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT---CCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccC---CCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999975433   245689999999999853   345 46899999999999999999999988


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+..+..+                                           .+...|+++.+|+.+||+.||.
T Consensus       218 ~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~~L~~dP~  254 (328)
T 3fe3_A          218 NLKELRERVLRGKYR-------------------------------------------IPFYMSTDCENLLKRFLVLNPI  254 (328)
T ss_dssp             SHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHCCSSTT
T ss_pred             CHHHHHHHHHhCCCC-------------------------------------------CCCCCCHHHHHHHHHHCCCChh
Confidence            776666555433210                                           0123578899999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy17952        478 DRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~  494 (804)
                      +|||++|+|+||||...
T Consensus       255 ~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          255 KRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             TSCCHHHHTTCTTTTTT
T ss_pred             HCcCHHHHhcCHhhcCC
Confidence            99999999999999764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-48  Score=430.03  Aligned_cols=265  Identities=27%  Similarity=0.387  Sum_probs=220.8

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccch---hhhhhHHHHHHHHhhcCCCceeEeeeEE
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA---EKWADILKEIRFLRQLKHPNTIEYRGCY  231 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~HpNIV~l~~~~  231 (804)
                      +...+..+.|++.+.||+|+||.||+|++..+|+.||+|.+........   ...+.+.+|+.+|++++|||||+++++|
T Consensus         5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~   84 (361)
T 2yab_A            5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY   84 (361)
T ss_dssp             CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence            3445566779999999999999999999999999999999875332211   1245688999999999999999999999


Q ss_pred             eecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      .+.+.+|+|||||.|+                                 +|++++...+.+++.++..++.||+.||.||
T Consensus        85 ~~~~~~~lv~e~~~gg---------------------------------~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~L  131 (361)
T 2yab_A           85 ENRTDVVLILELVSGG---------------------------------ELFDFLAQKESLSEEEATSFIKQILDGVNYL  131 (361)
T ss_dssp             ECSSEEEEEEECCCSC---------------------------------BHHHHHTTCSCCBHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCEEEEEEEcCCCC---------------------------------cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            9999999999999865                                 2333444556799999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCC----cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETG----TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g----~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      |++||+||||||+|||++.++    .+||+|||+|+....   ....+||+.|+|||++.   ...|+.++|||||||++
T Consensus       132 H~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil  208 (361)
T 2yab_A          132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVIT  208 (361)
T ss_dssp             HHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             HHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHc---CCCCCccccHHHHHHHH
Confidence            999999999999999998877    799999999976433   24578999999999984   45789999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      |+|++|.+||.+.+..+.+..|..+....                   +                    ......+|+++
T Consensus       209 ~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------~--------------------~~~~~~~s~~~  249 (361)
T 2yab_A          209 YILLSGASPFLGDTKQETLANITAVSYDF-------------------D--------------------EEFFSQTSELA  249 (361)
T ss_dssp             HHHHHSCCSSCCSSHHHHHHHHHTTCCCC-------------------C--------------------HHHHTTSCHHH
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------------C--------------------chhccCCCHHH
Confidence            99999999999988877776665432210                   0                    00013468899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ++||.+||.+||.+|||+.|+|+||||...
T Consensus       250 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          250 KDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999999753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.5e-48  Score=422.88  Aligned_cols=253  Identities=26%  Similarity=0.435  Sum_probs=213.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||+||+|+++.+++.||||.+.............+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            45999999999999999999999999999999986432222334567889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+.                                 |+.++...+.+++..++.++.||+.||+|||++||+||||
T Consensus        85 E~~~gg~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl  131 (337)
T 1o6l_A           85 EYANGGE---------------------------------LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI  131 (337)
T ss_dssp             ECCTTCB---------------------------------HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred             eCCCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcC
Confidence            9998752                                 1222223457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.+|.+||+|||+|+...    ...+.+||+.|+|||++.   +..|+.++|||||||++|||++|++||.+.
T Consensus       132 kp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             CGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGS---SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhc---CCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence            9999999999999999999997532    234578999999999984   457899999999999999999999999887


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +.......+......                                           .+..+++++.+||.+||++||+
T Consensus       209 ~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~lL~~dP~  245 (337)
T 1o6l_A          209 DHERLFELILMEEIR-------------------------------------------FPRTLSPEAKSLLAGLLKKDPK  245 (337)
T ss_dssp             SHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHHHHHcCCCC-------------------------------------------CCCCCCHHHHHHHHHHhhcCHH
Confidence            766655554332110                                           1134688999999999999999


Q ss_pred             CCC-----CHHHHHcCccccC
Q psy17952        478 DRP-----SSGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rp-----sa~elL~Hp~~~~  493 (804)
                      +||     ++.++++||||..
T Consensus       246 ~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          246 QRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             TSTTCSTTTHHHHHTSGGGTT
T ss_pred             HhcCCCCCCHHHHHcCCCcCC
Confidence            999     9999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-47  Score=409.81  Aligned_cols=283  Identities=25%  Similarity=0.384  Sum_probs=217.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||+||+|++..+++.||||.+..... .......+.+|+.++++++||||+++++++.+++..|+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            359999999999999999999999999999999865332 2334467889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|++.+.+.                                 ...+.+++..+..++.|++.||+|||++||+||||
T Consensus        81 e~~~~~l~~~~~---------------------------------~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~di  127 (292)
T 3o0g_A           81 EFCDQDLKKYFD---------------------------------SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL  127 (292)
T ss_dssp             ECCSEEHHHHHH---------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             ecCCCCHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999987544331                                 12457999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC-CC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY-FN  396 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF-~~  396 (804)
                      ||+|||++.++.+||+|||+|+....    ....+||+.|+|||++.+  ...|+.++|||||||++|||++|..|| .+
T Consensus       128 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~~~~p~~~~  205 (292)
T 3o0g_A          128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT--CSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred             CHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcC--CCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence            99999999999999999999975432    234689999999999853  234889999999999999999887775 45


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+.+..+.+...... ...|..+....... ..+.+.            ............++++++||.+||+.||
T Consensus       206 ~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP  271 (292)
T 3o0g_A          206 NDVDDQLKRIFRLLGTPT-EEQWPSMTKLPDYK-PYPMYP------------ATTSLVNVVPKLNATGRDLLQNLLKCNP  271 (292)
T ss_dssp             SSHHHHHHHHHHHHCCCC-TTTCTTGGGSTTCC-CCCCCC------------TTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred             CCHHHHHHHHHHHhCCCC-hhhhhhhccccccc-cccccc------------CCcchhhcccccChHHHHHHHHHhccCh
Confidence            555556665554321111 11222221111100 000000            0001111224578999999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy17952        477 ADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~  494 (804)
                      ++|||++|+|+||||...
T Consensus       272 ~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          272 VQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GGSCCHHHHHTSGGGTTC
T ss_pred             hhCCCHHHHhcCcccccC
Confidence            999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=428.93  Aligned_cols=254  Identities=27%  Similarity=0.407  Sum_probs=211.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++++.||+|+||+||+|+++.+++.||||++.............+.+|..+|+.+ +|||||+++++|.+.+.+|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            3599999999999999999999999999999998653222333456678999999988 799999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+.                                 |+.++...+.+++..++.++.||+.||+|||++||+|||
T Consensus       103 ~E~~~gg~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrD  149 (353)
T 3txo_A          103 MEFVNGGD---------------------------------LMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRD  149 (353)
T ss_dssp             EECCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             EeCCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Confidence            99998752                                 222223346799999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.+|.+||+|||+|+...    ...+.+||+.|+|||++.+   ..|+.++|||||||++|||++|++||.+
T Consensus       150 lkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~  226 (353)
T 3txo_A          150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEA  226 (353)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH---HHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC---CCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence            99999999999999999999997532    2345789999999999853   4688999999999999999999999998


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+....|..+...                                           .+..+++++.+||.+||++||
T Consensus       227 ~~~~~~~~~i~~~~~~-------------------------------------------~p~~~~~~~~~li~~lL~~dP  263 (353)
T 3txo_A          227 ENEDDLFEAILNDEVV-------------------------------------------YPTWLHEDATGILKSFMTKNP  263 (353)
T ss_dssp             SSHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSSG
T ss_pred             CCHHHHHHHHHcCCCC-------------------------------------------CCCCCCHHHHHHHHHHhhhCH
Confidence            8887777666543211                                           012367889999999999999


Q ss_pred             CCCCCH------HHHHcCccccCC
Q psy17952        477 ADRPSS------GRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa------~elL~Hp~~~~~  494 (804)
                      ++||++      .++++||||...
T Consensus       264 ~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          264 TMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             GGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHccCCcccCCHHHHhhCCcccCC
Confidence            999999      899999999753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=417.15  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=214.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++..+++.||+|.+...........+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            45999999999999999999999999999999986432222234566789999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||.|+ +.+                                  ++...+.+++..++.++.||+.||+|||++||+|||
T Consensus        86 e~~~gg~L~~----------------------------------~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD  131 (318)
T 1fot_A           86 DYIEGGELFS----------------------------------LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD  131 (318)
T ss_dssp             CCCCSCBHHH----------------------------------HHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             eCCCCCCHHH----------------------------------HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            999875 322                                  223345789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |||+|||++.+|.+||+|||+|+.... ..+.+||+.|+|||++.   ...|+.++|||||||++|||++|.+||.+.+.
T Consensus       132 lkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  208 (318)
T 1fot_A          132 LKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT  208 (318)
T ss_dssp             CCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHT---TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CChheEEEcCCCCEEEeecCcceecCCccccccCCccccCHhHhc---CCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999976433 34678999999999984   45789999999999999999999999998877


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      ......+......                                           .+..+++++.+||.+||+.||++|
T Consensus       209 ~~~~~~i~~~~~~-------------------------------------------~p~~~~~~~~~li~~lL~~dp~~R  245 (318)
T 1fot_A          209 MKTYEKILNAELR-------------------------------------------FPPFFNEDVKDLLSRLITRDLSQR  245 (318)
T ss_dssp             HHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSCTTTC
T ss_pred             HHHHHHHHhCCCC-------------------------------------------CCCCCCHHHHHHHHHHhccCHHHc
Confidence            7666665442210                                           012468899999999999999999


Q ss_pred             C-----CHHHHHcCccccC
Q psy17952        480 P-----SSGRLLTHDLVTR  493 (804)
Q Consensus       480 p-----sa~elL~Hp~~~~  493 (804)
                      |     +++++++||||..
T Consensus       246 ~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          246 LGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             TTSSTTTTHHHHTSGGGSS
T ss_pred             CCCcCCCHHHHhcCccccC
Confidence            9     9999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.8e-47  Score=413.08  Aligned_cols=285  Identities=24%  Similarity=0.370  Sum_probs=214.2

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||.||+|++. +++.||+|++.... ........+.+|+++|++++||||+++++++.+.+..|+
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            3456999999999999999999985 58899999986432 223334678899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||||.|++.+.+.                                 .....+++..+..++.||+.||.|||++||+||
T Consensus        97 v~e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  143 (311)
T 3niz_A           97 VFEFMEKDLKKVLD---------------------------------ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHR  143 (311)
T ss_dssp             EEECCSEEHHHHHH---------------------------------TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEcCCCCCHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999987554432                                 123468999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+|||++.++.+||+|||+|+....    ....+||+.|+|||++.+  ...|+.++|||||||++|||++|++||.
T Consensus       144 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~  221 (311)
T 3niz_A          144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG--SKKYSTSVDIWSIGCIFAEMITGKPLFP  221 (311)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT--CCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC--CCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999975432    234579999999999853  3468899999999999999999999998


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+..+.+..+........ ...|.....+..........+...            ........+++++.+||.+||++|
T Consensus       222 ~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~L~~d  288 (311)
T 3niz_A          222 GVTDDDQLPKIFSILGTPN-PREWPQVQELPLWKQRTFQVFEKK------------PWSSIIPGFCQEGIDLLSNMLCFD  288 (311)
T ss_dssp             CSSTTTHHHHHHHHHCCCC-TTTSGGGTTSHHHHSCCCCCCCCC------------CHHHHSTTCCHHHHHHHHHHSCSC
T ss_pred             CCChHHHHHHHHHHHCCCC-hHHhhhhhccchhhhcccccccCC------------cHHHhCcccCHHHHHHHHHHcCCC
Confidence            8776666655544211110 011111111000000000000000            000112356889999999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy17952        476 PADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~~~  494 (804)
                      |++|||++|+|+||||+..
T Consensus       289 P~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          289 PNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             TTTSCCHHHHHTSGGGTTS
T ss_pred             hhHCCCHHHHhcCcccccC
Confidence            9999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=433.35  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=215.1

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+|++++|||||++++++.+.+..|+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS-CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3456999999999999999999999999999999986432 223345678899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||||.|+                                 +|++++...+.+++.++..++.||+.||.|||++||+||
T Consensus        88 v~E~~~gg---------------------------------~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHr  134 (444)
T 3soa_A           88 IFDLVTGG---------------------------------ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR  134 (444)
T ss_dssp             EECCCBCC---------------------------------BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEeCCCC---------------------------------CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999875                                 223333345679999999999999999999999999999


Q ss_pred             CCCCCCeeec---CCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        320 DVKAGNILLT---ETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       320 DLKP~NILl~---~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      ||||+|||++   .++.+||+|||+|......    ...+||+.|+|||++.   ...|+.++|||||||++|+|++|.+
T Consensus       135 DlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~DIwSlGvilyell~G~~  211 (444)
T 3soa_A          135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR---KDPYGKPVDLWACGVILYILLVGYP  211 (444)
T ss_dssp             CCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhc---CCCCCCccccHHHHHHHHHHHhCCC
Confidence            9999999998   4678999999999754332    3468999999999984   4578999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+..+....                                       +......+++++.+||.+||
T Consensus       212 Pf~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L  252 (444)
T 3soa_A          212 PFWDEDQHRLYQQIKAGAYDF---------------------------------------PSPEWDTVTPEAKDLINKML  252 (444)
T ss_dssp             SCCCSSHHHHHHHHHHTCCCC---------------------------------------CTTTTTTSCHHHHHHHHHHS
T ss_pred             CCCCccHHHHHHHHHhCCCCC---------------------------------------CccccccCCHHHHHHHHHHc
Confidence            999888777766665433211                                       11112356899999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +.||++|||+.|+|+||||..
T Consensus       253 ~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          253 TINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             CSSTTTSCCHHHHHHSCTTHH
T ss_pred             CCChhHCCCHHHHhcCccccC
Confidence            999999999999999999963

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-47  Score=413.18  Aligned_cols=294  Identities=22%  Similarity=0.313  Sum_probs=210.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++++.||+|+||.||+|++..+++.||||.+....  .....+.+.+|+.+|++++|||||++++++..++..|+||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            35999999999999999999999999999999886432  1223356789999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|++.+++....                            .......+++..+..++.||+.||.|||++||+||||
T Consensus        83 e~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl  134 (317)
T 2pmi_A           83 EFMDNDLKKYMDSRT----------------------------VGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL  134 (317)
T ss_dssp             ECCCCBHHHHHHHHH----------------------------SSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             EecCCCHHHHHHhcc----------------------------ccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence            999988766553110                            0012346899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|+....    ....+||+.|+|||++.+  ...|+.++|||||||++|||++|++||.+.
T Consensus       135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG--SRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999975432    234689999999999853  246889999999999999999999999998


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+..+....... ....|..+..+.......+.... .......       .......+++++.+||.+||+.||+
T Consensus       213 ~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-------~~~~~~~~~~~l~~li~~~L~~dP~  283 (317)
T 2pmi_A          213 NDEEQLKLIFDIMGTP-NESLWPSVTKLPKYNPNIQQRPP-RDLRQVL-------QPHTKEPLDGNLMDFLHGLLQLNPD  283 (317)
T ss_dssp             SHHHHHHHHHHHHCSC-CTTTCGGGGGCTTCCTTCCCCCC-CCSHHHH-------GGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred             ChHHHHHHHHHHhCCC-ChhHhhhhhhhhhcccccccccc-hhHHHhh-------cccccccCCHHHHHHHHHHCCCCcc
Confidence            8887777765532111 11122222211111000000000 0000000       0011235789999999999999999


Q ss_pred             CCCCHHHHHcCccccCCCC
Q psy17952        478 DRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~~~  496 (804)
                      +|||++|+|+||||.....
T Consensus       284 ~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          284 MRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GSCCHHHHTTSGGGGGGCC
T ss_pred             cCCCHHHHhCChhhhcccc
Confidence            9999999999999987544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.5e-47  Score=406.77  Aligned_cols=281  Identities=23%  Similarity=0.364  Sum_probs=214.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++ .+++.||+|++.... ........+.+|+.++++++||||+++++++...+..|+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccc-cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            3589999999999999999998 678999999986432 22223466789999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.|++.+++.                                 ...+.+++..+..++.||++||+|||++||+||||
T Consensus        80 e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  126 (288)
T 1ob3_A           80 EHLDQDLKKLLD---------------------------------VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL  126 (288)
T ss_dssp             ECCSEEHHHHHH---------------------------------TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EecCCCHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            999987655442                                 12356899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|+....    ....+||+.|+|||++.+  ...|+.++|||||||++|||++|++||.+.
T Consensus       127 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             CGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTT--CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999865332    234579999999999853  345889999999999999999999999998


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+..+.+...... ...|+.+.......   + .+.         .............+++++.+||.+||+.||+
T Consensus       205 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~-~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  270 (288)
T 1ob3_A          205 SEADQLMRIFRILGTPN-SKNWPNVTELPKYD---P-NFT---------VYEPLPWESFLKGLDESGIDLLSKMLKLDPN  270 (288)
T ss_dssp             SHHHHHHHHHHHHCCCC-TTTSTTGGGSTTCC---T-TCC---------CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHHHHHHHHCCCC-hhhchhhhcccccc---c-ccc---------cccCccHHHHhhhcCHHHHHHHHHHcCCCcc
Confidence            88777776654211111 11121111111000   0 000         0000000111245789999999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy17952        478 DRPSSGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~  493 (804)
                      +|||++|+|+||||..
T Consensus       271 ~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          271 QRITAKQALEHAYFKE  286 (288)
T ss_dssp             TSCCHHHHHTSGGGGC
T ss_pred             cCCCHHHHhcCcchhh
Confidence            9999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.9e-47  Score=419.70  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=215.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++..+++.||||.+...........+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            45999999999999999999999999999999986533222334567889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||.|+ +.+.                                  +...+.+++..++.++.||+.||+|||++||+|||
T Consensus       121 e~~~gg~L~~~----------------------------------l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD  166 (350)
T 1rdq_E          121 EYVAGGEMFSH----------------------------------LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD  166 (350)
T ss_dssp             ECCTTCBHHHH----------------------------------HHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             cCCCCCcHHHH----------------------------------HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence            999865 3222                                  22345789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA  399 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~  399 (804)
                      |||+|||++.+|.+||+|||+|+.... ..+.+||+.|+|||++.   ...|+.++|||||||++|||++|.+||.+.+.
T Consensus       167 lkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  243 (350)
T 1rdq_E          167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL---SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP  243 (350)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CccceEEECCCCCEEEcccccceeccCCcccccCCccccCHHHhc---CCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence            999999999999999999999976433 34678999999999985   35689999999999999999999999998877


Q ss_pred             HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q psy17952        400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADR  479 (804)
Q Consensus       400 ~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~R  479 (804)
                      .+....|..+..+                                           .+..+++++.+||.+||+.||.+|
T Consensus       244 ~~~~~~i~~~~~~-------------------------------------------~p~~~~~~~~~li~~lL~~dp~~R  280 (350)
T 1rdq_E          244 IQIYEKIVSGKVR-------------------------------------------FPSHFSSDLKDLLRNLLQVDLTKR  280 (350)
T ss_dssp             HHHHHHHHHCCCC-------------------------------------------CCTTCCHHHHHHHHHHSCSCTTTC
T ss_pred             HHHHHHHHcCCCC-------------------------------------------CCCCCCHHHHHHHHHHhhcCHHhc
Confidence            7666665443210                                           113468899999999999999999


Q ss_pred             CC-----HHHHHcCccccC
Q psy17952        480 PS-----SGRLLTHDLVTR  493 (804)
Q Consensus       480 ps-----a~elL~Hp~~~~  493 (804)
                      |+     ++++++||||..
T Consensus       281 ~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          281 FGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             TTSSTTTTHHHHTSGGGTT
T ss_pred             cCCccCCHHHHHhCcCcCC
Confidence            99     999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=414.64  Aligned_cols=266  Identities=26%  Similarity=0.406  Sum_probs=218.8

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccch---hhhhhHHHHHHHHhhcCCCceeEeeeEE
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA---EKWADILKEIRFLRQLKHPNTIEYRGCY  231 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~HpNIV~l~~~~  231 (804)
                      +...+..+.|++.+.||+|+||.||+|++..+++.||+|.+........   ...+.+.+|+.+|++++||||+++++++
T Consensus         4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A            4 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             CBCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3445566779999999999999999999999999999998865332111   1246688999999999999999999999


Q ss_pred             eecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      .+....|+|||||.|+.                                 |.+++...+.+++.++..++.||+.||.||
T Consensus        84 ~~~~~~~lv~e~~~~~~---------------------------------L~~~l~~~~~~~~~~~~~i~~qi~~al~~l  130 (326)
T 2y0a_A           84 ENKTDVILILELVAGGE---------------------------------LFDFLAEKESLTEEEATEFLKQILNGVYYL  130 (326)
T ss_dssp             ECSSEEEEEEECCCSCB---------------------------------HHHHHTTSSCCBHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCEEEEEEEcCCCCC---------------------------------HHHHHHhcCCcCHHHHHHHHHHHHHHHHHH
Confidence            99999999999998641                                 222333456799999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCC----cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETG----TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g----~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      |++||+||||||+|||++.++    .+||+|||+|+....   ....+||+.|+|||++.   ...|+.++|||||||++
T Consensus       131 H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  207 (326)
T 2y0a_A          131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVIT  207 (326)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             HHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeec---CCCCCcHHHHHHHHHHH
Confidence            999999999999999999887    899999999976432   24568999999999984   45789999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      |||++|.+||.+.+..+.+..+.......                   +                    .......++.+
T Consensus       208 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~--------------------~~~~~~~~~~~  248 (326)
T 2y0a_A          208 YILLSGASPFLGDTKQETLANVSAVNYEF-------------------E--------------------DEYFSNTSALA  248 (326)
T ss_dssp             HHHHHSCCSSCCSSHHHHHHHHHHTCCCC-------------------C--------------------HHHHTTSCHHH
T ss_pred             HHHHHCcCCCCCCCHHHHHHHHHhcCCCc-------------------C--------------------ccccccCCHHH
Confidence            99999999998887776666554322110                   0                    00013457899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||.+||+.||++|||+.++|+||||....
T Consensus       249 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999997643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-47  Score=421.02  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=212.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++.+.||+|+||.||+|+++.+++.||||.++............+.+|..+|+.+ +||||+++++++.+.+.+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            3599999999999999999999999999999998643222223345678899999987 899999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+.                                 |++++...+.+++..+..++.||+.||+|||++||+|||
T Consensus        97 ~E~~~gg~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD  143 (345)
T 1xjd_A           97 MEYLNGGD---------------------------------LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRD  143 (345)
T ss_dssp             EECCTTCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             EeCCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence            99998652                                 222222345789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.+|.+||+|||+|+...    ...+.+||+.|+|||++.   +..|+.++|||||||++|||++|.+||.+
T Consensus       144 lkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhc---CCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            99999999999999999999997532    234678999999999985   35689999999999999999999999998


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+....|......                                           .+..+++++.+||.+||+.||
T Consensus       221 ~~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~lL~~dp  257 (345)
T 1xjd_A          221 QDEEELFHSIRMDNPF-------------------------------------------YPRWLEKEAKDLLVKLFVREP  257 (345)
T ss_dssp             SSHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHSCSSG
T ss_pred             CCHHHHHHHHHhCCCC-------------------------------------------CCcccCHHHHHHHHHHhcCCH
Confidence            8776666555432110                                           012368899999999999999


Q ss_pred             CCCCCHH-HHHcCccccCC
Q psy17952        477 ADRPSSG-RLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa~-elL~Hp~~~~~  494 (804)
                      ++||++. ++++||||...
T Consensus       258 ~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          258 EKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             GGSBTTBSCGGGSGGGTTC
T ss_pred             hHcCCChHHHHcCccccCC
Confidence            9999998 99999999753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.1e-47  Score=426.27  Aligned_cols=262  Identities=26%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++++.||+|+||+||+|+++.+++.||+|+++..........+.+.+|..+|+++ +|||||+++++|.+.+.+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            4599999999999999999999999999999998754333344456678999999887 899999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+.                                 |+.++...+.+++..++.++.||+.||+|||++||+|||
T Consensus       132 ~E~~~gg~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD  178 (396)
T 4dc2_A          132 IEYVNGGD---------------------------------LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD  178 (396)
T ss_dssp             EECCTTCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             EEcCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecc
Confidence            99998752                                 222223345799999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.+|.+||+|||+|+...    ...+.+||+.|+|||++.   +..|+.++|||||||++|||++|++||..
T Consensus       179 LKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             CCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhc---CCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999999997522    234679999999999985   35789999999999999999999999964


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      ........          ..........+                      ... .+ ..+..++.++++||.+||++||
T Consensus       256 ~~~~~~~~----------~~~~~~~~~~i----------------------~~~-~~-~~p~~~s~~~~~li~~lL~~dP  301 (396)
T 4dc2_A          256 VGSSDNPD----------QNTEDYLFQVI----------------------LEK-QI-RIPRSLSVKAASVLKSFLNKDP  301 (396)
T ss_dssp             TTC----------------CCHHHHHHHH----------------------HHC-CC-CCCTTSCHHHHHHHHHHTCSCT
T ss_pred             cccccccc----------hhhHHHHHHHH----------------------hcc-cc-CCCCcCCHHHHHHHHHHhcCCH
Confidence            32111000          00000000000                      000 01 1123578999999999999999


Q ss_pred             CCCCCH------HHHHcCccccC
Q psy17952        477 ADRPSS------GRLLTHDLVTR  493 (804)
Q Consensus       477 ~~Rpsa------~elL~Hp~~~~  493 (804)
                      .+||++      +|+++||||..
T Consensus       302 ~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          302 KERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             TTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             hHcCCCCCCCCHHHHhcCccccC
Confidence            999995      89999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-47  Score=425.65  Aligned_cols=287  Identities=26%  Similarity=0.394  Sum_probs=208.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecC--ceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDH--TAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~--~~~  238 (804)
                      +.|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+++. |||||++++++...+  .+|
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            45999999999999999999999999999999886432 22344567889999999997 999999999997544  689


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|++.+++.                                   ...+++..+..++.||+.||+|||++||+|
T Consensus        88 lv~e~~~~~L~~~~~-----------------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH  132 (388)
T 3oz6_A           88 LVFDYMETDLHAVIR-----------------------------------ANILEPVHKQYVVYQLIKVIKYLHSGGLLH  132 (388)
T ss_dssp             EEEECCSEEHHHHHH-----------------------------------HTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecccCcCHHHHHH-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence            999999987554432                                   236889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-------------------------CCccccCcccccchhhcccCCCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-------------------------ANSFVGTPYWMAPEVILAMDEGQYDG  373 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-------------------------~~~~~GT~~Y~APEvl~~~~~~~y~~  373 (804)
                      |||||+|||++.++.+||+|||+|+....                         ....+||+.|+|||++.+  ...|+.
T Consensus       133 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~  210 (388)
T 3oz6_A          133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG--STKYTK  210 (388)
T ss_dssp             CCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT--CCCCCT
T ss_pred             CCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC--CCCCCC
Confidence            99999999999999999999999964321                         124689999999999853  356899


Q ss_pred             cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCC------CCc-hhhHHhhcccc----cCCCCccchhhh
Q psy17952        374 KVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQN-DTPCLQ------SSD-WSVIKTISSTA----ERKPPYFNMNAM  441 (804)
Q Consensus       374 ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~-~~p~~~------~~~-~~~i~~i~~~~----~~~pp~~~~~~~  441 (804)
                      ++|||||||++|||++|++||.+.+....+..|... ..|...      ... ...+..+....    ......+.. ..
T Consensus       211 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  289 (388)
T 3oz6_A          211 GIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK-WK  289 (388)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH-HH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc-hh
Confidence            999999999999999999999999988888877642 222110      000 00000000000    000000000 00


Q ss_pred             HHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        442 SALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       442 ~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ..+..       .......++++.+||.+||+.||++|||++|+|+||||+.-
T Consensus       290 ~~~~~-------~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          290 NLLLK-------INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             HHHHH-------HCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             hhccc-------ccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence            00000       01123578999999999999999999999999999998753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.9e-47  Score=420.01  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=215.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+|++++|||||++++++.+.+..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4569999999999999999999999999999999864322 234456788999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+                                 +|++++.....+++.++..++.||+.||.|||++||+|||
T Consensus       107 ~e~~~gg---------------------------------~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~D  153 (362)
T 2bdw_A          107 FDLVTGG---------------------------------ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN  153 (362)
T ss_dssp             ECCCCSC---------------------------------BHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             EecCCCC---------------------------------CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence            9999875                                 2233334456799999999999999999999999999999


Q ss_pred             CCCCCeeecCCC---cEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        321 VKAGNILLTETG---TVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       321 LKP~NILl~~~g---~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||+|||++.++   .+||+|||+|......   ...+||+.|+|||++.   ...|+.++|||||||++|||++|.+||
T Consensus       154 lkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~Pf  230 (362)
T 2bdw_A          154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYILLVGYPPF  230 (362)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHc---cCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999998654   5999999999764432   3468999999999984   457899999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+.......+..+....                                       +......+++++.+||.+||+.
T Consensus       231 ~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~~~~~~~li~~~L~~  271 (362)
T 2bdw_A          231 WDEDQHRLYAQIKAGAYDY---------------------------------------PSPEWDTVTPEAKSLIDSMLTV  271 (362)
T ss_dssp             CCSSHHHHHHHHHHTCCCC---------------------------------------CTTGGGGSCHHHHHHHHHHSCS
T ss_pred             CCCCHHHHHHHHHhCCCCC---------------------------------------CcccccCCCHHHHHHHHHHcCC
Confidence            9887776666655432110                                       0111124588999999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy17952        475 NPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||++|||+.++|+||||..
T Consensus       272 dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          272 NPKKRITADQALKVPWICN  290 (362)
T ss_dssp             SGGGSCCHHHHTTSHHHHT
T ss_pred             ChhhCcCHHHHhcCcccCC
Confidence            9999999999999999964

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-47  Score=414.92  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=213.6

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||+|.+...    ......+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            45699999999999999999999999999999988632    22335678999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~-~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+.                                 |++++.. ...+++.++..++.||+.||.|||++||+||
T Consensus        80 ~e~~~g~~---------------------------------L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~  126 (321)
T 1tki_A           80 FEFISGLD---------------------------------IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF  126 (321)
T ss_dssp             ECCCCCCB---------------------------------HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEeCCCCC---------------------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcC
Confidence            99998751                                 2222222 3469999999999999999999999999999


Q ss_pred             CCCCCCeeecC--CCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        320 DVKAGNILLTE--TGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       320 DLKP~NILl~~--~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||||+|||++.  ++.+||+|||+|+.....   ...+||+.|+|||++.   ...++.++|||||||++|||++|.+||
T Consensus       127 Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf  203 (321)
T 1tki_A          127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ---HDVVSTATDMWSLGTLVYVLLSGINPF  203 (321)
T ss_dssp             CCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHT---TCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999987  789999999999765433   2457999999999984   345788999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+.+..+..+..+..                                       ......+|+++.+||.+||..
T Consensus       204 ~~~~~~~~~~~i~~~~~~~~---------------------------------------~~~~~~~s~~~~~li~~~L~~  244 (321)
T 1tki_A          204 LAETNQQIIENIMNAEYTFD---------------------------------------EEAFKEISIEAMDFVDRLLVK  244 (321)
T ss_dssp             CCSSHHHHHHHHHHTCCCCC---------------------------------------HHHHTTSCHHHHHHHHTTSCS
T ss_pred             cCCCHHHHHHHHHcCCCCCC---------------------------------------hhhhccCCHHHHHHHHHHcCC
Confidence            98887777766654332110                                       000134688999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ||.+|||+.|+|+||||...
T Consensus       245 dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          245 ERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SGGGSCCHHHHHHSHHHHSC
T ss_pred             ChhHCcCHHHHhcChhhccC
Confidence            99999999999999999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.7e-47  Score=418.40  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=212.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ..|++++.||+|+||.||+|++..+++.||||.+...........+.+.+|..+|+.+ +||||+++++++.+.+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            3499999999999999999999999999999998653222233456678999999988 799999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ |.+                                  ++...+.+++..++.++.||+.||+|||++||+||
T Consensus       100 ~E~~~gg~L~~----------------------------------~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHr  145 (353)
T 2i0e_A          100 MEYVNGGDLMY----------------------------------HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR  145 (353)
T ss_dssp             EECCCSCBHHH----------------------------------HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EeCCCCCcHHH----------------------------------HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence            9999875 322                                  22234578999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+|||++.+|.+||+|||+|+...    ...+.+||+.|+|||++.   ...|+.++|||||||++|||++|++||.
T Consensus       146 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~G~~Pf~  222 (353)
T 2i0e_A          146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFE  222 (353)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT---TCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhc---CCCcCCcccccchHHHHHHHHcCCCCCC
Confidence            999999999999999999999997532    234678999999999984   4578999999999999999999999999


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+..+....|......                                           .+..+++++.+||.+||++|
T Consensus       223 ~~~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~lL~~d  259 (353)
T 2i0e_A          223 GEDEDELFQSIMEHNVA-------------------------------------------YPKSMSKEAVAICKGLMTKH  259 (353)
T ss_dssp             CSSHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSC
T ss_pred             CCCHHHHHHHHHhCCCC-------------------------------------------CCCCCCHHHHHHHHHHhhcC
Confidence            88777666665432210                                           11346889999999999999


Q ss_pred             CCCCCC-----HHHHHcCccccC
Q psy17952        476 PADRPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       476 P~~Rps-----a~elL~Hp~~~~  493 (804)
                      |.+||+     +.++++||||..
T Consensus       260 P~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          260 PGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             TTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHcCCCCCCCHHHHhcCccccC
Confidence            999994     699999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-46  Score=415.24  Aligned_cols=262  Identities=27%  Similarity=0.414  Sum_probs=207.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++++.||+|+||.||+|+++.+++.||||++...........+.+.+|+.+++++ +|||||+++++|.+.+.+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            3599999999999999999999999999999998754433444556788999999988 899999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+.                                 |.+++...+.+++..++.++.||+.||+|||++||+|||
T Consensus        89 ~e~~~gg~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD  135 (345)
T 3a8x_A           89 IEYVNGGD---------------------------------LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD  135 (345)
T ss_dssp             ECCCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             EeCCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence            99998752                                 112222345789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.+|.+||+|||+|+...    ...+.+||+.|+|||++.   ...|+.++|||||||++|||++|++||..
T Consensus       136 lkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccC---CCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            99999999999999999999997532    234578999999999985   35789999999999999999999999964


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      ........          ..........                      +... .. ..+..++.++++||.+||++||
T Consensus       213 ~~~~~~~~----------~~~~~~~~~~----------------------i~~~-~~-~~p~~~s~~~~~li~~lL~~dP  258 (345)
T 3a8x_A          213 VGSSDNPD----------QNTEDYLFQV----------------------ILEK-QI-RIPRSLSVKAASVLKSFLNKDP  258 (345)
T ss_dssp             TTC-----------------CHHHHHHH----------------------HHHC-CC-CCCTTSCHHHHHHHHHHTCSST
T ss_pred             cccccccc----------cccHHHHHHH----------------------HHcC-CC-CCCCCCCHHHHHHHHHHhcCCH
Confidence            21100000          0000000000                      0000 01 1123578999999999999999


Q ss_pred             CCCCCH------HHHHcCccccC
Q psy17952        477 ADRPSS------GRLLTHDLVTR  493 (804)
Q Consensus       477 ~~Rpsa------~elL~Hp~~~~  493 (804)
                      .+||++      +++++||||..
T Consensus       259 ~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          259 KERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             TTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             hHCCCCCCcCCHHHHhcCCccCC
Confidence            999995      89999999964

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=404.61  Aligned_cols=257  Identities=26%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccc-----------------------hhhhhhHHHHHHHHhh
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC-----------------------AEKWADILKEIRFLRQ  218 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~-----------------------~~~~~~~~~Ei~iL~~  218 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||.+.......                       ....+.+.+|+++|++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            45999999999999999999999999999999986432111                       1123568899999999


Q ss_pred             cCCCceeEeeeEEee--cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHH
Q psy17952        219 LKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEE  296 (804)
Q Consensus       219 L~HpNIV~l~~~~~~--~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~  296 (804)
                      ++||||+++++++.+  .+..|+|||||.|+..                                 .++ ....++++.+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l---------------------------------~~~-~~~~~~~~~~  138 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------------------------------MEV-PTLKPLSEDQ  138 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBS---------------------------------CCS-SCSSCCCHHH
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcH---------------------------------HHH-hhcCCCCHHH
Confidence            999999999999986  5678999999987521                                 111 1245799999


Q ss_pred             HHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCC
Q psy17952        297 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYD  372 (804)
Q Consensus       297 i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~  372 (804)
                      +..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....    ...+||+.|+|||++.+.....++
T Consensus       139 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  218 (298)
T 2zv2_A          139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSG  218 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEES
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCC
Confidence            9999999999999999999999999999999999999999999999754332    346899999999998532111246


Q ss_pred             CcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC
Q psy17952        373 GKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT  452 (804)
Q Consensus       373 ~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~  452 (804)
                      .++|||||||++|||++|+.||.+.+.......+.....                                         
T Consensus       219 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------------------------------  257 (298)
T 2zv2_A          219 KALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL-----------------------------------------  257 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------------------------------
T ss_pred             chhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccC-----------------------------------------
Confidence            789999999999999999999987765554443322110                                         


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       453 p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +......+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          258 EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            00112356899999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-46  Score=408.10  Aligned_cols=272  Identities=38%  Similarity=0.660  Sum_probs=224.2

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      ....++...|+..+.||+|+||.||+|++..+|+.||||.+....   ....+.+.+|+.+|++++||||+++++++...
T Consensus        38 ~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (321)
T 2c30_A           38 VDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG  114 (321)
T ss_dssp             SCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             cCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence            344566667889999999999999999999999999999886432   22345688999999999999999999999999


Q ss_pred             CceEEEEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +..|+||||+.|+. .+++                                   ....+++..+..++.|++.||.|||+
T Consensus       115 ~~~~lv~e~~~~~~L~~~l-----------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~  159 (321)
T 2c30_A          115 EELWVLMEFLQGGALTDIV-----------------------------------SQVRLNEEQIATVCEAVLQALAYLHA  159 (321)
T ss_dssp             TEEEEEECCCCSCBHHHHH-----------------------------------TTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEecCCCCCHHHHH-----------------------------------HhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999998752 2221                                   13468999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||+||||||+|||++.++.+||+|||+++....    ....+||+.|+|||++.   ...++.++|||||||++|||++
T Consensus       160 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~  236 (321)
T 2c30_A          160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RSLYATEVDIWSLGIMVIEMVD  236 (321)
T ss_dssp             TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhc---CCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999999875432    23568999999999984   4578999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |+.||.+.+....+..+.....+..                                        .....+++.+.+|+.
T Consensus       237 g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~  276 (321)
T 2c30_A          237 GEPPYFSDSPVQAMKRLRDSPPPKL----------------------------------------KNSHKVSPVLRDFLE  276 (321)
T ss_dssp             SSCTTTTSCHHHHHHHHHHSSCCCC----------------------------------------TTGGGSCHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCc----------------------------------------CccccCCHHHHHHHH
Confidence            9999988777666555433221100                                        011235788999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHH
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRT  507 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~  507 (804)
                      +||+.||++|||+.++|+||||.+...+..+..+++..
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~  314 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLY  314 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGGCCCGGGGHHHHHHC
T ss_pred             HHccCChhhCcCHHHHhcChhhccCCCcccchHHHHHH
Confidence            99999999999999999999999877777666655443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=420.49  Aligned_cols=258  Identities=27%  Similarity=0.418  Sum_probs=212.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++..+++.||+|.+.............+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            35699999999999999999999999999999998643322333456788999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+.                                 |..++...+.+++..++.++.||+.||.|||++||+|||
T Consensus        94 ~e~~~gg~---------------------------------L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD  140 (384)
T 4fr4_A           94 VDLLLGGD---------------------------------LRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD  140 (384)
T ss_dssp             ECCCTTEE---------------------------------HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             EecCCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence            99998752                                 222333456799999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |||+|||++.+|.+||+|||+|+....   ..+.+||+.|+|||++....+..|+.++|||||||++|||++|++||...
T Consensus       141 lkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999975432   34678999999999986533456899999999999999999999999753


Q ss_pred             Ch---HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        398 NA---MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       398 ~~---~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      +.   ......+...                                           ....+..+++++.+||.+||+.
T Consensus       221 ~~~~~~~~~~~~~~~-------------------------------------------~~~~p~~~s~~~~~li~~lL~~  257 (384)
T 4fr4_A          221 SSTSSKEIVHTFETT-------------------------------------------VVTYPSAWSQEMVSLLKKLLEP  257 (384)
T ss_dssp             TTSCHHHHHHHHHHC-------------------------------------------CCCCCTTSCHHHHHHHHHHSCS
T ss_pred             CCccHHHHHHHHhhc-------------------------------------------ccCCCCcCCHHHHHHHHHHhcC
Confidence            32   1111111100                                           0011235789999999999999


Q ss_pred             CCCCCCC-HHHHHcCccccCC
Q psy17952        475 NPADRPS-SGRLLTHDLVTRP  494 (804)
Q Consensus       475 dP~~Rps-a~elL~Hp~~~~~  494 (804)
                      ||.+||+ ++++++||||...
T Consensus       258 dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          258 NPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             SGGGSCCSHHHHHTSGGGTTC
T ss_pred             CHhHhcccHHHHHcChhhhcC
Confidence            9999998 8999999999753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-47  Score=432.77  Aligned_cols=283  Identities=27%  Similarity=0.361  Sum_probs=197.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----Cc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----HT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----~~  236 (804)
                      +.|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+|+.++|||||++++++...     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            56999999999999999999999999999999886432 2233456788999999999999999999998543     56


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +|+||||+.|++.+++                                  .....+++..++.|+.||+.||+|||++||
T Consensus       132 ~~lv~e~~~~~L~~~~----------------------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i  177 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLF----------------------------------RTPVYLTELHIKTLLYNLLVGVKYVHSAGI  177 (458)
T ss_dssp             EEEEECCCSEEHHHHH----------------------------------HSSCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEEEeccccchhhhc----------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            8999999987654433                                  234579999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC-------------------------------CCccccCcccccchhhcc
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP-------------------------------ANSFVGTPYWMAPEVILA  365 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~-------------------------------~~~~~GT~~Y~APEvl~~  365 (804)
                      |||||||+||||+.++.+||+|||+|+....                               ....+||+.|+|||++..
T Consensus       178 iHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  257 (458)
T 3rp9_A          178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL  257 (458)
T ss_dssp             BCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT
T ss_pred             CCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC
Confidence            9999999999999999999999999975321                               134588999999998743


Q ss_pred             cCCCCCCCcccHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------HHHHHHHHhc-CCCC
Q psy17952        366 MDEGQYDGKVDVWSLGITCIELAE-----------RKPPYFNMNA--------------------MSALYHIAQN-DTPC  413 (804)
Q Consensus       366 ~~~~~y~~ksDIWSlGvil~ELlt-----------G~~PF~~~~~--------------------~~~l~~I~~~-~~p~  413 (804)
                        ...|+.++|||||||++|||++           |++||.+.+.                    .+.+..|... ..|.
T Consensus       258 --~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~  335 (458)
T 3rp9_A          258 --QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS  335 (458)
T ss_dssp             --CCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC
T ss_pred             --CCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC
Confidence              4569999999999999999999           7777766542                    2222222211 1110


Q ss_pred             CCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCC--CCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        414 LQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND--TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       414 ~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~--~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                           ...+..+..          ......+.......  ......+..++++.+||.+||++||++|||++|+|+||||
T Consensus       336 -----~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f  400 (458)
T 3rp9_A          336 -----EEDIEALEK----------EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF  400 (458)
T ss_dssp             -----HHHHHTSSC----------HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             -----HHHHhhcCC----------HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence                 000000000          00000000000000  0011123568999999999999999999999999999999


Q ss_pred             cCCCC
Q psy17952        492 TRPRS  496 (804)
Q Consensus       492 ~~~~~  496 (804)
                      .....
T Consensus       401 ~~~~~  405 (458)
T 3rp9_A          401 KEVRI  405 (458)
T ss_dssp             TTTCC
T ss_pred             hhcCC
Confidence            87543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-47  Score=433.94  Aligned_cols=287  Identities=28%  Similarity=0.403  Sum_probs=210.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      +.|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|+.++|||||++++++....      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46999999999999999999999999999999986432 22344567889999999999999999999997654      


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+|+|||||.|++.+.+                                    ...+++..++.++.||+.||+|||++|
T Consensus       141 ~~~lv~E~~~~~l~~~~------------------------------------~~~l~~~~~~~~~~qil~aL~~lH~~~  184 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVI------------------------------------QMELDHERMSYLLYQMLCGIKHLHSAG  184 (464)
T ss_dssp             EEEEEEECCSEEHHHHH------------------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEeCCCCCHHHHH------------------------------------hhcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            46999999998754322                                    124889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |+||||||+|||++.++.+||+|||+|+....   ....+||+.|+|||++.+   ..|+.++|||||||++|||++|++
T Consensus       185 iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~  261 (464)
T 3ttj_A          185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKI  261 (464)
T ss_dssp             CCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC---CCCCHHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999976543   245789999999999953   579999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhc----ccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTIS----STAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~----~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ||.+.+..+.+..|... ..|..     ..+..+.    ......|.+... .....+...............++++.+|
T Consensus       262 pF~g~~~~~~~~~i~~~lg~p~~-----~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dL  335 (464)
T 3ttj_A          262 LFPGRDYIDQWNKVIEQLGTPCP-----EFMKKLQPTVRNYVENRPKYAGL-TFPKLFPDSLFPADSEHNKLKASQARDL  335 (464)
T ss_dssp             SSCCSSHHHHHHHHHHHHCSCCH-----HHHTTSCHHHHHHHTTSCCCCCC-CHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCH-----HHHHHcchhhhhHhhcccccCCC-ChHHhCcccccccccccccccCHHHHHH
Confidence            99999988888887653 22211     0010000    000000110000 0000000000000000000126789999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |.+||++||++|||++|+|+||||...
T Consensus       336 l~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          336 LSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            999999999999999999999999753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=403.68  Aligned_cols=282  Identities=30%  Similarity=0.403  Sum_probs=212.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEeccccccc--chhhhhhHHHHHHHHhhcC---CCceeEeeeEEeecC-
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLK---HPNTIEYRGCYLRDH-  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~---HpNIV~l~~~~~~~~-  235 (804)
                      ..|++++.||+|+||+||+|++..+++.||||.+......  .......+.+|+.+++.++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            4599999999999999999999999999999988643211  1112245677888877765   999999999998765 


Q ss_pred             ----ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        236 ----TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       236 ----~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                          ..|+||||+.|++.+++..                                .....+++.++..++.||+.||+||
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~i~~qi~~al~~l  136 (308)
T 3g33_A           89 DREIKVTLVFEHVDQDLRTYLDK--------------------------------APPPGLPAETIKDLMRQFLRGLDFL  136 (308)
T ss_dssp             SSEEEEEEEEECCCCBHHHHHHT--------------------------------CCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCceeEEEEehhhhcCHHHHHhh--------------------------------ccCCCCCHHHHHHHHHHHHHHHHHH
Confidence                4899999999876554430                                1123489999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |++||+||||||+|||++.++.+||+|||+|+....   ....+||+.|+|||++.   ...|+.++|||||||++|||+
T Consensus       137 H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~  213 (308)
T 3g33_A          137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMF  213 (308)
T ss_dssp             HHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH---TSCCCSTHHHHHHHHHHHHTT
T ss_pred             HHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHc---CCCCCchHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999975432   23468999999999985   356899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|++||.+.+..+.+..+......... ..|........  ...++..             ........+.+++++.+||
T Consensus       214 ~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~--~~~~~~~-------------~~~~~~~~~~~~~~~~~li  277 (308)
T 3g33_A          214 RRKPLFCGNSEADQLGKIFDLIGLPPE-DDWPRDVSLPR--GAFPPRG-------------PRPVQSVVPEMEESGAQLL  277 (308)
T ss_dssp             TSSCSCCCSSHHHHHHHHHHHHCCCCT-TTSCSSCSSCG--GGSCCCC-------------CCCHHHHSCSCCHHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCh-hhccchhhccc--cccCCCC-------------CCcHHHhCccccHHHHHHH
Confidence            999999999888877777653211111 11110000000  0000000             0000011245789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||++||++|||+.|+|+||||...
T Consensus       278 ~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          278 LEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HHHhcCCCccCCCHHHHhcCccccCC
Confidence            99999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.1e-47  Score=426.83  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=214.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||+||+|+++.+++.||+|++...........+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            34599999999999999999999999999999998643222222335578999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ |.+++                                   ....+++..++.++.||+.||+|||++||+||
T Consensus       148 ~E~~~gg~L~~~l-----------------------------------~~~~~~e~~~~~~~~qi~~aL~~LH~~givHr  192 (410)
T 3v8s_A          148 MEYMPGGDLVNLM-----------------------------------SNYDVPEKWARFYTAEVVLALDAIHSMGFIHR  192 (410)
T ss_dssp             ECCCTTEEHHHHH-----------------------------------HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EeCCCCCcHHHHH-----------------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            9999865 32222                                   12468999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCC-CCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~-~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.+|.+||+|||+|+....     ..+.+||+.|+|||++.+... +.|+.++|||||||++|||++|++|
T Consensus       193 DLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  272 (410)
T 3v8s_A          193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  272 (410)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence            9999999999999999999999975433     236789999999999964211 1278899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......|..+...                                       ........+|+++++||.+||+
T Consensus       273 f~~~~~~~~~~~i~~~~~~---------------------------------------~~~p~~~~~s~~~~~li~~lL~  313 (410)
T 3v8s_A          273 FYADSLVGTYSKIMNHKNS---------------------------------------LTFPDDNDISKEAKNLICAFLT  313 (410)
T ss_dssp             TCCSSHHHHHHHHHTHHHH---------------------------------------CCCCTTCCCCHHHHHHHHHHSS
T ss_pred             CCCCChhhHHHHHHhcccc---------------------------------------ccCCCcccccHHHHHHHHHHcc
Confidence            9988877776666432100                                       0001123578999999999999


Q ss_pred             cCCCC--CCCHHHHHcCccccCC
Q psy17952        474 KNPAD--RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~--Rpsa~elL~Hp~~~~~  494 (804)
                      .+|.+  ||+++|+++||||...
T Consensus       314 ~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          314 DREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             CGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             ChhhhCCCCCHHHHhcCccccCC
Confidence            99998  9999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-47  Score=412.57  Aligned_cols=282  Identities=22%  Similarity=0.372  Sum_probs=211.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++..+++.||||++.....  ......+.+|+.+|++++||||+++++++...+..|+||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            359999999999999999999999999999998864322  122234568999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|++.+.+.                                 .....+++..+..++.||+.||.|||++||+||||
T Consensus        80 e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Di  126 (324)
T 3mtl_A           80 EYLDKDLKQYLD---------------------------------DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL  126 (324)
T ss_dssp             ECCSEEHHHHHH---------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSC
T ss_pred             cccccCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCc
Confidence            999987655442                                 12346899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|+....    ....+||+.|+|||++.+  ...|+.++|||||||++|||++|++||.+.
T Consensus       127 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          127 KPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG--STDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             CGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999875432    234578999999999853  346889999999999999999999999998


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcc-cccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISS-TAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~-~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      +..+.+..+.+........ .|+....... .....+.+..             .........+++++.+||.+||+.||
T Consensus       205 ~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~L~~dP  270 (324)
T 3mtl_A          205 TVEEQLHFIFRILGTPTEE-TWPGILSNEEFKTYNYPKYRA-------------EALLSHAPRLDSDGADLLTKLLQFEG  270 (324)
T ss_dssp             SHHHHHHHHHHHHCCCCTT-TSTTGGGCHHHHHTCCCCCCC-------------CCHHHHCTTSCHHHHHHHHHHSCSSG
T ss_pred             CHHHHHHHHHHHhCCCChH-hchhhhcchhhcccccccccc-------------hhhhhhcCCCCHHHHHHHHHHcCcCc
Confidence            8887777765532211111 1111000000 0000000000             00001124578999999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy17952        477 ADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~  494 (804)
                      ++|||++|+|+||||...
T Consensus       271 ~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          271 RNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             GGSCCHHHHTTSGGGGGG
T ss_pred             ccCCCHHHHhcChhhhhc
Confidence            999999999999999753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-46  Score=408.81  Aligned_cols=285  Identities=22%  Similarity=0.395  Sum_probs=211.4

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++++||||+++++++.+.+..|+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34569999999999999999999999999999999864322 22334567899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||||.|++.+++.                                  ....+++..+..|+.||+.||.|||++||+||
T Consensus       111 v~e~~~~~L~~~~~----------------------------------~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~  156 (329)
T 3gbz_A          111 IFEYAENDLKKYMD----------------------------------KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHR  156 (329)
T ss_dssp             EEECCSEEHHHHHH----------------------------------HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEecCCCCHHHHHh----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECC
Confidence            99999986554432                                  34568999999999999999999999999999


Q ss_pred             CCCCCCeeec-----CCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        320 DVKAGNILLT-----ETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       320 DLKP~NILl~-----~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||+|||++     .++.+||+|||+|+....    ....+||+.|+|||++.+  ...|+.++|||||||++|||++|
T Consensus       157 Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g  234 (329)
T 3gbz_A          157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG--SRHYSTSVDIWSIACIWAEMLMK  234 (329)
T ss_dssp             CCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC--CCCCCcHHHHHHHHHHHHHHHHC
Confidence            9999999994     455699999999965332    234578999999999853  24589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .+||.+.+..+.+..+....... ....|.............+.+.. .....           .....+++++.+||.+
T Consensus       235 ~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----------~~~~~~~~~~~~li~~  301 (329)
T 3gbz_A          235 TPLFPGDSEIDQLFKIFEVLGLP-DDTTWPGVTALPDWKQSFPKFRG-KTLKR-----------VLGALLDDEGLDLLTA  301 (329)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGSTTCCTTCCCCCC-CCHHH-----------HHGGGSCHHHHHHHHH
T ss_pred             CCCcCCCCHHHHHHHHHHHhCCC-chhhhhhhhhhhhhhhhhhhhcc-ccHhh-----------hcccccCHHHHHHHHH
Confidence            99999998888877776532111 11112111111110000010000 00000           0012367899999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ||+.||++|||+.|+|+||||+..
T Consensus       302 ~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          302 MLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             HTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             HccCChhhCCCHHHHhCCcccCCC
Confidence            999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-47  Score=420.31  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=207.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45999999999999999999999999999999886432222233456889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.|++.+.+                                  ...+.+++.++..++.||+.||.|||++||+||||
T Consensus        89 E~~~g~l~~~l----------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dl  134 (336)
T 3h4j_B           89 EYAGGELFDYI----------------------------------VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL  134 (336)
T ss_dssp             CCCCEEHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCC
T ss_pred             ECCCCcHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence            99977654433                                  23457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|.....   ....+||+.|+|||++.+   ..| +.++|||||||++|||++|+.||.+.
T Consensus       135 kp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING---KLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             STTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCC---SGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             chhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcC---CCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999999975433   245689999999999853   344 67899999999999999999999653


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +....                   .+.+..                       . ....+..+|+++.+||.+||+.||.
T Consensus       212 ~~~~~-------------------~~~i~~-----------------------~-~~~~p~~~s~~~~~li~~~L~~dP~  248 (336)
T 3h4j_B          212 FIPNL-------------------FKKVNS-----------------------C-VYVMPDFLSPGAQSLIRRMIVADPM  248 (336)
T ss_dssp             SSTTC-------------------BCCCCS-----------------------S-CCCCCTTSCHHHHHHHHTTSCSSGG
T ss_pred             cHHHH-------------------HHHHHc-----------------------C-CCCCcccCCHHHHHHHHHHcCCChh
Confidence            21100                   000000                       0 0011234689999999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy17952        478 DRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~  494 (804)
                      +|||++|+++||||...
T Consensus       249 ~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          249 QRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             GSCCHHHHTTCHHHHTT
T ss_pred             HCcCHHHHHhChhhccC
Confidence            99999999999999753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-46  Score=415.57  Aligned_cols=258  Identities=28%  Similarity=0.431  Sum_probs=197.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++..+++.||||++.....    ..+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            3469999999999999999999999999999999864321    225578999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ +.+                                  ++...+.+++..+..++.||+.||.|||++||+||
T Consensus        95 ~e~~~~~~L~~----------------------------------~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~  140 (361)
T 3uc3_A           95 MEYASGGELYE----------------------------------RICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHR  140 (361)
T ss_dssp             EECCCSCBHHH----------------------------------HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSC
T ss_pred             EEeCCCCCHHH----------------------------------HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999864 322                                  22234579999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCc--EEEEecccccccC---CCCccccCcccccchhhcccCCCCCCCc-ccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGT--VKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~--vKL~DFGla~~~~---~~~~~~GT~~Y~APEvl~~~~~~~y~~k-sDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.++.  +||+|||+|+...   .....+||+.|+|||++.+   ..++.+ +|||||||++|||++|++|
T Consensus       141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~P  217 (361)
T 3uc3_A          141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---QEYDGKIADVWSCGVTLYVMLVGAYP  217 (361)
T ss_dssp             CCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHC---SSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcC---CCCCCCeeeeehhHHHHHHHHhCCCC
Confidence            99999999987765  9999999997432   2345689999999999853   455555 8999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+.               ..+.                      ...........+++++.+||.+||+
T Consensus       218 f~~~~~~~~~~~~~---------------~~~~----------------------~~~~~~~~~~~~s~~~~~li~~~L~  260 (361)
T 3uc3_A          218 FEDPEEPRDYRKTI---------------QRIL----------------------SVKYSIPDDIRISPECCHLISRIFV  260 (361)
T ss_dssp             CC----CCCHHHHH---------------HHHH----------------------TTCCCCCTTSCCCHHHHHHHHHHSC
T ss_pred             CCCCccHHHHHHHH---------------HHHh----------------------cCCCCCCCcCCCCHHHHHHHHHHcc
Confidence            97643211111110               0000                      0011111223568999999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .||++|||+.|+|+||||.+...
T Consensus       261 ~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          261 ADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             SCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             CChhHCcCHHHHHhCcchhcCCc
Confidence            99999999999999999976543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.4e-46  Score=407.28  Aligned_cols=293  Identities=26%  Similarity=0.352  Sum_probs=218.5

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-------
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-------  233 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-------  233 (804)
                      ...|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4569999999999999999999999999999998864332 22234567899999999999999999999887       


Q ss_pred             -cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 -DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 -~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                       .+..|+|||||.|++.+.+.                                 .....+++.++..++.||+.||.|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~~l~~LH  141 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLS---------------------------------NVLVKFTLSEIKRVMQMLLNGLYYIH  141 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHH---------------------------------CTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEEeccCCCHHHHHh---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHH
Confidence             34689999999987544332                                 12346899999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccC--------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ++||+||||||+|||++.++.+||+|||+|+...        .....+||+.|+|||++.+  ...|+.++|||||||++
T Consensus       142 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il  219 (351)
T 3mi9_A          142 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIM  219 (351)
T ss_dssp             HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT--CCSCCTHHHHHHHHHHH
T ss_pred             HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcC--CCCCCcHhHHHHHHHHH
Confidence            9999999999999999999999999999996532        1234679999999999853  34588999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccC-CCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER-KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~-~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++|++||.+.+....+..+.+....... ..|+.+......... ............+..           ...++.
T Consensus       220 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~  287 (351)
T 3mi9_A          220 AEMWTRSPIMQGNTEQHQLALISQLCGSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKA-----------YVRDPY  287 (351)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHH-----------HHCCHH
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-hhccccccchhhcccccccccccCHHHHhhh-----------ccCChH
Confidence            9999999999998887777766553221111 111111000000000 000000000000000           013678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccccCCCCCchhH
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLV  501 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~  501 (804)
                      +.+||.+||+.||++|||++|+|+||||.....+....
T Consensus       288 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  325 (351)
T 3mi9_A          288 ALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK  325 (351)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSH
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccccc
Confidence            99999999999999999999999999998766655443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-46  Score=427.97  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=215.3

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||+||+|+++.+++.||+|++.............+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            35699999999999999999999999999999998643222223344588999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ |.+++.                                 ...+.+++..++.++.||+.||+|||++|||||
T Consensus       153 ~Ey~~gg~L~~~l~---------------------------------~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHr  199 (437)
T 4aw2_A          153 MDYYVGGDLLTLLS---------------------------------KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR  199 (437)
T ss_dssp             ECCCTTCBHHHHHH---------------------------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCCCcHHHHHH---------------------------------HccCCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            9999765 322221                                 114579999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhccc--CCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      ||||+|||++.+|.+||+|||+|+.....     ...+||+.|||||++...  ..+.|+.++|||||||++|||++|++
T Consensus       200 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~  279 (437)
T 4aw2_A          200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET  279 (437)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence            99999999999999999999999654322     346899999999998632  13468999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....|......                                     ...|. ....+|+++++||.+||
T Consensus       280 Pf~~~~~~~~~~~i~~~~~~-------------------------------------~~~p~-~~~~~s~~~~dLi~~lL  321 (437)
T 4aw2_A          280 PFYAESLVETYGKIMNHKER-------------------------------------FQFPT-QVTDVSENAKDLIRRLI  321 (437)
T ss_dssp             TTCCSSHHHHHHHHHTHHHH-------------------------------------CCCCS-SCCCSCHHHHHHHHTTS
T ss_pred             CCCCCChhHHHHhhhhcccc-------------------------------------ccCCc-ccccCCHHHHHHHHHHh
Confidence            99988877776666431100                                     00010 11347899999999999


Q ss_pred             ccCCCC--CCCHHHHHcCccccCC
Q psy17952        473 AKNPAD--RPSSGRLLTHDLVTRP  494 (804)
Q Consensus       473 ~~dP~~--Rpsa~elL~Hp~~~~~  494 (804)
                      +.+|++  ||+++|+++||||...
T Consensus       322 ~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          322 CSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             SCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             cccccccCCCCHHHHhCCCccCCC
Confidence            999988  9999999999999753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-46  Score=417.47  Aligned_cols=253  Identities=27%  Similarity=0.438  Sum_probs=204.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHH-HhhcCCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRF-LRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ..|++++.||+|+||.||+|+++.+++.||||++.............+.+|..+ ++.++|||||+++++|.+.+.+|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            459999999999999999999999999999999875433333344566778777 5778999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+.                                 |++++...+.+++..++.++.||+.||+|||++||+|||
T Consensus       118 ~E~~~gg~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrD  164 (373)
T 2r5t_A          118 LDYINGGE---------------------------------LFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD  164 (373)
T ss_dssp             EECCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             EeCCCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence            99998752                                 222222345789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.+|.+||+|||+|+...    ...+.+||+.|+|||++.   +..|+.++|||||||++|||++|.+||.+
T Consensus       165 lkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             CCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhC---CCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999999997532    234678999999999985   45689999999999999999999999988


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+....|.....                                           .....++.++++||.+||++||
T Consensus       242 ~~~~~~~~~i~~~~~-------------------------------------------~~~~~~~~~~~~li~~lL~~dp  278 (373)
T 2r5t_A          242 RNTAEMYDNILNKPL-------------------------------------------QLKPNITNSARHLLEGLLQKDR  278 (373)
T ss_dssp             SBHHHHHHHHHHSCC-------------------------------------------CCCSSSCHHHHHHHHHHTCSSG
T ss_pred             CCHHHHHHHHHhccc-------------------------------------------CCCCCCCHHHHHHHHHHcccCH
Confidence            877666655543211                                           0113468899999999999999


Q ss_pred             CCCCCH----HHHHcCccccC
Q psy17952        477 ADRPSS----GRLLTHDLVTR  493 (804)
Q Consensus       477 ~~Rpsa----~elL~Hp~~~~  493 (804)
                      .+||++    .++++||||..
T Consensus       279 ~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          279 TKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             GGSTTTTTTHHHHHTSGGGTT
T ss_pred             HhCCCCCCCHHHHhCCccccC
Confidence            999997    69999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-46  Score=408.46  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=205.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++..+++.||||.+.....  ....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            469999999999999999999999999999998864322  223356889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+                                 +|++++.....+++.++..++.||+.||+|||++||+||||
T Consensus        85 e~~~~~---------------------------------~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dl  131 (323)
T 3tki_A           85 EYCSGG---------------------------------ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI  131 (323)
T ss_dssp             ECCTTE---------------------------------EGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             EcCCCC---------------------------------cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence            999874                                 23333444567999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||+|||++.++.+||+|||+|+....      ....+||+.|+|||++.+  ...++.++|||||||++|||++|+.||.
T Consensus       132 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~  209 (323)
T 3tki_A          132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWD  209 (323)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             chHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999964321      235689999999999853  2223678999999999999999999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+.....+......                                        .........+++.+.+||.+||+.|
T Consensus       210 ~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~~li~~~L~~d  249 (323)
T 3tki_A          210 QPSDSCQEYSDWKEK----------------------------------------KTYLNPWKKIDSAPLALLHKILVEN  249 (323)
T ss_dssp             SSCTTSHHHHHHHTT----------------------------------------CTTSTTGGGSCHHHHHHHHHHSCSS
T ss_pred             CCchHHHHHHHHhcc----------------------------------------cccCCccccCCHHHHHHHHHHccCC
Confidence            654322221111100                                        0000111346889999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCC
Q psy17952        476 PADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~~~~  495 (804)
                      |++|||+.|+|+||||....
T Consensus       250 P~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          250 PSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             TTTSCCHHHHTTCTTTTCCC
T ss_pred             hhhCcCHHHHhhChhhcccc
Confidence            99999999999999998653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-46  Score=413.60  Aligned_cols=261  Identities=27%  Similarity=0.322  Sum_probs=208.7

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEeccccccc--chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ..+.|++.+.||+|+||.||+|++..+++.||||.+......  .....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            345699999999999999999999999999999988642211  111246688999999999999999999999999999


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||.|+ |.+.+..                              .......+++..+..++.||+.||+|||++||
T Consensus       102 ~lv~e~~~g~~L~~~l~~------------------------------~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  151 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVK------------------------------RADAGFVYSEAVASHYMRQILEALRYCHDNNI  151 (351)
T ss_dssp             EEEEECCSSCBHHHHHHH------------------------------HHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEeCCCCCCHHHHHHH------------------------------hcccCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999999864 3333210                              01123458999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCc---EEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGT---VKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~---vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||++.++.   +||+|||++.....    ....+||+.|+|||++.   ...|+.++|||||||++|||++
T Consensus       152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~  228 (351)
T 3c0i_A          152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK---REPYGKPVDVWGCGVILFILLS  228 (351)
T ss_dssp             ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHH
T ss_pred             eeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHc---CCCCCchHhhHHHHHHHHHHHH
Confidence            99999999999987654   99999999975433    23468999999999985   3568999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||.+.+ ......+.++....                   +                    ......+++++.+||.
T Consensus       229 g~~pf~~~~-~~~~~~i~~~~~~~-------------------~--------------------~~~~~~~s~~~~~li~  268 (351)
T 3c0i_A          229 GCLPFYGTK-ERLFEGIIKGKYKM-------------------N--------------------PRQWSHISESAKDLVR  268 (351)
T ss_dssp             SSCSSCSSH-HHHHHHHHHTCCCC-------------------C--------------------HHHHTTSCHHHHHHHH
T ss_pred             CCCCCCCcH-HHHHHHHHcCCCCC-------------------C--------------------ccccccCCHHHHHHHH
Confidence            999997743 23333333321110                   0                    0001346889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +||+.||++|||+.++|+||||..
T Consensus       269 ~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          269 RMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHCCCChhHCcCHHHHhcChhhcC
Confidence            999999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=400.54  Aligned_cols=287  Identities=29%  Similarity=0.439  Sum_probs=213.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.++++++||||+++++++...+..|+||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            45999999999999999999999999999999886432 22333466789999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|++..                                 ++....+.+++..+..++.|++.||.|||++||+||||
T Consensus        82 e~~~~~~l~---------------------------------~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dl  128 (311)
T 4agu_A           82 EYCDHTVLH---------------------------------ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV  128 (311)
T ss_dssp             ECCSEEHHH---------------------------------HHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             EeCCCchHH---------------------------------HHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence            999876321                                 11223457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|.....    ....+||+.|+|||++.+  ...++.++|||||||++|||++|.+||.+.
T Consensus       129 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          129 KPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG--DTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHT--CSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999975432    234689999999999853  356889999999999999999999999998


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhccccc-CCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~-~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      +..+.+..+........+ ..+........... ..+......            ........+++++.+|+.+||+.||
T Consensus       207 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~L~~dP  273 (311)
T 4agu_A          207 SDVDQLYLIRKTLGDLIP-RHQQVFSTNQYFSGVKIPDPEDME------------PLELKFPNISYPALGLLKGCLHMDP  273 (311)
T ss_dssp             SHHHHHHHHHHHHCSCCH-HHHHHHHTCGGGTTCCCCCCSSCC------------CHHHHCTTCCHHHHHHHHHHCCSST
T ss_pred             CHHHHHHHHHHHhccccc-ccccccccccccccCcCCCccccc------------hhhhhcccccHHHHHHHHHHccCCh
Confidence            887776665442111100 00000000000000 000000000            0000113578999999999999999


Q ss_pred             CCCCCHHHHHcCccccCCCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPRSP  497 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~~~  497 (804)
                      ++|||++|+|+||||......
T Consensus       274 ~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          274 TERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TTSCCHHHHHTSGGGTTCC--
T ss_pred             hhcCCHHHHhcChHHHhccCH
Confidence            999999999999999876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-46  Score=426.57  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=205.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++..+++.||||.+.............+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35699999999999999999999999999999998643222333446678999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeec
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHR  319 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiHR  319 (804)
                      ||||.|+..                                 .++....+.+++..+..++.||+.||+|||+ +|||||
T Consensus       227 ~e~~~~~~L---------------------------------~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr  273 (446)
T 4ejn_A          227 MEYANGGEL---------------------------------FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR  273 (446)
T ss_dssp             ECCCSSCBH---------------------------------HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             EeeCCCCcH---------------------------------HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC
Confidence            999987521                                 1122234578999999999999999999998 999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+|||++.++.+||+|||+|+....    ....+||+.|+|||++.   ...|+.++|||||||++|||++|++||.
T Consensus       274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~  350 (446)
T 4ejn_A          274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFY  350 (446)
T ss_dssp             CCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHH---TSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcC---CCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence            9999999999999999999999975322    34578999999999985   4578999999999999999999999998


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+.......+.....+                                           .+..+++++.+||.+||++|
T Consensus       351 ~~~~~~~~~~i~~~~~~-------------------------------------------~p~~~~~~~~~li~~~L~~d  387 (446)
T 4ejn_A          351 NQDHEKLFELILMEEIR-------------------------------------------FPRTLGPEAKSLLSGLLKKD  387 (446)
T ss_dssp             CSSHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHHHHHhCCCC-------------------------------------------CCccCCHHHHHHHHHHcccC
Confidence            87776665555432110                                           11346889999999999999


Q ss_pred             CCCCC-----CHHHHHcCccccCC
Q psy17952        476 PADRP-----SSGRLLTHDLVTRP  494 (804)
Q Consensus       476 P~~Rp-----sa~elL~Hp~~~~~  494 (804)
                      |.+||     |+.|+|+||||...
T Consensus       388 P~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          388 PKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             TTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhCCCCCCCHHHHHhCccccCC
Confidence            99999     99999999999753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-46  Score=415.83  Aligned_cols=299  Identities=28%  Similarity=0.455  Sum_probs=211.2

Q ss_pred             cccccccccccc--cccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        162 KIFEDLREIGHG--SFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G--~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..|++++.||+|  +||.||+|++..+++.||||++..... .....+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            469999999999  999999999999999999999865322 23445678889999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+ +.+++..                                .....+++..+..++.||+.||+|||++||+|
T Consensus       104 v~e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH  151 (389)
T 3gni_B          104 VTSFMAYGSAKDLICT--------------------------------HFMDGMNELAIAYILQGVLKALDYIHHMGYVH  151 (389)
T ss_dssp             EEECCTTCBHHHHHHH--------------------------------TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEccCCCCHHHHHhh--------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            99999864 4333320                                11256899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccC-----------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKC-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~-----------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |||||+|||++.++.+||+|||++....           .....+||+.|+|||++.+. ...|+.++|||||||++|||
T Consensus       152 rDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el  230 (389)
T 3gni_B          152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACEL  230 (389)
T ss_dssp             CCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-SSCBCTHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhcc-CCCCCcHhHHHHHHHHHHHH
Confidence            9999999999999999999999875321           11235899999999998531 24689999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCC--CCccchhhhHHHHhhc-cCCCCCCCCCCccHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERK--PPYFNMNAMSALYHIA-QNDTPCLQSSDWSDTF  464 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~--pp~~~~~~~~~l~~i~-~~~~p~~~~~~~s~~l  464 (804)
                      ++|++||.+.+....+..+..+..+....................  ................ ...........+++++
T Consensus       231 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  310 (389)
T 3gni_B          231 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF  310 (389)
T ss_dssp             HHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHH
T ss_pred             HHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHH
Confidence            999999988777666665554433221110000000000000000  0000000000000000 0001111234578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||.+||+.||++|||+.|+|+||||...
T Consensus       311 ~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          311 HHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             HHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence            999999999999999999999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.5e-46  Score=428.53  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=214.8

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|++++|||||++++++.+...+|+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            446799999999999999999999999999999998643221 2234678899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||||.|+.                                 |++.+...+.+++..+..++.||+.||.|||++||+||
T Consensus        99 v~e~~~~~~---------------------------------L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  145 (486)
T 3mwu_A           99 VGELYTGGE---------------------------------LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR  145 (486)
T ss_dssp             EECCCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEcCCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            999998752                                 22222334578999999999999999999999999999


Q ss_pred             CCCCCCeeec---CCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLT---ETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~---~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++   .++.+||+|||+|+....   ....+||+.|+|||++.    +.|+.++|||||||++|+|++|.+|
T Consensus       146 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~p  221 (486)
T 3mwu_A          146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR----GTYDEKCDVWSAGVILYILLSGTPP  221 (486)
T ss_dssp             CCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG----SCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC----CCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999995   456799999999975433   23568999999999984    4589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+.+..+..+..+..                                       ......+|+++++||.+||+
T Consensus       222 f~~~~~~~~~~~i~~~~~~~~---------------------------------------~~~~~~~s~~~~~li~~~L~  262 (486)
T 3mwu_A          222 FYGKNEYDILKRVETGKYAFD---------------------------------------LPQWRTISDDAKDLIRKMLT  262 (486)
T ss_dssp             SCCSSHHHHHHHHHHTCCCSC---------------------------------------SGGGGGSCHHHHHHHHHHTC
T ss_pred             CCCCCHHHHHHHHHhCCCCCC---------------------------------------CcccCCCCHHHHHHHHHHcC
Confidence            999888777776655432210                                       00113468899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .||.+|||+.++|+||||....
T Consensus       263 ~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          263 FHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             SSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CChhhCcCHHHHhcCHhhccCc
Confidence            9999999999999999997643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=413.70  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=213.7

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.+|++++|||||++++++.+....|+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            4456999999999999999999999999999999886432   2233568899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~-~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+.                                 |++++. ....+++.++..++.||+.||+|||++||+|
T Consensus       126 v~E~~~gg~---------------------------------L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  172 (387)
T 1kob_A          126 ILEFLSGGE---------------------------------LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH  172 (387)
T ss_dssp             EEECCCCCB---------------------------------HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEcCCCCc---------------------------------HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            999998752                                 112222 2346899999999999999999999999999


Q ss_pred             cCCCCCCeeecC--CCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTE--TGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~--~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+|||++.  ++.+||+|||+|+.....   ...+||+.|+|||++.   ...++.++|||||||++|||++|.+|
T Consensus       173 rDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P  249 (387)
T 1kob_A          173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---REPVGFYTDMWAIGVLGYVLLSGLSP  249 (387)
T ss_dssp             CCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred             cccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhcc---CCCCCCcccEeeHhHHHHHHHhCCCC
Confidence            999999999974  468999999999765432   2457999999999984   45689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+.+..+.......                                       +......+++++.+||.+||+
T Consensus       250 f~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L~  290 (387)
T 1kob_A          250 FAGEDDLETLQNVKRCDWEF---------------------------------------DEDAFSSVSPEAKDFIKNLLQ  290 (387)
T ss_dssp             SCCSSHHHHHHHHHHCCCCC---------------------------------------CSSTTTTSCHHHHHHHHTTSC
T ss_pred             CCCCCHHHHHHHHHhCCCCC---------------------------------------CccccccCCHHHHHHHHHHcC
Confidence            99888777666654432110                                       011123568999999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .||.+|||+.++|+||||....
T Consensus       291 ~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          291 KEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             SSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999998643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.3e-46  Score=422.64  Aligned_cols=285  Identities=28%  Similarity=0.366  Sum_probs=209.8

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec----
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD----  234 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~----  234 (804)
                      ...+.|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+|++++|||||++++++...    
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            34456999999999999999999999999999999986432 2233456789999999999999999999999776    


Q ss_pred             -CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 -HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 -~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                       ..+|+|||||.|+|.+++                                  .....+++..++.++.||+.||.|||+
T Consensus       102 ~~~~~lv~e~~~~~L~~~~----------------------------------~~~~~l~~~~~~~i~~qil~aL~~LH~  147 (432)
T 3n9x_A          102 FDELYIVLEIADSDLKKLF----------------------------------KTPIFLTEEHIKTILYNLLLGENFIHE  147 (432)
T ss_dssp             CCCEEEEEECCSEEHHHHH----------------------------------HSSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCcCHHHHH----------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence             578999999988655443                                  234569999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC--------------------------CCccccCcccccchhhcccC
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--------------------------ANSFVGTPYWMAPEVILAMD  367 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------------------------~~~~~GT~~Y~APEvl~~~~  367 (804)
                      +||+||||||+|||++.++.+||+|||+|+....                          ....+||+.|+|||++..  
T Consensus       148 ~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--  225 (432)
T 3n9x_A          148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL--  225 (432)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT--
T ss_pred             CCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc--
Confidence            9999999999999999999999999999975321                          145789999999998753  


Q ss_pred             CCCCCCcccHHHHHHHHHHHHhCC-----------CCCCCCC-----------------hHHHHHHHHhc-CCCCCCCCc
Q psy17952        368 EGQYDGKVDVWSLGITCIELAERK-----------PPYFNMN-----------------AMSALYHIAQN-DTPCLQSSD  418 (804)
Q Consensus       368 ~~~y~~ksDIWSlGvil~ELltG~-----------~PF~~~~-----------------~~~~l~~I~~~-~~p~~~~~~  418 (804)
                      ...|+.++|||||||++|||++|.           ++|.+.+                 ..+.+..|... +.|.     
T Consensus       226 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~-----  300 (432)
T 3n9x_A          226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT-----  300 (432)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCC-----
T ss_pred             CCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCC-----
Confidence            456899999999999999999854           4443332                 12233333221 1110     


Q ss_pred             hhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC---CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        419 WSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC---LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       419 ~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~---~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ...+..+..          ......+.... ...+.   ...+.+++++.+||.+||+.||++|||++|+|+||||....
T Consensus       301 ~~~~~~~~~----------~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          301 EDDLKNINK----------PEVIKYIKLFP-HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHHTCCC----------HHHHHHHHTSC-CCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHHHhccC----------HHHHHHHHhCC-CCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            000000000          00000000000 00000   01135789999999999999999999999999999998754


Q ss_pred             C
Q psy17952        496 S  496 (804)
Q Consensus       496 ~  496 (804)
                      .
T Consensus       370 ~  370 (432)
T 3n9x_A          370 K  370 (432)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-46  Score=430.21  Aligned_cols=258  Identities=28%  Similarity=0.456  Sum_probs=217.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++.+.||+|+||.||+|++..+++.||||++.............+.+|+.+|++++|||||++++++.+.+..|+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            45679999999999999999999999999999999865433333345678999999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||||.|+                                 +|++++...+.+++.++..++.||+.||.|||++||+||
T Consensus       104 v~e~~~~~---------------------------------~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  150 (484)
T 3nyv_A          104 VGEVYTGG---------------------------------ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR  150 (484)
T ss_dssp             EECCCCSC---------------------------------BHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEecCCCC---------------------------------CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            99999875                                 122333345679999999999999999999999999999


Q ss_pred             CCCCCCeee---cCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILL---TETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl---~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||+   +.++.+||+|||+|+.....   ...+||+.|+|||++.    +.|+.++|||||||++|+|++|.+|
T Consensus       151 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~p  226 (484)
T 3nyv_A          151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSGCPP  226 (484)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH----TCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec----CCCCCcceeHHHHHHHHHHHHCCCC
Confidence            999999999   56789999999999764433   2457999999999984    3689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+.+..+.++..+..                                       ......+|+++++||.+||+
T Consensus       227 f~~~~~~~~~~~i~~~~~~~~---------------------------------------~~~~~~~s~~~~~li~~~L~  267 (484)
T 3nyv_A          227 FNGANEYDILKKVEKGKYTFE---------------------------------------LPQWKKVSESAKDLIRKMLT  267 (484)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCC---------------------------------------SGGGGGSCHHHHHHHHHHTC
T ss_pred             CCCCCHHHHHHHHHcCCCCCC---------------------------------------CcccccCCHHHHHHHHHHCC
Confidence            999888777777655432110                                       00112468899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccC
Q psy17952        474 KNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +||.+|||+.|+|+||||..
T Consensus       268 ~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          268 YVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             SSGGGSCCHHHHHTSHHHHH
T ss_pred             CChhHCcCHHHHhhChhhcc
Confidence            99999999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.4e-46  Score=404.50  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=202.8

Q ss_pred             ccccccccccccccccceEEEEee---eceeEEEEEeccccccc-chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQ-CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~-~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      .+.|++++.||+|+||.||+|++.   .+++.||+|.+...... .......+.+|+.+|++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            346999999999999999999985   68899999998643211 12234567889999999999999999999999999


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+|||||.|+ +.+                                  ++...+.+++..+..++.||+.||.|||++|
T Consensus        96 ~~lv~e~~~~~~L~~----------------------------------~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~  141 (327)
T 3a62_A           96 LYLILEYLSGGELFM----------------------------------QLEREGIFMEDTACFYLAEISMALGHLHQKG  141 (327)
T ss_dssp             EEEEEECCTTEEHHH----------------------------------HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEeCCCCCcHHH----------------------------------HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999864 222                                  2223456899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |+||||||+|||++.+|.+||+|||+++....    ....+||+.|+|||++.   ...++.++|||||||++|||++|+
T Consensus       142 ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~  218 (327)
T 3a62_A          142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM---RSGHNRAVDWWSLGALMYDMLTGA  218 (327)
T ss_dssp             CCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHT---TSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCc---CCCCCCcccchhHHHHHHHHHHCC
Confidence            99999999999999999999999999875322    24568999999999984   356889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+....+..+.....+                                           ....+++++.+||.+|
T Consensus       219 ~pf~~~~~~~~~~~i~~~~~~-------------------------------------------~p~~~~~~~~~li~~~  255 (327)
T 3a62_A          219 PPFTGENRKKTIDKILKCKLN-------------------------------------------LPPYLTQEARDLLKKL  255 (327)
T ss_dssp             CSCCCSSHHHHHHHHHHTCCC-------------------------------------------CCTTSCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCC-------------------------------------------CCCCCCHHHHHHHHHH
Confidence            999888776666555432110                                           1124688999999999


Q ss_pred             cccCCCCCC-----CHHHHHcCccccC
Q psy17952        472 LAKNPADRP-----SSGRLLTHDLVTR  493 (804)
Q Consensus       472 L~~dP~~Rp-----sa~elL~Hp~~~~  493 (804)
                      |+.||++||     ++.++++||||..
T Consensus       256 L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          256 LKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             SCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            999999999     8999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=421.98  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=212.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|+++.+++.||||++...........+.+.+|+.+|..++||||++++++|.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            45999999999999999999999999999999986432222334456889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||.|+ |.+++.                                 .....+++..++.++.||+.||+|||++||||||
T Consensus       141 E~~~gg~L~~~l~---------------------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrD  187 (412)
T 2vd5_A          141 EYYVGGDLLTLLS---------------------------------KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD  187 (412)
T ss_dssp             CCCCSCBHHHHHH---------------------------------HHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             cCCCCCcHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            999764 333221                                 1124689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccC----CCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~----~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |||+|||++.+|.+||+|||+|+.....     ...+||+.|+|||++....    .+.|+.++|||||||++|||++|+
T Consensus       188 LKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~  267 (412)
T 2vd5_A          188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ  267 (412)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred             cCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence            9999999999999999999999754332     3468999999999986311    246899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+..+....|......                 .                    ..|. ....+|+++++||.+|
T Consensus       268 ~Pf~~~~~~~~~~~i~~~~~~-----------------~--------------------~~p~-~~~~~s~~~~dli~~l  309 (412)
T 2vd5_A          268 TPFYADSTAETYGKIVHYKEH-----------------L--------------------SLPL-VDEGVPEEARDFIQRL  309 (412)
T ss_dssp             CTTCCSSHHHHHHHHHTHHHH-----------------C--------------------CCC-----CCCHHHHHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHhcccC-----------------c--------------------CCCc-cccCCCHHHHHHHHHH
Confidence            999988877766666431100                 0                    0000 1235789999999999


Q ss_pred             cccCCCCC---CCHHHHHcCccccCC
Q psy17952        472 LAKNPADR---PSSGRLLTHDLVTRP  494 (804)
Q Consensus       472 L~~dP~~R---psa~elL~Hp~~~~~  494 (804)
                      |+ +|.+|   |+++++++||||...
T Consensus       310 L~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          310 LC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             SS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             cC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            99 99998   599999999999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=407.16  Aligned_cols=258  Identities=26%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++.+.||+|+||.||+|++..+++.||||.+....     ..+.+.+|+.+|++++||||+++++++...+..|+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            4456999999999999999999999999999999886421     23457789999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+.|+.                                 |.+++...+.+++.++..++.||+.||.|||++||+||
T Consensus       126 v~e~~~~~~---------------------------------L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  172 (349)
T 2w4o_A          126 VLELVTGGE---------------------------------LFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR  172 (349)
T ss_dssp             EECCCCSCB---------------------------------HHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEeCCCCC---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            999998641                                 22223345678999999999999999999999999999


Q ss_pred             CCCCCCeeecC---CCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~---~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.   ++.+||+|||+++....   ....+||+.|+|||++.   +..|+.++|||||||++|||++|..|
T Consensus       173 Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p  249 (349)
T 2w4o_A          173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR---GCAYGPEVDMWSVGIITYILLCGFEP  249 (349)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhc---CCCCCcccchHHHHHHHHHHHhCCCC
Confidence            99999999975   88999999999975432   23568999999999985   35689999999999999999999999


Q ss_pred             CCCCChHH-HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        394 YFNMNAMS-ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       394 F~~~~~~~-~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      |.+..... .+..+.....+                                       .+......++.++.+||.+||
T Consensus       250 f~~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~~~~~~~li~~~L  290 (349)
T 2w4o_A          250 FYDERGDQFMFRRILNCEYY---------------------------------------FISPWWDEVSLNAKDLVRKLI  290 (349)
T ss_dssp             TCCTTCHHHHHHHHHTTCCC---------------------------------------CCTTTTTTSCHHHHHHHHTTS
T ss_pred             CCCCcccHHHHHHHHhCCCc---------------------------------------cCCchhhhCCHHHHHHHHHHc
Confidence            98765444 22233221110                                       001112356889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSP  497 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~  497 (804)
                      +.||++|||+.|+|+||||......
T Consensus       291 ~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          291 VLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             CSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             cCChhhCcCHHHHhcCcccCCCccc
Confidence            9999999999999999999876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-46  Score=414.74  Aligned_cols=284  Identities=25%  Similarity=0.385  Sum_probs=213.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----  235 (804)
                      .+.|++++.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+++|+.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            346999999999999999999999999999999985432 22334567889999999999999999999998763     


Q ss_pred             -ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 -TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 -~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                       .+|+||||+.+++.+++.                                   ...+++..+..++.||+.||+|||++
T Consensus       103 ~~~~lv~e~~~~~L~~~~~-----------------------------------~~~l~~~~~~~~~~qi~~~L~~LH~~  147 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKLMK-----------------------------------HEKLGEDRIQFLVYQMLKGLRYIHAA  147 (367)
T ss_dssp             CCCEEEEECCSEEHHHHHH-----------------------------------HCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ceEEEEEecCCCCHHHHHh-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence             469999999655544332                                   24689999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||+||||||+|||++.++.+||+|||+|+.... ....+||+.|+|||++.+  ...|+.++||||+||++|||++|++|
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~p  225 (367)
T 1cm8_A          148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCIMAEMITGKTL  225 (367)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CccccCcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhC--CCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999999976443 345789999999999863  25689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC--CCCCCCCccHHHHHHHHHh
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT--PCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~--p~~~~~~~s~~l~dli~~c  471 (804)
                      |.+.+..+.+..|.+......    ...+..+...          ....-+........  ........++.+.+||.+|
T Consensus       226 f~~~~~~~~l~~i~~~~g~~~----~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~m  291 (367)
T 1cm8_A          226 FKGSDHLDQLKEIMKVTGTPP----AEFVQRLQSD----------EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM  291 (367)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCC----HHHHHTCSCH----------HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCC----HHHHHHhhhH----------HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence            999998888877765321110    0111111000          00000000000000  0011235689999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCCC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      |+.||.+|||++++|+||||.....
T Consensus       292 L~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          292 LVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             SCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             ccCChhHCCCHHHHhcChHHHhhcC
Confidence            9999999999999999999986543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=401.55  Aligned_cols=251  Identities=27%  Similarity=0.393  Sum_probs=201.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|+++++||+|+||+||+|++..+++.||||++...... ........+|+..+.++ +|||||++++++.+.+..|+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            4699999999999999999999999999999987543222 23334556666666655 899999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|++.+.+.                                 .....+++..+..|+.||+.||+|||++||+|||
T Consensus       136 ~e~~~~~L~~~~~---------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  182 (311)
T 3p1a_A          136 TELCGPSLQQHCE---------------------------------AWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD  182 (311)
T ss_dssp             EECCCCBHHHHHH---------------------------------HHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             EeccCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence            9999887655432                                 1234689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |||+|||++.++.+||+|||+|.....   .....||+.|+|||++.    +.++.++|||||||++|||++|..||.+.
T Consensus       183 ikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~el~~g~~~~~~~  258 (311)
T 3p1a_A          183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ----GSYGTAADVFSLGLTILEVACNMELPHGG  258 (311)
T ss_dssp             CSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGG----TCCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred             CCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhc----CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999875432   23457999999999884    36899999999999999999998777553


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      ...   ..+..+.                     .++                    .....+++++.+||.+||+.||+
T Consensus       259 ~~~---~~~~~~~---------------------~~~--------------------~~~~~~~~~l~~li~~~L~~dP~  294 (311)
T 3p1a_A          259 EGW---QQLRQGY---------------------LPP--------------------EFTAGLSSELRSVLVMMLEPDPK  294 (311)
T ss_dssp             HHH---HHHTTTC---------------------CCH--------------------HHHTTSCHHHHHHHHHHSCSSTT
T ss_pred             cHH---HHHhccC---------------------CCc--------------------ccccCCCHHHHHHHHHHcCCChh
Confidence            221   1111100                     000                    01134688999999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy17952        478 DRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~  494 (804)
                      +|||+.|+|+||||+++
T Consensus       295 ~Rpt~~ell~hp~~~~p  311 (311)
T 3p1a_A          295 LRATAEALLALPVLRQP  311 (311)
T ss_dssp             TSCCHHHHHTSGGGSCC
T ss_pred             hCcCHHHHHhCccccCC
Confidence            99999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-45  Score=390.92  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=214.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.++++++||||+++++++...+..|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc-CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            456999999999999999999999999999999986432 2334456788999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.|+ +.+.                                  ......+++..+..++.|++.||.|||++||+||
T Consensus        84 ~e~~~~~~l~~~----------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  129 (284)
T 3kk8_A           84 FDLVTGGELFED----------------------------------IVAREFYSEADASHCIQQILESIAYCHSNGIVHR  129 (284)
T ss_dssp             ECCCCSCBHHHH----------------------------------HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EecCCCCCHHHH----------------------------------HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcC
Confidence            9999875 2222                                  2234568999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCc---EEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        320 DVKAGNILLTETGT---VKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~---vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||+|||++.++.   +||+|||++......   ....||+.|+|||++.   ...++.++|||||||++|+|++|..|
T Consensus       130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p  206 (284)
T 3kk8_A          130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYILLVGYPP  206 (284)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhc---CCCCCcccchHHHHHHHHHHHHCCCC
Confidence            99999999987665   999999999654332   3468999999999984   45689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+..+...                                       .+......+++++.+|+.+||+
T Consensus       207 f~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~li~~~l~  247 (284)
T 3kk8_A          207 FWDEDQHRLYAQIKAGAYD---------------------------------------YPSPEWDTVTPEAKSLIDSMLT  247 (284)
T ss_dssp             SCCSSHHHHHHHHHHTCCC---------------------------------------CCTTTTTTSCHHHHHHHHHHSC
T ss_pred             CCCCchhHHHHHHHhcccc---------------------------------------CCchhhcccCHHHHHHHHHHcc
Confidence            9887776655555432211                                       1111223568899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .||++|||+.|+|+||||....
T Consensus       248 ~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          248 VNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             SSTTTSCCHHHHTTSHHHHSCC
T ss_pred             cChhhCCCHHHHhcCccccCCh
Confidence            9999999999999999997654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.3e-46  Score=424.76  Aligned_cols=254  Identities=24%  Similarity=0.390  Sum_probs=213.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45999999999999999999999999999999986433222234467889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+                                 +|++++...+.+++.++..++.||+.||.|||++||+||||
T Consensus        96 E~~~gg---------------------------------~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDL  142 (476)
T 2y94_A           96 EYVSGG---------------------------------ELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL  142 (476)
T ss_dssp             ECCSSE---------------------------------EHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred             eCCCCC---------------------------------cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccc
Confidence            999865                                 23334445667999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|.....   ..+.+||+.|+|||++.+   ..| +.++|||||||++|||++|++||.+.
T Consensus       143 kp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~  219 (476)
T 2y94_A          143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG---RLYAGPEVDIWSSGVILYALLCGTLPFDDD  219 (476)
T ss_dssp             SGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTT---CCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccC---CCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999976433   235689999999999853   334 67899999999999999999999887


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +.......+..+...                                           .+..+++++.+||.+||+.||.
T Consensus       220 ~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~Li~~~L~~dP~  256 (476)
T 2y94_A          220 HVPTLFKKICDGIFY-------------------------------------------TPQYLNPSVISLLKHMLQVDPM  256 (476)
T ss_dssp             SSHHHHHHHHTTCCC-------------------------------------------CCTTCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHHHHhcCCcC-------------------------------------------CCccCCHHHHHHHHHHcCCCch
Confidence            665555544332110                                           1123578999999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy17952        478 DRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~~  494 (804)
                      +|||+.++++||||...
T Consensus       257 ~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          257 KRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TSCCHHHHHTCHHHHTT
T ss_pred             hCcCHHHHHhCHHhhhc
Confidence            99999999999999763

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.3e-46  Score=426.91  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=210.6

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      ...+.|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+.++|||||+++++|.+....|
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3456799999999999999999999999999999998653322 223467889999999999999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|+.                                 |++++.....+++..+..++.||+.||.|||++||+|
T Consensus       113 lv~e~~~~g~---------------------------------L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  159 (494)
T 3lij_A          113 LVMECYKGGE---------------------------------LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVH  159 (494)
T ss_dssp             EEEECCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEecCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            9999998752                                 2222233457899999999999999999999999999


Q ss_pred             cCCCCCCeeecCC---CcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTET---GTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~---g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+|||++..   +.+||+|||+|+....   ....+||+.|+|||++.    +.|+.++|||||||++|+|++|.+
T Consensus       160 ~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il~~ll~g~~  235 (494)
T 3lij_A          160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR----KKYDEKCDVWSIGVILFILLAGYP  235 (494)
T ss_dssp             SCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc----ccCCCchhHHHHHHHHHHHHhCCC
Confidence            9999999999764   4599999999975433   23568999999999983    469999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+.+..+..+..+.                                       +......+|+.+++||.+||
T Consensus       236 pf~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L  276 (494)
T 3lij_A          236 PFGGQTDQEILRKVEKGKYTF---------------------------------------DSPEWKNVSEGAKDLIKQML  276 (494)
T ss_dssp             SSCCSSHHHHHHHHHHTCCCC---------------------------------------CSGGGTTSCHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHHHhCCCCC---------------------------------------CchhcccCCHHHHHHHHHHC
Confidence            999988877776665543211                                       00111346889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +.||.+|||+.++|+||||..
T Consensus       277 ~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          277 QFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             CSSTTTSCCHHHHHTCHHHHH
T ss_pred             CCChhhCccHHHHhcCccccc
Confidence            999999999999999999964

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-45  Score=392.28  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=207.9

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      ...+.|++.+.||+|+||.||+|++..+++.||+|.+.....  ....+.+.+|+++|++++||||+++++++.+.+..|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            344679999999999999999999999999999998865322  223467889999999999999999999999999999


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.|+ +.+.+..                              .......+++..+..++.|++.||+|||++||+
T Consensus        97 lv~e~~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  146 (285)
T 3is5_A           97 IVMETCEGGELLERIVS------------------------------AQARGKALSEGYVAELMKQMMNALAYFHSQHVV  146 (285)
T ss_dssp             EEECCCSCCBHHHHHHH------------------------------HHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEeCCCCcHHHHHHh------------------------------hhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            999999864 4333321                              111245789999999999999999999999999


Q ss_pred             ecCCCCCCeee---cCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        318 HRDVKAGNILL---TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       318 HRDLKP~NILl---~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||||||+|||+   +.++.+||+|||+|.....   .....||+.|+|||++.    +.++.++|||||||++|||++|+
T Consensus       147 H~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~il~~ll~g~  222 (285)
T 3is5_A          147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK----RDVTFKCDIWSAGVVMYFLLTGC  222 (285)
T ss_dssp             CCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT----TCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc----cCCCcccCeehHHHHHHHHHhCC
Confidence            99999999999   4567899999999975332   23567999999999973    46888999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||.+.+..+....+......                                        .......+++++.+|+.+|
T Consensus       223 ~pf~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~  262 (285)
T 3is5_A          223 LPFTGTSLEEVQQKATYKEPN----------------------------------------YAVECRPLTPQAVDLLKQM  262 (285)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCC----------------------------------------CCC--CCCCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHhhhccCCcc----------------------------------------cccccCcCCHHHHHHHHHH
Confidence            999887665544433221110                                        0011123688999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      |+.||++|||+.|+|+||||++
T Consensus       263 L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          263 LTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             TCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ccCChhhCcCHHHHhcCHHhhc
Confidence            9999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-45  Score=427.06  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=213.6

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccc----------hhhhhhHHHHHHHHhhcCCCceeEee
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC----------AEKWADILKEIRFLRQLKHPNTIEYR  228 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~----------~~~~~~~~~Ei~iL~~L~HpNIV~l~  228 (804)
                      ...+.|+++++||+|+||+||+|++..+++.||||.+.......          ....+.+.+|+.+|++++|||||+++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            34567999999999999999999999999999999986432111          12346788999999999999999999


Q ss_pred             eEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHH
Q psy17952        229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGL  308 (804)
Q Consensus       229 ~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL  308 (804)
                      ++|.+....|+|||||.|+.                                 |++++...+.+++..+..++.||+.||
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~---------------------------------L~~~l~~~~~~~~~~~~~i~~qi~~~l  159 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGE---------------------------------LFEQIINRHKFDECDAANIMKQILSGI  159 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCB---------------------------------HHHHHHHHSCCCHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCEEEEEEecCCCCc---------------------------------HHHHHHHcCCCCHHHHHHHHHHHHHHH
Confidence            99999999999999998751                                 222223345799999999999999999


Q ss_pred             HHHHHCCCeecCCCCCCeeecCCC---cEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        309 NYLHSLGRIHRDVKAGNILLTETG---TVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       309 ~yLH~~gIiHRDLKP~NILl~~~g---~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      .|||++||+||||||+|||++.++   .+||+|||+|+.....   ...+||+.|+|||++.    +.|+.++|||||||
T Consensus       160 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~  235 (504)
T 3q5i_A          160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGV  235 (504)
T ss_dssp             HHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHH
T ss_pred             HHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc----cCCCchHHHHHHHH
Confidence            999999999999999999999876   6999999999764432   3568999999999983    46899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       383 il~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ++|+|++|.+||.+.+..+.+..+..+.....                                       ......+|+
T Consensus       236 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------------------~~~~~~~s~  276 (504)
T 3q5i_A          236 IMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD---------------------------------------FNDWKNISD  276 (504)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------------------------------HHHHTTSCH
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------------------------------ccccCCCCH
Confidence            99999999999999888777777655432100                                       000134688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ++++||.+||+.||.+|||+.|+|+||||....
T Consensus       277 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            999999999999999999999999999997644

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-45  Score=391.72  Aligned_cols=255  Identities=30%  Similarity=0.450  Sum_probs=213.5

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      +..+.|++.+.||+|+||.||+|++..++..||+|++.....   ...+.+.+|++++++++||||+++++++.+.+..|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            455679999999999999999999999999999998864322   23467889999999999999999999999999999


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.|+ +.+.                                  ....+.+++.++..++.|++.||.|||++||+
T Consensus        83 lv~e~~~~~~L~~~----------------------------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~  128 (277)
T 3f3z_A           83 LVMELCTGGELFER----------------------------------VVHKRVFRESDAARIMKDVLSAVAYCHKLNVA  128 (277)
T ss_dssp             EEEECCCSCBHHHH----------------------------------HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEeccCCCcHHHH----------------------------------HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999864 3222                                  22345689999999999999999999999999


Q ss_pred             ecCCCCCCeee---cCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        318 HRDVKAGNILL---TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       318 HRDLKP~NILl---~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||||||+|||+   +.++.+||+|||++.....   .....||+.|+|||++.    +.++.++|||||||++|||++|+
T Consensus       129 H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~  204 (277)
T 3f3z_A          129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE----GLYGPECDEWSAGVMMYVLLCGY  204 (277)
T ss_dssp             CCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT----TCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhc----ccCCchhhehhHHHHHHHHHHCC
Confidence            99999999999   7889999999999975433   23568999999999984    35899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||.+.+..+....+..+..+.                                       +......+++.+.+|+.+|
T Consensus       205 ~p~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~li~~~  245 (277)
T 3f3z_A          205 PPFSAPTDSEVMLKIREGTFTF---------------------------------------PEKDWLNVSPQAESLIRRL  245 (277)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCCC---------------------------------------CHHHHTTSCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCCC---------------------------------------CchhhhcCCHHHHHHHHHH
Confidence            9998887777666655432210                                       0000124688999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      |+.||++|||+.++|+||||..
T Consensus       246 l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          246 LTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             TCSSTTTSCCHHHHTTSHHHHH
T ss_pred             ccCChhhCcCHHHHhcCHHHhc
Confidence            9999999999999999999964

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=405.85  Aligned_cols=285  Identities=28%  Similarity=0.379  Sum_probs=213.5

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccc--hhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC--AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.|++++.||+|+||.||+|++..+++.||||.+.......  ......+.+|+.++++++||||+++++++...+..|
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            346999999999999999999999999999999986432211  112346789999999999999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|++.+.+.                                 .....+++.++..++.|++.||+|||++||+|
T Consensus        89 lv~e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  135 (346)
T 1ua2_A           89 LVFDFMETDLEVIIK---------------------------------DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  135 (346)
T ss_dssp             EEEECCSEEHHHHHT---------------------------------TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEEcCCCCHHHHHH---------------------------------hcCcCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Confidence            999999986544331                                 12346888999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||||+|||++.++.+||+|||+|+....    ....+||+.|+|||++.+  ...|+.++|||||||++|||++|.+||
T Consensus       136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~~~  213 (346)
T 1ua2_A          136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG--ARMYGVGVDMWAVGCILAELLLRVPFL  213 (346)
T ss_dssp             CCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT--CSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhC--CCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            99999999999999999999999975432    234689999999999853  345888999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+.+..+......... ..|......       +.+.....       .............++++.+||.+||+.
T Consensus       214 ~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~-------~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~  278 (346)
T 1ua2_A          214 PGDSDLDQLTRIFETLGTPTE-EQWPDMCSL-------PDYVTFKS-------FPGIPLHHIFSAAGDDLLDLIQGLFLF  278 (346)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCT-TTSSSTTSS-------TTCCCCCC-------CCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred             CCCCHHHHHHHHHHHcCCCCh-hhhhhhccC-------cccccccc-------cCCCChHHhhccCCHHHHHHHHHHhcc
Confidence            999888887777653211111 111111000       00000000       000000001245689999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||++|||+.|+|+||||....
T Consensus       279 dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          279 NPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTTSCCHHHHHTSGGGTSSS
T ss_pred             ChhhCCCHHHHhcChhhhcCC
Confidence            999999999999999998643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-45  Score=400.24  Aligned_cols=263  Identities=26%  Similarity=0.354  Sum_probs=216.4

Q ss_pred             CCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccch---hhhhhHHHHHHHHhhcCCCceeEeeeEEee
Q psy17952        157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA---EKWADILKEIRFLRQLKHPNTIEYRGCYLR  233 (804)
Q Consensus       157 ~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~  233 (804)
                      .....+.|++.+.||+|+||.||+|++..+++.||||.+........   ...+.+.+|+.+|++++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            34456679999999999999999999999999999998865332211   124668899999999999999999999999


Q ss_pred             cCceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..|+|||||.|+ +.++                                  +...+.+++..+..++.|++.||.|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~----------------------------------l~~~~~~~~~~~~~i~~qi~~aL~~lH  132 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDF----------------------------------LAQKESLSEEEATSFIKQILDGVNYLH  132 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHH----------------------------------HHTCSCEEHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEEEcCCCCcHHHH----------------------------------HHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            99999999999764 3332                                  223457899999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCC----cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETG----TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g----~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      ++||+||||||+|||++.++    .+||+|||++.....   .....||+.|+|||++.   ...++.++|||||||++|
T Consensus       133 ~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~  209 (321)
T 2a2a_A          133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVITY  209 (321)
T ss_dssp             HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHHH
T ss_pred             hCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCccccc---CCCCCCccccHHHHHHHH
Confidence            99999999999999999888    799999999975433   23467999999999984   457889999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      ||++|..||.+.+..+.+..+.......                   ++                    .....+++.+.
T Consensus       210 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------------------~~--------------------~~~~~~~~~~~  250 (321)
T 2a2a_A          210 ILLSGASPFLGDTKQETLANITSVSYDF-------------------DE--------------------EFFSHTSELAK  250 (321)
T ss_dssp             HHHHSCCSSCCSSHHHHHHHHHTTCCCC-------------------CH--------------------HHHTTCCHHHH
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHhccccc-------------------Ch--------------------hhhcccCHHHH
Confidence            9999999998887776666554322110                   00                    00134678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +||.+||+.||++|||+.++|+||||....
T Consensus       251 ~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            999999999999999999999999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.4e-46  Score=412.00  Aligned_cols=282  Identities=25%  Similarity=0.373  Sum_probs=203.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------C
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------H  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------~  235 (804)
                      +.|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            56999999999999999999999999999999986432 2233456788999999999999999999998754      5


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+||||+.++|.+++.                                   ...+++..+..++.||+.||.|||++|
T Consensus       108 ~~~lv~e~~~~~L~~~~~-----------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~g  152 (367)
T 2fst_X          108 DVYLVTHLMGADLNNIVK-----------------------------------CQKLTDDHVQFLIYQILRGLKYIHSAD  152 (367)
T ss_dssp             CCEEEEECCCEECC----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEecccCCCHHHHHh-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            689999999766544331                                   246899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+|||++.++.+||+|||+|+.... ....+||+.|+|||++.+  ...|+.++|||||||++|||++|++||
T Consensus       153 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf  230 (367)
T 2fst_X          153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLF  230 (367)
T ss_dssp             CCCCCCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHTT--CCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             eeeCCCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHcC--CcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999976433 345789999999999853  246889999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC--CCCCCccHHHHHHHHHh
Q psy17952        395 FNMNAMSALYHIAQND-TPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC--LQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~-~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~--~~~~~~s~~l~dli~~c  471 (804)
                      .+.+..+.+..|.+.. .|.     ...+..+...          ....-+..+.......  ......++.+.+||.+|
T Consensus       231 ~~~~~~~~l~~i~~~~g~p~-----~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~m  295 (367)
T 2fst_X          231 PGTDHIDQLKLILRLVGTPG-----AELLKKISSE----------SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM  295 (367)
T ss_dssp             CCSSHHHHHHHHHHHHCSCC-----HHHHTTCCCH----------HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHhCCCC-----HHHHHHhhhH----------HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHh
Confidence            9999888887776532 111     0111111000          0000000000000000  00134688999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCCC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      |+.||++|||+.|+|+||||.....
T Consensus       296 L~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          296 LVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCCCcccCcCHHHHhcChhhhhccC
Confidence            9999999999999999999986543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4e-45  Score=392.18  Aligned_cols=272  Identities=40%  Similarity=0.732  Sum_probs=217.3

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .++.+.|++++.||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+.++++++||||+++++++...+..
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            467778999999999999999999999999999999886432   23456788999999999999999999999999999


Q ss_pred             EEEEeecCCCch-hhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGSAS-DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~l~-dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||.|+.. +++.                                 .....+++..+..++.||+.||.|||++||
T Consensus        92 ~lv~e~~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  138 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIML---------------------------------ELDRGLTEPQIQVVCRQMLEALNFLHSKRI  138 (302)
T ss_dssp             EEEEECCTTEEHHHHHH---------------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEEEeCCCCcHHHHHH---------------------------------hhccCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence            999999987532 2221                                 123568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEeccccccc----CCCCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~----~~~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      +||||||+|||++.++.+||+|||++...    .......||+.|+|||++...  ....++.++|||||||++|||++|
T Consensus       139 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  218 (302)
T 2j7t_A          139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  218 (302)
T ss_dssp             CCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred             ccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence            99999999999999999999999997532    223456899999999998421  245688899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||...+....+..+.....+.                                        ......++..+.+||.+
T Consensus       219 ~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~~li~~  258 (302)
T 2j7t_A          219 EPPHHELNPMRVLLKIAKSDPPT----------------------------------------LLTPSKWSVEFRDFLKI  258 (302)
T ss_dssp             SCTTTTSCHHHHHHHHHHSCCCC----------------------------------------CSSGGGSCHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHhccCCcc----------------------------------------cCCccccCHHHHHHHHH
Confidence            99998877766655554332110                                        01123468899999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCCCchhHHHHH
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIR  505 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~  505 (804)
                      ||..||++|||+.++++||||........+.+.+.
T Consensus       259 ~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~  293 (302)
T 2j7t_A          259 ALDKNPETRPSAAQLLEHPFVSSITSNKALRELVA  293 (302)
T ss_dssp             HSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHHH
T ss_pred             HcccChhhCCCHHHHhcChHHhhhccchhHHHHHH
Confidence            99999999999999999999998776554444443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7e-46  Score=419.37  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=198.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEeccccccc-----chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-----CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .+.|++.+.||+|+||.||+|.+..+++.||||.+......     .......+.+|+.+|++++|||||++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            45699999999999999999999999999999998643211     11223457899999999999999999999754 5


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+|||||.|+                                 +|+++....+.+++.++..++.|++.||+|||++|
T Consensus       213 ~~~lv~e~~~~g---------------------------------~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  259 (419)
T 3i6u_A          213 DYYIVLELMEGG---------------------------------ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG  259 (419)
T ss_dssp             EEEEEEECCTTC---------------------------------BGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ceEEEEEcCCCC---------------------------------cHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            589999999875                                 23334445678999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCC---cEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETG---TVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g---~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||++.++   .+||+|||+|+.....   ...+||+.|+|||++.+.....|+.++|||||||++|||++
T Consensus       260 ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt  339 (419)
T 3i6u_A          260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  339 (419)
T ss_dssp             CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred             ccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence            99999999999997544   5999999999764332   35689999999999864344678889999999999999999


Q ss_pred             CCCCCCCCChHHHHH-HHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 G~~PF~~~~~~~~l~-~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      |.+||.+......+. .+..+..+                   .                    +......+++.+.+||
T Consensus       340 g~~pf~~~~~~~~~~~~i~~~~~~-------------------~--------------------~~~~~~~~~~~~~~li  380 (419)
T 3i6u_A          340 GYPPFSEHRTQVSLKDQITSGKYN-------------------F--------------------IPEVWAEVSEKALDLV  380 (419)
T ss_dssp             SSCSSCCCSSSCCHHHHHHTTCCC-------------------C--------------------CHHHHTTSCHHHHHHH
T ss_pred             CCCCCCCCcchHHHHHHHhcCCCC-------------------C--------------------CchhhcccCHHHHHHH
Confidence            999997643221111 11111000                   0                    0001134688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+||+.||++|||++|+|+||||..
T Consensus       381 ~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          381 KKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHccCChhHCcCHHHHhCCcccCC
Confidence            9999999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.3e-46  Score=412.56  Aligned_cols=288  Identities=25%  Similarity=0.347  Sum_probs=207.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      +.|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++...+      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46999999999999999999999999999999986432 22334567889999999999999999999997665      


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+|||||.|++.+.+.                                    ..+++..+..++.||+.||.|||++|
T Consensus       104 ~~~lv~e~~~~~l~~~~~------------------------------------~~~~~~~~~~i~~qi~~al~~lH~~~  147 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQ------------------------------------MELDHERMSYLLYQMLCGIKHLHSAG  147 (371)
T ss_dssp             EEEEEEECCSEEHHHHHH------------------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ceEEEEEcCCCCHHHHHh------------------------------------hccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            689999999987544331                                    24789999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |+||||||+|||++.++.+||+|||+|+....   ....+||+.|+|||++.   +..|+.++|||||||++|||++|++
T Consensus       148 ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~  224 (371)
T 2xrw_A          148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIKGGV  224 (371)
T ss_dssp             CCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             eecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhc---CCCCCchHhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999975433   23468999999999985   3568999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhc----ccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS----STAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~----~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      ||.+.+..+.+..+.+.......    ..+..+.    ......|.+.. .....++.-...+.........++++++||
T Consensus       225 pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  299 (371)
T 2xrw_A          225 LFPGTDHIDQWNKVIEQLGTPCP----EFMKKLQPTVRTYVENRPKYAG-YSFEKLFPDVLFPADSEHNKLKASQARDLL  299 (371)
T ss_dssp             SSCCSSHHHHHHHHHC-CCCCCH----HHHTTSCHHHHHHHHSSCCCCC-CCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCH----HHHHHhhhHHHHHHhhCccccc-cchhhhcccccCcccccccccccHHHHHHH
Confidence            99999888888777654221110    1110000    00000111100 000000000000000000011267899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||+.||++|||++|+|+||||...
T Consensus       300 ~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          300 SKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHCcCChhhCCCHHHHhCCcchhhh
Confidence            99999999999999999999999753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-45  Score=408.82  Aligned_cols=277  Identities=24%  Similarity=0.368  Sum_probs=213.4

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------  234 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+|+.++|||||+++++|...      
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            346999999999999999999999999999999885321       2234799999999999999999998543      


Q ss_pred             --------------------------------CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhccccc
Q psy17952        235 --------------------------------HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL  282 (804)
Q Consensus       235 --------------------------------~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L  282 (804)
                                                      ..+|+|||||.|++.+.+.                             
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-----------------------------  129 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK-----------------------------  129 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSEEHHHHHH-----------------------------
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHH-----------------------------
Confidence                                            3488999999987665543                             


Q ss_pred             chhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeec-CCCcEEEEecccccccCC---CCccccCcccc
Q psy17952        283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCP---ANSFVGTPYWM  358 (804)
Q Consensus       283 ~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~-~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~  358 (804)
                       .+......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....   ....+||+.|+
T Consensus       130 -~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~  208 (383)
T 3eb0_A          130 -SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR  208 (383)
T ss_dssp             -HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCC
T ss_pred             -HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCcc
Confidence             1223456799999999999999999999999999999999999998 688999999999975432   34568999999


Q ss_pred             cchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCCCchhhHHhhcccc--cCCCCc
Q psy17952        359 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQND-TPCLQSSDWSVIKTISSTA--ERKPPY  435 (804)
Q Consensus       359 APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~-~p~~~~~~~~~i~~i~~~~--~~~pp~  435 (804)
                      |||++.+  ...|+.++||||+||++|||++|++||.+.+..+.+..+.+.. .|..     ..+.......  ...|..
T Consensus       209 aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~-----~~~~~~~~~~~~~~~~~~  281 (383)
T 3eb0_A          209 APELMLG--ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTK-----EQMIRMNPHYTEVRFPTL  281 (383)
T ss_dssp             CHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH-----HHHHHHCTTC--CCCCCC
T ss_pred             CHHHhcC--CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH-----HHHHHhCcccccccCCcc
Confidence            9999853  3458999999999999999999999999999888887776532 2210     1111111000  000000


Q ss_pred             cchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        436 FNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       436 ~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                       .....           ........++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus       282 -~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          282 -KAKDW-----------RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             -CCCCH-----------HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             -CcccH-----------HhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence             00000           00122347889999999999999999999999999999953

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-45  Score=406.15  Aligned_cols=284  Identities=26%  Similarity=0.412  Sum_probs=214.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-----CCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-----HPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-----HpNIV~l~~~~~~~~~  236 (804)
                      +.|+++++||+|+||.||+|++..+++.||||.+...    ......+.+|+.+++.+.     |||||++++++...+.
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            4699999999999999999999999999999988632    223355678999999986     9999999999999999


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|+|||||.|+|.+++..                                .....+++.++..++.||+.||+|||++||
T Consensus       111 ~~lv~e~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  158 (360)
T 3llt_A          111 MCLIFEPLGPSLYEIITR--------------------------------NNYNGFHIEDIKLYCIEILKALNYLRKMSL  158 (360)
T ss_dssp             EEEEECCCCCBHHHHHHH--------------------------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eEEEEcCCCCCHHHHHHh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            999999997766555431                                112358999999999999999999999999


Q ss_pred             eecCCCCCCeeecC-------------------------CCcEEEEecccccccCC-CCccccCcccccchhhcccCCCC
Q psy17952        317 IHRDVKAGNILLTE-------------------------TGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQ  370 (804)
Q Consensus       317 iHRDLKP~NILl~~-------------------------~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~  370 (804)
                      +||||||+|||++.                         ++.+||+|||+|+.... ....+||+.|+|||++.   +..
T Consensus       159 vHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~---~~~  235 (360)
T 3llt_A          159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL---NLG  235 (360)
T ss_dssp             ECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT---TCC
T ss_pred             eeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHc---CCC
Confidence            99999999999975                         78999999999976443 34678999999999985   356


Q ss_pred             CCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccc-----------cCCCCccchh
Q psy17952        371 YDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA-----------ERKPPYFNMN  439 (804)
Q Consensus       371 y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~-----------~~~pp~~~~~  439 (804)
                      |+.++|||||||++|||++|++||.+.+..+.+..+.....+....    .........           ...|....  
T Consensus       236 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~----~~~~~~~~~~~~~~~~~~~~~~~p~~~~--  309 (360)
T 3llt_A          236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKN----MLYEATKTNGSKYVNKDELKLAWPENAS--  309 (360)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHH----HHHHHTTSGGGGGEETTTTEECTTTTCS--
T ss_pred             CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHH----HHhhhhhccCccccCcccceecCccccc--
Confidence            8999999999999999999999999988887777665543322110    000000000           00000000  


Q ss_pred             hhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy17952        440 AMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       440 ~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      .......... ..+ ......++.+.+||.+||+.||++|||++|+|+||||+
T Consensus       310 ~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          310 SINSIKHVKK-CLP-LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CHHHHHHHHT-CCC-HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             chhhhhhhhh-ccc-ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            0000000000 000 00112357899999999999999999999999999984

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-45  Score=406.63  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=204.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      ..+.|++.+.||+|+||.||+|+++.+++.||||.+....       ....+|+++|.++ +||||+++++++.+.+..|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            4456999999999999999999999999999999986422       2346799999888 7999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|+                                 +|++++...+.+++.++..++.||+.||+|||++||+|
T Consensus        93 lv~E~~~gg---------------------------------~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givH  139 (342)
T 2qr7_A           93 VVTELMKGG---------------------------------ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH  139 (342)
T ss_dssp             EEECCCCSC---------------------------------BHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEeCCCCC---------------------------------cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence            999999875                                 12233334567999999999999999999999999999


Q ss_pred             cCCCCCCeeecCC----CcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        319 RDVKAGNILLTET----GTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       319 RDLKP~NILl~~~----g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      |||||+|||+..+    +.+||+|||+|+....    ..+.+||+.|+|||++.+   ..|+.++|||||||++|||++|
T Consensus       140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g  216 (342)
T 2qr7_A          140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER---QGYDAACDIWSLGVLLYTMLTG  216 (342)
T ss_dssp             SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH---HHHHHHHHHHHHHHHHHHHHHS
T ss_pred             ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC---CCCCCccCeeeHhHHHHHHhcC
Confidence            9999999998543    3599999999975432    235689999999999853   3588899999999999999999


Q ss_pred             CCCCCCC---ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        391 KPPYFNM---NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       391 ~~PF~~~---~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      .+||.+.   +..+.+..+..+..+                                       .+......+|+++++|
T Consensus       217 ~~Pf~~~~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~s~~~~~l  257 (342)
T 2qr7_A          217 YTPFANGPDDTPEEILARIGSGKFS---------------------------------------LSGGYWNSVSDTAKDL  257 (342)
T ss_dssp             SCSSCSSTTSCHHHHHHHHHHCCCC---------------------------------------CCSTTTTTSCHHHHHH
T ss_pred             CCCCCCCCcCCHHHHHHHHccCCcc---------------------------------------cCccccccCCHHHHHH
Confidence            9999753   333333333322111                                       0111123578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      |.+||..||++|||+.++|+||||..
T Consensus       258 i~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          258 VSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHCCCChhHCcCHHHHhcCCeecC
Confidence            99999999999999999999999954

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-45  Score=408.46  Aligned_cols=282  Identities=25%  Similarity=0.393  Sum_probs=216.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----Cc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----HT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----~~  236 (804)
                      ..|++++.||+|+||.||+|++..+++.||||++....  .....+.+.+|+++|++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            46999999999999999999999999999999986422  233446788999999999999999999998765     36


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|+||||+.|++.+++.                                   .+.+++.++..++.||+.||+|||++||
T Consensus       105 ~~iv~e~~~~~L~~~l~-----------------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~i  149 (364)
T 3qyz_A          105 VYIVQDLMETDLYKLLK-----------------------------------TQHLSNDHICYFLYQILRGLKYIHSANV  149 (364)
T ss_dssp             EEEEEECCSEEHHHHHH-----------------------------------HCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEcccCcCHHHHHH-----------------------------------hCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            89999999987554432                                   2468999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||++.++.+||+|||+|+....       ....+||+.|+|||++.+  ...++.++|||||||++|||++
T Consensus       150 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~  227 (364)
T 3qyz_A          150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKSIDIWSVGCILAEMLS  227 (364)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT--BCSCSTHHHHHHHHHHHHHHHH
T ss_pred             ecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC--CCCCCcchhHHHHHHHHHHHHH
Confidence            9999999999999999999999999975432       234589999999998753  3458899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAHF  467 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~dl  467 (804)
                      |++||.+.+..+.+..+.........    ..+..+..          ................  .......++++.+|
T Consensus       228 g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  293 (364)
T 3qyz_A          228 NRPIFPGKHYLDQLNHILGILGSPSQ----EDLNCIIN----------LKARNYLLSLPHKNKVPWNRLFPNADSKALDL  293 (364)
T ss_dssp             SSCSSCCSSGGGHHHHHHHHHCSCCH----HHHHTCCC----------HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCH----HHHHHhhh----------hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHH
Confidence            99999998877777766542111100    00100000          0000000000000000  00123568899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      |.+||+.||++|||+.|+|+||||.....
T Consensus       294 i~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          294 LDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence            99999999999999999999999987543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-45  Score=391.13  Aligned_cols=252  Identities=29%  Similarity=0.441  Sum_probs=207.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            45999999999999999999999999999999886433222333456889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.|+ +.+.+                                  .....+++..+..++.|++.||.|||++||+|||
T Consensus        89 e~~~~~~l~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~d  134 (279)
T 3fdn_A           89 EYAPLGTVYREL----------------------------------QKLSKFDEQRTATYITELANALSYCHSKRVIHRD  134 (279)
T ss_dssp             CCCTTEEHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECC
T ss_pred             ecCCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence            999864 32222                                  2235689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |||+|||++.++.+||+|||++.....  .....||+.|+|||++.   ...++.++|||||||++|||++|..||.+.+
T Consensus       135 lkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  211 (279)
T 3fdn_A          135 IKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  211 (279)
T ss_dssp             CCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhc---cCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence            999999999999999999999865332  23568999999999984   4567889999999999999999999998776


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      .......+.....                                           .....+++.+.+||.+||+.||.+
T Consensus       212 ~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~  248 (279)
T 3fdn_A          212 YQETYKRISRVEF-------------------------------------------TFPDFVTEGARDLISRLLKHNPSQ  248 (279)
T ss_dssp             HHHHHHHHHHTCC-------------------------------------------CCCTTSCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHHHHhCCC-------------------------------------------CCCCcCCHHHHHHHHHHhccChhh
Confidence            6555444432110                                           011236788999999999999999


Q ss_pred             CCCHHHHHcCccccC
Q psy17952        479 RPSSGRLLTHDLVTR  493 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~  493 (804)
                      |||+.|+|+||||+.
T Consensus       249 Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          249 RPMLREVLEHPWITA  263 (279)
T ss_dssp             SCCHHHHHHCHHHHH
T ss_pred             CCCHHHHhhCccccC
Confidence            999999999999964

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-45  Score=402.28  Aligned_cols=285  Identities=27%  Similarity=0.409  Sum_probs=214.6

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            346999999999999999999999999999999885432 2233345678999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||+.|++.+.+                                 ......+++..+..++.||+.||.|||++||+|||
T Consensus       103 ~e~~~~~~l~~~---------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d  149 (331)
T 4aaa_A          103 FEFVDHTILDDL---------------------------------ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRD  149 (331)
T ss_dssp             EECCSEEHHHHH---------------------------------HHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             EecCCcchHHHH---------------------------------HhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccC
Confidence            999987643211                                 12345689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||+++....    ....+||+.|+|||++.+  ...++.++|||||||++|||++|++||.+
T Consensus       150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (331)
T 4aaa_A          150 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG--DVKYGKAVDVWAIGCLVTEMFMGEPLFPG  227 (331)
T ss_dssp             CCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTT--CTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccC--CCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999965332    234679999999999853  23688899999999999999999999999


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccc-cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~-~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      .+..+.+..+........+ ..+..+....... ...+....            ........+.+++.+.+||.+||+.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~L~~d  294 (331)
T 4aaa_A          228 DSDIDQLYHIMMCLGNLIP-RHQELFNKNPVFAGVRLPEIKE------------REPLERRYPKLSEVVIDLAKKCLHID  294 (331)
T ss_dssp             SSHHHHHHHHHHHHCSCCH-HHHHHHHHCGGGTTCCCCCCSS------------CCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred             CCcHHHHHHHHHHhCCCCh-hhhhHhhhccccccccCccccc------------cchhhhcccchhHHHHHHHHHHhccC
Confidence            8888777766542211110 0000000000000 00000000            00000112357899999999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy17952        476 PADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~~~  494 (804)
                      |++|||+.|+|+||||...
T Consensus       295 P~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          295 PDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGGSCCGGGGGGSHHHHGG
T ss_pred             cccCCCHHHHhcCchhccC
Confidence            9999999999999999653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-45  Score=403.27  Aligned_cols=294  Identities=26%  Similarity=0.356  Sum_probs=212.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccc--cchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK--QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~--~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||+|.+.....  ......+.+.+|+.+|++++|||||++++++.+.+..|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            4569999999999999999999999999999998864321  12344567889999999999999999999999999999


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhccc---chhh---hhhhhhhcccccchh-hccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGM---GNRL---QQLKCFTEHFALFNF-EVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~---~~~l---~~l~~~~~~~~L~~~-~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      +|||||.|+ |.+++....... ......   ....   ...........+..+ ......+++..+..++.||+.||+|
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDS-TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETT-TTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhccc-ccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            999999754 444332000000 000000   0000   000000000000000 0012235688899999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCC--cEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETG--TVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  380 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g--~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSl  380 (804)
                      ||++||+||||||+|||++.++  .+||+|||+|+....        .....||+.|+|||++.+. ...|+.++|||||
T Consensus       184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Diwsl  262 (345)
T 3hko_A          184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-NESYGPKCDAWSA  262 (345)
T ss_dssp             HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-SSCCCTHHHHHHH
T ss_pred             HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-CCCCCcHHHHHHH
Confidence            9999999999999999998777  899999999974321        2346799999999998532 3568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCc
Q psy17952        381 GITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW  460 (804)
Q Consensus       381 Gvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~  460 (804)
                      ||++|||++|+.||.+.+..+....+.......                                       +......+
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~  303 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF---------------------------------------ENPNYNVL  303 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT---------------------------------------TSGGGGGS
T ss_pred             HHHHHHHHHCCCCCCCCChHHHHHHHHhccccc---------------------------------------CCcccccC
Confidence            999999999999999888777766665432210                                       00011236


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       461 s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       304 ~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            88999999999999999999999999999997643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6e-45  Score=408.34  Aligned_cols=279  Identities=30%  Similarity=0.466  Sum_probs=213.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT----  236 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~----  236 (804)
                      ...|++.+.||+|+||+||+|++..+++ ||+|++....       ....+|+++|+.++|||||+++++|...+.    
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3469999999999999999999888776 8888875321       123479999999999999999999966543    


Q ss_pred             --eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        237 --AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       237 --~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                        +|+|||||.|++.+.+.                              .+......+++..++.++.||+.||+|||++
T Consensus       111 ~~~~lv~e~~~~~l~~~~~------------------------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~  160 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASR------------------------------HYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI  160 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHH------------------------------HHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEEEeeccCccHHHHHH------------------------------HHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence              88999999987544332                              1112345799999999999999999999999


Q ss_pred             CCeecCCCCCCeeec-CCCcEEEEecccccccC---CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        315 GRIHRDVKAGNILLT-ETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       315 gIiHRDLKP~NILl~-~~g~vKL~DFGla~~~~---~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||+||||||+|||++ .++.+||+|||+|+...   .....+||+.|+|||++.+  ...|+.++|||||||++|||++|
T Consensus       161 ~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g  238 (394)
T 4e7w_A          161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQG  238 (394)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC--CCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999999999 79999999999997643   2345789999999999853  34589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccc-cCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTA-ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~-~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      ++||.+.+..+.+..+.+. ..|.     ...+..+.... ...-+......           .........++++.+||
T Consensus       239 ~~pf~~~~~~~~l~~i~~~~g~p~-----~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li  302 (394)
T 4e7w_A          239 QPLFPGESGIDQLVEIIKVLGTPS-----REQIKTMNPNYMEHKFPQIRPHP-----------FSKVFRPRTPPDAIDLI  302 (394)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCC-----HHHHHHHCGGGSSSCCCCCCCCC-----------HHHHSCTTCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCC-----HHHHHhhChhhhhhccccccCCc-----------HHHhccccCCHHHHHHH
Confidence            9999999988888777653 2221     11111111000 00000000000           00112235789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||+.||.+|||+.|+|+||||...+
T Consensus       303 ~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          303 SRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            999999999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.3e-46  Score=401.70  Aligned_cols=257  Identities=28%  Similarity=0.413  Sum_probs=207.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce--
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA--  237 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~--  237 (804)
                      ..+.|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.++++++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            445699999999999999999999999999999998754333444556788999999999999999999998876544  


Q ss_pred             --EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        238 --WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       238 --~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                        |+|||||.| +|.+++                                  ...+.+++.++..++.|++.||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~  135 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIV----------------------------------HTEGPMTPKRAIEVIADACQALNFSHQN  135 (311)
T ss_dssp             EEEEEEECCCEEEHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccEEEEecCCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence              999999975 443332                                  2345789999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ||+||||||+|||++.++.+||+|||+++....       ....+||+.|+|||++.   +..++.++|||||||++|||
T Consensus       136 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l  212 (311)
T 3ork_A          136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCVLYEV  212 (311)
T ss_dssp             TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHH---TCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc---CCCCCchHhHHHHHHHHHHH
Confidence            999999999999999999999999999965322       22457999999999985   35789999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|+.||.+.+.......+......                    +                   +......+++++.+|
T Consensus       213 l~g~~pf~~~~~~~~~~~~~~~~~~--------------------~-------------------~~~~~~~~~~~l~~l  253 (311)
T 3ork_A          213 LTGEPPFTGDSPVSVAYQHVREDPI--------------------P-------------------PSARHEGLSADLDAV  253 (311)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHCCCC--------------------C-------------------HHHHSTTCCHHHHHH
T ss_pred             HhCCCCCCCCChHHHHHHHhcCCCC--------------------C-------------------cccccCCCCHHHHHH
Confidence            9999999988777666555432211                    0                   001123468999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCcccc
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                      |.+||+.||++||++.++|.|+|+.
T Consensus       254 i~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          254 VLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHhcCHhhChhhHHHHHHHHHH
Confidence            9999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-45  Score=399.51  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=185.4

Q ss_pred             ccccc---cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceE
Q psy17952        163 IFEDL---REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       163 ~y~~l---~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~  238 (804)
                      .|++.   +.||+|+||.||+|++..+++.||||.+...      ....+.+|+.+++.+. ||||+++++++.+....|
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            35554   7899999999999999999999999988532      2345678999999997 999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|+.                                 |.+++...+.+++.++..++.||+.||+|||++||+|
T Consensus        83 lv~e~~~~~~---------------------------------L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH  129 (325)
T 3kn6_A           83 LVMELLNGGE---------------------------------LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH  129 (325)
T ss_dssp             EEECCCCSCB---------------------------------HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEEccCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Confidence            9999998741                                 2222334567999999999999999999999999999


Q ss_pred             cCCCCCCeeecCCC---cEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        319 RDVKAGNILLTETG---TVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       319 RDLKP~NILl~~~g---~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |||||+|||++.++   .+||+|||+|+....    ....+||+.|+|||++.   ...|+.++|||||||++|||++|.
T Consensus       130 ~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~  206 (325)
T 3kn6_A          130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN---QNGYDESCDLWSLGVILYTMLSGQ  206 (325)
T ss_dssp             CCCCGGGEEEEC----CEEEECCCTTCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhc---CCCCCCccchHHHHHHHHHHHhCC
Confidence            99999999998766   899999999975432    23568999999999984   456899999999999999999999


Q ss_pred             CCCCCCCh-------HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        392 PPYFNMNA-------MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       392 ~PF~~~~~-------~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      +||.+.+.       .+.+..+..+..+                                       .+......+++++
T Consensus       207 ~pf~~~~~~~~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~s~~~  247 (325)
T 3kn6_A          207 VPFQSHDRSLTCTSAVEIMKKIKKGDFS---------------------------------------FEGEAWKNVSQEA  247 (325)
T ss_dssp             CTTC-------CCCHHHHHHHHTTTCCC---------------------------------------CCSHHHHTSCHHH
T ss_pred             CCCCCCccccccccHHHHHHHHHcCCCC---------------------------------------CCcccccCCCHHH
Confidence            99976432       1122222111100                                       0000012468899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||.+||+.||.+|||+.++++||||...
T Consensus       248 ~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          248 KDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.7e-45  Score=412.71  Aligned_cols=277  Identities=27%  Similarity=0.407  Sum_probs=211.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------C
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------H  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------~  235 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||++....       ....+|+++|++++|||||+++++|...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            45999999999999999999999999999999885321       2234799999999999999999988542      2


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+++||||+.|++.+++..                              +......+++..++.++.||+.||.|||++|
T Consensus       127 ~~~lv~e~~~~~l~~~~~~------------------------------~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  176 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARH------------------------------YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG  176 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHH------------------------------HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             eEEeehhcccccHHHHHHH------------------------------HhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3679999999876554421                              1123467999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCC-CcEEEEecccccccC---CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        316 RIHRDVKAGNILLTET-GTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       316 IiHRDLKP~NILl~~~-g~vKL~DFGla~~~~---~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |+||||||+|||++.+ +.+||+|||+|+...   .....+||+.|+|||++.+  ...|+.++|||||||++|||++|+
T Consensus       177 ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~G~  254 (420)
T 1j1b_A          177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCVLAELLLGQ  254 (420)
T ss_dssp             EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcC--CCCCCchhhhHHHHHHHHHHHhCC
Confidence            9999999999999965 578999999997543   2345789999999999853  246899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccccC-CCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        392 PPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAER-KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~-~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      +||.+.+..+.+..+.+. ..|.     ...+..+...... .-|.......           ........++++.+||.
T Consensus       255 ~pf~~~~~~~~l~~i~~~lg~p~-----~~~~~~~~~~~~~~~~p~~~~~~~-----------~~~~~~~~~~~~~~Li~  318 (420)
T 1j1b_A          255 PIFPGDSGVDQLVEIIKVLGTPT-----REQIREMNPNYTEFKFPQIKAHPW-----------TKVFRPRTPPEAIALCS  318 (420)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCSCC-----HHHHHHHCSCCCCCCCCCCCCCCH-----------HHHSCTTSCHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCC-----HHHHHhhChhhhhhccCccCCCCH-----------HHhcCCCCCHHHHHHHH
Confidence            999999888888777653 1111     1112111110000 0000000000           00112356899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +||++||.+|||+.|+|+||||..
T Consensus       319 ~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          319 RLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             HhccCChhHCCCHHHHhCCHhhcc
Confidence            999999999999999999999965

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=407.55  Aligned_cols=252  Identities=26%  Similarity=0.332  Sum_probs=204.2

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |...+.||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+.+|++++|||||++++++...+..|+||||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            344678999999999999999999999999986432   23446788999999999999999999999999999999999


Q ss_pred             cCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      |.|+ |.+.+.                                 .....+++.++..++.||+.||+|||++||+|||||
T Consensus       168 ~~~~~L~~~l~---------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  214 (373)
T 2x4f_A          168 VDGGELFDRII---------------------------------DESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK  214 (373)
T ss_dssp             CTTCEEHHHHH---------------------------------HTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             CCCCcHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence            9864 333221                                 122358899999999999999999999999999999


Q ss_pred             CCCeee--cCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        323 AGNILL--TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       323 P~NILl--~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |+|||+  +.++.+||+|||+++....   ....+||+.|+|||++.   ...++.++|||||||++|||++|..||.+.
T Consensus       215 p~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN---YDFVSFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             GGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHT---TCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             HHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhcc---CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999  5677899999999976433   23457999999999984   456888999999999999999999999998


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+..+.....+.                                       +......+++++.+||.+||+.||.
T Consensus       292 ~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~~~~~~~li~~~L~~dp~  332 (373)
T 2x4f_A          292 NDAETLNNILACRWDL---------------------------------------EDEEFQDISEEAKEFISKLLIKEKS  332 (373)
T ss_dssp             SHHHHHHHHHHTCCCS---------------------------------------CSGGGTTSCHHHHHHHHTTSCSSGG
T ss_pred             CHHHHHHHHHhccCCC---------------------------------------ChhhhccCCHHHHHHHHHHcCCChh
Confidence            8877777665432110                                       0001134688999999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy17952        478 DRPSSGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~  493 (804)
                      +|||+.|+|+||||..
T Consensus       333 ~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          333 WRISASEALKHPWLSD  348 (373)
T ss_dssp             GSCCHHHHHHSHHHHC
T ss_pred             hCCCHHHHhcCcCcCC
Confidence            9999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4e-45  Score=436.78  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=214.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|++++.||+|+||.||+|++..+++.||||++...........+.+.+|..+|..+ +||||++++++|.+.+.+||||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            489999999999999999999999999999998643222233456678999999987 7999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+.                                 |++++...+.+++..++.|+.||+.||+|||++|||||||
T Consensus       422 E~~~gg~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDL  468 (674)
T 3pfq_A          422 EYVNGGD---------------------------------LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL  468 (674)
T ss_dssp             ECCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCC
T ss_pred             eCcCCCc---------------------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccC
Confidence            9998752                                 2222233457999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccC----CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~----~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+||||+.+|.+||+|||+|+...    ...+.+||+.|||||++.   ...|+.++|||||||++|||++|++||.+.
T Consensus       469 Kp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             CSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHT---CCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhc---CCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999997532    234578999999999984   457999999999999999999999999998


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+..|......                                           .+..+++++.+||.+||++||+
T Consensus       546 ~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~lL~~dP~  582 (674)
T 3pfq_A          546 DEDELFQSIMEHNVA-------------------------------------------YPKSMSKEAVAICKGLMTKHPG  582 (674)
T ss_dssp             SHHHHHHHHHSSCCC-------------------------------------------CCTTSCHHHHHHHHHHSCSSST
T ss_pred             CHHHHHHHHHhCCCC-------------------------------------------CCccCCHHHHHHHHHHccCCHH
Confidence            887777666543211                                           1134689999999999999999


Q ss_pred             CCCCH-----HHHHcCccccC
Q psy17952        478 DRPSS-----GRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rpsa-----~elL~Hp~~~~  493 (804)
                      +||++     +|+++||||..
T Consensus       583 ~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          583 KRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             TCTTCSTTHHHHHHSSGGGSS
T ss_pred             HCCCCCCCcHHHHhcCccccC
Confidence            99997     99999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.7e-45  Score=413.23  Aligned_cols=295  Identities=25%  Similarity=0.333  Sum_probs=215.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc------CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL------KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L------~HpNIV~l~~~~~~  233 (804)
                      ....|++++.||+|+||.||+|++..+++.||||.+...    ......+.+|+.+++.+      +||||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            345699999999999999999999999999999998632    22335677888888877      57799999999999


Q ss_pred             cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       234 ~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      .+..|+||||+.|++.+++..                                .....+++..++.|+.||+.||+|||+
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~  218 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKK--------------------------------NKFQGFSLPLVRKFAHSILQCLDALHK  218 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHH--------------------------------TTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeccCCCHHHHHHh--------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999876665531                                112358999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCc--EEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        314 LGRIHRDVKAGNILLTETGT--VKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~--vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      +|||||||||+|||++.++.  +||+|||+|+.... ..+.+||+.|+|||++.+   ..|+.++|||||||++|||++|
T Consensus       219 ~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG  295 (429)
T 3kvw_A          219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILG---ARYGMPIDMWSLGCILAELLTG  295 (429)
T ss_dssp             HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHT---BCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhC---CCCCchHHHHhHHHHHHHHHhC
Confidence            99999999999999999987  99999999975433 346789999999999853   5689999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhh---HHhhcccccCCCCccchhhhH--HH-H-----hhcc-CCCCC----
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSV---IKTISSTAERKPPYFNMNAMS--AL-Y-----HIAQ-NDTPC----  454 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~---i~~i~~~~~~~pp~~~~~~~~--~l-~-----~i~~-~~~p~----  454 (804)
                      .+||.+.+..+.+..+......... ..+..   ....... ...|.+.......  .. .     .... ...+.    
T Consensus       296 ~~pf~~~~~~~~l~~i~~~~~~p~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (429)
T 3kvw_A          296 YPLLPGEDEGDQLACMIELLGMPSQ-KLLDASKRAKNFVSS-KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW  373 (429)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCH-HHHHTBTTHHHHBCT-TSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCCH-HHHHhhhhhhhccCC-CCCcccccccccccccccccccccchhhccCCccchhh
Confidence            9999999888887776653211100 00000   0000000 0000000000000  00 0     0000 00000    


Q ss_pred             --CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        455 --LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       455 --~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                        ......++.+.+||.+||++||++|||++|+|+||||++..
T Consensus       374 ~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          374 GNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             HhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence              01123478899999999999999999999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=401.11  Aligned_cols=253  Identities=27%  Similarity=0.376  Sum_probs=207.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccc-----hhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC-----AEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~-----~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      ..+.|++++.||+|+||.||+|++..+++.||||.+.......     ......+.+|+.+|++++||||++++++|.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4457999999999999999999999999999999886532211     12345678899999999999999999999999


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      +..|+||||+.+++                                +|.+++...+.+++..+..|+.||+.||.|||++
T Consensus       102 ~~~~lv~e~~~~g~--------------------------------~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  149 (335)
T 3dls_A          102 GFFQLVMEKHGSGL--------------------------------DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK  149 (335)
T ss_dssp             SEEEEEEECCTTSC--------------------------------BHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEEEEEeCCCCc--------------------------------cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            99999999986541                                1222333456799999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHHHHhC
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAER  390 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~ELltG  390 (804)
                      ||+||||||+|||++.++.+||+|||+++.....   ...+||+.|+|||++.+   ..+ +.++|||||||++|||++|
T Consensus       150 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g  226 (335)
T 3dls_A          150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG---NPYRGPELEMWSLGVTLYTLVFE  226 (335)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTT---CCBCSHHHHHHHHHHHHHHHHHS
T ss_pred             CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcC---CCCCCCcccchhHHHHHHHHHhC
Confidence            9999999999999999999999999999764332   34679999999999853   344 7789999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||.+....                         ...                        .......+++++.+||.+
T Consensus       227 ~~pf~~~~~~-------------------------~~~------------------------~~~~~~~~~~~l~~li~~  257 (335)
T 3dls_A          227 ENPFCELEET-------------------------VEA------------------------AIHPPYLVSKELMSLVSG  257 (335)
T ss_dssp             SCSCSSGGGG-------------------------TTT------------------------CCCCSSCCCHHHHHHHHH
T ss_pred             CCchhhHHHH-------------------------Hhh------------------------ccCCCcccCHHHHHHHHH
Confidence            9999642110                         000                        001122368899999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ||+.||++|||+.++|+||||+....
T Consensus       258 ~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          258 LLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             HccCChhhCcCHHHHhcCccccCCcc
Confidence            99999999999999999999987654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4e-45  Score=395.04  Aligned_cols=270  Identities=25%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             ccccccc-cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        161 EKIFEDL-REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       161 ~~~y~~l-~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.|++. +.||+|+||.||+|++..+++.||||.+....   ....+.+.+|+.+|+++ +||||+++++++.+.+..|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4468885 78999999999999999999999999986432   23346788999999985 7999999999999999999


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.|+ +.+++                                  ...+.+++.++..++.||+.||+|||++||+
T Consensus        88 lv~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  133 (316)
T 2ac3_A           88 LVFEKMRGGSILSHI----------------------------------HKRRHFNELEASVVVQDVASALDFLHNKGIA  133 (316)
T ss_dssp             EEEECCTTCBHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEcCCCCcHHHHH----------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence            999999854 33332                                  2235689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCc---EEEEecccccccCC-----------CCccccCcccccchhhcccC--CCCCCCcccHHHHH
Q psy17952        318 HRDVKAGNILLTETGT---VKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLG  381 (804)
Q Consensus       318 HRDLKP~NILl~~~g~---vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlG  381 (804)
                      ||||||+|||++.++.   +||+|||++.....           ....+||+.|+|||++.+..  ...|+.++||||||
T Consensus       134 H~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  213 (316)
T 2ac3_A          134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG  213 (316)
T ss_dssp             CCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHH
T ss_pred             eCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHH
Confidence            9999999999998776   99999999864321           12356999999999985311  13478899999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHH-hhccC--CCCCCCCC
Q psy17952        382 ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY-HIAQN--DTPCLQSS  458 (804)
Q Consensus       382 vil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~-~i~~~--~~p~~~~~  458 (804)
                      |++|||++|++||.+.+..+.               .|.....            .......+. .+...  ..+.....
T Consensus       214 ~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~------------~~~~~~~~~~~i~~~~~~~~~~~~~  266 (316)
T 2ac3_A          214 VILYILLSGYPPFVGRCGSDC---------------GWDRGEA------------CPACQNMLFESIQEGKYEFPDKDWA  266 (316)
T ss_dssp             HHHHHHHHSSCSCCCCCCSCS---------------CC----C------------CHHHHHHHHHHHHHCCCCCCHHHHT
T ss_pred             HHHHHHHHCCCCCcccccccc---------------ccccccc------------chhHHHHHHHHHhccCcccCchhcc
Confidence            999999999999976532110               0000000            000000000 00000  01111113


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       459 ~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+++++.+||.+||+.||++|||++|+|+||||...
T Consensus       267 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            468899999999999999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.7e-45  Score=388.94  Aligned_cols=261  Identities=30%  Similarity=0.488  Sum_probs=199.7

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++..+++.||||.+..... .......+.++...++.++||||+++++++.+.+..|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4569999999999999999999999999999999864322 122233344555568889999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeec
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHR  319 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiHR  319 (804)
                      |||+.|++.+++..                              .......+++..+..++.|++.||.|||++ ||+||
T Consensus        85 ~e~~~~~l~~~l~~------------------------------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~  134 (290)
T 3fme_A           85 MELMDTSLDKFYKQ------------------------------VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR  134 (290)
T ss_dssp             EECCSEEHHHHHHH------------------------------HHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCC
T ss_pred             EehhccchHHHHHH------------------------------HHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecC
Confidence            99999876655431                              112346799999999999999999999998 99999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhccc-CCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~-~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+|||++.++.+||+|||+|+....   .....||+.|+|||++... ....++.++|||||||++|||++|+.||.
T Consensus       135 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  214 (290)
T 3fme_A          135 DVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD  214 (290)
T ss_dssp             CCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             CCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            9999999999999999999999975432   2335799999999997321 24568889999999999999999999997


Q ss_pred             CC-ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        396 NM-NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       396 ~~-~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .. .....+..+...                                         ..+......+++++.+|+.+||+.
T Consensus       215 ~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~li~~~l~~  253 (290)
T 3fme_A          215 SWGTPFQQLKQVVEE-----------------------------------------PSPQLPADKFSAEFVDFTSQCLKK  253 (290)
T ss_dssp             CCSCHHHHHHHHHHS-----------------------------------------CCCCCCTTTSCHHHHHHHHHHTCS
T ss_pred             ccCchHHHHHHHhcc-----------------------------------------CCCCcccccCCHHHHHHHHHHhhc
Confidence            53 333322222211                                         111222345789999999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy17952        475 NPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||++|||+.|+++||||+.
T Consensus       254 ~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          254 NSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             SGGGSCCHHHHTTSHHHHH
T ss_pred             ChhhCcCHHHHHhCccccc
Confidence            9999999999999999964

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.9e-45  Score=387.55  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=210.7

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            34699999999999999999999999999999988643222222345688999999999999999999999999999999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.| ++.+.+                                  ...+.+++..+..++.|++.||.|||++||+||
T Consensus        93 ~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  138 (284)
T 2vgo_A           93 LEFAPRGELYKEL----------------------------------QKHGRFDEQRSATFMEELADALHYCHERKVIHR  138 (284)
T ss_dssp             ECCCTTEEHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             EEeCCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            999986 433322                                  223468999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||||+|||++.++.+||+|||++.....  .....||+.|+|||++.   ...++.++|||||||++|||++|..||...
T Consensus       139 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~  215 (284)
T 2vgo_A          139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE---GKTHDEKVDLWCAGVLCYEFLVGMPPFDSP  215 (284)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHT---TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhc---cCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence            9999999999999999999999865432  23568999999999985   356889999999999999999999999877


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +.......+.....                                           .....+++++.+||.+||+.||.
T Consensus       216 ~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~~p~  252 (284)
T 2vgo_A          216 SHTETHRRIVNVDL-------------------------------------------KFPPFLSDGSKDLISKLLRYHPP  252 (284)
T ss_dssp             SHHHHHHHHHTTCC-------------------------------------------CCCTTSCHHHHHHHHHHSCSSGG
T ss_pred             CHhHHHHHHhcccc-------------------------------------------CCCCcCCHHHHHHHHHHhhcCHh
Confidence            66555444432110                                           01134688999999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy17952        478 DRPSSGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~  493 (804)
                      +|||+.++++||||..
T Consensus       253 ~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          253 QRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             GSCCHHHHHTCHHHHH
T ss_pred             hCCCHHHHhhCHHHHh
Confidence            9999999999999964

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.2e-45  Score=403.47  Aligned_cols=259  Identities=25%  Similarity=0.415  Sum_probs=212.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEeccccccc-----chhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecC
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-----CAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~  235 (804)
                      ..|++.+.||+|+||.||+|++..+|+.||||++......     .....+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4599999999999999999999999999999988643211     112245678999999999 7999999999999999


Q ss_pred             ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+||||+.|+ +.+++                                  .....+++..+..++.||+.||.|||++
T Consensus       174 ~~~lv~e~~~g~~L~~~l----------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~  219 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYL----------------------------------TEKVALSEKETRSIMRSLLEAVSFLHAN  219 (365)
T ss_dssp             EEEEEECCCTTCBHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEEEEeCCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            999999999874 33322                                  2235689999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhccc---CCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~---~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||+||||||+|||++.+|.+||+|||++.....   ....+||+.|+|||++.+.   ....|+.++|||||||++|||+
T Consensus       220 gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell  299 (365)
T 2y7j_A          220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL  299 (365)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH
Confidence            999999999999999999999999999875433   2356899999999998532   1235888999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|..||.+.+....+..+..+....                                       +.......+..+.+||
T Consensus       300 ~g~~pf~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~~~~~~~li  340 (365)
T 2y7j_A          300 AGSPPFWHRRQILMLRMIMEGQYQF---------------------------------------SSPEWDDRSSTVKDLI  340 (365)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCC---------------------------------------CHHHHSSSCHHHHHHH
T ss_pred             HCCCCCCCCCHHHHHHHHHhCCCCC---------------------------------------CCcccccCCHHHHHHH
Confidence            9999998877666655554332110                                       0000124578899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+||+.||++|||+.++|+||||.+
T Consensus       341 ~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          341 SRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHcCCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4e-45  Score=392.71  Aligned_cols=258  Identities=25%  Similarity=0.371  Sum_probs=208.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||.||+|++..+++.||+|.+...........+.+.+|+.++++++||||+++++++..++..|+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            34569999999999999999999999999999999865444445556778999999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+ +.+++                                  ...+++++..+..++.|++.||.|||++||+|
T Consensus        89 v~e~~~g~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  134 (294)
T 4eqm_A           89 VMEYIEGPTLSEYI----------------------------------ESHGPLSVDTAINFTNQILDGIKHAHDMRIVH  134 (294)
T ss_dssp             EEECCCSCBHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEeCCCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999874 33332                                  23457899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+|||++.++.+||+|||+|+....     ....+||+.|+|||++.   ...++.++|||||||++|||++|++|
T Consensus       135 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p  211 (294)
T 4eqm_A          135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK---GEATDECTDIYSIGIVLYEMLVGEPP  211 (294)
T ss_dssp             CCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHH---TCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhc---CCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999975432     23467999999999985   35688899999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.............+..                                      +......+++.+.++|.+||+
T Consensus       212 f~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~l~~li~~~l~  253 (294)
T 4eqm_A          212 FNGETAVSIAIKHIQDSVPNV--------------------------------------TTDVRKDIPQSLSNVILRATE  253 (294)
T ss_dssp             SCSSCHHHHHHHHHSSCCCCH--------------------------------------HHHSCTTSCHHHHHHHHHHSC
T ss_pred             CCCCChHHHHHHHhhccCCCc--------------------------------------chhcccCCCHHHHHHHHHHhc
Confidence            988877665544433221100                                      001124568899999999999


Q ss_pred             cCCCCCCCHHHHHcCcccc
Q psy17952        474 KNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~  492 (804)
                      +||++||+..+.+.++|..
T Consensus       254 ~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          254 KDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             SSGGGSCSSHHHHHHHHHT
T ss_pred             CCHhHccccHHHHHHHHHH
Confidence            9999999777777676643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.4e-45  Score=401.66  Aligned_cols=292  Identities=28%  Similarity=0.446  Sum_probs=215.3

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++..+++.||+|.+....  .....+.+.+|+.+|++++||||+++++++..++..|+|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            456999999999999999999999999999999886432  234456788999999999999999999999999999999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCee
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIH  318 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiH  318 (804)
                      ||||.| +|.+++.                                  ..+.+++..+..++.|++.||.|||++ ||+|
T Consensus       110 ~e~~~~~~L~~~l~----------------------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H  155 (360)
T 3eqc_A          110 MEHMDGGSLDQVLK----------------------------------KAGRIPEQILGKVSIAVIKGLTYLREKHKIMH  155 (360)
T ss_dssp             ECCCTTCBHHHHHH----------------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             EECCCCCCHHHHHH----------------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            999986 4433332                                  234689999999999999999999996 9999


Q ss_pred             cCCCCCCeeecCCCcEEEEeccccccc--CCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIK--CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~--~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||||+|||++.++.+||+|||+|...  .......||+.|+|||++.   ...|+.++|||||||++|||++|+.||..
T Consensus       156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             SCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHT---TCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             CCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998643  2234568999999999985   35689999999999999999999999988


Q ss_pred             CChHHHHHHHHhc---CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        397 MNAMSALYHIAQN---DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       397 ~~~~~~l~~I~~~---~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      .+.......+...   ..+......+..............+  .......+..+.....+......++.++.+||.+||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  310 (360)
T 3eqc_A          233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP--PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI  310 (360)
T ss_dssp             CCHHHHHHHHC--------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHC
T ss_pred             CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCC--cccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhh
Confidence            7655543332110   0000000000000000000000000  0111122222333344445556689999999999999


Q ss_pred             cCCCCCCCHHHHHcCccccC
Q psy17952        474 KNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .||++|||++|+|+||||..
T Consensus       311 ~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          311 KNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             SSTTTSCCHHHHHTSHHHHH
T ss_pred             cChhhCCCHHHHhhChHhhc
Confidence            99999999999999999964

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-44  Score=387.65  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=213.9

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ....|++.+.||+|+||.||+|++..+++.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            34569999999999999999999999999999998865433334455678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+++                                  ...+.+++.++..++.|++.||.|||++||+|
T Consensus        93 v~e~~~~~~L~~~~----------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  138 (294)
T 2rku_A           93 VLELCRRRSLLELH----------------------------------KRRKALTEPEARYYLRQIVLGCQYLHRNRVIH  138 (294)
T ss_dssp             EEECCTTCBHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999864 32222                                  22357899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||||+|||++.++.+||+|||++.....    .....||+.|+|||++.   ...++.++|||||||++|||++|+.||
T Consensus       139 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~  215 (294)
T 2rku_A          139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCIMYTLLVGKPPF  215 (294)
T ss_dssp             CCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHT---TSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhc---cCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999975432    23467999999999984   356888999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+.....                                           .....+++.+.+|+.+||+.
T Consensus       216 ~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~  252 (294)
T 2rku_A          216 ETSCLKETYLRIKKNEY-------------------------------------------SIPKHINPVAASLIQKMLQT  252 (294)
T ss_dssp             CCSSHHHHHHHHHTTCC-------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred             CCCCHHHHHHHHhhccC-------------------------------------------CCccccCHHHHHHHHHHccc
Confidence            87766554444322110                                           01124678899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ||++|||+.++++||||.....
T Consensus       253 ~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          253 DPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             SGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ChhhCcCHHHHhhChheecCCc
Confidence            9999999999999999976543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.7e-45  Score=395.75  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=195.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH------  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~------  235 (804)
                      +.|++++.||+|+||.||+|++..+++.||||++....  .....+.+.+|+.+|++++|||||+++++|.+..      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            45999999999999999999999999999999986432  2334567899999999999999999999986543      


Q ss_pred             ---------------------------------------------------ceEEEEeecCC-CchhhHHHHHhhhhhhh
Q psy17952        236 ---------------------------------------------------TAWLVMEYCLG-SASDIIEVHWIEREFHV  263 (804)
Q Consensus       236 ---------------------------------------------------~~~lVmEy~~G-~l~dll~~~~~~~~~~~  263 (804)
                                                                         ..|+|||||.| ++.+++...        
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------  155 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--------  155 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--------
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--------
Confidence                                                               27999999986 444433210        


Q ss_pred             cccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEeccccc
Q psy17952        264 EGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS  343 (804)
Q Consensus       264 ~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~  343 (804)
                                             ......++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus       156 -----------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  212 (332)
T 3qd2_B          156 -----------------------CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT  212 (332)
T ss_dssp             -----------------------CSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             -----------------------cCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccc
Confidence                                   011234667789999999999999999999999999999999999999999999997


Q ss_pred             ccCCC----------------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy17952        344 IKCPA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIA  407 (804)
Q Consensus       344 ~~~~~----------------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~  407 (804)
                      .....                ...+||+.|+|||++.   ...|+.++|||||||++|||++|..|+..  .......+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~  287 (332)
T 3qd2_B          213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH---GNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR  287 (332)
T ss_dssp             ECSCC--------------CCCSCC-CGGGSCHHHHH---CCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH
T ss_pred             ccccchhhccccccccccccccccCCCcCccChHHhc---CCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh
Confidence            54321                3357999999999985   35789999999999999999999877521  111111111


Q ss_pred             hcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        408 QNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       408 ~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      ...                     .|.                     .....++++.+||.+||+.||++|||+.|+|+
T Consensus       288 ~~~---------------------~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          288 NLK---------------------FPL---------------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             TTC---------------------CCH---------------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ccC---------------------CCc---------------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            100                     000                     00123577899999999999999999999999


Q ss_pred             CccccC
Q psy17952        488 HDLVTR  493 (804)
Q Consensus       488 Hp~~~~  493 (804)
                      ||||..
T Consensus       326 ~~~f~~  331 (332)
T 3qd2_B          326 NAIFEN  331 (332)
T ss_dssp             STTCCC
T ss_pred             chhhhc
Confidence            999964

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.4e-45  Score=404.42  Aligned_cols=281  Identities=27%  Similarity=0.370  Sum_probs=213.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce----
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA----  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~----  237 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++...+..    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            45999999999999999999999999999999986432 2233456788999999999999999999999887665    


Q ss_pred             --EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        238 --WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       238 --~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                        |+||||+.|++.+.+                                    ...+++..+..++.||+.||+|||++|
T Consensus       121 ~~~lv~e~~~~~l~~~~------------------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~  164 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIM------------------------------------GMEFSEEKIQYLVYQMLKGLKYIHSAG  164 (371)
T ss_dssp             CCEEEEECCCEEHHHHT------------------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEccccccHHHHh------------------------------------hcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence              999999987643321                                    235899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+|||++.++.+||+|||+|+.... ....+||+.|+|||++.+  ...++.++|||||||++|||++|++||
T Consensus       165 ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf  242 (371)
T 4exu_A          165 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCIMAEMLTGKTLF  242 (371)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSC--CSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             CcCCCcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcC--CCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999975433 345789999999999853  256889999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC--CCCCCccHHHHHHHHHhc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC--LQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~--~~~~~~s~~l~dli~~cL  472 (804)
                      .+.+..+.+..+.........    ..+..+.          ..........+.......  .....+++++.+||.+||
T Consensus       243 ~~~~~~~~~~~i~~~~~~~~~----~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  308 (371)
T 4exu_A          243 KGKDYLDQLTQILKVTGVPGT----EFVQKLN----------DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKML  308 (371)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCH----HHHTTCS----------CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHS
T ss_pred             CCCChHHHHHHHHHHhCCCcH----HHHHHhh----------hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHC
Confidence            998888877776553211100    0000000          000000000010000000  012356899999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +.||++|||+.|+|+||||....
T Consensus       309 ~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          309 ELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             CCChhhcCCHHHHhcCcccccCC
Confidence            99999999999999999998644

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=397.95  Aligned_cols=257  Identities=26%  Similarity=0.387  Sum_probs=202.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC--CceeEeeeEEeecCceEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH--PNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIV~l~~~~~~~~~~~l  239 (804)
                      +.|++++.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.+|++++|  |||+++++++..++..|+
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            4599999999999999999987 468899999886432 223445678899999999987  999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||++.|++.+++                                  ...+.+++.++..++.||+.||.|||++||+||
T Consensus        87 v~e~~~~~L~~~l----------------------------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHr  132 (343)
T 3dbq_A           87 VMECGNIDLNSWL----------------------------------KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS  132 (343)
T ss_dssp             EECCCSEEHHHHH----------------------------------HHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEeCCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9997666554433                                  235678999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhccc--------CCCCCCCcccHHHHHHHHH
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAM--------DEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~--------~~~~y~~ksDIWSlGvil~  385 (804)
                      ||||+|||++ ++.+||+|||+|+....      ....+||+.|+|||++.+.        ....|+.++|||||||++|
T Consensus       133 Dikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~  211 (343)
T 3dbq_A          133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  211 (343)
T ss_dssp             CCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHH
T ss_pred             CCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHH
Confidence            9999999997 68899999999975432      2346899999999998531        1256888999999999999


Q ss_pred             HHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        386 ELAERKPPYFNMNA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       386 ELltG~~PF~~~~~-~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      ||++|++||.+... ...+..+...                                         ..........++++
T Consensus       212 ell~g~~pf~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~l  250 (343)
T 3dbq_A          212 YMTYGKTPFQQIINQISKLHAIIDP-----------------------------------------NHEIEFPDIPEKDL  250 (343)
T ss_dssp             HHHHSSCTTTTCCSHHHHHHHHHCT-----------------------------------------TSCCCCCCCSCHHH
T ss_pred             HHHhCCCcchhhhhHHHHHHHHhcC-----------------------------------------CcccCCcccCCHHH
Confidence            99999999976432 2222222110                                         00111123346889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .+|+.+||+.||.+|||+.|+|+||||.....
T Consensus       251 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          251 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             HHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            99999999999999999999999999986543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.9e-45  Score=424.55  Aligned_cols=256  Identities=24%  Similarity=0.333  Sum_probs=208.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+|++++|||||+++++|.+.+.+|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            35699999999999999999999999999999998643222223345678999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ |.+.+.                                ......+++..+..++.||+.||+|||++|||||
T Consensus       263 mEy~~gg~L~~~l~--------------------------------~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHr  310 (576)
T 2acx_A          263 LTLMNGGDLKFHIY--------------------------------HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR  310 (576)
T ss_dssp             ECCCCSCBHHHHHH--------------------------------SSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEcCCCCcHHHHHH--------------------------------hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            9999865 322221                                0112358999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      ||||+|||++.+|.+||+|||+|+.....   .+.+||+.|+|||++.   ...|+.++|||||||++|||++|.+||.+
T Consensus       311 DLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~~~~~DiwSLGvilyeLltG~~PF~~  387 (576)
T 2acx_A          311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK---NERYTFSPDWWALGCLLYEMIAGQSPFQQ  387 (576)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHT---TCEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred             CCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHc---CCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999999999764332   3468999999999985   35689999999999999999999999976


Q ss_pred             CCh---HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        397 MNA---MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       397 ~~~---~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      .+.   ...+......                                         . +......+|+++++||.+||+
T Consensus       388 ~~~~~~~~~i~~~i~~-----------------------------------------~-~~~~p~~~s~~~~dLI~~lL~  425 (576)
T 2acx_A          388 RKKKIKREEVERLVKE-----------------------------------------V-PEEYSERFSPQARSLCSQLLC  425 (576)
T ss_dssp             SSSCCCHHHHHHHHHH-----------------------------------------C-CCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccchhHHHHHHHhhc-----------------------------------------c-cccCCccCCHHHHHHHHHhcc
Confidence            432   1111111000                                         0 011124578999999999999


Q ss_pred             cCCCCCC-----CHHHHHcCccccC
Q psy17952        474 KNPADRP-----SSGRLLTHDLVTR  493 (804)
Q Consensus       474 ~dP~~Rp-----sa~elL~Hp~~~~  493 (804)
                      +||.+||     +++|+++||||..
T Consensus       426 ~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          426 KDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             SSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             CCHHHcCCCCCCCHHHHHhChhhcc
Confidence            9999999     8999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=386.51  Aligned_cols=255  Identities=29%  Similarity=0.439  Sum_probs=187.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||.+...........+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            35999999999999999999999999999999986432222233467889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.|+ +.+++.                                 .....+++..+..++.|++.||.|||++||+|||
T Consensus        91 e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  137 (278)
T 3cok_A           91 EMCHNGEMNRYLK---------------------------------NRVKPFSENEARHFMHQIITGMLYLHSHGILHRD  137 (278)
T ss_dssp             ECCTTEEHHHHHH---------------------------------TCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSS
T ss_pred             ecCCCCcHHHHHh---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            999864 322221                                 1235689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||++.....    .....||+.|+|||++.   ...++.++|||||||++|||++|++||..
T Consensus       138 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          138 LTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT---RSAHGLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999975432    23467999999999984   35678899999999999999999999976


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+....+..+..                                         ..  ......++.++.+||.+||+.||
T Consensus       215 ~~~~~~~~~~~~-----------------------------------------~~--~~~~~~~~~~~~~li~~~l~~dp  251 (278)
T 3cok_A          215 DTVKNTLNKVVL-----------------------------------------AD--YEMPSFLSIEAKDLIHQLLRRNP  251 (278)
T ss_dssp             CSCC-----CCS-----------------------------------------SC--CCCCTTSCHHHHHHHHHHSCSSG
T ss_pred             hhHHHHHHHHhh-----------------------------------------cc--cCCccccCHHHHHHHHHHcccCH
Confidence            432221111100                                         00  00123468899999999999999


Q ss_pred             CCCCCHHHHHcCccccCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ++|||+.++|+||||....
T Consensus       252 ~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          252 ADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             GGSCCHHHHTTSTTTC---
T ss_pred             hhCCCHHHHhcCccccCCC
Confidence            9999999999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-44  Score=389.13  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=211.4

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++.+.||+|+||.||+|++..+++.||+|.+.....   ...+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            45679999999999999999999999999999999864321   223567899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+.+                                  ...+.+++..+..++.|++.||.|||++||+|
T Consensus        84 v~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  129 (304)
T 2jam_A           84 VMQLVSGGELFDRI----------------------------------LERGVYTEKDASLVIQQVLSAVKYLHENGIVH  129 (304)
T ss_dssp             EECCCCSCBHHHHH----------------------------------HHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEcCCCccHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999864 33322                                  23356899999999999999999999999999


Q ss_pred             cCCCCCCeee---cCCCcEEEEecccccccCCC--CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILL---TETGTVKLADFGSASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl---~~~g~vKL~DFGla~~~~~~--~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+|||+   +.++.+||+|||++......  ...+||+.|+|||++.   ...++.++|||||||++|||++|..|
T Consensus       130 ~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p  206 (304)
T 2jam_A          130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVITYILLCGYPP  206 (304)
T ss_dssp             CSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBS---SCSCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhc---cCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999   77889999999998754322  2357999999999984   45688999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+..+..+.                                       +......+++++.+||.+||+
T Consensus       207 f~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~~~~~~~li~~~l~  247 (304)
T 2jam_A          207 FYEETESKLFEKIKEGYYEF---------------------------------------ESPFWDDISESAKDFICHLLE  247 (304)
T ss_dssp             TTTSCHHHHHHHHHHCCCCC---------------------------------------CTTTTTTSCHHHHHHHHHHHC
T ss_pred             CCCCCHHHHHHHHHcCCCCC---------------------------------------CccccccCCHHHHHHHHHHcC
Confidence            98877766655554332110                                       111123568999999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .||++|||+.++|+||||....
T Consensus       248 ~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          248 KDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             SSTTTSCCHHHHHTSHHHHSSC
T ss_pred             CChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999997643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-44  Score=384.18  Aligned_cols=254  Identities=27%  Similarity=0.445  Sum_probs=205.6

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee----cCc
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR----DHT  236 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----~~~  236 (804)
                      ...|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+.+|+.+|++++||||+++++++..    ...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh-hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            345899999999999999999999999999999886432 223445778899999999999999999999876    355


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      +|+||||+.|+ +.+++                                  ...+.+++..+..++.||+.||.|||++|
T Consensus       104 ~~lv~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  149 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYL----------------------------------KRFKVMKIKVLRSWCRQILKGLQFLHTRT  149 (290)
T ss_dssp             EEEEEECCCSCBHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             EEEEEEecCCCCHHHHH----------------------------------HHccCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            89999999764 43332                                  22356899999999999999999999999


Q ss_pred             --CeecCCCCCCeeec-CCCcEEEEecccccccCCC--CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        316 --RIHRDVKAGNILLT-ETGTVKLADFGSASIKCPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       316 --IiHRDLKP~NILl~-~~g~vKL~DFGla~~~~~~--~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                        |+||||||+|||++ .++.+||+|||+|......  ....||+.|+|||++.    +.++.++|||||||++|+|++|
T Consensus       150 ~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g  225 (290)
T 1t4h_A          150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHh----ccCCCcchHHHHHHHHHHHHhC
Confidence              99999999999998 7899999999999754332  3467999999999873    4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||.+...............                                        .+.......++++.+||.+
T Consensus       226 ~~pf~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~l~~li~~  265 (290)
T 1t4h_A          226 EYPYSECQNAAQIYRRVTSGV----------------------------------------KPASFDKVAIPEVKEIIEG  265 (290)
T ss_dssp             SCTTTTCSSHHHHHHHHTTTC----------------------------------------CCGGGGGCCCHHHHHHHHH
T ss_pred             CCCCCCcCcHHHHHHHHhccC----------------------------------------CccccCCCCCHHHHHHHHH
Confidence            999987554443333221110                                        0111122356889999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||+.||.+|||+.++|+||||..
T Consensus       266 ~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          266 CIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HccCChhhCCCHHHHhhCccccc
Confidence            99999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-44  Score=420.30  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=208.6

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|+++.+|+.||||++...........+.+.+|+.+|++++|||||+++++|.+...+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            35699999999999999999999999999999998653322233446788999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ |.+.+.                              ........+++..+..++.||+.||.|||++||+||
T Consensus       264 mE~~~gg~L~~~l~------------------------------~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHr  313 (543)
T 3c4z_A          264 MTIMNGGDIRYHIY------------------------------NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR  313 (543)
T ss_dssp             ECCCTTCBHHHHHH------------------------------TSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEeccCCCHHHHHH------------------------------HhhcccccccHHHHHHHHHHHHHHHHHHHHcCCccc
Confidence            9999875 322221                              001123469999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+|||++.+|.+||+|||+|+.....    ...+||+.|+|||++.   +..|+.++|||||||++|||++|++||.
T Consensus       314 DLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiwSlGvilyelltG~~PF~  390 (543)
T 3c4z_A          314 DLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL---GEEYDFSVDYFALGVTLYEMIAARGPFR  390 (543)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhc---CCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence            99999999999999999999999754322    3468999999999985   3578999999999999999999999997


Q ss_pred             CCCh----HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        396 NMNA----MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       396 ~~~~----~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +.+.    ......+....                                           ...+..+|+++.+||.+|
T Consensus       391 ~~~~~~~~~~~~~~i~~~~-------------------------------------------~~~p~~~s~~~~~li~~l  427 (543)
T 3c4z_A          391 ARGEKVENKELKQRVLEQA-------------------------------------------VTYPDKFSPASKDFCEAL  427 (543)
T ss_dssp             CTTCCCCHHHHHHHHHHCC-------------------------------------------CCCCTTSCHHHHHHHHHH
T ss_pred             CCccchhHHHHHHHHhhcc-------------------------------------------cCCCcccCHHHHHHHHHh
Confidence            6431    11211121100                                           011245789999999999


Q ss_pred             cccCCCCCCC-----HHHHHcCccccC
Q psy17952        472 LAKNPADRPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       472 L~~dP~~Rps-----a~elL~Hp~~~~  493 (804)
                      |++||++||+     ++++++||||..
T Consensus       428 L~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          428 LQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             SCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             ccCCHhHCCCCcccCHHHHHcCccccC
Confidence            9999999996     589999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-44  Score=379.63  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=207.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||.+.....  ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            459999999999999999999999999999998864322  233467889999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.|+                                 +|.+++.....+++..+..++.|++.||.|||++||+||||
T Consensus        85 e~~~~~---------------------------------~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl  131 (276)
T 2yex_A           85 EYCSGG---------------------------------ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI  131 (276)
T ss_dssp             ECCTTE---------------------------------EGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             EecCCC---------------------------------cHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence            999864                                 12223334457899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||+|||++.++.+||+|||++.....      ....+||+.|+|||++.+  ...++.++|||||||++|||++|..||.
T Consensus       132 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~  209 (276)
T 2yex_A          132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWD  209 (276)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC--SSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred             ChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc--CCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999864321      235679999999999853  2223668999999999999999999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+.............                                        ........+++.+.+||.+||+.|
T Consensus       210 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~li~~~l~~~  249 (276)
T 2yex_A          210 QPSDSCQEYSDWKEKK----------------------------------------TYLNPWKKIDSAPLALLHKILVEN  249 (276)
T ss_dssp             CSCTTSHHHHHHHTTC----------------------------------------TTSTTGGGSCHHHHHHHHHHSCSS
T ss_pred             CCchHHHHHHHhhhcc----------------------------------------cccCchhhcCHHHHHHHHHHCCCC
Confidence            6543221111110000                                        000011346889999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCCC
Q psy17952        476 PADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      |++|||+.++++||||.....
T Consensus       250 p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          250 PSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             TTTSCCHHHHTTCTTTTCCCC
T ss_pred             chhCCCHHHHhcCccccChhh
Confidence            999999999999999987654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-44  Score=384.11  Aligned_cols=256  Identities=26%  Similarity=0.370  Sum_probs=205.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ...|++++.||+|+||.||+|++..+++.||||.+...... ......+.+|+..+.++ +||||+++++++.+.+..|+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            34699999999999999999999999999999988643222 23346788999999999 99999999999999999999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.| +|.+++...                              ......+++.++..++.||+.||.|||++||+|
T Consensus        89 v~e~~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH  138 (289)
T 1x8b_A           89 QNEYCNGGSLADAISEN------------------------------YRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH  138 (289)
T ss_dssp             EEECCTTCBHHHHHHHH------------------------------HHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEecCCCcHHHHHHhh------------------------------cccccCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence            9999976 555544311                              011356899999999999999999999999999


Q ss_pred             cCCCCCCeeecCC-------------------CcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHH
Q psy17952        319 RDVKAGNILLTET-------------------GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  379 (804)
Q Consensus       319 RDLKP~NILl~~~-------------------g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWS  379 (804)
                      |||||+|||++.+                   ..+||+|||++..........||+.|+|||++.+  ...++.++||||
T Consensus       139 ~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~s  216 (289)
T 1x8b_A          139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQE--NYTHLPKADIFA  216 (289)
T ss_dssp             SCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTT--CCTTHHHHHHHH
T ss_pred             cCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhcC--CCCCCchhhHHH
Confidence            9999999999844                   4799999999987766666789999999999853  235667999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCC
Q psy17952        380 LGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD  459 (804)
Q Consensus       380 lGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~  459 (804)
                      |||++|||++|.+|+.....   ...+.++..                                         + .....
T Consensus       217 lG~il~~l~~~~~~~~~~~~---~~~~~~~~~-----------------------------------------~-~~~~~  251 (289)
T 1x8b_A          217 LALTVVCAAGAEPLPRNGDQ---WHEIRQGRL-----------------------------------------P-RIPQV  251 (289)
T ss_dssp             HHHHHHHHTTCCCCCSSSHH---HHHHHTTCC-----------------------------------------C-CCSSC
T ss_pred             HHHHHHHHhcCCCCCcchhH---HHHHHcCCC-----------------------------------------C-CCCcc
Confidence            99999999999988754322   111211110                                         0 11235


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       460 ~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +++++.+|+.+||+.||++|||+.++|+||||...
T Consensus       252 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          252 LSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             cCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            68999999999999999999999999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3e-46  Score=415.89  Aligned_cols=259  Identities=15%  Similarity=0.141  Sum_probs=198.5

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHH---HHHhhcCCCceeEee-------
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI---RFLRQLKHPNTIEYR-------  228 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei---~iL~~L~HpNIV~l~-------  228 (804)
                      .+.+.|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+   ++|++++|||||+++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3456799999999999999999999999999999998754333444567788999   556666899999998       


Q ss_pred             eEEeecC-----------------ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCC
Q psy17952        229 GCYLRDH-----------------TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRP  291 (804)
Q Consensus       229 ~~~~~~~-----------------~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~  291 (804)
                      +++...+                 ..|+|||||.|+|.+++...                  ..+         ......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~------------------~~~---------~~~~~~  202 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL------------------LSH---------SSTHKS  202 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH------------------HHT---------TTTTHH
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc------------------ccc---------cccccc
Confidence            6665543                 38999999988777666421                  000         001123


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccC---
Q psy17952        292 LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMD---  367 (804)
Q Consensus       292 l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~---  367 (804)
                      +++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ....+| +.|+|||++.+..   
T Consensus       203 l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~  281 (377)
T 3byv_A          203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATIS  281 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhccccccc
Confidence            45688889999999999999999999999999999999999999999999975433 235678 9999999986420   


Q ss_pred             -----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhH
Q psy17952        368 -----EGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS  442 (804)
Q Consensus       368 -----~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~  442 (804)
                           ...|+.++|||||||++|||++|+.||.+.+......                                      
T Consensus       282 ~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~--------------------------------------  323 (377)
T 3byv_A          282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE--------------------------------------  323 (377)
T ss_dssp             HHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG--------------------------------------
T ss_pred             ccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh--------------------------------------
Confidence                 0168999999999999999999999996533211000                                      


Q ss_pred             HHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy17952        443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       443 ~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                         .+..      ....+++++.+||.+||+.||++|||+.++|+||||.
T Consensus       324 ---~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  364 (377)
T 3byv_A          324 ---WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  364 (377)
T ss_dssp             ---GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred             ---hhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence               0000      0135689999999999999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.6e-44  Score=395.30  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=215.1

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++.+.||+|+||.||+|++..+++.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            44569999999999999999999999999999998865433334455778899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+ +.+++                                  .....+++.++..++.||+.||.|||++||+|
T Consensus       119 v~e~~~~~~L~~~~----------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  164 (335)
T 2owb_A          119 VLELCRRRSLLELH----------------------------------KRRKALTEPEARYYLRQIVLGCQYLHRNRVIH  164 (335)
T ss_dssp             EECCCTTCBHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCCCCHHHHH----------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCCEe
Confidence            99999864 32222                                  22356899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||||+|||++.++.+||+|||+++....    .....||+.|+|||++.   ...++.++|||||||++|||++|+.||
T Consensus       165 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf  241 (335)
T 2owb_A          165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCIMYTLLVGKPPF  241 (335)
T ss_dssp             SCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHH---TSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhc---cCCCCchhhHHHHHHHHHHHHHCcCCC
Confidence            99999999999999999999999975432    23467999999999985   356888999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      ...+..+....+.....                                           .....+++.+.+||.+||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~  278 (335)
T 2owb_A          242 ETSCLKETYLRIKKNEY-------------------------------------------SIPKHINPVAASLIQKMLQT  278 (335)
T ss_dssp             CCSSHHHHHHHHHHTCC-------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred             CCCCHHHHHHHHhcCCC-------------------------------------------CCCccCCHHHHHHHHHHccC
Confidence            87765554444332110                                           01124678899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPRSP  497 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~~~  497 (804)
                      ||++|||+.|+|+||||.....+
T Consensus       279 dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          279 DPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             SGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ChhHCcCHHHHhcCccccCCCcc
Confidence            99999999999999999875543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-44  Score=406.61  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=194.1

Q ss_pred             cccccc-cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHh-hcCCCceeEeeeEEee----cC
Q psy17952        162 KIFEDL-REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR-QLKHPNTIEYRGCYLR----DH  235 (804)
Q Consensus       162 ~~y~~l-~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~-~L~HpNIV~l~~~~~~----~~  235 (804)
                      +.|++. +.||+|+||+||+|++..+++.||||++...        ..+.+|+.++. ..+||||++++++|..    ..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            447776 6899999999999999999999999987521        34678888874 4589999999999876    56


Q ss_pred             ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      .+|+|||||.|+ |.+++..                                .....+++.++..|+.||+.||.|||++
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~--------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~  180 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQD--------------------------------RGDQAFTEREASEIMKSIGEAIQYLHSI  180 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHC--------------------------------C---CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEEEEeCCCCcHHHHHHH--------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            789999999864 3333210                                0123589999999999999999999999


Q ss_pred             CCeecCCCCCCeeecC---CCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~---~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||+||||||+|||++.   ++.+||+|||+|+....   ....+||+.|+|||++.   ...|+.++|||||||++|||+
T Consensus       181 ~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell  257 (400)
T 1nxk_A          181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYILL  257 (400)
T ss_dssp             TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSC---CCCSSSHHHHHHHHHHHHHHH
T ss_pred             CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcC---CCCCCCcccHHHHHHHHHHHH
Confidence            9999999999999998   78999999999975432   24568999999999984   467899999999999999999


Q ss_pred             hCCCCCCCCChHH----HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        389 ERKPPYFNMNAMS----ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       389 tG~~PF~~~~~~~----~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      +|.+||.+.+...    ....+..+                                       ....+......+++++
T Consensus       258 ~g~~pf~~~~~~~~~~~~~~~i~~~---------------------------------------~~~~~~~~~~~~s~~~  298 (400)
T 1nxk_A          258 CGYPPFYSNHGLAISPGMKTRIRMG---------------------------------------QYEFPNPEWSEVSEEV  298 (400)
T ss_dssp             HSSCSCCCCTTCSSCCSHHHHHHHT---------------------------------------CCCCCTTTTTTSCHHH
T ss_pred             hCCCCCCCCccccccHHHHHHHHcC---------------------------------------cccCCCcccccCCHHH
Confidence            9999997643211    01111100                                       0011112234578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||.+||+.||++|||+.++|+||||....
T Consensus       299 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999997643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.5e-44  Score=385.23  Aligned_cols=264  Identities=45%  Similarity=0.825  Sum_probs=212.2

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.+.|++++.||+|+||.||+|.+..+++.||||.+...     ...+.+.+|+.++++++||||+++++++...+..|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            4566799999999999999999999999999999988642     12356889999999999999999999999999999


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.| ++.+++.                                 .....+++..+..++.|++.||.|||++||+
T Consensus       101 lv~e~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~  147 (314)
T 3com_A          101 IVMEYCGAGSVSDIIR---------------------------------LRNKTLTEDEIATILQSTLKGLEYLHFMRKI  147 (314)
T ss_dssp             EEEECCTTEEHHHHHH---------------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEeecCCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence            99999987 4433332                                 1245789999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||||||+|||++.++.+||+|||++.....    .....||+.|+|||++.   ...++.++|||||||++|||++|..|
T Consensus       148 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p  224 (314)
T 3com_A          148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGYNCVADIWSLGITAIEMAEGKPP  224 (314)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHS---SSCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcC---CCCCCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999965432    23467999999999984   35688999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+.....+.                                        ......+++.+.+||.+||.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~~li~~~l~  264 (314)
T 3com_A          225 YADIHPMRAIFMIPTNPPPT----------------------------------------FRKPELWSDNFTDFVKQCLV  264 (314)
T ss_dssp             TTTSCHHHHHHHHHHSCCCC----------------------------------------CSSGGGSCHHHHHHHHHHTC
T ss_pred             CCCCChHHHHHHHhcCCCcc----------------------------------------cCCcccCCHHHHHHHHHHcc
Confidence            98877665554443321110                                        00113468899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCCCCchhHHH
Q psy17952        474 KNPADRPSSGRLLTHDLVTRPRSPSVLVDL  503 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~  503 (804)
                      .||.+|||+.++|+||||........+.+.
T Consensus       265 ~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~  294 (314)
T 3com_A          265 KSPEQRATATQLLQHPFVRSAKGVSILRDL  294 (314)
T ss_dssp             SCTTTSCCHHHHTTSHHHHTCCCGGGGHHH
T ss_pred             CChhhCcCHHHHHhCHHHhcCCcchHHHHH
Confidence            999999999999999999987665554443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.4e-44  Score=384.25  Aligned_cols=256  Identities=45%  Similarity=0.797  Sum_probs=214.8

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .++.+.|++++.||+|+||.||+|++..+++.||||.+.....  ....+.+.+|+.++++++||||+++++++......
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            3566779999999999999999999999999999998864322  23456788999999999999999999999999999


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+||||+.|+ +.+++                                   ..+.+++..+..++.|++.||.|||++||
T Consensus        96 ~lv~e~~~~~~L~~~~-----------------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  140 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLL-----------------------------------EPGPLDETQIATILREILKGLDYLHSEKK  140 (303)
T ss_dssp             EEEEECCTTEEHHHHH-----------------------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEeCCCCcHHHHH-----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            9999999874 22221                                   23568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+|||++.++.+||+|||++.....    .....||+.|+|||++.   ...++.++|||||||++|||++|.+
T Consensus       141 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~  217 (303)
T 3a7i_A          141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELARGEP  217 (303)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHh---cCCCCchhhhHHHHHHHHHHccCCC
Confidence            9999999999999999999999999965432    23567999999999984   4578899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||...+.......+.....+                                          .....++..+.+|+.+||
T Consensus       218 p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~~l  255 (303)
T 3a7i_A          218 PHSELHPMKVLFLIPKNNPP------------------------------------------TLEGNYSKPLKEFVEACL  255 (303)
T ss_dssp             TTTTSCHHHHHHHHHHSCCC------------------------------------------CCCSSCCHHHHHHHHHHC
T ss_pred             CCCCcCHHHHHHHhhcCCCC------------------------------------------CCccccCHHHHHHHHHHc
Confidence            99877766555444322111                                          112356889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ..||++|||+.++++||||....
T Consensus       256 ~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          256 NKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             CCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999996543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.2e-44  Score=384.37  Aligned_cols=262  Identities=28%  Similarity=0.422  Sum_probs=214.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccc------cchhhhhhHHHHHHHHhhcC-CCceeEeeeEEee
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK------QCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLR  233 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~------~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~  233 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+.....      ......+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            4569999999999999999999999999999999864321      11223456789999999996 9999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..|+||||+.| ++.+++                                  .....+++..+..++.||+.||.|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH  141 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYL----------------------------------TEKVTLSEKETRKIMRALLEVICALH  141 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeccCCCcHHHHH----------------------------------hccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999986 443332                                  22356899999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhccc---CCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~---~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++||+||||||+|||++.++.+||+|||++.....   .....||+.|+|||++.+.   ....++.++|||||||++||
T Consensus       142 ~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~  221 (298)
T 1phk_A          142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT  221 (298)
T ss_dssp             HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred             HCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence            99999999999999999999999999999975433   2346799999999998531   23468889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|..||.+.+.......+..+....                                       +......+++.+.+
T Consensus       222 l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~l~~  262 (298)
T 1phk_A          222 LLAGSPPFWHRKQMLMLRMIMSGNYQF---------------------------------------GSPEWDDYSDTVKD  262 (298)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHTCCCC---------------------------------------CTTTGGGSCHHHHH
T ss_pred             HHHCCCCCcCccHHHHHHHHhcCCccc---------------------------------------CcccccccCHHHHH
Confidence            999999998877766655554332110                                       00111346889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      |+.+||+.||++|||+.++|+||||....
T Consensus       263 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          263 LVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             HHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            99999999999999999999999998653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.5e-45  Score=394.52  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=201.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccc-----cchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK-----QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~-----~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||.+.....     ........+.+|+.+|++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            469999999999999999999999999999998864321     11222346789999999999999999999987654 


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|+||||+.|+.                                 |.+++.....+++..+..++.||+.||.|||++||
T Consensus        89 ~~lv~e~~~~~~---------------------------------L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  135 (322)
T 2ycf_A           89 YYIVLELMEGGE---------------------------------LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGI  135 (322)
T ss_dssp             EEEEEECCTTEE---------------------------------THHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eEEEEecCCCCc---------------------------------HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            899999998641                                 22222345678999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCc---EEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        317 IHRDVKAGNILLTETGT---VKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~---vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      +||||||+|||++.++.   +||+|||+++.....   ....||+.|+|||++.+.....++.++|||||||++|||++|
T Consensus       136 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g  215 (322)
T 2ycf_A          136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG  215 (322)
T ss_dssp             ECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHS
T ss_pred             eccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999987664   999999999765432   245799999999998543446788999999999999999999


Q ss_pred             CCCCCCCChHHHH-HHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        391 KPPYFNMNAMSAL-YHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       391 ~~PF~~~~~~~~l-~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      ..||.+......+ ..+..+..+                   ..                    ......+++.+.+||.
T Consensus       216 ~~pf~~~~~~~~~~~~~~~~~~~-------------------~~--------------------~~~~~~~~~~~~~li~  256 (322)
T 2ycf_A          216 YPPFSEHRTQVSLKDQITSGKYN-------------------FI--------------------PEVWAEVSEKALDLVK  256 (322)
T ss_dssp             SCSSCSTTCSSCHHHHHHHTCCC-------------------CC--------------------HHHHTTSCHHHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHhCccc-------------------cC--------------------chhhhhcCHHHHHHHH
Confidence            9999754322111 111111100                   00                    0001346889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +||+.||++|||++++|+||||..
T Consensus       257 ~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          257 KLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HHcccCHhhCCCHHHHhhCcCcCC
Confidence            999999999999999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-44  Score=403.71  Aligned_cols=256  Identities=26%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC--CCceeEeeeEEeecCceEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--HPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|++++  |||||++++++...+.+|+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            359999999999999999998865 88999998864322 2344577899999999997  5999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||++.|+|.+++                                  .....+++.++..|+.||+.||.|||++||+||
T Consensus       134 v~E~~~~~L~~~l----------------------------------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHr  179 (390)
T 2zmd_A          134 VMECGNIDLNSWL----------------------------------KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS  179 (390)
T ss_dssp             EEECCSEEHHHHH----------------------------------HHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred             EEecCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9996656554433                                  234578899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccC--------CCCCCCcccHHHHHHHHH
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMD--------EGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~--------~~~y~~ksDIWSlGvil~  385 (804)
                      ||||+|||++ ++.+||+|||+|+....      ....+||+.|+|||++.+..        ...|+.++|||||||++|
T Consensus       180 Dlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~  258 (390)
T 2zmd_A          180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  258 (390)
T ss_dssp             CCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHH
Confidence            9999999995 68999999999975432      23568999999999985421        236888999999999999


Q ss_pred             HHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        386 ELAERKPPYFNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       386 ELltG~~PF~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      ||++|++||.+.. ....+..+.....                                         ....+...+.++
T Consensus       259 ell~G~~Pf~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~  297 (390)
T 2zmd_A          259 YMTYGKTPFQQIINQISKLHAIIDPNH-----------------------------------------EIEFPDIPEKDL  297 (390)
T ss_dssp             HHHHSSCTTTTCCCHHHHHHHHHCTTS-----------------------------------------CCCCCCCSCHHH
T ss_pred             HHHHCCCcchhhhHHHHHHHHHhCccc-----------------------------------------cCCCCccchHHH
Confidence            9999999997653 2233333221100                                         000112347889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||.+||+.||.+|||+.|+|+||||....
T Consensus       298 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          298 QDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            9999999999999999999999999997644

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=405.98  Aligned_cols=296  Identities=27%  Similarity=0.450  Sum_probs=201.0

Q ss_pred             CCcccccccc-cccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-
Q psy17952        158 EDPEKIFEDL-REIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-  233 (804)
Q Consensus       158 ~dp~~~y~~l-~~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-  233 (804)
                      ....+.|++. ++||+|+||.||+|++.  .+++.||||++....     ....+.+|+.+|++++|||||+++++|.. 
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            3445567774 57999999999999965  578899999986422     12457899999999999999999999954 


Q ss_pred             -cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 -DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 -~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                       ...+|+||||+.|++.+++......                         ........+++..++.|+.||+.||.|||
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~i~~qi~~al~~LH  145 (405)
T 3rgf_A           91 ADRKVWLLFDYAEHDLWHIIKFHRAS-------------------------KANKKPVQLPRGMVKSLLYQILDGIHYLH  145 (405)
T ss_dssp             TTTEEEEEEECCSEEHHHHHHHHHHH-------------------------C-------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEEEEeCCCCCHHHHHHHhccc-------------------------cccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence             6789999999999877665421100                         00012235899999999999999999999


Q ss_pred             HCCCeecCCCCCCeee----cCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHH
Q psy17952        313 SLGRIHRDVKAGNILL----TETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  381 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl----~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlG  381 (804)
                      ++||+||||||+|||+    +.++.+||+|||+|+....       ....+||+.|+|||++.+  ...|+.++||||||
T Consensus       146 ~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG  223 (405)
T 3rgf_A          146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIG  223 (405)
T ss_dssp             HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT--CCSCCHHHHHHHHH
T ss_pred             hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC--CCcccchhhhHHHH
Confidence            9999999999999999    6778999999999975432       234689999999999853  24588999999999


Q ss_pred             HHHHHHHhCCCCCCCCCh---------HHHHHHHHhc-CCCCCCCCchhhHHhhccccc-----CCCCccchhhhHHHHh
Q psy17952        382 ITCIELAERKPPYFNMNA---------MSALYHIAQN-DTPCLQSSDWSVIKTISSTAE-----RKPPYFNMNAMSALYH  446 (804)
Q Consensus       382 vil~ELltG~~PF~~~~~---------~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~-----~~pp~~~~~~~~~l~~  446 (804)
                      |++|||++|++||.+.+.         .+.+..|... ..|  ....|..+..+.....     ....+....    +..
T Consensus       224 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~  297 (405)
T 3rgf_A          224 CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP--ADKDWEDIKKMPEHSTLMKDFRRNTYTNCS----LIK  297 (405)
T ss_dssp             HHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCC--CTTTCGGGGGSTTHHHHHHHCCGGGGTTCC----HHH
T ss_pred             HHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCC--ChhhcchhhcCcchhhhhhhccccCCCcch----hhh
Confidence            999999999999976543         2444444432 111  1122322211110000     000000000    000


Q ss_pred             hccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       447 i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ..     .......++.+.+||.+||+.||++|||++|+|+||||.....
T Consensus       298 ~~-----~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          298 YM-----EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             HH-----HTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred             hH-----hhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence            00     0011234678999999999999999999999999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.9e-44  Score=390.93  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=210.7

Q ss_pred             cccccccc-cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCce
Q psy17952        160 PEKIFEDL-REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       160 p~~~y~~l-~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~  237 (804)
                      ....|.+. +.||+|+||.||+|++..+++.||||.+...... ......+.+|+.+++++. ||||+++++++...+..
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            34557777 8899999999999999999999999988653322 233467889999999995 69999999999999999


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||.|+ +.+++.                                ......+++.++..++.||+.||+|||++||
T Consensus       105 ~lv~e~~~~~~L~~~~~--------------------------------~~~~~~~~~~~~~~i~~ql~~~L~~LH~~gi  152 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCL--------------------------------PELAEMVSENDVIRLIKQILEGVYYLHQNNI  152 (327)
T ss_dssp             EEEEECCTTEEGGGGGS--------------------------------SCC-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEecCCCcHHHHHH--------------------------------HhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            9999999875 222110                                0123578999999999999999999999999


Q ss_pred             eecCCCCCCeeecC---CCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        317 IHRDVKAGNILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       317 iHRDLKP~NILl~~---~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      +||||||+|||++.   ++.+||+|||+++....   ....+||+.|+|||++.   ...++.++|||||||++|||++|
T Consensus       153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g  229 (327)
T 3lm5_A          153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN---YDPITTATDMWNIGIIAYMLLTH  229 (327)
T ss_dssp             ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeec---CCCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999987   78999999999976433   23468999999999984   45788999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||.+.+..+....+......                                       .+......+++.+.+||.+
T Consensus       230 ~~pf~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~~~~~~~li~~  270 (327)
T 3lm5_A          230 TSPFVGEDNQETYLNISQVNVD---------------------------------------YSEETFSSVSQLATDFIQS  270 (327)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCC---------------------------------------CCTTTTTTSCHHHHHHHHH
T ss_pred             CCCCCCCCchHHHHHHHhcccc---------------------------------------cCchhhcccCHHHHHHHHH
Confidence            9999888776666555432211                                       0111123568899999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||+.||.+|||++++|+||||....
T Consensus       271 ~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          271 LLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             HSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             HcCCChhhCcCHHHHhCCHhhcccc
Confidence            9999999999999999999998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.1e-45  Score=406.54  Aligned_cols=265  Identities=12%  Similarity=0.115  Sum_probs=189.3

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc--CCCceeEee-------eEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL--KHPNTIEYR-------GCY  231 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIV~l~-------~~~  231 (804)
                      ...|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+.+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34599999999999999999999999999999998764433344556677886555544  699988855       444


Q ss_pred             eec-----------------CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCH
Q psy17952        232 LRD-----------------HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKE  294 (804)
Q Consensus       232 ~~~-----------------~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e  294 (804)
                      ...                 ..+|+|||||.|+|.+++...                                 ...+++
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------------------------------~~~~~~  187 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL---------------------------------DFVYVF  187 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHH---------------------------------HHSCCC
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHh---------------------------------ccccch
Confidence            433                 237999999998877766421                                 012223


Q ss_pred             HHH------HHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCC-ccccCcccccchhhcccC
Q psy17952        295 EEI------AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-SFVGTPYWMAPEVILAMD  367 (804)
Q Consensus       295 ~~i------~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~-~~~GT~~Y~APEvl~~~~  367 (804)
                      ...      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... ...||+.|+|||++.+ .
T Consensus       188 ~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~-~  266 (371)
T 3q60_A          188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNA-S  266 (371)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTC-S
T ss_pred             hhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccC-C
Confidence            333      5667999999999999999999999999999999999999999998654433 5678899999999843 1


Q ss_pred             CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhh
Q psy17952        368 EGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI  447 (804)
Q Consensus       368 ~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i  447 (804)
                      ...|+.++|||||||++|||++|++||.+.....             . ..+..   ......                 
T Consensus       267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------~-~~~~~---~~~~~~-----------------  312 (371)
T 3q60_A          267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------K-GSWKR---PSLRVP-----------------  312 (371)
T ss_dssp             EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------T-TCCCB---CCTTSC-----------------
T ss_pred             CCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------c-cchhh---hhhhhc-----------------
Confidence            2468999999999999999999999997643210             0 00000   000000                 


Q ss_pred             ccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       448 ~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ............+++.+.+||.+||+.||++|||+.++|+||||..
T Consensus       313 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          313 GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             CCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             cccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            0000111112467899999999999999999999999999999953

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=389.43  Aligned_cols=283  Identities=24%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe-------
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL-------  232 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~-------  232 (804)
                      ....|++++.||+|+||.||+|++..+++.||||++...   .....+.+.+|+.++++++||||+++++++.       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            345699999999999999999999999999999988643   2344567889999999999999999999874       


Q ss_pred             -------ecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHH
Q psy17952        233 -------RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVL  305 (804)
Q Consensus       233 -------~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil  305 (804)
                             .....|+||||+.|++.+++                                   ..+++++..+..++.|++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~-----------------------------------~~~~~~~~~~~~~~~qi~  130 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYMETDLANVL-----------------------------------EQGPLLEEHARLFMYQLL  130 (320)
T ss_dssp             C----CCSCSEEEEEEECCSEEHHHHH-----------------------------------TTCCCCHHHHHHHHHHHH
T ss_pred             cccccccccCceeEEeeccCCCHHHHh-----------------------------------hcCCccHHHHHHHHHHHH
Confidence                   34678999999987654433                                   135689999999999999


Q ss_pred             HHHHHHHHCCCeecCCCCCCeeec-CCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccH
Q psy17952        306 RGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDV  377 (804)
Q Consensus       306 ~gL~yLH~~gIiHRDLKP~NILl~-~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDI  377 (804)
                      .||+|||++||+||||||+|||++ .++.+||+|||+++....       .....||+.|+|||++.+  ...++.++||
T Consensus       131 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di  208 (320)
T 2i6l_A          131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS--PNNYTKAIDM  208 (320)
T ss_dssp             HHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC--TTCCCHHHHH
T ss_pred             HHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC--cccCCchhhh
Confidence            999999999999999999999997 567999999999975432       234568999999998853  3568889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC-CCC
Q psy17952        378 WSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP-CLQ  456 (804)
Q Consensus       378 WSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p-~~~  456 (804)
                      |||||++|||++|+.||.+.+..+.+..+....... ....+..+   ..   ..+.+..       ........+ ...
T Consensus       209 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~---~~~~~~~-------~~~~~~~~~~~~~  274 (320)
T 2i6l_A          209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV-HEEDRQEL---LS---VIPVYIR-------NDMTEPHKPLTQL  274 (320)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC-CHHHHHHH---HT---TSCHHHH-------HHTTSCCCCHHHH
T ss_pred             HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-chhhhhhh---hh---cCccccc-------ccccCCCCChhHh
Confidence            999999999999999999988877777766543211 11111110   00   0000000       000000000 011


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       457 ~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ...+++++.+||.+||+.||++|||++++|+||||+....
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          275 LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             STTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             cchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            2457899999999999999999999999999999986443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.7e-44  Score=392.77  Aligned_cols=282  Identities=26%  Similarity=0.344  Sum_probs=214.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----C
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----H  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----~  235 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+....  .......+.+|+.++++++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            345999999999999999999999999999999986422  233446678999999999999999999987654     6


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+||||+.|++.+++.                                   .+.+++..+..++.|++.||.|||++|
T Consensus        88 ~~~lv~e~~~~~L~~~~~-----------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~  132 (353)
T 2b9h_A           88 EVYIIQELMQTDLHRVIS-----------------------------------TQMLSDDHIQYFIYQTLRAVKVLHGSN  132 (353)
T ss_dssp             CEEEEECCCSEEHHHHHH-----------------------------------HCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEeccCccHHHHHh-----------------------------------hcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            789999999886544332                                   246899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC--------------CCccccCcccccchhhcccCCCCCCCcccHHHHH
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP--------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  381 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlG  381 (804)
                      |+||||||+|||++.++.+||+|||+|+....              ....+||+.|+|||++.+  ...++.++||||||
T Consensus       133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG  210 (353)
T 2b9h_A          133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT--SAKYSRAMDVWSCG  210 (353)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS--CCCCCHHHHHHHHH
T ss_pred             eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc--CCCccchhhHHHHH
Confidence            99999999999999999999999999965321              123579999999998753  35688999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC--CCCCCC
Q psy17952        382 ITCIELAERKPPYFNMNAMSALYHIAQN-DTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT--PCLQSS  458 (804)
Q Consensus       382 vil~ELltG~~PF~~~~~~~~l~~I~~~-~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~--p~~~~~  458 (804)
                      |++|||++|++||.+.+....+..+... ..|... ..+..+   .          ................  ......
T Consensus       211 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~----------~~~~~~~~~~~~~~~~~~~~~~~~  276 (353)
T 2b9h_A          211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD-NDLRCI---E----------SPRAREYIKSLPMYPAAPLEKMFP  276 (353)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST-TTTTTC---C----------CHHHHHHHHTSCCCCCCCHHHHST
T ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh-cccccc---c----------cchhhHHhhcccCCCCcchhhhcc
Confidence            9999999999999998877766655432 111100 000000   0          0000000000000000  000123


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       459 ~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+++++.+||.+||+.||++|||+.++|+||||....
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          277 RVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            5789999999999999999999999999999997644

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-44  Score=381.62  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=203.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|.+..+++.||||.+...........+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            45999999999999999999999999999999986433222334567889999999999999999999999999999999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.| ++.+++                                  ...+.+++..+..++.|++.||.|||++||+|||
T Consensus        91 e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  136 (276)
T 2h6d_A           91 EYVSGGELFDYI----------------------------------CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRD  136 (276)
T ss_dssp             ECCCSCBHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCC
T ss_pred             eccCCCcHHHHH----------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence            99976 443333                                  2234689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||++......   ....||+.|+|||++.+   ..+ +.++|||||||++|+|++|..||.+
T Consensus       137 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          137 LKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG---RLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             CCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTT---SCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcC---CCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999998764332   34579999999999853   333 5789999999999999999999987


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+.......+..+..                                           .....++..+.+|+.+||+.||
T Consensus       214 ~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l~~~p  250 (276)
T 2h6d_A          214 EHVPTLFKKIRGGVF-------------------------------------------YIPEYLNRSVATLLMHMLQVDP  250 (276)
T ss_dssp             SSHHHHHHHHHHCCC-------------------------------------------CCCTTSCHHHHHHHHHHTCSSG
T ss_pred             CcHHHHHHHhhcCcc-------------------------------------------cCchhcCHHHHHHHHHHccCCh
Confidence            665544443322110                                           0112357889999999999999


Q ss_pred             CCCCCHHHHHcCccccCCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ++|||+.++++||||++...
T Consensus       251 ~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          251 LKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             GGSCCHHHHHHSHHHHTTCC
T ss_pred             hhCCCHHHHHhChhhccCch
Confidence            99999999999999986543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.3e-44  Score=396.27  Aligned_cols=284  Identities=25%  Similarity=0.332  Sum_probs=205.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc-----
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT-----  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~-----  236 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||++....    .......+|++.++.++||||++++++|...+.     
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            35999999999999999999999999999999875322    223456788888999999999999999976543     


Q ss_pred             --eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH--
Q psy17952        237 --AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH--  312 (804)
Q Consensus       237 --~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH--  312 (804)
                        .|+|||||.|++.+.+.                              .+......+++..+..++.|++.||.|||  
T Consensus        99 ~~~~lv~e~~~~~l~~~~~------------------------------~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~  148 (360)
T 3e3p_A           99 IYLNVVMEYVPDTLHRCCR------------------------------NYYRRQVAPPPILIKVFLFQLIRSIGCLHLP  148 (360)
T ss_dssp             EEEEEEEECCSCBHHHHHH------------------------------HHHTTTCCCCHHHHHHHHHHHHHHHHHHTST
T ss_pred             eeEEEEeecccccHHHHHH------------------------------HHhhcccCCCHHHHHHHHHHHHHHHHHHhCC
Confidence              88999999987654332                              11223567899999999999999999999  


Q ss_pred             HCCCeecCCCCCCeeecC-CCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTE-TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~-~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ++||+||||||+|||++. ++.+||+|||+|+....   .....||+.|+|||++.+  ...++.++|||||||++|||+
T Consensus       149 ~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il~ell  226 (360)
T 3e3p_A          149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG--NQHYTTAVDIWSVGCIFAEMM  226 (360)
T ss_dssp             TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT--CSSCCTHHHHHHHHHHHHHHH
T ss_pred             CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC--CCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999999997 89999999999976433   235689999999999853  345889999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccch--hhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNM--NAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~--~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      +|++||.+.+....+..+.......    ....+..+....... .....  ......        ........++++.+
T Consensus       227 ~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  293 (360)
T 3e3p_A          227 LGEPIFRGDNSAGQLHEIVRVLGCP----SREVLRKLNPSHTDV-DLYNSKGIPWSNV--------FSDHSLKDAKEAYD  293 (360)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCC----CHHHHHHHCTTCCCG-GGGCCCCCCHHHH--------TTTCCCTTHHHHHH
T ss_pred             hCCCCcCCCChHHHHHHHHHHcCCC----CHHHHHhcccchhhc-cccccccCCcccc--------cchhhccccHHHHH
Confidence            9999999988887777765532111    111111111100000 00000  000000        00112346889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ||.+||+.||.+|||+.|+|+||||...
T Consensus       294 li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          294 LLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHHHhccCccccCCHHHHhcCcccccc
Confidence            9999999999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-44  Score=382.76  Aligned_cols=256  Identities=26%  Similarity=0.387  Sum_probs=208.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccc---hhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC---AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~---~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      +.|++.+.||+|+||.||+|++..+++.||+|.+.......   ....+.+.+|+.++++++||||+++++++.+....|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46999999999999999999999999999999886432211   112467889999999999999999999999999999


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.|+ +.+++                                  .....+++.++..++.||+.||.|||++||+
T Consensus        85 lv~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  130 (283)
T 3bhy_A           85 LILELVSGGELFDFL----------------------------------AEKESLTEDEATQFLKQILDGVHYLHSKRIA  130 (283)
T ss_dssp             EEEECCCSCBHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEeecCCCcHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            999999754 33332                                  2235689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCC----cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTETG----TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g----~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+|||++.++    .+||+|||++.....   .....||+.|+|||++.   ...++.++|||||||++|||++|
T Consensus       131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g  207 (283)
T 3bhy_A          131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSG  207 (283)
T ss_dssp             CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceec---CCCCCcchhhhhHHHHHHHHHHC
Confidence            999999999998877    899999999975432   23457999999999984   45688999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ..||.+.+..+.+..+.......                   +                    .......++.+.+|+.+
T Consensus       208 ~~p~~~~~~~~~~~~~~~~~~~~-------------------~--------------------~~~~~~~~~~~~~li~~  248 (283)
T 3bhy_A          208 ASPFLGETKQETLTNISAVNYDF-------------------D--------------------EEYFSNTSELAKDFIRR  248 (283)
T ss_dssp             SCTTCCSSHHHHHHHHHTTCCCC-------------------C--------------------HHHHTTCCHHHHHHHHT
T ss_pred             CCCCCCcchHHHHHHhHhcccCC-------------------c--------------------chhcccCCHHHHHHHHH
Confidence            99998877766655553321100                   0                    00013457889999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||+.||++|||+.++|+||||..
T Consensus       249 ~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          249 LLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             TSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HccCCHhHCcCHHHHHhCHHHHH
Confidence            99999999999999999999853

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=384.50  Aligned_cols=259  Identities=25%  Similarity=0.407  Sum_probs=209.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEeccccccc-chhhhhhHHHHHHHHhhcCCCceeEeeeEEe--ecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-CAEKWADILKEIRFLRQLKHPNTIEYRGCYL--RDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~--~~~~~~  238 (804)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.++++++||||+++++++.  .....|
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            3599999999999999999999999999999988643211 1233467889999999999999999999984  456889


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|++.+++..                                .....+++..+..++.||+.||.|||++||+|
T Consensus        85 lv~e~~~~~l~~~~~~--------------------------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H  132 (305)
T 2wtk_C           85 MVMEYCVCGMQEMLDS--------------------------------VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH  132 (305)
T ss_dssp             EEEECCSEEHHHHHHH--------------------------------STTCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEehhccCCHHHHHHh--------------------------------CcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            9999999876554421                                12356899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+|||++.++.+||+|||++.....      .....||+.|+|||++.+. ...++.++|||||||++|||++|..
T Consensus       133 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~  211 (305)
T 2wtk_C          133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLY  211 (305)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999975432      1245799999999998532 1234678999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+.++..                                           .....+++.+.+||.+||
T Consensus       212 p~~~~~~~~~~~~i~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l  248 (305)
T 2wtk_C          212 PFEGDNIYKLFENIGKGSY-------------------------------------------AIPGDCGPPLSDLLKGML  248 (305)
T ss_dssp             SCCCSSHHHHHHHHHHCCC-------------------------------------------CCCSSSCHHHHHHHHHHT
T ss_pred             CCCCchHHHHHHHHhcCCC-------------------------------------------CCCCccCHHHHHHHHHHc
Confidence            9988766555444432210                                           012346889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ..||.+|||+.++++||||.....
T Consensus       249 ~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          249 EYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             CSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             cCChhhCCCHHHHhcCcccccCCC
Confidence            999999999999999999976543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-44  Score=386.70  Aligned_cols=273  Identities=39%  Similarity=0.632  Sum_probs=193.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+.....  ....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3469999999999999999999999999999998864321  23346688999999999999999999999999999999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.| ++.+++.....                          ........+++..+..++.||+.||.|||++||+||
T Consensus        92 ~e~~~~~~L~~~l~~~~~--------------------------~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  145 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVA--------------------------KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR  145 (303)
T ss_dssp             EECCTTCBHHHHHHHHHH--------------------------TTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ehhccCCchHHHHHHHhh--------------------------ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            999975 55554431100                          001124568999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC---------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||+|||++.++.+||+|||++.....         .....||+.|+|||++.+  ...++.++|||||||++|||++|
T Consensus       146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g  223 (303)
T 2vwi_A          146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ--VRGYDFKADIWSFGITAIELATG  223 (303)
T ss_dssp             CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH--HHCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc--ccCCCchhhHHHHHHHHHHHHhC
Confidence            9999999999999999999999864321         134579999999999853  13578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||.+.+....+....+...+....                                 ..........+++++.+|+.+
T Consensus       224 ~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~~li~~  270 (303)
T 2vwi_A          224 AAPYHKYPPMKVLMLTLQNDPPSLET---------------------------------GVQDKEMLKKYGKSFRKMISL  270 (303)
T ss_dssp             SCTTTTSCGGGHHHHHHTSSCCCTTC--------------------------------------CCCCCCCHHHHHHHHH
T ss_pred             CCCCccCchhhHHHHHhccCCCcccc---------------------------------ccccchhhhhhhHHHHHHHHH
Confidence            99998776655544443322211100                                 000011124578999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      ||+.||.+|||+.++++||||.....
T Consensus       271 ~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          271 CLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             HCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             HccCChhhCcCHHHHhhChhhhcCCC
Confidence            99999999999999999999986543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=391.54  Aligned_cols=281  Identities=27%  Similarity=0.367  Sum_probs=212.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc-----
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT-----  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~-----  236 (804)
                      +.|.+.+.||+|+||.||+|++..+|+.||||++.... ........+.+|+.++++++||||+++++++.....     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            45999999999999999999999999999999986432 223345678899999999999999999999987654     


Q ss_pred             -eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 -AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 -~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                       .|+||||+.|++.+++                                    ...+++..+..++.||+.||.|||++|
T Consensus       103 ~~~lv~e~~~~~l~~~~------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~  146 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIM------------------------------------GLKFSEEKIQYLVYQMLKGLKYIHSAG  146 (353)
T ss_dssp             CCEEEEECCSEEGGGTT------------------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEeccccCCHHHHh------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence             4999999987643321                                    235899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+|||++.++.+||+|||+++.... ....+||+.|+|||++.+  ...++.++|||||||++|||++|+.||
T Consensus       147 ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~il~el~~g~~pf  224 (353)
T 3coi_A          147 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCIMAEMLTGKTLF  224 (353)
T ss_dssp             CCCSSCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHSC--CSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCCCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhC--cCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999975433 345689999999999853  256889999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHHHHHHhc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~dli~~cL  472 (804)
                      .+.+..+.+..+.+......    ......+.          +......+..+.....+  ......+++++.+||.+||
T Consensus       225 ~~~~~~~~~~~i~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  290 (353)
T 3coi_A          225 KGKDYLDQLTQILKVTGVPG----TEFVQKLN----------DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKML  290 (353)
T ss_dssp             BSSCHHHHHHHHHHHHCBCC----HHHHTTCS----------CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHS
T ss_pred             CCCCHHHHHHHHHHHhCCCC----HHHHHHHh----------hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHc
Confidence            99888777776654211100    00000000          00000000011111011  1112457899999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +.||++|||++++|+||||....
T Consensus       291 ~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          291 ELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             CCCcccCCCHHHHhcCcchhhcc
Confidence            99999999999999999997643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.8e-44  Score=389.84  Aligned_cols=279  Identities=25%  Similarity=0.371  Sum_probs=207.0

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEee--cCce
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLR--DHTA  237 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~--~~~~  237 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+...      ..+.+.+|+.+|++++ ||||+++++++..  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            35699999999999999999999999999999988632      2356789999999997 9999999999987  6678


Q ss_pred             EEEEeecCCCch-hhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGSAS-DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~l~-dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ++||||+.|+.. +++                                     ..+++.++..++.||+.||+|||++||
T Consensus       109 ~lv~e~~~~~~l~~~~-------------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i  151 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLY-------------------------------------QTLTDYDIRFYMYEILKALDYCHSMGI  151 (330)
T ss_dssp             EEEEECCCCCCHHHHG-------------------------------------GGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEeccCchhHHHHH-------------------------------------HhCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            999999987521 111                                     137889999999999999999999999


Q ss_pred             eecCCCCCCeeecCCC-cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETG-TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g-~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+|||++.++ .+||+|||+|+....   ....+||+.|+|||++.+  ...++.++|||||||++|||++|+.
T Consensus       152 vH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~  229 (330)
T 3nsz_A          152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKE  229 (330)
T ss_dssp             ECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             eeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcC--CCcCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999777 899999999975432   245689999999999853  3568899999999999999999999


Q ss_pred             CCCCC-ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhc----cCCCCCCCCCCccHHHHHH
Q psy17952        393 PYFNM-NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA----QNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       393 PF~~~-~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~----~~~~p~~~~~~~s~~l~dl  467 (804)
                      ||... +..+.+..+.....+.      .....+.......++.+.    ..+....    ....+......+++++.+|
T Consensus       230 p~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (330)
T 3nsz_A          230 PFFHGHDNYDQLVRIAKVLGTE------DLYDYIDKYNIELDPRFN----DILGRHSRKRWERFVHSENQHLVSPEALDF  299 (330)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHH------HHHHHHHHTTCCCCTHHH----HHHCCCCCCCGGGGCCTTTGGGCCHHHHHH
T ss_pred             CcccCCchHHHHHHHHHhcCCc------hhhhHHHHhccccccchh----hhhhhccccchhhhccccccccCCHHHHHH
Confidence            99543 4444444443211100      000000000000111000    0000000    0000111123368999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |.+||+.||++|||++|+|+||||+..
T Consensus       300 i~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          300 LDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            999999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.6e-44  Score=393.06  Aligned_cols=285  Identities=24%  Similarity=0.343  Sum_probs=208.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEeccccccc--------chhhhhhHHHHHHHHhhcCCCceeEeeeEEee
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ--------CAEKWADILKEIRFLRQLKHPNTIEYRGCYLR  233 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~--------~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~  233 (804)
                      ..|++.+.||+|+||.||+|.+.. ++.||||++......        .....+.+.+|+.+|++++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            459999999999999999998865 899999988542211        11223678899999999999999999999854


Q ss_pred             -----cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHH
Q psy17952        234 -----DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGL  308 (804)
Q Consensus       234 -----~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL  308 (804)
                           ...+|+|||||.|++.+.+.                                 .....+++..+..++.||+.||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~l  147 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIH---------------------------------DQRIVISPQHIQYFMYHILLGL  147 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHH---------------------------------CTTSCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHH
Confidence                 33589999999987654432                                 1234689999999999999999


Q ss_pred             HHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        309 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       309 ~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      .|||++||+||||||+|||++.++.+||+|||+|+....   .....||+.|+|||++.+  ...++.++|||||||++|
T Consensus       148 ~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~  225 (362)
T 3pg1_A          148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ--FKGFTKLVDMWSAGCVMA  225 (362)
T ss_dssp             HHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTT--CTTCCTHHHHHHHHHHHH
T ss_pred             HHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcC--CCCCCcHhHHHhHHHHHH
Confidence            999999999999999999999999999999999964332   234689999999999853  246889999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC----CchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCc
Q psy17952        386 ELAERKPPYFNMNAMSALYHIAQNDT-PCLQS----SDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW  460 (804)
Q Consensus       386 ELltG~~PF~~~~~~~~l~~I~~~~~-p~~~~----~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~  460 (804)
                      ||++|++||.+.+..+.+..+..... |....    ........+.......+.                ..........
T Consensus       226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~  289 (362)
T 3pg1_A          226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA----------------RAWTAVVPTA  289 (362)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC----------------CCHHHHSTTS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh----------------hhHHhhCCCC
Confidence            99999999999887777766654211 11000    000000000000000000                0000112356


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCCCCc
Q psy17952        461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS  498 (804)
Q Consensus       461 s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~  498 (804)
                      ++.+.+||.+||+.||++|||+.|+|+||||.....+.
T Consensus       290 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          290 DPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            88999999999999999999999999999998765543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.2e-44  Score=385.84  Aligned_cols=250  Identities=29%  Similarity=0.458  Sum_probs=196.1

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +...|++.+.||+|+||.||+|++  +++.||||.+.... ......+.+.+|+.+|++++||||+++++++.+.+..|+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            445699999999999999999975  67889999886432 223445678899999999999999999999999999999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--R  316 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g--I  316 (804)
                      |||||.| ++.+++...                               .....+++..+..++.||+.||+|||++|  |
T Consensus       112 v~e~~~~~~L~~~l~~~-------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~i  160 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKS-------------------------------GAREQLDERRRLSMAYDVAKGMNYLHNRNPPI  160 (309)
T ss_dssp             EEECCTTCBHHHHHHST-------------------------------THHHHSCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             EEecCCCCcHHHHHhhc-------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCE
Confidence            9999986 444433200                               00123889999999999999999999999  9


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+|||++.++.+||+|||+|+....    .....||+.|+|||++.   ...++.++|||||||++|||++|+.
T Consensus       161 vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~  237 (309)
T 3p86_A          161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDVYSFGVILWELATLQQ  237 (309)
T ss_dssp             CCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHT---TCCCCTTHHHHHHHHHHHHHHHCCC
T ss_pred             ECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999975432    23568999999999985   3568889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+.....                                         .......+++++.+||.+||
T Consensus       238 Pf~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l  276 (309)
T 3p86_A          238 PWGNLNPAQVVAAVGFKCK-----------------------------------------RLEIPRNLNPQVAAIIEGCW  276 (309)
T ss_dssp             TTTTSCHHHHHHHHHHSCC-----------------------------------------CCCCCTTSCHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHHHhcCC-----------------------------------------CCCCCccCCHHHHHHHHHHc
Confidence            9988776655544422110                                         00112356889999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      +.||.+|||+.++++
T Consensus       277 ~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          277 TNEPWKRPSFATIMD  291 (309)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=390.01  Aligned_cols=278  Identities=21%  Similarity=0.335  Sum_probs=207.8

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC--ceE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH--TAW  238 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~--~~~  238 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+.....  ....+.+.+|+++|++++||||+++++++....  ..|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            4569999999999999999999999999999999864322  223466789999999999999999999988765  789


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.| ++.+++..                               ......+++.++..++.||+.||+|||++||+
T Consensus        86 lv~e~~~~~~L~~~l~~-------------------------------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  134 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEE-------------------------------PSNAYGLPESEFLIVLRDVVGGMNHLRENGIV  134 (319)
T ss_dssp             EEEECCTTCBHHHHHHS-------------------------------GGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEeCCCCCCHHHHHHH-------------------------------hccccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            99999985 44443320                               01223489999999999999999999999999


Q ss_pred             ecCCCCCCeee----cCCCcEEEEecccccccCCC---CccccCcccccchhhccc-----CCCCCCCcccHHHHHHHHH
Q psy17952        318 HRDVKAGNILL----TETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       318 HRDLKP~NILl----~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~-----~~~~y~~ksDIWSlGvil~  385 (804)
                      ||||||+|||+    +.++.+||+|||+|+.....   ...+||+.|+|||++...     ....|+.++|||||||++|
T Consensus       135 H~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~  214 (319)
T 4euu_A          135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY  214 (319)
T ss_dssp             CSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHH
Confidence            99999999999    77788999999999764332   346799999999998521     1356889999999999999


Q ss_pred             HHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCcc
Q psy17952        386 ELAERKPPYFNMN----AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS  461 (804)
Q Consensus       386 ELltG~~PF~~~~----~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s  461 (804)
                      ||++|+.||....    ..+.+..+..+..+...    ..+....   . .+-.+.          .....++.....++
T Consensus       215 el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~---~-~~~~~~----------~~~~~~~~~~~~~~  276 (319)
T 4euu_A          215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI----SGVQKAE---N-GPIDWS----------GDMPVSCSLSRGLQ  276 (319)
T ss_dssp             HHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC----EEEECST---T-CCEEEE----------SSCCTTCSSCHHHH
T ss_pred             HHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc----hhhhccc---C-CccccC----------ccCCcccccchhHH
Confidence            9999999996432    34455555544322110    0000000   0 000000          00011112233467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy17952        462 DTFAHFVSSCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rpsa~elL~Hp  489 (804)
                      +.+.+||.+||+.||++|||++|+|+||
T Consensus       277 ~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          277 VLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            8899999999999999999999999997

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=385.06  Aligned_cols=261  Identities=44%  Similarity=0.796  Sum_probs=208.2

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee----
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR----  233 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~----  233 (804)
                      ++...|++.+.||+|+||.||+|++..+++.||||.+....    .....+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            45567999999999999999999999999999999886432    2235688999999999 79999999999987    


Q ss_pred             --cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        234 --DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       234 --~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                        .+..|+||||+.| ++.+++..                                .....+++..+..++.||+.||.|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~~l~~  144 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKN--------------------------------TKGNTLKEEWIAYICREILRGLSH  144 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHH--------------------------------SGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEEEEcCCCCcHHHHHHh--------------------------------cccCCCCHHHHHHHHHHHHHHHHH
Confidence              4678999999986 55444321                                012468899999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccC--CCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~--~~~y~~ksDIWSlGvil  384 (804)
                      ||++||+||||||+|||++.++.+||+|||++.....    .....||+.|+|||++....  ...++.++|||||||++
T Consensus       145 lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il  224 (326)
T 2x7f_A          145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA  224 (326)
T ss_dssp             HHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred             HHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence            9999999999999999999999999999999875432    23467999999999985311  34688899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       385 ~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      |||++|..||.+.+....+..+.....                                         +......+++.+
T Consensus       225 ~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l  263 (326)
T 2x7f_A          225 IEMAEGAPPLCDMHPMRALFLIPRNPA-----------------------------------------PRLKSKKWSKKF  263 (326)
T ss_dssp             HHHHHSSCTTTTSCHHHHHHHHHHSCC-----------------------------------------CCCSCSCSCHHH
T ss_pred             HHHHhCCCCCCCCcHHHHHHHhhcCcc-----------------------------------------ccCCccccCHHH
Confidence            999999999988776665554433211                                         112234578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      .+||.+||..||.+|||+.++++||||.....
T Consensus       264 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          264 QSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             HHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            99999999999999999999999999987544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-43  Score=383.54  Aligned_cols=283  Identities=30%  Similarity=0.436  Sum_probs=214.8

Q ss_pred             ccccccccccccccccceEEEEee-eceeEEEEEecccccccchhhhhhHHHHHHHHhhc---CCCceeEeeeEEe----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCL-VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL---KHPNTIEYRGCYL----  232 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~-~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~~~~~----  232 (804)
                      .+.|++++.||+|+||.||+|++. .+++.||+|.+...... ......+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            356999999999999999999985 67899999988643221 22234567888888776   8999999999987    


Q ss_pred             -ecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        233 -RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       233 -~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                       .....|+||||+.|++.+++..                                .....+++..+..++.||+.||.||
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~~~~qi~~~l~~l  136 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTTYLDK--------------------------------VPEPGVPTETIKDMMFQLLRGLDFL  136 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHH--------------------------------SCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCceEEEEEecCCCCHHHHHHh--------------------------------cccCCCCHHHHHHHHHHHHHHHHHH
Confidence             5667899999999876655431                                1123589999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |++||+||||||+|||++.++.+||+|||+++....   .....||+.|+|||++.   ...++.++|||||||++|||+
T Consensus       137 H~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~  213 (326)
T 1blx_A          137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMF  213 (326)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHHHHHHH
T ss_pred             HHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHh---cCCCCcchhHHHHHHHHHHHH
Confidence            999999999999999999999999999999975432   23568999999999985   356899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|++||.+.+....+..+....... ....|........      ..+         ..............+++.+.+||
T Consensus       214 ~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~------~~~---------~~~~~~~~~~~~~~~~~~~~~li  277 (326)
T 1blx_A          214 RRKPLFRGSSDVDQLGKILDVIGLP-GEEDWPRDVALPR------QAF---------HSKSAQPIEKFVTDIDELGKDLL  277 (326)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCC-CGGGSCTTCSSCG------GGS---------CCCCCCCGGGTCCSCCHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHcCCC-CcccCccccccch------hhh---------cccCcchhhhccccCCHHHHHHH
Confidence            9999999988877777665421110 0001100000000      000         00000011112346789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||..||++|||+.++|+||||....
T Consensus       278 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          278 LKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHcCCCcccCCCHHHHhcCccccccc
Confidence            999999999999999999999998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=394.76  Aligned_cols=258  Identities=24%  Similarity=0.386  Sum_probs=205.9

Q ss_pred             cccccccccccccccccceEEEE-----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYAR-----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~-----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      +.+.|++++.||+|+||.||+|+     +..+++.||||++....  .......+.+|+.++++++|||||++++++.+.
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            45679999999999999999999     45677899999986322  233345688999999999999999999999999


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ...|+|||||.| +|.+++...                  .         ........+++.++..++.||+.||+|||+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~------------------~---------~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  199 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRET------------------R---------PRPSQPSSLAMLDLLHVARDIACGCQYLEE  199 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHH------------------S---------CCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEeCCCCCHHHHHHhh------------------c---------cccCccccccHHHHHHHHHHHHHHHHHHHh
Confidence            999999999976 555544311                  0         000123468999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCC---cEEEEeccccccc------CCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETG---TVKLADFGSASIK------CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g---~vKL~DFGla~~~------~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      +||+||||||+|||++.+|   .+||+|||+|+..      .......||+.|+|||++.+   ..|+.++|||||||++
T Consensus       200 ~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il  276 (367)
T 3l9p_A          200 NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLL  276 (367)
T ss_dssp             TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHH
T ss_pred             CCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC---CCCCcHHHHHHHHHHH
Confidence            9999999999999999655   5999999999642      22334678999999999853   5689999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++ |.+||.+.+..+.+..+..+..+                                          .....+++.
T Consensus       277 ~ellt~g~~pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~  314 (367)
T 3l9p_A          277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRM------------------------------------------DPPKNCPGP  314 (367)
T ss_dssp             HHHHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHH
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCccCCHH
Confidence            99998 99999888776665555432211                                          112346788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +.+|+.+||+.||++|||+.+++++.++
T Consensus       315 l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          315 VYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            9999999999999999999999988654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9e-44  Score=379.83  Aligned_cols=256  Identities=27%  Similarity=0.465  Sum_probs=210.8

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||.||+|++..+++.||||.+...... ....+.+.+|++++++++||||+++++++...+..|+
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            345699999999999999999999999999999998643222 2345678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+.+                                  .....+++.++..++.||+.||.|||++||+|
T Consensus        99 v~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H  144 (287)
T 2wei_A           99 VGELYTGGELFDEI----------------------------------IKRKRFSEHDAARIIKQVFSGITYMHKHNIVH  144 (287)
T ss_dssp             EECCCCSCBHHHHH----------------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEccCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            99999864 32222                                  22346899999999999999999999999999


Q ss_pred             cCCCCCCeeecCC---CcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTET---GTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~---g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+|||++.+   +.+||+|||++.....   .....||+.|+|||++.    +.++.++|||||||++|+|++|.+
T Consensus       145 ~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~  220 (287)
T 2wei_A          145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR----GTYDEKCDVWSAGVILYILLSGTP  220 (287)
T ss_dssp             SCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHT----TCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhc----CCCCCchhhHhHHHHHHHHHhCCC
Confidence            9999999999764   4799999999875433   23457999999999984    358899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+.+..+..+..+.                                       +......+++++.+||.+||
T Consensus       221 p~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~li~~~l  261 (287)
T 2wei_A          221 PFYGKNEYDILKRVETGKYAF---------------------------------------DLPQWRTISDDAKDLIRKML  261 (287)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCC---------------------------------------CSGGGTTSCHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHHHcCCCCC---------------------------------------CchhhhhcCHHHHHHHHHHc
Confidence            999887766665554432110                                       00111346889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ..||++|||+.++|+||||.+
T Consensus       262 ~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          262 TFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHH
T ss_pred             ccChhhCcCHHHHhcCHHHhc
Confidence            999999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.1e-43  Score=393.63  Aligned_cols=292  Identities=23%  Similarity=0.307  Sum_probs=212.5

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CC-----ceeEeeeEEeec
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HP-----NTIEYRGCYLRD  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----NIV~l~~~~~~~  234 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||++...    ......+.+|+.+++.++ |+     +|+++++++...
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            34699999999999999999999999999999998632    223456778999998885 55     499999999999


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH--
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH--  312 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH--  312 (804)
                      +..|+||||+.|++.+++..                                ...+.+++..+..++.|++.||.|||  
T Consensus       129 ~~~~lv~e~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~al~~lH~~  176 (382)
T 2vx3_A          129 NHLCLVFEMLSYNLYDLLRN--------------------------------TNFRGVSLNLTRKFAQQMCTALLFLATP  176 (382)
T ss_dssp             TEEEEEEECCCCBHHHHHHH--------------------------------TTTSCCCHHHHHHHHHHHHHHHHHHTST
T ss_pred             CceEEEEecCCCCHHHHHhh--------------------------------cCcCCCCHHHHHHHHHHHHHHHHHhccC
Confidence            99999999999887665531                                11245899999999999999999999  


Q ss_pred             HCCCeecCCCCCCeeec--CCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        313 SLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~--~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +.|||||||||+|||++  .++.+||+|||+|+.... ....+||+.|+|||++.   +..|+.++|||||||++|||++
T Consensus       177 ~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt  253 (382)
T 2vx3_A          177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLL---GMPYDLAIDMWSLGCILVEMHT  253 (382)
T ss_dssp             TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHc---CCCCCcHHHHHHHHHHHHHHHh
Confidence            57999999999999995  477899999999976543 34678999999999985   3568999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCC--CchhhHHhhccc---------------ccCCCCccchhhhHHHHhhccCCC
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQS--SDWSVIKTISST---------------AERKPPYFNMNAMSALYHIAQNDT  452 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~--~~~~~i~~i~~~---------------~~~~pp~~~~~~~~~l~~i~~~~~  452 (804)
                      |++||.+.+..+.+..+.+...+....  ..++........               ....++...  .......... ..
T Consensus       254 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~-~~  330 (382)
T 2vx3_A          254 GEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTR--KLHNILGVET-GG  330 (382)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCS--CHHHHHTTTT-TS
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchh--hHHHHhhccc-cC
Confidence            999999998888887776532211100  000000000000               000001000  0000000000 00


Q ss_pred             CCCC---CC----CccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        453 PCLQ---SS----DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       453 p~~~---~~----~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +...   ..    ..++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             GGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             CCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            0000   00    112579999999999999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.7e-44  Score=396.81  Aligned_cols=282  Identities=22%  Similarity=0.292  Sum_probs=206.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC--------CCceeEeeeEEe-
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--------HPNTIEYRGCYL-  232 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--------HpNIV~l~~~~~-  232 (804)
                      ..|++++.||+|+||.||+|++..+++.||||.+...    ....+.+.+|+.+|++++        ||||++++++|. 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            4699999999999999999999999999999998632    233466889999999996        788999999987 


Q ss_pred             ---ecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHH
Q psy17952        233 ---RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN  309 (804)
Q Consensus       233 ---~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~  309 (804)
                         .....|+||||+.|++.+.+..                                .....+++..++.|+.||+.||+
T Consensus       113 ~~~~~~~~~lv~e~~~~~l~~~~~~--------------------------------~~~~~~~~~~~~~i~~qi~~aL~  160 (397)
T 1wak_A          113 SGVNGTHICMVFEVLGHHLLKWIIK--------------------------------SNYQGLPLPCVKKIIQQVLQGLD  160 (397)
T ss_dssp             EETTEEEEEEEECCCCCBHHHHHHH--------------------------------TTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCceEEEEEeccCccHHHHHHh--------------------------------cccCCCCHHHHHHHHHHHHHHHH
Confidence               5567999999998876544320                                12246899999999999999999


Q ss_pred             HHHHC-CCeecCCCCCCeeecCCC-------------------------------------------------cEEEEec
Q psy17952        310 YLHSL-GRIHRDVKAGNILLTETG-------------------------------------------------TVKLADF  339 (804)
Q Consensus       310 yLH~~-gIiHRDLKP~NILl~~~g-------------------------------------------------~vKL~DF  339 (804)
                      |||++ ||+||||||+|||++.++                                                 .+||+||
T Consensus       161 ~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df  240 (397)
T 1wak_A          161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL  240 (397)
T ss_dssp             HHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCG
T ss_pred             HHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccc
Confidence            99998 999999999999999775                                                 7999999


Q ss_pred             ccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCC
Q psy17952        340 GSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN------AMSALYHIAQNDTP  412 (804)
Q Consensus       340 Gla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~------~~~~l~~I~~~~~p  412 (804)
                      |+|+.... ....+||+.|+|||++.+   ..|+.++|||||||++|||++|++||.+.+      ....+..+.+...+
T Consensus       241 G~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  317 (397)
T 1wak_A          241 GNACWVHKHFTEDIQTRQYRSLEVLIG---SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK  317 (397)
T ss_dssp             GGCEETTBCSCSCCSCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS
T ss_pred             cccccccccCccCCCCCcccCChhhcC---CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC
Confidence            99975433 345689999999999853   568999999999999999999999997654      23333333321110


Q ss_pred             CCCCCchhhHHhhcccccCCCCccchhh---------hHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHH
Q psy17952        413 CLQSSDWSVIKTISSTAERKPPYFNMNA---------MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSG  483 (804)
Q Consensus       413 ~~~~~~~~~i~~i~~~~~~~pp~~~~~~---------~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~  483 (804)
                      ..    ...+..-.    ....++....         ...+......  ........++.+.+||.+||+.||++|||++
T Consensus       318 ~p----~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  387 (397)
T 1wak_A          318 VP----RKLIVAGK----YSKEFFTKKGDLKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAA  387 (397)
T ss_dssp             CC----HHHHHHCT----TGGGTBCTTSSBSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH
T ss_pred             CC----hHHhhccc----ccccccCCccccccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHH
Confidence            00    00000000    0000000000         0000000000  0001123467899999999999999999999


Q ss_pred             HHHcCcccc
Q psy17952        484 RLLTHDLVT  492 (804)
Q Consensus       484 elL~Hp~~~  492 (804)
                      |+|+||||+
T Consensus       388 e~l~hp~~~  396 (397)
T 1wak_A          388 ECLRHPWLN  396 (397)
T ss_dssp             HHHTSGGGG
T ss_pred             HHhhCcccc
Confidence            999999996

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.7e-43  Score=391.60  Aligned_cols=263  Identities=24%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             cccccccccccccccccceEEEEee-------eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCY  231 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-------~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~  231 (804)
                      +.+.|++.+.||+|+||.||+|++.       .++..||||.+...  ......+.+.+|+.+|+++ +|||||++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4456999999999999999999875       35678999998643  2234456789999999999 899999999999


Q ss_pred             eecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccch-hhccCCCCCHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN-FEVHKRPLKEEEIAAICSGVLRGLN  309 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~-~~~~~~~l~e~~i~~i~~qil~gL~  309 (804)
                      .+.+.+|+|||||.| +|.+++......      +.            . ..++ .......+++.++..++.||+.||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~------------~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~  217 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPP------GM------------E-YSYDINRVPEEQMTFKDLVSCTYQLARGME  217 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC------------------------------CCCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCc------cc------------c-ccccccccccccCCHHHHHHHHHHHHHHHH
Confidence            999999999999986 555554311000      00            0 0000 0112346899999999999999999


Q ss_pred             HHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHH
Q psy17952        310 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  383 (804)
Q Consensus       310 yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvi  383 (804)
                      |||++||+||||||+|||++.++.+||+|||+|+....      .....||+.|+|||++.   ...|+.++|||||||+
T Consensus       218 ~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~i  294 (370)
T 2psq_A          218 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVL  294 (370)
T ss_dssp             HHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH---TCCCCHHHHHHHHHHH
T ss_pred             HHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc---CCCCCcHHHHHHHHHH
Confidence            99999999999999999999999999999999975332      22346788999999985   3568999999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        384 CIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       384 l~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      +|||++ |.+||.+.+..+....+..+..                                          ......+++
T Consensus       295 l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~  332 (370)
T 2psq_A          295 MWEIFTLGGSPYPGIPVEELFKLLKEGHR------------------------------------------MDKPANCTN  332 (370)
T ss_dssp             HHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------------------------------------CCCCTTSCH
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHhcCCC------------------------------------------CCCCCCCCH
Confidence            999999 9999987665444433322110                                          011235688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ++.+||.+||+.||++|||+.|++++
T Consensus       333 ~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          333 ELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999865

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=392.26  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             cccccccccccccccceEEEEee---eceeEEEEEecccccc-cchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGK-QCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~-~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~  236 (804)
                      ..|++++.||+|+||.||+|++.   .+++.||||++..... ......+.+.+|+++|+++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            46999999999999999999985   4889999999864321 1122345677899999999 69999999999999999


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+|||||.|+ |.+++                                  .....+++..+..++.||+.||.|||++|
T Consensus       134 ~~lv~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  179 (355)
T 1vzo_A          134 LHLILDYINGGELFTHL----------------------------------SQRERFTEHEVQIYVGEIVLALEHLHKLG  179 (355)
T ss_dssp             EEEEECCCCSCBHHHHH----------------------------------HHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEeecCCCCCHHHHH----------------------------------HHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999864 33322                                  23356899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      |+||||||+|||++.++.+||+|||+|+....     ....+||+.|+|||++.+. ...++.++|||||||++|||++|
T Consensus       180 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~ell~g  258 (355)
T 1vzo_A          180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTG  258 (355)
T ss_dssp             CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHS
T ss_pred             cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999999999999999999875321     2346899999999998531 23578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||...+.......+.               ..+                      ....  ......++..+.+||.+
T Consensus       259 ~~pf~~~~~~~~~~~~~---------------~~~----------------------~~~~--~~~~~~~~~~~~~li~~  299 (355)
T 1vzo_A          259 ASPFTVDGEKNSQAEIS---------------RRI----------------------LKSE--PPYPQEMSALAKDLIQR  299 (355)
T ss_dssp             SCTTSCTTSCCCHHHHH---------------HHH----------------------HHCC--CCCCTTSCHHHHHHHHH
T ss_pred             CCCCccCCccchHHHHH---------------HHH----------------------hccC--CCCCcccCHHHHHHHHH
Confidence            99996532111000000               000                      0000  01123568899999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCccccCC
Q psy17952        471 CLAKNPADRP-----SSGRLLTHDLVTRP  494 (804)
Q Consensus       471 cL~~dP~~Rp-----sa~elL~Hp~~~~~  494 (804)
                      ||+.||.+||     |+.++++||||...
T Consensus       300 ~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          300 LLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            9999999999     99999999999753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-43  Score=383.83  Aligned_cols=290  Identities=21%  Similarity=0.267  Sum_probs=212.9

Q ss_pred             ccccccccccccccccceEEEEe-eeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCc------eeEeeeEEee
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARC-LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN------TIEYRGCYLR  233 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~-~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpN------IV~l~~~~~~  233 (804)
                      .+.|++++.||+|+||.||+|.+ ..+++.||||.+...    ....+.+.+|+.+++.++|+|      |+++++++..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            34699999999999999999998 568899999988632    233466789999999987765      9999999999


Q ss_pred             cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       234 ~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      .+..|+|||||.|++.+++..                                ....++++..+..++.||+.||+|||+
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~--------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~  136 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKE--------------------------------NGFLPFRLDHIRKMAYQICKSVNFLHS  136 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHH--------------------------------TTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcEEEEEcCCCCCHHHHHHh--------------------------------cCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997776554431                                112368899999999999999999999


Q ss_pred             CCCeecCCCCCCeeecC-------------------CCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCC
Q psy17952        314 LGRIHRDVKAGNILLTE-------------------TGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDG  373 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~-------------------~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~  373 (804)
                      +||+||||||+|||++.                   ++.+||+|||+|+.... ....+||+.|+|||++.   ...|+.
T Consensus       137 ~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  213 (339)
T 1z57_A          137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL---ALGWSQ  213 (339)
T ss_dssp             TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT---TSCCCT
T ss_pred             CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhh---CCCCCc
Confidence            99999999999999987                   66899999999976443 34568999999999985   356899


Q ss_pred             cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhccccc---CCCCccchhhh-HHHHhhcc
Q psy17952        374 KVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAE---RKPPYFNMNAM-SALYHIAQ  449 (804)
Q Consensus       374 ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~---~~pp~~~~~~~-~~l~~i~~  449 (804)
                      ++|||||||++|||++|.+||...+..+.+..+.....+..    ...+........   ....+...... ........
T Consensus       214 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
T 1z57_A          214 PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP----KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK  289 (339)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCC----HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred             chhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC----HHHHhhccchhHHhhccccccccccccchhhhcCc
Confidence            99999999999999999999998887766555543221111    011111100000   00000000000 00000000


Q ss_pred             C-CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        450 N-DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       450 ~-~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      . ..........++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus       290 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            0 0011122335788999999999999999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.8e-44  Score=377.33  Aligned_cols=258  Identities=29%  Similarity=0.486  Sum_probs=209.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cCceEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DHTAWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~~~~l  239 (804)
                      +.|++++.||+|+||.||+|++..+++.||+|.+..... .....+.+.+|+.++++++||||+++++++..  ....|+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            459999999999999999999999999999999864322 23345678899999999999999999998754  567999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG---  315 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g---  315 (804)
                      ||||+.| +|.+++...                              ......+++..+..++.|++.||.|||++|   
T Consensus        85 v~e~~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~  134 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKG------------------------------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGG  134 (279)
T ss_dssp             EEECCTTEEHHHHHHHH------------------------------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHC---
T ss_pred             EEeCCCCCCHHHHHHhh------------------------------cccCCCCCHHHHHHHHHHHHHHHHHHhcccCCC
Confidence            9999986 555544311                              112345899999999999999999999999   


Q ss_pred             --CeecCCCCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 --RIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 --IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                        |+||||||+|||++.++.+||+|||+++.....    ....||+.|+|||++.   ...++.++|||||||++|||++
T Consensus       135 ~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~  211 (279)
T 2w5a_A          135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCLLYELCA  211 (279)
T ss_dssp             ---CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHH---CC-CCHHHHHHHHHHHHHHHHH
T ss_pred             CeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhc---cCCCCchhhHHHHHHHHHHHHH
Confidence              999999999999999999999999998754432    2357999999999985   3568899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||.+.+..+....+..+..+                                          .....+++++.+|+.
T Consensus       212 g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~  249 (279)
T 2w5a_A          212 LMPPFTAFSQKELAGKIREGKFR------------------------------------------RIPYRYSDELNEIIT  249 (279)
T ss_dssp             SSCSSCCSSHHHHHHHHHHTCCC------------------------------------------CCCTTSCHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHhhcccc------------------------------------------cCCcccCHHHHHHHH
Confidence            99999887765555444332211                                          012346889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +||+.||++|||+.++|+|+|++.+.
T Consensus       250 ~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          250 RMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             HHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             HHcCCCcccCCCHHHHHhChhhhhhc
Confidence            99999999999999999999998654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.3e-43  Score=384.31  Aligned_cols=278  Identities=24%  Similarity=0.362  Sum_probs=211.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchh--------------hhhhHHHHHHHHhhcCCCceeEe
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAE--------------KWADILKEIRFLRQLKHPNTIEY  227 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~--------------~~~~~~~Ei~iL~~L~HpNIV~l  227 (804)
                      ..|++.+.||+|+||.||+|++  +++.||||.+.........              ..+.+.+|+.++++++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            4699999999999999999998  8999999988643221111              11678899999999999999999


Q ss_pred             eeEEeecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhcc--CCCCCHHHHHHHHHHH
Q psy17952        228 RGCYLRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH--KRPLKEEEIAAICSGV  304 (804)
Q Consensus       228 ~~~~~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~--~~~l~e~~i~~i~~qi  304 (804)
                      ++++.+.+..|+|||||.| +|.+++..                            +.....  ...+++..+..++.||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------------------~~~l~~~~~~~~~~~~~~~i~~qi  160 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEY----------------------------FFVLDKNYTCFIPIQVIKCIIKSV  160 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSS----------------------------EESSCSSSCCCCCHHHHHHHHHHH
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHH----------------------------hhhhhhccccCCCHHHHHHHHHHH
Confidence            9999999999999999987 44332110                            000112  4679999999999999


Q ss_pred             HHHHHHHHH-CCCeecCCCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCC-cccHHHH
Q psy17952        305 LRGLNYLHS-LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSL  380 (804)
Q Consensus       305 l~gL~yLH~-~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~-ksDIWSl  380 (804)
                      +.||.|||+ +||+||||||+|||++.++.+||+|||++.....  .....||+.|+|||++.+  ...++. ++|||||
T Consensus       161 ~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Di~sl  238 (348)
T 2pml_X          161 LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSN--ESSYNGAKVDIWSL  238 (348)
T ss_dssp             HHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSS--CCCEEHHHHHHHHH
T ss_pred             HHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcC--CCCCCcchhhHHHH
Confidence            999999999 9999999999999999999999999999976432  245689999999999853  225666 8999999


Q ss_pred             HHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCC
Q psy17952        381 GITCIELAERKPPYFNMNA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD  459 (804)
Q Consensus       381 Gvil~ELltG~~PF~~~~~-~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~  459 (804)
                      ||++|||++|..||...+. .+....+..+..+.......           ...+.             ...........
T Consensus       239 G~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~-----------~~~~~-------------~~~~~~~~~~~  294 (348)
T 2pml_X          239 GICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNH-----------FLYPL-------------TNKKSTCSNNF  294 (348)
T ss_dssp             HHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSS-----------STTTT-------------CC--------C
T ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhh-----------hhccc-------------cccccccchhh
Confidence            9999999999999987766 45555554332211110000           00000             00000111245


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       460 ~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       295 ~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            789999999999999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=382.27  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=202.8

Q ss_pred             CcccccccccccccccccceEEEEeeecee---EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~---~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      -....|++.+.||+|+||.||+|++..+++   .||||.+....  .....+.+.+|+.+|++++||||+++++++.+.+
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            345679999999999999999999986554   59999986422  2334567899999999999999999999999999


Q ss_pred             ceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+|||||.|+ |.+++.                                 ...+.+++.++..++.||+.||.|||++
T Consensus       124 ~~~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~  170 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLR---------------------------------THDGQFTIMQLVGMLRGVGAGMRYLSDL  170 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHH---------------------------------TTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccEEEeeCCCCCcHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            999999999864 433321                                 1235689999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ||+||||||+|||++.++.+||+|||+|+.....       ....||+.|+|||++.+   ..|+.++|||||||++|||
T Consensus       171 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el  247 (325)
T 3kul_A          171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF---RTFSSASDVWSFGVVMWEV  247 (325)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH---CEECHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC---CCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999754321       22356788999999853   5688999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |..||.+.+..+....+..+..+                                          .....+++.+.+
T Consensus       248 l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~  285 (325)
T 3kul_A          248 LAYGERPYWNMTNRDVISSVEEGYRL------------------------------------------PAPMGCPHALHQ  285 (325)
T ss_dssp             HTTSCCTTTTSCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHH
T ss_pred             HcCCCCCcccCCHHHHHHHHHcCCCC------------------------------------------CCCCCcCHHHHH
Confidence            99 99999888776665554332110                                          112356889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~  487 (804)
                      |+.+||..||.+|||+.++++
T Consensus       286 li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          286 LMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999885

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-43  Score=387.50  Aligned_cols=283  Identities=25%  Similarity=0.374  Sum_probs=203.0

Q ss_pred             cccccccccccccccccceEEEE-----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYAR-----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~-----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|+     +..+++.||||.+...  ......+.+.+|+++|+++ +|||||++++++..
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            55679999999999999999999     5567899999998642  2233446789999999999 78999999999887


Q ss_pred             cC-ceEEEEeecCC-CchhhHHHHHhhh--------hh----hh-----cccchhhh--------hhhhhhcccccchh-
Q psy17952        234 DH-TAWLVMEYCLG-SASDIIEVHWIER--------EF----HV-----EGMGNRLQ--------QLKCFTEHFALFNF-  285 (804)
Q Consensus       234 ~~-~~~lVmEy~~G-~l~dll~~~~~~~--------~~----~~-----~~~~~~l~--------~l~~~~~~~~L~~~-  285 (804)
                      .+ ..|+|||||.| +|.+++.......        .+    ..     ..+..++.        ....+.....+.+. 
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            55 48999999986 5666654210000        00    00     00000000        00000000000000 


Q ss_pred             ------hccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCcccc
Q psy17952        286 ------EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVG  353 (804)
Q Consensus       286 ------~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~G  353 (804)
                            ...+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....      .....|
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                  01133489999999999999999999999999999999999999999999999999975422      234578


Q ss_pred             CcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCC
Q psy17952        354 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERK  432 (804)
Q Consensus       354 T~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~  432 (804)
                      |+.|+|||++.   ...|+.++|||||||++|||++ |.+||.+.+....+........                     
T Consensus       258 t~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---------------------  313 (359)
T 3vhe_A          258 PLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------------  313 (359)
T ss_dssp             CGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC---------------------
T ss_pred             CceeEChhhhc---CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC---------------------
Confidence            99999999985   3568999999999999999998 9999987654333322221110                     


Q ss_pred             CCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        433 PPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       433 pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                                          .......+++++.+|+.+||+.||++|||+.++++|
T Consensus       314 --------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          314 --------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                                011123468899999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.4e-43  Score=383.20  Aligned_cols=290  Identities=20%  Similarity=0.253  Sum_probs=213.2

Q ss_pred             cccccccccccccccceEEEEeeece-eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCc------eeEeeeEEeec
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN------TIEYRGCYLRD  234 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~-~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpN------IV~l~~~~~~~  234 (804)
                      +.|++.+.||+|+||.||+|++..++ +.||+|.+...    ....+.+.+|+.++++++|+|      ++.+++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            46999999999999999999998776 79999998632    233456788999999998776      89999999999


Q ss_pred             CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        235 HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       235 ~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      +..|+||||+.|++.+.+..                                .....+++.++..++.||+.||+|||++
T Consensus        95 ~~~~lv~e~~~~~l~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~~L~~lH~~  142 (355)
T 2eu9_A           95 GHMCIAFELLGKNTFEFLKE--------------------------------NNFQPYPLPHVRHMAYQLCHALRFLHEN  142 (355)
T ss_dssp             TEEEEEEECCCCBHHHHHHH--------------------------------TTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CeEEEEEeccCCChHHHHHh--------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999999998876544320                                1124689999999999999999999999


Q ss_pred             CCeecCCCCCCeee-------------------cCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCc
Q psy17952        315 GRIHRDVKAGNILL-------------------TETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGK  374 (804)
Q Consensus       315 gIiHRDLKP~NILl-------------------~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~k  374 (804)
                      ||+||||||+|||+                   +.++.+||+|||+|+.... ....+||+.|+|||++.   +..|+.+
T Consensus       143 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~  219 (355)
T 2eu9_A          143 QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL---ELGWAQP  219 (355)
T ss_dssp             TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT---TCCCCTH
T ss_pred             CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeee---cCCCCCc
Confidence            99999999999999                   5678999999999976443 34568999999999985   4578999


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCC--CccchhhhHH--HHhhccC
Q psy17952        375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKP--PYFNMNAMSA--LYHIAQN  450 (804)
Q Consensus       375 sDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~p--p~~~~~~~~~--l~~i~~~  450 (804)
                      +|||||||++|||++|.+||.+.+..+.+..+.+...+...    ..+...........  ..+.......  +......
T Consensus       220 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (355)
T 2eu9_A          220 CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS----HMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP  295 (355)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH----HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC
T ss_pred             cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcH----HHhhhccchhhhcccccccccccchhccccccCCc
Confidence            99999999999999999999988877666555442211110    00100000000000  0000000000  0000000


Q ss_pred             -CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        451 -DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       451 -~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                       ..........+.++.+||.+||+.||++|||+.|+|+||||...
T Consensus       296 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             ccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence             00111223346789999999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-42  Score=367.07  Aligned_cols=244  Identities=28%  Similarity=0.441  Sum_probs=201.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++. +++.||+|++.....    ..+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            45999999999999999999876 466799999864322    2256889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.|+ +.+++.                                 .....+++..+..++.|++.||.|||++||+|||
T Consensus        85 e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d  131 (269)
T 4hcu_A           85 EFMEHGCLSDYLR---------------------------------TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD  131 (269)
T ss_dssp             ECCTTCBHHHHHH---------------------------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EeCCCCcHHHHHH---------------------------------hcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            999865 333321                                 1234689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPY  394 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF  394 (804)
                      |||+|||++.++.+||+|||+++....     .....||+.|+|||++.   ...++.++|||||||++|||++ |.+||
T Consensus       132 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~~g~~p~  208 (269)
T 4hcu_A          132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPY  208 (269)
T ss_dssp             CCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhc---CCCCCchhhhHHHHHHHHHHhcCCCCCC
Confidence            999999999999999999999975432     23456788999999985   3568999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+..+..                                          .......++.+.+|+.+||+.
T Consensus       209 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~  246 (269)
T 4hcu_A          209 ENRSNSEVVEDISTGFR------------------------------------------LYKPRLASTHVYQIMNHCWRE  246 (269)
T ss_dssp             TTCCHHHHHHHHHTTCC------------------------------------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred             CCCCHHHHHHHHhcCcc------------------------------------------CCCCCcCCHHHHHHHHHHccC
Confidence            88776665555433211                                          011234578899999999999


Q ss_pred             CCCCCCCHHHHHcC
Q psy17952        475 NPADRPSSGRLLTH  488 (804)
Q Consensus       475 dP~~Rpsa~elL~H  488 (804)
                      ||++|||+.++++|
T Consensus       247 ~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          247 RPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999976

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-43  Score=381.39  Aligned_cols=270  Identities=26%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             CCcccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL  232 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~  232 (804)
                      ..+.+.|++.+.||+|+||.||+|++.     .+++.||||.+....  .....+.+.+|+.++++++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            345567999999999999999999987     456899999986432  2334567899999999999999999999999


Q ss_pred             ecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccch----hhccCCCCCHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFN----FEVHKRPLKEEEIAAICSGVLRG  307 (804)
Q Consensus       233 ~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~----~~~~~~~l~e~~i~~i~~qil~g  307 (804)
                      ..+..|+|||||.| +|.+++.......          ...+    ....+..    .......+++.++..++.||++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~----~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~  186 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHT----------VCSL----SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG  186 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC------------------------------------CCCCHHHHHHHHHHHHHH
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCccc----------cccc----ccccccccccccccCCCCCCHHHHHHHHHHHHHH
Confidence            99999999999986 6666554210000          0000    0000000    00123579999999999999999


Q ss_pred             HHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccC------CCCccccCcccccchhhcccCCCCCCCcccHHHHH
Q psy17952        308 LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  381 (804)
Q Consensus       308 L~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlG  381 (804)
                      |.|||++||+||||||+|||++.++.+||+|||+++...      ......||+.|+|||++.+   ..++.++||||||
T Consensus       187 l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG  263 (343)
T 1luf_A          187 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYG  263 (343)
T ss_dssp             HHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH---CCCCHHHHHHHHH
T ss_pred             HHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc---CCcCcccccHHHH
Confidence            999999999999999999999999999999999986432      1234578999999999853   5689999999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCc
Q psy17952        382 ITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW  460 (804)
Q Consensus       382 vil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~  460 (804)
                      |++|||++ |..||.+.+..+....+..+..+                                          .....+
T Consensus       264 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~  301 (343)
T 1luf_A          264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL------------------------------------------ACPENC  301 (343)
T ss_dssp             HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------------------------------------------CCCTTC
T ss_pred             HHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC------------------------------------------CCCCCC
Confidence            99999999 99999887776665555432211                                          012346


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        461 SDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       461 s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ++++.+|+.+||+.||++|||+.+++++
T Consensus       302 ~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          302 PLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            8899999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.7e-43  Score=381.17  Aligned_cols=262  Identities=23%  Similarity=0.347  Sum_probs=189.0

Q ss_pred             CcccccccccccccccccceEEEEeeecee---EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~---~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .+.+.|++.+.||+|+||.||+|++..+++   .||||.+..... .....+.+.+|+.++++++||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            345679999999999999999999887775   899998864321 2334577899999999999999999999998776


Q ss_pred             ce------EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHH
Q psy17952        236 TA------WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGL  308 (804)
Q Consensus       236 ~~------~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL  308 (804)
                      ..      |+||||+.| ++.+++....                            .......+++..+..++.||+.||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~~i~~qi~~al  150 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASR----------------------------IGENPFNLPLQTLVRFMVDIACGM  150 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHH----------------------------C---CCCCCHHHHHHHHHHHHHHH
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhh----------------------------ccccccccCHHHHHHHHHHHHHHH
Confidence            55      999999986 4444432110                            001123689999999999999999


Q ss_pred             HHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        309 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       309 ~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      .|||++||+||||||+|||++.++.+||+|||+|+.....      ....||+.|+|||++.+   ..|+.++|||||||
T Consensus       151 ~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~  227 (323)
T 3qup_A          151 EYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD---NLYTVHSDVWAFGV  227 (323)
T ss_dssp             HHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH---CCCCHHHHHHHHHH
T ss_pred             HHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC---CCCCCccchhhHHH
Confidence            9999999999999999999999999999999999754221      23457889999999853   56899999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCcc
Q psy17952        383 TCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS  461 (804)
Q Consensus       383 il~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s  461 (804)
                      ++|||++ |.+||.+.+..+....+..+..                                          ......++
T Consensus       228 il~ell~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~  265 (323)
T 3qup_A          228 TMWEIMTRGQTPYAGIENAEIYNYLIGGNR------------------------------------------LKQPPECM  265 (323)
T ss_dssp             HHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------------------------------------CCCCTTCC
T ss_pred             HHHHHHhCCCCCccccChHHHHHHHhcCCC------------------------------------------CCCCCccC
Confidence            9999999 9999987766554444432211                                          11123568


Q ss_pred             HHHHHHHHHhcccCCCCCCC-------HHHHHcCccccCC
Q psy17952        462 DTFAHFVSSCLAKNPADRPS-------SGRLLTHDLVTRP  494 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rps-------a~elL~Hp~~~~~  494 (804)
                      +++.+|+.+||+.||++|||       .++++.|+|+...
T Consensus       266 ~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          266 EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            89999999999999999999       6777789988653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.2e-43  Score=372.83  Aligned_cols=253  Identities=29%  Similarity=0.474  Sum_probs=195.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--------  233 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--------  233 (804)
                      ..|++++.||+|+||.||+|++..+++.||||.+..    .....+.+.+|+.++++++||||+++++++.+        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            459999999999999999999999999999998853    23345678899999999999999999998865        


Q ss_pred             -----cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHH
Q psy17952        234 -----DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRG  307 (804)
Q Consensus       234 -----~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~g  307 (804)
                           ....|+|||||.| +|.+++..                                 ....+++..+..++.|++.|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------------------~~~~~~~~~~~~i~~qi~~~  128 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHS---------------------------------ENLNQQRDEYWRLFRQILEA  128 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHH---------------------------------SCGGGCHHHHHHHHHHHHHH
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhc---------------------------------cccccchHHHHHHHHHHHHH
Confidence                 4568999999986 55444320                                 12346788999999999999


Q ss_pred             HHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------------------CCccccCcccccchhhcccCCC
Q psy17952        308 LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------------------ANSFVGTPYWMAPEVILAMDEG  369 (804)
Q Consensus       308 L~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------------------~~~~~GT~~Y~APEvl~~~~~~  369 (804)
                      |+|||++||+||||||+|||++.++.+||+|||++.....                  .....||+.|+|||++.+  .+
T Consensus       129 l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~  206 (303)
T 1zy4_A          129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TG  206 (303)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS--CS
T ss_pred             HHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC--CC
Confidence            9999999999999999999999999999999999865321                  124579999999999853  34


Q ss_pred             CCCCcccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhc
Q psy17952        370 QYDGKVDVWSLGITCIELAERKPPYFNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA  448 (804)
Q Consensus       370 ~y~~ksDIWSlGvil~ELltG~~PF~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~  448 (804)
                      .++.++|||||||++|||++   ||.... .......+....                   ..                 
T Consensus       207 ~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~-------------------~~-----------------  247 (303)
T 1zy4_A          207 HYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVS-------------------IE-----------------  247 (303)
T ss_dssp             CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTT-------------------CC-----------------
T ss_pred             CCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccc-------------------cc-----------------
Confidence            68899999999999999998   664322 122222221100                   00                 


Q ss_pred             cCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       449 ~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                         .|.......++.+.+|+.+||+.||.+|||+.++|+||||....
T Consensus       248 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          248 ---FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             ---CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             ---cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence               11112244578899999999999999999999999999997643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.9e-43  Score=375.64  Aligned_cols=272  Identities=22%  Similarity=0.358  Sum_probs=204.2

Q ss_pred             cccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      +.+.|++.+.||+|+||.||+|.+.     .+++.||||.+...  ......+.+.+|+.+|++++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            4566999999999999999999884     45689999998643  2234456788999999999999999999999999


Q ss_pred             CceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +..|+|||||. |+|.+++......   .....    .....  ...... .......+++.++..++.||++||.|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~----~~~~~--~~~~~~-~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  168 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKV---GPGYL----GSGGS--RNSSSL-DHPDERALTMGDLISFAWQISQGMQYLAE  168 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTS---TTEEC-----------------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhc---cCCcc----ccccc--cccccc-ccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999998 4565555421000   00000    00000  000000 00123458999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      +||+||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.+   ..++.++|||||||++|||
T Consensus       169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el  245 (314)
T 2ivs_A          169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEI  245 (314)
T ss_dssp             TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHH
T ss_pred             CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC---CCcCchhhHHHHHHHHHHH
Confidence            9999999999999999999999999999975432      223467889999999853   4688999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |..||.+.+.......+..+.                                          .......+++++.+
T Consensus       246 ~t~g~~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~  283 (314)
T 2ivs_A          246 VTLGGNPYPGIPPERLFNLLKTGH------------------------------------------RMERPDNCSEEMYR  283 (314)
T ss_dssp             HTTSCCSSTTCCGGGHHHHHHTTC------------------------------------------CCCCCTTCCHHHHH
T ss_pred             HhCCCCCCCCCCHHHHHHHhhcCC------------------------------------------cCCCCccCCHHHHH
Confidence            99 999998766544333332211                                          01112356899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~H  488 (804)
                      |+.+||+.||++|||+.+++++
T Consensus       284 li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          284 LMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.5e-43  Score=376.04  Aligned_cols=247  Identities=28%  Similarity=0.453  Sum_probs=198.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            3589999999999999999999999999999987532   3344577899999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||.|+ +.+++.                                 .....+++.++..++.|++.||+|||++||+|||
T Consensus        87 e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~d  133 (310)
T 3s95_A           87 EYIKGGTLRGIIK---------------------------------SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD  133 (310)
T ss_dssp             ECCTTCBHHHHHH---------------------------------HCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             EecCCCcHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence            999864 433332                                 1245689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCC------------------CccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPA------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~------------------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      |||+|||++.++.+||+|||+++.....                  ...+||+.|+|||++.   ...++.++|||||||
T Consensus       134 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~  210 (310)
T 3s95_A          134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN---GRSYDEKVDVFSFGI  210 (310)
T ss_dssp             CSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHH
T ss_pred             CCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhc---CCCCCcHHHHHHHHH
Confidence            9999999999999999999999653211                  1467999999999984   457899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       383 il~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ++|||++|..||.......             ...                   .......+.        ......+++
T Consensus       211 ~l~el~~g~~~~~~~~~~~-------------~~~-------------------~~~~~~~~~--------~~~~~~~~~  250 (310)
T 3s95_A          211 VLCEIIGRVNADPDYLPRT-------------MDF-------------------GLNVRGFLD--------RYCPPNCPP  250 (310)
T ss_dssp             HHHHHHHTCCSSTTTSCBC-------------TTS-------------------SBCHHHHHH--------HTCCTTCCT
T ss_pred             HHHHHhcCCCCCcchhhhH-------------HHH-------------------hhhhhcccc--------ccCCCCCCH
Confidence            9999999999986432100             000                   000000000        011235678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+.+|+.+||+.||++|||+.++++
T Consensus       251 ~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          251 SFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             THHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=385.62  Aligned_cols=264  Identities=24%  Similarity=0.419  Sum_probs=207.1

Q ss_pred             cccccccccccccccccceEEEEeee-------ceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLV-------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCY  231 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~  231 (804)
                      +.+.|++.+.||+|+||.||+|++..       ++..||||++...  ........+.+|+++++++ +|||||++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            45679999999999999999999753       3468999988643  2234456788999999999 999999999999


Q ss_pred             eecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      ..++..|+|||||.| +|.+++......      +       +     .............+++.++..|+.||+.||.|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~-------~-----~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  206 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPP------G-------L-----EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY  206 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCS------S-------S-----SSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhccc------c-------c-----ccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            999999999999986 555554311000      0       0     00000011123569999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ||++||+||||||+|||++.++.+||+|||+|+....      .....||+.|+|||++.   +..++.++|||||||++
T Consensus       207 LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il  283 (382)
T 3tt0_A          207 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLL  283 (382)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH---SCCCCHHHHHHHHHHHH
T ss_pred             HHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc---CCCCCchhHHHHHHHHH
Confidence            9999999999999999999999999999999975432      23356789999999985   35789999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++ |..||.+.+..+....+..+..+                                          .....++++
T Consensus       284 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~  321 (382)
T 3tt0_A          284 WEIFTLGGSPYPGVPVEELFKLLKEGHRM------------------------------------------DKPSNCTNE  321 (382)
T ss_dssp             HHHHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------------------------CCCSSCCHH
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCccCCHH
Confidence            99999 99999887766554444322110                                          112356889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+|+.+||+.||++|||+.+++++
T Consensus       322 l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          322 LYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.8e-43  Score=372.93  Aligned_cols=247  Identities=18%  Similarity=0.264  Sum_probs=197.5

Q ss_pred             cccccccccccccccccceEEEEeeece-------eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSR-------EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL  232 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~-------~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~  232 (804)
                      ..+.|++.+.||+|+||.||+|++..++       ..||+|.+...   .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            3456999999999999999999998877       57999987542   2334467889999999999999999999999


Q ss_pred             ecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       233 ~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      .++..|+|||||.| +|.+++..                                 ....+++..+..++.||+.||.||
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~---------------------------------~~~~~~~~~~~~i~~qi~~~L~~L  129 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKK---------------------------------NKNCINILWKLEVAKQLAAAMHFL  129 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHH---------------------------------TGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             eCCCCEEEEECCCCCCHHHHHHh---------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Confidence            99999999999985 54444321                                 122488999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCc--------EEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGT--------VKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  383 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~--------vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvi  383 (804)
                      |++||+||||||+|||++.++.        +||+|||++..........||+.|+|||++.+  ...++.++|||||||+
T Consensus       130 H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  207 (289)
T 4fvq_A          130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN--PKNLNLATDKWSFGTT  207 (289)
T ss_dssp             HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHC--GGGCCHHHHHHHHHHH
T ss_pred             hhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhCC--CCCCCchhHHHHHHHH
Confidence            9999999999999999998887        99999999976655556679999999999853  2468889999999999


Q ss_pred             HHHHHhCC-CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        384 CIELAERK-PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       384 l~ELltG~-~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      +|||++|. +||...+...... +....                                           .......++
T Consensus       208 l~el~~g~~~~~~~~~~~~~~~-~~~~~-------------------------------------------~~~~~~~~~  243 (289)
T 4fvq_A          208 LWEICSGGDKPLSALDSQRKLQ-FYEDR-------------------------------------------HQLPAPKAA  243 (289)
T ss_dssp             HHHHHTTTCCTTTTSCHHHHHH-HHHTT-------------------------------------------CCCCCCSSC
T ss_pred             HHHHHcCCCCCccccchHHHHH-Hhhcc-------------------------------------------CCCCCCCCH
Confidence            99999955 4554433322221 11100                                           001122356


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ++.+|+.+||+.||++|||+.++++|
T Consensus       244 ~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          244 ELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            78899999999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=370.64  Aligned_cols=256  Identities=28%  Similarity=0.489  Sum_probs=200.7

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEY  243 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy  243 (804)
                      |.....||+|+||.||+|++..+++.||||.+....   ....+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            455668999999999999999999999999886432   23446788999999999999999999999999999999999


Q ss_pred             cCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        244 CLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       244 ~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      +.| ++.+++..                               ......+++..+..++.|++.||.|||++||+|||||
T Consensus       101 ~~~~~L~~~l~~-------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  149 (295)
T 2clq_A          101 VPGGSLSALLRS-------------------------------KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK  149 (295)
T ss_dssp             CSEEEHHHHHHH-------------------------------TTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCCCCHHHHHHh-------------------------------hccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCC
Confidence            975 44443321                               0112356789999999999999999999999999999


Q ss_pred             CCCeeecC-CCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        323 AGNILLTE-TGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       323 P~NILl~~-~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      |+|||++. ++.+||+|||++.....    .....||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.
T Consensus       150 p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (295)
T 2clq_A          150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG-PRGYGKAADIWSLGCTIIEMATGKPPFYEL  228 (295)
T ss_dssp             GGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHG-GGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred             hhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCC-CCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence            99999987 89999999999975432    2356799999999998532 123788999999999999999999999654


Q ss_pred             ChHHH-HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 NAMSA-LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 ~~~~~-l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      ..... .......                                         .........+++++.+|+.+||+.||
T Consensus       229 ~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~li~~~l~~dp  267 (295)
T 2clq_A          229 GEPQAAMFKVGMF-----------------------------------------KVHPEIPESMSAEAKAFILKCFEPDP  267 (295)
T ss_dssp             SSHHHHHHHHHHH-----------------------------------------CCCCCCCTTSCHHHHHHHHHTTCSST
T ss_pred             CchhHHHHhhccc-----------------------------------------cccccccccCCHHHHHHHHHHccCCh
Confidence            32211 1110000                                         00001124578999999999999999


Q ss_pred             CCCCCHHHHHcCccccCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ++|||+.++|+||||....
T Consensus       268 ~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          268 DKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             TTSCCHHHHHTSGGGCC--
T ss_pred             hhCCCHHHHhcChhhhhcc
Confidence            9999999999999998643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.3e-43  Score=380.32  Aligned_cols=263  Identities=30%  Similarity=0.506  Sum_probs=188.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHH-HHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIR-FLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++++.||+|+||.||+|.+..+++.||||.+....  .......+.+|+. +++.++||||+++++++...+..|+|
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            45899999999999999999999999999999986432  1223345566666 77888999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeec
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHR  319 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiHR  319 (804)
                      |||+.|++.+++...                             .......+++..+..++.|++.||.|||++ ||+||
T Consensus       100 ~e~~~~~l~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~  150 (327)
T 3aln_A          100 MELMSTSFDKFYKYV-----------------------------YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHR  150 (327)
T ss_dssp             ECCCSEEHHHHHHHH-----------------------------HHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCS
T ss_pred             EeecCCChHHHHHHH-----------------------------HhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeEC
Confidence            999998766655311                             011245789999999999999999999999 99999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC---CccccCcccccchhhccc-CCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~-~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||+|||++.++.+||+|||+++.....   ....||+.|+|||++... ....++.++|||||||++|||++|+.||.
T Consensus       151 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (327)
T 3aln_A          151 DIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP  230 (327)
T ss_dssp             CCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred             CCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999999754322   234799999999998421 23468899999999999999999999997


Q ss_pred             CCChH-HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        396 NMNAM-SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       396 ~~~~~-~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      +.+.. +.+..+.                      ...++.                .+......+++.+.+|+.+||+.
T Consensus       231 ~~~~~~~~~~~~~----------------------~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~  272 (327)
T 3aln_A          231 KWNSVFDQLTQVV----------------------KGDPPQ----------------LSNSEEREFSPSFINFVNLCLTK  272 (327)
T ss_dssp             CC-------CCCC----------------------CSCCCC----------------CCCCSSCCCCHHHHHHHHHHTCS
T ss_pred             CcchHHHHHHHHh----------------------cCCCCC----------------CCCcccccCCHHHHHHHHHHhhC
Confidence            64321 1110000                      000000                01112245789999999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy17952        475 NPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||++|||+.++++||||..
T Consensus       273 dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          273 DESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             SGGGSCCHHHHTTSHHHHH
T ss_pred             ChhhCcCHHHHHhChHHHH
Confidence            9999999999999999964

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-42  Score=363.67  Aligned_cols=251  Identities=18%  Similarity=0.273  Sum_probs=201.9

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--CceE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTAW  238 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~~  238 (804)
                      .+.|++.+.||+|+||.||+|++.  ++.||||.+.... ......+.+.+|+.++++++||||+++++++.+.  +..|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            456999999999999999999874  7889999886532 2234456789999999999999999999999887  7889


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--  315 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g--  315 (804)
                      +||||+.| +|.+++..                                .....+++.++..++.|++.||.|||++|  
T Consensus        86 lv~e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~  133 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHE--------------------------------GTNFVVDQSQAVKFALDMARGMAFLHTLEPL  133 (271)
T ss_dssp             EEEECCTTCBHHHHHHS--------------------------------CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSC
T ss_pred             eeecccCCCcHHHHHhh--------------------------------cccCCCCHHHHHHHHHHHHHHHHHHhcCCCc
Confidence            99999986 54443320                                11235899999999999999999999999  


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      |+||||||+|||++.++.+||+|||++.... .....||+.|+|||++.+.....++.++|||||||++|||++|+.||.
T Consensus       134 i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          134 IPRHALNSRSVMIDEDMTARISMADVKFSFQ-SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             CTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             eecCCCccceEEEcCCcceeEEeccceeeec-ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999999999999999999999999876432 345689999999999864322334448999999999999999999998


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+.......+.....                                         .......+++++.+|+.+||+.|
T Consensus       213 ~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~~~l~~~  251 (271)
T 3kmu_A          213 DLSNMEIGMKVALEGL-----------------------------------------RPTIPPGISPHVSKLMKICMNED  251 (271)
T ss_dssp             TSCHHHHHHHHHHSCC-----------------------------------------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             ccChHHHHHHHHhcCC-----------------------------------------CCCCCCCCCHHHHHHHHHHcCCC
Confidence            8776665544432211                                         00112356889999999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy17952        476 PADRPSSGRLLTH  488 (804)
Q Consensus       476 P~~Rpsa~elL~H  488 (804)
                      |++|||+.++++.
T Consensus       252 p~~Rps~~~il~~  264 (271)
T 3kmu_A          252 PAKRPKFDMIVPI  264 (271)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999853

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.1e-43  Score=388.52  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+...  ......+.+.+|+++|++++|||||++++++...+..|+|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            35689999999999999999999999999999988642  2233446788999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ +.+++.                                 .....+++..+..++.||+.||+|||++||+||
T Consensus       191 ~e~~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr  237 (377)
T 3cbl_A          191 MELVQGGDFLTFLR---------------------------------TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR  237 (377)
T ss_dssp             EECCTTCBHHHHHH---------------------------------HHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEcCCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCc
Confidence            9999854 433332                                 012357899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      ||||+|||++.++.+||+|||+|+.....      ....+|+.|+|||++.   .+.|+.++|||||||++|||++ |..
T Consensus       238 Dlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~t~g~~  314 (377)
T 3cbl_A          238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN---YGRYSSESDVWSFGILLWETFSLGAS  314 (377)
T ss_dssp             CCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhc---cCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999753321      2234677899999985   3568899999999999999998 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+..+..                                          ...+..+++++.+|+.+||
T Consensus       315 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~cl  352 (377)
T 3cbl_A          315 PYPNLSNQQTREFVEKGGR------------------------------------------LPCPELCPDAVFRLMEQCW  352 (377)
T ss_dssp             SSTTSCHHHHHHHHHTTCC------------------------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence            9988776554443322210                                          0112346789999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      +.||++|||+.++++
T Consensus       353 ~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          353 AYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCCchhCcCHHHHHH
Confidence            999999999999884

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.4e-42  Score=366.18  Aligned_cols=245  Identities=24%  Similarity=0.421  Sum_probs=198.7

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|.+. ++..||||.+.....    ..+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            346999999999999999999765 567899999864322    225688999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.|+ +.+++.                                 .....+++.++..++.|++.||.|||++||+||
T Consensus        98 ~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  144 (283)
T 3gen_A           98 TEYMANGCLLNYLR---------------------------------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR  144 (283)
T ss_dssp             ECCCTTCBHHHHHH---------------------------------CGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EeccCCCcHHHHHH---------------------------------HhccCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            9999764 433321                                 113468999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||||+|||++.++.+||+|||+++....     .....||+.|+|||++.+   ..++.++|||||||++|||++ |+.|
T Consensus       145 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~t~g~~p  221 (283)
T 3gen_A          145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMP  221 (283)
T ss_dssp             SCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999975422     234567889999999853   468899999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+.++..+                                          ......++.+.+|+.+||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~~l~  259 (283)
T 3gen_A          222 YERFTNSETAEHIAQGLRL------------------------------------------YRPHLASEKVYTIMYSCWH  259 (283)
T ss_dssp             TTTSCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHHHTTC
T ss_pred             ccccChhHHHHHHhcccCC------------------------------------------CCCCcCCHHHHHHHHHHcc
Confidence            9887766655554332110                                          1123457889999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .||.+|||+.++++|
T Consensus       260 ~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          260 EKADERPTFKILLSN  274 (283)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.4e-43  Score=379.62  Aligned_cols=253  Identities=26%  Similarity=0.356  Sum_probs=204.7

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccc---hhhhhhHHHHHHHHhhcC--CCceeEeeeEEeec
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC---AEKWADILKEIRFLRQLK--HPNTIEYRGCYLRD  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~---~~~~~~~~~Ei~iL~~L~--HpNIV~l~~~~~~~  234 (804)
                      ....|++.+.||+|+||.||+|++..+++.||||.+.......   ......+.+|+.++++++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4456999999999999999999999999999999986432211   112355778999999996  59999999999999


Q ss_pred             CceEEEEeecCC--CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG--SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       235 ~~~~lVmEy~~G--~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      +..++|||++.+  ++.+                                  ++...+.+++..+..++.||+.||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~----------------------------------~l~~~~~l~~~~~~~i~~qi~~~L~~LH  166 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFD----------------------------------FITERGALQEELARSFFWQVLEAVRHCH  166 (320)
T ss_dssp             SEEEEEEECCSSEEEHHH----------------------------------HHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CcEEEEEEcCCCCccHHH----------------------------------HHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            999999999974  3322                                  2223457899999999999999999999


Q ss_pred             HCCCeecCCCCCCeeec-CCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        313 SLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~-~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ++||+||||||+|||++ .++.+||+|||+++....  .....||+.|+|||++.+  ...++.++|||||||++|||++
T Consensus       167 ~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il~el~~  244 (320)
T 3a99_A          167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY--HRYHGRSAAVWSLGILLYDMVC  244 (320)
T ss_dssp             HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHH
T ss_pred             HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhcc--CCCCCccchHHhHHHHHHHHHH
Confidence            99999999999999999 789999999999975433  234679999999999853  2223678999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |+.||...+.      +....                                           ......+++++.+||.
T Consensus       245 g~~pf~~~~~------~~~~~-------------------------------------------~~~~~~~~~~~~~li~  275 (320)
T 3a99_A          245 GDIPFEHDEE------IIRGQ-------------------------------------------VFFRQRVSSECQHLIR  275 (320)
T ss_dssp             SSCSCCSHHH------HHHCC-------------------------------------------CCCSSCCCHHHHHHHH
T ss_pred             CCCCCCChhh------hhccc-------------------------------------------ccccccCCHHHHHHHH
Confidence            9999964211      11000                                           0012346889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSP  497 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~  497 (804)
                      +||+.||++|||++++++||||.....+
T Consensus       276 ~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          276 WCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             HHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            9999999999999999999999876543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-42  Score=365.00  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=200.7

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++++.||+|+||.||+|++. ++..||+|.+.....    ..+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            456999999999999999999765 566799998864322    235688999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.|+ +.+++..                                 ....+++..+..++.|++.||.|||++||+||
T Consensus        82 ~e~~~~~~L~~~l~~---------------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  128 (268)
T 3sxs_A           82 TEYISNGCLLNYLRS---------------------------------HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR  128 (268)
T ss_dssp             EECCTTCBHHHHHHH---------------------------------HGGGCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEccCCCcHHHHHHH---------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999865 4443321                                 12358899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||||+|||++.++.+||+|||++......     ....||+.|+|||++.+   ..++.++|||||||++|||++ |..|
T Consensus       129 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p  205 (268)
T 3sxs_A          129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY---FKYSSKSDVWAFGILMWEVFSLGKMP  205 (268)
T ss_dssp             SCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH---SEEETTHHHHHHHHHHHHHHTTTCCT
T ss_pred             CcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc---cCCchhhhhHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999754322     23456788999999853   468889999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |...+.......+..+..+                                          ......++.+.+|+.+||+
T Consensus       206 ~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~~l~  243 (268)
T 3sxs_A          206 YDLYTNSEVVLKVSQGHRL------------------------------------------YRPHLASDTIYQIMYSCWH  243 (268)
T ss_dssp             TTTSCHHHHHHHHHTTCCC------------------------------------------CCCTTSCHHHHHHHHHTTC
T ss_pred             ccccChHHHHHHHHcCCCC------------------------------------------CCCCcChHHHHHHHHHHcC
Confidence            9887766655444332110                                          1123357889999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .||++|||+.+++++
T Consensus       244 ~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          244 ELPEKRPTFQQLLSS  258 (268)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999976

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2e-42  Score=368.31  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=191.5

Q ss_pred             cccccccccccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      ..+.|++.+.||+|+||.||+|++..+   +..||+|.+...  ......+.+.+|+.++++++||||+++++++. ++.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            345699999999999999999998654   457999987642  22334567889999999999999999999984 567


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.|+ +.+++.                                 .....+++..+..++.|++.||.|||++|
T Consensus        90 ~~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  136 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQ---------------------------------VRKYSLDLASLILYAYQLSTALAYLESKR  136 (281)
T ss_dssp             CEEEEECCTTEEHHHHHH---------------------------------HTTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cEEEEecCCCCCHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            89999999864 433321                                 12346899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      |+||||||+|||++.++.+||+|||+|+.....     ....+|+.|+|||++.   ...++.++|||||||++|||++ 
T Consensus       137 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~ell~~  213 (281)
T 1mp8_A          137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMH  213 (281)
T ss_dssp             CCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             eecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcc---cCCCCCccCchHHHHHHHHHHhc
Confidence            999999999999999999999999999754321     2345788999999985   3568899999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||.+.+..+....+..+..                                          ......+++.+.+|+.
T Consensus       214 g~~pf~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~l~~li~  251 (281)
T 1mp8_A          214 GVKPFQGVKNNDVIGRIENGER------------------------------------------LPMPPNCPPTLYSLMT  251 (281)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCC------------------------------------------CCCCTTCCHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHHHHHH
Confidence            9999987765554444432211                                          0112356889999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||..||++|||+.+++++
T Consensus       252 ~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          252 KCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-42  Score=377.32  Aligned_cols=246  Identities=21%  Similarity=0.281  Sum_probs=197.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+....     ....+.+|+.+++++ +||||+++++++...+..|+|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            45999999999999999999999999999999875321     124578999999999 999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||+.|+|.+++..                                 ..+.+++..+..++.||+.||+|||++||+|||
T Consensus        84 ~e~~~~~L~~~~~~---------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrD  130 (330)
T 2izr_A           84 LELLGPSLEDLFDL---------------------------------CDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRD  130 (330)
T ss_dssp             EECCCCBHHHHHHH---------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             EEeCCCCHHHHHHH---------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence            99996666555431                                 135789999999999999999999999999999


Q ss_pred             CCCCCeeecCCCc-----EEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        321 VKAGNILLTETGT-----VKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       321 LKP~NILl~~~g~-----vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      |||+|||++.++.     +||+|||+|+....           ....+||+.|+|||++.   +..++.++|||||||++
T Consensus       131 lkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il  207 (330)
T 2izr_A          131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL---GKEQSRRDDLEALGHMF  207 (330)
T ss_dssp             CCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHH
T ss_pred             CCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHc---CCCCCchhHHHHHHHHH
Confidence            9999999998887     99999999975321           13568999999999985   35689999999999999


Q ss_pred             HHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCcc
Q psy17952        385 IELAERKPPYFNMNA---MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS  461 (804)
Q Consensus       385 ~ELltG~~PF~~~~~---~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s  461 (804)
                      |||++|+.||.+.+.   .+.+..+.....                   ..+                   +......++
T Consensus       208 ~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-------------------~~~-------------------~~~~~~~~p  249 (330)
T 2izr_A          208 MYFLRGSLPWQGLKADTLKERYQKIGDTKR-------------------ATP-------------------IEVLCENFP  249 (330)
T ss_dssp             HHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-------------------HSC-------------------HHHHTTTCH
T ss_pred             HHHhcCCCCccccccccHHHHHHHHHhhhc-------------------cCC-------------------HHHHhccCh
Confidence            999999999987432   222222211100                   000                   000012234


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        462 DTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                       ++.+|+.+||..||.+||+++++++
T Consensus       250 -~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          250 -EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             -HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             8999999999999999999998874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=371.10  Aligned_cols=258  Identities=31%  Similarity=0.523  Sum_probs=189.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||.||+|++..+++.||||.+...... ....+.+..+..+++.++||||+++++++...+..|+||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            4589999999999999999999999999999998643221 222233444556788899999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRD  320 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~-gIiHRD  320 (804)
                      ||+.+.+..+..                                 .....+++..+..++.|++.||.|||++ ||+|||
T Consensus       104 e~~~~~~~~l~~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~d  150 (318)
T 2dyl_A          104 ELMGTCAEKLKK---------------------------------RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD  150 (318)
T ss_dssp             CCCSEEHHHHHH---------------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred             eccCCcHHHHHH---------------------------------HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCC
Confidence            999433222111                                 1235689999999999999999999995 999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      |||+|||++.++.+||+|||++.....   .....||+.|+|||++...  ....++.++|||||||++|||++|+.||.
T Consensus       151 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (318)
T 2dyl_A          151 VKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK  230 (318)
T ss_dssp             CCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence            999999999999999999999865432   2345799999999998431  13468889999999999999999999997


Q ss_pred             CC-ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        396 NM-NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       396 ~~-~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      +. +..+.+..+.....+.                                        ......+++++.+||.+||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~  270 (318)
T 2dyl_A          231 NCKTDFEVLTKVLQEEPPL----------------------------------------LPGHMGFSGDFQSFVKDCLTK  270 (318)
T ss_dssp             TCCSHHHHHHHHHHSCCCC----------------------------------------CCSSSCCCHHHHHHHHHHTCS
T ss_pred             CCCccHHHHHHHhccCCCC----------------------------------------CCccCCCCHHHHHHHHHHccC
Confidence            63 3334444433321110                                        011234689999999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy17952        475 NPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ||.+|||++++++||||..
T Consensus       271 dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          271 DHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             CTTTSCCHHHHTTSHHHHH
T ss_pred             ChhHCcCHHHHhhCHHHHh
Confidence            9999999999999999964

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-42  Score=371.80  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=194.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+...........+.+.+|+.++++++||||+++++++..++..|+||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            45999999999999999999999999999999987543333444577889999999999999999999999999999999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.| ++.+++                                  ...+.+++.++..++.|++.||.|||++||+|||
T Consensus       114 e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d  159 (309)
T 2h34_A          114 RLINGVDLAAML----------------------------------RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRD  159 (309)
T ss_dssp             ECCCCEEHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EecCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCC
Confidence            99987 443332                                  2235689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      |||+|||++.++.+||+|||++.....     .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.
T Consensus       160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (309)
T 2h34_A          160 VKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS---ESHATYRADIYALTCVLYECLTGSPPYQ  236 (309)
T ss_dssp             CCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTC---C----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHc---CCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence            999999999999999999999865432     23457999999999984   3568889999999999999999999997


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+.... ........+                                       .+......+++++.+||.+||..|
T Consensus       237 ~~~~~~~-~~~~~~~~~---------------------------------------~~~~~~~~~~~~l~~li~~~l~~d  276 (309)
T 2h34_A          237 GDQLSVM-GAHINQAIP---------------------------------------RPSTVRPGIPVAFDAVIARGMAKN  276 (309)
T ss_dssp             SCHHHHH-HHHHHSCCC---------------------------------------CGGGTSTTCCTHHHHHHHHHTCSS
T ss_pred             CchHHHH-HHHhccCCC---------------------------------------CccccCCCCCHHHHHHHHHhccCC
Confidence            7554322 222111100                                       011122456889999999999999


Q ss_pred             CCCCC-CHHHHHc
Q psy17952        476 PADRP-SSGRLLT  487 (804)
Q Consensus       476 P~~Rp-sa~elL~  487 (804)
                      |++|| |+++++.
T Consensus       277 P~~Rp~s~~~l~~  289 (309)
T 2h34_A          277 PEDRYVTCGDLSA  289 (309)
T ss_dssp             GGGSCSSHHHHHH
T ss_pred             HHHHHHhHHHHHH
Confidence            99999 7777664

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.3e-42  Score=364.88  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=197.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccch----hhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA----EKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~----~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||.+........    ...+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            459999999999999999999999999999998864332211    12267889999999999999999999986554  


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG-  315 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g-  315 (804)
                      ++||||+.|+ +.+.+.                                 .....+++..+..++.|++.||+|||++| 
T Consensus        97 ~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~  143 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLL---------------------------------DKAHPIKWSVKLRLMLDIALGIEYMQNQNP  143 (287)
T ss_dssp             EEEEECCTTCBHHHHHH---------------------------------CTTSCCCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred             eEEEEecCCCCHHHHHh---------------------------------cccCCccHHHHHHHHHHHHHHHHHHHhCCC
Confidence            7999999854 322221                                 12457899999999999999999999999 


Q ss_pred             -CeecCCCCCCeeecCCCc-----EEEEecccccccCCC-CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        316 -RIHRDVKAGNILLTETGT-----VKLADFGSASIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       316 -IiHRDLKP~NILl~~~g~-----vKL~DFGla~~~~~~-~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                       |+||||||+|||++.++.     +||+|||+|+..... ....||+.|+|||++.+ ....++.++|||||||++|||+
T Consensus       144 ~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~Di~slG~~l~~l~  222 (287)
T 4f0f_A          144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGA-EEESYTEKADTYSFAMILYTIL  222 (287)
T ss_dssp             CCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSC-SSCEECHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhcc-CCCCcCchhhHHHHHHHHHHHH
Confidence             999999999999988776     999999999754332 34689999999999843 2345788999999999999999


Q ss_pred             hCCCCCCCCChHHH--HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        389 ERKPPYFNMNAMSA--LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       389 tG~~PF~~~~~~~~--l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      +|+.||.+.+....  ...+...                                         ..+......+++++.+
T Consensus       223 ~g~~pf~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~l~~  261 (287)
T 4f0f_A          223 TGEGPFDEYSYGKIKFINMIREE-----------------------------------------GLRPTIPEDCPPRLRN  261 (287)
T ss_dssp             HSSCTTTTCCCCHHHHHHHHHHS-----------------------------------------CCCCCCCTTSCHHHHH
T ss_pred             cCCCCCccccccHHHHHHHHhcc-----------------------------------------CCCCCCCcccCHHHHH
Confidence            99999976543221  1111110                                         0111122456899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~  487 (804)
                      |+.+||+.||.+|||+.++++
T Consensus       262 li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          262 VIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.1e-42  Score=371.55  Aligned_cols=256  Identities=26%  Similarity=0.390  Sum_probs=199.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC--CCceeEeeeEEeecCceEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK--HPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.|++++.||+|+||.||+|++. +++.||||.+.... ......+.+.+|+.++++++  ||||+++++++...+..|+
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            45999999999999999999885 58899999886432 22344577889999999997  5999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||++.|++.+++.                                  ..+.+++.++..++.|+++||.|||++||+||
T Consensus       106 v~e~~~~~L~~~l~----------------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  151 (313)
T 3cek_A          106 VMECGNIDLNSWLK----------------------------------KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS  151 (313)
T ss_dssp             EECCCSEEHHHHHH----------------------------------HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEecCCCcHHHHHH----------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            99976666554432                                  34578999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccC--------CCCCCCcccHHHHHHHHH
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMD--------EGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~--------~~~y~~ksDIWSlGvil~  385 (804)
                      ||||+|||++ ++.+||+|||+++.....      ...+||+.|+|||++.+..        ...++.++|||||||++|
T Consensus       152 dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~  230 (313)
T 3cek_A          152 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  230 (313)
T ss_dssp             CCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred             CCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence            9999999996 489999999999754321      2457999999999985321        136788999999999999


Q ss_pred             HHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        386 ELAERKPPYFNMNA-MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       386 ELltG~~PF~~~~~-~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      ||++|+.||.+... ...+..+....                                         .........++++
T Consensus       231 el~~g~~pf~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l  269 (313)
T 3cek_A          231 YMTYGKTPFQQIINQISKLHAIIDPN-----------------------------------------HEIEFPDIPEKDL  269 (313)
T ss_dssp             HHHHSSCTTTTCCSHHHHHHHHHCTT-----------------------------------------SCCCCCCCSCHHH
T ss_pred             HHHhCCCchhhHHHHHHHHHHHHhcc-----------------------------------------cccCCcccchHHH
Confidence            99999999976432 22222221100                                         0001122347889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+|+.+||+.||.+|||+.++|+||||....
T Consensus       270 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          270 QDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             HHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999997643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.8e-42  Score=382.81  Aligned_cols=290  Identities=20%  Similarity=0.285  Sum_probs=203.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-----------CCceeEeeeE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-----------HPNTIEYRGC  230 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpNIV~l~~~  230 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+...    ......+.+|+.++++++           ||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            4599999999999999999999999999999988632    223456788999999886           8999999999


Q ss_pred             EeecC----ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHH
Q psy17952        231 YLRDH----TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLR  306 (804)
Q Consensus       231 ~~~~~----~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~  306 (804)
                      +...+    ..++||||+.|++.+++..                                .....+++..+..++.||+.
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~i~~qi~~  142 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVLGENLLALIKK--------------------------------YEHRGIPLIYVKQISKQLLL  142 (373)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHH--------------------------------TTTSCCCHHHHHHHHHHHHH
T ss_pred             hhccCCCCceEEEEEecCCCCHHHHHHH--------------------------------hhccCCcHHHHHHHHHHHHH
Confidence            88654    7899999996666554431                                12345899999999999999


Q ss_pred             HHHHHHHC-CCeecCCCCCCeeec------CCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHH
Q psy17952        307 GLNYLHSL-GRIHRDVKAGNILLT------ETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVW  378 (804)
Q Consensus       307 gL~yLH~~-gIiHRDLKP~NILl~------~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIW  378 (804)
                      ||+|||++ ||+||||||+|||++      ..+.+||+|||+|+.... ....+||+.|+|||++.   +..|+.++|||
T Consensus       143 aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~  219 (373)
T 1q8y_A          143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIW  219 (373)
T ss_dssp             HHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH---TCCCCTHHHHH
T ss_pred             HHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHh---CCCCCchHhHH
Confidence            99999998 999999999999995      344899999999975443 34568999999999985   35689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhc--CCCCCCCCchhhHHhhcccc--cCCCCccchhhhHHHHhhc
Q psy17952        379 SLGITCIELAERKPPYFNMN------AMSALYHIAQN--DTPCLQSSDWSVIKTISSTA--ERKPPYFNMNAMSALYHIA  448 (804)
Q Consensus       379 SlGvil~ELltG~~PF~~~~------~~~~l~~I~~~--~~p~~~~~~~~~i~~i~~~~--~~~pp~~~~~~~~~l~~i~  448 (804)
                      ||||++|||++|++||.+.+      ....+..+...  ..|.................  ................   
T Consensus       220 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  296 (373)
T 1q8y_A          220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL---  296 (373)
T ss_dssp             HHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH---
T ss_pred             HHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh---
Confidence            99999999999999997654      22233333221  11100000000000000000  0000000000000000   


Q ss_pred             cCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       449 ~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ..  ........++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       297 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          297 TE--KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             HH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             hh--cccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence            00  0011234578899999999999999999999999999998653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.9e-42  Score=363.10  Aligned_cols=247  Identities=30%  Similarity=0.486  Sum_probs=191.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccc-hhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC-AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~-~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ..|++.+.||+|+||.||+|++  +++.||||.+....... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            4589999999999999999986  47889999886432221 23346788999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ce
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG---RI  317 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g---Ii  317 (804)
                      |||+.|+..+                                 ++. ..+.+++..+..++.|++.||.|||++|   |+
T Consensus        85 ~e~~~~~~L~---------------------------------~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~  130 (271)
T 3dtc_A           85 MEFARGGPLN---------------------------------RVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPII  130 (271)
T ss_dssp             EECCTTEEHH---------------------------------HHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCC
T ss_pred             EEcCCCCCHH---------------------------------HHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Confidence            9999875221                                 111 2457899999999999999999999999   89


Q ss_pred             ecCCCCCCeeecC--------CCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        318 HRDVKAGNILLTE--------TGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       318 HRDLKP~NILl~~--------~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ||||||+|||++.        ++.+||+|||++.....  .....||+.|+|||++.+   ..++.++|||||||++|||
T Consensus       131 H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l  207 (271)
T 3dtc_A          131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA---SMFSKGSDVWSYGVLLWEL  207 (271)
T ss_dssp             CSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHH---CCCSHHHHHHHHHHHHHHH
T ss_pred             ecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhcc---CCCCchhhHHHHHHHHHHH
Confidence            9999999999986        67899999999975432  234689999999999853   5688999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|+.||.+.+.......+.....                                         .......+++.+.+|
T Consensus       208 ~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~l  246 (271)
T 3dtc_A          208 LTGEVPFRGIDGLAVAYGVAMNKL-----------------------------------------ALPIPSTCPEPFAKL  246 (271)
T ss_dssp             HHCCCTTTTSCHHHHHHHHHTSCC-----------------------------------------CCCCCTTCCHHHHHH
T ss_pred             HhCCCCCCCCCHHHHHHhhhcCCC-----------------------------------------CCCCCcccCHHHHHH
Confidence            999999988776655544432211                                         011123568899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+||+.||.+|||+.|++++
T Consensus       247 i~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          247 MEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCcccCcCHHHHHHH
Confidence            999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-42  Score=369.95  Aligned_cols=262  Identities=27%  Similarity=0.424  Sum_probs=196.7

Q ss_pred             ccccccccccccccccceEEEE----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--
Q psy17952        161 EKIFEDLREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--  234 (804)
                      .+.|++++.||+|+||.||+|+    +..+++.||||++...   .....+.+.+|+.+|++++||||+++++++...  
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4569999999999999999998    5678999999988642   234456788999999999999999999998653  


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ..+|+|||||.| +|.+++.                                 .....+++..+..++.|++.||.|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~  132 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQ---------------------------------KHKERIDHIKLLQYTSQICKGMEYLGT  132 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHH---------------------------------HCGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CceEEEEEeCCCCCHHHHHH---------------------------------hcccccCHHHHHHHHHHHHHHHHHHhc
Confidence            568999999975 5444432                                 112348899999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      +||+||||||+|||++.++.+||+|||+|+....       .....||+.|+|||++.+   ..++.++|||||||++||
T Consensus       133 ~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~  209 (295)
T 3ugc_A          133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYE  209 (295)
T ss_dssp             TTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHH
T ss_pred             CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC---CCCChHHHHHHHHHHHHH
Confidence            9999999999999999999999999999975432       123457888999999853   568999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|..||.....  ......... +.                      .... ...+...............+++++.+
T Consensus       210 l~~g~~~~~~~~~--~~~~~~~~~-~~----------------------~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~  263 (295)
T 3ugc_A          210 LFTYIEKSKSPPA--EFMRMIGND-KQ----------------------GQMI-VFHLIELLKNNGRLPRPDGCPDEIYM  263 (295)
T ss_dssp             HHHTTCTTCSHHH--HHHHHHCTT-CC----------------------THHH-HHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             HHhcccccCCChH--HHHhhhcCc-cc----------------------cchh-HHHHHHHHhccCcCCCCcCcCHHHHH
Confidence            9999999854221  111111100 00                      0000 00011111111122234567899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~  487 (804)
                      |+.+||+.||++|||+.++++
T Consensus       264 li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          264 IMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999885

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-42  Score=377.09  Aligned_cols=273  Identities=25%  Similarity=0.353  Sum_probs=201.4

Q ss_pred             cccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|++.     .+++.||||.+....  .....+.+.+|+.+|+++ +||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            4466999999999999999999973     467789999986422  233456789999999999 89999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..|+|||||.| +|.+++.....           .+.....................+++..+..++.||+.||.|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  189 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKRE-----------KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE  189 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTT-----------CC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCccEEEEecCCCCcHHHHHhhccc-----------cccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999975 66555531100           00000000000000000111245899999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++||+||||||+|||++.++.+||+|||++......      ....||+.|+|||++.+   +.++.++|||||||++||
T Consensus       190 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~e  266 (344)
T 1rjb_A          190 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWE  266 (344)
T ss_dssp             HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHH
T ss_pred             hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc---CCCChhHhHHHHHHHHHH
Confidence            999999999999999999999999999999754322      23567889999999853   568999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |++ |..||.+.+....+..+.....                                         .......+++++.
T Consensus       267 l~t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~  305 (344)
T 1rjb_A          267 IFSLGVNPYPGIPVDANFYKLIQNGF-----------------------------------------KMDQPFYATEEIY  305 (344)
T ss_dssp             HTTTSCCSSTTCCCSHHHHHHHHTTC-----------------------------------------CCCCCTTCCHHHH
T ss_pred             HHcCCCCCcccCCcHHHHHHHHhcCC-----------------------------------------CCCCCCCCCHHHH
Confidence            998 9999987654443333322110                                         0011234688999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~Hp  489 (804)
                      +|+.+||..||.+|||+.++++|-
T Consensus       306 ~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          306 IIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHH
Confidence            999999999999999999999873

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.3e-42  Score=370.09  Aligned_cols=267  Identities=25%  Similarity=0.368  Sum_probs=204.0

Q ss_pred             cccccccccccccccccceEEEEe-----eeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~-----~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +...|++.+.||+|+||.||+|++     ..+++.||||.+....  .....+.+.+|+.+++++ +||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            445699999999999999999985     4578899999986432  223456788999999999 99999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..|+|||||.| +|.+++......              ..+...  ...........+++.++..++.||+.||.|||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  162 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDS--------------FICSKT--SPAIMEDDELALDLEDLLSFSYQVAKGMAFLA  162 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTT--------------C----------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccc--------------cccccc--cccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999986 665555321000              000000  00000112346899999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++||+||||||+|||++.++.+||+|||+++.....      ....||+.|+|||++.+   ..++.++|||||||++||
T Consensus       163 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~e  239 (313)
T 1t46_A          163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWE  239 (313)
T ss_dssp             HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHH
T ss_pred             HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC---CCCChHHHHHHHHHHHHH
Confidence            999999999999999999999999999999754332      23567889999999853   568899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |++ |..||.+.+....+..+....                                         ........+++++.
T Consensus       240 llt~g~~p~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~  278 (313)
T 1t46_A          240 LFSLGSSPYPGMPVDSKFYKMIKEG-----------------------------------------FRMLSPEHAPAEMY  278 (313)
T ss_dssp             HHTTTCCSSTTCCSSHHHHHHHHHT-----------------------------------------CCCCCCTTSCHHHH
T ss_pred             HHhCCCCCCCcccchhHHHHHhccC-----------------------------------------CCCCCcccCCHHHH
Confidence            999 999997765443333322211                                         00111234688999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +|+.+||+.||.+|||+.+++++
T Consensus       279 ~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          279 DIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHHH
Confidence            99999999999999999999865

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.4e-42  Score=376.18  Aligned_cols=247  Identities=24%  Similarity=0.356  Sum_probs=194.5

Q ss_pred             ccccccccccccccccceEEEEeeeceeE----EEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREI----VAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~----vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      ...|++++.||+|+||.||+|++..+++.    ||+|.+...  ........+.+|+.++++++||||+++++++. +..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT--TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc--ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            34599999999999999999999888876    666665422  12233456789999999999999999999886 567


Q ss_pred             eEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.|+ +.+.+.                                 ...+.+++..+..++.||+.||.|||++|
T Consensus        89 ~~~v~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  135 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVR---------------------------------QHRGALGPQLLLNWGVQIAKGMYYLEEHG  135 (325)
T ss_dssp             EEEEEECCTTCBSHHHHH---------------------------------SSGGGSCTTHHHHHHHHHHHHHHHHHHTT
T ss_pred             cEEEEEeCCCCCHHHHHH---------------------------------HccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            89999999854 433321                                 11346888999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |+||||||+|||++.++.+||+|||+|+.....      ....||+.|+|||++.   .+.|+.++|||||||++|||++
T Consensus       136 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~  212 (325)
T 3kex_A          136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH---FGKYTHQSDVWSYGVTVWELMT  212 (325)
T ss_dssp             CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhc---cCCCChhhHhHHhHHHHHHHHh
Confidence            999999999999999999999999999764321      2356888999999985   3568999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |..||.+.+..+....+..+..+                                          .....++.++.+|+
T Consensus       213 ~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li  250 (325)
T 3kex_A          213 FGAEPYAGLRLAEVPDLLEKGERL------------------------------------------AQPQICTIDVYMVM  250 (325)
T ss_dssp             TSCCTTTTSCTTHHHHHHHTTCBC------------------------------------------CCCTTBCTTTTHHH
T ss_pred             CCCCCccccCHHHHHHHHHcCCCC------------------------------------------CCCCcCcHHHHHHH
Confidence             99999876655444433322110                                          11123456788999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||.+|||+.+++++
T Consensus       251 ~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          251 VKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999976

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3e-42  Score=376.03  Aligned_cols=246  Identities=25%  Similarity=0.390  Sum_probs=190.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEE----EEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~v----AIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ..|++++.||+|+||.||+|++..+++.+    |+|.+...  ......+.+.+|+.++++++||||+++++++.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            45999999999999999999998887754    77766432  12233467889999999999999999999998754 7


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ++||||+.++ +.+.+.                                 .....+++..+..|+.||+.||.|||++||
T Consensus        92 ~~v~e~~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  138 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVR---------------------------------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL  138 (327)
T ss_dssp             EEEEECCTTCBHHHHHH---------------------------------HSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEEEecCCCcHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            8899999754 333221                                 124568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||++.++.+||+|||+|+.....      ....||+.|+|||++.   +..|+.++|||||||++|||++ 
T Consensus       139 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~  215 (327)
T 3poz_A          139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTF  215 (327)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             eCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhc---cCCCCchhhhhhhHHHHHHHHhc
Confidence            99999999999999999999999999754321      2345788999999985   3578999999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |+.||.+.+.......+..+.                                          .......++.++.+|+.
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~li~  253 (327)
T 3poz_A          216 GSKPYDGIPASEISSILEKGE------------------------------------------RLPQPPICTIDVYMIMV  253 (327)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTC------------------------------------------CCCCCTTBCHHHHHHHH
T ss_pred             CCCCccCCCHHHHHHHHHcCC------------------------------------------CCCCCccCCHHHHHHHH
Confidence            999998765544333332211                                          01112346789999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||+.||.+|||+.+++.+
T Consensus       254 ~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          254 KCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHTCSCGGGSCCHHHHHHH
T ss_pred             HHcCCChhhCCCHHHHHHH
Confidence            9999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.2e-42  Score=365.74  Aligned_cols=248  Identities=18%  Similarity=0.239  Sum_probs=199.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+....     ....+.+|+.+++.+ +||||+++++++......|+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            345999999999999999999999999999999875321     234578999999999 79999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+.|+|.+++..                                 ....+++.++..++.||+.||.|||++||+||
T Consensus        84 v~e~~~~~L~~~l~~---------------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  130 (298)
T 1csn_A           84 VIDLLGPSLEDLLDL---------------------------------CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR  130 (298)
T ss_dssp             EEECCCCBHHHHHHH---------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             EEEecCCCHHHHHHH---------------------------------hccCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            999996666554431                                 13468999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCc-----EEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHH
Q psy17952        320 DVKAGNILLTETGT-----VKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  383 (804)
Q Consensus       320 DLKP~NILl~~~g~-----vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvi  383 (804)
                      ||||+|||++.++.     +||+|||+|+....           .....||+.|+|||++.   +..++.++|||||||+
T Consensus       131 Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  207 (298)
T 1csn_A          131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHV  207 (298)
T ss_dssp             CCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             CCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhc---CCCCChHHHHHHHHHH
Confidence            99999999987776     99999999965322           23467999999999984   4568999999999999


Q ss_pred             HHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCc
Q psy17952        384 CIELAERKPPYFNMN---AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW  460 (804)
Q Consensus       384 l~ELltG~~PF~~~~---~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~  460 (804)
                      +|||++|+.||.+.+   ....+..+....                   .. ++                  .......+
T Consensus       208 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~-~~------------------~~~~~~~~  249 (298)
T 1csn_A          208 FMYFLRGSLPWQGLKAATNKQKYERIGEKK-------------------QS-TP------------------LRELCAGF  249 (298)
T ss_dssp             HHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-------------------HH-SC------------------HHHHTTTS
T ss_pred             HHHHHcCCCCcchhhccccHHHHHHHHhhc-------------------cC-cc------------------HHHHHhhC
Confidence            999999999997743   222222221110                   00 00                  00012356


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        461 SDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       461 s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      ++++.+|+.+||+.||++|||++++++
T Consensus       250 ~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          250 PEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            899999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-42  Score=379.23  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=176.5

Q ss_pred             ccccccccc-ccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHH-HHHhhcCCCceeEeeeEEee----
Q psy17952        160 PEKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI-RFLRQLKHPNTIEYRGCYLR----  233 (804)
Q Consensus       160 p~~~y~~l~-~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei-~iL~~L~HpNIV~l~~~~~~----  233 (804)
                      ..+.|++++ .||+|+||.||+|++..+++.||||++....        ...+|+ ..++.++||||+++++++..    
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            345688866 5999999999999999999999999875321        122333 34567799999999999876    


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      ....|+|||||.| +|.+++.                                ......+++.++..++.||+.||.|||
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~--------------------------------~~~~~~l~~~~~~~i~~ql~~~l~~LH  145 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQ--------------------------------ERGDQAFTEREAAEIMRDIGTAIQFLH  145 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHH--------------------------------TC-CCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             CceEEEEEeccCCCCHHHHHH--------------------------------hcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4558999999987 4433332                                011246899999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecC---CCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~---~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      ++||+||||||+|||++.   ++.+||+|||+++....  ....+||+.|+|||++.   ...|+.++|||||||++|||
T Consensus       146 ~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~~l  222 (336)
T 3fhr_A          146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYIL  222 (336)
T ss_dssp             HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHH
T ss_pred             hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhC---CCCCCchhhHHHHHHHHHHH
Confidence            999999999999999986   45599999999975432  24568999999999984   35688899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|..||.+.+.......+..               .+..                    .....+......+++++.+|
T Consensus       223 ~~g~~pf~~~~~~~~~~~~~~---------------~~~~--------------------~~~~~~~~~~~~~~~~~~~l  267 (336)
T 3fhr_A          223 LCGFPPFYSNTGQAISPGMKR---------------RIRL--------------------GQYGFPNPEWSEVSEDAKQL  267 (336)
T ss_dssp             HHSSCCC--------------------------------------------------------CCCTTTSTTCCHHHHHH
T ss_pred             HHCCCCCCCccchhhhhhHHH---------------hhhc--------------------cccccCchhhccCCHHHHHH
Confidence            999999976443221110000               0000                    00011122234578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |.+||+.||.+|||+.|+|+||||...
T Consensus       268 i~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          268 IRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHCCCChhHCcCHHHHhcCcccccc
Confidence            999999999999999999999999763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.9e-42  Score=381.36  Aligned_cols=248  Identities=24%  Similarity=0.408  Sum_probs=192.7

Q ss_pred             cccccccccccccccccceEEEEee---eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      ....|++.+.||+|+||.||+|++.   .++..||||.+....  .....+.+.+|+.+|++++||||+++++++...+.
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            3456999999999999999999887   467789999986432  23345678999999999999999999999999999


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+|||||.| +|.+++.                                 .....+++.++..++.||+.||.|||++|
T Consensus       121 ~~lv~e~~~~~sL~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  167 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLR---------------------------------KHDAQFTVIQLVGMLRGIASGMKYLSDMG  167 (373)
T ss_dssp             CEEEEECCTTCBHHHHHH---------------------------------TTTTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEeCCCCCcHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999975 4443332                                 12346899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |+||||||+|||++.++.+||+|||+|+.....       ....+|+.|+|||++.   ...|+.++|||||||++|||+
T Consensus       168 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~SlG~il~ell  244 (373)
T 2qol_A          168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA---YRKFTSASDVWSYGIVLWEVM  244 (373)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHH
T ss_pred             eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc---cCCcCchhcHHHHHHHHHHHH
Confidence            999999999999999999999999999754321       1224577899999985   356899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      + |+.||.+.+..+....+..+..                                          ......++..+.+|
T Consensus       245 t~g~~P~~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~l~~l  282 (373)
T 2qol_A          245 SYGERPYWEMSNQDVIKAVDEGYR------------------------------------------LPPPMDCPAALYQL  282 (373)
T ss_dssp             TTC-CTTTTCCHHHHHHHHHTTEE------------------------------------------CCCCTTCBHHHHHH
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCccccHHHHHH
Confidence            8 9999988776655544422100                                          00123468899999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q psy17952        468 VSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~  487 (804)
                      +.+||+.||++|||+.++++
T Consensus       283 i~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          283 MLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999885

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-41  Score=369.15  Aligned_cols=257  Identities=22%  Similarity=0.356  Sum_probs=205.9

Q ss_pred             ccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .+.|++.+.||+|+||.||+|++.     .+++.||||.+...  ........+.+|+.++++++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            356999999999999999999887     46889999998642  22334456889999999999999999999999999


Q ss_pred             ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+|||||.| +|.+++.....                        ..........+++..+..++.||+.||.|||++
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  157 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRP------------------------AMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN  157 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHH------------------------HHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccEEEEEeCCCCcHHHHHHHhch------------------------hhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999999985 66655532100                        000001124678999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||+||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.   ...++.++|||||||++|||+
T Consensus       158 ~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~  234 (322)
T 1p4o_A          158 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIA  234 (322)
T ss_dssp             TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc---cCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999999975322      12346789999999985   356889999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 E-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 t-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      + |..||.+.+.......+..+..+                                          .....+++.+.+|
T Consensus       235 ~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~l  272 (322)
T 1p4o_A          235 TLAEQPYQGLSNEQVLRFVMEGGLL------------------------------------------DKPDNCPDMLFEL  272 (322)
T ss_dssp             HTSCCTTTTSCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHH
T ss_pred             hcCCCccccCCHHHHHHHHHcCCcC------------------------------------------CCCCCCCHHHHHH
Confidence            9 89999887766555444332110                                          0123468899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+||+.||.+|||+.+++++
T Consensus       273 i~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          273 MRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=375.05  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=183.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEe--------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYL--------  232 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~--------  232 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+...   .......+.+|+.+++++. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            4699999999999999999999999999999987532   2344567889999999996 999999999984        


Q ss_pred             ecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       233 ~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      ....+|+|||||.|++.+++..                               ....+.+++.++..++.||+.||.|||
T Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~-------------------------------~~~~~~~~~~~~~~i~~qi~~~l~~LH  153 (337)
T 3ll6_A          105 GQAEFLLLTELCKGQLVEFLKK-------------------------------MESRGPLSCDTVLKIFYQTCRAVQHMH  153 (337)
T ss_dssp             SSEEEEEEEECCSEEHHHHHHH-------------------------------HHTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEEEecCCCHHHHHHH-------------------------------hhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3445899999999887665531                               112456999999999999999999999


Q ss_pred             HCC--CeecCCCCCCeeecCCCcEEEEecccccccCCC----------------CccccCcccccchhhcccCCCCCCCc
Q psy17952        313 SLG--RIHRDVKAGNILLTETGTVKLADFGSASIKCPA----------------NSFVGTPYWMAPEVILAMDEGQYDGK  374 (804)
Q Consensus       313 ~~g--IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~----------------~~~~GT~~Y~APEvl~~~~~~~y~~k  374 (804)
                      ++|  |+||||||+|||++.++.+||+|||+++.....                ...+||+.|+|||++.......++.+
T Consensus       154 ~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~  233 (337)
T 3ll6_A          154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK  233 (337)
T ss_dssp             TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHH
T ss_pred             hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChH
Confidence            999  999999999999999999999999999754321                13569999999999843345568889


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC
Q psy17952        375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC  454 (804)
Q Consensus       375 sDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~  454 (804)
                      +|||||||++|||++|+.||.+......+...                                             ...
T Consensus       234 ~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---------------------------------------------~~~  268 (337)
T 3ll6_A          234 QDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---------------------------------------------YSI  268 (337)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC---------------------------------------------------------CCC
T ss_pred             HhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc---------------------------------------------ccC
Confidence            99999999999999999999654322111000                                             000


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       455 ~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          269 PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1122345678899999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.6e-42  Score=364.77  Aligned_cols=254  Identities=30%  Similarity=0.498  Sum_probs=190.4

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +...|++.+.||+|+||.||+|++..   .||+|.+.... ......+.+.+|+.+|++++||||++++++. .....++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            44569999999999999999997543   49999886432 2334457789999999999999999999954 5667899


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+ +.+.+.                                 .....+++..+..++.|++.||.|||++||+|
T Consensus        97 v~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H  143 (289)
T 3og7_A           97 VTQWCEGSSLYHHLH---------------------------------ASETKFEMKKLIDIARQTARGMDYLHAKSIIH  143 (289)
T ss_dssp             EEECCCEEEHHHHHT---------------------------------TC---CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEecCCCcHHHHHh---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999864 222221                                 12356899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+|||++.++.+||+|||++.....      .....||+.|+|||++.......++.++|||||||++|||++|+.
T Consensus       144 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  223 (289)
T 3og7_A          144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL  223 (289)
T ss_dssp             SCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCC
Confidence            99999999999999999999999864322      234579999999999864335568889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+....+..+......                   .+                  ........+++.+.+|+.+||
T Consensus       224 p~~~~~~~~~~~~~~~~~~~-------------------~~------------------~~~~~~~~~~~~l~~li~~~l  266 (289)
T 3og7_A          224 PYSNINNRDQIIEMVGRGSL-------------------SP------------------DLSKVRSNCPKRMKRLMAECL  266 (289)
T ss_dssp             TTSSCCCHHHHHHHHHHTSC-------------------CC------------------CTTSSCTTSCHHHHHHHHHHT
T ss_pred             CccccchHHHHHHHhccccc-------------------Cc------------------chhhccccCCHHHHHHHHHHc
Confidence            99876655544433321100                   00                  011122457899999999999


Q ss_pred             ccCCCCCCCHHHHHcC
Q psy17952        473 AKNPADRPSSGRLLTH  488 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~H  488 (804)
                      +.||.+|||+.++++.
T Consensus       267 ~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          267 KKKRDERPSFPRILAE  282 (289)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCChhhCCCHHHHHHH
Confidence            9999999999999853

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-41  Score=371.88  Aligned_cols=264  Identities=23%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             cccccccccccccccccceEEEEee-------eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-------VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCY  231 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-------~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~  231 (804)
                      +.+.|++.+.||+|+||.||+|++.       .+++.||||.+....  .......+.+|+.+++++ +||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            4456999999999999999999975       467789999986432  234456788999999999 899999999999


Q ss_pred             eecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      ...+..|+|||||.| +|.+++......      +.            .............+++.++..++.||+.||.|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~------------~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  172 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPP------GM------------EYSYDINRVPEEQMTFKDLVSCTYQLARGMEY  172 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCT------TC------------CSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccc------cc------------cccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            999999999999986 555544311000      00            00000000123458999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ||++||+||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.+   ..++.++|||||||++
T Consensus       173 LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il  249 (334)
T 2pvf_A          173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLM  249 (334)
T ss_dssp             HHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHH
T ss_pred             HHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC---CCcChHHHHHHHHHHH
Confidence            9999999999999999999999999999999975432      223467889999999853   4688899999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++ |..||.+.+..+....+..+..+                                          .....++.+
T Consensus       250 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~  287 (334)
T 2pvf_A          250 WEIFTLGGSPYPGIPVEELFKLLKEGHRM------------------------------------------DKPANCTNE  287 (334)
T ss_dssp             HHHHTTSCCSSTTCCHHHHHHHHHHTCCC------------------------------------------CCCTTCCHH
T ss_pred             HHHHhCCCCCcCcCCHHHHHHHHhcCCCC------------------------------------------CCCccCCHH
Confidence            99999 99999887665544443322110                                          112346889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+|+.+||..||.+|||+.+++++
T Consensus       288 l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          288 LYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=390.63  Aligned_cols=251  Identities=23%  Similarity=0.310  Sum_probs=190.5

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|+..+.||+|+||+|+. ....+++.||||++....      ...+.+|+.+|+++ +|||||++++++.+....|+||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            489999999999999764 456788999999885321      23467899999999 7999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|++.+++..                                 ....+++.++..++.||+.||.|||++||+||||
T Consensus        98 E~~~g~L~~~l~~---------------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl  144 (432)
T 3p23_A           98 ELCAATLQEYVEQ---------------------------------KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL  144 (432)
T ss_dssp             ECCSEEHHHHHHS---------------------------------SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             ECCCCCHHHHHHh---------------------------------cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCC
Confidence            9999876655431                                 1223455567889999999999999999999999


Q ss_pred             CCCCeeecC---C--CcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        322 KAGNILLTE---T--GTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       322 KP~NILl~~---~--g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||+|||++.   +  ..+||+|||+|+....       ....+||+.|+|||++.+.....++.++|||||||++|||++
T Consensus       145 Kp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt  224 (432)
T 3p23_A          145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS  224 (432)
T ss_dssp             STTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHT
T ss_pred             CHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHc
Confidence            999999953   2  3688999999975432       234679999999999864324567789999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |.+||......... .+.....                     .                  .........+..+.+||
T Consensus       225 ~g~~pf~~~~~~~~~-~~~~~~~---------------------~------------------~~~~~~~~~~~~~~~li  264 (432)
T 3p23_A          225 EGSHPFGKSLQRQAN-ILLGACS---------------------L------------------DCLHPEKHEDVIARELI  264 (432)
T ss_dssp             TSCBTTBSTTTHHHH-HHTTCCC---------------------C------------------TTSCTTCHHHHHHHHHH
T ss_pred             CCCCCcchhhHHHHH-HHhccCC---------------------c------------------cccCccccccHHHHHHH
Confidence             99998554332211 1110000                     0                  00001122466789999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+||+.||.+|||+.++|+||||..
T Consensus       265 ~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          265 EKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             HHHHhCCHhhCCCHHHHHhCccccC
Confidence            9999999999999999999999964

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-41  Score=366.31  Aligned_cols=253  Identities=35%  Similarity=0.571  Sum_probs=194.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++++++||||+++++++...+..|+||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            45999999999999999999999999999999987543334455677899999999999999999999999999999999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.| ++.+++..                              .......+++..+..++.|++.||.|||++||+|||
T Consensus       112 e~~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d  161 (310)
T 2wqm_A          112 ELADAGDLSRMIKH------------------------------FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD  161 (310)
T ss_dssp             ECCCSCBHHHHHHH------------------------------HHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ecCCCCCHHHHHHH------------------------------hcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCC
Confidence            99986 55444421                              111245689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||+|||++.++.+||+|||++.....    .....||+.|+|||++.   ...++.++|||||||++|||++|..||.+
T Consensus       162 l~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             CCGGGEEECTTSCEEECCC------------------CCSSCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             CcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhC---CCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            999999999999999999999865432    23457999999999984   35688999999999999999999999975


Q ss_pred             CC--hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        397 MN--AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       397 ~~--~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      ..  .......+..                                         ...+......+++++.+|+.+||..
T Consensus       239 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~l~~li~~~l~~  277 (310)
T 2wqm_A          239 DKMNLYSLCKKIEQ-----------------------------------------CDYPPLPSDHYSEELRQLVNMCINP  277 (310)
T ss_dssp             --CCHHHHHHHHHT-----------------------------------------TCSCCCCTTTSCHHHHHHHHHHTCS
T ss_pred             cchhHHHHHHHhhc-----------------------------------------ccCCCCcccccCHHHHHHHHHHcCC
Confidence            42  1111111111                                         1111122345789999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q psy17952        475 NPADRPSSGRLLTH  488 (804)
Q Consensus       475 dP~~Rpsa~elL~H  488 (804)
                      ||++|||+.+++++
T Consensus       278 dp~~Rps~~~il~~  291 (310)
T 2wqm_A          278 DPEKRPDVTYVYDV  291 (310)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCCCHHHHHHH
Confidence            99999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-41  Score=362.75  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      ...|++.+.||+|+||.||+|.+..+++.||+|.+...    ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            34599999999999999999999999999999988632    23346788999999999999999999999999999999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||+.| ++.+++..                                .....+++..+..++.|++.||.|||++||+||
T Consensus        88 ~e~~~~~~L~~~~~~--------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  135 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRE--------------------------------CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR  135 (288)
T ss_dssp             EECCTTEEHHHHHHH--------------------------------CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCS
T ss_pred             EEcCCCCcHHHHHHh--------------------------------cccCCccHhHHHHHHHHHHHHHHHHHHCCccCC
Confidence            999985 44433320                                123468999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||||+|||++.++.+||+|||+|......     ....||+.|+|||++.   ...++.++|||||||++|+|++ |.+|
T Consensus       136 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~ll~~g~~p  212 (288)
T 3kfa_A          136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSP  212 (288)
T ss_dssp             CCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999754322     2346788999999985   3568899999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+.......+....                                          .......+++.+.+|+.+||.
T Consensus       213 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l~  250 (288)
T 3kfa_A          213 YPGIDLSQVYELLEKDY------------------------------------------RMERPEGCPEKVYELMRACWQ  250 (288)
T ss_dssp             STTCCGGGHHHHHHTTC------------------------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCHHHHHHHHhccC------------------------------------------CCCCCCCCCHHHHHHHHHHhC
Confidence            97765444333322110                                          111124568899999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .||.+|||+.++++.
T Consensus       251 ~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          251 WNPSDRPSFAEIHQA  265 (288)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999853

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.2e-42  Score=389.45  Aligned_cols=261  Identities=24%  Similarity=0.368  Sum_probs=192.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .+.|...+.||+|+||+||.+ ...+|+.||||++...      ..+.+.+|+.+|+++ +|||||++++++.+.+..|+
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l   86 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI   86 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence            345777789999999999875 4567999999987531      224568899999986 89999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||||.|+|.+++......                           .......++..+..++.||+.||+|||++||+||
T Consensus        87 v~E~~~gsL~~~l~~~~~~---------------------------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  139 (434)
T 2rio_A           87 ALELCNLNLQDLVESKNVS---------------------------DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHR  139 (434)
T ss_dssp             EECCCSEEHHHHHHTC---------------------------------------CCHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEecCCCCHHHHHhccCCC---------------------------chhhhhccchhHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999998877766411000                           0000112344567899999999999999999999


Q ss_pred             CCCCCCeeecCC-------------CcEEEEecccccccCCC--------CccccCcccccchhhccc----CCCCCCCc
Q psy17952        320 DVKAGNILLTET-------------GTVKLADFGSASIKCPA--------NSFVGTPYWMAPEVILAM----DEGQYDGK  374 (804)
Q Consensus       320 DLKP~NILl~~~-------------g~vKL~DFGla~~~~~~--------~~~~GT~~Y~APEvl~~~----~~~~y~~k  374 (804)
                      ||||+|||++.+             +.+||+|||+|+.....        ...+||+.|+|||++.+.    ....++.+
T Consensus       140 DLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  219 (434)
T 2rio_A          140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS  219 (434)
T ss_dssp             CCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred             CCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence            999999999754             48999999999754321        235799999999998642    12568899


Q ss_pred             ccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC
Q psy17952        375 VDVWSLGITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP  453 (804)
Q Consensus       375 sDIWSlGvil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p  453 (804)
                      +|||||||++|||++ |..||.+.....  ..+..+...                   .+                 ..+
T Consensus       220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~-------------------~~-----------------~~~  261 (434)
T 2rio_A          220 IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFS-------------------LD-----------------EMK  261 (434)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCC-------------------CC-----------------CCT
T ss_pred             hhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCC-------------------cc-----------------ccc
Confidence            999999999999999 999997654322  122221100                   00                 001


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       454 ~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ......+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus       262 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          262 CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            1112235788999999999999999999999999999964

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.8e-42  Score=371.17  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=200.9

Q ss_pred             cccccccccccccccccceEEEE-----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYAR-----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~-----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~  234 (804)
                      +.+.|++.+.||+|+||.||+|+     +..+++.||||.+....  .......+.+|+.++++++||||+++++++...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            44569999999999999999999     55678899999986322  233445788999999999999999999999999


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +..|+|||||.| +|.+++...                  .         ........+++.++..++.||+.||.|||+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~------------------~---------~~~~~~~~~~~~~~~~i~~qi~~al~~LH~  158 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRET------------------R---------PRPSQPSSLAMLDLLHVARDIACGCQYLEE  158 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT------------------S---------CCSSSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcEEEEecCCCCcHHHHHHhh------------------c---------ccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence            999999999975 555544310                  0         000112458999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCC---CcEEEEecccccccC------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTET---GTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~---g~vKL~DFGla~~~~------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      +||+||||||+|||++.+   ..+||+|||++....      ......||+.|+|||++.+   +.++.++|||||||++
T Consensus       159 ~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il  235 (327)
T 2yfx_A          159 NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLL  235 (327)
T ss_dssp             TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHH
T ss_pred             CCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC---CCCCchhhHHHHHHHH
Confidence            999999999999999844   469999999986421      2234578999999999853   5688999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++ |..||.+.+.......+..+..+                                          .....+++.
T Consensus       236 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~  273 (327)
T 2yfx_A          236 WEIFSLGYMPYPSKSNQEVLEFVTSGGRM------------------------------------------DPPKNCPGP  273 (327)
T ss_dssp             HHHHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHH
T ss_pred             HHHHcCCCCCCCCcCHHHHHHHHhcCCCC------------------------------------------CCCCCCCHH
Confidence            99998 99999877765555444332110                                          112346789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      +.+||.+||+.||.+|||+.+++++.|+
T Consensus       274 l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          274 VYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            9999999999999999999999998764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.2e-42  Score=374.07  Aligned_cols=266  Identities=26%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++.+.||+|+||.||+|++ .+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..|+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            345699999999999999999986 468899999876432   2345678899999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+ +.+++.                              ........+++.++..++.|++.||.|||++||+|
T Consensus       113 v~e~~~~~~L~~~l~------------------------------~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH  162 (321)
T 2qkw_B          113 IYKYMENGNLKRHLY------------------------------GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH  162 (321)
T ss_dssp             EEECCTTCBTGGGSS------------------------------SSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEcCCCCcHHHHHh------------------------------ccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeec
Confidence            99999864 333221                              00112236899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+|||++.++.+||+|||+++....      .....||+.|+|||++.+   +.++.++|||||||++|||++|+.
T Consensus       163 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~  239 (321)
T 2qkw_B          163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEVLCARS  239 (321)
T ss_dssp             SCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH---CBCCTHHHHHHHHHHHHHHHHCCT
T ss_pred             CCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC---CCCCcccchHhHHHHHHHHHhCCC
Confidence            99999999999999999999999975322      123569999999999853   568999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+....+....+           .|... ....  ....            .+.....+.......+..+.+|+.+||
T Consensus       240 p~~~~~~~~~~~~~-----------~~~~~-~~~~--~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~l  293 (321)
T 2qkw_B          240 AIVQSLPREMVNLA-----------EWAVE-SHNN--GQLE------------QIVDPNLADKIRPESLRKFGDTAVKCL  293 (321)
T ss_dssp             TCSCSSSSSCCCHH-----------HHTHH-HHTT--TCCC------------SSSSSSCTTCSCHHHHHHHHHHHHHHT
T ss_pred             cccccCcHHHHHHH-----------HHhhh-cccc--ccHH------------HhcChhhccccCHHHHHHHHHHHHHHc
Confidence            99754321100000           00000 0000  0000            000001111112345778999999999


Q ss_pred             ccCCCCCCCHHHHHcC
Q psy17952        473 AKNPADRPSSGRLLTH  488 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~H  488 (804)
                      +.||++|||+.+++++
T Consensus       294 ~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          294 ALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCCcccCcCHHHHHHH
Confidence            9999999999999976

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-41  Score=371.03  Aligned_cols=262  Identities=26%  Similarity=0.365  Sum_probs=201.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEE--EEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIV--AIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~v--AIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      ..|++.+.||+|+||.||+|++..++..+  |+|.+....  .....+.+.+|+.+|+++ +||||+++++++.+.+..|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            35899999999999999999999988865  999876422  223446688999999999 8999999999999999999


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.| +|.+++......            ....      ...........+++.++..++.||+.||.|||++||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~------------~~~~------~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  164 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVL------------ETDP------AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI  164 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHH------------HHCH------HHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEecCCCCCHHHHHHhcccc------------cccc------cccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            99999975 665555311000            0000      0000012345799999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccC---CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~---~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~P  393 (804)
                      ||||||+|||++.++.+||+|||+++...   ......+|+.|+|||++.+   ..++.++|||||||++|||++ |..|
T Consensus       165 H~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p  241 (327)
T 1fvr_A          165 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTP  241 (327)
T ss_dssp             CSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhcc---ccCCchhcchHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999986432   2233467889999999853   468889999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+....+..+..                                          ......+++.+.+|+.+||+
T Consensus       242 f~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~  279 (327)
T 1fvr_A          242 YCGMTCAELYEKLPQGYR------------------------------------------LEKPLNCDDEVYDLMRQCWR  279 (327)
T ss_dssp             TTTCCHHHHHHHGGGTCC------------------------------------------CCCCTTBCHHHHHHHHHHTC
T ss_pred             CCCCcHHHHHHHhhcCCC------------------------------------------CCCCCCCCHHHHHHHHHHcc
Confidence            988776554444322110                                          01123568899999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .||.+|||+.+++++
T Consensus       280 ~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          280 EKPYERPSFAQILVS  294 (327)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999965

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.3e-42  Score=373.24  Aligned_cols=265  Identities=25%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc----e
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT----A  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~----~  237 (804)
                      ..|++.+.||+|+||.||+|++.  ++.||||++....    .......+|+.+|++++|||||++++++.....    +
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            45999999999999999999764  7899999986422    223445679999999999999999999987553    6


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL--  314 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~--  314 (804)
                      |+|||||.| +|.+++.                                   ...+++..+..++.|++.||.|||+.  
T Consensus        98 ~lv~e~~~~g~L~~~l~-----------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~  142 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLK-----------------------------------ANVVSWNELCHIAETMARGLAYLHEDIP  142 (322)
T ss_dssp             EEEEECCTTCBHHHHHH-----------------------------------HCCBCHHHHHHHHHHHHHHHHHHTCCEE
T ss_pred             EEEEecCCCCCHHHHHH-----------------------------------hcCCCHHHHHHHHHHHHHHHHHHHhhcc
Confidence            999999986 4444332                                   23589999999999999999999999  


Q ss_pred             --------CCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCC--CCCCCcccHH
Q psy17952        315 --------GRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDE--GQYDGKVDVW  378 (804)
Q Consensus       315 --------gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~--~~y~~ksDIW  378 (804)
                              ||+||||||+|||++.++.+||+|||+|+....      ....+||+.|+|||++.+...  ..++.++|||
T Consensus       143 ~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  222 (322)
T 3soc_A          143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY  222 (322)
T ss_dssp             EETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHH
T ss_pred             ccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhH
Confidence                    999999999999999999999999999965322      233689999999999853211  2456689999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCC
Q psy17952        379 SLGITCIELAERKPPYFNMNAMSALY-HIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQS  457 (804)
Q Consensus       379 SlGvil~ELltG~~PF~~~~~~~~l~-~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~  457 (804)
                      ||||++|||++|++||.+........ .......+     ....+..........|..                ......
T Consensus       223 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~----------------~~~~~~  281 (322)
T 3soc_A          223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-----SLEDMQEVVVHKKKRPVL----------------RDYWQK  281 (322)
T ss_dssp             HHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-----CHHHHHHHHTTSCCCCCC----------------CGGGGS
T ss_pred             HHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-----chhhhhhhhhcccCCCCc----------------cccccc
Confidence            99999999999999997643211000 00000000     000000000000000000                000111


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       458 ~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ...++++.+||.+||+.||++|||+.++++.
T Consensus       282 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          282 HAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             SHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2235679999999999999999999999853

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-41  Score=355.72  Aligned_cols=244  Identities=28%  Similarity=0.438  Sum_probs=200.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||+|.+. +++.||+|.+.....    ..+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            45999999999999999999876 567899999864322    2256889999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||+.|+ +.+++.                                 .....+++..+..++.|++.||.|||++||+|||
T Consensus        83 e~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  129 (267)
T 3t9t_A           83 EFMEHGCLSDYLR---------------------------------TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD  129 (267)
T ss_dssp             CCCTTCBHHHHHH---------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred             eCCCCCcHHHHHh---------------------------------hCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            999864 433332                                 1234689999999999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPY  394 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF  394 (804)
                      |||+|||++.++.+||+|||++.....     .....||+.|+|||++.   ...++.++|||||||++|||++ |++||
T Consensus       130 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~  206 (267)
T 3t9t_A          130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPY  206 (267)
T ss_dssp             CCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhc---CCCccchhchhhhHHHHHHHhccCCCCC
Confidence            999999999999999999999875422     23456788999999985   3568889999999999999999 89999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+....+..+..                                          ......+++.+.+|+.+||..
T Consensus       207 ~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~~  244 (267)
T 3t9t_A          207 ENRSNSEVVEDISTGFR------------------------------------------LYKPRLASTHVYQIMNHCWRE  244 (267)
T ss_dssp             TTCCHHHHHHHHHTTCC------------------------------------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred             CCCCHHHHHHHHhcCCc------------------------------------------CCCCccCcHHHHHHHHHHccC
Confidence            88776655544432211                                          011234578899999999999


Q ss_pred             CCCCCCCHHHHHcC
Q psy17952        475 NPADRPSSGRLLTH  488 (804)
Q Consensus       475 dP~~Rpsa~elL~H  488 (804)
                      ||++|||+.+++++
T Consensus       245 ~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          245 RPEDRPAFSRLLRQ  258 (267)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999865

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.9e-42  Score=366.11  Aligned_cols=262  Identities=25%  Similarity=0.412  Sum_probs=198.3

Q ss_pred             ccccccccccccccccceEEEE----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--
Q psy17952        161 EKIFEDLREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--  234 (804)
                      .+.|++++.||+|+||.||+|+    +..+++.||||.+....  .....+.+.+|+.+|++++||||+++++++...  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            3459999999999999999998    67789999999986432  223346788999999999999999999999876  


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ..+|+||||+.| +|.+++.                                 .....+++..+..++.|++.||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~  144 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLP---------------------------------KNKNKINLKQQLKYAVQICKGMDYLGS  144 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHH---------------------------------HHTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEEEEeCCCCcHHHHHH---------------------------------hccccCCHHHHHHHHHHHHHHHHHhhc
Confidence            678999999986 4444332                                 123468999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      +||+||||||+|||++.++.+||+|||+|.....       .....||+.|+|||++.+   ..++.++|||||||++||
T Consensus       145 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~  221 (302)
T 4e5w_A          145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ---SKFYIASDVWSFGVTLHE  221 (302)
T ss_dssp             TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHH
T ss_pred             CCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC---CCCCcchhHHHHHHHHHH
Confidence            9999999999999999999999999999975432       234578899999999853   467889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|..||...  .........   +...                      ......+...............+++++.+
T Consensus       222 l~~g~~p~~~~--~~~~~~~~~---~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  274 (302)
T 4e5w_A          222 LLTYCDSDSSP--MALFLKMIG---PTHG----------------------QMTVTRLVNTLKEGKRLPCPPNCPDEVYQ  274 (302)
T ss_dssp             HHTTTCGGGSH--HHHHHHHHC---SCCG----------------------GGHHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             HHHccCCCcch--hhHHhhccC---Cccc----------------------ccCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence            99999997432  111111110   0000                      00011111111111222234568899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~  487 (804)
                      |+.+||+.||.+|||+.++++
T Consensus       275 li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          275 LMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCHHHHHH
Confidence            999999999999999999885

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-41  Score=362.10  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=197.0

Q ss_pred             cccccccc-ccccccccceEEEE--eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        161 EKIFEDLR-EIGHGSFGAVYYAR--CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       161 ~~~y~~l~-~LG~G~fG~Vy~a~--~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .+.|++.+ .||+|+||.||+|.  ...+++.||||.+.... ......+.+.+|+.++++++||||+++++++ ..+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            34688888 99999999999995  45678999999986432 2233356788999999999999999999998 66788


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+||||+.|+ +.+++                                  ...+.+++..+..++.||+.||.|||++||
T Consensus        93 ~lv~e~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  138 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYL----------------------------------QQNRHVKDKNIIELVHQVSMGMKYLEESNF  138 (291)
T ss_dssp             EEEEECCTTEEHHHHH----------------------------------HHCTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEeCCCCCHHHHH----------------------------------HhCcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            9999999864 33322                                  234568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||++.++.+||+|||++......       ....||+.|+|||++.+   ..++.++|||||||++|||++
T Consensus       139 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~  215 (291)
T 1xbb_A          139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFS  215 (291)
T ss_dssp             ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHT
T ss_pred             EcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc---CCCChhhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999754322       12356789999999853   457889999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |+.||.+.+..+....+..+..+                                          .....+++.+.+|+
T Consensus       216 ~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li  253 (291)
T 1xbb_A          216 YGQKPYRGMKGSEVTAMLEKGERM------------------------------------------GCPAGCPREMYDLM  253 (291)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCCHHHHHHH
Confidence             99999887765554444322110                                          11235688999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q psy17952        469 SSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~  487 (804)
                      .+||..||.+|||+.++++
T Consensus       254 ~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          254 NLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999884

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.3e-41  Score=364.14  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=194.3

Q ss_pred             ccccccccccccccccceEEEEeee---ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC--
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH--  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~---~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~--  235 (804)
                      .+.|++.+.||+|+||.||+|.+..   +++.||+|.+.... ......+.+.+|+.++++++||||+++++++....  
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4569999999999999999998765   67789999986432 22344567889999999999999999999988754  


Q ss_pred             ---ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        236 ---TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       236 ---~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                         ..|+||||+.| ++.+++...                            ........+++..+..++.||+.||.||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~~i~~qi~~aL~~L  163 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYS----------------------------RLETGPKHIPLQTLLKFMVDIALGMEYL  163 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHT----------------------------TBTTSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCcccEEEEecccCCCHHHHHHHh----------------------------hhhcCCccCCHHHHHHHHHHHHHHHHHH
Confidence               45999999986 444433210                            0012345799999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      |++||+||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.   ...++.++|||||||++|
T Consensus       164 H~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~  240 (313)
T 3brb_A          164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSDVWAFGVTMW  240 (313)
T ss_dssp             HTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHH---SSCCCHHHHHHHHHHHHH
T ss_pred             HhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhc---CCCccchhhhHHHHHHHH
Confidence            999999999999999999999999999999965422      22346788999999985   456899999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        386 ELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       386 ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      ||++ |.+||.+.+.......+..+..                                          ......+++++
T Consensus       241 el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l  278 (313)
T 3brb_A          241 EIATRGMTPYPGVQNHEMYDYLLHGHR------------------------------------------LKQPEDCLDEL  278 (313)
T ss_dssp             HHHTTSCCSSTTCCGGGHHHHHHTTCC------------------------------------------CCCBTTCCHHH
T ss_pred             HHHhcCCCCCccCCHHHHHHHHHcCCC------------------------------------------CCCCccccHHH
Confidence            9999 9999977665444333322110                                          01123568899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+|+.+||..||.+|||+.+++++
T Consensus       279 ~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          279 YEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999865

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.5e-42  Score=377.94  Aligned_cols=258  Identities=19%  Similarity=0.248  Sum_probs=192.1

Q ss_pred             cccccccccccccccceEEEEeeec-----eeEEEEEecccccccchh--------hhhhHHHHHHHHhhcCCCceeEee
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVS-----REIVAIKKMSYLGKQCAE--------KWADILKEIRFLRQLKHPNTIEYR  228 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~-----~~~vAIK~i~~~~~~~~~--------~~~~~~~Ei~iL~~L~HpNIV~l~  228 (804)
                      +.|++.+.||+|+||.||+|.+..+     ++.||||.+.........        ....+.+|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4699999999999999999988765     578999987643211110        012345567778888999999999


Q ss_pred             eEEeec----CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHH
Q psy17952        229 GCYLRD----HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGV  304 (804)
Q Consensus       229 ~~~~~~----~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qi  304 (804)
                      +++...    ...|+|||||.|+|.+++.                                 ...+.+++..+..|+.||
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~---------------------------------~~~~~l~~~~~~~i~~qi  161 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYE---------------------------------ANAKRFSRKTVLQLSLRI  161 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECEEEEHHHHHH---------------------------------HTTSCCCHHHHHHHHHHH
T ss_pred             eeeeeccCCcceEEEEEeCCCCCHHHHHH---------------------------------hccCCCCHHHHHHHHHHH
Confidence            998775    4589999999555544432                                 123579999999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCCeeec--CCCcEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCC
Q psy17952        305 LRGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQY  371 (804)
Q Consensus       305 l~gL~yLH~~gIiHRDLKP~NILl~--~~g~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y  371 (804)
                      +.||+|||++||+||||||+|||++  .++.+||+|||+|+....           ....+||+.|+|||++.   +..|
T Consensus       162 ~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~  238 (364)
T 3op5_A          162 LDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN---GVAP  238 (364)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT---TCCC
T ss_pred             HHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC---CCCC
Confidence            9999999999999999999999999  889999999999964321           13456999999999985   3568


Q ss_pred             CCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCC
Q psy17952        372 DGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND  451 (804)
Q Consensus       372 ~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~  451 (804)
                      +.++|||||||++|||++|+.||.+..............              ..               ..+..+.   
T Consensus       239 ~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------------~~---------------~~~~~~~---  286 (364)
T 3op5_A          239 SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR--------------YR---------------ENIASLM---  286 (364)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHH--------------HH---------------HCHHHHH---
T ss_pred             CchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHH--------------hh---------------hhHHHHH---
Confidence            999999999999999999999997533222111111000              00               0000000   


Q ss_pred             CCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       452 ~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      .++.....+++++.+|+..||..||.+||++.++++
T Consensus       287 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          287 DKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            012223467899999999999999999999998874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-41  Score=367.19  Aligned_cols=265  Identities=25%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             cccccccccccccccccceEEEEe-----eeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~-----~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||.||+|++     ..+++.||||.+....  .......+.+|+.+++++ +||||+++++++..
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            445699999999999999999985     3577899999986432  233446788999999999 69999999999877


Q ss_pred             cC-ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        234 DH-TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       234 ~~-~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      .+ .+|+|||||.| +|.+++......                 +. ..........+..+++..+..++.|++.||.||
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~-~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  164 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNE-----------------FV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  164 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTS-----------------EE-CC-------CTTCEEHHHHHHHHHHHHHHHHHH
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccc-----------------cc-cccccchhhhccccCHHHHHHHHHHHHHHHHHH
Confidence            54 59999999986 555544310000                 00 000000011133488999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      |++||+||||||+|||++.++.+||+|||+++.....      ....||+.|+|||++.   ...++.++|||||||++|
T Consensus       165 H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~  241 (316)
T 2xir_A          165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLW  241 (316)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             HhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc---cccccchhHHHHHHHHHH
Confidence            9999999999999999999999999999999754322      2356889999999985   356889999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        386 ELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       386 ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      ||++ |..||.+.+....+........                                         .......+++++
T Consensus       242 ~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l  280 (316)
T 2xir_A          242 EIFSLGASPYPGVKIDEEFCRRLKEGT-----------------------------------------RMRAPDYTTPEM  280 (316)
T ss_dssp             HHHTTSCCSSTTCCCSHHHHHHHHHTC-----------------------------------------CCCCCTTCCHHH
T ss_pred             HHHhCCCCCCcccchhHHHHHHhccCc-----------------------------------------cCCCCCCCCHHH
Confidence            9998 9999976553332222111100                                         001123468899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+++.+||+.||.+|||+.++++|
T Consensus       281 ~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          281 YQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-41  Score=367.91  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=199.0

Q ss_pred             CCCcccccccccccccccccceEEEEeeece----eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe
Q psy17952        157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL  232 (804)
Q Consensus       157 ~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~  232 (804)
                      .+.....|++.+.||+|+||.||+|++..++    ..||||.+....  .......+.+|+.++++++||||+++++++.
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            3344556899999999999999999987653    469999886422  2334567889999999999999999999999


Q ss_pred             ecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       233 ~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      ..+..|+|||||.| ++.+++.                                 .....+++.++..++.||+.||.||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~aL~~L  163 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLR---------------------------------EKDGEFSVLQLVGMLRGIAAGMKYL  163 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHH---------------------------------HTTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcEEEEeCCCCCcHHHHHH---------------------------------hCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            99999999999987 4433331                                 1235689999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      |++||+||||||+|||++.++.+||+|||+++.....       ....||+.|+|||++.   ...++.++|||||||++
T Consensus       164 H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il  240 (333)
T 1mqb_A          164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIVM  240 (333)
T ss_dssp             HHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH---SCCCCHHHHHHHHHHHH
T ss_pred             HhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc---cCCCCchhhhHHHHHHH
Confidence            9999999999999999999999999999999754321       1235688999999984   45688999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++ |..||.+.+..+....+..+..+                                          .....+++.
T Consensus       241 ~ellt~g~~pf~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~  278 (333)
T 1mqb_A          241 WEVMTYGERPYWELSNHEVMKAINDGFRL------------------------------------------PTPMDCPSA  278 (333)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTCBHH
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHHCCCcC------------------------------------------CCcccCCHH
Confidence            99999 99999887766555444322100                                          012346889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+|+.+||+.||++|||+.+++++
T Consensus       279 l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          279 IYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=370.96  Aligned_cols=250  Identities=28%  Similarity=0.384  Sum_probs=193.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccc---hhhhhhHHHHHHHHhhc----CCCceeEeeeEEe
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC---AEKWADILKEIRFLRQL----KHPNTIEYRGCYL  232 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~---~~~~~~~~~Ei~iL~~L----~HpNIV~l~~~~~  232 (804)
                      ..+.|++.+.||+|+||.||+|++..+++.||||.+.......   ......+.+|+.+++++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3456999999999999999999999999999999986432211   12234567899999999    8999999999999


Q ss_pred             ecCceEEEEee-cCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEY-CLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       233 ~~~~~~lVmEy-~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      ..+..|+|||| +.| ++.+++                                  ...+.+++..+..++.||+.||.|
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l----------------------------------~~~~~~~~~~~~~~~~qi~~~l~~  154 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYI----------------------------------TEKGPLGEGPSRCFFGQVVAAIQH  154 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHH----------------------------------HHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCCHHHHH----------------------------------HhcCCCCHHHHHHHHHHHHHHHHH
Confidence            99999999999 554 333322                                  234568999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeec-CCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIE  386 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~-~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~E  386 (804)
                      ||++||+||||||+|||++ .++.+||+|||+++....  .....||+.|+|||++.+   ..+ +.++|||||||++||
T Consensus       155 lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~  231 (312)
T 2iwi_A          155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISR---HQYHALPATVWSLGILLYD  231 (312)
T ss_dssp             HHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHH---SCBCHHHHHHHHHHHHHHH
T ss_pred             HHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeec---CCCCCccchHHHHHHHHHH
Confidence            9999999999999999999 889999999999975433  235679999999999853   334 458999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|+.||.+...      +....                                           ......+++.+.+
T Consensus       232 l~~g~~pf~~~~~------~~~~~-------------------------------------------~~~~~~~~~~~~~  262 (312)
T 2iwi_A          232 MVCGDIPFERDQE------ILEAE-------------------------------------------LHFPAHVSPDCCA  262 (312)
T ss_dssp             HHHSSCSCCSHHH------HHHTC-------------------------------------------CCCCTTSCHHHHH
T ss_pred             HHHCCCCCCChHH------Hhhhc-------------------------------------------cCCcccCCHHHHH
Confidence            9999999964211      11000                                           0011346889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||.+||+.||++|||+.++++||||....
T Consensus       263 li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          263 LIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            99999999999999999999999998653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-41  Score=360.85  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=199.0

Q ss_pred             ccccccc-ccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLR-EIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~-~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      +.|.+.+ .||+|+||.||+|.+.  .+++.||||.+...  ......+.+.+|++++++++||||+++++++ ..+..|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            3466666 9999999999999854  46788999998643  2234456788999999999999999999999 566799


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.|+ +.+++.                                 .....+++..+..++.|++.||.|||++||+
T Consensus        86 lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  132 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLV---------------------------------GKREEIPVSNVAELLHQVSMGMKYLEEKNFV  132 (287)
T ss_dssp             EEEECCTTEEHHHHHT---------------------------------TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEeCCCCCHHHHHH---------------------------------hCCccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            999999874 322221                                 1235689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      ||||||+|||++.++.+||+|||++.....       .....||+.|+|||++.+   ..++.++|||||||++|||++ 
T Consensus       133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~  209 (287)
T 1u59_A          133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSY  209 (287)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTT
T ss_pred             eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHcC
Confidence            999999999999999999999999975432       123457899999999853   468889999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |+.||.+.+..+....+..+..+                                          .....+++++.+||.
T Consensus       210 g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~  247 (287)
T 1u59_A          210 GQKPYKKMKGPEVMAFIEQGKRM------------------------------------------ECPPECPPELYALMS  247 (287)
T ss_dssp             SCCTTTTCCTHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHhcCCcC------------------------------------------CCCCCcCHHHHHHHH
Confidence            99999877665555444332110                                          112356889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCc
Q psy17952        470 SCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp  489 (804)
                      +||..||++|||+.+++++.
T Consensus       248 ~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          248 DCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HTTCSSGGGSCCHHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999773

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=375.52  Aligned_cols=257  Identities=21%  Similarity=0.191  Sum_probs=189.7

Q ss_pred             cccccccccccccccceEEEEeee---ceeEEEEEecccccccchh--------hhhhHHHHHHHHhhcCCCceeEeeeE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAE--------KWADILKEIRFLRQLKHPNTIEYRGC  230 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~---~~~~vAIK~i~~~~~~~~~--------~~~~~~~Ei~iL~~L~HpNIV~l~~~  230 (804)
                      +.|++.+.||+|+||.||+|++..   ++..||||.+.........        ....+.+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            469999999999999999999987   8889999987643211100        12346688999999999999999999


Q ss_pred             Eee----cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHH
Q psy17952        231 YLR----DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLR  306 (804)
Q Consensus       231 ~~~----~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~  306 (804)
                      +..    ....|+|||||.|+|.++                                  +...+.+++.++..|+.||+.
T Consensus       117 ~~~~~~~~~~~~lv~e~~~~~L~~~----------------------------------l~~~~~~~~~~~~~i~~qi~~  162 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERLGIDLQKI----------------------------------SGQNGTFKKSTVLQLGIRMLD  162 (345)
T ss_dssp             EEEESSSCEEEEEEEECEEEEHHHH----------------------------------CBGGGBCCHHHHHHHHHHHHH
T ss_pred             cccccCCCcEEEEEEeccCCCHHHH----------------------------------HHhcCCCCHHHHHHHHHHHHH
Confidence            988    678999999994444332                                  223347899999999999999


Q ss_pred             HHHHHHHCCCeecCCCCCCeeecCCC--cEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCC
Q psy17952        307 GLNYLHSLGRIHRDVKAGNILLTETG--TVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDG  373 (804)
Q Consensus       307 gL~yLH~~gIiHRDLKP~NILl~~~g--~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~  373 (804)
                      ||+|||++||+||||||+|||++.++  .+||+|||+|+....           .....||+.|+|||++.   +..++.
T Consensus       163 aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  239 (345)
T 2v62_A          163 VLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK---GVALSR  239 (345)
T ss_dssp             HHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH---TCCCCH
T ss_pred             HHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc---CCCCCc
Confidence            99999999999999999999999887  999999999965321           13457999999999985   356899


Q ss_pred             cccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCC
Q psy17952        374 KVDVWSLGITCIELAERKPPYFNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT  452 (804)
Q Consensus       374 ksDIWSlGvil~ELltG~~PF~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~  452 (804)
                      ++|||||||++|||++|+.||.+.. ............                  ....|+.        +.       
T Consensus       240 ~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------------------~~~~~~~--------~~-------  286 (345)
T 2v62_A          240 RSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNL------------------LDELPQS--------VL-------  286 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHH------------------HHTTTHH--------HH-------
T ss_pred             hhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhh------------------cccccHH--------HH-------
Confidence            9999999999999999999996422 111111111000                  0000000        00       


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       453 p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .......+++++.+|+.+||..||++|||+.++++.
T Consensus       287 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          287 KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            011123578999999999999999999999998853

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-41  Score=359.22  Aligned_cols=246  Identities=28%  Similarity=0.408  Sum_probs=193.4

Q ss_pred             ccccccccccccccceEEEEeeece---eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce-E
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA-W  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~---~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~-~  238 (804)
                      .|+..+.||+|+||.||+|++..++   ..||+|.+...  ......+.+.+|+.++++++||||+++++++.+.+.. |
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            4777899999999999999976544   47999988642  2234457788999999999999999999999876655 9


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +||||+.|+ +.+++.                                 .....+++..+..++.|++.||+|||++||+
T Consensus       100 ~v~e~~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  146 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIR---------------------------------SPQRNPTVKDLISFGLQVARGMEYLAEQKFV  146 (298)
T ss_dssp             EEECCCTTCBHHHHHH---------------------------------CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEecccCCCHHHHHh---------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            999999754 333221                                 1245688999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccC--------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||||||+|||++.++.+||+|||+|+...        ......||+.|+|||++.   ...++.++|||||||++|||++
T Consensus       147 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~  223 (298)
T 3pls_A          147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ---TYRFTTKSDVWSFGVLLWELLT  223 (298)
T ss_dssp             CSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT---TCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhc---cCCCChhhchhhHHHHHHHHhh
Confidence            99999999999999999999999996432        123457899999999984   4568899999999999999999


Q ss_pred             C-CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 R-KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 G-~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      | .+||.+.+..+....+..+.                                          .......+++.+.+|+
T Consensus       224 g~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li  261 (298)
T 3pls_A          224 RGAPPYRHIDPFDLTHFLAQGR------------------------------------------RLPQPEYCPDSLYQVM  261 (298)
T ss_dssp             TSCCTTTTSCGGGHHHHHHTTC------------------------------------------CCCCCTTCCHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHhhcCC------------------------------------------CCCCCccchHHHHHHH
Confidence            5 45554444433333222211                                          0111234688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||.+|||+.++++.
T Consensus       262 ~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          262 QQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999998853

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=384.78  Aligned_cols=277  Identities=21%  Similarity=0.325  Sum_probs=204.5

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC--ceE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH--TAW  238 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~--~~~  238 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+.....  ....+.+.+|+++|++++||||+++++++...+  ..|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            4569999999999999999999999999999999864322  223456789999999999999999999998765  789


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.|+ +.+++.                               .......+++..+..++.||+.||+|||++||+
T Consensus        86 lv~e~~~~g~L~~~l~-------------------------------~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  134 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLE-------------------------------EPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV  134 (396)
T ss_dssp             EEECCCTTEEHHHHTT-------------------------------SGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEecCCCCCHHHHHH-------------------------------hhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            999999864 333221                               001223489999999999999999999999999


Q ss_pred             ecCCCCCCeee----cCCCcEEEEecccccccCC---CCccccCcccccchhhcccC-----CCCCCCcccHHHHHHHHH
Q psy17952        318 HRDVKAGNILL----TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       318 HRDLKP~NILl----~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~-----~~~y~~ksDIWSlGvil~  385 (804)
                      ||||||+|||+    +.++.+||+|||+|+....   ....+||+.|+|||++.+..     ...|+.++|||||||++|
T Consensus       135 H~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~  214 (396)
T 4eut_A          135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY  214 (396)
T ss_dssp             CCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHH
T ss_pred             ECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHH
Confidence            99999999999    7778899999999976433   23567999999999985310     135678999999999999


Q ss_pred             HHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCcc
Q psy17952        386 ELAERKPPYFNM----NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS  461 (804)
Q Consensus       386 ELltG~~PF~~~----~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s  461 (804)
                      ||++|+.||...    ...+.+..+..+..+...    ..+....   .. +-.+.          .....++.....++
T Consensus       215 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~---~~-~~~~~----------~~~~~~~~l~~~~~  276 (396)
T 4eut_A          215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI----SGVQKAE---NG-PIDWS----------GDMPVSCSLSRGLQ  276 (396)
T ss_dssp             HHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC----EEEECST---TC-CEEEE----------SSCCTTCSSCHHHH
T ss_pred             HHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc----hhheecc---CC-CcccC----------ccCCcccccchHHH
Confidence            999999999642    334556666554432111    0000000   00 00000          00011112223457


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        462 DTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+.+|+.+||++||++|||+.+++++
T Consensus       277 ~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          277 VLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             hhchHHHHHhhccChhhhccHHHHHHH
Confidence            789999999999999999999998653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.3e-41  Score=390.60  Aligned_cols=247  Identities=22%  Similarity=0.366  Sum_probs=202.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ....|++.+.||+|+||.||+|++..++..||||.+....    ...+.+.+|+.+|++++|||||++++++.....+|+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3456899999999999999999999999999999986432    234678999999999999999999999999999999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.| +|.+++..                                .....+++..+..++.||+.||+|||++||+|
T Consensus       294 v~E~~~~g~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH  341 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRE--------------------------------CNRQEVSAVVLLYMATQISSAMEYLEKKNFIH  341 (495)
T ss_dssp             EEECCTTCBHHHHHHH--------------------------------SCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEccCCCCHHHHHHh--------------------------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9999985 44443320                                12345889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+|||++.++.+||+|||+|+....     .....+|+.|+|||++.   .+.|+.++|||||||++|||++ |..
T Consensus       342 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlG~~l~el~t~g~~  418 (495)
T 1opk_A          342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMS  418 (495)
T ss_dssp             SCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh---cCCCCcHHhHHhHHHHHHHHHhCCCC
Confidence            99999999999999999999999976432     12345678999999985   3568999999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+..+.                                          .......+++.+.+||.+||
T Consensus       419 p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~cl  456 (495)
T 1opk_A          419 PYPGIDLSQVYELLEKDY------------------------------------------RMERPEGCPEKVYELMRACW  456 (495)
T ss_dssp             SSTTCCGGGHHHHHHTTC------------------------------------------CCCCCTTCCHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHHHcCC------------------------------------------CCCCCCCCCHHHHHHHHHHc
Confidence            998766544333322110                                          01112356889999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      +.||++|||+.++++
T Consensus       457 ~~dP~~RPs~~el~~  471 (495)
T 1opk_A          457 QWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CcChhHCcCHHHHHH
Confidence            999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-41  Score=362.51  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=185.7

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhh--cCCCceeEeeeEEeec----
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ--LKHPNTIEYRGCYLRD----  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIV~l~~~~~~~----  234 (804)
                      .+.|++++.||+|+||.||+|++  +++.||||++...      ....+.+|.+++..  ++||||+++++++...    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            45699999999999999999976  6889999987532      12345567777666  8999999999986553    


Q ss_pred             CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH-
Q psy17952        235 HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH-  312 (804)
Q Consensus       235 ~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH-  312 (804)
                      ...|+|||||.|+ |.+++                                   +...+++..+..++.|++.||+||| 
T Consensus        79 ~~~~lv~e~~~~g~L~~~l-----------------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~  123 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYL-----------------------------------QLTTLDTVSCLRIVLSIASGLAHLHI  123 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHH-----------------------------------TTCCBCHHHHHHHHHHHHHHHHHHHS
T ss_pred             ceeEEehhhccCCCHHHHH-----------------------------------hhcccCHHHHHHHHHHHHHHHHHHHH
Confidence            4589999999864 33322                                   2346899999999999999999999 


Q ss_pred             -------HCCCeecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCC---CCCCc
Q psy17952        313 -------SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEG---QYDGK  374 (804)
Q Consensus       313 -------~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~---~y~~k  374 (804)
                             ++||+||||||+|||++.++.+||+|||+|+....        ....+||+.|+|||++.+....   .++.+
T Consensus       124 ~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  203 (301)
T 3q4u_A          124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR  203 (301)
T ss_dssp             CBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHH
T ss_pred             hhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCch
Confidence                   99999999999999999999999999999965322        2235899999999998532110   34468


Q ss_pred             ccHHHHHHHHHHHHhC----------CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHH
Q psy17952        375 VDVWSLGITCIELAER----------KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL  444 (804)
Q Consensus       375 sDIWSlGvil~ELltG----------~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l  444 (804)
                      +|||||||++|||++|          .+||.+.....               .....+..........++.         
T Consensus       204 ~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~---------  259 (301)
T 3q4u_A          204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND---------------PSFEDMRKVVCVDQQRPNI---------  259 (301)
T ss_dssp             HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS---------------CCHHHHHHHHTTSCCCCCC---------
T ss_pred             hhHHHHHHHHHHHHhhhcCccccccccccccccCCCC---------------cchhhhhHHHhccCCCCCC---------
Confidence            9999999999999999          77875432100               0000000000000000000         


Q ss_pred             HhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        445 YHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       445 ~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                             .+.......++++.+|+.+||+.||++|||+.++++.
T Consensus       260 -------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          260 -------PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             -------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             -------ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                   0000112356789999999999999999999999853

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.3e-41  Score=384.60  Aligned_cols=244  Identities=24%  Similarity=0.367  Sum_probs=196.2

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-ceE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-TAW  238 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-~~~  238 (804)
                      ..+.|++.+.||+|+||.||+|...  ++.||||.++...     ..+.+.+|+.+|++++|||||++++++.... ..|
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            4456999999999999999999764  7799999986421     3467899999999999999999999987665 799


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.| +|.+++..                                .....+++..+..++.||+.||+|||++||+
T Consensus       264 iv~e~~~~g~L~~~l~~--------------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv  311 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRS--------------------------------RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV  311 (450)
T ss_dssp             EEEECCTTCBHHHHHHH--------------------------------HCTTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEecCCCcHHHHHHh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            99999986 44444321                                0122478999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||||||+|||++.++.+||+|||+|+.... .....+|+.|+|||++.   ...|+.++|||||||++|||++ |..||.
T Consensus       312 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~t~g~~P~~  388 (450)
T 1k9a_A          312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYP  388 (450)
T ss_dssp             CSCCCGGGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHH---SSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999999975432 22346789999999985   4578999999999999999998 999998


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+..+....+.++..                                          ...+..+++++.+||.+||..|
T Consensus       389 ~~~~~~~~~~i~~~~~------------------------------------------~~~p~~~~~~l~~li~~cl~~d  426 (450)
T 1k9a_A          389 RIPLKDVVPRVEKGYK------------------------------------------MDAPDGCPPAVYDVMKNCWHLD  426 (450)
T ss_dssp             TSCTTTHHHHHHTTCC------------------------------------------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHHHHHcCCC------------------------------------------CCCCCcCCHHHHHHHHHHcCCC
Confidence            7655444433322110                                          0112356899999999999999


Q ss_pred             CCCCCCHHHHHc
Q psy17952        476 PADRPSSGRLLT  487 (804)
Q Consensus       476 P~~Rpsa~elL~  487 (804)
                      |++|||+.+++.
T Consensus       427 p~~Rpt~~~l~~  438 (450)
T 1k9a_A          427 AATRPTFLQLRE  438 (450)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhHCcCHHHHHH
Confidence            999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1e-41  Score=371.04  Aligned_cols=262  Identities=27%  Similarity=0.429  Sum_probs=199.6

Q ss_pred             ccccccccccccccccceEEEE----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe--ec
Q psy17952        161 EKIFEDLREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL--RD  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~--~~  234 (804)
                      .+.|++++.||+|+||.||+|+    +..+++.||||++...   .....+.+.+|++++++++||||+++++++.  ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            3469999999999999999998    5678999999998643   2344567889999999999999999999887  45


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ...|+|||||.| +|.+++..                                 ....+++..+..++.|++.||.|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~---------------------------------~~~~~~~~~~~~i~~qi~~al~~lH~  145 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQR---------------------------------HRARLDASRLLLYSSQICKGMEYLGS  145 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHH---------------------------------HGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEEEeecCCCCHHHHHHh---------------------------------cccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            568999999975 44443321                                 12358899999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      +||+||||||+|||++.++.+||+|||++.....       .....||+.|+|||++.+   ..++.++|||||||++||
T Consensus       146 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~  222 (327)
T 3lxl_A          146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD---NIFSRQSDVWSFGVVLYE  222 (327)
T ss_dssp             TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH---CEEEHHHHHHHHHHHHHH
T ss_pred             CCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhcc---CCCChHHhHHHHHHHHHH
Confidence            9999999999999999999999999999975432       223568899999999853   467889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|..||........  ......                    ...+     ....+...............+++.+.+
T Consensus       223 ll~g~~p~~~~~~~~~--~~~~~~--------------------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~  275 (327)
T 3lxl_A          223 LFTYCDKSCSPSAEFL--RMMGCE--------------------RDVP-----ALSRLLELLEEGQRLPAPPACPAEVHE  275 (327)
T ss_dssp             HHTTTCGGGSHHHHHH--HHCC------------------------CC-----HHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             HHhCCCCCccccchhh--hhcccc--------------------cccc-----cHHHHHHHhhcccCCCCCCcccHHHHH
Confidence            9999999965322111  000000                    0000     001111111111222234567999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~H  488 (804)
                      |+.+||+.||++|||+.+++++
T Consensus       276 li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          276 LMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.4e-41  Score=384.77  Aligned_cols=246  Identities=22%  Similarity=0.387  Sum_probs=200.3

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.+.|++.+.||+|+||.||+|.+. ++..||||.+....    ...+.+.+|+.+|++++|||||++++++. ....|
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34567999999999999999999875 46679999986432    23467899999999999999999999986 66789


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.| +|.+++...                                ....+++..+..++.||+.||+|||++||+
T Consensus       259 lv~e~~~~g~L~~~l~~~--------------------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv  306 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSD--------------------------------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI  306 (454)
T ss_dssp             EEECCCTTCBHHHHHHSH--------------------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEeecCCCcHHHHHHhc--------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            99999975 554443210                                112578889999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      ||||||+|||++.++.+||+|||+|+....     .....+|+.|+|||++.   .+.|+.++|||||||++|||++ |+
T Consensus       307 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~t~g~  383 (454)
T 1qcf_A          307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGR  383 (454)
T ss_dssp             CSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc---cCCCCcHHHHHhHHHHHHHHHhCCC
Confidence            999999999999999999999999975432     22345778999999985   3568999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||.+.+..+....+..+...                                          .....+++++.+||.+|
T Consensus       384 ~P~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~~c  421 (454)
T 1qcf_A          384 IPYPGMSNPEVIRALERGYRM------------------------------------------PRPENCPEELYNIMMRC  421 (454)
T ss_dssp             CSSTTCCHHHHHHHHHHTCCC------------------------------------------CCCTTSCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCCHHHHHHHHHH
Confidence            999888776665555332110                                          01234688999999999


Q ss_pred             cccCCCCCCCHHHHHc
Q psy17952        472 LAKNPADRPSSGRLLT  487 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~  487 (804)
                      |..||++|||+.+++.
T Consensus       422 l~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          422 WKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHHH
Confidence            9999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4e-41  Score=357.90  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=196.6

Q ss_pred             ccccccccccccccccceEEEEeee---ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLV---SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~---~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .+.|++.+.||+|+||.||+|++..   ++..||+|.+....  .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            3459999999999999999998654   45679999886432  23345678899999999999999999999865 567


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+||||+.|+ +.+++.                                 .....+++..+..++.|++.||.|||++||
T Consensus        88 ~~v~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  134 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLE---------------------------------RNKNSLKVLTLVLYSLQICKAMAYLESINC  134 (281)
T ss_dssp             EEEEECCTTCBHHHHHH---------------------------------HHTTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEEecCCCCCHHHHHH---------------------------------hccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999999864 433332                                 123458999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      +||||||+|||++.++.+||+|||++......     ....||+.|+|||++.   ...++.++|||||||++|||++ |
T Consensus       135 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~llt~g  211 (281)
T 3cc6_A          135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN---FRRFTTASDVWMFAVCMWEILSFG  211 (281)
T ss_dssp             CCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             ccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhc---cCCCCchhccHHHHHHHHHHHhCC
Confidence            99999999999999999999999998754321     2346788999999984   3568899999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      +.||...+..+....+..+..                                          ......+++.+.+|+.+
T Consensus       212 ~~p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~  249 (281)
T 3cc6_A          212 KQPFFWLENKDVIGVLEKGDR------------------------------------------LPKPDLCPPVLYTLMTR  249 (281)
T ss_dssp             CCTTTTSCGGGHHHHHHHTCC------------------------------------------CCCCTTCCHHHHHHHHH
T ss_pred             CCCcccCChHHHHHHHhcCCC------------------------------------------CCCCCCCCHHHHHHHHH
Confidence            999976655444333322110                                          01123467899999999


Q ss_pred             hcccCCCCCCCHHHHHcC
Q psy17952        471 CLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~H  488 (804)
                      ||..||++|||+.+++++
T Consensus       250 ~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          250 CWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCCchhCcCHHHHHHH
Confidence            999999999999999965

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=369.62  Aligned_cols=246  Identities=25%  Similarity=0.389  Sum_probs=192.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEE----EEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIV----AIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~v----AIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ..|++++.||+|+||.||+|++..+++.|    |+|.+...  ........+.+|+.++++++||||+++++++.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            45999999999999999999998888765    55655322  12234467889999999999999999999998754 7


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ++||||+.++ +.+.+.                                 .....+++..+..++.||+.||.|||++||
T Consensus        92 ~~v~~~~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  138 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVR---------------------------------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL  138 (327)
T ss_dssp             EEEECCCSSCBHHHHHH---------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             eEEEEecCCCcHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Confidence            8899998754 333221                                 124568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      +||||||+|||++.++.+||+|||+|+.....      ....||+.|+|||++.+   ..|+.++|||||||++|||++ 
T Consensus       139 vH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~  215 (327)
T 3lzb_A          139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTF  215 (327)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC---CCCChHHHHHHHHHHHHHHHHC
Confidence            99999999999999999999999999754321      23457889999999853   568999999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||.+.+..+....+..+.                                          .......++.++.+|+.
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~  253 (327)
T 3lzb_A          216 GSKPYDGIPASEISSILEKGE------------------------------------------RLPQPPICTIDVYMIMR  253 (327)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTC------------------------------------------CCCCCTTBCHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCC------------------------------------------CCCCCccCCHHHHHHHH
Confidence            999998766544433332211                                          01112346889999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||+.||.+|||+.++++.
T Consensus       254 ~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          254 KCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHH
Confidence            9999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=368.07  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=196.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee----cCce
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR----DHTA  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----~~~~  237 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||.+...   .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4699999999999999999999999999999988542   23445678899999999999999999999873    4578


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||.| +|.+++..                              .......+++.++..++.||+.||.|||++||
T Consensus       106 ~lv~e~~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i  155 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIER------------------------------LKDKGNFLTEDQILWLLLGICRGLEAIHAKGY  155 (317)
T ss_dssp             EEEEECCTTCBHHHHHHH------------------------------HHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEeCCCCcHHHHHHH------------------------------HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            999999986 55444321                              01124578999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-------------CccccCcccccchhhcccCCCCCCCcccHHHHHHH
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  383 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvi  383 (804)
                      +||||||+|||++.++.+||+|||++......             ....||+.|+|||++.+.....++.++|||||||+
T Consensus       156 vH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  235 (317)
T 2buj_A          156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV  235 (317)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred             ccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998653211             12457999999999854322347889999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       384 l~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      +|||++|+.||......        ..         .....+.                       ..........++++
T Consensus       236 l~el~~g~~p~~~~~~~--------~~---------~~~~~~~-----------------------~~~~~~~~~~~~~~  275 (317)
T 2buj_A          236 LYAMMFGEGPYDMVFQK--------GD---------SVALAVQ-----------------------NQLSIPQSPRHSSA  275 (317)
T ss_dssp             HHHHHHSSCTTHHHHHT--------TS---------CHHHHHH-----------------------CC--CCCCTTSCHH
T ss_pred             HHHHHhCCCChhhhhcc--------cc---------hhhHHhh-----------------------ccCCCCccccCCHH
Confidence            99999999999421000        00         0000000                       00011122457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCc
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~Hp  489 (804)
                      +.+||.+||+.||.+|||+.+++++-
T Consensus       276 l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          276 LWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            99999999999999999999999873

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-41  Score=369.59  Aligned_cols=262  Identities=24%  Similarity=0.374  Sum_probs=202.9

Q ss_pred             ccccccccccccccccceEEEEeeecee-----EEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeec
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSRE-----IVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRD  234 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~-----~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~  234 (804)
                      .+.|++.+.||+|+||.||+|.+..+++     .||+|.+....  .....+.+.+|+.+|+++ +||||+++++++...
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            4569999999999999999999876654     79999886432  233456788999999999 899999999999999


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      +..|+|||||.| +|.+++......                  ..  ....+......+++..+..++.||+.||.|||+
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~--~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  182 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRV------------------LE--TDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS  182 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHH------------------HS--CC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CceEEEEecCCCCcHHHHHHHhccc------------------cc--ccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            999999999986 666655421000                  00  000011123568999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      +||+||||||+|||++.++.+||+|||+|+....      .....||+.|+|||++.+   ..++.++|||||||++|||
T Consensus       183 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el  259 (333)
T 2i1m_A          183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEI  259 (333)
T ss_dssp             TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHH
T ss_pred             CCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc---CCCChHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999975322      123567889999999853   5688999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |.+||.+......+..+.....                                         ........++.+.+
T Consensus       260 ~t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~  298 (333)
T 2i1m_A          260 FSLGLNPYPGILVNSKFYKLVKDGY-----------------------------------------QMAQPAFAPKNIYS  298 (333)
T ss_dssp             TTTSCCSSTTCCSSHHHHHHHHHTC-----------------------------------------CCCCCTTCCHHHHH
T ss_pred             HcCCCCCCcccchhHHHHHHHhcCC-----------------------------------------CCCCCCCCCHHHHH
Confidence            98 9999987654443333322110                                         00112335788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q psy17952        467 FVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~H  488 (804)
                      |+.+||+.||.+|||+.+++++
T Consensus       299 li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          299 IMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccChhhCcCHHHHHHH
Confidence            9999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.4e-41  Score=358.27  Aligned_cols=248  Identities=22%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeE-EeecCceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGC-YLRDHTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~-~~~~~~~~l  239 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+....     ....+.+|+.+++.++|+|++..+.. +...+..|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            356999999999999999999999999999999764321     22457899999999998887765554 466778899


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+.|++.+++.                                 .....+++.++..++.||+.||.|||++||+||
T Consensus        83 v~e~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~  129 (296)
T 4hgt_A           83 VMELLGPSLEDLFN---------------------------------FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR  129 (296)
T ss_dssp             EEECCCCBHHHHHH---------------------------------HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEccCCCHHHHHH---------------------------------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999666655442                                 123468999999999999999999999999999


Q ss_pred             CCCCCCeee---cCCCcEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        320 DVKAGNILL---TETGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       320 DLKP~NILl---~~~g~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      ||||+|||+   +.++.+||+|||+|+....           .....||+.|+|||++.   +..++.++|||||||++|
T Consensus       130 Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~  206 (296)
T 4hgt_A          130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYVLM  206 (296)
T ss_dssp             CCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT---TCCCCHHHHHHHHHHHHH
T ss_pred             CCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc---CCCCCchhHHHHHHHHHH
Confidence            999999999   7889999999999975322           12468999999999985   356889999999999999


Q ss_pred             HHHhCCCCCCCCChHH---HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        386 ELAERKPPYFNMNAMS---ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       386 ELltG~~PF~~~~~~~---~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ||++|+.||.+.+...   .+..+..                   ....                   .........+++
T Consensus       207 ~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------~~~~-------------------~~~~~~~~~~~~  248 (296)
T 4hgt_A          207 YFNLGSLPWQGLKAATKRQKYERISE-------------------KKMS-------------------TPIEVLCKGYPS  248 (296)
T ss_dssp             HHHHSSCTTSSCCCSSSSSHHHHHHH-------------------HHHH-------------------SCHHHHTTTSCH
T ss_pred             HHhcCCCCCcccchhhhhhhhhhhhc-------------------cccc-------------------chhhhhhccCCH
Confidence            9999999997643211   1111100                   0000                   000011235689


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      ++.+|+.+||+.||++|||++++++
T Consensus       249 ~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          249 EFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            9999999999999999999999885

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6e-41  Score=359.28  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=193.4

Q ss_pred             ccccccccccccccccceEEEEeeece---eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEE-eecCc
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCY-LRDHT  236 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~---~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~-~~~~~  236 (804)
                      ...|++.+.||+|+||.||+|++..++   ..||+|.+...  ......+.+.+|+.++++++||||+++++++ ..++.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            345999999999999999999875433   46899987642  2334456788999999999999999999985 45668


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .|+||||+.| +|.+++.                                 .....+++..+..++.|++.||.|||++|
T Consensus       102 ~~~v~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~  148 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIR---------------------------------NETHNPTVKDLIGFGLQVAKGMKYLASKK  148 (298)
T ss_dssp             CEEEEECCTTCBHHHHHH---------------------------------CTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEeCCCCCCHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            8999999987 4433331                                 12356889999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |+||||||+|||++.++.+||+|||+|+....        .....||+.|+|||++.+   ..++.++|||||||++|||
T Consensus       149 i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l  225 (298)
T 3f66_A          149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWEL  225 (298)
T ss_dssp             CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC---CCCChHHHHHHHHHHHHHH
Confidence            99999999999999999999999999964321        234568899999999853   5688999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        388 AE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       388 lt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      ++ |.+||.+.+..+....+..+.                                          .......+++.+.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~  263 (298)
T 3f66_A          226 MTRGAPPYPDVNTFDITVYLLQGR------------------------------------------RLLQPEYCPDPLYE  263 (298)
T ss_dssp             HTTSCCSSTTSCTTTHHHHHHTTC------------------------------------------CCCCCTTCCHHHHH
T ss_pred             HhCCCCCCccCCHHHHHHHHhcCC------------------------------------------CCCCCccCCHHHHH
Confidence            99 667776655443333332211                                          11112346789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~  487 (804)
                      |+.+||..||.+|||+.++++
T Consensus       264 li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          264 VMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999885

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.6e-41  Score=357.46  Aligned_cols=243  Identities=27%  Similarity=0.462  Sum_probs=197.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--------  233 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--------  233 (804)
                      ..|++++.||+|+||.||+|++..+++.||+|.+....       ..+.+|++++++++||||+++++++..        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            45999999999999999999999999999999886421       356789999999999999999998864        


Q ss_pred             --------cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHH
Q psy17952        234 --------DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGV  304 (804)
Q Consensus       234 --------~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qi  304 (804)
                              ....|+|||||.| +|.+++..                                .....+++..+..++.||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi  131 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--------------------------------RRGEKLDKVLALELFEQI  131 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHH--------------------------------GGGSCCCHHHHHHHHHHH
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhh--------------------------------ccCCCCCHHHHHHHHHHH
Confidence                    4558999999986 55444321                                123468999999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHH
Q psy17952        305 LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  381 (804)
Q Consensus       305 l~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlG  381 (804)
                      +.||.|||++||+||||||+|||++.++.+||+|||++.....   .....||+.|+|||++.   ...++.++||||||
T Consensus       132 ~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG  208 (284)
T 2a19_B          132 TKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALG  208 (284)
T ss_dssp             HHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH---CSCCCTHHHHHHHH
T ss_pred             HHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhc---cCCCcchhhhHHHH
Confidence            9999999999999999999999999999999999999875433   23467999999999985   35688999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCcc
Q psy17952        382 ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS  461 (804)
Q Consensus       382 vil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s  461 (804)
                      |++|||++|..||....  .....+..                                         .    .....++
T Consensus       209 ~il~~l~~~~~~~~~~~--~~~~~~~~-----------------------------------------~----~~~~~~~  241 (284)
T 2a19_B          209 LILAELLHVCDTAFETS--KFFTDLRD-----------------------------------------G----IISDIFD  241 (284)
T ss_dssp             HHHHHHHSCCSSHHHHH--HHHHHHHT-----------------------------------------T----CCCTTSC
T ss_pred             HHHHHHHhcCCcchhHH--HHHHHhhc-----------------------------------------c----cccccCC
Confidence            99999999999874211  00000000                                         0    0113467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        462 DTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      ..+.+||.+||..||.+|||+.++++|.+...
T Consensus       242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            88999999999999999999999999977543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-41  Score=369.00  Aligned_cols=269  Identities=25%  Similarity=0.343  Sum_probs=196.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||+|++ .+++.||||++......  .....+.+|+.++++++||||+++++++...+..|+||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  106 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY  106 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred             hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence            4599999999999999999974 46889999998653221  22235789999999999999999999999999999999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCe
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL---GRI  317 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~---gIi  317 (804)
                      |||.| ++.+++..                              .......+++..+..++.|++.||.|||++   ||+
T Consensus       107 e~~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  156 (326)
T 3uim_A          107 PYMANGSVASCLRE------------------------------RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII  156 (326)
T ss_dssp             ECCTTCBHHHHHHC------------------------------CSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEE
T ss_pred             EeccCCCHHHHHHh------------------------------ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Confidence            99986 44443320                              011234589999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      ||||||+|||++.++.+||+|||+|+.....     ....||+.|+|||++.+   ..++.++|||||||++|||++|+.
T Consensus       157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~  233 (326)
T 3uim_A          157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQR  233 (326)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH---SEECHHHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc---CCCCccccchhHHHHHHHHHhCCC
Confidence            9999999999999999999999999754321     23569999999999853   468899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.....       ....    .......+....... ...            ...............+..+.+|+.+||
T Consensus       234 pf~~~~~-------~~~~----~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl  289 (326)
T 3uim_A          234 AFDLARL-------ANDD----DVMLLDWVKGLLKEK-KLE------------ALVDVDLQGNYKDEEVEQLIQVALLCT  289 (326)
T ss_dssp             SBCHHHH-------TTTS----CSBHHHHHTTTTSSC-CST------------TSSCTTCTTSCCHHHHHHHHHHHHHHT
T ss_pred             ccccccc-------cccc----chhHHHHHHHHhhch-hhh------------hhcChhhccccCHHHHHHHHHHHHHHh
Confidence            9952100       0000    000000000000000 000            000000111112234678999999999


Q ss_pred             ccCCCCCCCHHHHHcCcc
Q psy17952        473 AKNPADRPSSGRLLTHDL  490 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~  490 (804)
                      +.||.+|||+.++++|-.
T Consensus       290 ~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          290 QSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CSCGGGSCCHHHHHHHHH
T ss_pred             CcCCccCCCHHHHHHHhc
Confidence            999999999999998853

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.6e-41  Score=354.27  Aligned_cols=245  Identities=24%  Similarity=0.424  Sum_probs=197.1

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|++++.||+|+||.||+|.+. +++.||||.+....    ...+.+.+|+++|++++||||+++++++. ++..|+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence            4467999999999999999999865 56789999886432    12356889999999999999999999886 456899


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.| +|.+++..                                .....+++.++..++.|++.||.|||++||+|
T Consensus        85 v~e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  132 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKT--------------------------------PSGIKLTINKLLDMAAQIAEGMAFIEERNYIH  132 (279)
T ss_dssp             EEECCTTCBHHHHTTS--------------------------------HHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCCCCHHHHHhc--------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            9999975 44333210                                01125889999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~  392 (804)
                      |||||+|||++.++.+||+|||++......     ....||+.|+|||++.   .+.++.++|||||||++|||++ |..
T Consensus       133 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~g~~  209 (279)
T 1qpc_A          133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRI  209 (279)
T ss_dssp             SCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999754321     2346788999999985   3568889999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+....+..+..                                          ......+++++.+|+.+||
T Consensus       210 p~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l  247 (279)
T 1qpc_A          210 PYPGMTNPEVIQNLERGYR------------------------------------------MVRPDNCPEELYQLMRLCW  247 (279)
T ss_dssp             SSTTCCHHHHHHHHHTTCC------------------------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred             CCcccCHHHHHHHHhcccC------------------------------------------CCCcccccHHHHHHHHHHh
Confidence            9988776655544432210                                          0112356889999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy17952        473 AKNPADRPSSGRLLT  487 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~  487 (804)
                      ..||++|||+.++++
T Consensus       248 ~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          248 KERPEDRPTFDYLRS  262 (279)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             ccChhhCCCHHHHHH
Confidence            999999999999885

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.5e-41  Score=357.09  Aligned_cols=248  Identities=22%  Similarity=0.284  Sum_probs=193.9

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeE-EeecCceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGC-YLRDHTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~-~~~~~~~~l  239 (804)
                      .+.|++.+.||+|+||.||+|++..+++.||||.+....     ....+.+|+.+++.++|+|++..+.. +...+..|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            346999999999999999999999999999999875422     12457899999999999887765554 466777899


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+.|++.+++.                                 .....+++.++..++.||+.||.|||++||+||
T Consensus        83 v~e~~~~~L~~~~~---------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  129 (296)
T 3uzp_A           83 VMELLGPSLEDLFN---------------------------------FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR  129 (296)
T ss_dssp             EEECCCCBHHHHHH---------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEecCCCHHHHHH---------------------------------hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            99999666655442                                 123468999999999999999999999999999


Q ss_pred             CCCCCCeee---cCCCcEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        320 DVKAGNILL---TETGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       320 DLKP~NILl---~~~g~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      ||||+|||+   +.++.+||+|||+|+....           .....||+.|+|||++.   +..++.++|||||||++|
T Consensus       130 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~  206 (296)
T 3uzp_A          130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYVLM  206 (296)
T ss_dssp             CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHH
T ss_pred             CCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhc---CCCCCcchhhHHHHHHHH
Confidence            999999999   4889999999999965322           23467999999999985   356889999999999999


Q ss_pred             HHHhCCCCCCCCChH---HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        386 ELAERKPPYFNMNAM---SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       386 ELltG~~PF~~~~~~---~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ||++|+.||.+.+..   ..+..+...                   ....                   ........+++
T Consensus       207 ~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------~~~~-------------------~~~~~~~~~~~  248 (296)
T 3uzp_A          207 YFNLGSLPWQGLKAATKRQKYERISEK-------------------KMST-------------------PIEVLCKGYPS  248 (296)
T ss_dssp             HHHHSSCTTSSCCCSSSSSHHHHHHHH-------------------HHHS-------------------CHHHHTTTSCH
T ss_pred             HHHhCCCCCCCcCchhhhhhhhhhccc-------------------ccCC-------------------chHHHHhhCCH
Confidence            999999999764311   111111100                   0000                   00001235789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      ++.+|+.+||+.||++|||+.++++
T Consensus       249 ~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          249 EFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            9999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.7e-41  Score=358.23  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=191.5

Q ss_pred             ccccccccccccccccceEEEEeee-c--eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLV-S--REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~-~--~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      .+.|++.+.||+|+||.||+|++.. +  +..||||.+...........+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3469999999999999999998653 2  3469999886543333445677899999999999999999999998765 8


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      ++||||+.| ++.+.+.                                 .....+++..+..++.|++.||.|||++||
T Consensus        96 ~~v~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  142 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLR---------------------------------KHQGHFLLGTLSRYAVQVAEGMGYLESKRF  142 (291)
T ss_dssp             EEEEECCTTCBHHHHHH---------------------------------HHGGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eeeEecccCCCHHHHHH---------------------------------hccCCcCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            999999985 4433332                                 112458899999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||++.++.+||+|||++......       ....||+.|+|||++.+   ..++.++|||||||++|||++
T Consensus       143 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~  219 (291)
T 1u46_A          143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT---RTFSHASDTWMFGVTLWEMFT  219 (291)
T ss_dssp             ECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcC---CCCCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999998754321       23467889999999853   457889999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |+.||.+.+..+.+..+......                                         ......+++++.+++
T Consensus       220 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~l~~li  258 (291)
T 1u46_A          220 YGQEPWIGLNGSQILHKIDKEGER-----------------------------------------LPRPEDCPQDIYNVM  258 (291)
T ss_dssp             TSCCTTTTCCHHHHHHHHHTSCCC-----------------------------------------CCCCTTCCHHHHHHH
T ss_pred             CCCCCcccCCHHHHHHHHHccCCC-----------------------------------------CCCCcCcCHHHHHHH
Confidence             99999887776655554332110                                         011235688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||..||++|||+.+++++
T Consensus       259 ~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          259 VQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHH
Confidence            99999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-41  Score=374.19  Aligned_cols=246  Identities=26%  Similarity=0.393  Sum_probs=188.4

Q ss_pred             ccccccccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEe-ecCceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYL-RDHTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~-~~~~~~  238 (804)
                      .|++.+.||+|+||.||+|....+   +..||+|.+...  ......+.+.+|+.+|++++|||||++++++. .++..|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            488899999999999999987643   357899988642  22344577899999999999999999999865 456889


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.|+ |.+++.                                 .....+++.++..++.||+.||.|||++||+
T Consensus       168 lv~e~~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  214 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIR---------------------------------NETHNPTVKDLIGFGLQVAKGMKFLASKKFV  214 (373)
T ss_dssp             EEEECCTTCBHHHHHH---------------------------------CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEECCCCCCHHHHHh---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            999999864 433321                                 1234578999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      ||||||+|||++.++.+||+|||+|+....        .....||+.|+|||++.   ...|+.++|||||||++|||++
T Consensus       215 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~il~ellt  291 (373)
T 3c1x_A          215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMT  291 (373)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhc---CCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999974321        12346788999999985   3578999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        390 -RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       390 -G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                       |.+||.+.+..+....+.++.                                          .......+++.+.+|+
T Consensus       292 ~~~~p~~~~~~~~~~~~~~~~~------------------------------------------~~~~p~~~~~~l~~li  329 (373)
T 3c1x_A          292 RGAPPYPDVNTFDITVYLLQGR------------------------------------------RLLQPEYCPDPLYEVM  329 (373)
T ss_dssp             TSCCSCTTSCSSCHHHHHHTTC------------------------------------------CCCCCTTCCHHHHHHH
T ss_pred             CcCCCCCCCCHHHHHHHHHcCC------------------------------------------CCCCCCCCCHHHHHHH
Confidence             788887655433333332211                                          0111234688999999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q psy17952        469 SSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+||+.||++|||+.+++++
T Consensus       330 ~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          330 LKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=358.02  Aligned_cols=242  Identities=30%  Similarity=0.504  Sum_probs=185.0

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++.+.||+|+||.||+|++  .++.||||.+...     ...+.+.+|+++|++++||||+++++++.  +..|+||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence            4589999999999999999976  4778999988532     23467889999999999999999999886  4589999


Q ss_pred             eecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCe
Q psy17952        242 EYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS---LGRI  317 (804)
Q Consensus       242 Ey~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~---~gIi  317 (804)
                      ||+.| ++.+++..                               ......+++..+..++.|+++||.|||+   +||+
T Consensus        79 e~~~~~~L~~~l~~-------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~iv  127 (307)
T 2eva_A           79 EYAEGGSLYNVLHG-------------------------------AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI  127 (307)
T ss_dssp             ECCTTCBHHHHHHC-------------------------------SSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCC
T ss_pred             EcCCCCCHHHHHhc-------------------------------cCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Confidence            99986 44443320                               0011247889999999999999999999   8999


Q ss_pred             ecCCCCCCeeecCCCc-EEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        318 HRDVKAGNILLTETGT-VKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       318 HRDLKP~NILl~~~g~-vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||||+|||++.++. +||+|||++..... .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.
T Consensus       128 H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~  204 (307)
T 2eva_A          128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE---GSNYSEKCDVFSWGIILWEVITRRKPFD  204 (307)
T ss_dssp             CCCCSGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHHT---CCCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred             cCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhhC---CCCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence            9999999999998886 79999999965432 33457999999999984   4578999999999999999999999997


Q ss_pred             CCCh--HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        396 NMNA--MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       396 ~~~~--~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      ....  ......+..+.                                         .+ .....+++.+.+|+.+||+
T Consensus       205 ~~~~~~~~~~~~~~~~~-----------------------------------------~~-~~~~~~~~~l~~li~~~l~  242 (307)
T 2eva_A          205 EIGGPAFRIMWAVHNGT-----------------------------------------RP-PLIKNLPKPIESLMTRCWS  242 (307)
T ss_dssp             TTCSSHHHHHHHHHTTC-----------------------------------------CC-CCBTTCCHHHHHHHHHHTC
T ss_pred             hhCccHHHHHHHHhcCC-----------------------------------------CC-CcccccCHHHHHHHHHHhc
Confidence            5422  11111111110                                         00 1123468899999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .||++|||+++++++
T Consensus       243 ~dp~~Rps~~ell~~  257 (307)
T 2eva_A          243 KDPSQRPSMEEIVKI  257 (307)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999854

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.5e-41  Score=359.29  Aligned_cols=265  Identities=27%  Similarity=0.374  Sum_probs=198.3

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccc-cchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGK-QCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~-~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      +....|...+.||+|+||.||+|.+  +++.||||++..... ......+.+.+|+.++++++||||+++++++.+.+..
T Consensus        28 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  105 (307)
T 2nru_A           28 DERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL  105 (307)
T ss_dssp             CCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence            3444567779999999999999986  678999998864321 2233456788999999999999999999999999999


Q ss_pred             EEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+||||+.| ++.+++.                               ......++++..+..++.|++.||.|||++||
T Consensus       106 ~lv~e~~~~~~L~~~l~-------------------------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  154 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLS-------------------------------CLDGTPPLSWHMRCKIAQGAANGINFLHENHH  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHH-------------------------------TGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEecCCCcHHHHHH-------------------------------hccCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            999999975 4433332                               01123568999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      +||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.    +.++.++|||||||++|||++|
T Consensus       155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~Dv~slG~il~~l~~g  230 (307)
T 2nru_A          155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR----GEITPKSDIYSFGVVLLEIITG  230 (307)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT----TEECTHHHHHHHHHHHHHHHHC
T ss_pred             ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc----CCCCccchhHHHHHHHHHHHHC
Confidence            9999999999999999999999999875432      23457999999999884    3588899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .+||.+.+....+..+..               .+...    .+.        +....... ........++.+.+++.+
T Consensus       231 ~~p~~~~~~~~~~~~~~~---------------~~~~~----~~~--------~~~~~~~~-~~~~~~~~~~~l~~li~~  282 (307)
T 2nru_A          231 LPAVDEHREPQLLLDIKE---------------EIEDE----EKT--------IEDYIDKK-MNDADSTSVEAMYSVASQ  282 (307)
T ss_dssp             CCSBCTTBSSSBTTHHHH---------------HHHTT----SCC--------HHHHSCSS-CSCCCHHHHHHHHHHHHH
T ss_pred             CCCcccCcchHHHHHHHH---------------Hhhhh----hhh--------hhhhcccc-ccccchHHHHHHHHHHHH
Confidence            999976432211111110               00000    000        00000000 001122356789999999


Q ss_pred             hcccCCCCCCCHHHHHcC
Q psy17952        471 CLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~H  488 (804)
                      ||..||.+|||+.+++++
T Consensus       283 cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          283 CLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HTCSSTTTSCCHHHHHHH
T ss_pred             HcCCCcccCcCHHHHHHH
Confidence            999999999999999865

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-40  Score=380.21  Aligned_cols=246  Identities=25%  Similarity=0.403  Sum_probs=196.7

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.+.|++.+.||+|+||.||+|.+..+ ..||||.+....    ...+.+.+|+++|++++||||+++++++.+ +..|
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            3456799999999999999999988654 569999986432    123568999999999999999999999876 7789


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.| +|.+++..                                .....+++.++..++.||+.||+|||++||+
T Consensus       255 iv~e~~~~gsL~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv  302 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKG--------------------------------ETGKYLRLPQLVDMAAQIASGMAYVERMNYV  302 (452)
T ss_dssp             EEECCCTTCBHHHHHSH--------------------------------HHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEehhhcCCCHHHHHHh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            99999986 44443320                                0124588999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      ||||||+|||++.++.+||+|||+|+....     .....+|+.|+|||++.   .+.|+.++|||||||++|||++ |+
T Consensus       303 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~t~g~  379 (452)
T 1fmk_A          303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGR  379 (452)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHh---cCCCCccccHHhHHHHHHHHHhCCC
Confidence            999999999999999999999999975432     12345778999999985   3578999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||.+.+..+.+..+..+..+                                          ..+..+++.+.+||.+|
T Consensus       380 ~P~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~~c  417 (452)
T 1fmk_A          380 VPYPGMVNREVLDQVERGYRM------------------------------------------PCPPECPESLHDLMCQC  417 (452)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTSCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCCHHHHHHHHHH
Confidence            999888776665554332110                                          11235688999999999


Q ss_pred             cccCCCCCCCHHHHHc
Q psy17952        472 LAKNPADRPSSGRLLT  487 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~  487 (804)
                      |+.||++|||++++++
T Consensus       418 l~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          418 WRKEPEERPTFEYLQA  433 (452)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             ccCChhhCcCHHHHHH
Confidence            9999999999999885

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-40  Score=354.10  Aligned_cols=243  Identities=24%  Similarity=0.368  Sum_probs=188.8

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-CceEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-HTAWL  239 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-~~~~l  239 (804)
                      .+.|++.+.||+|+||.||+|.+  +++.||||.+...     ...+.+.+|+.++++++||||+++++++... +..|+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            35699999999999999999976  4889999988632     1346688999999999999999999987554 57999


Q ss_pred             EEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.| ++.+++...                                ....+++..+..++.|++.||.|||++||+|
T Consensus        93 v~e~~~~~~L~~~l~~~--------------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  140 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSR--------------------------------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH  140 (278)
T ss_dssp             EECCCTTEEHHHHHHHH--------------------------------HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEecCCCCCHHHHHHhc--------------------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9999986 555544210                                0123788999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFN  396 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~  396 (804)
                      |||||+|||++.++.+||+|||++..... .....+|+.|+|||++.   ...++.++|||||||++|||++ |.+||..
T Consensus       141 ~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~t~g~~p~~~  217 (278)
T 1byg_A          141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPR  217 (278)
T ss_dssp             SCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             cCCCcceEEEeCCCcEEEeeccccccccccccCCCccccccCHHHhC---CCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999875433 23456889999999985   3568899999999999999998 9999976


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+....+.++.                                          .......+++.+.+++.+||..||
T Consensus       218 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p  255 (278)
T 1byg_A          218 IPLKDVVPRVEKGY------------------------------------------KMDAPDGCPPAVYEVMKNCWHLDA  255 (278)
T ss_dssp             SCGGGHHHHHTTTC------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             CCHHHHHHHHhcCC------------------------------------------CCCCcccCCHHHHHHHHHHhcCCh
Confidence            65443333322110                                          011123568899999999999999


Q ss_pred             CCCCCHHHHHc
Q psy17952        477 ADRPSSGRLLT  487 (804)
Q Consensus       477 ~~Rpsa~elL~  487 (804)
                      ++|||+.++++
T Consensus       256 ~~Rps~~~l~~  266 (278)
T 1byg_A          256 AMRPSFLQLRE  266 (278)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hhCCCHHHHHH
Confidence            99999999885

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=368.45  Aligned_cols=250  Identities=19%  Similarity=0.277  Sum_probs=192.4

Q ss_pred             cccccccccccccccceEEEEeeec--------eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeE-------
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVS--------REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE-------  226 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~--------~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~-------  226 (804)
                      +.|++.+.||+|+||.||+|++..+        ++.||||.+...        +.+.+|++++++++|||||+       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            5699999999999999999999874        889999987532        35789999999999999998       


Q ss_pred             --------eeeEEee-cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHH
Q psy17952        227 --------YRGCYLR-DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEI  297 (804)
Q Consensus       227 --------l~~~~~~-~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i  297 (804)
                              +++++.. +...|+|||||.|+|.+++..                                .....+++.++
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--------------------------------~~~~~l~~~~~  161 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV--------------------------------SPKHVLSERSV  161 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHH--------------------------------SGGGCCCHHHH
T ss_pred             CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHh--------------------------------CCcCCCCHHHH
Confidence                    5666665 678899999995565554431                                01256899999


Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCC--cEEEEecccccccCC-----------CCccccCcccccchhhc
Q psy17952        298 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG--TVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVIL  364 (804)
Q Consensus       298 ~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g--~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~  364 (804)
                      ..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+....           .....||+.|+|||++.
T Consensus       162 ~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  241 (352)
T 2jii_A          162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK  241 (352)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc
Confidence            99999999999999999999999999999999998  999999999965321           12358999999999984


Q ss_pred             ccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHH
Q psy17952        365 AMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA  443 (804)
Q Consensus       365 ~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~  443 (804)
                         +..++.++|||||||++|||++|+.||.+.. ....+......               ..   ...++.        
T Consensus       242 ---~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------~~---~~~~~~--------  292 (352)
T 2jii_A          242 ---GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQK---------------FV---DKPGPF--------  292 (352)
T ss_dssp             ---TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHH---------------HH---HSCCCE--------
T ss_pred             ---cCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHh---------------cc---CChhhh--------
Confidence               3568999999999999999999999997653 22222211110               00   000000        


Q ss_pred             HHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       444 l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                             ...+.....+++++.+|+.+||+.||++|||+.++++
T Consensus       293 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          293 -------VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             -------ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -------hhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence                   0011112346899999999999999999999999884

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-40  Score=393.75  Aligned_cols=240  Identities=23%  Similarity=0.340  Sum_probs=193.3

Q ss_pred             cccccccccceEEEEe--eeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        168 REIGHGSFGAVYYARC--LVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~--~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      ++||+|+||.||+|.+  ..+++.||||+++... ......+.+.+|+++|++++|||||++++++. .+..|+|||||.
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence            4799999999999954  4677899999886432 22334567899999999999999999999986 456899999998


Q ss_pred             CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        246 GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       246 G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      |+.                                 |.+++...+.+++..+..|+.||+.||+|||++|||||||||+|
T Consensus       453 ~g~---------------------------------L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~N  499 (635)
T 4fl3_A          453 LGP---------------------------------LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN  499 (635)
T ss_dssp             TEE---------------------------------HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCC---------------------------------HHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHh
Confidence            651                                 22222334578999999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        326 ILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      ||++.++.+||+|||+|+.....       ....||+.|+|||++.   ...|+.++|||||||++|||++ |+.||.+.
T Consensus       500 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~---~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~  576 (635)
T 4fl3_A          500 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  576 (635)
T ss_dssp             EEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             EEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999754321       2345788999999985   3578999999999999999998 99999988


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+..+..+                                          .....+++++.+||.+||+.||+
T Consensus       577 ~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~l~~li~~cl~~dP~  614 (635)
T 4fl3_A          577 KGSEVTAMLEKGERM------------------------------------------GCPAGCPREMYDLMNLCWTYDVE  614 (635)
T ss_dssp             CHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHHHHHcCCCC------------------------------------------CCCCCCCHHHHHHHHHHcCCCHh
Confidence            877666555433211                                          01234688999999999999999


Q ss_pred             CCCCHHHHHc
Q psy17952        478 DRPSSGRLLT  487 (804)
Q Consensus       478 ~Rpsa~elL~  487 (804)
                      +|||++++++
T Consensus       615 ~RPs~~~l~~  624 (635)
T 4fl3_A          615 NRPGFAAVEL  624 (635)
T ss_dssp             TSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-41  Score=383.18  Aligned_cols=258  Identities=16%  Similarity=0.135  Sum_probs=192.8

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC-Ccee-------------
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH-PNTI-------------  225 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV-------------  225 (804)
                      +...|...+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++| +|+.             
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            33458888999999999999999999999999998874444444446778999999999987 3211             


Q ss_pred             --E------eeeEEee-----cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCC
Q psy17952        226 --E------YRGCYLR-----DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPL  292 (804)
Q Consensus       226 --~------l~~~~~~-----~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l  292 (804)
                        .      +..++..     ....+++|+++.|++.++++...                           ......+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~---------------------------~~~~~~~~l  208 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL---------------------------SHSSTHKSL  208 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCSEEHHHHHHHHH---------------------------HHTTTSHHH
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhh---------------------------cccccCCCC
Confidence              1      1111111     23468899998888877664210                           001123356


Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhccc-----
Q psy17952        293 KEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAM-----  366 (804)
Q Consensus       293 ~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~-----  366 (804)
                      ++..+..++.||++||+|||++|||||||||+|||++.++.+||+|||+|+.... ....+| +.|||||++...     
T Consensus       209 ~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~  287 (413)
T 3dzo_A          209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFG  287 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTG
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccc
Confidence            7888999999999999999999999999999999999999999999999875432 345678 999999998421     


Q ss_pred             --CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHH
Q psy17952        367 --DEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL  444 (804)
Q Consensus       367 --~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l  444 (804)
                        ....|+.++|||||||++|||++|+.||.+.+......                                        
T Consensus       288 ~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------------------------------  327 (413)
T 3dzo_A          288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE----------------------------------------  327 (413)
T ss_dssp             GGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------------------------------
T ss_pred             cccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------------------------------
Confidence              23457889999999999999999999996543211000                                        


Q ss_pred             HhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy17952        445 YHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       445 ~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~  492 (804)
                       .+..      ....+++++.+||.+||+.||++|||+.++|+||||.
T Consensus       328 -~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~  368 (413)
T 3dzo_A          328 -WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  368 (413)
T ss_dssp             -GGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             -HHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence             0000      1124678999999999999999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.7e-41  Score=371.03  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=186.4

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEeccccccc-----chhhhhhHHHHHHHHhhcC---------CCcee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-----CAEKWADILKEIRFLRQLK---------HPNTI  225 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~~~Ei~iL~~L~---------HpNIV  225 (804)
                      +.+.|++++.||+|+||+||+|++  +++.||||++......     .....+.+.+|+.+|+.++         |||||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            345699999999999999999987  7899999998754221     2223467889999999886         66666


Q ss_pred             EeeeE-----------------Eee-------------cCceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhh
Q psy17952        226 EYRGC-----------------YLR-------------DHTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLK  274 (804)
Q Consensus       226 ~l~~~-----------------~~~-------------~~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~  274 (804)
                      ++.++                 |.+             .+.+|+|||||.|+ +.+.                       
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~-----------------------  152 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQ-----------------------  152 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGG-----------------------
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHH-----------------------
Confidence            66554                 333             67899999999875 2221                       


Q ss_pred             hhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCeeecCCC--------------------c
Q psy17952        275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH-SLGRIHRDVKAGNILLTETG--------------------T  333 (804)
Q Consensus       275 ~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH-~~gIiHRDLKP~NILl~~~g--------------------~  333 (804)
                                 . .++.+++..++.|+.||+.||+||| ++|||||||||+|||++.++                    .
T Consensus       153 -----------~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~  220 (336)
T 2vuw_A          153 -----------M-RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQ  220 (336)
T ss_dssp             -----------G-TTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEE
T ss_pred             -----------H-HhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCce
Confidence                       1 1246899999999999999999999 99999999999999999887                    8


Q ss_pred             EEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHhcCC
Q psy17952        334 VKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT-CIELAERKPPYFNMNAMS-ALYHIAQNDT  411 (804)
Q Consensus       334 vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvi-l~ELltG~~PF~~~~~~~-~l~~I~~~~~  411 (804)
                      +||+|||+|+.... ...+||+.|||||++.+    ..+.++||||+|++ .+++++|..||.+..... ....+.....
T Consensus       221 vkL~DFG~a~~~~~-~~~~gt~~y~aPE~~~g----~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~  295 (336)
T 2vuw_A          221 VSIIDYTLSRLERD-GIVVFCDVSMDEDLFTG----DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT  295 (336)
T ss_dssp             EEECCCTTCBEEET-TEEECCCCTTCSGGGCC----CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC
T ss_pred             EEEeeccccEecCC-CcEEEeecccChhhhcC----CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc
Confidence            99999999986543 35689999999999853    33779999998877 788999999984321101 1111111000


Q ss_pred             CCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHH-cCcc
Q psy17952        412 PCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL-THDL  490 (804)
Q Consensus       412 p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL-~Hp~  490 (804)
                                     .  ...+                   +......+|+++.+||.+||++|     |++|+| +|||
T Consensus       296 ---------------~--~~~~-------------------~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          296 ---------------F--KTKC-------------------NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             ---------------C--SSCC-------------------CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred             ---------------c--Cccc-------------------chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence                           0  0000                   00001235889999999999987     999999 9999


Q ss_pred             cc
Q psy17952        491 VT  492 (804)
Q Consensus       491 ~~  492 (804)
                      |+
T Consensus       335 f~  336 (336)
T 2vuw_A          335 FK  336 (336)
T ss_dssp             GC
T ss_pred             cC
Confidence            84

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-40  Score=360.28  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=193.9

Q ss_pred             cccccccccccccceEEEE----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec--Cce
Q psy17952        164 FEDLREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD--HTA  237 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~--~~~  237 (804)
                      |++++.||+|+||.||+|.    +..+++.||||++...  ......+.+.+|+++|++++||||+++++++.+.  ..+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            5999999999999997764    4458899999998643  2234456789999999999999999999999874  578


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||.|+ +.+++                                   ....+++..+..++.||+.||.|||++||
T Consensus       111 ~lv~e~~~~~~L~~~l-----------------------------------~~~~~~~~~~~~i~~~l~~~l~~LH~~~i  155 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYL-----------------------------------PRHSIGLAQLLLFAQQICEGMAYLHAQHY  155 (318)
T ss_dssp             EEEECCCTTCBHHHHG-----------------------------------GGSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEecccCCcHHHHH-----------------------------------hhCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            9999999864 33322                                   12358999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +||||||+|||++.++.+||+|||++......       ....||+.|+|||++.+   ..++.++|||||||++|||++
T Consensus       156 vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~  232 (318)
T 3lxp_A          156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE---YKFYYASDVWSFGVTLYELLT  232 (318)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHT
T ss_pred             cCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcC---CCCCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999754322       23568899999999853   467889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |..||.......  .......     .   .                 ......+...............+++++.+||.
T Consensus       233 g~~p~~~~~~~~--~~~~~~~-----~---~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  285 (318)
T 3lxp_A          233 HCDSSQSPPTKF--LELIGIA-----Q---G-----------------QMTVLRLTELLERGERLPRPDKCPAEVYHLMK  285 (318)
T ss_dssp             TTCGGGSHHHHH--HHHHCSC-----C---H-----------------HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             CCCcccccchhh--hhhhccc-----c---c-----------------chhHHHHHHHHhcccCCCCCccccHHHHHHHH
Confidence            999996432111  0000000     0   0                 00000011111111222234567899999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q psy17952        470 SCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~  487 (804)
                      +||+.||++|||+.++++
T Consensus       286 ~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          286 NCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHH
Confidence            999999999999999984

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=369.97  Aligned_cols=244  Identities=15%  Similarity=0.148  Sum_probs=188.8

Q ss_pred             ccccccccccccccccceEEE-----EeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC---CCceeEeeeEEe
Q psy17952        161 EKIFEDLREIGHGSFGAVYYA-----RCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK---HPNTIEYRGCYL  232 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a-----~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~~~~~  232 (804)
                      .+.|++.+.||+|+||.||+|     .+..+++.||||.+...      ....+.+|+++++.++   |+||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            356999999999999999999     46778999999988642      1235677888887776   999999999999


Q ss_pred             ecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        233 RDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       233 ~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      ..+..|+|||||.| +|.+++...                             .......+++..+..|+.||+.||+||
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~-----------------------------~~~~~~~l~~~~~~~i~~qi~~~L~~l  188 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLY-----------------------------KNTPEKVMPQGLVISFAMRMLYMIEQV  188 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHH-----------------------------HTSTTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHh-----------------------------hcccccCCCHHHHHHHHHHHHHHHHHH
Confidence            99999999999985 555544310                             001245699999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecC-----------CCcEEEEecccccccC------CCCccccCcccccchhhcccCCCCCCCc
Q psy17952        312 HSLGRIHRDVKAGNILLTE-----------TGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGK  374 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~-----------~g~vKL~DFGla~~~~------~~~~~~GT~~Y~APEvl~~~~~~~y~~k  374 (804)
                      |++|||||||||+|||++.           ++.+||+|||+|+...      .....+||+.|||||++.   +..|+.+
T Consensus       189 H~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~  265 (365)
T 3e7e_A          189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS---NKPWNYQ  265 (365)
T ss_dssp             HTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT---TCCBSTH
T ss_pred             hhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc---CCCCCcc
Confidence            9999999999999999998           8999999999996432      123568999999999985   3568999


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCC
Q psy17952        375 VDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPC  454 (804)
Q Consensus       375 sDIWSlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~  454 (804)
                      +|||||||++|||++|+.||......                 .+.    +                       .   ..
T Consensus       266 ~DiwslG~il~elltg~~pf~~~~~~-----------------~~~----~-----------------------~---~~  298 (365)
T 3e7e_A          266 IDYFGVAATVYCMLFGTYMKVKNEGG-----------------ECK----P-----------------------E---GL  298 (365)
T ss_dssp             HHHHHHHHHHHHHHHSSCCCEEEETT-----------------EEE----E-----------------------C---SC
T ss_pred             ccHHHHHHHHHHHHhCCCccccCCCC-----------------cee----e-----------------------c---hh
Confidence            99999999999999999999532110                 000    0                       0   00


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy17952        455 LQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHD  489 (804)
Q Consensus       455 ~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp  489 (804)
                      ......++.+.+++..||..+|.+|++..+.+.+.
T Consensus       299 ~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            00112367889999999999999997766666553

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=358.51  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=196.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|++.+.||+|+||.||+|++..   .||+|.+..... .....+.+.+|+.++++++||||+++++++...+..|+
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            44569999999999999999998653   499998864322 22334567889999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||+.|+ +.+++.                                 .....+++..+..++.||+.||.|||++||+|
T Consensus       107 v~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H  153 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVR---------------------------------DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH  153 (319)
T ss_dssp             ECBCCCSEEHHHHTT---------------------------------SSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EeecccCCcHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999864 322211                                 12346899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccC---------CCCccccCcccccchhhcccC------CCCCCCcccHHHHHHH
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKC---------PANSFVGTPYWMAPEVILAMD------EGQYDGKVDVWSLGIT  383 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~---------~~~~~~GT~~Y~APEvl~~~~------~~~y~~ksDIWSlGvi  383 (804)
                      |||||+|||++ ++.+||+|||+++...         ......||+.|+|||++.+..      ...|+.++|||||||+
T Consensus       154 ~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i  232 (319)
T 2y4i_B          154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI  232 (319)
T ss_dssp             CCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred             cCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence            99999999998 6899999999986432         112346999999999985421      2357889999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       384 l~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      +|||++|+.||.+.+.......+..+..+                                         ......++.+
T Consensus       233 l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~  271 (319)
T 2y4i_B          233 WYELHAREWPFKTQPAEAIIWQMGTGMKP-----------------------------------------NLSQIGMGKE  271 (319)
T ss_dssp             HHHHHHSSCSSSSCCHHHHHHHHHTTCCC-----------------------------------------CCCCSSCCTT
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHhccCCCC-----------------------------------------CCCcCCCCHH
Confidence            99999999999887766555544332111                                         1112245778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +.+|+.+||..||++|||+.++++.
T Consensus       272 l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          272 ISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=388.29  Aligned_cols=238  Identities=24%  Similarity=0.347  Sum_probs=191.8

Q ss_pred             ccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecCC
Q psy17952        169 EIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       169 ~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      .||+|+||.||+|.+.  .++..||||.++...  .....+.+.+|+++|++++|||||++++++.. +..|+|||||.|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            7999999999999876  456789999986432  22345678999999999999999999999876 569999999987


Q ss_pred             C-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        247 S-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       247 ~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      + |.+++.                                 .....+++..+..++.||+.||+|||++|||||||||+|
T Consensus       420 g~L~~~l~---------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  466 (613)
T 2ozo_A          420 GPLHKFLV---------------------------------GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARN  466 (613)
T ss_dssp             CBHHHHHT---------------------------------TCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CcHHHHHh---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHH
Confidence            5 322221                                 124568999999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        326 ILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      ||++.++.+||+|||+|+.....       ....+|+.|+|||++.   .+.|+.++|||||||++|||++ |+.||.+.
T Consensus       467 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~---~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~  543 (613)
T 2ozo_A          467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  543 (613)
T ss_dssp             EEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999754321       1234668999999985   3578999999999999999998 99999887


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+.++..+                                          .....+++++.+||.+||..||+
T Consensus       544 ~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~l~~li~~cl~~dP~  581 (613)
T 2ozo_A          544 KGPEVMAFIEQGKRM------------------------------------------ECPPECPPELYALMSDCWIYKWE  581 (613)
T ss_dssp             CSHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHHHTTCSSTT
T ss_pred             CHHHHHHHHHcCCCC------------------------------------------CCCCcCCHHHHHHHHHHcCCChh
Confidence            776665555432210                                          11234688999999999999999


Q ss_pred             CCCCHHHHHc
Q psy17952        478 DRPSSGRLLT  487 (804)
Q Consensus       478 ~Rpsa~elL~  487 (804)
                      +|||+.++++
T Consensus       582 ~RPs~~~l~~  591 (613)
T 2ozo_A          582 DRPDFLTVEQ  591 (613)
T ss_dssp             TSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999873

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=360.20  Aligned_cols=252  Identities=25%  Similarity=0.427  Sum_probs=183.9

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhh--cCCCceeEeeeEEeec---
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ--LKHPNTIEYRGCYLRD---  234 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIV~l~~~~~~~---  234 (804)
                      ..+.|++.+.||+|+||.||+|++.  ++.||||.+...      ......+|.+++..  ++||||+++++++...   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3457999999999999999999864  889999987532      11334556666655  4999999999999887   


Q ss_pred             -CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        235 -HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       235 -~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                       ...|+|||||.| +|.+++.                                   ...+++..+..++.|++.||.|||
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~-----------------------------------~~~~~~~~~~~i~~~i~~~l~~lH  151 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLK-----------------------------------STTLDAKSMLKLAYSSVSGLCHLH  151 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHH-----------------------------------HCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEeccCCCcHHHHhh-----------------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Confidence             679999999986 4433331                                   236889999999999999999999


Q ss_pred             HC--------CCeecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCC---
Q psy17952        313 SL--------GRIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDG---  373 (804)
Q Consensus       313 ~~--------gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~---  373 (804)
                      ++        ||+||||||+|||++.++.+||+|||+|+....        ....+||+.|+|||++.+   ..++.   
T Consensus       152 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~  228 (337)
T 3mdy_A          152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE---SLNRNHFQ  228 (337)
T ss_dssp             SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT---CCCTTCTH
T ss_pred             HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc---ccCCcccc
Confidence            99        999999999999999999999999999964322        124689999999999853   23333   


Q ss_pred             ---cccHHHHHHHHHHHHhC----------CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhh
Q psy17952        374 ---KVDVWSLGITCIELAER----------KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA  440 (804)
Q Consensus       374 ---ksDIWSlGvil~ELltG----------~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~  440 (804)
                         ++|||||||++|||++|          ..||......               ...+..+..........+..     
T Consensus       229 ~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~-----  288 (337)
T 3mdy_A          229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS---------------DPSYEDMREIVCIKKLRPSF-----  288 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS---------------SCCHHHHHHHHTTSCCCCCC-----
T ss_pred             CccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC---------------CCchhhhHHHHhhhccCccc-----
Confidence               39999999999999999          4454332100               00000010000000000000     


Q ss_pred             hHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       441 ~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                                 ........+++++.+|+.+||+.||++|||+.++++|
T Consensus       289 -----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          289 -----------PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             -----------CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -----------cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                       0001122457889999999999999999999999976

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.3e-40  Score=353.24  Aligned_cols=240  Identities=23%  Similarity=0.346  Sum_probs=183.9

Q ss_pred             Ccccccccc-cccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHH-hhcCCCceeEeeeEEee---
Q psy17952        159 DPEKIFEDL-REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL-RQLKHPNTIEYRGCYLR---  233 (804)
Q Consensus       159 dp~~~y~~l-~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIV~l~~~~~~---  233 (804)
                      .....|.++ +.||+|+||.||+|.+..+++.||||.+..        ...+.+|+.++ +.++||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            344457777 779999999999999999999999998752        13467899888 56689999999999887   


Q ss_pred             -cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        234 -DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       234 -~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                       ....|+|||||.| +|.+++..                                .....+++..+..++.|++.||.||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~--------------------------------~~~~~~~~~~~~~i~~qi~~~l~~l  133 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQD--------------------------------RGDQAFTEREASEIMKSIGEAIQYL  133 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHH--------------------------------CTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEEeecCCCcHHHHHHh--------------------------------ccCCCCCHHHHHHHHHHHHHHHHHH
Confidence             6789999999986 44443320                                1124689999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecC---CCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~---~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |++||+||||||+|||++.   ++.+||+|||+|....                     ...|+.++|||||||++|||+
T Consensus       134 H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~  192 (299)
T 3m2w_A          134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILL  192 (299)
T ss_dssp             HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHH
T ss_pred             HhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHHHHHHHHHH
Confidence            9999999999999999998   7899999999986422                     234778999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|.+||.+.+.......+..               .+.    ..                ....+......+++++.+||
T Consensus       193 tg~~pf~~~~~~~~~~~~~~---------------~~~----~~----------------~~~~~~~~~~~~~~~~~~li  237 (299)
T 3m2w_A          193 CGYPPFYSNHGLAISPGMKT---------------RIR----MG----------------QYEFPNPEWSEVSEEVKMLI  237 (299)
T ss_dssp             HSSCSCCC-------CCSCC---------------SSC----TT----------------CCSSCHHHHTTSCHHHHHHH
T ss_pred             HCCCCCCCCcchhhhHHHHH---------------HHh----hc----------------cccCCchhcccCCHHHHHHH
Confidence            99999976543221100000               000    00                00001111135789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||+.||.+|||+.|+|+||||...
T Consensus       238 ~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          238 RNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHHcccChhhCCCHHHHhcChhhccc
Confidence            99999999999999999999999764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7e-40  Score=381.70  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=200.4

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .+.+.|++.+.||+|+||.||+|.+..+ ..||||++....    ...+.+.+|+++|++++|||||++++++.+ +..|
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            3456699999999999999999987654 569999986432    123568999999999999999999999876 7789


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.| +|.+++..                                .....+++.++..|+.||+.||+|||++|||
T Consensus       338 lv~e~~~~gsL~~~l~~--------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv  385 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKG--------------------------------ETGKYLRLPQLVDMAAQIASGMAYVERMNYV  385 (535)
T ss_dssp             EEECCCTTEEHHHHHSH--------------------------------HHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EeeehhcCCcHHHHHhh--------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            99999986 44443320                                0124588999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      ||||||+|||++.++.+||+|||+++....     .....+|+.|+|||++.   .+.|+.++|||||||++|||++ |+
T Consensus       386 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~t~g~  462 (535)
T 2h8h_A          386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGR  462 (535)
T ss_dssp             CSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTTC
T ss_pred             CCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhc---cCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999975432     22345788999999985   3578999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||.+.+..+.+..+..+..                                          ......+++.+.+||.+|
T Consensus       463 ~P~~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~l~~li~~c  500 (535)
T 2h8h_A          463 VPYPGMVNREVLDQVERGYR------------------------------------------MPCPPECPESLHDLMCQC  500 (535)
T ss_dssp             CSSTTCCHHHHHHHHHTTCC------------------------------------------CCCCTTCCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCCHHHHHHHHHH
Confidence            99988877666555433210                                          001235688999999999


Q ss_pred             cccCCCCCCCHHHHHcC
Q psy17952        472 LAKNPADRPSSGRLLTH  488 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~H  488 (804)
                      |+.||++|||+.+++..
T Consensus       501 l~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          501 WRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             cCCChhHCcCHHHHHHH
Confidence            99999999999998853

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-40  Score=355.63  Aligned_cols=262  Identities=26%  Similarity=0.427  Sum_probs=196.8

Q ss_pred             ccccccccccccccccceEEEE----eeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-
Q psy17952        161 EKIFEDLREIGHGSFGAVYYAR----CLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~----~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-  235 (804)
                      .+.|++++.||+|+||.||+|+    +..+++.||||++...   .....+.+.+|+.++++++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            3459999999999999999998    4678999999998642   2344567899999999999999999999987654 


Q ss_pred             -ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        236 -TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       236 -~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                       ..|+||||+.| +|.+++.                                 .....+++..+..++.||+.||.|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~aL~~LH~  163 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQ---------------------------------KHKERIDHIKLLQYTSQICKGMEYLGT  163 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHH---------------------------------HSTTSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CceEEEEECCCCCCHHHHHH---------------------------------hcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence             78999999986 5444332                                 123458999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      +||+||||||+|||++.++.+||+|||+++.....       ....||+.|+|||++.+   ..++.++|||||||++||
T Consensus       164 ~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~e  240 (326)
T 2w1i_A          164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYE  240 (326)
T ss_dssp             TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHH
T ss_pred             CCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC---CCCCchhhHHHHHHHHHH
Confidence            99999999999999999999999999999754322       23457888999999853   457889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|..||....  ............    ..+                    ....+...............+++++.+
T Consensus       241 l~tg~~~~~~~~--~~~~~~~~~~~~----~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~  294 (326)
T 2w1i_A          241 LFTYIEKSKSPP--AEFMRMIGNDKQ----GQM--------------------IVFHLIELLKNNGRLPRPDGCPDEIYM  294 (326)
T ss_dssp             HHHTTCGGGSHH--HHHHHHHCTTCC----THH--------------------HHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             HHhcCCCCCCCH--HHHHHhhccccc----hhh--------------------hHHHHHHHhhcCCCCCCCCcccHHHHH
Confidence            999999985321  111111110000    000                    000011111111111223467899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q psy17952        467 FVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~elL~  487 (804)
                      ||.+||+.||++|||+.++++
T Consensus       295 li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          295 IMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999884

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-39  Score=374.52  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=194.7

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC-CceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH-PNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~~~~~~~~~~~lV  240 (804)
                      +.|++.+.||+|+||.||+|++..+++.||||++....     ....+.+|+++++.|+| ++|..+..++...+..|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            46999999999999999999999999999999865322     12457899999999987 4555666667778889999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|+|.+++..                                 ..+.+++.++..|+.||+.||+|||++||||||
T Consensus        82 me~~g~sL~~ll~~---------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrD  128 (483)
T 3sv0_A           82 MDLLGPSLEDLFNF---------------------------------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD  128 (483)
T ss_dssp             EECCCCBHHHHHHH---------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             EECCCCCHHHHHHh---------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence            99997766555431                                 134689999999999999999999999999999


Q ss_pred             CCCCCeee---cCCCcEEEEecccccccCCC-----------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        321 VKAGNILL---TETGTVKLADFGSASIKCPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       321 LKP~NILl---~~~g~vKL~DFGla~~~~~~-----------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      |||+||||   +.++.+||+|||+|+.....           ...+||+.|+|||++.   ...++.++|||||||++||
T Consensus       129 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDvwSlGvil~e  205 (483)
T 3sv0_A          129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL---GIEQSRRDDLESLGYVLMY  205 (483)
T ss_dssp             CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHH
T ss_pred             cCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc---CCCCChHHHHHHHHHHHHH
Confidence            99999999   68899999999999753321           2568999999999985   3568999999999999999


Q ss_pred             HHhCCCCCCCCCh---HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        387 LAERKPPYFNMNA---MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       387 LltG~~PF~~~~~---~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |++|+.||.+...   ...+..+....              +.     .       .   +.         .....++++
T Consensus       206 lltG~~Pf~~~~~~~~~~~~~~i~~~~--------------~~-----~-------~---~~---------~l~~~~p~~  247 (483)
T 3sv0_A          206 FLRGSLPWQGLKAGTKKQKYEKISEKK--------------VA-----T-------S---IE---------ALCRGYPTE  247 (483)
T ss_dssp             HHHSSCTTSSCCCSSHHHHHHHHHHHH--------------HH-----S-------C---HH---------HHHTTSCHH
T ss_pred             HHhCCCCCccccchhHHHHHHHHhhcc--------------cc-----c-------c---HH---------HHhcCCcHH
Confidence            9999999977543   22222221100              00     0       0   00         001346889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      +.+|+.+||+.||++||++.++++
T Consensus       248 l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          248 FASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999998875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-40  Score=390.93  Aligned_cols=277  Identities=24%  Similarity=0.287  Sum_probs=201.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee------cC
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR------DH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~------~~  235 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+...  ......+.+.+|+.+|++++||||+++++++..      .+
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            4599999999999999999999999999999988642  223445678899999999999999999998765      67


Q ss_pred             ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..|+|||||.| +|.+++..                               ......+++..+..++.|++.||+|||++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~-------------------------------~~~~~~lse~~i~~I~~QLl~aL~yLHs~  140 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQ-------------------------------FENCCGLKEGPIRTLLSDISSALRYLHEN  140 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHS-------------------------------SSCTTCCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEEEEeCCCCCHHHHHHh-------------------------------cccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            78999999976 44333320                               01123588999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCc---EEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGT---VKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~---vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      ||+||||||+|||++.++.   +||+|||++.....   .....||+.|+|||++.   +..|+.++|||||||++|||+
T Consensus       141 gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSLGviLyeLl  217 (676)
T 3qa8_A          141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE---QKKYTVTVDYWSFGTLAFECI  217 (676)
T ss_dssp             TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSC---CSCCSTTHHHHHHHHHHHHHH
T ss_pred             CCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhc---cCCCCchhHHHHHHHHHHHHH
Confidence            9999999999999997765   99999999976433   23568999999999984   467899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|..||.+.................    .     ............+.          .....+......+++.+.+||
T Consensus       218 tG~~Pf~~~~~~~~~~~~i~~~~~~----~-----~~~~~~l~g~~~~~----------~~lp~p~~l~~~ls~~L~dLI  278 (676)
T 3qa8_A          218 TGFRPFLPNWQPVQWHGKVREKSNE----H-----IVVYDDLTGAVKFS----------SVLPTPNHLSGILAGKLERWL  278 (676)
T ss_dssp             SSCSSCCSSCHHHHSSTTCC---------------CCSCCCCSSSCCCC----------SSSCCSCCCCGGGHHHHHHHH
T ss_pred             HCCCCCCcccchhhhhhhhhcccch----h-----hhhhhhhccccccc----------cccCCchhhchhhhHHHHHHH
Confidence            9999997654322111000000000    0     00000000000000          000112223345789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      .+||..||++|||+.++|+||||..
T Consensus       279 ~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          279 QCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             HHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             HHHccCCHhhCcCHHHHhcCHHHHH
Confidence            9999999999999999999999853

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=362.69  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=180.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHH--HHHHHhhcCCCceeEeeeEEee-----c
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILK--EIRFLRQLKHPNTIEYRGCYLR-----D  234 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~--Ei~iL~~L~HpNIV~l~~~~~~-----~  234 (804)
                      +.|++++.||+|+||.||+|+.  +++.||||++....      ...+..  |+..++.++||||+++++++..     .
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            4599999999999999999965  78999999886321      123333  4444556899999999976543     2


Q ss_pred             CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ..+|+|||||.| +|.+++.                                   ...+++..+..++.||+.||.|||+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~-----------------------------------~~~~~~~~~~~i~~qi~~~L~~LH~  129 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLS-----------------------------------LHTSDWVSSCRLAHSVTRGLAYLHT  129 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHH-----------------------------------HCCBCHHHHHHHHHHHHHHHHHHHC
T ss_pred             ceEEEEEecCCCCcHHHHHh-----------------------------------hcccchhHHHHHHHHHHHHHHHHHh
Confidence            357899999976 4444332                                   2345788999999999999999999


Q ss_pred             C---------CCeecCCCCCCeeecCCCcEEEEecccccccCC------------CCccccCcccccchhhcccCC----
Q psy17952        314 L---------GRIHRDVKAGNILLTETGTVKLADFGSASIKCP------------ANSFVGTPYWMAPEVILAMDE----  368 (804)
Q Consensus       314 ~---------gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------------~~~~~GT~~Y~APEvl~~~~~----  368 (804)
                      +         ||+||||||+|||++.++.+||+|||+|+....            ....+||+.|+|||++.+...    
T Consensus       130 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  209 (336)
T 3g2f_A          130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX  209 (336)
T ss_dssp             CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGH
T ss_pred             hhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccc
Confidence            9         999999999999999999999999999965321            124579999999999853111    


Q ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHH
Q psy17952        369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA---LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY  445 (804)
Q Consensus       369 ~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~~---l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~  445 (804)
                      ..++.++|||||||++|||++|..||+.......   ......+..|     ....+..........+.           
T Consensus       210 ~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-----------  273 (336)
T 3g2f_A          210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHP-----TFEDMQVLVSREKQRPK-----------  273 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSC-----CHHHHHHHHTTSCCCCC-----------
T ss_pred             cccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCc-----hHHHHHhhhcccccCCC-----------
Confidence            2456789999999999999999777654221000   0000000000     00000000000000000           


Q ss_pred             hhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       446 ~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                          ...........++++.+||.+||+.||++|||+.|+++
T Consensus       274 ----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          274 ----FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             ----CCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                00001112235678999999999999999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.6e-39  Score=384.23  Aligned_cols=247  Identities=25%  Similarity=0.394  Sum_probs=198.6

Q ss_pred             ccccccccccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ...|++.+.||+|+||.||+|.+..+   +..||||.+...  ......+.+.+|+.+|++++|||||++++++. ++..
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            35688999999999999999998654   467999987642  22334567899999999999999999999985 5678


Q ss_pred             EEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||.|+ |.+++.                                 .....+++..+..++.|++.||.|||++||
T Consensus       466 ~lv~E~~~~g~L~~~l~---------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  512 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQ---------------------------------VRKFSLDLASLILYAYQLSTALAYLESKRF  512 (656)
T ss_dssp             EEEEECCTTCBHHHHHH---------------------------------HTTTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEEEcCCCCcHHHHHH---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            9999999854 433321                                 123468999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      +||||||+|||++.++.+||+|||+|+.....     ....||+.|||||++.   ...|+.++|||||||++|||++ |
T Consensus       513 vHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt~g  589 (656)
T 2j0j_A          513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHG  589 (656)
T ss_dssp             CCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhc---CCCCCchhhHHHHHHHHHHHHHcC
Confidence            99999999999999999999999999754322     2345788999999985   3578999999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      .+||.+.+..+.+..+..+..+                                          .....+++.+.+|+.+
T Consensus       590 ~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~~  627 (656)
T 2j0j_A          590 VKPFQGVKNNDVIGRIENGERL------------------------------------------PMPPNCPPTLYSLMTK  627 (656)
T ss_dssp             CCTTTTCCHHHHHHHHHHTCCC------------------------------------------CCCTTCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCccccHHHHHHHHH
Confidence            9999888776666555432211                                          0123468899999999


Q ss_pred             hcccCCCCCCCHHHHHcC
Q psy17952        471 CLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~H  488 (804)
                      ||..||++|||+.++++.
T Consensus       628 ~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          628 CWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcCCChhHCcCHHHHHHH
Confidence            999999999999998853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3e-39  Score=352.60  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=189.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhh--cCCCceeEeeeEEeecC---
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ--LKHPNTIEYRGCYLRDH---  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIV~l~~~~~~~~---  235 (804)
                      .+.|++.+.||+|+||.||+|++  +++.||||.+...      ....+.+|+++++.  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            35699999999999999999986  5889999988532      22456789999887  79999999999998876   


Q ss_pred             -ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH-
Q psy17952        236 -TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH-  312 (804)
Q Consensus       236 -~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH-  312 (804)
                       ..|+||||+.| +|.+++.                                   +..+++.++..++.|++.||.||| 
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~-----------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~  157 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLN-----------------------------------RYTVTVEGMIKLALSTASGLAHLHM  157 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHH-----------------------------------HCCBCHHHHHHHHHHHHHHHHHHHC
T ss_pred             ceeEEEEeecCCCcHHHHHh-----------------------------------ccCccHHHHHHHHHHHHHHHHHHHH
Confidence             78999999986 4444332                                   235889999999999999999999 


Q ss_pred             -------HCCCeecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCC---CCCCc
Q psy17952        313 -------SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEG---QYDGK  374 (804)
Q Consensus       313 -------~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~---~y~~k  374 (804)
                             ++||+||||||+|||++.++.+||+|||++.....        .....||+.|+|||++.+....   .++.+
T Consensus       158 ~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  237 (342)
T 1b6c_B          158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR  237 (342)
T ss_dssp             CBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHH
T ss_pred             HHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCc
Confidence                   89999999999999999999999999999965332        2345799999999998532110   23368


Q ss_pred             ccHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhh
Q psy17952        375 VDVWSLGITCIELAER----------KPPYFNMNA----MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNA  440 (804)
Q Consensus       375 sDIWSlGvil~ELltG----------~~PF~~~~~----~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~  440 (804)
                      +|||||||++|||++|          ..||.+...    ...+.....                  ... ..+..     
T Consensus       238 ~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~-~~~~~-----  293 (342)
T 1b6c_B          238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC------------------EQK-LRPNI-----  293 (342)
T ss_dssp             HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT------------------TSC-CCCCC-----
T ss_pred             ccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHH------------------HHH-hCCCC-----
Confidence            9999999999999999          677754321    111111100                  000 00000     


Q ss_pred             hHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        441 MSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       441 ~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                                 .........++.+.+|+.+||+.||++|||+.++++|
T Consensus       294 -----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          294 -----------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             -----------CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             -----------cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                       0000122346789999999999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-39  Score=388.08  Aligned_cols=239  Identities=25%  Similarity=0.332  Sum_probs=195.0

Q ss_pred             cccccccccccccccceEEEEeee-ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc----
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLV-SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT----  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~-~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~----  236 (804)
                      ..|++.+.||+|+||.||+|++.. +++.||||.+...  ........+.+|+.+|++++|||||++++++...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            569999999999999999999976 7899999987642  223445678899999999999999999999988766    


Q ss_pred             -eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 -AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 -~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                       .|||||||.|+..                                 .++.  ...+++.++..|+.||+.||.|||++|
T Consensus       158 ~~~lv~E~~~g~~L---------------------------------~~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g  202 (681)
T 2pzi_A          158 VGYIVMEYVGGQSL---------------------------------KRSK--GQKLPVAEAIAYLLEILPALSYLHSIG  202 (681)
T ss_dssp             EEEEEEECCCCEEC---------------------------------C------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEeCCCCcH---------------------------------HHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence             7999999987521                                 1111  126899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF  395 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~  395 (804)
                      ||||||||+|||++.+ .+||+|||+++........+||+.|+|||++.+    .++.++|||||||++|||++|.+||.
T Consensus       203 iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDi~slG~~l~~l~~g~~~~~  277 (681)
T 2pzi_A          203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRT----GPTVATDIYTVGRTLAALTLDLPTRN  277 (681)
T ss_dssp             EECCCCSGGGEEECSS-CEEECCCTTCEETTCCSCCCCCTTTSCTTHHHH----CSCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred             CeecccChHHeEEeCC-cEEEEecccchhcccCCccCCCccccCHHHHcC----CCCCceehhhhHHHHHHHHhCCCCCc
Confidence            9999999999999875 899999999987666667789999999999843    35789999999999999999999985


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +...         .                     ..+..                   ......++.+.+||.+||++|
T Consensus       278 ~~~~---------~---------------------~~~~~-------------------~~~~~~~~~l~~li~~~l~~d  308 (681)
T 2pzi_A          278 GRYV---------D---------------------GLPED-------------------DPVLKTYDSYGRLLRRAIDPD  308 (681)
T ss_dssp             TEEC---------S---------------------SCCTT-------------------CHHHHHCHHHHHHHHHHTCSS
T ss_pred             cccc---------c---------------------ccccc-------------------ccccccCHHHHHHHhhhccCC
Confidence            4210         0                     00000                   000113577899999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy17952        476 PADRPSSGRLLTHDLV  491 (804)
Q Consensus       476 P~~Rpsa~elL~Hp~~  491 (804)
                      |++||++.+++.|+|+
T Consensus       309 P~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          309 PRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             GGGSCSSHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHHH
Confidence            9999999999998875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-38  Score=341.33  Aligned_cols=228  Identities=14%  Similarity=0.075  Sum_probs=178.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ..|++.+.||+|+||.||+|++..+++.||||.+...........+.+.+|+.++++++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            45999999999999999999999999999999987544433445577899999999999999999999999999999999


Q ss_pred             eecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        242 EYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       242 Ey~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      |||.|+ |.+++                                  . . ...+.++..|+.||+.||+|||++||+|||
T Consensus       111 e~~~g~~L~~~l----------------------------------~-~-~~~~~~~~~i~~ql~~aL~~lH~~givH~D  154 (286)
T 3uqc_A          111 EWIRGGSLQEVA----------------------------------D-T-SPSPVGAIRAMQSLAAAADAAHRAGVALSI  154 (286)
T ss_dssp             ECCCEEEHHHHH----------------------------------T-T-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             EecCCCCHHHHH----------------------------------h-c-CCChHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence            999864 32222                                  1 1 235567889999999999999999999999


Q ss_pred             CCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        321 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       321 LKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      |||+|||++.+|.+||+++|                |++|          ++.++|||||||++|||++|+.||.+.+..
T Consensus       155 ikp~NIll~~~g~~kl~~~~----------------~~~~----------~~~~~Di~slG~il~elltg~~Pf~~~~~~  208 (286)
T 3uqc_A          155 DHPSRVRVSIDGDVVLAYPA----------------TMPD----------ANPQDDIRGIGASLYALLVNRWPLPEAGVR  208 (286)
T ss_dssp             CSGGGEEEETTSCEEECSCC----------------CCTT----------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred             CCcccEEEcCCCCEEEEecc----------------ccCC----------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence            99999999999999998543                4443          577999999999999999999999765421


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      +.+..                   ........++                 .+......+++++.+||.+||++||++| 
T Consensus       209 ~~~~~-------------------~~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-  251 (286)
T 3uqc_A          209 SGLAP-------------------AERDTAGQPI-----------------EPADIDRDIPFQISAVAARSVQGDGGIR-  251 (286)
T ss_dssp             CCSEE-------------------CCBCTTSCBC-----------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-
T ss_pred             hhhHH-------------------HHHHhccCCC-----------------ChhhcccCCCHHHHHHHHHHcccCCccC-
Confidence            10000                   0000000000                 0011124578999999999999999999 


Q ss_pred             CHHHHHcC
Q psy17952        481 SSGRLLTH  488 (804)
Q Consensus       481 sa~elL~H  488 (804)
                      |+.++++.
T Consensus       252 s~~el~~~  259 (286)
T 3uqc_A          252 SASTLLNL  259 (286)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99998853

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-33  Score=306.09  Aligned_cols=135  Identities=30%  Similarity=0.507  Sum_probs=120.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++|+|||||+++++|.+++.+|||||||+| +|.+++. ..+.+++..++.|+.||+.||+|||+++||||||||+
T Consensus        83 ~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPe  161 (311)
T 4aw0_A           83 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE  161 (311)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence            4689999999999999999999999999999986 5666664 4578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||+|+...      ...+++|||.|||||++.   ...|+.++|+||+|+++
T Consensus       162 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvil  224 (311)
T 4aw0_A          162 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT---EKSACKSSDLWALGCII  224 (311)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHH---HSCBCHHHHHHHHHHHH
T ss_pred             HeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHc---CCCCCcHHHHHHHHHHH
Confidence            9999999999999999997532      234579999999999984   45799999999999983

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-33  Score=307.17  Aligned_cols=134  Identities=46%  Similarity=0.829  Sum_probs=119.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+|+++|.+++.+|||||||+|+. .+++.  +.++++++++.++.||+.||+|||++|||||||||+
T Consensus       122 i~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~  199 (346)
T 4fih_A          122 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD  199 (346)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH
Confidence            368999999999999999999999999999999754 45443  357999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||+|+...    ...+.+||+.|||||++   ....|+.++|+||+|+++
T Consensus       200 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl---~~~~y~~~~DiWSlGvil  260 (346)
T 4fih_A          200 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMV  260 (346)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH---TTCCBCTHHHHHHHHHHH
T ss_pred             HEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHH---CCCCCCcHHHHHHHHHHH
Confidence            9999999999999999997532    23467999999999998   345799999999999984

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.98  E-value=2.6e-33  Score=302.52  Aligned_cols=134  Identities=31%  Similarity=0.506  Sum_probs=119.5

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ++|++|+|||||+++++|.+++.+|||||||+| +|.+++. ..+++++..++.++.||+.||+|||++|||||||||+|
T Consensus        78 ~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N  156 (304)
T 3ubd_A           78 DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN  156 (304)
T ss_dssp             CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred             HHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence            468899999999999999999999999999985 5666665 45789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.+|.+||+|||+|+..    ....+.+||+.|||||++.   ...|+.++|+||+|+++
T Consensus       157 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvil  216 (304)
T 3ubd_A          157 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN---RRGHTQSADWWSFGVLM  216 (304)
T ss_dssp             EEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHH---TSCCCTHHHHHHHHHHH
T ss_pred             eEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhc---cCCCCCCCcccchHHHH
Confidence            99999999999999999753    2344678999999999983   46799999999999983

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.98  E-value=6.7e-33  Score=295.28  Aligned_cols=135  Identities=33%  Similarity=0.493  Sum_probs=113.0

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      ++|++|+|||||+++++|.+++.+|||||||.|++.+.+.. ++++++..++.++.||+.||+|||++||+||||||+||
T Consensus        65 ~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NI  143 (275)
T 3hyh_A           65 SYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL  143 (275)
T ss_dssp             HHHHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred             HHHHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHe
Confidence            57899999999999999999999999999998888888764 57899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.+|.+||+|||+|+...   ...+.+||+.|||||++.+  ...++.++|+||+|+++
T Consensus       144 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvil  202 (275)
T 3hyh_A          144 LLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVIL  202 (275)
T ss_dssp             EECTTCCEEECCSSCC---------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHH
T ss_pred             EECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHH
Confidence            99999999999999997532   2345789999999999842  22346899999999983

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.97  E-value=4.5e-33  Score=305.85  Aligned_cols=135  Identities=35%  Similarity=0.683  Sum_probs=120.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++|+|||||+++++|.+++.+|||||||+| +|.+++...+ ..+++.+++.|+.||+.||+|||++|||||||||
T Consensus        74 ~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp  153 (350)
T 4b9d_A           74 VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS  153 (350)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCG
T ss_pred             HHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCH
Confidence            3689999999999999999999999999999985 6667776544 4689999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.+|.+||+|||+|+....    ....+||+.|||||++.   ...|+.++|+||+|++
T Consensus       154 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~---~~~y~~~~DiwSlGvi  214 (350)
T 4b9d_A          154 QNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE---NKPYNNKSDIWALGCV  214 (350)
T ss_dssp             GGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             HHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHC---CCCCCcHHHHHHHHHH
Confidence            999999999999999999986432    23468999999999983   4579999999999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=6.2e-33  Score=303.27  Aligned_cols=134  Identities=33%  Similarity=0.454  Sum_probs=117.4

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++|+|||||+++++|.+++.+|||||||+| +|.+++. ..+++++..++.|+.||+.||+|||+++||||||||+|
T Consensus       102 ~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N  180 (336)
T 4g3f_A          102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADN  180 (336)
T ss_dssp             HTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGG
T ss_pred             HHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHH
Confidence            578999999999999999999999999999986 5556554 45789999999999999999999999999999999999


Q ss_pred             EEEcCCC-ceEEeccCcccccCC---------CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETG-TVKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~-~~kl~DFG~a~~~~~---------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.+| .+||+|||+|+....         ...++||+.|||||++.   ...|+.++|+||+|+++
T Consensus       181 ILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvil  246 (336)
T 4g3f_A          181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM---GKPCDAKVDIWSSCCMM  246 (336)
T ss_dssp             EEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             EEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC---CCCCCcHHHHHHHHHHH
Confidence            9999988 699999999975321         23468999999999984   46799999999999983

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=1.1e-32  Score=295.80  Aligned_cols=134  Identities=34%  Similarity=0.614  Sum_probs=115.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe----CCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--RIH   77 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~--IiH   77 (804)
                      .++|++|+|||||+++++|.+    +..+|||||||+|+ |.+++. ...++++..++.++.||+.||+|||+++  |||
T Consensus        76 ~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiH  154 (290)
T 3fpq_A           76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH  154 (290)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred             HHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEe
Confidence            368999999999999999875    34689999999865 555554 4578999999999999999999999998  999


Q ss_pred             cccccccEEEcC-CCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         78 RDVKAGNILLTE-TGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        78 RDlKp~Nill~~-~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||||+|||++. +|.+||+|||+|+...  ...+.+|||.|||||++.    +.|+.++|+||+|+++
T Consensus       155 RDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~----~~y~~~~DiwSlGvil  219 (290)
T 3fpq_A          155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCM  219 (290)
T ss_dssp             CCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHH
T ss_pred             cccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcC----CCCCcHHHHHHHHHHH
Confidence            999999999984 7999999999997633  334578999999999872    4699999999999983

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=1.3e-32  Score=309.15  Aligned_cols=134  Identities=46%  Similarity=0.829  Sum_probs=119.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+|+++|.+++.+|||||||+|+. .+++.  ...+++.+++.|+.||+.||+|||++|||||||||+
T Consensus       199 i~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~  276 (423)
T 4fie_A          199 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD  276 (423)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTT
T ss_pred             HHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHH
Confidence            368999999999999999999999999999999754 45543  357999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||+|+...    ...+.+||++|||||++   ....|+.++|+||+|+++
T Consensus       277 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl---~~~~y~~~~DiWSlGvil  337 (423)
T 4fie_A          277 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMV  337 (423)
T ss_dssp             TEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHH---TTCCBCTHHHHHHHHHHH
T ss_pred             HEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHH---CCCCCCcHHHHHHHHHHH
Confidence            9999999999999999997532    23467999999999998   346799999999999983

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.6e-33  Score=326.10  Aligned_cols=188  Identities=20%  Similarity=0.175  Sum_probs=133.8

Q ss_pred             ccccccccccceEEEEeeeceeEEEEEeccccc-------ccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLG-------KQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~-------~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      ....+.|++|.+..++....|+.+|||.+....       ......++.+.+|+++|+++ .|+||+++++++++++.+|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            345788999999999999999999999886431       11233456789999999999 6999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      ||||||+|+                                 +|++.+...+++++.   .|+.||++||+|||++||||
T Consensus       319 LVMEyv~G~---------------------------------~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIH  362 (569)
T 4azs_A          319 LVMEKLPGR---------------------------------LLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWH  362 (569)
T ss_dssp             EEEECCCSE---------------------------------EHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEE
T ss_pred             EEEecCCCC---------------------------------cHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCcee
Confidence            999999985                                 234444556677765   48899999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||||+||||+.+|.+||+|||+|+....    ..+.+||+.|||||++.    +.+..++|+||+|+++++|.++..||
T Consensus       363 RDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~----g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          363 DDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFA----ENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---------------------CCCCTTHHHH
T ss_pred             ccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhC----CCCCCcccccccccchhhhccccchh
Confidence            99999999999999999999999976433    23568999999999984    45677899999999999887765554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.97  E-value=1e-32  Score=298.48  Aligned_cols=147  Identities=33%  Similarity=0.557  Sum_probs=122.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++|+|||||+|++++. ++.+|||||||+ |+|.+++...+.++++.++..++.||++||+|||+++||||||||+
T Consensus        83 ~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~  161 (307)
T 3omv_A           83 VAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSN  161 (307)
T ss_dssp             HHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSS
T ss_pred             HHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHH
Confidence            36789999999999999765 467899999998 5666777666778999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDK  157 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~  157 (804)
                      |||+++++.+||+|||+|+...      .....+||+.|||||++.+...+.|+.++||||+|++        +.|++..
T Consensus       162 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvv--------l~Elltg  233 (307)
T 3omv_A          162 NIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIV--------LYELMTG  233 (307)
T ss_dssp             SEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHH--------HHHHHHS
T ss_pred             HEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHH--------HHHHHHC
Confidence            9999999999999999997532      1234689999999999865445679999999999998        4555544


Q ss_pred             CCc
Q psy17952        158 EDP  160 (804)
Q Consensus       158 ~dp  160 (804)
                      ..|
T Consensus       234 ~~P  236 (307)
T 3omv_A          234 ELP  236 (307)
T ss_dssp             SCT
T ss_pred             CCC
Confidence            444

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.97  E-value=7.2e-32  Score=291.09  Aligned_cols=135  Identities=28%  Similarity=0.513  Sum_probs=118.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH------------KRPLKEEEIAAICSGVLRGLNYLH   71 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~------------~~~l~~~~~~~~~~qi~~aL~ylH   71 (804)
                      .++|++|+|||||+|+++|.+++.+|||||||+ |+|.+++...            ...+++.++..++.||++||+|||
T Consensus        66 ~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH  145 (299)
T 4asz_A           66 AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA  145 (299)
T ss_dssp             HHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            367899999999999999999999999999998 5667777543            247999999999999999999999


Q ss_pred             hcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         72 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        72 ~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +++||||||||+|||++.++.+||+|||+|+...      .....+||+.|||||++.   .+.|+.++||||+|++
T Consensus       146 ~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~---~~~~~~k~DVwS~Gvv  219 (299)
T 4asz_A          146 SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSLGVV  219 (299)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHc---CCCCCchhhHHHHHHH
Confidence            9999999999999999999999999999997422      122357999999999984   4679999999999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.97  E-value=2e-31  Score=288.88  Aligned_cols=135  Identities=26%  Similarity=0.522  Sum_probs=118.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH---------------KRPLKEEEIAAICSGVLRGLN   68 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~---------------~~~l~~~~~~~~~~qi~~aL~   68 (804)
                      ..+|++|+|||||+|+|+|.+++.+|||||||+ |+|.+++..+               +..+++.++..++.||++||+
T Consensus        80 ~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~  159 (308)
T 4gt4_A           80 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME  159 (308)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            367899999999999999999999999999998 5667777532               246999999999999999999


Q ss_pred             HHHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         69 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        69 ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+++||||||||+|||+++++.+||+|||+|+...      .....+||+.|||||++.   .+.|+.++||||||++
T Consensus       160 yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~~s~ksDVwSfGvv  236 (308)
T 4gt4_A          160 YLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM---YGKFSIDSDIWSYGVV  236 (308)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh---CCCCCccchhhhHHHH
Confidence            9999999999999999999999999999999997531      223468999999999984   4679999999999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.97  E-value=2.8e-31  Score=290.33  Aligned_cols=135  Identities=29%  Similarity=0.490  Sum_probs=113.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH--------------KRPLKEEEIAAICSGVLRGLNY   69 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~y   69 (804)
                      .++|++|+|||||+|+++|.+++.+|||||||+ |+|.+++...              ..++++.++..++.||++||+|
T Consensus        94 ~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y  173 (329)
T 4aoj_A           94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY  173 (329)
T ss_dssp             HHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHH
Confidence            368899999999999999999999999999998 4566666532              2469999999999999999999


Q ss_pred             HHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         70 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        70 lH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++||||||||+|||+++++.+||+|||+|+...      .....+||+.|||||++   ....|+.++||||||++
T Consensus       174 LH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~---~~~~~~~~sDvwS~Gvv  249 (329)
T 4aoj_A          174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI---LYRKFTTESDVWSFGVV  249 (329)
T ss_dssp             HHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHH---TTCCCCHHHHHHHHHHH
T ss_pred             HhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhh---cCCCCCccccccchHHH
Confidence            999999999999999999999999999999997532      12346799999999998   35679999999999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=3e-31  Score=286.37  Aligned_cols=135  Identities=30%  Similarity=0.504  Sum_probs=108.6

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCC------------eEEEEEeccCC-CcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHH
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDH------------TAWLVMEYCLG-SASDIIEVHK--RPLKEEEIAAICSGVLRGLNYL   70 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~------------~~~lV~Ey~~g-~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~yl   70 (804)
                      .+|++|+|||||+++++|.+.+            .+|||||||.| +|.+++....  ...++..++.++.||++||+||
T Consensus        55 ~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yl  134 (299)
T 4g31_A           55 KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL  134 (299)
T ss_dssp             HHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH
Confidence            5789999999999999987644            37999999985 5556654332  2345677899999999999999


Q ss_pred             HhcCccccccccccEEEcCCCceEEeccCcccccCC----------------CCccccccccCcchhhhhcccCccCCcc
Q psy17952         71 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----------------ANSFVGTPYWMAPEVILAMDEGQYDGKV  134 (804)
Q Consensus        71 H~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~----------------~~~~~gt~~y~APE~l~~~~~~~~~~~v  134 (804)
                      |++|||||||||+|||++.+|.+||+|||+|+....                ....+||+.|||||++.   ...|+.++
T Consensus       135 H~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~  211 (299)
T 4g31_A          135 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH---GNSYSHKV  211 (299)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT---TCCCCTHH
T ss_pred             HHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc---CCCCCCHH
Confidence            999999999999999999999999999999975321                12358999999999984   45799999


Q ss_pred             cccccccCC
Q psy17952        135 DVWSLGITP  143 (804)
Q Consensus       135 DvwslG~~~  143 (804)
                      |+||+|+++
T Consensus       212 DiwSlGvil  220 (299)
T 4g31_A          212 DIFSLGLIL  220 (299)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999999984

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.8e-30  Score=290.99  Aligned_cols=135  Identities=32%  Similarity=0.576  Sum_probs=118.7

Q ss_pred             HHHHhcCCCCeeeEeEEEEe------CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLR------DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~------~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .+|++|+|||||++++++..      .+.+|||||||.|++.+++. ..+++++..++.++.||+.||+|||++||||||
T Consensus       105 ~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRD  183 (398)
T 4b99_A          105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRD  183 (398)
T ss_dssp             HHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             HHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCC
Confidence            68999999999999999764      35799999999999888775 457899999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccC--------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+|||++.+|.+||+|||+|+...        ...+.+||++|||||++.+  ...|+.++|+||+|+++
T Consensus       184 lKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~--~~~~~~~~DiWSlG~il  253 (398)
T 4b99_A          184 LKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS--LHEYTQAIDLWSVGCIF  253 (398)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT--CSCCCTHHHHHHHHHHH
T ss_pred             cCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC--CCCCCChhheehhHHHH
Confidence            99999999999999999999997421        2345799999999999853  34579999999999984

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=1.9e-30  Score=304.57  Aligned_cols=134  Identities=26%  Similarity=0.362  Sum_probs=118.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ++|+.++|||||+|+++|.+++.+|||||||.|+ |.+++ ...+.+++..++.|+.||+.||+|||++|||||||||+|
T Consensus       244 ~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l-~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeN  322 (689)
T 3v5w_A          244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN  322 (689)
T ss_dssp             HHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred             HHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHH
Confidence            3556779999999999999999999999999865 44555 446789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc--CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIK--CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+|.+||+|||+|+..  ....+.+|||.|||||++.  ....|+.++|+||+|++
T Consensus       323 ILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~--~~~~y~~~vDiWSLGvi  380 (689)
T 3v5w_A          323 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ--KGVAYDSSADWFSLGCM  380 (689)
T ss_dssp             EEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHS--TTCCCCTHHHHHHHHHH
T ss_pred             eEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHh--CCCCCCcHHHHHHHHHH
Confidence            99999999999999999753  2345679999999999983  23469999999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=4.7e-30  Score=284.25  Aligned_cols=133  Identities=27%  Similarity=0.416  Sum_probs=113.2

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|+.+ +|||||+++++|.+++.+|||||||+| ++.+++    ..+++.+++.++.||+.||+|||++|||||||||+
T Consensus        71 ~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPe  146 (361)
T 4f9c_A           71 QCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPS  146 (361)
T ss_dssp             HHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHH
Confidence            467777 699999999999999999999999985 555555    35999999999999999999999999999999999


Q ss_pred             cEEEcCC-CceEEeccCcccccCC--------------------------------CCccccccccCcchhhhhcccCcc
Q psy17952         84 NILLTET-GTVKLADFGSASIKCP--------------------------------ANSFVGTPYWMAPEVILAMDEGQY  130 (804)
Q Consensus        84 Nill~~~-~~~kl~DFG~a~~~~~--------------------------------~~~~~gt~~y~APE~l~~~~~~~~  130 (804)
                      |||++.+ +.+||+|||+|+....                                ..+.+||++|||||++.+  ...|
T Consensus       147 NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~y  224 (361)
T 4f9c_A          147 NFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK--CPNQ  224 (361)
T ss_dssp             GEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT--CSCC
T ss_pred             HeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCC
Confidence            9999876 7999999999963211                                123579999999999843  3458


Q ss_pred             CCcccccccccCCC
Q psy17952        131 DGKVDVWSLGITPG  144 (804)
Q Consensus       131 ~~~vDvwslG~~~g  144 (804)
                      +.++|+||+|+++.
T Consensus       225 ~~~~DiWSlG~il~  238 (361)
T 4f9c_A          225 TTAIDMWSAGVIFL  238 (361)
T ss_dssp             CTHHHHHHHHHHHH
T ss_pred             CCccchhhhHHHHH
Confidence            99999999999843

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.96  E-value=6.9e-30  Score=281.70  Aligned_cols=134  Identities=32%  Similarity=0.518  Sum_probs=115.1

Q ss_pred             HHHHhcCC-CCeeeEeEEEEeC-CeEEEEEeccC-CCcHHHHHHc---------------CCCCCHHHHHHHHHHHHHHH
Q psy17952          6 SLLRQLKH-PNTIEYRGCYLRD-HTAWLVMEYCL-GSASDIIEVH---------------KRPLKEEEIAAICSGVLRGL   67 (804)
Q Consensus         6 ~iL~~l~H-pnIV~l~~~~~~~-~~~~lV~Ey~~-g~l~~~~~~~---------------~~~l~~~~~~~~~~qi~~aL   67 (804)
                      .+|++++| ||||+|+++|..+ +.+|||||||+ |+|.++++..               +..+++.++..++.||++||
T Consensus       119 ~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl  198 (353)
T 4ase_A          119 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM  198 (353)
T ss_dssp             HHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHH
Confidence            57888866 8999999998764 57999999998 5667777543               24589999999999999999


Q ss_pred             HHHHhcCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCccccccccc
Q psy17952         68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  141 (804)
Q Consensus        68 ~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~  141 (804)
                      +|||+++||||||||+|||+++++.+||+|||+|+....      ....+||+.|||||++.   .+.|+.++||||||+
T Consensus       199 ~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~y~~ksDVwS~Gv  275 (353)
T 4ase_A          199 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGV  275 (353)
T ss_dssp             HHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHH
T ss_pred             HhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh---cCCCCCcccEeehHH
Confidence            999999999999999999999999999999999985322      23457999999999984   467999999999999


Q ss_pred             C
Q psy17952        142 T  142 (804)
Q Consensus       142 ~  142 (804)
                      +
T Consensus       276 ~  276 (353)
T 4ase_A          276 L  276 (353)
T ss_dssp             H
T ss_pred             H
Confidence            8

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.96  E-value=1e-29  Score=274.89  Aligned_cols=133  Identities=29%  Similarity=0.422  Sum_probs=109.3

Q ss_pred             HHhcCCCCeeeEeEEEEeCC----eEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--------C
Q psy17952          8 LRQLKHPNTIEYRGCYLRDH----TAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL--------G   74 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~~~----~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~--------~   74 (804)
                      +.+++|||||+|++++.+++    .+|||||||+| +|.+++..  .+++++.+..++.|+++||+|||++        +
T Consensus        51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~  128 (303)
T 3hmm_A           51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA  128 (303)
T ss_dssp             STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC
T ss_pred             HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC
Confidence            35789999999999998654    58999999985 56666653  5799999999999999999999987        9


Q ss_pred             ccccccccccEEEcCCCceEEeccCcccccCC--------CCccccccccCcchhhhhc---ccCccCCcccccccccC
Q psy17952         75 RIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        75 IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~--------~~~~~gt~~y~APE~l~~~---~~~~~~~~vDvwslG~~  142 (804)
                      ||||||||+|||++.++.+||+|||+|+....        ....+||+.|||||++.+.   ....|+.++||||+|++
T Consensus       129 IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv  207 (303)
T 3hmm_A          129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  207 (303)
T ss_dssp             EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred             EeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence            99999999999999999999999999975321        1235899999999998431   12247889999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=1.3e-28  Score=288.40  Aligned_cols=136  Identities=25%  Similarity=0.418  Sum_probs=120.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+|+++|.+++.+|||||||+| +|.+++....+.+++.+++.|+.||+.||+|||+++|+||||||+
T Consensus       205 i~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~  284 (573)
T 3uto_A          205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE  284 (573)
T ss_dssp             HHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh
Confidence            3679999999999999999999999999999985 566766555678999999999999999999999999999999999


Q ss_pred             cEEEcCC--CceEEeccCcccccCCC---CccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTET--GTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~--~~~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+  +.+||+|||+|+.....   ...+||+.|||||++.   ...|+.++|+||+|+++
T Consensus       285 Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~---~~~y~~~~DiWSlGvil  346 (573)
T 3uto_A          285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVLS  346 (573)
T ss_dssp             GEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHH
T ss_pred             hccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhC---CCCCCcHHHHHHHHHHH
Confidence            9999854  89999999999864332   3468999999999984   45789999999999983

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3.3e-27  Score=274.95  Aligned_cols=184  Identities=20%  Similarity=0.188  Sum_probs=138.5

Q ss_pred             ccccccccccccceEEEEeeeceeEEEEEeccccccc-----chhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ-----CAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       165 ~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ...+.||+|+||.||+|  ...++.+|+|+.......     .....+.+.+|+++|++++||||+++..++...+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            34568999999999999  456778899875432111     11123557899999999999999966666667788899


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||+|+ |.+++                                  ..        +..++.|+++||+|||++||+|
T Consensus       417 VmE~~~ggsL~~~l----------------------------------~~--------~~~i~~qi~~aL~~LH~~gIiH  454 (540)
T 3en9_A          417 MMSYINGKLAKDVI----------------------------------ED--------NLDIAYKIGEIVGKLHKNDVIH  454 (540)
T ss_dssp             EEECCCSEEHHHHS----------------------------------TT--------CTHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEECCCCCCHHHHH----------------------------------HH--------HHHHHHHHHHHHHHHHHCcCcc
Confidence            99999854 32222                                  11        4579999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |||||+|||++.  .+||+|||+|+.....           .+.+||+.|||||++.... ..|+..+|+||..+-..+.
T Consensus       455 rDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~-~~Y~~~~d~ws~vl~~l~~  531 (540)
T 3en9_A          455 NDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL-EGYKSVYDRWEIILELMKD  531 (540)
T ss_dssp             TTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH-HHHHHHCTTHHHHHHHHHH
T ss_pred             CCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH-HHHHHHHhHHHHHHHHHHH
Confidence            999999999998  9999999999865432           3568999999999995421 3578889999999999998


Q ss_pred             HhCCCCCC
Q psy17952        388 AERKPPYF  395 (804)
Q Consensus       388 ltG~~PF~  395 (804)
                      ..++.+|.
T Consensus       532 v~~r~rY~  539 (540)
T 3en9_A          532 VERRARYV  539 (540)
T ss_dssp             HHTCSCCC
T ss_pred             HHhccccC
Confidence            88887763

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.93  E-value=1.9e-26  Score=253.88  Aligned_cols=139  Identities=79%  Similarity=1.314  Sum_probs=127.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+++..|||||||.|++.+++...+.++++..+..++.|++.||+|||+++|+||||||+|
T Consensus       105 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  184 (348)
T 1u5q_A          105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN  184 (348)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred             HHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence            45789999999999999999999999999999999988887777889999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||++.........+||+.|+|||++.+...+.++.++|+||+|++.
T Consensus       185 Ill~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il  243 (348)
T 1u5q_A          185 ILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  243 (348)
T ss_dssp             EEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHH
T ss_pred             EEECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHH
Confidence            99999999999999999876666678999999999998654566799999999999983

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.93  E-value=3.2e-26  Score=251.15  Aligned_cols=135  Identities=30%  Similarity=0.554  Sum_probs=118.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|+.++|||||+++++|.+.+.+|||||||.|+.+..+......+++..++.++.||+.||+|||+++|+||||||+|
T Consensus        56 ~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N  135 (337)
T 1o6l_A           56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN  135 (337)
T ss_dssp             HHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred             HHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHH
Confidence            46789999999999999999999999999999875544433445789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+|.+||+|||+++..    ......+||+.|+|||++   ....|+.++|+||+|++
T Consensus       136 Ill~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~i  194 (337)
T 1o6l_A          136 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL---EDNDYGRAVDWWGLGVV  194 (337)
T ss_dssp             EEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGG---SSSCBCTTHHHHHHHHH
T ss_pred             EEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhh---cCCCCCchhhcccchhH
Confidence            99999999999999999752    123457899999999997   34578999999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=2.8e-26  Score=257.09  Aligned_cols=135  Identities=32%  Similarity=0.574  Sum_probs=117.9

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+++ +|||||+++++|.+++.+|||||||.|+.+..+......+++..++.++.||+.||+|||+++|+||||||+
T Consensus       103 ~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~  182 (396)
T 4dc2_A          103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD  182 (396)
T ss_dssp             HHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred             HHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHH
Confidence            4566666 899999999999999999999999987554444344578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||+|+..    ......+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       183 NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~~DiwslGvl  242 (396)
T 4dc2_A          183 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVL  242 (396)
T ss_dssp             GEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             HEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhc---CCCCChHHHHHHHHHH
Confidence            999999999999999999752    2344578999999999984   4578999999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=3.8e-26  Score=255.02  Aligned_cols=138  Identities=30%  Similarity=0.494  Sum_probs=121.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|+.++|||||+++++|.+++.+|+|||||.|+.+..+......+++..++.++.||+.||+|||++||+||||||+|
T Consensus        66 ~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N  145 (384)
T 4fr4_A           66 LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDN  145 (384)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHH
Confidence            46889999999999999999999999999999876655554556789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+|.+||+|||++....   .....+||+.|+|||++.......|+.++|+||+|++
T Consensus       146 Ill~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i  206 (384)
T 4fr4_A          146 ILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT  206 (384)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred             eEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence            999999999999999997532   3345789999999999854334468999999999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=2.1e-26  Score=254.14  Aligned_cols=135  Identities=30%  Similarity=0.528  Sum_probs=114.3

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.+ +|||||+++++|.+++.+|||||||.|+.+..+......+++..++.++.||+.||+|||+++|+||||||+
T Consensus        74 ~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~  153 (353)
T 3txo_A           74 KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD  153 (353)
T ss_dssp             HHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred             HHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHH
Confidence            4567777 799999999999999999999999987544433344578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||+|+...    .....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       154 NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  213 (353)
T 3txo_A          154 NVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ---EMLYGPAVDWWAMGVL  213 (353)
T ss_dssp             GEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHH---HHHCTTHHHHHHHHHH
T ss_pred             HEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcC---CCCcCCccCCCcchHH
Confidence            9999999999999999997522    234568999999999984   3468999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=4e-26  Score=248.24  Aligned_cols=134  Identities=31%  Similarity=0.538  Sum_probs=119.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+++.+|+|||||.| ++.+++. ....+++..++.++.||+.||+|||+++|+||||||+
T Consensus        57 ~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~  135 (318)
T 1fot_A           57 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE  135 (318)
T ss_dssp             HHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred             HHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChh
Confidence            4678899999999999999999999999999986 4555554 4578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCccccc-CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIK-CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||+++.. ......+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       136 NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  192 (318)
T 1fot_A          136 NILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS---TKPYNKSIDWWSFGIL  192 (318)
T ss_dssp             GEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHT---TCCBCTTHHHHHHHHH
T ss_pred             eEEEcCCCCEEEeecCcceecCCccccccCCccccCHhHhc---CCCCCcccchhhhHHH
Confidence            999999999999999999753 3344578999999999973   4578999999999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=2.8e-26  Score=268.62  Aligned_cols=136  Identities=21%  Similarity=0.205  Sum_probs=102.4

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|+++ .|+||++|++++++++.+|||||||+|+.+..+....+++++.   .++.||+.||+|||++|||||||||+
T Consensus       292 ~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPe  368 (569)
T 4azs_A          292 IKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPW  368 (569)
T ss_dssp             HHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGG
T ss_pred             HHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchH
Confidence            4678898 7999999999999999999999999986555544566788775   47899999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCCCCCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLK  147 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~  147 (804)
                      |||++++|.+||+|||+|+...    ...+.+||+.|||||++.    +.+...+|+|++|+++..+.
T Consensus       369 NILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~----g~~~~~~d~~s~g~~~~~l~  432 (569)
T 4azs_A          369 NVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFA----ENKSWNGFWRSAPVHPFNLP  432 (569)
T ss_dssp             GEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---------------------CCCC
T ss_pred             hEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhC----CCCCCcccccccccchhhhc
Confidence            9999999999999999997542    233568999999999973    45677899999999865543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.93  E-value=4.3e-26  Score=258.76  Aligned_cols=138  Identities=30%  Similarity=0.531  Sum_probs=120.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+++.+|||||||.| +|.+++......+++..++.++.||+.||+|||+++||||||||+
T Consensus       125 ~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~  204 (437)
T 4aw2_A          125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD  204 (437)
T ss_dssp             HHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHH
Confidence            5688999999999999999999999999999975 566666554678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcc--cCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~--~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||+|+....     ....+||+.|||||++....  .+.|+.++|+||+|++
T Consensus       205 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvi  270 (437)
T 4aw2_A          205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC  270 (437)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHH
T ss_pred             HeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHH
Confidence            99999999999999999964322     23368999999999985321  3568999999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.92  E-value=8.1e-26  Score=241.38  Aligned_cols=137  Identities=29%  Similarity=0.486  Sum_probs=122.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.|++.+.+....+.+++..++.++.|++.||+|||+++|+||||||+|
T Consensus        52 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~N  131 (292)
T 3o0g_A           52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN  131 (292)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            35788999999999999999999999999999999998888777899999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||++....    ......||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       132 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il  192 (292)
T 3o0g_A          132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIF  192 (292)
T ss_dssp             EEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT--CSCCCTHHHHHHHHHHH
T ss_pred             EEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcC--CCCcCchHHHHHHHHHH
Confidence            999999999999999997532    2234589999999999843  33489999999999983

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.92  E-value=7.6e-26  Score=248.86  Aligned_cols=134  Identities=32%  Similarity=0.591  Sum_probs=117.2

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|+++ +|||||+++++|.+++.+|||||||.|+ +.+++. ....+++..++.++.||+.||+|||+++|+||||||
T Consensus        60 ~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp  138 (345)
T 3a8x_A           60 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL  138 (345)
T ss_dssp             HHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred             HHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence            3567777 8999999999999999999999999865 445544 456899999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.+|.+||+|||+++..    ......+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       139 ~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  199 (345)
T 3a8x_A          139 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVL  199 (345)
T ss_dssp             GGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             HHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccC---CCCCChHHhHHHHHHH
Confidence            9999999999999999999752    2234568999999999984   4568999999999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.92  E-value=9.1e-26  Score=248.38  Aligned_cols=134  Identities=32%  Similarity=0.566  Sum_probs=116.9

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|+.+ +|||||+++++|.+++.+|||||||.|+ +.+++. ....+++..++.++.||+.||+|||++||+||||||
T Consensus        68 ~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp  146 (345)
T 1xjd_A           68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL  146 (345)
T ss_dssp             HHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred             HHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCh
Confidence            3566665 9999999999999999999999999865 555554 456899999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.+|.+||+|||+++..    ......+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       147 ~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  207 (345)
T 1xjd_A          147 DNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVL  207 (345)
T ss_dssp             GGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             hhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhc---CCCCCChhhhHHHHHH
Confidence            9999999999999999999753    2334578999999999984   4568999999999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.92  E-value=9e-26  Score=246.53  Aligned_cols=136  Identities=31%  Similarity=0.533  Sum_probs=117.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||++++++.+++.+|+|||||.| ++.+++. ..+++++..++.++.|++.||+|||+++|+||||||+
T Consensus        65 ~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~  143 (328)
T 3fe3_A           65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAE  143 (328)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHH
Confidence            3578999999999999999999999999999985 5556554 3468999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++.+||+|||++....   .....+||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       144 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il  204 (328)
T 3fe3_A          144 NLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVIL  204 (328)
T ss_dssp             GEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHH
T ss_pred             HEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccC--CCcCCchhhhhhhHHHH
Confidence            9999999999999999997533   2345689999999999843  22235789999999983

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.92  E-value=1e-25  Score=248.29  Aligned_cols=134  Identities=28%  Similarity=0.507  Sum_probs=119.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.++..+|||||||.| ++.+++. ..+.+++..++.++.||+.||+|||+++|+||||||+
T Consensus        92 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~  170 (350)
T 1rdq_E           92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE  170 (350)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccc
Confidence            4678899999999999999999999999999985 5555554 3467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCccccc-CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIK-CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||+++.. ......+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       171 NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  227 (350)
T 1rdq_E          171 NLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL---SKGYNKAVDWWALGVL  227 (350)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             eEEECCCCCEEEcccccceeccCCcccccCCccccCHHHhc---CCCCCCcCCEecccHh
Confidence            999999999999999999753 3344678999999999984   4568999999999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.92  E-value=7.7e-26  Score=244.61  Aligned_cols=137  Identities=31%  Similarity=0.504  Sum_probs=121.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.++..+|||||||.|++.+.+......+++..++.++.|++.||+|||+++|+||||||+|
T Consensus        70 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~N  149 (311)
T 3niz_A           70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQN  149 (311)
T ss_dssp             HHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHh
Confidence            46789999999999999999999999999999999988887777789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||++....    .....+||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       150 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il  210 (311)
T 3niz_A          150 LLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG--SKKYSTSVDIWSIGCIF  210 (311)
T ss_dssp             EEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT--CCSCCTHHHHHHHHHHH
T ss_pred             EEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC--CCCCCchHHhHHHHHHH
Confidence            999999999999999997532    2234579999999999842  35689999999999983

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=8.2e-26  Score=251.37  Aligned_cols=132  Identities=32%  Similarity=0.540  Sum_probs=115.9

Q ss_pred             HHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEE
Q psy17952          8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL   87 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill   87 (804)
                      ++.++|||||+++++|.+++.+|||||||.|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll  172 (373)
T 2r5t_A           93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL  172 (373)
T ss_dssp             BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE
Confidence            56789999999999999999999999999875444333445689999999999999999999999999999999999999


Q ss_pred             cCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         88 TETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        88 ~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +.+|.+||+|||+++..    ......+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       173 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  228 (373)
T 2r5t_A          173 DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAV  228 (373)
T ss_dssp             CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhC---CCCCCchhhhHHHHHH
Confidence            99999999999999752    2334578999999999983   4568999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.92  E-value=1e-25  Score=253.63  Aligned_cols=137  Identities=31%  Similarity=0.539  Sum_probs=118.1

Q ss_pred             HHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          4 GSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         4 ~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      -..+|+.++|||||+++++|.++..+|||||||.|+ |.+++..  ..+++..++.++.||+.||+|||+++|+||||||
T Consensus       119 E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp  196 (410)
T 3v8s_A          119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP  196 (410)
T ss_dssp             HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH
Confidence            357899999999999999999999999999999864 5555543  5799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcc-cCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~-~~~~~~~vDvwslG~~  142 (804)
                      +|||++.+|.+||+|||+|+....     ....+||+.|+|||++.+.. .+.|+.++|+||+|++
T Consensus       197 ~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvi  262 (410)
T 3v8s_A          197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF  262 (410)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHH
T ss_pred             HHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHH
Confidence            999999999999999999975322     23578999999999985321 1238899999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.2e-25  Score=253.29  Aligned_cols=138  Identities=28%  Similarity=0.504  Sum_probs=120.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      +.+|+.++|||||+++++|.+++.+|||||||.| ++.+++......+++..++.++.||+.||+|||+++|+||||||+
T Consensus       112 ~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~  191 (412)
T 2vd5_A          112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD  191 (412)
T ss_dssp             HHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHH
Confidence            5688999999999999999999999999999975 566666655568999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcc----cCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~----~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||+++....     ....+||+.|+|||++....    .+.|+.++|+||+|++
T Consensus       192 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi  259 (412)
T 2vd5_A          192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF  259 (412)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred             HeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence            99999999999999999975322     23468999999999985211    3468999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.92  E-value=1.6e-25  Score=247.24  Aligned_cols=134  Identities=31%  Similarity=0.543  Sum_probs=117.1

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|+.+ +||||++++++|.+++.+|||||||.|+ |.+++. ..+.+++..++.++.||+.||+|||++||+||||||
T Consensus        71 ~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp  149 (353)
T 2i0e_A           71 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL  149 (353)
T ss_dssp             HHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred             HHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCH
Confidence            3566666 8999999999999999999999999865 555554 446799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.+|.+||+|||+++..    ......+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       150 ~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  210 (353)
T 2i0e_A          150 DNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVL  210 (353)
T ss_dssp             GGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT---TCCBSTHHHHHHHHHH
T ss_pred             HHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhc---CCCcCCcccccchHHH
Confidence            9999999999999999999752    2234578999999999983   4578999999999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.92  E-value=2.9e-25  Score=238.45  Aligned_cols=134  Identities=45%  Similarity=0.810  Sum_probs=117.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|..++.+|+|||||.|+ +.+++..  ..+++..+..++.|++.||+|||+++|+||||||+
T Consensus        68 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~  145 (297)
T 3fxz_A           68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD  145 (297)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH
Confidence            35788999999999999999999999999999754 5555543  46999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++.+||+|||++....    .....+||+.|+|||++.   ...|+.++|+||+|++.
T Consensus       146 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  206 (297)
T 3fxz_A          146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMA  206 (297)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHH---CSCBCTHHHHHHHHHHH
T ss_pred             HEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhc---CCCCCcHHHHHHHHHHH
Confidence            9999999999999999986532    223468999999999984   45789999999999983

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.92  E-value=2.5e-25  Score=239.64  Aligned_cols=135  Identities=36%  Similarity=0.650  Sum_probs=119.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.+++..|+|||||.| ++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        58 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~  137 (310)
T 3s95_A           58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH  137 (310)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred             HHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcC
Confidence            4678899999999999999999999999999986 666777666778999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC------------------CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~------------------~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++......                  ...+||+.|+|||++.   ...++.++|+||+|++
T Consensus       138 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  211 (310)
T 3s95_A          138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN---GRSYDEKVDVFSFGIV  211 (310)
T ss_dssp             SEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             eEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhc---CCCCCcHHHHHHHHHH
Confidence            999999999999999999642110                  1457999999999983   4678999999999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.92  E-value=1.1e-25  Score=239.92  Aligned_cols=136  Identities=27%  Similarity=0.468  Sum_probs=118.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||++++++.+++.+|+||||+.|++.+++......+++..++.++.|+++||+|||+++|+||||||+|
T Consensus        51 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  130 (288)
T 1ob3_A           51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN  130 (288)
T ss_dssp             HHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             HHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            35788999999999999999999999999999999888887666889999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||++....    ......||+.|+|||++.+  ...++.++|+||+|++
T Consensus       131 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  190 (288)
T 1ob3_A          131 LLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCI  190 (288)
T ss_dssp             EEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTT--CCSCCTHHHHHHHHHH
T ss_pred             EEEcCCCCEEEeECccccccCccccccccccccccccCchheeC--CCCCCcHHHHHHHHHH
Confidence            999999999999999986432    2234579999999999842  3458999999999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.92  E-value=1.4e-25  Score=255.74  Aligned_cols=136  Identities=29%  Similarity=0.477  Sum_probs=115.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC-----CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~-----~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|+.++|||||+++++|...     ..+||||||+.|++.+++. ....+++..++.++.||+.||+|||+++|||||
T Consensus       103 ~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrD  181 (458)
T 3rp9_A          103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRD  181 (458)
T ss_dssp             HHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             HHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCC
Confidence            4678999999999999998543     5699999999998888775 456799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccC-------------------------------CCCccccccccCcchhhhhcccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKC-------------------------------PANSFVGTPYWMAPEVILAMDEG  128 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~-------------------------------~~~~~~gt~~y~APE~l~~~~~~  128 (804)
                      |||+|||++.++.+||+|||+|+...                               .....+||++|+|||++.  ...
T Consensus       182 lKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~  259 (458)
T 3rp9_A          182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL--LQE  259 (458)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT--TCC
T ss_pred             CChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh--CCC
Confidence            99999999999999999999997532                               112357899999999873  345


Q ss_pred             ccCCcccccccccCC
Q psy17952        129 QYDGKVDVWSLGITP  143 (804)
Q Consensus       129 ~~~~~vDvwslG~~~  143 (804)
                      .|+.++|+||+|+++
T Consensus       260 ~~~~~~DiwSlG~il  274 (458)
T 3rp9_A          260 NYTEAIDVWSIGCIF  274 (458)
T ss_dssp             CCCTHHHHHHHHHHH
T ss_pred             CCCcHhHHHHHHHHH
Confidence            699999999999983

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=2.6e-25  Score=242.36  Aligned_cols=135  Identities=30%  Similarity=0.493  Sum_probs=116.0

Q ss_pred             HHHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          4 GSSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         4 ~~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      -..+|++++|||||+++++|.+++.+|||||||.|+ +.+++. ....+++..+..++.||+.||+|||+++|+||||||
T Consensus        71 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp  149 (327)
T 3a62_A           71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKP  149 (327)
T ss_dssp             HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred             HHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence            356899999999999999999999999999999865 555554 456799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.+|.+||+|||+++...    .....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       150 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  210 (327)
T 3a62_A          150 ENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM---RSGHNRAVDWWSLGAL  210 (327)
T ss_dssp             TTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHT---TSCCCTHHHHHHHHHH
T ss_pred             HHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCc---CCCCCCcccchhHHHH
Confidence            99999999999999999987422    233468999999999983   4568999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.92  E-value=3.1e-25  Score=245.61  Aligned_cols=134  Identities=34%  Similarity=0.562  Sum_probs=117.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+.+.+|||||||.|+ +.+++ .....+++..+..++.||+.||+|||++||+||||||+
T Consensus        66 ~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~  144 (361)
T 2yab_A           66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE  144 (361)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH-TTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            45788999999999999999999999999999855 55555 44578999999999999999999999999999999999


Q ss_pred             cEEEcCCC----ceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETG----TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~----~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++    .+||+|||++....   .....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       145 NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvi  207 (361)
T 2yab_A          145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVI  207 (361)
T ss_dssp             GEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             HEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHc---CCCCCccccHHHHHHH
Confidence            99998877    79999999997532   234568999999999973   4578999999999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=2.4e-25  Score=241.26  Aligned_cols=137  Identities=28%  Similarity=0.461  Sum_probs=120.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-----RPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.|++.+++....     ..+++..++.++.||+.||+|||++||+|||
T Consensus        54 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~D  133 (317)
T 2pmi_A           54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRD  133 (317)
T ss_dssp             HHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence            35788999999999999999999999999999999888876542     4699999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+|||++.+|.+||+|||++....    .....+||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       134 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il  199 (317)
T 2pmi_A          134 LKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG--SRTYSTSIDIWSCGCIL  199 (317)
T ss_dssp             CCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT--CCCCCTHHHHHHHHHHH
T ss_pred             CChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhC--CCCCCcHHHHHHHHHHH
Confidence            99999999999999999999997532    2234579999999999842  34689999999999983

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.92  E-value=3.3e-25  Score=237.57  Aligned_cols=134  Identities=31%  Similarity=0.478  Sum_probs=113.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.+++.+|+|||||+| ++.+++. ..+++++..+..++.|++.||+|||+++|+||||||+
T Consensus        62 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~  140 (294)
T 4eqm_A           62 VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ  140 (294)
T ss_dssp             HHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            3567889999999999999999999999999986 5555554 4468999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++....     ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       141 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  201 (294)
T 4eqm_A          141 NILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK---GEATDECTDIYSIGIV  201 (294)
T ss_dssp             GEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHH---TCCCCTTHHHHHHHHH
T ss_pred             HEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhc---CCCCCchHhHHHHHHH
Confidence            9999999999999999997532     223457999999999984   4568889999999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.2e-25  Score=241.14  Aligned_cols=135  Identities=27%  Similarity=0.420  Sum_probs=118.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+.+.+|||||||.| ++.+.+......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        52 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~  131 (321)
T 1tki_A           52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE  131 (321)
T ss_dssp             HHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence            4678999999999999999999999999999986 566666544567999999999999999999999999999999999


Q ss_pred             cEEEcC--CCceEEeccCcccccCCC---CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTE--TGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~--~~~~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.  ++.+||+|||++......   ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       132 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  192 (321)
T 1tki_A          132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ---HDVVSTATDMWSLGTL  192 (321)
T ss_dssp             GEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHT---TCEECHHHHHHHHHHH
T ss_pred             HEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhc---CCCCCchhhHHHHHHH
Confidence            999987  789999999999754322   2357999999999973   4567899999999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.91  E-value=4.2e-25  Score=238.70  Aligned_cols=132  Identities=32%  Similarity=0.445  Sum_probs=116.9

Q ss_pred             HHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEE
Q psy17952          8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL   87 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill   87 (804)
                      .+..+|||||+++++|.+++.+|||||||.|++.+++.....++++..++.++.|++.||+|||+++|+||||||+|||+
T Consensus       111 ~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll  190 (311)
T 3p1a_A          111 EKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL  190 (311)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence            34449999999999999999999999999999988887777789999999999999999999999999999999999999


Q ss_pred             cCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         88 TETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        88 ~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +.++.+||+|||++....   ......||+.|+|||++.    +.++.++|+||+|++.
T Consensus       191 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il  245 (311)
T 3p1a_A          191 GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ----GSYGTAADVFSLGLTI  245 (311)
T ss_dssp             CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGG----TCCSTHHHHHHHHHHH
T ss_pred             CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhc----CCCCchhhHHHHHHHH
Confidence            999999999999986532   223457999999999873    3689999999999983

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.91  E-value=3.5e-25  Score=242.80  Aligned_cols=134  Identities=34%  Similarity=0.530  Sum_probs=118.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|+.++|||||++++++.++..+||||||+.|++.+++.. ..++++..++.++.|++.||+|||++||+||||||+|
T Consensus        60 ~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~N  138 (336)
T 3h4j_B           60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPEN  138 (336)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTT
T ss_pred             HHHHHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhh
Confidence            357889999999999999999999999999998888887764 4679999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCcc-CCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~-~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||++....   .....+||+.|+|||++.   ...+ +.++|+||+|++
T Consensus       139 Ill~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~i  197 (336)
T 3h4j_B          139 LLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN---GKLYAGPEVDVWSCGIV  197 (336)
T ss_dssp             EEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSC---CSGGGCHHHHHHHHHHH
T ss_pred             EEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHc---CCCCCCCccchhHHHHH
Confidence            999999999999999997532   234568999999999973   2334 688999999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=4e-25  Score=246.29  Aligned_cols=133  Identities=31%  Similarity=0.542  Sum_probs=115.0

Q ss_pred             HHHHhcC-CCCeeeEeEEEEeCC--eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          6 SLLRQLK-HPNTIEYRGCYLRDH--TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         6 ~iL~~l~-HpnIV~l~~~~~~~~--~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      .+|+.+. |||||+++++|..++  .+|||||||.|++.+++..  ..+++..++.++.||+.||+|||++||+||||||
T Consensus        60 ~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp  137 (388)
T 3oz6_A           60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP  137 (388)
T ss_dssp             HHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH
Confidence            5677886 999999999998654  6999999999988887764  5799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-------------------------CCccccccccCcchhhhhcccCccCCccccc
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVW  137 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-------------------------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvw  137 (804)
                      +|||++.++.+||+|||+|+....                         ....+||++|+|||++.+  ...|+.++|+|
T Consensus       138 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Diw  215 (388)
T 3oz6_A          138 SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG--STKYTKGIDMW  215 (388)
T ss_dssp             GGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT--CCCCCTHHHHH
T ss_pred             HHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC--CCCCCChhhHH
Confidence            999999999999999999964211                         123589999999999843  35689999999


Q ss_pred             ccccC
Q psy17952        138 SLGIT  142 (804)
Q Consensus       138 slG~~  142 (804)
                      |+|++
T Consensus       216 SlG~i  220 (388)
T 3oz6_A          216 SLGCI  220 (388)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.91  E-value=6.9e-25  Score=249.48  Aligned_cols=135  Identities=29%  Similarity=0.496  Sum_probs=117.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+++++|.+++..|||||||.|+ +.+.+. ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus        61 ~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~-~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~  139 (444)
T 3soa_A           61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE  139 (444)
T ss_dssp             HHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSST
T ss_pred             HHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence            46789999999999999999999999999999865 555554 4578999999999999999999999999999999999


Q ss_pred             cEEEc---CCCceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLT---ETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~---~~~~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++   +++.+||+|||++.....    ....+||+.|+|||++.   ...|+.++|+||+|++.
T Consensus       140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~DIwSlGvil  203 (444)
T 3soa_A          140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR---KDPYGKPVDLWACGVIL  203 (444)
T ss_dssp             TEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHH
T ss_pred             HEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhc---CCCCCCccccHHHHHHH
Confidence            99998   467899999999975332    23468999999999973   45789999999999983

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.91  E-value=7.8e-25  Score=242.30  Aligned_cols=135  Identities=30%  Similarity=0.542  Sum_probs=116.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+++++|.+++..|||||||.|+ +.+.+. ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus        79 ~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~  157 (362)
T 2bdw_A           79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE  157 (362)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH
Confidence            46789999999999999999999999999999865 555553 4567999999999999999999999999999999999


Q ss_pred             cEEEcCCC---ceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETG---TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~---~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++   .+||+|||++.....   ....+||+.|+|||++.   ...|+.++|+||+|++.
T Consensus       158 NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  220 (362)
T 2bdw_A          158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVIL  220 (362)
T ss_dssp             GEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             HEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHc---cCCCCchhhHHHHHHHH
Confidence            99998654   599999999975432   23468999999999973   45789999999999983

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.91  E-value=4e-25  Score=244.09  Aligned_cols=135  Identities=18%  Similarity=0.263  Sum_probs=116.4

Q ss_pred             HHHHHhcC---CCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q psy17952          5 SSLLRQLK---HPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEV----HKRPLKEEEIAAICSGVLRGLNYLHSLGRI   76 (804)
Q Consensus         5 ~~iL~~l~---HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~----~~~~l~~~~~~~~~~qi~~aL~ylH~~~Ii   76 (804)
                      ..+++.++   |||||++++++..++..|||||||. |+|.+++..    ....+++..+..++.||+.||+|||+++|+
T Consensus       115 ~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~iv  194 (365)
T 3e7e_A          115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEII  194 (365)
T ss_dssp             HHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            35666676   9999999999999999999999998 566676654    245799999999999999999999999999


Q ss_pred             ccccccccEEEcC-----------CCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCccccccc
Q psy17952         77 HRDVKAGNILLTE-----------TGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  139 (804)
Q Consensus        77 HRDlKp~Nill~~-----------~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwsl  139 (804)
                      ||||||+|||++.           ++.+||+|||+|+...      .....+||+.|||||++.   ...|+.++|+||+
T Consensus       195 HrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Diwsl  271 (365)
T 3e7e_A          195 HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS---NKPWNYQIDYFGV  271 (365)
T ss_dssp             CCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT---TCCBSTHHHHHHH
T ss_pred             cCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc---CCCCCccccHHHH
Confidence            9999999999998           8999999999996421      123457999999999984   4568999999999


Q ss_pred             ccC
Q psy17952        140 GIT  142 (804)
Q Consensus       140 G~~  142 (804)
                      |++
T Consensus       272 G~i  274 (365)
T 3e7e_A          272 AAT  274 (365)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.91  E-value=3.5e-25  Score=251.71  Aligned_cols=134  Identities=29%  Similarity=0.531  Sum_probs=116.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~N   84 (804)
                      .+|+.++|||||+++++|.+++.+|||||||.|+.+..+......+++..++.++.||+.||+|||+ ++|+||||||+|
T Consensus       200 ~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~N  279 (446)
T 4ejn_A          200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  279 (446)
T ss_dssp             -CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGG
T ss_pred             HHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHH
Confidence            4677889999999999999999999999999875544433445689999999999999999999998 999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||+|+...    .....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       280 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  338 (446)
T 4ejn_A          280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVV  338 (446)
T ss_dssp             EEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHH---TSCCCTHHHHHHHHHH
T ss_pred             EEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcC---CCCCCCccchhhhHHH
Confidence            999999999999999997522    234568999999999983   4578999999999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.91  E-value=9.7e-25  Score=237.69  Aligned_cols=134  Identities=33%  Similarity=0.582  Sum_probs=117.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.++..+|||||||.| ++.+++ .....+++..+..++.|++.||.|||+++|+||||||+
T Consensus        65 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~  143 (326)
T 2y0a_A           65 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE  143 (326)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH-TTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHH-HhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHH
Confidence            4678999999999999999999999999999986 555555 34578999999999999999999999999999999999


Q ss_pred             cEEEcCCC----ceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETG----TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~----~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++    .+||+|||++....   .....+||+.|+|||++   ....++.++|+||+|++
T Consensus       144 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~i  206 (326)
T 2y0a_A          144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV---NYEPLGLEADMWSIGVI  206 (326)
T ss_dssp             GEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHH---TTCCCCTHHHHHHHHHH
T ss_pred             HEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceee---cCCCCCcHHHHHHHHHH
Confidence            99999887    89999999997532   23346799999999997   34578999999999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.91  E-value=5e-25  Score=239.50  Aligned_cols=136  Identities=30%  Similarity=0.520  Sum_probs=118.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|+.++|||||++++++.+++.+|||||||.|++.+++......+++..++.++.|++.||+|||++||+||||||+|
T Consensus        51 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~N  130 (324)
T 3mtl_A           51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQN  130 (324)
T ss_dssp             HHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGG
T ss_pred             HHHHHhcCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHH
Confidence            46789999999999999999999999999999999999888777789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||++....    .....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       131 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  190 (324)
T 3mtl_A          131 LLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG--STDYSTQIDMWGVGCI  190 (324)
T ss_dssp             EEECTTCCEEECSSSEEECC------------CGGGCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             EEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcC--CCCCCcHHHHHHHHHH
Confidence            999999999999999997532    2234578999999999842  3468999999999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.91  E-value=1.6e-24  Score=233.18  Aligned_cols=132  Identities=36%  Similarity=0.536  Sum_probs=114.8

Q ss_pred             HhcCCCCeeeEeEEEEeCC-----eEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          9 RQLKHPNTIEYRGCYLRDH-----TAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         9 ~~l~HpnIV~l~~~~~~~~-----~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      +.++|||||+++++|....     .+|+||||+.|++.+++.... ..+++..++.++.|++.||+|||+++|+||||||
T Consensus        69 ~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp  148 (308)
T 3g33_A           69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP  148 (308)
T ss_dssp             HHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCT
T ss_pred             hhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence            3445999999999998765     589999999999888876543 3499999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +|||++.++.+||+|||+++...   .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       149 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  209 (308)
T 3g33_A          149 ENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIF  209 (308)
T ss_dssp             TTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH---TSCCCSTHHHHHHHHHH
T ss_pred             HHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHc---CCCCCchHHHHHHHHHH
Confidence            99999999999999999997532   234468999999999984   45689999999999984

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.91  E-value=5.4e-25  Score=249.28  Aligned_cols=136  Identities=32%  Similarity=0.489  Sum_probs=117.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC-----CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~-----~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|++++|||||++++++...     ..+|||||||.|++.+++. ....+++..++.++.||++||+|||+++|+|||
T Consensus        76 ~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrD  154 (432)
T 3n9x_A           76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRD  154 (432)
T ss_dssp             HHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Confidence            3578999999999999999776     5799999999998888775 456799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccCC--------------------------CCccccccccCcchhhhhcccCccCCc
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKCP--------------------------ANSFVGTPYWMAPEVILAMDEGQYDGK  133 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~~--------------------------~~~~~gt~~y~APE~l~~~~~~~~~~~  133 (804)
                      |||+|||++.++.+||+|||+|+....                          ....+||++|+|||++.  ....|+.+
T Consensus       155 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~~~~~  232 (432)
T 3n9x_A          155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL--LQENYTKS  232 (432)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHT--TCSCCCTH
T ss_pred             CCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh--cCCCCCcc
Confidence            999999999999999999999975321                          14568999999999874  34569999


Q ss_pred             ccccccccCC
Q psy17952        134 VDVWSLGITP  143 (804)
Q Consensus       134 vDvwslG~~~  143 (804)
                      +|+||+|+++
T Consensus       233 ~DiwSlG~il  242 (432)
T 3n9x_A          233 IDIWSTGCIF  242 (432)
T ss_dssp             HHHHHHHHHH
T ss_pred             cccchHHHHH
Confidence            9999999983

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.91  E-value=9.1e-25  Score=237.71  Aligned_cols=135  Identities=22%  Similarity=0.272  Sum_probs=120.1

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++| +||||+++++++..++..|||||||.|++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        55 ~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~  134 (330)
T 2izr_A           55 YRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPE  134 (330)
T ss_dssp             HHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence            4688999 999999999999999999999999977788888766678999999999999999999999999999999999


Q ss_pred             cEEEcCCCc-----eEEeccCcccccCC-----------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGT-----VKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~-----~kl~DFG~a~~~~~-----------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.     +||+|||+++....           ....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       135 Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  206 (330)
T 2izr_A          135 NFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL---GKEQSRRDDLEALGHM  206 (330)
T ss_dssp             GEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             HeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHc---CCCCCchhHHHHHHHH
Confidence            999998887     99999999974211           23568999999999984   4568999999999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.91  E-value=1.1e-24  Score=239.73  Aligned_cols=135  Identities=35%  Similarity=0.494  Sum_probs=115.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.| ++.+.+...   ...+++..+..++.||+.||+|||+++|+||||
T Consensus        77 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDl  156 (351)
T 3c0i_A           77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDV  156 (351)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             HHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence            4678999999999999999999999999999985 455555432   246899999999999999999999999999999


Q ss_pred             ccccEEEcCCCc---eEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLTETGT---VKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~~~~~---~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+|||++.++.   +||+|||++.....    ....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       157 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  222 (351)
T 3c0i_A          157 KPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK---REPYGKPVDVWGCGVI  222 (351)
T ss_dssp             SGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             ChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHc---CCCCCchHhhHHHHHH
Confidence            999999987654   99999999975322    23468999999999983   4568999999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.91  E-value=5.5e-25  Score=243.06  Aligned_cols=133  Identities=25%  Similarity=0.347  Sum_probs=114.3

Q ss_pred             HHHhcCCCCeeeEeEEEEeC----CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          7 LLRQLKHPNTIEYRGCYLRD----HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~----~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      .++.++|||||++++++...    ...|||||||.|+|.+++.....++++..+..++.||+.||+|||+++|+||||||
T Consensus       101 ~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp  180 (364)
T 3op5_A          101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKA  180 (364)
T ss_dssp             HHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCH
Confidence            45678899999999998764    45899999996667777766667899999999999999999999999999999999


Q ss_pred             ccEEEc--CCCceEEeccCcccccC-----------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLT--ETGTVKLADFGSASIKC-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~--~~~~~kl~DFG~a~~~~-----------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++  .++.+||+|||+++...           .....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  250 (364)
T 3op5_A          181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN---GVAPSRRGDLEILGYC  250 (364)
T ss_dssp             GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC---CCCCCchhhHHHHHHH
Confidence            999999  88999999999996421           113356999999999983   4568999999999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.91  E-value=6e-25  Score=251.40  Aligned_cols=131  Identities=34%  Similarity=0.564  Sum_probs=111.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEeC------CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRD------HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~------~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .+|+.++|||||+++++|...      ..+|||||||.|++.+.+.   ..+++..++.++.||+.||+|||++||+|||
T Consensus       113 ~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrD  189 (464)
T 3ttj_A          113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRD  189 (464)
T ss_dssp             HHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            578999999999999999755      3579999999998877664   4599999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||++.++.+||+|||+|+....   ....+||++|+|||++.   ...|+.++|+||+|++
T Consensus       190 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~i  252 (464)
T 3ttj_A          190 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  252 (464)
T ss_dssp             CCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             CChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHc---CCCCCHHHHHHHHHHH
Confidence            999999999999999999999975432   34578999999999984   3468999999999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.91  E-value=1.2e-24  Score=253.97  Aligned_cols=135  Identities=26%  Similarity=0.349  Sum_probs=117.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.|+. .+++... ...+++..++.++.||+.||+|||+++|+||||||
T Consensus       235 ~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKP  314 (576)
T 2acx_A          235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP  314 (576)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCch
Confidence            468999999999999999999999999999998654 4455432 23599999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.+|.+||+|||+++....   ....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       315 eNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~~~~~DiwSLGvi  374 (576)
T 2acx_A          315 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK---NERYTFSPDWWALGCL  374 (576)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHT---TCEESSHHHHHHHHHH
T ss_pred             heEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHc---CCCCCccchHHHHHHH
Confidence            999999999999999999975322   23468999999999983   4568999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.91  E-value=1.6e-24  Score=251.87  Aligned_cols=135  Identities=28%  Similarity=0.421  Sum_probs=118.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|++++|||||+++++|.++..+|||||||.|+ +.+++...   ...+++..++.++.||+.||+|||+++|+||||
T Consensus       236 ~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDL  315 (543)
T 3c4z_A          236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL  315 (543)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCC
Confidence            46889999999999999999999999999999865 44555432   346999999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+|||++.+|.+||+|||+++...    .....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       316 KP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiwSlGvi  378 (543)
T 3c4z_A          316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL---GEEYDFSVDYFALGVT  378 (543)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             ChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhc---CCCCChHHhcCcchHH
Confidence            9999999999999999999997532    223468999999999984   4578999999999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.91  E-value=1.5e-24  Score=237.90  Aligned_cols=137  Identities=30%  Similarity=0.502  Sum_probs=119.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe--------CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR--------DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI   76 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~--------~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~Ii   76 (804)
                      ..+|++++|||||++++++..        .+.+|||||||.|++.+.+......+++..++.++.|++.||+|||++||+
T Consensus        67 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv  146 (351)
T 3mi9_A           67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKIL  146 (351)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            467899999999999999987        446899999999999888876667899999999999999999999999999


Q ss_pred             ccccccccEEEcCCCceEEeccCcccccC--------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         77 HRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        77 HRDlKp~Nill~~~~~~kl~DFG~a~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||||||+|||++.++.+||+|||++....        .....+||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       147 H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il  219 (351)
T 3mi9_A          147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIM  219 (351)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT--CCSCCTHHHHHHHHHHH
T ss_pred             CCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcC--CCCCCcHhHHHHHHHHH
Confidence            99999999999999999999999996422        1234578999999999842  34589999999999983

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.91  E-value=2.4e-24  Score=240.01  Aligned_cols=137  Identities=35%  Similarity=0.598  Sum_probs=117.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.| ++.+++... ...+++..++.++.||+.||+|||+++|+||||||
T Consensus        77 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp  156 (389)
T 3gni_B           77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKA  156 (389)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            4678999999999999999999999999999985 555665543 36799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc-----------CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIK-----------CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||++...           ......+||+.|+|||++.+ ....|+.++|+||+|++
T Consensus       157 ~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwslG~i  226 (389)
T 3gni_B          157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ-NLQGYDAKSDIYSVGIT  226 (389)
T ss_dssp             GGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST-TSSCBCTHHHHHHHHHH
T ss_pred             HHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhc-cCCCCCcHhHHHHHHHH
Confidence            9999999999999999987531           11123479999999999843 12468999999999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.91  E-value=1.2e-24  Score=243.37  Aligned_cols=136  Identities=34%  Similarity=0.594  Sum_probs=117.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC------eEEEEEeccCCCcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH------TAWLVMEYCLGSASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSLGR   75 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~------~~~lV~Ey~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~I   75 (804)
                      ..+|+.++|||||+++++|....      .+|||||||.+++++.+..   ....+++..++.++.||+.||+|||+++|
T Consensus        83 ~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  162 (394)
T 4e7w_A           83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI  162 (394)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            46899999999999999986543      3899999999987765542   35689999999999999999999999999


Q ss_pred             cccccccccEEEc-CCCceEEeccCccccc---CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         76 IHRDVKAGNILLT-ETGTVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        76 iHRDlKp~Nill~-~~~~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +||||||+|||++ .++.+||+|||+|+..   ......+||+.|+|||++.+  ...|+.++|+||+|++
T Consensus       163 vHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~i  231 (394)
T 4e7w_A          163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCV  231 (394)
T ss_dssp             ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             cCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC--CCCCCcHHHHHHHHHH
Confidence            9999999999999 7899999999999753   23345689999999999843  3458999999999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.90  E-value=6.1e-25  Score=233.53  Aligned_cols=136  Identities=24%  Similarity=0.351  Sum_probs=120.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.+++..|+|||||. |++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        63 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~  142 (289)
T 4fvq_A           63 ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAK  142 (289)
T ss_dssp             HHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcc
Confidence            467899999999999999999999999999998 5677777665556999999999999999999999999999999999


Q ss_pred             cEEEcCCCc--------eEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGT--------VKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~--------~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.        +||+|||++..........||+.|+|||++.+  ...++.++|+||+|++
T Consensus       143 NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  207 (289)
T 4fvq_A          143 NILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN--PKNLNLATDKWSFGTT  207 (289)
T ss_dssp             GEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHC--GGGCCHHHHHHHHHHH
T ss_pred             eEEEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhCC--CCCCCchhHHHHHHHH
Confidence            999998887        99999999976555555679999999999842  2568899999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.90  E-value=1.5e-24  Score=240.75  Aligned_cols=135  Identities=29%  Similarity=0.529  Sum_probs=116.7

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---------------CCCCHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---------------RPLKEEEIAAICSGVLRGL   67 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~aL   67 (804)
                      ..+|+.+ +|||||+++++|.+++.+|||||||.| +|.+++....               ..+++..+..++.||+.||
T Consensus       137 ~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL  216 (370)
T 2psq_A          137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM  216 (370)
T ss_dssp             HHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence            4678888 899999999999999999999999985 6677766542               3589999999999999999


Q ss_pred             HHHHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCccccccccc
Q psy17952         68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  141 (804)
Q Consensus        68 ~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~  141 (804)
                      +|||+++|+||||||+|||++.++.+||+|||+++...      ......||+.|+|||++.   ...|+.++|+||+|+
T Consensus       217 ~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~  293 (370)
T 2psq_A          217 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGV  293 (370)
T ss_dssp             HHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH---TCCCCHHHHHHHHHH
T ss_pred             HHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc---CCCCCcHHHHHHHHH
Confidence            99999999999999999999999999999999997432      122346788999999984   456899999999999


Q ss_pred             C
Q psy17952        142 T  142 (804)
Q Consensus       142 ~  142 (804)
                      +
T Consensus       294 i  294 (370)
T 2psq_A          294 L  294 (370)
T ss_dssp             H
T ss_pred             H
Confidence            8

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.90  E-value=9.9e-25  Score=237.43  Aligned_cols=135  Identities=33%  Similarity=0.562  Sum_probs=116.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||++++++.+++..|||||||.| ++.+++. ....+++..++.++.|++.||+|||+++|+||||||+
T Consensus        56 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~  134 (323)
T 3tki_A           56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE  134 (323)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchH
Confidence            4578999999999999999999999999999986 4555543 4467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++....      .....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       135 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~i  197 (323)
T 3tki_A          135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIV  197 (323)
T ss_dssp             GEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC--SSBCHHHHHHHHHHHH
T ss_pred             HEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc--CCCCCCcccHHHHHHH
Confidence            9999999999999999996421      2235689999999999842  2334778999999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.90  E-value=1.2e-24  Score=236.98  Aligned_cols=134  Identities=31%  Similarity=0.544  Sum_probs=100.8

Q ss_pred             HHHHhcC-CCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~-HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|+.+. |||||+++++|.++...|||||||.| ++.+++. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        57 ~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  135 (325)
T 3kn6_A           57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK-KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPE  135 (325)
T ss_dssp             HHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHH
Confidence            5677886 99999999999999999999999986 5556554 4578999999999999999999999999999999999


Q ss_pred             cEEEcCCC---ceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETG---TVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~---~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++   .+||+|||+++....    ....+||+.|+|||++.   ...|+.++|+||+|++.
T Consensus       136 NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il  199 (325)
T 3kn6_A          136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN---QNGYDESCDLWSLGVIL  199 (325)
T ss_dssp             GEEEEC----CEEEECCCTTCEECCC-------------------------CCCCHHHHHHHHHHHH
T ss_pred             HEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhc---CCCCCCccchHHHHHHH
Confidence            99998766   899999999975322    23457899999999973   45689999999999983

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.90  E-value=1.5e-24  Score=241.03  Aligned_cols=136  Identities=30%  Similarity=0.446  Sum_probs=118.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+++++|.+.+.+|||||||.| ++.+.+......+++..+..++.||+.||+|||+++|+||||||+
T Consensus       137 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  216 (373)
T 2x4f_A          137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE  216 (373)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH
Confidence            3678899999999999999999999999999985 677777666667999999999999999999999999999999999


Q ss_pred             cEEE--cCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILL--TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill--~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+  +.++.+||+|||+++....   ....+||+.|+|||++   ....++.++|+||+|++.
T Consensus       217 NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il  278 (373)
T 2x4f_A          217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV---NYDFVSFPTDMWSVGVIA  278 (373)
T ss_dssp             GEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHH---TTCBCCHHHHHHHHHHHH
T ss_pred             HEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhc---cCCCCCcHHhHHHHHHHH
Confidence            9999  5677999999999975332   2345799999999997   345688899999999983

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.90  E-value=2.9e-24  Score=236.24  Aligned_cols=136  Identities=32%  Similarity=0.549  Sum_probs=119.2

Q ss_pred             HHHHHhcC-----CCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          5 SSLLRQLK-----HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         5 ~~iL~~l~-----HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      ..+|++++     |||||+++++|...+.+|||||||.|++.+++.... ..+++..++.++.||+.||+|||+++|+||
T Consensus        82 ~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  161 (360)
T 3llt_A           82 ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHT  161 (360)
T ss_dssp             HHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            35677776     999999999999999999999999778888876543 469999999999999999999999999999


Q ss_pred             ccccccEEEcC-------------------------CCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCC
Q psy17952         79 DVKAGNILLTE-------------------------TGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDG  132 (804)
Q Consensus        79 DlKp~Nill~~-------------------------~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~  132 (804)
                      ||||+|||++.                         ++.+||+|||++.... ......||+.|+|||++.   ...|+.
T Consensus       162 Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  238 (360)
T 3llt_A          162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL---NLGWDV  238 (360)
T ss_dssp             CCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT---TCCCCT
T ss_pred             CCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHc---CCCCCC
Confidence            99999999975                         7899999999997533 344578999999999984   456899


Q ss_pred             cccccccccCC
Q psy17952        133 KVDVWSLGITP  143 (804)
Q Consensus       133 ~vDvwslG~~~  143 (804)
                      ++|+||+|++.
T Consensus       239 ~~DiwslG~il  249 (360)
T 3llt_A          239 SSDMWSFGCVL  249 (360)
T ss_dssp             THHHHHHHHHH
T ss_pred             ccchHHHHHHH
Confidence            99999999983

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.90  E-value=1.8e-24  Score=233.90  Aligned_cols=135  Identities=33%  Similarity=0.590  Sum_probs=109.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcC--ccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLG--RIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~--IiHRD   79 (804)
                      ..+|++++|||||++++++.+.+.+|+|||||.| ++.+++....  ..+++..+..++.|++.||+|||+++  |+|||
T Consensus        85 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~D  164 (309)
T 3p86_A           85 VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN  164 (309)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTT
T ss_pred             HHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCC
Confidence            4678999999999999999999999999999986 5556554322  23999999999999999999999999  99999


Q ss_pred             cccccEEEcCCCceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||++.++.+||+|||+++....    .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       165 ikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  228 (309)
T 3p86_A          165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDVYSFGVI  228 (309)
T ss_dssp             CCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             CChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhc---CCCCCchhhHHHHHHH
Confidence            999999999999999999999975322    23468999999999983   4568899999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=9.3e-25  Score=239.56  Aligned_cols=136  Identities=34%  Similarity=0.496  Sum_probs=120.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+.+..|+|||||.|++.+++......+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        63 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  142 (346)
T 1ua2_A           63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN  142 (346)
T ss_dssp             HHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             HHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHH
Confidence            35789999999999999999999999999999998888877666689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||+++...    .....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  202 (346)
T 1ua2_A          143 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG--ARMYGVGVDMWAVGCI  202 (346)
T ss_dssp             EEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT--CSCCCHHHHHHHHHHH
T ss_pred             EEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhC--CCCCCchhhhHhHHHH
Confidence            999999999999999997532    2234579999999999842  3458889999999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.90  E-value=1.4e-24  Score=232.44  Aligned_cols=137  Identities=30%  Similarity=0.532  Sum_probs=113.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe--CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~--~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++.+  +..+|||||||.|+.+..+. ...++++..+..++.|++.||+|||+++|+||||||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            367889999999999999987  56899999999865433222 346799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||++.....    .....||+.|+|||++.+.....++.++|+||+|++
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~  229 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT  229 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence            999999999999999999975332    234579999999999743211124778999999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.90  E-value=1.6e-24  Score=258.86  Aligned_cols=135  Identities=30%  Similarity=0.513  Sum_probs=117.1

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.+ +||||++|+++|.+.+.+|||||||.|+.+..+....+.+++..++.|+.||+.||+|||+++||||||||+
T Consensus       392 ~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~  471 (674)
T 3pfq_A          392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD  471 (674)
T ss_dssp             HHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCST
T ss_pred             HHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChh
Confidence            3456666 799999999999999999999999986544443344578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||+|+..    ......+||+.|||||++.   ...|+.++|+||+|++
T Consensus       472 NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DvwSlGvi  531 (674)
T 3pfq_A          472 NVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVL  531 (674)
T ss_dssp             TEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHT---CCCBSTHHHHHHHHHH
T ss_pred             hEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhc---CCCCCccceEechHHH
Confidence            999999999999999999742    2334578999999999983   4679999999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.90  E-value=3.8e-24  Score=232.51  Aligned_cols=135  Identities=46%  Similarity=0.787  Sum_probs=117.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|+.++|||||+++++|...+..||||||+.|+.+..+. .+..+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        93 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  171 (321)
T 2c30_A           93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS  171 (321)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            35788999999999999999999999999999876544443 24679999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|+||+|++.
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il  231 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RSLYATEVDIWSLGIMV  231 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHH
T ss_pred             EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhc---CCCCCchhhHHHHHHHH
Confidence            999999999999999987532    223468999999999973   45789999999999983

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.90  E-value=2.4e-24  Score=238.20  Aligned_cols=134  Identities=35%  Similarity=0.583  Sum_probs=107.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+...+|||||||.| ++.+++. ..+++++..++.++.|++.||+|||++||+||||||+
T Consensus        67 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~  145 (361)
T 3uc3_A           67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE  145 (361)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGG
T ss_pred             HHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            3578899999999999999999999999999976 5555554 3567999999999999999999999999999999999


Q ss_pred             cEEEcCCCc--eEEeccCccccc---CCCCccccccccCcchhhhhcccCccC-CcccccccccC
Q psy17952         84 NILLTETGT--VKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~--~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~-~~vDvwslG~~  142 (804)
                      |||++.++.  +||+|||+++..   ......+||+.|+|||++.+   ..++ .++|+||+|++
T Consensus       146 Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~i  207 (361)
T 3uc3_A          146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---QEYDGKIADVWSCGVT  207 (361)
T ss_dssp             GEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHC---SSCCHHHHHHHHHHHH
T ss_pred             HEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcC---CCCCCCeeeeehhHHH
Confidence            999987765  999999999742   22345689999999999843   3444 45899999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.90  E-value=3.6e-24  Score=234.25  Aligned_cols=135  Identities=32%  Similarity=0.442  Sum_probs=116.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-C-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-G-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||+++++|.+++.+|+||||+. | ++.+++ .....+++..+..++.|++.||+|||+++|+||||||
T Consensus        80 ~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp  158 (335)
T 3dls_A           80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKD  158 (335)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHH-HTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCH
Confidence            468899999999999999999999999999996 4 444544 4556899999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||++.....   ....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       159 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~i  219 (335)
T 3dls_A          159 ENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVT  219 (335)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHH
T ss_pred             HHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcC--CCCCCCcccchhHHHH
Confidence            999999999999999999975332   234679999999999842  2233788999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.90  E-value=2.1e-24  Score=235.06  Aligned_cols=136  Identities=29%  Similarity=0.496  Sum_probs=113.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||++++++.+++.+|||||||.|++.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus        84 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~N  162 (329)
T 3gbz_A           84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQN  162 (329)
T ss_dssp             HHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             HHHHHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHH
Confidence            467899999999999999999999999999999988888764 4579999999999999999999999999999999999


Q ss_pred             EEEc-----CCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLT-----ETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~-----~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++     ..+.+||+|||++....    .....+||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       163 Ill~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il  228 (329)
T 3gbz_A          163 LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG--SRHYSTSVDIWSIACIW  228 (329)
T ss_dssp             EEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT--CCCCCTHHHHHHHHHHH
T ss_pred             EEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC--CCCCCcHHHHHHHHHHH
Confidence            9994     45569999999996432    2234578999999999843  34589999999999983

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.90  E-value=3.1e-24  Score=230.80  Aligned_cols=137  Identities=34%  Similarity=0.569  Sum_probs=116.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+++..|+|||||.|+++..+......+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        53 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~N  132 (311)
T 4agu_A           53 IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPEN  132 (311)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhh
Confidence            46789999999999999999999999999999988777666667789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |+++.++.+||+|||++.....    ....+||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       133 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il  193 (311)
T 4agu_A          133 ILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG--DTQYGPPVDVWAIGCVF  193 (311)
T ss_dssp             EEECTTSCEEECCCTTCEECC------------GGGCCHHHHHT--CSCCCTHHHHHHHHHHH
T ss_pred             EEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhc--CCCCCcchhhHHHHHHH
Confidence            9999999999999999975321    234579999999999842  35689999999999983

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.90  E-value=4.2e-24  Score=230.99  Aligned_cols=135  Identities=30%  Similarity=0.502  Sum_probs=111.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC---------------------------------------------------------
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH---------------------------------------------------------   27 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~---------------------------------------------------------   27 (804)
                      ..+|++++|||||+++++|.+..                                                         
T Consensus        55 ~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (332)
T 3qd2_B           55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKV  134 (332)
T ss_dssp             HHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCC
T ss_pred             HHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCc
Confidence            35788999999999999986543                                                         


Q ss_pred             eEEEEEeccCC-CcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCccccc
Q psy17952         28 TAWLVMEYCLG-SASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIK  104 (804)
Q Consensus        28 ~~~lV~Ey~~g-~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~  104 (804)
                      .+|||||||.| ++.+++....  ...++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus       135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence            38999999986 5555554332  24567779999999999999999999999999999999999999999999999753


Q ss_pred             CC----------------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952        105 CP----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus       105 ~~----------------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ..                ....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  265 (332)
T 3qd2_B          215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH---GNNYSHKVDIFSLGLI  265 (332)
T ss_dssp             SCC--------------CCCSCC-CGGGSCHHHHH---CCCCCTHHHHHHHHHH
T ss_pred             ccchhhccccccccccccccccCCCcCccChHHhc---CCCCcchhhHHHHHHH
Confidence            21                12357999999999984   4568999999999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.90  E-value=2.3e-24  Score=240.86  Aligned_cols=135  Identities=26%  Similarity=0.432  Sum_probs=116.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||+++++|.++..+|||||||.| ++.+++......+++..+..++.||+.||+|||+++|+||||||+
T Consensus        99 ~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~  178 (387)
T 1kob_A           99 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE  178 (387)
T ss_dssp             HHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchH
Confidence            4678999999999999999999999999999986 555665544457999999999999999999999999999999999


Q ss_pred             cEEEcC--CCceEEeccCcccccCCC---CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTE--TGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~--~~~~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.  .+.+||+|||++......   ...+||+.|+|||++.   ...++.++|+||+|++
T Consensus       179 NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~i  239 (387)
T 1kob_A          179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---REPVGFYTDMWAIGVL  239 (387)
T ss_dssp             GEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHH
T ss_pred             HeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhcc---CCCCCCcccEeeHhHH
Confidence            999974  468999999999754332   2357999999999973   4568899999999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.90  E-value=1.3e-24  Score=236.69  Aligned_cols=135  Identities=30%  Similarity=0.521  Sum_probs=116.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+++..|||||||+| ++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus       101 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~  180 (325)
T 3kul_A          101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAAR  180 (325)
T ss_dssp             HHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence            4678899999999999999999999999999986 566666655678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++....       .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       181 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  243 (325)
T 3kul_A          181 NVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA---FRTFSSASDVWSFGVV  243 (325)
T ss_dssp             GEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             eEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhc---CCCCCcHHHHHHHHHH
Confidence            99999999999999999975321       11234678899999984   3568899999999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.90  E-value=2.3e-24  Score=227.12  Aligned_cols=135  Identities=29%  Similarity=0.525  Sum_probs=118.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.+++..|+|||||.| ++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        56 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~  135 (269)
T 4hcu_A           56 AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR  135 (269)
T ss_dssp             HHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchh
Confidence            4678999999999999999999999999999986 566666655677999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....     ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       136 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  196 (269)
T 4hcu_A          136 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVL  196 (269)
T ss_dssp             GEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhc---CCCCCchhhhHHHHHH
Confidence            9999999999999999997532     223356788999999973   4568899999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.90  E-value=4e-24  Score=235.26  Aligned_cols=135  Identities=33%  Similarity=0.543  Sum_probs=109.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+.+.+|||||||.| ++.+.+. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        99 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  177 (349)
T 2w4o_A           99 IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE  177 (349)
T ss_dssp             CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcc
Confidence            3678999999999999999999999999999986 5555554 4567999999999999999999999999999999999


Q ss_pred             cEEEcC---CCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~---~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.   ++.+||+|||+++....   ....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       178 NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  240 (349)
T 2w4o_A          178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR---GCAYGPEVDMWSVGIIT  240 (349)
T ss_dssp             GEEESSSSTTCCEEECCCC----------------CGGGSCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             cEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhc---CCCCCcccchHHHHHHH
Confidence            999975   88999999999975322   23467999999999973   45689999999999983

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.90  E-value=1.2e-24  Score=241.83  Aligned_cols=135  Identities=30%  Similarity=0.527  Sum_probs=118.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++..++.+|||||||. |++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus       163 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  242 (377)
T 3cbl_A          163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR  242 (377)
T ss_dssp             HHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHH
Confidence            578999999999999999999999999999997 5677777766667999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++....      .....+++.|+|||++.   .+.++.++|+||+|++
T Consensus       243 Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~i  304 (377)
T 3cbl_A          243 NCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN---YGRYSSESDVWSFGIL  304 (377)
T ss_dssp             GEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             HEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhc---cCCCCchhhHHHHHHH
Confidence            99999999999999999975321      12234677899999984   4568999999999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.90  E-value=4.6e-24  Score=225.53  Aligned_cols=136  Identities=28%  Similarity=0.435  Sum_probs=115.1

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      .+++.+ +|||||++++++.+++..|||||||+| +|.+++...   ...+++..++.++.||+.||+|||+++|+||||
T Consensus        62 ~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Di  141 (289)
T 1x8b_A           62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI  141 (289)
T ss_dssp             HHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             HHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCC
Confidence            345566 999999999999999999999999986 666766543   267999999999999999999999999999999


Q ss_pred             ccccEEEcCC-------------------CceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCccccccccc
Q psy17952         81 KAGNILLTET-------------------GTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  141 (804)
Q Consensus        81 Kp~Nill~~~-------------------~~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~  141 (804)
                      ||+|||++.+                   ..+||+|||++..........||+.|+|||++.+  ...++.++|+||+|+
T Consensus       142 kp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~  219 (289)
T 1x8b_A          142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQE--NYTHLPKADIFALAL  219 (289)
T ss_dssp             SGGGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTT--CCTTHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhcC--CCCCCchhhHHHHHH
Confidence            9999999844                   4799999999987655556689999999999842  235667999999999


Q ss_pred             CC
Q psy17952        142 TP  143 (804)
Q Consensus       142 ~~  143 (804)
                      +.
T Consensus       220 il  221 (289)
T 1x8b_A          220 TV  221 (289)
T ss_dssp             HH
T ss_pred             HH
Confidence            83

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.90  E-value=6.6e-24  Score=224.35  Aligned_cols=133  Identities=35%  Similarity=0.631  Sum_probs=116.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.++...|+|||||.|+ +.+.+. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        57 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~  135 (277)
T 3f3z_A           57 IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE  135 (277)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence            46789999999999999999999999999999864 555554 4567999999999999999999999999999999999


Q ss_pred             cEEE---cCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILL---TETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill---~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++   +.++.+||+|||++....   ......||+.|+|||++.    +.++.++|+||+|++
T Consensus       136 Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~  196 (277)
T 3f3z_A          136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE----GLYGPECDEWSAGVM  196 (277)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT----TCBCTTHHHHHHHHH
T ss_pred             HEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhc----ccCCchhhehhHHHH
Confidence            9999   788899999999996532   223467999999999873    458999999999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=4.2e-24  Score=235.56  Aligned_cols=136  Identities=29%  Similarity=0.502  Sum_probs=115.4

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|+++ +|||||+++++|..+..+|||||||.| ++.+++.. ...+++..++.++.|++.||+|||+++|+||||||
T Consensus       109 ~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp  187 (355)
T 1vzo_A          109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL  187 (355)
T ss_dssp             HHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence            4678888 699999999999999999999999986 55565543 46799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||+++...     .....+||+.|+|||++.+ ....++.++|+||+|++
T Consensus       188 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~i  251 (355)
T 1vzo_A          188 ENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVL  251 (355)
T ss_dssp             GGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT-CC---CTHHHHHHHHHH
T ss_pred             HHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcC-CCCCCCchhhHHHHHHH
Confidence            99999999999999999996421     2234689999999999843 12357889999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.90  E-value=2.2e-24  Score=236.91  Aligned_cols=133  Identities=31%  Similarity=0.525  Sum_probs=112.5

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ++|.++ +|||||+++++|.+++.+|||||||.|+ +.+.+. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus        67 ~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~  145 (342)
T 2qr7_A           67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS  145 (342)
T ss_dssp             HHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHH
Confidence            456666 8999999999999999999999999864 555554 4578999999999999999999999999999999999


Q ss_pred             cEEEcCC----CceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTET----GTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~----~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+.+.    +.+||+|||++....    .....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  209 (342)
T 2qr7_A          146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE---RQGYDAACDIWSLGVL  209 (342)
T ss_dssp             GEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHH---HHHHHHHHHHHHHHHH
T ss_pred             HEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhc---CCCCCCccCeeeHhHH
Confidence            9998543    359999999997532    223468999999999984   3458889999999998

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.90  E-value=3e-24  Score=242.30  Aligned_cols=136  Identities=32%  Similarity=0.545  Sum_probs=115.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC------CeEEEEEeccCCCcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD------HTAWLVMEYCLGSASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSLGR   75 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~------~~~~lV~Ey~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~I   75 (804)
                      ..+|+.|+|||||+++++|...      ..++||||||.+++.+.+..   .+..+++..++.++.||++||+|||+++|
T Consensus        98 ~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i  177 (420)
T 1j1b_A           98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI  177 (420)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             HHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4689999999999999988642      24789999999987776543   35789999999999999999999999999


Q ss_pred             cccccccccEEEcCC-CceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         76 IHRDVKAGNILLTET-GTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        76 iHRDlKp~Nill~~~-~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +||||||+|||++.+ +.+||+|||+++...   .....+||+.|+|||++.+  ...|+.++|+||+|++
T Consensus       178 vHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~i  246 (420)
T 1j1b_A          178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCV  246 (420)
T ss_dssp             ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             cccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcC--CCCCCchhhhHHHHHH
Confidence            999999999999965 578999999997532   2345689999999999843  3468999999999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.90  E-value=2e-24  Score=242.17  Aligned_cols=136  Identities=35%  Similarity=0.654  Sum_probs=112.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe--CCeEEEEEeccCCCcHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHK--------RPLKEEEIAAICSGVLRGLNYLHSLG   74 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~--~~~~~lV~Ey~~g~l~~~~~~~~--------~~l~~~~~~~~~~qi~~aL~ylH~~~   74 (804)
                      ..+|++|+|||||+++++|..  +..+|||||||.|++.+++....        ..+++..++.++.||+.||+|||+++
T Consensus        69 ~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~  148 (405)
T 3rgf_A           69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW  148 (405)
T ss_dssp             HHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            368899999999999999965  66899999999999888775321        25999999999999999999999999


Q ss_pred             ccccccccccEEE----cCCCceEEeccCcccccC-------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         75 RIHRDVKAGNILL----TETGTVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        75 IiHRDlKp~Nill----~~~~~~kl~DFG~a~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||||||+|||+    +.++.+||+|||+|+...       .....+||+.|+|||++.+  ...|+.++|+||+|++
T Consensus       149 ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~i  225 (405)
T 3rgf_A          149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCI  225 (405)
T ss_dssp             CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT--CCSCCHHHHHHHHHHH
T ss_pred             EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC--CCcccchhhhHHHHHH
Confidence            9999999999999    677899999999997532       2234689999999999843  2458999999999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.90  E-value=3.8e-24  Score=240.03  Aligned_cols=132  Identities=33%  Similarity=0.526  Sum_probs=107.6

Q ss_pred             HHhcCCCCeeeEeEEEEe----CCeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          8 LRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ++.++|||||+++++|..    +..+|||||||.| ++.+++.... ..+++..++.++.||+.||+|||+++|+|||||
T Consensus       109 ~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  188 (400)
T 1nxk_A          109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK  188 (400)
T ss_dssp             HHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence            356699999999999876    5679999999986 5666665432 469999999999999999999999999999999


Q ss_pred             cccEEEcC---CCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~---~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.   ++.+||+|||+++....   ....+||+.|+|||++   ....|+.++|+||+|++
T Consensus       189 p~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~i  252 (400)
T 1nxk_A          189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---GPEKYDKSCDMWSLGVI  252 (400)
T ss_dssp             GGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGS---CCCCSSSHHHHHHHHHH
T ss_pred             cceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhc---CCCCCCCcccHHHHHHH
Confidence            99999997   78999999999975332   2356899999999997   35678999999999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.90  E-value=2.2e-24  Score=234.29  Aligned_cols=134  Identities=31%  Similarity=0.484  Sum_probs=114.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++. +...|+||||+. |++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        66 ~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~  144 (325)
T 3kex_A           66 MLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAAR  144 (325)
T ss_dssp             HHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSST
T ss_pred             HHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchh
Confidence            35788999999999999876 456899999997 5777777655578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++....      .....||+.|+|||++.   .+.++.++|+||+|++
T Consensus       145 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  206 (325)
T 3kex_A          145 NVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH---FGKYTHQSDVWSYGVT  206 (325)
T ss_dssp             TEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhc---cCCCChhhHhHHhHHH
Confidence            99999999999999999975321      22356888999999984   3568999999999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=4.2e-24  Score=237.75  Aligned_cols=137  Identities=28%  Similarity=0.552  Sum_probs=116.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC--------------------------------------CeEEEEEeccCCCcHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD--------------------------------------HTAWLVMEYCLGSASDIIEV   46 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~--------------------------------------~~~~lV~Ey~~g~l~~~~~~   46 (804)
                      ..+|+.++|||||+++++|...                                      ..+|||||||.|++.+.+..
T Consensus        51 ~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~  130 (383)
T 3eb0_A           51 LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS  130 (383)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHH
T ss_pred             HHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHH
Confidence            4689999999999999998543                                      34899999999987766653


Q ss_pred             ---cCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEEc-CCCceEEeccCcccccC---CCCccccccccCcc
Q psy17952         47 ---HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKC---PANSFVGTPYWMAP  119 (804)
Q Consensus        47 ---~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~-~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~AP  119 (804)
                         ....+++..++.++.||++||+|||++||+||||||+|||++ .++.+||+|||+|+...   ......||+.|+||
T Consensus       131 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP  210 (383)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence               356899999999999999999999999999999999999998 68899999999997532   23456899999999


Q ss_pred             hhhhhcccCccCCcccccccccCC
Q psy17952        120 EVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus       120 E~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.+  ...|+.++|+||+|++.
T Consensus       211 E~~~~--~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          211 ELMLG--ATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHHTT--CSSCCTHHHHHHHHHHH
T ss_pred             HHhcC--CCCCCcchhhhhHHHHH
Confidence            99843  34589999999999983

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.90  E-value=4.1e-24  Score=236.92  Aligned_cols=132  Identities=33%  Similarity=0.547  Sum_probs=109.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC------eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH------TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~------~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      ..+|+.++|||||+++++|....      .+|||||||.|++.+.+.   ..+++..+..++.|++.||+|||+++|+||
T Consensus        75 ~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  151 (371)
T 2xrw_A           75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHR  151 (371)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            35788999999999999998765      789999999998887764   469999999999999999999999999999


Q ss_pred             ccccccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         79 DVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        79 DlKp~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||||+|||++.++.+||+|||+++....   ....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       152 Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  215 (371)
T 2xrw_A          152 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  215 (371)
T ss_dssp             CCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             cCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhc---CCCCCchHhHHHHHHH
Confidence            9999999999999999999999975322   23468999999999984   3568999999999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.90  E-value=4e-24  Score=245.12  Aligned_cols=135  Identities=31%  Similarity=0.513  Sum_probs=116.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||++++++.+.+.+|||||||.|+ +.+++ ...+.+++..++.++.||+.||+|||+++|+||||||+
T Consensus        67 i~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~  145 (476)
T 2y94_A           67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE  145 (476)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHT-TSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHH
Confidence            35788999999999999999999999999999865 55554 44578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++.....   ....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       146 NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  205 (476)
T 2y94_A          146 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSSGVI  205 (476)
T ss_dssp             GEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTT--CCBCSHHHHHHHHHHH
T ss_pred             HEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccC--CCCCCCcceehhhHHH
Confidence            99999999999999999975322   235689999999999842  2234678999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.90  E-value=6.7e-24  Score=230.98  Aligned_cols=137  Identities=31%  Similarity=0.517  Sum_probs=118.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+++..|+||||+.|++++.+......+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        75 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~N  154 (331)
T 4aaa_A           75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPEN  154 (331)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             HHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChhe
Confidence            45789999999999999999999999999999998877776667789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||++....    ......||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~il  215 (331)
T 4aaa_A          155 ILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG--DVKYGKAVDVWAIGCLV  215 (331)
T ss_dssp             EEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTT--CTTCCTHHHHHHHHHHH
T ss_pred             EEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccC--CCCcchHHHHHHHHHHH
Confidence            999999999999999996532    2234579999999999832  23688999999999983

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=2.8e-24  Score=238.18  Aligned_cols=134  Identities=34%  Similarity=0.581  Sum_probs=116.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC------eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH------TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~------~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      ..+|+.++|||||+++++|....      .+|||||||.+++.+++..  ..+++..++.++.|+++||+|||++||+||
T Consensus        75 ~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~  152 (367)
T 1cm8_A           75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHR  152 (367)
T ss_dssp             HHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            36789999999999999998763      4699999997677776654  579999999999999999999999999999


Q ss_pred             ccccccEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         79 DVKAGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        79 DlKp~Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||||+|||++.++.+||+|||+++... .....+||++|+|||++.+  ...|+.++|+||+|++
T Consensus       153 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  215 (367)
T 1cm8_A          153 DLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCI  215 (367)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHH
T ss_pred             CcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhC--CCCCChhhhHHHHHHH
Confidence            999999999999999999999997643 3345689999999999843  3568999999999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.90  E-value=1.1e-24  Score=234.99  Aligned_cols=133  Identities=30%  Similarity=0.513  Sum_probs=107.8

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCC----eEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDH----TAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~----~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      .+|++++|||||++++++....    ..|||||||+| ++.+++. ..+++++..+..++.|++.||+|||+++|+||||
T Consensus        64 ~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl  142 (311)
T 3ork_A           64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV  142 (311)
T ss_dssp             TTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             HHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            3567789999999999987654    35999999985 5555554 4568999999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccC-------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+|||++.++.+||+|||++....       ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       143 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  208 (311)
T 3ork_A          143 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCV  208 (311)
T ss_dssp             CGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHH---TCCCCHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc---CCCCCchHhHHHHHHH
Confidence            9999999999999999999996432       122357999999999984   4568899999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.2e-24  Score=229.45  Aligned_cols=146  Identities=15%  Similarity=0.114  Sum_probs=115.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccch---------------hhhhhHHHHHHHHhhcCCCceeEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCA---------------EKWADILKEIRFLRQLKHPNTIEY  227 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~---------------~~~~~~~~Ei~iL~~L~HpNIV~l  227 (804)
                      .|++.+.||+|+||.||+|++ .+|+.||||.++.......               .....+.+|+.+|++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            467789999999999999999 8899999999864221100               13456889999999999  5 666


Q ss_pred             eeEEeecCceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHH
Q psy17952        228 RGCYLRDHTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLR  306 (804)
Q Consensus       228 ~~~~~~~~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~  306 (804)
                      .+++.. +..|+|||||+|+ |.+ +                                        ...+...++.|++.
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l----------------------------------------~~~~~~~i~~qi~~  204 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-V----------------------------------------RVENPDEVLDMILE  204 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-C----------------------------------------CCSCHHHHHHHHHH
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-c----------------------------------------chhhHHHHHHHHHH
Confidence            665544 5679999999874 211 0                                        11234579999999


Q ss_pred             HHHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhc
Q psy17952        307 GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVIL  364 (804)
Q Consensus       307 gL~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~  364 (804)
                      ||.|||++||+||||||+|||++ ++.+||+|||+|+         .+..|+|||++.
T Consensus       205 ~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~---------~~~~~~a~e~l~  252 (282)
T 1zar_A          205 EVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV---------EVGEEGWREILE  252 (282)
T ss_dssp             HHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE---------ETTSTTHHHHHH
T ss_pred             HHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe---------ECCCCCHHHHHH
Confidence            99999999999999999999999 9999999999985         456789999884

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.90  E-value=2.4e-24  Score=238.65  Aligned_cols=135  Identities=27%  Similarity=0.491  Sum_probs=116.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhcCccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK------RPLKEEEIAAICSGVLRGLNYLHSLGRIH   77 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~------~~l~~~~~~~~~~qi~~aL~ylH~~~IiH   77 (804)
                      ..+|++++|||||+++++|.++...|||||||.| +|.+++....      ..+++..+..++.||+.||+|||+++|+|
T Consensus       125 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  204 (367)
T 3l9p_A          125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIH  204 (367)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            3578899999999999999999999999999975 6777776543      45999999999999999999999999999


Q ss_pred             cccccccEEEcCCC---ceEEeccCccccc------CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         78 RDVKAGNILLTETG---TVKLADFGSASIK------CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        78 RDlKp~Nill~~~~---~~kl~DFG~a~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||||+|||++.+|   .+||+|||+++..      .......||+.|+|||++.   ...++.++|+||+|++
T Consensus       205 rDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~i  275 (367)
T 3l9p_A          205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVL  275 (367)
T ss_dssp             SCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhc---CCCCCcHHHHHHHHHH
Confidence            99999999999655   5999999999642      2233457899999999984   3568999999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.90  E-value=6.6e-24  Score=229.63  Aligned_cols=138  Identities=30%  Similarity=0.488  Sum_probs=115.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC--eEEEEEeccCC-CcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH--TAWLVMEYCLG-SASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~--~~~lV~Ey~~g-~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|++++|||||++++++....  .+|||||||.| ++.+++....  ..+++..++.++.|++.||+|||+++|+|||
T Consensus        58 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D  137 (319)
T 4euu_A           58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN  137 (319)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence            35889999999999999998765  78999999985 5666665432  3499999999999999999999999999999


Q ss_pred             cccccEEE----cCCCceEEeccCcccccCC---CCccccccccCcchhhhhc-----ccCccCCcccccccccC
Q psy17952         80 VKAGNILL----TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill----~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~-----~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||+    +.++.+||+|||+++....   .....||+.|+|||++...     ....++.++|+||+|++
T Consensus       138 lkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i  212 (319)
T 4euu_A          138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT  212 (319)
T ss_dssp             CSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred             CCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence            99999999    7778899999999975322   2346799999999997421     13568899999999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.89  E-value=4e-24  Score=232.61  Aligned_cols=134  Identities=29%  Similarity=0.488  Sum_probs=115.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.++. .++||||+. |++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        68 ~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~  146 (327)
T 3poz_A           68 AYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR  146 (327)
T ss_dssp             HHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChh
Confidence            35788999999999999988765 689999997 5677777776788999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++....      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       147 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (327)
T 3poz_A          147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVT  208 (327)
T ss_dssp             GEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhc---cCCCCchhhhhhhHHH
Confidence            99999999999999999975321      12245788999999984   4578999999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.89  E-value=5.1e-24  Score=224.09  Aligned_cols=135  Identities=28%  Similarity=0.489  Sum_probs=117.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.++...|+|||||+| ++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        54 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~  133 (268)
T 3sxs_A           54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR  133 (268)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGG
T ss_pred             HHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcc
Confidence            3678899999999999999999999999999975 567777665567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC-----CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~-----~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++......     ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       134 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  194 (268)
T 3sxs_A          134 NCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH---YFKYSSKSDVWAFGIL  194 (268)
T ss_dssp             GEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHH---HSEEETTHHHHHHHHH
T ss_pred             eEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHh---ccCCchhhhhHHHHHH
Confidence            999999999999999999753221     2245677899999984   3468899999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.89  E-value=6.7e-24  Score=244.35  Aligned_cols=134  Identities=36%  Similarity=0.626  Sum_probs=115.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+...+|||||||.|+ +.+.+. ....+++..++.++.||+.||.|||+++|+||||||+
T Consensus        87 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~  165 (494)
T 3lij_A           87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPE  165 (494)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChh
Confidence            46789999999999999999999999999999864 555554 3467999999999999999999999999999999999


Q ss_pred             cEEEcCC---CceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTET---GTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~---~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++..   +.+||+|||++....   .....+||+.|+|||++.    +.|+.++|+||+|++.
T Consensus       166 Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il  227 (494)
T 3lij_A          166 NLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR----KKYDEKCDVWSIGVIL  227 (494)
T ss_dssp             GEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHH
T ss_pred             hEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc----ccCCCchhHHHHHHHH
Confidence            9999764   459999999997532   223468999999999872    4689999999999983

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.89  E-value=7e-24  Score=224.61  Aligned_cols=134  Identities=31%  Similarity=0.523  Sum_probs=114.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+++.++||||++++++|.+....|+||||+.|+ +.+.+. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        60 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~  138 (279)
T 3fdn_A           60 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE  138 (279)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGG
T ss_pred             HHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChH
Confidence            46788899999999999999999999999999864 555554 3467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....  ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       139 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  196 (279)
T 3fdn_A          139 NLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVL  196 (279)
T ss_dssp             GEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             hEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhc---cCCCCccchhHhHHHH
Confidence            9999999999999999986432  233468999999999973   4567889999999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.89  E-value=7.6e-24  Score=243.33  Aligned_cols=134  Identities=34%  Similarity=0.588  Sum_probs=114.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+...+|+|||||.|+ +.+.+.. ...+++..++.++.||+.||.|||+++|+||||||+
T Consensus        72 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~  150 (486)
T 3mwu_A           72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE  150 (486)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH
Confidence            46789999999999999999999999999999864 5555543 467999999999999999999999999999999999


Q ss_pred             cEEEc---CCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLT---ETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~---~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++   .++.+||+|||++....   .....+||+.|+|||++.    +.|+.++|+||+|++.
T Consensus       151 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il  212 (486)
T 3mwu_A          151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR----GTYDEKCDVWSAGVIL  212 (486)
T ss_dssp             GEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG----SCCCHHHHHHHHHHHH
T ss_pred             HEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC----CCCCchhhHHHHHHHH
Confidence            99995   45679999999997532   223468999999999973    4689999999999983

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.89  E-value=1e-23  Score=228.60  Aligned_cols=134  Identities=34%  Similarity=0.541  Sum_probs=117.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+++..|+|||||.| ++.+++. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        66 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~  144 (321)
T 2a2a_A           66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE  144 (321)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChH
Confidence            4678999999999999999999999999999975 5555554 4678999999999999999999999999999999999


Q ss_pred             cEEEcCCC----ceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETG----TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~----~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++    .+||+|||++.....   .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       145 NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  207 (321)
T 2a2a_A          145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVI  207 (321)
T ss_dssp             GEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             HEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCccccc---CCCCCCccccHHHHHH
Confidence            99999888    799999999975322   23457999999999973   4578999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.89  E-value=4e-24  Score=226.94  Aligned_cols=133  Identities=29%  Similarity=0.509  Sum_probs=107.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++++|||||++++++ .++..|+||||+.| ++.+++......+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        68 ~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  146 (281)
T 1mp8_A           68 LTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN  146 (281)
T ss_dssp             HHHHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHH
Confidence            578899999999999987 45678999999986 6677776666689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||+++....     .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       147 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  206 (281)
T 1mp8_A          147 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVC  206 (281)
T ss_dssp             EEEEETTEEEECC-------------------CCGGGCCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             EEECCCCCEEECccccccccCcccccccccCCCcccccChhhcc---cCCCCCccCchHHHHH
Confidence            9999999999999999975322     12345788999999984   3568899999999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.89  E-value=1.2e-23  Score=224.34  Aligned_cols=135  Identities=18%  Similarity=0.228  Sum_probs=118.1

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+++.+ +||||+++++++..+...|+||||+.|++.+++.....++++..+..++.|++.||+|||+++|+||||||+
T Consensus        56 ~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~  135 (298)
T 1csn_A           56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD  135 (298)
T ss_dssp             HHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred             HHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence            3567788 899999999999999999999999977788888766677999999999999999999999999999999999


Q ss_pred             cEEEcCCCc-----eEEeccCcccccC-----------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGT-----VKLADFGSASIKC-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~-----~kl~DFG~a~~~~-----------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.     +||+|||++....           ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       136 NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  207 (298)
T 1csn_A          136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHV  207 (298)
T ss_dssp             GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             HEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhc---CCCCChHHHHHHHHHH
Confidence            999987775     9999999996422           123457999999999973   4568999999999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.89  E-value=4e-24  Score=232.97  Aligned_cols=135  Identities=27%  Similarity=0.464  Sum_probs=116.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC-----------------------CCCCHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK-----------------------RPLKEEEIAAIC   60 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~-----------------------~~l~~~~~~~~~   60 (804)
                      ..+|++++|||||+++++|.+++..|||||||.| ++.+++....                       ..+++..+..++
T Consensus       101 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  180 (343)
T 1luf_A          101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA  180 (343)
T ss_dssp             HHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHH
T ss_pred             HHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHH
Confidence            4678999999999999999999999999999985 6677766532                       579999999999


Q ss_pred             HHHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcc
Q psy17952         61 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKV  134 (804)
Q Consensus        61 ~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~v  134 (804)
                      .||++||.|||+++|+||||||+|||++.++.+||+|||++....      ......||+.|+|||++.   ...++.++
T Consensus       181 ~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~  257 (343)
T 1luf_A          181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTES  257 (343)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH---HCCCCHHH
T ss_pred             HHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc---cCCcCccc
Confidence            999999999999999999999999999999999999999986421      223457899999999984   35689999


Q ss_pred             cccccccC
Q psy17952        135 DVWSLGIT  142 (804)
Q Consensus       135 DvwslG~~  142 (804)
                      |+||+|++
T Consensus       258 Di~slG~i  265 (343)
T 1luf_A          258 DVWAYGVV  265 (343)
T ss_dssp             HHHHHHHH
T ss_pred             ccHHHHHH
Confidence            99999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.89  E-value=1.3e-23  Score=224.23  Aligned_cols=135  Identities=32%  Similarity=0.531  Sum_probs=117.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||++++++.+++..|+|||||.|+.+..+......+++..+..++.|+++||+|||+++|+||||||+|
T Consensus        66 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N  145 (294)
T 2rku_A           66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN  145 (294)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence            45788999999999999999999999999999865444343445689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       146 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  204 (294)
T 2rku_A          146 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCI  204 (294)
T ss_dssp             EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHT---TSCBCTHHHHHHHHHH
T ss_pred             EEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhc---cCCCCchhhHHHHHHH
Confidence            999999999999999997532    223457999999999973   4568889999999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.89  E-value=1e-23  Score=230.12  Aligned_cols=134  Identities=32%  Similarity=0.546  Sum_probs=117.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||+++++|.+++.+|+|||||.|+ +.+++ .....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        92 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~  170 (335)
T 2owb_A           92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG  170 (335)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCch
Confidence            46788999999999999999999999999999865 44544 34568999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       171 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  230 (335)
T 2owb_A          171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCI  230 (335)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHH---TSCBCTHHHHHHHHHH
T ss_pred             hEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhc---cCCCCchhhHHHHHHH
Confidence            9999999999999999997532    223457999999999984   4568889999999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.89  E-value=5.7e-24  Score=225.54  Aligned_cols=135  Identities=22%  Similarity=0.505  Sum_probs=118.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.+++..|+|||||.| ++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        70 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~  149 (283)
T 3gen_A           70 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR  149 (283)
T ss_dssp             HHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG
T ss_pred             HHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccc
Confidence            4678999999999999999999999999999975 566666654678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....     ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       150 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~  210 (283)
T 3gen_A          150 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVL  210 (283)
T ss_dssp             GEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhc---cCCCCchhhHHHHHHH
Confidence            9999999999999999997532     122346788999999984   3568899999999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.89  E-value=5.1e-24  Score=240.36  Aligned_cols=137  Identities=33%  Similarity=0.598  Sum_probs=108.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.. +..|||||||.| ++.+.+ .....+++..++.++.|++.||+|||+++|+||||||+
T Consensus       191 ~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~  268 (419)
T 3i6u_A          191 IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE  268 (419)
T ss_dssp             HHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGT-SSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence            468999999999999998754 568999999986 454544 34578999999999999999999999999999999999


Q ss_pred             cEEEcCCC---ceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETG---TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~---~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++   .+||+|||+++....   ....+||+.|+|||++.......|+.++|+||+|++.
T Consensus       269 NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il  334 (419)
T 3i6u_A          269 NVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL  334 (419)
T ss_dssp             GEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHH
T ss_pred             hEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHH
Confidence            99997544   599999999976432   2356899999999998543346788899999999983

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.89  E-value=4.9e-24  Score=234.59  Aligned_cols=136  Identities=28%  Similarity=0.519  Sum_probs=112.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC-----CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~-----~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|++++|||||+++++|...     ..+|||||||.|++.+.+......+++..+..++.||+.||.|||+++|+|||
T Consensus        80 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D  159 (362)
T 3pg1_A           80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRD  159 (362)
T ss_dssp             HHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecC
Confidence            4678999999999999998543     36899999999999998876667899999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||++.++.+||+|||++....   ......||+.|+|||++.+  ...++.++|+||+|++
T Consensus       160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  223 (362)
T 3pg1_A          160 LHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ--FKGFTKLVDMWSAGCV  223 (362)
T ss_dssp             CCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTT--CTTCCTHHHHHHHHHH
T ss_pred             CChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcC--CCCCCcHhHHHhHHHH
Confidence            99999999999999999999997432   2334679999999999742  3568899999999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=3.5e-24  Score=234.89  Aligned_cols=133  Identities=25%  Similarity=0.275  Sum_probs=113.7

Q ss_pred             HHHHhcCCCCeeeEeEEEEe----CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      .+++.++|||||++++++..    +...|||||||.|+|.+++.. ...+++..+..++.||+.||+|||+++|+|||||
T Consensus       100 ~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  178 (345)
T 2v62_A          100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIK  178 (345)
T ss_dssp             HHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HhhccccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcC
Confidence            35677899999999999988    778999999995556665543 3489999999999999999999999999999999


Q ss_pred             cccEEEcCCC--ceEEeccCcccccCC-----------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETG--TVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~--~~kl~DFG~a~~~~~-----------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.++  .+||+|||+++....           .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       179 p~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  249 (345)
T 2v62_A          179 AANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK---GVALSRRSDVEILGYC  249 (345)
T ss_dssp             GGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH---TCCCCHHHHHHHHHHH
T ss_pred             HHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc---CCCCCchhhHHHHHHH
Confidence            9999999877  999999999964211           13457999999999974   4568999999999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.89  E-value=7.3e-24  Score=224.12  Aligned_cols=135  Identities=32%  Similarity=0.569  Sum_probs=100.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..++++++||||+++++++.+.+..|+|||||.| ++.+++.....++++..+..++.|+++||+|||+++|+||||||+
T Consensus        62 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~  141 (278)
T 3cok_A           62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS  141 (278)
T ss_dssp             HHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGG
T ss_pred             HHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence            4577889999999999999999999999999976 566666655578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       142 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  201 (278)
T 3cok_A          142 NLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT---RSAHGLESDVWSLGCM  201 (278)
T ss_dssp             GEEECTTCCEEECCCTTCEECC-------------------------------CTHHHHHHHH
T ss_pred             HEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhc---CCCCCchhhHHHHHHH
Confidence            9999999999999999997532    123457999999999973   4567889999999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.89  E-value=6e-24  Score=225.77  Aligned_cols=136  Identities=32%  Similarity=0.569  Sum_probs=110.0

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhc-Ccccccccc
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRDVKA   82 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp   82 (804)
                      +++.++|||||++++++.+++..|||||||.|++.+++..   ....+++..++.++.|++.||+|||++ +|+||||||
T Consensus        59 ~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp  138 (290)
T 3fme_A           59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP  138 (290)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSG
T ss_pred             HHHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence            4677899999999999999999999999999988776653   356899999999999999999999998 999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhh-cccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILA-MDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~-~~~~~~~~~vDvwslG~~  142 (804)
                      +||+++.++.+||+|||++.....   .....||+.|+|||++.. .....++.++|+||+|++
T Consensus       139 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i  202 (290)
T 3fme_A          139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT  202 (290)
T ss_dssp             GGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred             HHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence            999999999999999999975322   233579999999999621 124568889999999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.89  E-value=8.9e-24  Score=235.17  Aligned_cols=135  Identities=30%  Similarity=0.549  Sum_probs=117.0

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---------------CCCCHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---------------RPLKEEEIAAICSGVLRGL   67 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~aL   67 (804)
                      .++|+++ +|||||+++++|..++.+|||||||.| +|.+++....               ..+++..+..++.|++.||
T Consensus       125 ~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL  204 (382)
T 3tt0_A          125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM  204 (382)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence            3567888 999999999999999999999999985 6677776543               3599999999999999999


Q ss_pred             HHHHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCccccccccc
Q psy17952         68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  141 (804)
Q Consensus        68 ~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~  141 (804)
                      +|||+++|+||||||+|||++.++.+||+|||+++...      ......||+.|+|||++.   ...++.++|+||+|+
T Consensus       205 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~  281 (382)
T 3tt0_A          205 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGV  281 (382)
T ss_dssp             HHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH---SCCCCHHHHHHHHHH
T ss_pred             HHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc---CCCCCchhHHHHHHH
Confidence            99999999999999999999999999999999997532      122346789999999984   456899999999999


Q ss_pred             C
Q psy17952        142 T  142 (804)
Q Consensus       142 ~  142 (804)
                      +
T Consensus       282 i  282 (382)
T 3tt0_A          282 L  282 (382)
T ss_dssp             H
T ss_pred             H
Confidence            8

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.89  E-value=8.1e-24  Score=242.77  Aligned_cols=134  Identities=35%  Similarity=0.602  Sum_probs=116.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+.+.+|+|||||.|+ +.+.+. ....+++..+..++.||+.||.|||+++|+||||||+
T Consensus        77 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~  155 (484)
T 3nyv_A           77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE  155 (484)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence            46789999999999999999999999999999865 555554 4578999999999999999999999999999999999


Q ss_pred             cEEE---cCCCceEEeccCcccccCCC---CccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILL---TETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill---~~~~~~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+   +.++.+||+|||++......   ...+||+.|+|||++.    +.|+.++|+||+|++.
T Consensus       156 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il  217 (484)
T 3nyv_A          156 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH----GTYDEKCDVWSTGVIL  217 (484)
T ss_dssp             GEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH----TCCCTHHHHHHHHHHH
T ss_pred             HEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec----CCCCCcceeHHHHHHH
Confidence            9999   46789999999999753322   2357999999999973    3689999999999983

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.89  E-value=1.2e-23  Score=242.71  Aligned_cols=134  Identities=36%  Similarity=0.605  Sum_probs=116.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+++++|.++..+|||||||.| ++.+.+.. ...+++..+..++.||+.||+|||+++|+||||||+
T Consensus        97 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~  175 (504)
T 3q5i_A           97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE  175 (504)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHH
Confidence            3578999999999999999999999999999986 45565543 467999999999999999999999999999999999


Q ss_pred             cEEEcCCC---ceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETG---TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~---~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++   .+||+|||++.....   ....+||+.|+|||++.    +.|+.++|+||+|++.
T Consensus       176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il  237 (504)
T 3q5i_A          176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGVIM  237 (504)
T ss_dssp             GEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHH
T ss_pred             HEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc----cCCCchHHHHHHHHHH
Confidence            99999876   699999999975332   23468999999999972    4689999999999983

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.89  E-value=1.6e-23  Score=221.93  Aligned_cols=134  Identities=31%  Similarity=0.550  Sum_probs=115.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++||||+++++++..++..|+|||||.|+ +.+.+. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        56 ~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~  134 (284)
T 3kk8_A           56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE  134 (284)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHH
Confidence            46789999999999999999999999999999865 555554 3467999999999999999999999999999999999


Q ss_pred             cEEEcCCCc---eEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGT---VKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~---~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.   +||+|||++.....   .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       135 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  196 (284)
T 3kk8_A          135 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVI  196 (284)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             HEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhc---CCCCCcccchHHHHHH
Confidence            999986654   99999999965332   23468999999999973   4568999999999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.89  E-value=1.4e-23  Score=222.89  Aligned_cols=134  Identities=26%  Similarity=0.466  Sum_probs=117.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|+.++||||+++++++.+++..|+||||+.| ++.+++.. ...+++..+..++.|++.||+|||+++|+||||||+
T Consensus        65 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~  143 (284)
T 2vgo_A           65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE  143 (284)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG
T ss_pred             HHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence            4678899999999999999999999999999986 56666653 467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....  ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       144 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  201 (284)
T 2vgo_A          144 NLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE---GKTHDEKVDLWCAGVL  201 (284)
T ss_dssp             GEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHT---TCCBCTTHHHHHHHHH
T ss_pred             HEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhc---cCCCCcccchhhHHHH
Confidence            9999999999999999986432  234568999999999973   4568899999999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.89  E-value=1.1e-23  Score=224.23  Aligned_cols=134  Identities=32%  Similarity=0.555  Sum_probs=113.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|++++|||||+++++|.+.+..|+|||||.| ++.+.+...   ...+++..+..++.|++.||+|||+++|+||||
T Consensus        71 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~di  150 (285)
T 3is5_A           71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL  150 (285)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             HHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCC
Confidence            4678999999999999999999999999999986 566665432   467999999999999999999999999999999


Q ss_pred             ccccEEE---cCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILL---TETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill---~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+||++   +.++.+||+|||++....   ......||+.|+|||++    .+.++.++|+||+|++
T Consensus       151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~Di~slG~i  214 (285)
T 3is5_A          151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF----KRDVTFKCDIWSAGVV  214 (285)
T ss_dssp             SGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHH----TTCCCHHHHHHHHHHH
T ss_pred             CHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHh----ccCCCcccCeehHHHH
Confidence            9999999   456789999999997532   23346799999999987    2468889999999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.89  E-value=3.2e-24  Score=229.11  Aligned_cols=135  Identities=30%  Similarity=0.550  Sum_probs=114.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC--CeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~--~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||++++++...  ..+|||||||.| ++.+++......+++..+..++.|++.||+|||+++|+|||||
T Consensus        62 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik  141 (295)
T 3ugc_A           62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA  141 (295)
T ss_dssp             HHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             HHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence            4678999999999999998653  458999999975 6777777666679999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.++.+||+|||++.....       .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       142 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  206 (295)
T 3ugc_A          142 TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVV  206 (295)
T ss_dssp             GGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc---CCCCChHHHHHHHHHH
Confidence            9999999999999999999975321       22345788899999984   4568999999999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.89  E-value=8.2e-24  Score=226.26  Aligned_cols=135  Identities=28%  Similarity=0.524  Sum_probs=117.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC--CeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~--~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++||||+++++++..+  ..+|+|||||.| ++.+++......+++..+..++.|++.||+|||+++|+|||||
T Consensus        74 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik  153 (302)
T 4e5w_A           74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA  153 (302)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCc
Confidence            4678999999999999999876  668999999975 6777776667789999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||+++.++.+||+|||++.....       .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       154 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  218 (302)
T 4e5w_A          154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM---QSKFYIASDVWSFGVT  218 (302)
T ss_dssp             GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec---CCCCCcchhHHHHHHH
Confidence            9999999999999999999975322       22356888999999984   3568889999999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.89  E-value=5.7e-24  Score=236.30  Aligned_cols=135  Identities=28%  Similarity=0.521  Sum_probs=109.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.+++.+|||||||+| ++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        97 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  176 (373)
T 2qol_A           97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR  176 (373)
T ss_dssp             HHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence            4678899999999999999999999999999975 666777655568999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC-------CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~-------~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++.....       ....+|+.|+|||++.   ...++.++|+||+|++
T Consensus       177 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~SlG~i  239 (373)
T 2qol_A          177 NILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA---YRKFTSASDVWSYGIV  239 (373)
T ss_dssp             GEEECTTCCEEECCC----------------------CTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc---cCCcCchhcHHHHHHH
Confidence            999999999999999999753221       1124577899999984   4568999999999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.89  E-value=7.1e-24  Score=240.32  Aligned_cols=139  Identities=28%  Similarity=0.417  Sum_probs=114.6

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+++ +|||||++++++.++..+|||||||.|++.+++......+++..+..++.||+.||+|||+++|+||||||+
T Consensus        68 ~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~  147 (432)
T 3p23_A           68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH  147 (432)
T ss_dssp             HHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTT
T ss_pred             HHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHH
Confidence            3578888 899999999999999999999999999999988766666777778899999999999999999999999999


Q ss_pred             cEEEcC---CC--ceEEeccCcccccC-------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTE---TG--TVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~---~~--~~kl~DFG~a~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.   ++  .+||+|||+|+...       .....+||+.|+|||++.......++.++|+||+|++.
T Consensus       148 NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il  219 (432)
T 3p23_A          148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF  219 (432)
T ss_dssp             SEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred             HEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence            999953   33  57899999997532       22346799999999998432245677899999999983

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.89  E-value=2.4e-24  Score=238.61  Aligned_cols=135  Identities=14%  Similarity=0.156  Sum_probs=101.9

Q ss_pred             HHHhcCCCCeeeEe-------EEEEeC-----------------CeEEEEEeccCCCcHHHHHHcCCCCCHHHH------
Q psy17952          7 LLRQLKHPNTIEYR-------GCYLRD-----------------HTAWLVMEYCLGSASDIIEVHKRPLKEEEI------   56 (804)
Q Consensus         7 iL~~l~HpnIV~l~-------~~~~~~-----------------~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~------   56 (804)
                      +|+. +|||||+++       +++..+                 ..+|||||||.|+|.+++......+++..+      
T Consensus       118 ~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk  196 (371)
T 3q60_A          118 RLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL  196 (371)
T ss_dssp             HHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHH
T ss_pred             Hhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhH
Confidence            4555 799988765       555543                 338999999999999988765445555555      


Q ss_pred             HHHHHHHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCcccccCCCC-ccccccccCcchhhhhcccCccCCccc
Q psy17952         57 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-SFVGTPYWMAPEVILAMDEGQYDGKVD  135 (804)
Q Consensus        57 ~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~~~vD  135 (804)
                      ..++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+...... ...||+.|+|||++.+ ....|+.++|
T Consensus       197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~D  275 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNA-STATFTHALN  275 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTC-SEEECCHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccC-CCCCcCcccc
Confidence            6777999999999999999999999999999999999999999998644333 4577899999999832 1256899999


Q ss_pred             ccccccCC
Q psy17952        136 VWSLGITP  143 (804)
Q Consensus       136 vwslG~~~  143 (804)
                      +||+|+++
T Consensus       276 iwSlG~il  283 (371)
T 3q60_A          276 AWQLGLSI  283 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999983

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.89  E-value=1.4e-23  Score=239.11  Aligned_cols=135  Identities=29%  Similarity=0.501  Sum_probs=115.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC-eEEEEEeccCC-CcHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH-TAWLVMEYCLG-SASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~-~~~lV~Ey~~g-~l~~~~~~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||++++++..+. .+|||||||.| +|.+++..... .+++..+..++.|++.||+|||+++|+|||||
T Consensus       237 ~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk  316 (450)
T 1k9a_A          237 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA  316 (450)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             HHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            56899999999999999987765 79999999975 67777765543 47999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC-CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.++.+||+|||+++.... .....+++.|+|||++.   ...++.++|+||+|++
T Consensus       317 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~  375 (450)
T 1k9a_A          317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGIL  375 (450)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHH---SSCCCHHHHHHHHHHH
T ss_pred             HhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhc---CCCCCcHHHHHHHHHH
Confidence            9999999999999999999975322 22346788999999983   4578999999999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.89  E-value=1.7e-23  Score=236.88  Aligned_cols=128  Identities=27%  Similarity=0.457  Sum_probs=115.1

Q ss_pred             CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEEcCC
Q psy17952         12 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET   90 (804)
Q Consensus        12 ~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~~   90 (804)
                      +|||||+++++|.....+|||||||.|++.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus       157 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~  236 (429)
T 3kvw_A          157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ  236 (429)
T ss_dssp             SCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST
T ss_pred             CCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC
Confidence            6889999999999999999999999999988887654 469999999999999999999999999999999999999998


Q ss_pred             Cc--eEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         91 GT--VKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        91 ~~--~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +.  +||+|||+|.... .....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       237 ~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~i  288 (429)
T 3kvw_A          237 GRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVIL---GARYGMPIDMWSLGCI  288 (429)
T ss_dssp             TSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHH---TBCCCTHHHHHHHHHH
T ss_pred             CCcceEEeecccceecCCcccccCCCCCccChHHHh---CCCCCchHHHHhHHHH
Confidence            87  9999999996533 344578999999999984   3468999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.89  E-value=1.4e-23  Score=226.09  Aligned_cols=136  Identities=33%  Similarity=0.494  Sum_probs=111.4

Q ss_pred             HHHHh-cCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQ-LKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~-l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|++ ++|||||+++++|.+++.+|||||||.| ++.+++.. ...+++..++.++.|++.||+|||+++|+||||||+
T Consensus        62 ~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~  140 (316)
T 2ac3_A           62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE  140 (316)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH
Confidence            45666 5899999999999999999999999985 56666644 467999999999999999999999999999999999


Q ss_pred             cEEEcCCCc---eEEeccCcccccCC-----------CCccccccccCcchhhhhcc--cCccCCcccccccccC
Q psy17952         84 NILLTETGT---VKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~---~kl~DFG~a~~~~~-----------~~~~~gt~~y~APE~l~~~~--~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.   +||+|||++.....           ....+||+.|+|||++....  ...++.++|+||+|++
T Consensus       141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i  215 (316)
T 2ac3_A          141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI  215 (316)
T ss_dssp             GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred             HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence            999998775   99999999864211           11346999999999984311  1358899999999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.89  E-value=1.1e-23  Score=231.66  Aligned_cols=134  Identities=32%  Similarity=0.595  Sum_probs=115.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc-Ccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp   82 (804)
                      ..+|++++|||||+++++|..++..|||||||.| ++.+++. ....+++..+..++.|++.||.|||++ +|+||||||
T Consensus        82 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp  160 (360)
T 3eqc_A           82 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP  160 (360)
T ss_dssp             HGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSG
T ss_pred             HHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccH
Confidence            3567889999999999999999999999999986 5555554 446799999999999999999999986 999999999


Q ss_pred             ccEEEcCCCceEEeccCccccc--CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIK--CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||++...  .......||+.|+|||++.   ...++.++|+||+|++
T Consensus       161 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  219 (360)
T 3eqc_A          161 SNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLS  219 (360)
T ss_dssp             GGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHT---TCCCSHHHHHHHHHHH
T ss_pred             HHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHc---CCCCCchhhHHHHHHH
Confidence            9999999999999999998642  2334568999999999983   4568999999999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.89  E-value=9.4e-24  Score=226.88  Aligned_cols=135  Identities=29%  Similarity=0.518  Sum_probs=116.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcC-----------------------CCCCHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHK-----------------------RPLKEEEIAAIC   60 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~-----------------------~~l~~~~~~~~~   60 (804)
                      ..+|++++|||||++++++.+++..|+|||||. |++.+++....                       ..+++..+..++
T Consensus        77 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  156 (314)
T 2ivs_A           77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA  156 (314)
T ss_dssp             HHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHH
T ss_pred             HHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHH
Confidence            457889999999999999999999999999998 56667665432                       238999999999


Q ss_pred             HHHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcc
Q psy17952         61 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKV  134 (804)
Q Consensus        61 ~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~v  134 (804)
                      .|++.||+|||+++|+||||||+||+++.++.+||+|||++.....      .....||+.|+|||++.   ...++.++
T Consensus       157 ~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~  233 (314)
T 2ivs_A          157 WQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF---DHIYTTQS  233 (314)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH---HCEECHHH
T ss_pred             HHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc---CCCcCchh
Confidence            9999999999999999999999999999999999999999975321      22346788999999984   35688999


Q ss_pred             cccccccC
Q psy17952        135 DVWSLGIT  142 (804)
Q Consensus       135 DvwslG~~  142 (804)
                      |+||+|++
T Consensus       234 Di~slG~i  241 (314)
T 2ivs_A          234 DVWSFGVL  241 (314)
T ss_dssp             HHHHHHHH
T ss_pred             hHHHHHHH
Confidence            99999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.89  E-value=7e-24  Score=235.12  Aligned_cols=135  Identities=30%  Similarity=0.563  Sum_probs=105.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC------CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD------HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~------~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      ..+|+.++|||||+++++|...      ..+|+||||+.+++.+++..  ..+++..++.++.||++||+|||++||+||
T Consensus        79 ~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~  156 (367)
T 2fst_X           79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR  156 (367)
T ss_dssp             HHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            3678999999999999998764      56899999998888777653  579999999999999999999999999999


Q ss_pred             ccccccEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         79 DVKAGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        79 DlKp~Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||||+|||++.++.+||+|||+++... .....+||+.|+|||++.+  ...|+.++|+||+|++.
T Consensus       157 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il  220 (367)
T 2fst_X          157 DLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIM  220 (367)
T ss_dssp             CCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHTT--CCSCCTTHHHHHHHHHH
T ss_pred             CCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHcC--CcCCCchhhHHHHHHHH
Confidence            999999999999999999999997532 2345689999999999842  35689999999999983

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.89  E-value=2.5e-23  Score=221.63  Aligned_cols=133  Identities=34%  Similarity=0.638  Sum_probs=113.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe----CCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--RIH   77 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~--IiH   77 (804)
                      ..+|++++|||||+++++|..    +..+|+|||||.| ++.+++. ....+++..++.++.|++.||.|||+++  |+|
T Consensus        76 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H  154 (290)
T 1t4h_A           76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH  154 (290)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred             HHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH-HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEE
Confidence            467889999999999999875    4568999999986 5555554 3467999999999999999999999999  999


Q ss_pred             cccccccEEEc-CCCceEEeccCcccccCC--CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         78 RDVKAGNILLT-ETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        78 RDlKp~Nill~-~~~~~kl~DFG~a~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||||+|||++ .++.+||+|||++.....  .....||+.|+|||++.    +.++.++|+||+|++
T Consensus       155 ~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~  218 (290)
T 1t4h_A          155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMC  218 (290)
T ss_dssp             SCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHH
T ss_pred             CCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHh----ccCCCcchHHHHHHH
Confidence            99999999998 789999999999965332  23467999999999872    458999999999998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.89  E-value=6.9e-24  Score=230.27  Aligned_cols=135  Identities=31%  Similarity=0.463  Sum_probs=112.9

Q ss_pred             HHHhcCCCCeeeEeEEEEeCC----eEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--------
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDH----TAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL--------   73 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~----~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~--------   73 (804)
                      +|++++|||||++++++....    .+|||||||.| +|.+++..  ..+++..+..++.|++.||+|||++        
T Consensus        71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~  148 (322)
T 3soc_A           71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGH  148 (322)
T ss_dssp             TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEE
T ss_pred             HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhcccccccc
Confidence            478899999999999998744    47999999986 66666654  4699999999999999999999999        


Q ss_pred             --CccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhccc--CccCCcccccccccCC
Q psy17952         74 --GRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITP  143 (804)
Q Consensus        74 --~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~--~~~~~~vDvwslG~~~  143 (804)
                        +|+||||||+|||++.++.+||+|||+++...      .....+||+.|+|||++.+...  ..++.++|+||+|++.
T Consensus       149 ~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il  228 (322)
T 3soc_A          149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL  228 (322)
T ss_dssp             ECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHH
Confidence              99999999999999999999999999996422      1223579999999999843111  3467789999999983

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.89  E-value=2e-23  Score=220.79  Aligned_cols=135  Identities=30%  Similarity=0.534  Sum_probs=116.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe----------------CCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR----------------DHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRG   66 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~----------------~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~a   66 (804)
                      ..+|++++||||++++++|..                ...+|+|||||.| ++.+++... ...+++..+..++.|++.|
T Consensus        55 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~  134 (284)
T 2a19_B           55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG  134 (284)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence            467899999999999998865                4458999999986 677777644 3679999999999999999


Q ss_pred             HHHHHhcCccccccccccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         67 LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        67 L~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |.|||+++|+||||||+||+++.++.+||+|||++.....   .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       135 l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  210 (284)
T 2a19_B          135 VDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALGLI  210 (284)
T ss_dssp             HHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH---CSCCCTHHHHHHHHHH
T ss_pred             HHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhc---cCCCcchhhhHHHHHH
Confidence            9999999999999999999999999999999999875322   23457999999999973   4568899999999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.89  E-value=2.6e-23  Score=230.15  Aligned_cols=136  Identities=30%  Similarity=0.538  Sum_probs=116.8

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|+++ +||||++++++|......|||||||.| ++.+++. ....+++..+..++.||+.||.|||++||+||||||+
T Consensus       151 ~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~  229 (365)
T 2y7j_A          151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE  229 (365)
T ss_dssp             HHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            467777 899999999999999999999999986 4555554 4467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhc---ccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~---~~~~~~~~vDvwslG~~  142 (804)
                      |||++.+|.+||+|||++....   .....+||+.|+|||++.+.   ....++.++|+||+|++
T Consensus       230 NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i  294 (365)
T 2y7j_A          230 NILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI  294 (365)
T ss_dssp             GEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHH
T ss_pred             HEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHH
Confidence            9999999999999999987533   23346899999999998432   12358889999999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.89  E-value=2.8e-23  Score=224.05  Aligned_cols=134  Identities=28%  Similarity=0.401  Sum_probs=109.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++||||+++++++..++.+|+||||+.| ++.+++. ...++++..+..++.|++.||+|||+++|+||||||+
T Consensus        85 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~  163 (309)
T 2h34_A           85 ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE  163 (309)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChH
Confidence            3578889999999999999999999999999986 5566554 3467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++.....     .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  224 (309)
T 2h34_A          164 NILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS---ESHATYRADIYALTCV  224 (309)
T ss_dssp             GEEECTTSCEEECSCCC----------------CCGGGCCGGGTC---C----CCCHHHHHHHH
T ss_pred             HEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHc---CCCCCchHhHHHHHHH
Confidence            99999999999999999865322     23457999999999973   4578899999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.89  E-value=3.6e-23  Score=222.71  Aligned_cols=135  Identities=50%  Similarity=0.919  Sum_probs=119.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++||||+++++++.+++.+|+|||||.| ++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        75 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~  154 (314)
T 3com_A           75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG  154 (314)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHH
Confidence            4678999999999999999999999999999986 666666656778999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       155 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  214 (314)
T 3com_A          155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGYNCVADIWSLGIT  214 (314)
T ss_dssp             GEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHS---SSCBCTTHHHHHHHHH
T ss_pred             HEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcC---CCCCCccccHHHHHHH
Confidence            9999999999999999996432    223457999999999973   4568999999999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.89  E-value=1.5e-23  Score=229.54  Aligned_cols=136  Identities=30%  Similarity=0.470  Sum_probs=113.3

Q ss_pred             HHHHHhcCC--CCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKH--PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~H--pnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|  ||||++++++.+++.+||||||+.|++.+++.. ...+++..+..++.|++.||+|||+++|+||||||
T Consensus        58 ~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp  136 (343)
T 3dbq_A           58 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP  136 (343)
T ss_dssp             HHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            357788877  999999999999999999999877888887764 56899999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhc--------ccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAM--------DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~--------~~~~~~~~vDvwslG~~  142 (804)
                      +|||++ ++.+||+|||++.....      ....+||+.|+|||++.+.        ....++.++|+||+|++
T Consensus       137 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i  209 (343)
T 3dbq_A          137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  209 (343)
T ss_dssp             GGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred             ceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence            999997 58899999999975321      2245799999999998531        12568889999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.2e-23  Score=229.70  Aligned_cols=135  Identities=31%  Similarity=0.516  Sum_probs=115.8

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCC----------------------CCCHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKR----------------------PLKEEEIAAIC   60 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~----------------------~l~~~~~~~~~   60 (804)
                      ..+|+++ +|||||++++++..++.+|||||||.| +|.+++.....                      .+++..+..++
T Consensus        99 ~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  178 (344)
T 1rjb_A           99 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA  178 (344)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred             HHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHH
Confidence            3578888 999999999999999999999999975 67777654332                      37999999999


Q ss_pred             HHHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcc
Q psy17952         61 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKV  134 (804)
Q Consensus        61 ~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~v  134 (804)
                      .||+.||+|||+++|+||||||+|||++.++.+||+|||++.....      .....||+.|+|||++.   .+.++.++
T Consensus       179 ~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~  255 (344)
T 1rjb_A          179 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKS  255 (344)
T ss_dssp             HHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH---HCCCCHHH
T ss_pred             HHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc---cCCCChhH
Confidence            9999999999999999999999999999999999999999975321      12346788999999974   35689999


Q ss_pred             cccccccC
Q psy17952        135 DVWSLGIT  142 (804)
Q Consensus       135 DvwslG~~  142 (804)
                      |+||+|++
T Consensus       256 Di~slG~i  263 (344)
T 1rjb_A          256 DVWSYGIL  263 (344)
T ss_dssp             HHHHHHHH
T ss_pred             hHHHHHHH
Confidence            99999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.89  E-value=1.1e-24  Score=237.80  Aligned_cols=110  Identities=22%  Similarity=0.304  Sum_probs=94.2

Q ss_pred             CCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hcCccccccccccEEEcCCC------------
Q psy17952         26 DHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH-SLGRIHRDVKAGNILLTETG------------   91 (804)
Q Consensus        26 ~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~Nill~~~~------------   91 (804)
                      ++.+|||||||.|+ +++.+.  +..+++..++.++.||+.||+||| +++|+||||||+|||++.++            
T Consensus       134 ~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~  211 (336)
T 2vuw_A          134 DDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS  211 (336)
T ss_dssp             TTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEE
T ss_pred             cCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCcc
Confidence            67899999999765 666553  367899999999999999999999 99999999999999999887            


Q ss_pred             --------ceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         92 --------TVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        92 --------~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                              .+||+|||+|+.... ...+||+.|||||++.    +..+.++|+||++.+
T Consensus       212 ~~~~~~~~~vkL~DFG~a~~~~~-~~~~gt~~y~aPE~~~----g~~~~~~Diwsl~~~  265 (336)
T 2vuw_A          212 STIPSCGLQVSIIDYTLSRLERD-GIVVFCDVSMDEDLFT----GDGDYQFDIYRLMKK  265 (336)
T ss_dssp             EEEECTTEEEEECCCTTCBEEET-TEEECCCCTTCSGGGC----CCSSHHHHHHHHHHH
T ss_pred             ccccCCCceEEEeeccccEecCC-CcEEEeecccChhhhc----CCCccceehhhhhCC
Confidence                    899999999986433 3458999999999984    233779999998766

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.89  E-value=1.8e-23  Score=226.48  Aligned_cols=136  Identities=32%  Similarity=0.608  Sum_probs=115.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||++++++..++ .|+|||||.| ++.+.+. ....+++..+..++.|++.||.|||+++|+||||||+
T Consensus        66 ~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  143 (322)
T 2ycf_A           66 IEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE  143 (322)
T ss_dssp             HHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            46789999999999999987665 8999999986 5666554 4568999999999999999999999999999999999


Q ss_pred             cEEEcCCCc---eEEeccCcccccCCC---CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGT---VKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~---~kl~DFG~a~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.   +||+|||++......   ....||+.|+|||++.......++.++|+||+|++
T Consensus       144 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  208 (322)
T 2ycf_A          144 NVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI  208 (322)
T ss_dssp             GEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHH
T ss_pred             HEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHH
Confidence            999987664   999999999754332   23579999999999754345678899999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.88  E-value=1.3e-23  Score=230.59  Aligned_cols=135  Identities=30%  Similarity=0.484  Sum_probs=113.0

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCC-eEEEEEeccCC-CcHHHHHHcCC--------------------------------
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDH-TAWLVMEYCLG-SASDIIEVHKR--------------------------------   49 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~-~~~lV~Ey~~g-~l~~~~~~~~~--------------------------------   49 (804)
                      ..+|+++ +|||||+++++|...+ .+|+|||||.| +|.+++.....                                
T Consensus        76 ~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (359)
T 3vhe_A           76 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS  155 (359)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------
T ss_pred             HHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccc
Confidence            3567788 7999999999988755 48999999986 56666654321                                


Q ss_pred             ---------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEEcCCCceEEe
Q psy17952         50 ---------------------------------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA   96 (804)
Q Consensus        50 ---------------------------------~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~   96 (804)
                                                       .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~  235 (359)
T 3vhe_A          156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC  235 (359)
T ss_dssp             ----------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             cCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEE
Confidence                                             18999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         97 DFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        97 DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.....      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  284 (359)
T 3vhe_A          236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVL  284 (359)
T ss_dssp             CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eccceeeecccccchhccccCCCceeEChhhhc---CCCCCchhhhhhHHHH
Confidence            9999975321      22357899999999984   4568999999999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.88  E-value=1.1e-23  Score=225.04  Aligned_cols=135  Identities=28%  Similarity=0.449  Sum_probs=114.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEE-eCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYL-RDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~-~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++. .++..|+|||||.| ++.+++......+++..+..++.|++.||+|||+++|+||||||
T Consensus        77 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp  156 (298)
T 3f66_A           77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAA  156 (298)
T ss_dssp             HHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             HHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCch
Confidence            35789999999999999854 55678999999986 66677765566799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC--------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +||+++.++.+||+|||++....        ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       157 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  221 (298)
T 3f66_A          157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVL  221 (298)
T ss_dssp             GGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             heEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhc---CCCCChHHHHHHHHHH
Confidence            99999999999999999997432        122346888999999984   3568899999999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.88  E-value=3.1e-23  Score=219.67  Aligned_cols=134  Identities=31%  Similarity=0.567  Sum_probs=114.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++||||+++++++.+....|+||||+.| ++.+++. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        59 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~  137 (283)
T 3bhy_A           59 VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPE  137 (283)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChH
Confidence            4678999999999999999999999999999975 5566554 3567999999999999999999999999999999999


Q ss_pred             cEEEcCCC----ceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETG----TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~----~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++    .+||+|||++.....   .....||+.|+|||++   ....++.++|+||+|++
T Consensus       138 Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~i  200 (283)
T 3bhy_A          138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV---NYEPLGLEADMWSIGVI  200 (283)
T ss_dssp             GEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHH---TTCCCCTHHHHHHHHHH
T ss_pred             HEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCccee---cCCCCCcchhhhhHHHH
Confidence            99998877    899999999975322   2345799999999997   34568899999999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.88  E-value=7.5e-24  Score=229.40  Aligned_cols=135  Identities=30%  Similarity=0.458  Sum_probs=115.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|+.++|||||++++++.+++..|+|||||.| ++.+++....   ..+++..+..++.|++.||+|||+++|+||||
T Consensus        86 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dl  165 (321)
T 2qkw_B           86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV  165 (321)
T ss_dssp             HHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             HHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCC
Confidence            3567889999999999999999999999999985 5666554332   35899999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+||+++.++.+||+|||++.....      .....||+.|+|||++.   .+.++.++|+||+|++
T Consensus       166 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  230 (321)
T 2qkw_B          166 KSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI---KGRLTEKSDVYSFGVV  230 (321)
T ss_dssp             CSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHH---HCBCCTHHHHHHHHHH
T ss_pred             CHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhc---CCCCCcccchHhHHHH
Confidence            99999999999999999999964221      22356999999999984   3568999999999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=1.7e-23  Score=223.17  Aligned_cols=135  Identities=30%  Similarity=0.445  Sum_probs=116.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeE-EEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~-~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++.+.+.. |+||||+. |++.+++......+++..+..++.|++.||+|||+++|+||||||
T Consensus        73 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp  152 (298)
T 3pls_A           73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAA  152 (298)
T ss_dssp             HHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             HHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence            4578999999999999999876654 99999996 566777765567899999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC--------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +||+++.++.+||+|||++....        ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       153 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  217 (298)
T 3pls_A          153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ---TYRFTTKSDVWSFGVL  217 (298)
T ss_dssp             GGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             ceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhc---cCCCChhhchhhHHHH
Confidence            99999999999999999996421        223357889999999973   4568899999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.88  E-value=1.8e-23  Score=230.98  Aligned_cols=134  Identities=29%  Similarity=0.563  Sum_probs=117.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC-----CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~-----~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|++++|||||++++++...     ..+|+||||+.|++.+++..  ..+++..+..++.|++.||+|||+++|+|||
T Consensus        76 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D  153 (364)
T 3qyz_A           76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRD  153 (364)
T ss_dssp             HHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            4678999999999999998765     36899999999988888764  5699999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||++.++.+||+|||++.....       ....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       154 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~i  221 (364)
T 3qyz_A          154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKSIDIWSVGCI  221 (364)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT--BCSCSTHHHHHHHHHH
T ss_pred             CChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC--CCCCCcchhHHHHHHH
Confidence            999999999999999999999975321       234589999999998742  3458999999999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.88  E-value=9.9e-24  Score=224.99  Aligned_cols=137  Identities=34%  Similarity=0.580  Sum_probs=106.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++ ......++|||||.| ++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        71 ~~~l~~l~h~~iv~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~  149 (289)
T 3og7_A           71 VGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN  149 (289)
T ss_dssp             HHHHTTCCCTTBCCEEEE-ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCcEEEEEee-ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence            357889999999999995 456678999999985 566666555678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++.....      .....||+.|+|||++.......++.++|+||+|++
T Consensus       150 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  214 (289)
T 3og7_A          150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV  214 (289)
T ss_dssp             GEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHH
T ss_pred             eEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHH
Confidence            99999999999999999864321      223579999999999853335568889999999998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.88  E-value=1.1e-23  Score=229.77  Aligned_cols=137  Identities=34%  Similarity=0.592  Sum_probs=111.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHc------------------------------------
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVH------------------------------------   47 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~------------------------------------   47 (804)
                      ..+|++++|||||+++++|.+++..|||||||.|+ +.+++...                                    
T Consensus        79 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (345)
T 3hko_A           79 VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFR  158 (345)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CE
T ss_pred             HHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccc
Confidence            35789999999999999999999999999999855 44544210                                    


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEEcCCC--ceEEeccCcccccC--------CCCcccccc
Q psy17952         48 ---KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG--TVKLADFGSASIKC--------PANSFVGTP  114 (804)
Q Consensus        48 ---~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~--~~kl~DFG~a~~~~--------~~~~~~gt~  114 (804)
                         ...+++..++.++.|++.||+|||+++|+||||||+|||++.++  .+||+|||++....        ......||+
T Consensus       159 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  238 (345)
T 3hko_A          159 ESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP  238 (345)
T ss_dssp             EECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred             ccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence               11246788999999999999999999999999999999998776  89999999997421        123457999


Q ss_pred             ccCcchhhhhcccCccCCcccccccccC
Q psy17952        115 YWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus       115 ~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      .|+|||++.+ ....++.++|+||+|++
T Consensus       239 ~y~aPE~~~~-~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          239 YFVAPEVLNT-TNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             GGCCHHHHTC-SSSCCCTHHHHHHHHHH
T ss_pred             cccCchhhcc-CCCCCCcHHHHHHHHHH
Confidence            9999999843 23568899999999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=2.3e-23  Score=227.41  Aligned_cols=135  Identities=24%  Similarity=0.453  Sum_probs=114.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.+.+..|||||||.| ++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        97 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  176 (333)
T 1mqb_A           97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR  176 (333)
T ss_dssp             HHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence            3578899999999999999999999999999986 666777666678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC-------CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~-------~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||++......       ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       177 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  239 (333)
T 1mqb_A          177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIV  239 (333)
T ss_dssp             GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH---SCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc---cCCCCchhhhHHHHHH
Confidence            999999999999999999753211       1234678999999973   4568899999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.88  E-value=1.5e-23  Score=227.06  Aligned_cols=135  Identities=33%  Similarity=0.453  Sum_probs=116.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhc---Cccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---RPLKEEEIAAICSGVLRGLNYLHSL---GRIH   77 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---~~l~~~~~~~~~~qi~~aL~ylH~~---~IiH   77 (804)
                      ..+|++++|||||+++++|.+....|+|||||.| ++.+++....   .++++..+..++.|++.||+|||++   +|+|
T Consensus        78 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH  157 (326)
T 3uim_A           78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH  157 (326)
T ss_dssp             HHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEEC
T ss_pred             HHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Confidence            3578889999999999999999999999999986 5666665432   3599999999999999999999999   9999


Q ss_pred             cccccccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         78 RDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        78 RDlKp~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||||+|||++.++.+||+|||++.....     .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       158 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  224 (326)
T 3uim_A          158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVM  224 (326)
T ss_dssp             CCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH---HSEECHHHHHHHHHHH
T ss_pred             CCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhc---cCCCCccccchhHHHH
Confidence            99999999999999999999999975321     22346999999999984   3568899999999998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.88  E-value=1.6e-23  Score=219.78  Aligned_cols=135  Identities=29%  Similarity=0.520  Sum_probs=118.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++||||+++++++.+++..|+||||++| ++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        54 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~  133 (267)
T 3t9t_A           54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR  133 (267)
T ss_dssp             HHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG
T ss_pred             HHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh
Confidence            4678899999999999999999999999999985 677777666678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....     ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       134 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  194 (267)
T 3t9t_A          134 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVL  194 (267)
T ss_dssp             GEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCCEEEcccccccccccccccccccccccccccChhhhc---CCCccchhchhhhHHH
Confidence            9999999999999999997532     223346788999999973   3568889999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.88  E-value=3e-23  Score=227.81  Aligned_cols=134  Identities=31%  Similarity=0.525  Sum_probs=114.2

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCe-------EEEEEeccCCCcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hcC
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHT-------AWLVMEYCLGSASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLH--SLG   74 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~-------~~lV~Ey~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH--~~~   74 (804)
                      .|+.++|||||+++++|.....       +|+|||||.|++.+.+..   ....+++..++.++.|++.||.|||  +++
T Consensus        72 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~  151 (360)
T 3e3p_A           72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN  151 (360)
T ss_dssp             HHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred             HHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            4577899999999999876433       899999999988766543   3567999999999999999999999  999


Q ss_pred             ccccccccccEEEcC-CCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         75 RIHRDVKAGNILLTE-TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        75 IiHRDlKp~Nill~~-~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||||||+|||++. ++.+||+|||++.....   .....||+.|+|||++.+  ...++.++|+||+|++
T Consensus       152 ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~i  221 (360)
T 3e3p_A          152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG--NQHYTTAVDIWSVGCI  221 (360)
T ss_dssp             CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC--CCCCCcHHHHHHHHHH
Confidence            999999999999997 89999999999975332   234679999999999842  3458999999999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.88  E-value=2.4e-23  Score=223.50  Aligned_cols=134  Identities=31%  Similarity=0.566  Sum_probs=116.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++||||++++++|.+.+..|+|||||.| ++.+.+.. ...+++..+..++.|++.||+|||+++|+||||||+
T Consensus        57 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~  135 (304)
T 2jam_A           57 IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE  135 (304)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGG
T ss_pred             HHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence            3678999999999999999999999999999985 56566543 467999999999999999999999999999999999


Q ss_pred             cEEE---cCCCceEEeccCcccccCC--CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILL---TETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill---~~~~~~kl~DFG~a~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++   +.++.+||+|||++.....  .....||+.|+|||++   ....++.++|+||+|++
T Consensus       136 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~i  196 (304)
T 2jam_A          136 NLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL---AQKPYSKAVDCWSIGVI  196 (304)
T ss_dssp             GCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTB---SSCSCCHHHHHHHHHHH
T ss_pred             HEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHh---ccCCCCchhhHHHHHHH
Confidence            9999   7788999999999975332  2335799999999997   34578899999999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.88  E-value=2.1e-23  Score=233.17  Aligned_cols=135  Identities=30%  Similarity=0.470  Sum_probs=113.2

Q ss_pred             HHHHhcC--CCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLK--HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~--HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|++|+  |||||++++++..++.+||||||+.|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+
T Consensus       106 ~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~  184 (390)
T 2zmd_A          106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA  184 (390)
T ss_dssp             HHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGG
T ss_pred             HHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence            5778886  5999999999999999999999767778887764 458999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcc--------cCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMD--------EGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~--------~~~~~~~vDvwslG~~  142 (804)
                      |||++ ++.+||+|||+++....      ....+||+.|+|||++.+..        ...|+.++|+||+|++
T Consensus       185 NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi  256 (390)
T 2zmd_A          185 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  256 (390)
T ss_dssp             GEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred             HEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence            99996 58999999999975321      23467999999999985321        1358889999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.88  E-value=1.6e-23  Score=223.64  Aligned_cols=136  Identities=29%  Similarity=0.468  Sum_probs=111.1

Q ss_pred             HHHHh--cCCCCeeeEeEEEEeC----CeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-------
Q psy17952          6 SLLRQ--LKHPNTIEYRGCYLRD----HTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH-------   71 (804)
Q Consensus         6 ~iL~~--l~HpnIV~l~~~~~~~----~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH-------   71 (804)
                      ++++.  ++|||||++++++...    ..+|||||||.| ++.+++.  ...+++..+..++.|++.||+|||       
T Consensus        52 ~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~  129 (301)
T 3q4u_A           52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ  129 (301)
T ss_dssp             HHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTT
T ss_pred             HHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence            45555  7999999999987542    458999999985 5666663  467999999999999999999999       


Q ss_pred             -hcCccccccccccEEEcCCCceEEeccCcccccCC--------CCccccccccCcchhhhhcccC---ccCCccccccc
Q psy17952         72 -SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEG---QYDGKVDVWSL  139 (804)
Q Consensus        72 -~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~--------~~~~~gt~~y~APE~l~~~~~~---~~~~~vDvwsl  139 (804)
                       +++|+||||||+|||++.++.+||+|||+++....        ....+||+.|+|||++.+....   .++.++|+||+
T Consensus       130 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl  209 (301)
T 3q4u_A          130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF  209 (301)
T ss_dssp             CBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred             CCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence             99999999999999999999999999999964221        2235899999999998431111   45578999999


Q ss_pred             ccCC
Q psy17952        140 GITP  143 (804)
Q Consensus       140 G~~~  143 (804)
                      |++.
T Consensus       210 G~il  213 (301)
T 3q4u_A          210 GLVL  213 (301)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9983

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.88  E-value=1.7e-23  Score=228.03  Aligned_cols=134  Identities=29%  Similarity=0.488  Sum_probs=112.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.++. .++||||+. |++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        68 ~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  146 (327)
T 3lzb_A           68 AYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR  146 (327)
T ss_dssp             HHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHH
Confidence            35788999999999999988765 789999997 5677777777788999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++....      .....||+.|+|||++.   ...|+.++|+||+|++
T Consensus       147 NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (327)
T 3lzb_A          147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVT  208 (327)
T ss_dssp             GEEEEETTEEEECCTTC----------------CCCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHc---CCCCChHHHHHHHHHH
Confidence            99999999999999999975321      12245788999999984   4568999999999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.88  E-value=2.1e-23  Score=219.52  Aligned_cols=134  Identities=36%  Similarity=0.598  Sum_probs=108.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC---ccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG---RIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~---IiHRDlK   81 (804)
                      ..+++.++||||+++++++.+++..|+||||+.|+.+..+. ....+++..+..++.|++.||+|||+++   |+|||||
T Consensus        57 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dik  135 (271)
T 3dtc_A           57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK  135 (271)
T ss_dssp             HHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCS
T ss_pred             HHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCc
Confidence            46788999999999999999999999999999876554443 3568999999999999999999999999   9999999


Q ss_pred             cccEEEcC--------CCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTE--------TGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~--------~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.        ++.+||+|||++....  ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       136 p~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  203 (271)
T 3dtc_A          136 SSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR---ASMFSKGSDVWSYGVL  203 (271)
T ss_dssp             GGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             hHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhc---cCCCCchhhHHHHHHH
Confidence            99999986        6789999999997532  223467999999999974   3568899999999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.88  E-value=2.2e-24  Score=239.48  Aligned_cols=134  Identities=20%  Similarity=0.238  Sum_probs=110.1

Q ss_pred             HHHhcCCCCeeeEe-------EEEEeCCe-----------------EEEEEeccCCCcHHHHHHcCCCCC-------HHH
Q psy17952          7 LLRQLKHPNTIEYR-------GCYLRDHT-----------------AWLVMEYCLGSASDIIEVHKRPLK-------EEE   55 (804)
Q Consensus         7 iL~~l~HpnIV~l~-------~~~~~~~~-----------------~~lV~Ey~~g~l~~~~~~~~~~l~-------~~~   55 (804)
                      +|++++|||||+++       +++.+++.                 .|||||||.|+|.+++... ..++       +..
T Consensus       129 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~  207 (377)
T 3byv_A          129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHA  207 (377)
T ss_dssp             GSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHH
T ss_pred             hccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHH
Confidence            45667899999998       77766542                 8999999988888887643 2233       478


Q ss_pred             HHHHHHHHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhc--------c
Q psy17952         56 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAM--------D  126 (804)
Q Consensus        56 ~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~--------~  126 (804)
                      +..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+... .....+| +.|+|||++.+.        .
T Consensus       208 ~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~  286 (377)
T 3byv_A          208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDR  286 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccc
Confidence            88899999999999999999999999999999999999999999997533 2334578 999999998532        0


Q ss_pred             cCccCCcccccccccC
Q psy17952        127 EGQYDGKVDVWSLGIT  142 (804)
Q Consensus       127 ~~~~~~~vDvwslG~~  142 (804)
                      ...|+.++|+||+|++
T Consensus       287 ~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          287 RTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EEECCHHHHHHHHHHH
T ss_pred             cccCChhhhHHHHHHH
Confidence            0268999999999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.88  E-value=1.3e-23  Score=242.14  Aligned_cols=135  Identities=24%  Similarity=0.473  Sum_probs=117.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||+++++|..+..+|||||||. |+|.+++... ...+++..+..++.||+.||+|||+++|+||||||
T Consensus       267 ~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp  346 (495)
T 1opk_A          267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA  346 (495)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            468999999999999999999999999999998 5677777654 35699999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||+++....     .....+++.|+|||++.   .+.++.++|+||+|++
T Consensus       347 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlG~~  408 (495)
T 1opk_A          347 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVL  408 (495)
T ss_dssp             GGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             hhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh---cCCCCcHHhHHhHHHH
Confidence            999999999999999999975322     12235678899999984   4568999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.88  E-value=2.2e-23  Score=221.50  Aligned_cols=135  Identities=27%  Similarity=0.483  Sum_probs=114.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--RIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~--IiHRDlK   81 (804)
                      ..+|++++|||||++++++.+..  ++||||+. |++.+.+.....++++..+..++.|++.||+|||+++  |+|||||
T Consensus        74 ~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dik  151 (287)
T 4f0f_A           74 VFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR  151 (287)
T ss_dssp             HHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCS
T ss_pred             HHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCC
Confidence            35788899999999999986655  79999998 5666777666678999999999999999999999999  9999999


Q ss_pred             cccEEEcCCCc-----eEEeccCcccccCC-CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGT-----VKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~-----~kl~DFG~a~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.++.     +||+|||+++.... .....||+.|+|||++.. ....++.++|+||+|++
T Consensus       152 p~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~Di~slG~~  217 (287)
T 4f0f_A          152 SPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGA-EEESYTEKADTYSFAMI  217 (287)
T ss_dssp             GGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSC-SSCEECHHHHHHHHHHH
T ss_pred             cceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhcc-CCCCcCchhhHHHHHHH
Confidence            99999988776     99999999975332 334689999999998732 23457889999999998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.88  E-value=1.9e-23  Score=224.34  Aligned_cols=135  Identities=31%  Similarity=0.458  Sum_probs=116.8

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCC-----------------CCCHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKR-----------------PLKEEEIAAICSGVLR   65 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~-----------------~l~~~~~~~~~~qi~~   65 (804)
                      ..+|+++ +|||||++++++..++..|+|||||.| ++.+++.....                 ++++..+..++.|++.
T Consensus        77 ~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~  156 (313)
T 1t46_A           77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK  156 (313)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHH
Confidence            3578888 999999999999999999999999986 67777765432                 4899999999999999


Q ss_pred             HHHHHHhcCccccccccccEEEcCCCceEEeccCcccccCCC------CccccccccCcchhhhhcccCccCCccccccc
Q psy17952         66 GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  139 (804)
Q Consensus        66 aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~~------~~~~gt~~y~APE~l~~~~~~~~~~~vDvwsl  139 (804)
                      ||.|||+++|+||||||+||+++.++.+||+|||++......      ....||+.|+|||++.   ...++.++|+||+
T Consensus       157 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~sl  233 (313)
T 1t46_A          157 GMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSY  233 (313)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHH
T ss_pred             HHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc---CCCCChHHHHHHH
Confidence            999999999999999999999999999999999999753221      2346788999999974   3568899999999


Q ss_pred             ccC
Q psy17952        140 GIT  142 (804)
Q Consensus       140 G~~  142 (804)
                      |++
T Consensus       234 G~i  236 (313)
T 1t46_A          234 GIF  236 (313)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.88  E-value=3.5e-23  Score=223.86  Aligned_cols=130  Identities=36%  Similarity=0.568  Sum_probs=113.9

Q ss_pred             hcCCCCeeeEeEEEE-----eCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952         10 QLKHPNTIEYRGCYL-----RDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus        10 ~l~HpnIV~l~~~~~-----~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|||||+++++|.     ....+|+||||+.|++.+++.... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus        70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~  149 (326)
T 1blx_A           70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ  149 (326)
T ss_dssp             HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             ccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence            348999999999987     456799999999999888887653 45999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....   ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       150 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (326)
T 1blx_A          150 NILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCI  208 (326)
T ss_dssp             GEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             HeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHh---cCCCCcchhHHHHHHH
Confidence            9999999999999999997533   223467999999999983   4568999999999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.88  E-value=4e-23  Score=221.69  Aligned_cols=134  Identities=34%  Similarity=0.503  Sum_probs=116.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH--KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||++++++.+.+..|+||||+.| ++.+++...  ..++++..+..++.|++.||+|||+++|+|||||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk  160 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIK  160 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence            4578999999999999999999999999999975 566666532  3569999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||+++.++.+||+|||++.....      .....||+.|+|||++.    +.++.++|+||+|++
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~Dv~slG~i  223 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR----GEITPKSDIYSFGVV  223 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT----TEECTHHHHHHHHHH
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc----CCCCccchhHHHHHH
Confidence            9999999999999999999865321      22357999999999873    458899999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.88  E-value=1.6e-23  Score=226.85  Aligned_cols=137  Identities=29%  Similarity=0.503  Sum_probs=103.5

Q ss_pred             HHHHhcC-CCCeeeEeEEEE--------eCCeEEEEEeccCCCcHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy17952          6 SLLRQLK-HPNTIEYRGCYL--------RDHTAWLVMEYCLGSASDIIEV--HKRPLKEEEIAAICSGVLRGLNYLHSLG   74 (804)
Q Consensus         6 ~iL~~l~-HpnIV~l~~~~~--------~~~~~~lV~Ey~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~aL~ylH~~~   74 (804)
                      .+|+++. |||||++++++.        ....+|+|||||.|++.+++..  ...++++..+..++.||+.||+|||+++
T Consensus        77 ~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  156 (337)
T 3ll6_A           77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK  156 (337)
T ss_dssp             HHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4677785 999999999984        3345899999999999888764  3467999999999999999999999999


Q ss_pred             --ccccccccccEEEcCCCceEEeccCcccccCCC----------------CccccccccCcchhhhhcccCccCCcccc
Q psy17952         75 --RIHRDVKAGNILLTETGTVKLADFGSASIKCPA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDV  136 (804)
Q Consensus        75 --IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~~----------------~~~~gt~~y~APE~l~~~~~~~~~~~vDv  136 (804)
                        |+||||||+|||++.++.+||+|||++......                ....||+.|+|||++.......++.++|+
T Consensus       157 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv  236 (337)
T 3ll6_A          157 PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI  236 (337)
T ss_dssp             SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHH
T ss_pred             CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhH
Confidence              999999999999999999999999999753221                13469999999999743234568889999


Q ss_pred             cccccC
Q psy17952        137 WSLGIT  142 (804)
Q Consensus       137 wslG~~  142 (804)
                      ||+|++
T Consensus       237 ~slG~i  242 (337)
T 3ll6_A          237 WALGCI  242 (337)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.88  E-value=2.1e-23  Score=225.70  Aligned_cols=136  Identities=24%  Similarity=0.412  Sum_probs=107.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeE------EEEEeccCC-CcHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLG-SASDIIEVHK-----RPLKEEEIAAICSGVLRGLNYLHS   72 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~------~lV~Ey~~g-~l~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~ylH~   72 (804)
                      ..+|++++|||||++++++......      |+|||||.| ++.+++....     ..+++..+..++.|++.||+|||+
T Consensus        76 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~  155 (323)
T 3qup_A           76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS  155 (323)
T ss_dssp             HHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc
Confidence            3578899999999999999887655      999999986 5666654322     269999999999999999999999


Q ss_pred             cCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         73 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        73 ~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ++|+||||||+|||++.++.+||+|||++.....      .....||+.|+|||++.   ...++.++|+||+|++.
T Consensus       156 ~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il  229 (323)
T 3qup_A          156 RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA---DNLYTVHSDVWAFGVTM  229 (323)
T ss_dssp             TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             CCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhc---CCCCCCccchhhHHHHH
Confidence            9999999999999999999999999999975321      12345788999999984   35688999999999983

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.88  E-value=3.2e-23  Score=220.88  Aligned_cols=137  Identities=35%  Similarity=0.587  Sum_probs=112.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe-------------CCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR-------------DHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYL   70 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~-------------~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~yl   70 (804)
                      ..+|++++||||++++++|.+             ...+|+|||||+| ++.+++......+++..+..++.|++.||+||
T Consensus        53 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L  132 (303)
T 1zy4_A           53 VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI  132 (303)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHH
Confidence            457889999999999998865             3568999999975 67777766666789999999999999999999


Q ss_pred             HhcCccccccccccEEEcCCCceEEeccCcccccCC------------------CCccccccccCcchhhhhcccCccCC
Q psy17952         71 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------------------ANSFVGTPYWMAPEVILAMDEGQYDG  132 (804)
Q Consensus        71 H~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------------------~~~~~gt~~y~APE~l~~~~~~~~~~  132 (804)
                      |+++|+||||||+|||++.++.+||+|||++.....                  .....||+.|+|||++.+  .+.++.
T Consensus       133 H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~  210 (303)
T 1zy4_A          133 HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGHYNE  210 (303)
T ss_dssp             HHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS--CSCCCT
T ss_pred             HhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC--CCCCcc
Confidence            999999999999999999999999999999864321                  123579999999999742  346889


Q ss_pred             cccccccccCC
Q psy17952        133 KVDVWSLGITP  143 (804)
Q Consensus       133 ~vDvwslG~~~  143 (804)
                      ++|+||+|++.
T Consensus       211 ~~Di~slG~il  221 (303)
T 1zy4_A          211 KIDMYSLGIIF  221 (303)
T ss_dssp             HHHHHHHHHHH
T ss_pred             hhhHHHHHHHH
Confidence            99999999983

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.88  E-value=2.3e-23  Score=218.60  Aligned_cols=136  Identities=18%  Similarity=0.310  Sum_probs=114.0

Q ss_pred             HHHHhcCCCCeeeEeEEEEeC--CeEEEEEeccCC-CcHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcC--ccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLG-SASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLG--RIHRD   79 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~--~~~~lV~Ey~~g-~l~~~~~~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~--IiHRD   79 (804)
                      .+|++++|||||++++++.+.  ...|+|||||+| ++.+++..... .+++..+..++.|++.||+|||+++  |+|||
T Consensus        59 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~d  138 (271)
T 3kmu_A           59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA  138 (271)
T ss_dssp             GGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCC
T ss_pred             HHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCC
Confidence            467788999999999999877  778999999985 67777654433 5999999999999999999999999  99999


Q ss_pred             cccccEEEcCCCceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+||+++.++.+|++|||++.... .....||+.|+|||++.+.....++.++|+||+|++
T Consensus       139 ikp~Nil~~~~~~~~l~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~i  200 (271)
T 3kmu_A          139 LNSRSVMIDEDMTARISMADVKFSFQ-SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL  200 (271)
T ss_dssp             CSGGGEEECTTSCEEEEGGGSCCTTS-CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHH
T ss_pred             CccceEEEcCCcceeEEeccceeeec-ccCccCCccccChhhhccCCCCCCCchhhHHHHHHH
Confidence            99999999999999999998875422 234579999999999854323334458999999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.88  E-value=3.4e-23  Score=224.79  Aligned_cols=135  Identities=30%  Similarity=0.450  Sum_probs=114.9

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---------------CCCCHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---------------RPLKEEEIAAICSGVLRGL   67 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~aL   67 (804)
                      .++|+++ +|||||++++++.+++.+|||||||+| +|.+++....               ..+++..+..++.|++.||
T Consensus        76 ~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL  155 (327)
T 1fvr_A           76 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM  155 (327)
T ss_dssp             HHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence            4578889 999999999999999999999999975 6667665432               4799999999999999999


Q ss_pred             HHHHhcCccccccccccEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        68 ~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||+++|+||||||+|||++.++.+||+|||+++...   ......+++.|+|||++.   ...++.++|+||+|++
T Consensus       156 ~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  230 (327)
T 1fvr_A          156 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVL  230 (327)
T ss_dssp             HHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             HHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhc---cccCCchhcchHHHHH
Confidence            99999999999999999999999999999999996422   223346788999999973   3568899999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=9.6e-24  Score=234.60  Aligned_cols=134  Identities=28%  Similarity=0.446  Sum_probs=108.0

Q ss_pred             HHHHhcCCCCeeeEeEEEE-eCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYL-RDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~-~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|++++|||||++++++. .++..|+|||||.| +|.+++......+++..+..++.|+++||+|||+++|+||||||+
T Consensus       142 ~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  221 (373)
T 3c1x_A          142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR  221 (373)
T ss_dssp             TTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchh
Confidence            4678889999999999865 45678999999985 677777655567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC--------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++....        .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       222 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~i  285 (373)
T 3c1x_A          222 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVL  285 (373)
T ss_dssp             GEEECTTCCEEECCC---------------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhc---CCCCCcHHHHHHHHHH
Confidence            99999999999999999974211        12346788999999974   4568999999999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.88  E-value=1.4e-23  Score=239.29  Aligned_cols=134  Identities=25%  Similarity=0.451  Sum_probs=114.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++. ++.+|||||||.| +|.+++.... ..+++..+..++.||+.||+|||+++|+||||||
T Consensus       234 ~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp  312 (454)
T 1qcf_A          234 ANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA  312 (454)
T ss_dssp             HHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred             HHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence            46889999999999999876 5678999999975 6777765332 3689999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||+++....     .....+|+.|+|||++.   .+.++.++|+||+|++
T Consensus       313 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~  374 (454)
T 1qcf_A          313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGIL  374 (454)
T ss_dssp             GGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc---cCCCCcHHHHHhHHHH
Confidence            999999999999999999975321     22345778899999984   4568999999999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.88  E-value=2.6e-23  Score=227.57  Aligned_cols=134  Identities=31%  Similarity=0.507  Sum_probs=116.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC-----CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~-----~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|++++|||||++++++..+     ...|+||||+.|++.+++..  ..+++..+..++.|++.||+|||+++|+|||
T Consensus        60 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~D  137 (353)
T 2b9h_A           60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD  137 (353)
T ss_dssp             HHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            4678999999999999987654     67899999999988887764  5799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccCC--------------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKCP--------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~~--------------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||++.++.+||+|||++.....              ....+||+.|+|||++.  ....++.++|+||+|++
T Consensus       138 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~Di~slG~i  212 (353)
T 2b9h_A          138 LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML--TSAKYSRAMDVWSCGCI  212 (353)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHH--SCCCCCHHHHHHHHHHH
T ss_pred             CCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeec--cCCCccchhhHHHHHHH
Confidence            999999999999999999999964221              12357899999999874  23568899999999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.88  E-value=2.9e-23  Score=225.34  Aligned_cols=135  Identities=30%  Similarity=0.538  Sum_probs=116.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEE--eCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYL--RDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~--~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++||||+++++++.  ++..+|||||||.| ++.+++......+++..+..++.|++.||+|||+++|+|||||
T Consensus        75 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik  154 (327)
T 3lxl_A           75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA  154 (327)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence            46789999999999999987  45679999999975 6667776656679999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccC-------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.++.+||+|||++....       ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       155 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  219 (327)
T 3lxl_A          155 ARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVV  219 (327)
T ss_dssp             GGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             hhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc---cCCCChHHhHHHHHHH
Confidence            999999999999999999997532       122346889999999974   3568899999999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.88  E-value=2e-23  Score=231.69  Aligned_cols=135  Identities=26%  Similarity=0.361  Sum_probs=115.5

Q ss_pred             HHHHhcC--------CCCeeeEeEEEE----eCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q psy17952          6 SLLRQLK--------HPNTIEYRGCYL----RDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHS   72 (804)
Q Consensus         6 ~iL~~l~--------HpnIV~l~~~~~----~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~   72 (804)
                      .+|++++        |||||+++++|.    ....+|||||||.|++++.+.... ..+++..++.++.||+.||+|||+
T Consensus        85 ~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~  164 (397)
T 1wak_A           85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT  164 (397)
T ss_dssp             HHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4566664        889999999987    455799999999999888876554 679999999999999999999999


Q ss_pred             c-CccccccccccEEEcCCC-------------------------------------------------ceEEeccCccc
Q psy17952         73 L-GRIHRDVKAGNILLTETG-------------------------------------------------TVKLADFGSAS  102 (804)
Q Consensus        73 ~-~IiHRDlKp~Nill~~~~-------------------------------------------------~~kl~DFG~a~  102 (804)
                      + +|+||||||+|||++.++                                                 .+||+|||++.
T Consensus       165 ~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~  244 (397)
T 1wak_A          165 KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC  244 (397)
T ss_dssp             TTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCE
T ss_pred             hCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccc
Confidence            8 999999999999999775                                                 79999999997


Q ss_pred             ccC-CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952        103 IKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus       103 ~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ... .....+||+.|+|||++.   ...|+.++|+||+|+++
T Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  283 (397)
T 1wak_A          245 WVHKHFTEDIQTRQYRSLEVLI---GSGYNTPADIWSTACMA  283 (397)
T ss_dssp             ETTBCSCSCCSCGGGCCHHHHH---TSCCCTHHHHHHHHHHH
T ss_pred             cccccCccCCCCCcccCChhhc---CCCCCcHHHHHHHHHHH
Confidence            532 334568999999999984   35689999999999983

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.88  E-value=2.3e-23  Score=230.83  Aligned_cols=133  Identities=34%  Similarity=0.586  Sum_probs=113.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeE------EEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~------~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      ..+|+.++|||||+++++|...+..      |+||||+.|++.+.+   ...+++..+..++.|++.||+|||+++|+||
T Consensus        92 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  168 (371)
T 4exu_A           92 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHR  168 (371)
T ss_dssp             HHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            3578899999999999999877654      999999998876654   3569999999999999999999999999999


Q ss_pred             ccccccEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         79 DVKAGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        79 DlKp~Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||||+|||++.++.+||+|||+++... .....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       169 Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  231 (371)
T 4exu_A          169 DLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCI  231 (371)
T ss_dssp             CCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSC--CSCCCTTHHHHHHHHH
T ss_pred             CcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcC--CCCCCcHHhHHHHHHH
Confidence            999999999999999999999997533 3345689999999999842  3568999999999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.88  E-value=2.4e-23  Score=224.96  Aligned_cols=135  Identities=22%  Similarity=0.430  Sum_probs=116.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---------RPLKEEEIAAICSGVLRGLNYLHSLG   74 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---------~~l~~~~~~~~~~qi~~aL~ylH~~~   74 (804)
                      ..+|++++||||+++++++.+.+..|+|||||.| ++.+++....         .++++..+..++.|++.||.|||+++
T Consensus        79 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  158 (322)
T 1p4o_A           79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK  158 (322)
T ss_dssp             HHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3578899999999999999999999999999985 6767665422         46799999999999999999999999


Q ss_pred             ccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         75 RIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        75 IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||||||+||+++.++.+||+|||++.....      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       159 i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  229 (322)
T 1p4o_A          159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVV  229 (322)
T ss_dssp             CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc---cCCCCchhhHHHHHHH
Confidence            99999999999999999999999999974321      22346789999999974   4568899999999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=3.4e-23  Score=220.41  Aligned_cols=134  Identities=27%  Similarity=0.452  Sum_probs=115.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++ ..+..|+||||+.| ++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        61 ~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  139 (287)
T 1u59_A           61 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR  139 (287)
T ss_dssp             HHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchh
Confidence            4678999999999999998 55678999999986 566666555567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++.....       .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       140 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  202 (287)
T 1u59_A          140 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVT  202 (287)
T ss_dssp             GEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             eEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc---cCCCCchhhHHHHHHH
Confidence            99999999999999999975321       12345789999999984   3568899999999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.88  E-value=3.9e-23  Score=217.84  Aligned_cols=135  Identities=33%  Similarity=0.562  Sum_probs=115.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+++.++||||+++++++.+++..|+||||+.| ++.+++. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        56 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~  134 (276)
T 2yex_A           56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE  134 (276)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChH
Confidence            4578899999999999999999999999999986 5555543 3457999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....      ......||+.|+|||++.+  ...++.++|+||+|++
T Consensus       135 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~i  197 (276)
T 2yex_A          135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIV  197 (276)
T ss_dssp             GEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC--SSBCHHHHHHHHHHHH
T ss_pred             HEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc--CCCCCCcchHHHHHHH
Confidence            9999999999999999986421      1234679999999999732  2234778999999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.88  E-value=1.6e-23  Score=227.57  Aligned_cols=135  Identities=30%  Similarity=0.480  Sum_probs=116.2

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH-------------KRPLKEEEIAAICSGVLRGLNY   69 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~-------------~~~l~~~~~~~~~~qi~~aL~y   69 (804)
                      ..+|+++ +|||||+++++|.+++.+|||||||.| ++.+++...             ...+++..+..++.|++.||+|
T Consensus       100 ~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  179 (333)
T 2i1m_A          100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF  179 (333)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            4578888 899999999999999999999999986 677776543             3468999999999999999999


Q ss_pred             HHhcCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         70 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        70 lH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++|+||||||+|||++.++.+||+|||++.....      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       180 lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  255 (333)
T 2i1m_A          180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGIL  255 (333)
T ss_dssp             HHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc---cCCCChHHHHHHHHHH
Confidence            9999999999999999999999999999999975321      12346788999999974   3568899999999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.88  E-value=3e-23  Score=221.86  Aligned_cols=138  Identities=45%  Similarity=0.868  Sum_probs=114.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++|||||++++++..++..|+|||||.|+. .+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        67 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  146 (302)
T 2j7t_A           67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG  146 (302)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             HHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHH
Confidence            467889999999999999999999999999998754 4555555678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCccccc----CCCCccccccccCcchhhhh--cccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIK----CPANSFVGTPYWMAPEVILA--MDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~----~~~~~~~gt~~y~APE~l~~--~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++...    .......||+.|+|||++..  .....++.++|+||+|++
T Consensus       147 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i  211 (302)
T 2j7t_A          147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT  211 (302)
T ss_dssp             GEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHH
T ss_pred             HEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHH
Confidence            999999999999999987531    22334689999999999731  124568889999999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.88  E-value=2.9e-23  Score=245.39  Aligned_cols=134  Identities=26%  Similarity=0.439  Sum_probs=112.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.. +.+|||||||.| +|.+++......+++..+..++.||+.||+|||+++|+||||||+
T Consensus       387 ~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~  465 (613)
T 2ozo_A          387 AQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR  465 (613)
T ss_dssp             HHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHH
Confidence            468899999999999999876 568999999986 566666555667999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC-------CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~-------~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++.....       ....+|+.|+|||++.   .+.|+.++|+||+|++
T Consensus       466 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~---~~~~~~~sDvwSlGv~  528 (613)
T 2ozo_A          466 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVT  528 (613)
T ss_dssp             GEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc---CCCCCcHHHHHHHHHH
Confidence            999999999999999999753211       1224668899999984   4578999999999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.88  E-value=3.8e-23  Score=219.13  Aligned_cols=134  Identities=26%  Similarity=0.465  Sum_probs=114.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++||||+++++++.+ +..|+||||+.| ++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        64 ~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  142 (281)
T 3cc6_A           64 AVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR  142 (281)
T ss_dssp             HHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             HHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc
Confidence            457889999999999998765 456899999985 667777666678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++.....     .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       143 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  203 (281)
T 3cc6_A          143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN---FRRFTTASDVWMFAVC  203 (281)
T ss_dssp             GEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhc---cCCCCchhccHHHHHH
Confidence            99999999999999999975322     22346788999999973   4568899999999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.88  E-value=5e-23  Score=222.96  Aligned_cols=135  Identities=28%  Similarity=0.438  Sum_probs=116.7

Q ss_pred             HHHHhcCCC------CeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          6 SLLRQLKHP------NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         6 ~iL~~l~Hp------nIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      .+|+.++|+      +|++++++|.+++.+|||||||.+++.+++.... .++++..+..++.|++.||+|||+++|+||
T Consensus        63 ~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  142 (339)
T 1z57_A           63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT  142 (339)
T ss_dssp             HHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            456666655      5999999999999999999999888888886554 479999999999999999999999999999


Q ss_pred             ccccccEEEcC-------------------CCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccc
Q psy17952         79 DVKAGNILLTE-------------------TGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  138 (804)
Q Consensus        79 DlKp~Nill~~-------------------~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvws  138 (804)
                      ||||+|||++.                   ++.+||+|||++.... ......||+.|+|||++.   ...++.++|+||
T Consensus       143 Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s  219 (339)
T 1z57_A          143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL---ALGWSQPCDVWS  219 (339)
T ss_dssp             CCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT---TSCCCTHHHHHH
T ss_pred             CCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhh---CCCCCcchhhHH
Confidence            99999999987                   6689999999997643 334568999999999984   456899999999


Q ss_pred             cccCC
Q psy17952        139 LGITP  143 (804)
Q Consensus       139 lG~~~  143 (804)
                      +|++.
T Consensus       220 lG~il  224 (339)
T 1z57_A          220 IGCIL  224 (339)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99983

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.88  E-value=6.6e-23  Score=216.33  Aligned_cols=135  Identities=30%  Similarity=0.472  Sum_probs=108.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++||||+++++++.+.+..|+||||+.| ++.+++.. ...+++..+..++.|++.||+|||+++|+||||||+
T Consensus        62 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~  140 (276)
T 2h6d_A           62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE  140 (276)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGG
T ss_pred             HHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChh
Confidence            3578899999999999999999999999999985 56666643 467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++.....   .....||+.|+|||++.+  ...++.++|+||+|++
T Consensus       141 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~  200 (276)
T 2h6d_A          141 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVI  200 (276)
T ss_dssp             GEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTT--SCCCHHHHHHHHHHHH
T ss_pred             hEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcC--CCCCCccchHHHHHHH
Confidence            99999999999999999975432   234579999999999732  2223678999999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.88  E-value=1e-22  Score=218.24  Aligned_cols=133  Identities=53%  Similarity=0.945  Sum_probs=116.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.++||||++++++|.++...|+||||+.|+ +.+++.  ..++++..+..++.|++.||.|||+++|+||||||+
T Consensus        71 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~  148 (303)
T 3a7i_A           71 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA  148 (303)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChh
Confidence            45788999999999999999999999999999874 555543  467999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++....    ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       149 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (303)
T 3a7i_A          149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGIT  208 (303)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             eEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHh---cCCCCchhhhHHHHHH
Confidence            9999999999999999996532    223467999999999973   4568899999999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.88  E-value=3.8e-23  Score=219.56  Aligned_cols=135  Identities=24%  Similarity=0.455  Sum_probs=117.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++.+++.+|+|||||.| ++.+++... ...+++..+..++.|++.||+|||+++|+||||||
T Consensus        60 ~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp  139 (288)
T 3kfa_A           60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA  139 (288)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSG
T ss_pred             HHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCc
Confidence            4678999999999999999999999999999984 666776553 35699999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCCC-----CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~~-----~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +||+++.++.+||+|||++......     ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       140 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  201 (288)
T 3kfa_A          140 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVL  201 (288)
T ss_dssp             GGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhc---cCCCCchhhHHHHHHH
Confidence            9999999999999999999754322     2245788999999984   3568899999999998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.88  E-value=2.6e-23  Score=228.41  Aligned_cols=135  Identities=23%  Similarity=0.358  Sum_probs=115.7

Q ss_pred             HHHHHhcCCCCeee---------------EeEEEEe-CCeEEEEEeccCCCcHHHHHHc-CCCCCHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIE---------------YRGCYLR-DHTAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGL   67 (804)
Q Consensus         5 ~~iL~~l~HpnIV~---------------l~~~~~~-~~~~~lV~Ey~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL   67 (804)
                      ..+|++++|||||+               +++++.. +...|||||||.|+|.+++... ...+++..+..++.||+.||
T Consensus        93 ~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L  172 (352)
T 2jii_A           93 QNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDAL  172 (352)
T ss_dssp             HHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHH
Confidence            46789999999998               6777776 7789999999966777777654 36899999999999999999


Q ss_pred             HHHHhcCccccccccccEEEcCCC--ceEEeccCcccccCC-----------CCccccccccCcchhhhhcccCccCCcc
Q psy17952         68 NYLHSLGRIHRDVKAGNILLTETG--TVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKV  134 (804)
Q Consensus        68 ~ylH~~~IiHRDlKp~Nill~~~~--~~kl~DFG~a~~~~~-----------~~~~~gt~~y~APE~l~~~~~~~~~~~v  134 (804)
                      +|||+++|+||||||+|||++.++  .+||+|||+++....           .....||+.|+|||++.   ...++.++
T Consensus       173 ~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~  249 (352)
T 2jii_A          173 EFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK---GCGPSRRS  249 (352)
T ss_dssp             HHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT---TCCCCHHH
T ss_pred             HHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc---cCCCCchh
Confidence            999999999999999999999998  899999999964221           13357999999999973   45689999


Q ss_pred             cccccccC
Q psy17952        135 DVWSLGIT  142 (804)
Q Consensus       135 DvwslG~~  142 (804)
                      |+||+|++
T Consensus       250 Di~slG~i  257 (352)
T 2jii_A          250 DLQSLGYC  257 (352)
T ss_dssp             HHHHHHHH
T ss_pred             hHHHHHHH
Confidence            99999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.88  E-value=8.7e-23  Score=217.20  Aligned_cols=135  Identities=23%  Similarity=0.291  Sum_probs=115.8

Q ss_pred             HHHHHhcCCCCeeeEeEEE-EeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCY-LRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~-~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+++.++|+|+|..+..+ ...+..|+||||+.|++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        55 ~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  134 (296)
T 4hgt_A           55 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD  134 (296)
T ss_dssp             HHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence            4678899888877776654 677889999999977888888766778999999999999999999999999999999999


Q ss_pred             cEEE---cCCCceEEeccCcccccCC-----------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILL---TETGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill---~~~~~~kl~DFG~a~~~~~-----------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+   +.++.+||+|||+++....           .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       135 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  204 (296)
T 4hgt_A          135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYV  204 (296)
T ss_dssp             GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             HeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc---CCCCCchhHHHHHHHH
Confidence            9999   7889999999999974221           22457999999999974   4568899999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.88  E-value=1e-22  Score=217.41  Aligned_cols=137  Identities=34%  Similarity=0.559  Sum_probs=117.1

Q ss_pred             HHHHHhcC-CCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~-HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|+++. |||||++++++.++...|+||||+.| ++.+++.. ...+++..+..++.|++.||+|||+++|+||||||
T Consensus        74 ~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p  152 (298)
T 1phk_A           74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP  152 (298)
T ss_dssp             HHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCc
Confidence            35677884 99999999999999999999999985 56666653 46899999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhc---ccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~---~~~~~~~~vDvwslG~~  142 (804)
                      +||+++.++.+||+|||++.....   .....||+.|+|||++...   ....++.++|+||+|++
T Consensus       153 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~  218 (298)
T 1phk_A          153 ENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI  218 (298)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred             ceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHH
Confidence            999999999999999999975322   2345799999999997421   13457889999999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.87  E-value=3.6e-23  Score=223.03  Aligned_cols=138  Identities=33%  Similarity=0.531  Sum_probs=114.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe----CCeEEEEEeccCC-CcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLG-SASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSLGRI   76 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g-~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~Ii   76 (804)
                      ..+|+.++|||||++++++..    ....|+|||||.| ++.+++..   ....+++..+..++.|++.||.|||+++|+
T Consensus        77 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  156 (317)
T 2buj_A           77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA  156 (317)
T ss_dssp             HHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            467899999999999999873    3478999999986 66666654   246799999999999999999999999999


Q ss_pred             ccccccccEEEcCCCceEEeccCcccccCCC-------------CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         77 HRDVKAGNILLTETGTVKLADFGSASIKCPA-------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        77 HRDlKp~Nill~~~~~~kl~DFG~a~~~~~~-------------~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||||||+|||++.++.+||+|||++......             ....||+.|+|||++.+.....++.++|+||+|++
T Consensus       157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  235 (317)
T 2buj_A          157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV  235 (317)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence            9999999999999999999999988643210             12458999999999743223347889999999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.87  E-value=8.4e-23  Score=221.16  Aligned_cols=133  Identities=33%  Similarity=0.549  Sum_probs=113.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC--CeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD--HTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~--~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||++++++.+.  ..+|||||||.| ++.+++.  ...+++..+..++.|++.||+|||+++|+|||||
T Consensus        84 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dik  161 (318)
T 3lxp_A           84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA  161 (318)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence            4678999999999999999884  679999999986 5555553  3459999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.++.+||+|||++.....       .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       162 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  226 (318)
T 3lxp_A          162 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK---EYKFYYASDVWSFGVT  226 (318)
T ss_dssp             GGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             hheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc---CCCCCcHHHHHHHHHH
Confidence            9999999999999999999975322       22346888999999984   3468889999999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.87  E-value=6.3e-23  Score=223.53  Aligned_cols=135  Identities=29%  Similarity=0.528  Sum_probs=115.6

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---------------CCCCHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---------------RPLKEEEIAAICSGVLRGL   67 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~aL   67 (804)
                      ..+|+++ +|||||++++++..++.+|+|||||.| ++.+++....               ..+++..+..++.|++.||
T Consensus        91 ~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL  170 (334)
T 2pvf_A           91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM  170 (334)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence            3577888 999999999999999999999999985 6666665432               2489999999999999999


Q ss_pred             HHHHhcCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCccccccccc
Q psy17952         68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  141 (804)
Q Consensus        68 ~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~  141 (804)
                      +|||+++|+||||||+|||++.++.+||+|||++.....      .....||+.|+|||++.   ...++.++|+||+|+
T Consensus       171 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~  247 (334)
T 2pvf_A          171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGV  247 (334)
T ss_dssp             HHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH---HCEECHHHHHHHHHH
T ss_pred             HHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc---CCCcChHHHHHHHHH
Confidence            999999999999999999999999999999999975322      22346788999999984   356889999999999


Q ss_pred             C
Q psy17952        142 T  142 (804)
Q Consensus       142 ~  142 (804)
                      +
T Consensus       248 i  248 (334)
T 2pvf_A          248 L  248 (334)
T ss_dssp             H
T ss_pred             H
Confidence            8

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.87  E-value=2.9e-23  Score=221.70  Aligned_cols=136  Identities=49%  Similarity=0.814  Sum_probs=112.6

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEV-------HKRPLKEEEIAAICSGVLRGLNYLHSLGRIH   77 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiH   77 (804)
                      .+|++++|||||++++++..++..|+||||+.| ++.+++..       ....+++..+..++.|++.||.|||+++|+|
T Consensus        65 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  144 (303)
T 2vwi_A           65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH  144 (303)
T ss_dssp             -CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            456778999999999999999999999999975 56666653       2456999999999999999999999999999


Q ss_pred             cccccccEEEcCCCceEEeccCcccccCC---------CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         78 RDVKAGNILLTETGTVKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        78 RDlKp~Nill~~~~~~kl~DFG~a~~~~~---------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||||+||+++.++.+||+|||++.....         .....||+.|+|||++..  ...++.++|+||+|++.
T Consensus       145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il  217 (303)
T 2vwi_A          145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ--VRGYDFKADIWSFGITA  217 (303)
T ss_dssp             CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH--HHCCCTHHHHHHHHHHH
T ss_pred             CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc--ccCCCchhhHHHHHHHH
Confidence            99999999999999999999999864221         123579999999999742  23578899999999983

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.87  E-value=4e-23  Score=245.06  Aligned_cols=133  Identities=28%  Similarity=0.444  Sum_probs=111.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||++++++.. +..|||||||.|+ |.+++. ....+++..+..++.||+.||+|||+++||||||||+
T Consensus       421 ~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~  498 (635)
T 4fl3_A          421 ANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR  498 (635)
T ss_dssp             HHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChH
Confidence            468899999999999998865 5589999999865 555554 4578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++....       .....||+.|+|||++.   ...|+.++|+||+|++
T Consensus       499 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~---~~~~~~~sDvwSlGv~  561 (635)
T 4fl3_A          499 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVL  561 (635)
T ss_dssp             GEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             hEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc---CCCCCcHHHHHHHHHH
Confidence            99999999999999999975321       12235778999999984   4568999999999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.87  E-value=2.5e-23  Score=232.78  Aligned_cols=139  Identities=29%  Similarity=0.468  Sum_probs=114.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC--eEEEEEeccCC-CcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH--TAWLVMEYCLG-SASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~--~~~lV~Ey~~g-~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .++|++++|||||++++++...+  ..|||||||.| ++.+++....  ..+++..++.++.|++.||+|||+++|+|||
T Consensus        58 ~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  137 (396)
T 4eut_A           58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN  137 (396)
T ss_dssp             HHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECC
Confidence            35889999999999999998765  78999999986 5556554322  2499999999999999999999999999999


Q ss_pred             cccccEEE----cCCCceEEeccCcccccCC---CCccccccccCcchhhhhcc-----cCccCCcccccccccCC
Q psy17952         80 VKAGNILL----TETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITP  143 (804)
Q Consensus        80 lKp~Nill----~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~-----~~~~~~~vDvwslG~~~  143 (804)
                      |||+|||+    +.++.+||+|||+++....   .....||+.|+|||++.+..     ...++.++|+||+|++.
T Consensus       138 lkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il  213 (396)
T 4eut_A          138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF  213 (396)
T ss_dssp             CCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence            99999999    7777899999999975322   23467999999999974311     14578899999999983

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.87  E-value=7.1e-23  Score=223.45  Aligned_cols=134  Identities=24%  Similarity=0.425  Sum_probs=117.8

Q ss_pred             HHHHhcCCCC------eeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          6 SLLRQLKHPN------TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         6 ~iL~~l~Hpn------IV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      .+|++++|+|      |+.++++|...+.+|||||||.|++++.+.... .++++..++.++.||+.||+|||+++|+||
T Consensus        68 ~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~  147 (355)
T 2eu9_A           68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHT  147 (355)
T ss_dssp             HHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            5677777666      999999999999999999999999888876654 579999999999999999999999999999


Q ss_pred             ccccccEEE-------------------cCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccc
Q psy17952         79 DVKAGNILL-------------------TETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  138 (804)
Q Consensus        79 DlKp~Nill-------------------~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvws  138 (804)
                      ||||+|||+                   +.++.+||+|||++.... ......||+.|+|||++.   ...++.++|+||
T Consensus       148 Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s  224 (355)
T 2eu9_A          148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL---ELGWAQPCDVWS  224 (355)
T ss_dssp             CCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT---TCCCCTHHHHHH
T ss_pred             CCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeee---cCCCCCccchHH
Confidence            999999999                   567899999999997533 334568999999999984   456899999999


Q ss_pred             cccC
Q psy17952        139 LGIT  142 (804)
Q Consensus       139 lG~~  142 (804)
                      +|++
T Consensus       225 lG~i  228 (355)
T 2eu9_A          225 IGCI  228 (355)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.87  E-value=1.1e-22  Score=216.61  Aligned_cols=135  Identities=23%  Similarity=0.291  Sum_probs=115.3

Q ss_pred             HHHHHhcCCCCeeeEeEEE-EeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCY-LRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~-~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+++.++|+|++..+.++ ..++..|+||||+.|++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        55 ~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~  134 (296)
T 3uzp_A           55 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD  134 (296)
T ss_dssp             HHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence            4678899988877666644 677789999999977888888766778999999999999999999999999999999999


Q ss_pred             cEEE---cCCCceEEeccCcccccCC-----------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILL---TETGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill---~~~~~~kl~DFG~a~~~~~-----------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+   +.++.+||+|||++.....           .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       135 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  204 (296)
T 3uzp_A          135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYV  204 (296)
T ss_dssp             GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             HeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhc---CCCCCcchhhHHHHHH
Confidence            9999   4888999999999964221           23457999999999973   4568899999999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.87  E-value=6.7e-23  Score=218.60  Aligned_cols=133  Identities=28%  Similarity=0.452  Sum_probs=112.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++||||+++++++ ..+..|+||||+.| ++.+++. ....+++..+..++.|++.||+|||+++|+||||||+
T Consensus        69 ~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~  146 (291)
T 1xbb_A           69 ANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR  146 (291)
T ss_dssp             HHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHH-hCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcc
Confidence            4678899999999999998 56778999999985 5555554 4567999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC-------CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~-------~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++......       ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       147 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  209 (291)
T 1xbb_A          147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVL  209 (291)
T ss_dssp             GEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             eEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc---cCCCChhhhHHHHHHH
Confidence            999999999999999999753221       1235678999999984   3468889999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.87  E-value=7e-23  Score=219.36  Aligned_cols=137  Identities=32%  Similarity=0.618  Sum_probs=114.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEE--eCCeEEEEEeccCCCcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYL--RDHTAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~--~~~~~~lV~Ey~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||++++++.  +....|||||||.+++.+++... ...+++..+..++.|++.||+|||+++|+|||||
T Consensus        57 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlk  136 (305)
T 2wtk_C           57 IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIK  136 (305)
T ss_dssp             HHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            35788999999999999985  44578999999998887777654 4579999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||+++.++.+||+|||++.....      .....||+.|+|||++.+. ...++.++|+||+|++
T Consensus       137 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~i  202 (305)
T 2wtk_C          137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVT  202 (305)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHH
T ss_pred             cccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHH
Confidence            9999999999999999999975321      1235699999999997431 2235778999999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.87  E-value=1.4e-22  Score=217.97  Aligned_cols=135  Identities=39%  Similarity=0.636  Sum_probs=109.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|++++|||||+++++|..++..|+||||+.| ++.+++..   ....+++..+..++.|++.||.|||+++|+||||
T Consensus        83 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl  162 (310)
T 2wqm_A           83 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDI  162 (310)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             HHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCC
Confidence            4678899999999999999999999999999986 56666543   3467999999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+||+++.++.+||+|||++.....    .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       163 ~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  225 (310)
T 2wqm_A          163 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCL  225 (310)
T ss_dssp             CGGGEEECTTSCEEECCC------------------CCSSCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             cHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhC---CCCCCchhhHHHHHHH
Confidence            99999999999999999999875322    23457999999999973   4568899999999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.87  E-value=4.8e-23  Score=226.23  Aligned_cols=133  Identities=34%  Similarity=0.583  Sum_probs=112.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCe------EEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHT------AWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~------~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      ..+|+.++|||||+++++|.....      +|+||||+.|++.+++.   ..+++..+..++.||+.||+|||++||+||
T Consensus        74 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~  150 (353)
T 3coi_A           74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHR  150 (353)
T ss_dssp             HHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            357889999999999999987654      49999999988776542   469999999999999999999999999999


Q ss_pred             ccccccEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         79 DVKAGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        79 DlKp~Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||||+||+++.++.+||+|||++.... ......||+.|+|||++.+  ...++.++|+||+|++
T Consensus       151 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~i  213 (353)
T 3coi_A          151 DLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCI  213 (353)
T ss_dssp             SCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHSC--CSCCCTTHHHHHHHHH
T ss_pred             CCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhC--cCCCCchhhHHHHHHH
Confidence            999999999999999999999997533 2334689999999999742  3568899999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.87  E-value=1e-22  Score=219.21  Aligned_cols=135  Identities=22%  Similarity=0.402  Sum_probs=109.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC-----eEEEEEeccCC-CcHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH-----TAWLVMEYCLG-SASDIIEVH-----KRPLKEEEIAAICSGVLRGLNYLHSL   73 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~-----~~~lV~Ey~~g-~l~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~   73 (804)
                      ..+|++++|||||++++++....     ..|+||||+.| ++.+++...     ...+++..+..++.|++.||.|||++
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (313)
T 3brb_A           87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR  166 (313)
T ss_dssp             HHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45788999999999999988755     35999999985 566665432     35699999999999999999999999


Q ss_pred             CccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         74 GRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        74 ~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|+||||||+||+++.++.+||+|||++....      ......|++.|+|||++.   ...++.++|+||+|++
T Consensus       167 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  238 (313)
T 3brb_A          167 NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSDVWAFGVT  238 (313)
T ss_dssp             TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHH---SSCCCHHHHHHHHHHH
T ss_pred             CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhc---CCCccchhhhHHHHHH
Confidence            99999999999999999999999999997532      122346788999999973   4568899999999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.87  E-value=4.2e-23  Score=235.15  Aligned_cols=134  Identities=28%  Similarity=0.494  Sum_probs=111.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++.+ +.+|||||||.| +|.+++... ...+++..+..++.|++.||+|||+++|+||||||
T Consensus       230 ~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp  308 (452)
T 1fmk_A          230 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA  308 (452)
T ss_dssp             HHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             HHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence            468999999999999998866 678999999975 677777543 35699999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||+++....     .....+|+.|+|||++.   .+.++.++|+||+|++
T Consensus       309 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~  370 (452)
T 1fmk_A          309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGIL  370 (452)
T ss_dssp             GGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             hhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHh---cCCCCccccHHhHHHH
Confidence            999999999999999999975321     12345778899999984   4578999999999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.87  E-value=1.5e-22  Score=219.18  Aligned_cols=138  Identities=50%  Similarity=0.862  Sum_probs=110.9

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEe------CCeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLR------DHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGR   75 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~------~~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~I   75 (804)
                      ..+|+++ +||||++++++|..      .+.+|||||||.| ++.+++.... ..+++..+..++.||+.||.|||+++|
T Consensus        71 ~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  150 (326)
T 2x7f_A           71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV  150 (326)
T ss_dssp             HHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            3567777 89999999999987      4689999999986 6677776543 579999999999999999999999999


Q ss_pred             cccccccccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhc--ccCccCCcccccccccC
Q psy17952         76 IHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        76 iHRDlKp~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~--~~~~~~~~vDvwslG~~  142 (804)
                      +||||||+||+++.++.+||+|||++....    ......||+.|+|||++...  ....++.++|+||+|++
T Consensus       151 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i  223 (326)
T 2x7f_A          151 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT  223 (326)
T ss_dssp             CCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred             cccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence            999999999999999999999999987532    22345799999999998421  13468899999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.87  E-value=7.8e-23  Score=221.79  Aligned_cols=136  Identities=33%  Similarity=0.535  Sum_probs=101.7

Q ss_pred             HHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhc-Cccccccc
Q psy17952          7 LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEV----HKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRDVK   81 (804)
Q Consensus         7 iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~aL~ylH~~-~IiHRDlK   81 (804)
                      +++.++|||||++++++..++..|||||||.|++.+++..    ....+++..+..++.|++.||.|||++ +|+|||||
T Consensus        74 ~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk  153 (327)
T 3aln_A           74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK  153 (327)
T ss_dssp             HHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred             HHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence            6677899999999999999999999999999988777653    256799999999999999999999999 99999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhc-ccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~-~~~~~~~~vDvwslG~~  142 (804)
                      |+|||++.++.+||+|||+++....   .....||+.|+|||++... ....++.++|+||+|++
T Consensus       154 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i  218 (327)
T 3aln_A          154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT  218 (327)
T ss_dssp             GGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence            9999999999999999999975322   2234799999999997321 23458899999999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.87  E-value=1.5e-22  Score=219.45  Aligned_cols=134  Identities=29%  Similarity=0.472  Sum_probs=113.5

Q ss_pred             HHHHHhcC-CCCeeeEeEEEEe--CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLK-HPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~-HpnIV~l~~~~~~--~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++ ||||+++++++.+  ....++||||+.|+.+..+.   ..+++..++.++.|++.||+|||+++|+|||||
T Consensus        81 ~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik  157 (330)
T 3nsz_A           81 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK  157 (330)
T ss_dssp             HHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             HHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHH---HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            35788886 9999999999987  66799999999866544433   248999999999999999999999999999999


Q ss_pred             cccEEEcCCC-ceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         82 AGNILLTETG-TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        82 p~Nill~~~~-~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |+|||++.++ .+||+|||+++...   ......||+.|+|||++.+  ...++.++|+||+|++.
T Consensus       158 p~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il  221 (330)
T 3nsz_A          158 PHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCML  221 (330)
T ss_dssp             GGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcC--CCcCCchhhHHHHHHHH
Confidence            9999999777 89999999997532   2334689999999999842  35689999999999983

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.87  E-value=1.1e-22  Score=218.57  Aligned_cols=134  Identities=29%  Similarity=0.543  Sum_probs=114.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEE--------------eCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQLKHPNTIEYRGCYL--------------RDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYL   70 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~--------------~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~yl   70 (804)
                      ..+|++++|||||++++++.              .....|+||||+.|++.+++.  ++++++..++.++.|++.||+||
T Consensus        59 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~l  136 (320)
T 2i6l_A           59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYI  136 (320)
T ss_dssp             HHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHH
Confidence            46788999999999999873              346799999999998887764  46799999999999999999999


Q ss_pred             HhcCccccccccccEEEc-CCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         71 HSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        71 H~~~IiHRDlKp~Nill~-~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+++|+||||||+|||++ .++.+||+|||++.....       .....||+.|+|||++.  ....++.++|+||+|++
T Consensus       137 H~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~i  214 (320)
T 2i6l_A          137 HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL--SPNNYTKAIDMWAAGCI  214 (320)
T ss_dssp             HHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH--CTTCCCHHHHHHHHHHH
T ss_pred             HhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhc--CcccCCchhhhHhHHHH
Confidence            999999999999999997 567999999999975321       22346899999999874  23568899999999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.87  E-value=1.6e-22  Score=215.36  Aligned_cols=137  Identities=34%  Similarity=0.567  Sum_probs=116.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|+.++|||||+++++|..++..|+||||+.| ++.+++....  ..+++..+..++.|++.||+|||+++|+|||||
T Consensus        70 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  149 (295)
T 2clq_A           70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK  149 (295)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             HHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCC
Confidence            4678899999999999999999999999999975 5666665543  356799999999999999999999999999999


Q ss_pred             cccEEEcC-CCceEEeccCcccccCC----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTE-TGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~-~~~~kl~DFG~a~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||+++. ++.+||+|||++.....    .....||+.|+|||++.+. ...++.++|+||+|++
T Consensus       150 p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~i  214 (295)
T 2clq_A          150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG-PRGYGKAADIWSLGCT  214 (295)
T ss_dssp             GGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHG-GGGCSHHHHHHHHHHH
T ss_pred             hhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCC-CCCCCcHHHHHHHHHH
Confidence            99999987 89999999999975321    2346799999999998431 1237889999999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.87  E-value=9.4e-23  Score=221.81  Aligned_cols=135  Identities=27%  Similarity=0.505  Sum_probs=112.6

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      .+|+.+ +|||||+++++|.+...+|+|||||.| ++.+++... ...+++..++.++.|++.||+|||+++|+||||||
T Consensus        80 ~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp  159 (327)
T 3lm5_A           80 AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP  159 (327)
T ss_dssp             HHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             HHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCh
Confidence            456777 579999999999999999999999986 555554322 36799999999999999999999999999999999


Q ss_pred             ccEEEcC---CCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~---~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +|||++.   ++.+||+|||++.....   .....||+.|+|||++.   ...++.++|+||+|++.
T Consensus       160 ~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il  223 (327)
T 3lm5_A          160 QNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN---YDPITTATDMWNIGIIA  223 (327)
T ss_dssp             GGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             HHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeec---CCCCCchhhHHHHHHHH
Confidence            9999988   78999999999975322   23468999999999973   45789999999999983

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=1.8e-22  Score=219.06  Aligned_cols=127  Identities=28%  Similarity=0.478  Sum_probs=107.9

Q ss_pred             cCCCCeeeEeEEEEeC----CeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--------Cccc
Q psy17952         11 LKHPNTIEYRGCYLRD----HTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL--------GRIH   77 (804)
Q Consensus        11 l~HpnIV~l~~~~~~~----~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~--------~IiH   77 (804)
                      ++|||||++++++...    ..+|||||||.| +|.+++..  ..+++..+..++.|++.||+|||++        +|+|
T Consensus        88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  165 (337)
T 3mdy_A           88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH  165 (337)
T ss_dssp             CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred             hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence            4999999999999887    789999999986 66676653  4799999999999999999999999        9999


Q ss_pred             cccccccEEEcCCCceEEeccCcccccC--------CCCccccccccCcchhhhhcccCccCC------cccccccccC
Q psy17952         78 RDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDG------KVDVWSLGIT  142 (804)
Q Consensus        78 RDlKp~Nill~~~~~~kl~DFG~a~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~------~vDvwslG~~  142 (804)
                      |||||+|||++.++.+||+|||++....        .....+||+.|+|||++.+   ..++.      ++|+||+|++
T Consensus       166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~~~~~DiwslG~i  241 (337)
T 3mdy_A          166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE---SLNRNHFQSYIMADMYSFGLI  241 (337)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT---CCCTTCTHHHHHHHHHHHHHH
T ss_pred             cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc---ccCCccccCccccchHHHHHH
Confidence            9999999999999999999999996421        1224589999999999842   23333      4899999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.87  E-value=7.1e-23  Score=232.10  Aligned_cols=137  Identities=29%  Similarity=0.464  Sum_probs=106.8

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhcCcccc
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRP------LKEEEIAAICSGVLRGLNYLHSLGRIHR   78 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~------l~~~~~~~~~~qi~~aL~ylH~~~IiHR   78 (804)
                      .+|+++ +|||||++++++.+++.+|||||||.|+|.+++......      .++..+..++.||+.||+|||+++|+||
T Consensus        60 ~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  139 (434)
T 2rio_A           60 KLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHR  139 (434)
T ss_dssp             HHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCcccc
Confidence            466665 899999999999999999999999999888887643211      1333467899999999999999999999


Q ss_pred             ccccccEEEcCC-------------CceEEeccCcccccCC--------CCccccccccCcchhhhhc----ccCccCCc
Q psy17952         79 DVKAGNILLTET-------------GTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAM----DEGQYDGK  133 (804)
Q Consensus        79 DlKp~Nill~~~-------------~~~kl~DFG~a~~~~~--------~~~~~gt~~y~APE~l~~~----~~~~~~~~  133 (804)
                      ||||+|||++.+             +.+||+|||+++....        ....+||+.|+|||++.+.    ....++.+
T Consensus       140 DLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  219 (434)
T 2rio_A          140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS  219 (434)
T ss_dssp             CCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred             CCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence            999999999754             4899999999975322        1235799999999998431    12568899


Q ss_pred             ccccccccC
Q psy17952        134 VDVWSLGIT  142 (804)
Q Consensus       134 vDvwslG~~  142 (804)
                      +|+||+|++
T Consensus       220 ~DiwSlG~i  228 (434)
T 2rio_A          220 IDIFSMGCV  228 (434)
T ss_dssp             HHHHHHHHH
T ss_pred             hhhHhHHHH
Confidence            999999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.87  E-value=1.4e-22  Score=217.99  Aligned_cols=137  Identities=32%  Similarity=0.558  Sum_probs=108.3

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc-Ccccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~N   84 (804)
                      .+++.++|||||++++++.+++.+||||||+.+.+..+.......+++..+..++.|++.||.|||++ +|+||||||+|
T Consensus        76 ~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N  155 (318)
T 2dyl_A           76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN  155 (318)
T ss_dssp             HHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred             HHHHhcCCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence            36778899999999999999999999999994444444444467899999999999999999999995 99999999999


Q ss_pred             EEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhc--ccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~--~~~~~~~~vDvwslG~~  142 (804)
                      |+++.++.+||+|||++....   ......||+.|+|||++...  ....++.++|+||+|++
T Consensus       156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i  218 (318)
T 2dyl_A          156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS  218 (318)
T ss_dssp             EEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred             EEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence            999999999999999996432   22345799999999997321  13457889999999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.87  E-value=9.4e-23  Score=219.82  Aligned_cols=133  Identities=36%  Similarity=0.576  Sum_probs=106.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---cCcccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK--RPLKEEEIAAICSGVLRGLNYLHS---LGRIHR   78 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~--~~l~~~~~~~~~~qi~~aL~ylH~---~~IiHR   78 (804)
                      ..+|++++|||||++++++.  +..|||||||+| ++.+++....  ..+++..+..++.|+++||+|||+   ++|+||
T Consensus        52 ~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~  129 (307)
T 2eva_A           52 LRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR  129 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCC
T ss_pred             HHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence            45788999999999999876  347899999986 5666665332  247899999999999999999999   899999


Q ss_pred             ccccccEEEcCCCc-eEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         79 DVKAGNILLTETGT-VKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        79 DlKp~Nill~~~~~-~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||||+|||++.++. +||+|||++.... ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       130 dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  192 (307)
T 2eva_A          130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE---GSNYSEKCDVFSWGII  192 (307)
T ss_dssp             CCSGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHHT---CCCCCTHHHHHHHHHH
T ss_pred             CCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhhC---CCCCCcHHHHHHHHHH
Confidence            99999999998886 7999999996532 233457999999999973   4578999999999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.87  E-value=5.2e-23  Score=221.80  Aligned_cols=137  Identities=26%  Similarity=0.458  Sum_probs=112.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.++..+|+|||||.| ++.+++......+++..+..++.|++.||+|||+++|+||||||+
T Consensus        80 ~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~  159 (319)
T 2y4i_B           80 VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSK  159 (319)
T ss_dssp             GGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCST
T ss_pred             HHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChh
Confidence            3578899999999999999999999999999985 556666544457999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC---------CCCccccccccCcchhhhhcc------cCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC---------PANSFVGTPYWMAPEVILAMD------EGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~---------~~~~~~gt~~y~APE~l~~~~------~~~~~~~vDvwslG~~  142 (804)
                      ||+++ ++.+||+|||++....         ......||+.|+|||++.+..      ...++.++|+||+|++
T Consensus       160 NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i  232 (319)
T 2y4i_B          160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI  232 (319)
T ss_dssp             TEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred             hEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence            99998 6899999999976421         112346999999999984321      2357889999999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.87  E-value=7.4e-23  Score=217.42  Aligned_cols=134  Identities=28%  Similarity=0.403  Sum_probs=114.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++.++. .++||||+. |++.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus        72 ~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~  150 (291)
T 1u46_A           72 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR  150 (291)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh
Confidence            35788999999999999988765 789999998 5677777766678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||++.....       .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       151 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  213 (291)
T 1u46_A          151 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVT  213 (291)
T ss_dssp             GEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             eEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc---CCCCCchhhHHHHHHH
Confidence            99999999999999999875322       12346788999999974   3468889999999998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.87  E-value=8.3e-23  Score=219.67  Aligned_cols=135  Identities=30%  Similarity=0.484  Sum_probs=113.4

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCC-eEEEEEeccCC-CcHHHHHHcCC---------------CCCHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDH-TAWLVMEYCLG-SASDIIEVHKR---------------PLKEEEIAAICSGVLRG   66 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~-~~~lV~Ey~~g-~l~~~~~~~~~---------------~l~~~~~~~~~~qi~~a   66 (804)
                      ..+|+++ +|||||++++++...+ .+|+|||||.| ++.+++.....               .+++..+..++.|++.|
T Consensus        81 ~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  160 (316)
T 2xir_A           81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG  160 (316)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHH
Confidence            3567778 7999999999987754 58999999986 66666654332               28999999999999999


Q ss_pred             HHHHHhcCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccc
Q psy17952         67 LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  140 (804)
Q Consensus        67 L~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG  140 (804)
                      |.|||+++|+||||||+||+++.++.+||+|||++.....      .....||+.|+|||++.   ...++.++|+||+|
T Consensus       161 l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG  237 (316)
T 2xir_A          161 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFG  237 (316)
T ss_dssp             HHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHH
T ss_pred             HHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc---cccccchhHHHHHH
Confidence            9999999999999999999999999999999999975322      12346889999999984   45688999999999


Q ss_pred             cC
Q psy17952        141 IT  142 (804)
Q Consensus       141 ~~  142 (804)
                      ++
T Consensus       238 ~i  239 (316)
T 2xir_A          238 VL  239 (316)
T ss_dssp             HH
T ss_pred             HH
Confidence            98

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.87  E-value=6.4e-23  Score=217.06  Aligned_cols=135  Identities=28%  Similarity=0.483  Sum_probs=109.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeC-CeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRD-HTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~-~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||++++++..+ +..|+||||+.| ++.+++.... ..+++..+..++.|++.||+|||+++|+|||||
T Consensus        65 ~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  144 (278)
T 1byg_A           65 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA  144 (278)
T ss_dssp             HHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             HHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence            4578899999999999987554 478999999986 6777765432 248999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||+++.++.+||+|||++.... ......+++.|+|||++.   ...++.++|+||+|++
T Consensus       145 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  203 (278)
T 1byg_A          145 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGIL  203 (278)
T ss_dssp             GGGEEECTTSCEEECCCCC------------CCTTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             cceEEEeCCCcEEEeeccccccccccccCCCccccccCHHHhC---CCCCCchhcHHHHHHH
Confidence            999999999999999999987533 223456889999999973   4568899999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.87  E-value=1e-22  Score=215.25  Aligned_cols=135  Identities=39%  Similarity=0.671  Sum_probs=113.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe--CCeEEEEEeccCC-CcHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcC----
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLG-SASDIIEVH---KRPLKEEEIAAICSGVLRGLNYLHSLG----   74 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~--~~~~~lV~Ey~~g-~l~~~~~~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~----   74 (804)
                      ..+|++++|||||++++++..  +..+|+|||||+| ++.+++...   ...+++..+..++.|++.||+|||+++    
T Consensus        56 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~  135 (279)
T 2w5a_A           56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH  135 (279)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC----
T ss_pred             HHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCC
Confidence            457889999999999998864  5689999999986 677766543   345999999999999999999999999    


Q ss_pred             -ccccccccccEEEcCCCceEEeccCcccccCCC----CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         75 -RIHRDVKAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        75 -IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                       |+||||||+||+++.++.+||+|||++......    ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       136 ~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  205 (279)
T 2w5a_A          136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCL  205 (279)
T ss_dssp             --CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHH---CC-CCHHHHHHHHHHH
T ss_pred             eeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhc---cCCCCchhhHHHHHHH
Confidence             999999999999999999999999998753322    2357999999999984   4568899999999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.87  E-value=1e-22  Score=221.09  Aligned_cols=135  Identities=30%  Similarity=0.545  Sum_probs=115.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC--eEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH--TAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~--~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||++++++...+  .+|+||||+.| ++.+++......+++..+..++.|++.||+|||+++|+|||||
T Consensus        93 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik  172 (326)
T 2w1i_A           93 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA  172 (326)
T ss_dssp             HHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             HHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC
Confidence            46789999999999999886644  68999999975 7777777666789999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||+++.++.+||+|||++.....       .....|++.|+|||++.   ...++.++|+||+|++
T Consensus       173 p~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  237 (326)
T 2w1i_A          173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVV  237 (326)
T ss_dssp             GGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             cceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc---CCCCCchhhHHHHHHH
Confidence            9999999999999999999975322       12345778899999984   3468889999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.86  E-value=8.7e-23  Score=244.31  Aligned_cols=132  Identities=30%  Similarity=0.445  Sum_probs=112.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCe-----EEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHT-----AWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~-----~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..+|++++|||||+++++|...+.     .|||||||.|+.+..+.  ..++++..+..++.||+.||+|||+++|||||
T Consensus       130 ~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrD  207 (681)
T 2pzi_A          130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYND  207 (681)
T ss_dssp             HGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Confidence            456889999999999999987665     79999999875443332  23799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+|||++.+ .+||+|||+++........+||+.|+|||++.+    .++.++|+||+|+++
T Consensus       208 lkp~NIll~~~-~~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDi~slG~~l  266 (681)
T 2pzi_A          208 LKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRT----GPTVATDIYTVGRTL  266 (681)
T ss_dssp             CSGGGEEECSS-CEEECCCTTCEETTCCSCCCCCTTTSCTTHHHH----CSCHHHHHHHHHHHH
T ss_pred             cChHHeEEeCC-cEEEEecccchhcccCCccCCCccccCHHHHcC----CCCCceehhhhHHHH
Confidence            99999999985 899999999987655566789999999999742    347899999999983

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.86  E-value=3e-22  Score=213.08  Aligned_cols=133  Identities=35%  Similarity=0.596  Sum_probs=114.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++||||+++++++.+.+..|+||||+.| ++.+.+.. ...+++..+..++.|++.||+|||+++|+||||||+
T Consensus        72 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~  150 (287)
T 2wei_A           72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE  150 (287)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChh
Confidence            4678899999999999999999999999999975 55565543 457999999999999999999999999999999999


Q ss_pred             cEEEcCC---CceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTET---GTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~---~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.+   +.+||+|||++.....   .....||+.|+|||++.    +.++.++|+||+|++
T Consensus       151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~  211 (287)
T 2wei_A          151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR----GTYDEKCDVWSAGVI  211 (287)
T ss_dssp             GEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHT----TCCCTHHHHHHHHHH
T ss_pred             hEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhc----CCCCCchhhHhHHHH
Confidence            9999764   4799999999875322   23457999999999873    358899999999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.86  E-value=9e-23  Score=237.44  Aligned_cols=134  Identities=28%  Similarity=0.494  Sum_probs=115.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++|+|||||++++++.+ +.+|||||||.| +|.+++... ...+++..+..++.||+.||+|||+++|+||||||
T Consensus       313 ~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp  391 (535)
T 2h8h_A          313 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA  391 (535)
T ss_dssp             HHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             HHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH
Confidence            468999999999999998865 678999999985 677777543 35699999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||+++....     .....++..|+|||++.   .+.++.++|+||+|++
T Consensus       392 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlGv~  453 (535)
T 2h8h_A          392 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGIL  453 (535)
T ss_dssp             GGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             hhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhc---cCCCCchhhHHHHHHH
Confidence            999999999999999999975321     22345778999999984   4568999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.86  E-value=2.7e-22  Score=223.02  Aligned_cols=134  Identities=26%  Similarity=0.437  Sum_probs=115.7

Q ss_pred             HHHHhcC-CC-----CeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hcCcc
Q psy17952          6 SLLRQLK-HP-----NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLH--SLGRI   76 (804)
Q Consensus         6 ~iL~~l~-Hp-----nIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH--~~~Ii   76 (804)
                      .+|+.++ |+     |||+++++|..++.+|||||||.|++.+++.... ..+++..++.++.|++.||.|||  +++|+
T Consensus       102 ~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~iv  181 (382)
T 2vx3_A          102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSII  181 (382)
T ss_dssp             HHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEE
T ss_pred             HHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEE
Confidence            4566664 45     4999999999999999999999999998887654 56999999999999999999999  57999


Q ss_pred             ccccccccEEEc--CCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         77 HRDVKAGNILLT--ETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        77 HRDlKp~Nill~--~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||||||+|||++  .++.+||+|||++.... .....+||+.|+|||++.   ...|+.++|+||+|++
T Consensus       182 HrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~i  247 (382)
T 2vx3_A          182 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLL---GMPYDLAIDMWSLGCI  247 (382)
T ss_dssp             CCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             cCCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHc---CCCCCcHHHHHHHHHH
Confidence            999999999995  47789999999997543 334578999999999984   3468999999999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.86  E-value=1.9e-22  Score=240.15  Aligned_cols=134  Identities=29%  Similarity=0.526  Sum_probs=113.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++. ++..|||||||. |++.+++...+..+++..+..++.|++.||+|||+++|+||||||+
T Consensus       442 ~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~  520 (656)
T 2j0j_A          442 ALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR  520 (656)
T ss_dssp             HHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchH
Confidence            35788999999999999884 566899999998 5667777666668999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCCC-----CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~~-----~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+++.....     ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       521 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~i  581 (656)
T 2j0j_A          521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVC  581 (656)
T ss_dssp             GEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             hEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhc---CCCCCchhhHHHHHHH
Confidence            999999999999999999753221     2245788999999984   3568999999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.86  E-value=1.6e-22  Score=214.00  Aligned_cols=134  Identities=28%  Similarity=0.495  Sum_probs=112.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      .++|++++||||+++++++.. +..|+||||+.| ++.+++.... ..+++..+..++.|++.||+|||+++|+||||||
T Consensus        59 ~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp  137 (279)
T 1qpc_A           59 ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA  137 (279)
T ss_dssp             HHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            468899999999999998764 568999999975 5666554322 2699999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +||+++.++.+||+|||++.....     .....||+.|+|||++.   .+.++.++|+||+|++
T Consensus       138 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  199 (279)
T 1qpc_A          138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGIL  199 (279)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             hhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhc---cCCCCchhhhHHHHHH
Confidence            999999999999999999975322     12345788999999983   3568899999999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.86  E-value=1.4e-22  Score=219.96  Aligned_cols=135  Identities=27%  Similarity=0.473  Sum_probs=114.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhcCccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK------RPLKEEEIAAICSGVLRGLNYLHSLGRIH   77 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~------~~l~~~~~~~~~~qi~~aL~ylH~~~IiH   77 (804)
                      ..+|++++|||||++++++..+...|||||||.| +|.+++....      ..+++..+..++.|++.||.|||+++|+|
T Consensus        84 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H  163 (327)
T 2yfx_A           84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIH  163 (327)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeec
Confidence            3578899999999999999999999999999975 6777776543      35899999999999999999999999999


Q ss_pred             cccccccEEEcC---CCceEEeccCccccc------CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         78 RDVKAGNILLTE---TGTVKLADFGSASIK------CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        78 RDlKp~Nill~~---~~~~kl~DFG~a~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||||+|||++.   +..+||+|||++...      .......||+.|+|||++.   ...++.++|+||+|++
T Consensus       164 ~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  234 (327)
T 2yfx_A          164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVL  234 (327)
T ss_dssp             SCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhc---CCCCCchhhHHHHHHH
Confidence            999999999984   446999999998632      1223457899999999974   3568899999999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.86  E-value=1.7e-22  Score=219.63  Aligned_cols=133  Identities=30%  Similarity=0.383  Sum_probs=107.7

Q ss_pred             HhcCCCCeeeEeEEEEe-----CCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc---------
Q psy17952          9 RQLKHPNTIEYRGCYLR-----DHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSL---------   73 (804)
Q Consensus         9 ~~l~HpnIV~l~~~~~~-----~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~---------   73 (804)
                      +.++||||+++++++..     ...+|||||||+| +|.+++..  ...++..+..++.|++.||+|||++         
T Consensus        62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~  139 (336)
T 3g2f_A           62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKP  139 (336)
T ss_dssp             TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBC
T ss_pred             HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhcccccccc
Confidence            35799999999986643     2367999999975 66666654  3458999999999999999999999         


Q ss_pred             CccccccccccEEEcCCCceEEeccCcccccCC------------CCccccccccCcchhhhhcc----cCccCCccccc
Q psy17952         74 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP------------ANSFVGTPYWMAPEVILAMD----EGQYDGKVDVW  137 (804)
Q Consensus        74 ~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------------~~~~~gt~~y~APE~l~~~~----~~~~~~~vDvw  137 (804)
                      +|+||||||+|||++.++.+||+|||++.....            ....+||+.|+|||++.+..    ...++.++|+|
T Consensus       140 ~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw  219 (336)
T 3g2f_A          140 AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY  219 (336)
T ss_dssp             CEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred             ceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence            999999999999999999999999999964221            12357999999999984311    13567789999


Q ss_pred             ccccCC
Q psy17952        138 SLGITP  143 (804)
Q Consensus       138 slG~~~  143 (804)
                      |+|++.
T Consensus       220 slG~il  225 (336)
T 3g2f_A          220 ALGLIY  225 (336)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999983

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.86  E-value=1.6e-22  Score=220.94  Aligned_cols=137  Identities=31%  Similarity=0.526  Sum_probs=116.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-cCc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDI------IEVH-KRPLKEEEIAAICSGVLRGLNYLHS-LGR   75 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~------~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~-~~I   75 (804)
                      ..+|++++|||||++++++.+++..|+|||||+| ++.++      +... ...+++..+..++.|++.||.|||+ ++|
T Consensus        94 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i  173 (348)
T 2pml_X           94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI  173 (348)
T ss_dssp             HHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCE
T ss_pred             HHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCE
Confidence            3678899999999999999999999999999986 66665      3322 4679999999999999999999999 999


Q ss_pred             cccccccccEEEcCCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCC-cccccccccCC
Q psy17952         76 IHRDVKAGNILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITP  143 (804)
Q Consensus        76 iHRDlKp~Nill~~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~-~vDvwslG~~~  143 (804)
                      +||||||+||+++.++.+||+|||++....  ......||+.|+|||++.+  ...++. ++|+||+|++.
T Consensus       174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Di~slG~il  242 (348)
T 2pml_X          174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSN--ESSYNGAKVDIWSLGICL  242 (348)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSS--CCCEEHHHHHHHHHHHHH
T ss_pred             eecCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcC--CCCCCcchhhHHHHHHHH
Confidence            999999999999999999999999997532  2334679999999999732  225655 89999999983

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.86  E-value=6.3e-22  Score=227.32  Aligned_cols=135  Identities=23%  Similarity=0.307  Sum_probs=115.9

Q ss_pred             HHHHHhcCC-CCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKH-PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~H-pnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|+.|+| ++|+.+..++...+..|||||||.|+|.+++......+++..++.++.||+.||+|||+++|+||||||+
T Consensus        53 ~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~  132 (483)
T 3sv0_A           53 SKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD  132 (483)
T ss_dssp             HHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcc
Confidence            467888977 5666666677888899999999977888888766778999999999999999999999999999999999


Q ss_pred             cEEE---cCCCceEEeccCcccccCC-----------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILL---TETGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill---~~~~~~kl~DFG~a~~~~~-----------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+   +.++.+||+|||+++....           ....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDvwSlGvi  202 (483)
T 3sv0_A          133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL---GIEQSRRDDLESLGYV  202 (483)
T ss_dssp             GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             eEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc---CCCCChHHHHHHHHHH
Confidence            9999   6889999999999974221           12568999999999984   4568999999999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.86  E-value=2.5e-22  Score=219.50  Aligned_cols=134  Identities=31%  Similarity=0.480  Sum_probs=98.2

Q ss_pred             HHHHhcCCCCeeeEeEEEEe----CCeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      ..++.++||||++++++|..    +..+|||||||.| ++.+++.... ..+++..++.++.|++.||+|||+++|+|||
T Consensus        74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~d  153 (336)
T 3fhr_A           74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD  153 (336)
T ss_dssp             HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            35677899999999999876    4458999999986 6666665443 4799999999999999999999999999999


Q ss_pred             cccccEEEcC---CCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTE---TGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~---~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||++.   ++.+||+|||++....  ......||+.|+|||++   ....++.++|+||+|++
T Consensus       154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~i  218 (336)
T 3fhr_A          154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVL---GPEKYDKSCDMWSLGVI  218 (336)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhh---CCCCCCchhhHHHHHHH
Confidence            9999999976   4569999999997532  22346799999999997   34568889999999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.86  E-value=3.4e-22  Score=217.52  Aligned_cols=136  Identities=29%  Similarity=0.436  Sum_probs=113.2

Q ss_pred             HHHHHh--cCCCCeeeEeEEEEeCC----eEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH------
Q psy17952          5 SSLLRQ--LKHPNTIEYRGCYLRDH----TAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLH------   71 (804)
Q Consensus         5 ~~iL~~--l~HpnIV~l~~~~~~~~----~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH------   71 (804)
                      .++++.  ++|||||++++++....    .+|+||||+.| +|.+++..  ..+++..+..++.|++.||+|||      
T Consensus        85 ~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~  162 (342)
T 1b6c_B           85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGT  162 (342)
T ss_dssp             HHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred             HHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            356666  79999999999998876    79999999986 67777653  47999999999999999999999      


Q ss_pred             --hcCccccccccccEEEcCCCceEEeccCcccccC--------CCCccccccccCcchhhhhcccC---ccCCcccccc
Q psy17952         72 --SLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEG---QYDGKVDVWS  138 (804)
Q Consensus        72 --~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~--------~~~~~~gt~~y~APE~l~~~~~~---~~~~~vDvws  138 (804)
                        +++|+||||||+|||++.++.+||+|||++....        ......||+.|+|||++.+....   .++.++|+||
T Consensus       163 ~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~s  242 (342)
T 1b6c_B          163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA  242 (342)
T ss_dssp             TCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHH
T ss_pred             cccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHH
Confidence              8999999999999999999999999999996432        12345799999999998421110   2446899999


Q ss_pred             cccC
Q psy17952        139 LGIT  142 (804)
Q Consensus       139 lG~~  142 (804)
                      +|++
T Consensus       243 lG~i  246 (342)
T 1b6c_B          243 MGLV  246 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.85  E-value=5.2e-22  Score=215.28  Aligned_cols=135  Identities=30%  Similarity=0.423  Sum_probs=115.6

Q ss_pred             HHHHHhcC--CCCeeeEeEEEEeCCeEEEEEeccC--CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLK--HPNTIEYRGCYLRDHTAWLVMEYCL--GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~--HpnIV~l~~~~~~~~~~~lV~Ey~~--g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|++++  ||||++++++|..++..|+||||+.  +++.+++.. ...+++..++.++.|++.||+|||+++|+||||
T Consensus        97 ~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl  175 (320)
T 3a99_A           97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDI  175 (320)
T ss_dssp             HHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCC
Confidence            46788886  5999999999999999999999997  566666654 468999999999999999999999999999999


Q ss_pred             ccccEEEc-CCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLT-ETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~-~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+|||++ +++.+||+|||++....  ......||+.|+|||++.+  ...++.++|+||+|++
T Consensus       176 kp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~i  238 (320)
T 3a99_A          176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY--HRYHGRSAAVWSLGIL  238 (320)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHH--SCBCHHHHHHHHHHHH
T ss_pred             CHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhcc--CCCCCccchHHhHHHH
Confidence            99999999 78899999999997532  2334679999999999842  2334778999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.85  E-value=3.4e-22  Score=220.26  Aligned_cols=127  Identities=24%  Similarity=0.355  Sum_probs=109.3

Q ss_pred             CCCeeeEeEEEEeCC----eEEEEEeccCCCcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CccccccccccEE
Q psy17952         13 HPNTIEYRGCYLRDH----TAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSL-GRIHRDVKAGNIL   86 (804)
Q Consensus        13 HpnIV~l~~~~~~~~----~~~lV~Ey~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~Nil   86 (804)
                      ||||++++++|...+    .+++||||+.+++.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||
T Consensus        85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL  164 (373)
T ss_dssp             HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred             cchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence            899999999988654    78999999977888887654 35699999999999999999999998 9999999999999


Q ss_pred             Ec------CCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         87 LT------ETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        87 l~------~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ++      ..+.+||+|||++.... ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  224 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTACL  224 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH---TCCCCTHHHHHHHHHH
T ss_pred             EeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHh---CCCCCchHhHHHHHHH
Confidence            95      34489999999997533 334568999999999984   4568999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.85  E-value=5.4e-22  Score=213.54  Aligned_cols=134  Identities=34%  Similarity=0.470  Sum_probs=108.8

Q ss_pred             HHHHhc----CCCCeeeEeEEEEeCCeEEEEEec-cC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          6 SLLRQL----KHPNTIEYRGCYLRDHTAWLVMEY-CL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         6 ~iL~~l----~HpnIV~l~~~~~~~~~~~lV~Ey-~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .+|+++    +|||||+++++|..++..|+|||| +. +++.+++.. ...+++..+..++.|++.||+|||+++|+|||
T Consensus        86 ~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  164 (312)
T 2iwi_A           86 ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRD  164 (312)
T ss_dssp             HHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCC
T ss_pred             HHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence            456677    899999999999999999999999 55 466666654 46799999999999999999999999999999


Q ss_pred             cccccEEEc-CCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLT-ETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~-~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+||+++ .++.+||+|||++....  ......||+.|+|||++.+  ...++.++|+||+|++
T Consensus       165 lkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~i  228 (312)
T 2iwi_A          165 IKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISR--HQYHALPATVWSLGIL  228 (312)
T ss_dssp             CSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHH--SCBCHHHHHHHHHHHH
T ss_pred             CChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeec--CCCCCccchHHHHHHH
Confidence            999999999 78999999999987532  2334679999999999742  2233558999999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.84  E-value=1.3e-21  Score=210.96  Aligned_cols=136  Identities=30%  Similarity=0.473  Sum_probs=111.8

Q ss_pred             HHHHHhcC--CCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLK--HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~--HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++  |||||++++++..++.+|||||++.|++.+++.. ...+++..+..++.|++.||.|||+++|+||||||
T Consensus        77 ~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp  155 (313)
T 3cek_A           77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP  155 (313)
T ss_dssp             HHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc
Confidence            35677886  5999999999999999999999777888888764 46899999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcc--------cCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMD--------EGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~--------~~~~~~~vDvwslG~~  142 (804)
                      +|||+++ +.+||+|||++.....      .....||+.|+|||++....        ...++.++|+||+|++
T Consensus       156 ~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i  228 (313)
T 3cek_A          156 ANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  228 (313)
T ss_dssp             GGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred             ccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence            9999964 8999999999975322      12457999999999984311        1367889999999998

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	804
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-110
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-18
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-68
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-14
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-67
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-17
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-66
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-12
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-57
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-12
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-57
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-15
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-36
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-12
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-13
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-35
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-13
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-12
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-32
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-12
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-28
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-07
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-14
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-11
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-12
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-52
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-11
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-09
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-10
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-26
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-10
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-10
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-49
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-11
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-48
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-06
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-48
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-11
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-07
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-47
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-24
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-10
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-12
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-30
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-09
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-26
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-09
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-10
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-27
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-10
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-46
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-11
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-46
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-08
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-28
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-10
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-09
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-11
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-29
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-09
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-28
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-11
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-45
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-23
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-07
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-45
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-07
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-10
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-24
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-08
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-13
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-44
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-10
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-24
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-09
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-44
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-06
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-27
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-10
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-09
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-26
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-10
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-08
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-10
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-43
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-29
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-11
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-10
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-27
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-10
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-22
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-09
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-10
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-26
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-09
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-10
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-23
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-08
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-21
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-11
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-10
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-20
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-36
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-06

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  337 bits (865), Expect = e-110
 Identities = 229/380 (60%), Positives = 259/380 (68%), Gaps = 74/380 (19%)

Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA 207
           DP++AELF K+DPEK+F DLREIGHGSFGAVY+AR + + E+VAIKKMSY GKQ  EKW 
Sbjct: 1   DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60

Query: 208 DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
           DI+KE+RFL++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSA                   
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA------------------- 101

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
                             EVHK+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNIL
Sbjct: 102 --------------SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147

Query: 328 LTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           L+E G VKL DFGSASI  PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                                                    AERKPP FNMNAMSALYHI
Sbjct: 208 -----------------------------------------AERKPPLFNMNAMSALYHI 226

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRT 507
           AQN++P LQS  WS+ F +FV SCL K P DRP+S  LL H  V R R P+V++DLI+RT
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286

Query: 508 KAAVRDLDNLNYRKMKKILM 527
           K AVR+LDNL YRKMKKIL 
Sbjct: 287 KDAVRELDNLQYRKMKKILF 306

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (453), Expect = 7e-51
 Identities = 110/137 (80%), Positives = 122/137 (89%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
             L++L+HPNTI+YRGCYLR+HTAWLVMEYCLGSASD++EVHK+PL+E EIAA+  G L+
Sbjct: 67  RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAM 125
           GL YLHS   IHRDVKAGNILL+E G VKL DFGSASI  PANSFVGTPYWMAPEVILAM
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186

Query: 126 DEGQYDGKVDVWSLGIT 142
           DEGQYDGKVDVWSLGIT
Sbjct: 187 DEGQYDGKVDVWSLGIT 203

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 48/65 (73%), Positives = 55/65 (84%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVMEYCLGSASD++EVHK+PL+E EIAA+  G L+GL YLHS   IHRDVKAGNILL+E 
Sbjct: 92  LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151

Query: 676 GTVKL 680
           G VKL
Sbjct: 152 GLVKL 156

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 8e-68
 Identities = 84/340 (24%), Positives = 137/340 (40%), Gaps = 42/340 (12%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE + E+G G+ G V+      S  ++A K +    K        I++E++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPY 65

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            + + G +  D    + ME+  G +                                 L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGS---------------------------------LD 92

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSA 342
                   + E+ +  +   V++GL YL    +I HRDVK  NIL+   G +KL DFG +
Sbjct: 93  QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

Query: 343 SI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
                  ANSFVGT  +M+PE +       Y  + D+WS+G++ +E+A  + P    +A 
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

Query: 401 S-ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
              L    Q +    ++           ++        M     L +I     P L S  
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV 269

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
           +S  F  FV+ CL KNPA+R    +L+ H  + R  +  V
Sbjct: 270 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-38
 Identities = 44/140 (31%), Positives = 71/140 (50%), Gaps = 6/140 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +L +   P  + + G +  D    + ME+  G + D +      + E+ +  +   V++
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115

Query: 66  GLNYLHSLGRI-HRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTPYWMAPEVI 122
           GL YL    +I HRDVK  NIL+   G +KL DFG +       ANSFVGT  +M+PE +
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175

Query: 123 LAMDEGQYDGKVDVWSLGIT 142
                  Y  + D+WS+G++
Sbjct: 176 Q---GTHYSVQSDIWSMGLS 192

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 1/66 (1%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI-HRDVKAGNILLTE 674
           + ME+  G + D +      + E+ +  +   V++GL YL    +I HRDVK  NIL+  
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140

Query: 675 TGTVKL 680
            G +KL
Sbjct: 141 RGEIKL 146

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 4e-67
 Identities = 113/356 (31%), Positives = 161/356 (45%), Gaps = 82/356 (23%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           +PE  +E + E+G G+FG VY A+   +  + A K +     +  E+  D + EI  L  
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID---TKSEEELEDYMVEIDILAS 65

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
             HPN ++    +  ++  W+++E+C G A D + +                        
Sbjct: 66  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE----------------------- 102

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                     +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T  G +KLAD
Sbjct: 103 ---------LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLAD 153

Query: 339 FGSASI----KCPANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKP 392
           FG ++         +SF+GTPYWMAPEV++     +  YD K DVWSLGIT IE+AE +P
Sbjct: 154 FGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+  +N M  L  IA+++ P L                                      
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTLA------------------------------------- 236

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK 508
              Q S WS  F  F+  CL KN   R ++ +LL H  VT   S   + +LI   K
Sbjct: 237 ---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV-DSNKPIRELIAEAK 288

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-39
 Identities = 61/144 (42%), Positives = 86/144 (59%), Gaps = 7/144 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            +L    HPN ++    +  ++  W+++E+C  G+   ++   +RPL E +I  +C   L
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPE 120
             LNYLH    IHRD+KAGNIL T  G +KLADFG ++         +SF+GTPYWMAPE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 121 VILAM--DEGQYDGKVDVWSLGIT 142
           V++     +  YD K DVWSLGIT
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGIT 204

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.6 bits (196), Expect = 7e-17
 Identities = 29/66 (43%), Positives = 41/66 (62%), Gaps = 1/66 (1%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +++E+C  G+   ++   +RPL E +I  +C   L  LNYLH    IHRD+KAGNIL T 
Sbjct: 86  ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145

Query: 675 TGTVKL 680
            G +KL
Sbjct: 146 DGDIKL 151

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 1e-66
 Identities = 114/365 (31%), Positives = 160/365 (43%), Gaps = 84/365 (23%)

Query: 150 EIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI 209
           ++  +    DP+K +    +IG G+ G VY A  + + + VAI++M+    Q   K   I
Sbjct: 8   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELI 64

Query: 210 LKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
           + EI  +R+ K+PN + Y   YL     W+VMEY                       G  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL---------------------AGGS 103

Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
           L  +             V +  + E +IAA+C   L+ L +LHS   IHRD+K+ NILL 
Sbjct: 104 LTDV-------------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150

Query: 330 ETGTVKLADFGSASI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
             G+VKL DFG  +     +   ++ VGTPYWMAPEV+       Y  KVD+WSLGI  I
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAI 207

Query: 386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
           E+ E +PPY N N + ALY IA N TP LQ+ +                           
Sbjct: 208 EMIEGEPPYLNENPLRALYLIATNGTPELQNPEK-------------------------- 241

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIR 505
                          S  F  F++ CL  +   R S+  LL H  +   +  S L  LI 
Sbjct: 242 --------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

Query: 506 RTKAA 510
             K A
Sbjct: 288 AAKEA 292

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 8e-34
 Identities = 61/142 (42%), Positives = 85/142 (59%), Gaps = 10/142 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++R+ K+PN + Y   YL     W+VMEY   GS +D++   +  + E +IAA+C   L
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPE 120
           + L +LHS   IHRD+K+ NILL   G+VKL DFG  +     +   ++ VGTPYWMAPE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           V+       Y  KVD+WSLGI 
Sbjct: 187 VVT---RKAYGPKVDIWSLGIM 205

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 12/99 (12%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCL-GSASDIIEVHKRPLKEEE 640
                + + + V +L   SY   +  +       +VMEY   GS +D++   +  + E +
Sbjct: 69  LVMRENKNPNIVNYL--DSYLVGDELW-------VVMEYLAGGSLTDVV--TETCMDEGQ 117

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
           IAA+C   L+ L +LHS   IHRD+K+ NILL   G+VK
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK 156

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  198 bits (504), Expect = 1e-57
 Identities = 72/424 (16%), Positives = 131/424 (30%), Gaps = 92/424 (21%)

Query: 148 DPEIAELFDKEDPEKI----------FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSY 197
           D  + +++ +  P+ +          ++   E+G G+FG V+      +    A K +  
Sbjct: 2   DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM- 60

Query: 198 LGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI 257
                      + KEI+ +  L+HP  +     +  D+   ++ E+  G           
Sbjct: 61  --TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG----------- 107

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
                    G   +++                  + E+E       V +GL ++H    +
Sbjct: 108 ---------GELFEKVAD------------EHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146

Query: 318 HRDVKAGNILLT--ETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYD 372
           H D+K  NI+ T   +  +KL DFG  +    K       GT  + APEV          
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE---GKPVG 203

Query: 373 GKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERK 432
              D+WS+G+    L     P+   N    L ++   D                      
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-------------------- 243

Query: 433 PPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
                                    S  S+    F+   L  +P  R +  + L H  +T
Sbjct: 244 -------------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284

Query: 493 RPRSPSVLVDLIRRTKAAVRDLDNLNYRKMKKILMADGADTESTIDPDDTPDEQAGNDSS 552
              +P     +       +RD     Y    + L   G  +  +      P E +  D+ 
Sbjct: 285 PGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAF 344

Query: 553 KSNS 556
              S
Sbjct: 345 WDRS 348

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  127 bits (319), Expect = 2e-32
 Identities = 44/200 (22%), Positives = 75/200 (37%), Gaps = 21/200 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
             +  L+HP  +     +  D+   ++ E+   G   + +      + E+E       V 
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSASI---KCPANSFVGTPYWMAP 119
           +GL ++H    +H D+K  NI+ T   +  +KL DFG  +    K       GT  + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 120 EVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDP---EKIFEDLREIGHGSFG 176
           EV             D+WS+G+            L     P   E   E LR +    + 
Sbjct: 195 EVAE---GKPVGYYTDMWSVGVL--------SYILLSGLSPFGGENDDETLRNVKSCDWN 243

Query: 177 AVYYARCLVSREIVA-IKKM 195
               A   +S +    I+K+
Sbjct: 244 MDDSAFSGISEDGKDFIRKL 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 65.5 bits (159), Expect = 7e-12
 Identities = 16/68 (23%), Positives = 31/68 (45%), Gaps = 3/68 (4%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 673
           ++ E+   G   + +      + E+E       V +GL ++H    +H D+K  NI+ T 
Sbjct: 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159

Query: 674 -ETGTVKL 680
             +  +KL
Sbjct: 160 KRSNELKL 167

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 7e-57
 Identities = 73/337 (21%), Positives = 121/337 (35%), Gaps = 80/337 (23%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P+      + IG GSFG VY  +       VA+K ++ +     ++      E+  LR
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLN-VTAPTPQQLQAFKNEVGVLR 59

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           + +H N + + G         +V ++C G                     +    L    
Sbjct: 60  KTRHVNILLFMGYSTAPQL-AIVTQWCEG--------------------SSLYHHLH--- 95

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                    + +   +  ++  I     +G++YLH+   IHRD+K+ NI L E  TVK+ 
Sbjct: 96  ---------IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIG 146

Query: 338 DFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           DFG A++K             G+  WMAPEVI   D+  Y  + DV++ GI   EL   +
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
            PY N+N    +  +                          P    +             
Sbjct: 207 LPYSNINNRDQIIFMVGRG-------------------YLSPDLSKVR------------ 235

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                 S+        ++ CL K   +RP   ++L  
Sbjct: 236 ------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 5e-39
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            +LR+ +H N + + G         +V ++C   S    + + +   +  ++  I     
Sbjct: 56  GVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMA 118
           +G++YLH+   IHRD+K+ NI L E  TVK+ DFG A++K             G+  WMA
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PEVI   D+  Y  + DV++ GI 
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIV 198

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.1 bits (179), Expect = 8e-15
 Identities = 20/66 (30%), Positives = 36/66 (54%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V ++C   S    + + +   +  ++  I     +G++YLH+   IHRD+K+ NI L E
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE 139

Query: 675 TGTVKL 680
             TVK+
Sbjct: 140 DLTVKI 145

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 3e-56
 Identities = 72/330 (21%), Positives = 116/330 (35%), Gaps = 87/330 (26%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY 227
            EIG GSF  VY      +   VA  ++    K    +     +E   L+ L+HPN + +
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 228 RGCYL----RDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
              +           LV E                                       L 
Sbjct: 74  YDSWESTVKGKKCIVLVTELM---------------------------------TSGTLK 100

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLT-ETGTVKLADFG 340
            +    + +K + + + C  +L+GL +LH+     IHRD+K  NI +T  TG+VK+ D G
Sbjct: 101 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160

Query: 341 SASIK--CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
            A++K    A + +GTP +MAPE+     E +YD  VDV++ G+  +E+A  + PY    
Sbjct: 161 LATLKRASFAKAVIGTPEFMAPEMY----EEKYDESVDVYAFGMCMLEMATSEYPYSECQ 216

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
             + +Y                                          +     P     
Sbjct: 217 NAAQIYR----------------------------------------RVTSGVKPASFDK 236

Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                    +  C+ +N  +R S   LL H
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-36
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 13/146 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYL----RDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICS 61
            +L+ L+HPN + +   +           LV E              + +K + + + C 
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119

Query: 62  GVLRGLNYLHSLGR--IHRDVKAGNILLT-ETGTVKLADFGSASIK--CPANSFVGTPYW 116
            +L+GL +LH+     IHRD+K  NI +T  TG+VK+ D G A++K    A + +GTP +
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 179

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
           MAPE+     E +YD  VDV++ G+ 
Sbjct: 180 MAPEMY----EEKYDESVDVYAFGMC 201

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 3/68 (4%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR--IHRDVKAGNILLT 673
           LV E              + +K + + + C  +L+GL +LH+     IHRD+K  NI +T
Sbjct: 89  LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 148

Query: 674 -ETGTVKL 680
             TG+VK+
Sbjct: 149 GPTGSVKI 156

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 3e-56
 Identities = 73/331 (22%), Positives = 117/331 (35%), Gaps = 81/331 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           FE  R +G G FG VY AR   S+ I+A+K +     + A     + +E+     L+HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +   G +      +L++EY                                      ++
Sbjct: 68  ILRLYGYFHDATRVYLILEYA---------------------------------PLGTVY 94

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                     E+  A   + +   L+Y HS   IHRD+K  N+LL   G +K+ADFG + 
Sbjct: 95  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154

Query: 343 -SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
            +      +  GT  ++ PE+I       +D KVD+WSLG+ C E    KPP+       
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211

Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 461
               I++ +                                                  +
Sbjct: 212 TYKRISRVEFTF-------------------------------------------PDFVT 228

Query: 462 DTFAHFVSSCLAKNPADRPSSGRLLTHDLVT 492
           +     +S  L  NP+ RP    +L H  +T
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 8e-35
 Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 5/139 (3%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +   L+HPN +   G +      +L++EY                 E+  A   + +  
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA--SIKCPANSFVGTPYWMAPEVIL 123
            L+Y HS   IHRD+K  N+LL   G +K+ADFG +  +      +  GT  ++ PE+I 
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIE 177

Query: 124 AMDEGQYDGKVDVWSLGIT 142
                 +D KVD+WSLG+ 
Sbjct: 178 ---GRMHDEKVDLWSLGVL 193

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 19/65 (29%), Positives = 29/65 (44%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L++EY                 E+  A   + +   L+Y HS   IHRD+K  N+LL   
Sbjct: 83  LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 142

Query: 676 GTVKL 680
           G +K+
Sbjct: 143 GELKI 147

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-55
 Identities = 65/337 (19%), Positives = 115/337 (34%), Gaps = 83/337 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++ ++ +G G++G V  A   V+ E VA+K +    K+  +   +I KEI   + L H N
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHEN 64

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +++ G     +  +L +EYC                                     LF
Sbjct: 65  VVKFYGHRREGNIQYLFLEYC---------------------------------SGGELF 91

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           +       + E +       ++ G+ YLH +G  HRD+K  N+LL E   +K++DFG A+
Sbjct: 92  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 151

Query: 344 IKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM 397
           +          N   GT  ++APE++       +   VDVWS GI    +   + P+   
Sbjct: 152 VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209

Query: 398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQS 457
           +     Y                                            +  T     
Sbjct: 210 SDSCQEYSD----------------------------------------WKEKKTYLNPW 229

Query: 458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
                     +   L +NP+ R +   +       +P
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (337), Expect = 1e-35
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 8/143 (5%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            + + L H N +++ G     +  +L +EYC G            + E +       ++ 
Sbjct: 55  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 114

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAP 119
           G+ YLH +G  HRD+K  N+LL E   +K++DFG A++          N   GT  ++AP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 120 EVILAMDEGQYDGKVDVWSLGIT 142
           E++       +   VDVWS GI 
Sbjct: 175 ELL--KRREFHAEPVDVWSCGIV 195

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 20/65 (30%), Positives = 31/65 (47%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L +EYC G            + E +       ++ G+ YLH +G  HRD+K  N+LL E 
Sbjct: 80  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 139

Query: 676 GTVKL 680
             +K+
Sbjct: 140 DNLKI 144

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-55
 Identities = 80/375 (21%), Positives = 137/375 (36%), Gaps = 64/375 (17%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           + +L  IG G++G V  A   V++  VAIKK+S    Q        L+EI+ L + +H N
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHEN 67

Query: 224 TIEYRGCYLRDHTA-----WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
            I                 +LV          ++                          
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-------------------------- 101

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                      + L  + I      +LRGL Y+HS   +HRD+K  N+LL  T  +K+ D
Sbjct: 102 ---------KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 152

Query: 339 FGSASIKCPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           FG A +  P +        +V T ++ APE++  ++   Y   +D+WS+G    E+   +
Sbjct: 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIM--LNSKGYTKSIDIWSVGCILAEMLSNR 210

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           P +   + +  L HI        Q     +I   +       P+ N    + L+      
Sbjct: 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP----- 265

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAV 511
                  +        +   L  NP  R    + L H  + +   PS    +        
Sbjct: 266 -------NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE-PIAEAPFKFD 317

Query: 512 RDLDNLNYRKMKKIL 526
            +LD+L   K+K+++
Sbjct: 318 MELDDLPKEKLKELI 332

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 5e-28
 Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 16/149 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA-----WLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
            +L + +H N I                 +LV          ++    + L  + I    
Sbjct: 58  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFL 115

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-------SFVGT 113
             +LRGL Y+HS   +HRD+K  N+LL  T  +K+ DFG A +  P +        +V T
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 114 PYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
            ++ APE++  ++   Y   +D+WS+G  
Sbjct: 176 RWYRAPEIM--LNSKGYTKSIDIWSVGCI 202

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (162), Expect = 2e-12
 Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 5/95 (5%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 645
               H  +  ++             ++   LV          ++    + L  + I    
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVY---LVTHLMGADLYKLL--KTQHLSNDHICYFL 115

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
             +LRGL Y+HS   +HRD+K  N+LL  T  +K+
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 150

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-54
 Identities = 81/337 (24%), Positives = 122/337 (36%), Gaps = 88/337 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L  IG GS+G     R     +I+  K++ Y     AEK   ++ E+  LR+LKHPN
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPN 64

Query: 224 TIEYRGCYL--RDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            + Y    +   + T ++VMEYC  G  + +I     ER+                    
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-------------------- 104

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR-----IHRDVKAGNILLTETGTVK 335
                      L EE +  + + +   L   H         +HRD+K  N+ L     VK
Sbjct: 105 ----------YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154

Query: 336 LADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
           L DFG A I       A +FVGTPY+M+PE +   +   Y+ K D+WSLG    EL    
Sbjct: 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQM---NRMSYNEKSDIWSLGCLLYELCALM 211

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           PP+   +       I +     +                                     
Sbjct: 212 PPFTAFSQKELAGKIREGKFRRI------------------------------------- 234

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                   +SD     ++  L      RPS   +L +
Sbjct: 235 -----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-32
 Identities = 57/179 (31%), Positives = 85/179 (47%), Gaps = 20/179 (11%)

Query: 6   SLLRQLKHPNTIEYRGCYL--RDHTAWLVMEYC-LGSASDIIEVHKR---PLKEEEIAAI 59
           +LLR+LKHPN + Y    +   + T ++VMEYC  G  + +I    +    L EE +  +
Sbjct: 55  NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 114

Query: 60  CSGVLRGLNYLHSLGR-----IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSF 110
            + +   L   H         +HRD+K  N+ L     VKL DFG A I       A +F
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF 174

Query: 111 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLRE 169
           VGTPY+M+PE +   +   Y+ K D+WSLG     L        F     +++   +RE
Sbjct: 175 VGTPYYMSPEQM---NRMSYNEKSDIWSLGCLLYELCALMP--PFTAFSQKELAGKIRE 228

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 25/108 (23%), Positives = 40/108 (37%), Gaps = 16/108 (14%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKR---PLK 637
                  H + V +  +     N + Y       +VMEYC  G  + +I    +    L 
Sbjct: 55  NLLRELKHPNIVRYYDRIIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLD 107

Query: 638 EEEIAAICSGVLRGLNYLHSLGR-----IHRDVKAGNILLTETGTVKL 680
           EE +  + + +   L   H         +HRD+K  N+ L     VKL
Sbjct: 108 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 8e-54
 Identities = 81/377 (21%), Positives = 138/377 (36%), Gaps = 87/377 (23%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           ED   I++    +G G+F  V  A    ++++VAIK ++   K    K   +  EI  L 
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK--KALEGKEGSMENEIAVLH 62

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           ++KHPN +     Y      +L+M+   G                               
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGG------------------------------ 92

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTV 334
               LF+  V K    E + + +   VL  + YLH LG +HRD+K  N+L     E   +
Sbjct: 93  ---ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 149

Query: 335 KLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 391
            ++DFG + ++ P    ++  GTP ++APEV+    +  Y   VD WS+G+    L    
Sbjct: 150 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIAYILLCGY 206

Query: 392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQND 451
           PP+++ N       I + +                       PY++              
Sbjct: 207 PPFYDENDAKLFEQILKAEYE------------------FDSPYWD-------------- 234

Query: 452 TPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAV 511
                  D SD+   F+   + K+P  R +  + L H  +    +    +      +   
Sbjct: 235 -------DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI-- 285

Query: 512 RDLDNLNYRKMKKILMA 528
               N    K K+   A
Sbjct: 286 --KKNFAKSKWKQAFNA 300

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (287), Expect = 1e-28
 Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 11/144 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           ++L ++KHPN +     Y      +L+M+    G   D I   K    E + + +   VL
Sbjct: 59  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVL 117

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCP---ANSFVGTPYWMA 118
             + YLH LG +HRD+K  N+L     E   + ++DFG + ++ P    ++  GTP ++A
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PEV+    +  Y   VD WS+G+ 
Sbjct: 178 PEVLA---QKPYSKAVDCWSIGVI 198

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 21/69 (30%), Positives = 32/69 (46%), Gaps = 5/69 (7%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 673
           L+M+    G   D I   K    E + + +   VL  + YLH LG +HRD+K  N+L   
Sbjct: 84  LIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142

Query: 674 --ETGTVKL 680
             E   + +
Sbjct: 143 LDEDSKIMI 151

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  184 bits (468), Expect = 2e-53
 Identities = 75/338 (22%), Positives = 118/338 (34%), Gaps = 85/338 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKM------SYLGKQCAEKWADILKEIRFLR 217
           +E    +G G    V       + +  A+K +      S+  ++  E     LKE+  LR
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 218 QLK-HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           ++  HPN I+ +  Y  +   +LV +                                  
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLM-------------------------------- 92

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            +   LF++   K  L E+E   I   +L  +  LH L  +HRD+K  NILL +   +KL
Sbjct: 93  -KKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 151

Query: 337 ADFGSASIKCPA---NSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELAER 390
            DFG +    P        GTP ++APE+I      +   Y  +VD+WS G+    L   
Sbjct: 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
            PP+++   M  L  I   +                                        
Sbjct: 212 SPPFWHRKQMLMLRMIMSGNYQ-------------------------------------- 233

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                +  D+SDT    VS  L   P  R ++   L H
Sbjct: 234 -FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  123 bits (309), Expect = 7e-32
 Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 9/145 (6%)

Query: 6   SLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGV 63
            +LR++  HPN I+ +  Y  +   +LV +    G   D +   K  L E+E   I   +
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---NSFVGTPYWMAPE 120
           L  +  LH L  +HRD+K  NILL +   +KL DFG +    P        GTP ++APE
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 121 VILAM---DEGQYDGKVDVWSLGIT 142
           +I      +   Y  +VD+WS G+ 
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVI 204

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 30/119 (25%), Positives = 44/119 (36%), Gaps = 10/119 (8%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LV +    G   D +   K  L E+E   I   +L  +  LH L  +HRD+K  NILL +
Sbjct: 87  LVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 145

Query: 675 TGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPNSSSQAHNRHHHHHPV 733
              +KL         D   S  +     ++ V    +   P     S   N   +   V
Sbjct: 146 DMNIKL--------TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 4e-53
 Identities = 66/341 (19%), Positives = 109/341 (31%), Gaps = 86/341 (25%)

Query: 157 KEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           K+ PE  F+  + +G GSF  V  AR L +    AIK +         K   + +E   +
Sbjct: 4   KKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
            +L HP  ++    +  D   +  + Y                                 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYA-------------------------------- 90

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
            ++  L  +        E       + ++  L YLH  G IHRD+K  NILL E   +++
Sbjct: 91  -KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 149

Query: 337 ADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 390
            DFG+A +  P      ANSFVGT  +++PE++    E       D+W+LG    +L   
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLT---EKSACKSSDLWALGCIIYQLVAG 206

Query: 391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
            PP+   N       I + +                                        
Sbjct: 207 LPPFRAGNEYLIFQKIIKLEYDF------------------------------------- 229

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
                    +       V   L  +   R     +  +  +
Sbjct: 230 ------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 5e-33
 Identities = 40/143 (27%), Positives = 64/143 (44%), Gaps = 9/143 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            ++ +L HP  ++    +  D   +  + Y                 E       + ++ 
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAP 119
            L YLH  G IHRD+K  NILL E   +++ DFG+A +  P      ANSFVGT  +++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 120 EVILAMDEGQYDGKVDVWSLGIT 142
           E++    E       D+W+LG  
Sbjct: 180 ELLT---EKSACKSSDLWALGCI 199

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 17/65 (26%), Positives = 25/65 (38%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
             + Y                 E       + ++  L YLH  G IHRD+K  NILL E 
Sbjct: 85  FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144

Query: 676 GTVKL 680
             +++
Sbjct: 145 MHIQI 149

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  184 bits (467), Expect = 2e-52
 Identities = 67/384 (17%), Positives = 119/384 (30%), Gaps = 98/384 (25%)

Query: 135 DVWS-LGITPGSLKDPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIK 193
           D+W      P  +K   +   +D       ++ L E+G G+FG V+      +  +   K
Sbjct: 10  DIWKKYVPQPVEVKQGSV---YDY------YDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 194 KMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIE 253
            ++            +  EI  + QL HP  I     +   +   L++E+  G       
Sbjct: 61  FIN---TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------- 110

Query: 254 VHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS 313
                        G    ++                  + E E+         GL ++H 
Sbjct: 111 -------------GELFDRIAA------------EDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 314 LGRIHRDVKAGNILL--TETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDE 368
              +H D+K  NI+    +  +VK+ DFG A+             T  + APE++   D 
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV---DR 202

Query: 369 GQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISST 428
                  D+W++G+    L     P+   + +  L ++ + D                  
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------------- 246

Query: 429 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                  F                     S  S     F+ + L K P  R +    L H
Sbjct: 247 --FDEDAF---------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283

Query: 489 DLVT------RPRSPSVLVDLIRR 506
             +         R PS   + IR+
Sbjct: 284 PWLKGDHSNLTSRIPSSRYNKIRQ 307

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  127 bits (319), Expect = 2e-32
 Identities = 35/143 (24%), Positives = 60/143 (41%), Gaps = 9/143 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S++ QL HP  I     +   +   L++E+   G   D I      + E E+        
Sbjct: 78  SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137

Query: 65  RGLNYLHSLGRIHRDVKAGNILL--TETGTVKLADFGSASI---KCPANSFVGTPYWMAP 119
            GL ++H    +H D+K  NI+    +  +VK+ DFG A+             T  + AP
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197

Query: 120 EVILAMDEGQYDGKVDVWSLGIT 142
           E++   D        D+W++G+ 
Sbjct: 198 EIV---DREPVGFYTDMWAIGVL 217

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 3/68 (4%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL-- 672
           L++E+   G   D I      + E E+         GL ++H    +H D+K  NI+   
Sbjct: 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162

Query: 673 TETGTVKL 680
            +  +VK+
Sbjct: 163 KKASSVKI 170

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 3e-52
 Identities = 79/340 (23%), Positives = 119/340 (35%), Gaps = 56/340 (16%)

Query: 165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK--WADILKEIRFLRQLKHP 222
           E L  +G G F  VY AR   + +IVAIKK+    +  A+       L+EI+ L++L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           N I     +       LV ++                                  E    
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFM---------------------------------ETDLE 87

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
              + +   L    I A     L+GL YLH    +HRD+K  N+LL E G +KLADFG A
Sbjct: 88  VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 147

Query: 343 SI----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                        V T ++ APE++       Y   VD+W++G    EL  R P     +
Sbjct: 148 KSFGSPNRAYTHQVVTRWYRAPELL--FGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
            +  L  I                +T+ +  E + P          +            S
Sbjct: 206 DLDQLTRI---------------FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 250

Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
              D     +      NP  R ++ + L     +    P+
Sbjct: 251 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-30
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 8/212 (3%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            LL++L HPN I     +       LV ++       II+ +   L    I A     L+
Sbjct: 52  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 111

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPEV 121
           GL YLH    +HRD+K  N+LL E G +KLADFG A             V T ++ APE+
Sbjct: 112 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSL--KDPEIAELFDKEDPEKIFEDLREIGHGSFGAVY 179
           +       Y   VD+W++G     L  + P +    D +   +IFE L       +  + 
Sbjct: 172 L--FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 180 YARCLVSREIVAIKKMSYLGKQCAEKWADILK 211
                V+ +      + ++     +   D+++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 261

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.5 bits (156), Expect = 1e-11
 Identities = 32/128 (25%), Positives = 49/128 (38%), Gaps = 17/128 (13%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
           +      H + +  L    + +N S         LV ++       II+ +   L    I
Sbjct: 52  KLLQELSHPNIIGLLDAFGHKSNIS---------LVFDFMETDLEVIIKDNSLVLTPSHI 102

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEH 701
            A     L+GL YLH    +HRD+K  N+LL E G +KL         D   + S  S +
Sbjct: 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL--------ADFGLAKSFGSPN 154

Query: 702 SVQSVGVG 709
              +  V 
Sbjct: 155 RAYTHQVV 162

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (454), Expect = 3e-51
 Identities = 71/351 (20%), Positives = 117/351 (33%), Gaps = 71/351 (20%)

Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSYLGKQC 202
           +P++  L   E P    E +R+IG G+FG V+ AR           +VA+K +       
Sbjct: 2   NPKLLSL---EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD 58

Query: 203 AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREF 261
            +   D  +E   + +  +PN ++  G         L+ EY   G  ++ +         
Sbjct: 59  MQA--DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR-------- 108

Query: 262 HVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV 321
                 + +  L                 PL   E   I   V  G+ YL     +HRD+
Sbjct: 109 --SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166

Query: 322 KAGNILLTETGTVKLADFGSASIKCPAN------SFVGTPYWMAPEVILAMDEGQYDGKV 375
              N L+ E   VK+ADFG +     A+      +      WM PE I      +Y  + 
Sbjct: 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTES 223

Query: 376 DVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPY 435
           DVW+ G+   E+                                              PY
Sbjct: 224 DVWAYGVVLWEIFSY----------------------------------------GLQPY 243

Query: 436 FNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
           + M     +Y++   +       +      + +  C +K PADRPS   + 
Sbjct: 244 YGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (266), Expect = 5e-26
 Identities = 39/167 (23%), Positives = 61/167 (36%), Gaps = 33/167 (19%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR--------------- 49
           +L+ +  +PN ++  G         L+ EY   G  ++ +                    
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 50  --------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 101
                   PL   E   I   V  G+ YL     +HRD+   N L+ E   VK+ADFG +
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 102 SIKCPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                A+      +      WM PE I      +Y  + DVW+ G+ 
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVV 231

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 58.3 bits (140), Expect = 1e-09
 Identities = 22/123 (17%), Positives = 34/123 (27%), Gaps = 33/123 (26%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKR------ 634
                  + + V  L   +               L+ EY   G  ++ +           
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKP---------MCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 635 -----------------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGT 677
                            PL   E   I   V  G+ YL     +HRD+   N L+ E   
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 178

Query: 678 VKL 680
           VK+
Sbjct: 179 VKI 181

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 6e-50
 Identities = 63/361 (17%), Positives = 105/361 (29%), Gaps = 90/361 (24%)

Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKE 212
           EL++K      +    ++G G FG V+      S++    K +    K        + KE
Sbjct: 2   ELYEK------YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV----KVKGTDQVLVKKE 51

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
           I  L   +H N +     +       ++ E+  G                     +  ++
Sbjct: 52  ISILNIARHRNILHLHESFESMEELVMIFEFISG--------------------LDIFER 91

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT--E 330
           +                  L E EI +    V   L +LHS    H D++  NI+     
Sbjct: 92  INT------------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139

Query: 331 TGTVKLADFGSA---SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           + T+K+ +FG A               P + APEV             D+WSLG     L
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV---HQHDVVSTATDMWSLGTLVYVL 196

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                P+        + +I  N         +                            
Sbjct: 197 LSGINPFLAETNQQIIENI-MNAEYTFDEEAF---------------------------- 227

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRT 507
                      + S     FV   L K    R ++   L H  + + +   V   +IR  
Sbjct: 228 ----------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ-KIERVSTKVIRTL 276

Query: 508 K 508
           K
Sbjct: 277 K 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 4e-30
 Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 23/176 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S+L   +H N +     +       ++ E+       + I      L E EI +    V 
Sbjct: 53  SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 65  RGLNYLHSLGRIHRDVKAGNILLT--ETGTVKLADFGSA---SIKCPANSFVGTPYWMAP 119
             L +LHS    H D++  NI+     + T+K+ +FG A               P + AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

Query: 120 EVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFEDLRE 169
           EV             D+WSLG          +  L      F  E  ++I E++  
Sbjct: 173 EV---HQHDVVSTATDMWSLGTL--------VYVLLSGINPFLAETNQQIIENIMN 217

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 15/66 (22%), Positives = 26/66 (39%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ E+       + I      L E EI +    V   L +LHS    H D++  NI+   
Sbjct: 78  MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137

Query: 675 TGTVKL 680
             +  +
Sbjct: 138 RRSSTI 143

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 7e-50
 Identities = 72/346 (20%), Positives = 118/346 (34%), Gaps = 71/346 (20%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREI-----VAIKKMSYLGKQCAEKWADI 209
           F +E+     E  + +G G+FG V  A      +      VA+K +         +   +
Sbjct: 34  FPREN----LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--AL 87

Query: 210 LKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGN 268
           + E++ + QL  H N +   G        +L+ EYC             +   ++     
Sbjct: 88  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG----------DLLNYLRSKRE 137

Query: 269 RLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL 328
           +  + +   E+      E     L  E++      V +G+ +L     +HRD+ A N+L+
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 197

Query: 329 TETGTVKLADFGSA------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 382
           T    VK+ DFG A      S      +      WMAPE +    EG Y  K DVWS GI
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGI 254

Query: 383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
              E+                                         +    PY  +   +
Sbjct: 255 LLWEIF----------------------------------------SLGVNPYPGIPVDA 274

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
             Y + QN     Q    ++     + SC A +   RPS   L + 
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-26
 Identities = 42/165 (25%), Positives = 62/165 (37%), Gaps = 32/165 (19%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR---------------- 49
           + +   H N +   G        +L+ EYC  G   + +   +                 
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 50  ------PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-- 101
                  L  E++      V +G+ +L     +HRD+ A N+L+T    VK+ DFG A  
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 102 ----SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
               S      +      WMAPE +    EG Y  K DVWS GI 
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGIL 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (142), Expect = 6e-10
 Identities = 19/88 (21%), Positives = 33/88 (37%), Gaps = 23/88 (26%)

Query: 616 LVMEYC-LGSASDIIEVHKR----------------------PLKEEEIAAICSGVLRGL 652
           L+ EYC  G   + +   +                        L  E++      V +G+
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177

Query: 653 NYLHSLGRIHRDVKAGNILLTETGTVKL 680
            +L     +HRD+ A N+L+T    VK+
Sbjct: 178 EFLEFKSCVHRDLAARNVLVTHGKVVKI 205

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  173 bits (440), Expect = 2e-49
 Identities = 68/339 (20%), Positives = 111/339 (32%), Gaps = 86/339 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E    +G G    V+ AR L     VA+K +     +    +    +E +    L HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 224 TIEYRGCYLRDHTA----WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +        +  A    ++VMEY                                  + 
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYV---------------------------------DG 95

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
             L +    + P+  +    + +   + LN+ H  G IHRDVK  NI+++ T  VK+ DF
Sbjct: 96  VTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 155

Query: 340 GSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           G A              + +GT  +++PE          D + DV+SLG    E+   +P
Sbjct: 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEP 212

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
           P+   + +S  Y   + D                                          
Sbjct: 213 PFTGDSPVSVAYQHVREDPIP--------------------------------------- 233

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLV 491
           P  +    S      V   LAKNP +R  +   +  DLV
Sbjct: 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  106 bits (266), Expect = 4e-26
 Identities = 40/147 (27%), Positives = 62/147 (42%), Gaps = 14/147 (9%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA----WLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG 62
               L HP  +        +  A    ++VMEY  G     I   + P+  +    + + 
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPY 115
             + LN+ H  G IHRDVK  NI+++ T  VK+ DFG A              + +GT  
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           +++PE          D + DV+SLG  
Sbjct: 180 YLSPEQARG---DSVDARSDVYSLGCV 203

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 59.4 bits (143), Expect = 3e-10
 Identities = 27/126 (21%), Positives = 45/126 (35%), Gaps = 5/126 (3%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
           Q     +H   V                    P +VMEY  G     I   + P+  +  
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPL-----PYIVMEYVDGVTLRDIVHTEGPMTPKRA 113

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEH 701
             + +   + LN+ H  G IHRDVK  NI+++ T  VK+           S ++   +  
Sbjct: 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 702 SVQSVG 707
            + +  
Sbjct: 174 VIGTAQ 179

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 7e-49
 Identities = 78/343 (22%), Positives = 125/343 (36%), Gaps = 47/343 (13%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L +IG G+FG V+ AR   + + VA+KK+  +  +        L+EI+ L+ LKH N
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHEN 70

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +          + +   +  +          ++  +F                EH    
Sbjct: 71  VVNLIEICRTKASPYNRCKGSI----------YLVFDFC---------------EHDLAG 105

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
                       EI  +   +L GL Y+H    +HRD+KA N+L+T  G +KLADFG A 
Sbjct: 106 LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165

Query: 343 -------SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
                  S      + V T ++  PE++L   E  Y   +D+W  G    E+  R P   
Sbjct: 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLL--GERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223

Query: 396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL 455
                  L  I+Q     +    W  +            Y     +  +    +     L
Sbjct: 224 GNTEQHQLALISQLC-GSITPEVWPNVDN----------YELYEKLELVKGQKRKVKDRL 272

Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
           ++          +   L  +PA R  S   L HD       PS
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 3e-26
 Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 18/153 (11%)

Query: 6   SLLRQLKHPNTIEYRGCYL--------RDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIA 57
            +L+ LKH N +                  + +LV ++C    + ++          EI 
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120

Query: 58  AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA--------SIKCPANS 109
            +   +L GL Y+H    +HRD+KA N+L+T  G +KLADFG A        S      +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 110 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
            V T ++  PE++L   E  Y   +D+W  G  
Sbjct: 181 RVVTLWYRPPELLL--GERDYGPPIDLWGAGCI 211

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.0 bits (152), Expect = 4e-11
 Identities = 25/95 (26%), Positives = 42/95 (44%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 645
           +   H  V +L +      +       S  LV ++C    + ++          EI  + 
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
             +L GL Y+H    +HRD+KA N+L+T  G +KL
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 158

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-48
 Identities = 74/357 (20%), Positives = 121/357 (33%), Gaps = 85/357 (23%)

Query: 154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMS---YLGKQCAEKWADIL 210
           +F +E+ +  ++   E+G G F  V   R   +    A K +        +      DI 
Sbjct: 2   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61

Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E+  L++++HPN I     Y       L++E                            
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELV-------------------------- 95

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
                      LF+F   K  L EEE       +L G+ YLHSL   H D+K  NI+L +
Sbjct: 96  -------AGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148

Query: 331 TGT----VKLADFGSASIKCPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
                  +K+ DFG A      N F    GTP ++APE++   +      + D+WS+G+ 
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV---NYEPLGLEADMWSIGVI 205

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
              L     P+        L +++  +                     +  YF       
Sbjct: 206 TYILLSGASPFLGDTKQETLANVSAVNYEF------------------EDEYF------- 240

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVL 500
                         S+ S     F+   L K+P  R +    L H  +    +   L
Sbjct: 241 --------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 5e-26
 Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 10/144 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           S+L++++HPN I     Y       L++E   G         K  L EEE       +L 
Sbjct: 65  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGT----VKLADFGSASIKCPANSF---VGTPYWMA 118
           G+ YLHSL   H D+K  NI+L +       +K+ DFG A      N F    GTP ++A
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PE++   +      + D+WS+G+ 
Sbjct: 185 PEIV---NYEPLGLEADMWSIGVI 205

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (112), Expect = 3e-06
 Identities = 22/64 (34%), Positives = 29/64 (45%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           L++E   G         K  L EEE       +L G+ YLHSL   H D+K  NI+L + 
Sbjct: 90  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149

Query: 676 GTVK 679
              K
Sbjct: 150 NVPK 153

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 6e-48
 Identities = 72/382 (18%), Positives = 127/382 (33%), Gaps = 96/382 (25%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL-RQLKHPNTIE 226
           + +G G  G V       ++E  A+K +        +      +E+    R  + P+ + 
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVR 69

Query: 227 YRGCY----LRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
               Y           +VME   G                    G    +++        
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDG--------------------GELFSRIQ-------- 101

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADF 339
              +   +   E E + I   +   + YLHS+   HRDVK  N+L T       +KL DF
Sbjct: 102 ---DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158

Query: 340 GSASIKCPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           G A      NS      TPY++APEV+      +YD   D+WSLG+    L    PP+++
Sbjct: 159 GFAKETTSHNSLTTPCYTPYYVAPEVL---GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            + ++    +                                        + Q + P  +
Sbjct: 216 NHGLAISPGMKTR-----------------------------------IRMGQYEFPNPE 240

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTR----PRSPSVLVDLIRRTKAAVR 512
            S+ S+     + + L   P  R +    + H  + +    P++P     +++  K    
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 300

Query: 513 DLDNLNYRKMKKILMADGADTE 534
           D+      +M   L     D E
Sbjct: 301 DVKE----EMTSALATMRVDYE 318

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 6e-29
 Identities = 59/234 (25%), Positives = 90/234 (38%), Gaps = 23/234 (9%)

Query: 7   LLRQLKHPNTIEYRGCY----LRDHTAWLVMEYCLGS--ASDIIEVHKRPLKEEEIAAIC 60
             R  + P+ +     Y           +VME   G    S I +   +   E E + I 
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKLADFGSASIKCPANS---FVGTP 114
             +   + YLHS+   HRDVK  N+L T       +KL DFG A      NS      TP
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177

Query: 115 YWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLRE-IGHG 173
           Y++APEV+      +YD   D+WSLG+    L        F       I   ++  I  G
Sbjct: 178 YYVAPEVL---GPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGLAISPGMKTRIRMG 232

Query: 174 SFGAVYYARCLVSREIVA-IKKMSYLGKQCAEKW--ADILKEIRFLRQLKHPNT 224
            +         VS E+   I+ +  L  +  ++    + +     ++  K P T
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNL--LKTEPTQRMTITEFMNHPWIMQSTKVPQT 284

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 28/104 (26%), Positives = 41/104 (39%), Gaps = 9/104 (8%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGS--ASDIIEVHKRPLKEE 639
           + H R      +  +    Y N  +    L    +VME   G    S I +   +   E 
Sbjct: 56  ELHWRASQCPHIVRI-VDVYENLYAGRKCLL---IVMECLDGGELFSRIQDRGDQAFTER 111

Query: 640 EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT---ETGTVKL 680
           E + I   +   + YLHS+   HRDVK  N+L T       +KL
Sbjct: 112 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 9e-48
 Identities = 71/338 (21%), Positives = 129/338 (38%), Gaps = 53/338 (15%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ + +IG G++G VY AR  ++ E+VA+KK+  L  +     +  ++EI  L++L HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 62

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++       ++  +LV E+        ++                              
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA--------------------------- 95

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                   +    I +    +L+GL + HS   +HRD+K  N+L+   G +KLADFG A 
Sbjct: 96  -----LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

Query: 344 IKCPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                       V T ++ APE++  +    Y   VD+WSLG    E+  R+  +   + 
Sbjct: 151 AFGVPVRTYTHEVVTLWYRAPEIL--LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           +  L+ I +          W  + ++       P +   +    +  +            
Sbjct: 209 IDQLFRIFRT-LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL------------ 255

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSP 497
             +     +S  L  +P  R S+   L H        P
Sbjct: 256 -DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 7e-24
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 7/142 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVL 64
           SLL++L HPN ++       ++  +LV E+        ++      +    I +    +L
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN----SFVGTPYWMAPE 120
           +GL + HS   +HRD+K  N+L+   G +KLADFG A             V T ++ APE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           ++  +    Y   VD+WSLG  
Sbjct: 173 IL--LGCKYYSTAVDIWSLGCI 192

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.1 bits (116), Expect = 8e-07
 Identities = 21/99 (21%), Positives = 36/99 (36%), Gaps = 10/99 (10%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVH-KRPLKEEE 640
                 +H + V  L      N            LV E+        ++      +    
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENK---------LYLVFEFLHQDLKKFMDASALTGIPLPL 103

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
           I +    +L+GL + HS   +HRD+K  N+L+   G +K
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 142

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-47
 Identities = 81/354 (22%), Positives = 131/354 (37%), Gaps = 66/354 (18%)

Query: 158 EDPEKI-FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           + P+++ + D + IG+GSFG VY A+   S E+VAIKK+        +      +E++ +
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-------QDKRFKNRELQIM 67

Query: 217 RQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           R+L H N +  R  +             LV++Y   +   +                   
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV------------------- 108

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT- 329
                        ++   K+ L    +      + R L Y+HS G  HRD+K  N+LL  
Sbjct: 109 -----------ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157

Query: 330 ETGTVKLADFGSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           +T  +KL DFGSA       P  S++ + Y+ APE+I       Y   +DVWS G    E
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI--FGATDYTSSIDVWSAGCVLAE 215

Query: 387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY- 445
           L   +P +   + +  L  I               IK + +    +    N N     + 
Sbjct: 216 LLLGQPIFPGDSGVDQLVEI---------------IKVLGTPTREQIREMNPNYTEFKFP 260

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSV 499
            I  +    +             S  L   P  R +      H      R P+V
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 6e-24
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 15/150 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVH---KRPLKEEEI 56
            ++R+L H N +  R  +             LV++Y   +   +   +   K+ L    +
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 57  AAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASI---KCPANSFVG 112
                 + R L Y+HS G  HRD+K  N+LL  +T  +KL DFGSA       P  S++ 
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184

Query: 113 TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           + Y+ APE+I       Y   +DVWS G  
Sbjct: 185 SRYYRAPELI--FGATDYTSSIDVWSAGCV 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (144), Expect = 4e-10
 Identities = 22/98 (22%), Positives = 37/98 (37%), Gaps = 6/98 (6%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVH---KRPLKE 638
           Q   +  H + V        +    +   L    LV++Y   +   +   +   K+ L  
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN---LVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 639 EEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
             +      + R L Y+HS G  HRD+K  N+LL    
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 159

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 1e-47
 Identities = 58/327 (17%), Positives = 100/327 (30%), Gaps = 84/327 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
            + L+ IG G FG V           VA+K +         +    L E   + QL+H N
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK---NDATAQ--AFLAEASVMTQLRHSN 61

Query: 224 TIEYRGCYLRDHTA-WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            ++  G  + +    ++V EY                       G+ +  L+        
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAK--------------------GSLVDYLR-------- 93

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                 +  L  + +      V   + YL     +HRD+ A N+L++E    K++DFG  
Sbjct: 94  ---SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 150

Query: 343 SIKCPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS 401
                  ++      W APE +    E ++  K DVWS GI   E+              
Sbjct: 151 KEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSF----------- 196

Query: 402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS 461
                                         + PY  +     +  + +            
Sbjct: 197 -----------------------------GRVPYPRIPLKDVVPRVEKGYKMDA-PDGCP 226

Query: 462 DTFAHFVSSCLAKNPADRPSSGRLLTH 488
                 + +C   + A RPS  +L   
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-32
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 7/141 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA-WLVMEYC-LGSASDIIEVHKR-PLKEEEIAAICSG 62
           S++ QL+H N ++  G  + +    ++V EY   GS  D +    R  L  + +      
Sbjct: 52  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-NSFVGTPYWMAPEV 121
           V   + YL     +HRD+ A N+L++E    K++DFG         ++      W APE 
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 171

Query: 122 ILAMDEGQYDGKVDVWSLGIT 142
           +    E ++  K DVWS GI 
Sbjct: 172 LR---EKKFSTKSDVWSFGIL 189

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 22/96 (22%), Positives = 33/96 (34%), Gaps = 9/96 (9%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKR-PLKEEEIAA 643
               H  +  L           Y       +V EY   GS  D +    R  L  + +  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLY-------IVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107

Query: 644 ICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
               V   + YL     +HRD+ A N+L++E    K
Sbjct: 108 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 143

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-47
 Identities = 64/335 (19%), Positives = 114/335 (34%), Gaps = 87/335 (25%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP+     L+E+G G FG V Y +    +  VAIK +    K+ +    + ++E + +  
Sbjct: 2   DPKD-LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMN 55

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
           L H   ++  G   +    +++ EY                       G  L  L+    
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMAN--------------------GCLLNYLRE--- 92

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLAD 338
                     +   + +++  +C  V   + YL S   +HRD+ A N L+ + G VK++D
Sbjct: 93  ---------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSD 143

Query: 339 FGSASIKCPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           FG +                   W  PEV++     ++  K D+W+ G+   E+      
Sbjct: 144 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVLMWEIYSL--- 197

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
                                                 K PY          HIAQ    
Sbjct: 198 -------------------------------------GKMPYERFTNSETAEHIAQGLRL 220

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
             +    S+     + SC  +   +RP+   LL++
Sbjct: 221 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 4e-30
 Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 24/186 (12%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++  L H   ++  G   +    +++ EY   G   + +   +   + +++  +C  V 
Sbjct: 51  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-----SFVGTPYWMAP 119
             + YL S   +HRD+ A N L+ + G VK++DFG +                   W  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 120 EVILAMDEGQYDGKVDVWSLGIT-----------PGSLKDPEIAELFDK----EDPEKIF 164
           EV++     ++  K D+W+ G+                 + E AE   +      P    
Sbjct: 171 EVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227

Query: 165 EDLREI 170
           E +  I
Sbjct: 228 EKVYTI 233

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 17/66 (25%), Positives = 33/66 (50%), Gaps = 1/66 (1%)

Query: 616 LVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ EY   G   + +   +   + +++  +C  V   + YL S   +HRD+ A N L+ +
Sbjct: 76  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135

Query: 675 TGTVKL 680
            G VK+
Sbjct: 136 QGVVKV 141

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  166 bits (422), Expect = 4e-47
 Identities = 68/329 (20%), Positives = 121/329 (36%), Gaps = 55/329 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  L +IG G++G VY A+     E  A+KK+  L K+     +  ++EI  L++LKH N
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSN 61

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++            LV E+                                        
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ---------------------------------DLKK 88

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
             +V +  L+     +    +L G+ Y H    +HRD+K  N+L+   G +K+ADFG A 
Sbjct: 89  LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148

Query: 344 I----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                       + T ++ AP+V+  M   +Y   +D+WS+G    E+    P +  ++ 
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVL--MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
              L  I         S +W  +  +         Y  +   S L  +            
Sbjct: 207 ADQLMRI-FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL------------ 253

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
             ++    +S  L  +P  R ++ + L H
Sbjct: 254 -DESGIDLLSKMLKLDPNQRITAKQALEH 281

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  107 bits (268), Expect = 2e-26
 Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 6/142 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           S+L++LKH N ++            LV E+       +++V +  L+     +    +L 
Sbjct: 52  SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI----KCPANSFVGTPYWMAPEV 121
           G+ Y H    +HRD+K  N+L+   G +K+ADFG A             + T ++ AP+V
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 122 ILAMDEGQYDGKVDVWSLGITP 143
           +  M   +Y   +D+WS+G   
Sbjct: 172 L--MGSKKYSTTIDIWSVGCIF 191

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 56.4 bits (135), Expect = 4e-09
 Identities = 17/65 (26%), Positives = 32/65 (49%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LV E+       +++V +  L+     +    +L G+ Y H    +HRD+K  N+L+   
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136

Query: 676 GTVKL 680
           G +K+
Sbjct: 137 GELKI 141

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (424), Expect = 7e-47
 Identities = 68/332 (20%), Positives = 114/332 (34%), Gaps = 80/332 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ LR +G GSFG V+  R   +    A+K +        ++      E   L  + HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I   G +      +++M+Y  G                                   LF
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEG---------------------------------GELF 92

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA- 342
           +     +           + V   L YLHS   I+RD+K  NILL + G +K+ DFG A 
Sbjct: 93  SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK 152

Query: 343 SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA 402
            +     +  GTP ++APEV+       Y+  +D WS GI   E+     P+++ N M  
Sbjct: 153 YVPDVTYTLCGTPDYIAPEVVS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209

Query: 403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD 462
              I   +                      PP+                        +++
Sbjct: 210 YEKILNAELRF-------------------PPF------------------------FNE 226

Query: 463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
                +S  + ++ + R  + +  T D+   P
Sbjct: 227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (285), Expect = 3e-28
 Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 4/138 (2%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +L  + HP  I   G +      +++M+Y  G     +    +           + V  
Sbjct: 56  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAPEVILA 124
            L YLHS   I+RD+K  NILL + G +K+ DFG A  +     +  GTP ++APEV+  
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS- 174

Query: 125 MDEGQYDGKVDVWSLGIT 142
                Y+  +D WS GI 
Sbjct: 175 --TKPYNKSIDWWSFGIL 190

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 19/64 (29%), Positives = 29/64 (45%)

Query: 617 VMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 676
           +M+Y  G     +    +           + V   L YLHS   I+RD+K  NILL + G
Sbjct: 82  IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG 141

Query: 677 TVKL 680
            +K+
Sbjct: 142 HIKI 145

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (421), Expect = 1e-46
 Identities = 75/374 (20%), Positives = 120/374 (32%), Gaps = 94/374 (25%)

Query: 141 ITPGSLKDPEIA-ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMS 196
           I P + +DP  A   F KE      +  + IG G FG V      +  +    VAIK + 
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 197 YLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHW 256
                  ++  D L E   + Q  HPN I   G   +     ++ E+    + D      
Sbjct: 64  --SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ- 120

Query: 257 IEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR 316
                                          +       ++  +  G+  G+ YL  +  
Sbjct: 121 -------------------------------NDGQFTVIQLVGMLRGIAAGMKYLADMNY 149

Query: 317 IHRDVKAGNILLTETGTVKLADFGSASI---------KCPANSFVGTPYWMAPEVILAMD 367
           +HRD+ A NIL+      K++DFG +              A        W APE I    
Sbjct: 150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ--- 206

Query: 368 EGQYDGKVDVWSLGITCIE-LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTIS 426
             ++    DVWS GI   E ++  + PY++M     +  I Q+                 
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD----------------- 249

Query: 427 STAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
               R PP                        D        +  C  K+   RP  G+++
Sbjct: 250 ---YRLPP----------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 487 THDLVTRPRSPSVL 500
            + L    R+P+ L
Sbjct: 285 -NTLDKMIRNPNSL 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (277), Expect = 2e-27
 Identities = 47/241 (19%), Positives = 90/241 (37%), Gaps = 41/241 (17%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           S++ Q  HPN I   G   +     ++ E+   GS    +  +       ++  +  G+ 
Sbjct: 79  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---------KCPANSFVGTPY 115
            G+ YL  +  +HRD+ A NIL+      K++DFG +              A        
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGITP---GSLKDPEIAELFDKEDPEKIFEDLREIGH 172
           W APE I      ++    DVWS GI      S  +    ++ +++    I +D R    
Sbjct: 199 WTAPEAIQ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---- 251

Query: 173 GSFGAVYYARCLVSREIVAIKKMSYLGKQCAEK-------WADILKEIRFLRQLKHPNTI 225
                       +   +     +  L   C +K       +  I+  +   + +++PN++
Sbjct: 252 ------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD--KMIRNPNSL 297

Query: 226 E 226
           +
Sbjct: 298 K 298

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ E+   GS    +  +       ++  +  G+  G+ YL  +  +HRD+ A NIL+  
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163

Query: 675 TGTVKL 680
               K+
Sbjct: 164 NLVCKV 169

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-46
 Identities = 74/339 (21%), Positives = 129/339 (38%), Gaps = 45/339 (13%)

Query: 161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK 220
             ++ DL+ +G G++GAV  A    +   VAIKK+     Q         +E+R L+ ++
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMR 75

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           H N I     +  D T     ++ L                 +  MG  L +L       
Sbjct: 76  HENVIGLLDVFTPDETLDDFTDFYLV----------------MPFMGTDLGKL------- 112

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
                 +    L E+ I  +   +L+GL Y+H+ G IHRD+K GN+ + E   +K+ DFG
Sbjct: 113 ------MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166

Query: 341 SA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
            A         +V T ++ APEVIL  +  +Y   VD+WS+G    E+   K  +   + 
Sbjct: 167 LARQADSEMTGYVVTRWYRAPEVIL--NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           +  L  I +            +    +    +  P       +++             ++
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL------------TN 272

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
            S    + +   L  +   R ++G  L H          
Sbjct: 273 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 5e-25
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 11/144 (7%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAI 59
            LL+ ++H N I     +  D T       +LVM +       +++     L E+ I  +
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFL 126

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMA 118
              +L+GL Y+H+ G IHRD+K GN+ + E   +K+ DFG A         +V T ++ A
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRA 186

Query: 119 PEVILAMDEGQYDGKVDVWSLGIT 142
           PEVIL  +  +Y   VD+WS+G  
Sbjct: 187 PEVIL--NWMRYTQTVDIWSVGCI 208

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (154), Expect = 3e-11
 Identities = 23/98 (23%), Positives = 46/98 (46%), Gaps = 5/98 (5%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
           +      H + +  L   + +    +++  +   LVM +       +++     L E+ I
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFY---LVMPFMGTDLGKLMK--HEKLGEDRI 123

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
             +   +L+GL Y+H+ G IHRD+K GN+ + E   +K
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 161

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 2e-46
 Identities = 78/366 (21%), Positives = 133/366 (36%), Gaps = 38/366 (10%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +++L+ IG G+ G V  A   V    VAIKK+S    Q         +E+  ++ + H N
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            I     +    T     +  L                                E     
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYL------------------------------VMELMDAN 107

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
             +V +  L  E ++ +   +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A 
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 344 IKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM 400
                     +V T Y+ APEVIL M    Y   VD+WS+G    E+   K  +   + +
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224

Query: 401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW 460
                + +            +  T+ +  E +P Y  +     L+  +        +   
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT-FPKLFPDSLFPADSEHNKLK 283

Query: 461 SDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYR 520
           +      +S  L  +PA R S    L H  +     P+ +     +      D       
Sbjct: 284 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 343

Query: 521 KMKKIL 526
           + K+++
Sbjct: 344 EWKELI 349

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 1e-19
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 17/174 (9%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA------WLVMEYCLGSASDIIEVHKRPLKEEEIAAI 59
            L++ + H N I     +    T       +LVME       ++ +V +  L  E ++ +
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYL 124

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYW 116
              +L G+ +LHS G IHRD+K  NI++    T+K+ DFG A           +V T Y+
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFEDLREI 170
            APEVIL M    Y   VD+WS+G   G +   +I  LF   D    +  + E 
Sbjct: 185 RAPEVILGM---GYKENVDIWSVGCIMGEMVRHKI--LFPGRDYIDQWNKVIEQ 233

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (125), Expect = 8e-08
 Identities = 24/98 (24%), Positives = 47/98 (47%), Gaps = 6/98 (6%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
                 +H + ++ L+  +       +  ++   LVME       ++ +V +  L  E +
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVY---LVMELMDA---NLCQVIQMELDHERM 121

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
           + +   +L G+ +LHS G IHRD+K  NI++    T+K
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 2e-46
 Identities = 63/332 (18%), Positives = 93/332 (28%), Gaps = 86/332 (25%)

Query: 160 PEKIFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFL 216
            EK    L ++G GSFG V              VA+K +        E   D ++E+  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
             L H N I   G  L      +V E     +                            
Sbjct: 66  HSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL--------------------------- 97

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                L     H+       ++     V  G+ YL S   IHRD+ A N+LL     VK+
Sbjct: 98  -----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKI 152

Query: 337 ADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
            DFG                       W APE +       +    D W  G+T  E+  
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVTLWEMF- 208

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
                                                     + P+  +N    L+ I +
Sbjct: 209 ---------------------------------------TYGQEPWIGLNGSQILHKIDK 229

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
                 +  D      + +  C A  P DRP+
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 7e-28
 Identities = 39/145 (26%), Positives = 53/145 (36%), Gaps = 12/145 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
           + +  L H N I   G  L      +V E   LGS  D +  H+       ++     V 
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWM 117
            G+ YL S   IHRD+ A N+LL     VK+ DFG                       W 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 118 APEVILAMDEGQYDGKVDVWSLGIT 142
           APE +       +    D W  G+T
Sbjct: 182 APESLK---TRTFSHASDTWMFGVT 203

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (140), Expect = 8e-10
 Identities = 22/65 (33%), Positives = 30/65 (46%), Gaps = 1/65 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           +V E   LGS  D +  H+       ++     V  G+ YL S   IHRD+ A N+LL  
Sbjct: 87  MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 146

Query: 675 TGTVK 679
              VK
Sbjct: 147 RDLVK 151

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-46
 Identities = 62/331 (18%), Positives = 102/331 (30%), Gaps = 85/331 (25%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFL-RQLKHP 222
           F   + +G GSFG V+ A    + +  AIK +        +     + E R L    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 223 NTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
                   +      + VMEY  G                                   L
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGG---------------------------------DL 90

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA 342
                              + ++ GL +LHS G ++RD+K  NILL + G +K+ADFG  
Sbjct: 91  MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150

Query: 343 SIKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
                 ++    F GTP ++APE++L     +Y+  VD WS G+   E+   + P+   +
Sbjct: 151 KENMLGDAKTNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
                + I  ++                                                
Sbjct: 208 EEELFHSIRMDNPFY-------------------------------------------PR 224

Query: 459 DWSDTFAHFVSSCLAKNPADRPSS-GRLLTH 488
                    +     + P  R    G +  H
Sbjct: 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-28
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 21/173 (12%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
           L    +HP        +      + VMEY  G                      + ++ G
Sbjct: 56  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEVI 122
           L +LHS G ++RD+K  NILL + G +K+ADFG        ++    F GTP ++APE++
Sbjct: 116 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 123 LAMDEGQYDGKVDVWSLGITPGSLKDPEIAEL------FDKEDPEKIFEDLRE 169
           L     +Y+  VD WS G+         + E+      F  +D E++F  +R 
Sbjct: 176 L---GQKYNHSVDWWSFGVL--------LYEMLIGQSPFHGQDEEELFHSIRM 217

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (133), Expect = 9e-09
 Identities = 24/99 (24%), Positives = 38/99 (38%), Gaps = 8/99 (8%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
           +  +    H  +TH+        N           VMEY  G                  
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKEN--------LFFVMEYLNGGDLMYHIQSCHKFDLSRA 105

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
               + ++ GL +LHS G ++RD+K  NILL + G +K+
Sbjct: 106 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 144

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-46
 Identities = 59/333 (17%), Positives = 102/333 (30%), Gaps = 90/333 (27%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSR--EIVAIKKMSYLGKQCAEKWADILKEIRFL 216
           D + +  + +E+G G+FG V      + +  + VA+K +       A K  ++L E   +
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK-DELLAEANVM 62

Query: 217 RQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCF 276
           +QL +P  +   G    +    LVME                                  
Sbjct: 63  QQLDNPYIVRMIGICEAESW-MLVMEMAELG----------------------------- 92

Query: 277 TEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 336
                L  +    R +K++ I  +   V  G+ YL     +HRD+ A N+LL      K+
Sbjct: 93  ----PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 148

Query: 337 ADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LA 388
           +DFG +                     W APE I      ++  K DVWS G+   E  +
Sbjct: 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFS 205

Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
             + PY  M        + + +                                      
Sbjct: 206 YGQKPYRGMKGSEVTAMLEKGERMGC---------------------------------- 231

Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
                    +         ++ C   +  +RP 
Sbjct: 232 --------PAGCPREMYDLMNLCWTYDVENRPG 256

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 6e-30
 Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 26/187 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           ++++QL +P  +   G    +    LVME       +      R +K++ I  +   V  
Sbjct: 60  NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMA 118
           G+ YL     +HRD+ A N+LL      K++DFG +                     W A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 119 PEVILAMDEGQYDGKVDVWSLGITP-----------GSLKDPEIAELFDK----EDPEKI 163
           PE I      ++  K DVWS G+               +K  E+  + +K      P   
Sbjct: 179 PECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235

Query: 164 FEDLREI 170
             ++ ++
Sbjct: 236 PREMYDL 242

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 19/65 (29%), Positives = 29/65 (44%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           LVME       +      R +K++ I  +   V  G+ YL     +HRD+ A N+LL   
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143

Query: 676 GTVKL 680
              K+
Sbjct: 144 HYAKI 148

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 7e-46
 Identities = 72/336 (21%), Positives = 112/336 (33%), Gaps = 89/336 (26%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQ 218
           DP +    ++EIG G FG V+     ++++ VAIK +    ++ A    D ++E   + +
Sbjct: 3   DPSE-LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI----REGAMSEEDFIEEAEVMMK 56

Query: 219 LKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           L HP  ++  G  L      LV E+   G  SD +                         
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA----------------- 99

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                            E +  +C  V  G+ YL     IHRD+ A N L+ E   +K++
Sbjct: 100 ----------------AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVS 143

Query: 338 DFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           DFG                     W +PEV       +Y  K DVWS G+   E+     
Sbjct: 144 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVF---- 196

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
                                               +E K PY N +    +  I+    
Sbjct: 197 ------------------------------------SEGKIPYENRSNSEVVEDISTGFR 220

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
              +    S      ++ C  + P DRP+  RLL  
Sbjct: 221 L-YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-29
 Identities = 45/186 (24%), Positives = 68/186 (36%), Gaps = 24/186 (12%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++ +L HP  ++  G  L      LV E+   G  SD +   +     E +  +C  V 
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-----FVGTPYWMAP 119
            G+ YL     IHRD+ A N L+ E   +K++DFG                     W +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 120 EVILAMDEGQYDGKVDVWSLGIT----------PGSLKDPE-----IAELFDKEDPEKIF 164
           EV       +Y  K DVWS G+           P   +        I+  F    P    
Sbjct: 172 EVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228

Query: 165 EDLREI 170
             + +I
Sbjct: 229 THVYQI 234

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 21/66 (31%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LV E+   G  SD +   +     E +  +C  V  G+ YL     IHRD+ A N L+ E
Sbjct: 77  LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136

Query: 675 TGTVKL 680
              +K+
Sbjct: 137 NQVIKV 142

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-45
 Identities = 60/334 (17%), Positives = 107/334 (32%), Gaps = 86/334 (25%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +  + +  +G G FG V+          VA+K +    KQ +      L E   ++
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSL----KQGSMSPDAFLAEANLMK 63

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           QL+H   +       ++   +++ EY                                  
Sbjct: 64  QLQHQRLVRLYAVVTQEP-IYIITEYMENG------------------------------ 92

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                F        L   ++  + + +  G+ ++     IHRD++A NIL+++T + K+A
Sbjct: 93  -SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151

Query: 338 DFGSASI-----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           DFG A +                 W APE I     G +  K DVWS GI   E+     
Sbjct: 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIV---- 204

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
                                                  + PY  M     + ++ +   
Sbjct: 205 ------------------------------------THGRIPYPGMTNPEVIQNLERGYR 228

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
             ++  +  +     +  C  + P DRP+   L 
Sbjct: 229 M-VRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 1e-28
 Identities = 44/187 (23%), Positives = 81/187 (43%), Gaps = 26/187 (13%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR-PLKEEEIAAICSGV 63
           +L++QL+H   +       ++   +++ EY   GS  D ++      L   ++  + + +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-----KCPANSFVGTPYWMA 118
             G+ ++     IHRD++A NIL+++T + K+ADFG A +                 W A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 119 PEVILAMDEGQYDGKVDVWSLG------ITPGSLKDPE---------IAELFDKEDPEKI 163
           PE I     G +  K DVWS G      +T G +  P          +   +    P+  
Sbjct: 179 PEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235

Query: 164 FEDLREI 170
            E+L ++
Sbjct: 236 PEELYQL 242

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 17/67 (25%), Positives = 36/67 (53%), Gaps = 2/67 (2%)

Query: 616 LVMEYC-LGSASDIIEVHKR-PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++ EY   GS  D ++      L   ++  + + +  G+ ++     IHRD++A NIL++
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143

Query: 674 ETGTVKL 680
           +T + K+
Sbjct: 144 DTLSCKI 150

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-45
 Identities = 74/338 (21%), Positives = 117/338 (34%), Gaps = 53/338 (15%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +E L +IG G++G V+ A+   + EIVA+K++  L        +  L+EI  L++LKH N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKN 62

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            +        D    LV E+C                                 +     
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC---------------------------------DQDLKK 89

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
            F+     L  E + +    +L+GL + HS   +HRD+K  N+L+   G +KLA+FG A 
Sbjct: 90  YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

Query: 344 IKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                       V T ++  P+V+       Y   +D+WS G    ELA    P F  N 
Sbjct: 150 AFGIPVRCYSAEVVTLWYRPPDVL--FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
           +                  W             P    +             +       
Sbjct: 208 VDDQLKRIFRLLGTPTEEQW-------------PSMTKLPDYKPYPMYPATTSLVNVVPK 254

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSP 497
            + T    + + L  NP  R S+   L H   +    P
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (248), Expect = 1e-23
 Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 6/141 (4%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            LL++LKH N +        D    LV E+C        +     L  E + +    +L+
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEV 121
           GL + HS   +HRD+K  N+L+   G +KLA+FG A             V T ++  P+V
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 122 ILAMDEGQYDGKVDVWSLGIT 142
           +       Y   +D+WS G  
Sbjct: 173 L--FGAKLYSTSIDMWSAGCI 191

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (123), Expect = 1e-07
 Identities = 22/99 (22%), Positives = 36/99 (36%), Gaps = 9/99 (9%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
                  H + V        +             LV E+C        +     L  E +
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKL---------TLVFEFCDQDLKKYFDSCNGDLDPEIV 103

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            +    +L+GL + HS   +HRD+K  N+L+   G +KL
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  163 bits (413), Expect = 3e-45
 Identities = 69/332 (20%), Positives = 119/332 (35%), Gaps = 56/332 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HP 222
           ++ +R++G G +  V+ A  + + E V +K +         K   I +EI+ L  L+  P
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGP 90

Query: 223 NTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
           N I            T  LV E+   +                                 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNT--------------------------------- 117

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADF 339
              +F+   + L + +I      +L+ L+Y HS+G +HRDVK  N+++  E   ++L D+
Sbjct: 118 ---DFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW 174

Query: 340 GSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           G A    P    N  V + Y+  PE++  +D   YD  +D+WSLG     +  RK P+F+
Sbjct: 175 GLAEFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            +                   D+     I        P FN           +       
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDY-----IDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
               S     F+   L  +   R ++   + H
Sbjct: 288 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 94.5 bits (234), Expect = 1e-21
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 6   SLLRQLK-HPNTIEYRGCYLR--DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSG 62
            +L  L+  PN I            T  LV E+   +     +   + L + +I      
Sbjct: 81  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD---FKQLYQTLTDYDIRFYMYE 137

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASIKCPA---NSFVGTPYWMA 118
           +L+ L+Y HS+G +HRDVK  N+++  E   ++L D+G A    P    N  V + Y+  
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197

Query: 119 PEVILAMDEGQYDGKVDVWSLGITPGSL 146
           PE++  +D   YD  +D+WSLG    S+
Sbjct: 198 PELL--VDYQMYDYSLDMWSLGCMLASM 223

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 51.8 bits (123), Expect = 2e-07
 Identities = 21/100 (21%), Positives = 42/100 (42%), Gaps = 10/100 (10%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
           +          +  L+    +  +        P LV E+   +     +   + L + +I
Sbjct: 81  KILENLRGGPNIITLADIVKDPVSRT------PALVFEHVNNTD---FKQLYQTLTDYDI 131

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 680
                 +L+ L+Y HS+G +HRDVK  N+++  E   ++L
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 8e-45
 Identities = 79/332 (23%), Positives = 131/332 (39%), Gaps = 54/332 (16%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSR-EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-- 220
           +E + EIG G++G V+ AR L +    VA+K++     +        ++E+  LR L+  
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHLETF 67

Query: 221 -HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            HPN +          T        +                            +   + 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLV---------------------------FEHVDQD 100

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
              +  +V +  +  E I  +   +LRGL++LHS   +HRD+K  NIL+T +G +KLADF
Sbjct: 101 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160

Query: 340 GSASI---KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           G A I   +    S V T ++ APEV+L   +  Y   VD+WS+G    E+  RKP +  
Sbjct: 161 GLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLFRG 217

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            + +  L  I                  +      +    ++      +H          
Sbjct: 218 SSDVDQLGKILD----------------VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF 261

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
            +D  +     +  CL  NPA R S+   L+H
Sbjct: 262 VTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-24
 Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 12/146 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTA-----WLVMEYCLGSASDIIEVHKRP-LKEEEIAAI 59
             L   +HPN +          T       LV E+     +  ++    P +  E I  +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 60  CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI---KCPANSFVGTPYW 116
              +LRGL++LHS   +HRD+K  NIL+T +G +KLADFG A I   +    S V T ++
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 181

Query: 117 MAPEVILAMDEGQYDGKVDVWSLGIT 142
            APEV+L   +  Y   VD+WS+G  
Sbjct: 182 RAPEVLL---QSSYATPVDLWSVGCI 204

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (147), Expect = 1e-10
 Identities = 29/102 (28%), Positives = 45/102 (44%), Gaps = 4/102 (3%)

Query: 584 HNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRP-LKEEEIA 642
           H     H  V  L      +     + L    LV E+     +  ++    P +  E I 
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLT---LVFEHVDQDLTTYLDKVPEPGVPTETIK 119

Query: 643 AICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPD 684
            +   +LRGL++LHS   +HRD+K  NIL+T +G +KL    
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-44
 Identities = 74/347 (21%), Positives = 109/347 (31%), Gaps = 75/347 (21%)

Query: 149 PEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVS--REIVAIKKMSYLGKQCAEKW 206
           P I  + D  D     +    IG G+FG V  AR      R   AIK+M     +   + 
Sbjct: 1   PTIYPVLDWND----IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR- 55

Query: 207 ADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVE 264
            D   E+  L +L  HPN I   G        +L +EY   G+  D +            
Sbjct: 56  -DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR-------- 106

Query: 265 GMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG 324
                           A          L  +++    + V RG++YL     IHRD+ A 
Sbjct: 107 ----------VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156

Query: 325 NILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           NIL+ E    K+ADFG +  +              WMA E +   +   Y    DVWS G
Sbjct: 157 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL---NYSVYTTNSDVWSYG 213

Query: 382 ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAM 441
           +   E+                                              PY  M   
Sbjct: 214 VLLWEIVSL----------------------------------------GGTPYCGMTCA 233

Query: 442 SALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                + Q      +  +  D     +  C  + P +RPS  ++L  
Sbjct: 234 ELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 3e-24
 Identities = 48/198 (24%), Positives = 75/198 (37%), Gaps = 37/198 (18%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVH---------------KRP 50
           L +   HPN I   G        +L +EY   G+  D +                     
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 51  LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---A 107
           L  +++    + V RG++YL     IHRD+ A NIL+ E    K+ADFG +  +      
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 108 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI------TPGSL--KDPEIAELFDK-- 157
                   WMA E +   +   Y    DVWS G+      + G         AEL++K  
Sbjct: 184 TMGRLPVRWMAIESL---NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 158 -----EDPEKIFEDLREI 170
                E P    +++ ++
Sbjct: 241 QGYRLEKPLNCDDEVYDL 258

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.3 bits (127), Expect = 5e-08
 Identities = 21/81 (25%), Positives = 33/81 (40%), Gaps = 16/81 (19%)

Query: 616 LVMEYC-LGSASDIIEVH---------------KRPLKEEEIAAICSGVLRGLNYLHSLG 659
           L +EY   G+  D +                     L  +++    + V RG++YL    
Sbjct: 88  LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 147

Query: 660 RIHRDVKAGNILLTETGTVKL 680
            IHRD+ A NIL+ E    K+
Sbjct: 148 FIHRDLAARNILVGENYVAKI 168

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (411), Expect = 1e-44
 Identities = 56/336 (16%), Positives = 98/336 (29%), Gaps = 80/336 (23%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS---YLGKQCAEKWADILKEIRFLRQLK 220
           F   R IG G FG VY  R   + ++ A+K +       KQ      +    +  +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 221 HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHF 280
            P  +     +        +++                                      
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLM---------------------------------NGG 92

Query: 281 ALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG 340
            L           E ++    + ++ GL ++H+   ++RD+K  NILL E G V+++D G
Sbjct: 93  DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152

Query: 341 SASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN 398
            A    K   ++ VGT  +MAPEV+       YD   D +SLG    +L     P+    
Sbjct: 153 LACDFSKKKPHASVGTHGYMAPEVL--QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210

Query: 399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS 458
                       T  ++  D                                        
Sbjct: 211 TKDKHEIDRMTLTMAVELPDS--------------------------------------- 231

Query: 459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
            +S      +   L ++   R         ++   P
Sbjct: 232 -FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  118 bits (297), Expect = 2e-29
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 4/139 (2%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           SL+     P  +     +        +++   G              E ++    + ++ 
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI--KCPANSFVGTPYWMAPEVIL 123
           GL ++H+   ++RD+K  NILL E G V+++D G A    K   ++ VGT  +MAPEV+ 
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL- 177

Query: 124 AMDEGQYDGKVDVWSLGIT 142
                 YD   D +SLG  
Sbjct: 178 -QKGVAYDSSADWFSLGCM 195

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 69.8 bits (170), Expect = 3e-13
 Identities = 16/94 (17%), Positives = 37/94 (39%), Gaps = 7/94 (7%)

Query: 587 HHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAICS 646
                P      ++++  +           +++   G              E ++    +
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLS-------FILDLMNGGDLHYHLSQHGVFSEADMRFYAA 114

Query: 647 GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
            ++ GL ++H+   ++RD+K  NILL E G V++
Sbjct: 115 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 148

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-44
 Identities = 73/388 (18%), Positives = 119/388 (30%), Gaps = 94/388 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQL 219
           F+ ++ +G G+FG VY    +   E     VAIK++       A K  +IL E   +  +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 68

Query: 220 KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEH 279
            +P+     G  L      +      G                                 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGC-------------------------------- 96

Query: 280 FALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADF 339
             L     HK  +  + +   C  + +G+NYL     +HRD+ A N+L+     VK+ DF
Sbjct: 97  -LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 155

Query: 340 GSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 393
           G A +         A        WMA E IL      Y  + DVWS G+T  EL      
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELM----- 207

Query: 394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP 453
                                                   PY  +   S +  I +    
Sbjct: 208 -----------------------------------TFGSKPYDGIP-ASEISSILEKGER 231

Query: 454 CLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRD 513
             Q    +      +  C   +   RP    L+        R P   + +    +  +  
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQRYLVIQGDERMHLPS 290

Query: 514 LDNLNYRKMKKILMADGADTESTIDPDD 541
             + N+ +     + D  D +  +D D+
Sbjct: 291 PTDSNFYRA----LMDEEDMDDVVDADE 314

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 4e-28
 Identities = 44/186 (23%), Positives = 70/186 (37%), Gaps = 24/186 (12%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            ++  + +P+     G  L      +      G   D +  HK  +  + +   C  + +
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAP 119
           G+NYL     +HRD+ A N+L+     VK+ DFG A +         A        WMA 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 120 EVILAMDEGQYDGKVDVWSLGIT-----------PGSLKDPEIAELFDK----EDPEKIF 164
           E IL      Y  + DVWS G+T              +   EI+ + +K      P    
Sbjct: 183 ESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239

Query: 165 EDLREI 170
            D+  I
Sbjct: 240 IDVYMI 245

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (147), Expect = 2e-10
 Identities = 17/65 (26%), Positives = 30/65 (46%)

Query: 616 LVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTET 675
           +      G   D +  HK  +  + +   C  + +G+NYL     +HRD+ A N+L+   
Sbjct: 88  ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP 147

Query: 676 GTVKL 680
             VK+
Sbjct: 148 QHVKI 152

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 4e-44
 Identities = 65/335 (19%), Positives = 110/335 (32%), Gaps = 83/335 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ L+ +G G+FG V   R   +    A+K +        ++ A  + E R L+  +HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
               +  +        VMEY  G                                   LF
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGG---------------------------------ELF 93

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
                +R   EE      + ++  L YLHS   ++RD+K  N++L + G +K+ DFG   
Sbjct: 94  FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

Query: 344 IKCPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNA 399
                 +    F GTP ++APEV+   ++  Y   VD W LG+   E+   + P++N + 
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVL---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

Query: 400 MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSD 459
                 I   +                                                 
Sbjct: 211 ERLFELILMEEIRF-------------------------------------------PRT 227

Query: 460 WSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
            S      ++  L K+P  R   G     +++   
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-24
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 15/167 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +L+  +HP     +  +        VMEY  G         +R   EE      + ++ 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS----FVGTPYWMAPEV 121
            L YLHS   ++RD+K  N++L + G +K+ DFG         +    F GTP ++APEV
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 122 ILAMDEGQYDGKVDVWSLGITPGSL---KDPEIAELFDKEDPEKIFE 165
           +   ++  Y   VD W LG+    +   + P     F  +D E++FE
Sbjct: 177 L---EDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFE 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (134), Expect = 6e-09
 Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 22/155 (14%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 645
           ++  H  +T L      ++            VMEY  G         +R   EE      
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLC--------FVMEYANGGELFFHLSRERVFTEERARFYG 111

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDSSKSNSITSEHSVQS 705
           + ++  L YLHS   ++RD+K  N++L + G +K+         D        S+ +   
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKIT--------DFGLCKEGISDGATMK 163

Query: 706 VGVGVNPHDPTPNSSSQAHNRHHHHHPVTHLIAVG 740
              G      TP   +      + +        +G
Sbjct: 164 TFCG------TPEYLAPEVLEDNDYGRAVDWWGLG 192

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 6e-44
 Identities = 64/342 (18%), Positives = 124/342 (36%), Gaps = 46/342 (13%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E PE+ +++L  +G G++G+V  A    +   VA+KK+S    Q         +E+R L+
Sbjct: 15  EVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLK 72

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
            +KH N I     +    +     +  L                 +    N +       
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYL-------------VTHLMGADLNNIV------ 113

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                       + L ++ +  +   +LRGL Y+HS   IHRD+K  N+ + E   +K+ 
Sbjct: 114 ----------KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163

Query: 338 DFGSA-SIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN 396
           DFG A         +V T ++ APE++  ++   Y+  VD+WS+G    EL   +  +  
Sbjct: 164 DFGLARHTDDEMTGYVATRWYRAPEIM--LNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

Query: 397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQ 456
            + +  L  I +            +    +    +          + ++           
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI---------- 271

Query: 457 SSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS 498
               +      +   L  +   R ++ + L H    +   P 
Sbjct: 272 --GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 7e-21
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 9/143 (6%)

Query: 6   SLLRQLKHPNTIEYRGCY-----LRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 60
            LL+ +KH N I     +     L +     ++ + +G+  + I    + L ++ +  + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLI 127

Query: 61  SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSA-SIKCPANSFVGTPYWMAP 119
             +LRGL Y+HS   IHRD+K  N+ + E   +K+ DFG A         +V T ++ AP
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAP 187

Query: 120 EVILAMDEGQYDGKVDVWSLGIT 142
           E++  ++   Y+  VD+WS+G  
Sbjct: 188 EIM--LNWMHYNQTVDIWSVGCI 208

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.1 bits (116), Expect = 1e-06
 Identities = 21/98 (21%), Positives = 44/98 (44%), Gaps = 5/98 (5%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEI 641
           +      H + +  L   +   +   ++ ++   LV        ++I+    + L ++ +
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVY---LVTHLMGADLNNIV--KCQKLTDDHV 123

Query: 642 AAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 679
             +   +LRGL Y+HS   IHRD+K  N+ + E   +K
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 161

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 7e-44
 Identities = 64/347 (18%), Positives = 109/347 (31%), Gaps = 88/347 (25%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR 217
           E P +      ++G G FG V+      +   VAIK +    K         L+E + ++
Sbjct: 13  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMK 67

Query: 218 QLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFT 277
           +L+H   ++       +   ++V EY                                  
Sbjct: 68  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKG------------------------------ 96

Query: 278 EHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLA 337
                F      + L+  ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+A
Sbjct: 97  -SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 155

Query: 338 DFGSASI-----KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 392
           DFG A +                 W APE  L    G++  K DVWS GI   EL     
Sbjct: 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELT---- 208

Query: 393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDT 452
                                                + + PY  M     L  + +   
Sbjct: 209 ------------------------------------TKGRVPYPGMVNREVLDQVERGYR 232

Query: 453 PCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT--HDLVTRPRSP 497
                 +  ++    +  C  K P +RP+   L     D  T     
Sbjct: 233 MPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-27
 Identities = 37/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHK--RPLKEEEIAAICSGV 63
            ++++L+H   ++       +   ++V EY    +       +  + L+  ++  + + +
Sbjct: 64  QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASI-----KCPANSFVGTPYWMA 118
             G+ Y+  +  +HRD++A NIL+ E    K+ADFG A +                 W A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 119 PEVILAMDEGQYDGKVDVWSLGITP---GSLKDPEIAELFDKEDPEKIFEDLR 168
           PE  L    G++  K DVWS GI      +        + ++E  +++    R
Sbjct: 183 PEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 232

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 19/101 (18%), Positives = 39/101 (38%), Gaps = 12/101 (11%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHK--RPLKEE 639
           Q   +  H   V   +  S               +V EY    +       +  + L+  
Sbjct: 64  QVMKKLRHEKLVQLYAVVSEEP----------IYIVTEYMSKGSLLDFLKGETGKYLRLP 113

Query: 640 EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           ++  + + +  G+ Y+  +  +HRD++A NIL+ E    K+
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 154

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (403), Expect = 9e-44
 Identities = 69/384 (17%), Positives = 124/384 (32%), Gaps = 93/384 (24%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           F+ ++ +G GSFG V   +   S    A+K +        ++    L E R L+ +  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
            ++    +  +   ++VMEY                                      +F
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYV---------------------------------AGGEMF 129

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSAS 343
           +         E       + ++    YLHSL  I+RD+K  N+L+ + G +++ DFG A 
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 344 IKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSA 402
                  +  GTP  +APE+IL      Y+  VD W+LG+   E+A   PP+F    +  
Sbjct: 190 RVKGRTWTLCGTPEALAPEIIL---SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

Query: 403 LYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD 462
              I                                                   S +S 
Sbjct: 247 YEKIVSGKVRF-------------------------------------------PSHFSS 263

Query: 463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLNYRKM 522
                + + L  +   R  + +   +D+       +              D   +  RK+
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT-------------DWIAIYQRKV 310

Query: 523 KKILMADGADTESTIDPDDTPDEQ 546
           +   +        T + DD  +E+
Sbjct: 311 EAPFIPKFKGPGDTSNFDDYEEEE 334

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  100 bits (250), Expect = 1e-23
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 6/161 (3%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
            +L+ +  P  ++    +  +   ++VMEY  G              E       + ++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILA 124
              YLHSL  I+RD+K  N+L+ + G +++ DFG A        +  GTP  +APE+IL 
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL- 211

Query: 125 MDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKIFE 165
                Y+  VD W+LG+    +        F  + P +I+E
Sbjct: 212 --SKGYNKAVDWWALGVLIYEMAAGYP--PFFADQPIQIYE 248

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 56.7 bits (136), Expect = 4e-09
 Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 8/95 (8%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 645
           +  +   +  L     +N+N           VMEY  G              E       
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYM--------VMEYVAGGEMFSHLRRIGRFSEPHARFYA 147

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
           + ++    YLHSL  I+RD+K  N+L+ + G +++
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 61/341 (17%), Positives = 115/341 (33%), Gaps = 78/341 (22%)

Query: 148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWA 207
           DP        E          ++G G +G VY          VA+K +    K+   +  
Sbjct: 3   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVE 58

Query: 208 DILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
           + LKE   ++++KHPN ++  G   R+   +++ E+                       G
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY--------------------G 98

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
           N L  L            E +++ +    +  + + +   + YL     IHRD+ A N L
Sbjct: 99  NLLDYL-----------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147

Query: 328 LTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 385
           + E   VK+ADFG + +       +  G  + +      ++   ++  K DVW+ G+   
Sbjct: 148 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 207

Query: 386 ELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY 445
           E+A      +    +S +Y + + D                     +             
Sbjct: 208 EIATYGMSPYPGIDLSQVYELLEKD--------------------YRMER---------- 237

Query: 446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
                           +     + +C   NP+DRPS   + 
Sbjct: 238 -----------PEGCPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (266), Expect = 5e-26
 Identities = 38/184 (20%), Positives = 81/184 (44%), Gaps = 19/184 (10%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASD--IIEVHKRPLKEEEIAAICSGV 63
           ++++++KHPN ++  G   R+   +++ E+         + E +++ +    +  + + +
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEV 121
              + YL     IHRD+ A N L+ E   VK+ADFG + +       +  G  + +    
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 122 ILAMDEGQYDGKVDVWSLGIT-----------PGSLKDPEIAELFDK----EDPEKIFED 166
             ++   ++  K DVW+ G+               +   ++ EL +K    E PE   E 
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244

Query: 167 LREI 170
           + E+
Sbjct: 245 VYEL 248

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 59.4 bits (143), Expect = 4e-10
 Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 10/105 (9%)

Query: 616 LVMEYCLGSASD--IIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 673
           ++ E+         + E +++ +    +  + + +   + YL     IHRD+ A N L+ 
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 149

Query: 674 ETGTVKLDTPDEQAGNDSSKSNSITSEHSVQSVGVGVNPHDPTPN 718
           E   VK+         D   S  +T +      G         P 
Sbjct: 150 ENHLVKV--------ADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-43
 Identities = 66/348 (18%), Positives = 109/348 (31%), Gaps = 91/348 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMS---YLGKQCAEKWADILKEIRFLRQLK 220
           ++    +G G FG+VY    +     VAIK +                +  E+  L+++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 221 --HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTE 278
                 I     + R  +  L++E                                    
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQD----------------------------- 96

Query: 279 HFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLA 337
              LF+F   +  L+EE   +    VL  + + H+ G +HRD+K  NIL+    G +KL 
Sbjct: 97  ---LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 153

Query: 338 DFGSASI--KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           DFGS ++        F GT  +  PE I       +     VWSLGI   ++     P+ 
Sbjct: 154 DFGSGALLKDTVYTDFDGTRVYSPPEWI--RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

Query: 396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCL 455
           +   +                              R   +F                   
Sbjct: 212 HDEEII-----------------------------RGQVFFR------------------ 224

Query: 456 QSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDL 503
                S    H +  CLA  P+DRP+   +  H  +     P    ++
Sbjct: 225 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 7e-26
 Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 8/143 (5%)

Query: 6   SLLRQLK--HPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKR-PLKEEEIAAICSG 62
            LL+++       I     + R  +  L++E           + +R  L+EE   +    
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 63  VLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKLADFGSASI--KCPANSFVGTPYWMAP 119
           VL  + + H+ G +HRD+K  NIL+    G +KL DFGS ++        F GT  +  P
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPP 178

Query: 120 EVILAMDEGQYDGKVDVWSLGIT 142
           E I       +     VWSLGI 
Sbjct: 179 EWI--RYHRYHGRSAAVWSLGIL 199

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 9/101 (8%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKR-PLKEEE 640
               +              +   +S         L++E           + +R  L+EE 
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFV-------LILERPEPVQDLFDFITERGALQEEL 111

Query: 641 IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT-ETGTVKL 680
             +    VL  + + H+ G +HRD+K  NIL+    G +KL
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 152

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 6e-43
 Identities = 69/342 (20%), Positives = 109/342 (31%), Gaps = 74/342 (21%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKE 212
           E P       + +G G+FG V  A         +   VA+K +         +   ++ E
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALMSE 76

Query: 213 IRFLRQLK-HPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHWIEREFHVEGMGNRL 270
           ++ L  L  H N +   G         ++ EYC  G   + +                R 
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----------------RR 120

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
           ++        +    E  +  L  E++ +    V +G+ +L S   IHRD+ A NILLT 
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180

Query: 331 TGTVKLADFGSASIKCPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
               K+ DFG A      ++            WMAPE I       Y  + DVWS GI  
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFL 237

Query: 385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
            EL                                              PY  M   S  
Sbjct: 238 WELFSL----------------------------------------GSSPYPGMPVDSKF 257

Query: 445 YHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
           Y + +     L            + +C   +P  RP+  +++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 7e-23
 Identities = 53/206 (25%), Positives = 76/206 (36%), Gaps = 44/206 (21%)

Query: 6   SLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLG------------------SASDIIEV 46
            +L  L  H N +   G         ++ EYC                    ++  I+E 
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 47  HKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP 106
            +  L  E++ +    V +G+ +L S   IHRD+ A NILLT     K+ DFG A     
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 107 ANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI------TPGSLKDPE---- 150
            ++            WMAPE I       Y  + DVWS GI      + GS   P     
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 151 ------IAELFDKEDPEKIFEDLREI 170
                 I E F    PE    ++ +I
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDI 280

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.4 bits (143), Expect = 5e-10
 Identities = 22/83 (26%), Positives = 36/83 (43%), Gaps = 18/83 (21%)

Query: 616 LVMEYCLG------------------SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS 657
           ++ EYC                    ++  I+E  +  L  E++ +    V +G+ +L S
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163

Query: 658 LGRIHRDVKAGNILLTETGTVKL 680
              IHRD+ A NILLT     K+
Sbjct: 164 KNCIHRDLAARNILLTHGRITKI 186

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 6e-43
 Identities = 68/339 (20%), Positives = 112/339 (33%), Gaps = 92/339 (27%)

Query: 153 ELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE--IVAIKKMSYLGKQCAEKWADIL 210
           +LF K D   I +   E+G G+FG+V      + ++   VAIK +    ++   +  +++
Sbjct: 2   KLFLKRDNLLIAD--IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMM 57

Query: 211 KEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRL 270
           +E + + QL +P  +   G   +     LVME   G                    G   
Sbjct: 58  REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG--------------------GPLH 96

Query: 271 QQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 330
           + L               +  +    +A +   V  G+ YL     +HRD+ A N+LL  
Sbjct: 97  KFLVG------------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144

Query: 331 TGTVKLADFGSASIKCPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 383
               K++DFG +      +       +      W APE I      ++  + DVWS G+T
Sbjct: 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVT 201

Query: 384 CIE-LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMS 442
             E L+  + PY  M     +  I Q                        PP        
Sbjct: 202 MWEALSYGQKPYKKMKGPEVMAFIEQGKRM------------------ECPP-------- 235

Query: 443 ALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
                           +        +S C      DRP 
Sbjct: 236 ----------------ECPPELYALMSDCWIYKWEDRPD 258

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 27/188 (14%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++ QL +P  +   G   +     LVME    G     +   +  +    +A +   V 
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN-------SFVGTPYWM 117
            G+ YL     +HRD+ A N+LL      K++DFG +      +       +      W 
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 118 APEVILAMDEGQYDGKVDVWSLGITPG-----------SLKDPEIAELFDK----EDPEK 162
           APE I      ++  + DVWS G+T              +K PE+    ++    E P +
Sbjct: 180 APECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236

Query: 163 IFEDLREI 170
              +L  +
Sbjct: 237 CPPELYAL 244

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 18/67 (26%), Positives = 28/67 (41%), Gaps = 1/67 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           LVME    G     +   +  +    +A +   V  G+ YL     +HRD+ A N+LL  
Sbjct: 85  LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144

Query: 675 TGTVKLD 681
               K+ 
Sbjct: 145 RHYAKIS 151

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 7e-43
 Identities = 70/343 (20%), Positives = 120/343 (34%), Gaps = 84/343 (24%)

Query: 167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIE 226
              IG G FG V+  +     E VA+K  S   ++   + A    EI     L+H N + 
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREA----EIYQTVMLRHENILG 61

Query: 227 YRGCYLRDHTA----WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
           +     +D+      WLV +Y                       G+             L
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEH--------------------GS-------------L 88

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHS--------LGRIHRDVKAGNILLTETGTV 334
           F++ +++  +  E +  +      GL +LH             HRD+K+ NIL+ + GT 
Sbjct: 89  FDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147

Query: 335 KLADFG--------SASIKCPANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGIT 383
            +AD G        + +I    N  VGT  +MAPEV+   + M   +   + D++++G+ 
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207

Query: 384 CIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSA 443
             E+A R             Y+      P ++                      M  +  
Sbjct: 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE---------------------EMRKVVC 246

Query: 444 LYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
              +  N     QS +     A  +  C   N A R ++ R+ 
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-28
 Identities = 46/231 (19%), Positives = 90/231 (38%), Gaps = 34/231 (14%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTA----WLVMEYCL-GSASDIIEVHKRPLKEEEIAAICS 61
               L+H N + +     +D+      WLV +Y   GS  D +  ++  +  E +  +  
Sbjct: 50  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLAL 107

Query: 62  GVLRGLNYLHS--------LGRIHRDVKAGNILLTETGTVKLADFG--------SASIKC 105
               GL +LH             HRD+K+ NIL+ + GT  +AD G        + +I  
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167

Query: 106 PANSFVGTPYWMAPEVI---LAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEK 162
             N  VGT  +MAPEV+   + M   +   + D++++G+           E+  +     
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV--------FWEIARRCSIGG 219

Query: 163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEI 213
           I ED +   +    +      +         + +   +  + +   ++ +I
Sbjct: 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 270

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.4 bits (148), Expect = 1e-10
 Identities = 24/108 (22%), Positives = 45/108 (41%), Gaps = 16/108 (14%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCL-GSASDIIEVHKRPLKEEE 640
                  H + +  +   + N +N  ++ L+   LV +Y   GS  D +  ++  +  E 
Sbjct: 49  YQTVMLRHENILGFI--AADNKDNGTWTQLW---LVSDYHEHGSLFDYL--NRYTVTVEG 101

Query: 641 IAAICSGVLRGLNYLHS--------LGRIHRDVKAGNILLTETGTVKL 680
           +  +      GL +LH             HRD+K+ NIL+ + GT  +
Sbjct: 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 3e-42
 Identities = 66/340 (19%), Positives = 103/340 (30%), Gaps = 89/340 (26%)

Query: 158 EDPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSYLGKQCAEKWADILKEIR 214
           E   +  E  R IG G FG V+    +        VAIK           +    L+E  
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEAL 60

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            +RQ  HP+ ++  G    ++  W++ME C                         L+   
Sbjct: 61  TMRQFDHPHIVKLIGVI-TENPVWIIMELC---------------------TLGELRSFL 98

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                       V K  L    +      +   L YL S   +HRD+ A N+L++    V
Sbjct: 99  Q-----------VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 147

Query: 335 KLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LA 388
           KL DFG +          A+       WMAPE I   +  ++    DVW  G+   E L 
Sbjct: 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEILM 204

Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
               P+  +     +  I   +   +                                  
Sbjct: 205 HGVKPFQGVKNNDVIGRIENGERLPM---------------------------------- 230

Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                     +   T    ++ C A +P+ RP    L   
Sbjct: 231 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 5e-27
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 10/143 (6%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVL 64
             +RQ  HP+ ++  G    ++  W++ME C LG     ++V K  L    +      + 
Sbjct: 60  LTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAP 119
             L YL S   +HRD+ A N+L++    VKL DFG +          A+       WMAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 120 EVILAMDEGQYDGKVDVWSLGIT 142
           E I   +  ++    DVW  G+ 
Sbjct: 179 ESI---NFRRFTSASDVWMFGVC 198

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (145), Expect = 2e-10
 Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 1/65 (1%)

Query: 616 LVMEYC-LGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
           ++ME C LG     ++V K  L    +      +   L YL S   +HRD+ A N+L++ 
Sbjct: 84  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143

Query: 675 TGTVK 679
              VK
Sbjct: 144 NDCVK 148

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 62/357 (17%), Positives = 107/357 (29%), Gaps = 86/357 (24%)

Query: 149 PEIAELFDKEDPEKI------FEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSY 197
           PE     D   P++           RE+G GSFG VY               VAIK ++ 
Sbjct: 1   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60

Query: 198 LGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWI 257
                     + L E   +++    + +   G   +     ++ME               
Sbjct: 61  AASMRERI--EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR----------- 107

Query: 258 EREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI 317
                    G+    L+                P    ++  +   +  G+ YL++   +
Sbjct: 108 ---------GDLKSYLRS---LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155

Query: 318 HRDVKAGNILLTETGTVKLADFG------SASIKCPANSFVGTPYWMAPEVILAMDEGQY 371
           HRD+ A N ++ E  TVK+ DFG                 +    WM+PE +    +G +
Sbjct: 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVF 212

Query: 372 DGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAER 431
               DVWS G+   E+A                                           
Sbjct: 213 TTYSDVWSFGVVLWEIATL----------------------------------------A 232

Query: 432 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
           + PY  ++    L  + +         +  D     +  C   NP  RPS   +++ 
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 4e-22
 Identities = 31/153 (20%), Positives = 60/153 (39%), Gaps = 19/153 (12%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYC-LGSASDIIEVHKR---------PLKEEE 55
           S++++    + +   G   +     ++ME    G     +   +          P    +
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 56  IAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFG------SASIKCPANS 109
           +  +   +  G+ YL++   +HRD+ A N ++ E  TVK+ DFG                
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 110 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
            +    WM+PE +    +G +    DVWS G+ 
Sbjct: 195 GLLPVRWMSPESLK---DGVFTTYSDVWSFGVV 224

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (134), Expect = 5e-09
 Identities = 21/109 (19%), Positives = 38/109 (34%), Gaps = 19/109 (17%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDIIEVHKR------ 634
                 + HH V  L   S               ++ME    G     +   +       
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQP---------TLVIMELMTRGDLKSYLRSLRPAMANNP 125

Query: 635 ---PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
              P    ++  +   +  G+ YL++   +HRD+ A N ++ E  TVK+
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-40
 Identities = 62/337 (18%), Positives = 118/337 (35%), Gaps = 77/337 (22%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSRE-------IVAIKKMSYLGKQCAEKWADILKEIRFL 216
               + +G G+FG V  A  +   +        VA+K +        +  +D++ E+  +
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDLISEMEMM 72

Query: 217 RQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKC 275
           + + KH N I   G   +D   ++++EY                      +   LQ  + 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKG-----------------NLREYLQARRP 115

Query: 276 FTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVK 335
               ++       +  L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K
Sbjct: 116 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175

Query: 336 LADFGSASIKCPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 389
           +ADFG A      + +           WMAPE +    +  Y  + DVWS G+   E+  
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFT 232

Query: 390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQ 449
                +    +  L+ + +                       +                 
Sbjct: 233 LGGSPYPGVPVEELFKLLKEG--------------------HRMDK-------------- 258

Query: 450 NDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLL 486
                   S+ ++     +  C    P+ RP+  +L+
Sbjct: 259 -------PSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 7e-23
 Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 40/201 (19%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRP--------------- 50
           +    KH N I   G   +D   ++++EY   G+  + ++  + P               
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 51  LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSF 110
           L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+ADFG A      + +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 111 V------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI------TPGSL--KDPEIAELFD 156
                      WMAPE +    +  Y  + DVWS G+      T G        + ELF 
Sbjct: 192 KKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

Query: 157 K-------EDPEKIFEDLREI 170
                   + P     +L  +
Sbjct: 249 LLKEGHRMDKPSNCTNELYMM 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.7 bits (141), Expect = 7e-10
 Identities = 24/130 (18%), Positives = 47/130 (36%), Gaps = 25/130 (19%)

Query: 588 HHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCL-GSASDIIEVHKRP----------- 635
            H + +  L   + +             +++EY   G+  + ++  + P           
Sbjct: 77  KHKNIINLLGACTQDGP---------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 636 ----LKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLDTPDEQAGNDS 691
               L  +++ +    V RG+ YL S   IHRD+ A N+L+TE   +K+           
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 692 SKSNSITSEH 701
                 T+  
Sbjct: 188 IDYYKKTTNG 197

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-40
 Identities = 63/357 (17%), Positives = 99/357 (27%), Gaps = 92/357 (25%)

Query: 159 DPEKIFEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIR 214
            P       + IG G FG VY      S       VAIK +        ++  D L E  
Sbjct: 5   HPSC-VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--AGYTEKQRVDFLGEAG 61

Query: 215 FLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLK 274
            + Q  H N I   G   +     ++ EY    A D                        
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE------------------- 102

Query: 275 CFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTV 334
                                ++  +  G+  G+ YL ++  +HRD+ A NIL+      
Sbjct: 103 -------------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 149

Query: 335 KLADFGSASIKCPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 387
           K++DFG + +                   W APE I      ++    DVWS GI   E+
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI---SYRKFTSASDVWSFGIVMWEV 206

Query: 388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHI 447
                  +   +   +     +                      + P             
Sbjct: 207 MTYGERPYWELSNHEVMKAINDG--------------------FRLPT------------ 234

Query: 448 AQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT--HDLVTRPRSPSVLVD 502
                      D        +  C  +  A RP    +++    L+  P S   L D
Sbjct: 235 ---------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 4e-26
 Identities = 39/174 (22%), Positives = 67/174 (38%), Gaps = 14/174 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVL 64
            ++ Q  H N I   G   +     ++ EY   G+    +          ++  +  G+ 
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 65  RGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-------FVGTPYWM 117
            G+ YL ++  +HRD+ A NIL+      K++DFG + +                   W 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 118 APEVILAMDEGQYDGKVDVWSLGITP---GSLKDPEIAELFDKEDPEKIFEDLR 168
           APE I      ++    DVWS GI      +  +    EL + E  + I +  R
Sbjct: 181 APEAI---SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.8 bits (136), Expect = 3e-09
 Identities = 19/107 (17%), Positives = 40/107 (37%), Gaps = 4/107 (3%)

Query: 578 NSSSQAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQ---LVMEYCL-GSASDIIEVHK 633
            +      R         + Q S++N       +   +   ++ EY   G+    +    
Sbjct: 45  KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD 104

Query: 634 RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
                 ++  +  G+  G+ YL ++  +HRD+ A NIL+      K+
Sbjct: 105 GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 151

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 5e-40
 Identities = 58/357 (16%), Positives = 102/357 (28%), Gaps = 94/357 (26%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +   R+IG GSFG +Y    + + E VAIK           K   +  E +  + ++   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 63

Query: 224 TI-EYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            I   R C        +VME    S                                   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSL---------------------------------E 90

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG---TVKLADF 339
             F    R    + +  +   ++  + Y+HS   IHRDVK  N L+        V + DF
Sbjct: 91  DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150

Query: 340 GSASI-----------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 388
           G A                  +  GT  + +    L     +   + D+ SLG   +   
Sbjct: 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFN 207

Query: 389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIA 448
               P+  + A +      +     + +    + K                         
Sbjct: 208 LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK------------------------- 242

Query: 449 QNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSG---RLLTHDLVTRPRSPSVLVD 502
                      +   FA +++ C +    D+P      +L  +    +  S   + D
Sbjct: 243 ----------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (257), Expect = 7e-25
 Identities = 32/151 (21%), Positives = 53/151 (35%), Gaps = 18/151 (11%)

Query: 7   LLRQLKHPNTI-EYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           + + ++    I   R C        +VME    S  D+     R    + +  +   ++ 
Sbjct: 55  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 114

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETG---TVKLADFGSASI-----------KCPANSFV 111
            + Y+HS   IHRDVK  N L+        V + DFG A                  +  
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 112 GTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
           GT  + +    L     +   + D+ SLG  
Sbjct: 175 GTARYASINTHLG---IEQSRRDDLESLGYV 202

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 59.5 bits (143), Expect = 4e-10
 Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 7/95 (7%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 645
           +           +      + N        +VME    S  D+     R    + +  + 
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNV-------MVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
             ++  + Y+HS   IHRDVK  N L+       L
Sbjct: 110 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 9e-40
 Identities = 70/361 (19%), Positives = 114/361 (31%), Gaps = 97/361 (26%)

Query: 145 SLKDPEIAE-----LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMS 196
           S  +PE+ +     +         F ++  IG G FG VY+   L +   +   A+K ++
Sbjct: 7   SALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64

Query: 197 YLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-DHTAWLVMEYCLGSASDIIEVH 255
            +      + +  L E   ++   HPN +   G  LR + +  +V+ Y            
Sbjct: 65  RITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM----------- 111

Query: 256 WIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG 315
                         L+                       +++      V +G+ +L S  
Sbjct: 112 ----------KHGDLRNFIRN-----------ETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 316 RIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPYWMAPEVILAMD 367
            +HRD+ A N +L E  TVK+ADFG A                      WMA E +    
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--- 207

Query: 368 EGQYDGKVDVWSLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISS 427
             ++  K DVWS G+   EL  R                                     
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTR------------------------------------- 230

Query: 428 TAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLT 487
                PPY ++N      ++ Q     LQ     D     +  C       RPS   L++
Sbjct: 231 ---GAPPYPDVNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286

Query: 488 H 488
            
Sbjct: 287 R 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 2e-23
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 13/147 (8%)

Query: 6   SLLRQLKHPNTIEYRGCYLR-DHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGV 63
            +++   HPN +   G  LR + +  +V+ Y   G   + I         +++      V
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139

Query: 64  LRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPAN--------SFVGTPY 115
            +G+ +L S   +HRD+ A N +L E  TVK+ADFG A                      
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 116 WMAPEVILAMDEGQYDGKVDVWSLGIT 142
           WMA E +      ++  K DVWS G+ 
Sbjct: 200 WMALESLQ---TQKFTTKSDVWSFGVL 223

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (128), Expect = 3e-08
 Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 8/96 (8%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCL-GSASDIIEVHKRPLKEEEIAAI 644
           +   H  V  L      +  S         +V+ Y   G   + I         +++   
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPL-------VVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135

Query: 645 CSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
              V +G+ +L S   +HRD+ A N +L E  TVK+
Sbjct: 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKV 171

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 62/347 (17%), Positives = 108/347 (31%), Gaps = 79/347 (22%)

Query: 155 FDKEDPEKIFEDLREIGHGSFGAVYYARC-----LVSREIVAIKKMSYLGKQCAEKWADI 209
           F ++      +  + +G G+FG V  A         +   VA+K +         +   +
Sbjct: 10  FPRDR----LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--AL 63

Query: 210 LKEIRFLRQLKHPNTIEYRG--CYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMG 267
           + E++ L  + H   +      C        +++E+C                       
Sbjct: 64  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY--------------- 108

Query: 268 NRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNIL 327
             L+  +     + +   +++K  L  E +      V +G+ +L S   IHRD+ A NIL
Sbjct: 109 --LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166

Query: 328 LTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 381
           L+E   VK+ DFG A                    WMAPE I    +  Y  + DVWS G
Sbjct: 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFG 223

Query: 382 ITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAM 441
           +   E+                                         +    PY  +   
Sbjct: 224 VLLWEIF----------------------------------------SLGASPYPGVKID 243

Query: 442 SALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTH 488
                  +  T        +      +  C    P+ RP+   L+ H
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.9 bits (227), Expect = 7e-21
 Identities = 46/186 (24%), Positives = 73/186 (39%), Gaps = 26/186 (13%)

Query: 7   LLRQLKHPNTIEYRGCYLRD-HTAWLVMEYC-LGSASDII---------------EVHKR 49
           L+    H N +   G   +      +++E+C  G+ S  +               +++K 
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 50  PLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--- 106
            L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+ DFG A        
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 107 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDKEDPEKI 163
                       WMAPE I    +  Y  + DVWS G+    +     +     +  E+ 
Sbjct: 190 YVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246

Query: 164 FEDLRE 169
              L+E
Sbjct: 247 CRRLKE 252

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (154), Expect = 2e-11
 Identities = 27/115 (23%), Positives = 45/115 (39%), Gaps = 23/115 (20%)

Query: 582 QAHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYC-LGSASDII----------- 629
           +      HH  V +L                   +++E+C  G+ S  +           
Sbjct: 68  KILIHIGHHLNVVNLLGACTKPGGPLM-------VIVEFCKFGNLSTYLRSKRNEFVPYK 120

Query: 630 ----EVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
               +++K  L  E +      V +G+ +L S   IHRD+ A NILL+E   VK+
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 175

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (364), Expect = 5e-39
 Identities = 44/335 (13%), Positives = 89/335 (26%), Gaps = 93/335 (27%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           ++  R IG GSFG ++    L++ + VAIK               +  E R  + L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCT 61

Query: 224 TIEY-RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFAL 282
            I              LV++    S  D++++                            
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--------------------------- 94

Query: 283 FNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTE-----TGTVKLA 337
                  R    + +A     +L  +  +H    ++RD+K  N L+          + + 
Sbjct: 95  ------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148

Query: 338 DFGSASI-----------KCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 386
           DFG                    +  GT  +M+    L     +   + D+ +LG   + 
Sbjct: 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHVFMY 205

Query: 387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYH 446
                 P+  + A +      +                                   +  
Sbjct: 206 FLRGSLPWQGLKAATNKQKYER-----------------------------------IGE 230

Query: 447 IAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPS 481
             Q+       + + + F  ++           P 
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 25/153 (16%), Positives = 50/153 (32%), Gaps = 20/153 (13%)

Query: 7   LLRQLKHPNTIEY-RGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
             + L     I              LV++    S  D++++  R    + +A     +L 
Sbjct: 53  TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112

Query: 66  GLNYLHSLGRIHRDVKAGNILLTE-----TGTVKLADFGSASI-----------KCPANS 109
            +  +H    ++RD+K  N L+          + + DFG                    +
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 110 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
             GT  +M+    L     +   + D+ +LG  
Sbjct: 173 LSGTARYMSINTHL---GREQSRRDDLEALGHV 202

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 60.6 bits (146), Expect = 2e-10
 Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 10/89 (11%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 645
                 P  +   +       N        LV++    S  D++++  R    + +A   
Sbjct: 58  AGCTGIPNVY---YFGQEGLHNV-------LVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 107

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTE 674
             +L  +  +H    ++RD+K  N L+  
Sbjct: 108 KQMLARVQSIHEKSLVYRDIKPDNFLIGR 136

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-37
 Identities = 71/350 (20%), Positives = 118/350 (33%), Gaps = 87/350 (24%)

Query: 159 DPEKI----FEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMSY-LGKQCAEKWADIL 210
             EK+    FE L+ +G G++G V+  R +      ++ A+K +      Q A+      
Sbjct: 17  HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 211 KEIRFLRQLKH-PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNR 269
            E + L  ++  P  +     +  +    L+++Y  G                       
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE--------------------- 115

Query: 270 LQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLT 329
                       LF     +    E E+      ++  L +LH LG I+RD+K  NILL 
Sbjct: 116 ------------LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 163

Query: 330 ETGTVKLADFGSASIKCPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 384
             G V L DFG +       +     F GT  +MAP+++   D G +D  VD WSLG+  
Sbjct: 164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLM 222

Query: 385 IELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSAL 444
            EL     P+      ++   I++                       +PPY         
Sbjct: 223 YELLTGASPFTVDGEKNSQAEISRRILKS------------------EPPYP-------- 256

Query: 445 YHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP 494
                         + S      +   L K+P  R   G     ++    
Sbjct: 257 -------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 9e-20
 Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 7/142 (4%)

Query: 7   LLRQLKH-PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLR 65
           +L  ++  P  +     +  +    L+++Y  G         +    E E+      ++ 
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140

Query: 66  GLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANS-----FVGTPYWMAPE 120
            L +LH LG I+RD+K  NILL   G V L DFG +       +     F GT  +MAP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 121 VILAMDEGQYDGKVDVWSLGIT 142
           ++   D G +D  VD WSLG+ 
Sbjct: 201 IVRGGDSG-HDKAVDWWSLGVL 221

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.8 bits (123), Expect = 2e-07
 Identities = 23/95 (24%), Positives = 37/95 (38%), Gaps = 7/95 (7%)

Query: 586 RHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIAAIC 645
            H    P      +++      +       L+++Y  G         +    E E+    
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLH-------LILDYINGGELFTHLSQRERFTEHEVQIYV 135

Query: 646 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKL 680
             ++  L +LH LG I+RD+K  NILL   G V L
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 170

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  137 bits (344), Expect = 9e-36
 Identities = 63/367 (17%), Positives = 121/367 (32%), Gaps = 37/367 (10%)

Query: 164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN 223
           +  +R++G G F  V+ A+ +V+   VA+K +    +           EI+ L+++   +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDAD 70

Query: 224 TIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALF 283
             +                     A+ I+++          G+   +          AL 
Sbjct: 71  NTKEDSM----------------GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114

Query: 284 NFEVHKRPLKEEEIAAICSGVLRGLNYL-HSLGRIHRDVKAGNILLTETGT------VKL 336
             +   R +    +  I   +L GL+Y+    G IH D+K  N+L+    +      +K+
Sbjct: 115 K-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 173

Query: 337 ADFGSASIKCPANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYF 395
           AD G+A       +    T  + +PEV+L      +    D+WS      EL      + 
Sbjct: 174 ADLGNACWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTACLIFELITGDFLFE 230

Query: 396 NMNAMSALYHIAQ-----NDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN 450
                S                 L S      K   +    +    N++ +         
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290

Query: 451 DTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAA 510
                 S D +   + F+S  L  +P  R  +G L+ H  +        +    R    +
Sbjct: 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350

Query: 511 VRDLDNL 517
             D+   
Sbjct: 351 GSDIPGW 357

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 63.9 bits (154), Expect = 2e-11
 Identities = 32/160 (20%), Positives = 61/160 (38%), Gaps = 27/160 (16%)

Query: 7   LLRQLKHPNTIEYRG---------------CYLRDHTAWLVMEYCLGSASDIIEVHK-RP 50
           LL+++   +  +                           +V E    +   +I+ ++ R 
Sbjct: 62  LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121

Query: 51  LKEEEIAAICSGVLRGLNYLH-SLGRIHRDVKAGNILLTETGT------VKLADFGSASI 103
           +    +  I   +L GL+Y+H   G IH D+K  N+L+    +      +K+AD G+A  
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181

Query: 104 KCPANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 142
                +    T  + +PEV+L      +    D+WS    
Sbjct: 182 YDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTACL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 43.1 bits (100), Expect = 9e-05
 Identities = 18/95 (18%), Positives = 35/95 (36%), Gaps = 5/95 (5%)

Query: 583 AHNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHKRPLKEEEIA 642
             +    +H +  L   ++   N  +  +              + I +   R +    + 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMV----FEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 643 AICSGVLRGLNYLH-SLGRIHRDVKAGNILLTETG 676
            I   +L GL+Y+H   G IH D+K  N+L+    
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.8 bits (183), Expect = 6e-16
 Identities = 31/241 (12%), Positives = 63/241 (26%), Gaps = 77/241 (31%)

Query: 168 REIGHGSFGAVYYARCLVSREIVAIKKM-----SYLGKQCAEKWAD----------ILKE 212
           + +G G   AV+        E   +K       S+   +    + D             E
Sbjct: 6   KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 213 IRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQ 272
            R L++L+     +            ++ME         + V   +              
Sbjct: 65  FRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVRVENPDE------------- 107

Query: 273 LKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETG 332
                                      +   +L  +   +  G +H D+   N+L++E G
Sbjct: 108 ---------------------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG 140

Query: 333 TVKLADFGSASIKCPANSFVGTPYWMAPE-------VILAMDEGQYDGKVDVWSLGITCI 385
            + + DF  +         V        E        I+      Y  + D+ S     +
Sbjct: 141 -IWIIDFPQS---------VEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRIL 190

Query: 386 E 386
           +
Sbjct: 191 Q 191

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 65.6 bits (159), Expect = 7e-13
 Identities = 21/141 (14%), Positives = 44/141 (31%), Gaps = 28/141 (19%)

Query: 7   LLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRG 66
            L++L+     +            ++ME                ++ E    +   +L  
Sbjct: 67  ALQKLQGLAVPKVYAWE----GNAVLMELI-------DAKELYRVRVENPDEVLDMILEE 115

Query: 67  LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPE------ 120
           +   +  G +H D+   N+L++E G + + DF  +         V        E      
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS---------VEVGEEGWREILERDV 165

Query: 121 -VILAMDEGQYDGKVDVWSLG 140
             I+      Y  + D+ S  
Sbjct: 166 RNIITYFSRTYRTEKDINSAI 186

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 46.3 bits (109), Expect = 3e-06
 Identities = 17/102 (16%), Positives = 37/102 (36%), Gaps = 4/102 (3%)

Query: 584 HNRHHHHHPVTHLSQHSYNNNNSNYSSLFSPQLVMEYCLGSASDIIEVHK----RPLKEE 639
             R +     + L+  S  N       L    +   Y     + ++E+        ++ E
Sbjct: 44  EKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVE 103

Query: 640 EIAAICSGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLD 681
               +   +L  +   +  G +H D+   N+L++E G   +D
Sbjct: 104 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIID 145

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	804
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.96
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.96
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.96
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.95
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.95
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.95
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.95
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.95
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.95
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.95
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.95
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.95
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.95
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.94
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.94
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.94
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.94
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.94
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.94
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.93
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.93
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.93
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.93
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.93
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.93
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.93
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.92
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.92
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.92
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.92
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.92
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.92
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.92
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.91
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.91
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.91
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.91
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.91
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.89
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.78
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.52
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.78
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.53
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.11
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	94.73
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.32
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	90.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	87.15
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	82.79

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-63  Score=534.91  Aligned_cols=297  Identities=75%  Similarity=1.244  Sum_probs=255.4

Q ss_pred             CcchhccccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEe
Q psy17952        148 DPEIAELFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEY  227 (804)
Q Consensus       148 ~~~i~elf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l  227 (804)
                      +|++.++|.++||++.|+.+++||+|+||+||+|+++.+++.||||+++..........+.+.+|+++|++|+|||||++
T Consensus         1 ~p~~~~~~~~~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~   80 (309)
T d1u5ra_           1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY   80 (309)
T ss_dssp             CHHHHHHCCCSCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             CCchhhhccccCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeE
Confidence            46778889999999999999999999999999999999999999999876555455566789999999999999999999


Q ss_pred             eeEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHH
Q psy17952        228 RGCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRG  307 (804)
Q Consensus       228 ~~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~g  307 (804)
                      +++|.+++.+|+|||||.||+.+.+                                 ...++++++.+++.|+.||++|
T Consensus        81 ~~~~~~~~~~~iv~E~~~~g~l~~~---------------------------------~~~~~~l~e~~~~~i~~qi~~a  127 (309)
T d1u5ra_          81 RGCYLREHTAWLVMEYCLGSASDLL---------------------------------EVHKKPLQEVEIAAVTHGALQG  127 (309)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHH---------------------------------HHHTSCCCHHHHHHHHHHHHHH
T ss_pred             EEEEEECCEEEEEEEecCCCchHHH---------------------------------HHhCCCCCHHHHHHHHHHHHHH
Confidence            9999999999999999998743322                                 1235679999999999999999


Q ss_pred             HHHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        308 LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       308 L~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      |.|||++|||||||||+|||++.++.+||+|||+|+........+||+.|||||++.+...+.|+.++|||||||++|||
T Consensus       128 L~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel  207 (309)
T d1u5ra_         128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  207 (309)
T ss_dssp             HHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999887777788999999999999765556799999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|.+||.+.+..+.+..+.++..|                                         ......+|+++++|
T Consensus       208 ~~g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------~~~~~~~s~~~~~l  246 (309)
T d1u5ra_         208 AERKPPLFNMNAMSALYHIAQNESP-----------------------------------------ALQSGHWSEYFRNF  246 (309)
T ss_dssp             HHSSCTTTTSCHHHHHHHHHHSCCC-----------------------------------------CCSCTTSCHHHHHH
T ss_pred             HHCCCCCCCCCHHHHHHHHHhCCCC-----------------------------------------CCCCCCCCHHHHHH
Confidence            9999999988888777776654322                                         12234578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHHHHHhhhhhhh
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTKAAVRDLDNLN  518 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (804)
                      |.+||++||++|||++|+|+||||.+...+....++.++.+...+.+.+..
T Consensus       247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (309)
T d1u5ra_         247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ  297 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             HHHHCcCChhHCcCHHHHHhCHHhcCCCCchhhHHHHHHHHHHHHhhhHHH
Confidence            999999999999999999999999988777777666665555544444333

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=495.17  Aligned_cols=275  Identities=40%  Similarity=0.679  Sum_probs=229.9

Q ss_pred             cccCCCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee
Q psy17952        154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR  233 (804)
Q Consensus       154 lf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~  233 (804)
                      .....+|.+.|+++++||+|+||+||+|+++.+|+.||||++.....   ...+.+.+|+.+|++++|||||+++++|.+
T Consensus        12 ~~~~~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   88 (293)
T d1yhwa1          12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLV   88 (293)
T ss_dssp             HSBSSCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cCCCCCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence            34556788889999999999999999999999999999999864322   234678999999999999999999999999


Q ss_pred             cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       234 ~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ++.+|+|||||.|+...                                 ++. .++++++.+++.|+.||+.||+|||+
T Consensus        89 ~~~~~ivmEy~~gg~L~---------------------------------~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~  134 (293)
T d1yhwa1          89 GDELWVVMEYLAGGSLT---------------------------------DVV-TETCMDEGQIAAVCRECLQALEFLHS  134 (293)
T ss_dssp             TTEEEEEEECCTTCBHH---------------------------------HHH-HHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEEEecCCCcHH---------------------------------HHh-hccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999976311                                 111 23469999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      +|||||||||+|||++.+|.+||+|||+|+....    ....+||+.|||||++.   ++.|+.++|||||||++|||++
T Consensus       135 ~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DiwSlGvilyemlt  211 (293)
T d1yhwa1         135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMIE  211 (293)
T ss_dssp             TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHS---SSCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhc---CCCCCchhceehHhHHHHHHhh
Confidence            9999999999999999999999999999976432    23568999999999985   4679999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |++||.+.+..+.+..+.....+..                                        .....+|+++++||.
T Consensus       212 G~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         212 GEPPYLNENPLRALYLIATNGTPEL----------------------------------------QNPEKLSAIFRDFLN  251 (293)
T ss_dssp             SSCTTTTSCHHHHHHHHHHHCSCCC----------------------------------------SSGGGSCHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCC----------------------------------------CCcccCCHHHHHHHH
Confidence            9999999888887777655432211                                        011346899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCCCCchhHHHHHHHH
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPRSPSVLVDLIRRTK  508 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~~~~~~~~~~~  508 (804)
                      +||++||++|||++|+|+||||+...+.+.+.+++.+.+
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~~~~~~~l~p~~~~~~  290 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK  290 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGGCCCGGGGHHHHHHHH
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCCCCCCcCCCCCcccc
Confidence            999999999999999999999987666555555554433

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-58  Score=482.66  Aligned_cols=252  Identities=29%  Similarity=0.447  Sum_probs=215.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||+|+++.+++.||||++...........+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            49999999999999999999999999999999865433333445678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||+|+.                                 |++++...+.+++.+++.|+.||++||+|||++||||||||
T Consensus        87 y~~~g~---------------------------------L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiK  133 (263)
T d2j4za1          87 YAPLGT---------------------------------VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK  133 (263)
T ss_dssp             CCTTCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ecCCCc---------------------------------HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeec
Confidence            998752                                 22222334679999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      |+|||++.++.+||+|||+|+....  ....+||+.|||||++.   +..|+.++|||||||++|||++|++||.+.+..
T Consensus       134 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  210 (263)
T d2j4za1         134 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ  210 (263)
T ss_dssp             GGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             cccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHc---CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999999976433  24568999999999985   457899999999999999999999999888877


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      +.+..+.+...+                                           .+..+|+++++||.+||++||++||
T Consensus       211 ~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~~L~~dp~~R~  247 (263)
T d2j4za1         211 ETYKRISRVEFT-------------------------------------------FPDFVTEGARDLISRLLKHNPSQRP  247 (263)
T ss_dssp             HHHHHHHTTCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHcCCCC-------------------------------------------CCccCCHHHHHHHHHHccCCHhHCc
Confidence            766665432210                                           1124688999999999999999999


Q ss_pred             CHHHHHcCccccC
Q psy17952        481 SSGRLLTHDLVTR  493 (804)
Q Consensus       481 sa~elL~Hp~~~~  493 (804)
                      |++|+|+||||+.
T Consensus       248 t~~eil~hp~~~~  260 (263)
T d2j4za1         248 MLREVLEHPWITA  260 (263)
T ss_dssp             CHHHHHTCHHHHH
T ss_pred             CHHHHHcCcCcCC
Confidence            9999999999963

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=488.10  Aligned_cols=262  Identities=41%  Similarity=0.745  Sum_probs=222.2

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      -+|++.|+++++||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+++|++++|||||++++++.+++.+
T Consensus         8 ~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   84 (288)
T d2jfla1           8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   84 (288)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence            36788899999999999999999999999999999998643   234457789999999999999999999999999999


Q ss_pred             EEEEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        238 WLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       238 ~lVmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      |+|||||.|+. .+++.                                 ...+++++.+++.|+.||++||+|||++||
T Consensus        85 ~lvmEy~~~g~L~~~~~---------------------------------~~~~~l~e~~~~~i~~qi~~gL~ylH~~~i  131 (288)
T d2jfla1          85 WILIEFCAGGAVDAVML---------------------------------ELERPLTESQIQVVCKQTLDALNYLHDNKI  131 (288)
T ss_dssp             EEEEECCTTEEHHHHHH---------------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEecCCCCcHHHHHH---------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            99999998763 22211                                 124579999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhccc--CCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~--~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      |||||||+|||++.+|.+||+|||+|+....    ..+.+||+.|||||++...  ....|+.++|||||||++|||++|
T Consensus       132 vHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg  211 (288)
T d2jfla1         132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI  211 (288)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHS
T ss_pred             EEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhC
Confidence            9999999999999999999999999965322    3467899999999998532  245689999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.+..+.+..+.++..+..                                        .....+|+++++||.+
T Consensus       212 ~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------------------~~~~~~s~~~~~li~~  251 (288)
T d2jfla1         212 EPPHHELNPMRVLLKIAKSEPPTL----------------------------------------AQPSRWSSNFKDFLKK  251 (288)
T ss_dssp             SCTTTTSCGGGHHHHHHHSCCCCC----------------------------------------SSGGGSCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCC----------------------------------------CccccCCHHHHHHHHH
Confidence            999998888777777765432211                                        0113468999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||++||++|||++|+|+||||+...
T Consensus       252 ~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         252 CLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999997543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=483.02  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=209.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||+||+|+++.+|+.||||.++....  .+..+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            359999999999999999999999999999999864322  233467899999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+                                 +|++++...+.+++.+++.|+.||++||+|||++|||||||
T Consensus        83 Ey~~gg---------------------------------~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDi  129 (271)
T d1nvra_          83 EYCSGG---------------------------------ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI  129 (271)
T ss_dssp             ECCTTE---------------------------------EGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             eccCCC---------------------------------cHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcc
Confidence            999875                                 34444555678999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCC-CCcccHHHHHHHHHHHHhCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y-~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||+|||++.++.+||+|||+|+....      ..+.+||+.|||||++.+   ..| +.++|||||||++|||++|++||
T Consensus       130 Kp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~~~~~DiwSlGvilyeml~G~~pf  206 (271)
T d1nvra_         130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAMLAGELPW  206 (271)
T ss_dssp             CGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC---SSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC---CCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence            99999999999999999999975321      245789999999999853   344 56899999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+.............                                        ........+|+++.+||.+||+.
T Consensus       207 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~s~~~~~li~~~L~~  246 (271)
T d1nvra_         207 DQPSDSCQEYSDWKEKK----------------------------------------TYLNPWKKIDSAPLALLHKILVE  246 (271)
T ss_dssp             SSSSTTSHHHHHHHTTC----------------------------------------TTSTTGGGSCHHHHHHHHHHSCS
T ss_pred             CCCChHHHHHHHHhcCC----------------------------------------CCCCccccCCHHHHHHHHHHcCC
Confidence            76554333322221110                                        00011234688999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||++|||++|+|+||||+++.
T Consensus       247 dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         247 NPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             STTTSCCHHHHTTCTTTTCCC
T ss_pred             ChhHCcCHHHHhcCHhhCcCC
Confidence            999999999999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=491.98  Aligned_cols=291  Identities=29%  Similarity=0.464  Sum_probs=217.2

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|+++++||+|+||+||+|+++.+|+.||+|+++...  .....+.+.+|+.+|++++|||||+++++|.+++.+|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            346999999999999999999999999999999986432  233446789999999999999999999999999999999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCee
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIH  318 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~-~gIiH  318 (804)
                      ||||.|+ |.++                                  +.+.+.+++..++.++.|+++||+|||+ +||||
T Consensus        83 mEy~~gg~L~~~----------------------------------l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiH  128 (322)
T d1s9ja_          83 MEHMDGGSLDQV----------------------------------LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH  128 (322)
T ss_dssp             EECCTTEEHHHH----------------------------------HHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             EEcCCCCcHHHH----------------------------------HhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            9999975 3222                                  2334579999999999999999999997 59999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccC--CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~--~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |||||+||||+.+|.+||+|||+|+...  ...+.+||+.|||||++.+   ..|+.++||||+||++|||++|+.||.+
T Consensus       129 RDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             SCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHC---SCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             cccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999999997532  3456899999999999963   5799999999999999999999999987


Q ss_pred             CChHHHHHHH-Hh--cCCCCCCCCchhhHHhhccc-ccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        397 MNAMSALYHI-AQ--NDTPCLQSSDWSVIKTISST-AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       397 ~~~~~~l~~I-~~--~~~p~~~~~~~~~i~~i~~~-~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      .+........ ..  +................... ....++   ......+..+.....+..+...+|.++.|||.+||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  282 (322)
T d1s9ja_         206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP---MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL  282 (322)
T ss_dssp             CCTTHHHHHC------------------------------CC---CCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccc---hhHHHHHhhhhccCCccCccccCCHHHHHHHHHHc
Confidence            6543322111 11  11000000000000000000 000111   11122233344445555566678999999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +.||++||||+|+|+||||++
T Consensus       283 ~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         283 IKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             CSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCChhHCcCHHHHhhCHhhCc
Confidence            999999999999999999965

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-56  Score=481.03  Aligned_cols=261  Identities=28%  Similarity=0.474  Sum_probs=206.2

Q ss_pred             CCcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCce
Q psy17952        158 EDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTA  237 (804)
Q Consensus       158 ~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~  237 (804)
                      ++..+.|++.+.||+|+||+||+|+++.+++.||||.+......  .....+.+|+.+|++++|||||+++++|.+++.+
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45667799999999999999999999999999999998643322  2235678999999999999999999999999999


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+|||||+|+                                 +|++++...+.+++.++..++.||+.||+|||++|||
T Consensus        83 ~lvmE~~~gg---------------------------------~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  129 (307)
T d1a06a_          83 YLIMQLVSGG---------------------------------ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV  129 (307)
T ss_dssp             EEEECCCCSC---------------------------------BHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEeccCCC---------------------------------cHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceee
Confidence            9999999865                                 2333334567899999999999999999999999999


Q ss_pred             ecCCCCCCeeec---CCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        318 HRDVKAGNILLT---ETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       318 HRDLKP~NILl~---~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      ||||||+|||+.   +++.+||+|||+|+....   ..+.+||+.|||||++.   +..|+.++|||||||++|||++|+
T Consensus       130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~---~~~~~~~~DiwSlGvilyell~g~  206 (307)
T d1a06a_         130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIAYILLCGY  206 (307)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHc---CCCCCcHHHhhhhhHHHHHHHhCC
Confidence            999999999995   578999999999976433   24578999999999985   457999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+..+....+.++..+.                                       +......+|+++.+||.+|
T Consensus       207 ~Pf~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~  247 (307)
T d1a06a_         207 PPFYDENDAKLFEQILKAEYEF---------------------------------------DSPYWDDISDSAKDFIRHL  247 (307)
T ss_dssp             CSCCCSSHHHHHHHHHTTCCCC---------------------------------------CTTTTTTSCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHhccCCCC---------------------------------------CCccccCCCHHHHHHHHHH
Confidence            9999888877777665543210                                       1112245789999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      |++||++|||++|+|+||||+...
T Consensus       248 L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         248 MEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             SCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             ccCCHhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999997543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=476.63  Aligned_cols=252  Identities=26%  Similarity=0.384  Sum_probs=213.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||+|+++.+++.||||++...........+.+.+|+++|++++|||||+++++|.+++.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999865332233445678999999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+.                                 |++++...+.+++.+++.++.|++.||+|||++||||||||
T Consensus        89 y~~gg~---------------------------------L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK  135 (288)
T d1uu3a_          89 YAKNGE---------------------------------LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK  135 (288)
T ss_dssp             CCTTEE---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ccCCCC---------------------------------HHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCC
Confidence            998751                                 22233345689999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFN  396 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~  396 (804)
                      |+|||++++|.+||+|||+|+....      ..+.+||+.|||||++.   +..|+.++|||||||++|||++|++||.+
T Consensus       136 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         136 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT---EKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHH---TCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccCCCceEEecccccceecccCCcccccccccCCccccCceeec---cCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence            9999999999999999999975432      23568999999999985   45789999999999999999999999998


Q ss_pred             CChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        397 MNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       397 ~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                      .+..+.+.+|.++...                                           .+..+|+++++||.+||++||
T Consensus       213 ~~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~~L~~dP  249 (288)
T d1uu3a_         213 GNEYLIFQKIIKLEYD-------------------------------------------FPEKFFPKARDLVEKLLVLDA  249 (288)
T ss_dssp             SSHHHHHHHHHTTCCC-------------------------------------------CCTTCCHHHHHHHHTTSCSSG
T ss_pred             cCHHHHHHHHHcCCCC-------------------------------------------CCccCCHHHHHHHHHHccCCH
Confidence            8877777666543210                                           013468899999999999999


Q ss_pred             CCCCCHHH------HHcCccccC
Q psy17952        477 ADRPSSGR------LLTHDLVTR  493 (804)
Q Consensus       477 ~~Rpsa~e------lL~Hp~~~~  493 (804)
                      ++|||++|      +++||||..
T Consensus       250 ~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         250 TKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             GGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             hHCcCHHHHcCCHHHHcCCccCC
Confidence            99999987      578898865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=468.05  Aligned_cols=251  Identities=28%  Similarity=0.451  Sum_probs=205.1

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee----cCceEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR----DHTAWL  239 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----~~~~~l  239 (804)
                      |+..++||+|+||+||+|+++.+++.||+|++.... ......+.+.+|+++|++++|||||+++++|.+    +..+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            567778999999999999999999999999986532 223445678999999999999999999999875    345899


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ce
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--RI  317 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g--Ii  317 (804)
                      |||||+|+.                                 |.+++...+.+++.+++.|+.||++||+|||+++  ||
T Consensus        90 vmE~~~~g~---------------------------------L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~Ii  136 (270)
T d1t4ha_          90 VTELMTSGT---------------------------------LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII  136 (270)
T ss_dssp             EEECCCSCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred             EEeCCCCCc---------------------------------HHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEE
Confidence            999998752                                 2222233457899999999999999999999999  99


Q ss_pred             ecCCCCCCeeec-CCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        318 HRDVKAGNILLT-ETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       318 HRDLKP~NILl~-~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||||||+|||++ +++.+||+|||+|+....  ..+.+||+.|||||++.    +.|+.++|||||||++|||++|++||
T Consensus       137 HrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~~DIwSlGvilyel~~g~~Pf  212 (270)
T d1t4ha_         137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPY  212 (270)
T ss_dssp             CSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhC----CCCCCcCchhhHHHHHHHHHHCCCCC
Confidence            999999999996 578999999999976443  23578999999999983    46999999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+....+........+                                        |.......++++++||.+||++
T Consensus       213 ~~~~~~~~~~~~i~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~l~~  252 (270)
T d1t4ha_         213 SECQNAAQIYRRVTSGVK----------------------------------------PASFDKVAIPEVKEIIEGCIRQ  252 (270)
T ss_dssp             TTCSSHHHHHHHHTTTCC----------------------------------------CGGGGGCCCHHHHHHHHHHSCS
T ss_pred             CCcccHHHHHHHHHcCCC----------------------------------------CcccCccCCHHHHHHHHHHccC
Confidence            876555444333221110                                        0111234578899999999999


Q ss_pred             CCCCCCCHHHHHcCcccc
Q psy17952        475 NPADRPSSGRLLTHDLVT  492 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~  492 (804)
                      ||++|||++|+|+||||+
T Consensus       253 dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         253 NKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             SGGGSCCHHHHHTSGGGC
T ss_pred             CHhHCcCHHHHhCCcccC
Confidence            999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=473.49  Aligned_cols=265  Identities=26%  Similarity=0.391  Sum_probs=222.1

Q ss_pred             cccCCCcccccccccccccccccceEEEEeeeceeEEEEEeccccccc---chhhhhhHHHHHHHHhhcCCCceeEeeeE
Q psy17952        154 LFDKEDPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ---CAEKWADILKEIRFLRQLKHPNTIEYRGC  230 (804)
Q Consensus       154 lf~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~---~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~  230 (804)
                      +|.+.+..+.|++.+.||+|+||+||+|+++.+|+.||||+++.....   .....+.+.+|+.+|++++|||||+++++
T Consensus         2 ~~~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             CCBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CccCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            356667778899999999999999999999999999999998643221   11234678899999999999999999999


Q ss_pred             EeecCceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHH
Q psy17952        231 YLRDHTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN  309 (804)
Q Consensus       231 ~~~~~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~  309 (804)
                      |.+++.+|+|||||+|+ |.+                                  ++...+.+++.+++.++.||+.||+
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~----------------------------------~i~~~~~l~~~~~~~~~~qi~~al~  127 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFD----------------------------------FLAEKESLTEEEATEFLKQILNGVY  127 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHH----------------------------------HHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             EEECCEEEEEEEcCCCccccc----------------------------------hhccccccchhHHHHHHHHHHHHHH
Confidence            99999999999999865 323                                  2233467999999999999999999


Q ss_pred             HHHHCCCeecCCCCCCeeecCCC----cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        310 YLHSLGRIHRDVKAGNILLTETG----TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       310 yLH~~gIiHRDLKP~NILl~~~g----~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      |||++|||||||||+|||++.++    .+||+|||+|+....   ..+.+||+.|||||++.   ...|+.++|||||||
T Consensus       128 yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~---~~~~~~~~DiwSlGv  204 (293)
T d1jksa_         128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGV  204 (293)
T ss_dssp             HHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHT---TCCBCTHHHHHHHHH
T ss_pred             hhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHc---CCCCCCcccchhhhH
Confidence            99999999999999999998877    499999999976433   34568999999999984   457899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccH
Q psy17952        383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSD  462 (804)
Q Consensus       383 il~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~  462 (804)
                      ++|||++|++||.+.+..+.+..+.+...+.                                       +......+|+
T Consensus       205 ilyell~g~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~  245 (293)
T d1jksa_         205 ITYILLSGASPFLGDTKQETLANVSAVNYEF---------------------------------------EDEYFSNTSA  245 (293)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC---------------------------------------CHHHHTTSCH
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---------------------------------------CchhcCCCCH
Confidence            9999999999999988888777775543210                                       0001134688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        463 TFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       463 ~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ++++||.+||+.||++|||++|+|+||||+..
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-56  Score=469.26  Aligned_cols=253  Identities=30%  Similarity=0.498  Sum_probs=203.2

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee--cCceEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR--DHTAWLV  240 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--~~~~~lV  240 (804)
                      .|++++.||+|+||+||+|+++.+|+.||||.+..... .....+.+.+|+++|++++|||||++++++.+  ++.+|+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            49999999999999999999999999999999875432 23445678999999999999999999999864  5678999


Q ss_pred             EeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----
Q psy17952        241 MEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG----  315 (804)
Q Consensus       241 mEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g----  315 (804)
                      ||||+| +|.+++...                              ....+.+++..++.++.||+.||+|||++|    
T Consensus        84 mEy~~~g~L~~~i~~~------------------------------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~  133 (269)
T d2java1          84 MEYCEGGDLASVITKG------------------------------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH  133 (269)
T ss_dssp             EECCTTEEHHHHHHHH------------------------------HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---
T ss_pred             EecCCCCcHHHHHHhc------------------------------cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            999986 444444211                              113467999999999999999999999976    


Q ss_pred             -CeecCCCCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        316 -RIHRDVKAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       316 -IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                       ||||||||+||||+.++.+||+|||+|+....    ..+.+||+.|||||++.   +..|+.++|||||||++|||++|
T Consensus       134 ~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~DIwSlGvilyel~tg  210 (269)
T d2java1         134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCLLYELCAL  210 (269)
T ss_dssp             ------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHc---CCCCChHHHHHhhCHHHHHHhhC
Confidence             99999999999999999999999999976432    24578999999999984   46799999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.+..+....|..+..+                                          ..+..+|+++.+||.+
T Consensus       211 ~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~s~~l~~li~~  248 (269)
T d2java1         211 MPPFTAFSQKELAGKIREGKFR------------------------------------------RIPYRYSDELNEIITR  248 (269)
T ss_dssp             SCSCCCSSHHHHHHHHHHTCCC------------------------------------------CCCTTSCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCcccCHHHHHHHHH
Confidence            9999988877666665443211                                          1123578999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      ||+.||.+|||++|+|+|||+
T Consensus       249 ~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         249 MLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HTCSSGGGSCCHHHHHTSTTC
T ss_pred             HcCCChhHCcCHHHHHhCCcC
Confidence            999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-55  Score=478.79  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=216.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            49999999999999999999999999999999875332233345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+.                                 |++++...+.++|+.++.++.||+.||+|||++||||||||
T Consensus        86 y~~gg~---------------------------------L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlK  132 (337)
T d1o6la_          86 YANGGE---------------------------------LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK  132 (337)
T ss_dssp             CCTTCB---------------------------------HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             ccCCCc---------------------------------hhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccC
Confidence            999762                                 33334456789999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.+|.+||+|||+|+....    ..+.+||+.|||||++.   +..|+.++|||||||++|||++|++||.+.+
T Consensus       133 P~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         133 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             GGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGS---SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhcc---CCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence            9999999999999999999975432    24579999999999985   4679999999999999999999999999988


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+....+..+..+                                           .+..+|+++++||.+||++||++
T Consensus       210 ~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~dli~~~L~~dP~~  246 (337)
T d1o6la_         210 HERLFELILMEEIR-------------------------------------------FPRTLSPEAKSLLAGLLKKDPKQ  246 (337)
T ss_dssp             HHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHhcCCCC-------------------------------------------CCccCCHHHHHHHHhhccCCchh
Confidence            77666555432211                                           11346899999999999999999


Q ss_pred             CCC-----HHHHHcCccccC
Q psy17952        479 RPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       479 Rps-----a~elL~Hp~~~~  493 (804)
                      ||+     ++|+++||||..
T Consensus       247 R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         247 RLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             STTCSTTTHHHHHTSGGGTT
T ss_pred             hcccccccHHHHHcCccccc
Confidence            994     999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.1e-55  Score=472.38  Aligned_cols=253  Identities=25%  Similarity=0.395  Sum_probs=217.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++++.||+|+||+||+|+++.+|+.||||+++..........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            49999999999999999999999999999999864332333445678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|+..                                 .........+++..++.++.||+.||+|||++||||||||
T Consensus        85 ~~~gg~l---------------------------------~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiK  131 (316)
T d1fota_          85 YIEGGEL---------------------------------FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK  131 (316)
T ss_dssp             CCCSCBH---------------------------------HHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             ecCCccc---------------------------------cccccccccccccHHHHHHHHHHHhhhhhccCcEEccccC
Confidence            9998632                                 1222345678999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAMS  401 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~~  401 (804)
                      |+||||+.+|.+||+|||+|+.... ..+.+||+.|||||++.   +..|+.++|||||||++|||++|++||.+.+..+
T Consensus       132 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~---~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~  208 (316)
T d1fota_         132 PENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK  208 (316)
T ss_dssp             GGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHT---TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             chheeEcCCCCEEEecCccceEeccccccccCcccccCHHHHc---CCCCCchhhccccchhHHHHHhCCCCCCCcCHHH
Confidence            9999999999999999999976543 34678999999999984   4579999999999999999999999999988877


Q ss_pred             HHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC-
Q psy17952        402 ALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP-  480 (804)
Q Consensus       402 ~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp-  480 (804)
                      .+..+.++..+                                           .+..+|+++++++.+||++||.+|+ 
T Consensus       209 ~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~~L~~dp~~R~~  245 (316)
T d1fota_         209 TYEKILNAELR-------------------------------------------FPPFFNEDVKDLLSRLITRDLSQRLG  245 (316)
T ss_dssp             HHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred             HHHHHHcCCCC-------------------------------------------CCCCCCHHHHHHHHHHhhhCHHhccc
Confidence            77666543211                                           1124688999999999999999996 


Q ss_pred             ----CHHHHHcCccccCC
Q psy17952        481 ----SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 ----sa~elL~Hp~~~~~  494 (804)
                          |++++|+||||...
T Consensus       246 ~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         246 NLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             SSTTTTHHHHTSGGGSSC
T ss_pred             cchhhHHHHHcCcccccC
Confidence                99999999999753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-54  Score=477.26  Aligned_cols=257  Identities=22%  Similarity=0.323  Sum_probs=218.2

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||+||+|+++.+|+.||||+++...   ......+.+|+.+|++|+|||||+++++|.+++.+|+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3456999999999999999999999999999999986432   2334568899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~-~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+.                                 |+++.. ...++++.+++.|+.||+.||+|||++||||
T Consensus       104 vmE~~~gg~---------------------------------L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiH  150 (352)
T d1koba_         104 ILEFLSGGE---------------------------------LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH  150 (352)
T ss_dssp             EEECCCCCB---------------------------------HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEcCCCCh---------------------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            999999762                                 222222 3446999999999999999999999999999


Q ss_pred             cCCCCCCeeec--CCCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLT--ETGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~--~~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+||||+  .++.+||+|||+|+.....   .+.+||+.|||||++.   +..|+.++|||||||++|||++|++|
T Consensus       151 RDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvilyelltG~~P  227 (352)
T d1koba_         151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---REPVGFYTDMWAIGVLGYVLLSGLSP  227 (352)
T ss_dssp             CCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred             cccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHc---CCCCCCccchHHHHHHHHHHHhCCCC
Confidence            99999999998  5789999999999865443   3468999999999984   46799999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+.+..|..+..+.                                       +......+|+++++||.+||+
T Consensus       228 f~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L~  268 (352)
T d1koba_         228 FAGEDDLETLQNVKRCDWEF---------------------------------------DEDAFSSVSPEAKDFIKNLLQ  268 (352)
T ss_dssp             SCCSSHHHHHHHHHHCCCCC---------------------------------------CSSTTTTSCHHHHHHHHTTSC
T ss_pred             CCCCCHHHHHHHHHhCCCCC---------------------------------------CcccccCCCHHHHHHHHHHcc
Confidence            99988888877776543211                                       111224578999999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +||.+|||++|+|+||||+..
T Consensus       269 ~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         269 KEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             SSGGGSCCHHHHHTSTTTSSC
T ss_pred             CChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-54  Score=477.15  Aligned_cols=257  Identities=24%  Similarity=0.315  Sum_probs=217.1

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      -+.|++++.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+|++|+|||||+++++|.+++.+|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            346999999999999999999999999999999986432   23446788999999999999999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFE-VHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~-~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+|+.                                 |++++ ...+.+++.+++.|+.||+.||+|||++|||||
T Consensus       102 mE~~~gg~---------------------------------L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHr  148 (350)
T d1koaa2         102 YEFMSGGE---------------------------------LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL  148 (350)
T ss_dssp             ECCCCSCB---------------------------------HHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEcCCCCC---------------------------------HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeee
Confidence            99998752                                 22222 234579999999999999999999999999999


Q ss_pred             CCCCCCeeecC--CCcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        320 DVKAGNILLTE--TGTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       320 DLKP~NILl~~--~g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      ||||+|||++.  ++.+||+|||+|+.....   .+.+||+.|||||++.   +..|+.++|||||||++|||++|++||
T Consensus       149 DiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~---~~~~~~~~DiwSlGvilyell~G~~Pf  225 (350)
T d1koaa2         149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVLSYILLSGLSPF  225 (350)
T ss_dssp             CCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHH---TCCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHc---CCCCChhHhhhhhhHHHHHHHhCCCCC
Confidence            99999999964  578999999999765433   3468999999999985   457899999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhccc
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAK  474 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~  474 (804)
                      .+.+..+.+..|.......                                       +......+|+++++||.+||++
T Consensus       226 ~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L~~  266 (350)
T d1koaa2         226 GGENDDETLRNVKSCDWNM---------------------------------------DDSAFSGISEDGKDFIRKLLLA  266 (350)
T ss_dssp             CCSSHHHHHHHHHHTCCCS---------------------------------------CCGGGGGCCHHHHHHHHHHCCS
T ss_pred             CCCCHHHHHHHHHhCCCCC---------------------------------------CcccccCCCHHHHHHHHHHccC
Confidence            9988888777776543211                                       0011124688999999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCC
Q psy17952        475 NPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       475 dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      ||++|||++|+|+||||+...
T Consensus       267 dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         267 DPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             SGGGSCCHHHHHHSTTTSCTT
T ss_pred             ChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999998654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-55  Score=467.29  Aligned_cols=281  Identities=27%  Similarity=0.354  Sum_probs=214.0

Q ss_pred             ccccccccccccceEEEEeeeceeEEEEEecccccccc--hhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        165 EDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC--AEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       165 ~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      |.++.||+|+||+||+|+++.+|+.||||+++......  ....+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            45789999999999999999999999999986533221  1223568899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|++...                                 .......+++.+++.+++||+.||+|||++||+|||||
T Consensus        81 ~~~~~~~~~---------------------------------~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiK  127 (299)
T d1ua2a_          81 FMETDLEVI---------------------------------IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK  127 (299)
T ss_dssp             CCSEEHHHH---------------------------------HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             hhcchHHhh---------------------------------hhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCC
Confidence            998863221                                 12235678999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||+|+....    ..+.+||+.|||||++..  ...|+.++|||||||++|||++|.+||.+.+
T Consensus       128 p~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  205 (299)
T d1ua2a_         128 PNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG--ARMYGVGVDMWAVGCILAELLLRVPFLPGDS  205 (299)
T ss_dssp             GGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT--CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHcc--CCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence            9999999999999999999975432    235689999999999853  3468999999999999999999999999999


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+.+..|.+........ .|.......... ..... .            ...........++++.+||.+||++||++
T Consensus       206 ~~~~l~~i~~~~~~~~~~-~~~~~~~~~~~~-~~~~~-~------------~~~~~~~~~~~s~~~~dll~~~L~~dP~~  270 (299)
T d1ua2a_         206 DLDQLTRIFETLGTPTEE-QWPDMCSLPDYV-TFKSF-P------------GIPLHHIFSAAGDDLLDLIQGLFLFNPCA  270 (299)
T ss_dssp             HHHHHHHHHHHHCCCCTT-TSSSTTSSTTCC-CCCCC-C------------CCCHHHHCTTCCHHHHHHHHHHHCSSTTT
T ss_pred             HHHHHHHHHHhcCCCChh-hccchhccchhh-hhccC-C------------CCChHHhcccCCHHHHHHHHHHccCChhh
Confidence            999888876532111110 010000000000 00000 0            00000012356899999999999999999


Q ss_pred             CCCHHHHHcCccccCCC
Q psy17952        479 RPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~~~  495 (804)
                      ||||+|+|+||||+...
T Consensus       271 R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         271 RITATQALKMKYFSNRP  287 (299)
T ss_dssp             SCCHHHHHTSGGGTSSS
T ss_pred             CcCHHHHhCCHhhCCCC
Confidence            99999999999998643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-54  Score=475.29  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=217.9

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|++++.||+|+||+||+|+++.+|+.||||++...........+.+++|+++|++++|||||+++++|.+....|+||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46999999999999999999999999999999986433233344567899999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.|+.                                 ++.++...+.+++.+++.|+.||+.||.|||++|||||||
T Consensus       121 e~~~~g~---------------------------------l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDI  167 (350)
T d1rdqe_         121 EYVAGGE---------------------------------MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL  167 (350)
T ss_dssp             ECCTTCB---------------------------------HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             ccccccc---------------------------------hhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcC
Confidence            9998762                                 2222234467999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMNAM  400 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~~~  400 (804)
                      ||+|||++.+|.+||+|||+|+.... ..+.+||+.|||||++.   +..|+.++|||||||++|||++|++||.+.+..
T Consensus       168 KP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~  244 (350)
T d1rdqe_         168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL---SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI  244 (350)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CHHHcccCCCCCEEeeeceeeeecccccccccCccccCCHHHHc---CCCCCccccccchhHHHHHHHhCCCCCCCcCHH
Confidence            99999999999999999999976543 34678999999999985   457899999999999999999999999988877


Q ss_pred             HHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCC
Q psy17952        401 SALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRP  480 (804)
Q Consensus       401 ~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rp  480 (804)
                      ..+..|..+..+                                           ....+|+++.+||.+||++||.+|+
T Consensus       245 ~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~~li~~~L~~dP~kR~  281 (350)
T d1rdqe_         245 QIYEKIVSGKVR-------------------------------------------FPSHFSSDLKDLLRNLLQVDLTKRF  281 (350)
T ss_dssp             HHHHHHHHCCCC-------------------------------------------CCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred             HHHHHHhcCCCC-------------------------------------------CCccCCHHHHHHHHHHhhhCHHhcc
Confidence            776666543211                                           1134689999999999999999995


Q ss_pred             -----CHHHHHcCccccCC
Q psy17952        481 -----SSGRLLTHDLVTRP  494 (804)
Q Consensus       481 -----sa~elL~Hp~~~~~  494 (804)
                           |++++|+||||...
T Consensus       282 ~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         282 GNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             TSSTTTTHHHHTSGGGTTC
T ss_pred             ccccccHHHHHcCccccCC
Confidence                 99999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.2e-54  Score=457.09  Aligned_cols=261  Identities=29%  Similarity=0.442  Sum_probs=218.3

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccc------hhhhhhHHHHHHHHhhcC-CCceeEeeeEEee
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC------AEKWADILKEIRFLRQLK-HPNTIEYRGCYLR  233 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~------~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~  233 (804)
                      .+.|++.+.||+|+||+||+|+++.+++.||||+++......      ....+.+++|+.+|++++ |||||+++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            356999999999999999999999999999999986532211      123356889999999997 9999999999999


Q ss_pred             cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       234 ~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ++.+|||||||+|+                                 +|++++...+++++.+++.++.||+.||+|||+
T Consensus        82 ~~~~~ivmE~~~~g---------------------------------~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~  128 (277)
T d1phka_          82 NTFFFLVFDLMKKG---------------------------------ELFDYLTEKVTLSEKETRKIMRALLEVICALHK  128 (277)
T ss_dssp             SSEEEEEEECCTTC---------------------------------BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcceEEEEEcCCCc---------------------------------hHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999864                                 122233345689999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhccc---CCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~---~~~~y~~ksDIWSlGvil~EL  387 (804)
                      +|||||||||+|||++.++.+||+|||+|+...+   ....+||+.|+|||++.+.   ....|+.++||||+||++|||
T Consensus       129 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem  208 (277)
T d1phka_         129 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  208 (277)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             cCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence            9999999999999999999999999999976543   2457899999999998642   234578899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|+.||.+.+.......+..+...                                       .+......+|+++++|
T Consensus       209 l~g~~Pf~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~s~~~~~l  249 (277)
T d1phka_         209 LAGSPPFWHRKQMLMLRMIMSGNYQ---------------------------------------FGSPEWDDYSDTVKDL  249 (277)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCC---------------------------------------CCTTTGGGSCHHHHHH
T ss_pred             ccCCCCCCCCCHHHHHHHHHhCCCC---------------------------------------CCCcccccCCHHHHHH
Confidence            9999999998887777766554211                                       0111123578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTR  493 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~  493 (804)
                      +.+||+.||++|||++|+|+||||++
T Consensus       250 i~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         250 VSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHHccCChhHCcCHHHHHcCHHHHH
Confidence            99999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=458.95  Aligned_cols=285  Identities=25%  Similarity=0.393  Sum_probs=221.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+++++||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+++|++++|||||+++++|.+++.+|+|||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5999999999999999999999999999999986432 222335678899999999999999999999999999999999


Q ss_pred             ecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q psy17952        243 YCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK  322 (804)
Q Consensus       243 y~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLK  322 (804)
                      ||.|++.+.+.                                ......+++.+++.++.||+.||+|||++||||||||
T Consensus        82 ~~~~~~~~~~~--------------------------------~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiK  129 (298)
T d1gz8a_          82 FLHQDLKKFMD--------------------------------ASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK  129 (298)
T ss_dssp             CCSEEHHHHHH--------------------------------HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ecCCchhhhhh--------------------------------hhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccC
Confidence            99887544332                                1234579999999999999999999999999999999


Q ss_pred             CCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy17952        323 AGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNMN  398 (804)
Q Consensus       323 P~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~~  398 (804)
                      |+|||++.++.+||+|||+|+....    ....+||+.|+|||++..  ...++.++||||+||++|||++|++||.+.+
T Consensus       130 peNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~--~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~  207 (298)
T d1gz8a_         130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  207 (298)
T ss_dssp             GGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             chheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhcc--ccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence            9999999999999999999965432    234689999999999853  3446789999999999999999999999999


Q ss_pred             hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCCC
Q psy17952        399 AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPAD  478 (804)
Q Consensus       399 ~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~  478 (804)
                      ..+.++.+.+...... ...|.............+.+... ..            ......+|+++++||.+||++||++
T Consensus       208 ~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~s~~~~dll~~mL~~dP~~  273 (298)
T d1gz8a_         208 EIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPSFPKWARQ-DF------------SKVVPPLDEDGRSLLSQMLHYDPNK  273 (298)
T ss_dssp             HHHHHHHHHHHHCCCC-TTTSTTGGGSTTCCTTSCCCCCC-CH------------HHHSTTCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhcCCCc-hhhcccccccccccccccccccc-ch------------hhhccCCCHHHHHHHHHHccCChhH
Confidence            8888888766432211 11122111111111111111000 00            0012357899999999999999999


Q ss_pred             CCCHHHHHcCccccCCCC
Q psy17952        479 RPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       479 Rpsa~elL~Hp~~~~~~~  496 (804)
                      |||++|+|+||||.....
T Consensus       274 R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         274 RISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             SCCHHHHHTSGGGTTCCC
T ss_pred             CcCHHHHhCCHhhccCCC
Confidence            999999999999976543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=463.43  Aligned_cols=256  Identities=22%  Similarity=0.297  Sum_probs=215.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      ..+.|++++.||+|+||+||+|+++.+++.||||.++...    .....+.+|+++|++++|||||+++++|.+++.+|+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            3456999999999999999999999999999999986432    223457899999999999999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~-~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.|+                                 +|++++.. ...+++.+++.|+.||+.||+|||++||+|
T Consensus        79 vmE~~~gg---------------------------------~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiH  125 (321)
T d1tkia_          79 IFEFISGL---------------------------------DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH  125 (321)
T ss_dssp             EECCCCCC---------------------------------BHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCCC---------------------------------cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCc
Confidence            99999975                                 23333333 347999999999999999999999999999


Q ss_pred             cCCCCCCeeecCC--CcEEEEecccccccCCC---CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTET--GTVKLADFGSASIKCPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~--g~vKL~DFGla~~~~~~---~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+|||++.+  +.+||+|||+|+.....   ...+||+.|+|||++.   +..|+.++|||||||++|||++|.+|
T Consensus       126 rDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~---~~~~~~~~DiWSlGvily~ll~G~~P  202 (321)
T d1tkia_         126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ---HDVVSTATDMWSLGTLVYVLLSGINP  202 (321)
T ss_dssp             CCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHT---TCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhcc---CCCCCchhhcccHHHHHHHHHhCCCC
Confidence            9999999999854  48999999999765432   3467999999999984   45689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+.+..|.++....                                       +......+|+++++||.+||+
T Consensus       203 f~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L~  243 (321)
T d1tkia_         203 FLAETNQQIIENIMNAEYTF---------------------------------------DEEAFKEISIEAMDFVDRLLV  243 (321)
T ss_dssp             TCCSSHHHHHHHHHHTCCCC---------------------------------------CHHHHTTSCHHHHHHHHTTSC
T ss_pred             CCCCCHHHHHHHHHhCCCCC---------------------------------------ChhhccCCCHHHHHHHHHHcc
Confidence            99988888777776543211                                       000113468899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +||++|||++|+|+||||++.
T Consensus       244 ~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         244 KERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SSGGGSCCHHHHHHSHHHHSC
T ss_pred             CChhHCcCHHHHhcCHhhccC
Confidence            999999999999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-53  Score=467.82  Aligned_cols=256  Identities=20%  Similarity=0.263  Sum_probs=204.4

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhH---HHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADI---LKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~---~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|++++.||+|+||.||+|+++.+|+.||||++.............+   .+|+++++.++|||||+++++|.+.+.+|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            49999999999999999999999999999999864321111112223   345777888899999999999999999999


Q ss_pred             EEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        240 VMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       240 VmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      |||||.|+.                                 |++++.....+++.+++.|+.||+.||+|||++|||||
T Consensus        85 vmE~~~gg~---------------------------------L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHr  131 (364)
T d1omwa3          85 ILDLMNGGD---------------------------------LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR  131 (364)
T ss_dssp             EECCCCSCB---------------------------------HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEecCCCc---------------------------------HHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccce
Confidence            999998652                                 22223345678999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||||+|||++.+|.+||+|||+|+....  ....+||+.|||||++..  +..|+.++|||||||++|||++|++||.+.
T Consensus       132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         132 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             CCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             eeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhc--CCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999976443  345789999999999852  346899999999999999999999999764


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +...... +.+.               ..                        ..+...+..+|+++++||.+||++||+
T Consensus       210 ~~~~~~~-~~~~---------------~~------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~  249 (364)
T d1omwa3         210 KTKDKHE-IDRM---------------TL------------------------TMAVELPDSFSPELRSLLEGLLQRDVN  249 (364)
T ss_dssp             CSSCHHH-HHHH---------------SS------------------------SCCCCCCSSSCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHH-HHHh---------------cc------------------------cCCCCCCCCCCHHHHHHHHHHcccCHH
Confidence            3221111 1000               00                        001111235789999999999999999


Q ss_pred             CCCC-----HHHHHcCccccC
Q psy17952        478 DRPS-----SGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rps-----a~elL~Hp~~~~  493 (804)
                      +|||     |+|+++||||..
T Consensus       250 ~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         250 RRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             TSTTTSSSTHHHHHTSGGGTT
T ss_pred             HhCCCcccCHHHHHcCccccC
Confidence            9999     799999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=460.59  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=212.3

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHh-hcCCCceeEeeeEEeecCceEEEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLR-QLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~-~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      .|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|+.++. .++|||||++++++.+++.+|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            4899999999999999999999999999999986432222334456778888765 689999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |||.||.                                 |++++...+.+++.+++.++.||+.||+|||++|||||||
T Consensus        83 Ey~~~g~---------------------------------L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDi  129 (320)
T d1xjda_          83 EYLNGGD---------------------------------LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL  129 (320)
T ss_dssp             ECCTTCB---------------------------------HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred             eecCCCc---------------------------------HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            9998752                                 2223334567899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|+....    ....+||+.|||||++.   ++.|+.++|||||||++|||++|+.||.+.
T Consensus       130 kp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvilyemltG~~PF~~~  206 (320)
T d1xjda_         130 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  206 (320)
T ss_dssp             CGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence            99999999999999999999975432    23468999999999995   467999999999999999999999999988


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+..|..+..+                                           .+..+|+++++||.+||++||+
T Consensus       207 ~~~~~~~~i~~~~~~-------------------------------------------~p~~~s~~~~dli~~~L~~dP~  243 (320)
T d1xjda_         207 DEEELFHSIRMDNPF-------------------------------------------YPRWLEKEAKDLLVKLFVREPE  243 (320)
T ss_dssp             SHHHHHHHHHHCCCC-------------------------------------------CCTTSCHHHHHHHHHHSCSSGG
T ss_pred             CHHHHHHHHHcCCCC-------------------------------------------CCccCCHHHHHHHHHhcccCCC
Confidence            877766666432210                                           1124688999999999999999


Q ss_pred             CCCCHH-HHHcCccccC
Q psy17952        478 DRPSSG-RLLTHDLVTR  493 (804)
Q Consensus       478 ~Rpsa~-elL~Hp~~~~  493 (804)
                      +|||+. ++++||||..
T Consensus       244 ~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         244 KRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             GSBTTBSCGGGSGGGTT
T ss_pred             CCcCHHHHHHhCchhcc
Confidence            999995 8999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=450.62  Aligned_cols=282  Identities=29%  Similarity=0.430  Sum_probs=215.5

Q ss_pred             ccccccccccccccccceEEEEeeec-eeEEEEEecccccccchhhhhhHHHHHHHHhhc---CCCceeEeeeEEee---
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVS-REIVAIKKMSYLGKQCAEKWADILKEIRFLRQL---KHPNTIEYRGCYLR---  233 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~-~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~~~~~~---  233 (804)
                      .+.|+++++||+|+||+||+|++..+ ++.||||+++..... ......+.+|+.+|+.|   +|||||+++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            45799999999999999999999765 678999998643222 22234567888888776   79999999999863   


Q ss_pred             --cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        234 --DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       234 --~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                        ...+|++||||.|++..+..                                ......+++..++.++.|++.||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~qi~~aL~yL  132 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLD--------------------------------KVPEPGVPTETIKDMMFQLLRGLDFL  132 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHH--------------------------------HSCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             ccCceEEEEEEeccCCchhhhh--------------------------------hccCCCCCHHHHHHHHHHHHHHHHHH
Confidence              34689999999987543221                                12345789999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      |++|||||||||+|||++.++.+||+|||+++....   ....+||+.|||||++.   +..|+.++||||+||++|||+
T Consensus       133 H~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~---~~~y~~~~DiwSlG~il~ell  209 (305)
T d1blxa_         133 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMF  209 (305)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHHHHHHH
T ss_pred             HhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhc---CCCCChhehhhchHHHHHHHH
Confidence            999999999999999999999999999999875432   34678999999999985   467999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHH
Q psy17952        389 ERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFV  468 (804)
Q Consensus       389 tG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli  468 (804)
                      +|++||.+.+..+.+..|.+....... ..|+.......               ..+...............++.+++||
T Consensus       210 ~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~s~~~~dli  273 (305)
T d1blxa_         210 RRKPLFRGSSDVDQLGKILDVIGLPGE-EDWPRDVALPR---------------QAFHSKSAQPIEKFVTDIDELGKDLL  273 (305)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCG-GGSCTTCSSCG---------------GGSCCCCCCCGGGTCCSCCHHHHHHH
T ss_pred             HCCCCCCCCCHHHHHHHHHHhhCCCch-hcccccccchh---------------hhhccccccchhhccccCCHHHHHHH
Confidence            999999999988888887653211110 01100000000               00000000111112346789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        469 SSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       469 ~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .+||++||++||||+|+|+||||+..
T Consensus       274 ~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         274 LKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHCcCChhHCcCHHHHhcChhhcCc
Confidence            99999999999999999999999754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.9e-52  Score=444.96  Aligned_cols=281  Identities=22%  Similarity=0.337  Sum_probs=217.8

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      +.|+++++||+|+||+||+|+++ +++.||||+++... ......+.+.+|+.+|++++|||||+++++|..++..|++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            36999999999999999999885 78999999986532 22334567899999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+.|++.+.+                                 ....+.+++.++..|+.||+.||+|||++|||||||
T Consensus        80 e~~~~~~~~~~---------------------------------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDi  126 (286)
T d1ob3a_          80 EHLDQDLKKLL---------------------------------DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL  126 (286)
T ss_dssp             ECCSEEHHHHH---------------------------------HTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EeehhhhHHHH---------------------------------HhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCC
Confidence            99987643322                                 234567999999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||+|.....    .....||+.|+|||++.+  ...++.++|||||||++|||++|++||.+.
T Consensus       127 Kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             CGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTT--CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhC--CCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            99999999999999999999865432    234679999999999853  346789999999999999999999999999


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+.+.++........ ...|...............             ............+++++.|||.+||++||+
T Consensus       205 ~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~s~~~~dli~~~L~~dP~  270 (286)
T d1ob3a_         205 SEADQLMRIFRILGTPN-SKNWPNVTELPKYDPNFTV-------------YEPLPWESFLKGLDESGIDLLSKMLKLDPN  270 (286)
T ss_dssp             SHHHHHHHHHHHHCCCC-TTTSTTGGGSTTCCTTCCC-------------CCCCCGGGTCCSCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHHHHHHhhCCCC-hhhccchhhhhhccccccc-------------ccCcchhhhcccCCHHHHHHHHHHccCChh
Confidence            88888887765322111 1111111111100000000             000111122355789999999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy17952        478 DRPSSGRLLTHDLVTR  493 (804)
Q Consensus       478 ~Rpsa~elL~Hp~~~~  493 (804)
                      +|||++|+|+||||++
T Consensus       271 ~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         271 QRITAKQALEHAYFKE  286 (286)
T ss_dssp             TSCCHHHHHTSGGGGC
T ss_pred             HCcCHHHHhcCcccCc
Confidence            9999999999999964

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=448.61  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=205.6

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccc---hhhhhhHHHHHHHHhhcC--CCceeEeeeEEeecC
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQC---AEKWADILKEIRFLRQLK--HPNTIEYRGCYLRDH  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~---~~~~~~~~~Ei~iL~~L~--HpNIV~l~~~~~~~~  235 (804)
                      ...|++.+.||+|+||+||+|+++.+++.||||++.......   .....++.+|+.+|++++  |||||+++++|.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            346999999999999999999999999999999986432211   122345679999999997  899999999999999


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      ..|+||||+.|+.                                .+++++.....+++++++.++.||++||+|||++|
T Consensus        83 ~~~lv~e~~~~~~--------------------------------~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~  130 (273)
T d1xwsa_          83 SFVLILERPEPVQ--------------------------------DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG  130 (273)
T ss_dssp             EEEEEEECCSSEE--------------------------------EHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEEeccCcc--------------------------------hHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999997631                                11222334567999999999999999999999999


Q ss_pred             CeecCCCCCCeeecC-CCcEEEEecccccccCC--CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        316 RIHRDVKAGNILLTE-TGTVKLADFGSASIKCP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       316 IiHRDLKP~NILl~~-~g~vKL~DFGla~~~~~--~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      ||||||||+|||++. ++.+||+|||+|+....  ..+.+||+.|||||++.+  ...++.++|||||||++|||++|++
T Consensus       131 iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~~DiwSlGvilyell~g~~  208 (273)
T d1xwsa_         131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY--HRYHGRSAAVWSLGILLYDMVCGDI  208 (273)
T ss_dssp             EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcC--CCCCCcccccccceeeehhHhhCCC
Confidence            999999999999985 47999999999975433  346789999999999853  2234567999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+      .+.++..                                           .....+|+++++||.+||
T Consensus       209 Pf~~~~------~i~~~~~-------------------------------------------~~~~~~s~~~~~li~~~L  239 (273)
T d1xwsa_         209 PFEHDE------EIIRGQV-------------------------------------------FFRQRVSSECQHLIRWCL  239 (273)
T ss_dssp             SCCSHH------HHHHCCC-------------------------------------------CCSSCCCHHHHHHHHHHT
T ss_pred             CCCCch------HHhhccc-------------------------------------------CCCCCCCHHHHHHHHHHc
Confidence            996532      1111100                                           011346899999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCCCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRPRSP  497 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~~~~  497 (804)
                      ++||++|||++|+|+||||+....+
T Consensus       240 ~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         240 ALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             CSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             cCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            9999999999999999999875443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=442.43  Aligned_cols=254  Identities=28%  Similarity=0.476  Sum_probs=202.0

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +...|++.+.||+|+||+||+|+..   ..||||+++... ......+.+.+|+.+|++++|||||++++++. ++.+|+
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence            3456899999999999999999743   359999986543 23345678899999999999999999999865 467899


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||+|+ |.+++.                                 ..+..+++.++..|+.||++||+|||++||||
T Consensus        81 v~Ey~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivH  127 (276)
T d1uwha_          81 VTQWCEGSSLYHHLH---------------------------------IIETKFEMIKLIDIARQTAQGMDYLHAKSIIH  127 (276)
T ss_dssp             EEECCCEEEHHHHHH---------------------------------TSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEecCCCCCHHHHHh---------------------------------hccCCCCHHHHHHHHHHHHHHHHHHhcCCEec
Confidence            99999854 333221                                 12456999999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |||||+||||+.++.+||+|||+|+....      ..+.+||+.|||||++.+...+.|+.++|||||||++|||+||+.
T Consensus       128 rDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~  207 (276)
T d1uwha_         128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL  207 (276)
T ss_dssp             SCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCC
Confidence            99999999999999999999999975432      234689999999999965445578999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+....+..+......                    +|.                 .......+++++.+|+.+||
T Consensus       208 Pf~~~~~~~~~~~~~~~~~~--------------------~p~-----------------~~~~~~~~~~~l~~li~~cl  250 (276)
T d1uwha_         208 PYSNINNRDQIIFMVGRGYL--------------------SPD-----------------LSKVRSNCPKAMKRLMAECL  250 (276)
T ss_dssp             TTTTCCCHHHHHHHHHHTSC--------------------CCC-----------------GGGSCTTCCHHHHHHHHHHT
T ss_pred             CCCCCChHHHHHHHHhcCCC--------------------CCc-----------------chhccccchHHHHHHHHHHc
Confidence            99887766555444322110                    000                 01123457899999999999


Q ss_pred             ccCCCCCCCHHHHHcC
Q psy17952        473 AKNPADRPSSGRLLTH  488 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~H  488 (804)
                      ..||++|||++|++++
T Consensus       251 ~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         251 KKKRDERPLFPQILAS  266 (276)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHH
Confidence            9999999999999976

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.2e-52  Score=444.08  Aligned_cols=255  Identities=27%  Similarity=0.391  Sum_probs=206.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc----e
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT----A  237 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~----~  237 (804)
                      +.|++.+.||+|+||+||+|+++.+++.||||+++..........+.+.+|+++|++++|||||++++++...+.    +
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            459999999999999999999999999999999876544445556778999999999999999999999987653    8


Q ss_pred             EEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        238 WLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       238 ~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      |+|||||.|+.                                 |..+....+++++.+++.|+.||+.||+|||++|||
T Consensus        87 ~lvmE~~~g~~---------------------------------L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ii  133 (277)
T d1o6ya_          87 YIVMEYVDGVT---------------------------------LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII  133 (277)
T ss_dssp             EEEEECCCEEE---------------------------------HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEECCCCCE---------------------------------ehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            99999998752                                 222233456799999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccC-------CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  390 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~-------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG  390 (804)
                      ||||||+|||++.++.+||+|||++....       ...+.+||+.|||||++.   +..|+.++|||||||++|||++|
T Consensus       134 HrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~~DiwSlGvilyelltG  210 (277)
T d1o6ya_         134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCVLYEVLTG  210 (277)
T ss_dssp             CCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHc---CCCCCcceecccchHHHHHHHhC
Confidence            99999999999999999999999886432       123568999999999984   45799999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.+..+.+..+......                                       .+......+|+++.+||.+
T Consensus       211 ~~Pf~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~s~~l~~li~~  251 (277)
T d1o6ya_         211 EPPFTGDSPVSVAYQHVREDPI---------------------------------------PPSARHEGLSADLDAVVLK  251 (277)
T ss_dssp             SCSCCCSSHHHHHHHHHHCCCC---------------------------------------CGGGTSSSCCHHHHHHHHH
T ss_pred             CCCCCCcCHHHHHHHHHhcCCC---------------------------------------CCchhccCCCHHHHHHHHH
Confidence            9999998888777766553321                                       0111234578999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccc
Q psy17952        471 CLAKNPADRPSSGRLLTHDLV  491 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~  491 (804)
                      ||++||++||++.+.|.|+|.
T Consensus       252 ~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         252 ALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             HTCSSGGGSCSSHHHHHHHHH
T ss_pred             HccCCHhHCHhHHHHHHHHHH
Confidence            999999999965555667664

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=456.26  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=199.4

Q ss_pred             cccccccc-ccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee----c
Q psy17952        161 EKIFEDLR-EIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR----D  234 (804)
Q Consensus       161 ~~~y~~l~-~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~----~  234 (804)
                      -+.|+++. .||+|+||+||+|+++.+++.||||+++..        ..+.+|+.++.++ +|||||+++++|.+    +
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            34588886 599999999999999999999999988531        3467899987655 89999999999976    4


Q ss_pred             CceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        235 HTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       235 ~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                      ..+|+|||||+|+ |.+++.                                ......++|.+++.|+.||+.||+|||+
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~--------------------------------~~~~~~l~e~~~~~i~~qi~~al~ylH~  129 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQ--------------------------------DRGDQAFTEREASEIMKSIGEAIQYLHS  129 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHH--------------------------------SCSCCCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEECCCCCcHHHHHH--------------------------------hcCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence            6789999999864 333321                                0112469999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecC---CCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHH
Q psy17952        314 LGRIHRDVKAGNILLTE---TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  387 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~---~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~EL  387 (804)
                      +||+||||||+|||++.   ++.+||+|||+|+....   ....+||+.|||||++.   +..|+.++|||||||++|||
T Consensus       130 ~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~y~~~~DiwSlGvily~l  206 (335)
T d2ozaa1         130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYIL  206 (335)
T ss_dssp             TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCC---GGGGSHHHHHHHHHHHHHHH
T ss_pred             cCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHc---CCCCCHHHHHHhhchhHHHH
Confidence            99999999999999985   56799999999975433   34578999999999985   35699999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        388 AERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       388 ltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      ++|++||.+.+.......+...               +....                    ...|......+|+++++|
T Consensus       207 ltg~~Pf~~~~~~~~~~~~~~~---------------i~~~~--------------------~~~~~~~~~~~s~~~~~l  251 (335)
T d2ozaa1         207 LCGYPPFYSNHGLAISPGMKTR---------------IRMGQ--------------------YEFPNPEWSEVSEEVKML  251 (335)
T ss_dssp             TTSSCSCEETTCC--------C---------------CCSCS--------------------SSCCTTHHHHSCHHHHHH
T ss_pred             hhCCCCCCCCCHHHHHHHHHHH---------------HhcCC--------------------CCCCCcccccCCHHHHHH
Confidence            9999999776543332222110               00000                    001111112468999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      |.+||++||++|||+.|+|+||||.+.
T Consensus       252 i~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         252 IRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            999999999999999999999999754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-51  Score=442.10  Aligned_cols=254  Identities=24%  Similarity=0.411  Sum_probs=199.6

Q ss_pred             ccCCCcccccccccccccccccceEEEEeeecee---EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEE
Q psy17952        155 FDKEDPEKIFEDLREIGHGSFGAVYYARCLVSRE---IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCY  231 (804)
Q Consensus       155 f~~~dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~---~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~  231 (804)
                      |.++.....|++.+.||+|+||+||+|+++.+++   .||||.+...  ......+.+.+|+++|++++|||||++++++
T Consensus        19 f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             HSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            5555555679999999999999999999887765   5889987542  2234456789999999999999999999999


Q ss_pred             eecCceEEEEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      ..++.+|+|||||.|+. .+++.                                 ...+.+++.++..|+.||++||+|
T Consensus        97 ~~~~~~~iv~Ey~~~g~L~~~~~---------------------------------~~~~~l~~~~~~~i~~qia~gl~y  143 (299)
T d1jpaa_          97 TKSTPVMIITEFMENGSLDSFLR---------------------------------QNDGQFTVIQLVGMLRGIAAGMKY  143 (299)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHH---------------------------------TTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             eeCCEEEEEEEecCCCcceeeec---------------------------------cccCCCCHHHHHHHHHHHHHHHHH
Confidence            99999999999998763 22221                                 124568999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCC---------CccccCcccccchhhcccCCCCCCCcccHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  381 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~---------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlG  381 (804)
                      ||++|||||||||+||||+.++.+||+|||+|+.....         ....||+.|||||++.   .+.|+.++||||||
T Consensus       144 LH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~sDvwS~G  220 (299)
T d1jpaa_         144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ---YRKFTSASDVWSYG  220 (299)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHH---SCCCCHHHHHHHHH
T ss_pred             HhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHh---cCCCCcccccccch
Confidence            99999999999999999999999999999999754321         1246899999999984   46799999999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCc
Q psy17952        382 ITCIELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW  460 (804)
Q Consensus       382 vil~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~  460 (804)
                      |++|||+| |++||.+.+..+.+..+.++..+                                          ..+..+
T Consensus       221 vvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~  258 (299)
T d1jpaa_         221 IVMWEVMSYGERPYWDMTNQDVINAIEQDYRL------------------------------------------PPPMDC  258 (299)
T ss_dssp             HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTC
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCccc
Confidence            99999998 89999988877766665432211                                          012346


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        461 SDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       461 s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ++++.+|+.+||+.||++|||+.|++++
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8899999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-51  Score=440.11  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=201.9

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|++.++||+|+||+||+|++..+++.||||+++...    ...+++.+|+++|++++|||||+++++|.+++..|+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3456899999999999999999999999999999986432    234678999999999999999999999999999999


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.+| +.+++.                                ......+++..+..|+.||++||+|||++||||
T Consensus        91 v~E~~~~g~l~~~l~--------------------------------~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiH  138 (287)
T d1opja_          91 ITEFMTYGNLLDYLR--------------------------------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH  138 (287)
T ss_dssp             EEECCTTCBHHHHHH--------------------------------HSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EeecccCcchHHHhh--------------------------------hccccchHHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999865 333221                                012357899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      |||||+||||+.++.+||+|||+|+.....     ....||+.|||||++.   .+.|+.++|||||||++|||++|..|
T Consensus       139 rDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~k~DiwS~Gv~l~ell~~~~p  215 (287)
T d1opja_         139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMS  215 (287)
T ss_dssp             SCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHc---CCCCCchhhhhhHHHHHHHHHhCCCC
Confidence            999999999999999999999999864332     2245899999999985   35799999999999999999997766


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |+.......+..+.....                                         ....+..+|+++.+|+.+||+
T Consensus       216 ~~~~~~~~~~~~~i~~~~-----------------------------------------~~~~~~~~~~~l~~li~~cl~  254 (287)
T d1opja_         216 PYPGIDLSQVYELLEKDY-----------------------------------------RMERPEGCPEKVYELMRACWQ  254 (287)
T ss_dssp             SSTTCCHHHHHHHHHTTC-----------------------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCcchHHHHHHHHhcCC-----------------------------------------CCCCCccchHHHHHHHHHHcC
Confidence            654443333333322110                                         001123568999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy17952        474 KNPADRPSSGRLLT  487 (804)
Q Consensus       474 ~dP~~Rpsa~elL~  487 (804)
                      .||++|||++|+++
T Consensus       255 ~dP~~Rps~~ei~~  268 (287)
T d1opja_         255 WNPSDRPSFAEIHQ  268 (287)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCHhHCcCHHHHHH
Confidence            99999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=442.34  Aligned_cols=288  Identities=26%  Similarity=0.360  Sum_probs=214.8

Q ss_pred             CcccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-----
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-----  233 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-----  233 (804)
                      ++...|+++++||+|+||+||+|+++.+|+.||||++..... ......++.+|+.+|++++||||+++++++..     
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            345679999999999999999999999999999999864322 23345678899999999999999999998755     


Q ss_pred             ---cCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        234 ---DHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       234 ---~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                         .+.+|+|||||.+++....                                 ......+++..++.|++||++||.|
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~i~~qil~~l~~  132 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLL---------------------------------SNVLVKFTLSEIKRVMQMLLNGLYY  132 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHH---------------------------------TCTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccCceEEEEEeccCCCccchh---------------------------------hhcccccccHHHHHHHHHHHHHHHH
Confidence               3468999999987643221                                 1234578999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccC--------CCCccccCcccccchhhcccCCCCCCCcccHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  382 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGv  382 (804)
                      ||++|||||||||+|||++.++.+||+|||+|+...        ...+.+||+.|+|||++.+  ...|+.++||||+||
T Consensus       133 lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~~~~k~DiwSlGv  210 (318)
T d3blha1         133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGC  210 (318)
T ss_dssp             HHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT--CSSCCTHHHHHHHHH
T ss_pred             hccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC--CCCCCcHHHcccCCc
Confidence            999999999999999999999999999999996432        1234689999999999864  346899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCch-----hhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCC
Q psy17952        383 TCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDW-----SVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQS  457 (804)
Q Consensus       383 il~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~-----~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~  457 (804)
                      ++|||++|++||.+.+....+..+.+...........     .....+.... ..++.    ....+           ..
T Consensus       211 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~-----------~~  274 (318)
T d3blha1         211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVK-GQKRK----VKDRL-----------KA  274 (318)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCS-SCCBC----HHHHH-----------HH
T ss_pred             eeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccc-ccccc----chhhh-----------cc
Confidence            9999999999999988888777665532111110000     0000000000 00000    00000           01


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCCCCCc
Q psy17952        458 SDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRPRSPS  498 (804)
Q Consensus       458 ~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~~~~~  498 (804)
                      ...++++.|||.+||++||++||||+|+|+||||+...-|+
T Consensus       275 ~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~  315 (318)
T d3blha1         275 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  315 (318)
T ss_dssp             HHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence            12367899999999999999999999999999998654443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=446.85  Aligned_cols=283  Identities=25%  Similarity=0.380  Sum_probs=212.5

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC----
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH----  235 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~----  235 (804)
                      ..+.|+++++||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+++|++++|||||+++++|...+    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            3457999999999999999999999999999999987432 23344567899999999999999999999998655    


Q ss_pred             --ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17952        236 --TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS  313 (804)
Q Consensus       236 --~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~  313 (804)
                        .+|+|||||++++..++                                   +.+.+++..++.+++||+.||+|||+
T Consensus        95 ~~~~~lv~e~~~~~l~~~~-----------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~  139 (346)
T d1cm8a_          95 FTDFYLVMPFMGTDLGKLM-----------------------------------KHEKLGEDRIQFLVYQMLKGLRYIHA  139 (346)
T ss_dssp             CCCCEEEEECCSEEHHHHH-----------------------------------HHCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEEEecccccHHHHH-----------------------------------HhccccHHHHHHHHHHHHHHHHHHHh
Confidence              47999999954432221                                   23579999999999999999999999


Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +|||||||||+|||++.++.+||+|||+|+.... ....+||+.|+|||++.+  ...++.++||||+||++|||++|++
T Consensus       140 ~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~ell~g~~  217 (346)
T d1cm8a_         140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCIMAEMITGKT  217 (346)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCCcccccCcchhhcccccccccccccceeccCCccccccccccccCHHHHcC--CCCCCccchhhcchHHHHHHHHCcC
Confidence            9999999999999999999999999999976543 345789999999999864  3457889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccC--CCCCCCCCCccHHHHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQN--DTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~--~~p~~~~~~~s~~l~dli~~  470 (804)
                      ||.+.+....+..+.........    ..+.....       .   ............  ..........++++.+||.+
T Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-------~---~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~  283 (346)
T d1cm8a_         218 LFKGSDHLDQLKEIMKVTGTPPA----EFVQRLQS-------D---EAKNYMKGLPELEKKDFASILTNASPLAVNLLEK  283 (346)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCH----HHHHTCSC-------H---HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHHhccCCCcH----HHHhhhcc-------h---hhhhhhccCCcccccchHHhccCCCHHHHHHHHH
Confidence            99999888877766543211100    00000000       0   000000000000  00111224568999999999


Q ss_pred             hcccCCCCCCCHHHHHcCccccCC
Q psy17952        471 CLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ||+.||++|||++|+|+||||...
T Consensus       284 mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         284 MLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HCcCChhHCcCHHHHhcChhhCcC
Confidence            999999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=435.62  Aligned_cols=243  Identities=23%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             cccccccccceEEEEee--eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEeecC
Q psy17952        168 REIGHGSFGAVYYARCL--VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL  245 (804)
Q Consensus       168 ~~LG~G~fG~Vy~a~~~--~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmEy~~  245 (804)
                      ++||+|+||+||+|...  .+++.||||+++... ......+.+.+|+++|++++|||||++++++.+ +..|||||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            57999999999999764  467899999986432 233445678999999999999999999999864 56799999998


Q ss_pred             CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q psy17952        246 GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN  325 (804)
Q Consensus       246 G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDLKP~N  325 (804)
                      |+.                                 |.++.....++++.++..|+.||+.||+|||++|||||||||+|
T Consensus        91 ~g~---------------------------------L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~N  137 (277)
T d1xbba_          91 LGP---------------------------------LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN  137 (277)
T ss_dssp             TEE---------------------------------HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCc---------------------------------HHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchh
Confidence            752                                 22223345679999999999999999999999999999999999


Q ss_pred             eeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        326 ILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       326 ILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      ||++.++.+||+|||+|+.....       ....||+.|||||++.   .+.|+.++|||||||++|||++ |++||.+.
T Consensus       138 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~  214 (277)
T d1xbba_         138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  214 (277)
T ss_dssp             EEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             hcccccCcccccchhhhhhccccccccccccccCCCceecCchhhc---CCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence            99999999999999999754322       2357999999999985   3568999999999999999998 89999988


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+.++..+                                          ..+..+|+++.+||.+||+.||+
T Consensus       215 ~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~~~~li~~cl~~dp~  252 (277)
T d1xbba_         215 KGSEVTAMLEKGERM------------------------------------------GCPAGCPREMYDLMNLCWTYDVE  252 (277)
T ss_dssp             CHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHHHHHcCCCC------------------------------------------CCCcccCHHHHHHHHHHcCCCHh
Confidence            776665555433211                                          01234689999999999999999


Q ss_pred             CCCCHHHHH---cCcc
Q psy17952        478 DRPSSGRLL---THDL  490 (804)
Q Consensus       478 ~Rpsa~elL---~Hp~  490 (804)
                      +|||+++++   +|+|
T Consensus       253 ~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         253 NRPGFAAVELRLRNYY  268 (277)
T ss_dssp             TSCCHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHhhCHH
Confidence            999999984   4544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=445.08  Aligned_cols=272  Identities=26%  Similarity=0.377  Sum_probs=203.7

Q ss_pred             cccccccccccccccccceEEEEeeece-----eEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSR-----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~-----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.+.||+|+||+||+|++..++     ..||+|.+....  .......+.+|+.+|+++ +|||||++++++.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            4456999999999999999999987654     369999876432  233446789999999998 89999999999999


Q ss_pred             cCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+.+|+|||||+| +|.+++.....  .+     .   .....+ ..............+++.++..|+.||++||+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~--~~-----~---~~~~~~-~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH  181 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKRE--KF-----S---EDEIEY-ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE  181 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTT--CC------------------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccC--CC-----c---chhhhh-ccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999985 56555531100  00     0   000000 00001111123456999999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++|||||||||+|||++.++.+||+|||+|+.....      .+..||+.|||||++.   .+.|+.++|||||||++||
T Consensus       182 ~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwS~Gvil~e  258 (325)
T d1rjba_         182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGILLWE  258 (325)
T ss_dssp             HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHH
T ss_pred             hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc---CCCCCcceeccchhHHHHH
Confidence            999999999999999999999999999999754332      2457899999999985   4679999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |+| |++||.+.+....+..+......                                         ...+..+|++++
T Consensus       259 mlt~g~~Pf~~~~~~~~~~~~~~~~~~-----------------------------------------~~~p~~~~~~l~  297 (325)
T d1rjba_         259 IFSLGVNPYPGIPVDANFYKLIQNGFK-----------------------------------------MDQPFYATEEIY  297 (325)
T ss_dssp             HTTTSCCSSTTCCCSHHHHHHHHTTCC-----------------------------------------CCCCTTCCHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHhcCCC-----------------------------------------CCCCCcCCHHHH
Confidence            998 89999887665555555432210                                         011234688999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||.+||+.||++|||++|+++|
T Consensus       298 ~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         298 IIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999976

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=449.30  Aligned_cols=279  Identities=26%  Similarity=0.368  Sum_probs=214.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec------Cc
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD------HT  236 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~------~~  236 (804)
                      .|+.+++||+|+||+||+|+++.+|+.||||++....       ....+|+++|++++|||||+++++|...      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            5999999999999999999999999999999986422       2235799999999999999999998543      34


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +|||||||+|++.+.+.                              .+......+++.+++.|+.||+.||+|||++||
T Consensus        94 ~~lv~Ey~~~~~~~~l~------------------------------~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~I  143 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVAR------------------------------HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI  143 (350)
T ss_dssp             EEEEEECCSEEHHHHHH------------------------------HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             EEEEEeccCCccHHHHH------------------------------hhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence            78999999887544332                              112245679999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCC-cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        317 IHRDVKAGNILLTETG-TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       317 iHRDLKP~NILl~~~g-~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      +||||||+|||++.++ .+||+|||+|+....   ..+.+||+.|+|||++.+  ...|+.++||||+||++|||++|++
T Consensus       144 iHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DIwSlG~il~el~~g~~  221 (350)
T d1q5ka_         144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCVLAELLLGQP  221 (350)
T ss_dssp             ECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred             cccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhc--ccCCCcceeecccceEEEehhhCCC
Confidence            9999999999999876 899999999975432   346789999999999853  3468999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||.+.+..+.+..+.+.....    ....+..........  .+.        ...............++++.+||.+||
T Consensus       222 pf~~~~~~~~l~~i~~~~g~~----~~~~~~~~~~~~~~~--~~~--------~~~~~~~~~~~~~~~s~~~~dLl~~mL  287 (350)
T d1q5ka_         222 IFPGDSGVDQLVEIIKVLGTP----TREQIREMNPNYTEF--KFP--------QIKAHPWTKVFRPRTPPEAIALCSRLL  287 (350)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCC----CHHHHHHHCC---CC--CCC--------CCCCCCGGGTSCTTSCHHHHHHHHHHS
T ss_pred             CCCCCCHHHHHHHHHHHhCCC----hHHhhhhhccchhhc--ccc--------ccccCchhhhcccCCCHHHHHHHHHHc
Confidence            999999888888876532111    111111111100000  000        000000011223457899999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCC
Q psy17952        473 AKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      ++||++||||.|+|+||||...
T Consensus       288 ~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         288 EYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cCChhHCcCHHHHhcCHhhccc
Confidence            9999999999999999999653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=428.63  Aligned_cols=243  Identities=28%  Similarity=0.441  Sum_probs=193.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|+++++||+|+||+||+|++. +++.||||+++...    ...+++.+|+++|++++|||||++++++..++..|+|||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            4899999999999999999875 56789999986432    223568999999999999999999999999999999999


Q ss_pred             ecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.++ |.+++.                                 .....++++.+..|+.||++||+|||+++|+||||
T Consensus        81 ~~~~g~L~~~l~---------------------------------~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDl  127 (263)
T d1sm2a_          81 FMEHGCLSDYLR---------------------------------TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL  127 (263)
T ss_dssp             CCTTCBHHHHHH---------------------------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTC
T ss_pred             ecCCCcHHHHhh---------------------------------ccccCCCHHHHHHHHHHHHHHHHhhhccceeeccc
Confidence            99865 333221                                 12356889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||+|||++.++.+||+|||+|+....     .....||+.|||||++.   .+.|+.++|||||||++|||+| |.+||.
T Consensus       128 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvil~el~t~~~~~~~  204 (263)
T d1sm2a_         128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYE  204 (263)
T ss_dssp             SGGGEEECGGGCEEECSCC------------------CTTSCCHHHHT---TCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             chhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhc---CCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence            99999999999999999999975432     12357999999999984   4679999999999999999999 567776


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+..+.+..+..+..+                                          ..+...++++.+|+.+||+.|
T Consensus       205 ~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~l~~li~~cl~~~  242 (263)
T d1sm2a_         205 NRSNSEVVEDISTGFRL------------------------------------------YKPRLASTHVYQIMNHCWKER  242 (263)
T ss_dssp             SCCHHHHHHHHHHTCCC------------------------------------------CCCTTSCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHHHHHhcCCC------------------------------------------CCccccCHHHHHHHHHHccCC
Confidence            66666555555432111                                          111345789999999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy17952        476 PADRPSSGRLLTH  488 (804)
Q Consensus       476 P~~Rpsa~elL~H  488 (804)
                      |++|||++|+++|
T Consensus       243 p~~Rps~~~il~~  255 (263)
T d1sm2a_         243 PEDRPAFSRLLRQ  255 (263)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=433.37  Aligned_cols=250  Identities=24%  Similarity=0.430  Sum_probs=201.3

Q ss_pred             cccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      +.+.|++.++||+|+||+||+|++. +++.||||+++...    ...+.+.+|+++|++++|||||++++++.+ +..|+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            5567999999999999999999865 56789999986432    223568999999999999999999998754 56799


Q ss_pred             EEeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||.+|. .+.+.                                .....++++.++..|+.||++||.|||+++|+|
T Consensus        85 v~Ey~~~g~L~~~~~--------------------------------~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivH  132 (272)
T d1qpca_          85 ITEYMENGSLVDFLK--------------------------------TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH  132 (272)
T ss_dssp             EEECCTTCBHHHHTT--------------------------------SHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEeCCCCcHHHHHh--------------------------------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            999998653 22221                                011235899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC-CC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KP  392 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG-~~  392 (804)
                      |||||+||||++++.+||+|||+|+....     .....||+.|||||++.   .+.|+.++|||||||++|||+|| .+
T Consensus       133 rDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwS~Gvvl~ellt~~~~  209 (272)
T d1qpca_         133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRI  209 (272)
T ss_dssp             SCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHh---CCCCCchhhhhhhHHHHHHHHhCCCC
Confidence            99999999999999999999999976432     23457999999999985   35689999999999999999995 55


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      ||...+..+.+..+..+..+                                          ..+..+++++.+|+.+||
T Consensus       210 ~~~~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~l~~li~~cl  247 (272)
T d1qpca_         210 PYPGMTNPEVIQNLERGYRM------------------------------------------VRPDNCPEELYQLMRLCW  247 (272)
T ss_dssp             SSTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHHHhcCCC------------------------------------------CCcccChHHHHHHHHHHc
Confidence            56555655555544332111                                          112356889999999999


Q ss_pred             ccCCCCCCCHHHHHc--Ccccc
Q psy17952        473 AKNPADRPSSGRLLT--HDLVT  492 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~--Hp~~~  492 (804)
                      +.||++|||++++++  |+||+
T Consensus       248 ~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         248 KERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999987  77775

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=432.98  Aligned_cols=248  Identities=23%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             cccccc-ccccccccceEEEEeee--ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        163 IFEDLR-EIGHGSFGAVYYARCLV--SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       163 ~y~~l~-~LG~G~fG~Vy~a~~~~--~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      .|.+.+ +||+|+||+||+|.++.  ++..||||.++...  .....+.+.+|+++|++++|||||++++++.+ +.+|+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            366666 49999999999998754  45589999986432  23445778999999999999999999999865 56899


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      |||||+|+ |.+++                                 ...+..+++.++..|+.||++||+|||++||||
T Consensus        86 vmE~~~~g~L~~~l---------------------------------~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiH  132 (285)
T d1u59a_          86 VMEMAGGGPLHKFL---------------------------------VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH  132 (285)
T ss_dssp             EEECCTTEEHHHHH---------------------------------TTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEeCCCCcHHHHh---------------------------------hccccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            99999975 32221                                 123457999999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-C
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R  390 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G  390 (804)
                      |||||+|||++.++.+||+|||+|+....       ....+||+.|||||++.   .+.|+.++|||||||++|||+| |
T Consensus       133 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gv~l~E~lt~G  209 (285)
T d1u59a_         133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYG  209 (285)
T ss_dssp             CCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             CcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHh---CCCCCccchhhcchHHHHHHHhCC
Confidence            99999999999999999999999975432       22457899999999985   3578999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        391 KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       391 ~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      ++||.+.+..+.+..|.++..+                                          ..+..+|+++.+||.+
T Consensus       210 ~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~l~~li~~  247 (285)
T d1u59a_         210 QKPYKKMKGPEVMAFIEQGKRM------------------------------------------ECPPECPPELYALMSD  247 (285)
T ss_dssp             CCTTTTCCTHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCcCCHHHHHHHHH
Confidence            9999988776666655443211                                          0123568899999999


Q ss_pred             hcccCCCCCCCHHHHH---cCccc
Q psy17952        471 CLAKNPADRPSSGRLL---THDLV  491 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL---~Hp~~  491 (804)
                      ||+.||++|||+.+++   +|+|+
T Consensus       248 cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         248 CWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999884   45554

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=428.21  Aligned_cols=284  Identities=26%  Similarity=0.397  Sum_probs=217.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVM  241 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVm  241 (804)
                      ++|+++++||+|+||+||+|+++.+++.||||+++... ........+.+|+.+|+.++|||||+++++|.+....++||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            36999999999999999999999999999999986433 23345577899999999999999999999999999999999


Q ss_pred             eecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        242 EYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       242 Ey~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      |++.|+...                                 .+....+.+++..++.++.|+++||+|||++|||||||
T Consensus        81 ~~~~~~~l~---------------------------------~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDi  127 (292)
T d1unla_          81 EFCDQDLKK---------------------------------YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL  127 (292)
T ss_dssp             ECCSEEHHH---------------------------------HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             eeccccccc---------------------------------cccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecc
Confidence            999876321                                 22234567899999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCCC----CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPYFNM  397 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~~----~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF~~~  397 (804)
                      ||+|||++.++.+||+|||.|+.....    ....+++.|+|||++..  ...++.++||||+||++|||++|+.||+..
T Consensus       128 KP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~DiwSlG~il~ell~g~~p~~~~  205 (292)
T d1unla_         128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT--CSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred             cCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhcc--CCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence            999999999999999999999764332    24568899999999853  344788999999999999999999987554


Q ss_pred             -ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCC
Q psy17952        398 -NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNP  476 (804)
Q Consensus       398 -~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP  476 (804)
                       +..+.+..+.....+... ..|..........  ..+.           .............+++.+.+||.+||++||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~-----------~~~~~~~~~~~~~~s~~~~dll~~mL~~dP  271 (292)
T d1unla_         206 NDVDDQLKRIFRLLGTPTE-EQWPSMTKLPDYK--PYPM-----------YPATTSLVNVVPKLNATGRDLLQNLLKCNP  271 (292)
T ss_dssp             SSHHHHHHHHHHHHCCCCT-TTCTTGGGSTTCC--CCCC-----------CCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred             CCHHHHHHHHHhhcCCCCh-hhhhhhhhccccc--cccc-----------ccccchhhhccccCCHHHHHHHHHHccCCh
Confidence             455555555432221111 1111111110000  0000           000011122234678999999999999999


Q ss_pred             CCCCCHHHHHcCccccCCC
Q psy17952        477 ADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       477 ~~Rpsa~elL~Hp~~~~~~  495 (804)
                      .+||||+|+|+||||+.-.
T Consensus       272 ~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         272 VQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GGSCCHHHHTTSGGGSSCS
T ss_pred             hHCcCHHHHhcChhhcCCC
Confidence            9999999999999997643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=424.06  Aligned_cols=243  Identities=24%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEEEe
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      .|++.++||+|+||+||+|+++ +++.||||.++....    ..+.+++|+.++++++|||||++++++.+++.+|+|||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            4899999999999999999974 778999999864322    23568999999999999999999999999999999999


Q ss_pred             ecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||.+|. .+.+                                 ......+++..+..++.|+++||+|||++||+||||
T Consensus        80 y~~~g~l~~~~---------------------------------~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dl  126 (258)
T d1k2pa_          80 YMANGCLLNYL---------------------------------REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL  126 (258)
T ss_dssp             CCTTEEHHHHH---------------------------------HSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCC
T ss_pred             ccCCCcHHHhh---------------------------------hccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccc
Confidence            998653 2221                                 112346889999999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYF  395 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~  395 (804)
                      ||+|||++.++.+||+|||+|+....     .....||+.|||||++.   ...|+.++|||||||++|||+| |+.||.
T Consensus       127 k~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~ksDiwS~G~~l~el~t~g~~Pf~  203 (258)
T d1k2pa_         127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYE  203 (258)
T ss_dssp             SGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhc---CCCCCcceeecccchhhHhHHhcCCCCCC
Confidence            99999999999999999999975332     12367999999999985   3578999999999999999998 899999


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccC
Q psy17952        396 NMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKN  475 (804)
Q Consensus       396 ~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~d  475 (804)
                      +.+..+....+.++..+                                          ..+...++++.+||.+||+.|
T Consensus       204 ~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~l~~li~~cl~~d  241 (258)
T d1k2pa_         204 RFTNSETAEHIAQGLRL------------------------------------------YRPHLASEKVYTIMYSCWHEK  241 (258)
T ss_dssp             TSCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHHHTTCSS
T ss_pred             CCCHHHHHHHHHhCCCC------------------------------------------CCcccccHHHHHHHHHHccCC
Confidence            88877776666543211                                          011345789999999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy17952        476 PADRPSSGRLLTH  488 (804)
Q Consensus       476 P~~Rpsa~elL~H  488 (804)
                      |++|||++++|+|
T Consensus       242 P~~RPt~~eil~~  254 (258)
T d1k2pa_         242 ADERPTFKILLSN  254 (258)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=441.74  Aligned_cols=282  Identities=26%  Similarity=0.394  Sum_probs=208.6

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC-----c
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH-----T  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~-----~  236 (804)
                      .+|++++.||+|+||+||+|+++.+|+.||||+++...  .....+.+++|+.+|++|+|||||++++++....     .
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            35999999999999999999999999999999986432  2344567899999999999999999999987653     3


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      +|++|+++.|+|.+++.                                   .+.+++.+++.++.||+.||+|||++||
T Consensus        86 ~~l~~~~~~g~L~~~l~-----------------------------------~~~l~~~~i~~i~~qil~al~yLH~~~i  130 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLK-----------------------------------TQHLSNDHICYFLYQILRGLKYIHSANV  130 (345)
T ss_dssp             EEEEEECCCEEHHHHHH-----------------------------------HCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEeecCCchhhhhh-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            56666655555544332                                   2468999999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC-------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  389 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt  389 (804)
                      |||||||+|||++.++.+||+|||+|+....       ....+||+.|+|||++..  ...|+.++||||+||++|||++
T Consensus       131 iHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~eml~  208 (345)
T d1pmea_         131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKSIDIWSVGCILAEMLS  208 (345)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT--BCSCSTHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhc--CCCCCchhhhhccCceehHHhh
Confidence            9999999999999999999999999965322       234689999999999853  3467889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCC--CCCCCCccHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTP--CLQSSDWSDTFAHF  467 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p--~~~~~~~s~~l~dl  467 (804)
                      |++||.+.+..+....+.........    .....          ...................  ......+|+++++|
T Consensus       209 g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  274 (345)
T d1pmea_         209 NRPIFPGKHYLDQLNHILGILGSPSQ----EDLNC----------IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL  274 (345)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCSCCH----HHHHT----------CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHhhhccCCCh----hhhhh----------hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHH
Confidence            99999988877666555432111000    00000          0000000000000000000  00123568899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccCCCC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTHDLVTRPRS  496 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~Hp~~~~~~~  496 (804)
                      +.+||++||.+|||++|+|+||||+....
T Consensus       275 i~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         275 LDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            99999999999999999999999986543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=446.39  Aligned_cols=290  Identities=25%  Similarity=0.340  Sum_probs=207.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee------cC
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR------DH  235 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~------~~  235 (804)
                      +.|+++++||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|++++|||||+++++|..      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            469999999999999999999999999999999864322 23445678899999999999999999999964      35


Q ss_pred             ceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        236 TAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       236 ~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+|+|||||.|++.+.+                                    ...+++..++.+++||+.||+|||++|
T Consensus        96 ~~~iv~Ey~~~~l~~~~------------------------------------~~~~~~~~i~~~~~qil~gl~~LH~~g  139 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVI------------------------------------QMELDHERMSYLLYQMLCGIKHLHSAG  139 (355)
T ss_dssp             EEEEEEECCSEEHHHHH------------------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEeccchHHHHhh------------------------------------hcCCCHHHHHHHHHHHHHHHHHhhhcc
Confidence            78999999988743321                                    235899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  392 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~  392 (804)
                      |+||||||+|||++.++.+|++|||+++....   ....+||+.|+|||++.   +..|+.++||||+||++|||++|++
T Consensus       140 iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~---~~~~~~~~DiwSlG~~l~ell~g~~  216 (355)
T d2b1pa1         140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMVRHKI  216 (355)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhc---CCCCCCCcccccccchHHHHhhCCC
Confidence            99999999999999999999999999865432   34568999999999985   3578999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhcCCCCCC---CCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        393 PYFNMNAMSALYHIAQNDTPCLQ---SSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       393 PF~~~~~~~~l~~I~~~~~p~~~---~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      ||.+.+....+.++.........   ...+........   ..++.... ....+..-.............|+++.+||+
T Consensus       217 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dll~  292 (355)
T d2b1pa1         217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE---NRPKYAGL-TFPKLFPDSLFPADSEHNKLKASQARDLLS  292 (355)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHH---TSCCCCCC-CHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhh---cCcccccc-ccccccccccccccccccccCCHHHHHHHH
Confidence            99998887777766543211100   000011111100   00000000 000000000000000011224788999999


Q ss_pred             HhcccCCCCCCCHHHHHcCccccCCC
Q psy17952        470 SCLAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      +||++||++||||+|+|+||||+...
T Consensus       293 ~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         293 KMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999998643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=423.10  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=195.4

Q ss_pred             cccccccccccccccccceEEEEeeece---eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCc
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHT  236 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~---~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~  236 (804)
                      +.+.|++.+.||+|+||+||+|++..++   ..||||.++...  .....+.+.+|+.+|++++|||||++++++. ++.
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            4567999999999999999999886543   568999876432  2344567899999999999999999999985 567


Q ss_pred             eEEEEeecCCCch-hhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLGSAS-DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G~l~-dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      +|+|||||.|+.. +++                                 ......+++.++..++.||++||+|||++|
T Consensus        82 ~~iv~E~~~~g~l~~~~---------------------------------~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~  128 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFL---------------------------------QVRKYSLDLASLILYAYQLSTALAYLESKR  128 (273)
T ss_dssp             CEEEEECCTTEEHHHHH---------------------------------HHTTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeccCCcHHhhh---------------------------------hccCCCCCHHHHHHHHHHHHHHhhhhcccC
Confidence            8999999987632 211                                 123457899999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      ||||||||+|||++.++.+||+|||+|+....     .....||+.|||||++.   .+.|+.++|||||||++|||++ 
T Consensus       129 iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~---~~~~~~~~DiwSlGvil~e~lt~  205 (273)
T d1mp8a_         129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMH  205 (273)
T ss_dssp             CCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             eeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhc---cCCCCCccccccchHHHHHHHhc
Confidence            99999999999999999999999999975432     23457899999999985   3579999999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |.+||.+.+..+.+..+..+..+                                          ..+..+|+++.+||.
T Consensus       206 g~~P~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~~li~  243 (273)
T d1mp8a_         206 GVKPFQGVKNNDVIGRIENGERL------------------------------------------PMPPNCPPTLYSLMT  243 (273)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCCHHHHHHHH
Confidence            89999888777666655433211                                          112356899999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q psy17952        470 SCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL~H  488 (804)
                      +||..||++|||+.|+++|
T Consensus       244 ~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         244 KCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=437.04  Aligned_cols=281  Identities=23%  Similarity=0.346  Sum_probs=208.3

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeec-----Cc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRD-----HT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~-----~~  236 (804)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+++|++++|||||+++++|...     ..
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45999999999999999999999999999999987533 2233456788999999999999999999998643     23


Q ss_pred             eEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17952        237 AWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLG  315 (804)
Q Consensus       237 ~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~g  315 (804)
                      .+++|||+.| +|.+++                                   ..+.+++.+++.++.||+.||+|||++|
T Consensus        97 ~~~i~~~~~gg~L~~~~-----------------------------------~~~~l~e~~~~~i~~qil~aL~~LH~~g  141 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIV-----------------------------------KCQKLTDDHVQFLIYQILRGLKYIHSAD  141 (348)
T ss_dssp             CCEEEEECCSEEHHHHH-----------------------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEeecCCchhhhc-----------------------------------ccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            3555555554 433322                                   2346999999999999999999999999


Q ss_pred             CeecCCCCCCeeecCCCcEEEEecccccccC-CCCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        316 RIHRDVKAGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       316 IiHRDLKP~NILl~~~g~vKL~DFGla~~~~-~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |+||||||+|||++.+|.+|++|||+|.... ...+..||+.|+|||++.+  ...++.++|||||||++|||++|++||
T Consensus       142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~--~~~~~~~~DiwSlGv~l~~ll~g~~pF  219 (348)
T d2gfsa1         142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLF  219 (348)
T ss_dssp             CCCCCCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTT--CSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             CcccccCCccccccccccccccccchhcccCcccccccccccccCchhhcC--CccCCcccchhhhhHHHHHHHhCCCCC
Confidence            9999999999999999999999999996543 3356789999999999753  345688999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHH-hhccCCCCC--CCCCCccHHHHHHHHHh
Q psy17952        395 FNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALY-HIAQNDTPC--LQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       395 ~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~-~i~~~~~p~--~~~~~~s~~l~dli~~c  471 (804)
                      .+.+.......|.........    .......           ........ .........  ......+++++|||.+|
T Consensus       220 ~~~~~~~~~~~i~~~~~~~~~----~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m  284 (348)
T d2gfsa1         220 PGTDHIDQLKLILRLVGTPGA----ELLKKIS-----------SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM  284 (348)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCH----HHHTTCC-----------CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCCh----HHhhhcc-----------chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHH
Confidence            999888877777653211100    0000000           00000000 000000000  01134689999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCC
Q psy17952        472 LAKNPADRPSSGRLLTHDLVTRPR  495 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~Hp~~~~~~  495 (804)
                      |+.||++||||+|+|+||||++..
T Consensus       285 L~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         285 LVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CcCChhhCcCHHHHhcCHhhCCCC
Confidence            999999999999999999998643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-49  Score=430.92  Aligned_cols=283  Identities=24%  Similarity=0.331  Sum_probs=206.1

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEee--cCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLR--DHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~--~~~~~  238 (804)
                      +.|+++++||+|+||+||+|+++.+++.||||+++..      ..+++.+|+++|++++ ||||++++++|..  ...+|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            4599999999999999999999999999999998632      2356789999999996 9999999999975  35699


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.|+..                                 ..   ..+.+++.+++.+++||+.||+|||++||||
T Consensus       109 ~v~e~~~~~~L---------------------------------~~---~~~~l~e~~i~~i~~qil~aL~~LH~~gIvH  152 (328)
T d3bqca1         109 LVFEHVNNTDF---------------------------------KQ---LYQTLTDYDIRFYMYEILKALDYCHSMGIMH  152 (328)
T ss_dssp             EEEECCCSCBG---------------------------------GG---TTTSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEeecCCCcH---------------------------------HH---HhcCCCHHHHHHHHHHHHHHHHHHhhccccc
Confidence            99999987621                                 11   1246899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCC-cEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy17952        319 RDVKAGNILLTETG-TVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPY  394 (804)
Q Consensus       319 RDLKP~NILl~~~g-~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~PF  394 (804)
                      |||||+|||++.++ .+||+|||+|+....   ....+||+.|+|||++.+  ...|+.++||||+||++|||++|+.||
T Consensus       153 rDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~~l~e~~~g~~pf  230 (328)
T d3bqca1         153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPF  230 (328)
T ss_dssp             CCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             ccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccC--CCCCCcccchhhhhhhhHHhccCCCCC
Confidence            99999999998765 699999999976433   345789999999999864  345899999999999999999999999


Q ss_pred             CCCC-hHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        395 FNMN-AMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       395 ~~~~-~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      .... .......+.....+.   ..+.......   ....+.+................+......+|+++.|||++||+
T Consensus       231 ~~~~~~~~~~~~i~~~~g~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~  304 (328)
T d3bqca1         231 FHGHDNYDQLVRIAKVLGTE---DLYDYIDKYN---IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR  304 (328)
T ss_dssp             SCCSSHHHHHHHHHHHHCHH---HHHHHHHHTT---CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSC
T ss_pred             CCCchhHHHHHHHHHHHCCc---hhhhhhhhcc---cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHcc
Confidence            7654 333333332211000   0000000000   00000000000000000000001111223468999999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCC
Q psy17952        474 KNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       474 ~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      +||++|||++|+|+||||...
T Consensus       305 ~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         305 YDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             SSGGGSCCHHHHHTSGGGTTS
T ss_pred             CChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=419.04  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=192.6

Q ss_pred             ccccccccccccccceEEEEeeece----eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSR----EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~----~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      .|++.+.||+|+||.||+|....++    ..||||++....  .......+++|+++|++++|||||++++++.+.+..|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            4889999999999999999987654    479999986432  2334457899999999999999999999999999999


Q ss_pred             EEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        239 LVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       239 lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +|||||.+++..-.                                .......+++.++..++.||+.||+|||+++|||
T Consensus        86 ~v~e~~~~~~l~~~--------------------------------~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiH  133 (283)
T d1mqba_          86 IITEYMENGALDKF--------------------------------LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH  133 (283)
T ss_dssp             EEEECCTTEEHHHH--------------------------------HHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEEecccCcchhh--------------------------------hhcccccccHHHHHHHHHHHHHhhhhcccccccc
Confidence            99999987632211                                0113457899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |||||+||||+.++.+||+|||+|+.....       ....||+.|||||++.   .+.|+.++|||||||++|||++|.
T Consensus       134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~sDI~S~Gvil~el~t~~  210 (283)
T d1mqba_         134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIVMWEVMTYG  210 (283)
T ss_dssp             SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH---SCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHc---cCCCCCcccccccHHHHHHHHhCC
Confidence            999999999999999999999999754221       2346899999999984   467999999999999999999965


Q ss_pred             C-CCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHH
Q psy17952        392 P-PYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSS  470 (804)
Q Consensus       392 ~-PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~  470 (804)
                      . ||.+.+..+.+..+..+..+                                          ..+..+++++.+|+.+
T Consensus       211 ~~~~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~~  248 (283)
T d1mqba_         211 ERPYWELSNHEVMKAINDGFRL------------------------------------------PTPMDCPSAIYQLMMQ  248 (283)
T ss_dssp             CCTTTTCCHHHHHHHHHTTCCC------------------------------------------CCCTTCBHHHHHHHHH
T ss_pred             CCccccCCHHHHHHHHhccCCC------------------------------------------CCchhhHHHHHHHHHH
Confidence            4 45555554444443322110                                          1123468899999999


Q ss_pred             hcccCCCCCCCHHHHHc
Q psy17952        471 CLAKNPADRPSSGRLLT  487 (804)
Q Consensus       471 cL~~dP~~Rpsa~elL~  487 (804)
                      ||+.||++|||+.|+++
T Consensus       249 cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         249 CWQQERARRPKFADIVS  265 (283)
T ss_dssp             HTCSSTTTSCCHHHHHH
T ss_pred             HCcCCHhHCcCHHHHHH
Confidence            99999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=430.93  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             cccccccccccccccceEEEEee---eceeEEEEEecccccc-cchhhhhhHHHHHHHHhhcCC-CceeEeeeEEeecCc
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCL---VSREIVAIKKMSYLGK-QCAEKWADILKEIRFLRQLKH-PNTIEYRGCYLRDHT  236 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~---~~~~~vAIK~i~~~~~-~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~~~~~~~~~  236 (804)
                      +.|++++.||+|+||+||+|++.   .+|+.||||.++.... ......+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            34999999999999999999974   4689999999865322 122334678899999999987 899999999999999


Q ss_pred             eEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy17952        237 AWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGR  316 (804)
Q Consensus       237 ~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gI  316 (804)
                      .|++||||.|+.                                 |++++...+.+++..+..++.||+.||+|||++||
T Consensus       104 ~~~v~e~~~~~~---------------------------------L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i  150 (322)
T d1vzoa_         104 LHLILDYINGGE---------------------------------LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI  150 (322)
T ss_dssp             EEEEECCCCSCB---------------------------------HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             eeeeeecccccH---------------------------------HHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence            999999998752                                 22233345578899999999999999999999999


Q ss_pred             eecCCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy17952        317 IHRDVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  391 (804)
Q Consensus       317 iHRDLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~  391 (804)
                      |||||||+|||++.+|.+||+|||+|+....     ..+..||+.|+|||.+.+ ....++.++|||||||+||||++|+
T Consensus       151 vHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~-~~~~~~~ksDIWSlG~iLyelltG~  229 (322)
T d1vzoa_         151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVLMYELLTGA  229 (322)
T ss_dssp             CCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT-CC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             EeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhc-CCcCCCchhhhHHHHHHHHHHHhCC
Confidence            9999999999999999999999999965321     235689999999999864 2345788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      .||.+.+.......+.+..                                     . ...+ .....+|+++.+||.+|
T Consensus       230 ~PF~~~~~~~~~~~i~~~~-------------------------------------~-~~~~-~~~~~~s~~~~~li~~~  270 (322)
T d1vzoa_         230 SPFTVDGEKNSQAEISRRI-------------------------------------L-KSEP-PYPQEMSALAKDLIQRL  270 (322)
T ss_dssp             CTTSCTTSCCCHHHHHHHH-------------------------------------H-HCCC-CCCTTSCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhc-------------------------------------c-cCCC-CCcccCCHHHHHHHHHH
Confidence            9997765433322222110                                     0 0000 11235799999999999


Q ss_pred             cccCCCCCC-----CHHHHHcCccccC
Q psy17952        472 LAKNPADRP-----SSGRLLTHDLVTR  493 (804)
Q Consensus       472 L~~dP~~Rp-----sa~elL~Hp~~~~  493 (804)
                      |++||++||     |++|+|+||||..
T Consensus       271 l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         271 LMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             TCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            999999999     5899999999965

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=416.82  Aligned_cols=252  Identities=24%  Similarity=0.412  Sum_probs=199.3

Q ss_pred             ccccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEEE
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~lV  240 (804)
                      .+.|++.+.||+|+||+||+|++..+ +.||||++.....    ..+.+.+|+.+|++++|||||++++++. ++..|+|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv   89 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   89 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEE
Confidence            34699999999999999999998765 4699999864322    2356899999999999999999999985 4668999


Q ss_pred             EeecCCCc-hhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGSA-SDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~l-~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||.||. .+++.                                ......+++.++..|+.||+.||+|||++||+||
T Consensus        90 ~Ey~~~g~l~~~~~--------------------------------~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~  137 (285)
T d1fmka3          90 TEYMSKGSLLDFLK--------------------------------GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR  137 (285)
T ss_dssp             ECCCTTCBHHHHHS--------------------------------HHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEecCCCchhhhhh--------------------------------hcccccchHHHHHHHHHHHHHHHHHHhhhheecc
Confidence            99999763 22221                                1123468999999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-----CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhC-CCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPP  393 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG-~~P  393 (804)
                      ||||+||||+.++.+||+|||+|+....     .....||+.|+|||++.   .+.++.++|||||||++|||++| .+|
T Consensus       138 DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~S~Giil~el~t~~~p~  214 (285)
T d1fmka3         138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVP  214 (285)
T ss_dssp             CCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHh---CCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence            9999999999999999999999975422     22357999999999985   46789999999999999999995 555


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+.+..+.++..+                                          .....+++++++||.+||+
T Consensus       215 ~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~  252 (285)
T d1fmka3         215 YPGMVNREVLDQVERGYRM------------------------------------------PCPPECPESLHDLMCQCWR  252 (285)
T ss_dssp             STTCCHHHHHHHHHTTCCC------------------------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred             CCCCCHHHHHHHHHhcCCC------------------------------------------CCCcccCHHHHHHHHHHcc
Confidence            5556665555555432111                                          1123568899999999999


Q ss_pred             cCCCCCCCHHHHHc--CccccCCC
Q psy17952        474 KNPADRPSSGRLLT--HDLVTRPR  495 (804)
Q Consensus       474 ~dP~~Rpsa~elL~--Hp~~~~~~  495 (804)
                      .||++|||+++++.  ++||+...
T Consensus       253 ~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         253 KEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             SSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cCHhHCcCHHHHHHHHhhhhcCCC
Confidence            99999999999987  88887643

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-49  Score=424.38  Aligned_cols=244  Identities=26%  Similarity=0.399  Sum_probs=193.2

Q ss_pred             cccccccccccccceEEEEeeecee----EEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceEE
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSRE----IVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~----~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~l  239 (804)
                      |++++.||+|+||+||+|++..+|+    .||+|+++..  ......+.+.+|+.+|++++|||||++++++.++ ..++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            9999999999999999999988876    5788877532  2233456789999999999999999999999765 5677


Q ss_pred             EEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy17952        240 VMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIH  318 (804)
Q Consensus       240 VmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiH  318 (804)
                      +||||.++ +.+.+                                 ......+++..+..|+.||++||+|||++||||
T Consensus        88 v~e~~~~~~l~~~~---------------------------------~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiH  134 (317)
T d1xkka_          88 ITQLMPFGCLLDYV---------------------------------REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH  134 (317)
T ss_dssp             EEECCTTCBHHHHH---------------------------------HHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEeccCCcccccc---------------------------------cccccCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence            78887654 33322                                 123457899999999999999999999999999


Q ss_pred             cCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CC
Q psy17952        319 RDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RK  391 (804)
Q Consensus       319 RDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~  391 (804)
                      |||||+|||++.++.+||+|||+|+.....      ....||+.|||||++.   ++.|+.++|||||||++|||+| |.
T Consensus       135 rDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwS~Gvil~el~t~g~  211 (317)
T d1xkka_         135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGS  211 (317)
T ss_dssp             SCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHh---cCCCChhhhhhhHHHHHHHHHHCCC
Confidence            999999999999999999999999754321      2346899999999985   3579999999999999999998 79


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHh
Q psy17952        392 PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSC  471 (804)
Q Consensus       392 ~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~c  471 (804)
                      +||.+.+..+....+.++..+                                          ..+..+++++.+|+.+|
T Consensus       212 ~p~~~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~~~~li~~c  249 (317)
T d1xkka_         212 KPYDGIPASEISSILEKGERL------------------------------------------PQPPICTIDVYMIMVKC  249 (317)
T ss_dssp             CTTTTSCGGGHHHHHHHTCCC------------------------------------------CCCTTBCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCcccCHHHHHHHHHh
Confidence            999876655544433322111                                          11235688999999999


Q ss_pred             cccCCCCCCCHHHHHcC
Q psy17952        472 LAKNPADRPSSGRLLTH  488 (804)
Q Consensus       472 L~~dP~~Rpsa~elL~H  488 (804)
                      |+.||++|||+.|++.|
T Consensus       250 l~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         250 WMIDADSRPKFRELIIE  266 (317)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             CCCChhhCcCHHHHHHH
Confidence            99999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-48  Score=418.82  Aligned_cols=272  Identities=25%  Similarity=0.383  Sum_probs=207.1

Q ss_pred             CcccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee
Q psy17952        159 DPEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR  233 (804)
Q Consensus       159 dp~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~  233 (804)
                      -|.+.|+++++||+|+||+||+|+.+     .+++.||||+++...  .....+.+.+|+++|++++||||+++++++..
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            36677999999999999999999875     367899999986432  23345678999999999999999999999999


Q ss_pred             cCceEEEEeecC-CCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCL-GSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~-G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..+++||||. |++.+++...-...          ......................+++.++..|+.||+.||+|||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH  157 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHT----------VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS  157 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC--------------------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccc----------cccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence            999999999997 55666553210000          0000000000000011122346999999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      +++||||||||+|||++.++.+||+|||+|+....      ..+.+||+.|||||++.   ...|+.++|||||||++||
T Consensus       158 ~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~t~ksDVwS~Gvvl~e  234 (301)
T d1lufa_         158 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWE  234 (301)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHH
T ss_pred             cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc---cCCCChhhhhccchhhHHH
Confidence            99999999999999999999999999999964322      23467999999999985   3579999999999999999


Q ss_pred             HHhCC-CCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAERK-PPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 LltG~-~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |++|. +||.+.+..+.+..+..+..+                                          ..+..+++++.
T Consensus       235 ll~~~~~p~~~~~~~e~~~~v~~~~~~------------------------------------------~~p~~~~~~~~  272 (301)
T d1lufa_         235 IFSYGLQPYYGMAHEEVIYYVRDGNIL------------------------------------------ACPENCPLELY  272 (301)
T ss_dssp             HHTTTCCTTTTSCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHH
T ss_pred             HHccCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCccchHHHH
Confidence            99985 788888877776665443211                                          01234678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      +|+.+||+.||++|||+.|+++
T Consensus       273 ~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         273 NLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=413.63  Aligned_cols=247  Identities=26%  Similarity=0.353  Sum_probs=192.8

Q ss_pred             cccccccccccccccceEEEEeeec---eeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVS---REIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~---~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~~~~  238 (804)
                      +.|++++.||+|+||.||+|+...+   ...||||++........+..+.+.+|+.+|++++|||||++++++.+ +..|
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            3499999999999999999986533   34799999875444444556789999999999999999999999975 5678


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||.++ +.+.+.                                 .+.+.+++..+..++.||+.||.|||++||+
T Consensus        87 lv~e~~~~~~l~~~~~---------------------------------~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ii  133 (273)
T d1u46a_          87 MVTELAPLGSLLDRLR---------------------------------KHQGHFLLGTLSRYAVQVAEGMGYLESKRFI  133 (273)
T ss_dssp             EEEECCTTCBHHHHHH---------------------------------HHGGGSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             eeeeeecCcchhhhhh---------------------------------cccCCCCHHHHHHHHHHHHHHHHHhhhCCEe
Confidence            999999864 322221                                 1234689999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCCC-------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-  389 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~~-------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-  389 (804)
                      ||||||+|||++.++.+||+|||+|+.....       ....||+.|+|||++.   ...|+.++|||||||++|||+| 
T Consensus       134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~S~Gvil~emlt~  210 (273)
T d1u46a_         134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTY  210 (273)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh---CCCCCcchhhhhhHHHHHHHHhC
Confidence            9999999999999999999999999764322       2346888999999985   3568999999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHH
Q psy17952        390 RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVS  469 (804)
Q Consensus       390 G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~  469 (804)
                      |++||.+.+..+.+..+.+....                                         ......+|+++.+||.
T Consensus       211 G~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------~~~~~~~~~~l~~li~  249 (273)
T d1u46a_         211 GQEPWIGLNGSQILHKIDKEGER-----------------------------------------LPRPEDCPQDIYNVMV  249 (273)
T ss_dssp             SCCTTTTCCHHHHHHHHHTSCCC-----------------------------------------CCCCTTCCHHHHHHHH
T ss_pred             CCCCCCCcCHHHHHHHHHhCCCC-----------------------------------------CCCcccccHHHHHHHH
Confidence            89999998888877776543210                                         0112456889999999


Q ss_pred             HhcccCCCCCCCHHHHH
Q psy17952        470 SCLAKNPADRPSSGRLL  486 (804)
Q Consensus       470 ~cL~~dP~~Rpsa~elL  486 (804)
                      +||..||++|||+.+++
T Consensus       250 ~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         250 QCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             HHTCSSGGGSCCHHHHH
T ss_pred             HHcCCChhHCcCHHHHH
Confidence            99999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=417.27  Aligned_cols=265  Identities=24%  Similarity=0.359  Sum_probs=191.7

Q ss_pred             cccccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.++||+|+||.||+|++..     +++.||||+++...  .....+.+.+|+.++.++ +|||||.+++++..
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            44569999999999999999999754     56789999986432  233346678888888877 68899999998765


Q ss_pred             c-CceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy17952        234 D-HTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYL  311 (804)
Q Consensus       234 ~-~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yL  311 (804)
                      . ..+|+|||||+| ++.+++....                  ..............+..+++.++..|+.||++||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl  150 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKR------------------NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  150 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTG------------------GGBCC-----------CBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhcc------------------ccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH
Confidence            4 568999999985 5555553110                  0000000111112345689999999999999999999


Q ss_pred             HHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHH
Q psy17952        312 HSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  385 (804)
Q Consensus       312 H~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~  385 (804)
                      |++|||||||||+||||+.++.+||+|||+|+....      ..+.+||+.|||||++.   ++.|+.++|||||||++|
T Consensus       151 H~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDiwS~Gvil~  227 (299)
T d1ywna1         151 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLW  227 (299)
T ss_dssp             HHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             HhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh---cCCCCcccceeehHHHHH
Confidence            999999999999999999999999999999975322      23467999999999985   367899999999999999


Q ss_pred             HHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHH
Q psy17952        386 ELAER-KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTF  464 (804)
Q Consensus       386 ELltG-~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l  464 (804)
                      ||++| .+||.+.+..+.+..+.....                                        .+ .....+++++
T Consensus       228 ellt~~~~p~~~~~~~~~~~~~~~~~~----------------------------------------~~-~~~~~~~~~l  266 (299)
T d1ywna1         228 EIFSLGASPYPGVKIDEEFCRRLKEGT----------------------------------------RM-RAPDYTTPEM  266 (299)
T ss_dssp             HHHTTSCCSSTTCCCSHHHHHHHHHTC----------------------------------------CC-CCCTTCCHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCC----------------------------------------CC-CCCccCCHHH
Confidence            99986 567876654443333322110                                        00 1123468899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        465 AHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       465 ~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      .+|+.+||+.||++|||++|+++|
T Consensus       267 ~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         267 YQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=416.70  Aligned_cols=262  Identities=26%  Similarity=0.357  Sum_probs=202.9

Q ss_pred             cccccccccccccccceEEEEeeecee--EEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEeecCceE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSRE--IVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLRDHTAW  238 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~--~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~~~~~~  238 (804)
                      +.|++.++||+|+||+||+|+++.++.  .||||+++..  ...+..+.+.+|+++|+++ +|||||++++++.+.+.+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            458899999999999999999988876  4778876532  2233456789999999999 7999999999999999999


Q ss_pred             EEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy17952        239 LVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI  317 (804)
Q Consensus       239 lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIi  317 (804)
                      +|||||+| +|.+++...-                  .......+.........+++.++..++.||+.||.|||+++||
T Consensus        88 iV~ey~~~g~L~~~l~~~~------------------~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~ii  149 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSR------------------VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI  149 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTC------------------HHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEecCCCcHHHHHhhcc------------------ccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcc
Confidence            99999984 5656553110                  0000000011122356799999999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCcEEEEecccccccCC---CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCC-CC
Q psy17952        318 HRDVKAGNILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PP  393 (804)
Q Consensus       318 HRDLKP~NILl~~~g~vKL~DFGla~~~~~---~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~-~P  393 (804)
                      ||||||+|||++.++.+||+|||+|+....   .....||+.|+|||.+.   .+.|+.++|||||||++|||++|. +|
T Consensus       150 HrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSfGvil~ell~~~~~p  226 (309)
T d1fvra_         150 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP  226 (309)
T ss_dssp             CSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhc---cCCCCccceeehhHHHHHHHHhcCCCC
Confidence            999999999999999999999999975432   23457999999999985   457999999999999999999965 67


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcc
Q psy17952        394 YFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLA  473 (804)
Q Consensus       394 F~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~  473 (804)
                      |.+.+..+....+.++..+                                          ..+..+++++++||.+||+
T Consensus       227 ~~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~~li~~cl~  264 (309)
T d1fvra_         227 YCGMTCAELYEKLPQGYRL------------------------------------------EKPLNCDDEVYDLMRQCWR  264 (309)
T ss_dssp             TTTCCHHHHHHHGGGTCCC------------------------------------------CCCTTBCHHHHHHHHHHTC
T ss_pred             CCCCCHHHHHHHHHhcCCC------------------------------------------CCCccCCHHHHHHHHHHcC
Confidence            8777776666555432211                                          0123468999999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy17952        474 KNPADRPSSGRLLTH  488 (804)
Q Consensus       474 ~dP~~Rpsa~elL~H  488 (804)
                      .||++|||+.+++++
T Consensus       265 ~dP~~RPs~~eil~~  279 (309)
T d1fvra_         265 EKPYERPSFAQILVS  279 (309)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=410.99  Aligned_cols=263  Identities=24%  Similarity=0.398  Sum_probs=198.9

Q ss_pred             cccccccccccccccccceEEEEeeece-------eEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEE
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCLVSR-------EIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCY  231 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~~~~-------~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~  231 (804)
                      +.+.|++.+.||+|+||.||+|++..++       ..||||+++...  .......+.+|+..+.++ +|||||+++++|
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            4567999999999999999999976554       479999986432  233456788999999988 799999999999


Q ss_pred             eecCceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHH
Q psy17952        232 LRDHTAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNY  310 (804)
Q Consensus       232 ~~~~~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~y  310 (804)
                      .+++..|+|||||.| ++.+++....                  .................+++.++..++.||+.||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~------------------~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y  150 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARR------------------PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY  150 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTS------------------CC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhc------------------CCccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence            999999999999985 4545443110                  000000000111224569999999999999999999


Q ss_pred             HHHCCCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        311 LHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       311 LH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      ||+++||||||||+|||++.++.+||+|||+++....      ....+||+.|+|||++.   ++.|+.++|||||||++
T Consensus       151 lH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~---~~~y~~k~DiwS~Gvvl  227 (299)
T d1fgka_         151 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLL  227 (299)
T ss_dssp             HHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             hhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc---CCCCCchhhhHHhHHHH
Confidence            9999999999999999999999999999999975432      23467999999999985   46899999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHH
Q psy17952        385 IELAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDT  463 (804)
Q Consensus       385 ~ELlt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~  463 (804)
                      |||++ |.+||.+.+.......+..+..+                                          ..+..++++
T Consensus       228 ~ell~~g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~  265 (299)
T d1fgka_         228 WEIFTLGGSPYPGVPVEELFKLLKEGHRM------------------------------------------DKPSNCTNE  265 (299)
T ss_dssp             HHHHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------------------------CCCSSCCHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCccchHH
Confidence            99998 79999877765544433322111                                          112346889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q psy17952        464 FAHFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       464 l~dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      +++||.+||+.||++|||+.|+++
T Consensus       266 l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         266 LYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHH
Confidence            999999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=407.32  Aligned_cols=243  Identities=24%  Similarity=0.366  Sum_probs=190.5

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-cCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-DHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-~~~~~lV  240 (804)
                      +.|++++.||+|+||.||+|+.  +|+.||||+++..     ...+.+.+|+++|++++|||||++++++.+ .+.+|+|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            4589999999999999999987  4778999998642     233678899999999999999999998854 5678999


Q ss_pred             EeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy17952        241 MEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHR  319 (804)
Q Consensus       241 mEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHR  319 (804)
                      ||||+|+ +.+++...                                ....+++..+..|+.||++||.|||+++||||
T Consensus        80 ~ey~~~g~L~~~l~~~--------------------------------~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~  127 (262)
T d1byga_          80 TEYMAKGSLVDYLRSR--------------------------------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR  127 (262)
T ss_dssp             ECCCTTEEHHHHHHHH--------------------------------HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EeccCCCCHHHHHHhc--------------------------------CCCCCCHHHHHHHHHHHHhhccccccCceecc
Confidence            9999864 44443211                                11247899999999999999999999999999


Q ss_pred             CCCCCCeeecCCCcEEEEecccccccCC-CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy17952        320 DVKAGNILLTETGTVKLADFGSASIKCP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPYFNM  397 (804)
Q Consensus       320 DLKP~NILl~~~g~vKL~DFGla~~~~~-~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELlt-G~~PF~~~  397 (804)
                      ||||+|||++.++.+||+|||+++.... .....+|+.|+|||++.   ++.|+.++|||||||++|||+| |++||.+.
T Consensus       128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~---~~~~t~~sDIwSfG~il~el~t~~~~p~~~~  204 (262)
T d1byga_         128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  204 (262)
T ss_dssp             CCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             ccchHhheecCCCCEeecccccceecCCCCccccccccCCChHHHh---CCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence            9999999999999999999999986443 34567899999999985   3579999999999999999998 78888776


Q ss_pred             ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhcccCCC
Q psy17952        398 NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPA  477 (804)
Q Consensus       398 ~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~  477 (804)
                      +..+....+.++..+                                          .....+++++.+||.+||..||.
T Consensus       205 ~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~~li~~cl~~dP~  242 (262)
T d1byga_         205 PLKDVVPRVEKGYKM------------------------------------------DAPDGCPPAVYEVMKNCWHLDAA  242 (262)
T ss_dssp             CGGGHHHHHTTTCCC------------------------------------------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             CHHHHHHHHHcCCCC------------------------------------------CCCccCCHHHHHHHHHHcccCHh
Confidence            665555544322111                                          01234678999999999999999


Q ss_pred             CCCCHHHHHcC
Q psy17952        478 DRPSSGRLLTH  488 (804)
Q Consensus       478 ~Rpsa~elL~H  488 (804)
                      +|||+.+++++
T Consensus       243 ~Rps~~~l~~~  253 (262)
T d1byga_         243 MRPSFLQLREQ  253 (262)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=406.32  Aligned_cols=257  Identities=22%  Similarity=0.353  Sum_probs=207.0

Q ss_pred             ccccccccccccccccceEEEEeee-----ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC
Q psy17952        161 EKIFEDLREIGHGSFGAVYYARCLV-----SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH  235 (804)
Q Consensus       161 ~~~y~~l~~LG~G~fG~Vy~a~~~~-----~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~  235 (804)
                      .+.|++.++||+|+||.||+|.+..     +++.||||+++...  .......+.+|++++++++|||||++++++..++
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            3568999999999999999998763     46789999986432  2344567899999999999999999999999999


Q ss_pred             ceEEEEeecCC-CchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17952        236 TAWLVMEYCLG-SASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSL  314 (804)
Q Consensus       236 ~~~lVmEy~~G-~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~  314 (804)
                      ..++|||||.+ ++.+++.....                        ..........+++..+..++.|+++||.|||++
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~  152 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRP------------------------AMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN  152 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHH------------------------HHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ceeEEEeecCCCCHHHHHHhccc------------------------ccccccccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            99999999985 55555432100                        000011223578999999999999999999999


Q ss_pred             CCeecCCCCCCeeecCCCcEEEEecccccccCC------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHH
Q psy17952        315 GRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  388 (804)
Q Consensus       315 gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELl  388 (804)
                      +|+||||||+|||++.++++||+|||+|+....      .....||+.|+|||.+.   ++.|+.++|||||||++|||+
T Consensus       153 ~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~---~~~~~~~~Dv~S~G~il~El~  229 (308)
T d1p4oa_         153 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIA  229 (308)
T ss_dssp             TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHH
T ss_pred             CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHc---cCCCCcccccccHHHHHHHHH
Confidence            999999999999999999999999999975432      23457999999999985   467899999999999999999


Q ss_pred             hC-CCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHH
Q psy17952        389 ER-KPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHF  467 (804)
Q Consensus       389 tG-~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dl  467 (804)
                      || .+||.+.+..+.+..+.++..+                                          .....+++.+.+|
T Consensus       230 t~~~~p~~~~~~~~~~~~i~~~~~~------------------------------------------~~p~~~~~~l~~l  267 (308)
T d1p4oa_         230 TLAEQPYQGLSNEQVLRFVMEGGLL------------------------------------------DKPDNCPDMLFEL  267 (308)
T ss_dssp             HTSCCTTTTSCHHHHHHHHHTTCCC------------------------------------------CCCTTCCHHHHHH
T ss_pred             hCCCCCCCCCCHHHHHHHHHhCCCC------------------------------------------CCcccchHHHHHH
Confidence            98 5888888877776666543211                                          0123467899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q psy17952        468 VSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       468 i~~cL~~dP~~Rpsa~elL~H  488 (804)
                      |.+||+.||++|||+.+++++
T Consensus       268 i~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         268 MRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999973

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=407.98  Aligned_cols=266  Identities=25%  Similarity=0.352  Sum_probs=203.7

Q ss_pred             cccccccccccccccccceEEEEee-----eceeEEEEEecccccccchhhhhhHHHHHHHHhhc-CCCceeEeeeEEee
Q psy17952        160 PEKIFEDLREIGHGSFGAVYYARCL-----VSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQL-KHPNTIEYRGCYLR  233 (804)
Q Consensus       160 p~~~y~~l~~LG~G~fG~Vy~a~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~  233 (804)
                      +.+.|++.++||+|+||.||+|+..     .+++.||||+++...  .......+.+|+.+++++ +|||||++++++.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            4567999999999999999999864     467899999987533  233456788999999999 69999999999999


Q ss_pred             cCceEEEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17952        234 DHTAWLVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLH  312 (804)
Q Consensus       234 ~~~~~lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH  312 (804)
                      .+..|+|||||.|+ +.+++.....     ..    ..       ..............+++.++..|+.||+.||+|||
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~-----~~----~~-------~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH  162 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRD-----SF----IC-------SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA  162 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTT-----TC-------------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccc-----cc----cc-------cccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            99999999999864 4444431100     00    00       00000011123457999999999999999999999


Q ss_pred             HCCCeecCCCCCCeeecCCCcEEEEecccccccCCC------CccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        313 SLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       313 ~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~------~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      ++|||||||||+|||++.++.+||+|||+++.....      ...+||+.|+|||++.   .+.|+.++|||||||++||
T Consensus       163 ~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwS~G~~l~e  239 (311)
T d1t46a_         163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWE  239 (311)
T ss_dssp             HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHH
T ss_pred             hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc---CCCCCCcccccchHHHHHH
Confidence            999999999999999999999999999999754321      3468999999999985   3578999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHH
Q psy17952        387 LAE-RKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFA  465 (804)
Q Consensus       387 Llt-G~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~  465 (804)
                      |+| |.+||.+.+..+.+..+.....                                         +......+++++.
T Consensus       240 llt~g~p~~~~~~~~~~~~~~i~~~~-----------------------------------------~~~~~~~~~~~l~  278 (311)
T d1t46a_         240 LFSLGSSPYPGMPVDSKFYKMIKEGF-----------------------------------------RMLSPEHAPAEMY  278 (311)
T ss_dssp             HHTTTCCSSTTCCSSHHHHHHHHHTC-----------------------------------------CCCCCTTSCHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHhcCC-----------------------------------------CCCCcccccHHHH
Confidence            998 6666766655555544433211                                         1111235689999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q psy17952        466 HFVSSCLAKNPADRPSSGRLLT  487 (804)
Q Consensus       466 dli~~cL~~dP~~Rpsa~elL~  487 (804)
                      +||.+||+.||++|||++++++
T Consensus       279 ~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         279 DIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999885

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-46  Score=401.14  Aligned_cols=256  Identities=21%  Similarity=0.285  Sum_probs=195.2

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCcee-EeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI-EYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV-~l~~~~~~~~~~~lV  240 (804)
                      +.|++.++||+|+||+||+|++..+|+.||||.+....     ....+.+|++++++++|+|+| .+.+++.+.+..|+|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            35999999999999999999999999999999875422     224578999999999877655 556667788889999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|++.+.+.                                 ...+.+++..+..++.|++.||+|||++||||||
T Consensus        82 me~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrD  128 (299)
T d1ckia_          82 MELLGPSLEDLFN---------------------------------FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD  128 (299)
T ss_dssp             EECCCCBHHHHHH---------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             EEEcCCchhhhhh---------------------------------hccCCCcHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            9999887544321                                 1345799999999999999999999999999999


Q ss_pred             CCCCCeeecC---CCcEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHH
Q psy17952        321 VKAGNILLTE---TGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  386 (804)
Q Consensus       321 LKP~NILl~~---~g~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~E  386 (804)
                      |||+|||++.   +..+||+|||+|+....           ..+.+||+.|||||++.   +..|+.++|||||||++||
T Consensus       129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~e  205 (299)
T d1ckia_         129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYVLMY  205 (299)
T ss_dssp             CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT---TBCCCHHHHHHHHHHHHHH
T ss_pred             CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHh---CCCCCChhhEEecCHHHHH
Confidence            9999999864   45799999999975322           23468999999999985   4568999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHH
Q psy17952        387 LAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAH  466 (804)
Q Consensus       387 LltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~d  466 (804)
                      |++|++||.+.+.......+.+..                .....                   ..+......+|+++.+
T Consensus       206 l~tg~~P~~~~~~~~~~~~~~~~~----------------~~~~~-------------------~~~~~~~~~~p~~~~~  250 (299)
T d1ckia_         206 FNLGSLPWQGLKAATKRQKYERIS----------------EKKMS-------------------TPIEVLCKGYPSEFAT  250 (299)
T ss_dssp             HHHSSCTTCCCC-------HHHHH----------------HHHHH-------------------SCHHHHTTTSCHHHHH
T ss_pred             HHhCCCcccccchHHHHHHHHHhh----------------cccCC-------------------CChhHhccCCCHHHHH
Confidence            999999998765433322221100                00000                   0000112357899999


Q ss_pred             HHHHhcccCCCCCCCHHHH---HcCccccC
Q psy17952        467 FVSSCLAKNPADRPSSGRL---LTHDLVTR  493 (804)
Q Consensus       467 li~~cL~~dP~~Rpsa~el---L~Hp~~~~  493 (804)
                      |+.+||+.||++||+++++   |+|+|...
T Consensus       251 li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         251 YLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            9999999999999999754   56666543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=399.00  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=189.4

Q ss_pred             ccccccccccceEEEEeeece---eEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEee-cCceEEEEe
Q psy17952        167 LREIGHGSFGAVYYARCLVSR---EIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLR-DHTAWLVME  242 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~~~~---~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~-~~~~~lVmE  242 (804)
                      -++||+|+||+||+|++..++   ..||||+++..  ......+++.+|+++|++++|||||++++++.. ++..|+|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            467999999999999986643   36999998642  234456789999999999999999999999765 568999999


Q ss_pred             ecCCCch-hhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q psy17952        243 YCLGSAS-DIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV  321 (804)
Q Consensus       243 y~~G~l~-dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRDL  321 (804)
                      ||+|+.. +++.                                 .....+++..+..++.|++.||.|||+.+|+||||
T Consensus       110 ~~~~g~l~~~~~---------------------------------~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDL  156 (311)
T d1r0pa_         110 YMKHGDLRNFIR---------------------------------NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL  156 (311)
T ss_dssp             CCTTCBHHHHHH---------------------------------CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EeecCchhhhhc---------------------------------cccccchHHHHHHHHHHHHHhhhhhcccCcccCCc
Confidence            9997532 2221                                 12345778889999999999999999999999999


Q ss_pred             CCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy17952        322 KAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  393 (804)
Q Consensus       322 KP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil~ELltG~~P  393 (804)
                      ||+||||++++.+||+|||+++....        .....||+.|+|||++.   .+.|+.++|||||||++|||++|..|
T Consensus       157 K~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~SfGivl~El~t~~~p  233 (311)
T d1r0pa_         157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAP  233 (311)
T ss_dssp             SGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHh---cCCCCChhHhhhhHHHHHHHHHCCCC
Confidence            99999999999999999999975322        12357899999999985   36789999999999999999998777


Q ss_pred             CCCC-ChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCccHHHHHHHHHhc
Q psy17952        394 YFNM-NAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSDTFAHFVSSCL  472 (804)
Q Consensus       394 F~~~-~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s~~l~dli~~cL  472 (804)
                      |... +..+....+.++..                                          ...+..+++++.+||.+||
T Consensus       234 ~~~~~~~~~~~~~i~~g~~------------------------------------------~~~p~~~~~~l~~li~~cl  271 (311)
T d1r0pa_         234 PYPDVNTFDITVYLLQGRR------------------------------------------LLQPEYCPDPLYEVMLKCW  271 (311)
T ss_dssp             SCC------CHHHHHTTCC------------------------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHHHcCCC------------------------------------------CCCcccCcHHHHHHHHHHc
Confidence            7543 22222222222111                                          1112346889999999999


Q ss_pred             ccCCCCCCCHHHHHcC
Q psy17952        473 AKNPADRPSSGRLLTH  488 (804)
Q Consensus       473 ~~dP~~Rpsa~elL~H  488 (804)
                      +.||++|||+.|+++|
T Consensus       272 ~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         272 HPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHH
Confidence            9999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-44  Score=386.79  Aligned_cols=246  Identities=18%  Similarity=0.246  Sum_probs=195.4

Q ss_pred             cccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCC-CceeEeeeEEeecCceEEE
Q psy17952        162 KIFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKH-PNTIEYRGCYLRDHTAWLV  240 (804)
Q Consensus       162 ~~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~~~~~~~~~~~lV  240 (804)
                      ..|++.+.||+|+||+||+|++..+|+.||||.++...     ....+.+|+++++.|+| +||+.+++++..+...|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            45999999999999999999999999999999875321     12457789999999976 8999999999999999999


Q ss_pred             EeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q psy17952        241 MEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD  320 (804)
Q Consensus       241 mEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~~gIiHRD  320 (804)
                      ||||.|++.+++.                                 .....+++..+..++.|++.||+|||++||||||
T Consensus        80 me~~~~~l~~~~~---------------------------------~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrD  126 (293)
T d1csna_          80 IDLLGPSLEDLLD---------------------------------LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD  126 (293)
T ss_dssp             EECCCCBHHHHHH---------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             EEecCCCHHHHHH---------------------------------hhccchhhHHHHHHHHHHHHHHHHHHHCCceecc
Confidence            9999877655442                                 1234689999999999999999999999999999


Q ss_pred             CCCCCeeecC-----CCcEEEEecccccccCC-----------CCccccCcccccchhhcccCCCCCCCcccHHHHHHHH
Q psy17952        321 VKAGNILLTE-----TGTVKLADFGSASIKCP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       321 LKP~NILl~~-----~g~vKL~DFGla~~~~~-----------~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      |||+|||++.     ++.+||+|||+|+....           ..+.+||+.|||||++.   +..|+.++|||||||++
T Consensus       127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~---~~~~~~~~DiwSlG~~l  203 (293)
T d1csna_         127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHVF  203 (293)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHH
T ss_pred             CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhc---CCCCChHHHHHHhhHHH
Confidence            9999999974     57899999999975321           23468999999999985   45699999999999999


Q ss_pred             HHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCCCcc
Q psy17952        385 IELAERKPPYFNMNA---MSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWS  461 (804)
Q Consensus       385 ~ELltG~~PF~~~~~---~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~~~s  461 (804)
                      |||++|+.||.+.+.   ......+....                   ...+                   +......+|
T Consensus       204 ~elltg~~Pf~~~~~~~~~~~~~~i~~~~-------------------~~~~-------------------~~~l~~~~p  245 (293)
T d1csna_         204 MYFLRGSLPWQGLKAATNKQKYERIGEKK-------------------QSTP-------------------LRELCAGFP  245 (293)
T ss_dssp             HHHHHSSCTTSSCCSCCHHHHHHHHHHHH-------------------HHSC-------------------HHHHTTTSC
T ss_pred             HHHHhCCCcCCCccchhHHHHHHHHHhcc-------------------CCCC-------------------hHHhcCCCC
Confidence            999999999976432   22222221100                   0000                   000113467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHH
Q psy17952        462 DTFAHFVSSCLAKNPADRPSSGRLL  486 (804)
Q Consensus       462 ~~l~dli~~cL~~dP~~Rpsa~elL  486 (804)
                      +++.+|+..|+..+|++||+.+.+.
T Consensus       246 ~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         246 EEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHH
Confidence            8999999999999999999986653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-45  Score=391.45  Aligned_cols=264  Identities=25%  Similarity=0.295  Sum_probs=182.6

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCceeEeeeEEeecC----ceE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTIEYRGCYLRDH----TAW  238 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~~~----~~~  238 (804)
                      .|.+.+.||+|+||.||+|+.  +|+.||||+++...    .......+|+..+++++|||||++++++.+.+    .+|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            477889999999999999974  68899999886321    11112234555667889999999999998754    579


Q ss_pred             EEEeecCCC-chhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHHHHHH----
Q psy17952        239 LVMEYCLGS-ASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLNYLHS----  313 (804)
Q Consensus       239 lVmEy~~G~-l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~yLH~----  313 (804)
                      +|||||.++ |.++++                                   +.++++.++..++.|++.||.|||+    
T Consensus        78 lv~Ey~~~g~L~~~l~-----------------------------------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~  122 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLN-----------------------------------RYTVTVEGMIKLALSTASGLAHLHMEIVG  122 (303)
T ss_dssp             EEEECCTTCBHHHHHH-----------------------------------HCCBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred             EEEecccCCCHHHHHh-----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence            999999864 433332                                   2368899999999999999999997    


Q ss_pred             ----CCCeecCCCCCCeeecCCCcEEEEecccccccCC--------CCccccCcccccchhhcccCC---CCCCCcccHH
Q psy17952        314 ----LGRIHRDVKAGNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDE---GQYDGKVDVW  378 (804)
Q Consensus       314 ----~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~--------~~~~~GT~~Y~APEvl~~~~~---~~y~~ksDIW  378 (804)
                          +|||||||||+||||+.++.+||+|||+|+....        ....+||+.|||||++.+...   ..++.++|||
T Consensus       123 ~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~  202 (303)
T d1vjya_         123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY  202 (303)
T ss_dssp             TTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred             hccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhh
Confidence                5999999999999999999999999999975422        234689999999999853211   1267789999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCchhhHHhhcccccCCCCccchhhhHHHHhhccCCCCCCCCC
Q psy17952        379 SLGITCIELAERKPPYFNMNAMSALYHIAQNDTPCLQSSDWSVIKTISSTAERKPPYFNMNAMSALYHIAQNDTPCLQSS  458 (804)
Q Consensus       379 SlGvil~ELltG~~PF~~~~~~~~l~~I~~~~~p~~~~~~~~~i~~i~~~~~~~pp~~~~~~~~~l~~i~~~~~p~~~~~  458 (804)
                      ||||+||||+||.+||.........+.    . ..........+..........|+.                .......
T Consensus       203 S~Gvvl~el~tg~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~p~~----------------~~~~~~~  261 (303)
T d1vjya_         203 AMGLVFWEIARRCSIGGIHEDYQLPYY----D-LVPSDPSVEEMRKVVCEQKLRPNI----------------PNRWQSC  261 (303)
T ss_dssp             HHHHHHHHHHHTBCBTTBCCCCCCTTT----T-TSCSSCCHHHHHHHHTTSCCCCCC----------------CGGGGGC
T ss_pred             hhHHHHHHHhhCCCCCCcccccccchh----h-cccccchHHHHHHHHhccccCCCC----------------CcccCCh
Confidence            999999999999998854321100000    0 000000000000000000000000                0001112


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy17952        459 DWSDTFAHFVSSCLAKNPADRPSSGRLLTH  488 (804)
Q Consensus       459 ~~s~~l~dli~~cL~~dP~~Rpsa~elL~H  488 (804)
                      ..+..+.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         262 EALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            234668999999999999999999998864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.7e-43  Score=382.38  Aligned_cols=284  Identities=20%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             ccccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-----------CCceeEeeeEE
Q psy17952        163 IFEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-----------HPNTIEYRGCY  231 (804)
Q Consensus       163 ~y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpNIV~l~~~~  231 (804)
                      +|+++++||+|+||+||+|+++.+|+.||||+++..    ....+.+.+|+++|+.++           |||||++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            499999999999999999999999999999998642    122356678999888775           57899999887


Q ss_pred             eec--CceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHHH
Q psy17952        232 LRD--HTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGLN  309 (804)
Q Consensus       232 ~~~--~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL~  309 (804)
                      ...  ...+++|+++.+.....                              ..........+++..++.++.||+.||+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~i~~qil~al~  139 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLL------------------------------ALIKKYEHRGIPLIYVKQISKQLLLGLD  139 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHH------------------------------HHHHHTTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             eeccccceeeeeeecccccccc------------------------------cccccccccCCcHHHHHHHHHHHHHHHH
Confidence            654  45677777775431110                              0111223457899999999999999999


Q ss_pred             HHHH-CCCeecCCCCCCeeecCCCc------EEEEecccccccC-CCCccccCcccccchhhcccCCCCCCCcccHHHHH
Q psy17952        310 YLHS-LGRIHRDVKAGNILLTETGT------VKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  381 (804)
Q Consensus       310 yLH~-~gIiHRDLKP~NILl~~~g~------vKL~DFGla~~~~-~~~~~~GT~~Y~APEvl~~~~~~~y~~ksDIWSlG  381 (804)
                      |||+ +||+||||||+||||+.++.      +|++|||.|.... .....+||+.|+|||++.   ...|+.++||||+|
T Consensus       140 ~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG  216 (362)
T d1q8ya_         140 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTA  216 (362)
T ss_dssp             HHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH---TCCCCTHHHHHHHH
T ss_pred             HHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccccccccccccccChhhcc---ccCCCccccccchH
Confidence            9998 89999999999999987653      9999999997543 345678999999999985   35789999999999


Q ss_pred             HHHHHHHhCCCCCCCCCh------HHHHHHHHh--cCCCCCCCCchhhHHhhcc------c--ccCCCCccchhhhHHHH
Q psy17952        382 ITCIELAERKPPYFNMNA------MSALYHIAQ--NDTPCLQSSDWSVIKTISS------T--AERKPPYFNMNAMSALY  445 (804)
Q Consensus       382 vil~ELltG~~PF~~~~~------~~~l~~I~~--~~~p~~~~~~~~~i~~i~~------~--~~~~pp~~~~~~~~~l~  445 (804)
                      |+++||++|+.||...+.      ...+..+..  +..|.      ........      .  .....+...........
T Consensus       217 ~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (362)
T d1q8ya_         217 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS------YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL  290 (362)
T ss_dssp             HHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH------HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH
T ss_pred             HHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCH------HHhhcccccccccccchhhhccccccCCchhhhc
Confidence            999999999999975432      122222211  11110      00000000      0  00000000000000000


Q ss_pred             hhccCCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHcCccccCC
Q psy17952        446 HIAQNDTPCLQSSDWSDTFAHFVSSCLAKNPADRPSSGRLLTHDLVTRP  494 (804)
Q Consensus       446 ~i~~~~~p~~~~~~~s~~l~dli~~cL~~dP~~Rpsa~elL~Hp~~~~~  494 (804)
                      .   .  ........++++.|||.+||++||.+||||+|+|+||||+..
T Consensus       291 ~---~--~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         291 T---E--KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             H---H--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             c---c--ccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence            0   0  001123457889999999999999999999999999999854

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.5e-32  Score=295.38  Aligned_cols=138  Identities=80%  Similarity=1.326  Sum_probs=126.9

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|++|+|||||+++++|.+++.+|||||||.|++++.+...+.++++..++.++.||+.||.|||++||+||||||+||
T Consensus        67 ~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI  146 (309)
T d1u5ra_          67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  146 (309)
T ss_dssp             HHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             HHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence            57899999999999999999999999999999887777666678899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccCCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKCPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.++.+||+|||+|.........+||+.|||||++.+...+.|+.++|+||+|++.
T Consensus       147 Ll~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvil  204 (309)
T d1u5ra_         147 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  204 (309)
T ss_dssp             EEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHH
T ss_pred             EECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHH
Confidence            9999999999999999877666778999999999998654456799999999999983

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.4e-32  Score=282.57  Aligned_cols=135  Identities=30%  Similarity=0.514  Sum_probs=119.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.|+ +.+++. ....+++..++.++.||++||+|||++||+||||||+
T Consensus        57 ~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~  135 (263)
T d2j4za1          57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE  135 (263)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccc
Confidence            36889999999999999999999999999999865 555554 4568999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++++|.+||+|||+|....  .....+||+.|||||++.   ...|+.++|+||+|+++
T Consensus       136 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvil  194 (263)
T d2j4za1         136 NLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVLC  194 (263)
T ss_dssp             GEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHT---TCCCCTTHHHHHHHHHH
T ss_pred             cceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHc---CCCCCchhhhhhHhHHH
Confidence            9999999999999999997543  234568999999999983   45789999999999983

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=289.59  Aligned_cols=135  Identities=32%  Similarity=0.569  Sum_probs=116.9

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~N   84 (804)
                      .+|++++|||||+++++|.+++.+|||||||+|+.+..+..+.+.+++..++.++.|+++||.|||+ ++|+||||||+|
T Consensus        56 ~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N  135 (322)
T d1s9ja_          56 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  135 (322)
T ss_dssp             GGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred             HHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence            5789999999999999999999999999999975444433445689999999999999999999997 599999999999


Q ss_pred             EEEcCCCceEEeccCccccc--CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIK--CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.+|.+||+|||+|+..  ....+.+||++|||||++.   ...|+.++|+||+|+++
T Consensus       136 ILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvil  193 (322)
T d1s9ja_         136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLSL  193 (322)
T ss_dssp             EEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHH---CSCCCTTHHHHHHHHHH
T ss_pred             eeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHc---CCCCCcHHHHHHHHHHH
Confidence            99999999999999999752  3345679999999999984   45799999999999984

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=282.61  Aligned_cols=135  Identities=33%  Similarity=0.560  Sum_probs=117.5

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ++|++++|||||+++++|.+++.+|||||||+| +|.+++. ....+++..++.++.||++||+|||++|||||||||+|
T Consensus        55 ~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~N  133 (271)
T d1nvra_          55 CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN  133 (271)
T ss_dssp             HHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHH
Confidence            688999999999999999999999999999986 5666653 45689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||+|+...      .....+||+.|||||++.+  ...++.++|+||+|+++
T Consensus       134 ILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvil  196 (271)
T d1nvra_         134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVL  196 (271)
T ss_dssp             EEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHH
T ss_pred             EEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHH
Confidence            999999999999999997531      2345689999999999842  22346789999999983

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.8e-31  Score=281.40  Aligned_cols=134  Identities=44%  Similarity=0.781  Sum_probs=118.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.|+.+..+.. +.++++..++.++.||+.||+|||++|||||||||+|
T Consensus        68 ~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~N  146 (293)
T d1yhwa1          68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN  146 (293)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHH
Confidence            368999999999999999999999999999998765544433 3579999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+|.+||+|||+|+...    .....+||+.|||||++.   .+.|+.++|+||+|++
T Consensus       147 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DiwSlGvi  205 (293)
T d1yhwa1         147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIM  205 (293)
T ss_dssp             EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHS---SSCBCTHHHHHHHHHH
T ss_pred             eEECCCCcEeeccchhheeeccccccccccccCCCccChhhhc---CCCCCchhceehHhHH
Confidence            999999999999999997532    234568999999999983   4678999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=283.61  Aligned_cols=139  Identities=45%  Similarity=0.858  Sum_probs=120.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++|+|||||+++++|.+++.+|||||||.|+. .+++.....++++..++.++.||++||.|||+++|+||||||+
T Consensus        60 ~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~  139 (288)
T d2jfla1          60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAG  139 (288)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChh
Confidence            468999999999999999999999999999998655 4555555678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhc--ccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~--~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||+|+...    .....+||+.|||||++...  ....|+.++|+||+|+++
T Consensus       140 NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvil  205 (288)
T d2jfla1         140 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL  205 (288)
T ss_dssp             GEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHH
T ss_pred             heeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHH
Confidence            9999999999999999996432    23457899999999998422  235689999999999983

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.4e-31  Score=284.51  Aligned_cols=135  Identities=30%  Similarity=0.551  Sum_probs=120.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+++.+|||||||.|+.+..+....+.++++.++.++.||+.||+|||++|||||||||+|
T Consensus        56 ~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~N  135 (337)
T d1o6la_          56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN  135 (337)
T ss_dssp             HHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred             HHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHH
Confidence            35899999999999999999999999999999976655444556789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+|.+||+|||+|+...    .....+||+.|||||++   ....|+.++|+||+|++
T Consensus       136 ILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~---~~~~y~~~~DiwSlGvi  194 (337)
T d1o6la_         136 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL---EDNDYGRAVDWWGLGVV  194 (337)
T ss_dssp             EEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGG---SSSCBCTTHHHHHHHHH
T ss_pred             eEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhc---cCCCCChhhcccchhhH
Confidence            999999999999999997532    23457899999999998   34679999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.7e-31  Score=280.80  Aligned_cols=135  Identities=30%  Similarity=0.508  Sum_probs=117.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||+++++|.+++.+|||||||+|+ |.+++. ..+.+++..++.++.|++.||+|||+++||||||||+
T Consensus        59 ~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~  137 (288)
T d1uu3a_          59 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE  137 (288)
T ss_dssp             HHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcc
Confidence            35789999999999999999999999999999865 445544 4578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||+|+...      .....+||+.|||||++.   ...|+.++|+||+|+++
T Consensus       138 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~~~~DiwSlGvil  200 (288)
T d1uu3a_         138 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT---EKSACKSSDLWALGCII  200 (288)
T ss_dssp             GEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHH---TCCCCHHHHHHHHHHHH
T ss_pred             ccccCCCceEEecccccceecccCCcccccccccCCccccCceeec---cCCCCcccceehhhHHH
Confidence            9999999999999999997532      223468999999999984   45789999999999983

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=1.1e-30  Score=281.65  Aligned_cols=135  Identities=30%  Similarity=0.509  Sum_probs=122.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+++.+|+|||||.|+.+..+......++++.++.++.||+.||+|||++|||||||||+|
T Consensus        55 ~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~N  134 (316)
T d1fota_          55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN  134 (316)
T ss_dssp             HHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred             HHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchh
Confidence            35889999999999999999999999999999988776666677889999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCccccc-CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIK-CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+|.+||+|||+|+.. ......+||+.|||||++   ....|+.++|+||+|++
T Consensus       135 ILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l---~~~~y~~~~DiwSlGvi  190 (316)
T d1fota_         135 ILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVV---STKPYNKSIDWWSFGIL  190 (316)
T ss_dssp             EEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHH---TTCCBCTTHHHHHHHHH
T ss_pred             eeEcCCCCEEEecCccceEeccccccccCcccccCHHHH---cCCCCCchhhccccchh
Confidence            99999999999999999764 344567899999999998   34579999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.7e-31  Score=279.16  Aligned_cols=147  Identities=32%  Similarity=0.550  Sum_probs=122.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||++++++ .++.+|||||||+ |+|.+++...+.++++..+..++.||++||+|||+++||||||||+
T Consensus        55 ~~~l~~l~HpnIv~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~  133 (276)
T d1uwha_          55 VGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN  133 (276)
T ss_dssp             HHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCEeeeeEEE-eccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHH
Confidence            4678999999999999975 4567899999998 5667777666678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccCCCCCCCcchhccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITPGSLKDPEIAELFDK  157 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~g~l~~~~i~elf~~  157 (804)
                      |||++.++.+||+|||+|+....      .....||+.|||||++.+...+.|+.++|+||+|++        +.+++..
T Consensus       134 NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~--------l~el~tg  205 (276)
T d1uwha_         134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV--------LYELMTG  205 (276)
T ss_dssp             GEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHH--------HHHHHHS
T ss_pred             HEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHH--------HHHHHHC
Confidence            99999999999999999975321      234689999999999854444568999999999998        5555554


Q ss_pred             CCc
Q psy17952        158 EDP  160 (804)
Q Consensus       158 ~dp  160 (804)
                      ..|
T Consensus       206 ~~P  208 (276)
T d1uwha_         206 QLP  208 (276)
T ss_dssp             SCT
T ss_pred             CCC
Confidence            444

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-30  Score=275.29  Aligned_cols=134  Identities=34%  Similarity=0.615  Sum_probs=115.1

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe----CCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLG--RIH   77 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~--IiH   77 (804)
                      .++|++++|||||+++++|.+    +..+|||||||+|+ |.+++. ....++++.++.++.||++||+|||+++  |||
T Consensus        59 ~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiH  137 (270)
T d1t4ha_          59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH  137 (270)
T ss_dssp             HHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred             HHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEe
Confidence            367899999999999999875    35689999999865 445554 4568999999999999999999999998  999


Q ss_pred             cccccccEEEc-CCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         78 RDVKAGNILLT-ETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        78 RDlKp~Nill~-~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||||+|||++ +++.+||+|||+|+...  .....+||+.|||||++.    +.|+.++|+||+|+++
T Consensus       138 rDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~~DIwSlGvil  202 (270)
T d1t4ha_         138 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCM  202 (270)
T ss_dssp             SCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHH
T ss_pred             CCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhC----CCCCCcCchhhHHHHH
Confidence            99999999996 57899999999998643  334578999999999872    4699999999999983

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2.6e-30  Score=277.57  Aligned_cols=135  Identities=32%  Similarity=0.577  Sum_probs=108.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+++++|.+++.+|||||||+| +|.+++. .++++++..++.++.||+.||+|||+++|+||||||+
T Consensus        58 i~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~  136 (307)
T d1a06a_          58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE  136 (307)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEeccc
Confidence            3689999999999999999999999999999985 5556654 5678999999999999999999999999999999999


Q ss_pred             cEEEc---CCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLT---ETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~---~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+.   +++.+||+|||+|+...   .....+||+.|||||++.   ...|+.++|+||+|+++
T Consensus       137 Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~---~~~~~~~~DiwSlGvil  199 (307)
T d1a06a_         137 NLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIA  199 (307)
T ss_dssp             GEEESSSSTTCCEEECCC------------------CTTSCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             ceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHc---CCCCCcHHHhhhhhHHH
Confidence            99994   57899999999997643   234568999999999983   45799999999999983

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4e-30  Score=269.90  Aligned_cols=135  Identities=29%  Similarity=0.529  Sum_probs=112.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++|+|..++.+|||||||.+ ++.+++......++++.+..++.|++.||+|||+++|+||||||+
T Consensus        51 ~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~  130 (263)
T d1sm2a_          51 AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR  130 (263)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGG
T ss_pred             HHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchh
Confidence            4678999999999999999999999999999985 566666666678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+++++.+||+|||+|+....     .....||+.|||||++   ..+.|+.++|+||+|++
T Consensus       131 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~k~DVwS~Gvi  191 (263)
T d1sm2a_         131 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF---SFSRYSSKSDVWSFGVL  191 (263)
T ss_dssp             GEEECGGGCEEECSCC------------------CTTSCCHHHH---TTCCCCHHHHHHHHHHH
T ss_pred             heeecCCCCeEecccchheeccCCCceeecceecCcccCChHHh---cCCCCCchhhhcchHHH
Confidence            99999999999999999975321     2235799999999998   34679999999999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=1e-29  Score=277.83  Aligned_cols=134  Identities=28%  Similarity=0.474  Sum_probs=119.8

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|+.++|||||+++++|.+...+|+|||||.|+.+.......+.+++..++.++.||+.||.|||+++||||||||+||
T Consensus        93 ~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NI  172 (350)
T d1rdqe_          93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL  172 (350)
T ss_dssp             HHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHc
Confidence            57899999999999999999999999999998765444434457899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         86 LLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |++.+|.+||+|||+|+... .....+||+.|||||++.   ...|+.++|+||+|++
T Consensus       173 Ll~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvi  227 (350)
T d1rdqe_         173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL---SKGYNKAVDWWALGVL  227 (350)
T ss_dssp             EECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             ccCCCCCEEeeeceeeeecccccccccCccccCCHHHHc---CCCCCccccccchhHH
Confidence            99999999999999997643 445678999999999984   4578999999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=4.4e-30  Score=274.76  Aligned_cols=134  Identities=26%  Similarity=0.479  Sum_probs=110.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++|+|||||+++++|.+++.+|||||||+|+. .+++....+.+++.++..++.||++||+|||+++||||||||+|
T Consensus        79 ~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~N  158 (299)
T d1jpaa_          79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN  158 (299)
T ss_dssp             HHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             HHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccce
Confidence            57899999999999999999999999999998654 45555556689999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCC---------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKCP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~---------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||+|+....         .....||+.|||||++.   .+.|+.++||||+|++
T Consensus       159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~sDvwS~Gvv  222 (299)
T d1jpaa_         159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ---YRKFTSASDVWSYGIV  222 (299)
T ss_dssp             EEECTTCCEEECCC-----------------------CGGGSCHHHHH---SCCCCHHHHHHHHHHH
T ss_pred             EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHh---cCCCCcccccccchHH
Confidence            9999999999999999975321         11245899999999973   4679999999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.9e-30  Score=271.97  Aligned_cols=135  Identities=39%  Similarity=0.684  Sum_probs=106.7

Q ss_pred             HHHHhcCCCCeeeEeEEEEe--CCeEEEEEeccCC-CcHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhcC-----
Q psy17952          6 SLLRQLKHPNTIEYRGCYLR--DHTAWLVMEYCLG-SASDIIEV---HKRPLKEEEIAAICSGVLRGLNYLHSLG-----   74 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~--~~~~~lV~Ey~~g-~l~~~~~~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-----   74 (804)
                      .+|++++|||||+++++|.+  ++.+|||||||+| +|.+++..   .+..+++..++.++.||+.||+|||+++     
T Consensus        55 ~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~  134 (269)
T d2java1          55 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT  134 (269)
T ss_dssp             HHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC----
T ss_pred             HHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            57889999999999999864  4569999999985 56666543   2468999999999999999999999876     


Q ss_pred             ccccccccccEEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         75 RIHRDVKAGNILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        75 IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||||||||+|||++.+|.+||+|||+|+...    .....+||+.|||||++   ....|+.++|+||+|++.
T Consensus       135 IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l---~~~~~~~~~DIwSlGvil  204 (269)
T d2java1         135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM---NRMSYNEKSDIWSLGCLL  204 (269)
T ss_dssp             -----CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHH---TTCCCCHHHHHHHHHHHH
T ss_pred             EEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHH---cCCCCChHHHHHhhCHHH
Confidence            9999999999999999999999999997532    23456899999999998   345789999999999983

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.5e-30  Score=274.28  Aligned_cols=136  Identities=34%  Similarity=0.495  Sum_probs=122.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|++++|||||+++++|.+++.+|||||||.|+++..+......+++..++.++.||+.||+|||++||+||||||+||
T Consensus        52 ~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NI  131 (299)
T d1ua2a_          52 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL  131 (299)
T ss_dssp             HHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             HHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceE
Confidence            57899999999999999999999999999999988887776677899999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.++.+||+|||+|+...    .....+||+.|||||++..  ...|+.++|+||+|+++
T Consensus       132 li~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil  191 (299)
T d1ua2a_         132 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG--ARMYGVGVDMWAVGCIL  191 (299)
T ss_dssp             EECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT--CSCCCHHHHHHHHHHHH
T ss_pred             EecCCCccccccCccccccCCCcccccceecChhhccHHHHcc--CCCCChhhhhhhcchHH
Confidence            99999999999999997532    2234689999999999842  34689999999999984

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.1e-29  Score=279.11  Aligned_cols=134  Identities=26%  Similarity=0.372  Sum_probs=117.3

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ++|+.++|||||+++++|.+++.+|||||||.|+ |.+++. ....+++..++.++.||+.||+|||+++||||||||+|
T Consensus        59 ~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~N  137 (364)
T d1omwa3          59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN  137 (364)
T ss_dssp             HHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH-hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccce
Confidence            4567778999999999999999999999999865 455554 45789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+|.+||+|||+|+...  .....+||+.|||||++.  ....|+.++|+||+|++
T Consensus       138 ILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~--~~~~~~~~~DiwSlGvi  195 (364)
T d1omwa3         138 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ--KGVAYDSSADWFSLGCM  195 (364)
T ss_dssp             EEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHS--TTCCCCTHHHHHHHHHH
T ss_pred             eEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhh--cCCCCCcccchhHHHHH
Confidence            999999999999999997532  334568999999999983  23468999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.96  E-value=8.5e-30  Score=278.38  Aligned_cols=135  Identities=25%  Similarity=0.425  Sum_probs=118.9

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++|+|||||+++++|.+++.+|||||||+| +|.+++....+++++..++.++.||+.||+|||++|||||||||+
T Consensus        74 ~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~  153 (350)
T d1koaa2          74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE  153 (350)
T ss_dssp             HHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechh
Confidence            3679999999999999999999999999999985 556666555678999999999999999999999999999999999


Q ss_pred             cEEEcC--CCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTE--TGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~--~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.  ++.+||+|||+|+....   ....+||+.|||||++.   ...|+.++|+||+|++
T Consensus       154 NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~---~~~~~~~~DiwSlGvi  214 (350)
T d1koaa2         154 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVL  214 (350)
T ss_dssp             GEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHH---TCCBCHHHHHHHHHHH
T ss_pred             HeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHc---CCCCChhHhhhhhhHH
Confidence            999964  67899999999976432   23468999999999984   4578999999999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=9.4e-30  Score=270.59  Aligned_cols=135  Identities=24%  Similarity=0.455  Sum_probs=118.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      .++|++++|||||+++++|.+++.+|||||||++ ++.+++... ...+++..+..++.||+.||+|||+++|+||||||
T Consensus        64 ~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp  143 (287)
T d1opja_          64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA  143 (287)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             HHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCcccc
Confidence            3689999999999999999999999999999985 566666543 46799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCCC-----CccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~~-----~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++.+||+|||+|+.....     ....||+.|||||++.   .+.|+.++|+||+|++
T Consensus       144 ~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~k~DiwS~Gv~  205 (287)
T d1opja_         144 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVL  205 (287)
T ss_dssp             GGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             CeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHc---CCCCCchhhhhhHHHH
Confidence            9999999999999999999864322     2235889999999974   4679999999999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.95  E-value=8.3e-30  Score=278.69  Aligned_cols=135  Identities=26%  Similarity=0.437  Sum_probs=118.6

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++|+|||||+++++|.+++.+|||||||+|+ |.+.+.....++++.+++.++.||+.||+|||++|||||||||+|
T Consensus        78 ~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~N  157 (352)
T d1koba_          78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN  157 (352)
T ss_dssp             HHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccc
Confidence            5889999999999999999999999999999865 455555455679999999999999999999999999999999999


Q ss_pred             EEEc--CCCceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLT--ETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~--~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++  .++.+||+|||+|+....   .....||+.|||||++.   ...|+.++|+||+|+++
T Consensus       158 ILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil  218 (352)
T d1koba_         158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---REPVGFYTDMWAIGVLG  218 (352)
T ss_dssp             EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHH
T ss_pred             ccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHc---CCCCCCccchHHHHHHH
Confidence            9998  578999999999976433   23468999999999983   45799999999999983

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-29  Score=275.04  Aligned_cols=135  Identities=31%  Similarity=0.517  Sum_probs=115.9

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC----------------------CCCCHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK----------------------RPLKEEEIAAIC   60 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~----------------------~~l~~~~~~~~~   60 (804)
                      ..+|+++ +|||||+|+++|.+++.+|||||||+| +|.+++...+                      ..+++..++.++
T Consensus        91 ~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  170 (325)
T d1rjba_          91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA  170 (325)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred             HHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHH
Confidence            3567777 899999999999999999999999985 6666665432                      358999999999


Q ss_pred             HHHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCcccccCCC------CccccccccCcchhhhhcccCccCCcc
Q psy17952         61 SGVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPA------NSFVGTPYWMAPEVILAMDEGQYDGKV  134 (804)
Q Consensus        61 ~qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~~------~~~~gt~~y~APE~l~~~~~~~~~~~v  134 (804)
                      .||++||+|||+++||||||||+|||++.++.+||+|||+|+.....      ....||+.|||||++.   .+.|+.++
T Consensus       171 ~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~  247 (325)
T d1rjba_         171 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKS  247 (325)
T ss_dssp             HHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH---HCCCCHHH
T ss_pred             HHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc---CCCCCcce
Confidence            99999999999999999999999999999999999999999753221      2356899999999984   46799999


Q ss_pred             cccccccC
Q psy17952        135 DVWSLGIT  142 (804)
Q Consensus       135 DvwslG~~  142 (804)
                      |+||+|++
T Consensus       248 DiwS~Gvi  255 (325)
T d1rjba_         248 DVWSYGIL  255 (325)
T ss_dssp             HHHHHHHH
T ss_pred             eccchhHH
Confidence            99999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.3e-29  Score=266.93  Aligned_cols=134  Identities=33%  Similarity=0.572  Sum_probs=117.4

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++|+|||||+++++|.+++.+|||||||+|+ |.+++. ...++++..++.++.|++.||+|||+++|+||||||+|
T Consensus        65 ~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~-~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~N  143 (293)
T d1jksa_          65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN  143 (293)
T ss_dssp             HHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc-cccccchhHHHHHHHHHHHHHHhhhhcceeecccccce
Confidence            5789999999999999999999999999999864 555554 44689999999999999999999999999999999999


Q ss_pred             EEEcCCC----ceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETG----TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~----~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++    .+|++|||+|....   ......||+.|||||++.   ...|+.++|+||+|+++
T Consensus       144 ill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~---~~~~~~~~DiwSlGvil  206 (293)
T d1jksa_         144 IMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVIT  206 (293)
T ss_dssp             EEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHT---TCCBCTHHHHHHHHHHH
T ss_pred             EEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHc---CCCCCCcccchhhhHHH
Confidence            9998776    59999999997532   233568999999999983   45789999999999983

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-29  Score=269.19  Aligned_cols=134  Identities=27%  Similarity=0.444  Sum_probs=116.3

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|||||++++++.+ +.+|||||||+| +|.+++...+..+++..+..++.||++||+|||+++|+||||||+
T Consensus        60 ~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~  138 (285)
T d1u59a_          60 AQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR  138 (285)
T ss_dssp             HHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchh
Confidence            368899999999999998865 468999999986 555666555678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+|+....       .....||+.|||||++.   .+.|+.++||||+|++
T Consensus       139 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gv~  201 (285)
T d1u59a_         139 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVT  201 (285)
T ss_dssp             GEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             heeeccCCceeeccchhhhcccccccccccccccccCccccChHHHh---CCCCCccchhhcchHH
Confidence            99999999999999999975321       22357899999999983   4679999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.6e-29  Score=267.35  Aligned_cols=134  Identities=28%  Similarity=0.414  Sum_probs=113.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|.+ +..|||||||+|+.+..+.....++++..+..++.||+.||+|||+++||||||||+|
T Consensus        59 ~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~N  137 (277)
T d1xbba_          59 ANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN  137 (277)
T ss_dssp             HHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchh
Confidence            467899999999999999865 4578999999865444333456789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||+|+....       .....||+.|||||++.   .+.|+.++|+||+|++
T Consensus       138 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDiwS~Gv~  199 (277)
T d1xbba_         138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVL  199 (277)
T ss_dssp             EEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             hcccccCcccccchhhhhhccccccccccccccCCCceecCchhhc---CCCCCchhhhccchhh
Confidence            9999999999999999975321       12357999999999984   4578999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.4e-29  Score=265.60  Aligned_cols=135  Identities=25%  Similarity=0.469  Sum_probs=114.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++|++.+.+.+|+|||||.+++ .+.+......+++.++..++.|++.||+|||+++||||||||+
T Consensus        60 ~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~  139 (283)
T d1mqba_          60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR  139 (283)
T ss_dssp             HHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccc
Confidence            468999999999999999999999999999998665 4555556678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+|+....       .....||+.|||||++   ..+.|+.++||||+|++
T Consensus       140 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l---~~~~~~~~sDI~S~Gvi  202 (283)
T d1mqba_         140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI---SYRKFTSASDVWSFGIV  202 (283)
T ss_dssp             GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHH---HSCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHH---ccCCCCCcccccccHHH
Confidence            99999999999999999975321       1234689999999997   35679999999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.2e-29  Score=267.29  Aligned_cols=132  Identities=31%  Similarity=0.524  Sum_probs=115.9

Q ss_pred             HHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccEEE
Q psy17952          8 LRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNILL   87 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Nill   87 (804)
                      ++.++|||||+++++|.+++.+|||||||+|+.+..+......+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus        57 ~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~  136 (320)
T d1xjda_          57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL  136 (320)
T ss_dssp             HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred             HHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence            45789999999999999999999999999865444333456789999999999999999999999999999999999999


Q ss_pred             cCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         88 TETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        88 ~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +++|.+||+|||+|+...    .....+||+.|+|||++.   .+.|+.++|+||+|++
T Consensus       137 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvi  192 (320)
T d1xjda_         137 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVL  192 (320)
T ss_dssp             CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHc---CCCCCchhhhhhhhHH
Confidence            999999999999997532    223468999999999983   4679999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.7e-29  Score=261.84  Aligned_cols=134  Identities=28%  Similarity=0.492  Sum_probs=113.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCc-HHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSA-SDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l-~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++. ++.+|||||||+++. .+++... ..++++..+..++.||++||.|||+++|+||||||
T Consensus        59 ~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp  137 (272)
T d1qpca_          59 ANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA  137 (272)
T ss_dssp             HHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccch
Confidence            46889999999999999765 456799999998654 4444322 23699999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||+++++.+||+|||+|+....     .....||+.|||||++.   .+.|+.++||||+|++
T Consensus       138 ~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwS~Gvv  199 (272)
T d1qpca_         138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGIL  199 (272)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             hheeeecccceeeccccceEEccCCccccccccCCcccccChHHHh---CCCCCchhhhhhhHHH
Confidence            999999999999999999975322     23457999999999973   4578999999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.95  E-value=2.7e-28  Score=257.98  Aligned_cols=137  Identities=34%  Similarity=0.561  Sum_probs=119.0

Q ss_pred             HHHHhcC-CCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          6 SLLRQLK-HPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         6 ~iL~~l~-HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .+|++|+ |||||+++++|.+++.+|||||||+| +|.+++. .++++++++++.++.||+.||+|||++||+||||||+
T Consensus        61 ~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~  139 (277)
T d1phka_          61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE  139 (277)
T ss_dssp             HHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence            4678886 99999999999999999999999985 5666665 4578999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC---CCccccccccCcchhhhhc---ccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~---~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.++.+||+|||+|+....   ....+||+.|+|||++.+.   ....|+.++|+||+|+++
T Consensus       140 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvil  205 (277)
T d1phka_         140 NILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM  205 (277)
T ss_dssp             GEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred             eEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhh
Confidence            99999999999999999976432   3446899999999998532   223578899999999984

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.7e-28  Score=260.45  Aligned_cols=136  Identities=32%  Similarity=0.501  Sum_probs=120.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++++|||||+++++|.+++.+|||||||.|++.+++... ...+++..++.++.|++.||+|||++|||||||||+|
T Consensus        53 ~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN  132 (298)
T d1gz8a_          53 SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN  132 (298)
T ss_dssp             HHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             HHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence            678999999999999999999999999999999887776544 4679999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+||+|||+|+...    .....+||+.|+|||++.  ....++.++|+||+|+++
T Consensus       133 Il~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~--~~~~~~~~~DiwSlGvil  193 (298)
T d1gz8a_         133 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL--GCKYYSTAVDIWSLGCIF  193 (298)
T ss_dssp             EEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHT--TCSSCCTHHHHHHHHHHH
T ss_pred             eeecccCcceeccCCcceeccCCcccceeecccceeeehhhhc--cccCCCccccccccchhh
Confidence            999999999999999997532    233458999999999874  234568899999999984

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.7e-28  Score=265.03  Aligned_cols=134  Identities=27%  Similarity=0.423  Sum_probs=117.6

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++++|||||+++++|.+++.+|||||||.| +|.+++.....++++++++.++.||+.||+|||++||+||||||+|
T Consensus        53 ~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~N  132 (321)
T d1tkia_          53 SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN  132 (321)
T ss_dssp             HHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccc
Confidence            579999999999999999999999999999986 5666665555689999999999999999999999999999999999


Q ss_pred             EEEcCC--CceEEeccCcccccCC---CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTET--GTVKLADFGSASIKCP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~--~~~kl~DFG~a~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.+  .++||+|||+++....   .....||+.|+|||++   ....|+.++|+||+|++
T Consensus       133 Ill~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~---~~~~~~~~~DiWSlGvi  192 (321)
T d1tkia_         133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH---QHDVVSTATDMWSLGTL  192 (321)
T ss_dssp             EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHH---TTCEECHHHHHHHHHHH
T ss_pred             eeecCCCceEEEEcccchhhccccCCcccccccccccccchhc---cCCCCCchhhcccHHHH
Confidence            999854  4899999999975432   2345799999999997   34578999999999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.4e-28  Score=259.30  Aligned_cols=134  Identities=29%  Similarity=0.506  Sum_probs=108.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|. ++.+|||||||.|+ +.+++.....++++..++.++.||++||+|||+++||||||||+
T Consensus        59 ~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~  137 (273)
T d1mp8a_          59 ALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR  137 (273)
T ss_dssp             HHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchh
Confidence            46789999999999999885 56789999999865 55556666778999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+++.++.+||+|||+|+...     ......||+.|+|||++.   .+.|+.++|+||+|++
T Consensus       138 NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~---~~~~~~~~DiwSlGvi  198 (273)
T d1mp8a_         138 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVC  198 (273)
T ss_dssp             GEEEEETTEEEECC-------------------CCGGGCCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             heeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhc---cCCCCCccccccchHH
Confidence            9999999999999999997532     123357899999999983   4678999999999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.1e-28  Score=256.08  Aligned_cols=135  Identities=22%  Similarity=0.504  Sum_probs=118.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.+++.+|+|||||.++ +..++......+++..+..++.|+++||+|||+++|+||||||+
T Consensus        50 v~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~  129 (258)
T d1k2pa_          50 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR  129 (258)
T ss_dssp             HHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGG
T ss_pred             HHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccce
Confidence            46789999999999999999999999999999855 55665656678999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC-----CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+|+....     .....||+.|||||++.   .+.|+.++|+||+|++
T Consensus       130 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~ksDiwS~G~~  190 (258)
T d1k2pa_         130 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVL  190 (258)
T ss_dssp             GEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhc---CCCCCcceeecccchh
Confidence            99999999999999999975321     12357999999999984   4578999999999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.4e-28  Score=257.63  Aligned_cols=135  Identities=30%  Similarity=0.420  Sum_probs=114.8

Q ss_pred             HHHHHhcC--CCCeeeEeEEEEeCCeEEEEEeccCC-Cc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLK--HPNTIEYRGCYLRDHTAWLVMEYCLG-SA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~--HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|++++  |||||+++++|.+++.+|+||||+.| ++ .+++. ....++++.++.++.||++||+|||+++|+||||
T Consensus        58 ~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDi  136 (273)
T d1xwsa_          58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDI  136 (273)
T ss_dssp             HHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             HHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Confidence            36788886  99999999999999999999999975 33 44443 4578999999999999999999999999999999


Q ss_pred             ccccEEEcC-CCceEEeccCcccccC--CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLTE-TGTVKLADFGSASIKC--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~~-~~~~kl~DFG~a~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+|||++. ++.+||+|||+|+...  .....+||+.|||||++.+  ...++.++|+||+|++
T Consensus       137 Kp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~~DiwSlGvi  199 (273)
T d1xwsa_         137 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY--HRYHGRSAAVWSLGIL  199 (273)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHH--SCBCHHHHHHHHHHHH
T ss_pred             cccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcC--CCCCCcccccccceee
Confidence            999999985 4799999999997532  3345789999999999842  2335678999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.5e-28  Score=264.00  Aligned_cols=133  Identities=32%  Similarity=0.505  Sum_probs=113.1

Q ss_pred             HHhcCCCCeeeEeEEEEe----CCeEEEEEeccCC-CcHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          8 LRQLKHPNTIEYRGCYLR----DHTAWLVMEYCLG-SASDIIEVHK-RPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         8 L~~l~HpnIV~l~~~~~~----~~~~~lV~Ey~~g-~l~~~~~~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ++.++|||||+++++|.+    +..+|||||||+| +|.+++..+. .++++.+++.++.||+.||+|||++||+|||||
T Consensus        59 ~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiK  138 (335)
T d2ozaa1          59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK  138 (335)
T ss_dssp             HHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             HHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccc
Confidence            345689999999999976    4579999999985 6777776443 479999999999999999999999999999999


Q ss_pred             cccEEEcC---CCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         82 AGNILLTE---TGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        82 p~Nill~~---~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |+|||++.   .+.+||+|||+|+...   .....+||+.|||||++.   ...|+.++|+||+|+++
T Consensus       139 p~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~y~~~~DiwSlGvil  203 (335)
T d2ozaa1         139 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIM  203 (335)
T ss_dssp             GGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCC---GGGGSHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHc---CCCCCHHHHHHhhchhH
Confidence            99999985   5579999999997532   234568999999999973   45699999999999984

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.94  E-value=2.7e-28  Score=257.55  Aligned_cols=135  Identities=29%  Similarity=0.462  Sum_probs=110.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC----eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH----TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDV   80 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~----~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDl   80 (804)
                      ..+|++++|||||++++++..++    .+|||||||+|+.+..+....+++++.+++.++.||+.||+|||++||+||||
T Consensus        58 ~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDi  137 (277)
T d1o6ya_          58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV  137 (277)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccc
Confidence            45788999999999999987654    38999999997655544445578999999999999999999999999999999


Q ss_pred             ccccEEEcCCCceEEeccCcccccC-------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         81 KAGNILLTETGTVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        81 Kp~Nill~~~~~~kl~DFG~a~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||+|||++.++.++++|||++....       .....+||+.|||||++.   ...|+.++|+||+|++
T Consensus       138 KP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~~DiwSlGvi  203 (277)
T d1o6ya_         138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCV  203 (277)
T ss_dssp             SGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             cCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHc---CCCCCcceecccchHH
Confidence            9999999999999999999886421       233468999999999973   4578999999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=257.88  Aligned_cols=134  Identities=30%  Similarity=0.495  Sum_probs=114.6

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++|||||+++++|.++ ..+++||||. |++.+.+......+++..+..++.||+.||+|||+++||||||||+
T Consensus        62 ~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~  140 (317)
T d1xkka_          62 AYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR  140 (317)
T ss_dssp             HHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             HHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhh
Confidence            3688999999999999998765 5577888876 6777777777788999999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.++.+||+|||+|+....      .....||+.|||||++.   .+.|+.++|+||+|++
T Consensus       141 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwS~Gvi  202 (317)
T d1xkka_         141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVT  202 (317)
T ss_dssp             GEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             cceeCCCCCeEeeccccceecccccccccccccccCccccChHHHh---cCCCChhhhhhhHHHH
Confidence            99999999999999999975321      12346899999999984   4679999999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=254.26  Aligned_cols=134  Identities=27%  Similarity=0.498  Sum_probs=111.0

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ..+|++++|||||++++++. ++.+|+|||||.|+ +..++... ...+++.++..++.||+.||+|||+++|+||||||
T Consensus        63 ~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp  141 (285)
T d1fmka3          63 AQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA  141 (285)
T ss_dssp             HHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             HHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccc
Confidence            36789999999999999874 56689999999865 45454432 35799999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||++.++++||+|||+|+...     ......||+.|+|||++.   .+.++.++||||+|++
T Consensus       142 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~S~Gii  203 (285)
T d1fmka3         142 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGIL  203 (285)
T ss_dssp             GGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHh---CCCCCcHHhhhcchHH
Confidence            99999999999999999997532     122357999999999983   5678999999999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.9e-27  Score=252.69  Aligned_cols=135  Identities=36%  Similarity=0.564  Sum_probs=115.2

Q ss_pred             HHHHhc---CCCCeeeEeEEEEe-----CCeEEEEEeccCCCcHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q psy17952          6 SLLRQL---KHPNTIEYRGCYLR-----DHTAWLVMEYCLGSASDIIEV-HKRPLKEEEIAAICSGVLRGLNYLHSLGRI   76 (804)
Q Consensus         6 ~iL~~l---~HpnIV~l~~~~~~-----~~~~~lV~Ey~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~Ii   76 (804)
                      ++|+.|   +|||||+++++|..     +..+|++||||.|+++.+... ....++++.++.++.|++.||+|||+++|+
T Consensus        59 ~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iv  138 (305)
T d1blxa_          59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVV  138 (305)
T ss_dssp             HHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            345544   89999999999863     246899999999987765544 346799999999999999999999999999


Q ss_pred             ccccccccEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         77 HRDVKAGNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        77 HRDlKp~Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||||||+|||++.++.+||+|||+++...   .....+||+.|||||++.   ...|+.++|+||+|+++
T Consensus       139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~---~~~y~~~~DiwSlG~il  205 (305)
T d1blxa_         139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIF  205 (305)
T ss_dssp             CCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHHH
T ss_pred             ecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhc---CCCCChhehhhchHHHH
Confidence            99999999999999999999999987532   334568999999999984   46799999999999984

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.2e-28  Score=253.24  Aligned_cols=133  Identities=29%  Similarity=0.410  Sum_probs=113.9

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      .+|++++|||||+++++|.+ ..+|+|||||+ |++.+.+......+++..+..++.|++.||.|||+++|+||||||+|
T Consensus        63 ~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N  141 (273)
T d1u46a_          63 NAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN  141 (273)
T ss_dssp             HHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence            57999999999999999865 56789999998 55666666666789999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccCC-------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         85 ILLTETGTVKLADFGSASIKCP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      ||++.++.+||+|||+++....       .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       142 Ill~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~S~Gvi  203 (273)
T d1u46a_         142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVT  203 (273)
T ss_dssp             EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             hccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh---CCCCCcchhhhhhHHH
Confidence            9999999999999999975321       22346888999999983   4678999999999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.5e-27  Score=256.63  Aligned_cols=136  Identities=32%  Similarity=0.534  Sum_probs=116.5

Q ss_pred             HHHHhcCCCCeeeEeEEEEeC------CeEEEEEeccCCCcHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRD------HTAWLVMEYCLGSASDIIE---VHKRPLKEEEIAAICSGVLRGLNYLHSLGRI   76 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~------~~~~lV~Ey~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~aL~ylH~~~Ii   76 (804)
                      ++|++|+|||||+++++|...      ..+|||||||.|++.+.+.   ....++++.+++.++.||+.||+|||++||+
T Consensus        65 ~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~Ii  144 (350)
T d1q5ka_          65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC  144 (350)
T ss_dssp             HHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Confidence            589999999999999998643      3589999999988766554   2456899999999999999999999999999


Q ss_pred             ccccccccEEEcCCC-ceEEeccCccccc---CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         77 HRDVKAGNILLTETG-TVKLADFGSASIK---CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        77 HRDlKp~Nill~~~~-~~kl~DFG~a~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||||||+|||++.++ .+||+|||++...   ......+||+.|+|||++.+  ...|+.++|+||+|+++
T Consensus       145 HrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DIwSlG~il  213 (350)
T d1q5ka_         145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCVL  213 (350)
T ss_dssp             CCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT--CSSCCTHHHHHHHHHHH
T ss_pred             ccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhc--ccCCCcceeecccceEE
Confidence            999999999999776 8999999999753   23445689999999999743  45689999999999983

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.93  E-value=2.4e-27  Score=251.18  Aligned_cols=137  Identities=27%  Similarity=0.455  Sum_probs=120.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGN   84 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N   84 (804)
                      ..+|++++|||||+++++|..++..|++|||+.|++++.+......+++..++.++.||+.||+|||+++||||||||+|
T Consensus        51 ~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~N  130 (286)
T d1ob3a_          51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN  130 (286)
T ss_dssp             HHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             HHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCce
Confidence            35789999999999999999999999999999999888887778899999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         85 ILLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        85 ill~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||++.++.+|++|||+|....    ......|++.|+|||++.+  ...++.++|+||+|++.
T Consensus       131 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~~DiwslGv~l  191 (286)
T d1ob3a_         131 LLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCIF  191 (286)
T ss_dssp             EEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTT--CCSCCTHHHHHHHHHHH
T ss_pred             eeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhC--CCCCCcceeehhcCcHH
Confidence            999999999999999996532    2334579999999999843  45679999999999983

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.6e-27  Score=252.72  Aligned_cols=133  Identities=32%  Similarity=0.525  Sum_probs=106.1

Q ss_pred             HHHhc-CCCCeeeEeEEEEeC-CeEEEEEeccC-CCcHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHH
Q psy17952          7 LLRQL-KHPNTIEYRGCYLRD-HTAWLVMEYCL-GSASDIIEVH---------------KRPLKEEEIAAICSGVLRGLN   68 (804)
Q Consensus         7 iL~~l-~HpnIV~l~~~~~~~-~~~~lV~Ey~~-g~l~~~~~~~---------------~~~l~~~~~~~~~~qi~~aL~   68 (804)
                      +|.++ +|||||++++++..+ ..+|+|||||+ |++.+++...               +..+++.++..++.||++||.
T Consensus        69 ~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~  148 (299)
T d1ywna1          69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME  148 (299)
T ss_dssp             HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHH
Confidence            44444 799999999987654 46899999998 5566666533               235899999999999999999


Q ss_pred             HHHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         69 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        69 ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+++||||||||+|||++.++.+||+|||+|+...      .....+||+.|||||++.   .+.|+.++||||+|++
T Consensus       149 ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDiwS~Gvi  225 (299)
T d1ywna1         149 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVL  225 (299)
T ss_dssp             HHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh---cCCCCcccceeehHHH
Confidence            9999999999999999999999999999999997532      223467999999999984   4678999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.1e-27  Score=249.84  Aligned_cols=135  Identities=30%  Similarity=0.443  Sum_probs=115.5

Q ss_pred             HHHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHc---------------CCCCCHHHHHHHHHHHHHHH
Q psy17952          5 SSLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVH---------------KRPLKEEEIAAICSGVLRGL   67 (804)
Q Consensus         5 ~~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~---------------~~~l~~~~~~~~~~qi~~aL   67 (804)
                      .++|+++ +|||||+++++|.+++.+|||||||+| ++.+++...               ...+++..+..++.||+.||
T Consensus        61 ~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl  140 (309)
T d1fvra_          61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM  140 (309)
T ss_dssp             HHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHH
Confidence            3678888 799999999999999999999999985 566665422               35799999999999999999


Q ss_pred             HHHHhcCccccccccccEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         68 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        68 ~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      .|||+++|+||||||+|||++.++.+||+|||+|+...   ......||+.|+|||.+.   .+.|+.++|+||||++
T Consensus       141 ~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSfGvi  215 (309)
T d1fvra_         141 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVL  215 (309)
T ss_dssp             HHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             HhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhc---cCCCCccceeehhHHH
Confidence            99999999999999999999999999999999997532   223457999999999983   4679999999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9e-27  Score=248.74  Aligned_cols=134  Identities=31%  Similarity=0.557  Sum_probs=115.3

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCC-CcHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHH
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLG-SASDIIEVHK---------------RPLKEEEIAAICSGVLRGLN   68 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g-~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~aL~   68 (804)
                      .+|+++ +|||||+++++|.+++.+|+|||||+| ++.+++..+.               ..+++..++.++.||+.||+
T Consensus        70 ~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~  149 (299)
T d1fgka_          70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME  149 (299)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHH
Confidence            345555 899999999999999999999999985 5566664332               35899999999999999999


Q ss_pred             HHHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         69 YLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        69 ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+++||||||||+|||++.++.+||+|||+++...      ......||+.|+|||.+.   .+.|+.++|+||+|++
T Consensus       150 ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~---~~~y~~k~DiwS~Gvv  226 (299)
T d1fgka_         150 YLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVL  226 (299)
T ss_dssp             HHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc---CCCCCchhhhHHhHHH
Confidence            9999999999999999999999999999999997532      123357999999999983   4679999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-26  Score=248.73  Aligned_cols=135  Identities=28%  Similarity=0.457  Sum_probs=115.8

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe-CCeEEEEEeccCCCc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR-DHTAWLVMEYCLGSA-SDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~-~~~~~lV~Ey~~g~l-~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      .++|++++|||||++++++.. +...|+|||||+|+. .+++......+++..+..++.|++.||.|||+++|+||||||
T Consensus        79 ~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~  158 (311)
T d1r0pa_          79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA  158 (311)
T ss_dssp             HHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             HHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccH
Confidence            368899999999999998765 568999999998655 455554556788999999999999999999999999999999


Q ss_pred             ccEEEcCCCceEEeccCcccccCC--------CCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         83 GNILLTETGTVKLADFGSASIKCP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        83 ~Nill~~~~~~kl~DFG~a~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      +|||+++++.+||+|||+++....        .....||+.|+|||.+.   .+.++.++|+||||++
T Consensus       159 ~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~SfGiv  223 (311)
T d1r0pa_         159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVL  223 (311)
T ss_dssp             GGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             HhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHh---cCCCCChhHhhhhHHH
Confidence            999999999999999999975321        22357899999999973   4678999999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.5e-27  Score=247.31  Aligned_cols=135  Identities=28%  Similarity=0.487  Sum_probs=109.4

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe-CCeEEEEEeccCC-CcHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR-DHTAWLVMEYCLG-SASDIIEVH-KRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVK   81 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~-~~~~~lV~Ey~~g-~l~~~~~~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlK   81 (804)
                      ..+|++++|||||+++|++.+ ++.+|||||||+| ++.+++... ...++++.+..++.||++||.|||+++|+|||||
T Consensus        51 ~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlk  130 (262)
T d1byga_          51 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA  130 (262)
T ss_dssp             HHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             HHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccc
Confidence            367899999999999998865 4568999999985 566666443 3469999999999999999999999999999999


Q ss_pred             cccEEEcCCCceEEeccCcccccC-CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         82 AGNILLTETGTVKLADFGSASIKC-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        82 p~Nill~~~~~~kl~DFG~a~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |.|||++.++.+|++|||+++... ......+|+.|+|||++.   .+.|+.++|+||||++
T Consensus       131 p~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~---~~~~t~~sDIwSfG~i  189 (262)
T d1byga_         131 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGIL  189 (262)
T ss_dssp             GGGEEECTTSCEEECCCCC------------CCTTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             hHhheecCCCCEeecccccceecCCCCccccccccCCChHHHh---CCCCChHHHHHhHHHH
Confidence            999999999999999999998633 334467899999999984   4579999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.3e-26  Score=247.17  Aligned_cols=137  Identities=30%  Similarity=0.497  Sum_probs=118.5

Q ss_pred             HHHHHhcCCCCeeeEeEEEEe--------CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLR--------DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRI   76 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~--------~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~Ii   76 (804)
                      ..+|++++||||++++++|..        ++.+|+|||||.+++..........+++..++.++.|++.||.|||+++|+
T Consensus        60 ~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~iv  139 (318)
T d3blha1          60 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKIL  139 (318)
T ss_dssp             HHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEE
Confidence            368999999999999999855        345899999999888877766677899999999999999999999999999


Q ss_pred             ccccccccEEEcCCCceEEeccCccccc--------CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         77 HRDVKAGNILLTETGTVKLADFGSASIK--------CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        77 HRDlKp~Nill~~~~~~kl~DFG~a~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      ||||||+|||++.++.+|++|||+++..        ......+||+.|+|||++.+  ...|+.++|+||+|++.
T Consensus       140 HrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~~~~k~DiwSlGvil  212 (318)
T d3blha1         140 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIM  212 (318)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT--CSSCCTHHHHHHHHHHH
T ss_pred             ecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC--CCCCCcHHHcccCCcee
Confidence            9999999999999999999999999642        12334689999999999843  34689999999999984

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=1.5e-26  Score=247.15  Aligned_cols=134  Identities=28%  Similarity=0.490  Sum_probs=115.1

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHc-----------------------CCCCCHHHHHHHHH
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVH-----------------------KRPLKEEEIAAICS   61 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~-----------------------~~~l~~~~~~~~~~   61 (804)
                      ++|++++|||||+++++|...+.+++|||||. |++.+++...                       ...+++..+..++.
T Consensus        68 ~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  147 (301)
T d1lufa_          68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR  147 (301)
T ss_dssp             HHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHH
T ss_pred             HHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHH
Confidence            58899999999999999999999999999997 5666666432                       12489999999999


Q ss_pred             HHHHHHHHHHhcCccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCccc
Q psy17952         62 GVLRGLNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVD  135 (804)
Q Consensus        62 qi~~aL~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vD  135 (804)
                      |++.||+|||+++||||||||+|||++.++.+||+|||+|+...      ......||+.|+|||++.   ...|+.++|
T Consensus       148 qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~t~ksD  224 (301)
T d1lufa_         148 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESD  224 (301)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH---HCCCCHHHH
T ss_pred             HHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc---cCCCChhhh
Confidence            99999999999999999999999999999999999999996421      223457899999999984   457999999


Q ss_pred             ccccccC
Q psy17952        136 VWSLGIT  142 (804)
Q Consensus       136 vwslG~~  142 (804)
                      |||+|++
T Consensus       225 VwS~Gvv  231 (301)
T d1lufa_         225 VWAYGVV  231 (301)
T ss_dssp             HHHHHHH
T ss_pred             hccchhh
Confidence            9999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.9e-26  Score=251.03  Aligned_cols=133  Identities=34%  Similarity=0.605  Sum_probs=115.7

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCC------eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDH------TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~------~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .+|++++|||||+++++|...+      .+|||||||.+++..+..  ..++++..++.++.||+.||+|||++||+|||
T Consensus        69 ~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrD  146 (346)
T d1cm8a_          69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD  146 (346)
T ss_dssp             HHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence            5789999999999999998665      479999999655555543  36799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCccccc-CCCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIK-CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||+|||++.++.+|++|||+|+.. ......+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       147 iKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvi  208 (346)
T d1cm8a_         147 LKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCI  208 (346)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHH
T ss_pred             cCcchhhcccccccccccccceeccCCccccccccccccCHHHHcC--CCCCCccchhhcchHH
Confidence            9999999999999999999999764 33455789999999999843  3457899999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.5e-26  Score=246.63  Aligned_cols=134  Identities=31%  Similarity=0.458  Sum_probs=115.2

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCC-cHHHHHHc-----------------CCCCCHHHHHHHHHHHHHH
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGS-ASDIIEVH-----------------KRPLKEEEIAAICSGVLRG   66 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~-l~~~~~~~-----------------~~~l~~~~~~~~~~qi~~a   66 (804)
                      .+++++ +|||||++++++.+++.+|||||||.|+ +.+++...                 ...+++..+..++.||+.|
T Consensus        78 ~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~g  157 (311)
T d1t46a_          78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG  157 (311)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHH
Confidence            466777 7999999999999999999999999854 55555432                 2368999999999999999


Q ss_pred             HHHHHhcCccccccccccEEEcCCCceEEeccCcccccCC------CCccccccccCcchhhhhcccCccCCcccccccc
Q psy17952         67 LNYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  140 (804)
Q Consensus        67 L~ylH~~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG  140 (804)
                      |+|||+++|+||||||+|||++.++.+|++|||+++....      ....+||+.|+|||++.   .+.++.++|+||+|
T Consensus       158 l~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwS~G  234 (311)
T d1t46a_         158 MAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYG  234 (311)
T ss_dssp             HHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHH
T ss_pred             HHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc---CCCCCCcccccchH
Confidence            9999999999999999999999999999999999975321      12357999999999983   46789999999999


Q ss_pred             cC
Q psy17952        141 IT  142 (804)
Q Consensus       141 ~~  142 (804)
                      ++
T Consensus       235 ~~  236 (311)
T d1t46a_         235 IF  236 (311)
T ss_dssp             HH
T ss_pred             HH
Confidence            98

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.4e-26  Score=245.94  Aligned_cols=133  Identities=29%  Similarity=0.406  Sum_probs=108.9

Q ss_pred             HhcCCCCeeeEeEEEEeCC----eEEEEEeccCC-CcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------cCc
Q psy17952          9 RQLKHPNTIEYRGCYLRDH----TAWLVMEYCLG-SASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS--------LGR   75 (804)
Q Consensus         9 ~~l~HpnIV~l~~~~~~~~----~~~lV~Ey~~g-~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~--------~~I   75 (804)
                      .+++|||||++++++.+++    .+|||||||++ +|.+++..  .+++++++..++.|++.||.|||+        ++|
T Consensus        52 ~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~I  129 (303)
T d1vjya_          52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI  129 (303)
T ss_dssp             TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred             hhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCe
Confidence            4679999999999987654    58999999975 56666653  469999999999999999999996        699


Q ss_pred             cccccccccEEEcCCCceEEeccCcccccC--------CCCccccccccCcchhhhhcc---cCccCCcccccccccCC
Q psy17952         76 IHRDVKAGNILLTETGTVKLADFGSASIKC--------PANSFVGTPYWMAPEVILAMD---EGQYDGKVDVWSLGITP  143 (804)
Q Consensus        76 iHRDlKp~Nill~~~~~~kl~DFG~a~~~~--------~~~~~~gt~~y~APE~l~~~~---~~~~~~~vDvwslG~~~  143 (804)
                      +||||||+|||++.++.+||+|||+++...        .....+||+.|||||++....   ...++.++|+||+|+++
T Consensus       130 vHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl  208 (303)
T d1vjya_         130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF  208 (303)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred             eccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence            999999999999999999999999997521        123467999999999974311   11367789999999983

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.92  E-value=7.8e-26  Score=240.70  Aligned_cols=135  Identities=18%  Similarity=0.226  Sum_probs=118.8

Q ss_pred             HHHHHhcCC-CCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKH-PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~H-pnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++++.|+| +||+.+++++..+...|+|||||.|++.+++......+++..+..++.|++.||+|||++|||||||||+
T Consensus        51 ~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~  130 (293)
T d1csna_          51 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD  130 (293)
T ss_dssp             HHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred             HHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCcc
Confidence            357788865 9999999999999999999999988888888777778999999999999999999999999999999999


Q ss_pred             cEEEcC-----CCceEEeccCcccccC-----------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTE-----TGTVKLADFGSASIKC-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~-----~~~~kl~DFG~a~~~~-----------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.     ++.+||+|||+|+...           .....+||+.|||||++.   ...++.++|+||+|++
T Consensus       131 Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~---~~~~~~~~DiwSlG~~  202 (293)
T d1csna_         131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHV  202 (293)
T ss_dssp             GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             ceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhc---CCCCChHHHHHHhhHH
Confidence            999974     5789999999997421           123468999999999984   4568999999999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=9.6e-26  Score=245.48  Aligned_cols=135  Identities=29%  Similarity=0.528  Sum_probs=114.7

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCC-----eEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDH-----TAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~-----~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .++|++|+|||||++++++..+.     .+||+|+++.|+|.+++..  .++++..++.++.|++.||+|||++||||||
T Consensus        57 i~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRD  134 (345)
T d1pmea_          57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRD  134 (345)
T ss_dssp             HHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence            47899999999999999987643     4677777666788887754  4799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccC-------CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKC-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+|||+++++.+||+|||+|....       .....+||+.|+|||++.  ....|+.++|+||+|++.
T Consensus       135 IKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il  203 (345)
T d1pmea_         135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCIL  203 (345)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTT--TBCSCSTHHHHHHHHHHH
T ss_pred             CCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhh--cCCCCCchhhhhccCcee
Confidence            99999999999999999999996422       123467999999999973  345678999999999983

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.2e-25  Score=242.38  Aligned_cols=138  Identities=29%  Similarity=0.478  Sum_probs=115.9

Q ss_pred             HHHHHhcCC-CCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKH-PNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~H-pnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      ..+|++++| ||||+++++|.+...+|+|||||.|+.+..+......+++..++.++.||+.||+|||+++|+||||||+
T Consensus        79 ~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~  158 (322)
T d1vzoa_          79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE  158 (322)
T ss_dssp             HHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCcc
Confidence            468899977 8999999999999999999999986554444345567889999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeccCcccccC-----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         84 NILLTETGTVKLADFGSASIKC-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        84 Nill~~~~~~kl~DFG~a~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||++.+|.+||+|||+|+...     ......||+.|+|||.+.+ ....++.++||||+|+++
T Consensus       159 Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~-~~~~~~~ksDIWSlG~iL  222 (322)
T d1vzoa_         159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVLM  222 (322)
T ss_dssp             GEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT-CC---CTHHHHHHHHHHH
T ss_pred             ceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhc-CCcCCCchhhhHHHHHHH
Confidence            9999999999999999996421     2234679999999999853 233578899999999983

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=1.8e-25  Score=238.06  Aligned_cols=135  Identities=24%  Similarity=0.315  Sum_probs=115.1

Q ss_pred             HHHHHhcCCCCee-eEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccc
Q psy17952          5 SSLLRQLKHPNTI-EYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAG   83 (804)
Q Consensus         5 ~~iL~~l~HpnIV-~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~   83 (804)
                      .++|++++|+|+| .+.+++.+++..|+|||||.|++.+.+......+++..+..++.|++.||+|||+++||||||||+
T Consensus        53 ~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~  132 (299)
T d1ckia_          53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD  132 (299)
T ss_dssp             HHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHh
Confidence            4688999877655 555667888899999999999988888777789999999999999999999999999999999999


Q ss_pred             cEEEcC---CCceEEeccCcccccC-----------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         84 NILLTE---TGTVKLADFGSASIKC-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        84 Nill~~---~~~~kl~DFG~a~~~~-----------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |||++.   +..+|++|||+|+...           .....+||+.|||||++.   ...|+.++|+||+|++
T Consensus       133 NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~  202 (299)
T d1ckia_         133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYV  202 (299)
T ss_dssp             GEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT---TBCCCHHHHHHHHHHH
T ss_pred             hccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHh---CCCCCChhhEEecCHH
Confidence            999864   4579999999997521           123458999999999973   4568999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.7e-25  Score=235.31  Aligned_cols=136  Identities=29%  Similarity=0.494  Sum_probs=120.4

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      .+|++++|||||+++++|.+....++||||+.|+++..+....+.+++..++.++.|+++||+|||++||+||||||+||
T Consensus        53 ~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NI  132 (292)
T d1unla_          53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL  132 (292)
T ss_dssp             HHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccc
Confidence            57889999999999999999999999999999888777777778999999999999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccC----CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETGTVKLADFGSASIKC----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.++.+|++|||.|+...    ......++++|+|||++..  ...++.++|+||+|++.
T Consensus       133 li~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~DiwSlG~il  192 (292)
T d1unla_         133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIF  192 (292)
T ss_dssp             EECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT--CSCCCTHHHHHHHHHHH
T ss_pred             ccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhcc--CCCCCchhhccccchHH
Confidence            99999999999999997532    2233568889999999842  34578999999999984

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=9.5e-26  Score=241.76  Aligned_cols=135  Identities=23%  Similarity=0.448  Sum_probs=116.2

Q ss_pred             HHHHHhcCCCCeeeEeEEEEeCCeEEEEEeccC-CCcHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy17952          5 SSLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCL-GSASDIIEVHK---------RPLKEEEIAAICSGVLRGLNYLHSLG   74 (804)
Q Consensus         5 ~~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~-g~l~~~~~~~~---------~~l~~~~~~~~~~qi~~aL~ylH~~~   74 (804)
                      ..+|++++|||||++++++..++..|+|||||. |++.+++...+         ..+++..+..++.|+++||.|||+++
T Consensus        74 ~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~  153 (308)
T d1p4oa_          74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK  153 (308)
T ss_dssp             HHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            467899999999999999999999999999997 55666554321         35799999999999999999999999


Q ss_pred             ccccccccccEEEcCCCceEEeccCcccccC------CCCccccccccCcchhhhhcccCccCCcccccccccC
Q psy17952         75 RIHRDVKAGNILLTETGTVKLADFGSASIKC------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  142 (804)
Q Consensus        75 IiHRDlKp~Nill~~~~~~kl~DFG~a~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~  142 (804)
                      |+||||||+|||++.++++||+|||+|+...      ......||+.|+|||.+.   .+.++.++|+||+|++
T Consensus       154 ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~---~~~~~~~~Dv~S~G~i  224 (308)
T d1p4oa_         154 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVV  224 (308)
T ss_dssp             CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHc---cCCCCcccccccHHHH
Confidence            9999999999999999999999999997532      123347899999999983   4678899999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.91  E-value=1.8e-25  Score=241.26  Aligned_cols=133  Identities=29%  Similarity=0.478  Sum_probs=112.8

Q ss_pred             HHHHhcC-CCCeeeEeEEEEeC--CeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q psy17952          6 SLLRQLK-HPNTIEYRGCYLRD--HTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKA   82 (804)
Q Consensus         6 ~iL~~l~-HpnIV~l~~~~~~~--~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp   82 (804)
                      ++|++++ |||||+++++|...  ..+|+|||||.++.+..+   ...+++..++.++.||+.||+|||++||+||||||
T Consensus        81 ~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp  157 (328)
T d3bqca1          81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP  157 (328)
T ss_dssp             HHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccc
Confidence            5788985 99999999999854  469999999997654432   35799999999999999999999999999999999


Q ss_pred             ccEEEcCCC-ceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         83 GNILLTETG-TVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        83 ~Nill~~~~-~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      +|||++.++ .+||+|||+|+...   .....+||+.|+|||++.+  ...|+.++|+||+|+++
T Consensus       158 ~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~~l  220 (328)
T d3bqca1         158 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCML  220 (328)
T ss_dssp             GGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHHH
T ss_pred             cceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccC--CCCCCcccchhhhhhhh
Confidence            999998765 68999999997532   3345689999999999843  34689999999999983

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5.9e-25  Score=240.11  Aligned_cols=132  Identities=34%  Similarity=0.533  Sum_probs=109.4

Q ss_pred             HHHHhcCCCCeeeEeEEEEe------CCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLR------DHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~------~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .+|++++|||||+++++|..      ...+|+|||||.|++++.+   ...+++..++.++.||+.||+|||++||+|||
T Consensus        68 ~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrD  144 (355)
T d2b1pa1          68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRD  144 (355)
T ss_dssp             HHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhccccccc
Confidence            57789999999999999964      3679999999999887765   35799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCcccccC---CCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIKC---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+|||++.++.+|++|||+++...   .....+||+.|+|||++.   ...++.++|+||+|++.
T Consensus       145 lKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~---~~~~~~~~DiwSlG~~l  208 (355)
T d2b1pa1         145 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIM  208 (355)
T ss_dssp             CCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHT---TCCCCTTHHHHHHHHHH
T ss_pred             CCccccccccccceeeechhhhhccccccccccccccccccChhhhc---CCCCCCCcccccccchH
Confidence            99999999999999999999987532   234468999999999984   45789999999999983

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=5e-25  Score=219.39  Aligned_cols=171  Identities=15%  Similarity=0.061  Sum_probs=119.4

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEeccccccc---------------chhhhhhHHHHHHHHhhcCCCceeEee
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQ---------------CAEKWADILKEIRFLRQLKHPNTIEYR  228 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~---------------~~~~~~~~~~Ei~iL~~L~HpNIV~l~  228 (804)
                      +.+.++||+|+||+||+|++. +|+.||||.++.....               .........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356789999999999999874 6889999976531110               001123345789999999999999877


Q ss_pred             eEEeecCceEEEEeecCCCchhhHHHHHhhhhhhhcccchhhhhhhhhhcccccchhhccCCCCCHHHHHHHHHHHHHHH
Q psy17952        229 GCYLRDHTAWLVMEYCLGSASDIIEVHWIEREFHVEGMGNRLQQLKCFTEHFALFNFEVHKRPLKEEEIAAICSGVLRGL  308 (804)
Q Consensus       229 ~~~~~~~~~~lVmEy~~G~l~dll~~~~~~~~~~~~~~~~~l~~l~~~~~~~~L~~~~~~~~~l~e~~i~~i~~qil~gL  308 (804)
                      ++.    ..+++|||++|...                                        ..+++..+..++.|++.||
T Consensus        81 ~~~----~~~lvme~~~~~~~----------------------------------------~~l~~~~~~~i~~ql~~~l  116 (191)
T d1zara2          81 AWE----GNAVLMELIDAKEL----------------------------------------YRVRVENPDEVLDMILEEV  116 (191)
T ss_dssp             EEE----TTEEEEECCCCEEG----------------------------------------GGCCCSCHHHHHHHHHHHH
T ss_pred             Eec----CCEEEEEeeccccc----------------------------------------cchhhHHHHHHHHHHHHHH
Confidence            653    24799999987421                                        0133445678999999999


Q ss_pred             HHHHHCCCeecCCCCCCeeecCCCcEEEEecccccccCCCCccccCcccccc--hhhcccCCCCCCCcccHHHHHHHH
Q psy17952        309 NYLHSLGRIHRDVKAGNILLTETGTVKLADFGSASIKCPANSFVGTPYWMAP--EVILAMDEGQYDGKVDVWSLGITC  384 (804)
Q Consensus       309 ~yLH~~gIiHRDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~GT~~Y~AP--Evl~~~~~~~y~~ksDIWSlGvil  384 (804)
                      .|||++||+||||||+|||++++ .++|+|||+|........    ..|...  +.+...-...|+.++|+||+.--+
T Consensus       117 ~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~----~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         117 AKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW----REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             HHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH----HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             HHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCc----HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999999999999999999965 489999999865432221    112211  111000024578899999986443

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.8e-24  Score=233.55  Aligned_cols=134  Identities=29%  Similarity=0.544  Sum_probs=107.5

Q ss_pred             HHHHhcCCCCeeeEeEEEEeC-----CeEEEEEeccC-CCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRD-----HTAWLVMEYCL-GSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRD   79 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~-----~~~~lV~Ey~~-g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRD   79 (804)
                      .+|++|+|||||+++++|...     ...+++|||+. |+|.+++.  ..++++..++.++.||+.||+|||++||+|||
T Consensus        69 ~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrD  146 (348)
T d2gfsa1          69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRD  146 (348)
T ss_dssp             HHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence            688999999999999998643     23345555555 55666553  45799999999999999999999999999999


Q ss_pred             cccccEEEcCCCceEEeccCccccc-CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         80 VKAGNILLTETGTVKLADFGSASIK-CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        80 lKp~Nill~~~~~~kl~DFG~a~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |||+|||++.+|.+|++|||+|... .......||+.|+|||++.  ....++.++|+||+|++.
T Consensus       147 iKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~--~~~~~~~~~DiwSlGv~l  209 (348)
T d2gfsa1         147 LKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIM  209 (348)
T ss_dssp             CCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHT--TCSCCCTTHHHHHHHHHH
T ss_pred             cCCccccccccccccccccchhcccCcccccccccccccCchhhc--CCccCCcccchhhhhHHH
Confidence            9999999999999999999999753 3344578999999999874  234578899999999983

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.78  E-value=4.4e-20  Score=200.78  Aligned_cols=129  Identities=23%  Similarity=0.372  Sum_probs=104.2

Q ss_pred             CCCCeeeEeEEEEe--CCeEEEEEeccCC--CcHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCccccccccccE
Q psy17952         12 KHPNTIEYRGCYLR--DHTAWLVMEYCLG--SASDII-EVHKRPLKEEEIAAICSGVLRGLNYLHS-LGRIHRDVKAGNI   85 (804)
Q Consensus        12 ~HpnIV~l~~~~~~--~~~~~lV~Ey~~g--~l~~~~-~~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~Ni   85 (804)
                      .|||||++++++..  ....++||+++..  +..... ......+++..++.++.||++||+|||+ +||+||||||+||
T Consensus        78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI  157 (362)
T d1q8ya_          78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV  157 (362)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred             CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence            46899999998764  4567788887753  222322 2334679999999999999999999998 8999999999999


Q ss_pred             EEcCCC------ceEEeccCccccc-CCCCccccccccCcchhhhhcccCccCCcccccccccCC
Q psy17952         86 LLTETG------TVKLADFGSASIK-CPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITP  143 (804)
Q Consensus        86 ll~~~~------~~kl~DFG~a~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~vDvwslG~~~  143 (804)
                      |++.++      .+|++|||.|... ......+||+.|+|||++.   ...|+.++|+||+|+++
T Consensus       158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il  219 (362)
T d1q8ya_         158 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTACLI  219 (362)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH---TCCCCTHHHHHHHHHHH
T ss_pred             eeeccCcccccceeeEeecccccccccccccccccccccChhhcc---ccCCCccccccchHHHH
Confidence            998765      3899999998753 3445678999999999984   45689999999999983

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.52  E-value=9.7e-16  Score=151.36  Aligned_cols=119  Identities=16%  Similarity=0.123  Sum_probs=85.3

Q ss_pred             HHHHhcCCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCccccccccccE
Q psy17952          6 SLLRQLKHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHSLGRIHRDVKAGNI   85 (804)
Q Consensus         6 ~iL~~l~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~Ni   85 (804)
                      ..|.++.|+|++..+++..    .+|||||+.+....       .++......++.|++.||+|||++||+||||||+||
T Consensus        66 ~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NI  134 (191)
T d1zara2          66 RALQKLQGLAVPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV  134 (191)
T ss_dssp             HHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred             HHHHHccCCCcceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhhe
Confidence            4678899999999887532    27999999876432       245566778999999999999999999999999999


Q ss_pred             EEcCCCceEEeccCcccccCCCCccccccccCcc--hhhhhcccCccCCcccccccc
Q psy17952         86 LLTETGTVKLADFGSASIKCPANSFVGTPYWMAP--EVILAMDEGQYDGKVDVWSLG  140 (804)
Q Consensus        86 ll~~~~~~kl~DFG~a~~~~~~~~~~gt~~y~AP--E~l~~~~~~~~~~~vDvwslG  140 (804)
                      |+++++ ++|+|||.|.......    ...|...  +.+...-...|+..+|+||..
T Consensus       135 Lv~~~~-~~liDFG~a~~~~~~~----~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~  186 (191)
T d1zara2         135 LVSEEG-IWIIDFPQSVEVGEEG----WREILERDVRNIITYFSRTYRTEKDINSAI  186 (191)
T ss_dssp             EEETTE-EEECCCTTCEETTSTT----HHHHHHHHHHHHHHHHHHHHCCCCCHHHHH
T ss_pred             eeeCCC-EEEEECCCcccCCCCC----cHHHHHHHHHHHHHHHcCCCCCcccHHHHH
Confidence            999755 8899999986432211    1122221  111000024688899999963

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.78  E-value=4.9e-05  Score=76.20  Aligned_cols=80  Identities=15%  Similarity=0.004  Sum_probs=52.4

Q ss_pred             cccccccccccccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcC-CCceeEeeeEEeecCceEEEEe
Q psy17952        164 FEDLREIGHGSFGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLK-HPNTIEYRGCYLRDHTAWLVME  242 (804)
Q Consensus       164 y~~l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~~~~~~lVmE  242 (804)
                      |+..+..+-++.+.||+..  ..++.+.+|......   ......+.+|...++.|. +--+.+++.+...++..|+||+
T Consensus        16 ~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~---~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY---KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG---TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc---ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            4555555555567899764  455667888764322   122345678988888774 3224556677777888999999


Q ss_pred             ecCCCc
Q psy17952        243 YCLGSA  248 (804)
Q Consensus       243 y~~G~l  248 (804)
                      +++|..
T Consensus        91 ~l~G~~   96 (263)
T d1j7la_          91 EADGVL   96 (263)
T ss_dssp             CCSSEE
T ss_pred             eccccc
Confidence            998853

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.53  E-value=7e-05  Score=80.50  Aligned_cols=79  Identities=19%  Similarity=0.039  Sum_probs=48.8

Q ss_pred             ccccccccccceEEEEeeeceeEEEEEecccc----cccchhhhhhHHHHHHHHhhcC-C--CceeEeeeEEeecCceEE
Q psy17952        167 LREIGHGSFGAVYYARCLVSREIVAIKKMSYL----GKQCAEKWADILKEIRFLRQLK-H--PNTIEYRGCYLRDHTAWL  239 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~~~~~~vAIK~i~~~----~~~~~~~~~~~~~Ei~iL~~L~-H--pNIV~l~~~~~~~~~~~l  239 (804)
                      .+.||.|....||++....+++.|+||.-...    +..-.....+..+|...|+.+. +  ..+.+++.  .+....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence            45789999999999988778889999964321    1111112344567888887663 2  23444443  35566789


Q ss_pred             EEeecCCC
Q psy17952        240 VMEYCLGS  247 (804)
Q Consensus       240 VmEy~~G~  247 (804)
                      |||++.|.
T Consensus       109 vmE~L~~~  116 (392)
T d2pula1         109 VMEDLSHL  116 (392)
T ss_dssp             EECCCTTS
T ss_pred             EEeccCCc
Confidence            99999763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.11  E-value=0.00055  Score=67.80  Aligned_cols=71  Identities=15%  Similarity=0.135  Sum_probs=46.9

Q ss_pred             ccccc-ccceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCc--eeEeeeEEeecCceEEEEeecCC
Q psy17952        170 IGHGS-FGAVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPN--TIEYRGCYLRDHTAWLVMEYCLG  246 (804)
Q Consensus       170 LG~G~-fG~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~~~~~~~~~~~lVmEy~~G  246 (804)
                      +..|. -+.||+... ..+..+.+|.-...      ....+.+|...|+.|....  +.+++.+..+++..|+||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            44444 357887653 34556788864321      2245678888888775433  45567777788889999999987


Q ss_pred             C
Q psy17952        247 S  247 (804)
Q Consensus       247 ~  247 (804)
                      .
T Consensus        91 ~   91 (255)
T d1nd4a_          91 Q   91 (255)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.10  E-value=0.0045  Score=61.20  Aligned_cols=93  Identities=17%  Similarity=0.098  Sum_probs=60.2

Q ss_pred             HHHHhc-CCCCeeeEeEEEEeCCeEEEEEeccCCCcHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------
Q psy17952          6 SLLRQL-KHPNTIEYRGCYLRDHTAWLVMEYCLGSASDIIEVHKRPLKEEEIAAICSGVLRGLNYLHS------------   72 (804)
Q Consensus         6 ~iL~~l-~HpnIV~l~~~~~~~~~~~lV~Ey~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~aL~ylH~------------   72 (804)
                      .+|+.| .+--+.+++++...++..|+||++++|....-..     .+......++.++.+.|..||+            
T Consensus        61 ~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~  135 (263)
T d1j7la_          61 DMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSL  135 (263)
T ss_dssp             HHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT-----TTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCH
T ss_pred             HHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc-----cccccHHHHHHHHHHHHHHHhccCccccccCcch
Confidence            344444 2434667788888888999999999986542111     1111222334444444444442            


Q ss_pred             -----------------------------------------------cCccccccccccEEEcCCCceEEeccCcccc
Q psy17952         73 -----------------------------------------------LGRIHRDVKAGNILLTETGTVKLADFGSASI  103 (804)
Q Consensus        73 -----------------------------------------------~~IiHRDlKp~Nill~~~~~~kl~DFG~a~~  103 (804)
                                                                     ..++|+|+.|.|||+++++..-|.||+.+..
T Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         136 DSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                                           1268999999999999766667999998864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.65  E-value=0.009  Score=61.59  Aligned_cols=67  Identities=18%  Similarity=0.114  Sum_probs=41.7

Q ss_pred             ceEEEEeeeceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCce-----eEee--eEEeecCceEEEEeecCCCc
Q psy17952        177 AVYYARCLVSREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNT-----IEYR--GCYLRDHTAWLVMEYCLGSA  248 (804)
Q Consensus       177 ~Vy~a~~~~~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-----V~l~--~~~~~~~~~~lVmEy~~G~l  248 (804)
                      .||++.. .+|+.|++|.-+...    ...+++..|...|..|....|     +..-  ..+...+..+.+++++.|..
T Consensus        37 ~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          37 RVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             EEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             eeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            6888754 567889999765321    123457788888887753222     1111  12345667889999998843

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=94.73  E-value=0.015  Score=56.99  Aligned_cols=29  Identities=21%  Similarity=0.257  Sum_probs=25.2

Q ss_pred             ccccccccccEEEcCCCceEEeccCcccc
Q psy17952         75 RIHRDVKAGNILLTETGTVKLADFGSASI  103 (804)
Q Consensus        75 IiHRDlKp~Nill~~~~~~kl~DFG~a~~  103 (804)
                      ++|+|+.|.|||+++++.+-|.||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            69999999999999876677999987754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.32  E-value=0.049  Score=57.33  Aligned_cols=72  Identities=13%  Similarity=0.114  Sum_probs=44.3

Q ss_pred             ccccccccccceEEEEeee-------ceeEEEEEecccccccchhhhhhHHHHHHHHhhcCCCcee-EeeeEEeecCceE
Q psy17952        167 LREIGHGSFGAVYYARCLV-------SREIVAIKKMSYLGKQCAEKWADILKEIRFLRQLKHPNTI-EYRGCYLRDHTAW  238 (804)
Q Consensus       167 l~~LG~G~fG~Vy~a~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV-~l~~~~~~~~~~~  238 (804)
                      ++.|+.|---.+|++....       ..+.|.++....  ..   ......+|..+++.+.-.+++ ++++++.+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cc---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            3567777778889886542       234455554321  11   123456899998888533443 56666642    6


Q ss_pred             EEEeecCCC
Q psy17952        239 LVMEYCLGS  247 (804)
Q Consensus       239 lVmEy~~G~  247 (804)
                      +||||+.|.
T Consensus       118 ~I~efi~g~  126 (395)
T d1nw1a_         118 RLEEYIPSR  126 (395)
T ss_dssp             EEECCCCEE
T ss_pred             eEEEEeccc
Confidence            899999873

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=90.27  E-value=0.11  Score=54.56  Aligned_cols=26  Identities=31%  Similarity=0.479  Sum_probs=20.4

Q ss_pred             CccccCCCCCceEEcCCCceeecCccc
Q psy17952        659 GRIHRDVKAGNILLTETGTVKLDTPDE  685 (804)
Q Consensus       659 ~ivHrDlkp~NiLl~~~~~~k~~~~~~  685 (804)
                      ..+|+|+.|.|||++.++ .+|-|++.
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~  249 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEF  249 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTT
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhh
Confidence            579999999999998776 45555544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=87.15  E-value=0.07  Score=53.93  Aligned_cols=31  Identities=29%  Similarity=0.306  Sum_probs=27.3

Q ss_pred             CCCeecCCCCCCeeecCCCcEEEEecccccc
Q psy17952        314 LGRIHRDVKAGNILLTETGTVKLADFGSASI  344 (804)
Q Consensus       314 ~gIiHRDLKP~NILl~~~g~vKL~DFGla~~  344 (804)
                      .|+||+|+.+.||+++.+...-|+||+.|..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4799999999999999887778999998753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=82.79  E-value=0.17  Score=50.79  Aligned_cols=30  Identities=30%  Similarity=0.347  Sum_probs=26.7

Q ss_pred             cCccccccccccEEEcCCCceEEeccCccc
Q psy17952         73 LGRIHRDVKAGNILLTETGTVKLADFGSAS  102 (804)
Q Consensus        73 ~~IiHRDlKp~Nill~~~~~~kl~DFG~a~  102 (804)
                      .++||.|+.+.||++++++..-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999874